Citrus Sinensis ID: 047954
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 582 | 2.2.26 [Sep-21-2011] | |||||||
| O48788 | 658 | Probable inactive recepto | yes | no | 0.920 | 0.814 | 0.351 | 6e-81 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.900 | 0.8 | 0.345 | 1e-79 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.905 | 0.805 | 0.338 | 6e-78 | |
| C0LGR9 | 676 | Probable LRR receptor-lik | no | no | 0.881 | 0.758 | 0.332 | 2e-77 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.891 | 0.810 | 0.333 | 8e-76 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.903 | 0.812 | 0.342 | 1e-75 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.905 | 0.823 | 0.336 | 2e-74 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.895 | 0.777 | 0.342 | 2e-73 | |
| Q9M8T0 | 627 | Probable inactive recepto | no | no | 0.893 | 0.829 | 0.339 | 2e-71 | |
| Q84MA9 | 652 | Inactive leucine-rich rep | no | no | 0.890 | 0.794 | 0.344 | 3e-71 |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 301 bits (772), Expect = 6e-81, Method: Compositional matrix adjust.
Identities = 208/591 (35%), Positives = 303/591 (51%), Gaps = 55/591 (9%)
Query: 6 DFPSQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNF-MN 64
D W G++C+ N + + + L L G+I S + + EL V++ ++N +SG +
Sbjct: 51 DSACNWVGVECNSNQSSIHSLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSD 110
Query: 65 FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVP-------------- 110
FS+ L+ + L N+F GE S L L L + +NN TG +P
Sbjct: 111 FSNLTHLRSLYLQHNEFSGEFPTSFTQLNNLIRLDISSNNFTGSIPFSVNNLTHLTGLFL 170
Query: 111 -----EFNQSSLKV----FNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCS 161
N S+ + FNVSNNNL+GSIP + L F + S++ N LCG P L C
Sbjct: 171 GNNGFSGNLPSISLGLVDFNVSNNNLNGSIPSS--LSRFSAESFTGNVDLCGGP-LKPCK 227
Query: 162 STGNYVTNSDDKG----SNDLKIFYFLLAALCIVTVLMLFIFYLTKRTRKPNIMIKKQ-- 215
S +V+ S SN L L+ IV +++ + ++
Sbjct: 228 SF--FVSPSPSPSLINPSNRLSSKKSKLSKAAIVAIIVASALVALLLLALLLFLCLRKRR 285
Query: 216 ---EEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGE--------DRNLVFIEDEQPAGFK 264
E Q K +G + G K V G +RN + + F
Sbjct: 286 GSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVYSFD 345
Query: 265 LNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHP 324
L DLL+A AE LGKG G SYKA+LE VVVKRL+D+ +EF Q+ V+ KHP
Sbjct: 346 LEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVM-ASKKEFETQMEVVGKIKHP 404
Query: 325 NLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALE 384
N++PL AYY+S DEKLLV+ F G+L +HG + S R P +R+ +A AR L
Sbjct: 405 NVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGS-GRTPLDWDNRMRIAITAARGLA 463
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEY 444
+LH K ++HGN+K++NILL N+ VSDYG + L + R+ Y +PE
Sbjct: 464 HLHVSAK------LVHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLAGYHAPEV 517
Query: 445 QSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504
++K++ KSDV+SFG LLLELLTG+ S + A G G DL WVL VREEWTAE+FD
Sbjct: 518 LETRKVTFKSDVYSFGVLLLELLTGK-SPNQASLGEEGIDLPRWVLSVVREEWTAEVFDV 576
Query: 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEE 555
E+ + M++LLQ+A+ C + P++RP M EV+ +E + +E+T++
Sbjct: 577 ELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNRSETTDD 627
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 297 bits (761), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 207/600 (34%), Positives = 317/600 (52%), Gaps = 76/600 (12%)
Query: 8 PSQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNF-MNFS 66
P W G++C+ N VT + L + L+G+I F ++ +L ++ + N +SG+ + S
Sbjct: 61 PCNWAGVKCESN--RVTALRLPGVALSGDIPEGIFGNLTQLRTLSLRLNALSGSLPKDLS 118
Query: 67 SNHKLKDIDLSGNKFYGEISRSLLSLKFL------------------------ESLQLQN 102
++ L+ + L GN+F GEI L SL L ++L L+N
Sbjct: 119 TSSNLRHLYLQGNRFSGEIPEVLFSLSHLVRLNLASNSFTGEISSGFTNLTKLKTLFLEN 178
Query: 103 NNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNC-- 160
N L+G +P+ + L FNVSNN+L+GSIPK LQ F S S+ LCG P L C
Sbjct: 179 NQLSGSIPDLDLP-LVQFNVSNNSLNGSIPKN--LQRFESDSFLQT-SLCGKP-LKLCPD 233
Query: 161 --------SSTGNY----VTNSDDKGSNDLKIFYFLLAAL---CIVTVLMLFIFYLT--- 202
+S GN V S++K + K+ +A + C+V ++ + +
Sbjct: 234 EETVPSQPTSGGNRTPPSVEGSEEKKKKN-KLSGGAIAGIVIGCVVGFALIVLILMVLCR 292
Query: 203 ----KRTRKPNI-MIKKQEEYMDQEKESGDD-------EEEEEEKIGKGKRKLVVAGEDR 250
KR+R +I IK+QE + +KE+ D+ G GK +
Sbjct: 293 KKSNKRSRAVDISTIKQQEPEIPGDKEAVDNGNVYSVSAAAAAAMTGNGKASEGNGPATK 352
Query: 251 NLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEE 310
LVF + F L DLL+A AE LGKG FG +YKA+L+ V VKRL+D+ + +E
Sbjct: 353 KLVFFGNATKV-FDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDVM-MADKE 410
Query: 311 FRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCR 370
F++++ ++ H NL+PL AYYFS DEKLLVY F G+L +HG + + R P
Sbjct: 411 FKEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGA-GRSPLNWD 469
Query: 371 SRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430
R +A G AR L+YLH + S + HGN+KS+NILL + VSD+G + LV
Sbjct: 470 VRSRIAIGAARGLDYLHSQGTSTS-----HGNIKSSNILLTKSHDAKVSDFGLAQLVGSS 524
Query: 431 IA-AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWV 489
R Y++PE K++S+K DV+SFG +LLEL+TG+ ++S G DL WV
Sbjct: 525 ATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSNSV-MNEEGVDLPRWV 583
Query: 490 LRAVREEWTAEIFDSE-ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548
R+EW E+FDSE +S+ M +++Q+ ++C ++ P++RPEM+EVV ++E ++
Sbjct: 584 KSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLR 643
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (747), Expect = 6e-78, Method: Compositional matrix adjust.
Identities = 194/573 (33%), Positives = 298/573 (52%), Gaps = 46/573 (8%)
Query: 11 WYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM------- 63
W G+ C + V + L + L G I + + L +++ ++N++SGN
Sbjct: 77 WVGVTCTSDGTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLP 136
Query: 64 ----------NFSS------NHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTG 107
NFS + +L +DLS N F G+I + +LK L L LQNN L+G
Sbjct: 137 SLDYIYLQHNNFSGEVPSFVSRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSG 196
Query: 108 PVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCSSTGNYV 167
PVP + SL+ N+SNN+L+GSIP L F S S+S N LCG P L C+++
Sbjct: 197 PVPNLDTVSLRRLNLSNNHLNGSIP--SALGGFPSSSFSGNTLLCGLP-LQPCATSSPPP 253
Query: 168 TNSDDKGSNDLKIFYF-------LLAALCIVTVLMLFIFYLTKRTRKPNIMIKKQEEYMD 220
+ + + L F L + I L IKK+++ D
Sbjct: 254 SLTPHISTPPLPPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKRED 313
Query: 221 QEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGI 280
+ E+ +++ G G V E LVF F L DLL+A AE LGKG
Sbjct: 314 SIVKVKTLTEKAKQEFGSG----VQEPEKNKLVFFNGCS-YNFDLEDLLRASAEVLGKGS 368
Query: 281 FGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIAD-QKHPNLLPLLAYYFSNDEK 339
+G +YKA+LE VVVKRL+++ EF +Q+ +I+ HP+++PL AYY+S DEK
Sbjct: 369 YGTAYKAVLEESTTVVVKRLKEVA-AGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEK 427
Query: 340 LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVI 399
L+V + GNL + +HG + S+ + P SR+ + A+ + +LH +
Sbjct: 428 LMVCDYYPAGNLSSLLHGNRGSE-KTPLDWDSRVKITLSAAKGIAHLHAAGGPKFS---- 482
Query: 400 HGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSF 459
HGN+KS+N+++ +SD+G + L+A PIA R Y++PE ++K + KSDV+SF
Sbjct: 483 HGNIKSSNVIMKQESDACISDFGLTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSF 542
Query: 460 GCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKL 519
G L+LE+LTG+ S P + DL WV VREEWT+E+FD E+ ++ M+++
Sbjct: 543 GVLILEMLTGKSPVQS-PSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQM 601
Query: 520 LQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552
LQ+A+ C + PE RP M +VV +E I+V++S
Sbjct: 602 LQIAMACVAQVPEVRPTMDDVVRMIEEIRVSDS 634
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGR9|Y4312_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g31250 OS=Arabidopsis thaliana GN=At4g31250 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 290 bits (743), Expect = 2e-77, Method: Compositional matrix adjust.
Identities = 199/599 (33%), Positives = 290/599 (48%), Gaps = 86/599 (14%)
Query: 9 SQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN---- 64
S+W G+ C ++ V + LE+M L+GE+ A I L I+F N G
Sbjct: 64 SKWKGVMC--SNGSVFALRLENMSLSGELDVQALGSIRGLKSISFMRNHFEGKIPRGIDG 121
Query: 65 ----------------------FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQN 102
FS L + L GN+F GEI SL L L L L++
Sbjct: 122 LVSLAHLYLAHNQFTGEIDGDLFSGMKALLKVHLEGNRFSGEIPESLGKLPKLTELNLED 181
Query: 103 NNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCSS 162
N TG +P F Q +L NV+NN L G IP TL L +S N LCG P L +
Sbjct: 182 NMFTGKIPAFKQKNLVTVNVANNQLEGRIP--LTLGLMNITFFSGNKGLCGAPLLPCRYT 239
Query: 163 TGNYVTNSDDKGSNDLKIFYFLLAALCIVTVLMLF--IFYLTKRTRKPNIMIKKQ----- 215
+ T +F L L +V ++ +F + L++R K I+
Sbjct: 240 RPPFFT-----------VFLLALTILAVVVLITVFLSVCILSRRQGKGQDQIQNHGVGHF 288
Query: 216 --EEYMDQEKESGDDEEEEEEKIGKGKRKLV-------------------------VAGE 248
+ Y E++ ++ ++ K+ RKL G+
Sbjct: 289 HGQVYGQPEQQQHSEKSSQDSKV---YRKLANETVQRDSTATSGAISVGGLSPDEDKRGD 345
Query: 249 DRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLIT 308
R L F+ ++Q F L D+L+A AE LG G FG+SYKA L VVVKR R + +
Sbjct: 346 QRKLHFVRNDQER-FTLQDMLRASAEVLGSGGFGSSYKAALSSGRAVVVKRFRFMSNIGR 404
Query: 309 EEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFR 368
EEF + I HPNLLPL+A+Y+ +EKLLV + NG+L N +H ++ ++
Sbjct: 405 EEFYDHMKKIGRLSHPNLLPLIAFYYRKEEKLLVTNYISNGSLANLLHANRTP-GQVVLD 463
Query: 369 CRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428
RL + RGV R L YL+ + + HG+LKS+N+LLD N L++DY +V
Sbjct: 464 WPIRLKIVRGVTRGLAYLY---RVFPDLNLPHGHLKSSNVLLDPNFEPLLTDYALVPVVN 520
Query: 429 QPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD--LC 486
+ + Q M++YK+PE+ + SR+SDVWS G L+LE+LTG+ + QG GAD L
Sbjct: 521 RDQSQQFMVAYKAPEFTQQDRTSRRSDVWSLGILILEILTGKFPANYLRQG-KGADDELA 579
Query: 487 SWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+WV R EWTA++FD E+ + MLKLL++ ++CC+ EKR E+ E V +E
Sbjct: 580 AWVESVARTEWTADVFDKEMKAGKEHEAQMLKLLKIGLRCCDWDIEKRIELHEAVDRIE 638
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (728), Expect = 8e-76, Method: Compositional matrix adjust.
Identities = 198/594 (33%), Positives = 304/594 (51%), Gaps = 75/594 (12%)
Query: 9 SQWYGIQCDIN--SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM--- 63
S W GI CD + ++ V + L + L G I + L V++ ++N + G
Sbjct: 59 SSWIGITCDESNPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDI 118
Query: 64 --------------NFSS----------NHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99
NFS + +L +DLS N G I L +L + L
Sbjct: 119 LSLPSLEYLYLQHNNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLY 178
Query: 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNN 159
LQNN+ GP+ + S+KV N+S NNLSG IP + L+ YS+ N LCGPP LN
Sbjct: 179 LQNNSFDGPIDSLDLPSVKVVNLSYNNLSGPIP--EHLKKSPEYSFIGNSLLCGPP-LNA 235
Query: 160 CSSTGNYVTNSDDKG---SNDL--------KIFYFLLAALCIVTVLMLFIFYLTKRTRKP 208
CS G ++ S + + +L K + + C V VL L I +L +K
Sbjct: 236 CS--GGAISPSSNLPRPLTENLHPVRRRQSKAYIIAIVVGCSVAVLFLGIVFLVCLVKK- 292
Query: 209 NIMIKKQEEYMDQ--EKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLN 266
K+EE + + G ++ + G G V ++N +F + F L
Sbjct: 293 ----TKKEEGGGEGVRTQMGGVNSKKPQDFGSG-----VQDPEKNKLFFFERCNHNFDLE 343
Query: 267 DLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIAD-QKHPN 325
DLLKA AE LGKG FG +YKA+LE VVVKRLR++ +EF +Q+ ++ +H N
Sbjct: 344 DLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREVVA-SKKEFEQQMEIVGKINQHSN 402
Query: 326 LLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
+PLLAYY+S DEKLLVYK+ G+LF +HG + + +R+ +A G ++A+ Y
Sbjct: 403 FVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGNRGDRG---VDWETRMKIATGTSKAISY 459
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQ 445
LH +HG++KS+NILL ++ +SD +L P R I Y +PE
Sbjct: 460 LHSLK-------FVHGDIKSSNILLTEDLEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVI 512
Query: 446 SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGING----ADLCSWVLRAVREEWTAEI 501
++++S++SDV+SFG ++LE+LTG+ T G+ DL WV VREEWTAE+
Sbjct: 513 ETRRVSQRSDVYSFGVVILEMLTGK--TPLTQPGLEDERVVIDLPRWVRSVVREEWTAEV 570
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEE 555
FD E+ ++ M+++LQ+A+ C ++PE RP+M EV +E ++ + +++
Sbjct: 571 FDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMIEDVRRLDQSQQ 624
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 284 bits (727), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 204/596 (34%), Positives = 298/596 (50%), Gaps = 70/596 (11%)
Query: 8 PSQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNF-MNFS 66
P W G+ CD VT + L L+G I F ++ +L ++ + N ++G+ ++
Sbjct: 59 PCNWTGVLCD--GGRVTALRLPGETLSGHIPEGIFGNLTQLRTLSLRLNGLTGSLPLDLG 116
Query: 67 SNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKV----- 119
S L+ + L GN+F GEI L SL L L L N +G + N + LK
Sbjct: 117 SCSDLRRLYLQGNRFSGEIPEVLFSLSNLVRLNLAENEFSGEISSGFKNLTRLKTLYLEN 176
Query: 120 ----------------FNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCSST 163
FNVSNN L+GSIPK+ LQ F S S+ LCG P L CS+
Sbjct: 177 NKLSGSLLDLDLSLDQFNVSNNLLNGSIPKS--LQKFDSDSFVGTS-LCGKP-LVVCSNE 232
Query: 164 GNY-------------VTNSDDK-------GSNDLKIFYFLLAALCIVTVLMLFIFYL-- 201
G V S++K G I + L ++ ++++ +F
Sbjct: 233 GTVPSQPISVGNIPGTVEGSEEKKKRKKLSGGAIAGIVIGCVVGLSLIVMILMVLFRKKG 292
Query: 202 TKRTRKPNIMIKKQEEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGED-----RNLVFIE 256
+RTR ++ K E +++ + E + + V A E + LVF
Sbjct: 293 NERTRAIDLATIKHHEVEIPGEKAAVEAPENRSYVNEYSPSAVKAVEVNSSGMKKLVFFG 352
Query: 257 DEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLL 316
+ F L DLL+A AE LGKG FG +YKA+L+ V VKRL+D+ + EF++++
Sbjct: 353 NATKV-FDLEDLLRASAEVLGKGTFGTAYKAVLDAVTLVAVKRLKDVT-MADREFKEKIE 410
Query: 317 VIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVA 376
V+ H NL+PL AYY+S DEKLLVY F G+L +HG K + R P R +A
Sbjct: 411 VVGAMDHENLVPLRAYYYSGDEKLLVYDFMPMGSLSALLHGNKGA-GRPPLNWEVRSGIA 469
Query: 377 RGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV-AQPIAAQR 435
G AR L+YLH +D + HGN+KS+NILL ++ VSD+G + LV A R
Sbjct: 470 LGAARGLDYLHSQDPLSS-----HGNVKSSNILLTNSHDARVSDFGLAQLVSASSTTPNR 524
Query: 436 MISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE 495
Y++PE +++S+K+DV+SFG +LLELLTG+ ++S G DL WV RE
Sbjct: 525 ATGYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNSV-MNEEGMDLARWVHSVARE 583
Query: 496 EWTAEIFDSE---ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548
EW E+FDSE I S M ++LQ+ I C + P+KRP M EVV ++ ++
Sbjct: 584 EWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELR 639
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 280 bits (717), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 196/582 (33%), Positives = 291/582 (50%), Gaps = 55/582 (9%)
Query: 9 SQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM----- 63
+ W GI C N+A VT + L L G + F + L +I+ ++N + GN
Sbjct: 55 ASWTGITCSKNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILS 114
Query: 64 ------------NFSS------NHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNL 105
NFS +H+L ++DLS N G I SL +L L L LQNN+L
Sbjct: 115 LPFIRSLYFHENNFSGTIPPVLSHRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSL 174
Query: 106 TGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCSSTGN 165
+GP+P LK N+S NNL+GS+P +++ F + S+ N LCG P L C
Sbjct: 175 SGPIPNL-PPRLKYLNLSFNNLNGSVP--SSVKSFPASSFQGNSLLCGAP-LTPCPENTT 230
Query: 166 YVTNSD------------DKGSNDLKIFYFLLAALCIVTVLMLFIFYLTKRTRKPNIMIK 213
+ S +G+ + + + + ++LFI
Sbjct: 231 APSPSPTTPTEGPGTTNIGRGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDG 290
Query: 214 KQEEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLNDLLKAPA 273
Q+ + + G + + EE G G V E LVF E F L DLL+A A
Sbjct: 291 GQDSTAVPKAKPGRSDNKAEE-FGSG----VQEAEKNKLVFFEGSS-YNFDLEDLLRASA 344
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIAD-QKHPNLLPLLAY 332
E LGKG +G +YKA+LE VVVKRL+++ EF +Q+ + H N+ PL AY
Sbjct: 345 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVA-AGKREFEQQMEAVGRISPHVNVAPLRAY 403
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
YFS DEKLLVY + GN +H G + R +RL + AR + ++H S
Sbjct: 404 YFSKDEKLLVYDYYQGGNFSMLLH-GNNEGGRAALDWETRLRICLEAARGISHIH----S 458
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA-QPIAAQRMISYKSPEYQSSKKIS 451
+ + ++HGN+KS N+LL V VSD+G + L++ + R + Y++PE ++K +
Sbjct: 459 ASGAKLLHGNIKSPNVLLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHT 518
Query: 452 RKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE-ISVQR 510
+KSDV+SFG LLLE+LTG+ + + DL WV VREEWT E+FD E I Q
Sbjct: 519 QKSDVYSFGVLLLEMLTGKAAGKTTGHE-EVVDLPKWVQSVVREEWTGEVFDVELIKQQH 577
Query: 511 SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552
+ M+++LQ+A+ C +K P+ RP M EVV+ +E I+ + S
Sbjct: 578 NVEEEMVQMLQIAMACVSKHPDSRPSMEEVVNMMEEIRPSGS 619
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (708), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 206/601 (34%), Positives = 293/601 (48%), Gaps = 80/601 (13%)
Query: 8 PSQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSS 67
P QW G+ C+ N VT +VLED+ L G I S V++ K+N +SG N S+
Sbjct: 57 PCQWTGVSCNRN--RVTRLVLEDINLTGSISSLTSLTSLR--VLSLKHNNLSGPIPNLSN 112
Query: 68 NHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVP----------------- 110
LK + LS N+F G S+ SL L L L NN +G +P
Sbjct: 113 LTALKLLFLSNNQFSGNFPTSITSLTRLYRLDLSFNNFSGQIPPDLTDLTHLLTLRLESN 172
Query: 111 -------EFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCSST 163
N S L+ FNVS NN +G IP +L F ++ NP LCG P L C+
Sbjct: 173 RFSGQIPNINLSDLQDFNVSGNNFNGQIP--NSLSQFPESVFTQNPSLCGAPLLK-CTKL 229
Query: 164 GNYVT--------------------------NSDDKGSNDLKIFYFLLAA--------LC 189
+ T + DK +N +I L A L
Sbjct: 230 SSDPTKPGRPDEAKASPLNKPETVPSSPTSIHGGDKSNNTSRISTISLIAIILGDFIILS 289
Query: 190 IVTVLMLFIFYLTKRTRKPNIMIKKQEEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGED 249
V++L+ + F+ R+ + KK + ++ EK + V G+
Sbjct: 290 FVSLLLYYCFW-----RQYAVNKKKHSKILEGEKIVYSSNPYPTSTQNNNNQNQQV-GDK 343
Query: 250 RNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLI-T 308
+VF E + F+L DLL+A AE LGKG FG +YKA+LE V VKRL+D +
Sbjct: 344 GKMVFFEGTRR--FELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGK 401
Query: 309 EEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFR 368
+EF +Q+ V+ +H NL+ L AYYF+ +EKLLVY + NG+LF +HG + R P
Sbjct: 402 KEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRG-PGRTPLD 460
Query: 369 CRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428
+RL +A G AR L ++H K+ + HG++KSTN+LLD + VSD+G S
Sbjct: 461 WTTRLKIAAGAARGLAFIHGSCKTL---KLTHGDIKSTNVLLDRSGNARVSDFGLSIFAP 517
Query: 429 QPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGA-DLCS 487
A+ Y++PE +K ++KSDV+SFG LLLE+LTG+ GA DL
Sbjct: 518 SQTVAKSN-GYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLPR 576
Query: 488 WVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547
WV VREEWTAE+FD E+ + M+ LLQ+A+ C + + RP+M VV +E I
Sbjct: 577 WVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDI 636
Query: 548 K 548
+
Sbjct: 637 R 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (691), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 196/578 (33%), Positives = 301/578 (52%), Gaps = 58/578 (10%)
Query: 8 PSQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNF-MNFS 66
P W+G+ CD + VT + L L G + ++ +L ++ + N +SG +FS
Sbjct: 54 PCNWHGVHCD--AGRVTALRLPGSGLFGSLPIGGIGNLTQLKTLSLRFNSLSGPIPSDFS 111
Query: 67 SNHKLKDIDLSGNKFYGEISRSLLSL-----------KF-------------LESLQLQN 102
+ L+ + L GN F GEI L +L KF L +L L+
Sbjct: 112 NLVLLRYLYLQGNAFSGEIPSLLFTLPSIIRINLGENKFSGRIPDNVNSATRLVTLYLER 171
Query: 103 NNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCSS 162
N L+GP+PE L+ FNVS+N L+GSIP +L + ++ N LCG P L+ C +
Sbjct: 172 NQLSGPIPEITLP-LQQFNVSSNQLNGSIP--SSLSSWPRTAFEGN-TLCGKP-LDTCEA 226
Query: 163 -------TGNYVTNSDDKGSNDLKIFYFLLAAL-CIVTVLMLFIFYLT---KRTRKPNIM 211
G T + K S+ L + + C+V +L+L + KR ++ N+
Sbjct: 227 ESPNGGDAGGPNTPPEKKDSDKLSAGAIVGIVIGCVVGLLLLLLILFCLCRKRKKEENVP 286
Query: 212 IKKQEEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGE-DRNLVFIEDEQPAGFKLNDLLK 270
+ E + S +E + K +G +++L F F L+ LLK
Sbjct: 287 SRNVEAPVAAATSSAAIPKETVVVVPPAKATGSESGAVNKDLTFFVKSF-GEFDLDGLLK 345
Query: 271 APAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLL 330
A AE LGKG G+SYKA E V VKRLRD+ + +EFR++L V+ H NL+ L+
Sbjct: 346 ASAEVLGKGTVGSSYKASFEHGLVVAVKRLRDVV-VPEKEFRERLHVLGSMSHANLVTLI 404
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
AYYFS DEKLLV+++ G+L +HG K + R P +R +A G ARA+ YLH +D
Sbjct: 405 AYYFSRDEKLLVFEYMSKGSLSAILHGNKGN-GRTPLNWETRAGIALGAARAISYLHSRD 463
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKI 450
+ + HGN+KS+NILL D+ VSDYG + +++ A R+ Y++PE ++KI
Sbjct: 464 GTTS-----HGNIKSSNILLSDSYEAKVSDYGLAPIISSTSAPNRIDGYRAPEITDARKI 518
Query: 451 SRKSDVWSFGCLLLELLTGRISTHSAPQGIN--GADLCSWVLRAVREEWTAEIFDSEIS- 507
S+K+DV+SFG L+LELLTG+ TH Q +N G DL WV ++ +++ D E++
Sbjct: 519 SQKADVYSFGVLILELLTGKSPTH---QQLNEEGVDLPRWVQSVTEQQTPSDVLDPELTR 575
Query: 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
Q +++LL++ + C + P+ RP MAEV +E
Sbjct: 576 YQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEVTRLIE 613
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q84MA9|Y1063_ARATH Inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At1g60630 OS=Arabidopsis thaliana GN=At1g60630 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (690), Expect = 3e-71, Method: Compositional matrix adjust.
Identities = 200/580 (34%), Positives = 300/580 (51%), Gaps = 62/580 (10%)
Query: 8 PSQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFS- 66
P W G++ V+ +VLE++ L+G + + + +L V++FK N +SG+ N S
Sbjct: 49 PCNWEGVK-KCMKGRVSKLVLENLNLSGSLNGKSLNQLDQLRVLSFKGNSLSGSIPNLSG 107
Query: 67 -----------------------SNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNN 103
S H+LK + LS N+F G+I SLL L L + +Q+N
Sbjct: 108 LVNLKSLYLNDNNFSGEFPESLTSLHRLKTVVLSRNRFSGKIPSSLLRLSRLYTFYVQDN 167
Query: 104 NLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCSST 163
+G +P NQ++L+ FNVSNN LSG IP TQ L F S+++N LCG N+C+ T
Sbjct: 168 LFSGSIPPLNQATLRFFNVSNNQLSGHIPPTQALNRFNESSFTDNIALCGDQIQNSCNDT 227
Query: 164 GNYVTNSDDKGS-------NDLKIFYFLLAALC----IVTVLMLFIFYLTKRTRKPNIMI 212
+ K + + K+ + ++C I+ + L I L +R R +
Sbjct: 228 TGITSTPSAKPAIPVAKTRSRTKLIGIISGSICGGILILLLTFLLICLLWRRKRSKSKRE 287
Query: 213 KKQEEYMDQEKESGDDEEEEEEKIGKGKR----KLVVAGEDRNLVFI-EDEQPAGFKLND 267
+++ + + + KE+ E EE K KR K G LVF+ D + ++D
Sbjct: 288 ERRSKRVAESKEAKTAETEEGTSDQKNKRFSWEKESEEGSVGTLVFLGRDITVVRYTMDD 347
Query: 268 LLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLL 327
LLKA AE LG+G G++YKA++E + VKRL+D +EF++ + ++ KHPNL+
Sbjct: 348 LLKASAETLGRGTLGSTYKAVMESGFIITVKRLKDAGFPRMDEFKRHIEILGRLKHPNLV 407
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
PL AY+ + +E LLVY + NG+LF+ IHG K S + P S L +A +A L Y+H
Sbjct: 408 PLRAYFQAKEECLLVYDYFPNGSLFSLIHGSKVSGSGKPLHWTSCLKIAEDLAMGLVYIH 467
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL-----VAQPIAAQRMISYKSP 442
+ HGNLKS+N+LL + ++DYG S L + AA + YK+P
Sbjct: 468 Q------NPGLTHGNLKSSNVLLGPDFESCLTDYGLSDLHDPYSIEDTSAAS--LFYKAP 519
Query: 443 EYQSSKKISRK-SDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501
E + +K S + +DV+SFG LLLELLTGR S G+D+ +WV RAVREE T
Sbjct: 520 ECRDLRKASTQPADVYSFGVLLLELLTGRTSFKDLVHKY-GSDISTWV-RAVREEETEVS 577
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVV 541
+ S ++ A LL +A C PE RP M EV+
Sbjct: 578 EELNASEEKLQA-----LLTIATACVAVKPENRPAMREVL 612
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 582 | ||||||
| 449525620 | 782 | PREDICTED: probable inactive receptor ki | 0.955 | 0.710 | 0.548 | 1e-164 | |
| 255578845 | 576 | serine-threonine protein kinase, plant-t | 0.840 | 0.848 | 0.566 | 1e-153 | |
| 224070521 | 343 | predicted protein [Populus trichocarpa] | 0.568 | 0.965 | 0.647 | 1e-120 | |
| 147834640 | 443 | hypothetical protein VITISV_016342 [Viti | 0.687 | 0.902 | 0.548 | 1e-115 | |
| 225447866 | 443 | PREDICTED: probable inactive receptor ki | 0.687 | 0.902 | 0.543 | 1e-114 | |
| 356557547 | 396 | PREDICTED: probable inactive receptor ki | 0.635 | 0.934 | 0.560 | 1e-110 | |
| 357445825 | 422 | Probably inactive leucine-rich repeat re | 0.637 | 0.879 | 0.550 | 1e-110 | |
| 115452837 | 634 | Os03g0332900 [Oryza sativa Japonica Grou | 0.857 | 0.787 | 0.377 | 8e-84 | |
| 359489936 | 633 | PREDICTED: probable leucine-rich repeat | 0.910 | 0.837 | 0.340 | 1e-83 | |
| 356537708 | 664 | PREDICTED: probable inactive receptor ki | 0.895 | 0.784 | 0.349 | 1e-82 |
| >gi|449525620|ref|XP_004169814.1| PREDICTED: probable inactive receptor kinase At2g26730-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1508), Expect = e-164, Method: Compositional matrix adjust.
Identities = 319/582 (54%), Positives = 405/582 (69%), Gaps = 26/582 (4%)
Query: 2 HCFKDFPSQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGN 61
HC + P WYG+QC VT I L+ + L G++ AF EL V++ KNN +SGN
Sbjct: 216 HCHNNQPPLWYGLQCV--DGRVTAISLDSLGLVGKMNFRAFNKFTELSVLSLKNNSLSGN 273
Query: 62 FMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFN 121
+F+SN K+K IDLS N F G I SL+SL LESLQLQNN TG +PEFNQSSL VFN
Sbjct: 274 VFSFTSNQKMKTIDLSFNAFDGSIPVSLVSLTSLESLQLQNNRFTGSIPEFNQSSLAVFN 333
Query: 122 VSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCSST--GNYVTNS---DDKGSN 176
VSNNNL+G IP+T+ LQ F + SY NP LCGPPS C+S G+ T + +K +N
Sbjct: 334 VSNNNLNGFIPRTKVLQSFGAGSYVGNPGLCGPPSDAVCNSIIKGSKATAAPPDTNKATN 393
Query: 177 DLKIFYFLLAALCIVTVLMLFIFYLTKRTRKPNIMIKKQEEYMDQEKESGDDEEEEEEKI 236
D + V++L I + R K I E +++ ES D + ++
Sbjct: 394 D--------NSSSKAHVILLLILVIKHRELKELIKKLGSNETKEKKNESMTDISIQNQQ- 444
Query: 237 GKGKRKLVVAGEDRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVV 296
+ A E L+F E+ + F+L DLLKA AEGLGKGIFGNSYKA+LEGR+P+V
Sbjct: 445 ---PAEAAAADEGGKLIFTEEGE--NFQLGDLLKASAEGLGKGIFGNSYKAMLEGRSPIV 499
Query: 297 VKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIH 356
VKRLRDLKPL +EF KQ+ +IA +HPNLLPL+AY+++ +EKLL+YK+A GNLF+RIH
Sbjct: 500 VKRLRDLKPLTVDEFMKQVQLIAKLRHPNLLPLVAYFYTKEEKLLLYKYAEKGNLFDRIH 559
Query: 357 GGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMV 416
G + R+PFR SRL+VA+GVARALE+LH K T + V HGNLKS+N+LL +N+ V
Sbjct: 560 G-RRGVGRVPFRWSSRLIVAQGVARALEFLHLNSKPNTIN-VPHGNLKSSNVLLGENDEV 617
Query: 417 LVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSA 476
LVSDYGF+SL+A PIAAQ M+SY+SPEYQ K++SRKSDVWSFGCLL+ELLTG+IS+HSA
Sbjct: 618 LVSDYGFASLIALPIAAQCMVSYRSPEYQQMKRVSRKSDVWSFGCLLIELLTGKISSHSA 677
Query: 477 PQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE 536
P+ +G DLC+WV RAVREEWTAEIFDSEI+ QRSA GML LLQ+AI C N SP+KRPE
Sbjct: 678 PEESHGIDLCAWVNRAVREEWTAEIFDSEIASQRSAIPGMLNLLQIAIHCSNVSPDKRPE 737
Query: 537 MAEVVSELEIIKVTESTEEEEDFWLDQSLTDESLSISTVASA 578
M+EV E+E IK+ E+ EE + D+SLTD+S+ STV S
Sbjct: 738 MSEVAKEIENIKLIENGEEYSSSF-DRSLTDDSM--STVGSG 776
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578845|ref|XP_002530277.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530209|gb|EEF32117.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1412), Expect = e-153, Method: Compositional matrix adjust.
Identities = 293/517 (56%), Positives = 366/517 (70%), Gaps = 28/517 (5%)
Query: 80 KFYGEI-SRSLLSLKFLESLQLQNNNLTG-PVPEFNQSSLKVFNVSNNNLSGSIPKTQTL 137
++YG I + +S FLE + L +++ +PEFNQSSL+VF+VSNNNL G IPKT L
Sbjct: 58 QWYGIICANGKVSGIFLEDMGLTASDIPDRSIPEFNQSSLRVFDVSNNNLQGEIPKTPIL 117
Query: 138 QLFRSYSYSNNPYLCGPPS------LNNCSSTGNYVTNSDDKGS----NDLKIFYFLLAA 187
Q F YS+N LCGPP+ LN+ + + + +K S N L + L
Sbjct: 118 QSFSFGFYSSNSELCGPPTNTACNNLNDTADSNTTAPSEPEKDSSSKPNKLGTVFLLFDV 177
Query: 188 LCIVTVLMLFIFYLTKRTRKPNIMIKKQEEYMDQEK---ESGDDEEEEEEK-------IG 237
++ V++LFI Y K + I+ K E +Q++ E DD E E+ +
Sbjct: 178 AGLLAVILLFILYFRKARKLKKILKKHGTEEREQKQSADEDYDDFETEQNRSMNVAAIYA 237
Query: 238 KGKRKLVVAGEDRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVV 297
GK +V E NL+F+++ FKLNDLLKA AEGLGKG+FGN+YKA++EG VVV
Sbjct: 238 HGKEAVVEGEEKGNLIFLQEN--VKFKLNDLLKASAEGLGKGVFGNTYKAMMEGMPAVVV 295
Query: 298 KRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHG 357
KRLRDLKPL +EEFRK +IADQKHPNLLPLLAYY+S +EKL+VY+FA GN+FNRIHG
Sbjct: 296 KRLRDLKPLTSEEFRKHSNIIADQKHPNLLPLLAYYYSKEEKLMVYRFAEKGNVFNRIHG 355
Query: 358 GKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL 417
G+ + +RIPFR +RL VARGVARALEYLH +++QS V HGNLKS+N+LLD+NEMVL
Sbjct: 356 GRGNNDRIPFRWNARLSVARGVARALEYLH---LNKSQSIVPHGNLKSSNVLLDENEMVL 412
Query: 418 VSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP 477
VSD+G +SL+A IA+ RM SYKSPEY +SKK++RKSDVWS+GCLLLELLTGR+S HSAP
Sbjct: 413 VSDHGLTSLIALTIASNRMASYKSPEYHTSKKVTRKSDVWSYGCLLLELLTGRVSAHSAP 472
Query: 478 QGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM 537
G G D+CSWV RAVREEWTAEIFD EISVQR++A GMLKLLQVAI+CC KSPEKRPEM
Sbjct: 473 PGTTGVDICSWVHRAVREEWTAEIFDIEISVQRNSAPGMLKLLQVAIRCCEKSPEKRPEM 532
Query: 538 AEVVSELEIIKVTESTEEEEDFWLDQSLTDESLSIST 574
+VV EL I+ +S EEE+ DQSLTDESLS S
Sbjct: 533 TQVVKELNNIRDADS-EEEDLSSFDQSLTDESLSTSA 568
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224070521|ref|XP_002303163.1| predicted protein [Populus trichocarpa] gi|222840595|gb|EEE78142.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 439 bits (1130), Expect = e-120, Method: Compositional matrix adjust.
Identities = 219/338 (64%), Positives = 272/338 (80%), Gaps = 7/338 (2%)
Query: 233 EEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGR 292
EE+ GK + + E R L+FIE+E+ + F LNDLLKA AE LG+G FG+ YKA+++G+
Sbjct: 13 EEERGKA---VDIEEEKRRLIFIEEEEKS-FTLNDLLKASAEDLGRGNFGDCYKAVMDGK 68
Query: 293 APVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352
VVVKR+RDLKPL ++EF +QL +IA QKHPNLLPLLAYY S DEKLLVYK+A GNLF
Sbjct: 69 EAVVVKRIRDLKPLSSKEFTRQLHIIAHQKHPNLLPLLAYYNSKDEKLLVYKYAEKGNLF 128
Query: 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD 412
NRIHG + ++RIPFR SR+ VA G+ARALEYLH S QS V HGNL+STN+LLD
Sbjct: 129 NRIHGNRG-RDRIPFRWSSRISVALGIARALEYLHLNTIS--QSIVPHGNLRSTNVLLDL 185
Query: 413 NEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRIS 472
NE VLVSDYG SS++AQPIAAQR++SYKSPEY+++K++S+KSDVWS+G LLLELLT RIS
Sbjct: 186 NEKVLVSDYGLSSIIAQPIAAQRLVSYKSPEYKTTKRVSKKSDVWSYGSLLLELLTARIS 245
Query: 473 THSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPE 532
SAP G +G ++CSWV +AVREEWTAEIFD EI+ QRSA+ GML+LLQ+AI+CC+KSPE
Sbjct: 246 VCSAPPGTDGMEVCSWVKKAVREEWTAEIFDIEIAAQRSASSGMLELLQIAIRCCDKSPE 305
Query: 533 KRPEMAEVVSELEIIKVTESTEEEEDFWLDQSLTDESL 570
RPEM EVV E+E IK +E+EE+ +D+SLTDESL
Sbjct: 306 NRPEMTEVVREVESIKALVESEDEENLSMDRSLTDESL 343
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147834640|emb|CAN60903.1| hypothetical protein VITISV_016342 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 420 bits (1080), Expect = e-115, Method: Compositional matrix adjust.
Identities = 233/425 (54%), Positives = 298/425 (70%), Gaps = 25/425 (5%)
Query: 155 PSLNNCSSTGNYVT---NSDDKGSNDLK----IFYFLLAALCIVTVLMLFIFYLTKRTRK 207
PS+++ + T + V ++DD N K I + +L + ++ V+ LFI Y K+ +K
Sbjct: 26 PSVDSTNPTSSSVVMNDSADDSYKNPFKSRMVIIFVVLDVVGLIVVVWLFILYY-KKAKK 84
Query: 208 PNIMIKKQEEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLND 267
N +K ++ +QE E + E E GK K KL+ F+ +E A F+L+D
Sbjct: 85 FNKEMKNRDSEEEQENEEEIEAGEGEVVXGKAKGKLI---------FMRNE--AYFELDD 133
Query: 268 LLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLL 327
LLKA AEGLGKG FGNSYKA+L+ VVVKR RDLKPL TEEF K L +IA HPNLL
Sbjct: 134 LLKASAEGLGKGNFGNSYKAMLDEDLIVVVKRFRDLKPLSTEEFGKHLXLIAAHNHPNLL 193
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
P LAYY S +EKLLVYKFA NGNLF+R+HGG+ +NR+PFR SRL VA+ VARALE+LH
Sbjct: 194 PPLAYYCSREEKLLVYKFADNGNLFDRLHGGR-GQNRVPFRWNSRLAVAQAVARALEHLH 252
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSS 447
K+ T V HGNLKSTN+L N ++VSDYG +S++A PIAAQRM+SYKSPEYQ+
Sbjct: 253 LNTKAETM--VPHGNLKSTNVLYTKNNTIVVSDYGLASIIAPPIAAQRMVSYKSPEYQNL 310
Query: 448 KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507
+++S+KSDVWS+G LLLELLTGRI +H+AP+G NG D+CSWV RAVREEWTAEIFD EI
Sbjct: 311 RRVSKKSDVWSYGSLLLELLTGRIPSHTAPEG-NGVDICSWVHRAVREEWTAEIFDHEIC 369
Query: 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEEDFWLDQ-SLT 566
+R + GML LLQ+AI CC+KSPEKRP+M EV E+ I+ EE++DF D+ S T
Sbjct: 370 TRRGSCEGMLSLLQIAIGCCDKSPEKRPDMTEVAKEVANIQAV-GAEEDDDFSFDRSSFT 428
Query: 567 DESLS 571
D+SLS
Sbjct: 429 DDSLS 433
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225447866|ref|XP_002268971.1| PREDICTED: probable inactive receptor kinase At2g26730-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 418 bits (1074), Expect = e-114, Method: Compositional matrix adjust.
Identities = 231/425 (54%), Positives = 299/425 (70%), Gaps = 25/425 (5%)
Query: 155 PSLNNCSSTGNYVT---NSDDKGSNDLK----IFYFLLAALCIVTVLMLFIFYLTKRTRK 207
PS+++ + T + V ++DD N K I + +L + ++ V+ LFI Y K+ +K
Sbjct: 26 PSVDSTNPTSSSVVMNDSADDSYKNPFKSRMVIIFVVLDVVGLIVVVWLFILYY-KKAKK 84
Query: 208 PNIMIKKQEEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLND 267
N +K ++ +QE E + E E GK K KL+ F+ +E A F+L+D
Sbjct: 85 FNKEMKNRDSEEEQENEEEIEAGEGEVVGGKAKGKLI---------FMRNE--AYFELDD 133
Query: 268 LLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLL 327
LLKA AEGLGKG FGNSYKA+L+ VVVKR RDLKPL TEEF K L +IA HPNLL
Sbjct: 134 LLKASAEGLGKGNFGNSYKAMLDEDLIVVVKRFRDLKPLSTEEFGKHLQLIAAHNHPNLL 193
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
P LAYY S +EKLLVYKFA NGNLF+R+HGG+ +NR+PFR SRL VA+ VARALE+LH
Sbjct: 194 PPLAYYCSREEKLLVYKFADNGNLFDRLHGGR-GQNRVPFRWNSRLAVAQAVARALEHLH 252
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSS 447
++T++ V HGNLKSTN+L N ++VSDYG +S++A PIAAQRM+SYKSPEYQ+
Sbjct: 253 L--NTKTETMVPHGNLKSTNVLYTKNNTIVVSDYGLASIIAPPIAAQRMVSYKSPEYQNL 310
Query: 448 KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507
+++S+KSDVWS+G LLLELLTGRI +H+AP+G NG D+CSWV RAVREEWTAEIFD EI
Sbjct: 311 RRVSKKSDVWSYGSLLLELLTGRIPSHTAPEG-NGVDICSWVHRAVREEWTAEIFDHEIC 369
Query: 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEEDFWLDQ-SLT 566
+R + GML LLQ+AI CC+KSPEKRP+M EV E+ I+ E ++DF D+ S T
Sbjct: 370 TRRGSCEGMLSLLQIAIGCCDKSPEKRPDMTEVAKEVANIQAV-GAEADDDFSFDRSSFT 428
Query: 567 DESLS 571
D+SLS
Sbjct: 429 DDSLS 433
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557547|ref|XP_003547077.1| PREDICTED: probable inactive receptor kinase At2g26730-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 406 bits (1043), Expect = e-110, Method: Compositional matrix adjust.
Identities = 212/378 (56%), Positives = 276/378 (73%), Gaps = 8/378 (2%)
Query: 205 TRKPNIMIKKQEEYMDQEKESGDDEEEEEEKIGKGK-RKLVVAGEDRNLVFIEDEQPAGF 263
TRK N ++K + +EKES D E ++KI G+ K+V E + LVF +D+ A F
Sbjct: 26 TRKLNKIVKLGQIPTVKEKESDDVEISVDKKIEIGEGTKMVTVEERKELVFFDDK--AKF 83
Query: 264 KLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKH 323
++ +LL+A AE LG GI GNSYKA+L + +VVKRL DLKPL EEF K L IA+ KH
Sbjct: 84 QMGELLRASAEALGHGILGNSYKAMLNDGSTIVVKRLWDLKPLSKEEFAKILNAIAEMKH 143
Query: 324 PNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARAL 383
PNLLPLLAYY S DEKL++Y +A GNLF+R+H G+ NR+PF SRL VARGVARAL
Sbjct: 144 PNLLPLLAYYHSRDEKLMLYTYAERGNLFSRLHDGRGG-NRVPFSWNSRLSVARGVARAL 202
Query: 384 EYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPE 443
YLH S+ + V HGNL+S+N+L D+N+ VLVSD+G +SL+AQPIAAQ M+ YKSPE
Sbjct: 203 VYLHLN--SKFHNVVPHGNLRSSNVLFDENDAVLVSDFGLASLIAQPIAAQHMVVYKSPE 260
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503
Y +++++ +SDVWS+G LL+ELLTG++S SAP G NG DLCSWV RAVREEWTAEIFD
Sbjct: 261 YGYARRVTVQSDVWSYGSLLIELLTGKVSVCSAPPGTNGVDLCSWVHRAVREEWTAEIFD 320
Query: 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEEDFWLDQ 563
EI Q+SA GML+LLQ+A++C + PEKRPEM EV+ E+E K+ ++ E+++D +D+
Sbjct: 321 KEICGQKSALPGMLRLLQIAMRCIERFPEKRPEMKEVMREVE--KIQQAPEDDDDGSVDR 378
Query: 564 SLTDESLSISTVASASER 581
SLTD+SLS ST ER
Sbjct: 379 SLTDDSLSTSTSIIGDER 396
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357445825|ref|XP_003593190.1| Probably inactive leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355482238|gb|AES63441.1| Probably inactive leucine-rich repeat receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1037), Expect = e-110, Method: Compositional matrix adjust.
Identities = 208/378 (55%), Positives = 273/378 (72%), Gaps = 7/378 (1%)
Query: 205 TRKPNIMIKKQEEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFK 264
++K N ++K ++++ + E+ +IG+G + V E + L+F +DE F+
Sbjct: 51 SKKLNRIVKGHINTFHEQEKDVETSIEKRIEIGEGTTMMTVE-ERKELMFFKDE--TKFQ 107
Query: 265 LNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHP 324
+ +LL+A AE LG GI GNSYKA+L +VVKRLRDLKP EEF K + +IAD +HP
Sbjct: 108 MGELLRASAEALGHGIMGNSYKAMLNNGPTIVVKRLRDLKPFTKEEFAKIVKMIADLRHP 167
Query: 325 NLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALE 384
NLLPLLAYY S +E+L++Y++A NGNLF+R+H G+ NR+PF SRL VARGVARALE
Sbjct: 168 NLLPLLAYYHSREERLMLYRYAQNGNLFSRLHDGRDG-NRVPFNWNSRLSVARGVARALE 226
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEY 444
YLH +K + V HGNLKS+N+L D+N+ VLVSD+ +SL+AQPIAAQ M+ YKSPEY
Sbjct: 227 YLHLNNK--FHNIVPHGNLKSSNVLFDENDSVLVSDFSLASLIAQPIAAQHMVVYKSPEY 284
Query: 445 QSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504
+KK++ +SDVWS+G LL+EL+TG++S SAPQG NG DLCSWV RAVREEWTAEIFD
Sbjct: 285 GYAKKVTMQSDVWSYGSLLIELVTGKVSMCSAPQGTNGVDLCSWVHRAVREEWTAEIFDK 344
Query: 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-IIKVTESTEEEEDFWLDQ 563
EIS Q+SA GML+LLQVA++C + PEKRPEM EVV E+E I +V +E+E+D DQ
Sbjct: 345 EISCQKSALPGMLRLLQVAMRCIERFPEKRPEMKEVVREVEKIQQVHLMSEDEDDVSCDQ 404
Query: 564 SLTDESLSISTVASASER 581
SLTD+S S S ER
Sbjct: 405 SLTDDSFSTSNSGIFVER 422
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|115452837|ref|NP_001050019.1| Os03g0332900 [Oryza sativa Japonica Group] gi|108707983|gb|ABF95778.1| Protein kinase domain containing protein, expressed [Oryza sativa Japonica Group] gi|108707984|gb|ABF95779.1| Protein kinase domain containing protein, expressed [Oryza sativa Japonica Group] gi|113548490|dbj|BAF11933.1| Os03g0332900 [Oryza sativa Japonica Group] gi|215736943|dbj|BAG95872.1| unnamed protein product [Oryza sativa Japonica Group] gi|222624871|gb|EEE59003.1| hypothetical protein OsJ_10722 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 317 bits (813), Expect = 8e-84, Method: Compositional matrix adjust.
Identities = 209/554 (37%), Positives = 306/554 (55%), Gaps = 55/554 (9%)
Query: 28 LEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISR 87
L RL G I SD +P L I ++N +SG+ +F S L IDLS N F G+I
Sbjct: 99 LRSNRLIGSIPSD-ITSLPSLQSIFLQDNELSGDLPSFFS-PTLNTIDLSYNSFAGQIPA 156
Query: 88 SLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSN 147
SL +L L +L L N+L+GP+P+ SL+ N+SNN L+GSIP LQ+F + S+
Sbjct: 157 SLQNLTQLSTLNLSKNSLSGPIPDLKLPSLRQLNLSNNELNGSIPPF--LQIFSNSSFLG 214
Query: 148 NPYLCGPPSLNNCSST-------------------GNYVTNSDDKGSNDLKIFYFLLAAL 188
NP LCGPP L CS G V + FLLAA
Sbjct: 215 NPGLCGPP-LAECSLPSPTSSPESSLPPPSALPHRGKKVGTGSIIAAAVGGFAVFLLAA- 272
Query: 189 CIVTVLMLFIFYLTKRTRKPNIMIKKQEEYMDQEKESGDDE--EEEEEKIGKGKRKLVVA 246
+F+ +KR +K+++ +D + D+ E+ +E++ G V
Sbjct: 273 ------AIFVVCFSKRK-------EKKDDGLDNNGKGTDNARIEKRKEQVSSG----VQM 315
Query: 247 GEDRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPL 306
E LVF+ D F L DLL+A AE LGKG +G +YKA+LE VVVKRL+D+
Sbjct: 316 AEKNKLVFL-DGCSYNFDLEDLLRASAEVLGKGSYGTAYKAILEDGTIVVVKRLKDVVA- 373
Query: 307 ITEEFRKQLLVIAD-QKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRI 365
+EF +Q+ I KH NL+PL AYY+S DEKL+VY++ G+ +HG K +
Sbjct: 374 GKKEFEQQMEQIGRVGKHANLVPLRAYYYSKDEKLVVYEYVATGSFSAMLHGIKGIAEKT 433
Query: 366 PFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425
P +R+ + G AR + ++H + S+ + HGN+K+TN+LLD + VSDYG S+
Sbjct: 434 PLDWNTRMKIILGTARGIAHIHAEGGSK----LAHGNIKATNVLLDQDHNPYVSDYGLSA 489
Query: 426 LVAQPIAAQRMI-SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD 484
L++ PI+ R++ Y++PE S+K + KSDV+SFG LL+E+LTG+ S Q + D
Sbjct: 490 LMSFPISTSRVVVGYRAPETFESRKFTHKSDVYSFGVLLMEMLTGKAPLQSQGQD-DVVD 548
Query: 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
L WV VREEWTAE+FD E+ + ++++LQ+A+ C ++SPE+RP MAEV+ +
Sbjct: 549 LPRWVHSVVREEWTAEVFDVELMKYLNIEDELVQMLQLAMACTSRSPERRPTMAEVIRMI 608
Query: 545 EIIKVTESTEEEED 558
E ++ +S E D
Sbjct: 609 EELR--QSASESRD 620
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489936|ref|XP_002267180.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 317 bits (812), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 192/564 (34%), Positives = 302/564 (53%), Gaps = 34/564 (6%)
Query: 3 CFKDFPSQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNF 62
C +D S+W+GI C + H+ IVLE + L G I L ++FKNN + G
Sbjct: 73 CQEDV-SKWFGITC--SKGHIIRIVLEGIELTGSFPPAFLQKIAFLNTVSFKNNSVFGPI 129
Query: 63 MNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNV 122
N + L+ + S N F G I + L L L+LQ N+L G +P F+Q +L FNV
Sbjct: 130 PNLTGLIHLESVFFSQNNFSGSIPLDYIGLPNLTVLELQENSLGGHIPPFDQPTLTTFNV 189
Query: 123 SNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNC-----------SSTGNYVTNSD 171
S N+L G IP+T LQ F SY +N +LCG P C + + N
Sbjct: 190 SYNHLEGPIPETPVLQRFPESSYDHNSHLCGLPLGKVCPAFPPAPATATAPPPHISPNPS 249
Query: 172 DKGSNDLKIF--YFLLAALCIVTVLMLFIFYLTKRTRKPNIMIKKQEEYMDQEKESGDDE 229
+ L+I+ ++AA +V VL++ +F R + Q+ M E +
Sbjct: 250 KEKKKGLEIWGVALIVAAATLVPVLVMVVFLCYYRKSQRKEATTGQQTGMSGSVEWAEKR 309
Query: 230 EEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALL 289
E G +R + L F + + P F L+DLL+A AE +GKG G +YKA L
Sbjct: 310 RHSWESRGDPERTVA-------LEFFDKDIPV-FDLDDLLRASAEVMGKGKLGTTYKATL 361
Query: 290 EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349
E + V VKRL+DL L +EF +Q+ ++ +H NL+ ++++Y+S +EKL+VY+F +G
Sbjct: 362 ESGSAVAVKRLKDLNGLSKKEFVQQMQLLGKTRHENLVEIVSFYYSKEEKLVVYEFVPHG 421
Query: 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNIL 409
+LF +H + + R+P RL + + +A+ L +LH +S V H NLKS+N+L
Sbjct: 422 SLFELLHENRGAA-RVPLNWSRRLSIIKDIAKGLTFLH---QSLPSHKVPHANLKSSNVL 477
Query: 410 LD---DNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLEL 466
+ N + D+GF L+ +++++ KSPE+ KK+++K+DV+ FG ++LE+
Sbjct: 478 IHSTGQNCHSKLVDFGFLPLLPSRKSSEKLAVAKSPEFALGKKLTQKADVYCFGIIILEV 537
Query: 467 LTGRISTHSAPQGINGA--DLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAI 524
+TGRI ++P GIN DL WV AV +W+ ++ D EI R MLKL +A+
Sbjct: 538 ITGRIPGEASP-GINATVEDLSDWVRTAVNNDWSTDVLDVEIVAAREGHDEMLKLTGIAL 596
Query: 525 QCCNKSPEKRPEMAEVVSELEIIK 548
+C + +PEKRP+M EV+ ++ I+
Sbjct: 597 ECTDTTPEKRPKMTEVLRRIQEIE 620
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537708|ref|XP_003537367.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 313 bits (803), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 204/583 (34%), Positives = 311/583 (53%), Gaps = 62/583 (10%)
Query: 9 SQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGN------- 61
S W GI C+ N V + L + L G I S+ + + +I+ ++N++SGN
Sbjct: 86 SSWVGITCNENRTRVVKVRLPGVGLVGTIPSNTLGKLDAVKIISLRSNLLSGNLPADIGS 145
Query: 62 -----FMNFSSNHKLKDI-----------DLSGNKFYGEISRSLLSLKFLESLQLQNNNL 105
++ N+ DI DLS N F G I ++ ++ L SL LQNN+L
Sbjct: 146 LPSLQYLYLQHNNLSGDIPASLSPQLIVLDLSYNSFTGVIPKTFQNMSVLTSLNLQNNSL 205
Query: 106 TGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCSSTGN 165
+G +P N + LK+ N+S N+L+GSIPK L++F + S+ N LCGPP L CS+
Sbjct: 206 SGQIPNLNVTLLKLLNLSYNHLNGSIPKA--LEIFPNSSFEGNSLLCGPP-LKPCSAVPP 262
Query: 166 YVT-------------NSDDKGSNDLKIFYFLLAALCIVTVLMLFIFYLTKR--TRKPNI 210
+ +S +K S I + A+ + + ++F+ K+ R N+
Sbjct: 263 TPSPASTPPPSTTGRQSSKNKLSKIAIIVIAVGGAVVLFFIALVFVICCLKKEDNRGSNV 322
Query: 211 MIKKQEEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLNDLLK 270
+ K SG E+ +E+ G G V E LVF E F L DLL+
Sbjct: 323 IKGK--------GPSGGRGEKPKEEFGSG----VQEPEKNKLVFFEGSS-YNFDLEDLLR 369
Query: 271 APAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIAD-QKHPNLLPL 329
A AE LGKG +G +YKA+LE VVVKRL+++ + ++F +Q+ ++ +H N++PL
Sbjct: 370 ASAEVLGKGSYGTAYKAILEESMTVVVKRLKEVV-VGKKDFEQQMEIMGRVGQHTNVVPL 428
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
AYY+S DEKLLVY + GNL +HGG++ R P SR+ ++ G A+ L ++H
Sbjct: 429 RAYYYSKDEKLLVYDYVPGGNLHTLLHGGRTG-GRTPLDWDSRIKISLGTAKGLAHIH-- 485
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKK 449
S HGN+KS+N+LL+ + +SD+G + L+ P R Y++PE ++K
Sbjct: 486 --SVGGPKFTHGNIKSSNVLLNQDNDGCISDFGLAPLMNVPATPSRAAGYRAPEVIETRK 543
Query: 450 ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQ 509
S KSDV+SFG LLLE+LTG+ S P + DL WV VREEWTAE+FD E+
Sbjct: 544 HSHKSDVYSFGVLLLEMLTGKAPLQS-PGRDDMVDLPRWVQSVVREEWTAEVFDVELMRY 602
Query: 510 RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552
++ M+++LQ+A+ C K P+ RP M E V +E I+ ++S
Sbjct: 603 QNIEEEMVQMLQIAMACVAKMPDMRPSMDEAVRMIEEIRQSDS 645
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 582 | ||||||
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.881 | 0.779 | 0.368 | 2.4e-76 | |
| TAIR|locus:2161308 | 654 | AT5G58300 [Arabidopsis thalian | 0.510 | 0.454 | 0.395 | 4.2e-71 | |
| TAIR|locus:2044913 | 672 | AT2G36570 [Arabidopsis thalian | 0.542 | 0.470 | 0.411 | 6.8e-71 | |
| TAIR|locus:2156784 | 640 | RUL1 "REDUCED IN LATERAL GROWT | 0.512 | 0.465 | 0.382 | 6e-70 | |
| TAIR|locus:2174190 | 625 | LRR1 [Arabidopsis thaliana (ta | 0.855 | 0.796 | 0.340 | 1.3e-68 | |
| TAIR|locus:2128156 | 676 | AT4G31250 [Arabidopsis thalian | 0.501 | 0.431 | 0.420 | 2.3e-68 | |
| TAIR|locus:2077898 | 640 | AT3G08680 [Arabidopsis thalian | 0.517 | 0.470 | 0.400 | 4.7e-68 | |
| TAIR|locus:2128414 | 638 | AT4G23740 [Arabidopsis thalian | 0.493 | 0.449 | 0.390 | 2.6e-67 | |
| TAIR|locus:2075502 | 627 | AT3G02880 [Arabidopsis thalian | 0.848 | 0.787 | 0.344 | 6.5e-67 | |
| TAIR|locus:2063621 | 647 | PRK2A "AT2G07040" [Arabidopsis | 0.520 | 0.468 | 0.367 | 2.6e-65 |
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 769 (275.8 bits), Expect = 2.4e-76, P = 2.4e-76
Identities = 201/545 (36%), Positives = 289/545 (53%)
Query: 28 LEDMRLNGEIKSDAFADIPELIVINFKNNIISGNF-MNFSSNHKLKDIDLSGNKFYGEIX 86
L RL+G+I SD F+++ L + ++N SG F +F+ + L +D+S N F G I
Sbjct: 98 LRSNRLSGQIPSD-FSNLTHLRSLYLQHNEFSGEFPTSFTQLNNLIRLDISSNNFTGSIP 156
Query: 87 XXXXXXXXXXXXXXQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYS 146
NN +G +P + L FNVSNNNL+GSIP + L F + S++
Sbjct: 157 FSVNNLTHLTGLFLGNNGFSGNLPSISLG-LVDFNVSNNNLNGSIPSS--LSRFSAESFT 213
Query: 147 NNPYLCGPPSLNNCSS-------------TGNYVTNSDDKGSNDLKIFYFLLAALCIVTV 193
N LCG P L C S N +++ K S + + +AL + +
Sbjct: 214 GNVDLCGGP-LKPCKSFFVSPSPSPSLINPSNRLSSKKSKLSKAAIVAIIVASALVALLL 272
Query: 194 LMLFIFYLTKRTRKPNIMIKKQEEYMXXXXXXXXXX-XXXXXXXXXXXXXLVVAGE-DRN 251
L L +F ++ R N KQ + + GE +RN
Sbjct: 273 LALLLFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERN 332
Query: 252 -LVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEE 310
LVF E + F L DLL+A AE LGKG G SYKA+LE VVVKRL+D+ +E
Sbjct: 333 KLVFTEGGVYS-FDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVMAS-KKE 390
Query: 311 FRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCR 370
F Q+ V+ KHPN++PL AYY+S DEKLLV+ F G+L +HG + S R P
Sbjct: 391 FETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGS-GRTPLDWD 449
Query: 371 SRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430
+R+ +A AR L +LH K ++HGN+K++NILL N+ VSDYG + L +
Sbjct: 450 NRMRIAITAARGLAHLHVSAK------LVHGNIKASNILLHPNQDTCVSDYGLNQLFSNS 503
Query: 431 IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVL 490
R+ Y +PE ++K++ KSDV+SFG LLLELLTG+ S + A G G DL WVL
Sbjct: 504 SPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGK-SPNQASLGEEGIDLPRWVL 562
Query: 491 RAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550
VREEWTAE+FD E+ + M++LLQ+A+ C + P++RP M EV+ +E + +
Sbjct: 563 SVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNRS 622
Query: 551 ESTEE 555
E+T++
Sbjct: 623 ETTDD 627
|
|
| TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 547 (197.6 bits), Expect = 4.2e-71, Sum P(2) = 4.2e-71
Identities = 121/306 (39%), Positives = 184/306 (60%)
Query: 248 EDRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLI 307
E LVF F L DLL+A AE LGKG +G +YKA+LE VVVKRL+++
Sbjct: 337 EKNKLVFFNGCS-YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVAAG- 394
Query: 308 TEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIP 366
EF +Q+ +I+ HP+++PL AYY+S DEKL+V + GNL + +HG + S+ + P
Sbjct: 395 KREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGSE-KTP 453
Query: 367 FRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426
SR+ + A+ + +LH + HGN+KS+N+++ +SD+G + L
Sbjct: 454 LDWDSRVKITLSAAKGIAHLHAAGGPKFS----HGNIKSSNVIMKQESDACISDFGLTPL 509
Query: 427 VAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLC 486
+A PIA R Y++PE ++K + KSDV+SFG L+LE+LTG+ S P + DL
Sbjct: 510 MAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQS-PSRDDMVDLP 568
Query: 487 SWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546
WV VREEWT+E+FD E+ ++ M+++LQ+A+ C + PE RP M +VV +E
Sbjct: 569 RWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEE 628
Query: 547 IKVTES 552
I+V++S
Sbjct: 629 IRVSDS 634
|
|
| TAIR|locus:2044913 AT2G36570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 585 (211.0 bits), Expect = 6.8e-71, Sum P(2) = 6.8e-71
Identities = 141/343 (41%), Positives = 205/343 (59%)
Query: 249 DRN-LVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPL 306
DR+ LVF E + F+L+DLLKA AE LGKG G YKA+L+ G V VKRL+D P
Sbjct: 337 DRSRLVFFERRKQ--FELDDLLKASAEMLGKGSLGTVYKAVLDDGSTTVAVKRLKDANPC 394
Query: 307 ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIP 366
+EF + + +I KH N++ L AYY++ +EKLLVY++ NG+L + +HG + RIP
Sbjct: 395 PRKEFEQYMEIIGRLKHQNVVKLRAYYYAKEEKLLVYEYLPNGSLHSLLHGNRGP-GRIP 453
Query: 367 FRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426
+R+ + G AR L +H + + S + HGN+KS+N+LLD N + L++D+G S L
Sbjct: 454 LDWTTRISLMLGAARGLAKIHDE---YSISKIPHGNIKSSNVLLDRNGVALIADFGLS-L 509
Query: 427 VAQPI-AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRI-STHSAPQGINGA- 483
+ P+ A R+ Y++PE K++S+K+DV+SFG LLLE+LTG+ S +P A
Sbjct: 510 LLNPVHAIARLGGYRAPEQSEIKRLSQKADVYSFGVLLLEVLTGKAPSIFPSPSRPRSAA 569
Query: 484 ------------DLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSP 531
DL WV V+EEWTAE+FD E+ ++ M+ +L + + C P
Sbjct: 570 SVAVEEEEEAVVDLPKWVRSVVKEEWTAEVFDPELLRYKNIEEEMVAMLHIGLACVVPQP 629
Query: 532 EKRPEMAEVVSELEIIKVTESTEEEEDFWLDQSLTDESLSIST 574
EKRP MAEVV +E I+V E + EDF D+S S S++T
Sbjct: 630 EKRPTMAEVVKMVEEIRV-EQSPVGEDF--DESRNSMSPSLAT 669
|
|
| TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 6.0e-70, Sum P(2) = 6.0e-70
Identities = 121/316 (38%), Positives = 190/316 (60%)
Query: 245 VAGEDRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLK 304
V ++N +F + F L DLLKA AE LGKG FG +YKA+LE VVVKRLR++
Sbjct: 322 VQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREVV 381
Query: 305 PLITEEFRKQLLVIAD-QKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKN 363
+EF +Q+ ++ +H N +PLLAYY+S DEKLLVYK+ G+LF +HG + +
Sbjct: 382 AS-KKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGNRGDRG 440
Query: 364 RIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423
+ + +R+ +A G ++A+ YLH +HG++KS+NILL ++ +SD
Sbjct: 441 -VDWE--TRMKIATGTSKAISYLH-------SLKFVHGDIKSSNILLTEDLEPCLSDTSL 490
Query: 424 SSLVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGA 483
+L P R I Y +PE ++++S++SDV+SFG ++LE+LTG+ T G+
Sbjct: 491 VTLFNLPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLTGK--TPLTQPGLEDE 548
Query: 484 ----DLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAE 539
DL WV VREEWTAE+FD E+ ++ M+++LQ+A+ C ++PE RP+M E
Sbjct: 549 RVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEE 608
Query: 540 VVSELEIIKVTESTEE 555
V +E ++ + +++
Sbjct: 609 VARMIEDVRRLDQSQQ 624
|
|
| TAIR|locus:2174190 LRR1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 696 (250.1 bits), Expect = 1.3e-68, P = 1.3e-68
Identities = 180/528 (34%), Positives = 270/528 (51%)
Query: 33 LNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSN-HKLKDIDLSGNKFYGEIXXXXXX 91
LNG + D FA++ L + + N SG +F + I+L+ N F G I
Sbjct: 99 LNGPLPPD-FANLTLLRYLYLQGNAFSGEIPSFLFTLPNIIRINLAQNNFLGRIPDNVNS 157
Query: 92 XXXXXXXXXQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYL 151
Q+N LTGP+PE + L+ FNVS+N L+GSIP L ++ N L
Sbjct: 158 ATRLATLYLQDNQLTGPIPEI-KIKLQQFNVSSNQLNGSIP--DPLSGMPKTAFLGN-LL 213
Query: 152 CGPPSLNNC--SSTGNYVTNSDDKGSNDL----KIFYFLLAALCIVTVLMLFIFYLTKRT 205
CG P L+ C + TGN KG +D I ++ ++ VL L +F L ++
Sbjct: 214 CGKP-LDACPVNGTGNGTVTPGGKGKSDKLSAGAIVGIVIGCFVLLLVLFLIVFCLCRKK 272
Query: 206 RKPNIMIKKQEEYMXXXXXXXXXXXXXXXXXXXXXXXLVVAGEDRNLVFIEDE-----QP 260
+K ++ + E G +N + + +
Sbjct: 273 KKEQVVQSRSIEAAPVPTSSAAVAKESNGPPAVVANGASENGVSKNPAAVSKDLTFFVKS 332
Query: 261 AG-FKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITE-EFRKQLLVI 318
G F L+ LLKA AE LGKG FG+SYKA + V VKRLRD+ ++ E EFR++L V+
Sbjct: 333 FGEFDLDGLLKASAEVLGKGTFGSSYKASFDHGLVVAVKRLRDV--VVPEKEFREKLQVL 390
Query: 319 ADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARG 378
H NL+ L+AYYFS DEKL+V+++ G+L +HG K S R P +R +A G
Sbjct: 391 GSISHANLVTLIAYYFSRDEKLVVFEYMSRGSLSALLHGNKGS-GRSPLNWETRANIALG 449
Query: 379 VARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS 438
ARA+ YLH +D + + HGN+KS+NILL ++ VSDY + +++ R+
Sbjct: 450 AARAISYLHSRDATTS-----HGNIKSSNILLSESFEAKVSDYCLAPMISPTSTPNRIDG 504
Query: 439 YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498
Y++PE ++KIS+K+DV+SFG L+LELLTG+ TH G DL WV ++
Sbjct: 505 YRAPEVTDARKISQKADVYSFGVLILELLTGKSPTHQQLHE-EGVDLPRWVSSITEQQSP 563
Query: 499 AEIFDSEIS-VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+++FD E++ Q + M++LL + I C + P+ RP M EV +E
Sbjct: 564 SDVFDPELTRYQSDSNENMIRLLNIGISCTTQYPDSRPTMPEVTRLIE 611
|
|
| TAIR|locus:2128156 AT4G31250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 571 (206.1 bits), Expect = 2.3e-68, Sum P(2) = 2.3e-68
Identities = 127/302 (42%), Positives = 181/302 (59%)
Query: 247 GEDRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP 305
G+ R L F+ ++Q F L D+L+A AE LG G FG+SYKA L GRA VVVKR R +
Sbjct: 344 GDQRKLHFVRNDQER-FTLQDMLRASAEVLGSGGFGSSYKAALSSGRA-VVVKRFRFMSN 401
Query: 306 LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRI 365
+ EEF + I HPNLLPL+A+Y+ +EKLLV + NG+L N +H ++ ++
Sbjct: 402 IGREEFYDHMKKIGRLSHPNLLPLIAFYYRKEEKLLVTNYISNGSLANLLHANRTP-GQV 460
Query: 366 PFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425
RL + RGV R L YL+ + HG+LKS+N+LLD N L++DY
Sbjct: 461 VLDWPIRLKIVRGVTRGLAYLYRVFPDLN---LPHGHLKSSNVLLDPNFEPLLTDYALVP 517
Query: 426 LVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD- 484
+V + + Q M++YK+PE+ + SR+SDVWS G L+LE+LTG+ + QG GAD
Sbjct: 518 VVNRDQSQQFMVAYKAPEFTQQDRTSRRSDVWSLGILILEILTGKFPANYLRQG-KGADD 576
Query: 485 -LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543
L +WV R EWTA++FD E+ + MLKLL++ ++CC+ EKR E+ E V
Sbjct: 577 ELAAWVESVARTEWTADVFDKEMKAGKEHEAQMLKLLKIGLRCCDWDIEKRIELHEAVDR 636
Query: 544 LE 545
+E
Sbjct: 637 IE 638
|
|
| TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 539 (194.8 bits), Expect = 4.7e-68, Sum P(2) = 4.7e-68
Identities = 125/312 (40%), Positives = 179/312 (57%)
Query: 244 VVAGEDRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDL 303
V E LVF E F L DLL+A AE LGKG +G +YKA+LE VVVKRL+++
Sbjct: 316 VQEAEKNKLVFFEGSS-YNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEV 374
Query: 304 KPLITEEFRKQLLVIAD-QKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSK 362
EF +Q+ + H N+ PL AYYFS DEKLLVY + GN +HG
Sbjct: 375 AAG-KREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNEG- 432
Query: 363 NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG 422
R +RL + AR + ++H S + + ++HGN+KS N+LL V VSD+G
Sbjct: 433 GRAALDWETRLRICLEAARGISHIH----SASGAKLLHGNIKSPNVLLTQELHVCVSDFG 488
Query: 423 FSSLVAQ-PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGIN 481
+ L++ + R + Y++PE ++K ++KSDV+SFG LLLE+LTG+ + +
Sbjct: 489 IAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGKTTGHE-E 547
Query: 482 GADLCSWVLRAVREEWTAEIFDSE-ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
DL WV VREEWT E+FD E I Q + M+++LQ+A+ C +K P+ RP M EV
Sbjct: 548 VVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEV 607
Query: 541 VSELEIIKVTES 552
V+ +E I+ + S
Sbjct: 608 VNMMEEIRPSGS 619
|
|
| TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 541 (195.5 bits), Expect = 2.6e-67, Sum P(2) = 2.6e-67
Identities = 116/297 (39%), Positives = 184/297 (61%)
Query: 263 FKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK 322
F L DLL+A AE LGKG FG +YKA+LE V VKRL+D+ +F +Q+ +I K
Sbjct: 330 FDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDVAAG-KRDFEQQMEIIGGIK 388
Query: 323 HPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARA 382
H N++ L AYY+S DEKL+VY + G++ + +HG + +NRIP +R+ +A G A+
Sbjct: 389 HENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGNRG-ENRIPLDWETRMKIAIGAAKG 447
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA--QRMISYK 440
+ +H ++ + ++HGN+KS+NI L+ VSD G +++++ P+A R Y+
Sbjct: 448 IARIHKENNGK----LVHGNIKSSNIFLNSESNGCVSDLGLTAVMS-PLAPPISRQAGYR 502
Query: 441 SPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAE 500
+PE ++K S+ SDV+SFG +LLELLTG+ H+ G L WV VREEWTAE
Sbjct: 503 APEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTA-GDEIIHLVRWVHSVVREEWTAE 561
Query: 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEE 557
+FD E+ + M+++LQ+A+ C K+ ++RP+M+++V +E + ++ E E
Sbjct: 562 VFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENVGNRRTSIEPE 618
|
|
| TAIR|locus:2075502 AT3G02880 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 680 (244.4 bits), Expect = 6.5e-67, P = 6.5e-67
Identities = 183/531 (34%), Positives = 280/531 (52%)
Query: 33 LNGEIKSDAFADIPELIVINFKNNIISGNFMN--FSSNHKLKDIDLSGNKFYGEIXXXXX 90
L+G I SD F+++ L + + N SG + F+ ++ I+L NKF G I
Sbjct: 102 LSGPIPSD-FSNLVLLRYLYLQGNAFSGEIPSLLFTLPSIIR-INLGENKFSGRIPDNVN 159
Query: 91 XXXXXXXXXXQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150
+ N L+GP+PE L+ FNVS+N L+GSIP + L + ++ N
Sbjct: 160 SATRLVTLYLERNQLSGPIPEITLP-LQQFNVSSNQLNGSIPSS--LSSWPRTAFEGNT- 215
Query: 151 LCGPPSLNNCSS-------TGNYVTNSDDKGSNDLKIFYFLLAAL-CIV--TVLMLFIFY 200
LCG P L+ C + G T + K S+ L + + C+V +L+L +F
Sbjct: 216 LCGKP-LDTCEAESPNGGDAGGPNTPPEKKDSDKLSAGAIVGIVIGCVVGLLLLLLILFC 274
Query: 201 LT-KRTRKPNIMIKKQEEYMXXXXXXXXXXXXXXXXXXXXXXXLVVAGE-DRNLVFIEDE 258
L KR ++ N+ + E + +G +++L F +
Sbjct: 275 LCRKRKKEENVPSRNVEAPVAAATSSAAIPKETVVVVPPAKATGSESGAVNKDLTFFV-K 333
Query: 259 QPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITE-EFRKQLLV 317
F L+ LLKA AE LGKG G+SYKA E V VKRLRD+ ++ E EFR++L V
Sbjct: 334 SFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGLVVAVKRLRDV--VVPEKEFRERLHV 391
Query: 318 IADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVAR 377
+ H NL+ L+AYYFS DEKLLV+++ G+L +HG K + R P +R +A
Sbjct: 392 LGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAILHGNKGN-GRTPLNWETRAGIAL 450
Query: 378 GVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI 437
G ARA+ YLH +D + + HGN+KS+NILL D+ VSDYG + +++ A R+
Sbjct: 451 GAARAISYLHSRDGTTS-----HGNIKSSNILLSDSYEAKVSDYGLAPIISSTSAPNRID 505
Query: 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGIN--GADLCSWVLRAVRE 495
Y++PE ++KIS+K+DV+SFG L+LELLTG+ TH Q +N G DL WV +
Sbjct: 506 GYRAPEITDARKISQKADVYSFGVLILELLTGKSPTH---QQLNEEGVDLPRWVQSVTEQ 562
Query: 496 EWTAEIFDSEIS-VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+ +++ D E++ Q +++LL++ + C + P+ RP MAEV +E
Sbjct: 563 QTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEVTRLIE 613
|
|
| TAIR|locus:2063621 PRK2A "AT2G07040" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 540 (195.1 bits), Expect = 2.6e-65, Sum P(2) = 2.6e-65
Identities = 114/310 (36%), Positives = 180/310 (58%)
Query: 252 LVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEF 311
L F+ D++ F+L DLLKA AE LG G FG SYK LL + +VVKR + + +EF
Sbjct: 321 LSFLRDDK-GKFELQDLLKASAEILGSGCFGASYKTLLSNGSVMVVKRFKHMNSAGIDEF 379
Query: 312 RKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRS 371
++ + + H NLLP++AYY+ +EKL V F NG+L +HG KS + +
Sbjct: 380 QEHMKRLGRLNHENLLPIVAYYYKKEEKLFVSDFVANGSLAAHLHGHKSL-GQPSLDWPT 438
Query: 372 RLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431
R + +GV R L YLH K+ HG+LKS+N+LL + L+ DYG ++ +
Sbjct: 439 RFNIVKGVGRGLLYLH---KNLPSLMAPHGHLKSSNVLLSEKFEPLLMDYGLIPMINEES 495
Query: 432 AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRI-STHSAPQGINGADLCSWVL 490
A + M++YKSPEY ++++K+DVW G L+LE+LTG++ + S + DL SWV
Sbjct: 496 AQELMVAYKSPEYVKQSRVTKKTDVWGLGVLILEILTGKLLESFSQVDKESEEDLASWVR 555
Query: 491 RAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550
+ + EWT E+FD E+ + +L L+++ + CC EKR ++ E V ++E + +
Sbjct: 556 SSFKGEWTQELFDQEMGKTSNCEAHILNLMRIGLSCCEVDVEKRLDIREAVEKMEDL-MK 614
Query: 551 ESTEEEEDFW 560
E + ++DF+
Sbjct: 615 EREQGDDDFY 624
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O48788 | Y2267_ARATH | No assigned EC number | 0.3519 | 0.9209 | 0.8145 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 582 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-28 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-28 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-23 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-19 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-18 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-17 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-12 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-11 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-09 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-09 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-06 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-05 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-04 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.001 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.001 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.002 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 0.002 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.002 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.002 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.003 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.003 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.003 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.003 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.003 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.004 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.004 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 6e-31
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 20/199 (10%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG+G FG Y A + V +K ++ + + EE +++ ++ HPN++ L +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+ LV ++ G+L + + +N L + + LEYLH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-----ENEGKLSEDEILRILLQILEGLEYLHSNG--- 112
Query: 394 TQSAVIHGNLKSTNILLDDNE-MVLVSDYGFSSLVAQP--IAAQRMIS--YKSPE-YQSS 447
+IH +LK NILLD + V ++D+G S L+ + + + Y +PE
Sbjct: 113 ----IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 448 KKISRKSDVWSFGCLLLEL 466
S KSD+WS G +L EL
Sbjct: 169 GYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 8e-30
Identities = 74/290 (25%), Positives = 123/290 (42%), Gaps = 55/290 (18%)
Query: 274 EGLGKGIFGNSYKALL-----EGRAPVVVKRLRDLKPLI-TEEFRKQLLVIADQKHPNLL 327
+ LG+G FG YK L V VK L++ EEF ++ ++ HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
LL + +V ++ G+L + + K+ + L +A +A+ +EYL
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLR-----KHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-------ISYK 440
K+ +H +L + N L+ +N +V +SD+G S + R I +
Sbjct: 120 SKN-------FVHRDLAARNCLVTENLVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWM 171
Query: 441 SPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR---- 494
+PE K + KSDVWSFG LL E+ T G P G++ ++ + R
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEEVLELLEDGYRLPRP 226
Query: 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
E E+++ L+ QC PE RP +E+V +L
Sbjct: 227 ENCPDELYE---------------LML---QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 74/290 (25%), Positives = 121/290 (41%), Gaps = 50/290 (17%)
Query: 276 LGKGIFGNSYKALLEGRA----PVVVKRLRDLKPLIT-EEFRKQLLVIADQKHPNLLPLL 330
LG+G FG YK L+G+ V VK L++ ++F K+ V+ HPN++ LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 331 AYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLL-VARGVARALEYLH 387
+ LV ++ G+L + R LL A +A+ +EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYK------S 441
K +H +L + N L+ ++ +V +SD+G S V ++ K +
Sbjct: 123 SK-------KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR----E 495
PE + KSDVWSFG LL E+ T G P G++ ++ ++ + R E
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGAT-----PYPGLSNEEVLEYLRKGYRLPKPE 230
Query: 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
E+++ + + C PE RP +E+V LE
Sbjct: 231 YCPDELYE------------------LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 72/284 (25%), Positives = 123/284 (43%), Gaps = 48/284 (16%)
Query: 276 LGKGIFGNSYKALLEG-----RAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPL 329
LG+G FG YK L+G + V VK L+ D EEF ++ ++ HPN++ L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
L + +V ++ G+L + + + ++ ++ L A +AR +EYL K
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDL--LSFALQIARGMEYLESK 121
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP---IAAQRMISYK--SPEY 444
+ IH +L + N L+ +N +V +SD+G S + + + +PE
Sbjct: 122 N-------FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPES 174
Query: 445 QSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR----EEWTAE 500
K + KSDVWSFG LL E+ T G++ ++ ++ R E
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTL---GEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPE 231
Query: 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
++D + +QC + PE RP +E+V L
Sbjct: 232 LYD------------------LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 69/270 (25%), Positives = 113/270 (41%), Gaps = 33/270 (12%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG+G FG Y A + V +K ++ E +++ ++ KHPN++ L +
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
D+ LV ++ G+LF+ + + R+ R + ALEYLH K
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEARF--YLRQILSALEYLHSKG--- 117
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS---YKSPEYQSSKKI 450
++H +LK NILLD++ V ++D+G + + + Y +PE K
Sbjct: 118 ----IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGY 173
Query: 451 SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQR 510
+ D+WS G +L ELLTG+ P G D + + + + E +
Sbjct: 174 GKAVDIWSLGVILYELLTGK-----PP--FPGDDQLLELFKKIGKP-KPPFPPPEWDISP 225
Query: 511 SAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
A + KLL K PEKR E
Sbjct: 226 EAKDLIRKLLV-------KDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 78/276 (28%), Positives = 120/276 (43%), Gaps = 37/276 (13%)
Query: 276 LGKGIFGNSYKALLEG-RAPVVVKRL--RDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
LG G FG YKA +G V VK L R K + R+++ ++ HPN++ L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFR-CRSRLLVARGVARALEYLHHKDK 391
+ D LV ++ G+LF+ + S + + +A + R LEYLH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKK---IALQILRGLEYLHSN-- 117
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSPE-YQS 446
+IH +LK NILLD+N +V ++D+G + + + ++ Y +PE
Sbjct: 118 -----GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLG 172
Query: 447 SKKISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAVREEWTAEIFDSE 505
K DVWS G +L ELLTG+ P G N D ++R + FD
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK-----PPFSGENILDQ-LQLIRRIL--GPPLEFDEP 224
Query: 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVV 541
S + +C NK P KRP E++
Sbjct: 225 KWSSGSEE-----AKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-28
Identities = 126/534 (23%), Positives = 215/534 (40%), Gaps = 82/534 (15%)
Query: 28 LEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEIS 86
L + +G + + EL+ + N +SG + SS KL +DLS N+ G+I
Sbjct: 482 LSRNQFSGAVPR-KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540
Query: 87 RSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYS 144
S + L L L N L+G +P+ N SL N+S+N+L GS+P T + +
Sbjct: 541 ASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASA 600
Query: 145 YSNNPYLCGPPS---LNNCSSTGNYVTNSDDKGSNDLKIFYFLLAALCIVTVLMLFI-FY 200
+ N LCG + L C K ++F + +++ + F
Sbjct: 601 VAGNIDLCGGDTTSGLPPC------------KRVRKTPSWWFYITCTLGAFLVLALVAFG 648
Query: 201 LTKRTRKPNIMIKKQEEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQP 260
+ N+ +K+ E E G E L F + +
Sbjct: 649 FVFIRGRNNLELKRVEN------EDGTWE----------------------LQFFDSKVS 680
Query: 261 AGFKLNDLLKAPAEG--LGKGIFGNSYKA-LLEGRAPVVVKRLRD---LKPLITEEFRKQ 314
+ND+L + E + +G G SYK ++ VVK + D + + K
Sbjct: 681 KSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKL 740
Query: 315 LLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLL 374
+HPN++ L+ S L++++ I G S+ R
Sbjct: 741 -------QHPNIVKLIGLCRSEKGAYLIHEY---------IEGKNLSEVLRNLSWERRRK 784
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD--DNEMVLVSDYGFSSLVAQPIA 432
+A G+A+AL +LH R AV+ GNL I++D D + +S L+
Sbjct: 785 IAIGIAKALRFLH----CRCSPAVVVGNLSPEKIIIDGKDEPHLRLS---LPGLLCTDTK 837
Query: 433 AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492
+Y +PE + +K I+ KSD++ FG +L+ELLTG+ A G++G+ + W
Sbjct: 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA-DAEFGVHGS-IVEWARYC 895
Query: 493 VREEWTAEIFDSEISVQRSAAHG-MLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+ D I S +++++ +A+ C P RP +V+ LE
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 72/284 (25%), Positives = 122/284 (42%), Gaps = 47/284 (16%)
Query: 276 LGKGIFGNSYKALLEG-----RAPVVVKRLRDLKPLIT-EEFRKQLLVIADQKHPNLLPL 329
LG+G FG YK L+G V VK L++ EEF ++ ++ HPN++ L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
L + ++V ++ G+L + + K+ + L A +AR +EYL K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDL--LSFALQIARGMEYLESK 122
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP---IAAQRMISYK--SPEY 444
+ IH +L + N L+ +N +V +SD+G S + + + +PE
Sbjct: 123 N-------FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 445 QSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR----EEWTAE 500
K + KSDVWSFG LL E+ T G++ A++ ++ + R E
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTL---GEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPE 232
Query: 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
++ + +QC + PE RP +E+V L
Sbjct: 233 LYK------------------LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 35/285 (12%)
Query: 265 LNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHP 324
+L +GKG FG+ G+ V VK L+D F + V+ +HP
Sbjct: 5 SKELKLG--ATIGKGEFGDVMLGDYRGQK-VAVKCLKDDSTAAQA-FLAEASVMTTLRHP 60
Query: 325 NLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALE 384
NL+ LL + +V ++ G+L + + S+ R +L A V +E
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR----SRGRAVITLAQQLGFALDVCEGME 116
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-ISYKSPE 443
YL K+ +H +L + N+L+ ++ + VSD+G + +Q + ++ + + +PE
Sbjct: 117 YLEEKN-------FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPE 169
Query: 444 YQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502
KK S KSDVWSFG LL E+ + GR+ P D+ V + R E E
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPHVEKGYRME-APEGC 224
Query: 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547
E+ +V C P KRP ++ +L +I
Sbjct: 225 PPEV-------------YKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 4e-22
Identities = 70/280 (25%), Positives = 118/280 (42%), Gaps = 64/280 (22%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
+GKG FG YKA V +K ++ E+ ++ ++ KHPN++ Y
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 335 SNDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
DE +V +F G+L + + ++++I + V + + + LEYLH
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-------VCKELLKGLEYLHSNG-- 118
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKSPEYQSSKK 449
+IH ++K+ NILL + V + D+G S+ ++ A M+ + +PE + K
Sbjct: 119 -----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173
Query: 450 ISRKSDVWSFGCLLLELLTGR--------------ISTHSAPQGINGADLCSWVLRAVRE 495
K+D+WS G +EL G+ I+T+ P N E
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNP------------E 221
Query: 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP 535
+W+ E D LK +C K+PEKRP
Sbjct: 222 KWSDEFKD------------FLK------KCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 73/279 (26%), Positives = 123/279 (44%), Gaps = 42/279 (15%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG G FG + G V VK LKP + E F ++ ++ +H L+ L A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVK---TLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+ +V ++ G+L + + G+ K R+P + +A +A + YL ++
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP----QLVDMAAQIAEGMAYLESRN--- 123
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQSSK 448
IH +L + NIL+ +N + ++D+G + L+ R I + +PE +
Sbjct: 124 ----YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG 179
Query: 449 KISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVREEWTAEIFDSEI 506
+ + KSDVWSFG LL E++T GR+ P G+ ++ V R R +
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRV-----PYPGMTNREVLEQVERGYRMPRPPNCPEE-- 232
Query: 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
L + +QC +K PE+RP + S LE
Sbjct: 233 ------------LYDLMLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (232), Expect = 4e-21
Identities = 75/275 (27%), Positives = 122/275 (44%), Gaps = 40/275 (14%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKR--LRDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
+GKG FG Y V+K L ++ E+ ++ ++ HPN++ Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII---KY 64
Query: 333 Y--FSNDEKLL-VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
Y F KL V ++A G+L +I K K PF L + AL+YLH
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIK--KQKKEGKPFPEEQILDWFVQLCLALKYLH-- 120
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA-AQRMI---SYKSPEYQ 445
SR ++H ++K NI L N +V + D+G S +++ + A+ ++ Y SPE
Sbjct: 121 --SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
Query: 446 SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505
+K + KSD+WS GC+L EL T + +G N +L +L+ + SE
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLK----HPFEGENLLELALKILKGQYPP-IPSQYSSE 230
Query: 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
+ L+ K PE+RP +A++
Sbjct: 231 LR----------NLVS---SLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-20
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG G FG ++ L PV VK L KP + ++F + ++ +HP L+ L A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+ +V + G+L + GG ++P + +A VA + YL
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLP----QLIDMAAQVASGMAYLE------ 120
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQSSK 448
IH +L + N+L+ +N + V+D+G + ++ + I R I + +PE
Sbjct: 121 -AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN 179
Query: 449 KISRKSDVWSFGCLLLELLT-GRI 471
+ S KSDVWSFG LL E++T GR+
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRM 203
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 72/282 (25%), Positives = 126/282 (44%), Gaps = 40/282 (14%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
E +GKG FG+ YK +L+G V VK R L P + +F ++ ++ HPN++ L+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
+V + G+L + + KNR+ + L ++ A +EYL K+
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL---RKKKNRLTVK--KLLQMSLDAAAGMEYLESKN-- 113
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA------QRMISYKSPEYQS 446
IH +L + N L+ +N ++ +SD+G S I Q I + +PE +
Sbjct: 114 -----CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 447 SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS-- 504
+ + +SDVWS+G LL E + + + G++ T E +S
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYP---GMSNQQ-------------TRERIESGY 212
Query: 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546
+ + + +L+ QC PE RP +E+ +EL+I
Sbjct: 213 RMPAPQLCPEEIYRLML---QCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 19/199 (9%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
LG G FG ++ L + R V +K L+ L ++F+K++ + +H +L+ L A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 336 NDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+ ++ + G+L F R G+ S + +A VA + YL ++
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQV------LPVASLIDMACQVAEGMAYLEEQN--- 124
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI--AAQRMISYK--SPEYQSSKK 449
IH +L + NIL+ ++ + V+D+G + L+ + + ++ + I YK +PE S
Sbjct: 125 ----SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 450 ISRKSDVWSFGCLLLELLT 468
S KSDVWSFG LL E+ T
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 77/277 (27%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 276 LGKGIFGNSYKALLEGRAPVV-VKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG G +G Y+ + + + V VK L+ D + EEF K+ V+ + KHPNL+ LL
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
++ +F GNL + + NR L +A ++ A+EYL K+
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLR----ECNRQEVNAVVLLYMATQISSAMEYLEKKN--- 124
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ-----PIAAQRMISYKSPEYQSSK 448
IH +L + N L+ +N +V V+D+G S L+ A+ I + +PE +
Sbjct: 125 ----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 449 KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508
K S KSDVW+FG LL E+ T +S + +L R R E
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP-------- 232
Query: 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
K+ ++ C +P RP AE+ E
Sbjct: 233 ---------KVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 87.5 bits (215), Expect = 2e-18
Identities = 71/285 (24%), Positives = 113/285 (39%), Gaps = 36/285 (12%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLR---DLKPLITEEFRKQLLVIAD-QKHPNLLPLLA 331
LG+G FG Y A R V +K L + K E F +++ ++A PN++ L
Sbjct: 8 LGEGSFGEVYLARD--RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
++ LV ++ G+L + + K + P L + + ALEYLH K
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLL---KKIGRKGPLSESEALFILAQILSALEYLHSKG- 121
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLV-SDYGFSSLVAQPIAAQRM----------ISYK 440
+IH ++K NILLD + V+ D+G + L+ P + + Y
Sbjct: 122 ------IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 441 SPEY---QSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497
+PE S S SD+WS G L ELLTG + +L
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVS 542
+ + S + AA +LK + K P+ R + +S
Sbjct: 236 ASPLSPSNPELISKAASDLLK------KLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
+G+G FG YK L LE V +K++ +K + +++ ++ + KHPN++ +
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVA---RALEYLHHK 389
++D ++ ++A NG+L I F LVA V + L YLH
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIK---------KFGPFPESLVAVYVYQVLQGLAYLH-- 116
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKS-------- 441
+ VIH ++K+ NIL + +V ++D+G VA +
Sbjct: 117 -----EQGVIHRDIKAANILTTKDGVVKLADFG----VATKLNDVSKDDASVVGTPYWMA 167
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTGR 470
PE S SD+WS GC ++ELLTG
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 82/292 (28%), Positives = 132/292 (45%), Gaps = 55/292 (18%)
Query: 276 LGKGIFGNSYKALLEGRAP----VVVK---RLRDLKPLITEEFRKQLLVIADQKHPNLLP 328
+GKG FG Y L VK R+ DL+ + E+F K+ +++ D HPN+L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV--EQFLKEGIIMKDFSHPNVLS 60
Query: 329 LLAYYFSND-EKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARG--VARALEY 385
LL ++ L+V + +G+L N I S+ P + L+ G VA+ +EY
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIR----SETHNP---TVKDLIGFGLQVAKGMEY 113
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS--------LVAQPIAAQRMI 437
L K +H +L + N +LD++ V V+D+G + V A+ +
Sbjct: 114 LASKK-------FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166
Query: 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP--QGINGADLCSWVLRAVRE 495
+ + E ++K + KSDVWSFG LL EL+ T AP ++ D+ ++L+ R
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELM-----TRGAPPYPDVDSFDITVYLLQGRRL 221
Query: 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547
D L +V + C + PE RP +E+VS +E I
Sbjct: 222 LQPEYCPDP--------------LYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 77/278 (27%), Positives = 124/278 (44%), Gaps = 41/278 (14%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG G FG + G V VK LKP + E F ++ ++ +H L+ L A
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVK---TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAV- 69
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
S + +V ++ G+L + + G+ ++P + + +A VA + Y+ +
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLP----NLVDMAAQVAAGMAYIERMN--- 122
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQSSK 448
IH +L+S NIL+ D + ++D+G + L+ R I + +PE
Sbjct: 123 ----YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 449 KISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507
+ + KSDVWSFG LL EL+T GR+ G+N ++ V R R D IS
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPY----PGMNNREVLEQVERGYRMPCPQ---DCPIS 231
Query: 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
L ++ +QC K PE+RP + S LE
Sbjct: 232 -----------LHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 3e-17
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 40/214 (18%)
Query: 276 LGKGIFGNSYKALLE--GRAPVVVKRLR-------DLKPLITE-EFRKQLLVIADQKHPN 325
LG+G FG+ Y AL + G + VK + +L+ L E L +HPN
Sbjct: 8 LGRGSFGSVYLALDKDTGEL-MAVKSVELSGDSEEELEALEREIRILSSL------QHPN 60
Query: 326 LLPLLAYYFSNDEK-LLVY-KFAGNGNLFNRIH-GGKSSKNRIPFRCRSRLLVARGVARA 382
++ ++ L ++ ++ G+L + + GK + I R R +
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI------RKY-TRQILEG 113
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS---- 438
L YLH ++H ++K NIL+D + +V ++D+G + + + S
Sbjct: 114 LAYLHSNG-------IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
Query: 439 --YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+ +PE ++ R +D+WS GC ++E+ TG+
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 71/284 (25%), Positives = 118/284 (41%), Gaps = 55/284 (19%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
+G G FG + + V +K +R+ + E+F ++ V+ HP L+ L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 336 NDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
LV++F +G L + R GK S+ + C L V G+A YL
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC---LDVCEGMA----YLE------ 117
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV-----AQPIAAQRMISYKSPEYQSSK 448
S VIH +L + N L+ +N++V VSD+G + V + + + SPE S
Sbjct: 118 -SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS 176
Query: 449 KISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507
K S KSDVWSFG L+ E+ + G+ + +SE+
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRS-------------------------NSEVV 211
Query: 508 VQRSAAHGMLK-------LLQVAIQCCNKSPEKRPEMAEVVSEL 544
+A + K + ++ C + PE RP + ++ +L
Sbjct: 212 ETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 69/289 (23%), Positives = 120/289 (41%), Gaps = 45/289 (15%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLV----IADQKHPNLLPLLA 331
LG+G G YK + + L+ + EEFRKQLL + + P ++
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYA--LKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
++ E +V ++ G+L + + +IP + +AR + + L+YLH K
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLA--YIARQILKGLDYLHTKRH 120
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQS 446
+IH ++K +N+L++ V ++D+G S ++ Q ++Y SPE
Sbjct: 121 ------IIHRDIKPSNLLINSKGEVKIADFGISKVLEN-TLDQCNTFVGTVTYMSPERIQ 173
Query: 447 SKKISRKSDVWSFGCLLLELLTGRISTH--SAPQGINGADLCSWVLRAVREEWTAEIFDS 504
+ S +D+WS G LLE G+ P + +L + AE F
Sbjct: 174 GESYSYAADIWSLGLTLLECALGK---FPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP 230
Query: 505 EISVQRSAAHGMLKLLQVAIQCC-NKSPEKRPEMAEVVSELEIIKVTES 552
E + I C K P+KRP AE++ + IK ++
Sbjct: 231 E--------------FRDFISACLQKDPKKRPSAAELL-QHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 41/278 (14%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG+G FG + G V +K LKP ++ E F ++ ++ +H L+PL A
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIK---TLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV- 69
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
S + +V +F G G+L + + G ++P + +A +A + Y+ +
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLP----QLVDMAAQIADGMAYIERMN--- 122
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQSSK 448
IH +L++ NIL+ DN + ++D+G + L+ R I + +PE
Sbjct: 123 ----YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 449 KISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507
+ + KSDVWSFG LL EL+T GR+ G+ ++ V R R +
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPY----PGMVNREVLEQVERGYR-----------MP 223
Query: 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+ + +L++ C K P++RP + S LE
Sbjct: 224 CPQGCPESLHELMK---LCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 72/283 (25%), Positives = 129/283 (45%), Gaps = 48/283 (16%)
Query: 272 PAEGLGKGIFGNSYKALLEGRAP----VVVKR--LRDLKPLITEEFRKQLLVIADQKHPN 325
P LGKG FG +A L R VV K L L + ++++++ +HPN
Sbjct: 4 PIRVLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 326 LLPLLAYY--FSNDEKLLV-YKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARA 382
++ AYY F +D LL+ ++A G L+++I + F L + A
Sbjct: 61 II---AYYNHFMDDNTLLIEMEYANGGTLYDKI----VRQKGQLFEEEMVLWYLFQIVSA 113
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA-AQRMIS--- 438
+ Y+H ++ ++H ++K+ NI L ++ + D+G S ++ + A+ ++
Sbjct: 114 VSYIH-------KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166
Query: 439 YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498
Y SPE K + KSD+W+ GC+L ELLT + + + + + V++ V+ +T
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLK-------RTFDATNPLNLVVKIVQGNYT 219
Query: 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVV 541
S S +L+ + + PEKRP EV+
Sbjct: 220 PV--VSVYS---------SELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 41/278 (14%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG+G FG + G V +K LKP + E F ++ V+ +H L+ L A
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 69
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
S + +V ++ G+L + + G R+P + +A +A + Y+ +
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERMN--- 122
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQSSK 448
+H +L++ NIL+ +N + V+D+G + L+ R I + +PE
Sbjct: 123 ----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 449 KISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507
+ + KSDVWSFG LL EL T GR+ G+ ++ V R R E +S
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPES--- 231
Query: 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
L + QC K PE+RP + + LE
Sbjct: 232 -----------LHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 79/284 (27%), Positives = 129/284 (45%), Gaps = 50/284 (17%)
Query: 276 LGKGIFGNSYKA--LLEGRAPVVVKRLR-----DLKPLITEEFRKQLLVIADQKHPNLLP 328
+GKG F YKA LL+GR V +K+++ D K ++ K++ ++ HPN++
Sbjct: 10 IGKGQFSVVYKAICLLDGR-VVALKKVQIFEMMDAKA--RQDCLKEIDLLKQLDHPNVIK 66
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
LA + N+E +V + A G+L I K K IP R + V + ALE++H
Sbjct: 67 YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ--LCSALEHMHS 124
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG----FSSLVAQPIAAQRMIS---YKS 441
K ++H ++K N+ + +V + D G FSS + AA ++ Y S
Sbjct: 125 K-------RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGTPYYMS 174
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP---QGINGADLCSWVLRAVREEWT 498
PE + KSD+WS GCLL E+ + +P +N LC + +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQ-----SPFYGDKMNLYSLCKKIEKCDYPPLP 229
Query: 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVS 542
A+ + E L + +C N PEKRP+++ V+
Sbjct: 230 ADHYSEE-------------LRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 274 EGLGKGIFGNSYKALLEGRAP------VVVKRLRD-LKPLITEEFRKQLLVIADQKHPNL 326
E LG+G FG YK L G V +K L++ +P + +EFR++ +++D +HPN+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 327 LPLLAYYFSNDEKLLVYKFAGNGNLF-----NRIH---GGKSSKNRI--PFRCRSRLLVA 376
+ LL +++++ +G+L N H G +S + C L +A
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 377 RGVARALEYL--HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV------A 428
+A +EYL HH +H +L + N L+ + V +SD+G S +
Sbjct: 131 IQIAAGMEYLSSHH---------FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181
Query: 429 QPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLEL 466
+ + + PE K + +SD+WSFG +L E+
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-16
Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 42/278 (15%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKR---LRDLKPLITEEFRKQLLVIADQKHPNLLPLL 330
+GKG FG +K + + V + L + EE + V+A ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII--- 62
Query: 331 AYY--FSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
YY F + KL +V ++A NG+L + +P R + + L +LH
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPEDQVWRFFIQ--ILLGLAHLH 118
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-SLVAQPIAAQRMIS---YKSPE 443
K ++H ++KS N+ LD + V + D G + L A ++ Y SPE
Sbjct: 119 SKK-------ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503
K + KSDVW+ G +L E TG+ + QG L ++R V
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA----LILKIIRGVFP-------- 219
Query: 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVV 541
+S S L Q+ QC K +RP+ +++
Sbjct: 220 -PVSQMYSQQ-----LAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 9e-16
Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 19/154 (12%)
Query: 322 KHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVA 380
HP ++ L Y F +EKL LV ++A G LF+ + S + R R+R A +
Sbjct: 51 NHPFIVKL-HYAFQTEEKLYLVLEYAPGGELFSHL----SKEGRFS-EERARFYAAE-IV 103
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI--- 437
ALEYLH +I+ +LK NILLD + + ++D+G + ++ +
Sbjct: 104 LALEYLHSLG-------IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGT 156
Query: 438 -SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y +PE K + D WS G LL E+LTG+
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 67/273 (24%), Positives = 112/273 (41%), Gaps = 37/273 (13%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLLPLLA 331
LG G G K L ++ + L+ I E +KQ+L ++ P ++
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
+++N + + ++ G+L ++I K + RIP R + +A V + L YLH K K
Sbjct: 67 AFYNNGDISICMEYMDGGSL-DKIL--KEVQGRIPERILGK--IAVAVLKGLTYLHEKHK 121
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS-LV---AQPIAAQRMISYKSPEYQSS 447
+IH ++K +NIL++ + + D+G S LV A+ Y +PE
Sbjct: 122 ------IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS--YMAPERIQG 173
Query: 448 KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGA-DLCSWVLRAVREEWTAEIFDSEI 506
S KSD+WS G L+EL TGR +G +L +++ + F +
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD- 232
Query: 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAE 539
C K P +RP E
Sbjct: 233 ------------FQDFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 67/278 (24%), Positives = 124/278 (44%), Gaps = 42/278 (15%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEE---FRKQLLVIADQKHPNLLPLLAY 332
+G+G FG + + +V+ + ++ + +E + + V+ HPN++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRL---LVARGVARALEYLHHK 389
+ + ++V ++A G L I RC S L + + L LHH
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQK----------RCNSLLDEDTILHFFVQILLALHHV 117
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVL-VSDYGFSSLVAQPIAAQRMIS---YKSPEYQ 445
++H +LK+ NILLD ++MV+ + D+G S +++ A ++ Y SPE
Sbjct: 118 H----TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173
Query: 446 SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505
K ++KSD+W+ GC+L EL S + A+L + VL+ + + A I D
Sbjct: 174 EGKPYNQKSDIWALGCVLYELA-------SLKRAFEAANLPALVLKIMSGTF-APISDRY 225
Query: 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543
R ML L P KRP++++++++
Sbjct: 226 SPDLRQLILSMLNL----------DPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 62/228 (27%), Positives = 97/228 (42%), Gaps = 50/228 (21%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLRDLKPLITEEFRKQLLVI-------ADQKHPNLL 327
+G+G F A E +K L K + +E +K V HP ++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKIL--DKRQLIKE-KKVKYVKIEKEVLTRLNGHPGII 65
Query: 328 PLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386
L Y F ++E L V ++A NG L I S + +C +R A + ALEYL
Sbjct: 66 KLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKC-TRFYAAE-ILLALEYL 118
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-------SLVAQPIAAQRMIS- 438
H K +IH +LK NILLD + + ++D+G + S + A + S
Sbjct: 119 HSK-------GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 439 ----------------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y SPE + K + SD+W+ GC++ ++LTG+
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 27/202 (13%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEF---RKQLLVIADQKHPNLLPLLAY 332
+G G +G+ YKA + ++ L+P E+F +++++++ D KH N++
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIH-GGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
Y D+ + +F G G+L + H G S+++I + R L + L YLH K K
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-------QGLYYLHSKGK 127
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSPEYQSS 447
+H ++K NILL DN V ++D+G S+ + IA ++ + +PE +
Sbjct: 128 -------MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 448 KK---ISRKSDVWSFGCLLLEL 466
++ ++ D+W+ G +EL
Sbjct: 181 ERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 47/180 (26%), Positives = 94/180 (52%), Gaps = 20/180 (11%)
Query: 295 VVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNR 354
V VK++ K E +++++ D +HPN++ + + Y DE +V +F G L +
Sbjct: 47 VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI 106
Query: 355 IHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE 414
+ + ++ +I C + V +AL +LH + VIH ++KS +ILL +
Sbjct: 107 VTHTRMNEEQIATVCLA-------VLKALSFLHAQ-------GVIHRDIKSDSILLTSDG 152
Query: 415 MVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISRK-----SDVWSFGCLLLELLTG 469
V +SD+GF + V++ + ++ + +P + + + ISR D+WS G +++E++ G
Sbjct: 153 RVKLSDFGFCAQVSKEVPRRKSL-VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 60/292 (20%), Positives = 115/292 (39%), Gaps = 46/292 (15%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVK-RLRDLKPLI-----TEEFRKQLLVIADQKHPNLLPL 329
LG+G FG+ + L +K ++ +K I EEF + + D HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 330 LAYYFSNDEK------LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARAL 383
+ F +++ F +G+L + + + ++ L +A +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 384 EYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV------AQPIAAQRMI 437
EYL +++ IH +L + N +L ++ V V+D+G S + Q A+ +
Sbjct: 127 EYLSNRN-------FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497
+ + E + + + KSDVW+FG + E+ T + + +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE------------------- 220
Query: 498 TAEIFDSEISVQR--SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547
EI+D R + +L + C P+ RP ++ LE I
Sbjct: 221 NHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 34/210 (16%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLL-------------VIADQK 322
LGKG +G+ YK VKRL D + +E + ++A
Sbjct: 8 LGKGSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN 57
Query: 323 HPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARA 382
HPN++ + ++ +V ++A G+L I K + IP + R+ + + R
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ--LLRG 115
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS--YK 440
L+ LH + ++H +LKS NILL N++V + D G S ++ + +A ++ + Y
Sbjct: 116 LQALHEQK-------ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYM 168
Query: 441 SPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+PE + S KSD+WS GCLL E+ T
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 66/279 (23%), Positives = 120/279 (43%), Gaps = 35/279 (12%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
E LGKG FG +K L+ + PV VK + DL + +F + ++ HPN++ L+
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
+V + G+ + + K + + + + A A + YL K+
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLR-----KKKDELKTKQLVKFALDAAAGMAYLESKN-- 113
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-----SLVAQPIAAQRMISYKSPEYQSS 447
IH +L + N L+ +N ++ +SD+G S + + Q I + +PE +
Sbjct: 114 -----CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY 168
Query: 448 KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507
+ S +SDVWS+G LL E + + + G+ V + R +S
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYP---GMTNQQAREQVEKGYR-----------MS 214
Query: 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546
+ + K++Q +C + PE RP+ +E+ EL
Sbjct: 215 CPQKCPDDVYKVMQ---RCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 70/277 (25%), Positives = 124/277 (44%), Gaps = 36/277 (12%)
Query: 276 LGKGIFGNSYKA--LLEGRAPVVVKRLRDLKPLITEEFR----KQLLVIADQKHPNLLPL 329
+G+G F Y+A LL+G PV +K+++ + L+ + R K++ ++ HPN++
Sbjct: 10 IGRGQFSEVYRATCLLDG-VPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
A + ++E +V + A G+L I K K IP + + V + ALE++H +
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ--LCSALEHMHSR 125
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA-QPIAAQRMIS---YKSPEYQ 445
V+H ++K N+ + +V + D G + + AA ++ Y SPE
Sbjct: 126 -------RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 446 SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505
+ KSD+WS GCLL E+ + + +N LC + + ++ + E
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM--AALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236
Query: 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVS 542
L Q+ C N PEKRP++ V
Sbjct: 237 -------------LRQLVNMCINPDPEKRPDITYVYD 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVK--RLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
+G G FG Y A+ L+ + VK R++D P +E ++ V+ KHPNL+ Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV---KY 64
Query: 333 YFS--NDEKLLVY-KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
Y + EK+ ++ ++ G L + G+ + +LL L YLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL------EGLAYLH-- 116
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP--IAAQRMIS------YKS 441
++H ++K NI LD N ++ + D+G + + + + S Y +
Sbjct: 117 -----SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171
Query: 442 PEYQSSKKIS---RKSDVWSFGCLLLELLTGR 470
PE + K R +D+WS GC++LE+ TG+
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 50/166 (30%), Positives = 74/166 (44%), Gaps = 34/166 (20%)
Query: 8 PSQ--WYGIQC--DINSAH--VTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGN 61
P Q W G C D + G+ L++ L G I +D I +L
Sbjct: 399 PQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPND----ISKL------------- 441
Query: 62 FMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKV 119
L+ I+LSGN G I SL S+ LE L L N+ G +PE +SL++
Sbjct: 442 -------RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRI 494
Query: 120 FNVSNNNLSGSIPKTQTLQLFR--SYSYSNNPYLCGPPSLNNCSST 163
N++ N+LSG +P +L S+++++N LCG P L C
Sbjct: 495 LNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPH 540
|
Length = 623 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 72/287 (25%), Positives = 115/287 (40%), Gaps = 48/287 (16%)
Query: 274 EGLGKGIFG----NSYKALLEGRAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLP 328
+ LG G FG + PV VK L+ K I ++F K+ ++ H NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 329 LLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLL-VARGVARALEYL 386
L Y L +V + A G+L +R+ K+ + S L A +A + YL
Sbjct: 61 L--YGVVLTHPLMMVTELAPLGSLLDRLR-----KDALGHFLISTLCDYAVQIANGMRYL 113
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-------ISY 439
IH +L + NILL ++ V + D+G + Q M ++
Sbjct: 114 E-------SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAW 166
Query: 440 KSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVREEW 497
+PE ++ S SDVW FG L E+ T G P G++G+ +L+ + +E
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFTYGE-----EPWAGLSGSQ----ILKKIDKE- 216
Query: 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
E + A + V +QC +P RP A + L
Sbjct: 217 ------GERLERPEACP--QDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
E +G+G FG + G+ V VK ++ + + F ++ V+ H NL+ LL
Sbjct: 12 EIIGEGEFGAVLQGEYTGQK-VAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
N +V + GNL N + ++ R L + VA +EYL K
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFLR----TRGRALVSVIQLLQFSLDVAEGMEYLESKK--- 120
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-ISYKSPEYQSSKKISR 452
++H +L + NIL+ ++ + VSD+G + + + + ++ + + +PE KK S
Sbjct: 121 ----LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSS 176
Query: 453 KSDVWSFGCLLLELLT-GR 470
KSDVWS+G LL E+ + GR
Sbjct: 177 KSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 53/202 (26%), Positives = 102/202 (50%), Gaps = 21/202 (10%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
E +G+G G Y A+ + V +K++ + E ++LV+ + K+PN++ L
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
Y DE +V ++ G+L + + + +I CR L +AL++LH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALDFLH----- 132
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISR 452
+ VIH ++KS NILL + V ++D+GF + + P ++R +P + + + ++R
Sbjct: 133 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTR 189
Query: 453 KS-----DVWSFGCLLLELLTG 469
K+ D+WS G + +E++ G
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 46/283 (16%)
Query: 276 LGKGIFGNSYKALL--EGRA---PVVVKRLRD-LKPLITEEFRKQLLVIADQKHPNLLPL 329
LG G FG YK + EG PV +K LR+ P +E + V+A HP+++ L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
L S + L+ + G L + + ++ + L +A+ + YL K
Sbjct: 75 LGICLS-SQVQLITQLMPLGCLLDYVR-----NHKDNIGSQYLLNWCVQIAKGMSYLEEK 128
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV----AQPIAAQRM--ISYKSPE 443
++H +L + N+L+ + V ++D+G + L+ + A I + + E
Sbjct: 129 -------RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 444 YQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVREEWTAEI 501
+ + KSDVWS+G + EL+T G P +GI ++ + + R
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGA-----KPYEGIPAVEIPDLLEKGERLP----- 231
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
I + + V ++C E RP E+++E
Sbjct: 232 -QPPICT--------IDVYMVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 21/202 (10%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFR-KQLLVIADQKHPNLLPLLAY 332
E +G+G G Y A+ V R +L+ +E ++LV+ + K+PN++ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
Y DE +V ++ G+L + + + +I CR L +ALE+LH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLH----- 133
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISR 452
+ VIH ++KS NILL + V ++D+GF + + P ++R +P + + + ++R
Sbjct: 134 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTR 190
Query: 453 KS-----DVWSFGCLLLELLTG 469
K+ D+WS G + +E++ G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-14
Identities = 51/203 (25%), Positives = 100/203 (49%), Gaps = 24/203 (11%)
Query: 276 LGKGIFGNSYKALL-----EGRAPVVVK-RLRDLKPLITEEFRKQLLVIADQKHPNLLPL 329
+G+G FG KA+L +G+ V+ + + + P EE RK++ V+++ KHPN++
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
+ N +V + G+L+ +I+ + + F L + AL+++H +
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDR 120
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSPEYQ 445
++H ++KS NI L + + + D+G + ++ + R Y SPE
Sbjct: 121 K-------ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC 173
Query: 446 SSKKISRKSDVWSFGCLLLELLT 468
++ + KSD+W+ GC+L E+ T
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 21/202 (10%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
E +G+G G Y A+ + V +K++ + E ++LV+ + KHPN++ L
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
Y DE +V ++ G+L + + + +I CR L +ALE+LH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLH----- 132
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISR 452
+ VIH ++KS NILL + V ++D+GF + + P ++R +P + + + ++R
Sbjct: 133 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTR 189
Query: 453 KS-----DVWSFGCLLLELLTG 469
K+ D+WS G + +E++ G
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 22/200 (11%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
LG G FG + + V +K + + + E+F ++ V+ HP L+ L
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 336 NDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+V +F NG L N R GK SK+ + L + + V +EYL
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-------LSMCQDVCEGMEYLE------ 117
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV-----AQPIAAQRMISYKSPEYQSSK 448
+++ IH +L + N L+ +V VSD+G + V A+ + + PE +
Sbjct: 118 -RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS 176
Query: 449 KISRKSDVWSFGCLLLELLT 468
K S KSDVWSFG L+ E+ T
Sbjct: 177 KYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 67/275 (24%), Positives = 120/275 (43%), Gaps = 36/275 (13%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPL---ITEEFRKQLLVIADQKHPNLLPLLA 331
+G+G F Y+A L R PV +K+++ + + ++ K++ ++ HPN++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
+ ++E +V + A G+L I K K IP R + V + A+E++H +
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ--LCSAVEHMHSR-- 125
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA-QPIAAQRMIS---YKSPEYQSS 447
V+H ++K N+ + +V + D G + + AA ++ Y SPE
Sbjct: 126 -----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 448 KKISRKSDVWSFGCLLLELLTGRISTHSAPQG--INGADLCSWVLRAVREEWTAEIFDSE 505
+ KSD+WS GCLL E+ + S G +N LC + + E
Sbjct: 181 NGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQKIEQCDYPPLPTE----- 231
Query: 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
H KL ++ C P++RP++ V
Sbjct: 232 --------HYSEKLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVV-VKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLL 330
E +G G Y A+ V +KR+ DL+ +E RK++ ++ HPN++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVV--- 62
Query: 331 AYYFS---NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVA---RGVARALE 384
YY S DE LV + G+L + + K+ P ++A + V + LE
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIM------KSSYPRGGLDEAIIATVLKEVLKGLE 116
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS------ 438
YLH + IH ++K+ NILL ++ V ++D+G S+ +A R +
Sbjct: 117 YLH-------SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
Query: 439 --YKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGRISTHSAP 477
+ +PE K+D+WSFG +EL TG P
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 47/223 (21%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPL---------ITEEFRKQLL----VIAD 320
E +GKG FG K V+R D K L +TE+ ++QL+ ++ +
Sbjct: 6 ETIGKGSFGTVRK----------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRE 55
Query: 321 QKHPNLLPLLAYY--FSNDEKLLVY---KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLV 375
KHPN++ YY + +Y ++ G+L I K + I R+L
Sbjct: 56 LKHPNIV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112
Query: 376 ARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR 435
+ AL H++ V+H +LK NI LD N V + D+G +A+ +
Sbjct: 113 Q--LLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFG----LAKILGHDS 164
Query: 436 MIS--------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+ Y SPE + KSD+WS GCL+ EL
Sbjct: 165 SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 64/275 (23%), Positives = 108/275 (39%), Gaps = 35/275 (12%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
LG G FG G+ V +K +++ + +EF ++ V+ H L+ L
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 336 NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQ 395
+V ++ NG L N + F+ L + + V + YL K
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKR-----FQPSQLLEMCKDVCEGMAYLESKQ----- 120
Query: 396 SAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV-----AQPIAAQRMISYKSPEYQSSKKI 450
IH +L + N L+DD V VSD+G S V + ++ + + PE K
Sbjct: 121 --FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 451 SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQR 510
S KSDVW+FG L+ E+ + + + S LR R +E
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASE---------- 228
Query: 511 SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
K+ + C ++ E+RP +++S +E
Sbjct: 229 -------KVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 22/201 (10%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
LG G FG + G+ V +K +R+ + ++F ++ V+ HPNL+ L
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 336 NDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+V ++ NG L N R GK L + V A+EYL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGK-------LGTEWLLDMCSDVCEAMEYLE------ 117
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV-----AQPIAAQRMISYKSPEYQSSK 448
+ IH +L + N L+ ++ +V VSD+G + V + + + PE
Sbjct: 118 -SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYS 176
Query: 449 KISRKSDVWSFGCLLLELLTG 469
+ S KSDVWSFG L+ E+ +
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 49/188 (26%), Positives = 95/188 (50%), Gaps = 20/188 (10%)
Query: 295 VVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNR 354
V VK++ K E +++++ D H N++ + Y DE +V +F G L +
Sbjct: 50 VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI 109
Query: 355 IHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE 414
+ + ++ +I C S V RAL YLH++ VIH ++KS +ILL +
Sbjct: 110 VTHTRMNEEQIATVCLS-------VLRALSYLHNQ-------GVIHRDIKSDSILLTSDG 155
Query: 415 MVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISR-----KSDVWSFGCLLLELLTG 469
+ +SD+GF + V++ + ++ + +P + + + ISR + D+WS G +++E++ G
Sbjct: 156 RIKLSDFGFCAQVSKEVPKRKSL-VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
Query: 470 RISTHSAP 477
+ P
Sbjct: 215 EPPYFNEP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 7e-13
Identities = 52/202 (25%), Positives = 102/202 (50%), Gaps = 21/202 (10%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
E +G+G G + A+ + V +K++ K E ++LV+ + K+PN++ L
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
+ DE +V ++ G+L + + + +I CR L +ALE+LH
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-------QALEFLH----- 132
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISR 452
+ VIH ++KS N+LL + V ++D+GF + + P ++R +P + + + ++R
Sbjct: 133 --ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTR 189
Query: 453 KS-----DVWSFGCLLLELLTG 469
K+ D+WS G + +E++ G
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 48/282 (17%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG G FG + V VK LKP + + F ++ ++ +H L+ L A
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVK---TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+ ++ ++ G+L + + + K +P +A G+A Y+ K+
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA----YIERKN--- 123
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQSSK 448
IH +L++ N+L+ ++ M ++D+G + ++ R I + +PE +
Sbjct: 124 ----YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 179
Query: 449 KISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVR----EEWTAEIFD 503
+ KSDVWSFG LL E++T G+I G++ +D+ S + R R E E++D
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPY----PGMSNSDVMSALQRGYRMPRMENCPDELYD 235
Query: 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+ C + E+RP + S L+
Sbjct: 236 ------------------IMKTCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 68/291 (23%), Positives = 126/291 (43%), Gaps = 59/291 (20%)
Query: 276 LGKGIFGNSYKALLE--GRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLLPL 329
+G G FG ++ +L+ GR V V ++ LKP TE+ R+ L ++ H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVA-IKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 330 LAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
+++ ++ NG L + R H G+ S ++ L RG+A ++YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFS----SYQLVGML---RGIAAGMKYL- 123
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-------ISYK 440
+ +H +L + NIL++ N VSD+G S ++ I +
Sbjct: 124 ------SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177
Query: 441 SPEYQSSKKISRKSDVWSFGCLLLELLT------GRISTHSAPQGINGADLCSWVLRAVR 494
+PE + +K + SDVWSFG ++ E+++ +S H + IN
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN------------- 224
Query: 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+ F + +A + Q+ +QC + +RP ++V+ L+
Sbjct: 225 -----DGFRLPAPMDCPSA-----VYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 67/296 (22%), Positives = 120/296 (40%), Gaps = 61/296 (20%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVV-VK----------RLRDLKPLITEEFRKQLLVIADQK 322
E +GKG +G Y AL ++ VK R + + + R ++ + D
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 323 HPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARA 382
H N++ L + + + + ++ G++ G + F + V
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSI------GSCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA------QPIAAQRM 436
L YLH K ++H +LK+ N+L+D + + +SD+G S Q ++ Q
Sbjct: 121 LAYLHSK-------GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 437 ISYKSPE--YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR 494
+ + +PE + S+ S K D+WS GC++LE+ GR P
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR-----RPWS--------------D 214
Query: 495 EEWTAEIFDSEISVQRSA----AHGMLKLLQVAIQ----CCNKSPEKRPEMAEVVS 542
EE A +F ++ +RSA + L VA+ C +P+ RP E++
Sbjct: 215 EEAIAAMF--KLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 267 DLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEE---FRKQLLVIADQKH 323
+++K +G+G FG Y A + + V + DL + +E +K+++++A KH
Sbjct: 3 EIIKK----IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH 58
Query: 324 PNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRI---HGGKSSKNRIPFRCRSRLLVARGVA 380
PN++ A + N +V ++ G+L RI G S+++I L ++
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI-------LSWFVQIS 111
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL-VSDYGFSSLVAQPIAAQRMIS- 438
L+++H + ++H ++KS NI L N MV + D+G + + +
Sbjct: 112 LGLKHIHDRK-------ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG 164
Query: 439 ---YKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
Y SPE ++ + K+D+WS GC+L EL T
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 53/247 (21%), Positives = 98/247 (39%), Gaps = 46/247 (18%)
Query: 248 EDRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLE-----GRAPVVVKRLR- 301
E R+L FI+ LG+G FG + V VK L
Sbjct: 2 EKRHLKFIKQ------------------LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH 43
Query: 302 DLKPLITEEFRKQLLVIADQKHPNLLPL--LAYYFSNDEKLLVYKFAGNGNLFNRIHGGK 359
+ +F +++ ++ H N++ + L+ ++ +G+L + + +
Sbjct: 44 SGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR 103
Query: 360 SSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVS 419
N LL + + + ++YL + IH +L + NIL++ ++V +S
Sbjct: 104 DQINLKRL-----LLFSSQICKGMDYLGSQ-------RYIHRDLAARNILVESEDLVKIS 151
Query: 420 DYGFSSLVAQPIAAQRM-------ISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRI 471
D+G + ++ + + I + +PE + K S SDVWSFG L EL T G
Sbjct: 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
Query: 472 STHSAPQ 478
S +
Sbjct: 212 SQSPPAE 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 24/202 (11%)
Query: 274 EGLGKGIFGNSYKALLEG-RAPVVVKRLRD-LKPLITEEFRKQLLVIADQKHPNLLPLLA 331
E +G+G FG + L PV VK R+ L P + +F ++ ++ HPN++ L+
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 332 YYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
+V + G+ F R G + + + + + A +EYL K
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPR-------LKVKELIQMVENAAAGMEYLESK 113
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA------QRMISYKSPE 443
IH +L + N L+ + ++ +SD+G S + A Q + + +PE
Sbjct: 114 -------HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166
Query: 444 YQSSKKISRKSDVWSFGCLLLE 465
+ + S +SDVWSFG LL E
Sbjct: 167 ALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 23/202 (11%)
Query: 276 LGKGIFGNSYKALL----EGRAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLL 330
+G+G FG +ALL +K +R K E+ RK+ +++A KHPN++
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
+ ++ +V ++ G+L +I K + ++ F + L + ++++H K
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKI---KLQRGKL-FPEDTILQWFVQMCLGVQHIHEK- 119
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA-AQRMIS---YKSPEYQS 446
V+H ++KS NI L N V + D+G + L+ P A A + Y PE
Sbjct: 120 ------RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE 173
Query: 447 SKKISRKSDVWSFGCLLLELLT 468
+ + KSD+WS GC+L EL T
Sbjct: 174 NMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-12
Identities = 56/189 (29%), Positives = 83/189 (43%), Gaps = 23/189 (12%)
Query: 296 VVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRI 355
++K LR + E+ ++ L I PN++ L Y S D LV + A G L++ I
Sbjct: 22 ILKGLRK-----SSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76
Query: 356 HGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM 415
S IP C R A + AL+ LH + ++ +L NILLDD
Sbjct: 77 ----SKFLNIPEECVKRW--AAEMVVALDALH-------REGIVCRDLNPNNILLDDRGH 123
Query: 416 VLVSDYGFSSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRIS 472
+ ++ + S V A + M Y +PE + + D WS G +L ELLTG+
Sbjct: 124 IQLTYFSRWSEVEDSCDGEAVENM--YCAPEVGGISEETEACDWWSLGAILFELLTGKTL 181
Query: 473 THSAPQGIN 481
P GIN
Sbjct: 182 VECHPSGIN 190
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 70/278 (25%), Positives = 125/278 (44%), Gaps = 41/278 (14%)
Query: 276 LGKGIFGN-SYKALLEGRAPVVVKRLRDLKPLITEEFR---KQLLVIADQKHPNLLPLLA 331
+GKG +G S V+K+L +L+ E + ++ +++ KHPN++
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKL-NLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 332 YYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRI-PFRCRSRLLVARGVARALEYLHHK 389
+ D L +V F G+L++++ K K ++ P V +A AL+YLH K
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKL---KEQKGKLLPENQVVEWFVQ--IAMALQYLHEK 121
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS-LVAQPIAAQRMIS---YKSPEYQ 445
++H +LK+ N+ L ++ V D G + L Q A +I Y SPE
Sbjct: 122 H-------ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174
Query: 446 SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505
S+K + KSDVW+ GC + E+ T + N D+ S V R + +
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLK-------HAFNAKDMNSLVYRIIEGKLP------- 220
Query: 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543
+ + + + +L+ + +K PEKRP + ++ +
Sbjct: 221 -PMPKDYSPELGELIATML---SKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 67/292 (22%), Positives = 131/292 (44%), Gaps = 46/292 (15%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVK-RLRDLKPLI-----TEEFRKQLLVIADQKHPNLLPL 329
LGKG FG+ +A L+ K ++ LK I EEF ++ + + HPN++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 330 LAYYFSNDEK------LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLV--ARGVAR 381
+ + K +++ F +G+L + + + PF + LV +A
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEE--PFTLPLQTLVRFMIDIAS 124
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV------AQPIAAQR 435
+EYL K+ IH +L + N +L++N V V+D+G S + Q A++
Sbjct: 125 GMEYLSSKN-------FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 436 MISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE 495
+ + + E + + SDVW+FG + E++T R T A G+ +++ +++++ R
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT-RGQTPYA--GVENSEIYNYLIKGNRL 234
Query: 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547
+ + + + ++ QC + P+ RP + +LE+I
Sbjct: 235 KQPPDCLE--------------DVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 276 LGKGIFGN----SYKALLEGRAPVV-VKRLRDLKPLITEEFRKQLLVIADQKHPNLLPL- 329
LGKG FG+ Y L + VV VK+L+ +F +++ ++ +H N++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 330 -LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
+ Y LV ++ G+L + + K+R R LL A + + +EYL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL-----QKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL---------VAQPIAAQRMISY 439
K +H +L + NIL++ V + D+G + + V +P + I +
Sbjct: 127 K-------RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREP--GESPIFW 177
Query: 440 KSPEYQSSKKISRKSDVWSFGCLLLELLT 468
+PE + K S SDVWSFG +L EL T
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 47/188 (25%), Positives = 94/188 (50%), Gaps = 20/188 (10%)
Query: 295 VVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNR 354
V VK++ K E +++++ D +H N++ + Y DE +V +F G L +
Sbjct: 48 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 107
Query: 355 IHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE 414
+ + ++ +I C + V +AL LH + VIH ++KS +ILL +
Sbjct: 108 VTHTRMNEEQIAAVCLA-------VLKALSVLHAQ-------GVIHRDIKSDSILLTHDG 153
Query: 415 MVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISR-----KSDVWSFGCLLLELLTG 469
V +SD+GF + V++ + ++ + +P + + + ISR + D+WS G +++E++ G
Sbjct: 154 RVKLSDFGFCAQVSKEVPRRKSL-VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
Query: 470 RISTHSAP 477
+ P
Sbjct: 213 EPPYFNEP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 276 LGKGIFGNSYKALLEGRAP------VVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPL 329
LG+G FG + A +P V VK L+D ++F+++ ++ + +H +++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 330 LAYYFSNDEKLLVYKFAGNGNL--FNRIHG--------GKSSKNRIPFRCRSRLLVARGV 379
D ++V+++ +G+L F R HG G+ + + L +A +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 380 ARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP----IAAQR 435
A + YL +H +L + N L+ N +V + D+G S V +
Sbjct: 133 ASGMVYL-------ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 436 M--ISYKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
M I + PE +K + +SDVWSFG +L E+ T
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 33/88 (37%), Positives = 53/88 (60%), Gaps = 7/88 (7%)
Query: 64 NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE---FNQSSLKVF 120
N S ++ IDLSG G+IS ++ L +++++ L NN L+GP+P+ SSL+
Sbjct: 67 NSS---RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL 123
Query: 121 NVSNNNLSGSIPKTQTLQLFRSYSYSNN 148
N+SNNN +GSIP+ ++ + SNN
Sbjct: 124 NLSNNNFTGSIPRG-SIPNLETLDLSNN 150
|
Length = 968 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
+GKG FG+ G V VK +++ + F + V+ +H NL+ LL
Sbjct: 14 IGKGEFGDVMLGDYRGNK-VAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 336 NDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRT 394
L +V ++ G+L + + S+ R L + V A+EYL +
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVCEAMEYLEANN---- 122
Query: 395 QSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-ISYKSPEYQSSKKISRK 453
+H +L + N+L+ ++ + VSD+G + + ++ + + +PE KK S K
Sbjct: 123 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 454 SDVWSFGCLLLELLT-GRI 471
SDVWSFG LL E+ + GR+
Sbjct: 180 SDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 276 LGKGIFGNSYKALLE--GRAPVVVKRLRDLKPLITEEFRKQLL---VIADQ-KHPNLLPL 329
+G G FG + L+ G+ + V ++ LK +++ R L I Q HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVA-IKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 330 LAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
+ +++ ++ NG+L F R + GK + ++ + + RG+A ++YL
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL-------VGMLRGIASGMKYL- 122
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM------ISYKS 441
++ +H +L + NIL++ N + VSD+G S + A I + +
Sbjct: 123 ------SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA 176
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLT 468
PE + +K + SDVWSFG ++ E+++
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 27/202 (13%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEF---RKQLLVIADQKHPNLLPLLAY 332
+G G +G+ YKA + ++ L+P ++F ++++ ++ + KH N++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIH-GGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
Y S ++ + ++ G G+L + H G S+ +I + CR L + L YLH K K
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-------QGLAYLHSKGK 127
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSPEYQSS 447
+H ++K NILL DN V ++D+G ++ + IA ++ + +PE +
Sbjct: 128 -------MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 448 KK---ISRKSDVWSFGCLLLEL 466
+K ++ D+W+ G +EL
Sbjct: 181 EKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 30/208 (14%)
Query: 276 LGKGIFGN--SYKALLEGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLLPL 329
+G G FG S + L G+ + V ++ LK TE+ R+ L ++ HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVA-IKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 330 LAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
+ ++V ++ NG+L F R H G+ F + + RG+A ++YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-------FTVIQLVGMLRGIASGMKYL- 122
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ-PIAAQRM------ISYK 440
+ +H +L + NIL++ N + VSD+G S ++ P AA I +
Sbjct: 123 ------SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176
Query: 441 SPEYQSSKKISRKSDVWSFGCLLLELLT 468
+PE + +K + SDVWS+G ++ E+++
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRD--LKPLITEEFRKQLLVIADQKHPNLLPLLA 331
+ LG G FG + G V +K L+ + P E F + ++ +HP L+ L A
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLYA 68
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLL-VARGVARALEYLHHKD 390
+ + ++ ++ NG+L + + + K I +L+ +A +A + ++ K+
Sbjct: 69 V-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTIN-----KLIDMAAQIAEGMAFIERKN 122
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV------AQPIAAQRMISYKSPEY 444
IH +L++ NIL+ + ++D+G + L+ A+ A+ I + +PE
Sbjct: 123 -------YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEA 174
Query: 445 QSSKKISRKSDVWSFGCLLLELLT-GRI 471
+ + KSDVWSFG LL E++T GRI
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRI 202
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEF---RKQLLVIADQKHPNLLPLLAY 332
+G G +G+ YKA +V ++ L+P ++F ++++ ++ + +HPN++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIH--GGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
Y D+ +V ++ G G+L + G S+ +I + CR L + L YLH
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-------KGLAYLHETG 121
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA-QRMIS---YKSPEYQS 446
K IH ++K NILL ++ V ++D+G S+ + IA + I + +PE +
Sbjct: 122 K-------IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 447 SKKISR---KSDVWSFGCLLLEL 466
++ K D+W+ G +EL
Sbjct: 175 VERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 79/330 (23%), Positives = 139/330 (42%), Gaps = 67/330 (20%)
Query: 276 LGKGIFGNSYKALLEGRAP--------VVVKRLRD------LKPLITEEFRKQLLVIADQ 321
LG+G FG +A G V VK L+D L LI+E +L+ +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE---MELMKLIG- 75
Query: 322 KHPNLLPLLAYYFSNDEKLLVYKFAGNGNL--FNRIH----------GGKSSKNRIPFRC 369
KH N++ LL ++ ++A GNL F R K + ++ F+
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK- 134
Query: 370 RSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429
+ A VAR +EYL + IH +L + N+L+ ++ ++ ++D+G + V
Sbjct: 135 -DLVSCAYQVARGMEYLESR-------RCIHRDLAARNVLVTEDNVMKIADFGLARGVHD 186
Query: 430 -----PIAAQRM-ISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGA 483
+ R+ + + +PE + + +SDVWSFG L+ E+ T S + GI
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP---GIPVE 243
Query: 484 DLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543
+L + R + + + H + L++ +C + P +RP ++V
Sbjct: 244 ELFKLLREGHRMDKPS-----------NCTHELYMLMR---ECWHAVPTQRPTFKQLVEA 289
Query: 544 LEIIKVTESTEEEEDFWLDQSLTDESLSIS 573
L+ + S E +LD S+ E S S
Sbjct: 290 LDKVLAAVSEE-----YLDLSMPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 274 EGLGKGIFGNSYKALLEGRAP------VVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNL 326
E LG+ FG YK L G AP V +K L+D + EEF+ + ++ + +HPN+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 327 LPLLAYYFSNDEKLLVYKFAGNGNLFNRI-----HGGKSSKN-----RIPFRCRSRLLVA 376
+ LL +++ + + +L + H S + + + +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 377 RGVARALEYL--HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ 434
+A +E+L HH V+H +L + N+L+ D V +SD G V +
Sbjct: 131 TQIAAGMEFLSSHH---------VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 435 RM------ISYKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
M I + SPE K S SD+WS+G +L E+ +
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 276 LGKGIFGNSYKALL--EG---RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPL 329
LG G FG YK + EG + PV +K L + P EF + L++A HP+L+ L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLV--ARGVARALEYLH 387
L S +L V + +G L + +H K + S+LL+ +A+ + YL
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIG-------SQLLLNWCVQIAKGMMYLE 126
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA------QPIAAQRMISYKS 441
+ ++H +L + N+L+ V ++D+G + L+ + I + +
Sbjct: 127 ER-------RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLT 468
E +K + +SDVWS+G + EL+T
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 69/289 (23%), Positives = 119/289 (41%), Gaps = 49/289 (16%)
Query: 274 EGLGKGIFGNSYK-----------ALLE--GRAPVVVKRLRDLKPLITEEFRKQLLVIAD 320
E LG G FG YK AL E P K R+ I + ++ +I +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSI-GDIVSEVTIIKE 64
Query: 321 Q-KHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGV 379
Q +HPN++ + ND +V L + K K R + V +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ--M 122
Query: 380 ARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
AL YLH K+K ++H +L NI+L +++ V ++D+G L Q ++ S
Sbjct: 123 VLALRYLH-KEKR-----IVHRDLTPNNIMLGEDDKVTITDFG---LAKQKQPESKLTSV 173
Query: 439 -----YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAV 493
Y PE ++ K+DVW+FGC+L ++ T + +S N L + ++ AV
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST----NMLSLATKIVEAV 229
Query: 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVS 542
E ++ +++ ++ C E RP++ +V +
Sbjct: 230 YEPLPEGMYSEDVT-------DVIT------SCLTPDAEARPDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 35/215 (16%)
Query: 276 LGKGIFGN----------SYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPN 325
LGKG FG Y A+ R V++ + ++ +TE V+ + +HP
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVTES-----RVLQNTRHP- 55
Query: 326 LLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALE 384
L L Y F ++L V ++A G LF + S+ R+ R+R A V+ ALE
Sbjct: 56 FLTALKYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVS-ALE 109
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYK 440
YLH +D V++ ++K N++LD + + ++D+G A + Y
Sbjct: 110 YLHSRD-------VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 162
Query: 441 SPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHS 475
+PE R D W G ++ E++ GR+ ++
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 6e-11
Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 276 LGKGIFGNSYKALLEGRAP------VVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPL 329
LG+G FG + A P V VK L+D ++F ++ ++ + +H +++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 330 LAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKS---SKNRIPFR-CRSRLL-VARGVARA 382
D ++V+++ +G+L F R HG + ++ P +S++L +A+ +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP----IAAQRM-- 436
+ YL +H +L + N L+ +N +V + D+G S V + M
Sbjct: 133 MVYL-------ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 437 ISYKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
I + PE +K + +SDVWS G +L E+ T
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 76/327 (23%), Positives = 137/327 (41%), Gaps = 64/327 (19%)
Query: 276 LGKGIFGNSYKALLEG--------RAPVVVKRLRD------LKPLITE-EFRKQLLVIAD 320
LG+G FG A G V VK L+D L L++E E K +
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMI----- 74
Query: 321 QKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKS-------SKNRIP---FRCR 370
KH N++ LL + ++ ++A GNL + + ++P +
Sbjct: 75 GKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 371 SRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV--- 427
+ A VAR +EYL + IH +L + N+L+ ++ ++ ++D+G + V
Sbjct: 135 DLVSCAYQVARGMEYLASQK-------CIHRDLAARNVLVTEDNVMKIADFGLARDVHNI 187
Query: 428 ---AQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD 484
+ + + + +PE + + +SDVWSFG LL E+ T S + GI +
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP---GIPVEE 244
Query: 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
L + R + A + H + +++ +C + P +RP ++V +L
Sbjct: 245 LFKLLKEGHRMDKPA-----------NCTHELYMIMR---ECWHAVPSQRPTFKQLVEDL 290
Query: 545 EIIKVTESTEEEEDFWLDQSLTDESLS 571
+ + ST+E +LD S+ E S
Sbjct: 291 DRVLTVTSTDE----YLDLSVPFEQYS 313
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 42/211 (19%)
Query: 276 LGKGIFGNSYKAL--LEGRAPVVVKRLR----DLKPLITEEFRKQLLVIADQKHPNLLPL 329
+G+G G YKA G+ V +K++R + + +I E +L++ D KHPN++
Sbjct: 27 IGEGASGEVYKATDRATGKE-VAIKKMRLRKQNKELIINE-----ILIMKDCKHPNIVDY 80
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKN--RIPFRCRSRLLVARGVARALEYLH 387
Y DE +V ++ G+L + I N +I + CR V + LEYLH
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCRE-------VLQGLEYLH 133
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR---------MIS 438
++ VIH ++KS NILL + V ++D+GF++ + + ++R M
Sbjct: 134 SQN-------VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE-KSKRNSVVGTPYWM-- 183
Query: 439 YKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
+PE K K D+WS G + +E+ G
Sbjct: 184 --APEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 7e-11
Identities = 49/156 (31%), Positives = 70/156 (44%), Gaps = 30/156 (19%)
Query: 11 WYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHK 70
W GI C+ NS+ V I L ++G+I S F +P + IN NN +SG
Sbjct: 60 WQGITCN-NSSRVVSIDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSG---------- 107
Query: 71 LKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGS 130
+I + SL++L L NNN TG +P + +L+ ++SNN LSG
Sbjct: 108 ---------PIPDDIFTTSSSLRYL---NLSNNNFTGSIPRGSIPNLETLDLSNNMLSGE 155
Query: 131 IPKTQTLQLFRSYSYSN--NPYLCG--PPSLNNCSS 162
IP + F S + L G P SL N +S
Sbjct: 156 IP--NDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTS 189
|
Length = 968 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIAD-QKHPNLLPLLAY 332
E +G+G +G YKA + +V ++ D+ EE +++ ++ HPN+
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 333 YFSN------DEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386
+ D+ LV + G G++ + + G + R+ + +L R R L YL
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL--RETLRGLAYL 129
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSP---- 442
H ++ VIH ++K NILL N V + D+G S+ + + R +P
Sbjct: 130 H-------ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR-RNTFIGTPYWMA 181
Query: 443 ------EYQSSKKISRKSDVWSFGCLLLELLTG 469
+ Q +SDVWS G +EL G
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 7e-11
Identities = 54/212 (25%), Positives = 102/212 (48%), Gaps = 32/212 (15%)
Query: 274 EGLGKGIFGNSYKALLE--GRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLL 327
E +G G FG + L+ G+ + V ++ LK TE+ R+ L ++ HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVA-IKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
L + +++ +F NG L F R + G+ F + + RG+A ++Y
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-------FTVIQLVGMLRGIAAGMKY 121
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV----AQPIAAQRM----- 436
L ++ +H +L + NIL++ N + VSD+G S + + P +
Sbjct: 122 L-------SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174
Query: 437 ISYKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
I + +PE + +K + SDVWS+G ++ E+++
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 72/308 (23%), Positives = 128/308 (41%), Gaps = 69/308 (22%)
Query: 276 LGKGIFGNSYKAL---LEGRA---PVVVKRLR------DLKPLITEEFRKQLLVIADQKH 323
LG+G FG KA L+GRA V VK L+ +L+ L++E ++ H
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSE-----FNLLKQVNH 62
Query: 324 PNLLPLLAYYFSNDEKLLVYKFAGNGNL--FNRIH--------GGKSSKNRI-------- 365
P+++ L + LL+ ++A G+L F R G ++N
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 366 PFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425
+ A ++R ++YL + ++H +L + N+L+ + + +SD+G S
Sbjct: 123 ALTMGDLISFAWQISRGMQYL-------AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 426 LVAQPIAAQRM------ISYKSPEYQSSKKISRKSDVWSFGCLLLELLT--GRISTHSAP 477
V + + + + + + E + +SDVWSFG LL E++T G AP
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 478 QGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM 537
+ +L R R E +E ++ + + C + P+KRP
Sbjct: 236 E--RLFNLLKTGYRMERPENCSE-----------------EMYNLMLTCWKQEPDKRPTF 276
Query: 538 AEVVSELE 545
A++ ELE
Sbjct: 277 ADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 31/226 (13%)
Query: 259 QPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAP-----VVVKRLRDLKPLI-TEEFR 312
L+DLL+ +G FG + +L P V VK ++D I
Sbjct: 4 SRDRVTLSDLLQ-------EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLL 56
Query: 313 KQLLVIADQKHPNLLPLLAYYFSNDEKLLV-YKFAGNGNLFNRIHGGKSSKNRIPFRCRS 371
++ ++ H N+LP+L + E V Y + GNL + + + P +
Sbjct: 57 QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116
Query: 372 RLLVARG--VARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429
+ LV +A + YLH + VIH ++ + N ++D+ V ++D S +
Sbjct: 117 QQLVHMAIQIACGMSYLHKRG-------VIHKDIAARNCVIDEELQVKITDNALSRDLF- 168
Query: 430 PI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
P+ R + + + E +K+ S SDVWSFG LL EL+T
Sbjct: 169 PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 47/225 (20%)
Query: 276 LGKGIFGNSYKALL------EGRAPVVVKRL------RDLKPLITEEFRKQLLVIADQKH 323
LG+G FG KA + V VK L +DL L++E + + +I KH
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE--MEMMKMIG--KH 75
Query: 324 PNLLPLLAYYFSNDEKLLVYKFAGNGNL-----FNRIHGGKSSKN-----RIPFRCRSRL 373
N++ LL +V ++A +GNL R G +S + + +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 374 LVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA 433
A VAR +E+L K IH +L + N+L+ ++ ++ ++D+G +A+ I
Sbjct: 136 SFAYQVARGMEFLASKK-------CIHRDLAARNVLVTEDHVMKIADFG----LARDIHH 184
Query: 434 Q---------RM-ISYKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
R+ + + +PE + + +SDVWSFG LL E+ T
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 73/302 (24%), Positives = 129/302 (42%), Gaps = 39/302 (12%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPL-ITEEFRKQLL----VIADQKHPNLL 327
E LG G G YKA L R + VK + PL IT E +KQ++ ++ P ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVI----PLDITVELQKQIMSELEILYKCDSPYII 62
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
+F + + +F G+L +IP R+ VA V + L YL
Sbjct: 63 GFYGAFFVENRISICTEFMDGGSL--------DVYRKIPEHVLGRIAVA--VVKGLTYLW 112
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM--ISYKSPEYQ 445
++H ++K +N+L++ V + D+G S+ + IA + +Y +PE
Sbjct: 113 -------SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERI 165
Query: 446 SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505
S ++ SDVWS G +EL GR + Q G+ + +L+ + +E + +
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFP-YPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ 224
Query: 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEEDFWLDQSL 565
S K + QC K P++RP ++ I++ + E W+ ++L
Sbjct: 225 FSE---------KFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMWVCRAL 275
Query: 566 TD 567
+
Sbjct: 276 EE 277
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 276 LGKGIFGNSYKALL-------EGRAPVVVKRLRDLKPLITEEFRKQLL---VIADQKHPN 325
LG G FG Y+ G V VK LR K +E ++ L ++++ HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR--KGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 326 LLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLL-VARGVARALE 384
++ LL N+ + ++ + G+L + + + + P LL + VA+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILL-----DDNEMVLVSDYGFSSLVAQP----IAAQR 435
YL Q IH +L + N L+ D + +V + D+G + + + +
Sbjct: 121 YLE-------QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 436 MISYK--SPEYQSSKKISRKSDVWSFGCLLLELLT 468
++ + +PE K + +SDVWSFG L+ E+LT
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 276 LGKGIFGNSYKALLEGRAP------VVVKRLRDLKPLITEE-FRKQLLVIADQKHPNLLP 328
LG+G FG + P V VK L++ + F ++ ++ + +H N++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 329 LLAYYFSNDEKLLVYKFAGNGNL--FNRIHG-----GKSSKNRIPFRCRSRLL-VARGVA 380
D ++V+++ +G+L F R HG KS + + S+LL +A +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP----IAAQRM 436
+ YL +Q V H +L + N L+ + +V + D+G S V + M
Sbjct: 133 SGMVYL------ASQHFV-HRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 437 --ISYKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
I + PE +K + +SDVWSFG +L E+ T
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 36/228 (15%)
Query: 255 IEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAP-VVVKRLRD---LKPLITEE 310
+ +KL+D E LG G FG A +G +K L+ LK +
Sbjct: 7 FTKPDTSSWKLSDF--EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH 64
Query: 311 FRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIH-GGKSSKNRIPFRC 369
++ ++ + HP ++ ++ + + + +F G LF + G+ + F
Sbjct: 65 VAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH 124
Query: 370 RSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS----- 424
+L A EYLH KD +I+ +LK N+LLD+ V V+D+GF+
Sbjct: 125 AELVL-------AFEYLHSKD-------IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170
Query: 425 ---SLVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
+L P Y +PE SK + D W+ G LL E + G
Sbjct: 171 RTFTLCGTP-------EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 35/112 (31%), Positives = 59/112 (52%), Gaps = 22/112 (19%)
Query: 377 RGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV--------- 427
R + + L YLH++ +IH ++K NIL+D+ + +SD+G S +
Sbjct: 113 RQILKGLNYLHNRG-------IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKT 165
Query: 428 --AQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP 477
A+P + Q + + +PE +RK+D+WS GCL++E+LTG H P
Sbjct: 166 NGARP-SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG---KHPFP 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 45/163 (27%), Positives = 81/163 (49%), Gaps = 15/163 (9%)
Query: 312 RKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRS 371
R +L +A H ++ + S+D+ LL+ ++ G+L +I + K +PF+
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIK--QRLKEHLPFQEYE 170
Query: 372 RLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431
L+ + AL+ +H + ++H +LKS NI L ++ + D+GFS + +
Sbjct: 171 VGLLFYQIVLALDEVHSR-------KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223
Query: 432 AAQRMIS------YKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
+ S Y +PE K+ S+K+D+WS G +L ELLT
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 44/179 (24%), Positives = 89/179 (49%), Gaps = 18/179 (10%)
Query: 295 VVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNR 354
V VK + K E +++++ D +H N++ + Y +E ++ +F G L +
Sbjct: 49 VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI 108
Query: 355 IHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE 414
+ + ++ +I C S V +AL YLH + VIH ++KS +ILL +
Sbjct: 109 VSQTRLNEEQIATVCES-------VLQALCYLHSQ-------GVIHRDIKSDSILLTLDG 154
Query: 415 MVLVSDYGFSSLVAQPIAAQRMIS----YKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
V +SD+GF + +++ + ++ + + +PE S + D+WS G +++E++ G
Sbjct: 155 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 60/289 (20%), Positives = 110/289 (38%), Gaps = 43/289 (14%)
Query: 275 GLGKGIFGNSYKALLEGRA------PVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLL 327
LG G FG Y+ L GR V VK L + +F + L+++ H N++
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNR-IPFRCRSRLLVARGVARALEYL 386
L+ F + ++ + G+L + + + R + L AR VA+ +YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDD---NEMVLVSDYGFSSLVAQP----IAAQRM--I 437
IH ++ + N LL + ++D+G + + + + M I
Sbjct: 133 EEN-------HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREE 496
+ PE + K+DVWSFG LL E+ + G + G ++ +V R +
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY----PGRTNQEVMEFVTGGGRLD 241
Query: 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+ ++ C +PE RP A ++ ++
Sbjct: 242 PPKGCPGP--------------VYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 62/289 (21%), Positives = 121/289 (41%), Gaps = 45/289 (15%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLI-----TEEFRKQLLVIADQKHPNLLPLL 330
LG+G FG+ + L ++ ++ +K I E+F + + + + HPN++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 331 AYYFSNDEK------LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVA--RGVARA 382
E +++ F +G+L + + S P +++LV +A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL--YSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV------AQPIAAQRM 436
+EYL K IH +L + N +L++N V V+D+G S + Q A+
Sbjct: 125 MEYLSSKS-------FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 437 ISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496
+ + + E + + + KSDVWSFG + E+ T + G+ +++ ++ + R +
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIAT---RGQTPYPGVENSEIYDYLRQGNRLK 234
Query: 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+ D L + C +P+ RP + ELE
Sbjct: 235 QPPDCLDG--------------LYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLI--TEEFRKQLLVIADQKHPNLLPLLA 331
E +GKG FG +K + VV ++ DL+ E+ ++++ V++ P +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
Y + + ++ ++ G G+ + + G + +I + R + + L+YLH + K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-------TILREILKGLDYLHSEKK 122
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-SLVAQPIAAQRMIS---YKSPEYQSS 447
IH ++K+ N+LL ++ V ++D+G + L I + + +PE
Sbjct: 123 -------IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 448 KKISRKSDVWSFGCLLLELLTG 469
K+D+WS G +EL G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 52/226 (23%), Positives = 101/226 (44%), Gaps = 44/226 (19%)
Query: 276 LGKGIFGNSYKALLEGRAP------VVVKRLRDLKPLITE-EFRKQLLVIADQKHPNLLP 328
+G+G FG ++A G P V VK L++ + +F+++ ++A+ HPN++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRI------------HGG----KSSKNRIPFRCRSR 372
LL L++++ G+L + H K N +P C +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 373 LLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA 432
L +A+ VA + YL ++ +H +L + N L+ +N +V ++D+G S + I
Sbjct: 133 LCIAKQVAAGMAYL-------SERKFVHRDLATRNCLVGENMVVKIADFGLS----RNIY 181
Query: 433 AQRM----------ISYKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
+ I + PE + + +SDVW++G +L E+ +
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 47/150 (31%), Positives = 68/150 (45%), Gaps = 25/150 (16%)
Query: 330 LAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFR-CRSRLLVARGVARALEYLH 387
L Y F D KL L+ + G LF ++ R F R+ +A V AL++LH
Sbjct: 70 LHYAFQTDTKLHLILDYVNGGELFTHLY------QREHFTESEVRVYIAEIVL-ALDHLH 122
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISY-KSPEYQS 446
Q +I+ ++K NILLD V+++D+G S +R S+ + EY +
Sbjct: 123 -------QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTIEYMA 174
Query: 447 SKKISRKS-------DVWSFGCLLLELLTG 469
+ I S D WS G L ELLTG
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 66/278 (23%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG G FG + A V VK +KP + E F + V+ +H L+ L A
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVK---TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV- 69
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+ + ++ +F G+L + + + SK +P +A G+A ++ ++
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA----FIEQRN--- 122
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQSSK 448
IH +L++ NIL+ + + ++D+G + ++ R I + +PE +
Sbjct: 123 ----YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 449 KISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507
+ KSDVWSFG LL+E++T GRI G++ + V+RA+ + ++
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPY----PGMSNPE----VIRALERGYRMPRPENCPE 230
Query: 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+L + ++C PE+RP + S L+
Sbjct: 231 ----------ELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRL--RDLKPLITEEFRKQLLVIADQKHPNLLPL 329
LG G G K + ++ ++L ++KP I + ++L V+ + P ++
Sbjct: 9 RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 68
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
++S+ E + + G+L + K RIP ++ +A V R L YL K
Sbjct: 69 YGAFYSDGEISICMEHMDGGSLDQVLKEAK----RIPEEILGKVSIA--VLRGLAYLREK 122
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM--ISYKSPEYQSS 447
+ ++H ++K +NIL++ + + D+G S + +A + SY SPE
Sbjct: 123 HQ------IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG 176
Query: 448 KKISRKSDVWSFGCLLLELLTGR 470
S +SD+WS G L+EL GR
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 44/228 (19%)
Query: 276 LGKGIFGNSYKA-------LLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLP 328
LG G F + Y+A L+ + V+ + + E RK++ ++A HP+++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNR-IHGGKSS---KNRIPFRCRSRLLVARGVARALE 384
+L + NLF + GG S F+ + + R L
Sbjct: 68 MLG----------ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLS 117
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDN-EMVLVSDYGFSS-LVAQPIAAQRM------ 436
YLH ++ +IH ++K N+L+D + + ++D+G ++ L A+ A
Sbjct: 118 YLH-------ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLG 170
Query: 437 -ISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR-------ISTHSA 476
I++ +PE ++ R DVWS GC+++E+ T + S H A
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA 218
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 42/278 (15%)
Query: 276 LGKGIFGNSY----KALLEGRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPL 329
LGKG FG Y K + V+K + +L P T + ++ +++ HP ++
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFR--CRSRLLVARGVARALEYLH 387
A + D ++ ++ +L ++ K + + C + + GV Y+H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV----HYMH 123
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS----YKSPE 443
Q ++H +LK+ NI L +N ++ + D+G S L+ + Y SPE
Sbjct: 124 -------QRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503
+ KSD+WS GC+L E+ G + S VLR V T + +
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCC-------LAHAFEGQNFLSVVLRIVEGP-TPSLPE 227
Query: 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVV 541
+ S ML NK P RP AE++
Sbjct: 228 TYSRQLNSIMQSML----------NKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 37/211 (17%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLR---DLKPLITEEFRKQLLVIADQKHPNLLPL 329
E LG+G +G+ YKA+ E V +K + DL+ +I K++ ++ P ++
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII-----KEISILKQCDSPYIVKY 63
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRL------LVARGVARAL 383
YF N + +V ++ G G S + I L + + L
Sbjct: 64 YGSYFKNTDLWIVMEYCGAG-----------SVSDIMKITNKTLTEEEIAAILYQTLKGL 112
Query: 384 EYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA-AQRMIS---Y 439
EYLH K IH ++K+ NILL++ ++D+G S + +A +I +
Sbjct: 113 EYLHSNKK-------IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFW 165
Query: 440 KSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+PE + K+D+WS G +E+ G+
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 379 VARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-SLVAQPI-----A 432
VAR +E+L + IH +L + NILL +N +V + D+G + + P
Sbjct: 182 VARGMEFLASRK-------CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 433 AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492
A+ + + +PE K + +SDVWSFG LL E+ + S + Q I+ + C +
Sbjct: 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-ID-EEFCRRLKEG 292
Query: 493 VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
R R+ + ++ + + C + +PE RP +E+V L
Sbjct: 293 TR--------------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 19/100 (19%)
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS---------LVAQPIA 432
ALEYLH + +IH +LK NIL+D N + ++D+G S L
Sbjct: 105 ALEYLH-------SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157
Query: 433 AQRMIS---YKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
+R++ Y +PE + S+ D WS GC+L E L G
Sbjct: 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRL--RDLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG G G +K + ++ ++L ++KP I + ++L V+ + P ++ +
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+S+ E + + G+L + RIP + ++ +A V + L YL K K
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIA--VIKGLTYLREKHK-- 124
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM--ISYKSPEYQSSKKIS 451
++H ++K +NIL++ + + D+G S + +A + SY SPE S
Sbjct: 125 ----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 180
Query: 452 RKSDVWSFGCLLLELLTGR 470
+SD+WS G L+E+ GR
Sbjct: 181 VQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKR--LRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG+G G+ K L+ + + D P + ++ ++L + K P ++ YY
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV---KYY 65
Query: 334 --FSNDEKLLVY---KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLL--VARGVARALEYL 386
F ++ + ++ G+L + I+ + R ++L +A V + L YL
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGG---RIGEKVLGKIAESVLKGLSYL 121
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS--YKSPEY 444
H + +IH ++K +NILL V + D+G S + +A + Y +PE
Sbjct: 122 HSRK-------IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPER 174
Query: 445 QSSKKISRKSDVWSFGCLLLELLTGR 470
K S SDVWS G LLE+ R
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 35/223 (15%)
Query: 274 EGLGKGIFGNSYKALLEGRAP---------------VVVKRLR-DLKPLITEEFRKQLLV 317
E LG+G FG + EG A V VK LR D+ +F K++ +
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70
Query: 318 IADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF-----NRIHGGKSSKNRIPFRCRSR 372
++ K+PN++ LL S+D ++ ++ NG+L I + N IP +
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 373 LL-VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430
LL +A +A ++YL + +H +L + N L+ ++ + ++D+G S +
Sbjct: 131 LLYMAVQIASGMKYLASLN-------FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 431 ---IAAQRMISYKSPEYQSS--KKISRKSDVWSFGCLLLELLT 468
I + ++ + ++S K + SDVW+FG L E+ T
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 46/217 (21%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLIT------EEFRKQLLVIADQKHPNLLPL 329
LG G FG YKA + + K + E+F ++ ++++ KHPN++ L
Sbjct: 13 LGDGAFGKVYKA--QHKET---GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 330 LAYYFSNDEKLLVY-KFAGNGNLFNRI----HGGKSSKNRIPFRCRSRLLVARGVARALE 384
YF + KL + +F G L + + G + R V R + AL
Sbjct: 68 YEAYF-YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY---------VCRQMLEALN 117
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISY-KSP- 442
+LH VIH +LK+ NILL + V ++D+G S+ + Q+ ++ +P
Sbjct: 118 FLHSHK-------VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKRDTFIGTPY 168
Query: 443 ---------EYQSSKKISRKSDVWSFGCLLLELLTGR 470
E K+D+WS G L+EL
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 25/161 (15%)
Query: 317 VIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLV 375
++A+ HP ++ L Y F + KL L+ F G+LF R+ SK + + +
Sbjct: 51 ILAEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYL 104
Query: 376 ARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR 435
A +A AL++LH +I+ +LK NILLD+ + ++D+G S + I ++
Sbjct: 105 AE-LALALDHLH-------SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEK 153
Query: 436 -------MISYKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
+ Y +PE + + ++ +D WSFG L+ E+LTG
Sbjct: 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 66/293 (22%), Positives = 118/293 (40%), Gaps = 54/293 (18%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITE----EFRKQLLVIAD-QKHPNLLPLL 330
+G+G FG KA ++ + ++ +K ++ +F +L V+ HPN++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 331 AYYFSNDEKLLVYKFAGNGNL---------------FNRIHGGKSSKNRIPFRCRSRLLV 375
L ++A +GNL F + S+ + L
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST-----LSSQQLLHF 117
Query: 376 ARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS---SLVAQPIA 432
A VAR ++YL K IH +L + NIL+ +N + ++D+G S + +
Sbjct: 118 AADVARGMDYLSQKQ-------FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 170
Query: 433 AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQ-GINGADLCSWVLR 491
+ + + + E + + SDVWS+G LL E+ +S P G+ A+L + +
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI----VSLGGTPYCGMTCAELYEKLPQ 226
Query: 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
R E D + R QC + P +RP A+++ L
Sbjct: 227 GYRLEKPLNCDDEVYDLMR--------------QCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 32/210 (15%)
Query: 276 LGKGIFGN----------SYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPN 325
LGKG FG Y A+ + V+V + ++ +TE V+ + +HP
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-DEVAHTLTEN-----RVLQNSRHPF 56
Query: 326 LLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
L L + ++D V ++A G LF + S+ R+ R+R A + AL+Y
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAE-IVSALDY 110
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKS 441
LH ++ V++ +LK N++LD + + ++D+G + A + Y +
Sbjct: 111 LH------SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 164
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTGRI 471
PE R D W G ++ E++ GR+
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 68/293 (23%), Positives = 119/293 (40%), Gaps = 54/293 (18%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITE----EFRKQLLVIAD-QKHPNLLPLL 330
+G+G FG +A+++ + ++ LK +E +F +L V+ HPN++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 331 AYYFSNDEKLLVYKFAGNGNL---------------FNRIHGGKSSKNRIPFRCRSRLLV 375
+ + ++A GNL F + HG S+ + L
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST-----LTSQQLLQF 124
Query: 376 ARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS---SLVAQPIA 432
A VA ++YL K IH +L + N+L+ +N ++D+G S + +
Sbjct: 125 ASDVATGMQYLSEKQ-------FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM 177
Query: 433 AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQ-GINGADLCSWVLR 491
+ + + + E + + KSDVWSFG LL E+ +S P G+ A+L + +
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI----VSLGGTPYCGMTCAELYEKLPQ 233
Query: 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
R E D + R QC P +RP A++ +L
Sbjct: 234 GYRMEKPRNCDDEVYELMR--------------QCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 44/288 (15%)
Query: 276 LGKGIFGNSYKALLEG---RAPVVVKRLRDLKPLITE-EFRKQLLVIAD-QKHPNLLPLL 330
+G+G FG KA ++ R +KR+++ +F +L V+ HPN++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSR----------LLVARGVA 380
L ++A +GNL + + + + F + L A VA
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS---SLVAQPIAAQRMI 437
R ++YL +Q IH +L + NIL+ +N + ++D+G S + + + +
Sbjct: 135 RGMDYL-------SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 187
Query: 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQ-GINGADLCSWVLRAVREE 496
+ + E + + SDVWS+G LL E+ +S P G+ A+L + + R E
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEI----VSLGGTPYCGMTCAELYEKLPQGYRLE 243
Query: 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
D + R QC + P +RP A+++ L
Sbjct: 244 KPLNCDDEVYDLMR--------------QCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 35/103 (33%), Positives = 55/103 (53%), Gaps = 13/103 (12%)
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ 434
+A + +ALEYLH ++ +VIH ++K +N+L++ N V + D+G S + +A
Sbjct: 108 IAVSIVKALEYLH------SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT 161
Query: 435 RMIS---YKSPEY----QSSKKISRKSDVWSFGCLLLELLTGR 470
Y +PE + K KSDVWS G ++EL TGR
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 47/202 (23%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLI--TEEFRKQLLVIADQKHPNLLPLLA 331
E +GKG FG YK + VV ++ DL+ E+ ++++ V++ P +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
Y + ++ ++ G G+ + + G + I + R + + L+YLH + K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-------TILREILKGLDYLHSERK 122
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-SLVAQPIAAQRMIS---YKSPEYQSS 447
IH ++K+ N+LL + V ++D+G + L I + + +PE
Sbjct: 123 -------IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 448 KKISRKSDVWSFGCLLLELLTG 469
K+D+WS G +EL G
Sbjct: 176 SAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLIT--EEFRKQLLVIADQKHPNLLPLL 330
E +GKG FG YKA+ V +K + DL+ E+ ++++ ++ + P +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYIT--- 62
Query: 331 AYY--FSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
YY F KL ++ ++ G G+ + + GK + I F + R V LEYLH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------ILREVLLGLEYLH 115
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISY------KS 441
+ K IH ++K+ NILL + V ++D+G S + ++ + ++ +
Sbjct: 116 EEGK-------IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMA 166
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTG 469
PE K+D+WS G +EL G
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 3e-09
Identities = 26/95 (27%), Positives = 53/95 (55%), Gaps = 13/95 (13%)
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ---RMIS 438
L+YLH ++H ++K +NIL++++ ++ ++D+G + + +A R+I+
Sbjct: 112 GLQYLHSN-------GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVIT 164
Query: 439 --YKSPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
Y+ PE + + + D+WS GC+L EL G+
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 73/287 (25%), Positives = 116/287 (40%), Gaps = 78/287 (27%)
Query: 276 LGKGIFGN----SYKALLEGRAPVVVKR----LRD-LKPLITEEFRKQLLVIADQKHPNL 326
LG+G FG YK E A +K+ RD ++ L+ E ++ ++HP L
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCE--KRIFETANSERHPFL 64
Query: 327 LPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386
+ L A + + D V ++A G+L IH S+ R F A V L+YL
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-------YAACVVLGLQYL 117
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF-----------SSLVAQPIAAQR 435
H +++ +LK N+LLD V ++D+G S+ P
Sbjct: 118 HENK-------IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTP----- 165
Query: 436 MISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE 495
+ +PE + +R D W G L+ E+L G +P G D E
Sbjct: 166 --EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE-----SP--FPGDD----------E 206
Query: 496 EWTAEIFDSEIS--------VQRSAAHGMLKLLQVAIQCCNKSPEKR 534
E E+FDS ++ + R A M +LL+ ++PE+R
Sbjct: 207 E---EVFDSIVNDEVRYPRFLSREAISIMRRLLR-------RNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 48/156 (30%), Positives = 69/156 (44%), Gaps = 25/156 (16%)
Query: 322 KHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVA 380
KHP L+ L Y F +KL V + G LF + + R R+R A +A
Sbjct: 54 KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQ-----RERSFPEPRARFYAAE-IA 106
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-- 438
AL YLH + +I+ +LK NILLD V+++D+G L + I + S
Sbjct: 107 SALGYLHSLN-------IIYRDLKPENILLDSQGHVVLTDFG---LCKEGIEHSKTTSTF 156
Query: 439 -----YKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
Y +PE + R D W G +L E+L G
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 42/224 (18%)
Query: 274 EGLGKGIFGNSYKALL-----EGRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLL 327
E LG+ FG YK L + V +K L+D+ P EF+++ ++A+ HPN++
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRI-----HGG-----------KSSKNRIPFRCRS 371
LL +++++ G+L + H KSS + F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF---- 126
Query: 372 RLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV---- 427
L +A +A +EYL + +H +L + NIL+ + V +SD G S +
Sbjct: 127 -LHIAIQIAAGMEYL-------SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178
Query: 428 ---AQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
QP + I + PE K S SD+WSFG +L E+ +
Sbjct: 179 YYRVQP-KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 46/134 (34%), Positives = 68/134 (50%), Gaps = 15/134 (11%)
Query: 341 LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIH 400
LV +A G+L I ++ NR FR L+ V A+ ++H K +IH
Sbjct: 116 LVLDYANAGDLRQEIKS-RAKTNR-TFREHEAGLLFIQVLLAVHHVHSKH-------MIH 166
Query: 401 GNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ--RMIS----YKSPEYQSSKKISRKS 454
++KS NILL N +V + D+GFS + A ++ R Y +PE K S+K+
Sbjct: 167 RDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKA 226
Query: 455 DVWSFGCLLLELLT 468
D++S G LL ELLT
Sbjct: 227 DMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 276 LGKGIFGNSYKALL--EG---RAPVVVKRLRD-LKPLITEEFRKQLLVIADQKHPNLLPL 329
LG G FG YK L EG + PV +K LR+ P +E + V+A +P++ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLL-VARGVARALEYLHH 388
L ++ +L + + G L + + + K+ I LL +A+ + YL
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYV---REHKDNI---GSQYLLNWCVQIAKGMNYLEE 127
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA------QPIAAQRMISYKSP 442
+ ++H +L + N+L+ + V ++D+G + L+ + I + +
Sbjct: 128 RR-------LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 443 EYQSSKKISRKSDVWSFGCLLLELLT 468
E + + +SDVWS+G + EL+T
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 46/202 (22%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLI--TEEFRKQLLVIADQKHPNLLPLLA 331
E +GKG FG +K + VV ++ DL+ E+ ++++ V++ P +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
Y + ++ ++ G G+ + + G PF + + + + L+YLH + K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-SLVAQPIAAQRMIS---YKSPEYQSS 447
IH ++K+ N+LL + V ++D+G + L I + + +PE
Sbjct: 123 -------IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 448 KKISRKSDVWSFGCLLLELLTG 469
K+D+WS G +EL G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 54/283 (19%)
Query: 274 EGLGKGIFGNSYKA--LLEGRAPVVVKRLRDLKPLITEEFRKQL----LVIADQKHPNLL 327
E LG G FG+ Y+ L +G V + +E KQL +++ +HPN++
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 328 PLLAYYFS--NDEKLLVY-KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALE 384
Y + ++ L ++ + G+L + K F L R + LE
Sbjct: 66 ---QYLGTEREEDNLYIFLELVPGGSLAKLL------KKYGSFPEPVIRLYTRQILLGLE 116
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI-SYK-SP 442
YLH ++ +H ++K NIL+D N +V ++D+G +A+ + S+K SP
Sbjct: 117 YLHDRN-------TVHRDIKGANILVDTNGVVKLADFG----MAKQVVEFSFAKSFKGSP 165
Query: 443 EYQSSKKISRK------SDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496
+ + + I+++ +D+WS GC +LE+ TG+ S +G+ + V + R +
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP-WSQLEGV------AAVFKIGRSK 218
Query: 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAE 539
I D + A +LK LQ + P RP AE
Sbjct: 219 ELPPIPD---HLSDEAKDFILKCLQ-------RDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 5e-09
Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 17/100 (17%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
R L+YLH SA VIH +LK +NIL++ N + + D+G + V + ++
Sbjct: 114 RGLKYLH--------SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 439 ------YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGRI 471
Y++PE SS + ++ D+WS GC+ ELLT +
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 10/113 (8%)
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ 434
+A V L YL++ + ++H ++K +NIL++ + + D+G S + IA
Sbjct: 108 IAVAVVEGLTYLYNVHR------IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA-D 160
Query: 435 RMI---SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD 484
+ +Y SPE K + KSDVWS G ++EL G+ + +G D
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 35/220 (15%)
Query: 276 LGKGIFGNSYKALLEGRAP--------VVVKRL-RDLKPLITEEFRKQLLVIADQKHPNL 326
LG+G FG K L P V VK L R+ T ++K++ ++ H N+
Sbjct: 12 LGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 327 LPLLAYYFSNDEK--LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALE 384
+ K L+ ++ G+L + + K + ++ LL A+ + +
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-------LLFAQQICEGMA 121
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-------I 437
YLH + IH +L + N+LLD++ +V + D+G + V + R+ +
Sbjct: 122 YLHSQH-------YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 174
Query: 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP 477
+ + E K S SDVWSFG L ELLT S S P
Sbjct: 175 FWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 42/184 (22%), Positives = 82/184 (44%), Gaps = 35/184 (19%)
Query: 296 VVKR--LRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFN 353
VK+ LR++K L +QL +H N++ L + LV+++ L
Sbjct: 42 DVKKTALREVKVL------RQL------RHENIVNLKEAFRRKGRLYLVFEYVER-TLLE 88
Query: 354 RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN 413
+ ++S +P R + + + +A+ Y H + +IH ++K NIL+ ++
Sbjct: 89 LL---EASPGGLP-PDAVRSYIWQ-LLQAIAYCHSHN-------IIHRDIKPENILVSES 136
Query: 414 EMVLVSDYGFSSLVAQPIAAQRMISY------KSPEYQ-SSKKISRKSDVWSFGCLLLEL 466
++ + D+GF+ + A + Y ++PE + DVW+ GC++ EL
Sbjct: 137 GVLKLCDFGFARALRAR-PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAEL 195
Query: 467 LTGR 470
L G
Sbjct: 196 LDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 20/153 (13%)
Query: 323 HPNLLPLLAYYFSNDEKL-LVYKFAGNGNL-FNRIHGGKSSKNRIPFRCRSRLLVARGVA 380
HP L L Y F ++E + LV G+L ++ K S+ ++ + + +
Sbjct: 59 HP-FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV------KFWICE-IV 110
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM---I 437
ALEYLH K +IH ++K NILLD+ V ++D+ ++ V
Sbjct: 111 LALEYLHSKG-------IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTP 163
Query: 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y +PE + S D WS G E L G+
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 12/95 (12%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ--RMIS 438
R L+YLH + +IH +LK +N+LL D + ++D+G + P ++++
Sbjct: 119 RGLQYLHE-------NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVT 171
Query: 439 --YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE + D+W+ GC+L ELL +
Sbjct: 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 32/209 (15%)
Query: 276 LGKGIFGNSYKALLEGRAPV-VVKRLR--------DLKPLITEEFRKQLLVIADQKHPNL 326
LGKG FG A L+G + VK L+ D++ +TE K++L +A KHP L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE---KRVLALA-GKHPFL 58
Query: 327 LPLLAYYFSNDEKLLVYKFAGNGNLFNRIHG-GKSSKNRIPFRCRSRLLVARGVARALEY 385
L + + + D V ++ G+L I G+ + R F A + L++
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-------YAAEIVLGLQF 111
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKS 441
LH + +I+ +LK N+LLD + ++D+G Y +
Sbjct: 112 LHERG-------IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIA 164
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTGR 470
PE S + D W+ G LL E+L G+
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 274 EGLGKGIFGNSYKALLEG--------RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPN 325
E LG+G F +K + + V++K L +E F + +++ H +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 326 LLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
L+ DE ++V ++ G+L + K +KN I + L VA+ +A AL +
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYL---KKNKNLINISWK--LEVAKQLAWALHF 115
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNE--------MVLVSDYGFS-SLVAQPIAAQRM 436
L K + HGN+ + N+LL E + +SD G S +++ + I +R
Sbjct: 116 LEDK-------GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER- 167
Query: 437 ISYKSPE-YQSSKKISRKSDVWSFGCLLLELLTG 469
I + PE ++ + +S +D WSFG L E+ +G
Sbjct: 168 IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 32/208 (15%)
Query: 276 LGKGIFGNSYKALLEGR----APVVVKRLRDLKPLITEEFRKQLL-----VIADQKHPNL 326
+GKG FG K LL R + VK L+ K ++ ++ + ++ ++ + KHP L
Sbjct: 3 IGKGSFG---KVLLAKRKSDGSFYAVKVLQK-KTILKKKEQNHIMAERNVLLKNLKHPFL 58
Query: 327 LPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
+ L Y F EKL V + G LF + + R R+R A VA A+ Y
Sbjct: 59 VGL-HYSFQTAEKLYFVLDYVNGGELFFHLQ-----RERCFLEPRARFYAAE-VASAIGY 111
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKS 441
LH + +I+ +LK NILLD V+++D+G +P Y +
Sbjct: 112 LHSLN-------IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLA 164
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTG 469
PE + R D W G +L E+L G
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 37/127 (29%), Positives = 59/127 (46%), Gaps = 16/127 (12%)
Query: 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNIL 409
+ ++ K+ IP ++ VA +AL YL + + +IH ++K +NIL
Sbjct: 91 KFYKYVYE--VLKSVIPEEILGKIAVA--TVKALNYL------KEELKIIHRDVKPSNIL 140
Query: 410 LDDNEMVLVSDYGFSSLVAQPIAAQRMIS---YKSPEY---QSSKKISRKSDVWSFGCLL 463
LD N + + D+G S + IA R Y +PE + +SDVWS G L
Sbjct: 141 LDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITL 200
Query: 464 LELLTGR 470
E+ TG+
Sbjct: 201 YEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 29/212 (13%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKH----PNLLPL 329
+ LGKG +G+ YK L R V +++++ + E Q+++ D H P ++
Sbjct: 7 DELGKGNYGSVYKVL--HRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
+F + ++ G+L ++++ G + IP R + V + L++L
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFL--- 118
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-----SLVAQPIAAQRMISYKSPEY 444
+ + +IH ++K TN+L++ N V + D+G S SL I Q SY +PE
Sbjct: 119 ---KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQ---SYMAPER 172
Query: 445 QSSKKISR------KSDVWSFGCLLLELLTGR 470
S ++ +SDVWS G +LE+ GR
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 30/205 (14%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLIT-EEFRKQLLVIADQKHPNLLPLL-AYY 333
LG G FG YKA + + ++ D K E++ ++ ++A HPN++ LL A+Y
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKS-SKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
+ N+ +L+ AG + + ++ +I C+ L AL YLH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-------EALNYLH----- 120
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKI-- 450
++ +IH +LK+ NIL + + ++D+G S+ + I QR S+ Y + ++
Sbjct: 121 --ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVM 176
Query: 451 ---------SRKSDVWSFGCLLLEL 466
K+DVWS G L+E+
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 68/294 (23%), Positives = 114/294 (38%), Gaps = 56/294 (19%)
Query: 276 LGKGIFGNSYKALLEG------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLP 328
LG+G FG + A +G V+VK L+ K + EFR++L + H N++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 329 LLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRI-PFRCRSRLLVARGVARALEY 385
LL + ++ ++ G+L F R K K + P + ++ + +A +++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV--------AQPIAAQRMI 437
L +R +H +L + N L+ V VS S V + R
Sbjct: 133 LS---NAR----FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR-- 183
Query: 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLT------GRISTHSAPQGINGADLCSWVLR 491
+ +PE S KSDVWSFG L+ E+ T +S + L
Sbjct: 184 -WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL------ 236
Query: 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
E+ V + KL+ +C +P+ RP +E+VS L
Sbjct: 237 -------------ELPVPEGCPSRLYKLMT---RCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 44/215 (20%)
Query: 276 LGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRK----QLLVIADQKHPNLLPLL 330
+G G +G A + V +K+L +P + K +L ++ H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS--RPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 331 AYYFSNDEKL-------LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARAL 383
F+ L LV G +L N + K S + I F LV + + R L
Sbjct: 81 DV-FTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQF------LVYQ-ILRGL 131
Query: 384 EYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS---- 438
+Y+H SA +IH +LK +NI ++++ + + D+G + M
Sbjct: 132 KYIH--------SAGIIHRDLKPSNIAVNEDCELKILDFGLARH-----TDDEMTGYVAT 178
Query: 439 --YKSPEYQSSK-KISRKSDVWSFGCLLLELLTGR 470
Y++PE + ++ D+WS GC++ ELLTG+
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 29/110 (26%), Positives = 52/110 (47%), Gaps = 10/110 (9%)
Query: 361 SKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSD 420
+K P L++ + + L YLH +IH ++K+ NI ++D + V + D
Sbjct: 148 TKRSRPLPIDQALIIEKQILEGLRYLH-------AQRIIHRDVKTENIFINDVDQVCIGD 200
Query: 421 YGFSSL-VAQP--IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELL 467
G + V P + + +PE + K + K+D+WS G +L E+L
Sbjct: 201 LGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 40/119 (33%), Positives = 59/119 (49%), Gaps = 15/119 (12%)
Query: 359 KSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLV 418
K + IP ++ VA + +AL YL K+K VIH ++K +NILLD + V +
Sbjct: 105 KRIQGPIPEDILGKMTVA--IVKALHYL--KEKH----GVIHRDVKPSNILLDASGNVKL 156
Query: 419 SDYGFSSLVAQPIAAQRMI---SYKSPEYQSSKKISRK----SDVWSFGCLLLELLTGR 470
D+G S + A R +Y +PE + K +DVWS G L+EL TG+
Sbjct: 157 CDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 48/203 (23%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLL-----VIADQKHPNLLPLL 330
+GKG FG A + ++ K ++ ++ K ++ ++ + KHP L+ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
+ + D+ V + G LF + + R R+R A +A AL YLH +
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEPRARFYAAE-IASALGYLHSLN 116
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSPEYQS 446
+++ +LK NILLD ++++D+G + Y +PE
Sbjct: 117 -------IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH 169
Query: 447 SKKISRKSDVWSFGCLLLELLTG 469
+ R D W G +L E+L G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 46/204 (22%), Positives = 84/204 (41%), Gaps = 21/204 (10%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLLPLLA 331
LGKG FG + ++ + +I ++ L V+ + +HP L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
+ + D V ++ G LF + S+ R+ R+R A + AL+YLH
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAE-IVSALDYLH---- 112
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSPEYQSS 447
+++ +LK N++LD + + ++D+G A + Y +PE
Sbjct: 113 ---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED 169
Query: 448 KKISRKSDVWSFGCLLLELLTGRI 471
R D W G ++ E++ GR+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 25/110 (22%)
Query: 371 SRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS------ 424
+R +A V A EYLH++ +I+ +LK N+LLD N V + D+GF+
Sbjct: 95 ARFYIA-CVVLAFEYLHNRG-------IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146
Query: 425 ----SLVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+ P Y +PE +K D WS G LL ELLTGR
Sbjct: 147 QKTWTFCGTP-------EYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 28/214 (13%)
Query: 276 LGKGIFGNSYKALLEGRAP------VVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPL 329
LG+G FG + A P V VK L++ ++F+++ ++ +H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 330 LAYYFSNDEKLLVYKFAGNGNL--FNRIHG-------GKSSKNRIPFRCRSRLLVARGVA 380
L+V+++ +G+L F R HG G L +A +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP----IAAQRM 436
+ YL +H +L + N L+ +V + D+G S + + + M
Sbjct: 133 SGMVYL-------ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 437 --ISYKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
I + PE +K + +SD+WSFG +L E+ T
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 21/174 (12%)
Query: 304 KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSK 362
K TE R + V+ + L L Y F D KL L+ + G LF +
Sbjct: 44 KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL------S 97
Query: 363 NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG 422
R F+ + + + + ALE+LH + +I+ ++K NILLD N V+++D+G
Sbjct: 98 QRERFKEQEVQIYSGEIVLALEHLH-------KLGIIYRDIKLENILLDSNGHVVLTDFG 150
Query: 423 FS-----SLVAQPIAAQRMISYKSPEYQSSKKI--SRKSDVWSFGCLLLELLTG 469
S V + + I Y +P+ + D WS G L+ ELLTG
Sbjct: 151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 63/286 (22%), Positives = 105/286 (36%), Gaps = 86/286 (30%)
Query: 295 VVVKRLRDLKPLITEE-----FRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349
V +K LR P EE FR++ + A HPN++ LL D A G
Sbjct: 6 VAIKLLRTDAP--EEEHQRARFRRETALCARLYHPNIVALL------DSGE-----APPG 52
Query: 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH------------HKDKSRTQSA 397
LF + +P R +L A G A E H
Sbjct: 53 LLF-------AVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHN------QG 99
Query: 398 VIHGNLKSTNILL---DDNEMVLVSDYGFSSLV--AQPIAAQRMI---------SYKSPE 443
++H +LK NI++ V D+G +L+ + + +Y +PE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503
+ ++ SD++++G + LE LTG+ R V+ AEI
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLECLTGQ--------------------RVVQGASVAEILY 199
Query: 504 SEISVQRSA------AHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543
++S + H + ++L+ A+ NK P +R A ++E
Sbjct: 200 QQLSPVDVSLPPWIAGHPLGQVLRKAL---NKDPRQRAASAPALAE 242
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 59/223 (26%)
Query: 276 LGKGIFGNSYKA--LLEGRAPVVVKR--------------LRDLKPLITEEFRKQLLVIA 319
+G+G +G YKA L G V +K+ LR++K L K+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEI-VAIKKIKLRFESEGIPKTALREIKLL------KEL---- 55
Query: 320 DQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPF---RCRSRLLVA 376
HPN++ LL + + LV++F + +L+ I + +S L
Sbjct: 56 --NHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKD-----RQRGLPESLIKSYLYQ- 106
Query: 377 RGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM 436
+ + L + H ++H +LK N+L++ ++ ++D+G + P R
Sbjct: 107 --LLQGLAFCH-------SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP---VRP 154
Query: 437 IS-------YKSPE-YQSSKKISRKSDVWSFGCLLLELLTGRI 471
+ Y++PE K S D+WS GC+ ELL+ R
Sbjct: 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 42/211 (19%)
Query: 276 LGKGIFGNSYKALLEGRAPVV-VKRLRDLKPLITEEFRKQLLVIADQK-------HPNLL 327
LG G FG +G +K L K I + KQ+ + ++K HP L+
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILS--KAKIVK--LKQVEHVLNEKRILQSIRHPFLV 64
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIH-GGKSSKNRIPFRCRSRLLVARGVARALEYL 386
L + + LV ++ G LF+ + G+ + F A V ALEYL
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF-------YAAQVVLALEYL 117
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS--------SLVAQPIAAQRMIS 438
H D +++ +LK N+LLD + + ++D+GF+ +L P
Sbjct: 118 HSLD-------IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTP-------E 163
Query: 439 YKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
Y +PE SK + D W+ G L+ E+L G
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 330 LAY-YFSNDEKLLVYKFAGNGNL-FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
LAY Y + D LV G+L F+ H G++ F + A + LE LH
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-----FEEGRAVFYAAEICCGLEDLH 119
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV--AQPIAAQ-RMISYKSPEY 444
Q +++ +LK NILLDD+ + +SD G + V Q I + + Y +PE
Sbjct: 120 -------QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 172
Query: 445 QSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAE 500
+++ + D W+ GCLL E++ G+ + I ++ +++ V+EE++ +
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-ERLVKEVQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 17/99 (17%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
R L+Y+H SA V+H +LK +N+LL+ N + + D+G + + ++
Sbjct: 117 RGLKYIH--------SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 439 ------YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE +SK ++ D+WS GC+L E+L+ R
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 47/221 (21%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-------------- 321
LGKG FG K +L V+ K + +K++++ D+
Sbjct: 3 LGKGTFG---KVIL-------VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 322 KHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR 381
+HP L L + ++D V ++A G LF + S+ R+ R+R A V+
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVS- 106
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS--- 438
AL YLH D V++ +LK N++LD + + ++D+G L + I+ +
Sbjct: 107 ALGYLHSCD-------VVYRDLKLENLMLDKDGHIKITDFG---LCKEGISDGATMKTFC 156
Query: 439 ----YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHS 475
Y +PE R D W G ++ E++ GR+ ++
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 47/212 (22%), Positives = 96/212 (45%), Gaps = 38/212 (17%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKR--LRDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
+G+G G +KA E V +K+ LR L+ I + +++ + +HP ++ LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPF-----RCRSRLLVARGVARALEYLH 387
+ +LV ++ + L + P + R+L+ + + Y+H
Sbjct: 68 FPHGSGFVLVMEYMPSD-LSEVLR-----DEERPLPEAQVKSYMRMLL-----KGVAYMH 116
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-------YK 440
+ ++H +LK N+L+ + ++ ++D+G + L ++ R+ S Y+
Sbjct: 117 -------ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE--EPRLYSHQVATRWYR 167
Query: 441 SPE--YQSSKKISRKSDVWSFGCLLLELLTGR 470
+PE Y ++K D+W+ GC+ ELL G
Sbjct: 168 APELLY-GARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 58/214 (27%), Positives = 87/214 (40%), Gaps = 33/214 (15%)
Query: 276 LGKGIFGNSYKALL------EGRAPVVVKRLRD-LKPLITEEFRKQLLVIADQKHPNLLP 328
+G G FG K LL +A VVVK LR P F +++ + HPN+L
Sbjct: 3 IGNGWFG---KVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
L + LLV +F G+L N + + ++ + +A VA L +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA-QKDVLQRMACEVASGLLWLHQ 118
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP----IAAQRM---ISYKS 441
D IH +L N L + V + DYG + L P I + + +
Sbjct: 119 AD-------FIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLA 170
Query: 442 PEYQSS-------KKISRKSDVWSFGCLLLELLT 468
PE K ++KS++WS G + EL T
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 36/211 (17%)
Query: 276 LGKGIFGNSYKALLEGRAPV-VVKRLR--------DLKPLITEEFRKQLLVIADQKHPNL 326
LGKG FG A L+G V +K L+ D+ +TE K++L +A KHP L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTE---KRILALA-AKHPFL 58
Query: 327 LPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386
L + + D V ++ G+L +I +S K P RSR A V AL +L
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQ--RSRKFDEP---RSRFYAAE-VTLALMFL 112
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-------Y 439
H + VI+ +LK NILLD ++D+G + + I + Y
Sbjct: 113 H-------RHGVIYRDLKLDNILLDAEGHCKLADFG---MCKEGILNGVTTTTFCGTPDY 162
Query: 440 KSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+PE + D W+ G L+ E++ G+
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 37/209 (17%)
Query: 276 LGKGIFG--NSYKALLEGRAPVVVKRLRDLKPLITEEFRKQ----LLVIADQKHPNLLPL 329
+G G FG S + L G+ V +K++ +KP T K+ L ++ +H N++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQ-NVAIKKI--MKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 330 LAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
+ S E + V + G +L + K I + + R L+Y+H
Sbjct: 75 SDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQY-------FLYQILRGLKYVH- 125
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSS- 447
+ V+H +LK +NIL+++N + + D+G + I +M Y S Y +
Sbjct: 126 ------SAGVVHRDLKPSNILINENCDLKICDFGLAR-----IQDPQMTGYVSTRYYRAP 174
Query: 448 ------KKISRKSDVWSFGCLLLELLTGR 470
+K + D+WS GC+ E+L G+
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 36/215 (16%)
Query: 276 LGKGIFGNSYKALLEGRAPV-VVKRLRDLKPLITEE-------FRKQLLVIADQKHPNLL 327
LGKG FG A L+G +K L+ K ++ E+ +++L +A +HP L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALK--KDVVLEDDDVECTMVERRVLALA-WEHPFLT 59
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHG-GKSSKNRIPFRCRSRLLVARGVARALEYL 386
L + + + V ++ G+L I G+ + R F A + L++L
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-------YAAEIICGLQFL 112
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-------Y 439
H K +I+ +LK N+LLD + + ++D+G + + + + S Y
Sbjct: 113 HKK-------GIIYRDLKLDNVLLDKDGHIKIADFG---MCKENMNGEGKASTFCGTPDY 162
Query: 440 KSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTH 474
+PE +K + D WSFG LL E+L G+ H
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 52/225 (23%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLLAYYF 334
+G+G +G+ YKA + L+ ++ I+ +++ ++ + KHPN++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 335 SNDEK--LLVYKFAGNGNLFNRIHGGKSSK-NRIPFRCRSRLLVARGVARALEYLHHKDK 391
S+ ++ L++ +A + +L++ I ++SK N+ P + R +V + + L+ +H+
Sbjct: 69 SHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQL-PRSMVKSLLYQILDGIHYLHA 126
Query: 392 SRTQSAVIHGNLKSTNILL----DDNEMVLVSDYGFSSLVAQPIAAQRMIS-------YK 440
+ V+H +LK NIL+ + V ++D GF+ L P+ + Y+
Sbjct: 127 N----WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 441 SPEYQ-SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD 484
+PE ++ ++ D+W+ GC+ ELLT H + I ++
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 73/312 (23%), Positives = 125/312 (40%), Gaps = 61/312 (19%)
Query: 276 LGKGIFGNSYKALLEG--------RAPVVVKRLRD------LKPLITE-EFRKQLLVIAD 320
LG+G FG A G V VK L+D L L++E E K +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI----- 77
Query: 321 QKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSK-------NRIP---FRCR 370
KH N++ LL + ++ ++A GNL + + R+P +
Sbjct: 78 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 371 SRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV--- 427
+ VAR +EYL IH +L + N+L+ +N ++ ++D+G + V
Sbjct: 138 DLVSCTYQVARGMEYL-------ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI 190
Query: 428 ---AQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD 484
+ + + + +PE + + +SDVWSFG L+ E+ T S + GI +
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE 247
Query: 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
L + R + A + + R H + P RP ++V +L
Sbjct: 248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAI--------------PSHRPTFKQLVEDL 293
Query: 545 EIIKVTESTEEE 556
+ I +T +T EE
Sbjct: 294 DRI-LTLTTNEE 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 56/233 (24%), Positives = 113/233 (48%), Gaps = 38/233 (16%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLLAYYF 334
+G+G +G+ YKA + L+ ++ I+ +++ ++ + KHPN++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 335 SN-DEKL-LVYKFAGNGNLFNRIHGGKSSK-NRIPFRCRSRLLVARGVARAL-------- 383
S+ D K+ L++ +A + +L++ I ++SK N+ P + + RG+ ++L
Sbjct: 69 SHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQ------LPRGMVKSLLYQILDGI 121
Query: 384 EYLHHKDKSRTQSAVIHGNLKSTNILL----DDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
YLH + V+H +LK NIL+ + V ++D GF+ L P+ +
Sbjct: 122 HYLH-------ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 439 ------YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD 484
Y++PE ++ ++ D+W+ GC+ ELLT H + I ++
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 70/296 (23%), Positives = 110/296 (37%), Gaps = 73/296 (24%)
Query: 276 LGKGIFGNSYKALLEGRA----PVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLL 330
LG G FG+ K + ++ V VK L+ +EF ++ V+A HP ++ L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
+ +LV + A G L K K R +A VA + YL K
Sbjct: 63 GVCKG-EPLMLVMELAPLGPLL------KYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSK-- 448
+H +L + N+LL + +SD+G S R + S Y+++
Sbjct: 116 -------FVHRDLAARNVLLVNRHQAKISDFGMS----------RALGAGSDYYRATTAG 158
Query: 449 ---------------KISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRA 492
K S KSDVWS+G L E S + P + GA++ + +
Sbjct: 159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAF----SYGAKPYGEMKGAEVIAMLESG 214
Query: 493 VR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
R EE EI+ + + C PE RP +E+ S
Sbjct: 215 ERLPRPEECPQEIYS------------------IMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 63/217 (29%), Positives = 91/217 (41%), Gaps = 50/217 (23%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRD--------LKPLITEEFRKQLLVIADQ------ 321
+GKG FG K LL KR D L+ I ++Q ++A++
Sbjct: 3 IGKGSFG---KVLL-------AKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52
Query: 322 -KHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGV 379
KHP L+ L Y F EKL V F G LF + + R R+R A +
Sbjct: 53 VKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQ-----RERSFPEPRARFYAAE-I 105
Query: 380 ARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
A AL YLH + +++ +LK NILLD V+++D+G L + IA +
Sbjct: 106 ASALGYLHSIN-------IVYRDLKPENILLDSQGHVVLTDFG---LCKEGIAQSDTTTT 155
Query: 439 ------YKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
Y +PE + D W G +L E+L G
Sbjct: 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 43/224 (19%)
Query: 276 LGKGIFGNSYKAL---LEGRAP-----VVVKRLR------DLKPLITE-EFRKQLLVIAD 320
LG+G FG A L+ P V VK L+ DL LI+E E K +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI----- 80
Query: 321 QKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL-----FNRIHGGKSSKN--RIP---FRCR 370
KH N++ LL + ++ ++A GNL R G + N ++P +
Sbjct: 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 371 SRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV--- 427
+ A VAR +EYL K IH +L + N+L+ ++ ++ ++D+G + +
Sbjct: 141 DLVSCAYQVARGMEYLASKK-------CIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193
Query: 428 ---AQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
+ + + + +PE + + +SDVWSFG LL E+ T
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 46/210 (21%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEF-----RKQLLVIADQKH---PN 325
E +G+G +G Y+ VV ++ +L T + ++++ +++ + PN
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLD---TPDDDVSDIQREVALLSQLRQSQPPN 63
Query: 326 LLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
+ Y ++ ++A G++ + G I + S ++ R V AL+Y
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP-----IAEKYIS--VIIREVLVALKY 116
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQ 445
+H VIH ++K+ NIL+ + V + D+G ++L+ Q +++R +P +
Sbjct: 117 IHK-------VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ-NSSKRSTFVGTPYWM 168
Query: 446 SSKKISR------KSDVWSFGCLLLELLTG 469
+ + I+ K+D+WS G + E+ TG
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 9e-08
Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 47/233 (20%)
Query: 260 PAG-FKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVI 318
PAG F+L +L+ G G +G YK + ++ D+ EE ++++ ++
Sbjct: 4 PAGIFELVELV-------GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINML 56
Query: 319 ADQKHPNLLPLLAYYFS---------NDEKLLVYKFAGNG---NLFNRIHGGKSSKNRIP 366
+K+ + + YY + +D+ LV +F G G +L G + I
Sbjct: 57 --KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 114
Query: 367 FRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426
+ CR + R L +LH Q VIH ++K N+LL +N V + D+G S+
Sbjct: 115 YICRE-------ILRGLSHLH-------QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160
Query: 427 VAQPIAAQRMISYKSPEYQSSKKIS----------RKSDVWSFGCLLLELLTG 469
+ + + +R +P + + + I+ KSD+WS G +E+ G
Sbjct: 161 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 42/196 (21%)
Query: 286 KALLEGRAPVVVKR--LRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVY 343
K LE +VK+ +R+++ L KQL +H NL+ L+ + LV+
Sbjct: 32 KKFLESEDDKMVKKIAMREIRML------KQL------RHENLVNLIEVFRRKKRLYLVF 79
Query: 344 KFAGN---GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIH 400
+F + +L +G S+ R + L + R +E+ H + +IH
Sbjct: 80 EFVDHTVLDDLEKYPNGLDESRVR-------KYLFQ--ILRGIEFCHSHN-------IIH 123
Query: 401 GNLKSTNILLDDNEMVLVSDYGFSSLVAQP------IAAQRMISYKSPEYQ-SSKKISRK 453
++K NIL+ + +V + D+GF+ +A P A R Y++PE K R
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW--YRAPELLVGDTKYGRA 181
Query: 454 SDVWSFGCLLLELLTG 469
D+W+ GCL+ E+LTG
Sbjct: 182 VDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 276 LGKGIFGNSYKALLEGRAP-VVVKRLRDLKPLITEEFR-----KQLLVIADQKHPNLLPL 329
LGKG FG A L+G+ VK L+ LI ++ K++L +A ++P L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-WENPFLTHL 61
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
+ + + V +F G+L I K R F A + L++LH K
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQ----DKGR--FDLYRATFYAAEIVCGLQFLHSK 115
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF-----------SSLVAQPIAAQRMIS 438
+I+ +LK N++LD + + ++D+G S+ P
Sbjct: 116 -------GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP-------D 161
Query: 439 YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTH 474
Y +PE K + D WSFG LL E+L G+ H
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 41/219 (18%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKP---LITE-EFRK---QLLVIADQKHPNL 326
E LGKG +G Y L + VK++ +L L E E+ K ++ ++ KH N+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 327 LPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRI-----PFRCRSRLLVARGVAR 381
+ L ++ + +F G++ S NR P C+ + GVA
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSI-------SSILNRFGPLPEPVFCKYTKQILDGVA- 116
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS---SLVAQPIAAQRMIS 438
YLH + V+H ++K N++L N ++ + D+G + + V M+
Sbjct: 117 ---YLH-------NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166
Query: 439 -------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+ +PE + RKSD+WS GC + E+ TG+
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 47/213 (22%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 271 APAEGLGKGIFGNSYKA---LLEG-RAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPN 325
+G+G FG+ Y+ E + V VK + P + E+F ++ ++ HP+
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 326 LLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
++ L+ + + +V + A G L + + + +K + S +L + ++ AL Y
Sbjct: 69 IVKLIGV-ITENPVWIVMELAPLGELRSYL---QVNKYSLDLA--SLILYSYQLSTALAY 122
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-----------SLVAQPIAAQ 434
L K +H ++ + N+L+ + V + D+G S S PI
Sbjct: 123 LESKR-------FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPI--- 172
Query: 435 RMISYKSPEYQSSKKISRKSDVWSFGCLLLELL 467
+ +PE + ++ + SDVW FG + E+L
Sbjct: 173 ---KWMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 16/100 (16%)
Query: 377 RGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR- 435
R + +EYLH + ++H ++K NIL D V + D+G +S Q I +
Sbjct: 111 RQILEGVEYLH-------SNMIVHRDIKGANILRDSAGNVKLGDFG-ASKRLQTICSSGT 162
Query: 436 -MIS------YKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
M S + SPE S + RK+DVWS GC ++E+LT
Sbjct: 163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 7/88 (7%)
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKS 441
+E LH Q +IH ++K N+L+D + ++D+G S + Y +
Sbjct: 109 GVEDLH-------QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLA 161
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTG 469
PE + SD WS GC++ E L G
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 48/214 (22%)
Query: 276 LGKGIFG----------NSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPN 325
+G G FG Y AL P V+ RL+ + + V+ + HP
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQ-----EQHVHNEKRVLKEVSHPF 62
Query: 326 LLPLLAYYFSNDEKLL--VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARAL 383
++ L ++ +D++ L + ++ G LF+ + +N F + L A + AL
Sbjct: 63 IIRL--FWTEHDQRFLYMLMEYVPGGELFSYL------RNSGRFSNSTGLFYASEIVCAL 114
Query: 384 EYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS--------SLVAQPIAAQR 435
EYLH K+ +++ +LK NILLD + ++D+GF+ +L P
Sbjct: 115 EYLHSKE-------IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTP----- 162
Query: 436 MISYKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
Y +PE SK ++ D W+ G L+ E+L G
Sbjct: 163 --EYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 34/111 (30%), Positives = 54/111 (48%), Gaps = 14/111 (12%)
Query: 364 RIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423
RIP ++ +A V R L YL R + ++H ++K +NIL++ + + D+G
Sbjct: 95 RIPENILGKISIA--VLRGLTYL------REKHKIMHRDVKPSNILVNSRGEIKLCDFGV 146
Query: 424 SSLV----AQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
S + A R SY SPE + +SD+WS G L+E+ GR
Sbjct: 147 SGQLIDSMANSFVGTR--SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 44/172 (25%), Positives = 80/172 (46%), Gaps = 29/172 (16%)
Query: 379 VARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV------AQPIA 432
VAR +E+L SR IH +L + NILL +N +V + D+G + + + +
Sbjct: 183 VARGMEFL----ASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 433 AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492
A+ + + +PE K + +SDVWSFG LL E+ + S + Q
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-------------- 281
Query: 493 VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
+ EE+ + D + R+ + ++ ++ + C P++RP + +V L
Sbjct: 282 INEEFCQRLKDG--TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 41/172 (23%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 379 VARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV------AQPIA 432
VA+ +E+L + IH +L + NILL +N +V + D+G + + +
Sbjct: 188 VAKGMEFLASRK-------CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 433 AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492
A+ + + +PE + + +SDVWSFG LL E+ + S + +
Sbjct: 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-------------- 286
Query: 493 VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
+ EE+ + E + R+ + ++ Q + C + P +RP +E+V L
Sbjct: 287 IDEEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 23/103 (22%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ-------PI- 431
+AL+Y+H S VIH +LK +NILL+ + V ++D+G + +++ P+
Sbjct: 118 KALKYIH--------SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169
Query: 432 ---AAQRMISYKSPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
A R Y++PE S + ++ D+WS GC+L E+L G+
Sbjct: 170 TDYVATRW--YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 26/212 (12%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVI-ADQKHPNLLPLLAY 332
E +GKG +G +K L + ++ D I EE + ++ A HPN++
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 333 YFSNDEK-----LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
Y+ D K LV + G++ + + G R+ ++A + AL L
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM-----EEPIIAYILHEALMGLQ 138
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSP----- 442
H ++T IH ++K NILL V + D+G S+ + +R S +P
Sbjct: 139 HLHVNKT----IHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-TRLRRNTSVGTPFWMAP 193
Query: 443 -----EYQSSKKISRKSDVWSFGCLLLELLTG 469
E Q + DVWS G +EL G
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 31/208 (14%)
Query: 276 LGKGIFGNSYKALL--EG---RAPVVVKRLRDLKPLIT-EEFRKQLLVIADQKHPNLLPL 329
LG G+FG +K + EG + PV +K ++D T +E +L + H ++ L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGV--ARALEYLH 387
L LV + + G+L + + + S + + L+ V A+ + YL
Sbjct: 75 LGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLD-------PQRLLNWCVQIAKGMYYLE 126
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-YKSP---- 442
+ ++H NL + NILL + +V ++D+G + L+ P + S +K+P
Sbjct: 127 -------EHRMVHRNLAARNILLKSDSIVQIADFGVADLL-YPDDKKYFYSEHKTPIKWM 178
Query: 443 --EYQSSKKISRKSDVWSFGCLLLELLT 468
E + + +SDVWS+G + E+++
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 43/219 (19%)
Query: 276 LGKGIFGNS----YKALLEGRAPVVVKRLRDLKPLITEEFR---KQLLVIADQKHPNLLP 328
+GK K V VK++ +L E+ + ++++ +HPN+LP
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTL-VAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVA---RGVARALEY 385
+ + + E +V G+ + + K P L +A + V AL+Y
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLL------KTHFPEGL-PELAIAFILKDVLNALDY 116
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA-------------QPIA 432
+H K IH ++K+++ILL + V++S G V+ P +
Sbjct: 117 IHSKG-------FIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKS 167
Query: 433 AQRMISYKSPE--YQSSKKISRKSDVWSFGCLLLELLTG 469
+ + + + SPE Q+ + + KSD++S G EL G
Sbjct: 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 17/99 (17%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
R L+YLH SA ++H ++K N+L++ N ++ + D+G + V +P ++ M
Sbjct: 114 RGLKYLH--------SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQE 164
Query: 439 -----YKSPE-YQSSKKISRKSDVWSFGCLLLELLTGRI 471
Y++PE S+ + D+WS GC+ ELL RI
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 34/210 (16%)
Query: 276 LGKGIFGNSYKALLEGR--APVVVKRLRDLKPLITEEFRK----QLLVIADQKHPNLLPL 329
+G G +G AL + R A V +K+L +P +E F K +L ++ KH N++ L
Sbjct: 23 VGSGAYGTVCSAL-DRRTGAKVAIKKLY--RPFQSELFAKRAYRELRLLKHMKHENVIGL 79
Query: 330 LAYYFSNDEKL-------LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARA 382
L F+ D L LV F G +L + K S++RI F LV + + +
Sbjct: 80 LDV-FTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSEDRIQF------LVYQ-MLKG 130
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-YKS 441
L+Y+H + +IH +LK N+ ++++ + + D+G + + + Y++
Sbjct: 131 LKYIH-------AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRA 183
Query: 442 PEY-QSSKKISRKSDVWSFGCLLLELLTGR 470
PE + ++ D+WS GC++ E+LTG+
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 276 LGKGIFGNSYKALLEGRAPV-VVKRLRDLKPLITEEFR-----KQLLVIADQKHPNLLPL 329
LGKG FG + A L+G +K L+ L+ ++ K++L +A +HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
+ + + V ++ G+L I K +P R+ A + L++LH K
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQ--SCHKFDLP---RATFYAAEIIC-GLQFLHSK 115
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF-----------SSLVAQPIAAQRMIS 438
+++ +LK NILLD + + ++D+G + P
Sbjct: 116 -------GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP-------D 161
Query: 439 YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTH 474
Y +PE +K + D WSFG LL E+L G+ H
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 48/159 (30%), Positives = 69/159 (43%), Gaps = 21/159 (13%)
Query: 317 VIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHG-GKSSKNRIPFRCRSRLL 374
V+A P ++PL + F + EKL LV F G LF+ + G+ +R F L
Sbjct: 46 VLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLC 104
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ 434
ALE LH + VI+ +LK NILLD + + D+G L +
Sbjct: 105 -------ALENLHKFN-------VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT 150
Query: 435 RMI----SYKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
Y +PE ++ D W+ G LL E+LTG
Sbjct: 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 37/104 (35%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 33 LNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLS 91
L G I S + ++ L + N +SG S KL +DLS N GEI ++
Sbjct: 248 LTGPIPS-SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 92 LKFLESLQLQNNNLTGPVPEFNQS--SLKVFNVSNNNLSGSIPK 133
L+ LE L L +NN TG +P S L+V + +N SG IPK
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
|
Length = 968 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 32/212 (15%)
Query: 274 EGLGKGIFGNSYKALL------EGRAPVVVKR--LRDLKP--LITEEFRKQLLVIADQKH 323
E LG+G F N YK +L + P L+ L + F + +++ H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 324 PNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARAL 383
+L+ L DE ++V ++ G L +H KN + + L VA+ +A AL
Sbjct: 61 KHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLH---REKNNVSLHWK--LDVAKQLASAL 114
Query: 384 EYLHHKDKSRTQSAVIHGNLKSTNILL---DDNE----MVLVSDYGFSSLVAQPIAAQRM 436
YL K ++HGN+ NIL+ NE + +SD G V
Sbjct: 115 HYLEDKK-------LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER 167
Query: 437 ISYKSPEY--QSSKKISRKSDVWSFGCLLLEL 466
I + +PE ++ +D WSFG LLE+
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 14/101 (13%)
Query: 377 RGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS---SLVAQPIAA 433
R + + YLH + ++H ++K NIL D V + D+G S +
Sbjct: 113 RQILEGMSYLH-------SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 434 QRMIS----YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
R ++ + SPE S + RK+DVWS GC ++E+LT +
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 22/169 (13%)
Query: 309 EEFRKQLLVIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPF 367
E R + V+ + L L Y F + KL L+ + G +F ++ R F
Sbjct: 49 EHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY------QRDNF 102
Query: 368 RCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427
+ + ALE+LH + +++ ++K NILLD V+++D+G S
Sbjct: 103 SEDEVRFYSGEIILALEHLH-------KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155
Query: 428 AQPIAAQRMISY-KSPEYQSSKKISRKS------DVWSFGCLLLELLTG 469
+R S+ + EY + + I K D WS G L+ ELLTG
Sbjct: 156 LSE-EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 29/100 (29%), Positives = 53/100 (53%), Gaps = 18/100 (18%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVL-VSDYGFSSLVAQPIAAQRMIS 438
R L+Y+H SA V+H +LK N+ ++ ++VL + D+G + +V + + +S
Sbjct: 125 RGLKYIH--------SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176
Query: 439 -------YKSPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
Y+SP S ++ D+W+ GC+ E+LTG+
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 62/281 (22%), Positives = 113/281 (40%), Gaps = 42/281 (14%)
Query: 276 LGKGIFGNSYKALL--EG---RAPVVVKRLRD-LKPLITEEFRKQLLVIADQKHPNLLPL 329
LG G FG YK + +G + PV +K LR+ P +E + V+A P + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
L ++ +L V + G L + + + +K+RI + V +A+ + YL
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYV---RENKDRIGSQDLLNWCVQ--IAKGMSYLE-- 126
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA------QPIAAQRMISYKSPE 443
+ ++H +L + N+L+ V ++D+G + L+ + I + + E
Sbjct: 127 -----EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503
++ + +SDVWS+G + EL+T + DL + E +
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE------KGERLPQPPI 235
Query: 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
I V + ++C E RP E+V E
Sbjct: 236 CTIDV-----------YMIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 32/122 (26%), Positives = 58/122 (47%), Gaps = 16/122 (13%)
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI--- 431
VAR + + YLH + ++H ++K +N+L++ + V ++D+G S ++AQ +
Sbjct: 173 VARQILSGIAYLHRRH-------IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225
Query: 432 -AAQRMISYKSPE-----YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADL 485
++ I+Y SPE D+WS G +LE GR QG + +
Sbjct: 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM 285
Query: 486 CS 487
C+
Sbjct: 286 CA 287
|
Length = 353 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (120), Expect = 1e-06
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 47/218 (21%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEE------------FRKQLLVIAD 320
E LG+G +G YKA + V +K++R L EE K+L
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIR----LDNEEEGIPSTALREISLLKEL----- 55
Query: 321 QKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVA 380
KHPN++ LL + + LV+++ +L + K P + +
Sbjct: 56 -KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLD-----KRPGPLSPNLIKSIMYQLL 108
Query: 381 RALEYLH-HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
R L Y H H+ ++H +LK NIL++ + ++ ++D+G + P+ +
Sbjct: 109 RGLAYCHSHR--------ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RTYTHE 158
Query: 439 -----YKSPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE SK S D+WS GC+ E++TG+
Sbjct: 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 44/214 (20%)
Query: 276 LGKGIFGNSYKALLEGRAPV-VVKRLR--------DLKPLITEEFRKQLLVIADQKHPNL 326
LGKG FG A L+ + VK L+ D++ +TE K++L +A HP L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTE---KRILSLARN-HPFL 58
Query: 327 LPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386
L + + D V +F G+L I K+R R+R A + AL +L
Sbjct: 59 TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQ-----KSRRFDEARARFYAAE-ITSALMFL 112
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF-----------SSLVAQPIAAQR 435
H K +I+ +LK N+LLD ++D+G S+ P
Sbjct: 113 HDK-------GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP----- 160
Query: 436 MISYKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
Y +PE D W+ G LL E+L G
Sbjct: 161 --DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 16/119 (13%)
Query: 360 SSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVS 419
++K I C L + R V RA++YLH ++ +IH ++K+ NI ++ V +
Sbjct: 174 AAKRNIAI-C-DILAIERSVLRAIQYLH-------ENRIIHRDIKAENIFINHPGDVCLG 224
Query: 420 DYGFSSLVAQPIAAQR------MISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRIS 472
D+G ++ I A + I+ +PE + D+WS G +L E+ T S
Sbjct: 225 DFG-AACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282
|
Length = 391 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 38/213 (17%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRL-----RDLKPLITE-EFRKQLLVIADQKHPNLLP 328
LGKG +G Y A L + + +K + R ++PL E L KH N++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL------KHRNIVQ 69
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFN--RIHGG--KSSKNRIPFRCRSRLLVARGVARALE 384
L N + + G+L R G K ++ I F + L L+
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-------EGLK 122
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL-VSDYGFSSLVA--QPIAA--QRMISY 439
YLH ++H ++K N+L++ V+ +SD+G S +A P + Y
Sbjct: 123 YLHDNQ-------IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQY 175
Query: 440 KSPEY--QSSKKISRKSDVWSFGCLLLELLTGR 470
+PE + + +D+WS GC ++E+ TG+
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 14/102 (13%)
Query: 376 ARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS-LVAQPIAAQ 434
R + + YLH + ++H ++K NIL D V + D+G S L ++
Sbjct: 112 TRQILEGVSYLH-------SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGT 164
Query: 435 RMIS------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
M S + SPE S + RK+D+WS GC ++E+LT +
Sbjct: 165 GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 45/157 (28%), Positives = 69/157 (43%), Gaps = 27/157 (17%)
Query: 322 KHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIH-GGKSSKNRIPFRCRSRLLVARGV 379
KHP ++ L+ Y F KL L+ ++ G LF + G ++ F L
Sbjct: 58 KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISL----- 111
Query: 380 ARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM--- 436
ALE+LH + +I+ +LK NILLD V ++D+G L + I +
Sbjct: 112 --ALEHLHQQ-------GIIYRDLKPENILLDAQGHVKLTDFG---LCKESIHEGTVTHT 159
Query: 437 ----ISYKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
I Y +PE + D WS G L+ ++LTG
Sbjct: 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 57/234 (24%), Positives = 104/234 (44%), Gaps = 49/234 (20%)
Query: 260 PAG-FKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVI 318
PAG F+L E +G G +G YK + ++ D+ EE + ++ ++
Sbjct: 14 PAGIFEL-------VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 319 ADQKHPNLLPLLAYYFS--------NDEKL-LVYKFAGNG---NLFNRIHGGKSSKNRIP 366
+K+ + + YY + +D++L LV +F G G +L G ++ I
Sbjct: 67 --KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA 124
Query: 367 FRCRSRLLVARGVARALEYLH-HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425
+ CR + R L +LH HK VIH ++K N+LL +N V + D+G S+
Sbjct: 125 YICRE-------ILRGLAHLHAHK--------VIHRDIKGQNVLLTENAEVKLVDFGVSA 169
Query: 426 LVAQPIAAQRMISYKSPEYQSSKKIS----------RKSDVWSFGCLLLELLTG 469
+ + + +R +P + + + I+ +SD+WS G +E+ G
Sbjct: 170 QLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 65/225 (28%)
Query: 276 LGKGIFGNSYKALLEGRAPVV-VKR-------------LRDLKPLITEEFRKQLLVIADQ 321
LG G FG+ Y A + +V +K+ LR++K L RK
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSL-----RKL------N 55
Query: 322 KHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPF---RCRSRLLVARG 378
+HPN++ L + NDE V+++ GNL+ + + PF RS +
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLM----KDRKGKPFSESVIRSII---YQ 107
Query: 379 VARALEYLH-----HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA 433
+ + L ++H H+D LK N+L+ E+V ++D+G +A+ I +
Sbjct: 108 ILQGLAHIHKHGFFHRD------------LKPENLLVSGPEVVKIADFG----LAREIRS 151
Query: 434 QR----MIS---YKSPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
+ +S Y++PE S S D+W+ GC++ EL T R
Sbjct: 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 45/211 (21%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 276 LGKGIFGNSYKALL------EGRAPVVVKRLRDLKPLITE--EFRKQLLVIADQKHPNLL 327
LG+G FG Y+ L E V +K + + + E EF + V+ + +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE-NASMRERIEFLNEASVMKEFNCHHVV 72
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFR---CRSRLL-VARGVARAL 383
LL + L+V + G+L + + + P + + +A +A +
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 384 EYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP----IAAQRM--I 437
YL K +H +L + N ++ ++ V + D+G + + + + + +
Sbjct: 133 AYLAAKK-------FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
+ +PE + KSDVWSFG +L E+ T
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 49/230 (21%), Positives = 92/230 (40%), Gaps = 50/230 (21%)
Query: 276 LGKGIFGNSYKAL--LEGRAPVVVKRLR--DLKPLITEEFRK------------QLLVIA 319
LG+G +G KA L G+ V +K+++ ++ +T++ + +L ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKI-VAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 320 DQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGV 379
+ KH N++ L+ Y D LV +L K +I + +
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIM-ASDL------KKVVDRKIRLTESQVKCILLQI 128
Query: 380 ARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA------ 433
L LH + +H +L NI ++ + ++D+G + P +
Sbjct: 129 LNGLNVLH-------KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 434 ------QRMIS------YKSPEY-QSSKKISRKSDVWSFGCLLLELLTGR 470
+ M S Y++PE ++K D+WS GC+ ELLTG+
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 47/189 (24%), Positives = 90/189 (47%), Gaps = 31/189 (16%)
Query: 295 VVVKRL-RDLKPLI-TEEFRKQLLVIADQKHPNLLPLLAYYFS-------NDEKLLVYKF 345
V VK+L R + +I + ++L ++ KH N++ LL + ND L+ +
Sbjct: 45 VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 104
Query: 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKS 405
+ N N + K + + + F + + R L+Y+H D +IH +LK
Sbjct: 105 GADLN--NIVKCQKLTDDHVQF-------LIYQILRGLKYIHSAD-------IIHRDLKP 148
Query: 406 TNILLDDNEMVLVSDYGFSSLVAQPIA---AQRMISYKSPEYQSS-KKISRKSDVWSFGC 461
+N+ ++++ + + D+G + + A R Y++PE + ++ D+WS GC
Sbjct: 149 SNLAVNEDCELKILDFGLARHTDDEMTGYVATRW--YRAPEIMLNWMHYNQTVDIWSVGC 206
Query: 462 LLLELLTGR 470
++ ELLTGR
Sbjct: 207 IMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 17/146 (11%)
Query: 330 LAY-YFSNDEKLLVYKFAGNGNL-FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
LAY Y + D LV G+L F+ + G F + A + LE LH
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-----FDEERAVFYAAEITCGLEDLH 119
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV--AQPIAAQ-RMISYKSPEY 444
+ +++ +LK NILLDD + +SD G + + + I + + Y +PE
Sbjct: 120 RER-------IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEV 172
Query: 445 QSSKKISRKSDVWSFGCLLLELLTGR 470
+++ + D W GCL+ E++ G+
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 66/227 (29%)
Query: 276 LGKGIFGNSYKAL--LEGRAPVVVKR-----------------LRDLKPLITEEFRKQLL 316
LG+G + YKA GR V +K+ LR++K ++L
Sbjct: 8 LGEGTYAVVYKARDKETGR-IVAIKKIKLGERKEAKDGINFTALREIK------LLQEL- 59
Query: 317 VIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPF------RCR 370
KHPN++ LL + LV++F +L I K++ +
Sbjct: 60 -----KHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVI------KDKSIVLTPADIKSY 107
Query: 371 SRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430
+ + R LEYLH ++H +LK N+L+ + ++ ++D+G + P
Sbjct: 108 MLMTL-----RGLEYLHSN-------WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155
Query: 431 IAAQRMIS------YKSPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
++M Y++PE ++ D+WS GC+ ELL
Sbjct: 156 --NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 55/219 (25%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLK--PLITE----EFR--KQLLVIADQKHPNL 326
+G+G +G +K E V +K+ + + P+I + E R KQL KHPNL
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL------KHPNL 62
Query: 327 LPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLL--VARGVARAL 383
+ L+ F KL LV+++ + + N + + P L+ + +A+
Sbjct: 63 VNLIEV-FRRKRKLHLVFEYCDH-TVLNEL-------EKNPRGVPEHLIKKIIWQTLQAV 113
Query: 384 EYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP------IAAQRMI 437
+ H + IH ++K NIL+ + + D+GF+ ++ P A R
Sbjct: 114 NFCH-------KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW- 165
Query: 438 SYKSPE-------YQSSKKISRKSDVWSFGCLLLELLTG 469
Y++PE Y DVW+ GC+ ELLTG
Sbjct: 166 -YRAPELLVGDTQYGPP------VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 52/211 (24%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 274 EGLGKGIFGNSYKA--LLEGRAPVVVKRLRDLKPLITEE------FRKQLLVIADQKHPN 325
E +G+G +G YKA L G V +K++R L TE +++ ++ + HPN
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEV-VALKKIR----LDTETEGVPSTAIREISLLKELNHPN 60
Query: 326 LLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
++ LL + ++ LV++F + +L + S +P + +G+A +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115
Query: 386 LH-HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR----MISYK 440
H H+ V+H +LK N+L++ + ++D+G + P+ + Y+
Sbjct: 116 CHSHR--------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 167
Query: 441 SPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
+PE K S D+WS GC+ E++T R
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 15/145 (10%)
Query: 330 LAY-YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
LAY Y + D LV G+L I+ + F L A + LE LH
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG----FEEERALFYAAEILCGLEDLH- 119
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR---MISYKSPEYQ 445
+ ++ +LK NILLDD + +SD G + + + + + + Y +PE
Sbjct: 120 ------RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL 173
Query: 446 SSKKISRKSDVWSFGCLLLELLTGR 470
++++ + D W GCL+ E++ G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 29/99 (29%), Positives = 47/99 (47%), Gaps = 14/99 (14%)
Query: 377 RGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM 436
R + + + YLH + ++H ++K NIL D V + D+G S + +
Sbjct: 113 RQILQGVSYLH-------SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG 165
Query: 437 IS-------YKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
I + SPE S + RK+DVWS C ++E+LT
Sbjct: 166 IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 32/205 (15%)
Query: 276 LGKGIFGNSYKALLE---GRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLL 330
LG G FG K + + V VK L+ + P + +E ++ V+ +P ++ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGK--SSKNRIPFRCRSRLLVARGVARALEYLHH 388
+ +LV + A G L + K + KN LV + V+ ++YL
Sbjct: 63 GI-CEAESWMLVMELAELGPLNKFLQKNKHVTEKNITE-------LVHQ-VSMGMKYLE- 112
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV--------AQPIAAQRMISYK 440
++ +H +L + N+LL +SD+G S + A+ + Y
Sbjct: 113 ------ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY- 165
Query: 441 SPEYQSSKKISRKSDVWSFGCLLLE 465
+PE + K S KSDVWSFG L+ E
Sbjct: 166 APECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 42/227 (18%)
Query: 274 EGLGKGIFGNSYKALLEG---------------RAP--VVVKRLR-DLKPLITEEFRKQL 315
E LG+G FG + EG P V VK LR D +F K++
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 316 LVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSS--KNRIPFRCRS 371
+++ K PN++ LLA ++D ++ ++ NG+L F H + + K + S
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 372 RLL-VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS----- 425
L+ +A +A ++YL + +H +L + N L+ N + ++D+G S
Sbjct: 131 TLIFMATQIASGMKYL-------SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 426 ----LVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
+ + + R +S++S K + SDVW+FG L E+LT
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILL---GKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 276 LGKGIFGNSYKALLEGRAP---VVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLA 331
LG G FG K + + R V +K L+ + + + +E ++ ++ +P ++ ++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
+ +LV + A G L N+ GK K+ I L+ V+ ++YL K+
Sbjct: 63 V-CEAEALMLVMEMASGGPL-NKFLSGK--KDEITVSNVVELM--HQVSMGMKYLEGKN- 115
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP-------IAAQRMISYKSPEY 444
+H +L + N+LL + +SD+G S + A + + + +PE
Sbjct: 116 ------FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPEC 169
Query: 445 QSSKKISRKSDVWSFGCLLLELLT 468
+ +K S +SDVWS+G + E +
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 40/145 (27%), Positives = 60/145 (41%), Gaps = 15/145 (10%)
Query: 330 LAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
LAY F + L LV G+L I + F + A + LE+LH
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHI----YNVGEPGFPEARAIFYAAQIICGLEHLH- 112
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-SLVAQPIAAQRM--ISYKSPEYQ 445
Q +++ +LK N+LLDD+ V +SD G + L R Y +PE
Sbjct: 113 ------QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL 166
Query: 446 SSKKISRKSDVWSFGCLLLELLTGR 470
+ D ++ GC L E++ GR
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 45/207 (21%), Positives = 92/207 (44%), Gaps = 34/207 (16%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLIT-EEFRKQLLVIADQKHPNLLPLLAYYF 334
LG G FG YKA + + ++ + K E++ ++ ++A HP ++ LL ++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 335 SNDEKLLVYKFAGNGN----LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
+ + ++ +F G + G + ++ + R + AL+YLH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---------ICRQMLEALQYLHSM- 129
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKI 450
+IH +LK+ N+LL + + ++D+G S+ + + QR S+ Y + ++
Sbjct: 130 ------KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEV 181
Query: 451 -----------SRKSDVWSFGCLLLEL 466
K+D+WS G L+E+
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRL-RDLKPLI-TEEFRKQLLVIADQKHPNLLPLLAY 332
+G G +G+ A R V VK+L R + LI ++L ++ KH N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 333 YFSN------DEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386
+ +E LV G +L N + K S + F L R L+Y+
Sbjct: 83 FTPATSIENFNEVYLVTNLMG-ADLNNIVKCQKLSDEHVQFLIYQLL-------RGLKYI 134
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA---AQRMISYKSPE 443
H + +IH +LK +N+ ++++ + + D+G + + A R Y++PE
Sbjct: 135 H-------SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRW--YRAPE 185
Query: 444 YQSS-KKISRKSDVWSFGCLLLELLTGRI 471
+ ++ D+WS GC++ ELL G+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 13/104 (12%)
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-SLVAQPIAA 433
+ R + AL YLH + +IH ++K+ NI LD+ E ++ D+G + L A P
Sbjct: 190 IQRRLLEALAYLHGR-------GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242
Query: 434 Q-----RMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRIS 472
Q + SPE + K+D+WS G +L E+ ++
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 12/89 (13%)
Query: 66 SSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE--FNQSSLKVFNVS 123
S NH +DL N G I SL +LK L+ L L N L+GP+P F+ L ++S
Sbjct: 237 SLNH----LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLS 292
Query: 124 NNNLSGSIP----KTQTLQLFRSYSYSNN 148
+N+LSG IP + Q L++ + +SNN
Sbjct: 293 DNSLSGEIPELVIQLQNLEIL--HLFSNN 319
|
Length = 968 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 29/100 (29%), Positives = 54/100 (54%), Gaps = 19/100 (19%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ-PIAAQRMIS 438
R L+Y+H SA VIH +LK +N+L++++ + + D+G + ++ P + ++
Sbjct: 118 RGLKYIH--------SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169
Query: 439 -------YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE S + + D+WS GC+ E+L GR
Sbjct: 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 26/79 (32%), Positives = 36/79 (45%), Gaps = 15/79 (18%)
Query: 399 IHGNLKSTNILLDDNEMVLVSDYGFS--------SLVAQPIAAQRMISYKSPEYQSSKKI 450
IH +LK N L+D + + ++D+G S S+V P Y +PE K
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSP-------DYMAPEVLRGKGY 175
Query: 451 SRKSDVWSFGCLLLELLTG 469
D WS GC+L E L G
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 29/118 (24%), Positives = 52/118 (44%), Gaps = 3/118 (2%)
Query: 19 NSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNF-MNFSSNHKLKDIDLS 77
+S ++ ++L L GEI L + ++N SG F+ + +D+S
Sbjct: 378 SSGNLFKLILFSNSLEGEIPKS-LGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 78 GNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSS-LKVFNVSNNNLSGSIPKT 134
N G I+ + L+ L L N G +P+ S L+ ++S N SG++P+
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRK 494
|
Length = 968 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 27/207 (13%)
Query: 276 LGKGIFGNSYKALLE--GR---APVVVKRLRDLKPLITEEF--RKQLLVIADQKHPNLLP 328
+GKG FG Y+ + R V+ K+ K + R L+ + P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRI-HGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
L + ++ + LV + G LF + G+ S++R F +L ALE+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL-------ALEHLH 113
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS--SLVAQPIAAQ--RMISYKSPE 443
D +++ +LK NILLD + + D+G S +L Y +PE
Sbjct: 114 KYD-------IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166
Query: 444 -YQSSKKISRKSDVWSFGCLLLELLTG 469
K ++ D WS G L+ E+ G
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 20/101 (19%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS--SLVAQPIA------ 432
RAL+Y+H + V H +LK NIL + + + + D+G + + P A
Sbjct: 114 RALKYIH-------TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166
Query: 433 -AQRMISYKSPEYQSS--KKISRKSDVWSFGCLLLELLTGR 470
A R Y++PE S K + D+WS GC+ E+LTG+
Sbjct: 167 VATRW--YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 14/105 (13%)
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA--QPIAAQRMISYK 440
LE++H++ V++ +LK NILLD++ V +SD G + + +P A+ Y
Sbjct: 110 LEHMHNR-------FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM 162
Query: 441 SPE-YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD 484
+PE Q +D +S GC+L +LL G HS + D
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG----HSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 32/159 (20%)
Query: 321 QKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFR---CRSRLLVAR 377
+ +PN + L + +L+ + +G+LF+ + K + + R
Sbjct: 66 KDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL------KKEGKLSEAEVK---KIIR 116
Query: 378 GVARALEYLH-HKDKSRTQSAVIHGNLKSTNILLDDNEM-VLVSDYGFSSLVAQPIAAQR 435
+ AL LH H +IH ++K N+L D + + + DYG ++ P
Sbjct: 117 QLVEALNDLHKHN--------IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG 168
Query: 436 MISYKSPEYQSSKKISRKS-----DVWSFGCLLLELLTG 469
+ Y SPE KI + D W+ G L ELLTG
Sbjct: 169 TLDYFSPE-----KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 29/164 (17%)
Query: 322 KHPNLLPLLAYYFSNDEKL--LVYKFAGNGNLFNRIHGGKSSKNR-IPFRCRSRLL--VA 376
KH N++ L+ + + +K L++ +A + +L+ I + +K IP LL +
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 377 RGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL--DDNE--MVLVSDYGFSSLVAQPIA 432
GV YLH + V+H +LK NIL+ + E +V + D G + L P+
Sbjct: 119 NGVH----YLH-------SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 433 AQR-------MISYKSPE-YQSSKKISRKSDVWSFGCLLLELLT 468
I Y++PE ++ ++ D+W+ GC+ ELLT
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 36/217 (16%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIAD-QKHPNLLPLLAY 332
E +GKG +G YK + + ++ D + EE + ++ HPN++
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 333 YFSNDEKL-----LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRL---LVARGVARALE 384
++ D+ + LV + G++ + G C RL +++ + AL
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKG--------LLICGQRLDEAMISYILYGALL 139
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA--QRMISYKSP 442
L H +R +IH ++K NILL V + D+G S AQ + +R S +P
Sbjct: 140 GLQHLHNNR----IIHRDVKGNNILLTTEGGVKLVDFGVS---AQLTSTRLRRNTSVGTP 192
Query: 443 ----------EYQSSKKISRKSDVWSFGCLLLELLTG 469
E Q + DVWS G +EL G
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 36/152 (23%), Positives = 66/152 (43%), Gaps = 17/152 (11%)
Query: 323 HPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARA 382
HP L+ L + + + V ++ G+L + + ++P +R A ++ A
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEE-HARFYSAE-ISLA 108
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----S 438
L YLH + +I+ +LK N+LLD + ++DYG +P +
Sbjct: 109 LNYLHER-------GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 161
Query: 439 YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y +PE + D W+ G L+ E++ GR
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 43/205 (20%), Positives = 87/205 (42%), Gaps = 26/205 (12%)
Query: 276 LGKGIFGNSYKALLE--GRA--PVVVKRLRD-LKPLITEEFRKQLLVIADQKHPNLLPLL 330
LG G FG + L+ + PV + LR F + L + H N++ L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 331 AYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
+ ++V ++ NG L F R H G+ ++ + + G+A ++YL
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL-------MGMLPGLASGMKYL-- 123
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG-----FSSLVAQPIAAQRMISYKSPE 443
++ +H L + +L++ + + +S + S + ++ + + + +PE
Sbjct: 124 -----SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPE 178
Query: 444 YQSSKKISRKSDVWSFGCLLLELLT 468
S SDVWSFG ++ E+++
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 52/225 (23%)
Query: 274 EGLGKGIFGNSYKA--------------LL----EGRAPVVVKRLRDLKPLITEEFRKQL 315
E +G+G +G YKA L EG P ++ + L+ L + +L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 316 LVIADQKHPN---LLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSR 372
L + + N L L+ Y +D K KF G+ +P +
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLK----KFM--------DSNGRGPGRPLPAKTIKS 114
Query: 373 LL--VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL-VSDYGFSSLVAQ 429
+ + +GVA + H + V+H +LK N+L+D + +L ++D G +
Sbjct: 115 FMYQLLKGVA----HCH-------KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163
Query: 430 PIAAQR----MISYKSPE-YQSSKKISRKSDVWSFGCLLLELLTG 469
P+ + + Y++PE S S D+WS GC+ E+
Sbjct: 164 PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 47/199 (23%), Positives = 84/199 (42%), Gaps = 22/199 (11%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFR---KQLLVIADQKHPNLLPLLA 331
+G G FG Y A + V +K++ E+++ K++ + +HPN +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 332 YYFSNDEKLLVYKFA-GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
Y LV ++ G+ + +H + P + V G + L YLH +
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEY---QSS 447
+IH ++K+ NILL + +V + D+G +S++A + +PE
Sbjct: 136 -------MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDE 188
Query: 448 KKISRKSDVWSFGCLLLEL 466
+ K DVWS G +EL
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 6e-05
Identities = 25/97 (25%), Positives = 49/97 (50%), Gaps = 16/97 (16%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-- 438
+ +LH ++H +LK++N+LL++ ++ + D+G + P+ +
Sbjct: 117 SGVAHLHDN-------WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLV 167
Query: 439 ----YKSPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE +K+ S D+WS GC+ ELLT +
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 26/206 (12%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEE------FRKQLLVIADQKHPNLLPL 329
LGKG FG A +G + ++ +I ++ K++L + D K P L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-KPPFLTQL 66
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHG-GKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
+ + + D V ++ G+L I GK F+ + A ++ L +LH
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-------FKEPQAVFYAAEISVGLFFLHR 119
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSPEY 444
+ +I+ +LK N++LD + ++D+G R Y +PE
Sbjct: 120 R-------GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172
Query: 445 QSSKKISRKSDVWSFGCLLLELLTGR 470
+ + + D W++G LL E+L G+
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 31/129 (24%), Positives = 60/129 (46%), Gaps = 17/129 (13%)
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG--------FSSL 426
VAR + A++Y+H + +IH ++K+ N+L++ E + + D+G +S+
Sbjct: 265 VARQLLSAIDYIHGE-------GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317
Query: 427 VAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLC 486
IA + +PE + + D+WS G ++ E S SA +G
Sbjct: 318 FHYGIAG--TVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYD 375
Query: 487 SWVLRAVRE 495
+ +LR +R+
Sbjct: 376 AQILRIIRQ 384
|
Length = 461 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 24/79 (30%), Positives = 42/79 (53%), Gaps = 9/79 (11%)
Query: 398 VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM------ISYKSPEYQSSKKIS 451
+++ +LK NILLDD + +SD G L Q + + + Y +PE +++K +
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLG---LAVQIPEGETVRGRVGTVGYMAPEVINNEKYT 179
Query: 452 RKSDVWSFGCLLLELLTGR 470
D W GCL+ E++ G+
Sbjct: 180 FSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 35/100 (35%), Positives = 49/100 (49%), Gaps = 15/100 (15%)
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD----DNE---MVLVSDYGFSSLV 427
VA+ +A AL YL KD ++HGN+ + NILL D E + +SD G V
Sbjct: 110 VAKQLASALSYLEDKD-------LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV 162
Query: 428 AQPIAAQRMISYKSPE-YQSSKKISRKSDVWSFGCLLLEL 466
I + +PE + SK +S +D WSFG L E+
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 8e-05
Identities = 47/205 (22%), Positives = 83/205 (40%), Gaps = 36/205 (17%)
Query: 301 RDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF--SNDEKLLVYKFAGNGNLFNRIHG- 357
R LK + ++ V+ + KH N++ + + +N + ++ +F G+L I
Sbjct: 49 RGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC 108
Query: 358 ----GKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL--- 410
GK ++ I + + R + AL Y H+ V+H +LK NI L
Sbjct: 109 YKMFGKIEEHAI-------VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161
Query: 411 --------------DDNEMVLVSDYGFSSLVAQPIAAQRMIS---YKSPEY--QSSKKIS 451
+ + + D+G S + A + Y SPE +K
Sbjct: 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYD 221
Query: 452 RKSDVWSFGCLLLELLTGRISTHSA 476
KSD+W+ GC++ EL +G+ H A
Sbjct: 222 DKSDMWALGCIIYELCSGKTPFHKA 246
|
Length = 1021 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 52/194 (26%)
Query: 323 HPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCR------SRLLVA 376
HPN++P A + +++E +V F G S+K+ I C S L +A
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFMAYG----------SAKDLI---CTHFMDGMSELAIA 104
Query: 377 ---RGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ---- 429
+GV +AL+Y+HH +H ++K+++IL+ + V +S G S ++
Sbjct: 105 YILQGVLKALDYIHHM-------GYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHG 155
Query: 430 ---------PIAAQRMISYKSPEY--QSSKKISRKSDVWSFGCLLLELLTGRI------S 472
P + +++ + SPE Q+ + KSD++S G EL G + +
Sbjct: 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 215
Query: 473 THSAPQGINGADLC 486
T + +NG C
Sbjct: 216 TQMLLEKLNGTVPC 229
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 48/199 (24%), Positives = 82/199 (41%), Gaps = 22/199 (11%)
Query: 276 LGKGIFGNSYKALLEGRAPVV-VKRLRDLKPLITEEFR---KQLLVIADQKHPNLLPLLA 331
+G G FG Y A VV VK++ E+++ K++ + KHPN +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 332 YYFSNDEKLLVYKFA-GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
Y LV ++ G+ + +H + P + + G + L YLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAITHGALQGLAYLH--- 138
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEY---QSS 447
+IH ++K+ NILL + V ++D+G +S + + + +PE
Sbjct: 139 ----SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDE 194
Query: 448 KKISRKSDVWSFGCLLLEL 466
+ K DVWS G +EL
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 29/103 (28%), Positives = 50/103 (48%), Gaps = 24/103 (23%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-SLVAQPIAAQRMIS- 438
L+Y+H + V+H +LK N+L++ + + + D+G + P ++
Sbjct: 116 CGLKYIHSAN-------VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE 168
Query: 439 ------YKSPE----YQS-SKKISRKSDVWSFGCLLLELLTGR 470
Y++PE +QS +K I DVWS GC+L ELL +
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAI----DVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA--QPIAAQRMISY 439
LE++H++ V++ +LK NILLD++ V +SD G + + +P A+ Y
Sbjct: 109 GLEHMHNR-------FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGY 161
Query: 440 KSPE-YQSSKKISRKSDVWSFGCLLLELLTG 469
+PE Q +D +S GC+L +LL G
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 21/78 (26%), Positives = 41/78 (52%), Gaps = 5/78 (6%)
Query: 398 VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR----MISYKSPE-YQSSKKISR 452
V+H +LK N+L+D+ ++ ++D+G + P+ + Y++PE S + S
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 453 KSDVWSFGCLLLELLTGR 470
D+WS G + E+ T +
Sbjct: 182 PVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 25/95 (26%), Positives = 46/95 (48%), Gaps = 12/95 (12%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR----M 436
R L Y H + ++H +LK N+L+++ + ++D+G + + P
Sbjct: 114 RGLSYCHKRK-------ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVT 166
Query: 437 ISYKSPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
+ Y+ P+ S + S D+W GC+L E+ TGR
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 16/98 (16%)
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ 434
+ G + L YLH ++ IH ++K+ NILL + V ++D+G +SLV+ A
Sbjct: 120 ICHGALQGLAYLHSHER-------IHRDIKAGNILLTEPGTVKLADFGSASLVS---PAN 169
Query: 435 RMIS---YKSPEY---QSSKKISRKSDVWSFGCLLLEL 466
+ + +PE + K DVWS G +EL
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 60/278 (21%), Positives = 116/278 (41%), Gaps = 70/278 (25%)
Query: 215 QEEYMDQEKESGDDEEEE--EEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLNDLLKAP 272
+EE D++EE+ + I + K +KL +++
Sbjct: 37 EEERSHNNNAGEDEDEEKMIDNDINRSPNK-------------------SYKLGNII--- 74
Query: 273 AEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFR-KQLLVIADQKHPNLLPLL 330
G G FG Y+A+ ++ V +K++ L +++ ++LL++ + H N++ L
Sbjct: 75 ----GNGSFGVVYEAICIDTSEKVAIKKV-----LQDPQYKNRELLIMKNLNHINIIFLK 125
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRI-----------HGGKSSKNRIPFRCRSRLLVARGV 379
YY++ K N+F + + ++N L + +
Sbjct: 126 DYYYTECFK------KNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 380 ARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL-VSDYGFSSLVAQPIAAQRMIS 438
RAL Y+H K + H +LK N+L+D N L + D+G + + +A QR +S
Sbjct: 180 CRALAYIHSK-------FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL---LAGQRSVS 229
Query: 439 Y------KSPEYQ-SSKKISRKSDVWSFGCLLLELLTG 469
Y ++PE + + D+WS GC++ E++ G
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 29/205 (14%)
Query: 276 LGKGIFGN----SYKALLEGRAPVVVKRLRDLKPLITEEF------RKQLLVIADQKHPN 325
LG G FG +YK E PV +KR K + ++ RK L I HP
Sbjct: 38 LGTGSFGRVILATYKN--EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI---NHPF 92
Query: 326 LLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
+ L + LV +F G F + K N + A + EY
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG------CFYAAQIVLIFEY 146
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV-AQPIAAQRMISYKSPEY 444
L + +++ +LK N+LLD + + ++D+GF+ +V + Y +PE
Sbjct: 147 LQSLN-------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEI 199
Query: 445 QSSKKISRKSDVWSFGCLLLELLTG 469
+ + +D W+ G + E+L G
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 29/191 (15%)
Query: 295 VVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL-- 351
V VK LR D E+F K++ +++ PN+ LL + ++ ++ NG+L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 352 FNRIH-----GGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKST 406
F + H G + + F L +A +A + YL + +H +L +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFST--LLYMATQIASGMRYLESLN-------FVHRDLATR 159
Query: 407 NILLDDNEMVLVSDYGFSS---------LVAQPIAAQRMISYKSPEYQSSKKISRKSDVW 457
N L+ N + ++D+G S + + R ++++S K + KSDVW
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV-LLG--KFTTKSDVW 216
Query: 458 SFGCLLLELLT 468
+FG L E+LT
Sbjct: 217 AFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 276 LGKGIFGNSYKALLEG--RAPVVVK-RLRDLKPLITEEFRKQL---LVIADQ--KHPNLL 327
LG G FG +A G ++ V+K ++ LKP R+ L L I H N++
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLL-VARGVARALEYL 386
LL L++ ++ G+L N + + R F LL + VA+ + +L
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLR-----RKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF-------SSLVAQPIAAQRMISY 439
K+ IH +L + N+LL ++V + D+G S+ V + A+ + +
Sbjct: 158 ASKN-------CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG-NARLPVKW 209
Query: 440 KSPEYQSSKKISRKSDVWSFGCLLLELLT 468
+PE + + +SDVWS+G LL E+ +
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 23/90 (25%), Positives = 45/90 (50%), Gaps = 10/90 (11%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-- 438
R L++LH + ++H +LK NIL+ V ++D+G + + + +A ++
Sbjct: 119 RGLDFLH-------ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTL 171
Query: 439 -YKSPEYQSSKKISRKSDVWSFGCLLLELL 467
Y++PE + D+WS GC+ E+
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 32/209 (15%)
Query: 276 LGKGIFGNSYKALLEGRAPV-VVKRLR--------DLKPLITEEFRKQLLVIADQKHPNL 326
LGKG FG A +G + +K L+ D++ + E K++L + K P L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVE---KRVLALPG-KPPFL 63
Query: 327 LPLLAYYFSNDEKLLVYKFAGNGNLFNRIHG-GKSSKNRIPFRCRSRLLVARGVARALEY 385
L + + + D V ++ G+L I GK F+ + A +A L +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-------FKEPHAVFYAAEIAIGLFF 116
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKS 441
LH K +I+ +LK N++LD + ++D+G R Y +
Sbjct: 117 LHSK-------GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIA 169
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTGR 470
PE + + + D W+FG LL E+L G+
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 276 LGKGIFGNSYKALLEGRAPV----VVKRLRDLKPLITEEFRKQ--LLVIADQKHPNLLPL 329
+G+G FG L+ V ++ + LK T FR++ +LV D + +
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ---WITT 65
Query: 330 LAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
L Y F ++ L LV + G+L + ++R+P +R +A V A++ +H
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLP-EDMARFYLAEMVI-AIDSVH- 119
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSK 448
Q +H ++K NIL+D N + ++D+G + + Q ++ +P+Y S +
Sbjct: 120 ------QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 449 ----------KISRKSDVWSFGCLLLELLTG 469
K + D WS G + E+L G
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 50/215 (23%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 272 PAEGLGKGIFGNSYKA--LLEGRAPVVVKRLR-----DLKPLITEEFRKQLLVIADQKHP 324
+G+G +G +KA L G V +KR+R + PL T L + +HP
Sbjct: 5 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 325 NLLPLL----AYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGV 379
N++ L + KL LV++ + +L + K + +P ++ +
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLD--KVPEPGVPTETIKDMMFQ--L 119
Query: 380 ARALEYLH-HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS 438
R L++LH H+ V+H +LK NIL+ + + ++D+G + + + +A ++
Sbjct: 120 LRGLDFLHSHR--------VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 171
Query: 439 ---YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE + D+WS GC+ E+ +
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 57/237 (24%), Positives = 85/237 (35%), Gaps = 58/237 (24%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLLPLLA 331
LGKG G + L+G + ++ D K +I K++L ++A HP LP L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP-FLPTLY 67
Query: 332 YYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRS----RLLVARGVARALEYL 386
F + L LV + G LF R P +C S R A + ALEYL
Sbjct: 68 ASFQTETYLCLVMDYCPGGELF-------RLLQRQPGKCLSEEVARFYAAEVLL-ALEYL 119
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQS 446
H +++ +LK NILL ++ +++SD+ S K S
Sbjct: 120 HLL-------GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 447 SKKISRKS---------------------------------DVWSFGCLLLELLTGR 470
I ++ D W+ G LL E+L G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 47/199 (23%), Positives = 84/199 (42%), Gaps = 22/199 (11%)
Query: 276 LGKGIFGNSYKALLEGRAPVV-VKRLRDLKPLITEEFR---KQLLVIADQKHPNLLPLLA 331
+G G FG Y A VV +K++ E+++ K++ + KHPN +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 332 YYFSNDEKLLVYKFA-GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
Y LV ++ G+ + +H + P + + G + L YLH +
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAITHGALQGLAYLHSHN 145
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEY---QSS 447
+IH ++K+ NILL + V ++D+G +S+ + + + +PE
Sbjct: 146 -------MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDE 198
Query: 448 KKISRKSDVWSFGCLLLEL 466
+ K DVWS G +EL
Sbjct: 199 GQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 35/152 (23%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 323 HPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARA 382
+P L+ L + + + LV ++ G+L + + ++P +R A + A
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ----RQRKLPEE-HARFYAAE-ICIA 108
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----S 438
L +LH + +I+ +LK N+LLD + + ++DYG P +
Sbjct: 109 LNFLHER-------GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPN 161
Query: 439 YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y +PE ++ D W+ G L+ E++ GR
Sbjct: 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 26/97 (26%), Positives = 49/97 (50%), Gaps = 16/97 (16%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ-------PIAA 433
+A+ + H D ++H ++K N+L+ N+++ + D+GF+ +++ A
Sbjct: 111 KAIHWCHKND-------IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA 163
Query: 434 QRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
R Y+SPE + D+WS GC+L EL G+
Sbjct: 164 TRW--YRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 21/81 (25%), Positives = 41/81 (50%), Gaps = 7/81 (8%)
Query: 396 SAVIHGNLKSTNILLDDNEMVLVSDYGF-----SSLVAQPIAAQRMISYKSPEYQSSKKI 450
+ +IH +LK +NI++ + + + D+G ++ + P R Y++PE
Sbjct: 142 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY--YRAPEVILGMGY 199
Query: 451 SRKSDVWSFGCLLLELLTGRI 471
D+WS GC++ EL+ G +
Sbjct: 200 KENVDIWSVGCIMGELVKGSV 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 34/116 (29%), Positives = 53/116 (45%), Gaps = 17/116 (14%)
Query: 359 KSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL-------D 411
+ K R+P + + VA+ +A AL YL K+ ++HGN+ + NILL
Sbjct: 108 RKEKGRVPVAWK--ITVAQQLASALSYLEDKN-------LVHGNVCAKNILLARLGLAEG 158
Query: 412 DNEMVLVSDYGFSSLVAQPIAAQRMISYKSPE-YQSSKKISRKSDVWSFGCLLLEL 466
+ + +SD G S I + +PE +S +D WSFG LLE+
Sbjct: 159 TSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 25/95 (26%), Positives = 45/95 (47%), Gaps = 12/95 (12%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR----M 436
R L Y H + V+H +LK N+L+++ + ++D+G + + P
Sbjct: 115 RGLNYCHRRK-------VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVT 167
Query: 437 ISYKSPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
+ Y+ P+ S S + D+W GC+ E+ TGR
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 40/213 (18%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEE------FRKQLLVIADQKHPNLLPL 329
LGKG FG A +G + ++ +I ++ K++L ++ K P L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPFLTQL 66
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHG-GKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
+ + + D V ++ G+L +I G+ F+ + A +A L +LH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-------FKEPHAVFYAAEIAIGLFFLHS 119
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF-----------SSLVAQPIAAQRMI 437
K +I+ +LK N++LD + ++D+G + P
Sbjct: 120 K-------GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTP------- 165
Query: 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y +PE + + + D W+FG LL E+L G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 56/287 (19%), Positives = 119/287 (41%), Gaps = 41/287 (14%)
Query: 276 LGKGIFGNSYKALLEG------RAPVVVKRLRDLKPLITE-EFRKQLLVIADQKHPNLLP 328
LG+G FG Y+ + +G V +K + + + EF + V+ + +++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHG----GKSSKNRIPFRCRSRLLVARGVARALE 384
LL L++ + G+L + + +++ + P + + +A +A +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR------MIS 438
YL+ + +H +L + N ++ ++ V + D+G + + + ++ +
Sbjct: 134 YLN-------ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 439 YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498
+ SPE + SDVWSFG +L E+ T QG++ VLR V E
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---LAEQPYQGMSNEQ----VLRFVMEGGL 239
Query: 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+ D+ + L ++ C +P+ RP E++S ++
Sbjct: 240 LDKPDNCPDM----------LFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 21/81 (25%), Positives = 41/81 (50%), Gaps = 7/81 (8%)
Query: 396 SAVIHGNLKSTNILLDDNEMVLVSDYGF-----SSLVAQPIAAQRMISYKSPEYQSSKKI 450
+ +IH +LK +NI++ + + + D+G +S + P R Y++PE
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILGMGY 202
Query: 451 SRKSDVWSFGCLLLELLTGRI 471
D+WS GC++ E++ G +
Sbjct: 203 KENVDIWSVGCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 54/220 (24%), Positives = 82/220 (37%), Gaps = 52/220 (23%)
Query: 378 GVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR-- 435
G R L YLH Q+ IH N+K+++IL+ + +V +S G S L + Q+
Sbjct: 109 GALRGLNYLH-------QNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAK 159
Query: 436 -----------MISYKSPEY--QSSKKISRKSDVWSFGCLLLELLTGRISTHSAP----- 477
++ + SPE Q + KSD++S G EL TGR+
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219
Query: 478 -QGINGADLCSWVLRAV-----REEWTAEIFDSEIS---VQRSAAHGML---------KL 519
Q + G + R + + DS I V M K
Sbjct: 220 LQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKT 279
Query: 520 LQVAIQ-----CCNKSPEKRPEMAEVVSELEIIKVTESTE 554
A Q C + PEKRP + ++S +V E T+
Sbjct: 280 FSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQ 319
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 44/210 (20%), Positives = 94/210 (44%), Gaps = 35/210 (16%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRK----QLLVIADQKHPNLLPLL 330
+G G +G+ A+ V +K+L +P +E F K +L ++ +H N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLS--RPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 331 AYY--------FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARA 382
+ F + ++ Y +I G S++++ + L
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTD----LQKIMGHPLSEDKVQYLVYQML-------CG 129
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-YKS 441
L+Y+H + +IH +LK N+ ++++ + + D+G + + + Y++
Sbjct: 130 LKYIH-------SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRA 182
Query: 442 PEY-QSSKKISRKSDVWSFGCLLLELLTGR 470
PE + ++ D+WS GC++ E+LTG+
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 48/219 (21%)
Query: 274 EGLGKGIFGNSYKA--LLEGRAPVVVKRLRDLKPLITEE------------FRKQLLVIA 319
E +G+G +G YKA L G V +K++R L TE+ K+L
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEI-VALKKIR----LETEDEGVPSTAIREISLLKEL---- 55
Query: 320 DQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVAR-- 377
HPN++ LL S ++ LV++F + +L K + P L+
Sbjct: 56 --NHPNIVRLLDVVHSENKLYLVFEFL-DLDL-------KKYMDSSPLTGLDPPLIKSYL 105
Query: 378 -GVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA--Q 434
+ + + Y H V+H +LK N+L+D + ++D+G + P+
Sbjct: 106 YQLLQGIAYCH-------SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158
Query: 435 RMIS--YKSPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
+++ Y++PE S++ S D+WS GC+ E++ R
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 23/92 (25%), Positives = 45/92 (48%), Gaps = 12/92 (13%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-- 438
++L+++H + H ++K NIL+ D+ + L +D+G + IS
Sbjct: 111 KSLDHMHRN-------GIFHRDIKPENILIKDDILKL-ADFGSCRGIYSKPPYTEYISTR 162
Query: 439 -YKSPE-YQSSKKISRKSDVWSFGCLLLELLT 468
Y++PE + K D+W+ GC+ E+L+
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 51/193 (26%), Positives = 84/193 (43%), Gaps = 27/193 (13%)
Query: 295 VVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL-- 351
V VK LR D +F K++ +++ K PN++ LL D ++ ++ NG+L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 352 FNRIH-----GGKSSKNRIPFRC------RSRLLVARGVARALEYLHHKDKSRTQSAVIH 400
F H + P C S L VA +A ++YL + +H
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL-------SSLNFVH 161
Query: 401 GNLKSTNILLDDNEMVLVSDYGFS-SLVAQPI-----AAQRMISYKSPEYQSSKKISRKS 454
+L + N L+ +N + ++D+G S +L A A I + + E K + S
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTAS 221
Query: 455 DVWSFGCLLLELL 467
DVW+FG L E+L
Sbjct: 222 DVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 9e-04
Identities = 37/109 (33%), Positives = 48/109 (44%), Gaps = 16/109 (14%)
Query: 56 NIISGNFMNFSSNH-------------KLKDIDLSGNKFYGEISRSLLSLKFLESLQLQN 102
N+ S F+ +SN LK I L N GEI + L L L L
Sbjct: 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245
Query: 103 NNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQ-TLQLFRSYSYSNN 148
NNLTGP+P N +L+ + N LSG IP + +LQ S S+N
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294
|
Length = 968 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 41/174 (23%), Positives = 74/174 (42%), Gaps = 31/174 (17%)
Query: 379 VARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF-------SSLVAQPI 431
VA+ + +L K+ IH +L + NILL + + D+G S+ V +
Sbjct: 223 VAKGMSFLASKN-------CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG- 274
Query: 432 AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLR 491
A+ + + +PE + + +SDVWS+G LL E+ S S+P G + S +
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF----SLGSSP--YPGMPVDSKFYK 328
Query: 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
++E + S ++ + C + P KRP ++V +E
Sbjct: 329 MIKEGYRML----------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 18/98 (18%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
R L+Y+H SA V+H +LK +N+LL+ N + + D+G + ++ M
Sbjct: 119 RGLKYIH--------SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--KGDFMTEY 168
Query: 439 -----YKSPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE + + + DVWS GC+ ELL +
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 42/180 (23%), Positives = 78/180 (43%), Gaps = 42/180 (23%)
Query: 379 VARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF-------SSLVAQPI 431
VAR +E+L K+ +H +L + N+LL ++V + D+G S+ V++
Sbjct: 246 VARGMEFLASKN-------CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG- 297
Query: 432 AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLR 491
+ + + +PE + SDVWS+G LL E+ + + P I + + +
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS--LGGTPYPGMIVDSTFYNKIKS 355
Query: 492 AVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE---MAEVVSEL 544
R + T E++D + ++C N PEKRP ++++V L
Sbjct: 356 GYRMAKPDHATQEVYD------------------IMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 27/204 (13%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLR---DLKPLITEEFRKQLLVIADQKHPNLLPL 329
E +G+G +G +KA E V +KR+R D + + + R ++ ++ + KH N++ L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRL 64
Query: 330 LAYYFSNDEKLLVYKFAGNG--NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
S+ + LV+++ F+ +G P +S + + + L + H
Sbjct: 65 YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDID-----PEIVKSFMF---QLLKGLAFCH 116
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI----AAQRMISYKSPE 443
V+H +LK N+L++ N + ++D+G + P+ A + Y+ P+
Sbjct: 117 -------SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPD 169
Query: 444 YQSSKKISRKS-DVWSFGCLLLEL 466
K+ S D+WS GC+ EL
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 54/308 (17%), Positives = 111/308 (36%), Gaps = 61/308 (19%)
Query: 255 IEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLR----DLKPLITEE 310
I+ K ND + KGIF N V+++ + K LI +
Sbjct: 20 IDKYTSVLIKENDQNS-----IYKGIFNNK---------EVIIRTFKKFHKGHKVLI-DI 64
Query: 311 FRKQLLVIADQKHPNLLPLLAYYFSNDEKL----LVYKFAGNGNLFNRIHGGKSSKNRIP 366
++ + N+L + + + L L+ ++ G L + K +
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LS 120
Query: 367 FRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426
F+ + + A + L L+ + NL S + L+ +N + + +G +
Sbjct: 121 FKTKLDM--AIDCCKGLYNLYKYTNKP------YKNLTSVSFLVTENYKLKIICHGLEKI 172
Query: 427 VAQPIAAQ-RMISYKSPEYQSS--KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGA 483
++ P + Y S + + + + K D++S G +L E+ TG+I
Sbjct: 173 LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP-------FENL 225
Query: 484 DLCSWVLRAVREEWTAEIFD---SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
T EI+D ++ + + L++ + C + KRP + E+
Sbjct: 226 T-------------TKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
Query: 541 VSELEIIK 548
+ L + K
Sbjct: 273 LYNLSLYK 280
|
Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 24/97 (24%), Positives = 47/97 (48%), Gaps = 12/97 (12%)
Query: 379 VARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR--- 435
+ R L Y H + V+H +LK N+L+++ + ++D+G + + P
Sbjct: 113 ILRGLAYCHRRK-------VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV 165
Query: 436 -MISYKSPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
+ Y+ P+ S + S + D+W GC+ E+ +GR
Sbjct: 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 43/205 (20%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFR--KQLLVIADQKHPNLLPLLA 331
E LG+G + YK + +V ++ L+ F ++ ++ KH N++ L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 332 YYFSNDEKLLVYKFAGNG--NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
+ + LV+++ ++ GG +N F + + R L Y+H
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQ--------LLRGLSYIH-- 120
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP--IAAQRMIS--YKSPE-Y 444
Q ++H +LK N+L+ D + ++D+G + + P + +++ Y+ P+
Sbjct: 121 -----QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 445 QSSKKISRKSDVWSFGCLLLELLTG 469
S + S D+W GC+ +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 56/236 (23%), Positives = 100/236 (42%), Gaps = 64/236 (27%)
Query: 274 EGLGKGIFGNSYKA--LLEGRAPVVVKRL-----RDLKPLIT--EEFR--KQLLVIADQK 322
LG+G FG YKA + GR V +K++ +D P IT E + K+L K
Sbjct: 14 GKLGEGTFGEVYKARQIKTGRV-VALKKILMHNEKDGFP-ITALREIKILKKL------K 65
Query: 323 HPNLLPLLAYYF-----SNDEKLLVYKFAG------NGNLFN-RIHGGKSSKNRIPFRCR 370
HPN++PL+ S ++ VY +G L N + +S +C
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ-----IKCY 120
Query: 371 SRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430
L+ + YLH ++ ++H ++K+ NIL+D+ ++ ++D+G + P
Sbjct: 121 MLQLLE-----GINYLH-------ENHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
Query: 431 I---------AAQRMIS------YKSPEY-QSSKKISRKSDVWSFGCLLLELLTGR 470
++ + Y+ PE ++ + D+W GC+ E+ T R
Sbjct: 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 21/81 (25%), Positives = 41/81 (50%), Gaps = 7/81 (8%)
Query: 396 SAVIHGNLKSTNILLDDNEMVLVSDYGF-----SSLVAQPIAAQRMISYKSPEYQSSKKI 450
+ +IH +LK +NI++ + + + D+G +S + P R Y++PE
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILGMGY 195
Query: 451 SRKSDVWSFGCLLLELLTGRI 471
D+WS GC++ E++ +I
Sbjct: 196 KENVDIWSVGCIMGEMVRHKI 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 23/95 (24%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS---SLVAQPIAAQRM- 436
R L Y+H + ++H +LK N+L+ + ++D+G + S+ +Q +++ +
Sbjct: 114 RGLAYIHGQH-------ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVT 166
Query: 437 ISYKSPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
+ Y+ P+ + S D+W GC+ +E+L G+
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 20/74 (27%), Positives = 35/74 (47%), Gaps = 7/74 (9%)
Query: 71 LKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPV--PEFNQSSLKVFNVSNNNLS 128
L+ + L N F GE+ L + L + NNNL G + +++ SL++ +++ N
Sbjct: 406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF 465
Query: 129 GSIPKTQTLQLFRS 142
G +P F S
Sbjct: 466 GGLP-----DSFGS 474
|
Length = 968 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 276 LGKGIFGNSYKALLEGRAPV----VVKRLRDLKPLITEEFRKQ--LLVIADQKHPNLLPL 329
+G+G FG ++ + ++ + LK T FR++ +LV D + +
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ---WITT 65
Query: 330 LAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
L Y F ++ L LV + G+L + ++R+P +R +A V A+ +H
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLP-EDMARFYIAEMVL-AIHSIH- 119
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSK 448
Q +H ++K N+LLD N + ++D+G + Q Q ++ +P+Y S +
Sbjct: 120 ------QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 449 ----------KISRKSDVWSFGCLLLELLTG 469
K + D WS G + E+L G
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 13/94 (13%)
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV---AQPIAAQRMIS- 438
L Y H K+ +H ++K +NILL++ + ++D+G + L ++I+
Sbjct: 129 LNYCHKKN-------FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181
Query: 439 -YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y+ PE ++ DVWS GC+L EL T +
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 23/95 (24%), Positives = 46/95 (48%), Gaps = 14/95 (14%)
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF-----SSLVAQPIAAQRM 436
+++LH + +IH +LK +NI++ + + + D+G +S + P R
Sbjct: 130 GIKHLH-------SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 437 ISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRI 471
Y++PE D+WS GC++ E++ G +
Sbjct: 183 --YRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 27/114 (23%), Positives = 50/114 (43%), Gaps = 14/114 (12%)
Query: 362 KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421
+N+ + +L A + + ++YL + +H +L + N+L++ V + D+
Sbjct: 101 RNKNKINLKQQLKYAVQICKGMDYLGSRQ-------YVHRDLAARNVLVESEHQVKIGDF 153
Query: 422 GFSSLVAQPIAAQRM-------ISYKSPEYQSSKKISRKSDVWSFGCLLLELLT 468
G + + + + + +PE K SDVWSFG L ELLT
Sbjct: 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 22/78 (28%), Positives = 40/78 (51%), Gaps = 5/78 (6%)
Query: 398 VIHGNLKSTNILLDDNEMVLVSDYGFSSLV--AQPIAAQRMIS--YKSPEYQSSKKISRK 453
+++ ++K N+LLDD +SD G + + + I QR + Y +PE + S
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTIT-QRAGTNGYMAPEILKEEPYSYP 174
Query: 454 SDVWSFGCLLLELLTGRI 471
D ++ GC + E++ GR
Sbjct: 175 VDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 22/81 (27%), Positives = 48/81 (59%), Gaps = 5/81 (6%)
Query: 395 QSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA--AQRMIS--YKSPE-YQSSKK 449
++ V+H +LK N+L++ + ++D+G + P+ + +++ Y++P+ S+
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 450 ISRKSDVWSFGCLLLELLTGR 470
S D+WS GC++ E++TGR
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 26/100 (26%), Positives = 43/100 (43%), Gaps = 25/100 (25%)
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF-----------SSLVAQP 430
AL +LH + +I+ +LK N+LLD + ++DYG S+ P
Sbjct: 108 ALNFLHER-------GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160
Query: 431 IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+Y +PE + D W+ G L+ E++ GR
Sbjct: 161 -------NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 582 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.26 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.95 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.93 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.78 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.75 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.69 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.65 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.62 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.6 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.59 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.56 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.56 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.54 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.54 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.53 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.53 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.52 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.52 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.5 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.45 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.44 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.39 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.36 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.32 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.24 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.22 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.15 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.1 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.08 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.08 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.06 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.04 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.01 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.0 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.98 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.9 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.84 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.82 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.81 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.77 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.76 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.75 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.7 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-60 Score=557.13 Aligned_cols=470 Identities=24% Similarity=0.426 Sum_probs=346.8
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..+..|+|++|+++|.+|. .+.++++|+.|+|++|.++|.+| .+.++++|+.|+|++|.++|.+|..+.++++|+.||
T Consensus 475 ~~L~~L~ls~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPR-KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred ccceEEECcCCccCCccCh-hhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 4678889999999998865 48899999999999999999998 578899999999999999999999999999999999
Q ss_pred cccCcccCCCCCC--CCCCCCEEEeecCcccccCCCCCcccccccccccCCCCCCCCCC---CCCCCCCCCCccCCCCCC
Q 047954 100 LQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPS---LNNCSSTGNYVTNSDDKG 174 (582)
Q Consensus 100 l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l~~~~~---~~~~~~~~~~~~~~~~~~ 174 (582)
|++|+++|.+|.. .+++|+.|++++|+++|.+|..+.+..+...++.+|+.+||.+. ...|... .+.
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~--------~~~ 625 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV--------RKT 625 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc--------ccc
Confidence 9999999999984 78899999999999999999988888888899999999998642 1223210 011
Q ss_pred CCchhhHHHHHHHHHHHHHHHhhhheeeccCCCcchhhhhhhhhhcccccCCCchHHHHHHhccCcceeeeecCCCceEE
Q 047954 175 SNDLKIFYFLLAALCIVTVLMLFIFYLTKRTRKPNIMIKKQEEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVF 254 (582)
Q Consensus 175 s~~~~i~~iv~~~~~~~~l~~l~i~~~~kr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (582)
.....++.+++++++++++++++++++ +++++.. .++ .+...+ .. ....
T Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~-------~~~~~~-------------~~---------~~~~ 674 (968)
T PLN00113 626 PSWWFYITCTLGAFLVLALVAFGFVFI-RGRNNLE-LKR-------VENEDG-------------TW---------ELQF 674 (968)
T ss_pred ceeeeehhHHHHHHHHHHHHHHHHHHH-Hhhhccc-ccc-------cccccc-------------cc---------cccc
Confidence 111111111222222222222222222 2221111 000 000000 00 0000
Q ss_pred ecCCCCCCCChhHhhhcc--cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccce
Q 047954 255 IEDEQPAGFKLNDLLKAP--AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLA 331 (582)
Q Consensus 255 ~~~~~~~~~~~~~l~~~~--~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~ 331 (582)
........++++++.... .+.||+|+||.||+|.. .++..||||++...... ...|++.+++++|||||+++|
T Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~ 750 (968)
T PLN00113 675 FDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIG 750 (968)
T ss_pred cccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEE
Confidence 111112234555554443 35799999999999996 57889999998654322 234688899999999999999
Q ss_pred EEEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec
Q 047954 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD 411 (582)
Q Consensus 332 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~ 411 (582)
+|.+.+..++||||+++|+|.++++ .++|..+..|+.|||+||+|||+.+ .++|+||||||+||+++
T Consensus 751 ~~~~~~~~~lv~Ey~~~g~L~~~l~---------~l~~~~~~~i~~~ia~~L~yLH~~~----~~~iiH~dlkp~Nil~~ 817 (968)
T PLN00113 751 LCRSEKGAYLIHEYIEGKNLSEVLR---------NLSWERRRKIAIGIAKALRFLHCRC----SPAVVVGNLSPEKIIID 817 (968)
T ss_pred EEEcCCCCEEEEeCCCCCcHHHHHh---------cCCHHHHHHHHHHHHHHHHHhccCC----CCCeecCCCCHHhEEEC
Confidence 9999999999999999999999995 2789999999999999999999664 23599999999999999
Q ss_pred CCCceEEeeccccccccCcccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHH
Q 047954 412 DNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLR 491 (582)
Q Consensus 412 ~~~~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 491 (582)
.++.+++. ||.+..........++..|+|||++.+..++.|+|||||||++|||+||+.||+.... ....+.+|+..
T Consensus 818 ~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~ 894 (968)
T PLN00113 818 GKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARY 894 (968)
T ss_pred CCCceEEE-eccccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHHHH
Confidence 99988875 7766554444444567899999999999999999999999999999999999964322 33456666655
Q ss_pred HHhhcccccccchhhhhh-hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 492 AVREEWTAEIFDSEISVQ-RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 492 ~~~~~~~~~~~d~~~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
.........++|+.+... ....+++.++.+++.+||+.||++||||+||++.|+.+...
T Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred hcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 443333344445444221 22345667889999999999999999999999999988653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-55 Score=446.00 Aligned_cols=283 Identities=35% Similarity=0.580 Sum_probs=245.0
Q ss_pred CCCCCChhHhhhccc-----ccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEE
Q 047954 259 QPAGFKLNDLLKAPA-----EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333 (582)
Q Consensus 259 ~~~~~~~~~l~~~~~-----~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~ 333 (582)
....|+++++..||. ++||+|+||.||+|.+.++..||||++.........+|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 356799999999983 689999999999999999999999988764432145699999999999999999999999
Q ss_pred EeCC-eeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC
Q 047954 334 FSND-EKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD 412 (582)
Q Consensus 334 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~ 412 (582)
.+.+ +.+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.+ .++||||||||+|||||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~----~~~iiHrDiKssNILLD~ 212 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGC----PPPIIHRDIKSSNILLDE 212 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCC----CCCEecCCCCHHHeeECC
Confidence 9998 599999999999999999875432 6899999999999999999999987 457999999999999999
Q ss_pred CCceEEeeccccccccC-cccc----cccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHH
Q 047954 413 NEMVLVSDYGFSSLVAQ-PIAA----QRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCS 487 (582)
Q Consensus 413 ~~~~kl~DfG~a~~~~~-~~~~----~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~ 487 (582)
++++||+|||+|+.... .... .||.+|+|||+...+..++|+|||||||+|+||+||+.|.+... ......+..
T Consensus 213 ~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~ 291 (361)
T KOG1187|consen 213 DFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVE 291 (361)
T ss_pred CCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHH
Confidence 99999999999977654 3211 78999999999999999999999999999999999998887543 223445899
Q ss_pred HHHHHHhhcccccccchhhhhhhch-HHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 488 WVLRAVREEWTAEIFDSEISVQRSA-AHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 488 ~~~~~~~~~~~~~~~d~~~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
|....+......+++|+.+...... ..++.++.+++.+|++.+|++||+|.||++.|+.+...
T Consensus 292 w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 292 WAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 9988888888999999998643333 26888899999999999999999999999999665543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=396.39 Aligned_cols=253 Identities=30% Similarity=0.435 Sum_probs=208.3
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcc--hHHHHHHHHHHHhcCCCCCccccceEEEeCC-eeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPL--ITEEFRKQLLVIADQKHPNLLPLLAYYFSND-EKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~~g 349 (582)
.+.||+|+||+||+|.+.+...||||++...... ..+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4569999999999999998888999999754322 2568999999999999999999999999987 799999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC-ceEEeecccccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE-MVLVSDYGFSSLVA 428 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfG~a~~~~ 428 (582)
+|.++++... ...+++..++.+|.|||+||.|||+++ +||||||||+|||++.++ ++||+|||+++...
T Consensus 126 sL~~~l~~~~----~~~l~~~~~l~~aldiArGm~YLH~~~------~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 126 SLSVLLHKKR----KRKLPLKVRLRIALDIARGMEYLHSEG------PIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred cHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcCC------CeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 9999998741 236999999999999999999999987 299999999999999997 99999999998765
Q ss_pred Cc----ccccccccccCCCCCC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 429 QP----IAAQRMISYKSPEYQS--SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~--~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
.. ....||+.|||||++. ...|+.|+|||||||++|||+||+.||..... ..+.. ........+.+.
T Consensus 196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~~~---~v~~~~~Rp~~p 268 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQVAS---AVVVGGLRPPIP 268 (362)
T ss_pred cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHHHH---HHHhcCCCCCCC
Confidence 32 2356889999999999 56999999999999999999999999975421 12222 222222222221
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
. .+...+..++.+||..||+.||++.+++..|+.+.....
T Consensus 269 ~----------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 269 K----------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred c----------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 1 123367888889999999999999999999998865443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=372.22 Aligned_cols=263 Identities=25% Similarity=0.384 Sum_probs=214.5
Q ss_pred CCChhHhhhcccccccccCceEEEEEEEc-CCceEEEEEecC-CCcchHHHHHHHHHHHhcCCCCCccccceEEEeCC-e
Q 047954 262 GFKLNDLLKAPAEGLGKGIFGNSYKALLE-GRAPVVVKRLRD-LKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND-E 338 (582)
Q Consensus 262 ~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~ 338 (582)
.++.+||.. .+.||+|..|+|||++++ ++..+|+|.+.. .+....+++.+|++++++.+||+||++||.|..+. .
T Consensus 75 ~i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 355666654 478999999999999976 567789999853 34566788999999999999999999999999999 4
Q ss_pred eEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhc-cCCCCCCCcceecCCCCCCeeecCCCceE
Q 047954 339 KLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH-KDKSRTQSAVIHGNLKSTNILLDDNEMVL 417 (582)
Q Consensus 339 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~ivH~Dlkp~NILl~~~~~~k 417 (582)
..++||||.+|+|.+.+...+ .+++...-+|+.+|++||.|||+ ++ ||||||||+|||++..|++|
T Consensus 153 isI~mEYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~~~-------IIHRDIKPsNlLvNskGeVK 219 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEERK-------IIHRDIKPSNLLVNSKGEVK 219 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhccC-------eeeccCCHHHeeeccCCCEE
Confidence 999999999999999997542 48889999999999999999996 55 99999999999999999999
Q ss_pred EeeccccccccCcc--cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh
Q 047954 418 VSDYGFSSLVAQPI--AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE 495 (582)
Q Consensus 418 l~DfG~a~~~~~~~--~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 495 (582)
|||||.|+.+.... ...||..|||||.+.+..|+.++||||||++++|+.+|++|+.... ....++.+.+.....+
T Consensus 220 icDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~--~~~~~~~~Ll~~Iv~~ 297 (364)
T KOG0581|consen 220 ICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN--PPYLDIFELLCAIVDE 297 (364)
T ss_pred eccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC--CCCCCHHHHHHHHhcC
Confidence 99999999886653 4458899999999999999999999999999999999999997541 1223333333333222
Q ss_pred cccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 496 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
. .+...+. .+..++..++..||++||.+|||++|+++|.+-.+...
T Consensus 298 p-pP~lP~~---------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 298 P-PPRLPEG---------EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred C-CCCCCcc---------cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 1 1111111 23447889999999999999999999999998665443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-48 Score=389.43 Aligned_cols=248 Identities=26% Similarity=0.425 Sum_probs=211.3
Q ss_pred ccccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
..+.||+|-||.||.|.+.+...||+|.++.. ....+.|.+|+.+|++|+|+|||+++|+|..++.++||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 45789999999999999999999999999765 34567899999999999999999999999998999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.++|+... +..+...+.+.++.|||+|++||++++ +|||||.++||||+++..+||+|||+|+...++.
T Consensus 289 l~yLr~~~----~~~l~~~~Ll~~a~qIaeGM~YLes~~-------~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 289 LDYLRTRE----GGLLNLPQLLDFAAQIAEGMAYLESKN-------YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred HHHhhhcC----CCccchHHHHHHHHHHHHHHHHHHhCC-------ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 99998632 235888899999999999999999998 9999999999999999999999999999765543
Q ss_pred ccc-----ccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 432 AAQ-----RMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 432 ~~~-----~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
... -.+.|.|||.+...+++.|+|||||||+||||+| |+.|+... ...++++.+.++.+-..+.
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m----sn~ev~~~le~GyRlp~P~------ 427 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM----SNEEVLELLERGYRLPRPE------ 427 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC----CHHHHHHHHhccCcCCCCC------
Confidence 322 2367999999999999999999999999999999 88888533 4445555554443333222
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.+..++.++|..||+.+|++|||++.+...++.+..
T Consensus 428 --------~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 428 --------GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred --------CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 233478999999999999999999999998887754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=376.42 Aligned_cols=243 Identities=23% Similarity=0.382 Sum_probs=207.2
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecC---CCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRD---LKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.++||+|+|+.||+++. ..|..||+|++.+ .+....+...+|+++.++++|||||+++++|++.++.|||.|+|++
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~ 102 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHR 102 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCC
Confidence 57899999999999997 8899999999964 2455678899999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.++++.. .++++.+++.+.+||+.||.|||+++ |+|||||..|++|++++++||+|||+|..+.
T Consensus 103 ~sL~el~Krr------k~ltEpEary~l~QIv~GlkYLH~~~-------IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 103 GSLMELLKRR------KPLTEPEARYFLRQIVEGLKYLHSLG-------IIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred ccHHHHHHhc------CCCCcHHHHHHHHHHHHHHHHHHhcC-------ceecccchhheeecCcCcEEecccceeeeec
Confidence 9999999733 36999999999999999999999998 9999999999999999999999999999887
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.+ ....||+.|.|||++.....+..+||||+|||||.|++|++||+.. .+.+...+....++..
T Consensus 170 ~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-------~vkety~~Ik~~~Y~~----- 237 (592)
T KOG0575|consen 170 YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-------TVKETYNKIKLNEYSM----- 237 (592)
T ss_pred CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-------hHHHHHHHHHhcCccc-----
Confidence 54 3445899999999999999999999999999999999999999643 1222222222222211
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+.....+..+|+.++|+.||.+|||+++|+.|-..-
T Consensus 238 -------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 238 -------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred -------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 111223567889999999999999999999998773
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=365.55 Aligned_cols=273 Identities=22% Similarity=0.339 Sum_probs=209.0
Q ss_pred ccccccccCceEEEEEE-EcCCceEEEEEecCCCcc-------hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEE
Q 047954 272 PAEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPL-------ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 343 (582)
+.+.||+|+||.|-+|. ..+++.||||.+++.... ......+|+++|++++|||||+++++|...+..||||
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEE
Confidence 35789999999999998 567899999999653221 1233579999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC---CceEEee
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN---EMVLVSD 420 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~---~~~kl~D 420 (582)
||+.||+|.+.+-..+ .+.+.....+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|
T Consensus 256 E~v~GGeLfd~vv~nk------~l~ed~~K~~f~Qll~avkYLH~~G-------I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 256 EYVEGGELFDKVVANK------YLREDLGKLLFKQLLTAVKYLHSQG-------IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred EEecCccHHHHHHhcc------ccccchhHHHHHHHHHHHHHHHHcC-------cccccCCcceEEeccCCcceEEEecc
Confidence 9999999999997654 3556667889999999999999999 9999999999999766 6799999
Q ss_pred ccccccccCc---ccccccccccCCCCCCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 421 YGFSSLVAQP---IAAQRMISYKSPEYQSSKK---ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 421 fG~a~~~~~~---~~~~~~~~y~aPE~~~~~~---~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
||+|+..... ....||+.|.|||++.+.. +..|+||||+|||||-+++|.+||.+... ...+.+.+.++.-
T Consensus 323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~---~~sl~eQI~~G~y 399 (475)
T KOG0615|consen 323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT---DPSLKEQILKGRY 399 (475)
T ss_pred cchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC---CccHHHHHhcCcc
Confidence 9999998644 3456899999999998654 34588999999999999999999976432 2223333322211
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC-CCccccccccccCCCCCccc
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE-STEEEEDFWLDQSLTDESLS 571 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~-~~~~~~~~~~~~~~~~~~~~ 571 (582)
.. . +....+-..+.++++.+||..||++|||+.|+++|.|.--... ..+.......+.+.++...+
T Consensus 400 ~f------~-----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s~~~~l~~~~~l~~~e~~~~ 466 (475)
T KOG0615|consen 400 AF------G-----PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLSKQDILKKLQPLSIEENAAL 466 (475)
T ss_pred cc------c-----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccchHHHHhhcCccccccchhh
Confidence 10 0 0112233346788999999999999999999999999663332 22233334444444444333
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=358.15 Aligned_cols=190 Identities=26% Similarity=0.448 Sum_probs=171.4
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
..||+|+||+||+|++. ++..||||.+... .+...+....|+.+|+.++|||||.++++++.++..|||||||.+||
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGD 95 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGD 95 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCC
Confidence 45999999999999954 5788999999654 45566778899999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC------CceEEeecccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN------EMVLVSDYGFS 424 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~------~~~kl~DfG~a 424 (582)
|.++++... .+++...+.++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 96 Ls~yi~~~~------~l~e~t~r~Fm~QLA~alq~L~~~~-------IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 96 LSDYIRRRG------RLPEATARHFMQQLASALQFLHENN-------IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred HHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999998654 4888999999999999999999998 9999999999999864 45899999999
Q ss_pred ccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 047954 425 SLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSA 476 (582)
Q Consensus 425 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~ 476 (582)
+.+.... ...|++-|||||++..++|+.|+|+||.|+|+|+|++|+.||+..
T Consensus 163 R~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 163 RFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9997653 345888999999999999999999999999999999999999743
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=391.23 Aligned_cols=254 Identities=25% Similarity=0.433 Sum_probs=213.7
Q ss_pred ccccccccCceEEEEEEEc------CCceEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEE
Q 047954 272 PAEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 344 (582)
..+.||+|.||+||+|+.. +...||||.+++.... ...+|++|+++++.++|||||+++|+|..++..++|+|
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEE
Confidence 3578999999999999854 3467999999877655 77899999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcCCCCCC--------CCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCce
Q 047954 345 FAGNGNLFNRIHGGKSSKN--------RIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMV 416 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~ 416 (582)
||..|||.++|+....... ..+++..+.+.||.|||.|++||-++. +|||||..+|+||.++..+
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~-------FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH-------FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc-------ccccchhhhhceeccceEE
Confidence 9999999999986443211 334899999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCccccc------ccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHH
Q 047954 417 LVSDYGFSSLVAQPIAAQ------RMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWV 489 (582)
Q Consensus 417 kl~DfG~a~~~~~~~~~~------~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 489 (582)
||+|||+++.+-...... -.++||+||.+..+++|+++|||||||||||+++ |+.||... ..+++++.+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl----Sn~EVIe~i 718 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL----SNQEVIECI 718 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc----chHHHHHHH
Confidence 999999998765543332 1368999999999999999999999999999999 99999654 334444444
Q ss_pred HHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 490 LRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 490 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
. .+.. ...+..+..++++||..||+..|++||+++||-..|+...+.
T Consensus 719 ~----~g~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 719 R----AGQL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred H----cCCc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 3 3322 123445566899999999999999999999999999877543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=337.17 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=201.4
Q ss_pred cccccccCceEEEEEE-EcCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccce-EEEeCCe-eEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLA-YYFSNDE-KLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~-~~~~~~~-~~lv~e~~~ 347 (582)
.++||+|+||.|||+. ..++..||.|.++-. +....+....|+.+|++++|||||++++ .+..+.+ .++|||||.
T Consensus 24 l~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~ 103 (375)
T KOG0591|consen 24 LKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCD 103 (375)
T ss_pred HHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhc
Confidence 3679999999999998 568889999988632 3445677899999999999999999999 4444445 789999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
.|||...++..+.. +..+++..+++++.|++.||.++|+.-+ ...|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 104 ~GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~~~---r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 104 AGDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSKIP---RGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred ccCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhcccc---ccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999866543 3458999999999999999999999431 124999999999999999999999999999998
Q ss_pred cCcc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
.... ...||+.||+||.+.+..|+.|+||||+||++|||..-+.||... .+.+.- +.+.....+.+.+
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~L~-~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLSLC-KKIEQGDYPPLPD 250 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHHHH-HHHHcCCCCCCcH
Confidence 7653 345899999999999999999999999999999999999999643 222222 2222222222221
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
......+.+|+..|+..||+.||+...++..+..
T Consensus 251 ---------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 251 ---------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ---------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 2334468889999999999999996555555443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=348.95 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=202.2
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCC--eeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND--EKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~e~~~~g 349 (582)
.+.||+|+||.||++...+ +...|||.+........+.+.+|+.+|++++|||||+++|...... ..+++|||+++|
T Consensus 22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G 101 (313)
T KOG0198|consen 22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG 101 (313)
T ss_pred hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence 5789999999999999664 7889999986543333667899999999999999999999865555 588999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC-CCceEEeecccccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD-NEMVLVSDYGFSSLVA 428 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfG~a~~~~ 428 (582)
+|.+++..... .+++..+..+++||++||+|||+++ ||||||||+|||++. ++.+||+|||+++...
T Consensus 102 sL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~g-------~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 102 SLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSKG-------IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred cHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC-------EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999986542 4899999999999999999999998 999999999999999 7999999999998765
Q ss_pred C-------cccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 429 Q-------PIAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 429 ~-------~~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
. .....||+.|||||++..+ ....++||||+||++.||+||+.||... .+...++.........+.
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~P~ 243 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSLPE 243 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCCCC
Confidence 2 2345688999999999853 3345999999999999999999999642 222333333333332222
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
+.+. ...+..+++.+|+..||++||||.++++|........
T Consensus 244 ip~~----------ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 244 IPDS----------LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CCcc----------cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 2221 1225678888999999999999999999988766544
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=359.24 Aligned_cols=239 Identities=26% Similarity=0.487 Sum_probs=196.2
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChHH
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFN 353 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 353 (582)
+-||.|+.|.||+|++++.+ ||||+++..+ ..+|+-|++|+||||+.+.|+|....-++||||||..|-|.+
T Consensus 130 eWlGSGaQGAVF~Grl~net-VAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLHNET-VAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhccCcccceeeeeccCce-ehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 56999999999999998755 9999986543 256888999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc---
Q 047954 354 RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP--- 430 (582)
Q Consensus 354 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~--- 430 (582)
.|+... +++......+..+||.|+.|||.+. |||||||+-||||..+..+||+|||.++.....
T Consensus 202 VLka~~------~itp~llv~Wsk~IA~GM~YLH~hK-------IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk 268 (904)
T KOG4721|consen 202 VLKAGR------PITPSLLVDWSKGIAGGMNYLHLHK-------IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK 268 (904)
T ss_pred HHhccC------ccCHHHHHHHHHHhhhhhHHHHHhh-------HhhhccCCCceEeeccceEEeccccchHhhhhhhhh
Confidence 998654 4777778889999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhh
Q 047954 431 IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQR 510 (582)
Q Consensus 431 ~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 510 (582)
....||+.|||||++....+++|+||||||||||||+||..||.+-... .++ ..+.. ..+. + .
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AII----wGVGs----NsL~--L---p 331 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AII----WGVGS----NSLH--L---P 331 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeE----EeccC----Cccc--c---c
Confidence 3456899999999999999999999999999999999999999643211 110 00011 1111 1 1
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 511 SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 511 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
-+..+...+.-|+.+||+..|..||++.+|+.||+-....
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 1223333566778899999999999999999999866543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=361.11 Aligned_cols=248 Identities=23% Similarity=0.433 Sum_probs=200.9
Q ss_pred ccccccccCceEEEEEEEcCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
..+.||+|+||+||+|++.+. ||||+++... +...+.|++|+.++++-+|.||+-+.|||..+.. .+|+.+|+|-
T Consensus 396 l~~rIGsGsFGtV~Rg~whGd--VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs 472 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHGD--VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS 472 (678)
T ss_pred ccceeccccccceeecccccc--eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence 367899999999999999874 8999997543 4466889999999999999999999999988877 9999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|+.++|..+. .|++.+.+.||+|||+|+.|||.++ |||||||..||++.++++|||+|||++..-..
T Consensus 473 SLY~hlHv~et-----kfdm~~~idIAqQiaqGM~YLHAK~-------IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 473 SLYTHLHVQET-----KFDMNTTIDIAQQIAQGMDYLHAKN-------IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred hhhhhccchhh-----hhhHHHHHHHHHHHHHhhhhhhhhh-------hhhhhccccceEEccCCcEEEecccceeeeee
Confidence 99999996543 4899999999999999999999998 99999999999999999999999999865332
Q ss_pred c------ccccccccccCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc-c
Q 047954 430 P------IAAQRMISYKSPEYQSS---KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT-A 499 (582)
Q Consensus 430 ~------~~~~~~~~y~aPE~~~~---~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 499 (582)
. ....+...|||||++.. .+|+..+||||||+|+|||+||..||..... ..++-.+ ..++. +
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~----dqIifmV----GrG~l~p 612 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR----DQIIFMV----GRGYLMP 612 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh----hheEEEe----cccccCc
Confidence 1 12235678999998864 4789999999999999999999999973221 1111111 11111 1
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
+... ....+.+++.+|+..||..++++||.+.+|+..|+.+..
T Consensus 613 d~s~-------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 613 DLSK-------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cchh-------hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1111 112344578888999999999999999999998888765
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=328.02 Aligned_cols=254 Identities=19% Similarity=0.348 Sum_probs=195.5
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.++|+|+||.|||++.+ +|+.||||++.... +...+-..+|+++|++++|+|+|.++++|......+||+|||+. +
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-T 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-T 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-H
Confidence 46899999999999954 68899999997543 34556788999999999999999999999999999999999977 4
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
+.+-+.... ..++.....+++.|+++|+.|+|+++ +|||||||+||||+.++.+||||||+|+.+..+
T Consensus 87 vL~eLe~~p-----~G~~~~~vk~~l~Q~l~ai~~cHk~n-------~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 87 VLHELERYP-----NGVPSELVKKYLYQLLKAIHFCHKNN-------CIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred HHHHHHhcc-----CCCCHHHHHHHHHHHHHHhhhhhhcC-------eecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 444454332 24788889999999999999999998 999999999999999999999999999998754
Q ss_pred ccc----cccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh----------
Q 047954 431 IAA----QRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE---------- 495 (582)
Q Consensus 431 ~~~----~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---------- 495 (582)
... ..|..|+|||.+.+ .+|+..+||||.||++.||++|.+.|.+.+ ..+....+...+..
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S----DiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS----DIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc----hHHHHHHHHHHHcccCHHHHHHhc
Confidence 332 34677999999887 789999999999999999999998886432 22222222222111
Q ss_pred --cccccccchhhhh----hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 496 --EWTAEIFDSEISV----QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 496 --~~~~~~~d~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
+++..+.-|.... .........-+++++..|++.||++|++-+|++.|-
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~ 285 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP 285 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence 1111111111110 111112223578999999999999999999998774
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=337.95 Aligned_cols=239 Identities=22% Similarity=0.346 Sum_probs=195.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
-++||+|+||+||.++.. +++.+|+|++++.. ....+...+|..+|.+++||.||+++-.|++.+.+|||+||+.|
T Consensus 30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G 109 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG 109 (357)
T ss_pred eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence 367999999999999854 57789999997543 23456678999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|.|+.+|.+.. .+++..+..++..|+.||.|||+.+ ||||||||+|||||.+|+++|+|||+++...
T Consensus 110 GeLf~hL~~eg------~F~E~~arfYlaEi~lAL~~LH~~g-------IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 110 GELFYHLQREG------RFSEDRARFYLAEIVLALGYLHSKG-------IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred ccHHHHHHhcC------CcchhHHHHHHHHHHHHHHHHHhCC-------eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999997543 4888888899999999999999998 9999999999999999999999999998653
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc--ccccc
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW--TAEIF 502 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 502 (582)
.. ....||+.|||||++.+..|+..+|.||+||++|||++|.+||... +..++.....+... .+..+
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-------~~~~~~~~I~~~k~~~~p~~l 249 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-------DVKKMYDKILKGKLPLPPGYL 249 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-------cHHHHHHHHhcCcCCCCCccC
Confidence 32 2346889999999999999999999999999999999999999643 33333333333220 11111
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCC----ChHHHHHHH
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP----EMAEVVSEL 544 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP----s~~evl~~L 544 (582)
+ .+..+++.+.+..||++|. ++.+|-+|.
T Consensus 250 s-------------~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hp 282 (357)
T KOG0598|consen 250 S-------------EEARDLLKKLLKRDPRQRLGGPGDAEEIKRHP 282 (357)
T ss_pred C-------------HHHHHHHHHHhccCHHHhcCCCCChHHhhcCc
Confidence 1 2466788899999999995 566665554
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.76 Aligned_cols=258 Identities=16% Similarity=0.279 Sum_probs=205.2
Q ss_pred CCCChhHhhhcccccccccCceEEEEEEEcCCceEEEEEecCCCcch---HHHHHHHHHHHhcCCCCCccccceEEEe--
Q 047954 261 AGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLI---TEEFRKQLLVIADQKHPNLLPLLAYYFS-- 335 (582)
Q Consensus 261 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~-- 335 (582)
..++.+++.......||+|++|.||+|.+ +++.||||+++...... .+.|.+|+.+|.+++|||||+++|++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 44566677665567899999999999998 56789999997543322 4678899999999999999999999977
Q ss_pred --CCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeecC
Q 047954 336 --NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLDD 412 (582)
Q Consensus 336 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~~ 412 (582)
....++||||+++|+|.+++.... .+++...+.++.|++.||.|||+. + ++||||||+|||+++
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~-------~~Hrdlkp~nill~~ 158 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYTN-------KPYKNLTSVSFLVTE 158 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcCC-------CCCCcCChhhEEECC
Confidence 346789999999999999997532 478899999999999999999985 5 889999999999999
Q ss_pred CCceEEeeccccccccCcc-cccccccccCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHH
Q 047954 413 NEMVLVSDYGFSSLVAQPI-AAQRMISYKSPEYQSS--KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWV 489 (582)
Q Consensus 413 ~~~~kl~DfG~a~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~ 489 (582)
++.+||+|||+++.+.... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..++...+
T Consensus 159 ~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~----~~~~~~~i 234 (283)
T PHA02988 159 NYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT----TKEIYDLI 234 (283)
T ss_pred CCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC----HHHHHHHH
Confidence 9999999999998764432 3346788999999876 688999999999999999999999996432 12222221
Q ss_pred HHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 490 LRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 490 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
........ ++ .....++.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 235 ---~~~~~~~~-~~---------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 235 ---INKNNSLK-LP---------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ---HhcCCCCC-CC---------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11111111 00 0122367889999999999999999999999988764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=346.55 Aligned_cols=243 Identities=21% Similarity=0.328 Sum_probs=197.7
Q ss_pred ccccccccCceEEEEEE-EcCCceEEEEEecCC---CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeC
Q 047954 272 PAEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDL---KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
+++.||+|+|++||+|+ ...++.+|||++.+. +....+....|-.+|.+| .||.||+|+-.|++...+|+|+||+
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 35779999999999998 456889999998542 222234566788889998 9999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|.++|+... .|++...+.+|.+|+.||+|||++| ||||||||+|||||+|+++||+|||.|+.
T Consensus 157 ~nGdll~~i~K~G------sfde~caR~YAAeIldAleylH~~G-------IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 157 PNGDLLDLIKKYG------SFDETCARFYAAEILDALEYLHSNG-------IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred CCCcHHHHHHHhC------cchHHHHHHHHHHHHHHHHHHHhcC-------ceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999998653 4888889999999999999999998 99999999999999999999999999998
Q ss_pred ccCcc-----------------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHH
Q 047954 427 VAQPI-----------------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWV 489 (582)
Q Consensus 427 ~~~~~-----------------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~ 489 (582)
+.... ...||..|.+||++.....+..+|||+||||||+|+.|++||.... ...+.+.+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N----eyliFqkI 299 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN----EYLIFQKI 299 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc----HHHHHHHH
Confidence 75321 1236778999999999999999999999999999999999997532 22222222
Q ss_pred HHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 490 LRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 490 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
... .-.+.+.+ ...+.+|+.+.|..||.+|+|.++|-+|...
T Consensus 300 ~~l-~y~fp~~f--------------p~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF 341 (604)
T KOG0592|consen 300 QAL-DYEFPEGF--------------PEDARDLIKKLLVRDPSDRLTSQQIKAHPFF 341 (604)
T ss_pred HHh-cccCCCCC--------------CHHHHHHHHHHHccCccccccHHHHhhCccc
Confidence 111 11111111 1256778889999999999999999988653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=349.05 Aligned_cols=243 Identities=23% Similarity=0.380 Sum_probs=204.8
Q ss_pred ccccccCceEEEEEE-EcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+||+|+.|.||.|. ...++.||||++........+-+.+|+.+|+..+|+|||.+++.|...++.|+|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 579999999999998 5567889999998777777788899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+.+... .+++.++..|++++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+....
T Consensus 359 DvVt~~-------~~~E~qIA~Icre~l~aL~fLH~~g-------IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 359 DVVTKT-------RMTEGQIAAICREILQGLKFLHARG-------IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred hhhhcc-------cccHHHHHHHHHHHHHHHHHHHhcc-------eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 998643 4889999999999999999999998 9999999999999999999999999998775543
Q ss_pred ---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 432 ---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 432 ---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
...||+.|||||+.....|++|+||||||++++||+-|.+||-.... .+.+ ..++....+++-.+
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAl-yLIa~ng~P~lk~~---- 492 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRAL-YLIATNGTPKLKNP---- 492 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHH-HHHhhcCCCCcCCc----
Confidence 45588999999999999999999999999999999999999963211 1111 11222222222221
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
..-...+.+++.+||..||++|+++.|+|+|...
T Consensus 493 ----~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 493 ----EKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred ----cccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 1122367888999999999999999999999765
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=375.58 Aligned_cols=255 Identities=27% Similarity=0.444 Sum_probs=208.8
Q ss_pred ccccccccCceEEEEEEEcC--C----ceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEE
Q 047954 272 PAEGLGKGIFGNSYKALLEG--R----APVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 344 (582)
..+.||+|.||.||+|.+.+ + ..||||.++.. +.....+|.+|..+|++++|||||+++|+|.+....++++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 35789999999999999654 2 34899999765 34566789999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcCCCCCC-CCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 345 FAGNGNLFNRIHGGKSSKN-RIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||++|||..+|++.+.... ...++..+.+.++.|||+|+.||++++ +|||||..+|+||+....+||+|||+
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~-------fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH-------FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC-------CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999987643211 235889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCcccc------cccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 424 SSLVAQPIAA------QRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 424 a~~~~~~~~~------~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
|+.+...... .-.+.|||||.+..+.++.|+|||||||+|||++| |..||... ...++...+...-+-+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~----~n~~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR----SNFEVLLDVLEGGRLD 924 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc----chHHHHHHHHhCCccC
Confidence 9955433221 12367999999999999999999999999999999 88898543 3444444333221111
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
.+..+...++++|..||+.+|++||++.+|++.+..+....
T Consensus 925 --------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 925 --------------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred --------------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 22233447889999999999999999999999998886544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=342.39 Aligned_cols=258 Identities=21% Similarity=0.320 Sum_probs=200.4
Q ss_pred cccccccCceEEEEEE-EcCCceEEEEEecCCCcchHH-HHHHHHHHHhcCC-CCCccccceEEEeCC-eeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITE-EFRKQLLVIADQK-HPNLLPLLAYYFSND-EKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-H~niv~l~~~~~~~~-~~~lv~e~~~~ 348 (582)
.++||.|.||.||+|+ ...+..||||+++..-....+ .-.+|+..|+++. |||||++.+++.+.+ .+++|||||+.
T Consensus 15 i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~ 94 (538)
T KOG0661|consen 15 IRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC 94 (538)
T ss_pred HHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh
Confidence 4679999999999998 567888999999764433333 2368999999998 999999999999988 89999999965
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
+|+++++++. ..+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+|+.+.
T Consensus 95 -NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk~G-------fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 95 -NLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHKHG-------FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred -hHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHhcC-------cccccCChhheEecccceeEecccccccccc
Confidence 9999998663 36999999999999999999999998 9999999999999999999999999999886
Q ss_pred Ccc---cccccccccCCCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh----ccccc
Q 047954 429 QPI---AAQRMISYKSPEYQS-SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE----EWTAE 500 (582)
Q Consensus 429 ~~~---~~~~~~~y~aPE~~~-~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 500 (582)
... ....|..|+|||++. ...|+.+.||||+|||++|+.+-++.|.+.. ..+.+..+...+.. .|...
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s----E~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS----EIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc----HHHHHHHHHHHhCCCccccchhH
Confidence 542 344677899999765 5678999999999999999999998885432 22222222222221 11110
Q ss_pred -ccchhh----------hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 501 -IFDSEI----------SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 501 -~~d~~~----------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
-+...+ ....-......+.++++.+|+++||++|||+++++++....
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq 295 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQ 295 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence 000000 00011122445788999999999999999999999987543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=346.99 Aligned_cols=253 Identities=23% Similarity=0.410 Sum_probs=195.7
Q ss_pred cccccccCceEEEEEEE------cCCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCC-eeEEEE
Q 047954 273 AEGLGKGIFGNSYKALL------EGRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSND-EKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~-~~~lv~ 343 (582)
.+.||+|+||.||+|.. ..+..||||+++... ....+.+.+|+.++.++ +||||++++++|...+ ..++||
T Consensus 12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (338)
T cd05102 12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV 91 (338)
T ss_pred eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence 57899999999999974 234679999987533 23346788999999999 8999999999987654 578999
Q ss_pred EeCCCCChHHHHhcCCCCC--------------------------------------------------------CCCcc
Q 047954 344 KFAGNGNLFNRIHGGKSSK--------------------------------------------------------NRIPF 367 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~--------------------------------------------------------~~~~l 367 (582)
||+++|+|.+++....... ...++
T Consensus 92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (338)
T cd05102 92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL 171 (338)
T ss_pred ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence 9999999999987532100 01247
Q ss_pred chHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc------cccccccccC
Q 047954 368 RCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI------AAQRMISYKS 441 (582)
Q Consensus 368 ~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~a 441 (582)
++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.... ...++..|+|
T Consensus 172 ~~~~~~~~~~qi~~aL~~LH~~~-------ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 172 TMEDLICYSFQVARGMEFLASRK-------CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC-------EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 78889999999999999999988 9999999999999999999999999998653321 1223467999
Q ss_pred CCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHH
Q 047954 442 PEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLL 520 (582)
Q Consensus 442 PE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~ 520 (582)
||++.+..++.++|||||||++|||++ |..||..... ...+. ........... .......+.
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~---~~~~~----~~~~~~~~~~~----------~~~~~~~l~ 307 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---NEEFC----QRLKDGTRMRA----------PENATPEIY 307 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc---cHHHH----HHHhcCCCCCC----------CCCCCHHHH
Confidence 999998899999999999999999997 9999964321 11111 11111111110 011123578
Q ss_pred HHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 521 QVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 521 ~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
+++.+||+.||++|||+.|+++.|+.+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=331.29 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=202.7
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||.|..++||+|+. ..+..||||++.-.+.. ..+.+++|+..|+.++||||++++..|..+...|+||.||.+|+
T Consensus 31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS 110 (516)
T KOG0582|consen 31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGS 110 (516)
T ss_pred EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCc
Confidence 46799999999999994 56788999999754433 35889999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
+.+.++..... .+++..+..|.+++++||.|||.+| .||||||+.||||+.+|.+||+|||.+..+...
T Consensus 111 ~ldIik~~~~~----Gl~E~~Ia~iLre~LkaL~YLH~~G-------~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 111 LLDIIKTYYPD----GLEEASIATILREVLKALDYLHQNG-------HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred HHHHHHHHccc----cccHHHHHHHHHHHHHHHHHHHhcC-------ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999876644 4889999999999999999999998 999999999999999999999999987554332
Q ss_pred --------ccccccccccCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 431 --------IAAQRMISYKSPEYQSS--KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 431 --------~~~~~~~~y~aPE~~~~--~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
....+++.|||||++.. ..|+.|+||||||++..||.+|..||...++. +.....++... +.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-------kvLl~tLqn~p-p~ 251 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-------KVLLLTLQNDP-PT 251 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-------HHHHHHhcCCC-CC
Confidence 22357789999999653 57999999999999999999999999765431 11222222211 10
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
..-... ...........+.+++..||.+||++|||+++++++-+.-
T Consensus 252 ~~t~~~-~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk 297 (516)
T KOG0582|consen 252 LLTSGL-DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFK 297 (516)
T ss_pred cccccC-ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHh
Confidence 000000 0111122234688899999999999999999999886543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=342.02 Aligned_cols=256 Identities=22% Similarity=0.390 Sum_probs=198.7
Q ss_pred ccccccCceEEEEEE-EcCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~~ 348 (582)
++||+|.||.||+|+ ..++..||+|+++... ........+||.+|++++||||+++.+...+. ...|||+|||+.
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 579999999999998 5678899999997543 45566778999999999999999999999887 689999999987
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
||.-++.... ..|+..++..+++|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||+|+++.
T Consensus 203 -DL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~~g-------vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 203 -DLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHSRG-------VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred -hhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhhcC-------eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9998887543 35999999999999999999999998 9999999999999999999999999999876
Q ss_pred Ccccc-----cccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh----hccc
Q 047954 429 QPIAA-----QRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR----EEWT 498 (582)
Q Consensus 429 ~~~~~-----~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----~~~~ 498 (582)
..... .-|..|+|||.+.+. .|+.++|+||.||||.||++|++.|....+ .+....+.+... ..|.
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE----veQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE----VEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH----HHHHHHHHHHhCCCChhccc
Confidence 54322 245789999998874 799999999999999999999999865321 122222222111 1111
Q ss_pred ----c--cccchhhhhhhc----hHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 499 ----A--EIFDSEISVQRS----AAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 499 ----~--~~~d~~~~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
+ ..+.+.-...+. ........++|+..+|..||.+|.|+.+++..-..
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 0 111111110111 11122456788889999999999999999976544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.44 Aligned_cols=251 Identities=28% Similarity=0.456 Sum_probs=204.9
Q ss_pred cccccccCceEEEEEEEcCC----ce-EEEEEecC---CCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLEGR----AP-VVVKRLRD---LKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~----~~-vavK~~~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 344 (582)
.++||+|+||.||+|++..+ .. ||||..+. .......+|.+|.++|++++|||||++||++......++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 47899999999999996542 23 89999874 335567889999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
+|.||+|.++|..... .++..+++.++.+.|.||+|||+++ +|||||-++|+|++.++.+||+|||++
T Consensus 242 l~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~k~-------~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHSKN-------CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHHCC-------CcchhHhHHHheecCCCeEEeCccccc
Confidence 9999999999986543 4889999999999999999999998 999999999999999999999999998
Q ss_pred ccccCcc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 425 SLVAQPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 425 ~~~~~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
+.-..-. ...-...|+|||.+....|+.++|||||||++||+++ |..||... ...++..++. ..++..
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~----~~~~v~~kI~---~~~~r~ 382 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM----KNYEVKAKIV---KNGYRM 382 (474)
T ss_pred cCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC----CHHHHHHHHH---hcCccC
Confidence 7654211 1123468999999999999999999999999999999 88888543 3333433331 223222
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
.... .....+..++.+||..+|++||+|.++.+.++.+.....
T Consensus 383 ~~~~----------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 383 PIPS----------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CCCC----------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 2211 112256677779999999999999999999998876554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=356.25 Aligned_cols=247 Identities=24% Similarity=0.420 Sum_probs=211.2
Q ss_pred ccccccccCceEEEEEEEcC----CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 272 PAEGLGKGIFGNSYKALLEG----RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
..++||.|.||.||+|+++- ...||||.++... ...+.+|+.|..+|.+++||||++|.|+.......++|+|||
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence 35789999999999999652 3579999998653 345678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|..+|+.+.. .+++.+...+.++||.|+.||-+.+ +|||||.++|||++.+..+|++|||+++.
T Consensus 713 ENGsLDsFLR~~DG-----qftviQLVgMLrGIAsGMkYLsdm~-------YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 713 ENGSLDSFLRQNDG-----QFTVIQLVGMLRGIASGMKYLSDMN-------YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred hCCcHHHHHhhcCC-----ceEeehHHHHHHHHHHHhHHHhhcC-------chhhhhhhhheeeccceEEEeccccceee
Confidence 99999999987653 4899999999999999999999998 99999999999999999999999999998
Q ss_pred ccCcc-ccccc------ccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 427 VAQPI-AAQRM------ISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 427 ~~~~~-~~~~~------~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
+.++. ....| ++|.|||.+...+++.++|||||||||||.++ |..||-+. .++++++.+...++-
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm----SNQdVIkaIe~gyRL--- 853 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----SNQDVIKAIEQGYRL--- 853 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc----chHHHHHHHHhccCC---
Confidence 86543 22222 57999999999999999999999999999888 99998643 455655555443332
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
+.+.++...|.+||+.||++|-.+||.+.+|+..|.++.
T Consensus 854 -----------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 854 -----------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred -----------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 123345557999999999999999999999999998775
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=340.42 Aligned_cols=239 Identities=21% Similarity=0.376 Sum_probs=201.4
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCCc--chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
+.||+|+||.||||+.+ +.+.||+|.+.+... ...+.+++|++++++++|||||.++++|+...+.++|+||+.+ +
T Consensus 8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~ 86 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-D 86 (808)
T ss_pred HHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-h
Confidence 56999999999999955 567889998865433 2356789999999999999999999999999999999999976 9
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|+.++.... .+++..+..|+.|++.||.|||+.+ |+|||+||+|||++..+.+|+||||+|+.+...
T Consensus 87 L~~il~~d~------~lpEe~v~~~a~~LVsaL~yLhs~r-------ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 87 LFTILEQDG------KLPEEQVRAIAYDLVSALYYLHSNR-------ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred HHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHhcC-------cccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 999997554 4889999999999999999999998 999999999999999999999999999988665
Q ss_pred c----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 431 I----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
. ...||+.|||||+..++.|+..+|.||+|||+|||++|++||.. ..+.+.+.....+.-.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------~si~~Lv~~I~~d~v~-------- 218 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------RSITQLVKSILKDPVK-------- 218 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------HHHHHHHHHHhcCCCC--------
Confidence 3 34689999999999999999999999999999999999999953 2344444443333211
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.+......+..++...+.+||.+|.|..+++.|..
T Consensus 219 ----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 219 ----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred ----CcccccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence 11122335778888999999999999999998864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=340.80 Aligned_cols=244 Identities=24% Similarity=0.382 Sum_probs=199.8
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC----Cc-chHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL----KP-LITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||+||.|.. ..+..||+|.+... .. ...+.+.+|+.++++++ ||||+++++++......++||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 46799999999999974 46789999976542 11 23456678999999999 99999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC-CceEEeecccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN-EMVLVSDYGFS 424 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DfG~a 424 (582)
+.+|+|++++.... .+.+.....+++|++.|++|||+++ |+||||||+|||+|.+ +.+||+|||++
T Consensus 102 ~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H~~g-------i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 102 CSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCHSRG-------IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred cCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHhCC-------EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999998622 4777899999999999999999998 9999999999999999 99999999999
Q ss_pred cccc-C---cccccccccccCCCCCCCCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc-
Q 047954 425 SLVA-Q---PIAAQRMISYKSPEYQSSKK-IS-RKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW- 497 (582)
Q Consensus 425 ~~~~-~---~~~~~~~~~y~aPE~~~~~~-~~-~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 497 (582)
.... . .....|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.. ............+
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-------~~~l~~ki~~~~~~ 241 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-------VPNLYRKIRKGEFK 241 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-------HHHHHHHHhcCCcc
Confidence 8873 2 24566889999999999877 85 88999999999999999999997521 1111111111111
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.+..++ ..++..++.+|+..||.+|+|+.+|+++-|...
T Consensus 242 ~p~~~~------------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 242 IPSYLL------------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCCCcC------------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 111110 236788999999999999999999999888776
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=338.65 Aligned_cols=241 Identities=21% Similarity=0.309 Sum_probs=194.1
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 467889999986421 223456788999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~~-------ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 147 (323)
T cd05571 81 ELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSCD-------VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred cHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence 9999987432 4788899999999999999999998 99999999999999999999999999875422
Q ss_pred c----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 P----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
. ....+++.|+|||++.+..++.++|||||||++|||+||+.||.... ...+...+ .... . .+
T Consensus 148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~~~~---~~~~-~-~~---- 214 (323)
T cd05571 148 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFELI---LMEE-I-RF---- 214 (323)
T ss_pred CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC----HHHHHHHH---HcCC-C-CC----
Confidence 1 22347889999999999999999999999999999999999996421 11111111 1111 0 00
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhh
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEI 546 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 546 (582)
+.....++.+++.+||+.||++|| ++.++++|-+.
T Consensus 215 ------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f 254 (323)
T cd05571 215 ------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254 (323)
T ss_pred ------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCc
Confidence 001123577889999999999999 89999988654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=308.83 Aligned_cols=258 Identities=22% Similarity=0.342 Sum_probs=201.3
Q ss_pred cccccccCceEEEEEE-EcCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|.||.||+|+ ..+++.||||+++.. +........+|++.|+.++|+||+.++++|-..+..-||+|||+.
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t- 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT- 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence 4679999999999999 457889999999744 233456788999999999999999999999999999999999976
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
||+..++... ..++..++..++.++++||+|||.+. |+||||||.|+|++.+|.+||+|||+|+.+..
T Consensus 86 dLe~vIkd~~-----i~l~pa~iK~y~~m~LkGl~y~H~~~-------IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 86 DLEVVIKDKN-----IILSPADIKSYMLMTLKGLAYCHSKW-------ILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred cHHHHhcccc-----cccCHHHHHHHHHHHHHHHHHHHhhh-------hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 9999997543 46899999999999999999999998 99999999999999999999999999999876
Q ss_pred ccccc----ccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh----ccccc
Q 047954 430 PIAAQ----RMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE----EWTAE 500 (582)
Q Consensus 430 ~~~~~----~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 500 (582)
+.... .|..|+|||.+.+ ..|+..+||||.|||+.||+-|.+-|... ...+....+.+.+.. +|..-
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~----sDidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD----SDIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC----chHHHHHHHHHHcCCCCcccCccc
Confidence 54322 4567999998876 57999999999999999999988666432 222223333333321 22211
Q ss_pred ccchhh---h------hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 501 IFDSEI---S------VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 501 ~~d~~~---~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.--+.+ . ...-.......+++++..++..||.+|+++.|++++-..-
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~ 285 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK 285 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence 000000 0 0001112334568999999999999999999999886544
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=342.40 Aligned_cols=252 Identities=23% Similarity=0.398 Sum_probs=197.3
Q ss_pred ccccccccCceEEEEEEE------cCCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEE
Q 047954 272 PAEGLGKGIFGNSYKALL------EGRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 343 (582)
..+.||+|+||.||+|.. ..+..||||+++... ....+.+.+|+.++..+ +|||||+++++|...+..++||
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 368899999999999974 235579999986432 33456788999999999 8999999999999999999999
Q ss_pred EeCCCCChHHHHhcCCCC--------------------------------------------------------------
Q 047954 344 KFAGNGNLFNRIHGGKSS-------------------------------------------------------------- 361 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~-------------------------------------------------------------- 361 (582)
||+++|+|.++++.....
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 999999999999753210
Q ss_pred -------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCccc--
Q 047954 362 -------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA-- 432 (582)
Q Consensus 362 -------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~~-- 432 (582)
.....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-------ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN-------CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-------eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 01124788899999999999999999988 99999999999999999999999999976643221
Q ss_pred ----ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 433 ----AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 433 ----~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
..++..|+|||++.+..++.++|||||||++|||++ |..||..... ...+...+ ........ +.
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~---~~~~~~~~----~~~~~~~~--~~-- 340 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV---DSKFYKMI----KEGYRMLS--PE-- 340 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc---hHHHHHHH----HhCccCCC--CC--
Confidence 123456999999999999999999999999999998 8888864321 11222222 22211110 00
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
....++.+++.+||+.||++|||+.||++.|+..
T Consensus 341 ------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 ------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0123678999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=332.43 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=195.2
Q ss_pred cccccccCceEEEEEEEcC-----------------CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEE
Q 047954 273 AEGLGKGIFGNSYKALLEG-----------------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYF 334 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 334 (582)
.+.||+|+||.||+|.+.+ +..||+|.+.... ......|.+|+.++.+++||||+++++++.
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 89 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV 89 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 4679999999999998543 2369999987543 334567899999999999999999999999
Q ss_pred eCCeeEEEEEeCCCCChHHHHhcCCCC-------------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceec
Q 047954 335 SNDEKLLVYKFAGNGNLFNRIHGGKSS-------------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHG 401 (582)
Q Consensus 335 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~ 401 (582)
..+..++||||+++|+|.+++...... .....+++..++.++.||+.||+|||+.+ |+||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-------ivH~ 162 (304)
T cd05096 90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-------FVHR 162 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-------cccc
Confidence 999999999999999999998653211 01124778889999999999999999998 9999
Q ss_pred CCCCCCeeecCCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCCC
Q 047954 402 NLKSTNILLDDNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT--GRIST 473 (582)
Q Consensus 402 Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt--G~~P~ 473 (582)
||||+|||+++++.+||+|||+++.+.... ...++..|+|||++....++.++|||||||++|||++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 999999999999999999999997654322 1123567999999988889999999999999999987 56677
Q ss_pred CCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 474 HSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.... .......+.............. ........+.+++.+||+.||++|||+.+|.+.|+
T Consensus 243 ~~~~----~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 243 GELT----DEQVIENAGEFFRDQGRQVYLF-------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CcCC----HHHHHHHHHHHhhhcccccccc-------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 5321 2223333222222111000000 00112236789999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.52 Aligned_cols=260 Identities=20% Similarity=0.278 Sum_probs=209.3
Q ss_pred ChhHhhhcccccccccCceEEEEEEEcCC-ceEEEEEecCCCcchHHHHHHHHHHHhcCC-CCCccccce-EEEeC----
Q 047954 264 KLNDLLKAPAEGLGKGIFGNSYKALLEGR-APVVVKRLRDLKPLITEEFRKQLLVIADQK-HPNLLPLLA-YYFSN---- 336 (582)
Q Consensus 264 ~~~~l~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~-~~~~~---- 336 (582)
++........+.|.+|||+.||.|....+ ..+|+|++...+....+...+|+++|++|+ |+|||.+++ .....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 33344444567899999999999998776 999999998777778889999999999996 999999999 33221
Q ss_pred --CeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC
Q 047954 337 --DEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE 414 (582)
Q Consensus 337 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~ 414 (582)
-+.+|.||||.+|.|-+++..+... .|++.++++|+.|+++|+++||... +||||||||.+||||+.++
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~----~lte~eVLkIf~dv~~AVa~mH~~~-----pPiIHRDLKiENvLls~~g 183 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQT----RLTEDEVLKIFYDVCEAVAAMHYLK-----PPIIHRDLKIENVLLSADG 183 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhc----cCChHHHHHHHHHHHHHHHHHhcCC-----CccchhhhhhhheEEcCCC
Confidence 2578999999999999999865433 4999999999999999999999986 4699999999999999999
Q ss_pred ceEEeecccccccc-------------CcccccccccccCCCCC---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 047954 415 MVLVSDYGFSSLVA-------------QPIAAQRMISYKSPEYQ---SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQ 478 (582)
Q Consensus 415 ~~kl~DfG~a~~~~-------------~~~~~~~~~~y~aPE~~---~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~ 478 (582)
..||||||.|.-.- +......|+.|+|||++ .+..+++|+|||||||+||-|+....||+....
T Consensus 184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 99999999875321 12334568899999976 467889999999999999999999999975311
Q ss_pred CCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCC
Q 047954 479 GINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTEST 553 (582)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 553 (582)
..|++..+..+.. ......+.+||..||+.||++||++-+|+.++.++....-.
T Consensus 264 --------------------laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 264 --------------------LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred --------------------eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 1122222222111 23445788999999999999999999999999988866543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=341.12 Aligned_cols=247 Identities=24% Similarity=0.343 Sum_probs=204.7
Q ss_pred cccccccCceEEEEEE-EcCCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
++-||.|+-|.|-.|+ ..+|+.+|||.+.... ......+.+|+.+|+-+.||||+++|+++.+..++|+|.||+++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 3569999999999998 5689999999996542 22345678999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|.|++++...+ ++++.+..++++||+.|+.|+|..+ |+||||||+|+|||..+.+||+|||+|.+-.
T Consensus 97 GELFdylv~kG------~l~e~eaa~ff~QIi~gv~yCH~~~-------icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 97 GELFDYLVRKG------PLPEREAAHFFRQILDGVSYCHAFN-------ICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred chhHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhhhc-------ceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 99999997543 5889999999999999999999998 9999999999999999999999999997754
Q ss_pred Cc---ccccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP---IAAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~---~~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.+ ....|.+.|.|||++.+.+| +.++||||.|||||.|+||+.||++. +-..+...|.++..+ ++..+
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd----Nir~LLlKV~~G~f~--MPs~I-- 235 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD----NIRVLLLKVQRGVFE--MPSNI-- 235 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc----cHHHHHHHHHcCccc--CCCcC--
Confidence 44 35568889999999999998 68999999999999999999999742 222333333222111 11111
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
..+..+|+.+|+..||++|.|++||++|.+-..-..
T Consensus 236 -----------s~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 236 -----------SSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred -----------CHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 125678889999999999999999999998766433
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.34 Aligned_cols=243 Identities=32% Similarity=0.565 Sum_probs=188.9
Q ss_pred cccccccCceEEEEEEEc-----CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE-----GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||.|.||.||+|.+. .+..|+||.++... ....+.|.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 367999999999999987 25679999996533 334688999999999999999999999999888899999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|.+++.... ...+++..+..|+.|||+||.|||+.+ ++|+||+++||++++++.+||+|||++..
T Consensus 84 ~~g~L~~~L~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~~-------iiH~~l~~~nill~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 84 PGGSLDDYLKSKN----KEPLSEQQRLSIAIQIAEALSYLHSNN-------IIHGNLSPSNILLDSNGQVKLSDFGLSRP 152 (259)
T ss_dssp TTEBHHHHHHHTC----TTTSBHHHHHHHHHHHHHHHHHHHHTT-------EEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred ccccccccccccc----ccccccccccccccccccccccccccc-------ccccccccccccccccccccccccccccc
Confidence 9999999998762 235899999999999999999999998 99999999999999999999999999977
Q ss_pred ccCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 427 VAQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 427 ~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
.... ........|+|||.+....++.++||||||+++|||+| |+.||... ...++...+ ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~----~~~~~~~~~----~~~~~~ 224 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY----DNEEIIEKL----KQGQRL 224 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS----CHHHHHHHH----HTTEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccccc----cccccc
Confidence 6321 12234567999999988889999999999999999999 78887532 222222222 222111
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
...+ .....+.+++.+||+.||++||||+++++.|
T Consensus 225 ~~~~----------~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPD----------NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBT----------TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eecc----------chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1110 1122577899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.43 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=198.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||++... ++..||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence 357999999999999965 5677888888643 23345679999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++.... .+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~------~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 90 LDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKH------QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred HHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcC------CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999997532 4788889999999999999999863 2999999999999999999999999998765432
Q ss_pred --ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh---cccc------
Q 047954 431 --IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE---EWTA------ 499 (582)
Q Consensus 431 --~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~------ 499 (582)
....++..|+|||++.+..++.++|||||||++|||+||+.||..... .++...+...... ....
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA----KELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhcccccccccCCccccCccc
Confidence 223467899999999998999999999999999999999999964221 1111110000000 0000
Q ss_pred ---------------------cccchhhh---hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 500 ---------------------EIFDSEIS---VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 500 ---------------------~~~d~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
+..+.... ..........++.+++.+||++||++|||++|+++|.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 00000000 00000012246889999999999999999999999988654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=340.74 Aligned_cols=254 Identities=21% Similarity=0.369 Sum_probs=197.3
Q ss_pred cccccccccCceEEEEEEEc------CCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEE
Q 047954 271 APAEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLV 342 (582)
Q Consensus 271 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 342 (582)
...+.||+|+||.||+|... ++..||+|+++... ....+.+.+|+.+++.+ +|+|||+++++|...+..++|
T Consensus 41 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv 120 (374)
T cd05106 41 QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVI 120 (374)
T ss_pred eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEe
Confidence 34688999999999998742 23579999997543 23356788999999999 899999999999999999999
Q ss_pred EEeCCCCChHHHHhcCCCC-------------------------------------------------------------
Q 047954 343 YKFAGNGNLFNRIHGGKSS------------------------------------------------------------- 361 (582)
Q Consensus 343 ~e~~~~gsL~~~l~~~~~~------------------------------------------------------------- 361 (582)
|||+++|+|.++++.....
T Consensus 121 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (374)
T cd05106 121 TEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDE 200 (374)
T ss_pred HhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccch
Confidence 9999999999998643210
Q ss_pred ---CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCccc------
Q 047954 362 ---KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA------ 432 (582)
Q Consensus 362 ---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~~------ 432 (582)
....++++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 201 ~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-------iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 201 EDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN-------CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred hccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-------EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 01124788889999999999999999988 99999999999999999999999999976543221
Q ss_pred ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhc
Q 047954 433 AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRS 511 (582)
Q Consensus 433 ~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 511 (582)
..++..|+|||++....++.++|||||||++|||++ |+.||..... ...+. ............+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~---~~~~~----~~~~~~~~~~~~~-------- 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV---NSKFY----KMVKRGYQMSRPD-------- 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc---cHHHH----HHHHcccCccCCC--------
Confidence 123457999999988899999999999999999997 9999964321 11111 1111111110000
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 512 AAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 512 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
....++.+++.+||+.||++|||+.+|++.|+++.
T Consensus 339 --~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 --FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 01236788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=329.87 Aligned_cols=248 Identities=21% Similarity=0.269 Sum_probs=196.5
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++.+++|+||+++++++...+..++||||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g 85 (285)
T cd05631 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCC
Confidence 5799999999999985 578899999886432 222346788999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 86 ~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~-------iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 86 DLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRER-------IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred cHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99988864321 24888999999999999999999998 99999999999999999999999999977543
Q ss_pred c---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 430 P---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 ~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||...... .....+....... ....
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~----~~~~~~~~~~~~~-~~~~----- 224 (285)
T cd05631 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER----VKREEVDRRVKED-QEEY----- 224 (285)
T ss_pred CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHHhhcc-cccC-----
Confidence 2 2234678999999999999999999999999999999999999753221 1111111111111 0000
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHHhhc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSELEII 547 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~i 547 (582)
.......+.+|+.+||+.||++||+ ++++++|.+..
T Consensus 225 -----~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~ 265 (285)
T cd05631 225 -----SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265 (285)
T ss_pred -----CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence 0111235778999999999999997 89999887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.67 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=207.9
Q ss_pred ccccccccCceEEEEEEEcCCceEEEEEecCCCc-chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKP-LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
+.++||+|-||.|..+...++..||||+++.... ..+.+|.+|+++|.+++|||||+++|+|..++.+++|+|||++|+
T Consensus 542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 4688999999999999999999999999986543 445899999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++...... .+.-....+|+.|||.|++||.+.+ +|||||.++|+|+|.++++||+|||+++-+-..
T Consensus 622 LnqFl~aheap----t~~t~~~vsi~tqiasgmaYLes~n-------fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 622 LNQFLSAHELP----TAETAPGVSICTQIASGMAYLESLN-------FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHhccCc----ccccchhHHHHHHHHHHHHHHHhhc-------hhhccccccceeecCcccEEecCcccccccccC
Confidence 99999865432 2345567779999999999999998 999999999999999999999999999866544
Q ss_pred cccc--c----cccccCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 431 IAAQ--R----MISYKSPEYQSSKKISRKSDVWSFGCLLLELLT--GRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 431 ~~~~--~----~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt--G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
.... | .++|||||.+.-+++++++|||+|||++||+++ ...||.... ..++++......+.+-...+
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt----~e~vven~~~~~~~~~~~~~- 765 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT----DEQVVENAGEFFRDQGRQVV- 765 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh----HHHHHHhhhhhcCCCCccee-
Confidence 3322 1 368999999999999999999999999999976 678886432 23344433333333222211
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
...+.-+..++++++++||..|-++||+++++..+|++.
T Consensus 766 ------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 ------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 112334455789999999999999999999999988754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=334.30 Aligned_cols=262 Identities=27% Similarity=0.439 Sum_probs=213.4
Q ss_pred CCChhHhhhcccccccccCceEEEEEEEcC-CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeE
Q 047954 262 GFKLNDLLKAPAEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKL 340 (582)
Q Consensus 262 ~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 340 (582)
.+.++--......+||-|.||.||.|.|+. .-.||||.++.. ....++|++|..+|+.++|||+|+++|+|..+...|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 344433334456889999999999999865 457999999764 345789999999999999999999999999999999
Q ss_pred EEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEee
Q 047954 341 LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSD 420 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 420 (582)
||+|||..|+|.++|++... ..++....+.+|.||+.|++||..++ +|||||..+|+|+.++..+||+|
T Consensus 340 IiTEfM~yGNLLdYLRecnr----~ev~avvLlyMAtQIsSaMeYLEkkn-------FIHRDLAARNCLVgEnhiVKvAD 408 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNR----SEVPAVVLLYMATQISSAMEYLEKKN-------FIHRDLAARNCLVGENHIVKVAD 408 (1157)
T ss_pred EEEecccCccHHHHHHHhch----hhcchhHHHHHHHHHHHHHHHHHHhh-------hhhhhhhhhhccccccceEEeec
Confidence 99999999999999987643 35677788899999999999999998 99999999999999999999999
Q ss_pred ccccccccCccccc-----ccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 421 YGFSSLVAQPIAAQ-----RMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 421 fG~a~~~~~~~~~~-----~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
||+++++..+.... -.+.|.|||.+..+.++.|+|||+|||+|||+.| |..||.. .+-.++...+ .
T Consensus 409 FGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG----idlSqVY~LL----E 480 (1157)
T KOG4278|consen 409 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG----IDLSQVYGLL----E 480 (1157)
T ss_pred cchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC----ccHHHHHHHH----h
Confidence 99999987654332 2367999999999999999999999999999999 8888743 2222233333 3
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCC
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTEST 553 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 553 (582)
.++..+ .+..+..++++||+.||++.|.+||++.|+-+.++.+....+.
T Consensus 481 kgyRM~----------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 481 KGYRMD----------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred cccccc----------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 332211 1223344789999999999999999999999999988655543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=322.67 Aligned_cols=246 Identities=20% Similarity=0.329 Sum_probs=195.7
Q ss_pred ccccccccCceEEEEEEEc----CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 272 PAEGLGKGIFGNSYKALLE----GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
..+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++.+++||||+++++++...+..++||||+
T Consensus 9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (266)
T cd05064 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYM 88 (266)
T ss_pred EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeC
Confidence 3567999999999999853 35689999987543 233467899999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+..
T Consensus 89 ~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~~~-------iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 89 SNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEMG-------YVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred CCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------EeeccccHhhEEEcCCCcEEECCCccccc
Confidence 9999999987532 24789999999999999999999988 99999999999999999999999998765
Q ss_pred ccCcc-----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 427 VAQPI-----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 427 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
..... ...++..|+|||++.+..++.++|||||||++||+++ |+.||.... ..++...+ .......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~----~~~~~~~~----~~~~~~~ 228 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS----GQDVIKAV----EDGFRLP 228 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC----HHHHHHHH----HCCCCCC
Confidence 43221 1223467999999998999999999999999999875 999996432 12222222 1111111
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
. .......+.+++.+||+.+|++||++.+|++.|..+
T Consensus 229 ~----------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 A----------PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred C----------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 111223578899999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=318.81 Aligned_cols=241 Identities=26% Similarity=0.460 Sum_probs=195.5
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||++.+.++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 35799999999999999888889999886432 33567889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
++++.... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++......
T Consensus 88 ~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 88 NYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERNS-------FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred HHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHCC-------ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99875321 4788999999999999999999998 9999999999999999999999999987654322
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
...++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+....+.. .... ..+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~----~~~~~~~~i~~----~~~~--~~~~- 224 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK----SNYEVVEMISR----GFRL--YRPK- 224 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHC----CCCC--CCCC-
Confidence 1123457999999988889999999999999999999 89998542 12222222211 1110 0110
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
....++.+++.+||+.+|++||++.++++.|
T Consensus 225 -------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 -------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1123578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=331.44 Aligned_cols=240 Identities=21% Similarity=0.373 Sum_probs=197.4
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
++||+|+||.||+|.. ..++.||+|++.-. .....++.++|+.++..++++||.++||.+..+..++++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 6799999999999995 45778999999643 344567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+.+.... .+++..+.-|++++..||.|||+++ .+|||||+.|||+..+|.+||+|||.+..+...
T Consensus 99 ~~lL~~~~------~~~E~~i~~ilre~l~~l~ylH~~~-------kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 99 LDLLKSGN------ILDEFEIAVILREVLKGLDYLHSEK-------KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hhhhccCC------CCccceeeeehHHHHHHhhhhhhcc-------eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99997543 3466677778899999999999998 999999999999999999999999999777554
Q ss_pred ---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 431 ---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
....||+.|||||++....|+.|+||||||++.+||.+|.+|+....+. . +.. . +++-..|.+.
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-r---vlf----l-----Ipk~~PP~L~ 232 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-R---VLF----L-----IPKSAPPRLD 232 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-e---EEE----e-----ccCCCCCccc
Confidence 3456889999999999989999999999999999999999999754321 0 000 0 1111111111
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
. .....+.+++..||++||+.||++.++++|-
T Consensus 233 ~-----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~ 264 (467)
T KOG0201|consen 233 G-----DFSPPFKEFVEACLDKNPEFRPSAKELLKHK 264 (467)
T ss_pred c-----ccCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence 1 2333577888899999999999999999873
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=330.20 Aligned_cols=241 Identities=22% Similarity=0.324 Sum_probs=193.2
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+.||+|+||.||++... ++..||+|+++.. .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999864 6788999998643 2223456778999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-------ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 147 (323)
T cd05595 81 ELFFHLSRER------VFTEERARFYGAEIVSALEYLHSRD-------VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred cHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence 9998886432 4788999999999999999999998 99999999999999999999999999875422
Q ss_pred c----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 P----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ...... ....... .+ .
T Consensus 148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~----~~~~~~---~~~~~~~--~~-p-- 215 (323)
T cd05595 148 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERLFE---LILMEEI--RF-P-- 215 (323)
T ss_pred CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC----HHHHHH---HHhcCCC--CC-C--
Confidence 2 12347789999999999999999999999999999999999996422 111111 1111110 00 0
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhh
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEI 546 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 546 (582)
. ....++.+++.+||+.||++|| ++.++++|-+.
T Consensus 216 ----~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~ 254 (323)
T cd05595 216 ----R---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254 (323)
T ss_pred ----C---CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCc
Confidence 0 1122577889999999999998 89999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=308.95 Aligned_cols=276 Identities=18% Similarity=0.261 Sum_probs=205.8
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~~ 348 (582)
+.|++|+||.||+|+. ++++.||+|+++... ....-...+||.+|.+++|||||.+-.+.... +..|+|||||+.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 6799999999999995 467889999997543 22334568999999999999999999988754 568999999987
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
||..++.... .++...+...++.|+++||+|||.+. |+|||||++|+|+...|.+||+|||+|+.+.
T Consensus 162 -DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~~w-------ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 162 -DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHDNW-------ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred -hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhhce-------eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999997544 35888999999999999999999998 9999999999999999999999999999988
Q ss_pred Ccccc----cccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 429 QPIAA----QRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 429 ~~~~~----~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
.+... .-|..|+|||.+.+. .|++..|+||+|||+.||+++++-|....+ .+..+.+.+.+.. ..+.+.
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE----~dQl~~If~llGt--Pte~iw 302 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE----IDQLDKIFKLLGT--PSEAIW 302 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch----HHHHHHHHHHhCC--CccccC
Confidence 76433 246789999988864 689999999999999999999988865432 2222222222211 111111
Q ss_pred hhh---------hhhhch-------HH---HHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCCccccccccccC
Q 047954 504 SEI---------SVQRSA-------AH---GMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEEDFWLDQS 564 (582)
Q Consensus 504 ~~~---------~~~~~~-------~~---~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~ 564 (582)
+.+ .....+ .. -...-++|+...+..||.+|.|++|.++|=+........+.+....++.-
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k 382 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAK 382 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccc
Confidence 110 000000 00 11345688889999999999999999999877654444444333344444
Q ss_pred CCCC
Q 047954 565 LTDE 568 (582)
Q Consensus 565 ~~~~ 568 (582)
...+
T Consensus 383 ~~~~ 386 (419)
T KOG0663|consen 383 SEQQ 386 (419)
T ss_pred cccc
Confidence 4333
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.52 Aligned_cols=243 Identities=21% Similarity=0.288 Sum_probs=196.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 85 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG 85 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence 367999999999999965 67889999985322 12345688999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 86 GELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSKE-------IVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 99999996532 4788889999999999999999998 9999999999999999999999999998764
Q ss_pred Ccc-cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 429 QPI-AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 429 ~~~-~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
... ...+++.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+. ... . ++ ..
T Consensus 153 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~----~~~~~~~i~---~~~-~-~~-~~--- 219 (291)
T cd05612 153 DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN----PFGIYEKIL---AGK-L-EF-PR--- 219 (291)
T ss_pred CCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHH---hCC-c-CC-Cc---
Confidence 432 3347889999999998889999999999999999999999996421 112222111 111 0 00 00
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHHhhc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSELEII 547 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~i 547 (582)
.....+.+++.+||+.||.+||+ ++|+++|.|..
T Consensus 220 ------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 258 (291)
T cd05612 220 ------HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258 (291)
T ss_pred ------cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence 01125778999999999999995 99999988754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=331.71 Aligned_cols=241 Identities=21% Similarity=0.313 Sum_probs=193.7
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+.||+|+||.||++... ++..||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999854 6788999998643 2233457788999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~-------ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~ 147 (328)
T cd05593 81 ELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSGK-------IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT 147 (328)
T ss_pred CHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence 9999886432 4788999999999999999999998 99999999999999999999999999876432
Q ss_pred c----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 P----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
. ....+++.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.. ....... . +.
T Consensus 148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~----~~~~~~---~~~~~~~--~-~p-- 215 (328)
T cd05593 148 DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFE---LILMEDI--K-FP-- 215 (328)
T ss_pred cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC----HHHHHH---HhccCCc--c-CC--
Confidence 1 12347889999999998899999999999999999999999996421 111111 1111100 0 00
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhh
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEI 546 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 546 (582)
. ....++.+++.+||+.||++|| ++.|+++|.+.
T Consensus 216 ----~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 254 (328)
T cd05593 216 ----R---TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254 (328)
T ss_pred ----C---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence 0 1122577888999999999997 89999988654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=331.66 Aligned_cols=262 Identities=23% Similarity=0.400 Sum_probs=213.6
Q ss_pred CChhHhhhcccccccccCceEEEEEEEcCC-----ceEEEEEecC-CCcchHHHHHHHHHHHhcCCCCCccccceEEEeC
Q 047954 263 FKLNDLLKAPAEGLGKGIFGNSYKALLEGR-----APVVVKRLRD-LKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN 336 (582)
Q Consensus 263 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 336 (582)
+.+.--.....++||.|-||.||+|.+.+- -.||||..+. ......+.|..|..+|++++|||||+++|+|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 333333344578899999999999996432 3588999876 456678899999999999999999999999965
Q ss_pred CeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCce
Q 047954 337 DEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMV 416 (582)
Q Consensus 337 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~ 416 (582)
...|+|||.++.|.|..++..++. .++......++.||+.||+|||+.. +|||||..+|||+.....+
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk~-----sL~l~tL~ly~~Qi~talaYLeSkr-------fVHRDIAaRNiLVsSp~CV 530 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNKD-----SLPLRTLTLYCYQICTALAYLESKR-------FVHRDIAARNILVSSPQCV 530 (974)
T ss_pred cceeEEEecccchhHHHHHHhccc-----cchHHHHHHHHHHHHHHHHHHHhhc-------hhhhhhhhhheeecCccee
Confidence 468999999999999999987654 3888889999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCcccccc-----cccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHH
Q 047954 417 LVSDYGFSSLVAQPIAAQR-----MISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVL 490 (582)
Q Consensus 417 kl~DfG~a~~~~~~~~~~~-----~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~ 490 (582)
||+|||+++.+.+...... .+.|||||.+.-.+++.++|||-|||.+||++. |..||..-. +.+++-.+.
T Consensus 531 KLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk----NsDVI~~iE 606 (974)
T KOG4257|consen 531 KLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK----NSDVIGHIE 606 (974)
T ss_pred eecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc----ccceEEEec
Confidence 9999999999987654433 256999999999999999999999999999988 999996532 222221111
Q ss_pred HHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCCcc
Q 047954 491 RAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEE 555 (582)
Q Consensus 491 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 555 (582)
.+ +. .+.++.+...++.|+.+||..||.+||.+.++...|..+.+.++...
T Consensus 607 nG---eR-----------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~ 657 (974)
T KOG4257|consen 607 NG---ER-----------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINS 657 (974)
T ss_pred CC---CC-----------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhh
Confidence 11 00 12333455578999999999999999999999999999887665433
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=333.87 Aligned_cols=245 Identities=22% Similarity=0.357 Sum_probs=191.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||+.+|+
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 467999999999999865 67899999986433 2345678999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+.. ...+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 159 L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~-------ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 159 LEGTH----------IADEQFLADVARQILSGIAYLHRRH-------IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred ccccc----------cCCHHHHHHHHHHHHHHHHHHHHCC-------EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 86432 2456677889999999999999998 999999999999999999999999999876433
Q ss_pred ----ccccccccccCCCCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 431 ----IAAQRMISYKSPEYQSS-----KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 431 ----~~~~~~~~y~aPE~~~~-----~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
....++..|+|||++.. ...+.++|||||||++|||++|+.||..... .+........ ........
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~~~~~~~~~-~~~~~~~~ 296 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ----GDWASLMCAI-CMSQPPEA 296 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----ccHHHHHHHH-hccCCCCC
Confidence 23457789999998743 2345689999999999999999999963221 1111111111 11101100
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
......++.+++.+||+.||++|||+.|+++|.+..+.
T Consensus 297 ----------~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 297 ----------PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ----------CCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 01122367889999999999999999999999876664
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=315.46 Aligned_cols=241 Identities=24% Similarity=0.406 Sum_probs=202.0
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|.||+|-+|.. ..|+.||||.+++.. ..+.-.+++|+++|+.++||||+.+|++|...+...+||||..+
T Consensus 58 ~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~ 137 (668)
T KOG0611|consen 58 TETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASG 137 (668)
T ss_pred HHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCC
Confidence 35699999999999984 678999999997543 23344678999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|.|++++.+.. .+++.+...+++||..|+.|+|.++ +||||||.+|||+|+++++||+|||++.++.
T Consensus 138 GeLYDYiSer~------~LsErEaRhfFRQIvSAVhYCHknr-------VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 138 GELYDYISERG------SLSEREARHFFRQIVSAVHYCHKNR-------VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred ccHHHHHHHhc------cccHHHHHHHHHHHHHHHHHHhhcc-------ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999998654 5899999999999999999999998 9999999999999999999999999998886
Q ss_pred Ccc---cccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QPI---AAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~~---~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
+.. ...|++-|.+||.+.+..| ++.+|-||+||+||.|+.|..||+. .+....+.+.....+...
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-------~Dhk~lvrQIs~GaYrEP---- 273 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-------RDHKRLVRQISRGAYREP---- 273 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-------chHHHHHHHhhcccccCC----
Confidence 653 3457788999999999888 6889999999999999999999953 333344443333332211
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
..+. ...-|+.+||..+|++|.|+.||..|.|-
T Consensus 274 -----~~PS----dA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 274 -----ETPS----DASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred -----CCCc----hHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 1111 24457789999999999999999999873
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.40 Aligned_cols=240 Identities=23% Similarity=0.300 Sum_probs=192.2
Q ss_pred ccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 276 LGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 276 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
||+|+||.||+|... ++..||+|+++.. .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 5678999998642 223445678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-------i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 147 (312)
T cd05585 81 FHHLQREG------RFDLSRARFYTAELLCALENLHKFN-------VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147 (312)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence 99996432 4788899999999999999999998 999999999999999999999999998764322
Q ss_pred ---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 431 ---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
....++..|+|||++.+..++.++|||||||++|||+||+.||.... ............. .+
T Consensus 148 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-------~~~~~~~~~~~~~--~~------ 212 (312)
T cd05585 148 DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-------VNEMYRKILQEPL--RF------ 212 (312)
T ss_pred CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcCCC--CC------
Confidence 22347889999999999999999999999999999999999996421 1111212111110 00
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCC---ChHHHHHHHhhc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRP---EMAEVVSELEII 547 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~L~~i 547 (582)
. .....++.+++.+||+.||++|| ++.|++.|.+.-
T Consensus 213 -~---~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~ 251 (312)
T cd05585 213 -P---DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS 251 (312)
T ss_pred -C---CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence 0 01112577889999999999997 568888876543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=329.53 Aligned_cols=260 Identities=21% Similarity=0.302 Sum_probs=195.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||++++++|...+..++||||+++|+
T Consensus 10 ~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (333)
T cd06650 10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (333)
T ss_pred eccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCc
Confidence 467999999999999976 5677888887643 23345678999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++.... .+++.....++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 90 L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~------~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 90 LDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH------KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred HHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC------CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999996432 4778888999999999999999753 2999999999999999999999999998765432
Q ss_pred --ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccc---------
Q 047954 431 --IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTA--------- 499 (582)
Q Consensus 431 --~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 499 (582)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... ..+...+..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA----KELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch----hHHHHHhcCcccCCccccccCcccCC
Confidence 223467889999999988899999999999999999999999964321 01100000000000000
Q ss_pred -------------------cccchhhhhh---hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 500 -------------------EIFDSEISVQ---RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 500 -------------------~~~d~~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.+.+...... ........++.+++.+||+.||++|||+.|+++|.+.-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 0000000000 000001235789999999999999999999999977543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=318.01 Aligned_cols=244 Identities=22% Similarity=0.407 Sum_probs=198.1
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+++|+|.
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89 (261)
T ss_pred eeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHH
Confidence 46799999999999998888889999886432 34578899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
++++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~~-------i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 90 DFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERKN-------YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99975432 24788889999999999999999987 9999999999999999999999999998764322
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
...++..|+|||+.....++.++|||||||++|||+| |+.||.... .......+ ...+.....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~~~~~~~~----~~~~~~~~~---- 226 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS----NSDVMSAL----QRGYRMPRM---- 226 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC----HHHHHHHH----HcCCCCCCC----
Confidence 1223457999999988889999999999999999999 999985421 11222222 111111100
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.....++.+++.+||..+|++||+++++.+.|+.
T Consensus 227 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ------ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=295.83 Aligned_cols=256 Identities=24% Similarity=0.387 Sum_probs=208.0
Q ss_pred CCCChhHhhhcccccccccCceEEEEEEE-cCCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeC
Q 047954 261 AGFKLNDLLKAPAEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN 336 (582)
Q Consensus 261 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 336 (582)
..+++++.. .++.||+|.||.||.|+. +++..||+|++.+.. ......+.+|+++-+.|+||||+++|++|.+.
T Consensus 17 ~~~~l~dfe--igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 17 KTWTLDDFE--IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccchhhcc--ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 345555553 367899999999999995 467789999986432 23456789999999999999999999999999
Q ss_pred CeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCce
Q 047954 337 DEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMV 416 (582)
Q Consensus 337 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~ 416 (582)
...||++||.++|++...|.+.... .++......+..|+|.||.|+|..+ ||||||||+|+|++..+..
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h~k~-------VIhRdiKpenlLlg~~~~l 163 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCHLKR-------VIHRDIKPENLLLGSAGEL 163 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhccCC-------cccCCCCHHHhccCCCCCe
Confidence 9999999999999999999865543 4777788889999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCc--ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 417 LVSDYGFSSLVAQP--IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 417 kl~DfG~a~~~~~~--~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
||+|||.+-..... ....||.-|.+||+..+..++.++|+|++||+.||++.|..||.+.. ..+..+.+.+
T Consensus 164 kiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~----~~etYkrI~k--- 236 (281)
T KOG0580|consen 164 KIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS----HSETYKRIRK--- 236 (281)
T ss_pred eccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh----hHHHHHHHHH---
Confidence 99999998655322 34557889999999999999999999999999999999999997543 2222222221
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.++.+| ..-.....+++.+|+.++|.+|.+..|++.|.|-..
T Consensus 237 ----~~~~~p--------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 237 ----VDLKFP--------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ----ccccCC--------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 111111 111225778999999999999999999999988543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=320.82 Aligned_cols=250 Identities=24% Similarity=0.475 Sum_probs=198.1
Q ss_pred cccccccCceEEEEEEEcCC------ceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEGR------APVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|...+. ..|++|.++... ......|.+|+.++.+++||||+++++++......+++|||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY 89 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence 46799999999999986432 468999886433 23456789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCC----------CCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc
Q 047954 346 AGNGNLFNRIHGGKSSKN----------RIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM 415 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~ 415 (582)
+++|+|.+++........ ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~-------i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-------FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-------eeccccccceEEEcCCCc
Confidence 999999999975432110 135788899999999999999999998 999999999999999999
Q ss_pred eEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHH
Q 047954 416 VLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSW 488 (582)
Q Consensus 416 ~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 488 (582)
+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||.... ..++...
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~----~~~~~~~ 238 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS----NQEVIEM 238 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH
Confidence 9999999987653321 1223567999999988899999999999999999998 999986432 1222222
Q ss_pred HHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 489 VLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 489 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+ ........ ......++.+|+.+||+.||++||++.||+++|+.+
T Consensus 239 i----~~~~~~~~----------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 I----RSRQLLPC----------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred H----HcCCcCCC----------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 2 11111111 112234688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.70 Aligned_cols=254 Identities=22% Similarity=0.383 Sum_probs=197.6
Q ss_pred cccccccccCceEEEEEEEcC------CceEEEEEecCCC-cchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEE
Q 047954 271 APAEGLGKGIFGNSYKALLEG------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLV 342 (582)
Q Consensus 271 ~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv 342 (582)
...++||+|+||.||+|.... ...||||+++... ....+.+.+|+.+++++. |||||+++++|......++|
T Consensus 40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv 119 (400)
T cd05105 40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYII 119 (400)
T ss_pred ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEE
Confidence 345789999999999998532 2469999996533 234567899999999996 99999999999999999999
Q ss_pred EEeCCCCChHHHHhcCCCC-------------------------------------------------------------
Q 047954 343 YKFAGNGNLFNRIHGGKSS------------------------------------------------------------- 361 (582)
Q Consensus 343 ~e~~~~gsL~~~l~~~~~~------------------------------------------------------------- 361 (582)
||||++|+|.++++.....
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (400)
T cd05105 120 TEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASK 199 (400)
T ss_pred EEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhh
Confidence 9999999999998753210
Q ss_pred -----------------------------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC
Q 047954 362 -----------------------------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD 412 (582)
Q Consensus 362 -----------------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~ 412 (582)
.....+++..++.++.||+.||+|||+.+ |+||||||+|||+++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-------ivH~dikp~Nill~~ 272 (400)
T cd05105 200 YSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN-------CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-------eeCCCCChHhEEEeC
Confidence 00124778888999999999999999988 999999999999999
Q ss_pred CCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccch
Q 047954 413 NEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADL 485 (582)
Q Consensus 413 ~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~ 485 (582)
++.+||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...+
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~---~~~~ 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV---DSTF 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch---hHHH
Confidence 9999999999997654321 1224467999999998899999999999999999997 9999864221 1111
Q ss_pred HHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 486 CSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 486 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
. ........... .......+.+++.+||+.||++||++.+|.+.|+.+.
T Consensus 350 ~----~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 Y----NKIKSGYRMAK----------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H----HHHhcCCCCCC----------CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1 11121111100 0112236788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.83 Aligned_cols=248 Identities=20% Similarity=0.364 Sum_probs=198.0
Q ss_pred cccccccCceEEEEEEEcC------CceEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEG------RAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|...+ +..||+|.++..... ..+.+.+|++++++++|+||+++++++......++||||
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 89 (280)
T cd05049 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEY 89 (280)
T ss_pred HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEec
Confidence 3679999999999998643 468999998754433 457899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCC--------CCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceE
Q 047954 346 AGNGNLFNRIHGGKS--------SKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL 417 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~k 417 (582)
+++|+|.+++..... ......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+|
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-------i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH-------FVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-------eeccccccceEEEcCCCeEE
Confidence 999999999976432 111235788899999999999999999998 99999999999999999999
Q ss_pred EeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHH
Q 047954 418 VSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVL 490 (582)
Q Consensus 418 l~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~ 490 (582)
|+|||+++.+.... ....+..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+....+.
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~----~~~~~~~~~ 238 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS----NEEVIECIT 238 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHHHH
Confidence 99999987643221 1223467999999999999999999999999999999 999985432 222222221
Q ss_pred HHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 491 RAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 491 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
........ ......+.+++.+||+.||++||++.||++.|+
T Consensus 239 ----~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ----QGRLLQRP----------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----cCCcCCCC----------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111110 011236789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=332.23 Aligned_cols=243 Identities=22% Similarity=0.307 Sum_probs=196.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 102 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence 467999999999999975 5788999998642 122345688999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-------ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 103 GELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSKD-------IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred ChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999997532 4678888889999999999999998 9999999999999999999999999998765
Q ss_pred Ccc-cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 429 QPI-AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 429 ~~~-~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
... ...+++.|+|||++.+..++.++|||||||++|||+||+.||.... ....... +..... .+
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~----i~~~~~-~~------ 234 (329)
T PTZ00263 170 DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT----PFRIYEK----ILAGRL-KF------ 234 (329)
T ss_pred CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC----HHHHHHH----HhcCCc-CC------
Confidence 432 3457889999999999999999999999999999999999996421 1111111 111110 00
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHHhhc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSELEII 547 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~i 547 (582)
... ...++.+++.+||+.||++||+ +++++.|.+..
T Consensus 235 -p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~ 275 (329)
T PTZ00263 235 -PNW---FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275 (329)
T ss_pred -CCC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccC
Confidence 000 1124678999999999999997 79999887643
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=298.20 Aligned_cols=255 Identities=25% Similarity=0.343 Sum_probs=203.0
Q ss_pred ccccccccCceEEEEEE-EcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCC-----eeEEEEEe
Q 047954 272 PAEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND-----EKLLVYKF 345 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~e~ 345 (582)
..++||+|||+.||.++ ..+++.+|+|++........+..++|++..++++||||++++++...+. +.|++++|
T Consensus 25 i~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Py 104 (302)
T KOG2345|consen 25 IQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPY 104 (302)
T ss_pred EeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeeh
Confidence 34679999999999998 6778889999998776677888999999999999999999999886543 48999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
...|+|.+.+...+.+ ...+++.+.+.|+.+|++||++||+..+ ++.||||||.|||+.+++.++|.|||.++
T Consensus 105 y~~Gsl~d~i~~~k~k--g~~~sE~~iL~if~gic~gL~~lH~~~~-----~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 105 YKRGSLLDEIERLKIK--GNFVSEAQILWIFLGICRGLEALHEKEP-----PYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred hccccHHHHHHHHhhc--CCccCHHHHHHHHHHHHHHHHHHhccCC-----cccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999876544 2358999999999999999999999874 59999999999999999999999999987
Q ss_pred cccCcc-------------cccccccccCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHH
Q 047954 426 LVAQPI-------------AAQRMISYKSPEYQS---SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWV 489 (582)
Q Consensus 426 ~~~~~~-------------~~~~~~~y~aPE~~~---~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~ 489 (582)
...-.. ....|..|+|||.+. +...++++|||||||+||+|+.|..||+.... .+..+.-.+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--~GgSlaLAv 255 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--QGGSLALAV 255 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--cCCeEEEee
Confidence 653221 122467899999875 44678999999999999999999999975433 122211111
Q ss_pred HHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 490 LRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 490 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
....+..+.... ....+.+++..|++.||.+||++.+++.+++.+.
T Consensus 256 ------------~n~q~s~P~~~~-yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 256 ------------QNAQISIPNSSR-YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------------eccccccCCCCC-ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111111111 2336788889999999999999999999988653
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=326.59 Aligned_cols=248 Identities=22% Similarity=0.418 Sum_probs=195.5
Q ss_pred cccccccCceEEEEEEEc-CCc----eEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRA----PVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|.+. ++. .||+|.++... ....+.+.+|+.+++.++||||++++|+|... ..++|+||+
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~ 90 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 90 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecC
Confidence 367999999999999864 333 38999986443 34456788999999999999999999999765 567999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 91 ~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~-------iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 91 PFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEERR-------LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred CCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhcC-------eeccccchhheEecCCCcEEEcccccccc
Confidence 99999999975432 4788889999999999999999998 99999999999999999999999999987
Q ss_pred ccCccc------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 427 VAQPIA------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 427 ~~~~~~------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
+..... ...+..|+|||++....++.++|||||||++|||++ |+.||.... ..++.. ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~----~~~~~~----~~~~~~~~ 230 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISS----ILEKGERL 230 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHHH----HHhCCCCC
Confidence 653321 123457999999999999999999999999999998 999986421 111211 11111110
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
. . .......+.+++.+||..+|++||++.+++.++..+....
T Consensus 231 ~--~--------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 P--Q--------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred C--C--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0 0 0011235788999999999999999999999998886544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=322.88 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=191.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCe-----eEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE-----KLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----~~lv~e~~ 346 (582)
.+++|+|+||.||+|.+. .+..||||++..... .--+|+++|++++|||||++.-+|..... ..+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 478999999999999965 468899999865433 22368999999999999999988875432 34899999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC-CceEEeeccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN-EMVLVSDYGFSS 425 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DfG~a~ 425 (582)
+. +|.+.++..... ...++...+.-+..||.+||.|||+.+ |+||||||+|+|+|.+ +.+||||||.|+
T Consensus 105 P~-tL~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh~~~-------IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLHSHG-------ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred hH-HHHHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHHhcC-------cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 87 999998853222 224667778889999999999999988 9999999999999976 899999999999
Q ss_pred cccCccc---ccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccc--
Q 047954 426 LVAQPIA---AQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTA-- 499 (582)
Q Consensus 426 ~~~~~~~---~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 499 (582)
.+..... ...+..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+. ++.+....+.+.+...-..
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~----s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD----SSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC----CHHHHHHHHHHHhCCCCHHHH
Confidence 9865543 334567999999886 57999999999999999999999988653 2333333333332211111
Q ss_pred --------cccchhhhhhh----chHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 500 --------EIFDSEISVQR----SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 500 --------~~~d~~~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
+...+.+.... .......+.++++.+++..+|.+|.++.|++.|-.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 11111111111 11122346889999999999999999999998853
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=326.81 Aligned_cols=245 Identities=20% Similarity=0.289 Sum_probs=197.0
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCCc---chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKP---LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
..||+|+||.||+|+. .+|..+|+|++++... ...+..+.|-.+|...++|+||++|-.|++.+.+||||||++||
T Consensus 147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG 226 (550)
T KOG0605|consen 147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG 226 (550)
T ss_pred eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence 5799999999999995 4688999999986543 33456788999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
|+..+|.... .|+......++.+++.|++-+|..| +|||||||+|+|||..|++||+|||+++-+..
T Consensus 227 D~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~~g-------yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 227 DMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQLG-------YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred cHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHHcC-------cccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999997543 5888899999999999999999998 99999999999999999999999999843210
Q ss_pred -------------------------cc--------------------------cccccccccCCCCCCCCCCCcchhHHH
Q 047954 430 -------------------------PI--------------------------AAQRMISYKSPEYQSSKKISRKSDVWS 458 (582)
Q Consensus 430 -------------------------~~--------------------------~~~~~~~y~aPE~~~~~~~~~k~DVwS 458 (582)
.. ...||+-|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 00 112566799999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCC---
Q 047954 459 FGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP--- 535 (582)
Q Consensus 459 ~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP--- 535 (582)
+|||+|||+.|.+||...........+..|...... +.+. ....+..+||.+|+. ||++|.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---P~~~------------~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---PEEV------------DLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC---CCcC------------cccHHHHHHHHHHhc-CHHHhcCcc
Confidence 999999999999999865443223333333321111 1110 111367788999998 999996
Q ss_pred ChHHHHHHHhhc
Q 047954 536 EMAEVVSELEII 547 (582)
Q Consensus 536 s~~evl~~L~~i 547 (582)
.++||-+|.+.-
T Consensus 438 G~~EIK~HPfF~ 449 (550)
T KOG0605|consen 438 GAEEIKKHPFFK 449 (550)
T ss_pred cHHHHhcCCccc
Confidence 588888887643
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.47 Aligned_cols=241 Identities=21% Similarity=0.310 Sum_probs=192.2
Q ss_pred ccccccCceEEEEEEE----cCCceEEEEEecCCC----cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 274 EGLGKGIFGNSYKALL----EGRAPVVVKRLRDLK----PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
+.||+|+||.||+++. ..++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4699999999999985 356789999986421 22335678899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++|+|.+++.... .+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-------ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (323)
T cd05584 82 LSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQG-------IIYRDLKPENILLDAQGHVKLTDFGLCK 148 (323)
T ss_pred CCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence 99999999986432 4677788889999999999999998 9999999999999999999999999987
Q ss_pred cccCc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 426 LVAQP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 426 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
..... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ............. .+
T Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-------~~~~~~~~~~~~~--~~ 219 (323)
T cd05584 149 ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-------RKKTIDKILKGKL--NL 219 (323)
T ss_pred ecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCC--CC
Confidence 53222 12347789999999998889999999999999999999999996432 1111111111110 00
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhh
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEI 546 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 546 (582)
.+ ....++.+++.+||+.||++|| ++.+++++.+.
T Consensus 220 -~~---------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~ 259 (323)
T cd05584 220 -PP---------YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259 (323)
T ss_pred -CC---------CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCc
Confidence 00 0112577899999999999999 89999988653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=332.15 Aligned_cols=242 Identities=20% Similarity=0.282 Sum_probs=195.1
Q ss_pred cccccccCceEEEEEEEcC--CceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLEG--RAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~ 114 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence 4679999999999998644 357999988532 22344568899999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 115 ~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-------ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 115 GGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSLN-------IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999997542 4788889999999999999999998 999999999999999999999999999876
Q ss_pred cCc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 428 AQP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 428 ~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
... ....+++.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ ..... . +..
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~----~~~~~~~i----~~~~~-~-~p~-- 249 (340)
T PTZ00426 182 DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE----PLLIYQKI----LEGII-Y-FPK-- 249 (340)
T ss_pred CCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC----HHHHHHHH----hcCCC-C-CCC--
Confidence 543 23457889999999998889999999999999999999999996432 11111111 11110 0 000
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEI 546 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 546 (582)
.. ...+.+++.+|++.||++|+ +++++++|.+.
T Consensus 250 ----~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 250 ----FL---DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred ----CC---CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 01 12467889999999999995 89999998764
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=344.38 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=195.4
Q ss_pred ccccccccCceEEEEEEEcC--CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 272 PAEGLGKGIFGNSYKALLEG--RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
..+.||+|+||.||+|.... +..||+|.+..........+..|+.++++++|||||++++++...+..++||||+++|
T Consensus 71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg 150 (478)
T PTZ00267 71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150 (478)
T ss_pred EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence 35679999999999998543 5678888775544444567788999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.++++.... ...++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 151 ~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~-------ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 151 DLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSRK-------MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-------EEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99998864321 2336888899999999999999999998 99999999999999999999999999987643
Q ss_pred cc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 430 PI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 430 ~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
.. ...+++.|+|||++.+..++.++|||||||++|||+||+.||.... ...+...+ ..... ...
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~----~~~~~~~~---~~~~~-~~~-- 291 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS----QREIMQQV---LYGKY-DPF-- 291 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH---HhCCC-CCC--
Confidence 21 2237888999999999999999999999999999999999996421 11222211 11111 000
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHH
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 543 (582)
......++.+++.+||..||++||++.+++.+
T Consensus 292 --------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 292 --------PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --------CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 00112357889999999999999999999865
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.44 Aligned_cols=239 Identities=26% Similarity=0.390 Sum_probs=189.3
Q ss_pred ccccccCceEEEEEEEcCC-------------ceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeE
Q 047954 274 EGLGKGIFGNSYKALLEGR-------------APVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKL 340 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~-------------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 340 (582)
+.||+|+||.||+|..... ..|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999985432 258888876655555667889999999999999999999999999999
Q ss_pred EEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc-----
Q 047954 341 LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM----- 415 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~----- 415 (582)
+||||+++|+|..++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~-------ivH~dlkp~Nill~~~~~~~~~~ 148 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLEDKD-------LVHGNVCTKNILLAREGIDGECG 148 (262)
T ss_pred EEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhhCC-------eECCCCCcccEEEecCCccCCCC
Confidence 9999999999998886432 24788899999999999999999998 999999999999987654
Q ss_pred --eEEeeccccccccCcccccccccccCCCCCC-CCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCCccchHHHHHH
Q 047954 416 --VLVSDYGFSSLVAQPIAAQRMISYKSPEYQS-SKKISRKSDVWSFGCLLLELL-TGRISTHSAPQGINGADLCSWVLR 491 (582)
Q Consensus 416 --~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~-~~~~~~k~DVwS~Gvvl~ell-tG~~P~~~~~~~~~~~~~~~~~~~ 491 (582)
+|++|||++..........++..|+|||.+. +..++.++|||||||++|||+ +|+.|+..... .+ ...
T Consensus 149 ~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~----~~~ 220 (262)
T cd05077 149 PFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL----AE----KER 220 (262)
T ss_pred ceeEeCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch----hH----HHH
Confidence 8999999998776555556778899999886 467899999999999999998 58888753211 11 111
Q ss_pred HHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 492 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
...... .... ....++.+++.+||+.||++||++.+|++++
T Consensus 221 ~~~~~~--~~~~----------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 221 FYEGQC--MLVT----------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHhcCc--cCCC----------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 111110 0000 1123578899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.50 Aligned_cols=246 Identities=25% Similarity=0.467 Sum_probs=202.0
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..+++|.+..........+..|+.++++++|+||+++++++......++||||+++|+|.
T Consensus 11 ~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (261)
T cd05148 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL 90 (261)
T ss_pred hhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHH
Confidence 46799999999999998888999999987665555678999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++..... ..+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||.+.......
T Consensus 91 ~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~~-------i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 91 AFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQN-------SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred HHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99975432 25789999999999999999999988 9999999999999999999999999997664332
Q ss_pred ---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 432 ---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 432 ---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
...++..|+|||......++.++||||||+++|+|++ |+.||.... ..+....+. .......
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~----~~~~~~~~~----~~~~~~~------ 225 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN----NHEVYDQIT----AGYRMPC------ 225 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC----HHHHHHHHH----hCCcCCC------
Confidence 2223467999999988889999999999999999998 899985422 222222221 1111110
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.......+.+++.+||+.||++|||+.++++.|+.+
T Consensus 226 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 ----PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 011123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=301.77 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=200.0
Q ss_pred CChhHhhhcccccccccCceEEEEEEE-cCCceEEEEEecCCCc---chHHHHHHHHHHHhcCCCCCccccceEEEeCCe
Q 047954 263 FKLNDLLKAPAEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKP---LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE 338 (582)
Q Consensus 263 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 338 (582)
++++|... ...||.|+||.|.+++. .++..+|+|++...+- ...+...+|..+|+.+.||+++++++.|.+.+.
T Consensus 41 ~~l~dfe~--~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFER--LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhhhh--eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 44444432 35699999999999995 4678899999965432 233556789999999999999999999999999
Q ss_pred eEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEE
Q 047954 339 KLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLV 418 (582)
Q Consensus 339 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl 418 (582)
.+|||||.+||.|+.+++... .++....+.+|.||+.||+|||+.+ |++|||||+|||+|.+|.+||
T Consensus 119 lymvmeyv~GGElFS~Lrk~~------rF~e~~arFYAAeivlAleylH~~~-------iiYRDLKPENiLlD~~G~iKi 185 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSG------RFSEPHARFYAAEIVLALEYLHSLD-------IIYRDLKPENLLLDQNGHIKI 185 (355)
T ss_pred EEEEEeccCCccHHHHHHhcC------CCCchhHHHHHHHHHHHHHHHHhcC-------eeeccCChHHeeeccCCcEEE
Confidence 999999999999999998543 4889999999999999999999998 999999999999999999999
Q ss_pred eeccccccccCc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 419 SDYGFSSLVAQP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 419 ~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
+|||+|+.+... ....||+.|+|||.+....|+.++|.|||||++|||+.|..||....+ ..+.+.+... .-.
T Consensus 186 tDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~--~v~ 259 (355)
T KOG0616|consen 186 TDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEG--KVK 259 (355)
T ss_pred EeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhC--ccc
Confidence 999999988654 355689999999999999999999999999999999999999976432 2222222111 001
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCC-----CChHHHHHHHhh
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKR-----PEMAEVVSELEI 546 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-----Ps~~evl~~L~~ 546 (582)
.+..+. ..+.+|+...++.|-.+| .-..||..|-|.
T Consensus 260 fP~~fs-------------~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF 300 (355)
T KOG0616|consen 260 FPSYFS-------------SDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWF 300 (355)
T ss_pred CCcccC-------------HHHHHHHHHHHhhhhHhhhcCcCCCccccccCccc
Confidence 122222 246677778888888888 344566666554
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=327.68 Aligned_cols=246 Identities=22% Similarity=0.353 Sum_probs=203.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCe-eEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE-KLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-~~lv~e~~~~ 348 (582)
.+++|+|+||.++.++.+ ++..+++|++.-.. ...++...+|+.++++++|||||.+.+.|..++. .+|||+||+|
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG 88 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG 88 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence 367999999999998844 56789999986443 3344578899999999999999999999999888 8999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|++.+.+.+.+. ..+++..+..++.|++.|+.|||+.. |+|||||+.||+++.+..+||+|||+|+.+.
T Consensus 89 g~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH~~~-------iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 89 GDLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLHENR-------VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred CCHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhhh-------hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999987652 36899999999999999999999877 9999999999999999999999999999987
Q ss_pred Ccc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
... ...||+.||.||.+.+..|+.|+||||+||++|||++-+++|... +...++. +..+.. ..
T Consensus 158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~----~m~~Li~---ki~~~~-----~~- 224 (426)
T KOG0589|consen 158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS----NMSELIL---KINRGL-----YS- 224 (426)
T ss_pred CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc----chHHHHH---HHhhcc-----CC-
Confidence 764 345889999999999999999999999999999999999999643 2222322 222221 11
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+-+.....++..++..|++.+|+.||++.+++.+....
T Consensus 225 -----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 225 -----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred -----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 11122334688889999999999999999999885444
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=331.74 Aligned_cols=251 Identities=16% Similarity=0.197 Sum_probs=198.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|+.. ++..||+|+++... ....+.+..|+.++.+++||||+++++++...+..++||||+++
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 357999999999999976 47889999986431 22345688999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~-------ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 86 GDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHELG-------YIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999996432 4788889999999999999999998 9999999999999999999999999997664
Q ss_pred Cc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 429 QP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 429 ~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
.. ....+++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+.........+...++.
T Consensus 153 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~-- 226 (333)
T cd05600 153 TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST----PNETWENLKYWKETLQRPVYDDPR-- 226 (333)
T ss_pred cccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC----HHHHHHHHHhccccccCCCCCccc--
Confidence 42 23457889999999999999999999999999999999999996432 112222111110000000000000
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.....++.+++.+||..+|++||++.+++++.+..
T Consensus 227 -----~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~ 261 (333)
T cd05600 227 -----FNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK 261 (333)
T ss_pred -----cccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence 11123577889999999999999999999986643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=320.21 Aligned_cols=253 Identities=21% Similarity=0.372 Sum_probs=201.1
Q ss_pred cccccccCceEEEEEEEc------CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||+||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 89 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence 467999999999999842 34568899887665556678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCC-------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEe
Q 047954 347 GNGNLFNRIHGGKSS-------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVS 419 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 419 (582)
++++|.+++...... .....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~-------i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 90 KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH-------FVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred CCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------eeecccCcceEEEccCCcEEec
Confidence 999999999754310 11234899999999999999999999998 9999999999999999999999
Q ss_pred eccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHH
Q 047954 420 DYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRA 492 (582)
Q Consensus 420 DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 492 (582)
|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.... ...... .
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~----~~~~~~----~ 234 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS----NNEVIE----C 234 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHH----H
Confidence 999997653321 1223567999999998899999999999999999999 899985432 111211 1
Q ss_pred HhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 493 VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 493 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
..........+ ....++.+++.+||+.+|.+|||+.+|++.|+.+...
T Consensus 235 i~~~~~~~~~~----------~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQRPR----------TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCCCCC----------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111111100 1123588999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=313.94 Aligned_cols=244 Identities=27% Similarity=0.490 Sum_probs=198.1
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...+++.||+|.++... ...+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence 46799999999999998888889999986543 34567899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCccc
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA 432 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~~ 432 (582)
+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 90 EYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQN-------YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred HHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-------eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9997543 124789999999999999999999988 99999999999999999999999999987653221
Q ss_pred -----ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 433 -----AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 433 -----~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
......|+|||+..+..++.++||||||+++|||+| |+.||.... ...+.. ..........
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~----~~~~~~~~~~----- 225 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT----NAEVLQ----QVDQGYRMPC----- 225 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC----HHHHHH----HHHcCCCCCC-----
Confidence 112346999999998899999999999999999999 999985421 111111 1111111100
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.......+.+++.+|++.+|++||++.++++.|+.
T Consensus 226 -----~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 -----PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -----CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01112367889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=316.35 Aligned_cols=251 Identities=22% Similarity=0.378 Sum_probs=194.3
Q ss_pred ccccccccCceEEEEEEEcCCc---eEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeC------CeeE
Q 047954 272 PAEGLGKGIFGNSYKALLEGRA---PVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN------DEKL 340 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~ 340 (582)
..+.||+|+||.||+|...+.. .||+|.++.. .....+.+..|+.++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 3567999999999999976543 5889987643 233456788999999999999999999987542 2468
Q ss_pred EEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEee
Q 047954 341 LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSD 420 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 420 (582)
++|||+++|+|.+++...........+++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS-------FIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-------eeccccchhheEEcCCCCEEECC
Confidence 99999999999998854332222345889999999999999999999987 99999999999999999999999
Q ss_pred ccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHH
Q 047954 421 YGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 421 fG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
||+++...... ....+..|+|||+..+..++.++|||||||++|||++ |+.||... ....+...+
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----~~~~~~~~~---- 227 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV----ENSEIYDYL---- 227 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHH----
Confidence 99998764332 1123457999999998899999999999999999999 78888532 112222211
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
........ .......+.+++.+||+.||++|||+.+++++|+.+
T Consensus 228 ~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 RQGNRLKQ----------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111100 011123578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=317.68 Aligned_cols=239 Identities=25% Similarity=0.367 Sum_probs=187.2
Q ss_pred cccccCceEEEEEEEcC-------------------------CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCcccc
Q 047954 275 GLGKGIFGNSYKALLEG-------------------------RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPL 329 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l 329 (582)
.||+|+||.||+|.+.. ...|++|.+..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997521 13588888865444455678889999999999999999
Q ss_pred ceEEEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCee
Q 047954 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNIL 409 (582)
Q Consensus 330 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NIL 409 (582)
+++|......++||||+++|+|..++..... .+++..++.++.||++||+|||+.+ |+||||||+|||
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~-------iiH~dlkp~Nil 149 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-----RVPVAWKITVAQQLASALSYLEDKN-------LVHGNVCAKNIL 149 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHcCC-------ccCCCCCcccEE
Confidence 9999999999999999999999999864322 4778889999999999999999987 999999999999
Q ss_pred ecCCC-------ceEEeeccccccccCcccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCC
Q 047954 410 LDDNE-------MVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELL-TGRISTHSAPQGI 480 (582)
Q Consensus 410 l~~~~-------~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~ell-tG~~P~~~~~~~~ 480 (582)
+++.+ .+|++|||++..........++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.....
T Consensus 150 l~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-- 227 (274)
T cd05076 150 LARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-- 227 (274)
T ss_pred EeccCcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh--
Confidence 97643 379999999866544444456778999998865 56899999999999999995 69999864321
Q ss_pred CccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 481 NGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
...... ..... .... .....+.+++.+||+.+|++|||+.+|+++|.
T Consensus 228 --~~~~~~----~~~~~--~~~~----------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 --SEKERF----YEKKH--RLPE----------PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHHHH----HHhcc--CCCC----------CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111111 11110 0000 01125788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=325.79 Aligned_cols=256 Identities=17% Similarity=0.266 Sum_probs=192.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|... ++..||+|+++... ......+.+|+.++++++||||+++++++...+..++||||++ |+
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SD 88 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cC
Confidence 467999999999999865 57889999986432 2334567899999999999999999999999999999999997 49
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~-------ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 89 LKQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCHKRK-------ILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 999886432 23678889999999999999999998 999999999999999999999999998765322
Q ss_pred c----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---ccccc-
Q 047954 431 I----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE---WTAEI- 501 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~- 501 (582)
. ...++..|+|||++.+ ..++.++||||+||++|||+||+.||.... ..+....+.+..... ....+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST----VKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCChHHhhccc
Confidence 1 2345778999998865 568999999999999999999999996432 111111111111100 00000
Q ss_pred --------cchhhhhh---hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 502 --------FDSEISVQ---RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 502 --------~d~~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
..+..... ........++.+++.+|+..||.+|||++|+++|.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence 00000000 000011235678999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=314.65 Aligned_cols=242 Identities=25% Similarity=0.406 Sum_probs=195.6
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++.+++||||+++++++...+..++||||+.+|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence 35799999999999998887789999986433 34567899999999999999999999999888899999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++..... .+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||.++......
T Consensus 88 ~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 88 NYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESKQ-------FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred HHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC-------eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99875321 4789999999999999999999998 9999999999999999999999999987654332
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
...++..|+|||+..+..++.++|||||||++|||+| |+.||.... ...+...+.. .. .....
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~----~~~~~~~~~~---~~-~~~~~---- 223 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN----NSETVEKVSQ---GL-RLYRP---- 223 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC----HHHHHHHHhc---CC-CCCCC----
Confidence 1223457999999988889999999999999999999 999985322 1122222211 11 10000
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
......+.+++.+||+.+|++||++.++++.|+
T Consensus 224 ------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 ------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011236789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=316.23 Aligned_cols=250 Identities=22% Similarity=0.371 Sum_probs=196.7
Q ss_pred cccccccCceEEEEEEEcC----CceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCe------eE
Q 047954 273 AEGLGKGIFGNSYKALLEG----RAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE------KL 340 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~ 340 (582)
.+.||+|+||.||+|.... ...||+|+++... ....+.+.+|++.+++++||||+++++++..... .+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 4679999999999998643 3679999987432 2334678999999999999999999999876554 68
Q ss_pred EEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEee
Q 047954 341 LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSD 420 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 420 (582)
+++||+++|+|..++...........+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~-------i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN-------FIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-------eeccccchheEEECCCCeEEECC
Confidence 99999999999999865433222345888999999999999999999988 99999999999999999999999
Q ss_pred ccccccccCccc------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHH
Q 047954 421 YGFSSLVAQPIA------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 421 fG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
||+++....... ...+..|+|||++.+..++.++|||||||++|||++ |..||... ....+.+++..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~----~~~~~~~~~~~-- 230 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV----ENHEIYDYLRH-- 230 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHc--
Confidence 999986543321 123457999999988889999999999999999999 88888542 22222222211
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
...... ......++.+++.+||+.||++|||+.|++++|+.+
T Consensus 231 --~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 --GNRLKQ----------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --CCCCCC----------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111 111233688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=320.48 Aligned_cols=247 Identities=18% Similarity=0.215 Sum_probs=193.4
Q ss_pred ccccCceEEEEEEEc-CCceEEEEEecCCCc---chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 276 LGKGIFGNSYKALLE-GRAPVVVKRLRDLKP---LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 276 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
||+|+||+||++... +++.||+|++..... ...+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999864 678899999864321 1235677899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 151 (280)
T cd05608 81 RYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQRR-------IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ 151 (280)
T ss_pred HHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEECCCCCEEEeeCccceecCCCC
Confidence 988854321 1235889999999999999999999998 9999999999999999999999999997654322
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
...++..|+|||++.+..++.++|||||||++|||++|+.||......... ..+....... ...
T Consensus 152 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~~--------~~~ 219 (280)
T cd05608 152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRILND--------SVT 219 (280)
T ss_pred ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHHhhccc--------CCC
Confidence 234678899999999999999999999999999999999999643221111 1111111000 000
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhh
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEI 546 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 546 (582)
........+.+++.+||+.||++|| +++++++|.+.
T Consensus 220 ---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~ 260 (280)
T cd05608 220 ---YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260 (280)
T ss_pred ---CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence 0011223577899999999999999 77888888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=323.96 Aligned_cols=256 Identities=18% Similarity=0.250 Sum_probs=193.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN 85 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence 457999999999999975 56789999986432 234567889999999999999999999999999999999999987
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
.+..+.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~l~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~-------i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 86 MLELLEEMP------NGVPPEKVRSYIYQLIKAIHWCHKND-------IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 665544321 24788889999999999999999988 99999999999999999999999999987643
Q ss_pred cc-----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh----------
Q 047954 430 PI-----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR---------- 494 (582)
Q Consensus 430 ~~-----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---------- 494 (582)
.. ...++..|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE----IDQLFTIQKVLGPLPAEQMKLF 228 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhhCCCCHHHHHhh
Confidence 21 23467889999999988899999999999999999999999964321 111111111000
Q ss_pred --hcccccccchhhhhh-----hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 495 --EEWTAEIFDSEISVQ-----RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 495 --~~~~~~~~d~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.........+..... .........+.+++.+||+.||++|||++|+++|.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~ 286 (287)
T cd07848 229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286 (287)
T ss_pred hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 000000000000000 000112346889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=311.69 Aligned_cols=242 Identities=24% Similarity=0.437 Sum_probs=192.9
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999864 67889999876432 33456789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~-------i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 81 LTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESKH-------CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------ccccccchheEEEcCCCcEEECccccCccccccc
Confidence 99996432 24788999999999999999999998 9999999999999999999999999987654321
Q ss_pred cc------cccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 432 AA------QRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 432 ~~------~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.. .....|+|||.+.+..++.++|||||||++|||++ |..||.... ..... ...........
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~----~~~~~----~~~~~~~~~~~--- 217 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS----NQQTR----EAIEQGVRLPC--- 217 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC----HHHHH----HHHHcCCCCCC---
Confidence 11 12346999999998889999999999999999998 888885321 11111 11111111111
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
......++.+++.+||+.+|++|||+.++++.|+
T Consensus 218 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 -------PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0111236788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.31 Aligned_cols=248 Identities=19% Similarity=0.303 Sum_probs=194.8
Q ss_pred cccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 275 GLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.||+|+||.||+|... ++..||+|.++... ....+.+..|..++.++ +||||+++++++......++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6899999999999865 57789999986432 22345678899999888 7999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~-------ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 82 DLMFHMQRQR------KLPEEHARFYSAEISLALNFLHERG-------IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred CHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 9999886432 4889999999999999999999998 99999999999999999999999999875321
Q ss_pred ----cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-CccchHHHHHHHHhhcccccccch
Q 047954 430 ----PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGI-NGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 430 ----~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.....++..|+|||++.+..++.++|||||||++|||+||+.||+...... .......+.......... .+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--- 224 (329)
T cd05588 149 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-RI--- 224 (329)
T ss_pred CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-CC---
Confidence 122346788999999999999999999999999999999999996432111 111122222222222111 00
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCC------hHHHHHHHhh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE------MAEVVSELEI 546 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~L~~ 546 (582)
.. ....++.+++.+||+.||++||+ ++++++|.+.
T Consensus 225 ----p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~ 265 (329)
T cd05588 225 ----PR---SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265 (329)
T ss_pred ----CC---CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence 00 11225778999999999999997 7899888665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=313.01 Aligned_cols=245 Identities=29% Similarity=0.461 Sum_probs=197.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... .++.||+|.+... ....+.+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence 467999999999999865 4778999988643 33456789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 90 ~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~-------i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 90 LDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKKN-------FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred HHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------EeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999865432 24788999999999999999999988 9999999999999999999999999998765432
Q ss_pred c-----ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 432 A-----AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 432 ~-----~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
. ...+..|+|||++.+..++.++|||||||++|||++ |..||... ...+.. .........+..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~----~~~~~~----~~~~~~~~~~~~--- 227 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVY----ELLEKGYRMERP--- 227 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----CHHHHH----HHHHCCCCCCCC---
Confidence 1 122457999999998999999999999999999998 89898532 111111 111111111110
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.....++.+++.+||+.+|++||++.++++.|+.+
T Consensus 228 -------~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 -------EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11123688899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.92 Aligned_cols=249 Identities=19% Similarity=0.307 Sum_probs=193.8
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|... +++.||+|.++.. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 5678999998643 223345677888888776 899999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~~-------ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 81 GDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHERG-------IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 99998886432 4788899999999999999999998 9999999999999999999999999987542
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-CccchHHHHHHHHhhcccccccc
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGI-NGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
.. ....++..|+|||++.+..++.++|||||||++|||+||+.||....... .......++......... .+.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~p- 225 (329)
T cd05618 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIP- 225 (329)
T ss_pred CCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-CCC-
Confidence 21 22346889999999999999999999999999999999999996322111 111222233222222111 010
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCC------hHHHHHHHhh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE------MAEVVSELEI 546 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~L~~ 546 (582)
.....++.+++.+||+.||++||+ +.++++|.+.
T Consensus 226 ---------~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f 265 (329)
T cd05618 226 ---------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265 (329)
T ss_pred ---------CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence 011235778999999999999998 5788888653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=318.23 Aligned_cols=245 Identities=18% Similarity=0.219 Sum_probs=190.3
Q ss_pred ccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 276 LGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 276 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
||+|+||.||++... +++.||+|.+.... ......+..|++++++++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 57889999985321 12234556799999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~-------ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 81 KYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSMD-------IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred HHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHCC-------EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc
Confidence 988864332 24788899999999999999999998 9999999999999999999999999987664332
Q ss_pred ---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 432 ---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 432 ---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
...++..|+|||++.+..++.++||||+||++|||++|+.||....... ............. .. ..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~-~~-~~------ 218 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV---AKEELKRRTLEDE-VK-FE------ 218 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh---hHHHHHHHhhccc-cc-cc------
Confidence 2346788999999988889999999999999999999999996432111 1111111111111 00 00
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
......++.+++.+||+.||++||+++|+++++.
T Consensus 219 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 219 ---HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ---cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 0011235788999999999999999977664444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=313.15 Aligned_cols=245 Identities=23% Similarity=0.418 Sum_probs=196.9
Q ss_pred cccccccCceEEEEEEEcC----CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLEG----RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|.+.. ...||||.++... ......|.+|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 88 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME 88 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence 4679999999999998743 4578999886543 3345678899999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 89 ~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~~-------i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 89 NGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEMN-------YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999975332 4789999999999999999999988 999999999999999999999999999876
Q ss_pred cCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 428 AQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 428 ~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
.... ....+..|+|||...+..++.++||||||+++|||++ |..||.... ...+...+ ...+...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~----~~~~~~~~----~~~~~~~ 228 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS----NQDVIKAV----EDGYRLP 228 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC----HHHHHHHH----HcCCCCC
Confidence 4211 1123467999999998899999999999999999998 999985421 11222222 1111111
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
. .......+.+++.+||+.+|++||++.+|+++|+.+
T Consensus 229 ~----------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 P----------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 011123578999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=329.61 Aligned_cols=255 Identities=18% Similarity=0.244 Sum_probs=191.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... .++.||+|... .+.+.+|++++++++|||||++++++......++|+|++. ++|
T Consensus 97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred EEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 467999999999999864 57789999753 2457789999999999999999999999999999999995 689
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++.... .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 170 ~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~~-------IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 170 YCYLAAKR------NIAICDILAIERSVLRAIQYLHENR-------IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 88886432 4788899999999999999999998 999999999999999999999999999754321
Q ss_pred ----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc---cchHHHHHHHHhh---ccccc
Q 047954 431 ----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGING---ADLCSWVLRAVRE---EWTAE 500 (582)
Q Consensus 431 ----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~---~~~~~~~~~~~~~---~~~~~ 500 (582)
....+|+.|+|||++.+..++.++|||||||++|||+||+.||......... ......+...... .+...
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1235788999999999889999999999999999999999887543211110 0111111111000 00000
Q ss_pred ---ccchhh--------------hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 501 ---IFDSEI--------------SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 501 ---~~d~~~--------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.++... ...........++.+++.+||+.||++|||++|++++.+..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence 000000 00000112234688899999999999999999999988753
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=321.24 Aligned_cols=260 Identities=18% Similarity=0.299 Sum_probs=193.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc-chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP-LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++++++||||+++++++.+....++||||+. ++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD 88 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence 367999999999999975 678899999864332 233467889999999999999999999999999999999995 68
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++.... ..++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 89 l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~-------ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 89 LCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQRY-------ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 888886432 24778889999999999999999998 999999999999999999999999998754322
Q ss_pred ----ccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc----cccc-
Q 047954 431 ----IAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE----WTAE- 500 (582)
Q Consensus 431 ----~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~----~~~~- 500 (582)
....++..|+|||.+.+ ..++.++||||+||++|||+||+.||..... ..+....+....... +...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD---IQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHHHHHHHhCCCChhhccchh
Confidence 12345678999998765 4588999999999999999999999974321 111111111111000 0000
Q ss_pred ---ccchh-hh--hhhchH------HHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 501 ---IFDSE-IS--VQRSAA------HGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 501 ---~~d~~-~~--~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
..++. .. ...... .....+.+++.+||+.||++|||+.|+++|.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 00000 00 000000 01235678999999999999999999999877543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.18 Aligned_cols=240 Identities=24% Similarity=0.377 Sum_probs=189.4
Q ss_pred ccccccCceEEEEEEEcC--------CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 274 EGLGKGIFGNSYKALLEG--------RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
+.||+|+||.||+|.... ...|++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998542 234778887654445567788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc--------eE
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM--------VL 417 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~--------~k 417 (582)
+++|+|.++++.... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++
T Consensus 81 ~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-------iiH~dlkp~nili~~~~~~~~~~~~~~~ 148 (258)
T cd05078 81 VKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDKG-------LTHGNVCAKNVLLIREEDRKTGNPPFIK 148 (258)
T ss_pred CCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCccceEEEecccccccCCCceEE
Confidence 999999999975432 4788899999999999999999998 999999999999987765 69
Q ss_pred EeeccccccccCcccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCCccchHHHHHHHHhh
Q 047954 418 VSDYGFSSLVAQPIAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGR-ISTHSAPQGINGADLCSWVLRAVRE 495 (582)
Q Consensus 418 l~DfG~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~-~P~~~~~~~~~~~~~~~~~~~~~~~ 495 (582)
++|||++..........++..|+|||++.+ ..++.++|||||||++|||++|. .|+.... .. .... ....
T Consensus 149 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~----~~---~~~~-~~~~ 220 (258)
T cd05078 149 LSDPGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD----SQ---KKLQ-FYED 220 (258)
T ss_pred ecccccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc----HH---HHHH-HHHc
Confidence 999999877665555567788999999876 45799999999999999999985 5543211 11 1110 0010
Q ss_pred cccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 496 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
...+.. ....++.+++.+||+.||++|||++++++.|.
T Consensus 221 --~~~~~~----------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 --RHQLPA----------PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --cccCCC----------CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 001100 11135789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=329.16 Aligned_cols=240 Identities=21% Similarity=0.316 Sum_probs=192.2
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+.||+|+||.||++.. .++..||+|.+... .......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 46788999998642 2223456778999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhc-cCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH-KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
+|.+++.... .+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~~-------ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEKN-------VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcCC-------EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 9999886432 47889999999999999999997 56 9999999999999999999999999987532
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc-ccccccc
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE-WTAEIFD 503 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d 503 (582)
.. ....++..|+|||++.+..++.++|||||||++|||+||+.||.... ...+...+ .... ..+..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~----~~~~~~~i---~~~~~~~p~~-- 218 (325)
T cd05594 148 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFELI---LMEEIRFPRT-- 218 (325)
T ss_pred CCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC----HHHHHHHH---hcCCCCCCCC--
Confidence 21 12347889999999998899999999999999999999999996421 11111111 1110 00111
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEI 546 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 546 (582)
...++.+++.+||+.||++|+ ++.++++|.+.
T Consensus 219 -----------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 255 (325)
T cd05594 219 -----------LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255 (325)
T ss_pred -----------CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCc
Confidence 112577889999999999996 99999988653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=316.02 Aligned_cols=250 Identities=21% Similarity=0.300 Sum_probs=193.3
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC--------------cchHHHHHHHHHHHhcCCCCCccccceEEEeC-
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK--------------PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN- 336 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~- 336 (582)
...||+|.||+|-+|+. .+++.||||++.+.. ....+...+||.+|++++|||||+|+++..+.
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~ 181 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE 181 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence 35699999999999995 467889999985321 11235788999999999999999999998765
Q ss_pred -CeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc
Q 047954 337 -DEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM 415 (582)
Q Consensus 337 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~ 415 (582)
+..|||+|||..|.+...-- ....++..++++|++++..||+|||.++ ||||||||+|+||+++++
T Consensus 182 s~~~YlVley~s~G~v~w~p~------d~~els~~~Ar~ylrDvv~GLEYLH~Qg-------iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWCPP------DKPELSEQQARKYLRDVVLGLEYLHYQG-------IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred cCceEEEEEeccCCccccCCC------CcccccHHHHHHHHHHHHHHHHHHHhcC-------eeccccchhheEEcCCCc
Confidence 57899999999887753221 1123889999999999999999999998 999999999999999999
Q ss_pred eEEeeccccccccCc---------ccccccccccCCCCCCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 047954 416 VLVSDYGFSSLVAQP---------IAAQRMISYKSPEYQSSKK----ISRKSDVWSFGCLLLELLTGRISTHSAPQGING 482 (582)
Q Consensus 416 ~kl~DfG~a~~~~~~---------~~~~~~~~y~aPE~~~~~~----~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~ 482 (582)
+||+|||.+...... ....||+.|+|||...++. .+.+.||||+||+||.|+.|+.||.+..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----- 323 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----- 323 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-----
Confidence 999999998765221 2345889999999887632 3678999999999999999999996421
Q ss_pred cchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 483 ADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
..+...+.+.. .+..+. ..+.-..+.+|+.++|.+||++|.+..+|..|+|-......
T Consensus 324 --~~~l~~KIvn~---------pL~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 324 --ELELFDKIVND---------PLEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred --HHHHHHHHhcC---------cccCCC-cccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 11111111111 111111 11223357789999999999999999999999997776443
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=317.90 Aligned_cols=252 Identities=21% Similarity=0.378 Sum_probs=200.8
Q ss_pred cccccccCceEEEEEEEc------CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 367999999999999743 34568889887655555678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCC----------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCce
Q 047954 347 GNGNLFNRIHGGKSS----------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMV 416 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~ 416 (582)
++++|.+++...... .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-------i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-------FVHRDLATRNCLVGANLLV 162 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC-------eeecccCcceEEEccCCcE
Confidence 999999999754310 01124789999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHH
Q 047954 417 LVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWV 489 (582)
Q Consensus 417 kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 489 (582)
||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.... .....+
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~----~~~~~~-- 236 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS----NTEVIE-- 236 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHH--
Confidence 999999987654321 1223567999999998899999999999999999999 999985432 111111
Q ss_pred HHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 490 LRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 490 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
........... ......+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 237 --~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 --CITQGRVLERP----------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred --HHhCCCCCCCC----------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11222111110 1122367899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.51 Aligned_cols=241 Identities=22% Similarity=0.296 Sum_probs=192.0
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|+.. +++.||+|++... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 4678999998642 223345677888888865 899999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-------ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 81 GDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRHG-------VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 99999886432 4788889999999999999999998 9999999999999999999999999987542
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.. ....++..|+|||++.+..++.++|||||||++|||+||+.||.... .......+ ...... .+
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~----~~~~~~~i---~~~~~~----~p 216 (321)
T cd05591 148 LNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN----EDDLFESI---LHDDVL----YP 216 (321)
T ss_pred cCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC----HHHHHHHH---HcCCCC----CC
Confidence 22 22346788999999998899999999999999999999999996432 12222211 111110 00
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCC-------ChHHHHHHHhh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-------EMAEVVSELEI 546 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~evl~~L~~ 546 (582)
. ....++.+++.+||+.||++|| +++++++|.+.
T Consensus 217 ~--------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~ 257 (321)
T cd05591 217 V--------WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF 257 (321)
T ss_pred C--------CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence 0 0112577899999999999999 88999988653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=322.57 Aligned_cols=257 Identities=20% Similarity=0.348 Sum_probs=188.7
Q ss_pred cccccccCceEEEEEEEc--CCceEEEEEecCCC--cchHHHHHHHHHHHhcC---CCCCccccceEEEe-----CCeeE
Q 047954 273 AEGLGKGIFGNSYKALLE--GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQ---KHPNLLPLLAYYFS-----NDEKL 340 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~~~~~ 340 (582)
.+.||+|+||.||+|... ++..||+|+++... ......+.+|+.+++++ +||||++++++|.. ....+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 357999999999999863 46789999886432 22334566777776655 79999999999863 34589
Q ss_pred EEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEee
Q 047954 341 LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSD 420 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 420 (582)
+||||+. ++|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 86 lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~-------iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHR-------VVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred EEEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeeCCCCHHHEEEcCCCCEEEcc
Confidence 9999996 699999865332 24788999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh---
Q 047954 421 YGFSSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR--- 494 (582)
Q Consensus 421 fG~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--- 494 (582)
||+++...... ...++..|+|||.+.+..++.++|||||||++|||++|+.||..... .+....+.....
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~----~~~~~~i~~~~~~~~ 229 (290)
T cd07862 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVIGLPG 229 (290)
T ss_pred ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH----HHHHHHHHHHhCCCC
Confidence 99997664332 23467889999999888999999999999999999999999965321 222222222111
Q ss_pred -hccccc------ccchhh--hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 495 -EEWTAE------IFDSEI--SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 495 -~~~~~~------~~d~~~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
..+..+ .+.... ............+.+++.+||+.||++|||+.|+++|.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~ 289 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence 011100 000000 000000111235678999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=326.42 Aligned_cols=240 Identities=21% Similarity=0.346 Sum_probs=190.5
Q ss_pred ccccccCceEEEEEEE----cCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 274 EGLGKGIFGNSYKALL----EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
+.||+|+||.||++.. .++..||+|++.... ......+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999874 357889999986432 2233457789999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 82 GGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSLG-------IIYRDLKPENILLDEEGHIKLTDFGLSKES 148 (318)
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC-------EecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence 99999998643 24789999999999999999999998 999999999999999999999999998765
Q ss_pred cCc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
... ....++..|+|||.+.+..++.++|||||||++|||+||+.||.... .......+ ..... .+
T Consensus 149 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~----~~~~~~~i---~~~~~--~~-- 217 (318)
T cd05582 149 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD----RKETMTMI---LKAKL--GM-- 217 (318)
T ss_pred CCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC----HHHHHHHH---HcCCC--CC--
Confidence 433 12346788999999988889999999999999999999999996421 11111111 11110 00
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHHh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSELE 545 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~ 545 (582)
.. .....+.+++.+||+.||++||+ +.+++.+.+
T Consensus 218 -----p~---~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~ 256 (318)
T cd05582 218 -----PQ---FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256 (318)
T ss_pred -----CC---CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCC
Confidence 00 01125678899999999999999 555666543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=308.83 Aligned_cols=242 Identities=26% Similarity=0.432 Sum_probs=194.9
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
++||+|+||.||+|...++..+|+|.++... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888899999986543 233457889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~-------~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 81 SFLRKKK-----DELKTKQLVKFALDAAAGMAYLESKN-------CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY 148 (250)
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeecccChheEEEcCCCeEEECCCccceecccccc
Confidence 9986432 24788999999999999999999988 9999999999999999999999999987643321
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
....+..|+|||+..+..++.++||||||+++||+++ |..||.... ...... ...........
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~----~~~~~~----~~~~~~~~~~~---- 216 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT----NQQARE----QVEKGYRMSCP---- 216 (250)
T ss_pred ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC----HHHHHH----HHHcCCCCCCC----
Confidence 1123456999999988889999999999999999999 999985421 111111 11111111110
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
......+.+++.+||..+|++||++.|+++.|.
T Consensus 217 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 ------QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 011236888999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.43 Aligned_cols=246 Identities=23% Similarity=0.295 Sum_probs=192.2
Q ss_pred cccccccCceEEEEEEE----cCCceEEEEEecCC----CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALL----EGRAPVVVKRLRDL----KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 343 (582)
.+.||+|+||.||+++. .++..||+|++... .....+.+..|+.++.++ +|+||+++++++...+..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 46799999999999985 35788999998642 122345678899999999 5899999999999999999999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 85 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-------ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 85 DYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKLG-------IVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------cEecCCCHHHeEECCCCCEEEeeCcC
Confidence 9999999999986432 4788899999999999999999998 99999999999999999999999999
Q ss_pred cccccCc-----ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 424 SSLVAQP-----IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 424 a~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
++..... ....++..|+|||++.+. .++.++|||||||++|||+||+.||........ ...+.......
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~~~~~- 226 (332)
T cd05614 152 SKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----QSEVSRRILKC- 226 (332)
T ss_pred CccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----HHHHHHHHhcC-
Confidence 9765322 123478899999998765 478999999999999999999999964322111 11111111110
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhh
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEI 546 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 546 (582)
...+ .. .....+.+++.+||+.||++|| +++++++|.+.
T Consensus 227 ~~~~-~~---------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 270 (332)
T cd05614 227 DPPF-PS---------FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270 (332)
T ss_pred CCCC-CC---------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCc
Confidence 0000 00 1112567889999999999999 78899988763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=313.85 Aligned_cols=254 Identities=24% Similarity=0.430 Sum_probs=195.2
Q ss_pred cccccccCceEEEEEEEc-----CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-----GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~ 345 (582)
.+.||+|+||.||++... ++..||+|++........+.+.+|++++++++||||+++++++... ...++||||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 88 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY 88 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence 467999999999999753 4678999998766655567899999999999999999999987643 457899999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 89 ~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~~~-------i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 89 LPYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGSKR-------YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred cCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHCC-------ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 99999999996432 24789999999999999999999998 9999999999999999999999999998
Q ss_pred cccCccc-------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC--------CccchHHHHH
Q 047954 426 LVAQPIA-------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGI--------NGADLCSWVL 490 (582)
Q Consensus 426 ~~~~~~~-------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~--------~~~~~~~~~~ 490 (582)
.+..... ......|+|||+..+..++.++|||||||++|||++|..|+....... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 7643321 112345999999988889999999999999999999887764322110 0000011111
Q ss_pred HHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 491 RAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 491 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
......... ........++.+++.+||+.+|++|||+.||++.|+.++
T Consensus 237 ~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 237 ELLKNNGRL----------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHHhcCCcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 111111000 000112236889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.06 Aligned_cols=253 Identities=22% Similarity=0.381 Sum_probs=197.6
Q ss_pred ccccccccCceEEEEEEEcC------CceEEEEEecCCC-cchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEE
Q 047954 272 PAEGLGKGIFGNSYKALLEG------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 343 (582)
..+.||+|+||.||+|++.+ +..||+|+++... ....+.+.+|+.++.++. |||||+++++|......++||
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence 46889999999999998643 3579999997543 223457889999999997 999999999999999999999
Q ss_pred EeCCCCChHHHHhcCCCC--------------------------------------------------------------
Q 047954 344 KFAGNGNLFNRIHGGKSS-------------------------------------------------------------- 361 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~-------------------------------------------------------------- 361 (582)
||+++|+|.++++.....
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 999999999999754310
Q ss_pred ------------------------------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec
Q 047954 362 ------------------------------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD 411 (582)
Q Consensus 362 ------------------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~ 411 (582)
.....+++...+.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-------ivHrdlkp~NiLl~ 273 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN-------CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------cCcccCCcceEEEe
Confidence 01124677888999999999999999987 99999999999999
Q ss_pred CCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccc
Q 047954 412 DNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGAD 484 (582)
Q Consensus 412 ~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~ 484 (582)
+++.+||+|||+++...... ...++..|+|||.+....++.++|||||||++|||++ |..||.....
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~------ 347 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM------ 347 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc------
Confidence 99999999999997653221 1224567999999988889999999999999999998 8889854321
Q ss_pred hHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.+........+..... +.....++.+++.+||..+|++||+++||++.|+.+.
T Consensus 348 -~~~~~~~~~~~~~~~~----------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 -NEQFYNAIKRGYRMAK----------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -hHHHHHHHHcCCCCCC----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111111111110 0011236888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=311.36 Aligned_cols=242 Identities=21% Similarity=0.390 Sum_probs=191.2
Q ss_pred cccccCceEEEEEEEc---CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 275 GLGKGIFGNSYKALLE---GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 34568999886543 234567899999999999999999999885 457899999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 81 L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 81 LNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEGKN-------FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhcC-------eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 999987432 24888999999999999999999998 999999999999999999999999999765432
Q ss_pred cc-------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 431 IA-------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 431 ~~-------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
.. ...+..|+|||.+....++.++|||||||++|||++ |+.||.... ..++...+ ....... .
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~----~~~~~~~-~ 219 (257)
T cd05115 149 DSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK----GPEVMSFI----EQGKRLD-C 219 (257)
T ss_pred ccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC----HHHHHHHH----HCCCCCC-C
Confidence 11 112357999999888889999999999999999996 999996432 12222222 1111111 0
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+ .....++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 220 ~---------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 P---------AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred C---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1 11223677899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=321.51 Aligned_cols=265 Identities=24% Similarity=0.394 Sum_probs=203.2
Q ss_pred CChhHhhhcccccccccCceEEEEEEEcC--------CceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceE
Q 047954 263 FKLNDLLKAPAEGLGKGIFGNSYKALLEG--------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAY 332 (582)
Q Consensus 263 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~ 332 (582)
|.+........+.||+|+||.||+|...+ ...||+|.++... ....+.+.+|+.++.++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 33333333456789999999999997421 2368999886432 23456789999999999 89999999999
Q ss_pred EEeCCeeEEEEEeCCCCChHHHHhcCCCC----------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecC
Q 047954 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSS----------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGN 402 (582)
Q Consensus 333 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~D 402 (582)
|...+..+++|||+++|+|.+++...... .....+++..++.++.|++.||+|||+.+ |+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-------ivH~d 159 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK-------CIHRD 159 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-------eeccc
Confidence 99999999999999999999999754311 11234788899999999999999999998 99999
Q ss_pred CCCCCeeecCCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 047954 403 LKSTNILLDDNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHS 475 (582)
Q Consensus 403 lkp~NILl~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~ 475 (582)
|||+|||+++++.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred cccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999987654321 1122356999999998899999999999999999998 8888853
Q ss_pred CCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 476 APQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
.. ..++. ..+......+.. .....++.+++.+||+.+|++||++.|++++|+.+.....
T Consensus 240 ~~----~~~~~----~~~~~~~~~~~~----------~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 240 IP----VEELF----KLLKEGHRMDKP----------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred CC----HHHHH----HHHHcCCCCCCC----------CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 21 11111 111111111111 1112367889999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=314.42 Aligned_cols=249 Identities=20% Similarity=0.336 Sum_probs=194.0
Q ss_pred cccccccCceEEEEEEEc------CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|... .+..||+|++.... .....++.+|+.+++.++||||+++++++......++||||
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 90 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEec
Confidence 467999999999999754 24579999886432 23445788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCC----CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 346 AGNGNLFNRIHGGKSSK----NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
+++|+|.+++....... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-------~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK-------FVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCcchheEEEcCCCCEEECCC
Confidence 99999999987533211 0124678889999999999999999987 999999999999999999999999
Q ss_pred cccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 422 GFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 422 G~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
|+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||.... .......+ .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~----~~~~~~~~----~ 235 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS----NEQVLRFV----M 235 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHH----H
Confidence 9987653321 1223567999999988889999999999999999999 788885421 12222211 1
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
........ ......+.+++.+||+.+|++|||+.|++++|++
T Consensus 236 ~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGLLDKP----------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCcCCCC----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111110 1112357889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=323.93 Aligned_cols=241 Identities=23% Similarity=0.300 Sum_probs=191.5
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|+.. +++.||+|++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999965 5778999998642 223345677888888776 799999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~~-------ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 81 GDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDKG-------IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred chHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 99999886432 4788899999999999999999998 9999999999999999999999999987542
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.. ....+++.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ .... . ..+
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~----~~~~~~~i---~~~~-~---~~~ 216 (320)
T cd05590 148 FNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN----EDDLFEAI---LNDE-V---VYP 216 (320)
T ss_pred cCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC----HHHHHHHH---hcCC-C---CCC
Confidence 21 22347889999999998899999999999999999999999996432 11222211 1111 0 000
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh------HHHHHHHhh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM------AEVVSELEI 546 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L~~ 546 (582)
. ....++.+++.+||+.||++||++ ++++.|.+.
T Consensus 217 -----~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f 256 (320)
T cd05590 217 -----T---WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256 (320)
T ss_pred -----C---CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence 0 011257789999999999999998 788887654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.24 Aligned_cols=252 Identities=22% Similarity=0.368 Sum_probs=199.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|+.. +++.||||.+... .......+.+|++++++++||||+++++++...+..++|+||+++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA 86 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence 467999999999999854 6788999987542 223345688999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++...... ...++...++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 87 ~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~-------i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 87 GDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHSRR-------VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred CcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhhCC-------eeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 9999988643221 224788889999999999999999988 9999999999999999999999999988765
Q ss_pred Ccc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
... ...++..|+|||.+.+..++.++||||||+++|||++|+.||.... ......... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~-----~~~~~~~~~-~~~~~~~~~~-- 229 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLFSLCQK-IEQCDYPPLP-- 229 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc-----ccHHHHHHH-HhcCCCCCCC--
Confidence 432 2346678999999988889999999999999999999999986422 111222211 1111111110
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.......+.+++.+||..+|++||++.+|++.++.++
T Consensus 230 -------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 230 -------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1112236788999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.18 Aligned_cols=258 Identities=19% Similarity=0.315 Sum_probs=196.7
Q ss_pred ccccccCceEEEEEE-EcCCceEEEEEecCCCc--chHHHHHHHHHHHhcCCCCC-ccccceEEEeCC------eeEEEE
Q 047954 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPN-LLPLLAYYFSND------EKLLVY 343 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~------~~~lv~ 343 (582)
++||+|+||+||+|+ ..+|+.||+|+++.... .......+|+.++++++|+| ||.+++++.+.. ..++|+
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 569999999999999 45678999999975433 34556789999999999999 999999999877 788999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+.. +|..++....... ..++...++.++.||+.||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 97 e~~d~-DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~~-------IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 97 EFLDR-DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSHG-------ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred Eeecc-cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhCC-------eecccCCcceEEECCCCcEeeeccch
Confidence 99965 9999997654321 24666789999999999999999998 99999999999999999999999999
Q ss_pred cccccCccc----ccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh----
Q 047954 424 SSLVAQPIA----AQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR---- 494 (582)
Q Consensus 424 a~~~~~~~~----~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---- 494 (582)
|+...-+.. ...|..|+|||++.+. .|++..||||+|||+.||++++.-|....+ .+....+.+.+.
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se----~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE----IDQLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHHHcCCCCc
Confidence 987653332 2256779999998876 799999999999999999999988865432 222222222221
Q ss_pred hcccccccchhhh----hh-------hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 495 EEWTAEIFDSEIS----VQ-------RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 495 ~~~~~~~~d~~~~----~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
..|.....-+... .. ...........+++.+|++.+|.+|.|++.++.|-.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~y 304 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPY 304 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChh
Confidence 1222211111111 00 000111135788999999999999999999998844
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=310.01 Aligned_cols=240 Identities=23% Similarity=0.382 Sum_probs=191.1
Q ss_pred cccccCceEEEEEEEc---CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 275 GLGKGIFGNSYKALLE---GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.||+|+||.||+|.+. ++..+|+|+++... ....+.+.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 56789999886432 234567899999999999999999999885 45678999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~-------i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 81 PLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEETN-------FVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147 (257)
T ss_pred cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------EeecccchhhEEEcCCCeEEECCCccccccCC
Confidence 9999986432 4788999999999999999999998 99999999999999999999999999987643
Q ss_pred ccc-------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 430 PIA-------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 430 ~~~-------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
... ..++..|+|||.+....++.++|||||||++|||+| |+.||... ....+...+ ........
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~~~~~~~i----~~~~~~~~ 219 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM----KGNEVTQMI----ESGERMEC 219 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHH----HCCCCCCC
Confidence 321 112367999999988889999999999999999998 99999642 122222222 22211111
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.. ....++.+++.+||+.||++||++.+|.+.|+.
T Consensus 220 ~~----------~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQ----------RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CC----------CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 10 112357789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=310.26 Aligned_cols=241 Identities=25% Similarity=0.452 Sum_probs=194.6
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 9 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (256)
T cd05059 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87 (256)
T ss_pred hhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence 46799999999999998877789999886432 23457889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCccc
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA 432 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~~ 432 (582)
+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 88 ~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~-------i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 88 NYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESNG-------FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred HHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCC-------cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 99975332 4789999999999999999999998 99999999999999999999999999876543221
Q ss_pred -----ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 433 -----AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 433 -----~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
...+..|+|||+..+..++.++||||||+++|||+| |+.||.... ..+....+ ........
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~~----~~~~~~~~----- 222 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS----NSEVVESV----SAGYRLYR----- 222 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC----HHHHHHHH----HcCCcCCC-----
Confidence 112346999999998899999999999999999999 899986432 11122111 11111000
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
......++.+++.+||..+|++|||+.|+++.|
T Consensus 223 -----~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 -----PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 001223688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=316.83 Aligned_cols=255 Identities=23% Similarity=0.384 Sum_probs=197.3
Q ss_pred cccccccCceEEEEEEEcCC---ceEEEEEecCC-CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLEGR---APVVVKRLRDL-KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|...+. ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++|+||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 45799999999999987543 24688887643 233456789999999999 79999999999999999999999999
Q ss_pred CCChHHHHhcCCCCC----------CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceE
Q 047954 348 NGNLFNRIHGGKSSK----------NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL 417 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~k 417 (582)
+|+|.++++...... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-------ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ-------FIHRDLAARNVLVGENLASK 159 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCcCCcceEEECCCCeEE
Confidence 999999997543110 1124788899999999999999999988 99999999999999999999
Q ss_pred EeeccccccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHH
Q 047954 418 VSDYGFSSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 418 l~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
|+|||++...... .....+..|+|||+..+..++.++|||||||++|||+| |+.||.... ..++.. ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~----~~~~~~----~~ 231 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT----CAELYE----KL 231 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHH----HH
Confidence 9999998654321 11122356999999988889999999999999999998 999996432 111111 11
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
........ .......+.+++.+||+.+|.+||+++++++.|+.+.....
T Consensus 232 ~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 232 PQGYRMEK----------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred hcCCCCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11111110 00112357889999999999999999999999998876553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=314.46 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=194.7
Q ss_pred cccccccCceEEEEEEE-----cCCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALL-----EGRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|.. ..+..|++|.+.... ......+.+|++++++++||||+++++++......++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 89 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence 36799999999999984 345789999987433 233467889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCC-----------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc
Q 047954 347 GNGNLFNRIHGGKSS-----------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM 415 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~ 415 (582)
++|+|.+++...... .....+++.+.+.++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-------i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-------FVHKDLAARNILIGEQLH 162 (283)
T ss_pred CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC-------eehhccccceEEEcCCCc
Confidence 999999998643210 01124788889999999999999999998 999999999999999999
Q ss_pred eEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHH
Q 047954 416 VLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSW 488 (582)
Q Consensus 416 ~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 488 (582)
+||+|||+++...... ...++..|+|||+..+..++.++|||||||++|||++ |..||.... ...+.+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~----~~~~~~~ 238 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS----NQEVIEM 238 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH
Confidence 9999999997653321 1223457999999988889999999999999999999 998985321 1222222
Q ss_pred HHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 489 VLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 489 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
+ ........ . .....++.+++.+||+.||++||++.+|+++|..
T Consensus 239 ~----~~~~~~~~-~---------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 V----RKRQLLPC-S---------EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----HcCCcCCC-C---------CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 2 11111110 0 0112357788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.03 Aligned_cols=257 Identities=18% Similarity=0.334 Sum_probs=190.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCC-----eeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSND-----EKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~e 344 (582)
.+.||+|+||.||+|+.. ++..||||++.... ......+.+|+.++++++||||+++++++.... ..++|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 467999999999999954 67899999986422 223456889999999999999999999986543 4799999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+. ++|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 85 ~~~-~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~-------ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 85 LME-SDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTAN-------VFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred cCC-CCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHeEECCCCcEEEccCccc
Confidence 995 69999886432 4888999999999999999999998 999999999999999999999999999
Q ss_pred ccccCc-------ccccccccccCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh
Q 047954 425 SLVAQP-------IAAQRMISYKSPEYQSS--KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE 495 (582)
Q Consensus 425 ~~~~~~-------~~~~~~~~y~aPE~~~~--~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 495 (582)
+..... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||..... ......+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~----~~~~~~~~~~~~~ 226 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV----VHQLDLITDLLGT 226 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHHHhCC
Confidence 764322 12346788999998765 6789999999999999999999999964321 1111111111000
Q ss_pred c---------------ccccccchh-hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 496 E---------------WTAEIFDSE-ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 496 ~---------------~~~~~~d~~-~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
. ....+.... .............+.+++.+||+.||++|||++|+++|.+..
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~ 294 (338)
T cd07859 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294 (338)
T ss_pred CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence 0 000000000 000000001123567899999999999999999999997754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=316.95 Aligned_cols=256 Identities=23% Similarity=0.384 Sum_probs=199.7
Q ss_pred cccccccccCceEEEEEEEc--------CCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeE
Q 047954 271 APAEGLGKGIFGNSYKALLE--------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKL 340 (582)
Q Consensus 271 ~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 340 (582)
...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++..+ +||||+++++++......+
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (304)
T cd05101 18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 97 (304)
T ss_pred eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceE
Confidence 44678999999999999742 23468999886432 23456788999999999 8999999999999999999
Q ss_pred EEEEeCCCCChHHHHhcCCCCC----------CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee
Q 047954 341 LVYKFAGNGNLFNRIHGGKSSK----------NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL 410 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl 410 (582)
+||||+++|+|.+++....... ....+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g-------ivH~dlkp~Nili 170 (304)
T cd05101 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK-------CIHRDLAARNVLV 170 (304)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC-------eeecccccceEEE
Confidence 9999999999999997643210 1234788889999999999999999998 9999999999999
Q ss_pred cCCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 047954 411 DDNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGA 483 (582)
Q Consensus 411 ~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~ 483 (582)
++++.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 999999999999998764321 1223467999999988889999999999999999998 788875321
Q ss_pred chHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 484 DLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
..+.. ........... .......+.+++.+||+.+|++|||+.|+++.|..+....
T Consensus 245 -~~~~~-~~~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 245 -VEELF-KLLKEGHRMDK----------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred -HHHHH-HHHHcCCcCCC----------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11111 11222111110 0112236788999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=321.64 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=195.0
Q ss_pred cccccccCceEEEEEEEc------CCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeC-CeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSN-DEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~~~~lv~ 343 (582)
.+.||+|+||.||+|... .++.||+|+++... ....+.+..|+.++.++ +|+||++++++|... ...+++|
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ 91 (337)
T cd05054 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (337)
T ss_pred hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEE
Confidence 467999999999999743 24679999986432 22345678899999999 899999999988754 4678999
Q ss_pred EeCCCCChHHHHhcCCCCC-------------------------------------------------------CCCccc
Q 047954 344 KFAGNGNLFNRIHGGKSSK-------------------------------------------------------NRIPFR 368 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~-------------------------------------------------------~~~~l~ 368 (582)
||+++|+|.+++....... ....++
T Consensus 92 ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (337)
T cd05054 92 EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLT 171 (337)
T ss_pred ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCC
Confidence 9999999999986432100 012578
Q ss_pred hHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc------cccccccccCC
Q 047954 369 CRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI------AAQRMISYKSP 442 (582)
Q Consensus 369 ~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aP 442 (582)
+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.... ...++..|+||
T Consensus 172 ~~~~~~~~~qi~~aL~~lH~~~-------ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 172 LEDLISYSFQVARGMEFLASRK-------CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC-------eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 9999999999999999999988 9999999999999999999999999998764321 12234679999
Q ss_pred CCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHH
Q 047954 443 EYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQ 521 (582)
Q Consensus 443 E~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~ 521 (582)
|++.+..++.++|||||||++|||++ |+.||..... ...+. ........... ......++.+
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~---~~~~~----~~~~~~~~~~~----------~~~~~~~~~~ 307 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---DEEFC----RRLKEGTRMRA----------PEYATPEIYS 307 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc---cHHHH----HHHhccCCCCC----------CccCCHHHHH
Confidence 99999999999999999999999998 9999864221 11111 11111111100 0111236889
Q ss_pred HHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 522 VAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 522 l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
++.+||+.+|++||++.|++++|+.+.+
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=317.94 Aligned_cols=257 Identities=24% Similarity=0.398 Sum_probs=200.3
Q ss_pred cccccccccCceEEEEEEEcC--------CceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeE
Q 047954 271 APAEGLGKGIFGNSYKALLEG--------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKL 340 (582)
Q Consensus 271 ~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 340 (582)
...+.||+|+||.||+|...+ ...+|+|.++... ......+..|++++.++ +||||+++++++...+..+
T Consensus 21 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (307)
T cd05098 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 100 (307)
T ss_pred EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 345789999999999997532 2469999987532 23445788899999999 8999999999999999999
Q ss_pred EEEEeCCCCChHHHHhcCCCCC----------CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee
Q 047954 341 LVYKFAGNGNLFNRIHGGKSSK----------NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL 410 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl 410 (582)
+||||+++|+|.+++....... ....+++..++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 101 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-------i~H~dlkp~Nill 173 (307)
T cd05098 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-------CIHRDLAARNVLV 173 (307)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-------cccccccHHheEE
Confidence 9999999999999997643210 1124888999999999999999999988 9999999999999
Q ss_pred cCCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 047954 411 DDNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGA 483 (582)
Q Consensus 411 ~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~ 483 (582)
++++.+||+|||+++...... ....+..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~----~~ 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VE 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC----HH
Confidence 999999999999987654321 1123357999999988889999999999999999998 888885321 11
Q ss_pred chHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 484 DLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
++. .........+. ......++.+++.+||..+|++|||+.+|++.|+.+.....
T Consensus 250 ~~~----~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 250 ELF----KLLKEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HHH----HHHHcCCCCCC----------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 111 11222211111 01112367789999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=316.35 Aligned_cols=259 Identities=22% Similarity=0.330 Sum_probs=194.6
Q ss_pred cccccccCceEEEEEEE-----cCCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-----EGRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 344 (582)
.+.||+|+||+||++.. .++..||+|.++... ....+.+.+|++++++++||||+++++++... ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence 36799999999988653 356789999986543 23456788999999999999999999998764 35789999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++|+|.+++... .+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 89 ~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~~-------i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 89 YVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQH-------YIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred CCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeccccChheEEEcCCCcEEEeecccc
Confidence 99999999999642 3889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCccc-------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 425 SLVAQPIA-------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 425 ~~~~~~~~-------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
+....... ..++..|+|||......++.++||||||+++|||+||+.|+....... .+.............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~ 232 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVVR 232 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccccchhh
Confidence 87643221 123456999999988889999999999999999999999986432110 000000000000000
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
..+..+.... .........++.+++.+||+.+|++|||+++|++.|+.+.
T Consensus 233 ~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000000000 0001122347889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=309.68 Aligned_cols=245 Identities=29% Similarity=0.444 Sum_probs=188.8
Q ss_pred ccccccCceEEEEEEEcC----CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEe-CCeeEEEEEeCC
Q 047954 274 EGLGKGIFGNSYKALLEG----RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFS-NDEKLLVYKFAG 347 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~~ 347 (582)
+.||+|+||.||+|...+ ...||+|++.... ....+.+.+|+.+++.++||||+++++++.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998542 3568999885432 3345678899999999999999999998764 456789999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++..... ..++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+
T Consensus 81 ~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 81 HGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASKK-------FVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC-------ccccccCcceEEEcCCCcEEECCccccccc
Confidence 9999999975322 3567778899999999999999987 999999999999999999999999998755
Q ss_pred cCcc--------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 428 AQPI--------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR-ISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 428 ~~~~--------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
.... ...++..|+|||+..+..++.++|||||||++|||++|. .||... ...++...+. ... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~----~~~~~~~~~~---~~~-~ 220 (262)
T cd05058 149 YDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----DSFDITVYLL---QGR-R 220 (262)
T ss_pred cCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHh---cCC-C
Confidence 3211 222356799999998889999999999999999999964 455321 1222222211 111 0
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
... . ......+.+++.+||..+|++||++.||++.|+.+.
T Consensus 221 ~~~-~---------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 LLQ-P---------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCC-C---------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 000 0 011235788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=313.67 Aligned_cols=261 Identities=21% Similarity=0.315 Sum_probs=200.0
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.++.+++||||+++++++...+..++||||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 85 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence 35799999999999985 46788999988643 23345678899999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 86 l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 86 LDVYR----------KIPEHVLGRIAVAVVKGLTYLWSLK-------ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred hHHhh----------cCCHHHHHHHHHHHHHHHHHHHHCC-------EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 96543 3677788899999999999999998 999999999999999999999999999765433
Q ss_pred --ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 431 --IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 431 --~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
....++..|+|||++.+..++.++|||||||++|||++|+.||................ .............
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----- 222 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-QCIVDEDPPVLPV----- 222 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-HHHhccCCCCCCC-----
Confidence 22346788999999998899999999999999999999999996532211111111111 1111110111000
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCCccccccc
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEEDFW 560 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~ 560 (582)
.....++.+++.+||+.+|++||+++|++++.+.............+|
T Consensus 223 ----~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~~~~~~~ 270 (279)
T cd06619 223 ----GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMW 270 (279)
T ss_pred ----CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCccHHHHHHH
Confidence 011225788999999999999999999999987655544333333444
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=320.60 Aligned_cols=240 Identities=23% Similarity=0.335 Sum_probs=188.7
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhc-CCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIAD-QKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|... ++..||+|.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 35899999999999975 46789999986431 2234456677777776 5999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~~-------ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 81 GDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSKG-------IVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 99999986432 4788889999999999999999998 9999999999999999999999999987532
Q ss_pred C----cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 Q----PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~----~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
. .....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..++...+ ..... ....
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~----~~~~~~~i----~~~~~--~~~~ 217 (316)
T cd05619 148 LGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD----EEELFQSI----RMDNP--CYPR 217 (316)
T ss_pred CCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC----HHHHHHHH----HhCCC--CCCc
Confidence 1 122346788999999998899999999999999999999999996422 12222221 11100 0000
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChH-HHHHHHh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMA-EVVSELE 545 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~L~ 545 (582)
....++.+++.+||+.||++||++. ++.++.+
T Consensus 218 ---------~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05619 218 ---------WLTREAKDILVKLFVREPERRLGVKGDIRQHPF 250 (316)
T ss_pred ---------cCCHHHHHHHHHHhccCHhhcCCChHHHHcCcc
Confidence 0112567889999999999999997 6766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=307.68 Aligned_cols=264 Identities=21% Similarity=0.299 Sum_probs=199.2
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhc--CCCCCccccceEEEeCC----eeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIAD--QKHPNLLPLLAYYFSND----EKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~~----~~~lv~e~~ 346 (582)
.++||+|+||.||||.+.+ +.||||++.. ...+.|++|-++.+. ++|+||++++++-.... +.+||+||.
T Consensus 215 ~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 3579999999999999987 6799999954 446778888887765 69999999999877665 789999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCC--CCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS--RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~--~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
+.|+|.++|... .++|....+|+..+++||+|||+..+. +-+++|+|||||++|||+..|+++.|+|||+|
T Consensus 291 ~kGsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 291 PKGSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred cCCcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999754 589999999999999999999997654 33678999999999999999999999999999
Q ss_pred ccccCcc------cccccccccCCCCCCCCCC------CcchhHHHHHHHHHHHHhCCCCCCC--------CCCC-CCcc
Q 047954 425 SLVAQPI------AAQRMISYKSPEYQSSKKI------SRKSDVWSFGCLLLELLTGRISTHS--------APQG-INGA 483 (582)
Q Consensus 425 ~~~~~~~------~~~~~~~y~aPE~~~~~~~------~~k~DVwS~Gvvl~elltG~~P~~~--------~~~~-~~~~ 483 (582)
..+.... ...||.+|||||++.+..- -.+.||||+|.|||||+++-.-++. .++. ....
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 8775432 3347889999999886422 1368999999999999986433321 1110 0001
Q ss_pred chHHHHHHH-HhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 484 DLCSWVLRA-VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 484 ~~~~~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
--.+.++.. ++....+.+.+. -.....+.-+.+.+..||+.||+.|.|+.=|.+.++++.....
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~-----W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDA-----WRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhh-----hhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 111111111 111112222111 1111445678899999999999999999999999998876554
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=319.91 Aligned_cols=239 Identities=23% Similarity=0.326 Sum_probs=186.2
Q ss_pred cccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhc-CCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 275 GLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIAD-QKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.||+|+||.||+|... ++..||+|.++... ....+.+..|..++.. .+||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999965 46789999986421 2233455666666664 48999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~~-------ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 82 DLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKKG-------IIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred cHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------EEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 9999986432 4788889999999999999999998 99999999999999999999999999975432
Q ss_pred c----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 P----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ...+... +.... .. +..
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~----~~~~~~~----i~~~~-~~-~~~- 217 (316)
T cd05592 149 GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED----EDELFDS----ILNDR-PH-FPR- 217 (316)
T ss_pred CCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC----HHHHHHH----HHcCC-CC-CCC-
Confidence 1 22346889999999998899999999999999999999999996422 1111111 11110 00 000
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChH-HHHHHHh
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMA-EVVSELE 545 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~L~ 545 (582)
....++.+++.+||+.||++||++. +++++.+
T Consensus 218 --------~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05592 218 --------WISKEAKDCLSKLFERDPTKRLGVDGDIRQHPF 250 (316)
T ss_pred --------CCCHHHHHHHHHHccCCHHHcCCChHHHHcCcc
Confidence 0112567888999999999999875 5656543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=311.18 Aligned_cols=250 Identities=24% Similarity=0.397 Sum_probs=194.1
Q ss_pred ccccccCceEEEEEEEcCC-c--eEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLEGR-A--PVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~-~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|...++ . .+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 3689999999999997543 3 46888876432 33456788999999999 899999999999999999999999999
Q ss_pred CChHHHHhcCCCC----------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEE
Q 047954 349 GNLFNRIHGGKSS----------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLV 418 (582)
Q Consensus 349 gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl 418 (582)
|+|.+++...... .....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~-------i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-------FIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC-------EeecccccceEEEcCCCeEEE
Confidence 9999999754321 01124788999999999999999999987 999999999999999999999
Q ss_pred eeccccccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 419 SDYGFSSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 419 ~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
+|||++...... .....+..|+|||++....++.++|||||||++|||++ |+.||.... ..+... ...
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~----~~~~~~----~~~ 225 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAELYE----KLP 225 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC----HHHHHH----HHh
Confidence 999998643211 11122456999999988889999999999999999997 999985421 111111 111
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
..+..+.. .....++.+++.+||..+|.+|||+.+++..|..+.
T Consensus 226 ~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 QGYRLEKP----------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCCCC----------CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111110 011235789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=313.99 Aligned_cols=249 Identities=23% Similarity=0.383 Sum_probs=194.9
Q ss_pred cccccccCceEEEEEEEcC------CceEEEEEecCCCc-chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEG------RAPVVVKRLRDLKP-LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|...+ +..||+|+++.... ...+.+.+|+.++.+++||||+++++++......++++||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05091 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSY 89 (283)
T ss_pred HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEc
Confidence 4679999999999998643 46799999875432 2346788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCC----------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc
Q 047954 346 AGNGNLFNRIHGGKSS----------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM 415 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~ 415 (582)
+.+++|.+++...... .....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g-------i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 90 CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-------VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC-------ccccccchhheEecCCCc
Confidence 9999999998632210 01234788889999999999999999998 999999999999999999
Q ss_pred eEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHH
Q 047954 416 VLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSW 488 (582)
Q Consensus 416 ~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 488 (582)
+||+|||+++...... ...+++.|+|||.+.+..++.++|||||||++|||++ |..||... ...++...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~----~~~~~~~~ 238 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY----SNQDVIEM 238 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHH
Confidence 9999999987654322 1223567999999988889999999999999999998 88887532 11222222
Q ss_pred HHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 489 VLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 489 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
+. ......+ .......+.+++.+||+.+|++||++++|+..|+.
T Consensus 239 i~----~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IR----NRQVLPC----------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH----cCCcCCC----------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 21 1111110 11122357889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=313.09 Aligned_cols=248 Identities=23% Similarity=0.425 Sum_probs=194.1
Q ss_pred cccccccCceEEEEEEEcC------CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEG------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|...+ +..|++|.+.... ......|.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL 90 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence 3679999999999998754 5678888876433 23345789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCC-CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC---ceEEeec
Q 047954 346 AGNGNLFNRIHGGKSSK-NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE---MVLVSDY 421 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Df 421 (582)
+++++|.+++....... ....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||+||
T Consensus 91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-------ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH-------FIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------EeecccchheEEEeccCCCcceEeccC
Confidence 99999999997654211 1235889999999999999999999998 99999999999998654 5999999
Q ss_pred cccccccCccc------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 422 GFSSLVAQPIA------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 422 G~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
|+++.+..... ...+..|+|||++.+..++.++|||||||++|||++ |+.||.... ...+...+ .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~----~~~~~~~~----~ 235 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT----NQEVMEFV----T 235 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHH----H
Confidence 99987633211 112357999999988899999999999999999997 999986432 11222211 1
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
....... +......+.+++.+||+.+|++|||+.+|+++|.
T Consensus 236 ~~~~~~~----------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGRLDP----------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1101000 0111236788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=321.17 Aligned_cols=240 Identities=22% Similarity=0.351 Sum_probs=188.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHH---hcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVI---ADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|... +++.||||+++... ....+.+..|++++ ++++||||+++++++...+..++||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 357999999999999865 57889999986431 22334566666554 567899999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++|+|..+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 ~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH~~~-------ivHrdlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05589 84 AAGGDLMMHIHTD-------VFSEPRAVFYAACVVLGLQYLHENK-------IVYRDLKLDNLLLDTEGFVKIADFGLCK 149 (324)
T ss_pred CCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCC-------eEecCCCHHHeEECCCCcEEeCcccCCc
Confidence 9999999888532 4888999999999999999999998 9999999999999999999999999987
Q ss_pred cccCc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 426 LVAQP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 426 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
..... ....++..|+|||.+.+..++.++|||||||++|||++|+.||.... ..++...+ ......
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~----~~~~~~~i---~~~~~~--- 219 (324)
T cd05589 150 EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD----EEEVFDSI---VNDEVR--- 219 (324)
T ss_pred cCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC----HHHHHHHH---HhCCCC---
Confidence 54221 22346788999999999999999999999999999999999996432 11121111 111100
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHh
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELE 545 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~ 545 (582)
.. ......+.+++.+||+.||++|| ++.+++++.+
T Consensus 220 ~p---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~ 259 (324)
T cd05589 220 YP---------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259 (324)
T ss_pred CC---------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence 00 01122567899999999999999 6788887764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.23 Aligned_cols=244 Identities=27% Similarity=0.462 Sum_probs=198.6
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|... ++.||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 88 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence 467999999999999876 57799999976543 5678899999999999999999999999989999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCccc
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA 432 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~~ 432 (582)
+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.++.......
T Consensus 89 ~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~-------i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 89 DYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEKN-------FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred HHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 99975432 24889999999999999999999998 99999999999999999999999999987643322
Q ss_pred -ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhh
Q 047954 433 -AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQR 510 (582)
Q Consensus 433 -~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 510 (582)
...+..|+|||++....++.++||||||+++|||++ |+.||.... ..++. ......+.....
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~----~~~~~~~~~~~~-------- 221 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVV----PHVEKGYRMEAP-------- 221 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC----HHHHH----HHHhcCCCCCCc--------
Confidence 223457999999988889999999999999999997 999985431 11222 222222111111
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 511 SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 511 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
......+.+++.+||..+|++|||+.|+++.|+.+
T Consensus 222 --~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 222 --EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11123678899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.54 Aligned_cols=243 Identities=28% Similarity=0.459 Sum_probs=195.2
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (260)
T cd05070 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (260)
T ss_pred hheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHH
Confidence 467999999999999988888899999875432 4567999999999999999999999874 45689999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCccc
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA 432 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~~ 432 (582)
++++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..+.....
T Consensus 89 ~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~-------i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 89 DFLKDGEG----RALKLPNLVDMAAQVAAGMAYIERMN-------YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred HHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99975322 24788999999999999999999998 99999999999999999999999999976643321
Q ss_pred -----ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 433 -----AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 433 -----~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
..++..|+|||+..+..++.++||||||+++|||++ |+.||... ...+....+. .......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~----~~~~~~~~~~----~~~~~~~----- 224 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM----NNREVLEQVE----RGYRMPC----- 224 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHH----cCCCCCC-----
Confidence 123457999999988889999999999999999999 88898542 1222222221 1111111
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.......+.+++.+||..+|++|||+.++.+.|+.
T Consensus 225 -----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 -----PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01122368899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.59 Aligned_cols=248 Identities=20% Similarity=0.341 Sum_probs=196.4
Q ss_pred cccccccCceEEEEEEEc------CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++|+||+++++++...+..+++|||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence 467999999999999742 35578899887666666778999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCC---------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceE
Q 047954 347 GNGNLFNRIHGGKSS---------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL 417 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~k 417 (582)
++|+|.+++...... .....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-------i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH-------FVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC-------eecccccHhhEEEcCCCCEE
Confidence 999999999754321 01124788999999999999999999988 99999999999999999999
Q ss_pred EeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHH
Q 047954 418 VSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVL 490 (582)
Q Consensus 418 l~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~ 490 (582)
|+|||+++...... ...+++.|+|||+..+..++.++|||||||++|||++ |+.||.... ..+....+.
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~~~~~~~ 238 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS----NTEAIECIT 238 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC----HHHHHHHHH
Confidence 99999987553221 1123467999999998899999999999999999998 899985422 111111111
Q ss_pred HHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 491 RAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 491 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
........ ......+.+++.+||+.||++||++.||++.|+
T Consensus 239 ----~~~~~~~~----------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 ----QGRELERP----------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----cCccCCCC----------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11111100 011235778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=328.39 Aligned_cols=245 Identities=18% Similarity=0.298 Sum_probs=192.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 367999999999999965 57889999986421 23345678899999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~-------ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 86 GDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKLG-------YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred cHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999987532 4888999999999999999999998 9999999999999999999999999986542
Q ss_pred Ccc------------------------------------------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHH
Q 047954 429 QPI------------------------------------------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLEL 466 (582)
Q Consensus 429 ~~~------------------------------------------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~el 466 (582)
... ...||+.|+|||++....++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 210 12378899999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCC---hHHHHHH
Q 047954 467 LTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE---MAEVVSE 543 (582)
Q Consensus 467 ltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 543 (582)
++|+.||.... .......+ .. +.....-+. ... ....+.+++.+|+. +|.+|++ +.|+++|
T Consensus 233 ~~G~~Pf~~~~----~~~~~~~i---~~--~~~~~~~~~---~~~---~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 233 LVGYPPFCSDN----PQETYRKI---IN--WKETLQFPD---EVP---LSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred hcCCCCCCCCC----HHHHHHHH---Hc--CCCccCCCC---CCC---CCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999996432 11111111 11 010000000 000 11246677888886 9999998 9999998
Q ss_pred Hhh
Q 047954 544 LEI 546 (582)
Q Consensus 544 L~~ 546 (582)
.+.
T Consensus 297 ~~~ 299 (364)
T cd05599 297 PFF 299 (364)
T ss_pred CCc
Confidence 764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=315.68 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=197.9
Q ss_pred ccccccccCceEEEEEEEcC------CceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEE
Q 047954 272 PAEGLGKGIFGNSYKALLEG------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 343 (582)
..+.||+|+||.||++...+ ...+|+|.+.... ......+.+|+.++.++ +|+||+++++++...+..+++|
T Consensus 16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~ 95 (293)
T cd05053 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV 95 (293)
T ss_pred EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEE
Confidence 34689999999999998643 3578999886432 23345688999999999 8999999999999999999999
Q ss_pred EeCCCCChHHHHhcCCCC----------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC
Q 047954 344 KFAGNGNLFNRIHGGKSS----------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN 413 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~ 413 (582)
||+++|+|.++++..... .....+++..++.++.|++.||+|||+.+ |+||||||+|||++++
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK-------CIHRDLAARNVLVTED 168 (293)
T ss_pred EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-------ccccccceeeEEEcCC
Confidence 999999999999753210 12235889999999999999999999988 9999999999999999
Q ss_pred CceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchH
Q 047954 414 EMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLC 486 (582)
Q Consensus 414 ~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~ 486 (582)
+.+||+|||+++.+.... ...++..|+|||++.+..++.++|||||||++|||++ |..||.... ..++.
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~~~ 244 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----VEELF 244 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC----HHHHH
Confidence 999999999998764322 1223467999999988899999999999999999998 988885321 11121
Q ss_pred HHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 487 SWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 487 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
. .......... .......+.+++.+||..+|++|||+.|++++|+.+.
T Consensus 245 ~----~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 K----LLKEGYRMEK----------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H----HHHcCCcCCC----------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 1111111110 0111236889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=314.64 Aligned_cols=252 Identities=23% Similarity=0.400 Sum_probs=197.3
Q ss_pred cccccccCceEEEEEEEc------CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|... +...+++|.+.... ....+.+.+|+.++++++||||+++++.+...+..++++||
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence 467999999999999853 22468888876433 23346788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCC------------------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCC
Q 047954 346 AGNGNLFNRIHGGKSS------------------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTN 407 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~N 407 (582)
+.+|+|.+++...... .....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------ivH~dikp~n 157 (290)
T cd05045 85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK-------LVHRDLAARN 157 (290)
T ss_pred cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC-------eehhhhhhhe
Confidence 9999999998753211 11235788999999999999999999988 9999999999
Q ss_pred eeecCCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 047954 408 ILLDDNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGI 480 (582)
Q Consensus 408 ILl~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~ 480 (582)
||+++++.+||+|||+++...... ...++..|+|||+..+..++.++||||||+++|||+| |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 999999999999999987653221 1223467999999988889999999999999999999 999985421
Q ss_pred CccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 481 NGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
...+.+. ......... ......++.+++.+||+.+|++||++.++++.|+.+..
T Consensus 235 -~~~~~~~----~~~~~~~~~----------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 -PERLFNL----LKTGYRMER----------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -HHHHHHH----HhCCCCCCC----------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1222222 121111110 01112367889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.76 Aligned_cols=238 Identities=26% Similarity=0.410 Sum_probs=189.3
Q ss_pred ccccccCceEEEEEEEcCCc-----------eEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEE
Q 047954 274 EGLGKGIFGNSYKALLEGRA-----------PVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLV 342 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 342 (582)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999976543 4677776543332 6788999999999999999999999988 778999
Q ss_pred EEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC-------c
Q 047954 343 YKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE-------M 415 (582)
Q Consensus 343 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~-------~ 415 (582)
|||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 79 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~-------i~H~dlkp~Nill~~~~~~~~~~~~ 146 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDKK-------LVHGNVCGKNILVARYGLNEGYVPF 146 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCC-------eecccCccceEEEecCccccCCcee
Confidence 999999999999975432 4788889999999999999999988 99999999999999887 7
Q ss_pred eEEeeccccccccCcccccccccccCCCCCCCC--CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHH
Q 047954 416 VLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSK--KISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRA 492 (582)
Q Consensus 416 ~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~~--~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 492 (582)
+||+|||++..........+...|+|||++.+. .++.++|||||||++|||++ |..||..... .....+.
T Consensus 147 ~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~----~~~~~~~--- 219 (259)
T cd05037 147 IKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS----SEKERFY--- 219 (259)
T ss_pred EEeCCCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc----hhHHHHH---
Confidence 999999999876654444566789999998876 78999999999999999999 5777754321 1111111
Q ss_pred HhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 493 VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 493 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
... .....+ ....+.+++.+||..+|++|||+.+|++.|.
T Consensus 220 -~~~--~~~~~~----------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 -QDQ--HRLPMP----------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -hcC--CCCCCC----------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 110 000000 0146889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=311.89 Aligned_cols=246 Identities=20% Similarity=0.348 Sum_probs=191.1
Q ss_pred cccccccCceEEEEEEEc-CCc----eEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRA----PVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|.+. ++. .+++|.+.... .....++..|+..+++++||||+++++++. ....++++||+
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~ 90 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLS 90 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeC
Confidence 467999999999999864 333 37777775332 223456788888999999999999999875 44578999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 91 ~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~-------iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 91 PLGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEEHR-------MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred CCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCC-------EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 9999999997533 24889999999999999999999988 99999999999999999999999999976
Q ss_pred ccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 427 VAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 427 ~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
..... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.... ...+.+.+ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~----~~~~~~~~----~~~~~~ 230 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR----PHEVPDLL----EKGERL 230 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHH----HCCCcC
Confidence 53321 1234567999999988899999999999999999998 999986432 11122211 111111
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
..+. .....+.+++.+||..+|++|||+.|+++.|..+..
T Consensus 231 --~~~~--------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 --AQPQ--------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred --CCCC--------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0110 011246778899999999999999999999987663
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=316.16 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=196.7
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05605 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCC
Confidence 57999999999999864 67889999986432 122345778999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 86 ~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~-------ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 86 DLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRER-------IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred cHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHHCC-------cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99988864322 24888999999999999999999998 99999999999999999999999999987643
Q ss_pred cc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 430 PI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 ~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.. ...++..|+|||++.+..++.++||||+||++|||++|+.||..... ......+...+... ... .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~----~~~~~~~~~~~~~~-~~~-~---- 224 (285)
T cd05605 155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE----KVKREEVERRVKED-QEE-Y---- 224 (285)
T ss_pred CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch----hhHHHHHHHHhhhc-ccc-c----
Confidence 32 23467889999999888899999999999999999999999964321 11111121111111 000 0
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhhcc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEIIK 548 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~i~ 548 (582)
.......+.+++.+||+.||++|| ++++++.+.+...
T Consensus 225 -----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 225 -----SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred -----CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 011223577899999999999999 8889988866543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.43 Aligned_cols=243 Identities=25% Similarity=0.376 Sum_probs=193.9
Q ss_pred ccccccCceEEEEEEEcC----CceEEEEEecCCCc-chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLEG----RAPVVVKRLRDLKP-LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|.+.. ...+|+|.+..... ...+.+.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 369999999999998533 25799999875433 34567899999999999999999999876 4567999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++...
T Consensus 80 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~~-------i~H~di~p~nili~~~~~~kl~df~~~~~~~ 146 (257)
T cd05060 80 GPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESKH-------FVHRDLAARNVLLVNRHQAKISDFGMSRALG 146 (257)
T ss_pred CcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhcC-------eeccCcccceEEEcCCCcEEeccccccceee
Confidence 99999997542 4789999999999999999999988 9999999999999999999999999998664
Q ss_pred Cccc-------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 429 QPIA-------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 429 ~~~~-------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
.... ..++..|+|||...+..++.++|||||||++|||++ |+.||... ...++..++. ......
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~----~~~~~~~~~~----~~~~~~ 218 (257)
T cd05060 147 AGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM----KGAEVIAMLE----SGERLP 218 (257)
T ss_pred cCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC----CHHHHHHHHH----cCCcCC
Confidence 3321 112356999999998899999999999999999998 99998642 2222333222 111111
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.. ......+.+++.+||..+|++||++.++++.|+.+.
T Consensus 219 ~~----------~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 RP----------EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CC----------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 10 111236789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=319.31 Aligned_cols=240 Identities=23% Similarity=0.301 Sum_probs=188.4
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhc-CCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIAD-QKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|... ++..||+|.++... ....+.+..|..++.. .+||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999965 57789999986421 2234556677777765 4999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-------ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 81 GDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSKG-------IIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 99999886432 4788889999999999999999998 9999999999999999999999999987532
Q ss_pred C----cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 Q----PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~----~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
. .....++..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+.+ .... ....
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~----~~~~~~~~----~~~~-~~~~-- 216 (316)
T cd05620 148 FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD----EDELFESI----RVDT-PHYP-- 216 (316)
T ss_pred cCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHH----HhCC-CCCC--
Confidence 1 123347889999999999999999999999999999999999996422 11122111 1110 0000
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChH-HHHHHHh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMA-EVVSELE 545 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~L~ 545 (582)
. ....++.+++.+||+.||++||++. ++++|.+
T Consensus 217 -----~---~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~ 250 (316)
T cd05620 217 -----R---WITKESKDILEKLFERDPTRRLGVVGNIRGHPF 250 (316)
T ss_pred -----C---CCCHHHHHHHHHHccCCHHHcCCChHHHHcCCC
Confidence 0 0112567889999999999999985 6766654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=313.53 Aligned_cols=249 Identities=22% Similarity=0.389 Sum_probs=196.8
Q ss_pred cccccccccCceEEEEEEEc------CCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEE
Q 047954 271 APAEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLV 342 (582)
Q Consensus 271 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 342 (582)
...+.||+|+||.||+|... .+..||+|+++... ....+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 117 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVI 117 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEE
Confidence 34678999999999999742 23478999886543 23346789999999999 899999999999999999999
Q ss_pred EEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecc
Q 047954 343 YKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG 422 (582)
Q Consensus 343 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 422 (582)
|||+++|+|.++++.... ..+++.+++.++.|++.||+|||+.+ |+|+||||+|||++.++.+|++|||
T Consensus 118 ~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~-------ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 118 TEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASKN-------CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999975432 13789999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCccc------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhh
Q 047954 423 FSSLVAQPIA------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVRE 495 (582)
Q Consensus 423 ~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 495 (582)
+++.+..... ..++..|+|||.+.+..++.++|||||||++|||+| |+.||..... ...+ ......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~---~~~~----~~~~~~ 259 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV---DSKF----YKLIKE 259 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc---hHHH----HHHHHc
Confidence 9986543221 123467999999988889999999999999999998 9999864321 1111 111111
Q ss_pred cccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 496 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.+.... ......++.+++.+||..+|++|||+.|+++.|++.
T Consensus 260 ~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 GYRMAQ----------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCcCCC----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111110 001123688899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=307.57 Aligned_cols=244 Identities=26% Similarity=0.434 Sum_probs=194.5
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..||+|+++... ...+.+.+|+.++++++||||+++++++. ....++||||+++|+|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (262)
T cd05071 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (262)
T ss_pred eeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHH
Confidence 46799999999999998877789999987533 23567899999999999999999999874 45679999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCccc
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA 432 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~~ 432 (582)
+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.++.+.....
T Consensus 89 ~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~-------i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 89 DFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERMN-------YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred HHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHCC-------ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99975322 24788999999999999999999988 99999999999999999999999999976643321
Q ss_pred -----ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 433 -----AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 433 -----~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
..++..|+|||+..+..++.++||||||+++|||+| |+.||.... ..... ..........
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~----~~~~~----~~~~~~~~~~------ 223 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVL----DQVERGYRMP------ 223 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----hHHHH----HHHhcCCCCC------
Confidence 223457999999988889999999999999999999 888885422 11111 1111111000
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
...+....+.+++.+|++.+|++||++.++++.|+..
T Consensus 224 ----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0112234678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=329.32 Aligned_cols=246 Identities=19% Similarity=0.250 Sum_probs=189.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||+||+|+.. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 367999999999999854 56789999986432 23345788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 g~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~g-------ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 86 GDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKMG-------FIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 99999987532 4778888899999999999999998 9999999999999999999999999975431
Q ss_pred Cc---------------------------------------------------ccccccccccCCCCCCCCCCCcchhHH
Q 047954 429 QP---------------------------------------------------IAAQRMISYKSPEYQSSKKISRKSDVW 457 (582)
Q Consensus 429 ~~---------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~k~DVw 457 (582)
.. ....||..|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 00 112477889999999988999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHH--cccCCCCCCC
Q 047954 458 SFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQ--CCNKSPEKRP 535 (582)
Q Consensus 458 S~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~--Cl~~dP~~RP 535 (582)
||||++|||+||+.||..... ..... ..........+. . ... ...++.+++.+ |+..+|..||
T Consensus 233 SlG~il~elltG~~Pf~~~~~----~~~~~---~i~~~~~~~~~~-~----~~~---~s~~~~dli~~ll~~~~~~~~R~ 297 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPTP----TETQL---KVINWENTLHIP-P----QVK---LSPEAVDLITKLCCSAEERLGRN 297 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCCH----HHHHH---HHHccccccCCC-C----CCC---CCHHHHHHHHHHccCcccccCCC
Confidence 999999999999999964321 11111 111100000000 0 000 11245566666 6666777799
Q ss_pred ChHHHHHHHhh
Q 047954 536 EMAEVVSELEI 546 (582)
Q Consensus 536 s~~evl~~L~~ 546 (582)
++.|++.|.+.
T Consensus 298 ~~~~~l~hp~f 308 (381)
T cd05626 298 GADDIKAHPFF 308 (381)
T ss_pred CHHHHhcCccc
Confidence 99999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=307.32 Aligned_cols=243 Identities=27% Similarity=0.465 Sum_probs=194.4
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..++||||+++|+|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL 88 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence 35799999999999998887789999886433 34567899999999999999999999875 45688999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
++++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++......
T Consensus 89 ~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~-------i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 89 DFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERMN-------YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred HHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99975432 24788999999999999999999987 9999999999999999999999999997664322
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
...++..|+|||+..+..++.++|||||||++|||+| |+.||.... ..+...++ ........
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~~~----~~~~~~~~----- 224 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV----NREVLEQV----ERGYRMPC----- 224 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHH----HcCCCCCC-----
Confidence 1224467999999988889999999999999999999 899986432 11122211 11111110
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.......+.+++.+||..||++||++++|++.|+.
T Consensus 225 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 -----PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -----CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11123367889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=321.51 Aligned_cols=240 Identities=23% Similarity=0.305 Sum_probs=187.0
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHH-HHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLL-VIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||+||+|... +++.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999965 67889999986421 122234445544 56789999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~g-------ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 81 GELFFHLQRER------SFPEPRARFYAAEIASALGYLHSLN-------IIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 99999886432 4788889999999999999999998 9999999999999999999999999987542
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.. ....+++.|+|||++.+..++.++|||||||++|||++|+.||.... ..++ ........ . . ..+
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~~~~---~~~i~~~~-~-~-~~~ 217 (323)
T cd05575 148 EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----TAEM---YDNILNKP-L-R-LKP 217 (323)
T ss_pred cCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC----HHHH---HHHHHcCC-C-C-CCC
Confidence 21 22346789999999999999999999999999999999999996421 1111 11111111 0 0 001
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh----HHHHHHHh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM----AEVVSELE 545 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~~L~ 545 (582)
. ....+.+++.+||+.||++||++ .|++++.+
T Consensus 218 ~---------~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~ 253 (323)
T cd05575 218 N---------ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF 253 (323)
T ss_pred C---------CCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCC
Confidence 0 12257789999999999999998 47776654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=319.97 Aligned_cols=241 Identities=24% Similarity=0.321 Sum_probs=192.1
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||+||+|... ++..||+|.++.. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 4678999998643 223345677888888877 799999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~-------ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 81 GDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHERG-------IIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 99999886432 4889999999999999999999998 9999999999999999999999999986532
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ .... . . +.
T Consensus 148 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~----~~~~~~~i---~~~~-~-~-~~- 216 (318)
T cd05570 148 LGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD----EDELFQSI---LEDE-V-R-YP- 216 (318)
T ss_pred cCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC----HHHHHHHH---HcCC-C-C-CC-
Confidence 11 12346788999999999999999999999999999999999996422 11111111 1111 0 0 00
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh-----HHHHHHHhh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM-----AEVVSELEI 546 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~L~~ 546 (582)
......+.+++.+||+.||++||++ .+++++.+.
T Consensus 217 --------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~ 255 (318)
T cd05570 217 --------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255 (318)
T ss_pred --------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCc
Confidence 0112357789999999999999999 999888654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=306.95 Aligned_cols=247 Identities=28% Similarity=0.483 Sum_probs=198.6
Q ss_pred ccccccCceEEEEEEEcC----CceEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLEG----RAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|.... +..|++|.++..... ..+.+.+|++.+.+++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999999764 778999998754433 367889999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCC---CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 349 GNLFNRIHGGKSS---KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 349 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
++|.+++...... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.+.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-------i~H~di~p~nili~~~~~~~l~dfg~~~ 153 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-------FVHRDLAARNCLVGEDLVVKISDFGLSR 153 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC-------cccCccCcceEEECCCCcEEEccccccc
Confidence 9999999764210 00135899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 426 LVAQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 426 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
..... ....++..|+|||.+....++.++||||+||++|||++ |..||... ....+.+.+. ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~~~~~----~~~~ 225 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL----SNEEVLEYLR----KGYR 225 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHH----cCCC
Confidence 76543 22335678999999988889999999999999999999 69998643 1122222221 1111
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
... ......++.+++.+||..+|++|||+.|++++|+
T Consensus 226 ~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 LPK----------PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCC----------CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 110 0111236889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=309.54 Aligned_cols=245 Identities=21% Similarity=0.410 Sum_probs=195.2
Q ss_pred cccccccCceEEEEEEEcC-C---ceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-R---APVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|.... + ..+++|.++.. .....+.+..|++++++++|+||+++++++...+..++||||++
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME 89 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence 4679999999999998653 2 36889988643 23345678999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 90 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~~-------i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 90 NGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSDMN-------YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999987532 24788999999999999999999988 999999999999999999999999998766
Q ss_pred cCcccc-------cccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 428 AQPIAA-------QRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 428 ~~~~~~-------~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
...... ..+..|+|||++....++.++|||||||++|||++ |+.||.... ..++...+ ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~----~~~~~~~i----~~~~~~ 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS----NHEVMKAI----NDGFRL 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC----HHHHHHHH----hcCCCC
Confidence 432111 12346999999988889999999999999999998 999985422 11222222 111100
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
. ...+...++.+++.+||+.+|++||++.+|++.|.++
T Consensus 230 ~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 P----------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0011223678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=325.39 Aligned_cols=239 Identities=22% Similarity=0.347 Sum_probs=192.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
..+||+|+||+|+++... +++.+|||.+++.. .+..+....|.+++... +||.++.++..|++.++.|+||||+.
T Consensus 373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~ 452 (694)
T KOG0694|consen 373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA 452 (694)
T ss_pred EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence 468999999999999965 56789999998643 34556677788777666 69999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
|||+..+++.. .+++..+..+|..|+.||+|||+++ ||+||||.+|||||.+|.+||+|||+++..
T Consensus 453 Ggdm~~~~~~~-------~F~e~rarfyaAev~l~L~fLH~~~-------IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 453 GGDLMHHIHTD-------VFSEPRARFYAAEVVLGLQFLHENG-------IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred CCcEEEEEecc-------cccHHHHHHHHHHHHHHHHHHHhcC-------ceeeecchhheEEcccCcEEeccccccccc
Confidence 99966555432 4889999999999999999999998 999999999999999999999999999865
Q ss_pred c----CcccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 A----QPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~----~~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
. ......||+.|||||++.+..|+..+|.|||||+||||+.|..||... +..++.+.+. .++ ..
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd----dEee~FdsI~---~d~----~~- 586 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD----DEEEVFDSIV---NDE----VR- 586 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHh---cCC----CC-
Confidence 3 223455889999999999999999999999999999999999999643 2233333221 111 11
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh-----HHHHHHH
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM-----AEVVSEL 544 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~L 544 (582)
.+.-...+.+.|+.+.+.++|++|--+ .+|.+|.
T Consensus 587 -------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hp 625 (694)
T KOG0694|consen 587 -------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHP 625 (694)
T ss_pred -------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCC
Confidence 111223367788889999999999765 5565554
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.83 Aligned_cols=245 Identities=20% Similarity=0.292 Sum_probs=196.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||||+++.. .......+..|+.++..++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence 367999999999999965 6788999998643 223456788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g-------iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 86 GDLMNLLIRK------DVFPEETARFYIAELVLALDSVHKLG-------FIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 9999999754 24788899999999999999999988 9999999999999999999999999997654
Q ss_pred Ccc---------------------------------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 047954 429 QPI---------------------------------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHS 475 (582)
Q Consensus 429 ~~~---------------------------------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~ 475 (582)
... ...++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 332 23467889999999999999999999999999999999999964
Q ss_pred CCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCC-hHHHHHHHhh
Q 047954 476 APQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE-MAEVVSELEI 546 (582)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~~ 546 (582)
... . ........ +.....-+. .. ....++.+++.+|+. ||++||+ ++++++|.+.
T Consensus 233 ~~~----~---~~~~~i~~--~~~~~~~p~---~~---~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~ 288 (350)
T cd05573 233 DTL----Q---ETYNKIIN--WKESLRFPP---DP---PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288 (350)
T ss_pred CCH----H---HHHHHHhc--cCCcccCCC---CC---CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence 321 1 11111111 000000000 00 012357788889997 9999999 9999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=305.56 Aligned_cols=243 Identities=26% Similarity=0.400 Sum_probs=195.4
Q ss_pred ccccccCceEEEEEEEcC--C--ceEEEEEecCCCc-chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLEG--R--APVVVKRLRDLKP-LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|++|.||+|.+.. + ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 2 3589999876554 556789999999999999999999999988 888999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++..... ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+.
T Consensus 80 ~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~-------i~H~di~p~nil~~~~~~~kl~dfg~~~~~~ 148 (257)
T cd05040 80 GSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESKR-------FIHRDLAARNILLASDDKVKIGDFGLMRALP 148 (257)
T ss_pred CcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhCC-------ccccccCcccEEEecCCEEEecccccccccc
Confidence 999999976432 25889999999999999999999998 9999999999999999999999999998764
Q ss_pred Ccc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 429 QPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 429 ~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
... ...++..|+|||++.+..++.++|||||||++|||+| |+.||... ...++...+.. ......
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~~~~~~~~~~---~~~~~~ 221 (257)
T cd05040 149 QNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL----SGSQILKKIDK---EGERLE 221 (257)
T ss_pred ccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHh---cCCcCC
Confidence 421 1234568999999988899999999999999999999 99998532 12222222211 110000
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
. .......+.+++.+||+.+|++||++.++++.|.
T Consensus 222 --~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 --R--------PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --C--------CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 0111236888999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=307.29 Aligned_cols=243 Identities=25% Similarity=0.445 Sum_probs=195.5
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..+++|||+++++|.
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLV 88 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHH
Confidence 46799999999999998888999999987543 34567899999999999999999999874 55789999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 89 ~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~-------i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 89 DFLKTPEG----IKLTINKLIDMAAQIAEGMAFIERKN-------YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred HHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCC-------eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99865432 25788999999999999999999988 9999999999999999999999999997665221
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
...++..|+|||++....++.++||||||+++|||++ |+.||.... ..++...+ .........+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~----~~~~~~~~~~--- 226 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT----NPEVIQNL----ERGYRMPRPD--- 226 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC----hHHHHHHH----HcCCCCCCCC---
Confidence 1223467999999988889999999999999999999 999996432 11222221 1111111100
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
....++.+++.+||..+|++||+++++++.|+.
T Consensus 227 -------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 -------NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -------CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 112368889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.17 Aligned_cols=194 Identities=25% Similarity=0.482 Sum_probs=158.5
Q ss_pred cccccccCceEEEEEEEc---CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEe--CCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE---GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS--NDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~ 347 (582)
+.+||+|+||.||+|... ++..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999864 45789999986432 34557889999999999999999998865 346789999985
Q ss_pred CCChHHHHhcCCCC---CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee----cCCCceEEee
Q 047954 348 NGNLFNRIHGGKSS---KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL----DDNEMVLVSD 420 (582)
Q Consensus 348 ~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl----~~~~~~kl~D 420 (582)
++|.+++...... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-------VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-------EEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 5888887543221 11235788889999999999999999998 9999999999999 4567899999
Q ss_pred ccccccccCcc-------cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 047954 421 YGFSSLVAQPI-------AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSA 476 (582)
Q Consensus 421 fG~a~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~ 476 (582)
||+++...... ...+++.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99998764321 2345788999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=310.62 Aligned_cols=248 Identities=23% Similarity=0.394 Sum_probs=195.0
Q ss_pred cccccccCceEEEEEEEc-CCc----eEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRA----PVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|.+. ++. .||+|.++.. .....+.+.+|+.++..+.||||+++++++... ..++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~ 90 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLM 90 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcC
Confidence 367999999999999853 343 4789988643 333456788999999999999999999999754 578999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|.++++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 91 ~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~-------iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 91 PYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLEEVR-------LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred CCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC-------eeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999975432 4788999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccc------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 427 VAQPIA------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 427 ~~~~~~------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
+..... ...+..|+|||...+..++.++|||||||++|||+| |..||.... ...+..++. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~~~~----~~~~~ 230 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP----AREIPDLLE----KGERL 230 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHH----CCCcC
Confidence 643221 123467999999988899999999999999999998 899985421 122222221 11110
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
.. ......++.+++.+||+.||++||++.+++..|+.+....
T Consensus 231 ~~----------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 PQ----------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 00 0112236788999999999999999999999998776544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.05 Aligned_cols=243 Identities=25% Similarity=0.418 Sum_probs=193.4
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEe-CCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS-NDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||++... +..|++|.++.. ...+.+.+|+.++++++|+|++++++++.. ....++||||+++++|
T Consensus 11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 87 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87 (256)
T ss_pred eeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence 467999999999999876 566899988643 235678999999999999999999997654 4568999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 88 ~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 88 VDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEANN-------FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred HHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999875432 24788999999999999999999988 9999999999999999999999999987654322
Q ss_pred -cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhh
Q 047954 432 -AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQ 509 (582)
Q Consensus 432 -~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 509 (582)
....+..|+|||+..+..++.++|||||||++|||++ |+.||... ...++...+ ..++.....+
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~----~~~~~~~~~----~~~~~~~~~~------ 222 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRV----EKGYKMDAPD------ 222 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHH----hcCCCCCCCC------
Confidence 2234467999999988889999999999999999998 99998532 111222222 1221111111
Q ss_pred hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 510 RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 510 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.....+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 223 ----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 223 ----GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1123678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=311.80 Aligned_cols=246 Identities=20% Similarity=0.328 Sum_probs=193.2
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
...||+|+||.||+|+. .++..||+|++..........+.+|+.++.+++||||+++++++...+..++||||+++++|
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L 93 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL 93 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcH
Confidence 46799999999999996 56788999998755444556788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.++++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 94 ~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 94 QDIYHVTG------PLSELQIAYVCRETLQGLAYLHSKG-------KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99986432 4788899999999999999999988 999999999999999999999999999766432
Q ss_pred ---ccccccccccCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 431 ---IAAQRMISYKSPEYQS---SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~---~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
....++..|+|||.+. ...++.++|||||||++|||++|+.||........ .. ......... +
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---~~----~~~~~~~~~----~ 229 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LF----LMSKSNFQP----P 229 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---he----eeecCCCCC----C
Confidence 2234567899999874 34578899999999999999999999854321100 00 000000000 0
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
... ........+.+++.+||..+|++||++++++++|+
T Consensus 230 ~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 230 KLK---DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCc---cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000 00111236788999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=297.42 Aligned_cols=247 Identities=20% Similarity=0.285 Sum_probs=197.9
Q ss_pred cccccccCceEEEEEE-EcCCceEEEEEecC--CCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKAL-LEGRAPVVVKRLRD--LKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|.|+.||++. ...|+.+|+|.+.. ......+++.+|+++-+.++|||||++...+.+....|+|+|+|.|+
T Consensus 16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~ 95 (355)
T KOG0033|consen 16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 95 (355)
T ss_pred HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccch
Confidence 4679999999999987 45678888887742 33446788999999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC---CceEEeecccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN---EMVLVSDYGFSSL 426 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DfG~a~~ 426 (582)
+|..-+-.+ ..+++...-.+++||++||.|+|.++ |||||+||+|+|+... --+||+|||+|..
T Consensus 96 dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n~-------IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 96 ELFEDIVAR------EFYSEADASHCIQQILEALAYCHSNG-------IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred HHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhcC-------ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 997766432 35788888899999999999999998 9999999999999643 3489999999998
Q ss_pred ccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 427 VAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 427 ~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
+.... ...||++|||||++...+|+..+|||+.|||||-|+.|..||.+. +...+.+.+... .+ ++..
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~----~~~rlye~I~~g---~y--d~~~ 233 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQHRLYEQIKAG---AY--DYPS 233 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc----cHHHHHHHHhcc---cc--CCCC
Confidence 87543 345789999999999999999999999999999999999999642 222333333221 11 0100
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+ ..+....+..+|+.+||..||.+|.|+.|.++|.|-.
T Consensus 234 ~------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 234 P------EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred c------ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 0 1111122567888899999999999999999998844
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=309.34 Aligned_cols=245 Identities=23% Similarity=0.423 Sum_probs=195.2
Q ss_pred cccccccCceEEEEEEEcC-C---ceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-R---APVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|.... + ..||||.+... .....+.|..|+.++++++||||+++++++......++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence 4679999999999998653 2 35999998653 33345689999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++..... .+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+
T Consensus 89 ~~~L~~~l~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~g-------~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 89 NGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLSEMN-------YVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CCcHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC-------EeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999875422 4788999999999999999999988 999999999999999999999999998765
Q ss_pred cCcccc---------cccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 428 AQPIAA---------QRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 428 ~~~~~~---------~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
...... ..+..|+|||++.+..++.++|||||||++|||++ |..||... ...++..++. ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~----~~~~~~~~i~----~~~ 228 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----SNQDVINAIE----QDY 228 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC----CHHHHHHHHH----cCC
Confidence 432111 11246999999998899999999999999999987 99998542 1222222221 111
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.... ..+....+.+++.+||+.+|++||++.+|+..|+.+
T Consensus 229 ~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 RLPP----------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCC----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1000 011223577899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=310.66 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=199.2
Q ss_pred cccccccCceEEEEEEEcC-----CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEe-CCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEG-----RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFS-NDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|.... +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ....++++||
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~ 90 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY 90 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence 4679999999999999765 6789999886442 3345678899999999999999999998876 4678999999
Q ss_pred CCCCChHHHHhcCCCC--CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 346 AGNGNLFNRIHGGKSS--KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
+++|+|.+++...... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG-------VIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-------EeecccCHhhEEEcCCCcEEECCCCC
Confidence 9999999998654321 01235889999999999999999999988 99999999999999999999999999
Q ss_pred cccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 424 SSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 424 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
++.+.... ...++..|+|||++.+..++.++|||||||++||+++ |+.||... ...++..++. ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~~~~~~~~~----~~ 235 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI----DPFEMAAYLK----DG 235 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC----CHHHHHHHHH----cC
Confidence 98653321 1234567999999988889999999999999999999 99999642 1222222221 11
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
..... ......++.+++.+||..||++|||+.++++.|+.+..
T Consensus 236 ~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 YRLAQ----------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCC----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11000 00112357889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=328.33 Aligned_cols=246 Identities=22% Similarity=0.364 Sum_probs=201.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEE--EecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCe--eEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVK--RLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE--KLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK--~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~--~~lv~e~ 345 (582)
.++||+|+|-+||||... +|..||=- ++++. .+...+.|..|+.+|+.|+|||||++|.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 357999999999999965 35555521 22222 23445889999999999999999999999998765 6789999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC-CCceEEeecccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD-NEMVLVSDYGFS 424 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfG~a 424 (582)
+..|+|+.|+++.+ .++......|++||++||.|||++.| ||||||||.+||+|+. .|.+||+|+|+|
T Consensus 125 ~TSGtLr~Y~kk~~------~vn~kaik~W~RQILkGL~yLHs~~P-----PIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR------RVNIKAIKSWCRQILKGLVYLHSQDP-----PIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred ccCCcHHHHHHHhc------cCCHHHHHHHHHHHHHHhhhhhcCCC-----CccccccccceEEEcCCcCceeecchhHH
Confidence 99999999998654 36778899999999999999999974 6999999999999985 578999999999
Q ss_pred ccccCccc--ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 425 SLVAQPIA--AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 425 ~~~~~~~~--~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
+.+..... .-||+.|||||+.. ..|++.+||||||+.|+||+|+.+||.... +...+++.|..+++..-+..+-
T Consensus 194 tl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~---n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 194 TLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT---NPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred HHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC---CHHHHHHHHHcCCCHHHhhccC
Confidence 98866543 45999999999887 789999999999999999999999997543 4556666666665555555555
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
|+ ++.++|.+|+.. .++|||+.|+|.+-..-
T Consensus 270 dP-------------evr~fIekCl~~-~~~R~sa~eLL~d~Ff~ 300 (632)
T KOG0584|consen 270 DP-------------EVREFIEKCLAT-KSERLSAKELLKDPFFD 300 (632)
T ss_pred CH-------------HHHHHHHHHhcC-chhccCHHHHhhChhhc
Confidence 54 577899999999 99999999999886543
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=307.96 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=187.1
Q ss_pred cccccCceEEEEEEEcC---CceEEEEEecCCCc-chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 275 GLGKGIFGNSYKALLEG---RAPVVVKRLRDLKP-LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998654 34689998865432 334578899999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.++++..... .....++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~-------i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 82 LKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKNN-------FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred HHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCC-------EeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 99999754321 1234667788889999999999999998 999999999999999999999999998754332
Q ss_pred c------cccccccccCCCCCCCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 431 I------AAQRMISYKSPEYQSSK-------KISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 431 ~------~~~~~~~y~aPE~~~~~-------~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
. ...++..|+|||++... .++.++|||||||++|||++ |+.||.... ..+....... .
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~----~~~~~~~~~~----~ 225 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS----DEQVLTYTVR----E 225 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC----hHHHHHHHhh----c
Confidence 1 12245679999987532 35789999999999999996 999996432 1111111111 1
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
......++.... .....+.+++..|| .+|++|||++||+..|+
T Consensus 226 ~~~~~~~~~~~~-----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 QQLKLPKPRLKL-----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCCCCccCC-----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111111110 11124667888999 68999999999998775
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.14 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=196.9
Q ss_pred cccccccCceEEEEEEEc-CCc--eEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRA--PVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|... ++. .+++|.++... ....+.+.+|++++.++ +|+||+++++++...+..++||||++
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 467999999999999864 343 45777765432 33456788999999999 89999999999999999999999999
Q ss_pred CCChHHHHhcCCCCC----------CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceE
Q 047954 348 NGNLFNRIHGGKSSK----------NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL 417 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~k 417 (582)
+|+|.++++...... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-------i~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-------FIHRDLAARNILVGENYVAK 164 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC-------ccccccchheEEecCCCcEE
Confidence 999999997543210 1225788999999999999999999988 99999999999999999999
Q ss_pred EeeccccccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHH
Q 047954 418 VSDYGFSSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 418 l~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
|+|||+++..... .....+..|+|||++.+..++.++|||||||++|||+| |..||.... ..+.... .
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~~~~~~----~ 236 (303)
T cd05088 165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAELYEK----L 236 (303)
T ss_pred eCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC----hHHHHHH----H
Confidence 9999998643211 11122457999999988889999999999999999998 999985322 1112111 1
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
......+.. ......+.+++.+||+.+|++||++.+++.+|+.+.....
T Consensus 237 ~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 237 PQGYRLEKP----------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred hcCCcCCCC----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 111111100 0112257889999999999999999999999998765554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=327.51 Aligned_cols=245 Identities=20% Similarity=0.288 Sum_probs=189.9
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||++.. .+++.||||++... .....+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 36799999999999985 46788999998542 122345688899999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 g~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~g-------ivHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 86 GDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKLG-------FIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999986432 4778888899999999999999998 9999999999999999999999999986321
Q ss_pred Cc---------------------------------------------------ccccccccccCCCCCCCCCCCcchhHH
Q 047954 429 QP---------------------------------------------------IAAQRMISYKSPEYQSSKKISRKSDVW 457 (582)
Q Consensus 429 ~~---------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~k~DVw 457 (582)
.. ....+|+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 10 012477889999999988999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCC---
Q 047954 458 SFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKR--- 534 (582)
Q Consensus 458 S~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R--- 534 (582)
||||++|||+||+.||.... ..+... .... +...+.-+. ......++.+++.+|+. +|.+|
T Consensus 233 SlGvil~elltG~~Pf~~~~----~~~~~~---~i~~--~~~~~~~p~------~~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSEN----SHETYR---KIIN--WRETLYFPD------DIHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred ecchhhhhhhcCCCCCCCCC----HHHHHH---HHHc--cCCccCCCC------CCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 99999999999999996432 111111 1111 000000000 00111256788889997 66665
Q ss_pred CChHHHHHHHhh
Q 047954 535 PEMAEVVSELEI 546 (582)
Q Consensus 535 Ps~~evl~~L~~ 546 (582)
+++.|+++|.+.
T Consensus 297 ~~~~~~l~hp~~ 308 (377)
T cd05629 297 GGAHEIKSHPFF 308 (377)
T ss_pred CCHHHHhcCCCc
Confidence 699999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=324.90 Aligned_cols=190 Identities=18% Similarity=0.307 Sum_probs=165.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||+||+|... +++.||+|+++... ......+..|+.++.+++|+||+++++++.+....++||||+++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence 367999999999999865 57889999986422 22345678899999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g-------ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 86 GDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQLG-------FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999997532 4788999999999999999999998 9999999999999999999999999987543
Q ss_pred Cc---------------------------------------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhC
Q 047954 429 QP---------------------------------------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469 (582)
Q Consensus 429 ~~---------------------------------------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG 469 (582)
.. ....||..|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 21 112477889999999999999999999999999999999
Q ss_pred CCCCCC
Q 047954 470 RISTHS 475 (582)
Q Consensus 470 ~~P~~~ 475 (582)
+.||..
T Consensus 233 ~~Pf~~ 238 (363)
T cd05628 233 YPPFCS 238 (363)
T ss_pred CCCCCC
Confidence 999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.87 Aligned_cols=245 Identities=22% Similarity=0.294 Sum_probs=193.7
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCC--------eeEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND--------EKLL 341 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--------~~~l 341 (582)
.+.||+|+||+||+|+. .+++.||||++... .......+.+|+..+..++|+||+++++.+...+ ..++
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~l 116 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL 116 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEE
Confidence 46799999999999985 56889999998643 2334566889999999999999999988776432 3679
Q ss_pred EEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
||||+++|+|.+++...... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 117 V~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH~~~-------IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 117 VLDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVHSKH-------MIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred EEeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-------EecCCCCHHHEEEeCCCCEEEEec
Confidence 99999999999999754321 235888899999999999999999998 999999999999999999999999
Q ss_pred cccccccCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh
Q 047954 422 GFSSLVAQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE 495 (582)
Q Consensus 422 G~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 495 (582)
|+++.+... ....+++.|+|||++.+..++.++|||||||++|||++|+.||... .....+......
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-------~~~~~~~~~~~~ 260 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-------NMEEVMHKTLAG 260 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHhcC
Confidence 999765432 2234778899999999999999999999999999999999999632 122222222111
Q ss_pred cccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 496 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
. ...+ . .....++.+++.+||+.||++||++.+++++.
T Consensus 261 ~-~~~~-~---------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p 298 (496)
T PTZ00283 261 R-YDPL-P---------PSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298 (496)
T ss_pred C-CCCC-C---------CCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence 1 1110 0 11123578899999999999999999999874
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=302.49 Aligned_cols=257 Identities=19% Similarity=0.314 Sum_probs=194.7
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEec--CCCcchHHHHHHHHHHHhcCCCCCccccceEEEe-----CCeeEEEEEe
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS-----NDEKLLVYKF 345 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~~~lv~e~ 345 (582)
+.||+|+||.|..|.. .++..||||++. -......++-.+|+++|+.++|+||+.+++.+.. -...|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 5699999999999985 567899999997 3345566788899999999999999999999876 2468999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
| .-||...++.+. .++......+..||++||.|+|+.+ |+||||||+|+|++.+...||+|||+|+
T Consensus 108 M-etDL~~iik~~~------~L~d~H~q~f~YQiLrgLKyiHSAn-------ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 108 M-ETDLHQIIKSQQ------DLTDDHAQYFLYQILRGLKYIHSAN-------VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred H-hhHHHHHHHcCc------cccHHHHHHHHHHHHHhcchhhccc-------ccccccchhheeeccCCCEEecccccee
Confidence 9 459999997543 4788889999999999999999998 9999999999999999999999999999
Q ss_pred cccCc------ccccccccccCCCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh---
Q 047954 426 LVAQP------IAAQRMISYKSPEYQS-SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE--- 495 (582)
Q Consensus 426 ~~~~~------~~~~~~~~y~aPE~~~-~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--- 495 (582)
..... .....|..|+|||.+. ...|+...||||.|||+.||++|+.-|.+... .+..+.+...+..
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~----v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY----VHQLQLILELLGTPSE 249 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch----HHHHHHHHHhcCCCCH
Confidence 88532 2333567899999765 56899999999999999999999998864321 1111111111110
Q ss_pred ------------ccccccc-chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 496 ------------EWTAEIF-DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 496 ------------~~~~~~~-d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.+..... .+..+...-.+..-...++|+.+||..||.+|+|++|+++|.-...
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 0100000 0000000000112235778899999999999999999999975443
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.79 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=194.4
Q ss_pred ccccccccCceEEEEEEE------cCCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeC-CeeEEE
Q 047954 272 PAEGLGKGIFGNSYKALL------EGRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSN-DEKLLV 342 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~~~~lv 342 (582)
..+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... ...++|
T Consensus 11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (343)
T cd05103 11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (343)
T ss_pred ccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEE
Confidence 357899999999999973 346789999997533 22345688999999999 689999999988765 457899
Q ss_pred EEeCCCCChHHHHhcCCCCC------------------------------------------------------------
Q 047954 343 YKFAGNGNLFNRIHGGKSSK------------------------------------------------------------ 362 (582)
Q Consensus 343 ~e~~~~gsL~~~l~~~~~~~------------------------------------------------------------ 362 (582)
|||+++|+|.++++......
T Consensus 91 ~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (343)
T cd05103 91 VEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQED 170 (343)
T ss_pred EeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhh
Confidence 99999999999987532100
Q ss_pred -CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc------cccc
Q 047954 363 -NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI------AAQR 435 (582)
Q Consensus 363 -~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~------~~~~ 435 (582)
....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...+
T Consensus 171 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~-------i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 171 LYKKVLTLEDLICYSFQVAKGMEFLASRK-------CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhccCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 0123678888999999999999999998 9999999999999999999999999987653221 1223
Q ss_pred cccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHH
Q 047954 436 MISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAH 514 (582)
Q Consensus 436 ~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 514 (582)
+..|+|||.+.+..++.++||||||+++|||++ |..||..... ...+ .............. .
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~----~~~~~~~~~~~~~~----------~ 306 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DEEF----CRRLKEGTRMRAPD----------Y 306 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc---cHHH----HHHHhccCCCCCCC----------C
Confidence 457999999988899999999999999999997 8989854211 1111 11111111111000 0
Q ss_pred HHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 515 GMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 515 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
...++.+++.+||+.+|++|||+.||+++|+.+.+
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11257889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=325.81 Aligned_cols=245 Identities=19% Similarity=0.235 Sum_probs=192.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence 467999999999999865 5778999998532 222345578899999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 g~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~~-------ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 128 GDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSMG-------FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred CcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999998643 3667778889999999999999998 9999999999999999999999999997664
Q ss_pred Cc-----ccccccccccCCCCCCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 429 QP-----IAAQRMISYKSPEYQSSK----KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 429 ~~-----~~~~~~~~y~aPE~~~~~----~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
.. ....+++.|+|||++.+. .++.++|||||||++|||++|+.||..... .... ..........
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~---~~i~~~~~~~ 266 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTY---SKIMDHKNSL 266 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH----HHHH---HHHHcCCCcC
Confidence 32 123478899999988653 478999999999999999999999964321 1111 1111111000
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCC--CCChHHHHHHHhh
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEK--RPEMAEVVSELEI 546 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~~ 546 (582)
...+ ......++.+++.+|++.+|++ ||++.|+++|.+.
T Consensus 267 ~~~~--------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~ 307 (370)
T cd05596 267 TFPD--------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307 (370)
T ss_pred CCCC--------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence 0000 0011235778899999999988 9999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.51 Aligned_cols=247 Identities=19% Similarity=0.298 Sum_probs=192.6
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|... ++..||+|+++... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999865 56789999996432 22345678899998887 699999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~-------ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 81 GDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHERG-------IIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 99998886432 4889999999999999999999998 9999999999999999999999999987532
Q ss_pred C----cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 Q----PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~----~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
. .....++..|+|||++.+..++.++|||||||++|||+||+.||...... .......++......... .+ .
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~-~~-p- 223 (327)
T cd05617 148 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN-PDMNTEDYLFQVILEKPI-RI-P- 223 (327)
T ss_pred CCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC-cccccHHHHHHHHHhCCC-CC-C-
Confidence 2 12234778999999999999999999999999999999999999643221 111122222222221110 00 0
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh------HHHHHHHh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM------AEVVSELE 545 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L~ 545 (582)
. ....++.+++.+||+.||++|+++ .++++|.+
T Consensus 224 -----~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~ 262 (327)
T cd05617 224 -----R---FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF 262 (327)
T ss_pred -----C---CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCC
Confidence 0 011246788999999999999984 68887754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=303.70 Aligned_cols=243 Identities=22% Similarity=0.323 Sum_probs=196.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... ++..|++|.+... .....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 357999999999999864 5788999988532 3445677899999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.++++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~-------i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 85 DLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHSKK-------ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred cHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 99999975421 25888999999999999999999987 99999999999999999999999999887654
Q ss_pred ccc----ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 PIA----AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~~~----~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
... ..++..|+|||+..+..++.++|||||||++|||++|+.||.... ..... ..........+..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~----~~~~~~~~~~~~~-- 223 (256)
T cd08529 154 NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN----QGALI----LKIIRGVFPPVSQ-- 223 (256)
T ss_pred ccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHH----HHHHcCCCCCCcc--
Confidence 321 235678999999998889999999999999999999999996432 11111 1111111111111
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
.....+.+++.+||+.+|++||++.+++++.
T Consensus 224 --------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 254 (256)
T cd08529 224 --------MYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254 (256)
T ss_pred --------ccCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence 1223678899999999999999999998763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=322.58 Aligned_cols=246 Identities=15% Similarity=0.205 Sum_probs=193.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence 467999999999999864 67889999986432 22445688899999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 86 ~~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~-------i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 86 GDLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQMG-------YVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 99999997542 24888899999999999999999998 9999999999999999999999999997764
Q ss_pred Ccc-----cccccccccCCCCCC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 429 QPI-----AAQRMISYKSPEYQS------SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 429 ~~~-----~~~~~~~y~aPE~~~------~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
... ...++..|+|||++. ...++.++|||||||++|||++|+.||..... ............
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~~ 226 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-------AKTYNNIMNFQR 226 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-------HHHHHHHHcCCC
Confidence 332 224678899999886 45678999999999999999999999964321 111111111110
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.....+ .......+.+++..|+. +|++||++.+++.|.+.
T Consensus 227 ~~~~~~--------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~ 266 (330)
T cd05601 227 FLKFPE--------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF 266 (330)
T ss_pred ccCCCC--------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence 001000 00112256778889997 99999999999988653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.66 Aligned_cols=255 Identities=20% Similarity=0.273 Sum_probs=190.6
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
...||+|+||.||+|.... +..||||... ...+.+|++++++++|+|||++++++...+..++|||++. ++|
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 4679999999999999754 6779999642 2346789999999999999999999999999999999994 799
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++.... ..+++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.+....
T Consensus 247 ~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~g-------IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 247 YTYLGARL-----RPLGLAQVTAVARQLLSAIDYIHGEG-------IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 98886432 25899999999999999999999998 9999999999999999999999999997653321
Q ss_pred ------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc--ccc--
Q 047954 432 ------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT--AEI-- 501 (582)
Q Consensus 432 ------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-- 501 (582)
...+|..|+|||++.+..++.++|||||||++|||++|..|+...............+.+.+..... .+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2347889999999999999999999999999999999887664332211111111111111111000 000
Q ss_pred -cchhhhh--------------hhc----hHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 502 -FDSEISV--------------QRS----AAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 502 -~d~~~~~--------------~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
....+.. ... .......+.+|+.+||+.||++|||+.|+++|-+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 0000000 000 00111257789999999999999999999998764
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=307.31 Aligned_cols=249 Identities=26% Similarity=0.334 Sum_probs=184.5
Q ss_pred cccccCceEEEEEEEcCC---ceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 275 GLGKGIFGNSYKALLEGR---APVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.||+|+||.||+|...++ ..+++|.+.... ......+.+|+.+++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 589999999999975433 457788775432 2334568899999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++....... ....++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 82 L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-------ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 82 LKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQAD-------FIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred HHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHhcC-------EecccccHhheEecCCCcEEEeccccccccccc
Confidence 999997654321 123567778899999999999999998 999999999999999999999999998654221
Q ss_pred ------ccccccccccCCCCCC-------CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 431 ------IAAQRMISYKSPEYQS-------SKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 431 ------~~~~~~~~y~aPE~~~-------~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
....++..|+|||+.. ...++.++|||||||++|||++ |..||.... ..+..... ....
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~----~~~~~~~~---~~~~ 226 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS----DEQVLKQV---VREQ 226 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC----HHHHHHHH---hhcc
Confidence 1122346799999864 3456889999999999999999 788885321 11111111 1111
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.....++.. .......+.+++..|| .||++|||++||++.|.
T Consensus 227 -~~~~~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 227 -DIKLPKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -CccCCCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111111 1111234566778888 59999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=304.66 Aligned_cols=243 Identities=19% Similarity=0.302 Sum_probs=193.3
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCc-----chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKP-----LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|++|.||+|.. .++..|++|.+..... ...+.+.+|++++++++||||+++++++...+..++|+||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 46799999999999985 4678899998864321 12356888999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++++|.+++.... .++...+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++.
T Consensus 87 ~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~-------i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 87 PGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSNM-------IVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred CCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 9999999986432 4778888999999999999999998 99999999999999999999999999876
Q ss_pred ccCc-------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 427 VAQP-------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 427 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
.... ....++..|+|||++.+..++.++||||||+++|||++|+.||.... . ..............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~---~~~~~~~~~~~~~~ 226 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE----A---MAAIFKIATQPTNP 226 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc----h---HHHHHHHhccCCCC
Confidence 5332 12235567999999999889999999999999999999999986421 1 11111111111111
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.+ . ......+.+++.+||..+|++|||+.|++++.+
T Consensus 227 ~~-~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 227 QL-P---------SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred CC-C---------ccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 11 0 011225778999999999999999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=310.86 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=193.2
Q ss_pred cccccccCceEEEEEEEcCC---------------ceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEGR---------------APVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN 336 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~---------------~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 336 (582)
.+.||+|+||.||++...+. ..||+|.++.. .....+.|.+|++++++++|+||+++++++...
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 89 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD 89 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 36799999999999876432 24889998653 233456789999999999999999999999999
Q ss_pred CeeEEEEEeCCCCChHHHHhcCCCC------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee
Q 047954 337 DEKLLVYKFAGNGNLFNRIHGGKSS------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL 410 (582)
Q Consensus 337 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl 410 (582)
...++||||+++++|.+++...... .....+++..++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-------i~H~dlkp~Nill 162 (295)
T cd05097 90 DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-------FVHRDLATRNCLV 162 (295)
T ss_pred CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-------eeccccChhhEEE
Confidence 9999999999999999998643210 11124688899999999999999999998 9999999999999
Q ss_pred cCCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCCc
Q 047954 411 DDNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT--GRISTHSAPQGING 482 (582)
Q Consensus 411 ~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt--G~~P~~~~~~~~~~ 482 (582)
++++.+||+|||++....... ...++..|+|||+.....++.++|||||||++|||++ |..||.... .
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~----~ 238 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS----D 238 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC----h
Confidence 999999999999987653321 1123457999999988889999999999999999998 566775321 1
Q ss_pred cchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 483 ADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
......+.............. ........+.+++.+||+.||++|||+.+|++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 222222222111110000000 00011236889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=306.99 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=198.4
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|.. .++..++||.+.... ......+.+|+.+++.++|+||+++++++...+..+++|||+++
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 86 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence 35699999999999995 578899999876432 22345788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++..... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 87 ~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~-------i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 87 GDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMHSRR-------VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred CCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999998864321 1235889999999999999999999998 9999999999999999999999999987664
Q ss_pred Ccc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
... ...++..|+|||+..+..++.++||||||+++|||++|..||..... +............ ....
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~-~~~~--- 228 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCD-YPPL--- 228 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhhhhcCC-CCCC---
Confidence 322 22466789999999888899999999999999999999999864221 1111111111111 0000
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.......++.+++.+||+.+|++||||.+|++.+.++
T Consensus 229 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 ------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0011233678899999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.44 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=196.1
Q ss_pred cccccccCceEEEEEEEcC------CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEG------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++..++||||+++++++......++||||
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 90 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL 90 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence 4679999999999998643 3579999986432 23345788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCC----CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 346 AGNGNLFNRIHGGKSSK----NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
+++|+|.+++....... ....+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK-------FVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------ccccccChheEEEcCCCCEEECCc
Confidence 99999999997543211 1224788899999999999999999988 999999999999999999999999
Q ss_pred cccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 422 GFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 422 G~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
|+++.+.... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||... ....+...+.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~----~~~~~~~~~~---- 235 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL----SNEEVLKFVI---- 235 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC----CHHHHHHHHh----
Confidence 9987654321 2224568999999988889999999999999999998 89888532 2222222221
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
........+ ....++.+++.+||+.+|++|||+.++++.|+
T Consensus 236 ~~~~~~~~~----------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 DGGHLDLPE----------NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCCCCCCC----------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111111 11236889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=314.11 Aligned_cols=257 Identities=23% Similarity=0.387 Sum_probs=199.6
Q ss_pred cccccccccCceEEEEEEEc--------CCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeE
Q 047954 271 APAEGLGKGIFGNSYKALLE--------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKL 340 (582)
Q Consensus 271 ~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 340 (582)
...+.||+|+||.||+|... ....+|+|.++... ......+..|+.++.++ +||||+++++++...+..+
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY 94 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence 34678999999999999742 24468899886432 23346788999999999 6999999999999999999
Q ss_pred EEEEeCCCCChHHHHhcCCCC----------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee
Q 047954 341 LVYKFAGNGNLFNRIHGGKSS----------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL 410 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl 410 (582)
+||||+++|+|.+++...... .....+++..++.++.|++.||.|||+++ |+||||||+|||+
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-------i~H~dlkp~Nill 167 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR-------CIHRDLAARNVLV 167 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC-------eeeccccceeEEE
Confidence 999999999999999764310 11235888999999999999999999988 9999999999999
Q ss_pred cCCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 047954 411 DDNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGA 483 (582)
Q Consensus 411 ~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~ 483 (582)
+.++.+||+|||+++...... ....+..|+|||.+.+..++.++|||||||++|||++ |..||.... ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~----~~ 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP----VE 243 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC----HH
Confidence 999999999999998664321 1122356999999988889999999999999999999 888885321 12
Q ss_pred chHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 484 DLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
++... .......+.. .....++.+++.+||..+|++|||+.|+++.|+.+.....
T Consensus 244 ~~~~~----~~~~~~~~~~----------~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 244 ELFKL----LREGHRMDKP----------SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred HHHHH----HHcCCCCCCC----------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 22221 1221111110 1112257789999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=303.27 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=200.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA 86 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence 467999999999999976 7888999988632 223356789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 87 ~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~-------i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 87 GDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHSKR-------IMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred CCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHhCC-------EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999865322 1235788999999999999999999998 9999999999999999999999999987654
Q ss_pred Ccc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
... ...++..|+|||++.+..++.++|||||||++|+|++|+.||.... ....+.... ...........
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~-~~~~~~~~~~~- 230 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKK-IEKCDYPPLPA- 230 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHHhh-hhcCCCCCCCh-
Confidence 322 2345678999999988889999999999999999999999985422 112111111 11111111110
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
......+.+++.+||..+|++|||+.+|++.|+.+.
T Consensus 231 --------~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 231 --------DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --------hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 122236788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=308.24 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=194.5
Q ss_pred cccccccCceEEEEEEE-----cCCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-----EGRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 344 (582)
.+.||+|+||.||++.+ .++..||+|.++... ....+.+.+|+.++++++||||+++++++... ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05079 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88 (284)
T ss_pred ceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEE
Confidence 46799999999999984 346789999986442 33456789999999999999999999999875 56789999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 89 ~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~~g-------i~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 89 FLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGSRQ-------YVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred ccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeecccchheEEEcCCCCEEECCCccc
Confidence 999999999986432 24789999999999999999999998 999999999999999999999999999
Q ss_pred ccccCcc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-------CccchHHHHH
Q 047954 425 SLVAQPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGI-------NGADLCSWVL 490 (582)
Q Consensus 425 ~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~-------~~~~~~~~~~ 490 (582)
+.+.... ...++..|+|||++.+..++.++|||||||++|||+|++.|........ .+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 8764322 1223456999999988889999999999999999999877653221100 0011111111
Q ss_pred HHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 491 RAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 491 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
........... ......++.+++.+||+.+|++|||+.++++.++.+
T Consensus 237 ~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLPR----------PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCCC----------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111111000 111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=311.65 Aligned_cols=247 Identities=22% Similarity=0.306 Sum_probs=194.5
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++.+...+..++||||+++|
T Consensus 6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 85 (285)
T cd05630 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCC
Confidence 56999999999999865 57889999886432 122345778999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 86 ~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~-------iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 86 DLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQER-------IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred cHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC-------EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99998864322 24888899999999999999999988 99999999999999999999999999876543
Q ss_pred cc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 430 PI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 ~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.. ...++..|+|||++.+..++.++|||||||++|||++|+.||........ ............... .
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~-~------- 225 (285)
T cd05630 155 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKEVQEEY-S------- 225 (285)
T ss_pred CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHHHhhhhhhhhhc-C-------
Confidence 22 23467889999999988999999999999999999999999975321100 011111101001000 0
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHHhh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSELEI 546 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~ 546 (582)
......+.+++.+||+.||++||| ++|+++|.+.
T Consensus 226 ------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~ 264 (285)
T cd05630 226 ------EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264 (285)
T ss_pred ------ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence 011225778899999999999999 8999998774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=310.80 Aligned_cols=245 Identities=23% Similarity=0.363 Sum_probs=196.7
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
+.||+|+||.||+|.. .++..|++|.+........+.+.+|+.+++.++|+||+++++++......++||||+++++|.
T Consensus 26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (296)
T cd06654 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (296)
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHH
Confidence 5699999999999985 467889999987655555677899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 106 ~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~~g-------i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 106 DVVTET-------CMDEGQIAAVCRECLQALEFLHSNQ-------VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred HHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 998642 3678899999999999999999998 9999999999999999999999999987654321
Q ss_pred ---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 432 ---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 432 ---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
...++..|+|||.+.+..++.++|||||||++|||++|+.||..... . .......... ......
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----~---~~~~~~~~~~-~~~~~~----- 238 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----L---RALYLIATNG-TPELQN----- 238 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----H---HhHHHHhcCC-CCCCCC-----
Confidence 22466789999999888899999999999999999999999964321 0 1111111111 101000
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.......+.+++.+||..+|++||++.|++++-+...
T Consensus 239 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 239 ---PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred ---ccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 1111235778999999999999999999998766443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=302.56 Aligned_cols=242 Identities=26% Similarity=0.484 Sum_probs=194.7
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
++||+|+||.||++...+++.|++|.+...... ..+.+.+|++++++++|+||+++++++......++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999877899999988654333 4567899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCccc
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA 432 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~~ 432 (582)
+++..... .+++..++.++.+++.||+|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~~~-------i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 81 TFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESKN-------CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY 148 (251)
T ss_pred HHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC-------EehhhcCcceEEEcCCCcEEEeeccccccccCCcc
Confidence 99965322 4778889999999999999999998 99999999999999999999999999876542211
Q ss_pred ------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 433 ------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 433 ------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
...+..|+|||.+.+..++.++|||||||++|||+| |..||..... ......+ .......
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~----~~~~~~~----~~~~~~~----- 215 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN----QQTRERI----ESGYRMP----- 215 (251)
T ss_pred eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH----HHHHHHH----hcCCCCC-----
Confidence 112456999999988889999999999999999999 8888854321 1111111 1111000
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.......++.+++.+||..+|++||++.|+++.|.
T Consensus 216 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 -----APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -----CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 01112236888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=303.91 Aligned_cols=244 Identities=27% Similarity=0.465 Sum_probs=197.8
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..||||.+.... ...+++.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 89 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence 46799999999999998888889999987533 34567999999999999999999999999888999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 90 ~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~~~-------i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 90 DFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLESRN-------YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred HHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99975432 24888999999999999999999998 9999999999999999999999999987764321
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
....+..|+|||.+.+..++.++|||||||++|||+| |+.||... ........+. ....... .
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~----~~~~~~~~~~----~~~~~~~-~--- 226 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM----TNREVLEQVE----RGYRMPR-P--- 226 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHH----cCCCCCC-C---
Confidence 1223457999999998889999999999999999999 99998532 1122222211 1111000 0
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.....++.+++.+|+..+|++||+++++.+.|+.
T Consensus 227 ------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 ------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0112367889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=307.40 Aligned_cols=248 Identities=21% Similarity=0.318 Sum_probs=195.6
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l 89 (282)
T cd06643 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 89 (282)
T ss_pred HhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcH
Confidence 3569999999999999764 667788888655555567789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
..++.... .++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~-------i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 90 DAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHENK-------IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 98886432 25889999999999999999999998 999999999999999999999999998665332
Q ss_pred ---ccccccccccCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 431 ---IAAQRMISYKSPEYQS-----SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~-----~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
....++..|+|||++. +..++.++|||||||++|||++|+.||..... ...+........ ....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~ 229 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEP-PTLA 229 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-------HHHHHHHhhcCC-CCCC
Confidence 2234677899999874 34578899999999999999999999864211 111111111111 1110
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.+ .....++.+++.+||+.+|++||++.+++++.+...
T Consensus 230 ~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 230 QP--------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred Cc--------cccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 00 011235788999999999999999999998887544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=309.18 Aligned_cols=258 Identities=19% Similarity=0.291 Sum_probs=202.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||+||++... ++..||+|++.... ....+.+.+|+++++.++||||+++++++......++||||+++++
T Consensus 10 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (284)
T cd06620 10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGS 89 (284)
T ss_pred HHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCC
Confidence 367999999999999865 57788999876432 3345788999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
|.+++.... .+++..+..++.+++.||.|||+. + ++||||||+||++++++.++|+|||++.....
T Consensus 90 L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~~-------i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 90 LDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVHR-------IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred HHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhcC-------eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999886432 478899999999999999999974 5 99999999999999999999999999876532
Q ss_pred c--ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC----CccchHHHHHHHHhhcccccccc
Q 047954 430 P--IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGI----NGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 430 ~--~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
. ....++..|+|||++.+..++.++|||||||++|||+||+.||....... ....+..++....... ...+.
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~- 234 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PPRLP- 234 (284)
T ss_pred hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CCCCC-
Confidence 2 22346788999999988889999999999999999999999997543211 1111222222221111 01000
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCC
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTEST 553 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 553 (582)
......++.+++.+||+.||++|||+.|++++++.++.....
T Consensus 235 --------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~ 276 (284)
T cd06620 235 --------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS 276 (284)
T ss_pred --------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence 011234678899999999999999999999998777654433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=310.69 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=194.6
Q ss_pred cccccccCceEEEEEEEcC-----------------CceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEE
Q 047954 273 AEGLGKGIFGNSYKALLEG-----------------RAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 334 (582)
.+.||+|+||.||++...+ ...||+|+++.. .....+.+.+|+.++++++|+||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05095 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI 89 (296)
T ss_pred eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 4679999999999986432 346889998653 2334567999999999999999999999999
Q ss_pred eCCeeEEEEEeCCCCChHHHHhcCCCCC-----CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCee
Q 047954 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSK-----NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNIL 409 (582)
Q Consensus 335 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NIL 409 (582)
..+..++||||+++|+|.+++....... ....+++..+..++.|++.||+|||+.+ ++||||||+|||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-------i~H~dlkp~Nil 162 (296)
T cd05095 90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-------FVHRDLATRNCL 162 (296)
T ss_pred cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-------eecccCChheEE
Confidence 9999999999999999999997643211 1124778889999999999999999998 999999999999
Q ss_pred ecCCCceEEeeccccccccCccc------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCC
Q 047954 410 LDDNEMVLVSDYGFSSLVAQPIA------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT--GRISTHSAPQGIN 481 (582)
Q Consensus 410 l~~~~~~kl~DfG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt--G~~P~~~~~~~~~ 481 (582)
+++++.++|+|||+++.+..... ...+..|+|||+.....++.++|||||||++|||+| |..||....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~---- 238 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS---- 238 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC----
Confidence 99999999999999976533221 112457999998888889999999999999999998 778885322
Q ss_pred ccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 482 GADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
...+.................. ........+.+++.+||+.||++||++.+|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLP-------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hHHHHHHHHHHHhhccccccCC-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1122221111111111100000 001122467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.06 Aligned_cols=241 Identities=22% Similarity=0.281 Sum_probs=189.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCC-CccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHP-NLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|... +++.||+|++... .....+.+..|.+++..+.|+ +|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 367999999999999865 4678999998642 223446678899999998765 58889999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~~-------ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 85 GGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSKG-------IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 999999986432 4788899999999999999999998 999999999999999999999999998653
Q ss_pred cC----cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQ----PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~----~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
.. .....++..|+|||++.+..++.++|||||||++|||+||+.||.... ...+...+. ... ... .
T Consensus 152 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~----~~~~~~~i~----~~~-~~~-~ 221 (324)
T cd05587 152 IFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED----EDELFQSIM----EHN-VSY-P 221 (324)
T ss_pred CCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHH----cCC-CCC-C
Confidence 21 122346789999999999999999999999999999999999996421 112222111 110 000 0
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh-----HHHHHHHh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM-----AEVVSELE 545 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~L~ 545 (582)
. ....++.+++.+||..||++|++. .++++|.+
T Consensus 222 ------~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~ 259 (324)
T cd05587 222 ------K---SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAF 259 (324)
T ss_pred ------C---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCC
Confidence 0 111257789999999999999986 67777654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.29 Aligned_cols=239 Identities=22% Similarity=0.321 Sum_probs=185.9
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHH-HHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLL-VIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|... +++.||+|++... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 35899999999999854 6788999998642 1223344555554 46779999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~g-------ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 81 GELFFHLQRER------SFPEPRARFYAAEIASALGYLHSIN-------IVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (325)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence 99998886432 4788899999999999999999998 9999999999999999999999999987532
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.. ...... . ...+
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~----~~~~~~---~~~~~~-~--~~~~ 217 (325)
T cd05604 148 AQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD----VAEMYD---NILHKP-L--VLRP 217 (325)
T ss_pred CCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC----HHHHHH---HHHcCC-c--cCCC
Confidence 21 22347788999999999999999999999999999999999996421 111111 111111 0 0111
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChH----HHHHHH
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMA----EVVSEL 544 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~----evl~~L 544 (582)
.....+.+++.+|++.+|++||++. ++++|.
T Consensus 218 ---------~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~ 252 (325)
T cd05604 218 ---------GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHP 252 (325)
T ss_pred ---------CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCC
Confidence 1122567889999999999999885 555553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=305.70 Aligned_cols=245 Identities=24% Similarity=0.414 Sum_probs=194.8
Q ss_pred cccccccCceEEEEEEEc----CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE----GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|... ....+|+|.++... ....+.+..|+.++.+++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 467999999999999863 23368999886432 2345678999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++..+
T Consensus 89 ~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~-------i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 89 NGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSDMG-------YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999997542 24788999999999999999999998 999999999999999999999999999876
Q ss_pred cCccc-------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 428 AQPIA-------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 428 ~~~~~-------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
..... ...+..|+|||++.+..++.++|||||||++||+++ |+.||.... ..+....+. ..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~----~~~~~~~~~----~~~~~ 228 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS----NQDVIKAIE----EGYRL 228 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC----HHHHHHHHh----CCCcC
Confidence 43221 112356999999998899999999999999999887 999986432 112222221 11110
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.. .......+.+++.+||+.+|++||+|.++++.|..+
T Consensus 229 ~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 PA----------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CC----------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 011123577899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=305.91 Aligned_cols=248 Identities=23% Similarity=0.419 Sum_probs=196.0
Q ss_pred cccccccCceEEEEEEEcCC----ceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLEGR----APVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|...+. ..|+||...... ....+.+.+|+.++++++||||+++++++.. ...++||||++
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~ 89 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAP 89 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence 46799999999999986432 468899886543 3455689999999999999999999998875 45789999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 90 ~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~-------~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 90 LGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLESKR-------FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeccccChheEEEecCCCeEEccCceeeec
Confidence 999999997532 24789999999999999999999988 999999999999999999999999998765
Q ss_pred cCccc-----ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 428 AQPIA-----AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 428 ~~~~~-----~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
..... ...+..|+|||.+....++.++|||||||++|||++ |+.||.... ..+....+. ..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~----~~~~~~~~~---~~~~~-~~ 229 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK----NNDVIGRIE---NGERL-PM 229 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHH---cCCcC-CC
Confidence 43321 122357999999988889999999999999999996 999996432 112222111 11111 00
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
. ......+.+++.+|+..+|++|||+.++++.|+++...+
T Consensus 230 -------~---~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 230 -------P---PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred -------C---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 111236788999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=315.48 Aligned_cols=240 Identities=22% Similarity=0.312 Sum_probs=185.2
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHH-HHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLL-VIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|+.. ++..||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 57789999986421 122334555554 57889999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|..++.... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~~-------ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 81 GELFFHLQRER------CFLEPRARFYAAEVASAIGYLHSLN-------IIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147 (321)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence 99998886432 4777888889999999999999988 9999999999999999999999999987532
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ............ ..+.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~~--~~~~-- 216 (321)
T cd05603 148 EPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------VSQMYDNILHKP--LQLP-- 216 (321)
T ss_pred CCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-------HHHHHHHHhcCC--CCCC--
Confidence 22 12346788999999998899999999999999999999999996421 111111111110 0110
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChH----HHHHHHh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMA----EVVSELE 545 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~----evl~~L~ 545 (582)
......+.+++.+||+.||++||++. +++++.+
T Consensus 217 --------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05603 217 --------GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVF 253 (321)
T ss_pred --------CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCC
Confidence 01122577899999999999999764 6655543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.53 Aligned_cols=245 Identities=19% Similarity=0.276 Sum_probs=187.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|+.++++++|||||++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 367999999999999864 57789999986432 22345688999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 g~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~~-------ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 86 GDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKMG-------FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 99999986432 4677888889999999999999998 9999999999999999999999999975321
Q ss_pred Cc---------------------------------------------------ccccccccccCCCCCCCCCCCcchhHH
Q 047954 429 QP---------------------------------------------------IAAQRMISYKSPEYQSSKKISRKSDVW 457 (582)
Q Consensus 429 ~~---------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~k~DVw 457 (582)
.. ....||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 00 012367889999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCC-
Q 047954 458 SFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE- 536 (582)
Q Consensus 458 S~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs- 536 (582)
||||++|||++|+.||..... . ............... +. .... ..++.+++.+++ .+|++|++
T Consensus 233 SlGvil~elltG~~Pf~~~~~----~---~~~~~i~~~~~~~~~--p~---~~~~---s~~~~~li~~l~-~~p~~R~~~ 296 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQTP----L---ETQMKVINWQTSLHI--PP---QAKL---SPEASDLIIKLC-RGPEDRLGK 296 (382)
T ss_pred echHHHHHHHhCCCCCCCCCH----H---HHHHHHHccCCCcCC--CC---cccC---CHHHHHHHHHHc-cCHhHcCCC
Confidence 999999999999999964321 1 111111110000000 00 0001 123556666655 59999997
Q ss_pred --hHHHHHHHhh
Q 047954 537 --MAEVVSELEI 546 (582)
Q Consensus 537 --~~evl~~L~~ 546 (582)
+.++++|.+.
T Consensus 297 ~~~~ei~~hp~f 308 (382)
T cd05625 297 NGADEIKAHPFF 308 (382)
T ss_pred CCHHHHhcCCCc
Confidence 9999888653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=293.27 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=200.3
Q ss_pred cccccccCceEEEEEE-EcCCceEEEEEecCCC--------cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEE
Q 047954 273 AEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLK--------PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLV 342 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 342 (582)
.+.||+|..++|-++. ..+++.+|+|++.... ....+.-.+|+.+|+++ .||+|+++.++|+++...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 4679999999999887 4567889999885321 11234567899999997 899999999999999999999
Q ss_pred EEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecc
Q 047954 343 YKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG 422 (582)
Q Consensus 343 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 422 (582)
+|.|+.|.|++++... ..+++....+|++|+.+|++|||..+ ||||||||+|||+|++..+||+|||
T Consensus 102 Fdl~prGELFDyLts~------VtlSEK~tR~iMrqlfegVeylHa~~-------IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSK------VTLSEKETRRIMRQLFEGVEYLHARN-------IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred hhhcccchHHHHhhhh------eeecHHHHHHHHHHHHHHHHHHHHhh-------hhhcccChhheeeccccceEEeccc
Confidence 9999999999999643 46899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCcc---cccccccccCCCCCC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHH
Q 047954 423 FSSLVAQPI---AAQRMISYKSPEYQS------SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 423 ~a~~~~~~~---~~~~~~~y~aPE~~~------~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
+|+.+.... ...||++|.|||.+. ...|+..+|+||.|||||.|+.|..||.... +.+ +.+.+
T Consensus 169 Fa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----Qml---MLR~I 240 (411)
T KOG0599|consen 169 FACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----QML---MLRMI 240 (411)
T ss_pred eeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----HHH---HHHHH
Confidence 999987764 456899999999764 2468899999999999999999999995311 111 12222
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.++... +- .+...+....+.+|+.+||+.||.+|.|++|+++|.+.+.-
T Consensus 241 meGkyq-F~------speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 241 MEGKYQ-FR------SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred Hhcccc-cC------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 222111 10 11122333467889999999999999999999999987653
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=316.09 Aligned_cols=256 Identities=20% Similarity=0.267 Sum_probs=191.9
Q ss_pred cccccc--CceEEEEEEE-cCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKG--IFGNSYKALL-EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
++||+| +|++||++.. .++..||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 579999 7899999985 567889999986432 23345677899999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+....
T Consensus 84 ~~l~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~-------iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~ 152 (327)
T cd08227 84 GSAKDLICTHFM----DGMSELAIAYILQGVLKALDYIHHMG-------YVHRSVKASHILISVDGKVYLSGLRSNLSMI 152 (327)
T ss_pred CcHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC-------EecCCCChhhEEEecCCcEEEcccchhhccc
Confidence 999999864322 24788999999999999999999998 9999999999999999999999998653322
Q ss_pred Cc-----------ccccccccccCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh
Q 047954 429 QP-----------IAAQRMISYKSPEYQSS--KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE 495 (582)
Q Consensus 429 ~~-----------~~~~~~~~y~aPE~~~~--~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 495 (582)
.. ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ....... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~----~~ 225 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT---QMLLEKL----NG 225 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh---HHHHHHh----cC
Confidence 11 11234567999999875 46899999999999999999999999643211 0000000 00
Q ss_pred cccccccc-------------------hhh----------h------hhhchHHHHHHHHHHHHHcccCCCCCCCChHHH
Q 047954 496 EWTAEIFD-------------------SEI----------S------VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540 (582)
Q Consensus 496 ~~~~~~~d-------------------~~~----------~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 540 (582)
......+ ... . ...........+.+++.+||+.||++|||++|+
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~el 304 (327)
T cd08227 226 -TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTL 304 (327)
T ss_pred -CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHH
Confidence 0000000 000 0 000001123467889999999999999999999
Q ss_pred HHHHhhcc
Q 047954 541 VSELEIIK 548 (582)
Q Consensus 541 l~~L~~i~ 548 (582)
+++.+...
T Consensus 305 l~~p~f~~ 312 (327)
T cd08227 305 LNHSFFKQ 312 (327)
T ss_pred hcChhhhh
Confidence 99877543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.62 Aligned_cols=259 Identities=18% Similarity=0.294 Sum_probs=193.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|+.. ++..||+|.++... ......+.+|+.++++++||||+++++++..++..++||||+++ +
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 467999999999999865 56789999986432 22345678899999999999999999999999999999999975 8
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 90 l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~~-------ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 90 LKQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCHRRK-------VLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 888886432 24778889999999999999999998 999999999999999999999999998764332
Q ss_pred c----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---cccccc
Q 047954 431 I----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE---WTAEIF 502 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 502 (582)
. ...++..|+|||.+.+ ..++.++|||||||++|||+||+.||..... .+....+.+..... ....+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV----EDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCHHHHhhhc
Confidence 1 2235678999998765 4689999999999999999999999964321 11111111111100 000000
Q ss_pred ------chhhhh------hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 503 ------DSEISV------QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 503 ------d~~~~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
+..... .........++.+++.+|++.||++|||+.|+++|.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 000000 0000011235678999999999999999999999887654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=328.86 Aligned_cols=256 Identities=20% Similarity=0.296 Sum_probs=186.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeC--------CeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--------DEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~~~~lv~ 343 (582)
.+.||+|+||.||+|... .+..||||++.... ....+|+.++++++|||||++++++... ...++||
T Consensus 71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 467999999999999864 57889999885432 2345799999999999999999987542 2367899
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC-ceEEeecc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE-MVLVSDYG 422 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfG 422 (582)
||+++ +|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 147 E~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH~~~-------IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 147 EFIPQ-TVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHSKF-------ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred ecCCc-cHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-------EecCCcCHHHEEEcCCCCceeeeccc
Confidence 99975 78777653221 1235888899999999999999999998 99999999999999664 69999999
Q ss_pred ccccccCcc---cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc--
Q 047954 423 FSSLVAQPI---AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE-- 496 (582)
Q Consensus 423 ~a~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~-- 496 (582)
+|+.+.... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||..... .+....+.......
T Consensus 217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~----~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS----VDQLVRIIQVLGTPTE 292 (440)
T ss_pred cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCH
Confidence 998764322 2346788999998765 4689999999999999999999999964321 11111111111100
Q ss_pred ---------c----cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 497 ---------W----TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 497 ---------~----~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+ .+.+....+.. ..+.....++.+|+.+||..||++|||+.|+++|.+.-
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~-~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKK-VFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHH-HhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 0 00000000000 00011124678999999999999999999999998753
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=304.15 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=184.1
Q ss_pred cccccCceEEEEEEEcCCc---eEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 275 GLGKGIFGNSYKALLEGRA---PVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.||+|+||.||+|...++. .+++|.+.... ....+.+.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999855443 45566665432 2345689999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC-
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ- 429 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~- 429 (582)
|.++++..... ....++...+.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 82 L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~-------i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 82 LKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKHN-------FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE 152 (268)
T ss_pred HHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHCC-------eeccCCccceEEEcCCccEEecccccccccCcc
Confidence 99999764321 124566778889999999999999987 99999999999999999999999999864321
Q ss_pred -----cccccccccccCCCCCCC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 430 -----PIAAQRMISYKSPEYQSS-------KKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 430 -----~~~~~~~~~y~aPE~~~~-------~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
.....++..|+|||+... ..++.++|||||||++|||++ |..||.... ..+....+ ....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~----~~~~~~~~---~~~~ 225 (268)
T cd05086 153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS----DREVLNHV---IKDQ 225 (268)
T ss_pred hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHH---Hhhc
Confidence 122345678999998743 245789999999999999997 566774321 11222211 1111
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.....++.+... ....+.+++..|| .+|++||++++|++.|.
T Consensus 226 -~~~~~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 226 -QVKLFKPQLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -ccccCCCccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 112222222111 1125667888999 67999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=307.61 Aligned_cols=247 Identities=23% Similarity=0.405 Sum_probs=193.4
Q ss_pred cccccCceEEEEEEEcC-------CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 275 GLGKGIFGNSYKALLEG-------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.||+|+||.||+|...+ +..+++|.+.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998643 2468888875432 234567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCC-CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC-----ceEEee
Q 047954 347 GNGNLFNRIHGGKSSK-NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE-----MVLVSD 420 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~-----~~kl~D 420 (582)
++|+|.+++....... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.+. .++|+|
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-------i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH-------FIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC-------cccCCCChheEEEecCCCCCCcceEECC
Confidence 9999999997543221 2234788999999999999999999987 99999999999999877 899999
Q ss_pred ccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHH
Q 047954 421 YGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 421 fG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
||+++...... ....+..|+|||++.+..++.++|||||||++|||+| |+.||.... ..+....+
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~----~~~~~~~~---- 226 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN----NQEVLQHV---- 226 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC----HHHHHHHH----
Confidence 99987653321 1123467999999998899999999999999999998 999985321 12222211
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
........ .......+.+++.+||..+|++||++.+|++.|++
T Consensus 227 ~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 TAGGRLQK----------PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred hcCCccCC----------cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111000 01122357889999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.38 Aligned_cols=236 Identities=22% Similarity=0.311 Sum_probs=182.6
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHH-HHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQL-LVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|+.. ++..||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 56779999986421 11223344444 456789999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+.......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~g-------iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 81 GELFYHLQRER------CFLEPRARFYAAEIASALGYLHSLN-------IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 99999986432 3667788889999999999999998 9999999999999999999999999987543
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.. ....+++.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ ..... . +.+
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i---~~~~~--~-~~~ 217 (325)
T cd05602 148 EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----TAEMYDNI---LNKPL--Q-LKP 217 (325)
T ss_pred cCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC----HHHHHHHH---HhCCc--C-CCC
Confidence 21 22347889999999999999999999999999999999999996422 11222211 11110 0 111
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHH
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVV 541 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 541 (582)
.....+.+++.+|++.||.+||++.+.+
T Consensus 218 ---------~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 ---------NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred ---------CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 1122577888999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=323.13 Aligned_cols=258 Identities=18% Similarity=0.304 Sum_probs=192.9
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCC-----eeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND-----EKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~e 344 (582)
.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+++++.++|+||+++++++...+ ..++|+|
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 46799999999999996 46889999998643 2233467889999999999999999999998776 7899999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+. ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 85 ~~~-~~l~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~-------ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 85 LMQ-SDLHKIIVSP------QPLSSDHVKVFLYQILRGLKYLHSAG-------ILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred ccc-cCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeCCCCChHHEEECCCCCEEeccccce
Confidence 996 5888887543 24888999999999999999999998 999999999999999999999999999
Q ss_pred ccccCcc-----cccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc-
Q 047954 425 SLVAQPI-----AAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW- 497 (582)
Q Consensus 425 ~~~~~~~-----~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 497 (582)
+...... ...++..|+|||++.+. .++.++|||||||++|||++|+.||..... .+....+........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP----IQQLDLITDLLGTPSL 226 (372)
T ss_pred eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHHcCCCCH
Confidence 7654321 12356789999998764 479999999999999999999999965321 111111111100000
Q ss_pred --------------cccccc-hhhhh-hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 498 --------------TAEIFD-SEISV-QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 498 --------------~~~~~d-~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
...... +.... .........++.+++.+||+.||++|||+.|+++|.+.-.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 000000 00000 0000111236788999999999999999999999976443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.87 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=199.9
Q ss_pred ccccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCC-C-----CCccccceEEEeCCeeEEEEE
Q 047954 272 PAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-H-----PNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H-----~niv~l~~~~~~~~~~~lv~e 344 (582)
..+.||+|+||.|-+|... +++.||||+++... ....+...|+.+|..++ | -|+|++++||...++.|||+|
T Consensus 190 V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfE 268 (586)
T KOG0667|consen 190 VLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFE 268 (586)
T ss_pred EEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeeh
Confidence 3578999999999999954 58899999997643 45566778999999986 4 589999999999999999999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC--ceEEeecc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE--MVLVSDYG 422 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~--~~kl~DfG 422 (582)
.+.. +|.++++.++.. +++...+..|+.||+.||.+||..+ |||+||||+||||.+.. .+||+|||
T Consensus 269 LL~~-NLYellK~n~f~----Glsl~~ir~~~~Qil~~L~~L~~l~-------IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 269 LLST-NLYELLKNNKFR----GLSLPLVRKFAQQILTALLFLHELG-------IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred hhhh-hHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCC-------eeeccCChhheeeccCCcCceeEEecc
Confidence 9955 999999876543 6889999999999999999999998 99999999999997544 59999999
Q ss_pred ccccccCcccc-cccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh-------
Q 047954 423 FSSLVAQPIAA-QRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR------- 494 (582)
Q Consensus 423 ~a~~~~~~~~~-~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~------- 494 (582)
.|....+.... ..+..|+|||++.+.+|+.+.||||||||+.||++|.+.|... +..+....+...+.
T Consensus 337 SSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~----ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 337 SSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD----NEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred cccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC----CHHHHHHHHHHHhCCCCHHHH
Confidence 99888765442 2456799999999999999999999999999999997777543 22222222222110
Q ss_pred -----------h-ccccc-c----------------------cchhhh-hhhc-----hHHHHHHHHHHHHHcccCCCCC
Q 047954 495 -----------E-EWTAE-I----------------------FDSEIS-VQRS-----AAHGMLKLLQVAIQCCNKSPEK 533 (582)
Q Consensus 495 -----------~-~~~~~-~----------------------~d~~~~-~~~~-----~~~~~~~l~~l~~~Cl~~dP~~ 533 (582)
. .+... . .+...+ .... ....-..+++++.+|+++||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 0 00000 0 000000 0000 0022346899999999999999
Q ss_pred CCChHHHHHHHhhc
Q 047954 534 RPEMAEVVSELEII 547 (582)
Q Consensus 534 RPs~~evl~~L~~i 547 (582)
|+|..++++|.+.-
T Consensus 493 R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 493 RITPAQALNHPFLT 506 (586)
T ss_pred cCCHHHHhcCcccc
Confidence 99999999998865
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=323.25 Aligned_cols=244 Identities=24% Similarity=0.389 Sum_probs=201.6
Q ss_pred ccccccccCceEEEEEEEcC--C--ceEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 272 PAEGLGKGIFGNSYKALLEG--R--APVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
..++||+|.||.|++|.|.. | ..||||.++..... ...+|++|+.+|.+++|||++++||+..+ ....||||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 35789999999999999753 3 36899999876544 67899999999999999999999999987 6788999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
+.|+|.+.|+... +..|-......++.|||.|+.||.+++ +|||||..+|+|+.....+||+|||+.+-
T Consensus 193 plGSLldrLrka~----~~~llv~~Lcdya~QiA~aM~YLeskr-------lvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK----KAILLVSRLCDYAMQIAKAMQYLESKR-------LVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred ccchHHHHHhhcc----ccceeHHHHHHHHHHHHHHHHHHhhhh-------hhhhhhhhhhheecccceeeeecccceec
Confidence 9999999998722 235777888899999999999999998 99999999999999999999999999998
Q ss_pred ccCcccccc-------cccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 427 VAQPIAAQR-------MISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 427 ~~~~~~~~~-------~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
+......+. .+.|+|||.+....++.++|||+|||++|||+| |..||-.. .+..+.+.+.. .+.
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~----~g~qIL~~iD~---~er- 333 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC----RGIQILKNIDA---GER- 333 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC----CHHHHHHhccc---ccc-
Confidence 876654432 246999999999999999999999999999999 78898543 33344333321 111
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
...+..+...+++++..||..+|++|||+.+|.+.+-
T Consensus 334 ----------LpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 334 ----------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ----------CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 1223445568999999999999999999999985543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.06 Aligned_cols=246 Identities=19% Similarity=0.251 Sum_probs=189.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+++..++||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence 467999999999999965 5678999988532 222345678899999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 128 g~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~~-------IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 128 GDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSMG-------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred CcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999998642 3677888999999999999999998 9999999999999999999999999998764
Q ss_pred Cc-----ccccccccccCCCCCCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 429 QP-----IAAQRMISYKSPEYQSSK----KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 429 ~~-----~~~~~~~~y~aPE~~~~~----~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
.. ....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.... ...............
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~ 266 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-------LVGTYSKIMDHKNSL 266 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCccc
Confidence 32 133478899999988654 37899999999999999999999996432 111111111111000
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCC--CCChHHHHHHHhhc
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEK--RPEMAEVVSELEII 547 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~~i 547 (582)
.... .......+.+++..|+..++.+ |+++.|+++|.|.-
T Consensus 267 ~~p~--------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~ 308 (370)
T cd05621 267 NFPE--------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK 308 (370)
T ss_pred CCCC--------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence 1000 0011224667777888755543 89999999997753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=318.44 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=189.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCC------eeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND------EKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 343 (582)
.+.||+|+||.||++... .+..||+|++... .......+.+|+.+++.++||||+++++++.... ..++||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 105 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence 467999999999999864 5788999998643 2234567889999999999999999999987543 468999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+.+ +|.+.++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 106 e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~-------ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 106 ELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCCHHHEEECCCCCEEEecCCC
Confidence 99965 67766642 3677888899999999999999998 99999999999999999999999999
Q ss_pred cccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-----------CccchHHHH
Q 047954 424 SSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGI-----------NGADLCSWV 489 (582)
Q Consensus 424 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~-----------~~~~~~~~~ 489 (582)
++..... ....++..|+|||.+.+..++.++|||||||++|||+||+.||....... ....+...+
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 9765432 22346788999999999999999999999999999999999996432100 000000000
Q ss_pred HHHHh---hc--ccccc-cchhhh---h---hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 490 LRAVR---EE--WTAEI-FDSEIS---V---QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 490 ~~~~~---~~--~~~~~-~d~~~~---~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
..... .. ..... +..... . .........++.+++.+||..||++|||+.|+++|.+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 00000 00 00000 000000 0 000001123578899999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=309.88 Aligned_cols=255 Identities=23% Similarity=0.334 Sum_probs=195.8
Q ss_pred cccccccCceEEEEEEEcC-----------------CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEE
Q 047954 273 AEGLGKGIFGNSYKALLEG-----------------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYF 334 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 334 (582)
.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT 89 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 4679999999999988543 2458899886543 334567899999999999999999999999
Q ss_pred eCCeeEEEEEeCCCCChHHHHhcCCCC-----CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCee
Q 047954 335 SNDEKLLVYKFAGNGNLFNRIHGGKSS-----KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNIL 409 (582)
Q Consensus 335 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NIL 409 (582)
..+..+++|||+++++|.+++...... .....+++..++.++.|++.||+|||+.+ |+||||||+||+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-------i~H~dlkp~Nil 162 (296)
T cd05051 90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-------FVHRDLATRNCL 162 (296)
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC-------ccccccchhcee
Confidence 999999999999999999999764321 01125889999999999999999999988 999999999999
Q ss_pred ecCCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCC
Q 047954 410 LDDNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT--GRISTHSAPQGIN 481 (582)
Q Consensus 410 l~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt--G~~P~~~~~~~~~ 481 (582)
++.++.++|+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~---- 238 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT---- 238 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC----
Confidence 9999999999999987653321 1223567999999988889999999999999999998 677775321
Q ss_pred ccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 482 GADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
...+...+.............. .......++.+++.+||+.||++|||+.||++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLP-------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hHHHHHHHHhccccccccccCC-------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1222222222111111111000 01111236889999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.16 Aligned_cols=259 Identities=22% Similarity=0.321 Sum_probs=195.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++.+++||||+++++++..++..++||||+++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~ 85 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 85 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence 467999999999999865 5677888887643 23344668899999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
|.+++.... .+++..+..++.|+++||.|||+. + ++||||||+|||++.++.+||+|||++.....
T Consensus 86 L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~~-------i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 86 LDQVLKKAG------RIPENILGKISIAVLRGLTYLREKHK-------IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred HHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhCC-------EEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 999997432 478888999999999999999984 5 99999999999999999999999999876543
Q ss_pred c--ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccc--------
Q 047954 430 P--IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTA-------- 499 (582)
Q Consensus 430 ~--~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 499 (582)
. ....++..|+|||.+.+..++.++|||||||++|||++|+.||..... .................
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch----hhHHHhhcCccccccccCCcccccC
Confidence 2 223456789999999888899999999999999999999999853211 11111110000000000
Q ss_pred ------------cccchhhhh---hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 500 ------------EIFDSEISV---QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 500 ------------~~~d~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
+..+..... .........++.+++.+||..+|++|||+.+|+++.+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 000000000 0000012235789999999999999999999999988755
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=307.52 Aligned_cols=250 Identities=20% Similarity=0.325 Sum_probs=193.8
Q ss_pred cccccccCceEEEEEEEcC------CceEEEEEecCCCc-chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEG------RAPVVVKRLRDLKP-LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL 90 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence 4679999999999997542 45799998864332 2345678899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCC----CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 346 AGNGNLFNRIHGGKSS----KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
+++|+|.+++...... ......++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+||
T Consensus 91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-------i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-------FVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CcCCCCChheEEEcCCCcEEECcC
Confidence 9999999999753221 01234567788899999999999999998 999999999999999999999999
Q ss_pred cccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 422 GFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 422 G~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
|+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||... ...++...+ ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~----~~~~~~~~~---~~ 236 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL----SNEQVLKFV---MD 236 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHH---Hc
Confidence 9987653321 1123457999999988889999999999999999999 78888532 112222211 11
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.. .... .......+.+++.+||+.||++|||+.++++.+...
T Consensus 237 ~~-~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 237 GG-YLDQ----------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CC-CCCC----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11 1110 001123688999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=312.56 Aligned_cols=194 Identities=25% Similarity=0.485 Sum_probs=157.8
Q ss_pred cccccccCceEEEEEEEcC---CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEe--CCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLEG---RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS--NDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~ 347 (582)
+..||+|+||.||+|...+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4579999999999999653 4679999886432 33567889999999999999999999864 456789999986
Q ss_pred CCChHHHHhcCCCC---CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee----cCCCceEEee
Q 047954 348 NGNLFNRIHGGKSS---KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL----DDNEMVLVSD 420 (582)
Q Consensus 348 ~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl----~~~~~~kl~D 420 (582)
++|.+++...... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-------ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW-------VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-------EEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 4888877532211 12235788889999999999999999998 9999999999999 5667899999
Q ss_pred ccccccccCcc-------cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 047954 421 YGFSSLVAQPI-------AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSA 476 (582)
Q Consensus 421 fG~a~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~ 476 (582)
||+++...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 99998764321 2245778999998876 45799999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.61 Aligned_cols=245 Identities=18% Similarity=0.279 Sum_probs=188.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++++++|+||+++++.+.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence 367999999999999854 57889999985421 22345678999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+.
T Consensus 86 g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~~-------ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 86 GDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKMG-------FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 99999996532 4677888889999999999999998 9999999999999999999999999975321
Q ss_pred C-----------------------------------------------cccccccccccCCCCCCCCCCCcchhHHHHHH
Q 047954 429 Q-----------------------------------------------PIAAQRMISYKSPEYQSSKKISRKSDVWSFGC 461 (582)
Q Consensus 429 ~-----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gv 461 (582)
. .....|++.|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 0 00124678899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCC---ChH
Q 047954 462 LLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP---EMA 538 (582)
Q Consensus 462 vl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~ 538 (582)
++|||++|+.||..... .+... .... +......+. . .....++.+++.+|+ .+|++|+ ++.
T Consensus 233 ilyell~G~~Pf~~~~~----~~~~~---~i~~--~~~~~~~~~---~---~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 233 ILYEMLVGQPPFLADTP----AETQL---KVIN--WETTLHIPS---Q---AKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred eeeehhhCCCCCCCCCH----HHHHH---HHhc--cCccccCCC---C---CCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 99999999999964321 11111 1111 000000000 0 001124556666765 5999999 999
Q ss_pred HHHHHHhh
Q 047954 539 EVVSELEI 546 (582)
Q Consensus 539 evl~~L~~ 546 (582)
++++|.+.
T Consensus 297 ell~h~~~ 304 (376)
T cd05598 297 EIKAHPFF 304 (376)
T ss_pred HHhCCCCc
Confidence 99999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=319.91 Aligned_cols=245 Identities=18% Similarity=0.320 Sum_probs=196.4
Q ss_pred cccccCceEEEEEEEcC-CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChHH
Q 047954 275 GLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFN 353 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 353 (582)
+||+|.||+||-|+..+ ...+|||.+........+-+..|+.+.++++|+|||+++|.+..+++.-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999654 45789999977666666778899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec-CCCceEEeeccccccccC---
Q 047954 354 RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD-DNEMVLVSDYGFSSLVAQ--- 429 (582)
Q Consensus 354 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DfG~a~~~~~--- 429 (582)
+++..-. ...-.+.+.-.+.+||++||.|||++. |||||||-+|||++ -.|.+||+|||.++.+..
T Consensus 662 LLrskWG---PlKDNEstm~fYtkQILeGLkYLHen~-------IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP 731 (1226)
T KOG4279|consen 662 LLRSKWG---PLKDNESTMNFYTKQILEGLKYLHENK-------IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP 731 (1226)
T ss_pred HHHhccC---CCccchhHHHHHHHHHHHHhhhhhhcc-------eeeccccCCcEEEeeccceEEecccccchhhccCCc
Confidence 9975422 111266777889999999999999998 99999999999996 578999999999988743
Q ss_pred -cccccccccccCCCCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 430 -PIAAQRMISYKSPEYQSSK--KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 -~~~~~~~~~y~aPE~~~~~--~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.....||..|||||++..+ .|+.++|||||||++.||.||++||...... + ...++-+... ..
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---q------AAMFkVGmyK--vH--- 797 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---Q------AAMFKVGMYK--VH--- 797 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---h------Hhhhhhccee--cC---
Confidence 2455688999999999754 6899999999999999999999999743211 1 0111111111 11
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
++-+.+-..+...++++|+..||.+||++++++....
T Consensus 798 --P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpF 834 (1226)
T KOG4279|consen 798 --PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPF 834 (1226)
T ss_pred --CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcc
Confidence 1122333456788999999999999999999998754
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=308.36 Aligned_cols=249 Identities=24% Similarity=0.436 Sum_probs=195.2
Q ss_pred cccccccCceEEEEEEEc------CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
...||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY 89 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence 357999999999999864 45789999986533 23356788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCC----------------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCee
Q 047954 346 AGNGNLFNRIHGGKSS----------------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNIL 409 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NIL 409 (582)
+++|+|.+++...... .....+++..++.++.|++.||+|||+.+ ++||||||+||+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~-------i~H~dl~p~nil 162 (288)
T cd05050 90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK-------FVHRDLATRNCL 162 (288)
T ss_pred CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-------eecccccHhheE
Confidence 9999999999754321 11134788889999999999999999988 999999999999
Q ss_pred ecCCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 047954 410 LDDNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGING 482 (582)
Q Consensus 410 l~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~ 482 (582)
+++++.+||+|||++..+.... ....+..|+|||++.+..++.++|||||||++|||++ |..||.... .
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~----~ 238 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA----H 238 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----H
Confidence 9999999999999987653321 1123456999999988899999999999999999998 888885321 1
Q ss_pred cchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 483 ADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.+.. ........... ......++.+++.+||+.+|++|||+.|+++.|+.
T Consensus 239 ~~~~----~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVI----YYVRDGNVLSC----------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHH----HHHhcCCCCCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 11111111110 01122368889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.55 Aligned_cols=240 Identities=22% Similarity=0.297 Sum_probs=188.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|... ++..||+|.+.... ....+.+..|..++..+ +|++|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 357999999999999865 46789999986432 22334566777887776 68999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 ~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-------ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 85 GGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSKG-------IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------EEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 999999886432 4788899999999999999999998 999999999999999999999999998754
Q ss_pred cCc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
... ....+++.|+|||++.+..++.++|||||||++|||+||+.||.... ...+...+. ... . . +.
T Consensus 152 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~---~~~-~-~-~p 221 (323)
T cd05616 152 MWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----EDELFQSIM---EHN-V-A-YP 221 (323)
T ss_pred CCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC----HHHHHHHHH---hCC-C-C-CC
Confidence 321 23346889999999999999999999999999999999999996422 122222211 111 0 0 00
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh-----HHHHHHH
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM-----AEVVSEL 544 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~L 544 (582)
.....++.+++.+|++.||++|++. .++.+|.
T Consensus 222 ---------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~ 258 (323)
T cd05616 222 ---------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 258 (323)
T ss_pred ---------CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCC
Confidence 0112357789999999999999985 6776663
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.40 Aligned_cols=246 Identities=19% Similarity=0.333 Sum_probs=191.0
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
..||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++...+..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 46999999999999854 56789999887655556678999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC-CCceEEeeccccccccCc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD-NEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfG~a~~~~~~- 430 (582)
+++...... ...++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++......
T Consensus 94 ~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~-------i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 94 ALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHDNQ-------IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred HHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHHHCC-------EeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 999753211 11267788889999999999999988 999999999999986 678999999998765321
Q ss_pred ---ccccccccccCCCCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 431 ---IAAQRMISYKSPEYQSSK--KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~~~--~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
....++..|+|||++... .++.++|||||||++|||++|+.||..... .....+...... ....+
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~----~~~~~~~~~~~~--~~~~~---- 233 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE----PQAAMFKVGMFK--IHPEI---- 233 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC----hhhhHhhhhhhc--cCCCC----
Confidence 122356789999998654 378999999999999999999999864211 011111000000 00000
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
+.....++.+++.+||+.+|++|||+.|++.+.+
T Consensus 234 ------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 234 ------PESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred ------CcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 0111235778899999999999999999998754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=301.11 Aligned_cols=241 Identities=25% Similarity=0.485 Sum_probs=194.2
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|.+..+..+|+|.+.... .....|.+|++++++++|||++++++++......++||||+++++|.
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence 46799999999999998777889999886432 33567899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~-------i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 88 DYLRAQRG-----KFSQETLLGMCLDVCEGMAYLESSN-------VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred HHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHCC-------ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99875332 4788899999999999999999988 9999999999999999999999999987653321
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
....+.+|+|||+..+..++.++||||||+++|||++ |+.||.... ...+.+. ...... ...+..
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~~~~~~~----~~~~~~--~~~~~~ 225 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS----NSEVVET----INAGFR--LYKPRL 225 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC----HHHHHHH----HhCCCC--CCCCCC
Confidence 1123457999999998899999999999999999998 999986421 1111111 111111 011111
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
....+.+++.+||+.+|++|||+.|++++|
T Consensus 226 --------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 --------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 123688899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=308.31 Aligned_cols=247 Identities=23% Similarity=0.291 Sum_probs=193.6
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+.||+|+||+||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++..++..++||||++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05632 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence 56999999999999864 57789999986432 122345788999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 86 ~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~-------iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 86 DLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHREN-------TVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred cHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 99988864322 25899999999999999999999998 99999999999999999999999999876533
Q ss_pred c---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 430 P---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 ~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+....... .....
T Consensus 155 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~----~~~~~~~~~~~~~~--~~~~~--- 225 (285)
T cd05632 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE----KVKREEVDRRVLET--EEVYS--- 225 (285)
T ss_pred CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhhhcc--ccccC---
Confidence 2 223467889999999888999999999999999999999999964321 11111111111111 00000
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHHhh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSELEI 546 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~ 546 (582)
......+.+++..||+.||++||+ +.+++.+-+.
T Consensus 226 ------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~ 264 (285)
T cd05632 226 ------AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF 264 (285)
T ss_pred ------ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhh
Confidence 011225678899999999999999 7788777543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=316.29 Aligned_cols=242 Identities=22% Similarity=0.347 Sum_probs=198.6
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCCcch---HHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLI---TEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
..||.|+||.||-|+. .+...||||++.-..+.. -.++.+|+..|.+++|||+|.+-|+|..+...||||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 3499999999999984 567889999997543332 356889999999999999999999999999999999999 55
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+-.+++.-.+ .++....+..|..+.+.||+|||+++ .||||||..|||+++.|.+||+|||.|.+..+
T Consensus 111 SAsDlleVhk-----KplqEvEIAAi~~gaL~gLaYLHS~~-------~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 111 SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSHN-------RIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred cHHHHHHHHh-----ccchHHHHHHHHHHHHHHHHHHHHhh-------HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 8888776443 36888999999999999999999998 99999999999999999999999999999998
Q ss_pred cccccccccccCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 430 PIAAQRMISYKSPEYQS---SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 ~~~~~~~~~y~aPE~~~---~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.....||+.|||||++. .+.|+-|+||||+|++..||.-.++|+... +.+.....+.. .+ . |.+
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM----NAMSALYHIAQ---Ne-s-----PtL 245 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALYHIAQ---NE-S-----PTL 245 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc----hHHHHHHHHHh---cC-C-----CCC
Confidence 88899999999999876 467999999999999999999999998532 22222222211 11 1 111
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
...+....+..++..||++-|.+|||.++++.|-.
T Consensus 246 ----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 246 ----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred ----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 12233446788888999999999999999887653
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=312.32 Aligned_cols=257 Identities=19% Similarity=0.324 Sum_probs=188.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcC---CCCCccccceEEEeC-----CeeEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQ---KHPNLLPLLAYYFSN-----DEKLL 341 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~-----~~~~l 341 (582)
.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++++ +||||+++++++... ...++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 356999999999999865 57889999886432 22234456677766654 799999999988652 35789
Q ss_pred EEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
||||+. ++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 85 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~-------ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 85 VFEHVD-QDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHANC-------IVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred EEcccc-cCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEECCCCCEEECcc
Confidence 999997 489888865332 24888999999999999999999998 999999999999999999999999
Q ss_pred cccccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh----
Q 047954 422 GFSSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR---- 494 (582)
Q Consensus 422 G~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---- 494 (582)
|+++...... ...++..|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.....
T Consensus 153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~----~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 153 GLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----ADQLGKIFDLIGLPPE 228 (288)
T ss_pred CccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH----HHHHHHHHHHhCCCCh
Confidence 9998765332 23457789999999888999999999999999999999999864321 111111111110
Q ss_pred hcccccc------cchhhh--hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 495 EEWTAEI------FDSEIS--VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 495 ~~~~~~~------~d~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
..+.... +.+... ..........++.+++.+|++.||++|||+.|++.|.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~ 287 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 0111000 000000 00000112235778999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=305.53 Aligned_cols=245 Identities=21% Similarity=0.330 Sum_probs=193.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++||||+++++++..+...++||||+++++|
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 96 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV 96 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcH
Confidence 356999999999999975 4788999998766555667889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
..++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~-------i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 97 DAIMLELD-----RGLTEPQIQVICRQMLEALQYLHSMK-------IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC-------eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 88876432 24888999999999999999999988 999999999999999999999999998654322
Q ss_pred ---ccccccccccCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 431 ---IAAQRMISYKSPEYQS-----SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~-----~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
....++..|+|||++. ...++.++|||||||++|||++|+.||..... ...+....... .....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~-~~~~~ 236 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSE-PPTLS 236 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHHhcCC-CccCC
Confidence 2233567899999874 34568899999999999999999999854211 11111111111 11110
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
. ......++.+++.+||..+|++||+++|++++.+
T Consensus 237 ~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 237 Q--------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred C--------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0 1112235788999999999999999999988755
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=305.98 Aligned_cols=242 Identities=21% Similarity=0.380 Sum_probs=195.0
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06642 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcH
Confidence 56999999999999864 56789999886432 33456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 90 ~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~-------ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 90 LDLLKPG-------PLEETYIATILREILKGLDYLHSER-------KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred HHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhcCC-------eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 9988532 4788899999999999999999988 9999999999999999999999999997765432
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
...++..|+|||++.+..++.++|||||||++|||+||+.|+..... ...... .........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~----~~~~~~----~~~~~~~~~------ 221 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP----MRVLFL----IPKNSPPTL------ 221 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch----hhHHhh----hhcCCCCCC------
Confidence 12356789999999988899999999999999999999999864321 111111 111111100
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.......+.+++.+||+.+|++||+|.+++++.+..
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence 011223578899999999999999999999987744
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=303.64 Aligned_cols=245 Identities=21% Similarity=0.346 Sum_probs=192.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... ++..||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 14 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 93 (267)
T cd06645 14 IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL 93 (267)
T ss_pred HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcH
Confidence 356999999999999864 5788999998755444456688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++.... .+++.+.+.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 94 ~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 94 QDIYHVTG------PLSESQIAYVSRETLQGLYYLHSKG-------KMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99986432 4788999999999999999999998 999999999999999999999999998765432
Q ss_pred ---ccccccccccCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 431 ---IAAQRMISYKSPEYQS---SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~---~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
....++..|+|||++. ...++.++|||||||++|||++|+.||...... ..+ ...............
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~---~~~----~~~~~~~~~~~~~~~ 233 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM---RAL----FLMTKSNFQPPKLKD 233 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch---hhH----HhhhccCCCCCcccc
Confidence 2234678899999874 456889999999999999999999998543211 011 111111111110000
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
.. .....+.+++.+||..+|++||++++++++.
T Consensus 234 ~~-------~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~ 266 (267)
T cd06645 234 KM-------KWSNSFHHFVKMALTKNPKKRPTAEKLLQHP 266 (267)
T ss_pred cC-------CCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence 00 1112477899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.70 Aligned_cols=253 Identities=21% Similarity=0.391 Sum_probs=197.8
Q ss_pred ccccccCceEEEEEEEc-----CCceEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCCccccceEEEe--CCeeEEEEEe
Q 047954 274 EGLGKGIFGNSYKALLE-----GRAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLLAYYFS--NDEKLLVYKF 345 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~ 345 (582)
+.||+|+||.||+|.+. .+..+|||.+...... ..+.|.+|++++++++|+||+++++++.. ....++||||
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 89 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY 89 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence 67999999999999864 3578999999755443 46789999999999999999999999887 5578999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+.
T Consensus 90 ~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~~-------i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 90 LPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQR-------YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred CCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999975432 4889999999999999999999988 9999999999999999999999999998
Q ss_pred cccCccc-------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc-------cchHHHHHH
Q 047954 426 LVAQPIA-------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGING-------ADLCSWVLR 491 (582)
Q Consensus 426 ~~~~~~~-------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~-------~~~~~~~~~ 491 (582)
....... ...+..|+|||...+..++.++||||||+++|||+||+.|+......... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 7653211 12334699999998888999999999999999999999998643221100 001111111
Q ss_pred HHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 492 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
......... .......++.+++.+||+.+|++||||.||+++|+.+.
T Consensus 238 ~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 238 LLKEGERLP----------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHcCCcCC----------CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 111110000 01112246889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.71 Aligned_cols=248 Identities=17% Similarity=0.194 Sum_probs=188.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG 85 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence 467999999999999965 5788999998632 223345688899999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+.
T Consensus 86 ~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-------ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 86 GDLLTLLSKFE-----DRLPEDMARFYLAEMVLAIDSVHQLG-------YVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred CcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 99999996432 14788889999999999999999998 9999999999999999999999999987654
Q ss_pred Ccc-----cccccccccCCCCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 429 QPI-----AAQRMISYKSPEYQSS-----KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 429 ~~~-----~~~~~~~y~aPE~~~~-----~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
... ...+++.|+|||++.. ..++.++|||||||++|||++|+.||.... ..+...........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~-------~~~~~~~i~~~~~~ 226 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMNHKEH 226 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCCc
Confidence 322 1347889999998863 457889999999999999999999996421 11111111111100
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccC--CCCCCCChHHHHHHHhh
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNK--SPEKRPEMAEVVSELEI 546 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~L~~ 546 (582)
..+.. ........+.+++.+|+.. ++..||+++++++|.+.
T Consensus 227 ~~~~~-------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 227 FQFPP-------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred ccCCC-------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 00000 0001122455666676644 44458899999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=317.22 Aligned_cols=255 Identities=19% Similarity=0.309 Sum_probs=186.2
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|.... +..||+|..... ....|+.++++++||||+++++++......++|+||+. ++|
T Consensus 71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 143 (357)
T PHA03209 71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDL 143 (357)
T ss_pred EEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcH
Confidence 4679999999999999754 567888875322 23568999999999999999999999999999999994 689
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++.... ..+++..++.|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++.....
T Consensus 144 ~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~-------ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 144 YTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHAQR-------IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred HHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 88886432 25889999999999999999999998 999999999999999999999999999754322
Q ss_pred --ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc---chHHHHHHHHhh-cc-ccccc-
Q 047954 431 --IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGA---DLCSWVLRAVRE-EW-TAEIF- 502 (582)
Q Consensus 431 --~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~---~~~~~~~~~~~~-~~-~~~~~- 502 (582)
....++..|+|||++.+..++.++|||||||++|||+++..|+.......... .....+...... .. ..+..
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 23347789999999999999999999999999999999665553322111000 000111111110 00 00000
Q ss_pred --chhhhh-------------hh----chHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 503 --DSEISV-------------QR----SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 503 --d~~~~~-------------~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
...... .. ........+.+++.+||+.||++|||+.|+++|.+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f 354 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence 000000 00 000111245568999999999999999999998764
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=300.70 Aligned_cols=243 Identities=23% Similarity=0.411 Sum_probs=194.8
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..+++|.+.... ...+.+.+|+.++++++|+||+++++++.. ...+++|||+++|+|.
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 46799999999999998888889999886432 345678899999999999999999999887 7789999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+.......
T Consensus 89 ~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~-------i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 89 DFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQRN-------YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred HHHHhCCc----cccCHHHHHHHHHHHHHHHHHHHhCC-------ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99975432 24788889999999999999999987 9999999999999999999999999987654321
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
...++..|+|||++....++.++|||||||++|+++| |+.||.... ...+..++ .........
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~~~~~~~~----~~~~~~~~~---- 225 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----NPEVIRAL----ERGYRMPRP---- 225 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC----HHHHHHHH----hCCCCCCCc----
Confidence 1123456999999988889999999999999999999 899986421 11222221 111111111
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.....++.+++.+||+.+|++||++.++++.|+.
T Consensus 226 ------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ------ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122367889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=337.31 Aligned_cols=257 Identities=21% Similarity=0.269 Sum_probs=197.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.++||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG 86 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence 367999999999999865 57889999986432 23356789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCC-----CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 349 GNLFNRIHGGKSS-----KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 349 gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
|+|.+++...... .....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-------IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-------VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCchheEEEcCCCCEEEEecCc
Confidence 9999998642211 11124567788999999999999999998 99999999999999999999999999
Q ss_pred cccccCc----------------------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 047954 424 SSLVAQP----------------------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGIN 481 (582)
Q Consensus 424 a~~~~~~----------------------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~ 481 (582)
++..... ....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~---- 235 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK---- 235 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc----
Confidence 9765210 11246788999999999999999999999999999999999996421
Q ss_pred ccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCC-ChHHHHHHHhhcccCCC
Q 047954 482 GADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-EMAEVVSELEIIKVTES 552 (582)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~ 552 (582)
...+... .. +.++... ....+....+.+++.+|++.||++|| +++++++.|+.......
T Consensus 236 ~~ki~~~--~~--------i~~P~~~--~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 236 GRKISYR--DV--------ILSPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred hhhhhhh--hh--------ccChhhc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 1111100 00 0000000 00011123577899999999999995 67777788877755443
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.46 Aligned_cols=246 Identities=23% Similarity=0.346 Sum_probs=198.1
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 35699999999999985 56788999998765555567889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++... .+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 104 ~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~~-------i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 104 TDVVTET-------CMDEAQIAAVCRECLQALEFLHANQ-------VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred HHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9988632 3788999999999999999999998 9999999999999999999999999987654322
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
...++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ......... ........
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-------~~~~~~~~~-~~~~~~~~---- 237 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIAT-NGTPELQN---- 237 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh-cCCcccCC----
Confidence 22456789999999888899999999999999999999999964321 111111111 11111000
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.......+.+++.+||..||++||++.+++.+-+.-.
T Consensus 238 ----~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 238 ----PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred ----cccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 0111225778899999999999999999999877644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=302.94 Aligned_cols=250 Identities=23% Similarity=0.417 Sum_probs=193.4
Q ss_pred cccccccCceEEEEEEEc----CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCC------eeE
Q 047954 273 AEGLGKGIFGNSYKALLE----GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSND------EKL 340 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~ 340 (582)
.+.||+|+||.||+|.+. .+..||||++.... ....+.+.+|+.++++++||||+++++++.... ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 357999999999999853 35789999886432 234567889999999999999999999887543 247
Q ss_pred EEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEee
Q 047954 341 LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSD 420 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 420 (582)
+++||+.+|+|.+++...........+++...+.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN-------FIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------EeecccchhhEEEcCCCCEEECc
Confidence 88999999999988764332222335788889999999999999999988 99999999999999999999999
Q ss_pred ccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHH
Q 047954 421 YGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 421 fG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
||+++...... ...++..|++||.+....++.++|||||||++|||++ |+.||.... ..++..++..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~----~~~~~~~~~~-- 230 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE----NSEIYNYLIK-- 230 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC----HHHHHHHHHc--
Confidence 99988664321 1223467999999988889999999999999999999 888885321 1222222211
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
...... .......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 231 -~~~~~~-----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 -GNRLKQ-----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -CCcCCC-----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110000 011223688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=300.96 Aligned_cols=243 Identities=20% Similarity=0.342 Sum_probs=192.8
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCc------chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKP------LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|...++..+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 467999999999999988888999998864321 12346888999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++..
T Consensus 85 ~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 85 PGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNNC-------VVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 9999999996432 4778888999999999999999988 99999999999999999999999999875
Q ss_pred ccCc----------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 427 VAQP----------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 427 ~~~~----------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
.... ....++..|+|||+..+..++.++|||||||++|||++|+.||..... ............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~ 225 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR------LAAMFYIGAHRG 225 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh------HHHHHHhhhccC
Confidence 4211 122356789999999988899999999999999999999999964211 111000000001
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
....+. .....++.+++.+||+.+|++||++.+++++-
T Consensus 226 ~~~~~~----------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 263 (265)
T cd06631 226 LMPRLP----------DSFSAAAIDFVTSCLTRDQHERPSALQLLRHD 263 (265)
T ss_pred CCCCCC----------CCCCHHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence 111111 01123578899999999999999999998764
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=319.02 Aligned_cols=245 Identities=20% Similarity=0.256 Sum_probs=189.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++......++||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 127 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 467999999999999965 5678999988532 222345578899999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 g~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~-------ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 128 GDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSMG-------FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred CcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCC-------EEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999998642 3677788889999999999999998 9999999999999999999999999997764
Q ss_pred Cc-----ccccccccccCCCCCCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 429 QP-----IAAQRMISYKSPEYQSSK----KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 429 ~~-----~~~~~~~~y~aPE~~~~~----~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
.. ....+|+.|+|||++... .++.++|||||||++|||++|+.||.... ...............
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~ 266 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMNHKNSL 266 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCcc
Confidence 32 133478899999998654 37899999999999999999999996422 111111111111111
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCC--CCChHHHHHHHhh
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEK--RPEMAEVVSELEI 546 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~~ 546 (582)
...+ .......+.+++.+|+..++.+ |++++|+++|.+.
T Consensus 267 ~~~~--------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 267 TFPD--------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred cCCC--------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 1111 0111235677888999744433 7899999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.92 Aligned_cols=242 Identities=24% Similarity=0.382 Sum_probs=193.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||++... ++..+|+|.++.. .....+.+.+|+.++++++|+||+++++++...+..++||||+++|+
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 84 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence 467999999999999864 6788999988543 23345678899999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++..... ..++....+.++.|++.||.|||+.+ |+|+||||+||++++++.++++|||.+......
T Consensus 85 l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~~-------i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 85 LMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHEKR-------VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred HHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhhCC-------cccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 9998864332 24788889999999999999999998 999999999999999999999999998766443
Q ss_pred c----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 431 I----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
. ...++..|+|||++.+..++.++||||||+++|+|++|+.||.... ........ .......+ .
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-------~~~~~~~~-~~~~~~~~-~--- 221 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-------WKNLILKV-CQGSYKPL-P--- 221 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-------HHHHHHHH-hcCCCCCC-C---
Confidence 2 2346678999999988889999999999999999999999996421 11111111 11111111 0
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHH
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 543 (582)
......+.+++.+||+.||++||++.+++..
T Consensus 222 ------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 ------SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0112257789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.82 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=201.3
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCCcc---hHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPL---ITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|.||.||+++... ++.+|+|.+.+.... ..+...+|+.+|+++. |||||.+++.|.+....++|||++.
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 4789999999999999665 899999999654432 3468999999999998 9999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC----CceEEeeccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN----EMVLVSDYGF 423 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DfG~ 423 (582)
||.|++.+... .+++.....++.||+.|+.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 120 GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~g-------vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 120 GGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSLG-------VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred CchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhCC-------ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999754 2888999999999999999999998 9999999999999643 4799999999
Q ss_pred cccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 424 SSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 424 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
|...... ....||+.|+|||++....|+..+||||+||++|.|++|..||...... .... ......+ +
T Consensus 186 a~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~----~~~~---~i~~~~~--~ 256 (382)
T KOG0032|consen 186 AKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF----EIFL---AILRGDF--D 256 (382)
T ss_pred ceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh----HHHH---HHHcCCC--C
Confidence 9988763 3455889999999999999999999999999999999999999754321 1111 1111111 1
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+.++ ........+.+++..|+..||.+|+|+.++++|.|-.
T Consensus 257 f~~~------~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~ 297 (382)
T KOG0032|consen 257 FTSE------PWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIK 297 (382)
T ss_pred CCCC------CccccCHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence 1111 1111223567888899999999999999999998833
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=301.21 Aligned_cols=243 Identities=21% Similarity=0.367 Sum_probs=195.5
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|...+ +..+++|.+..... .+.+.+|++++++++|+||+++++++......++++||+++++|
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 85 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence 3569999999999999765 78899999864332 67899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 86 ~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~-------i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 86 SDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSNK-------KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred HHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99986432 25889999999999999999999988 9999999999999999999999999988765432
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
...++..|+|||++.+..++.++|||||||++|||++|+.||...... .. ... ......... .
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~----~~---~~~-~~~~~~~~~-----~ 220 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM----RA---IFM-IPNKPPPTL-----S 220 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh----hh---hhh-hccCCCCCC-----C
Confidence 223567899999998889999999999999999999999999643211 00 000 000000000 0
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
........+.+++.+||+.+|++|||+.||+++-+
T Consensus 221 ---~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 221 ---DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred ---chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 01111235788999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=297.15 Aligned_cols=245 Identities=21% Similarity=0.365 Sum_probs=195.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++||||+++++++......+++|||+++++|
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l 87 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL 87 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence 356999999999999864 5678999998765555667899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++.... ..++...+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 88 ~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~~-------i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 88 QDIYQVTR-----GPLSELQIAYVCRETLKGLAYLHETG-------KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred HHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC-------ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 99887542 24788899999999999999999988 9999999999999999999999999987664322
Q ss_pred ----cccccccccCCCCCCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 432 ----AAQRMISYKSPEYQSSK---KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~---~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
...++..|+|||..... .++.++|||||||++|||+||+.||..... . ...............
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~----~---~~~~~~~~~~~~~~~--- 225 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP----M---RALFLISKSNFPPPK--- 225 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH----H---HHHHHHHhccCCCcc---
Confidence 22356679999998776 889999999999999999999999964321 0 111111111100000
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHH
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 543 (582)
. ........++.+++.+||..+|++|||+.+|+.+
T Consensus 226 -~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 -L---KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred -c---cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0111223467899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.33 Aligned_cols=247 Identities=24% Similarity=0.430 Sum_probs=192.4
Q ss_pred cccccccCceEEEEEEEc-CCc----eEEEEEecCCCc-chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRA----PVVVKRLRDLKP-LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|... ++. .||+|.+..... ....++.+|+.++++++||||++++++|... ..++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 367999999999999853 333 468888764332 2344688999999999999999999998754 467999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 91 ~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~-------ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 91 PHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEERR-------LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred CCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhcC-------eeccccccceeeecCCCceEEcccccccc
Confidence 99999999875432 4788899999999999999999988 99999999999999999999999999987
Q ss_pred ccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 427 VAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 427 ~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
+.... ....+..|+|||++.+..++.++|||||||++|||++ |+.||.... .......+ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~----~~~~~~~~----~~~~~~ 230 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP----TREIPDLL----EKGERL 230 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHH----HCCCCC
Confidence 64322 1223467999999998899999999999999999998 889985421 11222221 111110
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
. .+ ......+.+++.+||..+|++||+++++++.+..+...
T Consensus 231 ~--~~--------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 P--QP--------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred C--CC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 00 01123578899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=303.08 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=197.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... ++..+|+|..........+.+..|++++++++||||+++++++......++||||+++++|
T Consensus 10 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (280)
T cd06611 10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGAL 89 (280)
T ss_pred HHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcH
Confidence 356999999999999964 5788999998765555667899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~~-------i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 90 DSIMLELE-----RGLTEPQIRYVCRQMLEALNFLHSHK-------VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99986432 24888999999999999999999998 999999999999999999999999998665332
Q ss_pred ---ccccccccccCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 431 ---IAAQRMISYKSPEYQS-----SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~-----~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
....++..|+|||++. ...++.++|||||||++|||++|+.||.... . ........... .....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~----~---~~~~~~~~~~~-~~~~~ 229 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN----P---MRVLLKILKSE-PPTLD 229 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC----H---HHHHHHHhcCC-CCCcC
Confidence 1234677899999874 3457889999999999999999999996421 1 11111111111 10000
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
. ......++.+++.+||+.+|++||++.+++++.+....
T Consensus 230 ~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 230 Q--------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred C--------cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 0 01112357789999999999999999999999775443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=303.77 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=194.8
Q ss_pred cccccccCceEEEEEEEcCC-ceEEEEEecCCCcchHH--HHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGR-APVVVKRLRDLKPLITE--EFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||+||++..... ..+|+|.+......... ...+|+.++++++||||+++++++......++||||+.++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 46799999999999997654 57999999765433322 3456999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc-
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA- 428 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~- 428 (582)
+|.+++... ..+++..++.++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||.+....
T Consensus 84 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~Lh~~~-------i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~ 150 (260)
T PF00069_consen 84 SLQDYLQKN------KPLSEEEILKIAYQILEALAYLHSKG-------IVHRDIKPENILLDENGEVKLIDFGSSVKLSE 150 (260)
T ss_dssp BHHHHHHHH------SSBBHHHHHHHHHHHHHHHHHHHHTT-------EEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred ccccccccc------cccccccccccccccccccccccccc-------cccccccccccccccccccccccccccccccc
Confidence 999999722 25889999999999999999999998 9999999999999999999999999987531
Q ss_pred ---CcccccccccccCCCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 ---QPIAAQRMISYKSPEYQS-SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ---~~~~~~~~~~y~aPE~~~-~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
......++..|+|||+.. +..++.++||||+|+++|+|++|+.||... ...+..................
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~-- 224 (260)
T PF00069_consen 151 NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES----NSDDQLEIIEKILKRPLPSSSQ-- 224 (260)
T ss_dssp TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS----SHHHHHHHHHHHHHTHHHHHTT--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc----cchhhhhhhhhccccccccccc--
Confidence 122344677899999988 788999999999999999999999999743 1111111121111111000000
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.......++.+++.+||+.||++||++.+++++.|
T Consensus 225 ------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 225 ------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp ------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred ------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 00001147889999999999999999999998765
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=313.27 Aligned_cols=240 Identities=21% Similarity=0.287 Sum_probs=188.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
...||+|+||.||+|... ++..||+|++... .....+.+..|..++..+. |++|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 357999999999999865 5788999998642 1233456778888888875 5778889999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~~-------ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 85 GGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRRG-------IIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeccCCCHHHeEECCCCCEEEecccccccc
Confidence 999999986432 4888999999999999999999998 999999999999999999999999998754
Q ss_pred cCc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
... ....++..|+|||++.+..++.++|||||||++|||+||+.||.... ...+...+. .... ..
T Consensus 152 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~----~~~~~~~i~---~~~~--~~-- 220 (323)
T cd05615 152 MVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED----EDELFQSIM---EHNV--SY-- 220 (323)
T ss_pred CCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHH---hCCC--CC--
Confidence 322 22347789999999998899999999999999999999999996432 112222211 1110 00
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh-----HHHHHHH
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM-----AEVVSEL 544 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~L 544 (582)
+.....++.+++.+||+.+|++|++. +++.+|.
T Consensus 221 --------p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~ 258 (323)
T cd05615 221 --------PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHA 258 (323)
T ss_pred --------CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCc
Confidence 00112256788999999999999984 5666553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.48 Aligned_cols=256 Identities=19% Similarity=0.306 Sum_probs=193.4
Q ss_pred cccccccCceEEEEEEEcC---CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLEG---RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
...||+|+||.||++...+ +..||+|.+... +...+|++++++++|||||++++++......++||||+. +
T Consensus 97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 170 (392)
T PHA03207 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-C 170 (392)
T ss_pred EEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-C
Confidence 4679999999999997543 467889987542 235689999999999999999999999999999999995 6
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++... ..+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.+..
T Consensus 171 ~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~g-------ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 171 DLFTYVDRS------GPLPLEQAITIQRRLLEALAYLHGRG-------IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 898888422 25889999999999999999999998 99999999999999999999999999976543
Q ss_pred cc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---cccc
Q 047954 430 PI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE---WTAE 500 (582)
Q Consensus 430 ~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 500 (582)
.. ...++..|+|||++.+..++.++|||||||++|||++|+.||...........+ ..+.+..... +...
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l-~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL-RSIIRCMQVHPLEFPQN 316 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHH-HHHHHHhccCccccCCc
Confidence 22 234788999999999999999999999999999999999999754332111111 1111111100 0000
Q ss_pred --------------ccchhhhhhhch--HHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 501 --------------IFDSEISVQRSA--AHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 501 --------------~~d~~~~~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
...+........ .....++.+++.+||..||++|||+.|++.+.+..+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 000000000000 011235678899999999999999999999987654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=328.56 Aligned_cols=260 Identities=20% Similarity=0.304 Sum_probs=188.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCC------CCccccceEEEeC-CeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKH------PNLLPLLAYYFSN-DEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H------~niv~l~~~~~~~-~~~~lv~e 344 (582)
.+.||+|+||+||+|... .+..||||+++... ...+.+..|+.++.+++| .+++++++++... .+.++|||
T Consensus 134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~ 212 (467)
T PTZ00284 134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMP 212 (467)
T ss_pred EEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEe
Confidence 467999999999999864 56789999986432 234456677777777655 4588888988765 46889999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeecCCC---------
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLDDNE--------- 414 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~~~~--------- 414 (582)
++ +++|.+++.... .+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 213 ~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~g-------IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 213 KY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTELH-------LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred cc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcCC-------eecCCCCHHHEEEecCCccccccccc
Confidence 88 778999886432 488899999999999999999984 6 99999999999998765
Q ss_pred -------ceEEeeccccccccCc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchH
Q 047954 415 -------MVLVSDYGFSSLVAQP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLC 486 (582)
Q Consensus 415 -------~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~ 486 (582)
.+||+|||.+...... ....+|..|+|||++.+..++.++|||||||++|||+||+.||..... .+..
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~----~~~~ 354 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN----LEHL 354 (467)
T ss_pred ccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHH
Confidence 4999999988654322 234578899999999999999999999999999999999999964321 1111
Q ss_pred HHHHHHHh---hcccc------------------cccchhhh----hhhc--hHHHHHHHHHHHHHcccCCCCCCCChHH
Q 047954 487 SWVLRAVR---EEWTA------------------EIFDSEIS----VQRS--AAHGMLKLLQVAIQCCNKSPEKRPEMAE 539 (582)
Q Consensus 487 ~~~~~~~~---~~~~~------------------~~~d~~~~----~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 539 (582)
..+..... ..+.. ...++... .... .......+.+|+.+||++||++|||++|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 11111100 00000 00000000 0000 0001235779999999999999999999
Q ss_pred HHHHHhhcccCC
Q 047954 540 VVSELEIIKVTE 551 (582)
Q Consensus 540 vl~~L~~i~~~~ 551 (582)
+++|.+..+...
T Consensus 435 ~L~Hp~~~~~~~ 446 (467)
T PTZ00284 435 MTTHPYVLKYYP 446 (467)
T ss_pred HhcCccccccCC
Confidence 999998765444
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.09 Aligned_cols=244 Identities=23% Similarity=0.346 Sum_probs=194.9
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
..||+|+||.||++... ++..||||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999864 57889999986555555677899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++... .+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 108 ~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~~-------ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 108 DIVTHT-------RMNEEQIATVCLSVLRALSYLHNQG-------VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred HHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-------EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 988532 3778889999999999999999998 9999999999999999999999999987543221
Q ss_pred ---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 432 ---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 432 ---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
...++..|+|||+..+..++.++|||||||++|||++|+.||.... .......+ .........+
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----~~~~~~~~----~~~~~~~~~~----- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP----PLQAMRRI----RDNLPPRVKD----- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH----HhcCCCcccc-----
Confidence 2235678999999988889999999999999999999999986421 11111111 1111111100
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.......+.+++.+||..||++|||++|++++.+..
T Consensus 241 ---~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~ 276 (292)
T cd06658 241 ---SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276 (292)
T ss_pred ---ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence 001122567888899999999999999999885544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.51 Aligned_cols=246 Identities=23% Similarity=0.359 Sum_probs=197.2
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCH
Confidence 46799999999999995 57889999999765555567788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++... .+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 104 ~~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~~-------i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 104 TDVVTET-------CMDEGQIAAVCRECLQALDFLHSNQ-------VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred HHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9998642 3778899999999999999999988 9999999999999999999999999987654322
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
...++..|+|||...+..++.++|||||||++|+|++|+.||...... ..+.. . .... ......
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~---~~~~~-~---~~~~-~~~~~~---- 237 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYL-I---ATNG-TPELQN---- 237 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc---hheee-e---ccCC-CCCCCC----
Confidence 224567899999999888999999999999999999999999643211 00000 0 0000 000000
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.......+.+++.+||+.+|++||++.+++++-+...
T Consensus 238 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 238 ----PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 0111234678899999999999999999999866443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=300.30 Aligned_cols=246 Identities=24% Similarity=0.416 Sum_probs=195.5
Q ss_pred cccccccCceEEEEEEEcC-C----ceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEG-R----APVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|.... + ..+|+|.+.... ....+.+.+|+.++++++||||+++++++.. ...++||||+
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 90 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM 90 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence 4689999999999998643 2 258888876543 2345678899999999999999999999987 7889999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 91 ~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~-------i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 91 PLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEKR-------LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred CCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC-------EEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999975432 4889999999999999999999987 99999999999999999999999999987
Q ss_pred ccCccc------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 427 VAQPIA------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 427 ~~~~~~------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
+..... ...+..|+|||......++.++|||||||++||+++ |+.||.... ..++...+. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~~----~~~~~ 230 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP----AVEIPDLLE----KGERL 230 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC----HHHHHHHHh----CCCCC
Confidence 653321 112457999999988889999999999999999999 999986432 122222221 11100
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
. . +......+.+++.+||..+|++||++.++++.|..+..
T Consensus 231 ~--~--------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 P--Q--------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred C--C--------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 0 00112257789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=297.60 Aligned_cols=243 Identities=19% Similarity=0.315 Sum_probs=202.4
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.++||+|+||.||+|.. +.|+.+|||++... .+.+++.+|+.+|.+++.|++|++||.|.....+|+|||||..|+.
T Consensus 38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 36799999999999985 56889999998643 3578899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+.++.+. .++++.++..+.+..++||+|||... -||||||..|||++.+|.+||+|||.|..+.+..
T Consensus 116 SDI~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH~~~-------KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 116 SDIMRARR-----KPLSEQEISAVLRDTLKGLQYLHDLK-------KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred HHHHHHhc-----CCccHHHHHHHHHHHHhHHHHHHHHH-------HHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99997553 36999999999999999999999987 8999999999999999999999999998876543
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
..-||+-|||||++..-.|++++||||+|++..||.-|++||.+..+-..- -.++.-..+.+
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-------------FMIPT~PPPTF- 249 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-------------FMIPTKPPPTF- 249 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-------------EeccCCCCCCC-
Confidence 445788999999999999999999999999999999999999753321000 00111111111
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
..+.....++-+++..||-+.|++|-|+-++++|..
T Consensus 250 --~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 250 --KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTF 285 (502)
T ss_pred --CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence 123344557889999999999999999999988853
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=311.32 Aligned_cols=261 Identities=18% Similarity=0.289 Sum_probs=194.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|... ++..||+|.++... ......+.+|+.++++++||||+++++++...+..++||||+. ++
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~ 89 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 89 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cC
Confidence 357999999999999865 57789999986432 2334567889999999999999999999999999999999997 59
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 90 l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~~-------i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 90 LKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRRK-------VLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred HHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC-------eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 9988865322 4778889999999999999999998 999999999999999999999999998765322
Q ss_pred c----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---cccccc
Q 047954 431 I----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE---WTAEIF 502 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 502 (582)
. ...++..|+|||.+.+ ..++.++|||||||++|||+||+.||.... ..+....+....... ....+.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST----VEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCChhhchhhh
Confidence 1 2234678999998765 457889999999999999999999996432 111111111111100 000000
Q ss_pred c---------hhhhh---hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 503 D---------SEISV---QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 503 d---------~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
+ +.... ..........+.+++.+|++.||.+|||++|+++|.|.....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0 00000 000001123567899999999999999999999998875544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=305.77 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=197.1
Q ss_pred cccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChHH
Q 047954 275 GLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFN 353 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 353 (582)
.||+|+||.||+|... ++..||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++++|.+
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 107 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence 5999999999999864 678899999865544556778899999999999999999999999999999999999999998
Q ss_pred HHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc---
Q 047954 354 RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP--- 430 (582)
Q Consensus 354 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~--- 430 (582)
++... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 108 ~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~-------ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 108 IVSQT-------RLNEEQIATVCESVLQALCYLHSQG-------VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred HHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence 87532 3788899999999999999999998 999999999999999999999999998755432
Q ss_pred -ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhh
Q 047954 431 -IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQ 509 (582)
Q Consensus 431 -~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 509 (582)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+ .........
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~~~~~----~~~~~~~~~------- 238 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS----PVQAMKRL----RDSPPPKLK------- 238 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH----hccCCCCcc-------
Confidence 12346678999999988889999999999999999999999996321 11111111 111000000
Q ss_pred hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 510 RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 510 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
........+.+++.+||+.+|++||++.+++++.+..+..
T Consensus 239 -~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 239 -NAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred -ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 0001122577889999999999999999999987766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=298.30 Aligned_cols=241 Identities=26% Similarity=0.425 Sum_probs=191.0
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||++.. .+..||+|..+.. ...+.+.+|+.++++++||||+++++++... ..++||||+++++|.
T Consensus 11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~ 86 (254)
T cd05083 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLV 86 (254)
T ss_pred eeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHH
Confidence 57799999999999975 5567999998643 2356789999999999999999999998654 479999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~-------~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~ 155 (254)
T cd05083 87 NFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESKK-------LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD 155 (254)
T ss_pred HHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence 99975432 24788899999999999999999987 9999999999999999999999999987654321
Q ss_pred cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhh
Q 047954 432 AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQR 510 (582)
Q Consensus 432 ~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 510 (582)
.......|+|||++.+..++.++|||||||++|||++ |+.||.... ..+.. .........+..
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~~~~~----~~~~~~~~~~~~-------- 219 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS----LKEVK----ECVEKGYRMEPP-------- 219 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC----HHHHH----HHHhCCCCCCCC--------
Confidence 2223457999999988889999999999999999998 999985422 11111 111111111110
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 511 SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 511 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
......+.+++.+||+.+|++||+++++++.|+.
T Consensus 220 --~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 --EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112357789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=296.35 Aligned_cols=244 Identities=24% Similarity=0.414 Sum_probs=196.3
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||.++. .++..+++|.+... .....+.+.+|+.++++++|+||+++++++.+.+..+++|||+++|
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG 84 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence 36799999999999884 45778999987543 3344567889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 85 ~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~-------i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 85 TLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHKAG-------ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153 (256)
T ss_pred cHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC-------ccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence 9999997542 125788999999999999999999988 99999999999999999999999999876644
Q ss_pred cc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 PI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
.. ...++..|+|||+..+..++.++||||||+++|||++|+.||.... ..+.........+. ...
T Consensus 154 ~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~~~~~~~-~~~--- 222 (256)
T cd08221 154 EYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-------PLNLVVKIVQGNYT-PVV--- 222 (256)
T ss_pred ccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCCC-CCc---
Confidence 32 2346778999999988888999999999999999999999985421 11222222111111 110
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.....++.+++.+||..+|++||++.|+++++.
T Consensus 223 -------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 223 -------SVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred -------cccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 111235778999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=319.95 Aligned_cols=246 Identities=25% Similarity=0.435 Sum_probs=201.9
Q ss_pred cccccccccCceEEEEEEEc-C----CceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEE
Q 047954 271 APAEGLGKGIFGNSYKALLE-G----RAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 271 ~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 344 (582)
....+||+|+||+||+|.+- . ..+||||++... .....+++..|+-+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34578999999999999853 3 347899998654 3445688999999999999999999999998776 789999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
||+.|+|.++++..+. .+.....+.|..|||+||.|||.+. +|||||-.+|||+..-..+||+|||+|
T Consensus 778 ~mP~G~LlDyvr~hr~-----~igsq~lLnw~~QIAkgM~YLe~qr-------lVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD-----NIGSQDLLNWCYQIAKGMKYLEEQR-------LVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred hcccchHHHHHHHhhc-----cccHHHHHHHHHHHHHHHHHHHhcc-------hhhhhhhhhheeecCCCeEEEEecchh
Confidence 9999999999987554 4788889999999999999999987 999999999999999999999999999
Q ss_pred ccccCccccc------ccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 425 SLVAQPIAAQ------RMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 425 ~~~~~~~~~~------~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
+.+....... ..+.|||-|.+....|+.++|||||||++||++| |..|++..+ ..++.+.+....+
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~----~~eI~dlle~geR--- 918 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP----AEEIPDLLEKGER--- 918 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC----HHHhhHHHhcccc---
Confidence 9987654322 2367999999999999999999999999999999 999986543 2233332222111
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
...+..+...+..++.+||..|+..||+++++...+.+.
T Consensus 919 -----------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 919 -----------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred -----------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 112334455789999999999999999999998877543
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=300.03 Aligned_cols=241 Identities=22% Similarity=0.399 Sum_probs=191.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcc---------hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPL---------ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLV 342 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 342 (582)
...||+|+||.||+|... ++..||+|.+...... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence 457999999999999864 5788999988643221 125688899999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecc
Q 047954 343 YKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG 422 (582)
Q Consensus 343 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 422 (582)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||
T Consensus 85 ~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~~-------ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 85 LEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNRG-------IIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred EEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhcC-------cccccCCHHHEEEcCCCCEEecccC
Confidence 99999999999996432 4788889999999999999999988 9999999999999999999999999
Q ss_pred ccccccCcc----------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHH
Q 047954 423 FSSLVAQPI----------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492 (582)
Q Consensus 423 ~a~~~~~~~----------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 492 (582)
.++...... ...++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~ 224 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------LQAIFKI 224 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------HHHHHHH
Confidence 987764211 12356789999999888899999999999999999999999964211 1111111
Q ss_pred HhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 493 VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 493 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
. ......+ . ......+.+++.+||+.||++||++.||+++-
T Consensus 225 ~-~~~~~~~-~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 265 (267)
T cd06628 225 G-ENASPEI-P---------SNISSEAIDFLEKTFEIDHNKRPTAAELLKHP 265 (267)
T ss_pred h-ccCCCcC-C---------cccCHHHHHHHHHHccCCchhCcCHHHHhhCC
Confidence 0 1101111 0 11123577889999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.12 Aligned_cols=240 Identities=20% Similarity=0.268 Sum_probs=184.1
Q ss_pred ccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcC---CCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 276 LGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQ---KHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 276 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
||+|+||+||+|+.. ++..||+|++.... ......+..|..++.+. +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 57889999985321 11223345566666654 799999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~~-------ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 81 GELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKYD-------IVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred ChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 99999886432 4788899999999999999999998 9999999999999999999999999987542
Q ss_pred Cc----ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 429 QP----IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
.. ....++..|+|||++.+. .++.++|||||||++|||+||+.||.... ...+.. . +..... .+..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~----~~~~~~---~-i~~~~~-~~~~ 218 (330)
T cd05586 148 TDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED----TQQMYR---N-IAFGKV-RFPK 218 (330)
T ss_pred CCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC----HHHHHH---H-HHcCCC-CCCC
Confidence 21 233478899999988754 47999999999999999999999996421 111111 1 111100 0000
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCC----ChHHHHHHHhh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP----EMAEVVSELEI 546 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP----s~~evl~~L~~ 546 (582)
. .....+.+++.+||+.||++|| ++.++++|.+.
T Consensus 219 ~---------~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~ 256 (330)
T cd05586 219 N---------VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256 (330)
T ss_pred c---------cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccc
Confidence 0 0112567889999999999998 67888887654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.51 Aligned_cols=255 Identities=18% Similarity=0.265 Sum_probs=190.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCC------eeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND------EKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 343 (582)
.+.||+|+||.||+|... .+..||||++... .......+.+|+.+++.++||||+++++++.... ..++||
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 101 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence 367999999999999854 5778999998643 2233467788999999999999999999886543 468999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+.+ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~g-------ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 102 ELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred hhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCChHHEEECCCCCEEEeeCcc
Confidence 99965 77776642 3678888899999999999999998 99999999999999999999999999
Q ss_pred cccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc----
Q 047954 424 SSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE---- 496 (582)
Q Consensus 424 a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---- 496 (582)
++...... ...++..|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.......
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHH
Confidence 98764432 23467889999999998999999999999999999999999964321 11111111100000
Q ss_pred ----------c------ccccc------chhhhhh-hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 497 ----------W------TAEIF------DSEISVQ-RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 497 ----------~------~~~~~------d~~~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+ ..... +...... ........++.+++.+||+.||++|||+.|+++|.+.-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 0 00000 0000000 00011124578999999999999999999999997653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=319.53 Aligned_cols=245 Identities=18% Similarity=0.280 Sum_probs=189.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... ++..||+|+++.. .......+..|+.++.+++||||+++++.+.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 367999999999999865 5788999998642 223345678899999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 g~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~g-------ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 86 GDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQLG-------FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred ccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999986432 4788899999999999999999998 9999999999999999999999999987542
Q ss_pred Cc---------------------------------------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhC
Q 047954 429 QP---------------------------------------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469 (582)
Q Consensus 429 ~~---------------------------------------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG 469 (582)
.. ....||+.|+|||++.+..++.++|||||||++|||+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 21 012467889999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCC---ChHHHHHHHhh
Q 047954 470 RISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP---EMAEVVSELEI 546 (582)
Q Consensus 470 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~L~~ 546 (582)
+.||..... ......+ ........ +.+.. . ...++.+++.+|+ .||++|+ ++.|+++|.+.
T Consensus 233 ~~Pf~~~~~----~~~~~~i---~~~~~~~~-~p~~~----~---~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f 296 (360)
T cd05627 233 YPPFCSETP----QETYRKV---MNWKETLV-FPPEV----P---ISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFF 296 (360)
T ss_pred CCCCCCCCH----HHHHHHH---HcCCCcee-cCCCC----C---CCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCC
Confidence 999964321 1111111 11000000 11100 0 1124566676766 4999998 47899988763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=315.49 Aligned_cols=254 Identities=17% Similarity=0.260 Sum_probs=190.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeC------CeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN------DEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~ 343 (582)
.+.||+|+||.||+|... .+..||||++... .......+.+|+.+++.++||||+++++++... ...++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~ 108 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence 467999999999999854 5778999998643 223446788899999999999999999988653 3479999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+.+ +|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 109 e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~-------ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 109 ELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eCCCC-CHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhCC-------eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 99965 78777742 3677888999999999999999998 99999999999999999999999999
Q ss_pred cccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc---
Q 047954 424 SSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW--- 497 (582)
Q Consensus 424 a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~--- 497 (582)
++...... ...++..|+|||++.+..++.++|||||||++|||++|+.||..... .+....+........
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCHHH
Confidence 98765432 23467889999999999999999999999999999999999964321 111111111000000
Q ss_pred --------------ccccc----c---hhhhh---hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 498 --------------TAEIF----D---SEISV---QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 498 --------------~~~~~----d---~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
..... . +.... .........++.+++.+|++.||++|||+.|+++|.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 00000 0 00000 00000112357899999999999999999999999775
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=299.75 Aligned_cols=243 Identities=21% Similarity=0.318 Sum_probs=189.3
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeC------CeeEEEEEe
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSN------DEKLLVYKF 345 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~------~~~~lv~e~ 345 (582)
+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +|+||+++++++... ...++||||
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred HheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 56999999999999865 56788999886433 3456788999999998 799999999998753 457899999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++|+|.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||++.
T Consensus 91 ~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~-------ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 91 CGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQHK-------VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 999999999875332 24788899999999999999999998 9999999999999999999999999997
Q ss_pred cccCc----ccccccccccCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 426 LVAQP----IAAQRMISYKSPEYQS-----SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 426 ~~~~~----~~~~~~~~y~aPE~~~-----~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
..... ....++..|+|||++. ...++.++|||||||++|||++|+.||..... ..... .. ...
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~------~~~~~-~~-~~~ 231 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALF-LI-PRN 231 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH------HHHHH-HH-hcC
Confidence 65432 2234667899999876 34578899999999999999999999964221 11110 10 111
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
......+. ....++.+++.+||..+|++|||+.|++++-|
T Consensus 232 ~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 232 PAPRLKSK---------KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred CCCCCCCC---------CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 11111111 11235788999999999999999999998754
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=302.26 Aligned_cols=253 Identities=22% Similarity=0.351 Sum_probs=196.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||++... .+..||+|.++.. .....+.+.+|+.++.+++|+||+++++++...+..++||||+++++
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (286)
T cd06622 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGS 85 (286)
T ss_pred hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCC
Confidence 357999999999999975 6788999988643 23334678899999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
|..++..... ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++..+..
T Consensus 86 l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~-------i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 86 LDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEEHN-------IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred HHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcCC-------EeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 9998875321 12588999999999999999999974 5 99999999999999999999999999876533
Q ss_pred c--ccccccccccCCCCCCCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 430 P--IAAQRMISYKSPEYQSSK------KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 430 ~--~~~~~~~~y~aPE~~~~~------~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
. ....++..|+|||.+.+. .++.++|||||||++|||++|+.||.... .......+..... .....+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~-~~~~~~ 230 (286)
T cd06622 156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET----YANIFAQLSAIVD-GDPPTL 230 (286)
T ss_pred CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc----hhhHHHHHHHHhh-cCCCCC
Confidence 2 223356789999988544 35889999999999999999999996421 1111111111111 111111
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
......++.+++.+||..+|++||++.+++.+.|.....
T Consensus 231 ----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 231 ----------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred ----------CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 111233577899999999999999999999988755443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.08 Aligned_cols=256 Identities=19% Similarity=0.300 Sum_probs=189.7
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeC------CeeEEEEE
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN------DEKLLVYK 344 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e 344 (582)
+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+.++++++||||+++++++... ...++++|
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 100 (343)
T cd07878 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100 (343)
T ss_pred eecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEee
Confidence 5799999999999985 467789999986432 12345677899999999999999999988643 34689999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
++ +++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 101 ~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~-------ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 101 LM-GADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSAG-------IIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-------eecccCChhhEEECCCCCEEEcCCccc
Confidence 88 77998887532 4888999999999999999999998 999999999999999999999999999
Q ss_pred ccccCcc-cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc---cc
Q 047954 425 SLVAQPI-AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW---TA 499 (582)
Q Consensus 425 ~~~~~~~-~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 499 (582)
+...... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+........ ..
T Consensus 166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 166 RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND----YIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred eecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHhCCCCHHHHH
Confidence 8765432 3346788999999876 568999999999999999999999996422 1111111111100000 00
Q ss_pred cccch-------hhhh-hhc-----hHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 500 EIFDS-------EISV-QRS-----AAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 500 ~~~d~-------~~~~-~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.+... .+.. ... .......+.+++.+|+..||++|||+.|+++|.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 00000 0000 000 0001124678999999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=304.16 Aligned_cols=246 Identities=22% Similarity=0.324 Sum_probs=195.1
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCCc---chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP---LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||++++++|...+..++||||+. |
T Consensus 21 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g 99 (307)
T cd06607 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 99 (307)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-C
Confidence 57999999999999864 678899998864322 233568899999999999999999999999999999999996 5
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
++.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++.....
T Consensus 100 ~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~L~~LH~~~-------i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 100 SASDILEVHK-----KPLQEVEIAAICHGALQGLAYLHSHE-------RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred CHHHHHHHcc-----cCCCHHHHHHHHHHHHHHHHHHHHCC-------ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 8877775332 24889999999999999999999988 99999999999999999999999999987765
Q ss_pred cccccccccccCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 430 PIAAQRMISYKSPEYQS---SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 ~~~~~~~~~y~aPE~~~---~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.....++..|+|||++. ...++.++||||||+++|||+||+.||.... ........ ........
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-------~~~~~~~~-~~~~~~~~----- 234 (307)
T cd06607 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHI-AQNDSPTL----- 234 (307)
T ss_pred CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-------HHHHHHHH-hcCCCCCC-----
Confidence 55556778899999874 3568899999999999999999999985321 11111111 11101110
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
........+.+++.+||..+|++||++.+|+.+.+..+.
T Consensus 235 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 235 ----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred ----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 011123468889999999999999999999998876553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=334.78 Aligned_cols=253 Identities=20% Similarity=0.331 Sum_probs=190.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~ 347 (582)
.+.||+|+||+||+|... .+..||+|.+... .......|..|+.++.+++|||||+++++|... ...++||||++
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~ 97 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD 97 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence 467999999999999965 4567888887543 233456789999999999999999999988654 46899999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC--------------
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN-------------- 413 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~-------------- 413 (582)
+|+|.++|...... ...+++..++.|+.||+.||+|||+.+.+....+||||||||+||||+.+
T Consensus 98 gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ 175 (1021)
T PTZ00266 98 AGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175 (1021)
T ss_pred CCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence 99999999753221 12588999999999999999999985421112349999999999999642
Q ss_pred ---CceEEeeccccccccCc---ccccccccccCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 047954 414 ---EMVLVSDYGFSSLVAQP---IAAQRMISYKSPEYQSS--KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADL 485 (582)
Q Consensus 414 ---~~~kl~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~ 485 (582)
..+||+|||+++.+... ....+++.|+|||++.+ ..++.++||||||||||||+||+.||.... ..
T Consensus 176 ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~------~~ 249 (1021)
T PTZ00266 176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN------NF 249 (1021)
T ss_pred CCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC------cH
Confidence 34899999999876433 23357889999998854 458999999999999999999999996421 11
Q ss_pred HHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 486 CSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 486 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.. +...+.... .. .. .....++.+|+..||..+|++||++.|++.+.+
T Consensus 250 ~q-li~~lk~~p--~l-----pi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 250 SQ-LISELKRGP--DL-----PI----KGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred HH-HHHHHhcCC--CC-----Cc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 11 111111110 00 00 011235788999999999999999999997644
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=299.51 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=198.6
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
..||.|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++......++|+||+++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (274)
T cd06609 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC 86 (274)
T ss_pred hhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcH
Confidence 56999999999999965 57889999986432 33446788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++.....
T Consensus 87 ~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~~-------i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 87 LDLLKPG-------KLDETYIAFILREVLLGLEYLHEEG-------KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred HHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9998643 4788999999999999999999988 999999999999999999999999999776543
Q ss_pred ---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 431 ---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
....++..|+|||++.+..++.++|||||||++|||+||+.||..... .... ...............
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~----~~~~----~~~~~~~~~~~~~~~-- 222 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP----MRVL----FLIPKNNPPSLEGNK-- 222 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch----HHHH----HHhhhcCCCCCcccc--
Confidence 123356679999999988899999999999999999999999964321 1111 111111111111110
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
....+.+++.+||..+|++|||+++++++.+.....
T Consensus 223 -------~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 223 -------FSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred -------cCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 122577899999999999999999999987765543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=297.71 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=193.8
Q ss_pred ccccccCceEEEEEEEc------CCceEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 274 EGLGKGIFGNSYKALLE------GRAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
..||+|+||.||+|+.. +...|++|.+...... ..+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (275)
T cd05046 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYT 90 (275)
T ss_pred eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEec
Confidence 56999999999999864 2456889988654433 4578999999999999999999999999989999999999
Q ss_pred CCCChHHHHhcCCCCC---CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 347 GNGNLFNRIHGGKSSK---NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
++|+|.+++....... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||+
T Consensus 91 ~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~-------i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 91 DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR-------FVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred CCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC-------cccCcCccceEEEeCCCcEEEccccc
Confidence 9999999997544211 1125899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCcc-----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 424 SSLVAQPI-----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 424 a~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
++...... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ...+.... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~----~~~~~~~~----~~~~ 235 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS----DEEVLNRL----QAGK 235 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc----hHHHHHHH----HcCC
Confidence 86543221 1223566999999988888999999999999999999 788885321 11111111 1111
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
...... ......+.+++.+||+.+|++||++.|++..|+
T Consensus 236 ~~~~~~---------~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LELPVP---------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCCCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 100000 011236788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=314.23 Aligned_cols=246 Identities=22% Similarity=0.356 Sum_probs=199.2
Q ss_pred ccccccCceEEEEEEEcCCce-EEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALLEGRAP-VVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
..||.|+||+||+|..++... .|.|++........++|..||++|+.++||+||++++.|+..+.++++.|||.||...
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 358999999999998665443 4567776656667789999999999999999999999999999999999999999998
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc--
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP-- 430 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~-- 430 (582)
..+.+-. .+++..++..+++|++.||.|||+++ |||||||+.|||++-+|.++|+|||.+......
T Consensus 118 aimlEL~-----r~LtE~QIqvvc~q~ldALn~LHs~~-------iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 118 AIMLELG-----RVLTEDQIQVVCYQVLDALNWLHSQN-------IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred HHHHHhc-----cccchHHHHHHHHHHHHHHHHHhhcc-------hhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 8876543 26999999999999999999999998 999999999999999999999999998654332
Q ss_pred --ccccccccccCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 431 --IAAQRMISYKSPEYQS-----SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 431 --~~~~~~~~y~aPE~~~-----~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
....||+.|||||+.. ..+|+.++||||||++|.||..+.+|.+... .+..+......+ ++.++.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------pMRVllKiaKSe-PPTLlq 257 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSE-PPTLLQ 257 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------hHHHHHHHhhcC-CCcccC
Confidence 3456899999999754 5689999999999999999999999875422 222222222221 222222
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+......+.+++.+||.++|..||++.++++|.+--
T Consensus 258 --------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 258 --------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred --------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 233445688899999999999999999999987643
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=299.43 Aligned_cols=246 Identities=20% Similarity=0.372 Sum_probs=198.2
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|+|
T Consensus 10 ~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06640 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred hhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcH
Confidence 56999999999999865 57889999886432 33456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++... .+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 90 ~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~~-------ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 90 LDLLRAG-------PFDEFQIATMLKEILKGLDYLHSEK-------KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred HHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCC-------ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9998632 3778888999999999999999988 9999999999999999999999999987654322
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
...++..|+|||++.+..++.++|||||||++|||+||+.||..... ..... .........
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~----~~~~~----~~~~~~~~~------- 220 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP----MRVLF----LIPKNNPPT------- 220 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh----HhHhh----hhhcCCCCC-------
Confidence 12356679999999888899999999999999999999999864321 11111 111111111
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
........+.+++.+||+.+|++||++.+++.+.+......
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 221 ---LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred ---CchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 11123346889999999999999999999999987665444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=297.81 Aligned_cols=242 Identities=18% Similarity=0.288 Sum_probs=186.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-----cchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-----PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 344 (582)
.+.||+|+||.||+|... .+..|++|++.... ....+.+.+|+.++++++||||+++++++... ...++++|
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 467999999999999864 57889999885322 12335688899999999999999999998763 56789999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++++|.+++.... .+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 87 ~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~-------i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 87 YMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSNM-------IVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 999999999996432 3778888999999999999999987 999999999999999999999999998
Q ss_pred ccccCc-------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 425 SLVAQP-------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 425 ~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
+.+... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ....+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~-------~~~~~~~~~~~~~ 226 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE-------AMAAIFKIATQPT 226 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc-------hHHHHHHHhcCCC
Confidence 765321 11235678999999998889999999999999999999999996421 1111111111111
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
. +.+. ......+.+++ +||..+|++||+++||++|.+
T Consensus 227 ~-----~~~~-----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~ 263 (266)
T cd06651 227 N-----PQLP-----SHISEHARDFL-GCIFVEARHRPSAEELLRHPF 263 (266)
T ss_pred C-----CCCc-----hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence 1 1100 01112344454 788899999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.02 Aligned_cols=255 Identities=19% Similarity=0.331 Sum_probs=192.5
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
..||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++||||++++.
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (286)
T cd07847 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTV 86 (286)
T ss_pred eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccH
Confidence 56999999999999976 57889999886432 2234568899999999999999999999999999999999999988
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|..++... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 87 l~~~~~~~------~~~~~~~~~~~~~ql~~~l~~LH~~~-------i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 87 LNELEKNP------RGVPEHLIKKIIWQTLQAVNFCHKHN-------CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred HHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCC-------ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 88776532 14789999999999999999999988 999999999999999999999999999876543
Q ss_pred c----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh----------
Q 047954 431 I----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE---------- 495 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---------- 495 (582)
. ...++..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+......
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD----VDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCChHHhhhcc
Confidence 3 2235577999998875 4578999999999999999999999964321 1111111111100
Q ss_pred --cccccccchhhhh----hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 496 --EWTAEIFDSEISV----QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 496 --~~~~~~~d~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.+......+.... ..........+.+++.+||+.+|++||++.|++.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~ 285 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence 0000000000000 0000111246789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=304.82 Aligned_cols=256 Identities=18% Similarity=0.297 Sum_probs=191.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... ++..||+|+++... ....+.+.+|+.++.+++||||+++++++..+...++||||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 357999999999999965 67889999986432 2334678899999999999999999999999999999999997 6
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~-------i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 84 DLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSRR-------VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred CHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhCC-------eeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 89888864332 135888999999999999999999998 99999999999999999999999999876543
Q ss_pred cc----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh----cc---
Q 047954 430 PI----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE----EW--- 497 (582)
Q Consensus 430 ~~----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----~~--- 497 (582)
.. ...++..|+|||.+.+ ..++.++|||||||++|||+||+.||...... ....... +.... .|
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~ 229 (285)
T cd07861 154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI---DQLFRIF-RILGTPTEDVWPGV 229 (285)
T ss_pred CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH-HHhCCCChhhhhcc
Confidence 22 1234678999998765 45789999999999999999999999643210 0011000 00000 00
Q ss_pred ---------cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 498 ---------TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 498 ---------~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.......... ........++.+++.+||..||++|||+.+|+++-+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~ 284 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLR--SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284 (285)
T ss_pred hhhHHHHhhccccCcchhH--HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence 0000000000 000011235678999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=295.16 Aligned_cols=242 Identities=24% Similarity=0.387 Sum_probs=193.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-----cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-----PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|+.++++++|+||+++++++......++|+||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 367999999999999976 78889999885432 224467889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++..
T Consensus 85 ~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dl~~~ni~~~~~~~~kl~d~~~~~~ 151 (258)
T cd06632 85 PGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDRN-------TVHRDIKGANILVDTNGVVKLADFGMAKQ 151 (258)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEECCCCCEEEccCcccee
Confidence 9999999986432 4788899999999999999999998 99999999999999999999999999876
Q ss_pred ccCcc---cccccccccCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 427 VAQPI---AAQRMISYKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 427 ~~~~~---~~~~~~~y~aPE~~~~~~-~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
..... ...++..|+|||.+.... ++.++|+|||||++|+|++|+.||.... -...............+
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~- 223 (258)
T cd06632 152 VVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-------GVAAVFKIGRSKELPPI- 223 (258)
T ss_pred ccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-------HHHHHHHHHhcccCCCc-
Confidence 54332 234567899999887766 8999999999999999999999996432 11111111110111111
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
.. .....+.+++.+||..+|++||++.+++.+.
T Consensus 224 ~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~ 256 (258)
T cd06632 224 PD---------HLSDEAKDFILKCLQRDPSLRPTAAELLEHP 256 (258)
T ss_pred CC---------CcCHHHHHHHHHHhhcCcccCcCHHHHhcCC
Confidence 00 1123567889999999999999999998764
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=295.75 Aligned_cols=244 Identities=23% Similarity=0.442 Sum_probs=195.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||++... ++..||+|.+... .....+++.+|+.++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG 84 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence 467999999999999854 6788999998642 2334567899999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~-------i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 85 DLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDRK-------ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred cHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 99999875332 24788889999999999999999988 99999999999999999999999999876644
Q ss_pred cc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 PI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
.. ...++..|+|||+..+..++.++|||||||++|+|++|+.||... +....+....... ....
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-------~~~~~~~~~~~~~-~~~~---- 221 (256)
T cd08218 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-------NMKNLVLKIIRGS-YPPV---- 221 (256)
T ss_pred chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-------CHHHHHHHHhcCC-CCCC----
Confidence 32 223567899999998888999999999999999999999998532 1122222222111 1111
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
......++.+++.+||+.+|++||++.||+++-+
T Consensus 222 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~ 255 (256)
T cd08218 222 ------SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255 (256)
T ss_pred ------cccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence 1111235788999999999999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.24 Aligned_cols=249 Identities=21% Similarity=0.327 Sum_probs=197.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... ++..||+|++.... ......+.+|++++++++|||++++++++......++||||+.
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 108 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL- 108 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-
Confidence 356999999999999964 67889999986432 2234568889999999999999999999999999999999996
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+.+.... .++++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++....
T Consensus 109 g~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~-------i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 109 GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSHN-------MIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 58888775432 24889999999999999999999998 9999999999999999999999999988776
Q ss_pred CcccccccccccCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 429 QPIAAQRMISYKSPEYQS---SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 429 ~~~~~~~~~~y~aPE~~~---~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
......++..|+|||++. ...++.++|||||||++|||++|+.||.... .... ........... .
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----~~~~---~~~~~~~~~~~-~---- 244 (317)
T cd06635 177 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSA---LYHIAQNESPT-L---- 244 (317)
T ss_pred CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc----HHHH---HHHHHhccCCC-C----
Confidence 655566788899999874 4568999999999999999999999986421 1111 11111111100 0
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
........+.+++.+||+.+|++||++.+++++++......
T Consensus 245 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 245 -----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred -----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 00112235788999999999999999999999988766444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=296.38 Aligned_cols=247 Identities=22% Similarity=0.401 Sum_probs=192.4
Q ss_pred cccccccCceEEEEEEEcC--CceEEEEEecCC----------CcchHHHHHHHHHHHhc-CCCCCccccceEEEeCCee
Q 047954 273 AEGLGKGIFGNSYKALLEG--RAPVVVKRLRDL----------KPLITEEFRKQLLVIAD-QKHPNLLPLLAYYFSNDEK 339 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~ 339 (582)
.+.||+|+||.||+|.... +..+|+|.+... ......++..|+.++.+ ++||||+++++++...+..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 3569999999999999765 678999987532 11233457788888865 7999999999999999999
Q ss_pred EEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhc-cCCCCCCCcceecCCCCCCeeecCCCceEE
Q 047954 340 LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH-KDKSRTQSAVIHGNLKSTNILLDDNEMVLV 418 (582)
Q Consensus 340 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl 418 (582)
++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+ ++|+||||+||+++.++.+||
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-------i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKE--KKQRFTEERIWNIFVQMVLALRYLHKEKR-------IVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHhccCCc-------eeecCCCHHHEEECCCCcEEE
Confidence 999999999999998854221 12358888999999999999999996 44 999999999999999999999
Q ss_pred eeccccccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh
Q 047954 419 SDYGFSSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE 495 (582)
Q Consensus 419 ~DfG~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 495 (582)
+|||.+....... ...++..|+|||+..+..++.++||||||+++|||++|+.||.... ...........
T Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-------~~~~~~~~~~~ 228 (269)
T cd08528 156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------MLSLATKIVEA 228 (269)
T ss_pred ecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-------HHHHHHHHhhc
Confidence 9999998765442 2345678999999998889999999999999999999999986321 11111111111
Q ss_pred cccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 496 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.+ ..... ......+.+++.+||+.||++||++.|+.++++
T Consensus 229 ~~-~~~~~---------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VY-EPLPE---------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cC-CcCCc---------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11 11100 011235788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=294.53 Aligned_cols=243 Identities=28% Similarity=0.507 Sum_probs=195.1
Q ss_pred cccccccCceEEEEEEEcC-----CceEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEG-----RAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||++...+ +..||+|.++..... ..+.+..|+.++.+++|+||+++++++...+..+++|||+
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 4679999999999999754 477999999755433 5678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++++|.+++...... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 84 ~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~-------~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 84 EGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLESKN-------FIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred CCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhcCC-------eeecccccceEEEccCCeEEEcccCCcee
Confidence 999999999754321 2889999999999999999999998 99999999999999999999999999976
Q ss_pred ccCcc-----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 427 VAQPI-----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 427 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
..... ...++..|+|||...+..++.++||||+|+++|||++ |+.||... ....+.+.+.. .....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~----~~~~~~~~~~~----~~~~~ 224 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM----SNEEVLEYLKK----GYRLP 224 (258)
T ss_pred cccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHhc----CCCCC
Confidence 65431 1224578999999988889999999999999999999 78887542 22222222211 11111
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
.. .....++.+++.+|+..+|++|||+.|+++.|
T Consensus 225 ~~----------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KP----------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC----------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 10 01223678899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=293.22 Aligned_cols=243 Identities=22% Similarity=0.287 Sum_probs=194.2
Q ss_pred ccccccCceEEEEEEEcCC-ceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLEGR-APVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
..||+|.-|+||++++.+. ..+|+|++.+.. .....+...|-+||+.++||.++.+|+.++.+...|++||||+||
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGG 162 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGG 162 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCc
Confidence 5699999999999998764 789999996532 223456778999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|..+++.+..+ .++...+..+|.+|+-||+|||-.| ||.|||||+||||-++|++-|+||.++.....
T Consensus 163 dL~~LrqkQp~~----~fse~~aRFYaAEvl~ALEYLHmlG-------ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 163 DLHSLRQKQPGK----RFSESAARFYAAEVLLALEYLHMLG-------IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred cHHHHHhhCCCC----ccchhhHHHHHHHHHHHHHHHHhhc-------eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999998765443 5889999999999999999999998 99999999999999999999999998643210
Q ss_pred ---------------------------------c-c--------------------------cccccccccCCCCCCCCC
Q 047954 430 ---------------------------------P-I--------------------------AAQRMISYKSPEYQSSKK 449 (582)
Q Consensus 430 ---------------------------------~-~--------------------------~~~~~~~y~aPE~~~~~~ 449 (582)
. . ...||-.|.|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 001334599999999999
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccC
Q 047954 450 ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNK 529 (582)
Q Consensus 450 ~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~ 529 (582)
.+.++|.|+|||++|||+.|..||...... ..+...+ ... +.... ..+.+..+.+||.+.|.+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~---~Tl~NIv----~~~---------l~Fp~-~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---ETLRNIV----GQP---------LKFPE-EPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCch---hhHHHHh----cCC---------CcCCC-CCcchhHHHHHHHHHhcc
Confidence 999999999999999999999999754321 1222211 111 11011 112334678999999999
Q ss_pred CCCCCCC----hHHHHHHH
Q 047954 530 SPEKRPE----MAEVVSEL 544 (582)
Q Consensus 530 dP~~RPs----~~evl~~L 544 (582)
||++|.. +.||-+|.
T Consensus 375 dP~kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKRHP 393 (459)
T ss_pred ChhhhhccccchHHhhcCc
Confidence 9999998 89998885
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=294.66 Aligned_cols=244 Identities=23% Similarity=0.354 Sum_probs=193.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeC-CeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN-DEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e~~~~ 348 (582)
.+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++|+|++++++.+... ...++||||+++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG 84 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence 467999999999999854 56789999986432 23456788999999999999999999987644 457899999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 85 ~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~-------i~H~di~p~nil~~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 85 GDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHEKH-------ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153 (257)
T ss_pred CcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeccCCCchhEEEecCCcEEEecccceEEec
Confidence 999999975322 25789999999999999999999998 9999999999999999999999999987664
Q ss_pred Ccc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
... ...++..|+|||+..+..++.++||||||+++|||++|+.||.... ........ ........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-------~~~~~~~~-~~~~~~~~--- 222 (257)
T cd08223 154 NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNSLVYRI-IEGKLPPM--- 222 (257)
T ss_pred ccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHH-HhcCCCCC---
Confidence 321 2235678999999998899999999999999999999999985321 11212111 11111111
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
......++.+++.+||+.+|++||++.+++++.+
T Consensus 223 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 223 -------PKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred -------ccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 0112236788999999999999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=297.52 Aligned_cols=247 Identities=22% Similarity=0.377 Sum_probs=191.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc----------chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP----------LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLL 341 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 341 (582)
.+.||+|+||.||+|... ++..||+|.++.... ...+.+..|+.++++++||||+++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 467999999999999854 678899998753211 123467889999999999999999999999999999
Q ss_pred EEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+||
T Consensus 86 v~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dl~~~nil~~~~~~~~l~d~ 152 (272)
T cd06629 86 FLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHSKG-------ILHRDLKADNLLVDADGICKISDF 152 (272)
T ss_pred EEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhCC-------eeecCCChhhEEEcCCCeEEEeec
Confidence 99999999999999754 24788889999999999999999988 999999999999999999999999
Q ss_pred cccccccCc------ccccccccccCCCCCCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHH
Q 047954 422 GFSSLVAQP------IAAQRMISYKSPEYQSSKK--ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 422 G~a~~~~~~------~~~~~~~~y~aPE~~~~~~--~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
|+++..... ....++..|+|||++.... ++.++||||||+++|||++|+.||..... ........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~ 225 (272)
T cd06629 153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAMFKLG 225 (272)
T ss_pred cccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHHHHHhh
Confidence 998765432 1234567899999887654 78999999999999999999999853211 11111111
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
... ....+.... .......+.+++.+||..+|++||++.+|+++.+
T Consensus 226 ~~~-~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 226 NKR-SAPPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred ccc-cCCcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 110 000011000 0112246788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.17 Aligned_cols=243 Identities=25% Similarity=0.373 Sum_probs=193.7
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||++.. .++..+|+|.+... .....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG 84 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence 46799999999999986 46778999988643 2334567889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC-CceEEeecccccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN-EMVLVSDYGFSSLVA 428 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DfG~a~~~~ 428 (582)
+|.+++..... ..+++..+..++.|++.||+|||+++ ++|+||||+||+++++ +.+||+|||.+....
T Consensus 85 ~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~-------i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 85 TLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTKL-------ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred CHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 99999975432 24788899999999999999999998 9999999999999855 458999999998765
Q ss_pred Ccc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 429 QPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 429 ~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....+....... ...+.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~~-- 223 (256)
T cd08220 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-------LPALVLKIMSGT-FAPISD-- 223 (256)
T ss_pred CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-------hHHHHHHHHhcC-CCCCCC--
Confidence 432 2345678999999998889999999999999999999999985421 111121211111 111111
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
.....+.+++.+||+.+|++|||+.|++++.
T Consensus 224 --------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p 254 (256)
T cd08220 224 --------RYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254 (256)
T ss_pred --------CcCHHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence 1123578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=302.15 Aligned_cols=256 Identities=19% Similarity=0.309 Sum_probs=190.1
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
+.||+|+||.||+|... ++..||+|+++... ......+.+|+.++++++||||+++++++.+....++|+||+. ++
T Consensus 6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 84 (284)
T cd07839 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QD 84 (284)
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CC
Confidence 56999999999999965 67889999986432 2233567889999999999999999999999999999999996 58
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++.... ..+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~-------i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 85 LKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHSHN-------VLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------EecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 888876432 24889999999999999999999998 999999999999999999999999998765432
Q ss_pred c----cccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc----c--cc
Q 047954 431 I----AAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE----W--TA 499 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~----~--~~ 499 (582)
. ...++..|+|||++.+. .++.++|||||||++|||+||..|+.... ........+.+..... + ..
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC---CHHHHHHHHHHHhCCCChHHhHHhh
Confidence 2 22346789999987664 47899999999999999999999875322 1111111111111000 0 00
Q ss_pred cccc--------hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 500 EIFD--------SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 500 ~~~d--------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
...+ ..............++.+++.+||+.||++|||+++++.|.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 0000 000000000112246778999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.14 Aligned_cols=247 Identities=17% Similarity=0.208 Sum_probs=189.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+++.. ++..||+|.+... .......+.+|+.++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g 85 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG 85 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999965 5678999998642 222345578899999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~~-------iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 86 GDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQLH-------YVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred CcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-------eeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 999999975321 4788888999999999999999998 9999999999999999999999999997664
Q ss_pred Ccc-----cccccccccCCCCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 429 QPI-----AAQRMISYKSPEYQSS-----KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 429 ~~~-----~~~~~~~y~aPE~~~~-----~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
... ...+++.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..............
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~ 226 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMNHEER 226 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-------HHHHHHHHHcCCCc
Confidence 332 2347889999998865 467899999999999999999999996422 11111111111100
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCC--CCChHHHHHHHh
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEK--RPEMAEVVSELE 545 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~ 545 (582)
... .........++.+++.+|+..++++ |++++++++|.+
T Consensus 227 ~~~-------p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 227 FQF-------PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred ccC-------CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 000 0001111235677888888765544 578999998865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=309.41 Aligned_cols=248 Identities=17% Similarity=0.198 Sum_probs=188.2
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+++... +..+|+|.+... .......+..|+.++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 3679999999999999764 667899988532 122334578899999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 86 g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~-------iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 86 GDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQLH-------YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred CcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-------eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 999999975322 4788889999999999999999998 9999999999999999999999999987653
Q ss_pred Ccc-----cccccccccCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 429 QPI-----AAQRMISYKSPEYQS-----SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 429 ~~~-----~~~~~~~y~aPE~~~-----~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
... ...+++.|+|||++. ...++.++|||||||++|||++|+.||.... ..+...........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~ 226 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMNHKER 226 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-------HHHHHHHHhCCCcc
Confidence 221 234788999999875 3468899999999999999999999996421 22222222111100
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCC--CCCCChHHHHHHHhh
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSP--EKRPEMAEVVSELEI 546 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP--~~RPs~~evl~~L~~ 546 (582)
..+. ........++.+++.+|+..++ ..|+++.|+++|.+.
T Consensus 227 ~~~p-------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f 269 (332)
T cd05623 227 FQFP-------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269 (332)
T ss_pred ccCC-------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCc
Confidence 0000 0001112346677778775544 447899999999653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=294.18 Aligned_cols=242 Identities=17% Similarity=0.248 Sum_probs=187.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-----cchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-----PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 344 (582)
.+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 467999999999999864 57889999875321 12345788899999999999999999988764 45789999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++++|.+++.... .+++...+.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 87 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~-------i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 87 HMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSNM-------IVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred ecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------EecCCCCHHHEEecCCCCEEECcCccc
Confidence 999999999986432 3677888999999999999999998 999999999999999999999999998
Q ss_pred ccccCc-------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 425 SLVAQP-------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 425 ~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
+..... ....++..|+|||.+.+..++.++|||||||++|||++|+.||.... ....+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~ 226 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AMAAIFKIATQPT 226 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hHHHHHHHhcCCC
Confidence 765321 12335678999999988889999999999999999999999996321 1111111111110
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
... .+......+.+++.+|+ .+|++||+++||+++.+
T Consensus 227 ~~~----------~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 227 NPV----------LPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTF 263 (265)
T ss_pred CCC----------CchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcc
Confidence 000 01122235677888898 49999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=302.86 Aligned_cols=256 Identities=21% Similarity=0.349 Sum_probs=191.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++......++||||++++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence 367999999999999975 57889999875432 223567889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.++..... .+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 86 ~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~-------i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 86 VLDDLEKYPN------GLDESRVRKYLFQILRGIEFCHSHN-------IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred HHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 8888765321 3789999999999999999999988 99999999999999999999999999876543
Q ss_pred ccc----ccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc--------
Q 047954 430 PIA----AQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE-------- 496 (582)
Q Consensus 430 ~~~----~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~-------- 496 (582)
... ..++..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+......-
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHHHHhCCCchhhHHHh
Confidence 321 235678999998875 4578899999999999999999988853221 11111111100000
Q ss_pred ----ccccccchhhh----hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 497 ----WTAEIFDSEIS----VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 497 ----~~~~~~d~~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.......+... ...........+.+++.+||+.+|++||++.+++++-+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 285 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence 00000000000 00000112346888999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.98 Aligned_cols=259 Identities=20% Similarity=0.323 Sum_probs=194.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcc-----hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPL-----ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|... +++.|+||+++..... ....+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 356999999999999965 5789999999654322 3456778999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
+|+|.+++.... ..+++..++.++.||++||+|||+++ |+|+||||+||+++.++.+||+|||+++.
T Consensus 85 -~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~-------i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 85 -ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSNW-------ILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred -CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeecCCChhhEEEcCCCCEEEccceeeee
Confidence 899999997532 24889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccc----ccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh----cc
Q 047954 427 VAQPIA----AQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE----EW 497 (582)
Q Consensus 427 ~~~~~~----~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----~~ 497 (582)
...... ..++..|+|||.+.+ ..++.++|||||||++|||++|..||.... ..+....+...... .+
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 152 FGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS----DIDQLGKIFEALGTPTEENW 227 (298)
T ss_pred ccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc----cHHHHHHHHHHcCCCchhhh
Confidence 654321 224567999998754 467899999999999999999977775322 11111111111100 00
Q ss_pred -----cccccc----hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 498 -----TAEIFD----SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 498 -----~~~~~d----~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
...... +..............+.+++.+||+.||++|||+.|++.+-+.-.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 000000 000000001112346789999999999999999999999766444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=301.45 Aligned_cols=245 Identities=23% Similarity=0.291 Sum_probs=193.2
Q ss_pred ccccccCceEEEEEEEcC-CceEEEEEecCCCcc---hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPL---ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+.||+|+||.||+|...+ +..||+|.+...... ..+.+..|++++.+++|+||+++++++......++||||+.++
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGG 86 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCC
Confidence 569999999999999764 788999998653322 4456889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 87 ~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 87 ELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLHLLG-------IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred CHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHHHCC-------eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999874322 25888899999999999999999998 99999999999999999999999999865432
Q ss_pred cc---------------------------------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 047954 430 PI---------------------------------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSA 476 (582)
Q Consensus 430 ~~---------------------------------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~ 476 (582)
.. ...++..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 11 112456799999999888999999999999999999999999643
Q ss_pred CCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCC----hHHHHHHHhh
Q 047954 477 PQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE----MAEVVSELEI 546 (582)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~~L~~ 546 (582)
.. .. ........... . . ........+.+++.+||..||++||+ ++|++.+-+.
T Consensus 236 ~~----~~---~~~~~~~~~~~--~-------~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 236 NR----DE---TFSNILKKEVT--F-------P-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred ch----HH---HHHHHhcCCcc--C-------C-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 21 11 11111111100 0 0 00012336888999999999999999 7777776543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.85 Aligned_cols=256 Identities=20% Similarity=0.330 Sum_probs=195.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... ++..|++|++.... ....+.+.+|+.++++++||||+++++++......++||||+ ++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~ 83 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS 83 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence 357999999999999964 67889999986543 334567899999999999999999999999999999999999 99
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... ..+++.+++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 84 DLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHANG-------IMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 9999987543 25889999999999999999999998 99999999999999999999999999887654
Q ss_pred cc-----cccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc----cc-
Q 047954 430 PI-----AAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE----WT- 498 (582)
Q Consensus 430 ~~-----~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~----~~- 498 (582)
.. ...++..|+|||.+.+. .++.++||||+||++|||+||+.||.... .......+....... +.
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN----DIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC----HHHHHHHHHHHcCCCChHHHhh
Confidence 32 23356789999988654 46899999999999999999987775322 111112221111100 00
Q ss_pred -------ccccch---hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 499 -------AEIFDS---EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 499 -------~~~~d~---~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
..+..+ .........+....+.+++.+|+..+|++||++++++.|.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 000000 00000000112257889999999999999999999998865
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=293.68 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=198.7
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
+.||+|+||.||++... +++.|++|.+.... ....+.+.+|++++++++||||+++++++......++++||+++++|
T Consensus 7 ~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (265)
T cd06605 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL 86 (265)
T ss_pred HHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcH
Confidence 57999999999999976 57889999886543 34456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhc-cCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH-KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
.+++.... ..++...+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+......
T Consensus 87 ~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~-------i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 87 DKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKHK-------IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred HHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCCC-------eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99997542 257888899999999999999999 77 999999999999999999999999998765332
Q ss_pred c--cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 431 I--AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 431 ~--~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
. ...++..|+|||++.+..++.++||||||+++|+|++|+.||..... ......+.+....... ......
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~----- 226 (265)
T cd06605 155 LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND--PPDGIFELLQYIVNEP-PPRLPS----- 226 (265)
T ss_pred HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--ccccHHHHHHHHhcCC-CCCCCh-----
Confidence 1 24466789999999988999999999999999999999999964321 1122222222222111 111100
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.....++.+++.+||..+|++|||+.+++.+.+.
T Consensus 227 ----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 227 ----GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred ----hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 0022357889999999999999999999988765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.56 Aligned_cols=246 Identities=21% Similarity=0.336 Sum_probs=192.2
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCC--CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.++||+||.+.||++...+.+.+|+|++... +......|.+|+.+|.++ .|.+||++++|-..++.+||||||= .-
T Consensus 366 lk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~ 444 (677)
T KOG0596|consen 366 LKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DI 444 (677)
T ss_pred HHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cc
Confidence 4679999999999999998888999987543 344567899999999999 6899999999999999999999976 55
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
||..+|..+... ...| .++.+..|++.|+.+.|.++ |||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 445 DL~kiL~k~~~~----~~~~-~lk~ywkqML~aV~~IH~~g-------IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 445 DLNKILKKKKSI----DPDW-FLKFYWKQMLLAVKTIHQHG-------IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred cHHHHHHhccCC----CchH-HHHHHHHHHHHHHHHHHHhc-------eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 999999865432 2334 77889999999999999998 99999999999997 47899999999988766
Q ss_pred cc------cccccccccCCCCCCCC-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHH
Q 047954 430 PI------AAQRMISYKSPEYQSSK-----------KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492 (582)
Q Consensus 430 ~~------~~~~~~~y~aPE~~~~~-----------~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 492 (582)
+. ...||+.||+||.+... ++++++||||+|||||+|+.|+.||.... .....+
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------n~~aKl--- 582 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------NQIAKL--- 582 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------HHHHHH---
Confidence 53 33589999999987543 25789999999999999999999996321 111111
Q ss_pred HhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 493 VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 493 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
..+.++...........-.+++++|..||.+||++||++.++++|..-.
T Consensus 583 ------~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~ 631 (677)
T KOG0596|consen 583 ------HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQ 631 (677)
T ss_pred ------HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence 1222221111100001112388999999999999999999999986543
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.25 Aligned_cols=246 Identities=22% Similarity=0.410 Sum_probs=193.8
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCc------chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKP------LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 46799999999999985 5678899999864321 1346788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC-ceEEeecccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE-MVLVSDYGFS 424 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfG~a 424 (582)
+++++|.+++.... ++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||.+
T Consensus 85 ~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~~-------i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 85 MAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHENQ-------IIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred cCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 99999999987432 4788899999999999999999998 99999999999998775 5999999998
Q ss_pred ccccCcc--------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 425 SLVAQPI--------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 425 ~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
..+.... ...++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... ..............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~ 227 (268)
T cd06630 152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH----SNHLALIFKIASAT 227 (268)
T ss_pred cccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----cchHHHHHHHhccC
Confidence 7764331 12356789999999888899999999999999999999999964321 11111111111111
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
...+ .......++.+++.+|+..+|++||++.+++++.+
T Consensus 228 ~~~~----------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~ 266 (268)
T cd06630 228 TAPS----------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV 266 (268)
T ss_pred CCCC----------CchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence 1111 11112236788999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=296.57 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=196.5
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
+.||+|++|.||++.. .++..+++|++........+.+.+|+.++++++||||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 5799999999999985 467889999986554445667889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++... .+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||.+.......
T Consensus 105 ~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~~-------i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 105 DIVTHT-------RMNEEQIATVCLAVLKALSFLHAQG-------VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred HHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 998652 3788889999999999999999998 9999999999999999999999999886543321
Q ss_pred ---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 432 ---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 432 ---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
...++..|+|||...+..++.++|||||||++|||++|+.||.... ....... ...........
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-------~~~~~~~-~~~~~~~~~~~----- 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-------PLQAMKR-IRDNLPPKLKN----- 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-------HHHHHHH-HHhcCCCCCcc-----
Confidence 2236678999999988889999999999999999999999986421 1111111 11111111100
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.......+.+++.+||..+|++||++.+++++-+..+
T Consensus 238 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 238 ---LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred ---cccCCHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence 0011236889999999999999999999998765444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=296.84 Aligned_cols=254 Identities=20% Similarity=0.301 Sum_probs=189.9
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+. ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (284)
T cd07860 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QD 84 (284)
T ss_pred eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cC
Confidence 56999999999999865 67889999886432 2234578899999999999999999999999999999999995 68
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++......
T Consensus 85 l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~-------i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 85 LKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred HHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9998865432 25788999999999999999999988 999999999999999999999999998765432
Q ss_pred c----cccccccccCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---------
Q 047954 431 I----AAQRMISYKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE--------- 496 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~~~-~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--------- 496 (582)
. ...++..|+|||+..+.. ++.++|||||||++|||+||+.||..... ...+.+.+ +.....
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~ 229 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIF-RTLGTPDEVVWPGVT 229 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHH-HHhCCCChhhhhhhh
Confidence 2 122456799999876644 58899999999999999999999964321 11111111 000000
Q ss_pred -------ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 497 -------WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 497 -------~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
........... ........++.+++.+||+.||++|||+++++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 283 (284)
T cd07860 230 SLPDYKPSFPKWARQDFS--KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283 (284)
T ss_pred HHHHHHhhcccccccCHH--HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence 00000000000 000011235678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.52 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=191.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHH-HhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLV-IADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... ++..||+|+++... ......+..|+.. ++.++||||+++++++......+++|||++ |
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 357999999999999965 58899999986532 2233455566665 566799999999999999999999999996 6
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
+|.+++...... ...+++..++.++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++....
T Consensus 85 ~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~-------i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 85 SLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKLS-------VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred cHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcCC-------eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 888887653322 23589999999999999999999987 5 9999999999999999999999999988664
Q ss_pred Cccc---ccccccccCCCCCCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 429 QPIA---AQRMISYKSPEYQSS----KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 429 ~~~~---~~~~~~y~aPE~~~~----~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
.... ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ..+.+...... ....+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~~~ 228 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------PFQQLKQVVEE-PSPQL 228 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------CHHHHHHHHhc-CCCCC
Confidence 3321 235678999998764 4568999999999999999999999853211 11111111111 11111
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
... ....++.+++.+||..+|++||++.+++++.+..+..
T Consensus 229 ~~~---------~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 229 PAE---------KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred Ccc---------ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 110 1123578899999999999999999999987766544
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=296.01 Aligned_cols=258 Identities=22% Similarity=0.314 Sum_probs=197.2
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~~g 349 (582)
+.||.|++|.||+|... +++.+|+|.+.... ......+.+|++++++++||||++++++|... ...++||||++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 86 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG 86 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence 57999999999999974 57889999886432 23456789999999999999999999998754 3689999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++..... ....++......++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 87 ~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~-------i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 87 SLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSRK-------IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred CHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99988754322 1234788889999999999999999998 99999999999999999999999999876543
Q ss_pred cc--cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-CCccchHHHHHHHHhhcccccccchhh
Q 047954 430 PI--AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQG-INGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 ~~--~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.. ...++..|+|||.+.+..++.++|||||||++|||++|+.||...... ....+...++.. .....+.+. .
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~ 232 (287)
T cd06621 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKDE-P 232 (287)
T ss_pred cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhccC-C
Confidence 22 233567899999998889999999999999999999999999754221 011122222211 000000000 0
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.........+.+++.+||+.+|++|||+.|++++.+...
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 233 ---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred ---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 000112346789999999999999999999999988643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=293.31 Aligned_cols=244 Identities=25% Similarity=0.328 Sum_probs=193.2
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~~ 348 (582)
+.||.|+||.||++.. .++..||+|.+... .....+.+..|+.++++++|+||+++++++... ...+++|||+++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 5699999999999985 46678999988643 233456788999999999999999999988643 457899999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHh-----ccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH-----HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-----~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
++|.+++..... ....+++..++.++.||+.||+||| +.+ ++|+||||+||+++.++.+||+|||+
T Consensus 86 ~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~-------i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 86 GDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT-------VLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred CCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc-------ceecCCCHHHEEEecCCCEEEecccc
Confidence 999999875422 1235889999999999999999999 665 99999999999999999999999999
Q ss_pred cccccCcc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 424 SSLVAQPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 424 a~~~~~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
+....... ...++..|+|||++.+..++.++||||||+++|+|++|+.||.... ...+.+. .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~----~~~~~~~ 228 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----QLQLASK----IKEGKFR 228 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----HHHHHHH----HhcCCCC
Confidence 98765433 2346778999999998889999999999999999999999996422 1122221 1111111
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
.+ .......+.+++.+|++.+|++||++.+|+++.
T Consensus 229 ~~----------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~ 263 (265)
T cd08217 229 RI----------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263 (265)
T ss_pred CC----------ccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence 11 111223678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=291.90 Aligned_cols=246 Identities=21% Similarity=0.357 Sum_probs=198.7
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCCc-chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKP-LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|++|.||+|.... +..|++|++..... ...+.+.+|+..+.+++|+||+++++++......++||||+++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 3679999999999999764 88899999865433 446789999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhc-cCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH-KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
|.+++... ..++...++.++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||.+.....
T Consensus 86 L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~~-------~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 86 LADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKRH-------IIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred HHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccCC-------CccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999753 258889999999999999999999 87 99999999999999999999999999887654
Q ss_pred ccc----ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 PIA----AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~~~----~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
... ..++..|+|||...+..++.++||||||+++|||+||+.||..... ....+...... ....... +..
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~-~~~~~~~-~~~ 226 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAIC-DGPPPSL-PAE 226 (264)
T ss_pred CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHHHh-cCCCCCC-Ccc
Confidence 322 2356789999999988899999999999999999999999965432 11111111111 1111111 000
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.....+.+++.+||..+|++||++.+++++-+
T Consensus 227 --------~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~ 258 (264)
T cd06623 227 --------EFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258 (264)
T ss_pred --------cCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence 02236888999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.94 Aligned_cols=245 Identities=20% Similarity=0.247 Sum_probs=186.4
Q ss_pred cccccCceEEEEEEEc-CCceEEEEEecCCCc---chHHHHHHHHHH---HhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 275 GLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP---LITEEFRKQLLV---IADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~---l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
+||+|+||.||++... +++.+|+|.+..... .....+.+|..+ +...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 578899998864321 112234444433 334589999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++...
T Consensus 81 ~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~~-------ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 81 GGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNRF-------VVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------cCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 999999886432 4889999999999999999999998 999999999999999999999999998755
Q ss_pred cCc--ccccccccccCCCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 428 AQP--IAAQRMISYKSPEYQS-SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 428 ~~~--~~~~~~~~y~aPE~~~-~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
... ....++..|+|||... +..++.++|||||||++|||++|+.||...... . ...+...... ....+
T Consensus 148 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~-~~~~~~~~~~-~~~~~--- 218 (279)
T cd05633 148 SKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----D-KHEIDRMTLT-VNVEL--- 218 (279)
T ss_pred cccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc----C-HHHHHHHhhc-CCcCC---
Confidence 432 2234678999999886 456899999999999999999999999643211 1 1111111110 00000
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhhcc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEIIK 548 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~i~ 548 (582)
......++.+++.+||..||++|| +++++++|.+...
T Consensus 219 -------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 219 -------PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred -------ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 011123677889999999999999 6999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.33 Aligned_cols=263 Identities=19% Similarity=0.240 Sum_probs=193.5
Q ss_pred ccccc--CceEEEEEEE-cCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 275 GLGKG--IFGNSYKALL-EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 275 ~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.||+| +||+||++.. ..++.||+|.+.... ....+.+.+|+.+++.++||||++++++|...+..++|+||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999986 478899999986432 223467889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+.....
T Consensus 85 ~l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~-------ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~ 153 (328)
T cd08226 85 SANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQNG-------YIHRNIKASHILISGDGLVSLSGLSHLYSLVR 153 (328)
T ss_pred CHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence 99999876432 24788888999999999999999988 99999999999999999999999985432211
Q ss_pred c-----------ccccccccccCCCCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHH-----
Q 047954 430 P-----------IAAQRMISYKSPEYQSSK--KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLR----- 491 (582)
Q Consensus 430 ~-----------~~~~~~~~y~aPE~~~~~--~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~----- 491 (582)
. ....++..|+|||++.+. .++.++|||||||++|||++|+.||...... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~ 230 (328)
T cd08226 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT---QMLLQKLKGPPYSP 230 (328)
T ss_pred cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH---HHHHHHhcCCCCCC
Confidence 1 111234569999998763 4789999999999999999999999643210 111000000
Q ss_pred -----------H----------------HhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 492 -----------A----------------VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 492 -----------~----------------~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
. ....+.....+.... ..........+.+++.+||..||++|||+.|++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0 000000000000000 011123445788999999999999999999999998
Q ss_pred hhcccCCC
Q 047954 545 EIIKVTES 552 (582)
Q Consensus 545 ~~i~~~~~ 552 (582)
+.....+.
T Consensus 310 ~~~~~~~~ 317 (328)
T cd08226 310 FFKQVKEQ 317 (328)
T ss_pred HHHHHHHh
Confidence 86554443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.33 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=196.0
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||++.. .++..|++|.+........+.+.+|+.++++++||||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcH
Confidence 36799999999999985 46788999998654444567789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 104 ~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~g-------i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 104 TDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQ-------VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred HHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCC-------EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9998642 3678889999999999999999998 9999999999999999999999999886654322
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
...++..|+|||......++.++|||||||++||+++|+.||...... ..+. ...... .....
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~---~~~~----~~~~~~-~~~~~----- 236 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALY----LIATNG-TPELQ----- 236 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---hhee----ehhcCC-CCCCC-----
Confidence 123567799999998888999999999999999999999999643211 0000 000000 00000
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
........+.+++.+||..+|++||++.+++.|-+.-.
T Consensus 237 ---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 237 ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred ---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 01111235778999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=301.50 Aligned_cols=257 Identities=19% Similarity=0.298 Sum_probs=190.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc-chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP-LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||+.+ +
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 88 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-D 88 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-C
Confidence 367999999999999965 678899999864322 2234577899999999999999999999999999999999974 9
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++..... .+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 89 L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~~-------i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 89 LKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQRR-------VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred HHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC-------eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9998865432 4788899999999999999999998 999999999999999999999999998654322
Q ss_pred c----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh---ccccc--
Q 047954 431 I----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE---EWTAE-- 500 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-- 500 (582)
. ...++..|+|||+..+ ..++.++||||+||++|||++|+.||..... ..+....+.+.... .....
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD---VEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHHHHHHhcCCCChhhhhhhh
Confidence 1 1224677999998865 4578999999999999999999999964321 11111111111000 00000
Q ss_pred ------------ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 501 ------------IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 501 ------------~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.....+............+.+++.+|++.+|++|||+.+++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~ 290 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 000000000000011246778999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=300.94 Aligned_cols=260 Identities=18% Similarity=0.243 Sum_probs=189.9
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
+.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3445555555555554 6788999998643 334456799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++...... .+++.....++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+..+...
T Consensus 87 ~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~-------ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 87 EDLLKTHFPE----GLPELAIAFILKDVLNALDYIHSKG-------FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCcceEEEecCCceEEecCccceeecccc
Confidence 9999754322 4778888999999999999999998 999999999999999999999999988654321
Q ss_pred ----------ccccccccccCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh---
Q 047954 431 ----------IAAQRMISYKSPEYQSS--KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE--- 495 (582)
Q Consensus 431 ----------~~~~~~~~y~aPE~~~~--~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--- 495 (582)
....++..|+|||++.. ..++.++|||||||++|||++|+.||..... .....+.+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~ 232 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA---TQMLLEKVRGTVPCLLD 232 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCccccc
Confidence 11234567999999865 3588999999999999999999999974321 11111111000000
Q ss_pred -cc-------ccc----ccchhhh---hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 496 -EW-------TAE----IFDSEIS---VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 496 -~~-------~~~----~~d~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.. ... ..++... ..........++.+++.+||..||++|||+++++++.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 00 000 0000000 00011122346788999999999999999999999987543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=292.01 Aligned_cols=243 Identities=22% Similarity=0.289 Sum_probs=194.8
Q ss_pred ccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 276 LGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 276 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
||+|+||.||+|+.. ++..|++|.+.... ....+.+.+|+.++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 47889999986432 23456789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++.... .+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~~-------~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~ 147 (262)
T cd05572 81 WTILRDRG------LFDEYTARFYIACVVLAFEYLHNRG-------IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147 (262)
T ss_pred HHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhCC-------cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence 99997532 3788889999999999999999988 999999999999999999999999999876543
Q ss_pred --ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 431 --IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 431 --~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
....++..|+|||.+.+..++.++||||||+++|||++|+.||..... +.................
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~------- 215 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNGKLEF------- 215 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCCCCCC-------
Confidence 223456789999999888899999999999999999999999965321 111112111110100000
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHHhh
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSELEI 546 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~ 546 (582)
+.....++.+++.+||..+|++||+ ++|++++.+.
T Consensus 216 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 255 (262)
T cd05572 216 ---PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255 (262)
T ss_pred ---CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence 0011236889999999999999999 8898887764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=294.00 Aligned_cols=245 Identities=20% Similarity=0.386 Sum_probs=195.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|... ++..||+|...... ....+.+.+|+.++++++||||+++++++..+...++||||+++++
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 88 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCc
Confidence 356999999999999864 67889999875432 2334678899999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++..+...
T Consensus 89 l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~-------i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 89 ALDLLEPG-------PLDETQIATILREILKGLDYLHSEK-------KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred HHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHccCC-------eecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 99998632 4788999999999999999999988 999999999999999999999999998765442
Q ss_pred c----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 431 I----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
. ...++..|+|||...+..++.++|||||||++|+|++|..||.... ...... . ........ ++
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~~~~---~-~~~~~~~~-~~--- 222 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH----PMKVLF---L-IPKNNPPT-LE--- 222 (277)
T ss_pred hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc----hHHHHH---H-HhcCCCCC-CC---
Confidence 2 1235677999999988888999999999999999999999985321 111111 1 11111111 11
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.....++.+++.+||+.+|++||++.+++++.+..+.
T Consensus 223 ------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 223 ------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ------cccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 1112357789999999999999999999998665554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=290.93 Aligned_cols=259 Identities=19% Similarity=0.295 Sum_probs=196.3
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhc--CCCCCccccceEEEeCC----eeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIAD--QKHPNLLPLLAYYFSND----EKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~~----~~~lv~e~~ 346 (582)
.+.||+|.||.||+|.+++.. ||||++.. .+.+.+.+|.++... ++|+||+.+++.-..+. +++||++|.
T Consensus 216 ~e~IGkGRyGEVwrG~wrGe~-VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWRGED-VAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeeccccCCc-eEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 578999999999999998755 99999954 345667788887765 69999999998766443 579999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccC-CCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD-KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+.|+|+|+|.+. .++....++++..+|.||+|||..- ..+.+|.|.|||||+.|||+..++.+.|+|+|+|-
T Consensus 292 e~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 292 EHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred cCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 999999999753 5888999999999999999999741 12346789999999999999999999999999996
Q ss_pred cccCc--------ccccccccccCCCCCCCCCC------CcchhHHHHHHHHHHHHhC----------CCCCCCCCCCCC
Q 047954 426 LVAQP--------IAAQRMISYKSPEYQSSKKI------SRKSDVWSFGCLLLELLTG----------RISTHSAPQGIN 481 (582)
Q Consensus 426 ~~~~~--------~~~~~~~~y~aPE~~~~~~~------~~k~DVwS~Gvvl~elltG----------~~P~~~~~~~~~ 481 (582)
..... ....||.+|||||++....- -..+||||||.|+||+..+ +.||++.-+...
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 55432 23457889999999864321 2468999999999999753 467665432211
Q ss_pred ccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 482 GADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.. +.+...+-. +-+.|.++..-...+.+..+.++|..||..+|.-|-|+--|-+.|.++.+
T Consensus 445 s~---eeMrkVVCv----~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 445 SF---EEMRKVVCV----QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CH---HHHhcceee----cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11 111111111 11222222233445777889999999999999999999999988888765
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=296.16 Aligned_cols=246 Identities=21% Similarity=0.254 Sum_probs=191.6
Q ss_pred ccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 276 LGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 276 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
||+|+||+||+|... +++.||+|.+.... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 57889999885422 22344567899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++..... ..+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~-------i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 81 KYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQRR-------IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK 149 (277)
T ss_pred HHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCCHHHEEECCCCCEEEccCcchhhhccCC
Confidence 999875432 25888999999999999999999998 9999999999999999999999999987654321
Q ss_pred ---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 432 ---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 432 ---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
...++..|+|||+..+..++.++|||||||++|+|++|+.||.......... .+....... ....
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~-~~~~------- 217 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE----ELKRRTLEM-AVEY------- 217 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH----HHHhccccc-cccC-------
Confidence 2235568999999988889999999999999999999999996533211111 111110000 0000
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhhc
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEII 547 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~i 547 (582)
.......+.+++.+||+.+|++|| ++.++++|.+..
T Consensus 218 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~ 258 (277)
T cd05577 218 ---PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258 (277)
T ss_pred ---CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence 001122577899999999999999 777788776553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=290.15 Aligned_cols=244 Identities=23% Similarity=0.388 Sum_probs=193.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc--chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... ++..|++|.++.... ...+.+..|+.++++++|+||+++++++...+..++|+||++++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence 367999999999999864 678899999875443 25678899999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 85 ~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~-------i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 85 TLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSHG-------IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred cHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 9999987432 3678889999999999999999998 99999999999999999999999999877643
Q ss_pred cc--------cccccccccCCCCCCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 430 PI--------AAQRMISYKSPEYQSSKK---ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 430 ~~--------~~~~~~~y~aPE~~~~~~---~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
.. ...++..|+|||++.+.. ++.++||||||+++|||++|+.||..... .......+ .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---~~~~~~~~----~~~~~ 224 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---EFQIMFHV----GAGHK 224 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---hHHHHHHH----hcCCC
Confidence 21 123567899999988766 88999999999999999999999964221 11111111 11111
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
..+.+ .......+.+++.+||+.+|++||++.|++.+-
T Consensus 225 ~~~~~--------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~ 262 (264)
T cd06626 225 PPIPD--------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHP 262 (264)
T ss_pred CCCCc--------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence 11100 001123567899999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=291.16 Aligned_cols=244 Identities=25% Similarity=0.432 Sum_probs=194.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+.++++++|+||+++++++......++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 357999999999999965 4678999988542 1234567889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC-ceEEeecccccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE-MVLVSDYGFSSLVA 428 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfG~a~~~~ 428 (582)
+|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+....
T Consensus 85 ~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~-------i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 85 DLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDRK-------ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred cHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------cccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 99999975432 24789999999999999999999988 99999999999999875 46999999987765
Q ss_pred Ccc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
... ...++..|+|||+..+..++.++|||||||++|||++|+.||... ...+.+...... ....+. +
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~-~~~~~~-~ 224 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-------NLHQLVLKICQG-YFAPIS-P 224 (257)
T ss_pred CCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHHHHHHhcc-cCCCCC-C
Confidence 432 123567899999998888999999999999999999999998532 122223222221 111111 0
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
....++.+++.+||..+|++|||+.|++++.+
T Consensus 225 ---------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 225 ---------NFSRDLRSLISQLFKVSPRDRPSITSILKRPF 256 (257)
T ss_pred ---------CCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence 11225788899999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=296.05 Aligned_cols=247 Identities=21% Similarity=0.336 Sum_probs=188.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEe-----CCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFS-----NDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~-----~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|... +++.+|+|.+.... ...+.+.+|+.+++++ +||||+++++++.. +...++||||
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 357999999999999864 56789999875432 2346688899999998 79999999998853 3568999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++++|.+++...... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 102 ~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 102 CNGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLHVNK-------TIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred cCCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHHhCC-------ccccCCCHHhEEECCCCCEEEccCCcee
Confidence 9999999988643221 235788889999999999999999987 9999999999999999999999999987
Q ss_pred cccCc----ccccccccccCCCCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 426 LVAQP----IAAQRMISYKSPEYQSS-----KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 426 ~~~~~----~~~~~~~~y~aPE~~~~-----~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
.+... ....++..|+|||++.. ..++.++|||||||++|||++|+.||...... ...... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-------~~~~~~-~~~ 244 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-------RALFKI-PRN 244 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-------HHHhhc-ccc
Confidence 65432 22346788999998753 45789999999999999999999998643210 111110 000
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
......++. ....++.+++.+||+.||++|||+.||+++++
T Consensus 245 ~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 245 PPPTLHQPE--------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred CCCcccCCC--------CcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 001111110 01125788999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=297.81 Aligned_cols=245 Identities=16% Similarity=0.244 Sum_probs=189.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 357999999999999865 46789999886432 22345678999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 86 ~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 86 GDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNYG-------IVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 99999996432 4788889999999999999999988 9999999999999999999999999986421
Q ss_pred Cc-------------------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHH
Q 047954 429 QP-------------------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWV 489 (582)
Q Consensus 429 ~~-------------------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~ 489 (582)
.. ....++..|+|||++....++.++|||||||++|||++|+.||.... ..++ .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~----~~~~---~ 225 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT----PEEL---F 225 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHH---H
Confidence 00 01234567999999988889999999999999999999999996321 1111 1
Q ss_pred HHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh---HHHHHHHhh
Q 047954 490 LRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM---AEVVSELEI 546 (582)
Q Consensus 490 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~---~evl~~L~~ 546 (582)
......... .+. ........+.+++.+||+.+|++||++ .+++++.+.
T Consensus 226 ~~~~~~~~~----~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 226 GQVISDDIE----WPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred HHHHhcccC----CCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 111111100 000 000112357889999999999999984 555665443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=293.20 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=195.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||.|+||.||+|... ++..+++|++.... ....+.+.+|++.++.++|+||+++++.+......++|+||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence 467999999999999954 67789999986432 2345778999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++..... ...+++.....++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..+...
T Consensus 86 l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~~-------i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 86 LLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSNG-------QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred HHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 9999975432 124788899999999999999999988 999999999999999999999999998766543
Q ss_pred cc--------ccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 431 IA--------AQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 431 ~~--------~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
.. ..++..|+|||++... .++.++|||||||++|||++|+.||...... . ......... ...
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~---~~~~~~~~~-~~~- 226 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM----K---VLMLTLQND-PPS- 226 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh----h---hHHHHhcCC-CCC-
Confidence 22 2356789999998766 7899999999999999999999999643211 1 111111111 000
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
... ..........+.+++.+||..||++||++.++++|.+
T Consensus 227 ~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 227 LET----GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266 (267)
T ss_pred cCC----ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence 000 0000122246788999999999999999999998743
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=293.58 Aligned_cols=246 Identities=27% Similarity=0.423 Sum_probs=198.4
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
+.||+|+||.||+|... ++..|++|++..... ..+.+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence 56999999999999976 678899999875443 4667889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 104 ~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~g-------i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 104 DIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQN-------VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred HHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC-------eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9997543 25889999999999999999999988 9999999999999999999999999887654331
Q ss_pred ---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 432 ---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 432 ---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
...++..|+|||++.+..++.++|||||||++|+|++|+.||..... . ........ ........
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~----~---~~~~~~~~-~~~~~~~~----- 238 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP----L---RALFLITT-KGIPPLKN----- 238 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH----H---HHHHHHHh-cCCCCCcc-----
Confidence 22356789999999888899999999999999999999999853211 1 11111111 11111111
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.......+.+++.+||+.+|.+||++.+++++.+..+
T Consensus 239 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 239 ---PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred ---hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 0111235788999999999999999999998877655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=296.74 Aligned_cols=256 Identities=18% Similarity=0.274 Sum_probs=188.0
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
+.||+|+||.||+|... ++..|++|.+.... ......+.+|+.++++++|+||+++++++...+..++||||+. ++|
T Consensus 11 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l 89 (291)
T cd07870 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDL 89 (291)
T ss_pred EEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCH
Confidence 57999999999999864 57889999986432 2233467889999999999999999999999999999999995 688
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++.... ..+.+..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~-------i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 90 AQYMIQHP-----GGLHPYNVRLFMFQLLRGLAYIHGQH-------ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 77775432 13677888889999999999999998 999999999999999999999999998764332
Q ss_pred ---ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh------------
Q 047954 431 ---IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR------------ 494 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~------------ 494 (582)
....++..|+|||++.+. .++.++|||||||++|||+||+.||..... ..+....+.....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD---VFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh---HHHHHHHHHHHcCCCChhhhhhhhh
Confidence 122346789999998754 578899999999999999999999964321 1111111111000
Q ss_pred -hccccccc----chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 495 -EEWTAEIF----DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 495 -~~~~~~~~----d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
..+..+.. ................+.+++.+|+..||++|||+.|++.|.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~ 290 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence 00000000 0000000000011246778999999999999999999987643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=292.13 Aligned_cols=237 Identities=20% Similarity=0.290 Sum_probs=184.7
Q ss_pred ccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhc-CCCCCccccceEEEeCCeeEEEEEeCCCCChHH
Q 047954 276 LGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIAD-QKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFN 353 (582)
Q Consensus 276 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 353 (582)
||+|+||.||++... ++..+|+|.......... |+..... .+||||+++++++...+..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 699999999999854 567788888754321111 2222221 279999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC-ceEEeeccccccccCccc
Q 047954 354 RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE-MVLVSDYGFSSLVAQPIA 432 (582)
Q Consensus 354 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfG~a~~~~~~~~ 432 (582)
++.... .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+++.......
T Consensus 99 ~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 165 (267)
T PHA03390 99 LLKKEG------KLSEAEVKKIIRQLVEALNDLHKHN-------IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC 165 (267)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCcc
Confidence 997532 5889999999999999999999998 99999999999999998 999999999987766655
Q ss_pred ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhch
Q 047954 433 AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSA 512 (582)
Q Consensus 433 ~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 512 (582)
..++..|+|||++.+..++.++|||||||++|||++|+.||...... ......+.... .. .....
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~-~~--~~~~~---------- 230 (267)
T PHA03390 166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE--ELDLESLLKRQ-QK--KLPFI---------- 230 (267)
T ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc--hhhHHHHHHhh-cc--cCCcc----------
Confidence 66788999999999889999999999999999999999999743221 11112221111 10 00000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-hHHHHHHHh
Q 047954 513 AHGMLKLLQVAIQCCNKSPEKRPE-MAEVVSELE 545 (582)
Q Consensus 513 ~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~ 545 (582)
......+.+++.+||+.+|.+||+ ++++++|-|
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~ 264 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence 112235788899999999999995 699997755
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=295.55 Aligned_cols=256 Identities=18% Similarity=0.274 Sum_probs=192.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... ++..|++|+++.. .....+.+.+|++++++++|+||+++++++...+..++||||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 85 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT 85 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence 457999999999999965 5778999988643 2334577899999999999999999999999999999999999987
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
.+..+.... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 86 ~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~-------i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 86 LLELLEASP------GGLPPDAVRSYIWQLLQAIAYCHSHN-------IIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 666555322 24788999999999999999999998 99999999999999999999999999877654
Q ss_pred cc-----cccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh--------
Q 047954 430 PI-----AAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE-------- 495 (582)
Q Consensus 430 ~~-----~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~-------- 495 (582)
.. ...++..|+|||++.+. .++.++||||||+++|+|++|+.||..... .+...........
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD----IDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHhhh
Confidence 32 12345679999999887 889999999999999999999999864321 1111111110000
Q ss_pred ----c-----ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 496 ----E-----WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 496 ----~-----~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
. ...+..+..............++.+++.+||..+|++||++++++++-+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 287 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence 0 0000000000000011112456889999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=294.29 Aligned_cols=246 Identities=23% Similarity=0.341 Sum_probs=195.8
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
..||+|+||.||++.. .++..||||++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 4699999999999986 467889999986544455667899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++... .+++.....++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 106 ~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~g-------ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 106 DIVTHT-------RMNEEQIAAVCLAVLKALSVLHAQG-------VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred HHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 987532 3678889999999999999999998 9999999999999999999999999886553321
Q ss_pred ---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 432 ---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 432 ---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
...++..|+|||+..+..++.++|||||||++|||++|+.||.... .......+ ..........
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~----~~~~~~~~----~~~~~~~~~~----- 238 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMI----RDNLPPKLKN----- 238 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH----HhhCCcccCC-----
Confidence 2335678999999988888999999999999999999999985321 11111111 1111111000
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.......+.+++.+||+.+|.+||++.+++++-+..+.
T Consensus 239 ---~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 239 ---LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred ---cccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 00112246788999999999999999999998665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=286.52 Aligned_cols=244 Identities=24% Similarity=0.410 Sum_probs=198.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|++|.||++... ++..+++|++........+.+.+|++++++++|+||+++++++......++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 357999999999999976 6788999999765544567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++.... ..+++..+..++.|++.||.|||..+ ++||||+|+||++++++.++|+|||.+.......
T Consensus 85 ~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~-------i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 85 KDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSNG-------IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred HHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcCC-------EecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 99987542 25889999999999999999999987 9999999999999999999999999988775542
Q ss_pred ---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 432 ---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 432 ---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
...++..|+|||++.+..++.++||||||+++|+|++|+.||.... .......... .........
T Consensus 153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~-~~~~~~~~~---- 220 (253)
T cd05122 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP-------PMKALFKIAT-NGPPGLRNP---- 220 (253)
T ss_pred cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc-------hHHHHHHHHh-cCCCCcCcc----
Confidence 3446678999999988889999999999999999999999986421 1111111111 111111111
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
......+.+++.+||+.||++|||+.|++++.
T Consensus 221 ----~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~ 252 (253)
T cd05122 221 ----EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHP 252 (253)
T ss_pred ----cccCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 00123588899999999999999999999764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=297.58 Aligned_cols=243 Identities=20% Similarity=0.317 Sum_probs=187.6
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEe------CCeeEEEEEe
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFS------NDEKLLVYKF 345 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~------~~~~~lv~e~ 345 (582)
+.||+|+||.||+|.. ..++.+|+|.+.... .....+..|+.++.++ +|+||+++++++.. ....+++|||
T Consensus 22 ~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 100 (282)
T cd06636 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100 (282)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence 5799999999999996 457788999875432 3345688899999988 79999999999863 4568999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++|+|.+++..... ..+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.++|+|||++.
T Consensus 101 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~-------ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 101 CGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAHK-------VIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 999999999875432 24777888899999999999999998 9999999999999999999999999987
Q ss_pred cccCc----ccccccccccCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 426 LVAQP----IAAQRMISYKSPEYQS-----SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 426 ~~~~~----~~~~~~~~y~aPE~~~-----~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
..... ....++..|+|||.+. ...++.++|||||||++|||++|+.||...... .. +... ...
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~----~~~~-~~~ 241 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM---RA----LFLI-PRN 241 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH---hh----hhhH-hhC
Confidence 65322 2234667899999875 346788999999999999999999999643211 00 0000 000
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
...... ......++.+++.+||..||.+||++.|++++-+
T Consensus 242 ~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 242 PPPKLK---------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred CCCCCc---------ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 011100 0112236888999999999999999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=291.87 Aligned_cols=256 Identities=20% Similarity=0.318 Sum_probs=190.8
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
+.||+|++|.||+|... ++..||+|++.... ....+.+.+|++++++++|||++++++++.+.+..+++|||+. ++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~ 83 (283)
T cd07835 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LD 83 (283)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cC
Confidence 56999999999999864 68899999986432 2234678899999999999999999999999999999999995 69
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++..... ..+++..++.++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 84 l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~~-------~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 84 LKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSHR-------VLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred HHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 9999865432 24889999999999999999999988 999999999999999999999999999765432
Q ss_pred c----cccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh----cc----
Q 047954 431 I----AAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE----EW---- 497 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----~~---- 497 (582)
. ...++..|+|||++.+. .++.++|||||||++|||++|+.||..... ...+...+ +.... .+
T Consensus 153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~ 228 (283)
T cd07835 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE---IDQLFRIF-RTLGTPDEDVWPGVT 228 (283)
T ss_pred ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH-HHhCCCChHHhhhhh
Confidence 1 11246779999987654 578999999999999999999999964321 01111111 00000 00
Q ss_pred -ccc----ccchhh-hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 498 -TAE----IFDSEI-SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 498 -~~~----~~d~~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
..+ ...... ............+.+++.+||+.||++|||++|++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 282 (283)
T cd07835 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282 (283)
T ss_pred hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence 000 000000 000000111236788999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=292.74 Aligned_cols=243 Identities=21% Similarity=0.352 Sum_probs=193.0
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCC-CcchHHHHHHHHHHHhcCC---CCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDL-KPLITEEFRKQLLVIADQK---HPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|.. .++..|++|.++.. .....+.+.+|+.++++++ |||++++++++......++||||+++
T Consensus 7 ~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06917 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEG 86 (277)
T ss_pred hheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCC
Confidence 5699999999999996 56788999988643 2334567889999999886 99999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++... .+++...+.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+.
T Consensus 87 ~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~~-------i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 87 GSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKVG-------VIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred CcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 9999988642 4788999999999999999999998 9999999999999999999999999987764
Q ss_pred Ccc----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 429 QPI----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 429 ~~~----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
... ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ...+.. ........+..
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-------~~~~~~-~~~~~~~~~~~ 224 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-------FRAMML-IPKSKPPRLED 224 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-------hhhhhc-cccCCCCCCCc
Confidence 432 2235677999998765 4568999999999999999999999964321 111110 00000111100
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.....++.+++.+||+.||++||++.|++.+.+.-
T Consensus 225 ---------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~ 259 (277)
T cd06917 225 ---------NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIK 259 (277)
T ss_pred ---------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhh
Confidence 01223678899999999999999999999886653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=294.35 Aligned_cols=241 Identities=22% Similarity=0.309 Sum_probs=194.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||+++
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence 467999999999999865 57889999886432 23346788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++.... .++...+..++.|++.||.|||+.+ |+|+||+|+|||++.++.+||+|||+++...
T Consensus 86 ~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~~-------i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 86 GELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSLD-------IVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------EecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 99999986542 4788899999999999999999988 9999999999999999999999999998765
Q ss_pred Cc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 429 QP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 429 ~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+ . .... .+ ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~---~-~~~~-~~-~~--- 219 (290)
T cd05580 153 GRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN----PIQIYEKI---L-EGKV-RF-PS--- 219 (290)
T ss_pred CCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH---h-cCCc-cC-Cc---
Confidence 43 22346778999999988888999999999999999999999996422 11111111 1 1100 00 00
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHh
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELE 545 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~ 545 (582)
.....+.+++.+||..||++|+ +++|++++.+
T Consensus 220 ------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 220 ------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred ------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 0122577899999999999999 8888887765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=297.67 Aligned_cols=264 Identities=19% Similarity=0.369 Sum_probs=192.3
Q ss_pred cccccccCceEEEEEEEcC---CceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLEG---RAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 344 (582)
.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++... ...++|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 3569999999999999654 6889999987632 34456778899999999999999999999988 78999999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC----CCceEEee
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD----NEMVLVSD 420 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~----~~~~kl~D 420 (582)
|+++ +|.+++...... ....++...++.++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|
T Consensus 85 ~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-------i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 85 YAEH-DLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVHYLHSNW-------VLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred CCCc-CHHHHHHhhccC-CCcCcCHHHHHHHHHHHHHHHHHHHhCC-------EeeCCCCHHHEEEcCCCCccceEEECC
Confidence 9965 787777543322 1235788899999999999999999998 999999999999999 89999999
Q ss_pred ccccccccCcc-------cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccc-----hHH
Q 047954 421 YGFSSLVAQPI-------AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD-----LCS 487 (582)
Q Consensus 421 fG~a~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~-----~~~ 487 (582)
||+++...... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||........... ...
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 99988754322 2234677999998765 4578999999999999999999999975433210000 000
Q ss_pred HHHHHHhh-------------cccc-------cccc-hhhhh-hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 488 WVLRAVRE-------------EWTA-------EIFD-SEISV-QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 488 ~~~~~~~~-------------~~~~-------~~~d-~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.+...+.. ++.. .... ..+.. .........++.+++.+||+.||++|||+.|++++.+
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 01010000 0000 0000 00000 0000022346889999999999999999999998744
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=297.08 Aligned_cols=246 Identities=21% Similarity=0.331 Sum_probs=194.3
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+.||+|+||.||+|... ++..+++|.+... .....+.+.+|++++++++|+|++++++++......++||||+. |
T Consensus 21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 99 (308)
T cd06634 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 99 (308)
T ss_pred HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-C
Confidence 56999999999999964 5678999988632 22234567889999999999999999999999999999999996 6
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
++.+.+.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 100 ~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH~~~-------i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 100 SASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN-------MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred CHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 8888775432 24788899999999999999999987 99999999999999999999999999987766
Q ss_pred cccccccccccCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 430 PIAAQRMISYKSPEYQS---SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 ~~~~~~~~~y~aPE~~~---~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.....++..|+|||++. ...++.++|||||||++|||++|+.||.... .... .... .........
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~---~~~~-~~~~~~~~~---- 235 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSA---LYHI-AQNESPALQ---- 235 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc----HHHH---HHHH-hhcCCCCcC----
Confidence 55556778899999874 3567889999999999999999999985321 1111 1111 111111100
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.......+.+++.+||..+|++||++.+++.+.+....
T Consensus 236 -----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 236 -----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -----cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 01122357789999999999999999999999887764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=294.72 Aligned_cols=254 Identities=18% Similarity=0.307 Sum_probs=190.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|... +++.+++|.++... ......+.+|+.++++++||||+++++++... ...++||||+.
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 357999999999999976 57889999986432 22334577899999999999999999999887 78999999997
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
++|.+++..... .+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 90 -~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~-------i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 90 -HDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDNW-------ILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred -cCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC-------eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 599998865321 4889999999999999999999998 999999999999999999999999998876
Q ss_pred cCcc----cccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh----cc-
Q 047954 428 AQPI----AAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE----EW- 497 (582)
Q Consensus 428 ~~~~----~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----~~- 497 (582)
.... ...++..|+|||.+.+. .++.++||||||+++|||++|+.||..... .+....+...... .|
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE----IDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCchHHHH
Confidence 5431 22356779999988754 468999999999999999999999964321 1111111111000 00
Q ss_pred ------------cccccchhhhhhhchHH--HHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 498 ------------TAEIFDSEISVQRSAAH--GMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 498 ------------~~~~~d~~~~~~~~~~~--~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
........+. ..... ....+.+++.+||+.+|++|||+.|++.+-|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~ 292 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLR--KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292 (293)
T ss_pred Hhhccchhcccccccccchhhh--ccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence 0000000000 00000 1345778999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.58 Aligned_cols=246 Identities=20% Similarity=0.326 Sum_probs=189.3
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeC-----CeeEEEEEeC
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSN-----DEKLLVYKFA 346 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-----~~~~lv~e~~ 346 (582)
+.||+|+||.||+|.. .+++.+|+|.+.... ...+.+.+|+.++.++ +|||++++++++... ...++||||+
T Consensus 28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~ 106 (291)
T cd06639 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELC 106 (291)
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEEC
Confidence 5799999999999996 467789999886432 2346678899999998 899999999998754 3579999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|.++++..... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 107 ~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~-------ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 107 NGGSVTELVKGLLIC--GQRLDEAMISYILYGALLGLQHLHNNR-------IIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred CCCcHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-------eeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 999999988643211 225788999999999999999999987 99999999999999999999999999876
Q ss_pred ccCcc----cccccccccCCCCCCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 427 VAQPI----AAQRMISYKSPEYQSSK-----KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 427 ~~~~~----~~~~~~~y~aPE~~~~~-----~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
..... ...++..|+|||++... .++.++|||||||++|||++|+.||..... ...+... ....
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-------~~~~~~~-~~~~ 249 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------VKTLFKI-PRNP 249 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-------HHHHHHH-hcCC
Confidence 54322 23456789999987543 368999999999999999999999964221 1111111 1111
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
...+.++ ......+.+++.+||+.+|++||++.|+++|.+
T Consensus 250 ~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~ 289 (291)
T cd06639 250 PPTLLHP--------EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289 (291)
T ss_pred CCCCCcc--------cccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence 1111111 112235788999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=294.10 Aligned_cols=245 Identities=22% Similarity=0.320 Sum_probs=192.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|+.. ++..|++|++.... ....+.+.+|++++++++|||++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 356999999999999864 57789999986432 2233567889999999999999999999999999999999995
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|++.+++.... .++++..++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 105 ~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH~~g-------i~H~dl~p~nili~~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 105 GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSHN-------MIHRDIKAGNILLTEPGQVKLADFGSASKSS 172 (313)
T ss_pred CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence 58888775432 24888999999999999999999998 9999999999999999999999999987655
Q ss_pred CcccccccccccCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 429 QPIAAQRMISYKSPEYQS---SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 429 ~~~~~~~~~~y~aPE~~~---~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
......++..|+|||++. ...++.++|||||||++|||++|+.||.... . ...+....... .......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~----~---~~~~~~~~~~~-~~~~~~~- 243 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----A---MSALYHIAQND-SPTLQSN- 243 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----h---HHHHHHHHhcC-CCCCCcc-
Confidence 444556778899999874 4568899999999999999999999985421 1 11111111111 1111110
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.....+.+++.+||+.+|++||++.+++.+.+.-
T Consensus 244 --------~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~ 277 (313)
T cd06633 244 --------EWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR 277 (313)
T ss_pred --------ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 1112477899999999999999999999886543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.03 Aligned_cols=245 Identities=21% Similarity=0.294 Sum_probs=187.2
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCCcc---hHHHHHHHHHHH-hcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPL---ITEEFRKQLLVI-ADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l-~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|... +++.||+|.+...... ....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 35899999999999864 5788999998643211 122344454443 456999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~-------i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQRG-------IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 99999986432 4788889999999999999999988 9999999999999999999999999987765
Q ss_pred CcccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 429 QPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 429 ~~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
......++..|+|||...+..++.++||||||+++|||+||..||.... .......+... ...+....
T Consensus 149 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-~~~~~~~~------- 216 (260)
T cd05611 149 ENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET----PDAVFDNILSR-RINWPEEV------- 216 (260)
T ss_pred ccccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHhc-ccCCCCcc-------
Confidence 5444557788999999988889999999999999999999999996421 11111111100 00000000
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCCh---HHHHHHHhh
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEM---AEVVSELEI 546 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~---~evl~~L~~ 546 (582)
.......+.+++.+||..+|++||++ +|++.|.+.
T Consensus 217 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 217 ---KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred ---cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 00112367889999999999999966 577666544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=321.28 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=203.4
Q ss_pred cccccccccCceEEEEEEEc--------CCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeE
Q 047954 271 APAEGLGKGIFGNSYKALLE--------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKL 340 (582)
Q Consensus 271 ~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 340 (582)
...+.||+|.||.|++|... ....||||.++... ....+.+..|+++|..+ +|+||+.++|+|...+..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 44568999999999999843 14579999997543 34567899999999998 7999999999999999999
Q ss_pred EEEEeCCCCChHHHHhcCC---------CCCCC-CccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee
Q 047954 341 LVYKFAGNGNLFNRIHGGK---------SSKNR-IPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL 410 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~---------~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl 410 (582)
+|+||+..|+|.++++..+ ..... ..++..+.+.++.|||.|++||++.. +|||||..+|||+
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~-------~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP-------CVHRDLAARNVLI 451 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-------ccchhhhhhhEEe
Confidence 9999999999999998776 11011 24888999999999999999999987 9999999999999
Q ss_pred cCCCceEEeeccccccccCcccc-----cc--cccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 047954 411 DDNEMVLVSDYGFSSLVAQPIAA-----QR--MISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGING 482 (582)
Q Consensus 411 ~~~~~~kl~DfG~a~~~~~~~~~-----~~--~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~ 482 (582)
.++..+||+|||+|+........ .+ ...|||||.+....|+.|+|||||||+|||++| |..||.... ..
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~---~~ 528 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP---PT 528 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC---cH
Confidence 99999999999999865443221 11 246999999999999999999999999999999 888885311 12
Q ss_pred cchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 483 ADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.++.+++..+.+.. .+..+..++.++|..||+.+|++||++.++.+.++..
T Consensus 529 ~~l~~~l~~G~r~~--------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 EELLEFLKEGNRME--------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHHHhcCCCCC--------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 33333333322222 1223344788999999999999999999999999885
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=295.00 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=190.4
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
+.||+|+||.||++... ++..||+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||+.. +
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~ 88 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-S 88 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-C
Confidence 57999999999999864 57889999986432 234567889999999996 99999999999999999999999864 5
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+.++....... ....+++.....++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++.+..
T Consensus 89 l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-------i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 89 LDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELK-------IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred HHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCC-------eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 55433211000 112588899999999999999999975 5 99999999999999999999999999876543
Q ss_pred c---ccccccccccCCCCCCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 430 P---IAAQRMISYKSPEYQSSK---KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 430 ~---~~~~~~~~y~aPE~~~~~---~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
. ....++..|+|||++.+. .++.++|||||||++|||++|+.||.... .....+....... ......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~-~~~~~~ 233 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKGD-PPILSN 233 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCCC-CCcCCC
Confidence 2 223467789999998765 68999999999999999999999996321 1122222111111 111100
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
........++.+++.+||+.+|++|||+++|+++.+.-.
T Consensus 234 ------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 234 ------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 000112336889999999999999999999999877543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.91 Aligned_cols=255 Identities=18% Similarity=0.275 Sum_probs=188.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCC-CCCccccceEEEeC--CeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQK-HPNLLPLLAYYFSN--DEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|... ++..||+|+++... ........+|+.++.++. |+||+++++++.+. +..++||||+.
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 356999999999999854 57889999986532 222334557888888885 99999999999987 88999999996
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
|+|.+.+.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++.+
T Consensus 84 -~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~-------i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 84 -MNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHRNG-------IFHRDIKPENILIKD-DILKLADFGSCRGI 149 (282)
T ss_pred -ccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------ceecccCHHHEEEcC-CCeEEEeccccccc
Confidence 58888886532 24889999999999999999999998 999999999999999 99999999999876
Q ss_pred cCcc---cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh--------
Q 047954 428 AQPI---AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE-------- 495 (582)
Q Consensus 428 ~~~~---~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~-------- 495 (582)
.... ...++..|+|||+... ..++.++|||||||++|||++|+.||.... ..+...+.......
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 150 YSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN----ELDQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred ccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC----HHHHHHHHHHHcCCCCHHHHHh
Confidence 4332 2235678999997644 557899999999999999999999996432 11222222111100
Q ss_pred ---cccccccchhh---hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 496 ---EWTAEIFDSEI---SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 496 ---~~~~~~~d~~~---~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
........+.. ...........++.+++.+||+.+|++||++++++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 00000000000 000001122457889999999999999999999998754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=294.68 Aligned_cols=243 Identities=22% Similarity=0.336 Sum_probs=199.3
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
+-||+|.|+.|-+|+. -.|..||||++.+.+ ......+.+|++-|+-++|||||++|++......+|||+|.-.+|+
T Consensus 24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GD 103 (864)
T KOG4717|consen 24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGD 103 (864)
T ss_pred hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCch
Confidence 4599999999999983 478889999997543 3344578899999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee-cCCCceEEeeccccccccC
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL-DDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl-~~~~~~kl~DfG~a~~~~~ 429 (582)
|++++..... .+.+....+++.||+.|+.|+|... +|||||||+||.+ .+-|-+||+|||++..+.+
T Consensus 104 l~DyImKHe~-----Gl~E~La~kYF~QI~~AI~YCHqLH-------VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 104 LFDYIMKHEE-----GLNEDLAKKYFAQIVHAISYCHQLH-------VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred HHHHHHhhhc-----cccHHHHHHHHHHHHHHHHHHhhhh-------hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999975433 4888889999999999999999988 9999999999876 5678899999999977655
Q ss_pred cc---cccccccccCCCCCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 PI---AAQRMISYKSPEYQSSKKIS-RKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~~---~~~~~~~y~aPE~~~~~~~~-~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
.. ...|...|-|||.+.+..|+ +++||||+|||||-|+.|+.||+...... . +.-++|-+
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----T------------LTmImDCK 235 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----T------------LTMIMDCK 235 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----h------------hhhhhccc
Confidence 43 34567889999999999885 68999999999999999999997654321 1 11223333
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+.. +..-..+..+|+..||..||++|.+.++|+.+-|--
T Consensus 236 Ytv---PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq 274 (864)
T KOG4717|consen 236 YTV---PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ 274 (864)
T ss_pred ccC---chhhhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence 222 223344678899999999999999999999887643
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=291.19 Aligned_cols=242 Identities=20% Similarity=0.301 Sum_probs=194.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||.|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++......++|+||+.+
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG 84 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence 467999999999999975 57889999986432 23456789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++... ..++...+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||.+....
T Consensus 85 ~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~-------i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~ 151 (258)
T cd05578 85 GDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSKG-------IIHRDIKPDNILLDEQGHVHITDFNIATKVT 151 (258)
T ss_pred CCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhCC-------eeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence 9999998643 25788899999999999999999988 9999999999999999999999999987664
Q ss_pred Cc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 429 QP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 429 ~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
.. ....++..|+|||...+..++.++||||||+++|+|++|+.||...... ...++...... ... ...
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~-~~~-- 222 (258)
T cd05578 152 PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET-ADV-LYP-- 222 (258)
T ss_pred CCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc-ccc-cCc--
Confidence 43 2334667899999998888999999999999999999999999753321 11122111111 000 000
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCCh--HHHHHH
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM--AEVVSE 543 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl~~ 543 (582)
......+.+++.+||+.||.+||++ +|++++
T Consensus 223 -------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 223 -------ATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred -------ccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 1112467889999999999999999 777654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=317.33 Aligned_cols=264 Identities=17% Similarity=0.242 Sum_probs=183.3
Q ss_pred cccccccCceEEEEEEEcCC--ceEEEE------------------EecCCCcchHHHHHHHHHHHhcCCCCCccccceE
Q 047954 273 AEGLGKGIFGNSYKALLEGR--APVVVK------------------RLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~--~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~ 332 (582)
.+.||+|+||+||++..+.. ..+++| ++. ........+.+|+.++++++|||||+++++
T Consensus 153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 231 (501)
T PHA03210 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENILKIEEI 231 (501)
T ss_pred EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCcCcEeEE
Confidence 46799999999999875421 111111 111 112234568899999999999999999999
Q ss_pred EEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC
Q 047954 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD 412 (582)
Q Consensus 333 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~ 412 (582)
+...+..++|+|++. ++|.+++........ ..........|+.||+.||+|||+++ ||||||||+|||++.
T Consensus 232 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~-~~~~~~~~~~i~~ql~~aL~yLH~~g-------IiHrDLKP~NILl~~ 302 (501)
T PHA03210 232 LRSEANTYMITQKYD-FDLYSFMYDEAFDWK-DRPLLKQTRAIMKQLLCAVEYIHDKK-------LIHRDIKLENIFLNC 302 (501)
T ss_pred EEECCeeEEEEeccc-cCHHHHHhhcccccc-ccccHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEECC
Confidence 999999999999984 588887764432111 12334567789999999999999998 999999999999999
Q ss_pred CCceEEeeccccccccCcc-----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHH
Q 047954 413 NEMVLVSDYGFSSLVAQPI-----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCS 487 (582)
Q Consensus 413 ~~~~kl~DfG~a~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~ 487 (582)
++.+||+|||+++.+.... ...++..|+|||++.+..++.++|||||||++|||++|..++...........+.+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 9999999999998765432 23478899999999999999999999999999999998765432211111111111
Q ss_pred HHHHHHhhcccccccchh-----------hhh-hhchHH------HHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 488 WVLRAVREEWTAEIFDSE-----------ISV-QRSAAH------GMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 488 ~~~~~~~~~~~~~~~d~~-----------~~~-~~~~~~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.+. .+.. ...++.+.. +.. ...... ....+.+++.+||+.||++|||+.|++.+.+.-.
T Consensus 383 ~~~-~~~~-~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 383 IID-SLSV-CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHH-hccc-ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 111 0000 000000000 000 000000 1124667788999999999999999999887544
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=282.30 Aligned_cols=265 Identities=20% Similarity=0.318 Sum_probs=205.9
Q ss_pred ChhHhhhcccccccccCceEEEEEE-EcCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEE
Q 047954 264 KLNDLLKAPAEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLL 341 (582)
Q Consensus 264 ~~~~l~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 341 (582)
+++|+...+.+.||+|+|+.|--++ ..++..+|||++.+.....+....+|++++... .|+||++++++|+++...||
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 5789999999999999999999987 778899999999887767788899999999887 79999999999999999999
Q ss_pred EEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc---eEE
Q 047954 342 VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM---VLV 418 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~---~kl 418 (582)
|||-|.||.|..+++..+ .+++.++.++.++||.||.|||.++ |.||||||+|||..+... +||
T Consensus 154 VfEKm~GGplLshI~~~~------~F~E~EAs~vvkdia~aLdFlH~kg-------IAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK------HFNEREASRVVKDIASALDFLHTKG-------IAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred EEecccCchHHHHHHHhh------hccHHHHHHHHHHHHHHHHHHhhcC-------cccccCCccceeecCCCCcCceee
Confidence 999999999999998653 5889999999999999999999998 999999999999976544 899
Q ss_pred eeccccccccC--cc---------cccccccccCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC---
Q 047954 419 SDYGFSSLVAQ--PI---------AAQRMISYKSPEYQS-----SKKISRKSDVWSFGCLLLELLTGRISTHSAPQG--- 479 (582)
Q Consensus 419 ~DfG~a~~~~~--~~---------~~~~~~~y~aPE~~~-----~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~--- 479 (582)
|||.+..-+.. +. ...|+..|||||+.. ...|+.++|.||+|||||-|+.|..||...-..
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 99988644321 11 112445699999753 346899999999999999999999999754221
Q ss_pred CCccch----HHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 480 INGADL----CSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 480 ~~~~~~----~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.+..+. .+.+...++++. -++.|.. ......+..+++...+..|+.+|-++.+++.+.|.-.
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGk-YeFPdkd------WahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGK-YEFPDKD------WAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccC-CcCChhh------hHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 111111 112222223322 1222221 1122334566777778899999999999999887544
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.27 Aligned_cols=247 Identities=16% Similarity=0.190 Sum_probs=174.3
Q ss_pred cccccccCceEEEEEEEcCC----ceEEEEEecCCCcch-HH----------HHHHHHHHHhcCCCCCccccceEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLEGR----APVVVKRLRDLKPLI-TE----------EFRKQLLVIADQKHPNLLPLLAYYFSND 337 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~-~~----------~~~~e~~~l~~l~H~niv~l~~~~~~~~ 337 (582)
.++||+|+||.||+|...++ ..+|+|......... .+ ....+...+..+.|+|++++++++....
T Consensus 17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 96 (294)
T PHA02882 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKR 96 (294)
T ss_pred eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEec
Confidence 46799999999999997654 345555433222111 11 1223344556779999999999776543
Q ss_pred ----eeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC
Q 047954 338 ----EKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN 413 (582)
Q Consensus 338 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~ 413 (582)
..++++|++.. ++.+.+.... ..++..+..|+.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~-------iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 97 CRMYYRFILLEKLVE-NTKEIFKRIK------CKNKKLIKNIMKDMLTTLEYIHEHG-------ISHGDIKPENIMVDGN 162 (294)
T ss_pred CCceEEEEEEehhcc-CHHHHHHhhc------cCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEEcCC
Confidence 34678887743 6666664321 2466778899999999999999988 9999999999999999
Q ss_pred CceEEeeccccccccCc-----------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 047954 414 EMVLVSDYGFSSLVAQP-----------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGING 482 (582)
Q Consensus 414 ~~~kl~DfG~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~ 482 (582)
+.++|+|||+|+.+... ....+|+.|+|||+..+..++.++|||||||++|||++|+.||......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~--- 239 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN--- 239 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc---
Confidence 99999999999765321 1234778899999999999999999999999999999999999754211
Q ss_pred cchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 483 ADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
..+...... ++...+........ .....+.+++..|+..+|++||++.++++.+
T Consensus 240 ~~~~~~~~~----~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 240 GNLIHAAKC----DFIKRLHEGKIKIK----NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHhHH----HHHHHhhhhhhccC----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111111110 01111111111111 1124688899999999999999999998865
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=333.69 Aligned_cols=242 Identities=21% Similarity=0.351 Sum_probs=194.6
Q ss_pred cccccccCceEEEEEE-EcCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+..||.|.||.||-|. ..+|...|+|-++.. .........+|+.++..++|||+|++||+-.+.+..+|.||||.+|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 4679999999999998 567888899877532 2333456789999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+.+..++ ..++.....+..|++.|++|||+++ ||||||||.||+++.+|.+|++|||.|..+..
T Consensus 1320 sLa~ll~~gr------i~dE~vt~vyt~qll~gla~LH~~g-------IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1320 SLASLLEHGR------IEDEMVTRVYTKQLLEGLAYLHEHG-------IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred cHHHHHHhcc------hhhhhHHHHHHHHHHHHHHHHHhcC-------ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999997553 3566666778899999999999998 99999999999999999999999999987765
Q ss_pred cc--------cccccccccCCCCCCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 430 PI--------AAQRMISYKSPEYQSSKK---ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 430 ~~--------~~~~~~~y~aPE~~~~~~---~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
+. ...||+.|||||++.+.. -..++||||+|||++||+||+.||.... +...++..|..+. .
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d---ne~aIMy~V~~gh----~ 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD---NEWAIMYHVAAGH----K 1459 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc---chhHHHhHHhccC----C
Confidence 43 234788999999997643 4678999999999999999999997533 3344444443332 2
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
+.+... -..+-.+++.+|+..||++|.++.|++++=
T Consensus 1460 Pq~P~~----------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1460 PQIPER----------LSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CCCchh----------hhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 222211 122456788899999999999998887764
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=290.48 Aligned_cols=256 Identities=18% Similarity=0.319 Sum_probs=192.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|... ++..+|+|++.... ......+.+|+.++++++|+|++++++++... +..++||||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 357999999999999966 47889999997542 33456788999999999999999999999988 78999999997
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+ +|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++...
T Consensus 84 ~-~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~~-------~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 84 H-DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSNG-------ILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred c-cHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------ceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 5 8988886432 25889999999999999999999998 999999999999999999999999999776
Q ss_pred cCcc-----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---cc
Q 047954 428 AQPI-----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE---WT 498 (582)
Q Consensus 428 ~~~~-----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~ 498 (582)
.... ...++..|+|||.+.+ ..++.++||||||+++|||+||+.||..... ......+....... ..
T Consensus 151 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 151 TKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE----LEQLEKIFELCGSPTDENW 226 (287)
T ss_pred cCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCchhhc
Confidence 5432 2234567999997664 4578999999999999999999999964321 11111111111000 00
Q ss_pred ccccc--------hhhhh----hhchHH-HHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 499 AEIFD--------SEISV----QRSAAH-GMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 499 ~~~~d--------~~~~~----~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
....+ ..... ...... ...++.+++.+||..+|++||++++++++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~ 286 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence 00000 00000 000001 1346889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.22 Aligned_cols=240 Identities=20% Similarity=0.314 Sum_probs=190.3
Q ss_pred ccccCceEEEEEEEcC-CceEEEEEecCCCc---chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 276 LGKGIFGNSYKALLEG-RAPVVVKRLRDLKP---LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 276 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
||+|+||.||++.... +..+++|.+..... ...+.+.+|++++.+++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 88999999864432 3456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++.... .+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~~-------i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~ 147 (265)
T cd05579 81 ASLLENVG------SLDEDVARIYIAEIVLALEYLHSNG-------IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147 (265)
T ss_pred HHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcC-------eecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence 99997532 4788999999999999999999988 9999999999999999999999999987543321
Q ss_pred ------------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 432 ------------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 432 ------------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
...++..|+|||......++.++||||||+++|||++|+.||.... .......+ .... ..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~~---~~~~-~~ 219 (265)
T cd05579 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET----PEEIFQNI---LNGK-IE 219 (265)
T ss_pred ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH---hcCC-cC
Confidence 1234567999999988889999999999999999999999996432 11111111 1100 00
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh---HHHHHHHh
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM---AEVVSELE 545 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~---~evl~~L~ 545 (582)
. + ........+.+++.+||+.+|++|||+ .+++++-+
T Consensus 220 -~--~------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 220 -W--P------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred -C--C------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 0 0 000012367889999999999999999 66666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=289.09 Aligned_cols=245 Identities=19% Similarity=0.224 Sum_probs=186.3
Q ss_pred cccccCceEEEEEEEc-CCceEEEEEecCCCc---chHHHHHHHH---HHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 275 GLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP---LITEEFRKQL---LVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.||+|+||.||+|... +++.||+|.+..... .....+..|. ..++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 578899998864321 1122233443 34455689999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 81 g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~~-------i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 81 GGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHNRF-------VVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-------EEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 99999988642 25889999999999999999999988 999999999999999999999999998765
Q ss_pred cCc--ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 428 AQP--IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 428 ~~~--~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
... ....++..|+|||++.+. .++.++||||+||++|||++|+.||...... .... ........ ...+.
T Consensus 148 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~-~~~~~-- 219 (278)
T cd05606 148 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHE-IDRMTLTM-AVELP-- 219 (278)
T ss_pred CccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc----chHH-HHHHhhcc-CCCCC--
Confidence 432 233467889999998744 6899999999999999999999999653211 1111 11111000 00000
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhhcc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEIIK 548 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~i~ 548 (582)
.....++.+++.+|+..+|++|| ++.+++++.+...
T Consensus 220 --------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 220 --------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred --------CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 01123678889999999999999 9999998776544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=283.59 Aligned_cols=243 Identities=21% Similarity=0.348 Sum_probs=197.1
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCCc--chHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~~ 348 (582)
+.||+|++|.||+|... ++..|++|++..... ...+.+.+|+.++++++|+||+++++++... ...++|+||+++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 85 (260)
T cd06606 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85 (260)
T ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence 57999999999999976 678899999865432 4467889999999999999999999999988 889999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 86 ~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~~-------~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 86 GSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSNG-------IVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 99999987542 5889999999999999999999987 9999999999999999999999999987765
Q ss_pred Ccc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 429 QPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 429 ~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
... ...++..|+|||...+...+.++||||||+++|+|++|+.||.... .................+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGEPPEIP 226 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCCCcCCC
Confidence 432 2345678999999988889999999999999999999999996432 1111111111101111111
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
......+.+++.+|+..+|++||++.|++.+.+
T Consensus 227 ----------~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~ 259 (260)
T cd06606 227 ----------EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF 259 (260)
T ss_pred ----------cccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence 111236888999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=290.26 Aligned_cols=247 Identities=24% Similarity=0.369 Sum_probs=190.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeCC------eeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSND------EKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~------~~~lv~e 344 (582)
.+.||+|+||.||+|... ++..+++|.+.... ...+.+.+|+.+++++ +|+||+++++++.... ..++|||
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 89 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence 367999999999999975 56789999886543 2456789999999998 7999999999997654 4899999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++
T Consensus 90 ~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~-------i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 90 LCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLHENK-------VIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred cCCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCC-------cccCCCCHHHEEEccCCeEEECCCccc
Confidence 99999999988653311 125788999999999999999999998 999999999999999999999999998
Q ss_pred ccccCc----ccccccccccCCCCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh
Q 047954 425 SLVAQP----IAAQRMISYKSPEYQSS-----KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE 495 (582)
Q Consensus 425 ~~~~~~----~~~~~~~~y~aPE~~~~-----~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 495 (582)
...... ....++..|+|||++.. ..++.++|||||||++|+|++|+.||..... . ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~---~~~~~~~~- 232 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP----M---RALFKIPR- 232 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch----H---HHHHHhhc-
Confidence 765432 22335678999998753 3468899999999999999999999963211 1 11111111
Q ss_pred cccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 496 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.....+. ........+.+++.+||..||++|||+.|++++.|
T Consensus 233 ~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 233 NPPPTLK--------SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred cCCCCCC--------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 1111111 11112346788999999999999999999998654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.99 Aligned_cols=256 Identities=19% Similarity=0.309 Sum_probs=189.3
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCC-----eeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND-----EKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~e~ 345 (582)
.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++|+||+++++++.... ..++|+||
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 46799999999999985 46788999998643 2334566888999999999999999999876543 47999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+. ++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 90 ~~-~~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~~-------ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 90 ME-TDLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSAN-------VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred cc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCC-------eeccCCCHHHEEECCCCCEEECccccee
Confidence 96 4888877532 4788899999999999999999998 9999999999999999999999999987
Q ss_pred cccCcc-------cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 426 LVAQPI-------AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 426 ~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
...... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~----~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD----YLHQLNLILGVLGTPS 230 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCC
Confidence 654321 1235678999998654 568999999999999999999999996422 1111111111111000
Q ss_pred c---ccccc-------------hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 498 T---AEIFD-------------SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 498 ~---~~~~d-------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
. ..+.+ +.............++.+++.+||+.+|++|||+.|++++.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~ 296 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 0 00000 00000000011234688999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=290.86 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=189.7
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|...+ ++.||||.++... ......+..|+.++.+. .||||+++++++......++||||+. +
T Consensus 20 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 98 (296)
T cd06618 20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-T 98 (296)
T ss_pred eeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-c
Confidence 5789999999999999875 7889999986533 22345566777767666 59999999999999999999999985 4
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
+|.+++.... ..+++..+..++.||+.||+|||+. + |+||||+|+||++++++.+||+|||++..+.
T Consensus 99 ~l~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~-------i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 99 CLDKLLKRIQ-----GPIPEDILGKMTVAIVKALHYLKEKHG-------VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCC-------EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 7777665422 1588899999999999999999974 5 9999999999999999999999999987664
Q ss_pred Ccc---cccccccccCCCCCCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 429 QPI---AAQRMISYKSPEYQSSKK----ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 429 ~~~---~~~~~~~y~aPE~~~~~~----~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
... ...++..|+|||++.+.. ++.++||||||+++|||++|+.||..... . .+......... ....
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~---~~~~~~~~~~~-~~~~ 239 (296)
T cd06618 167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---E---FEVLTKILQEE-PPSL 239 (296)
T ss_pred CCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh---H---HHHHHHHhcCC-CCCC
Confidence 322 223556899999987554 78999999999999999999999953211 1 11111111111 1111
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
... .....++.+++.+||..||++||++.+++.+.+....
T Consensus 240 ~~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 240 PPN--------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCC--------CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 000 0122367889999999999999999999999875543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=300.86 Aligned_cols=258 Identities=19% Similarity=0.286 Sum_probs=192.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcch--------------HHHHHHHHHHHhcCCCCCccccceEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLI--------------TEEFRKQLLVIADQKHPNLLPLLAYYFSND 337 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 337 (582)
.+.||+|+||.||+|... +++.||||+++...... ...+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 457999999999999854 68889999886432211 124778999999999999999999999999
Q ss_pred eeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceE
Q 047954 338 EKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL 417 (582)
Q Consensus 338 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~k 417 (582)
..++||||+. |+|.+++... ..+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.+|
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~-------i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK------IRLTESQVKCILLQILNGLNVLHKWY-------FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC-------eecccccHHHeEECCCCCEE
Confidence 9999999996 6999988642 24788899999999999999999988 99999999999999999999
Q ss_pred EeeccccccccCc------------------ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 047954 418 VSDYGFSSLVAQP------------------IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQ 478 (582)
Q Consensus 418 l~DfG~a~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~ 478 (582)
|+|||+++..... ....++..|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~- 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN- 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 9999998765411 011235679999988764 46899999999999999999999996432
Q ss_pred CCCccchHHHHHHHHhhc----cccccc-------chhh--hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 479 GINGADLCSWVLRAVREE----WTAEIF-------DSEI--SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~----~~~~~~-------d~~~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
..+....+....... |..... .... ...........++.+++.+||+.+|++|||++|++.+.+
T Consensus 239 ---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 239 ---EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred ---HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 112222222211110 000000 0000 000000112346788999999999999999999999877
Q ss_pred hcc
Q 047954 546 IIK 548 (582)
Q Consensus 546 ~i~ 548 (582)
.-.
T Consensus 316 ~~~ 318 (335)
T PTZ00024 316 FKS 318 (335)
T ss_pred cCC
Confidence 643
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=291.16 Aligned_cols=260 Identities=17% Similarity=0.274 Sum_probs=189.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCC-CCCccccceEEEeCCe-----eEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDE-----KLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~-----~~lv~ 343 (582)
.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.+++++. ||||+++++++...+. .++||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 357999999999999965 57889999876432 223467888999999995 6999999999987665 79999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC-CCceEEeecc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD-NEMVLVSDYG 422 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfG 422 (582)
||+++ +|.+++...... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 86 e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~-------i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKHG-------VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred eccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-------eeecCCChHHEEEecCCCeEEEeecc
Confidence 99985 898888654322 1235889999999999999999999998 999999999999998 8899999999
Q ss_pred ccccccCcc----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc-
Q 047954 423 FSSLVAQPI----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE- 496 (582)
Q Consensus 423 ~a~~~~~~~----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~- 496 (582)
+++...... ...+++.|+|||++.+ ..++.++|||||||++|||++|..||...... ..+.. +.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~-~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL---QQLLH-IFKLLGTPT 232 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH-HHHHhCCCC
Confidence 987653321 1234567999998765 45799999999999999999999999643210 11110 11100000
Q ss_pred --ccccc---cc----hh---hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 497 --WTAEI---FD----SE---ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 497 --~~~~~---~d----~~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
..... .+ +. ............++.+++.+||..||++||++.|++.+-|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~ 293 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence 00000 00 00 0000000112346788999999999999999999998754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=295.67 Aligned_cols=256 Identities=16% Similarity=0.272 Sum_probs=186.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCC--------eeEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSND--------EKLL 341 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--------~~~l 341 (582)
...||+|+||.||+|... ++..||||.+.... ......+.+|+.++++++||||+++++++.... ..++
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 96 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence 357999999999999965 57889999885432 223345678999999999999999999987654 3499
Q ss_pred EEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
||||+. ++|.+.+.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.+||+||
T Consensus 97 v~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~-------i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 97 VFEFCE-HDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHRNK-------ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred EEcCCC-cCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCC-------eeccCCCHHHEEECCCCcEEECcC
Confidence 999996 48888876432 24789999999999999999999998 999999999999999999999999
Q ss_pred cccccccCccc--------ccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHH
Q 047954 422 GFSSLVAQPIA--------AQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492 (582)
Q Consensus 422 G~a~~~~~~~~--------~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 492 (582)
|++........ ..++..|+|||.+.+. .++.++||||||+++|||+||+.||..... ......+...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~----~~~~~~~~~~ 239 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE----QHQLTLISQL 239 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHH
Confidence 99976643221 1245679999987654 478899999999999999999999864321 1111111111
Q ss_pred Hh---hccccccc-----------ch---hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 493 VR---EEWTAEIF-----------DS---EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 493 ~~---~~~~~~~~-----------d~---~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.. ....+... .. .....-........+.+++.+||..||++|||++|+++|.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~ 309 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence 10 00000000 00 00000000001234678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.56 Aligned_cols=256 Identities=21% Similarity=0.346 Sum_probs=190.0
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCC--cchHHHHHHHHHHHhcC---CCCCccccceEEEeCCe-----eEE
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLK--PLITEEFRKQLLVIADQ---KHPNLLPLLAYYFSNDE-----KLL 341 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~-----~~l 341 (582)
.+.||+|+||.||+|.... ++.||+|+++... ......+.+|+.++.++ +|+||+++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 3579999999999999764 7899999986432 22234566777776655 69999999999998776 899
Q ss_pred EEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
+|||+. ++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+||
T Consensus 84 ~~e~~~-~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~~-------i~h~~l~~~nili~~~~~~~l~df 151 (287)
T cd07838 84 VFEHVD-QDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSHR-------IVHRDLKPQNILVTSDGQVKIADF 151 (287)
T ss_pred Eehhcc-cCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeeccCChhhEEEccCCCEEEecc
Confidence 999997 489988865332 24889999999999999999999998 999999999999999999999999
Q ss_pred cccccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh----
Q 047954 422 GFSSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR---- 494 (582)
Q Consensus 422 G~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---- 494 (582)
|++....... ...++..|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.....
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 152 GLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE----ADQLDKIFDVIGLPSE 227 (287)
T ss_pred CcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh----HHHHHHHHHHcCCCCh
Confidence 9987764432 22356779999999988999999999999999999999999864321 111111111110
Q ss_pred hcccccc------cchhhh--hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 495 EEWTAEI------FDSEIS--VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 495 ~~~~~~~------~d~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
..+.... ...... ...........+.+++.+||+.||++||++.|++.+-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~ 285 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence 0000000 000000 0001112235678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=292.23 Aligned_cols=255 Identities=19% Similarity=0.337 Sum_probs=194.2
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCCc--chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
+.||+|++|.||+|... +++.+++|++..... .....+.+|+.++++++|+||+++++++..+...++|+||+++ +
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence 56999999999999864 678899999864332 3456788999999999999999999999999999999999975 8
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||.+......
T Consensus 84 l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~-------i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 84 LYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSHG-------ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred HHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHCC-------eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 888886532 25889999999999999999999998 999999999999999999999999998766543
Q ss_pred c----cccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---cccccc
Q 047954 431 I----AAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE---WTAEIF 502 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 502 (582)
. ...++..|+|||.+.+. .++.++||||||+++|+|+||+.||..... .+....+....... ......
T Consensus 152 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 152 VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE----IDQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCchHhcccch
Confidence 2 12345679999998776 789999999999999999999999864321 11111111111100 000000
Q ss_pred c-----------hh-hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 503 D-----------SE-ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 503 d-----------~~-~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
+ .. ............++.+++.+||+.||.+||++.+++.+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 0 00 0000011123457889999999999999999999998754
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=292.07 Aligned_cols=260 Identities=20% Similarity=0.310 Sum_probs=192.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|... ++..||+|+++... ......+.+|+.++++++|+||+++++++... +..++||||+.
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 357999999999999964 57889999986432 22234567899999999999999999998765 46899999996
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
++|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 92 -~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 92 -QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHENF-------IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred -CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 48988886432 25889999999999999999999998 999999999999999999999999999876
Q ss_pred cCcc----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---ccc
Q 047954 428 AQPI----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE---WTA 499 (582)
Q Consensus 428 ~~~~----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 499 (582)
.... ....+..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ..+....+....... ...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~----~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS----EIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcCCCChhhch
Confidence 5431 1123567999998865 457899999999999999999999996432 122222221111100 000
Q ss_pred ---------cc--cchhhh-hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 500 ---------EI--FDSEIS-VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 500 ---------~~--~d~~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.. ...... ..........++.+++.+|++.||++|||+.|++.|.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 00 000000 000001123457789999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=294.76 Aligned_cols=257 Identities=21% Similarity=0.380 Sum_probs=189.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCC--eeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSND--EKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~--~~~lv~e~~ 346 (582)
.+.||+|+||.||+|... ++..+|+|++... .......+.+|+.+++++ +||||+++++++...+ ..++||||+
T Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07852 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91 (337)
T ss_pred hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence 367999999999999965 5788999988542 223345677899999999 9999999999987543 579999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
. ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 92 ~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~-------i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 92 E-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSGN-------VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred c-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 7 5999988643 4778889999999999999999988 99999999999999999999999999976
Q ss_pred ccCcc---------cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHH---
Q 047954 427 VAQPI---------AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAV--- 493 (582)
Q Consensus 427 ~~~~~---------~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~--- 493 (582)
..... ...++..|+|||++.+ ..++.++||||||+++|||+||+.||...... +....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~----~~~~~~~~~~~~~ 232 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL----NQLEKIIEVIGPP 232 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCC
Confidence 54322 1235677999998754 45789999999999999999999999643211 1111111100
Q ss_pred --------hhcccccccch----hh-hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 494 --------REEWTAEIFDS----EI-SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 494 --------~~~~~~~~~d~----~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
......++++. .. ...........++.+++.+||+.||++|||+.+++++-+.-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 00000000000 00 000000112346789999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=296.95 Aligned_cols=255 Identities=18% Similarity=0.286 Sum_probs=190.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeC------CeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN------DEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~ 343 (582)
.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++... ...++||
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 367999999999999854 6788999998542 223445677899999999999999999988644 2469999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+. ++|.+.+.. .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 101 e~~~-~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~~g-------i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 101 ELMD-ANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred eccC-CCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhCC-------eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 9995 588888752 2677888899999999999999998 99999999999999999999999999
Q ss_pred cccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh-----
Q 047954 424 SSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE----- 495 (582)
Q Consensus 424 a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----- 495 (582)
++...... ...++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ......+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH----IDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHhcCCCCHHH
Confidence 98765432 22356789999999999999999999999999999999999964321 1111111000000
Q ss_pred ---------ccc-----------ccccchhhhh---hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 496 ---------EWT-----------AEIFDSEISV---QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 496 ---------~~~-----------~~~~d~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.+. .+.+...... .........++.+++.+||+.||++|||+.|++.+.+.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 000 0000000000 000112234578999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=290.27 Aligned_cols=257 Identities=18% Similarity=0.313 Sum_probs=192.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|++|.||+|+.. ++..||||+++... ....+.+.+|+.++++++|+||+++++++...+..++||||+++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 367999999999999975 57889999986543 23346678899999999999999999999999999999999985 8
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 84 l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-------i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 84 LKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHENR-------VLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred HHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHCC-------eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 9888865432 235889999999999999999999998 999999999999999999999999998765432
Q ss_pred c----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh----------
Q 047954 431 I----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE---------- 495 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---------- 495 (582)
. ...++..|++||++.+ ..++.++|||||||++|||++|+.||..... .+....+......
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN----EDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCChhhHHHHh
Confidence 1 2234678999998765 3578999999999999999999999965321 1111111111100
Q ss_pred ---cccccccchh-hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 496 ---EWTAEIFDSE-ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 496 ---~~~~~~~d~~-~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
.+........ .............+.+++.+|++.||++||++.+++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~ 282 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP 282 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence 0000000000 000000011234678899999999999999999998764
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=270.48 Aligned_cols=258 Identities=23% Similarity=0.357 Sum_probs=194.3
Q ss_pred CCCChhHhhhcccccccccCceEEEEEEEc-CCceEEEEEecCC-CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCC
Q 047954 261 AGFKLNDLLKAPAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL-KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSND 337 (582)
Q Consensus 261 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 337 (582)
...++.||.. -..||.|+.|.|++++.. .+...|||.++.. +....+++...+.++.+- +.|+||+.+|||..+.
T Consensus 87 ~~~dindl~~--l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 87 YQADINDLEN--LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred cccChHHhhh--HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 3445555543 356999999999999965 5788999999654 344456677777777665 4899999999999999
Q ss_pred eeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceE
Q 047954 338 EKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL 417 (582)
Q Consensus 338 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~k 417 (582)
..++.||.|.. -+..+++.-+ .++++...-++...+++||.||.++. .|+|||+||+|||+|+.|.+|
T Consensus 165 dV~IcMelMs~-C~ekLlkrik-----~piPE~ilGk~tva~v~AL~YLKeKH------~viHRDvKPSNILlDe~GniK 232 (391)
T KOG0983|consen 165 DVFICMELMST-CAEKLLKRIK-----GPIPERILGKMTVAIVKALYYLKEKH------GVIHRDVKPSNILLDERGNIK 232 (391)
T ss_pred hHHHHHHHHHH-HHHHHHHHhc-----CCchHHhhhhhHHHHHHHHHHHHHhc------ceeecccCccceEEccCCCEE
Confidence 99999998843 4444554332 25777777888899999999999875 499999999999999999999
Q ss_pred EeeccccccccCcc---cccccccccCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHH
Q 047954 418 VSDYGFSSLVAQPI---AAQRMISYKSPEYQSS---KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLR 491 (582)
Q Consensus 418 l~DfG~a~~~~~~~---~~~~~~~y~aPE~~~~---~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 491 (582)
+||||++..+.+.. ...|.+.|||||.+.. ..|+.++||||||++|+||.||+.||.....+ .+....+
T Consensus 233 lCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---Fe~ltkv-- 307 (391)
T KOG0983|consen 233 LCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---FEVLTKV-- 307 (391)
T ss_pred eecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---HHHHHHH--
Confidence 99999998775543 3456788999998864 47899999999999999999999999753221 1222222
Q ss_pred HHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 492 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+.++ . ..++... .....+.+++..||.+|+.+||...++++|..-.
T Consensus 308 -ln~e-P-P~L~~~~-------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~ 353 (391)
T KOG0983|consen 308 -LNEE-P-PLLPGHM-------GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK 353 (391)
T ss_pred -HhcC-C-CCCCccc-------CcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence 2211 1 1222111 1334678888899999999999999999986533
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=298.90 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=198.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
...||+|.|++|..|+.. .+..||||.+.+.. ......+.+|+++|..++|||||+++.+.......|+||||+.+|
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~g 140 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGG 140 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCc
Confidence 356999999999999854 57889999986542 334456889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
.+++++..... +.......++.|+.+|++|||+++ |||||||++||||+.++.+||+|||++..+..
T Consensus 141 e~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH~k~-------ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 141 ELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCHSKN-------IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred hhHHHHHhccc------chhhhhhhhhHHHHHHHHHHhhcc-------eeccccchhhcccccccceeeeccccceeecc
Confidence 99999976542 444778889999999999999998 99999999999999999999999999988865
Q ss_pred cc---cccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 PI---AAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~~---~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
.. ...|++.|.|||++.+..| ++++|+||+||++|-|+.|..||+...- ..+...+ +.. .
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----k~Lr~rv---l~g---------k 271 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----KELRPRV---LRG---------K 271 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc----ccccchh---eee---------e
Confidence 43 4457788999999998877 6899999999999999999999974321 1111111 111 1
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
+....... .+..+++.+++..+|.+|++++++.++-|.-...+
T Consensus 272 ~rIp~~ms---~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 272 YRIPFYMS---CDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred ecccceee---chhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 11111111 14567888999999999999999999988654433
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=288.71 Aligned_cols=257 Identities=18% Similarity=0.316 Sum_probs=188.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++......++||||++ +
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence 357999999999999965 67889999886432 2234678899999999999999999999999999999999996 5
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC-CCceEEeecccccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD-NEMVLVSDYGFSSLVA 428 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfG~a~~~~ 428 (582)
+|.+++..... ..+++.....++.||+.||+|||+++ ++||||||+||+++. ++.+||+|||++....
T Consensus 86 ~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~-------i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 86 DLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSHR-------VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred cHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhCC-------eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 88888754322 23577888899999999999999988 999999999999985 5579999999997653
Q ss_pred Ccc----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc-
Q 047954 429 QPI----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF- 502 (582)
Q Consensus 429 ~~~----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 502 (582)
... ...++..|+|||++.+ ..++.++|||||||++|+|+||+.||..... .+....+....... .....
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~----~~~~~~~~~~~~~~-~~~~~~ 229 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE----IDELFKIFRILGTP-NEETWP 229 (294)
T ss_pred CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCC-Chhhcc
Confidence 321 1234678999998765 4578999999999999999999999964321 11111111110000 00000
Q ss_pred ------ch-----h---hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 503 ------DS-----E---ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 503 ------d~-----~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
+- . ............++.+++.+|++.+|++||++.+++++-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~ 287 (294)
T PLN00009 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287 (294)
T ss_pred ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchH
Confidence 00 0 00000001112357789999999999999999999987553
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=280.68 Aligned_cols=240 Identities=25% Similarity=0.411 Sum_probs=194.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc--chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|++|.||++... ++..|++|.+..... ...+.+.+|++++++++|+|++++++++.+....+++|||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence 467999999999999865 567899999875543 35567899999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+.....
T Consensus 85 ~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 85 SLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHEQG-------VIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred cHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhhCC-------cccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 999998643 25889999999999999999999998 99999999999999999999999999987654
Q ss_pred ccc----ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 PIA----AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~~~----~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
... ..++..|+|||...+..++.++||||+|+++|+|++|+.||.... .. .......... ...+ ..
T Consensus 152 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~------~~-~~~~~~~~~~-~~~~-~~- 221 (254)
T cd06627 152 VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN------PM-AALFRIVQDD-HPPL-PE- 221 (254)
T ss_pred CcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc------HH-HHHHHHhccC-CCCC-CC-
Confidence 332 345678999999888888999999999999999999999986422 11 1111111111 1111 10
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHH
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 543 (582)
.....+.+++.+||..+|++||++.+++.+
T Consensus 222 --------~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 222 --------GISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred --------CCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 112357789999999999999999999865
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=295.52 Aligned_cols=258 Identities=19% Similarity=0.314 Sum_probs=195.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCC-----eeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSND-----EKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~e 344 (582)
.+.||+|+||.||+|... .+..|++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..++|||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 84 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence 467999999999999975 47889999986543 344567899999999999999999999998875 7899999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|++ ++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 85 ~~~-~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~g-------i~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 85 LME-TDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSAN-------VIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred chh-hhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEEcCCCCEEEcccCce
Confidence 997 58988886432 5889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCcc-------cccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 425 SLVAQPI-------AAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 425 ~~~~~~~-------~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
....... ...++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... .+....+.......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~ 226 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY----IDQLNLIVEVLGTP 226 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH----HHHHHHHHHhcCCC
Confidence 8765432 22346679999999887 789999999999999999999999965321 11111111111000
Q ss_pred c-----------cccccc-----hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 497 W-----------TAEIFD-----SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 497 ~-----------~~~~~d-----~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
. ..+.+. ...............+.+++.+||+++|++||++.+++.+.+.-.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0 000000 000000000112346788999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=282.03 Aligned_cols=241 Identities=17% Similarity=0.258 Sum_probs=188.0
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC-----CcchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL-----KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 344 (582)
.+.||+|+||.||+|.. .++..|++|.+... .......+.+|++++++++|+||+++++++.+. ...++++|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 46799999999999985 45788999987422 122345788999999999999999999998764 45789999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++++|.+++.... .+++...+.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 87 ~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~~-------i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 87 YMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSNM-------IVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred eCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------EecCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999986432 3678888999999999999999998 999999999999999999999999999
Q ss_pred ccccCc-------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 425 SLVAQP-------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 425 ~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
+..... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ....+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~ 226 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------AMAAIFKIATQPT 226 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-------HHHHHHHHHcCCC
Confidence 765321 12235678999999998889999999999999999999999996421 1111111111111
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
...+ . .....++.+++.+||. +|..||++.+++.|.
T Consensus 227 ~~~~-p---------~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 227 KPML-P---------DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred CCCC-C---------cccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 1111 1 1112357788889998 579999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=276.61 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=197.2
Q ss_pred cccccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeC----CeeEEEEE
Q 047954 271 APAEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSN----DEKLLVYK 344 (582)
Q Consensus 271 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~----~~~~lv~e 344 (582)
...++||-|-.|+|-.+.. .+++.+|+|++.+. ...++|+++.-.. .|||||.++++|.+. .-+.+|||
T Consensus 65 is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 65 ISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred ehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 3457899999999999884 46788999998653 4467788876554 799999999998753 34679999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC---CCceEEeec
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD---NEMVLVSDY 421 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Df 421 (582)
.|+||.|+..+...... .+++.++-.|++||+.|+.|||+.+ |.||||||+|+|... +-.+||+||
T Consensus 140 ~meGGeLfsriq~~g~~----afTErea~eI~~qI~~Av~~lH~~n-------IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGDQ----AFTEREASEIMKQIGLAVRYLHSMN-------IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cccchHHHHHHHHcccc----cchHHHHHHHHHHHHHHHHHHHhcc-------hhhccCChhheeeecCCCCcceEeccc
Confidence 99999999999876543 6999999999999999999999998 999999999999964 556999999
Q ss_pred cccccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 422 GFSSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 422 G~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
|+|+.-..+. ...-|+.|.|||++-..+|+..+|+||+||++|-|+.|.+||++.. +..+..-+.+.++.+..
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h----g~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH----GLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC----CccCChhHHhHhhccCc
Confidence 9998865432 2235688999999999999999999999999999999999998643 23333333333333321
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
++.++ ....-.....+++...|+.+|.+|.|+.++++|.|-..
T Consensus 285 -~FP~p------EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 285 -EFPEP------EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred -cCCCh------hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 12221 12223345667888889999999999999999988554
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=295.94 Aligned_cols=261 Identities=18% Similarity=0.330 Sum_probs=192.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEe----CCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFS----NDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 89 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence 357999999999999854 58899999986432 2345667889999999999999999998864 3467999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+. |+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 90 ~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~-------ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 90 ME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSAN-------VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred hh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHEEEcCCCcEEecccccce
Confidence 95 68998886432 4888999999999999999999988 9999999999999999999999999987
Q ss_pred cccCcc--------cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh-
Q 047954 426 LVAQPI--------AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE- 495 (582)
Q Consensus 426 ~~~~~~--------~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~- 495 (582)
...... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~----~~~~~~~~~~~g~~ 231 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY----VHQLKLILSVLGSP 231 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh----HHHHHHHHHHhCCC
Confidence 654321 1235677999998765 4689999999999999999999999964321 1111111111000
Q ss_pred ----------cccccccc---hh--hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 496 ----------EWTAEIFD---SE--ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 496 ----------~~~~~~~d---~~--~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
....+..+ .. ............++.+++.+||+.+|++||++.+++.+.+.-....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 00000000 00 0000000112346889999999999999999999999988664433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=286.72 Aligned_cols=257 Identities=21% Similarity=0.328 Sum_probs=190.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc-chHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP-LITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||+||+|... ++..|+||++..... .......+|+..+++++ |+||+++++++..++..++||||+ +|
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 357999999999999976 467899999864322 22234567899999999 999999999999999999999999 88
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++....
T Consensus 83 ~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~-------i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 83 NLYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIHKHG-------FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred CHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 99998875431 25789999999999999999999998 99999999999999999999999999977654
Q ss_pred cc---cccccccccCCCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh----------
Q 047954 430 PI---AAQRMISYKSPEYQS-SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE---------- 495 (582)
Q Consensus 430 ~~---~~~~~~~y~aPE~~~-~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---------- 495 (582)
.. ...++..|+|||++. ...++.++||||||+++|||++|+.||..... .+...........
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE----IDQLYKICSVLGTPTKQDWPEGY 227 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh----HHHHHHHHHhcCCCChhhhhhHh
Confidence 32 233567799999875 45578999999999999999999999864321 1111111110000
Q ss_pred ---cccccccchhhh--hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 496 ---EWTAEIFDSEIS--VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 496 ---~~~~~~~d~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
......+..... ...........+.+++.+||+.+|++|||++|++.+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282 (283)
T ss_pred hhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence 000000000000 00000011346889999999999999999999987643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=280.52 Aligned_cols=245 Identities=25% Similarity=0.416 Sum_probs=197.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc--chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||++... ++..+++|++..... ...+.+.+|++++++++|+|++++++.+...+..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 84 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG 84 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence 357999999999999965 578899999865432 45667889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++..... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 85 ~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~-------~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 85 DLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSRK-------ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred cHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhCC-------EecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999976431 1235889999999999999999999998 99999999999999999999999999877644
Q ss_pred cc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 PI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
.. ...++..|+|||...+..++.++||||+|+++|+|++|+.||.... ..+......... ...+..
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~~-~~~~~~-- 225 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-------LLELALKILKGQ-YPPIPS-- 225 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-------HHHHHHHHhcCC-CCCCCC--
Confidence 32 2235677999999988889999999999999999999999985421 111111111111 111100
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
.....+.+++.+||..+|++|||+.+++++.
T Consensus 226 --------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 256 (258)
T cd08215 226 --------QYSSELRNLVSSLLQKDPEERPSIAQILQSP 256 (258)
T ss_pred --------CCCHHHHHHHHHHcCCChhhCcCHHHHhcCC
Confidence 1123578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=273.41 Aligned_cols=268 Identities=21% Similarity=0.362 Sum_probs=197.0
Q ss_pred cccccccCceEEEEEEEcC-----CceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEe-CCeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLEG-----RAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFS-NDEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e 344 (582)
...||+|.||.||+|...+ ...+|||+++..+ ........+|+.+++.++||||+.+..++.. +...++++|
T Consensus 29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fd 108 (438)
T KOG0666|consen 29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFD 108 (438)
T ss_pred cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEeh
Confidence 3569999999999996432 2368999997543 2345677899999999999999999999987 667899999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC----CceEEee
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN----EMVLVSD 420 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~----~~~kl~D 420 (582)
|.+. ||.+.++-.+..+. ..++-.....|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+|
T Consensus 109 YAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~NW-------vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 109 YAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSNW-------VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred hhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhhh-------eeeccCCcceEEEeccCCccCeeEeec
Confidence 9977 99999986655433 36888899999999999999999998 9999999999999877 8999999
Q ss_pred ccccccccCcc-------cccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc-----chHH
Q 047954 421 YGFSSLVAQPI-------AAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGA-----DLCS 487 (582)
Q Consensus 421 fG~a~~~~~~~-------~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~-----~~~~ 487 (582)
||+++.+..+. ....|+.|+|||.+.+. .||.+.||||.|||+.||+|-++-|.......... +..+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999876542 23457889999998875 68999999999999999999988886543221111 1112
Q ss_pred HHHHHHh----hcccccccchhh-------hhhhc----hHH-------HHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 488 WVLRAVR----EEWTAEIFDSEI-------SVQRS----AAH-------GMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 488 ~~~~~~~----~~~~~~~~d~~~-------~~~~~----~~~-------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.+...+. ..|..-.--|.. ..... ... .....++|+.++|..||.+|.|+++.+++.-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 2222111 111100000000 00000 000 0113678999999999999999999998875
Q ss_pred hccc
Q 047954 546 IIKV 549 (582)
Q Consensus 546 ~i~~ 549 (582)
....
T Consensus 340 F~~d 343 (438)
T KOG0666|consen 340 FTED 343 (438)
T ss_pred cccC
Confidence 5443
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=286.67 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=190.8
Q ss_pred cccccccCceEEEEEEE----cCCceEEEEEecCCC----cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALL----EGRAPVVVKRLRDLK----PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 343 (582)
.+.||+|+||.||+|.. .++..||+|.++... ....+.+.+|+.++.++ +|+||+++++++..+...++||
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 35799999999999986 367889999986432 22346788899999999 6899999999999999999999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+++++|.+++.... .+++.....++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 85 e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~~-------i~H~dl~p~nil~~~~~~~kl~dfg~ 151 (290)
T cd05613 85 DYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKLG-------IIYRDIKLENILLDSNGHVVLTDFGL 151 (290)
T ss_pred ecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eeccCCCHHHeEECCCCCEEEeeCcc
Confidence 9999999999986432 4778888889999999999999988 99999999999999999999999999
Q ss_pred cccccCcc-----cccccccccCCCCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 424 SSLVAQPI-----AAQRMISYKSPEYQSSK--KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 424 a~~~~~~~-----~~~~~~~y~aPE~~~~~--~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
++...... ...++..|+|||++... .++.++||||||+++|+|++|+.||...... ..............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~ 228 (290)
T cd05613 152 SKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK---NSQAEISRRILKSE 228 (290)
T ss_pred ceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc---ccHHHHHHHhhccC
Confidence 87654321 22356789999998753 4688999999999999999999998632211 11111111111110
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhhcc
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEIIK 548 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~i~ 548 (582)
... .......+.+++.+||+.||++|| ++.+++.+.+.-+
T Consensus 229 --~~~----------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 229 --PPY----------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred --CCC----------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 000 001122567889999999999997 7888887765433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=281.88 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=195.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||++... ++..+++|.+... .......+.+|++++++++|+||+++++++......++||||++++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence 467999999999999854 6678999998643 2334557788999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++...... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 85 ~L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh~~~-------i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 85 DLSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALHEQK-------ILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred CHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCC-------cccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 999998753221 235788899999999999999999998 99999999999999999999999999877654
Q ss_pred cc--cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 430 PI--AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 430 ~~--~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
.. ...++..|+|||.+.+..++.++|+||||+++|||++|+.||.... ...+... ........+
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~----~~~~~~~----~~~~~~~~~------ 221 (256)
T cd08530 156 NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS----MQDLRYK----VQRGKYPPI------ 221 (256)
T ss_pred CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHH----HhcCCCCCC------
Confidence 32 2235678999999998889999999999999999999999996432 1111111 111111111
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
......++.+++.+|+..+|++||++.|++++.
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 222 ----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred ----chhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 112234688999999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=294.90 Aligned_cols=255 Identities=18% Similarity=0.289 Sum_probs=189.9
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCC-----eeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND-----EKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~e 344 (582)
.+.||+|+||.||+|.. .++..||||.+... .......+.+|+.++++++|+||+++++++.... ..++|||
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 35799999999999985 46788999998643 2233456778999999999999999999887543 4799999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 90 ~~~-~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~-------i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 90 LMD-TDLHQIIRSS------QTLSDDHCQYFLYQLLRGLKYIHSAN-------VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred CCC-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC-------EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 995 6898888643 24888999999999999999999998 999999999999999999999999999
Q ss_pred ccccCc----ccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---
Q 047954 425 SLVAQP----IAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE--- 496 (582)
Q Consensus 425 ~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--- 496 (582)
+..... ....++..|+|||.+.. ..++.++|||||||++|+|++|+.||.... .......+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD----YVHQLKLITELLGSPSEE 231 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHHHhCCCChH
Confidence 876433 12235677999998764 468999999999999999999999996432 111111111110000
Q ss_pred ------------c---cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 497 ------------W---TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 497 ------------~---~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+ .....+... .........++.+++.+||+.+|++|||++|+++|.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSF--ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCH--HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 0 000000000 000112234678999999999999999999999996643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=285.85 Aligned_cols=246 Identities=21% Similarity=0.278 Sum_probs=188.8
Q ss_pred cccccccCceEEEEEEE----cCCceEEEEEecCCC----cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALL----EGRAPVVVKRLRDLK----PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 343 (582)
.+.||+|+||.||++.. .++..||||.++... ....+.+.+|+.++.++ +||||+++++.+......++||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 46799999999999984 356789999986432 22345688999999999 6999999999999999999999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+++|+|.+++.... .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 85 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~-------~~H~dl~p~nil~~~~~~~~l~dfg~ 151 (288)
T cd05583 85 DYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQLG-------IIYRDIKLENILLDSEGHVVLTDFGL 151 (288)
T ss_pred ecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHCC-------eeccCCCHHHeEECCCCCEEEEECcc
Confidence 9999999999986432 4788889999999999999999987 99999999999999999999999999
Q ss_pred cccccCcc-----cccccccccCCCCCCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 424 SSLVAQPI-----AAQRMISYKSPEYQSSKK--ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 424 a~~~~~~~-----~~~~~~~y~aPE~~~~~~--~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
++...... ...++..|+|||...+.. .+.++||||||+++|||+||..||...... .............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~ 227 (288)
T cd05583 152 SKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRRILKS 227 (288)
T ss_pred ccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHHHHcc
Confidence 87654332 123567899999887654 788999999999999999999998532111 1111111111111
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.. .. .......+.+++.+||+.||++|||+.++.+.|..
T Consensus 228 ~~-~~----------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 KP-PF----------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CC-CC----------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 00 00 00112357788999999999999998777655544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=292.48 Aligned_cols=252 Identities=18% Similarity=0.313 Sum_probs=185.9
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCC------eeEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND------EKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 343 (582)
.+.||+|+||.||+|.. .++..||+|++... .......+.+|+.++++++||||+++++++.... ..++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 46799999999999985 46889999998642 2223456889999999999999999999987543 468999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+.. +|..++. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 100 e~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~-------i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 100 PYMQT-DLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSAG-------IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ccccc-CHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 99964 7776652 13788889999999999999999998 99999999999999999999999999
Q ss_pred cccccCcc-cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc-----
Q 047954 424 SSLVAQPI-AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE----- 496 (582)
Q Consensus 424 a~~~~~~~-~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~----- 496 (582)
++...... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 164 ARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCHHHH
Confidence 87654332 2235677999998876 4689999999999999999999999964321 11111111100000
Q ss_pred ----------c---cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 497 ----------W---TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 497 ----------~---~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
+ .......... ........++.+++.+||+.||++||++.+++.|-+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f 300 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFS--TLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHH--HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcch
Confidence 0 0000000000 0000112357789999999999999999999988443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.08 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=196.6
Q ss_pred cccccccCceEEEEEE-EcCCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCC------eeEEEEE
Q 047954 273 AEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND------EKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~e 344 (582)
.+.||+|+||.||+|+ ...|..||||.++.. .....+...+|+++|++++|+|||+++++-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 4679999999999999 678999999999764 3445677889999999999999999998765433 5689999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec--CCC--ceEEee
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD--DNE--MVLVSD 420 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~--~~~--~~kl~D 420 (582)
||.+|||+..+.... +...+++.+.+.+..+++.||.|||+++ ||||||||.||++- +++ ..||+|
T Consensus 98 yC~gGsL~~~L~~PE---N~~GLpE~e~l~lL~d~~~al~~LrEn~-------IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPE---NAYGLPESEFLDLLSDLVSALRHLRENG-------IVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ecCCCcHHHHhcCcc---cccCCCHHHHHHHHHHHHHHHHHHHHcC-------ceeccCCCCcEEEeecCCCceEEeeec
Confidence 999999999997654 3457999999999999999999999988 99999999999984 333 379999
Q ss_pred ccccccccCcc---cccccccccCCCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 421 YGFSSLVAQPI---AAQRMISYKSPEYQS-SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 421 fG~a~~~~~~~---~~~~~~~y~aPE~~~-~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
||.|+.++++. ...||..|.+||+.. ...|+..+|.|||||++||.+||..||..........++.-.+....+.+
T Consensus 168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 168 FGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99999998764 345889999999998 47889999999999999999999999965332222222222211111111
Q ss_pred cccc---------ccchhhhhhh-chHHHHHHHHHHHHHcccCCCCCCC--ChHHHHHHHhhcc
Q 047954 497 WTAE---------IFDSEISVQR-SAAHGMLKLLQVAIQCCNKSPEKRP--EMAEVVSELEIIK 548 (582)
Q Consensus 497 ~~~~---------~~d~~~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RP--s~~evl~~L~~i~ 548 (582)
.... .....++... ........+-+++..++..+|++|- ...+....+..|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 0000 0000111100 0112223456677778888999998 6666665555543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=295.52 Aligned_cols=256 Identities=20% Similarity=0.298 Sum_probs=187.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeC--------------C
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--------------D 337 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------------~ 337 (582)
.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++... .
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 467999999999999864 5788999998765555667788999999999999999999876654 3
Q ss_pred eeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec-CCCce
Q 047954 338 EKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD-DNEMV 416 (582)
Q Consensus 338 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~-~~~~~ 416 (582)
..++||||++ ++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+||+++ ++..+
T Consensus 90 ~~~lv~e~~~-~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g-------ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 90 SVYIVQEYME-TDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSAN-------VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred eEEEEeeccc-ccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCCHHHEEEcCCCceE
Confidence 5789999997 5998887532 3778899999999999999999998 99999999999997 45678
Q ss_pred EEeeccccccccCcc-------cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHH
Q 047954 417 LVSDYGFSSLVAQPI-------AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSW 488 (582)
Q Consensus 417 kl~DfG~a~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~ 488 (582)
||+|||.++.+.... ...++..|+|||.+.. ..++.++|||||||++|||++|+.||..... ......
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~----~~~~~~ 230 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE----LEQMQL 230 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence 999999997653321 1234667999997654 5688999999999999999999999964321 011110
Q ss_pred HHHHHhh-----------ccccc----ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 489 VLRAVRE-----------EWTAE----IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 489 ~~~~~~~-----------~~~~~----~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
....... ..... .................++.+++.+||..||++|||+.|++.+-+.-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 0000000 00000 00000000000011224577899999999999999999999886653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=282.88 Aligned_cols=255 Identities=21% Similarity=0.375 Sum_probs=193.5
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
+.||+|+||.||+|+.. +++.|++|.+.... ....+.+..|+.++++++|+||+++++++.+.+..++||||++ ++
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~ 83 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD 83 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence 56999999999999965 48889999987542 3345678889999999999999999999999999999999997 59
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||.++.....
T Consensus 84 l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~-------i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 84 LKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSHR-------ILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred HHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 999997542 24889999999999999999999998 999999999999999999999999998776443
Q ss_pred c----cccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc----c--cc
Q 047954 431 I----AAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE----W--TA 499 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~----~--~~ 499 (582)
. ....+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ..+....+....... | ..
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 152 LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS----EIDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHHHhCCCcHHHHHhhc
Confidence 2 12234679999988766 78999999999999999999999986432 111111111111000 0 00
Q ss_pred cc--cchhhhh------hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 500 EI--FDSEISV------QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 500 ~~--~d~~~~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
++ .+..... ..........+.+++.+||+.+|++||++.+++.+.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 00 0000000 0000011346889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=290.79 Aligned_cols=256 Identities=19% Similarity=0.308 Sum_probs=188.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCC----------ee
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSND----------EK 339 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----------~~ 339 (582)
.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++.+.. ..
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 91 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence 467999999999999975 57889999986432 233456788999999999999999999987655 78
Q ss_pred EEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEe
Q 047954 340 LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVS 419 (582)
Q Consensus 340 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 419 (582)
++|+||+++ ++...+.... ..+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 92 ~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~-------i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 92 YLVFEYMDH-DLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHKKN-------FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred EEEEcccCc-cHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEECCCCcEEeC
Confidence 999999976 7777775432 24889999999999999999999998 9999999999999999999999
Q ss_pred eccccccccCccc-----ccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHH
Q 047954 420 DYGFSSLVAQPIA-----AQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 420 DfG~a~~~~~~~~-----~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
|||++........ ...+..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~----~~~~~~~~~~~~ 234 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ----ELAQLELISRLC 234 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHh
Confidence 9999987643321 123567999998764 457899999999999999999999996432 111111122211
Q ss_pred hhcc---ccccc--------chhhhh----hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 494 REEW---TAEIF--------DSEISV----QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 494 ~~~~---~~~~~--------d~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.... .+++. +..... ..........+.+++.+||+.+|++||++.+++.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 301 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 1100 00000 000000 0000011246789999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=276.29 Aligned_cols=237 Identities=24% Similarity=0.346 Sum_probs=190.5
Q ss_pred ccccCceEEEEEEEc-CCceEEEEEecCCCc---chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 276 LGKGIFGNSYKALLE-GRAPVVVKRLRDLKP---LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 276 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
||+|+||.||++... +++.+++|.+..... ...+.+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 478899998864322 2445788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++.... .+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~~-------~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~ 147 (250)
T cd05123 81 FSHLSKEG------RFSEERARFYAAEIVLALEYLHSLG-------IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147 (250)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence 99996442 4788999999999999999999987 999999999999999999999999998776442
Q ss_pred ---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 431 ---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
....++..|+|||...+...+.++|+||||+++|||++|+.||..... ......+ ..... . +.
T Consensus 148 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~---~~~~~--~-~~---- 213 (250)
T cd05123 148 SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKI---LKDPL--R-FP---- 213 (250)
T ss_pred CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHH---hcCCC--C-CC----
Confidence 223456789999999888889999999999999999999999964321 1111111 11110 0 00
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCCh---HHHHHHH
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEM---AEVVSEL 544 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~---~evl~~L 544 (582)
.. ....+.+++.+||..||++||++ ++++++.
T Consensus 214 --~~---~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~ 248 (250)
T cd05123 214 --EF---LSPEARDLISGLLQKDPTKRLGSGGAEEIKAHP 248 (250)
T ss_pred --CC---CCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCC
Confidence 00 02357789999999999999999 6766654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=288.39 Aligned_cols=256 Identities=18% Similarity=0.323 Sum_probs=185.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCC--------eeEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSND--------EKLL 341 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--------~~~l 341 (582)
.+.||+|+||.||+|... +++.+|+|++.... ......+.+|++++++++||||+++++++.... ..++
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l 92 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence 357999999999999965 57889999885432 222346778999999999999999999876543 3589
Q ss_pred EEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
|+||+.. +|...+.... ..+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+||
T Consensus 93 v~~~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~~-------i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 93 VTPYMDH-DLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHENH-------ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred EEecCCc-CHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEECCCCCEEECcC
Confidence 9999964 7877775432 24889999999999999999999998 999999999999999999999999
Q ss_pred cccccccCccc---------------ccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 047954 422 GFSSLVAQPIA---------------AQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADL 485 (582)
Q Consensus 422 G~a~~~~~~~~---------------~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~ 485 (582)
|+++....... ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~----~~~ 235 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD----IDQ 235 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH----HHH
Confidence 99876533211 123566999998765 4578999999999999999999999864321 111
Q ss_pred HHHHHHHHhhc----c-----ccccc----chhhh--hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 486 CSWVLRAVREE----W-----TAEIF----DSEIS--VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 486 ~~~~~~~~~~~----~-----~~~~~----d~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
...+....... + ..... ..... ...........+.+++.+|++.||++|||+.|++.+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~ 310 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence 11111110000 0 00000 00000 00000111246789999999999999999999987754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=274.98 Aligned_cols=268 Identities=22% Similarity=0.307 Sum_probs=197.7
Q ss_pred cCCCCCCCChhHhhhcccccccccCceEEEEEEE-cCCceEEEEEecCCCc-chHHHHHHHHHHHhc-CCCCCccccceE
Q 047954 256 EDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKP-LITEEFRKQLLVIAD-QKHPNLLPLLAY 332 (582)
Q Consensus 256 ~~~~~~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~-l~H~niv~l~~~ 332 (582)
.+...-.|+-++|... ..||.|+||+|+|-.. +.++..|||+++.... ...++++.|.+...+ -+.||||++||.
T Consensus 54 ~~~~~~~F~~~~Lqdl--g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 54 DDAHLHTFTSDNLQDL--GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred CcccccccccchHHHH--HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 3344455666665542 5699999999999874 5688899999986543 455678888876555 478999999999
Q ss_pred EEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC
Q 047954 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD 412 (582)
Q Consensus 333 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~ 412 (582)
+..++..|+.||.|.- +|..+...-... ....+++...-.|+...+.||.||...- .|||||+||+|||+|.
T Consensus 132 ~F~EGdcWiCMELMd~-SlDklYk~vy~v-q~~~ipE~Ilg~ItvatV~AL~yLK~~l------kiIHRDvKPSNILldr 203 (361)
T KOG1006|consen 132 LFSEGDCWICMELMDI-SLDKLYKRVYSV-QKSRIPENILGHITVATVDALDYLKEEL------KIIHRDVKPSNILLDR 203 (361)
T ss_pred hhcCCceeeeHHHHhh-hHHHHHHHHHHH-HhccCcHhhhhheeeeehhHHHHHHHHh------hhhhccCChhheEEec
Confidence 9999999999999954 665543321111 1124667777778888899999998765 3999999999999999
Q ss_pred CCceEEeeccccccccCccc---ccccccccCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHH
Q 047954 413 NEMVLVSDYGFSSLVAQPIA---AQRMISYKSPEYQSS--KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCS 487 (582)
Q Consensus 413 ~~~~kl~DfG~a~~~~~~~~---~~~~~~y~aPE~~~~--~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~ 487 (582)
.|.+||||||++..+....+ -.|...|||||.+.. ..|+.++||||+|++|||+.||++|+... .++.+
T Consensus 204 ~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w------~svfe 277 (361)
T KOG1006|consen 204 HGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW------DSVFE 277 (361)
T ss_pred CCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH------HHHHH
Confidence 99999999999977654432 235667999998864 35899999999999999999999999632 23444
Q ss_pred HHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 488 WVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 488 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.+...+......-..+ ....+....+.+++..|+.+|-.+||...++.++-.
T Consensus 278 ql~~Vv~gdpp~l~~~------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f 329 (361)
T KOG1006|consen 278 QLCQVVIGDPPILLFD------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF 329 (361)
T ss_pred HHHHHHcCCCCeecCc------ccccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence 4444433332111111 112233456888999999999999999999887654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=279.26 Aligned_cols=245 Identities=23% Similarity=0.356 Sum_probs=188.5
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCC-----CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDL-----KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||++.... +..+++|.++.. .......+..|+.++++++||||+++++++.+....++||||+
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC 84 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence 4679999999999998653 344555555421 2233445778999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++ +.+||+|||+++.
T Consensus 85 ~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-------i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 85 EGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQRR-------ILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred CCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHHcC-------ccccCCChhheEeec-CCEeecccCceee
Confidence 999999988753221 235889999999999999999999998 999999999999985 5699999999876
Q ss_pred ccCcc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 427 VAQPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 427 ~~~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
..... ...++..|+|||...+..++.++||||||+++|+|++|..||.... .......... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~~~-~~~~~~- 225 (260)
T cd08222 155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIVE-GPTPSL- 225 (260)
T ss_pred cCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHc-CCCCCC-
Confidence 64322 2335678999999888888999999999999999999999985321 1121211111 111110
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
......++.+++.+||..+|++||++.|++++-+
T Consensus 226 ---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 226 ---------PETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred ---------cchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 1122236788999999999999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=281.78 Aligned_cols=241 Identities=22% Similarity=0.353 Sum_probs=192.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|... ++..|++|++... .....+.+..|++++.+++ ||||+++++++...+..++||||++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 356999999999999965 6888999988642 2233467888999999998 9999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 86 ~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~~-------~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 86 NGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSKG-------IIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 999999997532 5899999999999999999999998 999999999999999999999999998765
Q ss_pred cCccc------------------------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 047954 428 AQPIA------------------------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGA 483 (582)
Q Consensus 428 ~~~~~------------------------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~ 483 (582)
..... ..++..|+|||......++.++||||||++++++++|+.||.... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~ 228 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN----EY 228 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc----HH
Confidence 43221 124567999999888889999999999999999999999996432 11
Q ss_pred chHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh----HHHHHHHh
Q 047954 484 DLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM----AEVVSELE 545 (582)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~~L~ 545 (582)
.. ........+. +. ......+.+++.+||+.+|++||++ +++++|.+
T Consensus 229 ~~---~~~~~~~~~~---~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 229 LT---FQKILKLEYS---FP---------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred HH---HHHHHhcCCC---CC---------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 11 1111111110 00 0112357889999999999999999 88887653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=286.86 Aligned_cols=245 Identities=23% Similarity=0.281 Sum_probs=191.8
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+||+|+||.||-+... +|+.+|.|++.+.. ........+|-.+|.++..+.||.+--.|.+.+.+++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 57999999999999854 67888888874321 223345678999999999999999988899999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
||.-+|..... ..+++...+.+|.+|+.||++||... ||.|||||+|||+|++|+++|+|+|+|..+..
T Consensus 271 DLkfHiyn~g~----~gF~e~ra~FYAAEi~cGLehlH~~~-------iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 271 DLKFHIYNHGN----PGFDEQRARFYAAEIICGLEHLHRRR-------IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred ceeEEeeccCC----CCCchHHHHHHHHHHHhhHHHHHhcc-------eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99988875432 36999999999999999999999998 99999999999999999999999999988765
Q ss_pred cc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 430 PI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 ~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.. ...||.+|||||++....|+...|.||+||++|||+.|+.||.......... .+.+..... ..+
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e----Evdrr~~~~-~~e------ 408 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE----EVDRRTLED-PEE------ 408 (591)
T ss_pred CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH----HHHHHHhcc-hhh------
Confidence 43 3368999999999999999999999999999999999999996433221111 122222111 000
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHH
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSEL 544 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L 544 (582)
.......+..+|....|.+||++|.- +++|-+|.
T Consensus 409 ----y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hp 447 (591)
T KOG0986|consen 409 ----YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHP 447 (591)
T ss_pred ----cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCc
Confidence 11122234556666778899999964 44666554
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=287.79 Aligned_cols=256 Identities=19% Similarity=0.305 Sum_probs=190.0
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCC------eeEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSND------EKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 343 (582)
.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+.++++++||||+++++++.... ..++||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 35799999999999984 468889999985422 223456889999999999999999999987654 358999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+ +++|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 100 e~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~g-------i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 100 PFM-GTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAAG-------IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 999 77998887532 4788999999999999999999998 99999999999999999999999999
Q ss_pred cccccCcc-cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh---ccc
Q 047954 424 SSLVAQPI-AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE---EWT 498 (582)
Q Consensus 424 a~~~~~~~-~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~ 498 (582)
+....... ...++..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+...... .+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 165 ARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH----LDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred ccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCHHHH
Confidence 98765432 2345678999998875 4588999999999999999999999964321 1111000000000 000
Q ss_pred ---------------ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 499 ---------------AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 499 ---------------~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.......+. .........+.+++.+|++.||++|||+.+++.+.+.-..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFR--SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHH--HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000000000 0001112357899999999999999999999988665443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=287.70 Aligned_cols=256 Identities=20% Similarity=0.298 Sum_probs=186.6
Q ss_pred cccccccCceEEEEEEEcC---CceEEEEEecCC--CcchHHHHHHHHHHHhcC-CCCCccccceEEEeC----CeeEEE
Q 047954 273 AEGLGKGIFGNSYKALLEG---RAPVVVKRLRDL--KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSN----DEKLLV 342 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~----~~~~lv 342 (582)
.+.||+|+||.||++.... +..||+|++... .....+.+.+|+.++.++ .||||+++++++... ...+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 3579999999999999653 678999988642 222345678899999998 599999999876433 346788
Q ss_pred EEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecc
Q 047954 343 YKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG 422 (582)
Q Consensus 343 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 422 (582)
+||+. ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 85 ~e~~~-~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~g-------ivH~dlkp~Nili~~~~~~kl~Dfg 150 (332)
T cd07857 85 EELME-ADLHQIIRSG------QPLTDAHFQSFIYQILCGLKYIHSAN-------VLHRDLKPGNLLVNADCELKICDFG 150 (332)
T ss_pred Eeccc-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCCHHHeEEcCCCCEEeCcCC
Confidence 89885 6999988643 24888999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCcc--------cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHH
Q 047954 423 FSSLVAQPI--------AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 423 ~a~~~~~~~--------~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
+++.+.... ...++..|+|||+..+ ..++.++|||||||++|+|++|+.||.... .......+....
T Consensus 151 ~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~----~~~~~~~~~~~~ 226 (332)
T cd07857 151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD----YVDQLNQILQVL 226 (332)
T ss_pred CceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC----HHHHHHHHHHHh
Confidence 997654321 1246678999998765 468999999999999999999999986422 111111111110
Q ss_pred hh---cccccccch-------------hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 494 RE---EWTAEIFDS-------------EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 494 ~~---~~~~~~~d~-------------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.. +....+..+ ..............+.+++.+|++.||++|||+.|++.+-+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~ 295 (332)
T cd07857 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295 (332)
T ss_pred CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 00 000000000 000000000112367899999999999999999999988764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.34 Aligned_cols=261 Identities=19% Similarity=0.319 Sum_probs=192.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCe------eEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE------KLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~lv~ 343 (582)
...||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++...+. .++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 357999999999999975 5778999988642 22234567789999999999999999998876654 89999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+ +++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 100 e~~-~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g-------i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 100 HLM-GADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHSAG-------IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHeEECCCCCEEEccccc
Confidence 998 66999988642 4888999999999999999999998 99999999999999999999999999
Q ss_pred cccccCc-ccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh---ccc
Q 047954 424 SSLVAQP-IAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE---EWT 498 (582)
Q Consensus 424 a~~~~~~-~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~ 498 (582)
+...... ....++..|+|||...+ ..++.++|||||||++|||+||+.||.... .......+...... .+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 165 ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD----HIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCCCCHHHH
Confidence 9876443 22345677999998765 367899999999999999999999996432 11111111111000 000
Q ss_pred ccccchhh-------------hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 499 AEIFDSEI-------------SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 499 ~~~~d~~~-------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
..+..... ...........++.+++.+||..+|++|||+.+|+.+.+.-+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 00000000 0000000113468899999999999999999999998776554333
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=285.62 Aligned_cols=257 Identities=19% Similarity=0.346 Sum_probs=189.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEe-CCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFS-NDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... ++..||+|++... .....+.+..|++++.+++||||+++++++.. ....++|+||+ +
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 367999999999999855 7888999987532 22345678899999999999999999999876 45788999998 5
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++... .+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.+....
T Consensus 94 ~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~~-------iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 94 TDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSAG-------VVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 6898888632 3677778889999999999999998 9999999999999999999999999987654
Q ss_pred Ccc-cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh---hcccccccc
Q 047954 429 QPI-AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR---EEWTAEIFD 503 (582)
Q Consensus 429 ~~~-~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d 503 (582)
... ...++..|+|||.+.+ ..++.++|||||||++|||+||+.||..... ......+..... +++...+.+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 160 PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH----VNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHHHhccc
Confidence 332 2235678999998765 5689999999999999999999999964321 111110111000 000000000
Q ss_pred h-------------hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 504 S-------------EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 504 ~-------------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
. .............++.+++.+||+.+|++||++.+++.+-+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 0 00000000011246889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=286.41 Aligned_cols=256 Identities=21% Similarity=0.329 Sum_probs=188.1
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeC------CeeEEEEE
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN------DEKLLVYK 344 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e 344 (582)
+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.++.+++||||+++++++... ...+++++
T Consensus 23 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~ 102 (345)
T cd07877 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 102 (345)
T ss_pred EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEeh
Confidence 5699999999999985 568889999986432 22345678899999999999999999988643 23678888
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 103 ~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~-------ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 103 LM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSAD-------IIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred hc-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeecCCChHHEEEcCCCCEEEeccccc
Confidence 76 78998887532 3788899999999999999999998 999999999999999999999999998
Q ss_pred ccccCcc-cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh---cccc
Q 047954 425 SLVAQPI-AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE---EWTA 499 (582)
Q Consensus 425 ~~~~~~~-~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 499 (582)
+...... ...++..|+|||...+ ..++.++|||||||++|||++|+.||..... ......+.+.... ....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 168 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred ccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHHh
Confidence 7654432 2345678999998765 4678999999999999999999999854221 1111111110000 0000
Q ss_pred cccchhh-------------hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 500 EIFDSEI-------------SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 500 ~~~d~~~-------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.+.+... ...........++.+++.+|++.||++||++.+++.+-+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 0000000 000000011235778999999999999999999999987544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=273.15 Aligned_cols=224 Identities=25% Similarity=0.337 Sum_probs=175.9
Q ss_pred cCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChHHHHhc
Q 047954 279 GIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHG 357 (582)
Q Consensus 279 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 357 (582)
|.||.||++.. .+++.+|+|+++... .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999996 467889999986532 233455555566899999999999999999999999999999999864
Q ss_pred CCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-ccccc
Q 047954 358 GKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI-AAQRM 436 (582)
Q Consensus 358 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~-~~~~~ 436 (582)
.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+....... ...++
T Consensus 79 ~~------~l~~~~~~~~~~ql~~~l~~lH~~~-------i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 145 (237)
T cd05576 79 FL------NIPEECVKRWAAEMVVALDALHREG-------IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE 145 (237)
T ss_pred hc------CCCHHHHHHHHHHHHHHHHHHHhCC-------eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcC
Confidence 32 4788999999999999999999988 9999999999999999999999999876654432 22245
Q ss_pred ccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHH
Q 047954 437 ISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGM 516 (582)
Q Consensus 437 ~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 516 (582)
..|+|||...+..++.++||||+|+++|||++|+.|+........ .....++ . ....
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------~~~~~~~-~---------~~~~ 202 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------THTTLNI-P---------EWVS 202 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------cccccCC-c---------ccCC
Confidence 579999999888899999999999999999999988753221100 0000000 0 0111
Q ss_pred HHHHHHHHHcccCCCCCCCCh-----HHHHHH
Q 047954 517 LKLLQVAIQCCNKSPEKRPEM-----AEVVSE 543 (582)
Q Consensus 517 ~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 543 (582)
..+.+++.+|++.||++||++ +|++.|
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 257789999999999999997 565554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=307.09 Aligned_cols=140 Identities=23% Similarity=0.350 Sum_probs=124.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||||+++... ......+..|+.++..++||||+++++++......++||||+.+
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 367999999999999976 67889999986432 22346788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
++|.+++.... .+++..++.|+.||+.||+|||..+ ||||||||+|||++.++.+||+|||+++
T Consensus 89 ~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~g-------IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRHG-------IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999996432 3778889999999999999999988 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.66 Aligned_cols=241 Identities=21% Similarity=0.305 Sum_probs=177.1
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEe----------------
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFS---------------- 335 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~---------------- 335 (582)
++||+||||.||+++. -||..+|||++... .........+|+..+++++|||||+++..+.+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 4699999999999994 48899999999643 23334568899999999999999999755421
Q ss_pred ---------------------------------------C----------------------------------------
Q 047954 336 ---------------------------------------N---------------------------------------- 336 (582)
Q Consensus 336 ---------------------------------------~---------------------------------------- 336 (582)
.
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence 0
Q ss_pred ------------------------CeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCC
Q 047954 337 ------------------------DEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392 (582)
Q Consensus 337 ------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 392 (582)
..+||-||||+.-.|.++++.+... -.-...++++++|++||.|+|+++
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEGLaYIH~~g-- 717 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEGLAYIHDQG-- 717 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHHHHHHHhCc--
Confidence 0146888999887777777654321 034567889999999999999998
Q ss_pred CCCCcceecCCCCCCeeecCCCceEEeecccccccc----C------------------cccccccccccCCCCCCCC--
Q 047954 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA----Q------------------PIAAQRMISYKSPEYQSSK-- 448 (582)
Q Consensus 393 ~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~----~------------------~~~~~~~~~y~aPE~~~~~-- 448 (582)
||||||||.||++|++..+||+|||+|+... . .....||.-|+|||++.+.
T Consensus 718 -----iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 718 -----IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred -----eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9999999999999999999999999998721 0 0122366779999998765
Q ss_pred -CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcc
Q 047954 449 -KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCC 527 (582)
Q Consensus 449 -~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl 527 (582)
.|+.|+|+||+|||++||+. ||.. .++-+. +...++...++.- + ....+.+..-.+++.+++
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~T------sMERa~-iL~~LR~g~iP~~--~-----~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGT------SMERAS-ILTNLRKGSIPEP--A-----DFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCc------hHHHHH-HHHhcccCCCCCC--c-----ccccccchHHHHHHHHHh
Confidence 49999999999999999996 5642 111111 2222222222221 0 011222334567888999
Q ss_pred cCCCCCCCChHHHHHH
Q 047954 528 NKSPEKRPEMAEVVSE 543 (582)
Q Consensus 528 ~~dP~~RPs~~evl~~ 543 (582)
+.||.+|||+.|++..
T Consensus 856 ~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLNS 871 (1351)
T ss_pred cCCCccCCCHHHHhhc
Confidence 9999999999999864
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=267.32 Aligned_cols=239 Identities=21% Similarity=0.357 Sum_probs=189.4
Q ss_pred ccccccCceEEEEEE-EcCCceEEEEEecCCCcchHH---HHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITE---EFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~---~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
++||+|.||+|-+++ ...++.+|+|++++.--...+ .-..|-++|...+||.+..+.-.|+..++.|+||||..||
T Consensus 174 KvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGG 253 (516)
T KOG0690|consen 174 KVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGG 253 (516)
T ss_pred HHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCc
Confidence 579999999999998 456888999999765433333 3457889999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc-
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA- 428 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~- 428 (582)
.|+-+|.+.+ .+++.....+-..|+.||.|||+++ ||.||||.+|.|+|.+|++||+|||+++.--
T Consensus 254 eLf~HLsrer------~FsE~RtRFYGaEIvsAL~YLHs~~-------ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 254 ELFFHLSRER------VFSEDRTRFYGAEIVSALGYLHSRN-------IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred eEeeehhhhh------cccchhhhhhhHHHHHHhhhhhhCC-------eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999886533 4778888888999999999999998 9999999999999999999999999987532
Q ss_pred ---CcccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 429 ---QPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 429 ---~~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
......||+.|.|||++....|+..+|.|.+|||+|||+.|+.||..... ..+.+.+. ...
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh----~kLFeLIl------------~ed 384 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH----EKLFELIL------------MED 384 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch----hHHHHHHH------------hhh
Confidence 22345688999999999999999999999999999999999999975321 12222111 011
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHH
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSEL 544 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 544 (582)
+..+..... +...|+...|.+||.+|. .+.||.++-
T Consensus 385 ~kFPr~ls~---eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~ 425 (516)
T KOG0690|consen 385 LKFPRTLSP---EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHR 425 (516)
T ss_pred ccCCccCCH---HHHHHHHHHhhcChHhhcCCCchhHHHHHhhh
Confidence 111111112 455667788889999995 466776664
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=285.98 Aligned_cols=252 Identities=20% Similarity=0.351 Sum_probs=199.2
Q ss_pred hhHhhhcc-cccccccCceEEEEEEE-cCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeE
Q 047954 265 LNDLLKAP-AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKL 340 (582)
Q Consensus 265 ~~~l~~~~-~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 340 (582)
+..+...+ .+.||+|.||+||-|+. ++|+.||||++.+.+ ......+++|+.+|.+++||.||.+-..|+..+..+
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 33444333 57899999999999984 578999999997543 234467899999999999999999999999999999
Q ss_pred EEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC---CceE
Q 047954 341 LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN---EMVL 417 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~---~~~k 417 (582)
+|||-+ +||..+.+...... .++......++.||+.||.|||.++ |||+||||+|||+... -.+|
T Consensus 640 VVMEKl-~GDMLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~kn-------IvHCDLKPENVLLas~~~FPQvK 707 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILSSEKG----RLPERITKFLVTQILVALRYLHFKN-------IVHCDLKPENVLLASASPFPQVK 707 (888)
T ss_pred EEehhh-cchHHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhhcc-------eeeccCCchheeeccCCCCCcee
Confidence 999999 56777776544322 4888888889999999999999998 9999999999999754 3599
Q ss_pred EeeccccccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 418 VSDYGFSSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 418 l~DfG~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
|||||+|+++.... ...||+.|.|||++....|+..-|+||.|||+|--++|.+||... .++.+.+..+.-
T Consensus 708 lCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd------EdIndQIQNAaF 781 (888)
T KOG4236|consen 708 LCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED------EDINDQIQNAAF 781 (888)
T ss_pred eccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc------cchhHHhhcccc
Confidence 99999999987653 456899999999999999999999999999999999999999642 333333322111
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
. .. .....+.....++++...|+..-.+|-|....+.|.|
T Consensus 782 M------yP-----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 782 M------YP-----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred c------cC-----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 0 00 0111222335677788888888889999998888766
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=245.24 Aligned_cols=254 Identities=20% Similarity=0.336 Sum_probs=187.6
Q ss_pred ccccccCceEEEEEE-EcCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
++||+|.||+||+|+ .+.++.||+|+++-. .........+|+.+++.++|+|||++++..-++....+|+|||.. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 579999999999999 456788999998643 344556788999999999999999999999999999999999955 8
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|..+...-.. .++......++.|+++||.|+|+++ +.||||||+|.||+.+|+.|++|||+++-..-+
T Consensus 87 lkkyfdslng-----~~d~~~~rsfmlqllrgl~fchshn-------vlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 87 LKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSHN-------VLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred HHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhhh-------hhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 8777654322 4788888999999999999999998 999999999999999999999999999887655
Q ss_pred ccc----cccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHh----hcccc-
Q 047954 431 IAA----QRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVR----EEWTA- 499 (582)
Q Consensus 431 ~~~----~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~----~~~~~- 499 (582)
... ..|..|++|.++.+. -|++..|+||.|||+.|+.. |++.|.. .+..+....+.+.+. +.|..
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg----~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG----NDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC----CcHHHHHHHHHHHhCCCccccCCcc
Confidence 422 246789999998875 47999999999999999987 5554532 122222222222221 12221
Q ss_pred -cccch----hhhhhhchHHHHH----HHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 500 -EIFDS----EISVQRSAAHGML----KLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 500 -~~~d~----~~~~~~~~~~~~~----~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
...|- .++.......... .=.+++.+.+.-+|.+|.++++.+++.
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 11110 0110001111111 224566677777999999999998764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=287.82 Aligned_cols=235 Identities=24% Similarity=0.335 Sum_probs=187.9
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
..+|.|+|+.|-++.. ..++..++|++.... .+-.+|+.++.+. .||||+++.+.+.+..+.|+|||++.+|-+
T Consensus 328 ~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~el 403 (612)
T KOG0603|consen 328 EELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGEL 403 (612)
T ss_pred cccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHH
Confidence 4599999999999884 456778999986542 2234566555554 899999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee-cCCCceEEeeccccccccCc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL-DDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl-~~~~~~kl~DfG~a~~~~~~ 430 (582)
.+.+.... .....+..|+.+|+.|+.|||+++ ||||||||+|||+ ++.++++|+|||.++.+...
T Consensus 404 l~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~~g-------vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 404 LRRIRSKP-------EFCSEASQWAAELVSAVDYLHEQG-------VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred HHHHHhcc-------hhHHHHHHHHHHHHHHHHHHHhcC-------eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 88886432 223677789999999999999998 9999999999999 58899999999999988765
Q ss_pred ccc-cccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhh
Q 047954 431 IAA-QRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQ 509 (582)
Q Consensus 431 ~~~-~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 509 (582)
... .-|..|.|||+.....|++++||||||++||+|++|+.||...+.+ .++...+ ......+.
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i----~~~~~s~~-------- 534 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRI----QMPKFSEC-------- 534 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhh----cCCccccc--------
Confidence 222 3456799999999999999999999999999999999999865532 2222222 21111111
Q ss_pred hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 510 RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 510 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
-.....+|+.+||+.||.+||+|.++..|-|.
T Consensus 535 -----vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 535 -----VSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -----cCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11246788889999999999999999999888
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=275.31 Aligned_cols=261 Identities=19% Similarity=0.313 Sum_probs=198.1
Q ss_pred ccccccCceEEEEEEEcC-CceEEEEEecCCCcchHHHHHHHHHHHhcCCC--C----CccccceEEEeCCeeEEEEEeC
Q 047954 274 EGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQKH--P----NLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H--~----niv~l~~~~~~~~~~~lv~e~~ 346 (582)
..+|+|.||.|-++..+. +..||||+++... ...+..+-|++++.++.+ | -+|.+.++|.-.++.++|+|.+
T Consensus 95 ~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell 173 (415)
T KOG0671|consen 95 DLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL 173 (415)
T ss_pred hhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc
Confidence 469999999999998554 5789999997653 356778889999999833 2 3788889999999999999988
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC--------------
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD-------------- 412 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~-------------- 412 (582)
|-++++++..+. ..+++...+..|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 174 -G~S~~dFlk~N~----y~~fpi~~ir~m~~QL~~sv~fLh~~k-------l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 174 -GLSTFDFLKENN----YIPFPIDHIRHMGYQLLESVAFLHDLK-------LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred -ChhHHHHhccCC----ccccchHHHHHHHHHHHHHHHHHHhcc-------eeecCCChheEEEeccceEEEeccCCccc
Confidence 569999997654 347999999999999999999999998 999999999999832
Q ss_pred ------CCceEEeeccccccccCcc-cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 047954 413 ------NEMVLVSDYGFSSLVAQPI-AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADL 485 (582)
Q Consensus 413 ------~~~~kl~DfG~a~~~~~~~-~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~ 485 (582)
+..+||+|||.|+...+.. ....|..|+|||++.+-.++.++||||+||||+|+.||...|+..... ....+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~-EHLaM 320 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL-EHLAM 320 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH-HHHHH
Confidence 2348999999998876543 344677899999999999999999999999999999999988754311 10111
Q ss_pred HHHHHH--------HH------hh---ccccccc-----------chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh
Q 047954 486 CSWVLR--------AV------RE---EWTAEIF-----------DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM 537 (582)
Q Consensus 486 ~~~~~~--------~~------~~---~~~~~~~-----------d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 537 (582)
++.+.. .. .. +|..... .+..........+..+|++|+.+||..||.+|+|+
T Consensus 321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl 400 (415)
T KOG0671|consen 321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL 400 (415)
T ss_pred HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence 111111 00 00 0110000 00011112234566789999999999999999999
Q ss_pred HHHHHHHhhcc
Q 047954 538 AEVVSELEIIK 548 (582)
Q Consensus 538 ~evl~~L~~i~ 548 (582)
.|++.|...-.
T Consensus 401 ~EAL~HpFF~~ 411 (415)
T KOG0671|consen 401 REALSHPFFAR 411 (415)
T ss_pred HHHhcCHHhhc
Confidence 99999876544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=263.26 Aligned_cols=259 Identities=18% Similarity=0.351 Sum_probs=192.7
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEec--CCCcchHHHHHHHHHHHhcCCCCCccccceEEEeC--------CeeEEE
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--------DEKLLV 342 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~~~~lv 342 (582)
.+||+|.||.||+|+.. +++.||+|++- ..+........+|+.+|..++|+|++.+++.|... ...|+|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 46999999999999954 45667877653 33445566788999999999999999999998753 247999
Q ss_pred EEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecc
Q 047954 343 YKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG 422 (582)
Q Consensus 343 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 422 (582)
|++|+. +|..++.... ..++..++.+++.++..||.|+|... |+|||+|++|+||+.++.+||+|||
T Consensus 103 f~~ceh-DLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr~k-------ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHRNK-------ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred HHHhhh-hHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHHhh-------HHhhcccHhhEEEcCCceEEeeccc
Confidence 999977 9999886543 34888999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCccc--cc------ccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHH
Q 047954 423 FSSLVAQPIA--AQ------RMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 423 ~a~~~~~~~~--~~------~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
+++.+..... .. .|..|++||.+.+ ..|+++.|||..|||+.||.||.+-+....+ +.....+.. +
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte----qqql~~Is~-L 244 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE----QQQLHLISQ-L 244 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH----HHHHHHHHH-H
Confidence 9977654322 12 2678999998876 4689999999999999999999988764322 111222211 1
Q ss_pred hhccccccc----ch----h-----hhh--hhchHHHHH------HHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 494 REEWTAEIF----DS----E-----ISV--QRSAAHGML------KLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 494 ~~~~~~~~~----d~----~-----~~~--~~~~~~~~~------~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
-.....++. .- . +.. .+...+.+. +.++|+..++..||.+|+++.+++.|-+..+..
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 111111110 00 0 000 001112222 567888899999999999999999998766543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-33 Score=298.49 Aligned_cols=246 Identities=19% Similarity=0.215 Sum_probs=193.0
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecC---CCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRD---LKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+||+|+||.|..++.. .++.||.|++.+ .+.....-|..|-.+|..-+.+-||.++-.|+++.++|+|||||+||
T Consensus 81 KvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGG 160 (1317)
T KOG0612|consen 81 KVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGG 160 (1317)
T ss_pred HHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCc
Confidence 57999999999999965 567889999976 34445667999999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
||..++.... .++...+..++..|+-||.-||+.| +|||||||+|||||.+|++||+|||.+-.+..
T Consensus 161 DlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~mg-------yVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 161 DLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSMG-------YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred hHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhcc-------ceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 9999997543 4788888899999999999999998 99999999999999999999999999876654
Q ss_pred cc-----cccccccccCCCCCC----C-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 430 PI-----AAQRMISYKSPEYQS----S-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 430 ~~-----~~~~~~~y~aPE~~~----~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
+. ...|||-|.+||++. + +.|++.+|.||+||++|||+.|..||+.. .++.-..+.......-
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-------slveTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-------SLVETYGKIMNHKESL 300 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-------HHHHHHHHHhchhhhc
Confidence 32 345899999999875 2 57899999999999999999999999643 2333222222211111
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCC---hHHHHHHHhhcc
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE---MAEVVSELEIIK 548 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~L~~i~ 548 (582)
.+.+ .. +-..+..+||.+-+ -+|+.|.. ++|+-.|.+.-.
T Consensus 301 ~FP~-~~-------~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 301 SFPD-ET-------DVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred CCCc-cc-------ccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccC
Confidence 1110 00 11123444554433 48889988 999999886543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=259.57 Aligned_cols=236 Identities=26% Similarity=0.369 Sum_probs=190.0
Q ss_pred CceEEEEEEEcC-CceEEEEEecCCCcch-HHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChHHHHhc
Q 047954 280 IFGNSYKALLEG-RAPVVVKRLRDLKPLI-TEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHG 357 (582)
Q Consensus 280 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 357 (582)
+||.||+|...+ +..+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8889999997654433 67899999999999999999999999999999999999999999999864
Q ss_pred CCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc---cccc
Q 047954 358 GKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP---IAAQ 434 (582)
Q Consensus 358 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~---~~~~ 434 (582)
.. .+++..+..++.+++.++.|||+.+ ++|+||+|+||++++++.++|+|||.+...... ....
T Consensus 81 ~~------~~~~~~~~~~~~~l~~~l~~lh~~~-------i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 147 (244)
T smart00220 81 RG------RLSEDEARFYARQILSALEYLHSNG-------IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFV 147 (244)
T ss_pred cc------CCCHHHHHHHHHHHHHHHHHHHHcC-------eecCCcCHHHeEECCCCcEEEccccceeeecccccccccc
Confidence 32 2788899999999999999999998 999999999999999999999999999876553 2334
Q ss_pred ccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHH
Q 047954 435 RMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAH 514 (582)
Q Consensus 435 ~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 514 (582)
++..|++||......++.++||||||+++|+|++|..||.... ....+.+.. ....... ... ...
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~---~~~~~~~~~----~~~~~~~-~~~-------~~~ 212 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD---QLLELFKKI----GKPKPPF-PPP-------EWK 212 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHH----hccCCCC-ccc-------ccc
Confidence 5678999999988888999999999999999999999986421 111122211 1111100 000 000
Q ss_pred HHHHHHHHHHHcccCCCCCCCChHHHHHH
Q 047954 515 GMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543 (582)
Q Consensus 515 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 543 (582)
...++.+++.+|+..+|++||++.+++++
T Consensus 213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 213 ISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred CCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 12368889999999999999999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=264.46 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=198.9
Q ss_pred cccccccCceEEEEEEEcC------CceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeC-CeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLEG------RAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN-DEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e 344 (582)
..++-+|.||.||+|.+.+ .+.|.+|.++.. ++.....+..|-.++..+.|||+.++.+++... ...+.+|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 3468899999999997543 355677777643 333456788899999999999999999999865 45789999
Q ss_pred eCCCCChHHHHhcCCC--CCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecc
Q 047954 345 FAGNGNLFNRIHGGKS--SKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG 422 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 422 (582)
++.-|+|..++...+. ......++..+...+|.|++.|++|||.++ |||.||..+|++||+...+||+|=.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~-------ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG-------VIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC-------cccchhhhhcceehhheeEEeccch
Confidence 9999999999983332 122345777888999999999999999998 9999999999999999999999999
Q ss_pred ccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhh
Q 047954 423 FSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVRE 495 (582)
Q Consensus 423 ~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 495 (582)
+++.+-+.. ...+...||+||.+....|+.++|||||||+||||+| |+.|+.+. +..+...++..+.+-
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI----DPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI----DPFEMEHYLKDGYRL 517 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc----CHHHHHHHHhcccee
Confidence 998764432 2235578999999999999999999999999999999 99998643 333444444333322
Q ss_pred cccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 496 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.. +..+..++..+|.-||..+|++||+++|++.-|.+.
T Consensus 518 aQ--------------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 518 AQ--------------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred cC--------------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 22 223344799999999999999999999999988754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=268.86 Aligned_cols=246 Identities=22% Similarity=0.303 Sum_probs=184.9
Q ss_pred ccccccCceEEEEEE-EcCCceEEEEEecCCC-------cchHHHHHHHHHHHhcCCCCCccccceEEEe-CCeeEEEEE
Q 047954 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLK-------PLITEEFRKQLLVIADQKHPNLLPLLAYYFS-NDEKLLVYK 344 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e 344 (582)
.+||+|+|+.||+|. +...+.||||+-...+ ....+...+|.++.+.++||.||++|+||.- .+..|-|+|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 469999999999998 4556678888753211 1122346789999999999999999999974 566789999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec---CCCceEEeec
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD---DNEMVLVSDY 421 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~---~~~~~kl~Df 421 (582)
||+|.+|.-+|+..+ .+++.++..|+.||+.||.||.... +||||-||||.|||+. ..|.+||+||
T Consensus 549 YceGNDLDFYLKQhk------lmSEKEARSIiMQiVnAL~YLNEik-----pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQHK------LMSEKEARSIIMQIVNALKYLNEIK-----PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ecCCCchhHHHHhhh------hhhHHHHHHHHHHHHHHHHHHhccC-----CCeeeeccCCccEEEecCcccceeEeeec
Confidence 999999999987554 4889999999999999999999986 4699999999999995 4578999999
Q ss_pred cccccccCcc-----------cccccccccCCCCCCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchH
Q 047954 422 GFSSLVAQPI-----------AAQRMISYKSPEYQSS----KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLC 486 (582)
Q Consensus 422 G~a~~~~~~~-----------~~~~~~~y~aPE~~~~----~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~ 486 (582)
|++++++... ...||..|++||.+.- .+++.|+||||.|||+|..+.|+.||.... ..+++.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq---sQQdIL 694 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ---SQQDIL 694 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch---hHHHHH
Confidence 9999986543 2346788999997753 357899999999999999999999996422 222332
Q ss_pred HHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHH
Q 047954 487 SWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543 (582)
Q Consensus 487 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 543 (582)
+.-.-... .++ .++..+. ...+...++.+||++.-++|....++..+
T Consensus 695 qeNTIlkA----tEV---qFP~KPv---VsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 695 QENTILKA----TEV---QFPPKPV---VSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred hhhchhcc----eec---cCCCCCc---cCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 22111100 011 0110111 11245678889999999999988887654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=283.29 Aligned_cols=257 Identities=20% Similarity=0.273 Sum_probs=176.2
Q ss_pred cccccccCceEEEEEEE-----------------cCCceEEEEEecCCCcchHHHH--------------HHHHHHHhcC
Q 047954 273 AEGLGKGIFGNSYKALL-----------------EGRAPVVVKRLRDLKPLITEEF--------------RKQLLVIADQ 321 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e~~~l~~l 321 (582)
.++||+|+||.||+|.+ ..++.||||++........++| ..|+.++.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 47899999999999964 2346799999865443333333 3466777777
Q ss_pred CCCCc-----cccceEEEe--------CCeeEEEEEeCCCCChHHHHhcCCCCC------------------CCCccchH
Q 047954 322 KHPNL-----LPLLAYYFS--------NDEKLLVYKFAGNGNLFNRIHGGKSSK------------------NRIPFRCR 370 (582)
Q Consensus 322 ~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~ 370 (582)
+|.++ ++++++|.. .+..++||||+++|+|.++++...... ....+++.
T Consensus 230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~ 309 (507)
T PLN03224 230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309 (507)
T ss_pred hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence 76654 778888764 356899999999999999997532100 01235677
Q ss_pred HHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-----cccccccccCCCCC
Q 047954 371 SRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI-----AAQRMISYKSPEYQ 445 (582)
Q Consensus 371 ~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~y~aPE~~ 445 (582)
.+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ....++.|+|||.+
T Consensus 310 ~~~~i~~ql~~aL~~lH~~~-------ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 310 VIKGVMRQVLTGLRKLHRIG-------IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred HHHHHHHHHHHHHHHHHHCC-------eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 88899999999999999988 9999999999999999999999999997654322 12235789999987
Q ss_pred CCCC--------------------C--CcchhHHHHHHHHHHHHhCCC-CCCCCCCCCC-----ccchHHHHHHHHhhcc
Q 047954 446 SSKK--------------------I--SRKSDVWSFGCLLLELLTGRI-STHSAPQGIN-----GADLCSWVLRAVREEW 497 (582)
Q Consensus 446 ~~~~--------------------~--~~k~DVwS~Gvvl~elltG~~-P~~~~~~~~~-----~~~~~~~~~~~~~~~~ 497 (582)
.... + ..+.||||+||++|||++|.. |+........ ..++..|. .....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~~~- 459 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYKGQ- 459 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhccc-
Confidence 5322 1 235799999999999999875 6643211100 01111111 01100
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCC---CCCCChHHHHHHHhhc
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSP---EKRPEMAEVVSELEII 547 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~L~~i 547 (582)
..+ +. ..........+++.+++..+| .+|+|++|+++|.|..
T Consensus 460 ---~~~--~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 460 ---KYD--FS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred ---CCC--cc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 000 00 001112356778888888765 6899999999998764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=282.76 Aligned_cols=245 Identities=21% Similarity=0.329 Sum_probs=197.7
Q ss_pred cccccccCceEEEEEE-EcCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEe-----CCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFS-----NDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~-----~~~~~lv~e~ 345 (582)
.+.||.|.+|.||+++ .++++.+|||++... ....++...|.++++.. .|||++.++|+|.. ++.+||||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf 102 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF 102 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence 4679999999999998 567888889988653 34567788899999876 79999999999974 5689999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
|.+|+..|+++... ...+.|..+..|++.++.||.+||... ++|||||-.|||++.++.+||+|||.+.
T Consensus 103 C~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~nk-------viHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 103 CGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHNNK-------VIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred cCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhhcc-------eeeecccCceEEEeccCcEEEeeeeeee
Confidence 99999999998765 235889999999999999999999988 9999999999999999999999999998
Q ss_pred cccCcc----cccccccccCCCCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 426 LVAQPI----AAQRMISYKSPEYQSS-----KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 426 ~~~~~~----~~~~~~~y~aPE~~~~-----~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
.++... ...||+.|||||++.- ..|+..+|+||+|++..||--|.+|+.+.-+. +..+.
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----------raLF~-- 239 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----------RALFL-- 239 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh----------hhhcc--
Confidence 876653 4457889999999863 34678899999999999999999998754321 11110
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
++....+++ ..+..-..++.+++..|+.+|-++||++.++++|..
T Consensus 240 -IpRNPPPkL---krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF 284 (953)
T KOG0587|consen 240 -IPRNPPPKL---KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF 284 (953)
T ss_pred -CCCCCCccc---cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence 111111221 123344567899999999999999999999988753
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=262.30 Aligned_cols=232 Identities=24% Similarity=0.317 Sum_probs=181.4
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLK---PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
-.+||+|+||+|.+|..++ .+.+|||++++.- ..+.+--..|-++|+-. +-|.++++..+|+.-+.+|+||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 3579999999999998664 5679999987532 22233345566777665 67899999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|..+++... .+.+..+..+|..||-||-|||+++ ||.||||.+|||+|.+|.+||+|||+++.-
T Consensus 434 GGDLMyhiQQ~G------kFKEp~AvFYAaEiaigLFFLh~kg-------IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 434 GGDLMYHIQQVG------KFKEPVAVFYAAEIAIGLFFLHSKG-------IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred CchhhhHHHHhc------ccCCchhhhhhHHHHHHhhhhhcCC-------eeeeeccccceEeccCCceEeeeccccccc
Confidence 999999887543 3677788899999999999999998 999999999999999999999999998753
Q ss_pred cC----cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQ----PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~----~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
-. .....||+-|+|||.+..++|+..+|.|||||+||||+.|+.||+.. +..++.+.+.. .
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe----DE~elF~aI~e----h------- 565 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE----DEDELFQAIME----H------- 565 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHH----c-------
Confidence 22 22345789999999999999999999999999999999999999753 23333332221 1
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCC
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE 536 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 536 (582)
... .+.....+...+...-+.+.|.+|..
T Consensus 566 -nvs---yPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 -NVS---YPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -cCc---CcccccHHHHHHHHHHhhcCCccccC
Confidence 110 11222335566777788899999853
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=271.62 Aligned_cols=244 Identities=19% Similarity=0.289 Sum_probs=199.4
Q ss_pred cccccCceEEEEEEEcCCc-eEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 275 GLGKGIFGNSYKALLEGRA-PVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
-||-|+||.|-++...... .+|+|.+++. +....+....|-.+|...+.|.||++|-.|.+....|++||-|-||.
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 4999999999999876544 3777777543 33445667889999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|+..++.+. .++......++..+.+|++|||+++ ||.|||||+|.++|.+|.+||.|||+|+.+...
T Consensus 507 lWTiLrdRg------~Fdd~tarF~~acv~EAfeYLH~k~-------iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 507 LWTILRDRG------SFDDYTARFYVACVLEAFEYLHRKG-------IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhhhhhcC------CcccchhhhhHHHHHHHHHHHHhcC-------ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999997543 4778888889999999999999998 999999999999999999999999999998765
Q ss_pred c---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 431 I---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 431 ~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
. ...||+.|.|||.+.....+.++|.||+|+++|||+||++||... +.......+.+++..-..+.
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~----dpmktYn~ILkGid~i~~Pr------- 642 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV----DPMKTYNLILKGIDKIEFPR------- 642 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC----chHHHHHHHHhhhhhhhccc-------
Confidence 3 456899999999999999999999999999999999999999754 33344444444433211111
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHHhhcc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSELEIIK 548 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~i~ 548 (582)
.......+++.+.+..+|.+|.- +.||-+|-|...
T Consensus 643 ------~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 643 ------RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred ------ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 11224567777888899999975 788888887654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=286.76 Aligned_cols=259 Identities=16% Similarity=0.197 Sum_probs=164.0
Q ss_pred cccccccCceEEEEEEEcC-----CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceE------EEeCCeeEE
Q 047954 273 AEGLGKGIFGNSYKALLEG-----RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAY------YFSNDEKLL 341 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~------~~~~~~~~l 341 (582)
.+.||+|+||.||+|.+.+ +..||+|++..... .+.+..| .+....+.+++.++.. +......++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence 4689999999999999754 57899998764321 1222221 1222233333333222 234567899
Q ss_pred EEEeCCCCChHHHHhcCCCCC--------------CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCC
Q 047954 342 VYKFAGNGNLFNRIHGGKSSK--------------NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTN 407 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~N 407 (582)
||||+.+++|.+++....... .........+..++.||+.||+|||+++ |+||||||+|
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g-------IiHRDLKP~N 285 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG-------IVHRDVKPQN 285 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC-------EEeCcCCHHH
Confidence 999999999999987532100 0001122345679999999999999998 9999999999
Q ss_pred eeecC-CCceEEeeccccccccCc-----ccccccccccCCCCCCCC----------------------CCCcchhHHHH
Q 047954 408 ILLDD-NEMVLVSDYGFSSLVAQP-----IAAQRMISYKSPEYQSSK----------------------KISRKSDVWSF 459 (582)
Q Consensus 408 ILl~~-~~~~kl~DfG~a~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~~~k~DVwS~ 459 (582)
||+++ ++.+||+|||+|+.+... ....+++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 578999999999865432 233467889999954321 24557799999
Q ss_pred HHHHHHHHhCCCCCCCCCCC------CCccchHHHHHHHHhhcccccccchhhhh-hhchHHHHHHHHHHHHHcccCCCC
Q 047954 460 GCLLLELLTGRISTHSAPQG------INGADLCSWVLRAVREEWTAEIFDSEISV-QRSAAHGMLKLLQVAIQCCNKSPE 532 (582)
Q Consensus 460 Gvvl~elltG~~P~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~ 532 (582)
||+||||+++..|++..... ....+...|.... . ....+.... ............+|+.+||+.||+
T Consensus 366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV-E-----PRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh-c-----cccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999987665321000 0000111111000 0 000000000 000000112345799999999999
Q ss_pred CCCChHHHHHHHhhcc
Q 047954 533 KRPEMAEVVSELEIIK 548 (582)
Q Consensus 533 ~RPs~~evl~~L~~i~ 548 (582)
+|||+.|+++|.+...
T Consensus 440 kR~ta~e~L~Hpff~~ 455 (566)
T PLN03225 440 QRISAKAALAHPYFDR 455 (566)
T ss_pred cCCCHHHHhCCcCcCC
Confidence 9999999999987644
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=236.93 Aligned_cols=195 Identities=26% Similarity=0.344 Sum_probs=160.7
Q ss_pred ccccccccCceEEEEEEE-cCCceEEEEEecCC-CcchHHHHHHHHHHHhc-CCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 272 PAEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL-KPLITEEFRKQLLVIAD-QKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
..+.||+|++|.|-+-++ .+|...|+|+++.. .....+....|+.+..+ ...|.+|.+||.+......++.||.|.-
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 457799999999988774 57888999999743 33445667788877655 5889999999999999999999999954
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
+|..+..+-... ...+++...-+||..+.+||.|||++- .+||||+||+||||+.+|.+|+||||++..+.
T Consensus 130 -Sldkfy~~v~~~--g~~ipE~vlGkIa~Svv~al~~L~~kL------~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 130 -SLDKFYRKVLKK--GGTIPEDVLGKIAVSVVHALEFLHSKL------SVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred -hHHHHHHHHHhc--CCcCchHHhhHhHHHHHHHHHHHHHHh------hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 776665443222 235778888899999999999999976 39999999999999999999999999998887
Q ss_pred Ccccc---cccccccCCCCCCC----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 047954 429 QPIAA---QRMISYKSPEYQSS----KKISRKSDVWSFGCLLLELLTGRISTHS 475 (582)
Q Consensus 429 ~~~~~---~~~~~y~aPE~~~~----~~~~~k~DVwS~Gvvl~elltG~~P~~~ 475 (582)
+..+. .|.-.|||||.+.. ..|+.|+||||+|+++.||.++++||+.
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 65433 35567999998753 3789999999999999999999999974
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=284.84 Aligned_cols=242 Identities=20% Similarity=0.321 Sum_probs=183.8
Q ss_pred ccccccccCceE-EEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 272 PAEGLGKGIFGN-SYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 272 ~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+.+.+|.|+-|+ ||+|.+++ +.||||++-. ...+...+|+..|+.- +|||||++++.-.+....|+..|.|..
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye~-R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYEG-REVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred cHHHcccCCCCcEEEEEeeCC-ceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 457799999875 89999876 4799999843 2334567899988776 899999999999999999999999955
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC---C--CceEEeecccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD---N--EMVLVSDYGFS 424 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~---~--~~~kl~DfG~a 424 (582)
+|.+++..... ......-...+.+..|+++||++||+.+ ||||||||+||||+. + ..++|+|||++
T Consensus 588 sL~dlie~~~~--d~~~~~~i~~~~~l~q~~~GlaHLHsl~-------iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 588 SLQDLIESSGL--DVEMQSDIDPISVLSQIASGLAHLHSLK-------IVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred hHHHHHhcccc--chhhcccccHHHHHHHHHHHHHHHHhcc-------cccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99999976411 1111111345678899999999999987 999999999999976 3 46899999999
Q ss_pred ccccCc-------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 425 SLVAQP-------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTG-RISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 425 ~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
+.+... ....||-+|+|||.+....-+.++||||+|||+|..++| ++||.+.... -...+...
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R---------~~NIl~~~ 729 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER---------QANILTGN 729 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh---------hhhhhcCc
Confidence 987543 344578899999999988888899999999999999995 9999653211 00111111
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
+....+. ...++ +..+|+.+|+..+|..||++.+|+.|.-
T Consensus 730 ~~L~~L~-------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPl 769 (903)
T KOG1027|consen 730 YTLVHLE-------PLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPL 769 (903)
T ss_pred cceeeec-------cCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCc
Confidence 1111111 11111 6778999999999999999999998863
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=262.26 Aligned_cols=203 Identities=20% Similarity=0.340 Sum_probs=169.7
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCCcch---HHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLI---TEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+-||-|+||.|.++... +...+|.|.+++.+... ....+.|-.||+..+.+-||+||-.|++.+.+|+||+|++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 45999999999999854 45678899887544322 335678999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc--
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV-- 427 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~-- 427 (582)
|+..+|-... .|.+..+..++.++..|+++.|..| +|||||||+|||||.+|.+||+|||+++-+
T Consensus 715 DmMSLLIrmg------IFeE~LARFYIAEltcAiesVHkmG-------FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 715 DMMSLLIRMG------IFEEDLARFYIAELTCAIESVHKMG-------FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred cHHHHHHHhc------cCHHHHHHHHHHHHHHHHHHHHhcc-------ceecccCccceEEccCCceeeeecccccccee
Confidence 9999886432 4777778888889999999999998 999999999999999999999999997422
Q ss_pred -------cCc-------------------------------------ccccccccccCCCCCCCCCCCcchhHHHHHHHH
Q 047954 428 -------AQP-------------------------------------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLL 463 (582)
Q Consensus 428 -------~~~-------------------------------------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl 463 (582)
... ....||..|+|||++....|+..+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 100 011256679999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCccchHHHH
Q 047954 464 LELLTGRISTHSAPQGINGADLCSWV 489 (582)
Q Consensus 464 ~elltG~~P~~~~~~~~~~~~~~~~~ 489 (582)
|||+.|+.||...........+..|-
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~ 887 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWR 887 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehh
Confidence 99999999998877765555666553
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=241.85 Aligned_cols=238 Identities=19% Similarity=0.323 Sum_probs=184.6
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+||+|+|++|..+++. +.+.+|+|++++. .....+..+.|-.+..+. +||.+|.+..+|+.+...++|.||+++
T Consensus 256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~g 335 (593)
T KOG0695|consen 256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNG 335 (593)
T ss_pred eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecC
Confidence 57999999999999854 5678899988643 233445667777777665 899999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.-++.+.+ .+++..+..+...|+.||.|||+++ ||.||||.+|||+|..|.+||+|+|+.+.--
T Consensus 336 gdlmfhmqrqr------klpeeharfys~ei~lal~flh~rg-------iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 336 GDLMFHMQRQR------KLPEEHARFYSAEICLALNFLHERG-------IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred cceeeehhhhh------cCcHHHhhhhhHHHHHHHHHHhhcC-------eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99988876543 4888888999999999999999998 9999999999999999999999999987642
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.+ ....||+.|.|||.+.+..|+..+|.|++||+++||+.|+.||+--......+...+++.+.+-+..
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq------- 475 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ------- 475 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-------
Confidence 22 3445889999999999999999999999999999999999999743222222233333333322211
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCC
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRP 535 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 535 (582)
+..++.. ..+...++..-+.+||.+|.
T Consensus 476 -iriprsl---svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 -IRIPRSL---SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -cccccee---ehhhHHHHHHhhcCCcHHhc
Confidence 1111111 12344566678889999984
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=230.39 Aligned_cols=252 Identities=14% Similarity=0.300 Sum_probs=189.4
Q ss_pred ccccccCceEEEEEE-EcCCceEEEEEecCCCcchHHHHHHHHHHHhcCC-CCCccccceEEEeCC--eeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-HPNLLPLLAYYFSND--EKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~~lv~e~~~~g 349 (582)
+.+|+|.++.||.|. ..+.+.++||.++.. ..+.+.+|+.+|..++ ||||++++++..+.. ...||+||..+-
T Consensus 44 rk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~ 120 (338)
T KOG0668|consen 44 RKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNT 120 (338)
T ss_pred HHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccc
Confidence 579999999999998 566778999999654 4577899999999997 999999999998765 457999999998
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC-CceEEeecccccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN-EMVLVSDYGFSSLVA 428 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DfG~a~~~~ 428 (582)
+...+.. .++...+..++.++++||.|+|+.| |+|||+||.|++||.. -.++|+|+|+|.++.
T Consensus 121 Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS~G-------ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 121 DFKQLYP---------TLTDYDIRYYIYELLKALDYCHSMG-------IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred cHHHHhh---------hhchhhHHHHHHHHHHHHhHHHhcC-------cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 8776653 4777888999999999999999999 9999999999999954 569999999999887
Q ss_pred Cccccc---ccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc------
Q 047954 429 QPIAAQ---RMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT------ 498 (582)
Q Consensus 429 ~~~~~~---~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~------ 498 (582)
+..... .+..|.-||.+.. +.|+..-|+|||||++..|+..+.||.... ++.+..-.+.+.+.....
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~---dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH---DNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC---CCHHHHHHHHHHhChHHHHHHHHH
Confidence 654433 2345889998765 567899999999999999999999996422 222222222221111000
Q ss_pred -ccccchhhhh-----hhch---------HH-HHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 499 -AEIFDSEISV-----QRSA---------AH-GMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 499 -~~~~d~~~~~-----~~~~---------~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.-.+|+.+.. .+.. .. ...+.++++.+.|..|-.+|+|++|.+.|....
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 0012333211 0000 00 124678888899999999999999999987544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=231.86 Aligned_cols=207 Identities=30% Similarity=0.500 Sum_probs=180.2
Q ss_pred ccccCceEEEEEEEcC-CceEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChHH
Q 047954 276 LGKGIFGNSYKALLEG-RAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFN 353 (582)
Q Consensus 276 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 353 (582)
||+|.+|.||++...+ +..+++|++...... ..+.+.+|+..+++++|++|+++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 788999998754332 34679999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC-CCceEEeeccccccccCc--
Q 047954 354 RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD-NEMVLVSDYGFSSLVAQP-- 430 (582)
Q Consensus 354 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfG~a~~~~~~-- 430 (582)
++.... ..+++..+..++.+++++|+|||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~-------~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 81 LLKENE-----GKLSEDEILRILLQILEGLEYLHSNG-------IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred HHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 987542 24788999999999999999999998 999999999999999 899999999998776543
Q ss_pred --ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 431 --IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 431 --~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
........|++||..... .++.++|+|++|+++++|
T Consensus 149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------- 187 (215)
T cd00180 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------- 187 (215)
T ss_pred hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------
Confidence 223355779999998876 788999999999999998
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
..+.+++..|+..+|++||++.++++++
T Consensus 188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1577889999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=242.19 Aligned_cols=256 Identities=18% Similarity=0.324 Sum_probs=188.4
Q ss_pred ccccccccCceEEEEEEE-cCCceEEEEEecCCCc--chHHHHHHHHHHHhcCCCCCccccceEEEeCC-----eeEEEE
Q 047954 272 PAEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYYFSND-----EKLLVY 343 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~ 343 (582)
..+-||-|+||.||.+.. ++++.|+.|++...-. ...+.+.+|+++|..++|.|++..+++..... +.|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 356799999999999885 5788999999865322 34577889999999999999999998876543 467888
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
|.|.. +|...+-. ...++...+.-+..||++||.|||+.+ |.||||||.|.|++.+...||||||+
T Consensus 137 ELmQS-DLHKIIVS------PQ~Ls~DHvKVFlYQILRGLKYLHsA~-------ILHRDIKPGNLLVNSNCvLKICDFGL 202 (449)
T KOG0664|consen 137 ELMQS-DLHKIIVS------PQALTPDHVKVFVYQILRGLKYLHTAN-------ILHRDIKPGNLLVNSNCILKICDFGL 202 (449)
T ss_pred HHHHh-hhhheecc------CCCCCcchhhhhHHHHHhhhHHHhhcc-------hhhccCCCccEEeccCceEEeccccc
Confidence 98854 88877753 235777788889999999999999998 99999999999999999999999999
Q ss_pred cccccCccccc-----ccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh---
Q 047954 424 SSLVAQPIAAQ-----RMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR--- 494 (582)
Q Consensus 424 a~~~~~~~~~~-----~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~--- 494 (582)
++......... .|..|+|||.+++. .|+.+.||||.|||+.|++.++..|....+- +..+.+...+.
T Consensus 203 ARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi----qQL~lItdLLGTPs 278 (449)
T KOG0664|consen 203 ARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI----EQLQMIIDLLGTPS 278 (449)
T ss_pred ccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH----HHHHHHHHHhCCCc
Confidence 98876554333 24579999999874 6899999999999999999999988654321 11111111110
Q ss_pred --------hcccccccc-----hhhhh---hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 495 --------EEWTAEIFD-----SEISV---QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 495 --------~~~~~~~~d-----~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
++....++. +.... .......-.+.+.+...++..||++|.+..+.+.++.
T Consensus 279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 010011111 00000 0011122234566777889999999999999988764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=229.84 Aligned_cols=261 Identities=20% Similarity=0.288 Sum_probs=183.8
Q ss_pred CCCCCChhHhhhcccccccccCceEEEEEEEcC-CceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceE-EEe
Q 047954 259 QPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAY-YFS 335 (582)
Q Consensus 259 ~~~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~-~~~ 335 (582)
....++++|... ..+.+|+|.||.+-+++.+. .+.+++|.+.. ......+|.+|...--.| .|.||+.-|+. |+.
T Consensus 16 el~kv~l~d~y~-I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 16 ELKKVDLEDVYT-INKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred cccccchhhhhh-HHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 334455555432 35689999999999999765 56678887754 334567899998765555 68999998864 566
Q ss_pred CCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec--CC
Q 047954 336 NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD--DN 413 (582)
Q Consensus 336 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~--~~ 413 (582)
.+..++++||++.|+|.+-+... .+.+....+++.|++.||.|+|+++ +||||||.+||||- +.
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHskn-------lVHRdlK~eNiLif~~df 159 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHSKN-------LVHRDLKAENILIFDADF 159 (378)
T ss_pred CceEEEeeccCccchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhccc-------hhhcccccceEEEecCCc
Confidence 77888999999999999887542 3667778889999999999999998 99999999999993 34
Q ss_pred CceEEeeccccccccCccc-ccccccccCCCCCCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-CCccchH
Q 047954 414 EMVLVSDYGFSSLVAQPIA-AQRMISYKSPEYQSSK-----KISRKSDVWSFGCLLLELLTGRISTHSAPQG-INGADLC 486 (582)
Q Consensus 414 ~~~kl~DfG~a~~~~~~~~-~~~~~~y~aPE~~~~~-----~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~-~~~~~~~ 486 (582)
..+||||||.++..+.... ...+..|.+||..... ...+.+|||.||++++.++||+.||+..... ....+..
T Consensus 160 ~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~ 239 (378)
T KOG1345|consen 160 YRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE 239 (378)
T ss_pred cEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence 4799999999877654322 2234569999976432 3578899999999999999999999743221 1112222
Q ss_pred HHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCC---CChHHHHHHHhhc
Q 047954 487 SWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKR---PEMAEVVSELEII 547 (582)
Q Consensus 487 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~L~~i 547 (582)
+|..+... ..++.+. .....++++..+-+..+|++| -+++.....+|.-
T Consensus 240 ~w~~rk~~--~~P~~F~----------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 240 QWLKRKNP--ALPKKFN----------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred HHhcccCc--cCchhhc----------ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 22221111 1111111 112256667778889999999 5555555555543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=242.13 Aligned_cols=126 Identities=22% Similarity=0.327 Sum_probs=106.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCC-----C---CCccccceEEEe----CCee
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-----H---PNLLPLLAYYFS----NDEK 339 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H---~niv~l~~~~~~----~~~~ 339 (582)
..+||.|.|++||+|... +.+.||+|+++.. ....+....||++|++++ | ..||+|+++|.. +.+.
T Consensus 83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HV 161 (590)
T KOG1290|consen 83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHV 161 (590)
T ss_pred EEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEE
Confidence 468999999999999854 5677889988653 456788899999999872 3 479999999985 4579
Q ss_pred EEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee
Q 047954 340 LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL 410 (582)
Q Consensus 340 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl 410 (582)
+||+|++ |-+|..+|.....+ .++...+..|++||+.||.|||..+ +|||-||||+|||+
T Consensus 162 CMVfEvL-GdnLLklI~~s~Yr----Glpl~~VK~I~~qvL~GLdYLH~ec------gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 162 CMVFEVL-GDNLLKLIKYSNYR----GLPLSCVKEICRQVLTGLDYLHREC------GIIHTDLKPENVLL 221 (590)
T ss_pred EEEehhh-hhHHHHHHHHhCCC----CCcHHHHHHHHHHHHHHHHHHHHhc------CccccCCCcceeee
Confidence 9999999 66999999765433 5888899999999999999999998 59999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-29 Score=249.96 Aligned_cols=268 Identities=21% Similarity=0.312 Sum_probs=199.5
Q ss_pred CChhHhhhc---ccccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCC------CCCccccceE
Q 047954 263 FKLNDLLKA---PAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQK------HPNLLPLLAY 332 (582)
Q Consensus 263 ~~~~~l~~~---~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------H~niv~l~~~ 332 (582)
+.+.|++.. .....|+|-|++|.+|... .+..||||+++.. ....+.=+.|+++|.+|. --|+++++-.
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 344444443 2345899999999999854 4678999999764 344566678999999984 3589999999
Q ss_pred EEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC
Q 047954 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD 412 (582)
Q Consensus 333 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~ 412 (582)
|...+++|||+|-+. -+|.+.|..... ...|....+..++.|+.-||..|-..+ |+|.||||.|||+++
T Consensus 503 F~hknHLClVFE~Ls-lNLRevLKKyG~---nvGL~ikaVRsYaqQLflALklLK~c~-------vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLS-LNLREVLKKYGR---NVGLHIKAVRSYAQQLFLALKLLKKCG-------VLHADIKPDNILVNE 571 (752)
T ss_pred hhhcceeEEEehhhh-chHHHHHHHhCc---ccceeehHHHHHHHHHHHHHHHHHhcC-------eeecccCccceEecc
Confidence 999999999999885 499999986543 245788889999999999999999988 999999999999997
Q ss_pred CC-ceEEeeccccccccCccccc--ccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHH
Q 047954 413 NE-MVLVSDYGFSSLVAQPIAAQ--RMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWV 489 (582)
Q Consensus 413 ~~-~~kl~DfG~a~~~~~~~~~~--~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~ 489 (582)
.. .+||||||.|.......... .+..|.|||.+.+-.|+...|+||.||+||||.||+..|.... +.+ +....
T Consensus 572 ~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T---NN~-MLrl~ 647 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT---NNQ-MLRLF 647 (752)
T ss_pred CcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC---cHH-HHHHH
Confidence 65 58999999998876654332 2235999999999999999999999999999999999996543 122 11111
Q ss_pred HH--------HHhh-cccccccchh--------------------------------hh----hhhchHHHHHHHHHHHH
Q 047954 490 LR--------AVRE-EWTAEIFDSE--------------------------------IS----VQRSAAHGMLKLLQVAI 524 (582)
Q Consensus 490 ~~--------~~~~-~~~~~~~d~~--------------------------------~~----~~~~~~~~~~~l~~l~~ 524 (582)
.. +++. .+..+-+|.. +. .+......+.++.+|+.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 11 1110 1111111111 00 01112234567889999
Q ss_pred HcccCCCCCCCChHHHHHHHhh
Q 047954 525 QCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 525 ~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.|+..||++|.|..++|.|...
T Consensus 728 kml~LdP~KRit~nqAL~HpFi 749 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALKHPFI 749 (752)
T ss_pred HHhccChhhcCCHHHHhcCCcc
Confidence 9999999999999999998653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=233.13 Aligned_cols=248 Identities=19% Similarity=0.271 Sum_probs=180.1
Q ss_pred cccccCceEEEEEE-EcCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCC------eeEEEEEe
Q 047954 275 GLGKGIFGNSYKAL-LEGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND------EKLLVYKF 345 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~e~ 345 (582)
.+|.|.- .|-.|. .-.+++||+|++... .....+...+|...+..++|+||++++.+|.-.. +.|+||||
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 3666666 444443 224678999987432 2234466778999999999999999999997543 46899999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
|. .+|.+.++. .++-.....|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 103 m~-~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs~~-------IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 103 MD-ANLCQVILM--------ELDHETISYILYQMLCGIKHLHSAG-------IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred hh-hHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHhcc-------eeecccCcccceecchhheeeccchhhc
Confidence 95 599988872 3667788899999999999999998 9999999999999999999999999997
Q ss_pred cccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh-------
Q 047954 426 LVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE------- 495 (582)
Q Consensus 426 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~------- 495 (582)
..... .....+..|+|||++.+..|.+.+||||.||++.||++|+.-|.+.. .+-+|....-.-
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d------~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD------HIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch------HHHHHHHHHHHhcCCCHHH
Confidence 66544 12234567999999999999999999999999999999998885321 122221110000
Q ss_pred ----------------ccc-----ccccchhhhhh-hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 496 ----------------EWT-----AEIFDSEISVQ-RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 496 ----------------~~~-----~~~~d~~~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
++. ..+.|...... ....-....+.+++.+||..+|++|.|+++++.|.-
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 000 00111111100 111122335678899999999999999999999863
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=248.44 Aligned_cols=189 Identities=22% Similarity=0.367 Sum_probs=161.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcc--------hHHHHHHHHHHHhcCC---CCCccccceEEEeCCeeE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPL--------ITEEFRKQLLVIADQK---HPNLLPLLAYYFSNDEKL 340 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~ 340 (582)
-+.+|+|+||.|+.|.++ +...|+||.+.+.+-. .....-.|+.+|+.++ |+||++++++|++++..|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 467999999999999965 4567889988653211 1123457999999997 999999999999999999
Q ss_pred EEEEeC-CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEe
Q 047954 341 LVYKFA-GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVS 419 (582)
Q Consensus 341 lv~e~~-~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 419 (582)
|+||-- ++-+|++++... ..+++.....|++||+.|+++||+++ |||||||-+||.++.+|-+||+
T Consensus 646 l~te~hg~gIDLFd~IE~k------p~m~E~eAk~IFkQV~agi~hlh~~~-------ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFK------PRMDEPEAKLIFKQVVAGIKHLHDQG-------IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred EEecCCCCCcchhhhhhcc------CccchHHHHHHHHHHHhccccccccC-------ceecccccccEEEecCCeEEEe
Confidence 999964 455999999643 25889999999999999999999998 9999999999999999999999
Q ss_pred eccccccccCc--ccccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 047954 420 DYGFSSLVAQP--IAAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTH 474 (582)
Q Consensus 420 DfG~a~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~ 474 (582)
|||.|...... ....||+.|.|||++.+.+| +..-|||++|++||.++....||+
T Consensus 713 dfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999877654 34568999999999999887 677899999999999999988885
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=227.20 Aligned_cols=191 Identities=29% Similarity=0.501 Sum_probs=166.9
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|++|.||++...+ +..+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||+++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 3579999999999999875 788999999765444 56789999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++..... .+++.....++.+++.+|.|||..+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 84 L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~-------i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 84 LFDYLRKKGG-----KLSEEEARFYLRQILEALEYLHSLG-------IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred HHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999975431 1778899999999999999999997 999999999999999999999999998877544
Q ss_pred -----ccccccccccCCCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 047954 431 -----IAAQRMISYKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGRISTHS 475 (582)
Q Consensus 431 -----~~~~~~~~y~aPE~~-~~~~~~~k~DVwS~Gvvl~elltG~~P~~~ 475 (582)
....+...|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 223355679999988 667788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=253.87 Aligned_cols=243 Identities=20% Similarity=0.333 Sum_probs=190.6
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
..+|.|.||.|||++. ..+...|+|+++-.......-.++|+-+++..+|||||.++|.+...+..++.||||.+|+|.
T Consensus 21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQ 100 (829)
T KOG0576|consen 21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQ 100 (829)
T ss_pred eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccc
Confidence 5699999999999994 567889999998766666777889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc--
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP-- 430 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~-- 430 (582)
+..+... ++++.++..+.+...+||+|||+.+ -+|||||-.|||+++.+.+|++|||.+..+...
T Consensus 101 diy~~Tg------plselqiayvcRetl~gl~ylhs~g-------k~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 101 DIYHVTG------PLSELQIAYVCRETLQGLKYLHSQG-------KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred ceeeecc------cchhHHHHHHHhhhhccchhhhcCC-------cccccccccceeecccCceeecccCchhhhhhhhh
Confidence 9887543 6888899999999999999999998 799999999999999999999999998766543
Q ss_pred --ccccccccccCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 431 --IAAQRMISYKSPEYQS---SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 431 --~~~~~~~~y~aPE~~~---~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
....||+.|||||+.. ...|..++|||+.|+...|+---+.|..+.- .. +...-.....+- .+.
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh------pm-r~l~LmTkS~~q----pp~ 236 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH------PM-RALFLMTKSGFQ----PPT 236 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc------hH-HHHHHhhccCCC----CCc
Confidence 3456899999999763 4678999999999999999877666643211 00 000001111110 111
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHH
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 543 (582)
+..... ....+.+++..|+.++|++||+++.++.|
T Consensus 237 lkDk~k---ws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 237 LKDKTK---WSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ccCCcc---chHHHHHHHHHHhcCCCccCCChhhheec
Confidence 111111 12246678889999999999999886654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=272.01 Aligned_cols=195 Identities=19% Similarity=0.219 Sum_probs=140.8
Q ss_pred cCCC-CCccccceEEE-------eCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCC
Q 047954 320 DQKH-PNLLPLLAYYF-------SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391 (582)
Q Consensus 320 ~l~H-~niv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 391 (582)
.++| +||++++++|. .....+.++||+ +++|.+++.... ..+++.+++.++.||++||+|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~g- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQG- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3456 68888888872 234567788987 669999996432 25889999999999999999999998
Q ss_pred CCCCCcceecCCCCCCeeecC-------------------CCceEEeeccccccccCc--------------------cc
Q 047954 392 SRTQSAVIHGNLKSTNILLDD-------------------NEMVLVSDYGFSSLVAQP--------------------IA 432 (582)
Q Consensus 392 ~~~~~~ivH~Dlkp~NILl~~-------------------~~~~kl~DfG~a~~~~~~--------------------~~ 432 (582)
||||||||+||||+. ++.+|++|||+++..... ..
T Consensus 101 ------IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (793)
T PLN00181 101 ------IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL 174 (793)
T ss_pred ------eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence 999999999999954 455677777777542110 01
Q ss_pred ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhch
Q 047954 433 AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSA 512 (582)
Q Consensus 433 ~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 512 (582)
..+|+.|||||++.+..++.++|||||||+||||++|..|+... ......+ ... ...+..
T Consensus 175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~------~~~~~~~----~~~----~~~~~~------ 234 (793)
T PLN00181 175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK------SRTMSSL----RHR----VLPPQI------ 234 (793)
T ss_pred cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH------HHHHHHH----HHh----hcChhh------
Confidence 22566799999999999999999999999999999998876421 1111111 111 011110
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 513 AHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 513 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.....+...++.+||+.+|.+||+|.||+++.+..
T Consensus 235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~ 269 (793)
T PLN00181 235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFIN 269 (793)
T ss_pred hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhh
Confidence 01122456778899999999999999999987643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-26 Score=210.63 Aligned_cols=168 Identities=17% Similarity=0.203 Sum_probs=126.3
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.++++... ..+++..++.|+.||+.||+|||+++ ||+|||++.++.+|+ ||+++...
T Consensus 1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~~~-------------kp~Nil~~~~~~~~~--fG~~~~~~ 60 (176)
T smart00750 1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELHRQA-------------KSGNILLTWDGLLKL--DGSVAFKT 60 (176)
T ss_pred CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhcC-------------CcccEeEcCccceee--ccceEeec
Confidence 68999997532 25899999999999999999999862 999999999999999 99988765
Q ss_pred CcccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 429 QPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 429 ~~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
... ..++..|+|||++.+..++.++|||||||++|||+||+.||..... .......+............
T Consensus 61 ~~~-~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~------- 129 (176)
T smart00750 61 PEQ-SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE---LSAILEILLNGMPADDPRDR------- 129 (176)
T ss_pred ccc-CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch---hcHHHHHHHHHhccCCcccc-------
Confidence 433 3577999999999999999999999999999999999999964321 11111111111111100000
Q ss_pred hhchHHHH--HHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 509 QRSAAHGM--LKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 509 ~~~~~~~~--~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
....... .++.+++.+||..+|++||++.|++++++.+.
T Consensus 130 -~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 130 -SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred -ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0011111 25889999999999999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=226.09 Aligned_cols=255 Identities=20% Similarity=0.292 Sum_probs=188.1
Q ss_pred cccccccCceEEEEEEEc----CCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE----GRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.++||+|.|++||++.+. ....||+|.+.... ......+|+++|..+ -+.||+++.+++..++...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 478999999999999854 45789999986543 345688999999998 68999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC-CCceEEeecccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD-NEMVLVSDYGFSSL 426 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfG~a~~ 426 (582)
.-+..+++. .++...+..+++.+..||.++|..| ||||||||+|+|.+. -+.-.|.|||+|..
T Consensus 119 H~~f~~l~~---------~l~~~~i~~Yl~~ll~Al~~~h~~G-------IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 119 HDRFRDLYR---------SLSLAEIRWYLRNLLKALAHLHKNG-------IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred ccCHHHHHh---------cCCHHHHHHHHHHHHHHhhhhhccC-------ccccCCCccccccccccCCceEEechhHHH
Confidence 999988886 3667888999999999999999998 999999999999985 45578999999862
Q ss_pred cc-----------------C----------------c---------------ccccccccccCCCCCCC-CCCCcchhHH
Q 047954 427 VA-----------------Q----------------P---------------IAAQRMISYKSPEYQSS-KKISRKSDVW 457 (582)
Q Consensus 427 ~~-----------------~----------------~---------------~~~~~~~~y~aPE~~~~-~~~~~k~DVw 457 (582)
.. . + ....||+||+|||++.. ...++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 10 0 0 01236789999998865 4568899999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCccchHHHHH--------H-HHhhcc--cc------cc---------cc-hhhhh--
Q 047954 458 SFGCLLLELLTGRISTHSAPQGINGADLCSWVL--------R-AVREEW--TA------EI---------FD-SEISV-- 508 (582)
Q Consensus 458 S~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~--------~-~~~~~~--~~------~~---------~d-~~~~~-- 508 (582)
|.|||++-++++++||.......+ .+.+.+. + +...+. +. .+ ++ ..+..
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~--al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDAD--ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eccceeehhhccccccccCccccc--hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999976543221 1111110 0 000000 00 00 00 00000
Q ss_pred ----hh--chHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 509 ----QR--SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 509 ----~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.. ........+++++.+|++.||.+|.|++|.++|...-
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 00 0001123678999999999999999999999987654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-26 Score=210.00 Aligned_cols=247 Identities=23% Similarity=0.369 Sum_probs=187.1
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEec--CCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+|.+...|..|+|++.+.. +++|++. .......++|..|.-.|+-+.||||..++|.|....+..++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 46888999999999998766 4556653 34445567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
+..+++... ...+..+..++|.+||+|++|||+..+ -|.---|.+..|++|++.+++|+ .+-+++.-+..
T Consensus 275 ynvlhe~t~----vvvd~sqav~faldiargmaflhslep-----~ipr~~lns~hvmidedltaris-mad~kfsfqe~ 344 (448)
T KOG0195|consen 275 YNVLHEQTS----VVVDHSQAVRFALDIARGMAFLHSLEP-----MIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEV 344 (448)
T ss_pred HHHHhcCcc----EEEecchHHHHHHHHHhhHHHHhhcch-----hhhhhhcccceEEecchhhhhee-cccceeeeecc
Confidence 999998654 357888999999999999999999862 25555799999999999999874 22222222222
Q ss_pred cccccccccCCCCCCCCCC---CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 432 AAQRMISYKSPEYQSSKKI---SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 432 ~~~~~~~y~aPE~~~~~~~---~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
...-.+.||+||.+...+- -+++|+|||.+++||+.|+..||.+.++-.-+..+. . ++.... +
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia---l----eglrv~-i------ 410 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA---L----EGLRVH-I------ 410 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh---h----cccccc-C------
Confidence 3334578999998876543 357999999999999999999998655432222211 1 111111 1
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
++.... .+.+|+.-|+..||.+||.+..|+-.|++.+
T Consensus 411 ppgis~---hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 PPGISR---HMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCccH---HHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 112222 3556777899999999999999999888754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=206.73 Aligned_cols=153 Identities=18% Similarity=0.217 Sum_probs=118.6
Q ss_pred cccccccCceEEEEEEEc--CCceEEEEEecCC-----CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE--GRAPVVVKRLRDL-----KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||+||+|... ++..||||++... .....+.|.+|+++|.+++|+|+++.+.. .+..++||||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~ 99 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGW 99 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEc
Confidence 467999999999999864 5677899987532 12235678999999999999999863322 2467999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCC-CCCCeeecCCCceEEeecccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNL-KSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dl-kp~NILl~~~~~~kl~DfG~a 424 (582)
+++++|.. +. . .. ...++.++++||.|||+.+ |+|||| ||+|||++.++.+||+|||+|
T Consensus 100 ~~G~~L~~-~~---~------~~---~~~~~~~i~~aL~~lH~~g-------IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 100 TEGVPLHL-AR---P------HG---DPAWFRSAHRALRDLHRAG-------ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred cCCCCHHH-hC---c------cc---hHHHHHHHHHHHHHHHHCC-------CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 99999963 21 0 00 1357889999999999998 999999 999999999999999999999
Q ss_pred ccccCcc------------cccccccccCCCCCCCC
Q 047954 425 SLVAQPI------------AAQRMISYKSPEYQSSK 448 (582)
Q Consensus 425 ~~~~~~~------------~~~~~~~y~aPE~~~~~ 448 (582)
+.+.... ...+++.|+|||++...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 8664322 12345679999988654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-21 Score=198.48 Aligned_cols=253 Identities=18% Similarity=0.186 Sum_probs=185.6
Q ss_pred cccccccCceEEEEEEEcCC--ceEEEEEecCCCcchHHHHHHHHHHHhcCCC----CCccccceEE-EeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEGR--APVVVKRLRDLKPLITEEFRKQLLVIADQKH----PNLLPLLAYY-FSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H----~niv~l~~~~-~~~~~~~lv~e~ 345 (582)
...||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ......++||+.
T Consensus 23 ~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l 102 (322)
T KOG1164|consen 23 GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSL 102 (322)
T ss_pred eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEec
Confidence 46799999999999997654 4788887765433322367888888888863 6888888888 477788999998
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC-----CceEEee
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN-----EMVLVSD 420 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~-----~~~kl~D 420 (582)
+ |.+|.++...... ..++..+.+.|+.|++.+|++||+.+ ++||||||+|+++... ..+.|.|
T Consensus 103 ~-G~sL~dl~~~~~~----~~fs~~T~l~ia~q~l~~l~~lH~~G-------~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 103 L-GPSLEDLRKRNPP----GRFSRKTVLRIAIQNLNALEDLHSKG-------FIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred c-CccHHHHHHhCCC----CCcCHhHHHHHHHHHHHHHHHHHhcC-------cccCCcCHHHeeecCCCCcccceEEEEe
Confidence 7 7799998754431 25889999999999999999999998 9999999999999865 4589999
Q ss_pred ccccc--ccc-Cc-----------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchH
Q 047954 421 YGFSS--LVA-QP-----------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLC 486 (582)
Q Consensus 421 fG~a~--~~~-~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~ 486 (582)
||+++ ... .. ....||..|.++....+...+++.|+||++.++.|++.|..||........ .
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----~ 246 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----K 246 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----H
Confidence 99998 321 11 123378899999999999999999999999999999999999964332211 1
Q ss_pred HHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 487 SWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 487 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
..+........... ....... ++.++...+-..+..++|....+...++......
T Consensus 247 ~~~~~~~~~~~~~~-------~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDR-------FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHHhhhhcccc-------ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111111111100 0011112 3444444555589999999999999988776554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-21 Score=194.78 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=189.3
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcc---hHHHHHHHHHHHhcCCCC-CccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPL---ITEEFRKQLLVIADQKHP-NLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
...||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++++++......+++++|+.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 356899999999999987 67889988654322 367899999999999988 799999999777778999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC-ceEEeeccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE-MVLVSDYGFSSLV 427 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfG~a~~~ 427 (582)
+++.+++...... ..+.......++.|++.++.|+|..+ ++|||+||+||+++... .++++|||.++..
T Consensus 83 ~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~~-------~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 83 GSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSKG-------IIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred CcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhCC-------eeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 9999777643211 24778889999999999999999998 99999999999999988 7999999998755
Q ss_pred cCc----------ccccccccccCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 428 AQP----------IAAQRMISYKSPEYQSS---KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 428 ~~~----------~~~~~~~~y~aPE~~~~---~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
... ....++..|+|||.+.+ ..++...|+||+|++++++++|..||...... .........+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~ 228 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIIL 228 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHH
Confidence 432 23446788999999987 57899999999999999999999997543211 01111112111
Q ss_pred hcccc---cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHH
Q 047954 495 EEWTA---EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543 (582)
Q Consensus 495 ~~~~~---~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 543 (582)
..... ........ ......+.+++..|+..+|..|.++.+....
T Consensus 229 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 229 ELPTPSLASPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred hcCCcccccccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111 00000000 1112357788889999999999999988775
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-23 Score=223.41 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=180.6
Q ss_pred cccccccccCceEEEEEEEc-CCceEEEEEec----C-CCc-chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEE
Q 047954 271 APAEGLGKGIFGNSYKALLE-GRAPVVVKRLR----D-LKP-LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 271 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~-~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 343 (582)
....++|.|++|.|+.+... .....+.|..+ . ... .....+..|+.+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988877643 23334444332 1 111 11122556777788899999999988887777766679
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
|||++ ||+.++.... .+...++..+++|+..|++|+|+.+ |.|||+|++|++++.++.+||+|||.
T Consensus 401 E~~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~G-------iahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSMG-------LAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred hcccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhcC-------ceeccCccccEEEecCCceEEeecCc
Confidence 99999 9999997541 3667788889999999999999998 99999999999999999999999999
Q ss_pred cccccCcc--------cccccccccCCCCCCCCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 424 SSLVAQPI--------AAQRMISYKSPEYQSSKKISR-KSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 424 a~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~-k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
+.....+. ...|.-.|+|||++.+..|++ ..||||.||++..|++|+.||.......+.. .....
T Consensus 467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~ 540 (601)
T KOG0590|consen 467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNY 540 (601)
T ss_pred ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhcc
Confidence 86654332 233556799999999998865 5899999999999999999997654332111 00000
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
..+.. +..... .-......+...++.++++.||.+|.|+++|++.-|.
T Consensus 541 ~~~~~-~~~~~~---~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~ 588 (601)
T KOG0590|consen 541 SDQRN-IFEGPN---RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI 588 (601)
T ss_pred ccccc-cccChH---HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence 01110 111100 0111222345678889999999999999999987663
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-22 Score=205.15 Aligned_cols=215 Identities=22% Similarity=0.390 Sum_probs=166.3
Q ss_pred HhcCCCCCccccceEEEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCc
Q 047954 318 IADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSA 397 (582)
Q Consensus 318 l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ 397 (582)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.... ..++|.....+.++|+.||+|||+.. -
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~s~------i 69 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHNSP------I 69 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhcCc------c
Confidence 457899999999999999999999999999999999997633 35899999999999999999999864 1
Q ss_pred ceecCCCCCCeeecCCCceEEeeccccccccCc------ccccccccccCCCCCCCCC-------CCcchhHHHHHHHHH
Q 047954 398 VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP------IAAQRMISYKSPEYQSSKK-------ISRKSDVWSFGCLLL 464 (582)
Q Consensus 398 ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~-------~~~k~DVwS~Gvvl~ 464 (582)
..|+.+++.|+++|..+.+||+|||+....... .......-|.|||.+.... .+.++||||||++++
T Consensus 70 ~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ 149 (484)
T KOG1023|consen 70 GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMY 149 (484)
T ss_pred eeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHH
Confidence 399999999999999999999999998776421 1111224599999887631 467899999999999
Q ss_pred HHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 465 ELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 465 elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
|+++.+.||+.........++...+.. .....+.|.+.... +...++..++.+||..+|++||++++|-..+
T Consensus 150 ei~~r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~ 221 (484)
T KOG1023|consen 150 EILFRSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKL 221 (484)
T ss_pred HHHhccCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence 999999999865544333344444333 11222222222111 2223688899999999999999999999998
Q ss_pred hhcccCC
Q 047954 545 EIIKVTE 551 (582)
Q Consensus 545 ~~i~~~~ 551 (582)
+.+....
T Consensus 222 ~~~~~~~ 228 (484)
T KOG1023|consen 222 LTINKGG 228 (484)
T ss_pred hhhcccc
Confidence 8776543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=180.18 Aligned_cols=141 Identities=14% Similarity=0.135 Sum_probs=108.6
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcc--h------------------------HHHHHHHHHHHhcCCCCCcc
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPL--I------------------------TEEFRKQLLVIADQKHPNLL 327 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~H~niv 327 (582)
..||+|+||.||+|...+|+.||||+++..... . ......|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999888999999999653211 1 01223599999999888775
Q ss_pred ccceEEEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHH-hccCCCCCCCcceecCCCCC
Q 047954 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL-HHKDKSRTQSAVIHGNLKST 406 (582)
Q Consensus 328 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~~~~ivH~Dlkp~ 406 (582)
....+.. ...++||||++++++....... ..++......++.|++.+|.|+ |+.+ |+||||||+
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~------~~~~~~~~~~i~~qi~~~L~~l~H~~g-------iiHrDlkP~ 147 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD------APLSESKARELYLQVIQIMRILYQDCR-------LVHADLSEY 147 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHhCC-------cccCCCCHH
Confidence 4443322 2348999999988776543221 2478888999999999999999 6777 999999999
Q ss_pred CeeecCCCceEEeeccccccccCc
Q 047954 407 NILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 407 NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|||++ ++.++|+|||+|.....+
T Consensus 148 NIli~-~~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 148 NLLYH-DGKLYIIDVSQSVEHDHP 170 (190)
T ss_pred HEEEE-CCcEEEEEccccccCCCc
Confidence 99998 478999999999765443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.1e-21 Score=181.05 Aligned_cols=164 Identities=12% Similarity=0.122 Sum_probs=127.0
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHH---------HHHHHHHHhcCCCCCccccceEEEeC-------
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEE---------FRKQLLVIADQKHPNLLPLLAYYFSN------- 336 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~H~niv~l~~~~~~~------- 336 (582)
.+++|.|+||.||.+.. ++..+|||.++......... +.+|+..+.++.|++|..+..++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~ 114 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY 114 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence 46899999999999766 46679999997543322222 67899999999999999999886643
Q ss_pred -CeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc
Q 047954 337 -DEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM 415 (582)
Q Consensus 337 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~ 415 (582)
...++||||++|.+|.++.. ++. ....+++.+|..+|..+ ++|||+||+||+++.++
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~g-------i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQHG-------MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHcC-------CccCCCChHHEEEeCCC-
Confidence 35789999999999987732 222 24568999999999998 99999999999999988
Q ss_pred eEEeeccccccccCcccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHH
Q 047954 416 VLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELL 467 (582)
Q Consensus 416 ~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ell 467 (582)
++|+|||..+......... .+.....|+.++||||||+++.-..
T Consensus 173 i~liDfg~~~~~~e~~a~d--------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKD--------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhHH--------HHHHHhHhcccccccceeEeehHHH
Confidence 9999999876653322111 1333445678999999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=212.41 Aligned_cols=242 Identities=24% Similarity=0.321 Sum_probs=176.7
Q ss_pred ccccccccCceEEEEEEEcCCceEEEEEecCCC-cchHHHHHHHHHH--HhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLK-PLITEEFRKQLLV--IADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
..+.||++.|=+|.+|+.+.|. |+||++.+.. ....+.|.++++- ....+|||++++.-........|||=+|..+
T Consensus 27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh 105 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH 105 (1431)
T ss_pred eecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh
Confidence 4567999999999999998888 8899886544 3345556555443 4446999999998877777777888899866
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc-
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV- 427 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~- 427 (582)
+|+|.+.. +..+...+.+-|+.|++.||.-+|..+ |+|+|||.+||||+.-.-+.|+||..-+..
T Consensus 106 -nLyDRlST------RPFL~~iEKkWiaFQLL~al~qcH~~g-------VcHGDIKsENILiTSWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 106 -NLYDRLST------RPFLVLIEKKWIAFQLLKALSQCHKLG-------VCHGDIKSENILITSWNWLYLTDFASFKPTY 171 (1431)
T ss_pred -hhhhhhcc------chHHHHHHHHHHHHHHHHHHHHHHHcC-------ccccccccceEEEeeechhhhhcccccCCcc
Confidence 99999863 335777888889999999999999998 999999999999999888999999765432
Q ss_pred -cCcc---------cccccccccCCCCCCCC----------C-CCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccch
Q 047954 428 -AQPI---------AAQRMISYKSPEYQSSK----------K-ISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADL 485 (582)
Q Consensus 428 -~~~~---------~~~~~~~y~aPE~~~~~----------~-~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~ 485 (582)
..+. .......|.|||.+... . .+++.||||+||++.||++ |++||.- .++
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL 244 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQL 244 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHH
Confidence 1111 11223469999976431 2 5789999999999999999 6888842 111
Q ss_pred HHHHHH--HHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 486 CSWVLR--AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 486 ~~~~~~--~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
..+-.. ...+..+.++-|. .+.++++.|++.||++|.++++.++.-..+.
T Consensus 245 ~aYr~~~~~~~e~~Le~Ied~-------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 245 LAYRSGNADDPEQLLEKIEDV-------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred HhHhccCccCHHHHHHhCcCc-------------cHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 111000 0000001111111 4778999999999999999999998865554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=173.14 Aligned_cols=139 Identities=15% Similarity=0.178 Sum_probs=110.1
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcc--------------------------hHHHHHHHHHHHhcCCCCCcc
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPL--------------------------ITEEFRKQLLVIADQKHPNLL 327 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~H~niv 327 (582)
..||+|+||.||+|...+|+.||||+++..... ....+..|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 569999999999999878999999998754211 012346789999999999885
Q ss_pred ccceEEEeCCeeEEEEEeCCCCChHHH-HhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhc-cCCCCCCCcceecCCCC
Q 047954 328 PLLAYYFSNDEKLLVYKFAGNGNLFNR-IHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH-KDKSRTQSAVIHGNLKS 405 (582)
Q Consensus 328 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~ivH~Dlkp 405 (582)
....+... ..++||||++++++... +.. ..++......++.|++.++.|+|+ .+ |+||||||
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~g-------ivHrDlkP 146 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQEAG-------LVHGDLSE 146 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHhCC-------EecCCCCh
Confidence 55444333 34899999998865443 321 136677889999999999999999 87 99999999
Q ss_pred CCeeecCCCceEEeeccccccccC
Q 047954 406 TNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 406 ~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|||++ ++.++|+|||+++.+..
T Consensus 147 ~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 147 YNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhEEEE-CCCEEEEEcccceecCC
Confidence 999999 78999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=173.92 Aligned_cols=190 Identities=18% Similarity=0.294 Sum_probs=157.8
Q ss_pred ccccccccCceEEEEEE-EcCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 272 PAEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.+||+|+||..+.|+ +-++++||||.-... ...-.+..|.+..+.| ..+.|..+|-|-..+.+..||+|.+ |.
T Consensus 32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred eccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 46889999999999998 678899999986432 2234566777777776 4588888887777777889999988 77
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC-----ceEEeecccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE-----MVLVSDYGFS 424 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~-----~~kl~DfG~a 424 (582)
+|+|+..-... .++..++..||+|++.-++|+|++. +|.|||||+|+||...+ .+.|+|||+|
T Consensus 109 SLEDLFD~CgR-----~FSvKTV~miA~Qmi~rie~vH~k~-------LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 109 SLEDLFDLCGR-----RFSVKTVAMIAKQMITRIEYVHEKD-------LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred CHHHHHHHhcC-----cccHHhHHHHHHHHHHHHHHHHhcc-------eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 99887753332 4899999999999999999999998 99999999999997433 4889999999
Q ss_pred ccccCcc-----------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 047954 425 SLVAQPI-----------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSA 476 (582)
Q Consensus 425 ~~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~ 476 (582)
+.+.++. ...||..||+--.-.+..-+.+.|.=|+|-+++..+-|..||...
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 9876543 334788899999888888999999999999999999999999754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9e-20 Score=167.15 Aligned_cols=190 Identities=18% Similarity=0.264 Sum_probs=153.8
Q ss_pred cccccccCceEEEEEE-EcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCC-CCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKH-PNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.+|.|. ..+|..||||.-.... ....+..|..+...++| ..|..+..|..+.....+||+.+ |.+
T Consensus 20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPs 96 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPS 96 (341)
T ss_pred EEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Ccc
Confidence 3679999999999998 6789999999875432 22346678888888876 56666777777888899999988 889
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC---CceEEeeccccccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN---EMVLVSDYGFSSLV 427 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DfG~a~~~ 427 (582)
|+++..-... .++..+.+.+|-|++.-++|+|.++ +|||||||+|.|..-+ ..+.++|||+|+.+
T Consensus 97 LEdLfnfC~R-----~ftmkTvLMLaDQml~RiEyvH~r~-------fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 97 LEDLFNFCSR-----RFTMKTVLMLADQMLSRIEYVHLRN-------FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred HHHHHHHHhh-----hhhHHhHHHHHHHHHHHHHHHHhhc-------cccccCCccceeeccccccceEEEEeccchhhh
Confidence 9998764332 4889999999999999999999998 9999999999998643 45889999999876
Q ss_pred cCc-----------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 047954 428 AQP-----------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP 477 (582)
Q Consensus 428 ~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~ 477 (582)
.+. ....||..|.+--...+-.-+...|+=|+|.+|...--|..||+...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 432 23346778887776666667889999999999999999999997643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-19 Score=166.95 Aligned_cols=181 Identities=19% Similarity=0.196 Sum_probs=133.1
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcc----hHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPL----ITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
...|++|+||+||.+.. ++.+++.+.+.....- ....+.+|+++|+++. |+++++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999997766 6667777777543321 1225889999999995 4889999886 45699999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCC-CCCCeeecCCCceEEeecccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNL-KSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dl-kp~NILl~~~~~~kl~DfG~a~~ 426 (582)
|.+|...+.. ....++.|++.+|.++|+.+ |+|||| ||+|||++.++.++|+|||+|..
T Consensus 82 G~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~~G-------IvHrDL~kp~NILv~~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 82 GAAMYQRPPR-------------GDLAYFRAARRLLQQLHRCG-------VAHNDLAKEANWLVQEDGSPAVIDFQLAVR 141 (218)
T ss_pred CccHHhhhhh-------------hhHHHHHHHHHHHHHHHHCc-------CccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence 9888654321 11346789999999999998 999999 79999999999999999999986
Q ss_pred ccCcccc-----------------cccccccCCCCCCC-CCCC-cchhHHHHHHHHHHHHhCCCCCCCCCC
Q 047954 427 VAQPIAA-----------------QRMISYKSPEYQSS-KKIS-RKSDVWSFGCLLLELLTGRISTHSAPQ 478 (582)
Q Consensus 427 ~~~~~~~-----------------~~~~~y~aPE~~~~-~~~~-~k~DVwS~Gvvl~elltG~~P~~~~~~ 478 (582)
....... ..++.|++|+...- ...+ ...+.++-|.-+|.++||+.+..+..+
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 5432210 01234555543211 1222 456888999999999999998765543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.1e-21 Score=198.21 Aligned_cols=224 Identities=22% Similarity=0.317 Sum_probs=172.7
Q ss_pred ccccCceEEEEEE----EcCCceEEEEEecCCCc--chHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEEeCCC
Q 047954 276 LGKGIFGNSYKAL----LEGRAPVVVKRLRDLKP--LITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 276 lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+|+|+||.|+.+. ...+..+|.|.+++... ........|..++...+ ||.+|++.-.++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999875 33456678887754321 11224556777888886 99999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|...+.... .++......+...+|-|++++|..+ |+|||+|++||+++.+|.+++.|||+++..-
T Consensus 82 g~lft~l~~~~------~f~~~~~~~~~aelaLald~lh~l~-------iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 82 GDLFTRLSKEV------MFDELDVAFYLAELALALDHLHKLG-------IAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred chhhhccccCC------chHHHHHHHHHHHHHHHHhhcchhH-------HHHhcccccceeecccCccccCCchhhhHhH
Confidence 99998886432 4666667777788999999999998 9999999999999999999999999999876
Q ss_pred CcccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 429 QPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 429 ~~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
......|+..|||||.+. .....+|.||||++++||+||-.||.. ++...+ ...+.
T Consensus 149 ~~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------~~~~~I---l~~~~----------- 204 (612)
T KOG0603|consen 149 KEKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------DTMKRI---LKAEL----------- 204 (612)
T ss_pred hhhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------HHHHHH---hhhcc-----------
Confidence 666668899999999987 567889999999999999999999953 222222 11110
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCCh
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEM 537 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 537 (582)
..+.+....+.+++..++..+|..|--.
T Consensus 205 -~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 -EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 0111222245566667777888888654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.4e-19 Score=167.32 Aligned_cols=134 Identities=17% Similarity=0.154 Sum_probs=104.7
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcC-----CCCCccccceEEEeCC---eeE-EEE
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-----KHPNLLPLLAYYFSND---EKL-LVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~~~~~~~~---~~~-lv~ 343 (582)
.+.||+|+||.||. .......+||++........+.+.+|+.+++++ .||||++++|++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 46899999999996 433344578988655444567899999999999 6799999999998874 333 789
Q ss_pred Ee--CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHH-HHHhccCCCCCCCcceecCCCCCCeeecC----CCce
Q 047954 344 KF--AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARAL-EYLHHKDKSRTQSAVIHGNLKSTNILLDD----NEMV 416 (582)
Q Consensus 344 e~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~~~~~ivH~Dlkp~NILl~~----~~~~ 416 (582)
|| +.+|+|.+++.... ++.. ..++.+++.++ +|||+++ ||||||||+|||++. +..+
T Consensus 85 e~~G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh~~~-------IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 85 DFDGKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLLDNR-------IVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred cCCCCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHHHCC-------EeecCCCHHHEEEeccCCCCCcE
Confidence 99 55799999996431 3333 35677888888 9999998 999999999999974 3479
Q ss_pred EEeecccc
Q 047954 417 LVSDYGFS 424 (582)
Q Consensus 417 kl~DfG~a 424 (582)
+|+||+.+
T Consensus 149 ~LiDg~G~ 156 (210)
T PRK10345 149 VVCDNIGE 156 (210)
T ss_pred EEEECCCC
Confidence 99995443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3e-19 Score=196.81 Aligned_cols=131 Identities=34% Similarity=0.564 Sum_probs=104.8
Q ss_pred CcceeeeCCC----CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCccccc
Q 047954 10 QWYGIQCDIN----SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGE 84 (582)
Q Consensus 10 ~w~gv~c~~~----~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ 84 (582)
.|.||.|+.+ ...|+.|+|++|+|+|.+|.+ ++.|++|+.|+|++|.|+|.+| .++.+++|+.|||++|+|+|.
T Consensus 403 ~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~-i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~ 481 (623)
T PLN03150 403 PWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPND-ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481 (623)
T ss_pred ccccceeeccCCCCceEEEEEECCCCCccccCCHH-HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCC
Confidence 6999999532 135899999999999999864 8899999999999999999988 578889999999999999999
Q ss_pred ccccccCCCcCCeeecccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCCCCCCCCCCCCCC
Q 047954 85 ISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCS 161 (582)
Q Consensus 85 ip~~~~~l~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l~~~~~~~~~~ 161 (582)
+|.++++|++|+.|+|++|+|+|.+|.... .+ +..+..+++.+|+.+|+.|....|.
T Consensus 482 iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~-~~-------------------~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG-GR-------------------LLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred CchHHhcCCCCCEEECcCCcccccCChHHh-hc-------------------cccCceEEecCCccccCCCCCCCCc
Confidence 999999999999999999999998887411 00 0112335677888899877666664
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.7e-19 Score=171.34 Aligned_cols=228 Identities=20% Similarity=0.279 Sum_probs=143.6
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCC---cchHHHHHHHHHHHhcCCC-----------CCccccceEEE---
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLK---PLITEEFRKQLLVIADQKH-----------PNLLPLLAYYF--- 334 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H-----------~niv~l~~~~~--- 334 (582)
.+.||.|+++.||.++..+ ++.+|+|+..... ....+.+++|.-....+.+ .-++++ +...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~i~~ 95 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLRIPG 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEEETT
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEEEcC
Confidence 4679999999999999765 7889999885322 2234566666655444332 222222 2221
Q ss_pred ------eCC--------eeEEEEEeCCCCChHHHHhc---CCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCc
Q 047954 335 ------SND--------EKLLVYKFAGNGNLFNRIHG---GKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSA 397 (582)
Q Consensus 335 ------~~~--------~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ 397 (582)
... ..+++|+-+ .+||.+++.. .... ...+....++.+..|+++.+++||+.+
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~G------- 165 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSYG------- 165 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHTT-------
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhcc-------
Confidence 111 236788877 5588877542 2111 223556667888899999999999998
Q ss_pred ceecCCCCCCeeecCCCceEEeeccccccccCccc-ccccccccCCCCCCC--------CCCCcchhHHHHHHHHHHHHh
Q 047954 398 VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA-AQRMISYKSPEYQSS--------KKISRKSDVWSFGCLLLELLT 468 (582)
Q Consensus 398 ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~~-~~~~~~y~aPE~~~~--------~~~~~k~DVwS~Gvvl~ellt 468 (582)
+||+||||+|++++.+|.++|+||+.......... ...+..|.+||.... -.++.+.|.|++|+++|.|.+
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999999987655544332 233466889986533 247889999999999999999
Q ss_pred CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCC
Q 047954 469 GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKR 534 (582)
Q Consensus 469 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 534 (582)
|+.||........... ....+. +....+..|+..+|+.+|++|
T Consensus 246 ~~lPf~~~~~~~~~~~----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999975432211110 011122 333467788899999999988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.7e-17 Score=157.60 Aligned_cols=134 Identities=17% Similarity=0.316 Sum_probs=112.3
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcc--------hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPL--------ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
+.||+|++|.||+|.. .+..|++|+....... ....+.+|+.++..+.|++|.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 5566888876532211 124578899999999999998888888788888999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++++|.+++... .. .+..++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||.++
T Consensus 81 ~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~~~-------i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 81 IEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHSAG-------IIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred eCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHhCC-------cccCCCCcccEEEE-CCCEEEEECCccc
Confidence 9999999988532 12 77889999999999999998 99999999999999 7889999999876
Q ss_pred c
Q 047954 426 L 426 (582)
Q Consensus 426 ~ 426 (582)
.
T Consensus 143 ~ 143 (211)
T PRK14879 143 F 143 (211)
T ss_pred C
Confidence 4
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=163.74 Aligned_cols=192 Identities=22% Similarity=0.280 Sum_probs=133.5
Q ss_pred CCCCccccceEEEeC---------------------------CeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHH
Q 047954 322 KHPNLLPLLAYYFSN---------------------------DEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLL 374 (582)
Q Consensus 322 ~H~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~ 374 (582)
+|||||++.++|.+. ...|+||.-++. +|++++-... .+...+.-
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-------~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-------RSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-------CchHHHHH
Confidence 799999999988641 246899988755 9999886432 44556677
Q ss_pred HHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec--CCCc--eEEeeccccccccC----------ccccccccccc
Q 047954 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD--DNEM--VLVSDYGFSSLVAQ----------PIAAQRMISYK 440 (582)
Q Consensus 375 i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~--~~~~--~kl~DfG~a~~~~~----------~~~~~~~~~y~ 440 (582)
|..|+++|+.|||.++ |.|||+|++|||+. +|.. ..|+|||++---+. .....|.-.-|
T Consensus 346 ~laQlLEav~hL~~hg-------vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm 418 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHG-------VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM 418 (598)
T ss_pred HHHHHHHHHHHHHHcc-------chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence 8889999999999998 99999999999984 4443 67899998632111 11223445689
Q ss_pred CCCCCCCCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHH
Q 047954 441 SPEYQSSKK------ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAH 514 (582)
Q Consensus 441 aPE~~~~~~------~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 514 (582)
|||+....+ --.|+|.|+.|.+.||+++...||+..-+ --.+. +.+++...+.+.+.
T Consensus 419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~-----r~Yqe~qLPalp~~---------- 481 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDT-----RTYQESQLPALPSR---------- 481 (598)
T ss_pred chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heech-----hhhhhhhCCCCccc----------
Confidence 999875432 13589999999999999999999975211 11111 11222222222221
Q ss_pred HHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 515 GMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 515 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
....+.+++...++.||++|++..-....|.
T Consensus 482 vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 482 VPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred CChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 1124667888899999999999877666554
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-17 Score=155.98 Aligned_cols=131 Identities=19% Similarity=0.309 Sum_probs=106.9
Q ss_pred cccccCceEEEEEEEcCCceEEEEEecCCCc--------chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 275 GLGKGIFGNSYKALLEGRAPVVVKRLRDLKP--------LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.||+|+||.||+|.+ ++..|++|+...... ...+.+.+|++++.+++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 456788988643211 11255778999999999988776666667777789999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~-------~------~~~~~i~~~l~~lH~~g-------i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-------D------ELLREIGRLVGKLHKAG-------IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-------H------HHHHHHHHHHHHHHHCC-------eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875321 0 68899999999999998 99999999999999 78999999998865
Q ss_pred c
Q 047954 427 V 427 (582)
Q Consensus 427 ~ 427 (582)
.
T Consensus 139 ~ 139 (199)
T TIGR03724 139 S 139 (199)
T ss_pred C
Confidence 3
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-17 Score=158.25 Aligned_cols=140 Identities=18% Similarity=0.191 Sum_probs=106.2
Q ss_pred cccccccCceEEEEEE--EcCCceEEEEEecCCCcc------------------------hHHHHHHHHHHHhcCCCCC-
Q 047954 273 AEGLGKGIFGNSYKAL--LEGRAPVVVKRLRDLKPL------------------------ITEEFRKQLLVIADQKHPN- 325 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~H~n- 325 (582)
.+.||+|+||.||+|. ..+++.||+|.++..... ....+..|+..+.++.+..
T Consensus 33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i 112 (237)
T smart00090 33 GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGV 112 (237)
T ss_pred CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4679999999999998 568899999998643210 1123568999999997532
Q ss_pred -ccccceEEEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCC
Q 047954 326 -LLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLK 404 (582)
Q Consensus 326 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlk 404 (582)
+.+++++ ...++||||+++++|....... ..+.......++.||+.+|.|||+.+ .|+|||||
T Consensus 113 ~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~g------~iiH~Dik 176 (237)
T smart00090 113 PVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD------VEPEEEEEFELYDDILEEMRKLYKEG------ELVHGDLS 176 (237)
T ss_pred CCCeeeEe----cCceEEEEEecCCccccccccc------CCcchHHHHHHHHHHHHHHHHHHhcC------CEEeCCCC
Confidence 3333332 2358999999998887654221 13445566789999999999999886 39999999
Q ss_pred CCCeeecCCCceEEeeccccccccC
Q 047954 405 STNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 405 p~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
|+||+++ ++.++|+|||.+.....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccCC
Confidence 9999999 88999999999876544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.4e-17 Score=184.59 Aligned_cols=184 Identities=21% Similarity=0.320 Sum_probs=144.8
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCC---CCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK---HPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
...||+|+||+||+|...+++.||+|+-+....- +|--=.+++.||+ -+-|..+...+...+.-++|+||.+.|
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~G 779 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYG 779 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccc
Confidence 4679999999999999888999999998654321 1111123344444 234555556666677889999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec-------CCCceEEeecc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD-------DNEMVLVSDYG 422 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~-------~~~~~kl~DfG 422 (582)
+|.+++... ..++|...+.++.|+++-+++||..+ |||+||||+|.||. +...++|+|||
T Consensus 780 tlld~~N~~------~~m~e~lv~~~~~qml~ive~lH~~~-------IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 780 TLLDLINTN------KVMDEYLVMFFSCQMLRIVEHLHAMG-------IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred cHHHhhccC------CCCCchhhhHHHHHHHHHHHHHHhcc-------eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 999999732 25889999999999999999999998 99999999999994 23458999999
Q ss_pred cccccc---Cc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 047954 423 FSSLVA---QP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRIS 472 (582)
Q Consensus 423 ~a~~~~---~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P 472 (582)
.|-.+. +. ....+|-.+--+|+..+..++..+|-|.+.-+++-|+.|++-
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 985542 22 123355678889999999999999999999999999999754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.3e-17 Score=177.08 Aligned_cols=133 Identities=21% Similarity=0.397 Sum_probs=109.3
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCC-Cc------chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDL-KP------LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|.+.+...++.+++... .. ...+.+.+|++++.+++|++++....++......++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 5789999999999999876654433333221 11 1235688999999999999999888888887788999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 418 ~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~g-------iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 418 IGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKAG-------IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred cCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhCC-------CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 99999998874 34668999999999999998 9999999999999 57889999999987
Q ss_pred cc
Q 047954 426 LV 427 (582)
Q Consensus 426 ~~ 427 (582)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 54
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=150.65 Aligned_cols=134 Identities=18% Similarity=0.200 Sum_probs=104.8
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcc----------------------hHHHHHHHHHHHhcCCCCC--ccc
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPL----------------------ITEEFRKQLLVIADQKHPN--LLP 328 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~H~n--iv~ 328 (582)
.+.||+|+||.||++...+++.||||+++..... ....+..|+.++.++.|++ +.+
T Consensus 20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~ 99 (198)
T cd05144 20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPK 99 (198)
T ss_pred CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCc
Confidence 4779999999999999888999999987532210 1123667888898888874 444
Q ss_pred cceEEEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCe
Q 047954 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNI 408 (582)
Q Consensus 329 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NI 408 (582)
.++ ....++||||+++++|...... .....++.+++.++.++|+.+ |+||||||+||
T Consensus 100 ~~~----~~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~g-------i~H~Dl~p~Ni 156 (198)
T cd05144 100 PID----WNRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKHG-------IIHGDLSEFNI 156 (198)
T ss_pred eee----cCCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHCC-------CCcCCCCcccE
Confidence 433 3456899999999998765320 234568899999999999988 99999999999
Q ss_pred eecCCCceEEeeccccccccC
Q 047954 409 LLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 409 Ll~~~~~~kl~DfG~a~~~~~ 429 (582)
++++++.++|+|||.+.....
T Consensus 157 ll~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEcCCCcEEEEECCccccCCC
Confidence 999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.7e-17 Score=165.85 Aligned_cols=172 Identities=23% Similarity=0.339 Sum_probs=125.6
Q ss_pred eeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceE
Q 047954 338 EKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL 417 (582)
Q Consensus 338 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~k 417 (582)
..++.|++|...+|.+|+.+.... ..-++...+.++.|++.|++| ++ .+|||+||.||+...+..+|
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~---e~~s~s~~~~~~~q~~~~~~y---k~-------~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG---EERSLSLMLDIFKQIAPAVEY---KG-------LIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc---cccchhHHHHHHHhhccchhh---cc-------chhhhccccccccccchhhh
Confidence 468999999999999999755432 346778889999999999999 65 89999999999999999999
Q ss_pred EeeccccccccCcc----------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchH
Q 047954 418 VSDYGFSSLVAQPI----------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLC 486 (582)
Q Consensus 418 l~DfG~a~~~~~~~----------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~ 486 (582)
|.|||+........ ...+|..||+||.+.++.|+.|+||||+|++|+|+++ =..+++. .
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~ 466 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------I 466 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------H
Confidence 99999976654332 2346788999999999999999999999999999997 2222210 0
Q ss_pred HHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHH
Q 047954 487 SWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543 (582)
Q Consensus 487 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 543 (582)
. ...-++.+ ++++..... -.+=..++.+++...|.+||++.++.-+
T Consensus 467 ~-t~~d~r~g----~ip~~~~~d------~p~e~~ll~~lls~~p~~RP~~~~~~~~ 512 (516)
T KOG1033|consen 467 A-TLTDIRDG----IIPPEFLQD------YPEEYTLLQQLLSPSPEERPSAIEVALH 512 (516)
T ss_pred H-hhhhhhcC----CCChHHhhc------CcHHHHHHHHhcCCCcccCchHHHHhhh
Confidence 0 01111111 222211111 0123467789999999999966655433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.2e-17 Score=174.65 Aligned_cols=198 Identities=20% Similarity=0.331 Sum_probs=132.6
Q ss_pred ccccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 272 PAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
+.+.|..|+||.||.++++ ..+++|+ ++.+.+- +.+- ++.....|.+| ||
T Consensus 87 ~IklisngAygavylvrh~~trqrfa~-kiNkq~l-----ilRn--ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-----ILRN--ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred eeEeeccCCCCceeeeeccccccchhh-cccccch-----hhhc--cccccCCccee---------------------ch
Confidence 4567999999999999865 3566777 3332211 0000 23333344333 44
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC-
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ- 429 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~- 429 (582)
-...++.-. +++. +++.+++|||+.+ |||||+||+|.+|+.-|.+|++|||+++....
T Consensus 138 c~tllk~~g------~lPv--------dmvla~Eylh~yg-------ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 138 CATLLKNIG------PLPV--------DMVLAVEYLHSYG-------IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred hhhhcccCC------CCcc--------hhhHHhHhhccCC-------eecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 444443221 2221 2378999999998 99999999999999999999999999865311
Q ss_pred ------------------cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHH
Q 047954 430 ------------------PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLR 491 (582)
Q Consensus 430 ------------------~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 491 (582)
+....+|+.|+|||++..+.|+..+|.|++|+|+||.+.|..||..... .++...+..
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp----eelfg~vis 272 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP----EELFGQVIS 272 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH----HHHHhhhhh
Confidence 1234678999999999999999999999999999999999999975432 223322221
Q ss_pred HHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCC
Q 047954 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP 535 (582)
Q Consensus 492 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 535 (582)
.. -.|..+ |. ....++.+++.+.|+.+|..|-
T Consensus 273 d~-i~wpE~--de---------a~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 DD-IEWPEE--DE---------ALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hh-cccccc--Cc---------CCCHHHHHHHHHHHHhChHhhc
Confidence 11 112221 11 1122566777788889999994
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.7e-16 Score=137.90 Aligned_cols=134 Identities=18% Similarity=0.189 Sum_probs=111.1
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCC--CCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKH--PNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++.++++++...+..+++|||+.++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 468999999999999866 6789998865433 5678899999999977 5899999888887889999999988766
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
..+ +......++.+++++|++||... ..+++|+|++|+||++++.+.+++.|||.++..
T Consensus 81 ~~~-------------~~~~~~~~~~~~~~~l~~lh~~~----~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV-------------SEEEKEDIAEQLAELLAKLHQLP----LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC-------------CHHHHHHHHHHHHHHHHHHhCCC----ceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 533 34556778899999999999853 124999999999999999899999999988654
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.9e-16 Score=181.69 Aligned_cols=142 Identities=32% Similarity=0.543 Sum_probs=96.0
Q ss_pred CCCCcceeeeCCCCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC--CCCCCCCCEEeCCCCccc--
Q 047954 7 FPSQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN--FSSNHKLKDIDLSGNKFY-- 82 (582)
Q Consensus 7 ~~~~w~gv~c~~~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~--~~~~~~l~~l~l~~N~l~-- 82 (582)
..|.|.||+|+ +.++|+.|+|++|+++|.+|+ .+..+++|+.|+|++|.++|.+|. +..+.+|++|+|++|+++
T Consensus 56 ~~c~w~gv~c~-~~~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~ 133 (968)
T PLN00113 56 DVCLWQGITCN-NSSRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133 (968)
T ss_pred CCCcCcceecC-CCCcEEEEEecCCCccccCCh-HHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccc
Confidence 46899999997 357899999999999998865 477888888888888888887763 224555555555555555
Q ss_pred --------------------ccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-Ccccc
Q 047954 83 --------------------GEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQL 139 (582)
Q Consensus 83 --------------------g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~ 139 (582)
|.+|..++++++|++|+|++|.++|.+|.. .+++|++|+|++|+++|.+|.. ..+..
T Consensus 134 ~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 213 (968)
T PLN00113 134 IPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKS 213 (968)
T ss_pred cCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCC
Confidence 455555566666666666666666666653 4566666666666666666643 33455
Q ss_pred cccccccCCCC
Q 047954 140 FRSYSYSNNPY 150 (582)
Q Consensus 140 ~~~~~~~~n~~ 150 (582)
+..+++++|..
T Consensus 214 L~~L~L~~n~l 224 (968)
T PLN00113 214 LKWIYLGYNNL 224 (968)
T ss_pred ccEEECcCCcc
Confidence 55666666643
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-15 Score=140.53 Aligned_cols=137 Identities=18% Similarity=0.229 Sum_probs=96.8
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcch--HHH----------------------HHHHHHHHhcCCCCC--cc
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLI--TEE----------------------FRKQLLVIADQKHPN--LL 327 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~H~n--iv 327 (582)
+.||+|+||.||+|...+++.||||+++...... ... ...|...+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 5699999999999998889999999886432111 111 134555555554432 33
Q ss_pred ccceEEEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhc-cCCCCCCCcceecCCCCC
Q 047954 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH-KDKSRTQSAVIHGNLKST 406 (582)
Q Consensus 328 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~ivH~Dlkp~ 406 (582)
+.+++ ...++||||++++++........ ... .....++.+++.++.++|. .+ |+||||||+
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~~~~-------ivH~Dl~p~ 144 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYREAG-------LVHGDLSEY 144 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhhccC-------cCcCCCChh
Confidence 33332 24689999999965432111100 011 4567899999999999999 76 999999999
Q ss_pred CeeecCCCceEEeeccccccccC
Q 047954 407 NILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 407 NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
||+++ ++.++|+|||.+.....
T Consensus 145 Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 145 NILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred hEEEE-CCcEEEEECcccccccC
Confidence 99999 89999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-14 Score=140.97 Aligned_cols=138 Identities=16% Similarity=0.178 Sum_probs=105.5
Q ss_pred ccccccc-ccCceEEEEEEEcCCceEEEEEecCCC-------------cchHHHHHHHHHHHhcCCCCCc--cccceEEE
Q 047954 271 APAEGLG-KGIFGNSYKALLEGRAPVVVKRLRDLK-------------PLITEEFRKQLLVIADQKHPNL--LPLLAYYF 334 (582)
Q Consensus 271 ~~~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~ 334 (582)
..+..|| .|+.|+||.+... +..++||...... ......+.+|++++.+++|++| ++.+++..
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 3456798 8999999999876 5568888774211 1223467889999999998875 66777654
Q ss_pred eCC----eeEEEEEeCCC-CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCee
Q 047954 335 SND----EKLLVYKFAGN-GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNIL 409 (582)
Q Consensus 335 ~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NIL 409 (582)
... ..++||||+++ .+|.+++... .++.. .+.+|+.+|.+||+.+ |+||||||.|||
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~G-------I~HrDlkp~NIL 174 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDAG-------VYHADLNAHNIL 174 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHCC-------CCCCCCCchhEE
Confidence 432 23599999997 6898887532 23322 3568999999999998 999999999999
Q ss_pred ecCCCceEEeeccccccc
Q 047954 410 LDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 410 l~~~~~~kl~DfG~a~~~ 427 (582)
++.++.++|+|||.+...
T Consensus 175 v~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 175 LDPDGKFWLIDFDRGELR 192 (239)
T ss_pred EcCCCCEEEEECCCcccC
Confidence 999889999999988653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.9e-16 Score=169.85 Aligned_cols=249 Identities=21% Similarity=0.270 Sum_probs=180.8
Q ss_pred ccccccCceEEEEEEEcCC--ceEEEEEecCCC--cchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLEGR--APVVVKRLRDLK--PLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
..||+|+|+.|-....... ..+|+|.+.... ....+....|..+-..+. |+|++.+++.....+..+++++|..+
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 3489999999988875433 345555553322 223344455777777776 99999999999999999999999999
Q ss_pred CChHHHH-hcCCCCCCCCccchHHHHHHHHHHHHHHHHHh-ccCCCCCCCcceecCCCCCCeeecCCC-ceEEeeccccc
Q 047954 349 GNLFNRI-HGGKSSKNRIPFRCRSRLLVARGVARALEYLH-HKDKSRTQSAVIHGNLKSTNILLDDNE-MVLVSDYGFSS 425 (582)
Q Consensus 349 gsL~~~l-~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfG~a~ 425 (582)
+++.+.+ +... ...+......+..|+..|+.|+| ..+ +.|||+||+|.+++..+ ..+++|||+|.
T Consensus 106 ~~~f~~i~~~~~-----~~~~~~~~~~~~~ql~s~l~~~H~~~~-------~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 106 GSLFSKISHPDS-----TGTSSSSASRYLPQLNSGLSYLHPENG-------VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccccccccCCc-----cCCCCcchhhhhhhhccCccccCcccc-------cccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999888 3221 13555667778999999999999 766 99999999999999999 99999999998
Q ss_pred cccC-cc------cccc-cccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 426 LVAQ-PI------AAQR-MISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 426 ~~~~-~~------~~~~-~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
.+.. .. ...+ ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... .....|......
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~~-- 249 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNKGR-- 249 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeecccccc--
Confidence 7755 21 2235 7889999998874 45788999999999999999999997654321 111222211100
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.... ....-.....+++.+++..+|..|.+.+++...-+...
T Consensus 250 -~~~~---------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 250 -FTQL---------PWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -cccC---------ccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0000 00111124667777899899999999999987777665
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.3e-14 Score=136.50 Aligned_cols=203 Identities=17% Similarity=0.301 Sum_probs=141.3
Q ss_pred HHHHhcCCCCCccccceEEEeCC-----eeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc
Q 047954 315 LLVIADQKHPNLLPLLAYYFSND-----EKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389 (582)
Q Consensus 315 ~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 389 (582)
+.-+-++.|-|||+++.|+.+.. +..++.|||..|++..+|++.+. ....+......+++-||..||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--NQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--hhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 34556678999999999987643 46899999999999999987543 233566677788999999999999997
Q ss_pred CCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc---------CcccccccccccCCCCCCCCCCCcchhHHHHH
Q 047954 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA---------QPIAAQRMISYKSPEYQSSKKISRKSDVWSFG 460 (582)
Q Consensus 390 ~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~G 460 (582)
. |+|+|+++..+-|++..++-+|+.- +-..... ......+.++|.|||+-.....+..+|||+||
T Consensus 196 ~-----PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fg 269 (458)
T KOG1266|consen 196 D-----PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFG 269 (458)
T ss_pred C-----CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhh
Confidence 6 5699999999999999998888731 1111110 01112245789999998888888999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHH
Q 047954 461 CLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540 (582)
Q Consensus 461 vvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 540 (582)
...+||..+..--.... ........+.+.+.. .. +. .-..++..|++.+|..||+|+++
T Consensus 270 mcAlemailEiq~tnse---S~~~~ee~ia~~i~~--le---n~-------------lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 270 MCALEMAILEIQSTNSE---SKVEVEENIANVIIG--LE---NG-------------LQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred HHHHHHHHheeccCCCc---ceeehhhhhhhheee--cc---Cc-------------cccCcCcccccCCCCCCcchhhh
Confidence 99999988764321111 111111111110000 00 00 01245668999999999999999
Q ss_pred HHHHhh
Q 047954 541 VSELEI 546 (582)
Q Consensus 541 l~~L~~ 546 (582)
+.|.-.
T Consensus 329 lfHpll 334 (458)
T KOG1266|consen 329 LFHPLL 334 (458)
T ss_pred hcCcee
Confidence 887543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=6e-13 Score=140.64 Aligned_cols=141 Identities=18% Similarity=0.241 Sum_probs=99.9
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcchH------------------------------H----------HHHH
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLIT------------------------------E----------EFRK 313 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 313 (582)
+.||+|++|.||+|++.+|+.||||+.+..-.... + +|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 46999999999999999999999999864311000 0 2444
Q ss_pred HHHHHhcC----CCCCccccceEEE-eCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHH-HHHHHh
Q 047954 314 QLLVIADQ----KHPNLLPLLAYYF-SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR-ALEYLH 387 (582)
Q Consensus 314 e~~~l~~l----~H~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH 387 (582)
|...+.++ +|.+-+.+-.++. .....++||||++|++|.+....... .. .+..++..++. .+..+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-----~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-----GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-----CC---CHHHHHHHHHHHHHHHHH
Confidence 55444443 3333333333332 23457999999999999887653211 11 24456776666 478889
Q ss_pred ccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 388 ~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
..+ ++|+|++|.||++++++.++++|||++..+..
T Consensus 275 ~~g-------~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RDG-------FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hCC-------ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 887 99999999999999999999999999977754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.6e-13 Score=145.77 Aligned_cols=88 Identities=34% Similarity=0.526 Sum_probs=82.9
Q ss_pred CCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEee
Q 047954 47 ELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVS 123 (582)
Q Consensus 47 ~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls 123 (582)
.+..|+|++|.|+|.+| .+..+++|+.|+|++|+|+|.||.++++|++|+.|||++|+|+|.+|.. .+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999998 5889999999999999999999999999999999999999999999984 78999999999
Q ss_pred cCcccccCCCC
Q 047954 124 NNNLSGSIPKT 134 (582)
Q Consensus 124 ~N~l~g~ip~~ 134 (582)
+|+|+|.+|..
T Consensus 499 ~N~l~g~iP~~ 509 (623)
T PLN03150 499 GNSLSGRVPAA 509 (623)
T ss_pred CCcccccCChH
Confidence 99999999953
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.7e-12 Score=133.80 Aligned_cols=240 Identities=20% Similarity=0.243 Sum_probs=170.4
Q ss_pred cccccccc--cCceEEEEEEE---cCCceEEEEEecCCC--cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEE
Q 047954 271 APAEGLGK--GIFGNSYKALL---EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLV 342 (582)
Q Consensus 271 ~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 342 (582)
-+...+|. |.+|.||.+.. +++..+|+|+-+.-. ......=.+|+...+++ .|+|.|+.+..+...+..++-
T Consensus 117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiq 196 (524)
T KOG0601|consen 117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQ 196 (524)
T ss_pred ccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceee
Confidence 34567899 99999999986 467778888854221 22233334566666666 699999988889899999999
Q ss_pred EEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHH----HHHHHhccCCCCCCCcceecCCCCCCeeecCC-CceE
Q 047954 343 YKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR----ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN-EMVL 417 (582)
Q Consensus 343 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~-~~~k 417 (582)
+|++. .+|..+.+.... .++....+.+..+... ||.++|+.. ++|-|+||.||+...+ ...+
T Consensus 197 tE~~~-~sl~~~~~~~~~-----~~p~~~l~~~~~~~~~~~~~al~~~hs~~-------~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 197 TELCG-ESLQSYCHTPCN-----FLPDNLLWNSLRDWLSRDVTALSHLHSNN-------IVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred ecccc-chhHHhhhcccc-----cCCchhhhhHHhhhhhcccccccccCCCc-------ccccccchhheecccccceee
Confidence 99884 688888875433 2555667777777777 999999998 9999999999999999 8899
Q ss_pred EeeccccccccCccc---------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHH
Q 047954 418 VSDYGFSSLVAQPIA---------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSW 488 (582)
Q Consensus 418 l~DfG~a~~~~~~~~---------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~ 488 (582)
++|||+...+..... ..+-..|++||... ..++.+.|||++|.+..+..++..+...... ..|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-------~~W 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-------SSW 335 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-------CCc
Confidence 999999876654321 13445699999876 4678999999999999999998766542210 001
Q ss_pred HHHHHhhcc-cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHH
Q 047954 489 VLRAVREEW-TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543 (582)
Q Consensus 489 ~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 543 (582)
. ..+..+ ..+..+ ....++...+..+++.+|-.|++.+.+..+
T Consensus 336 ~--~~r~~~ip~e~~~----------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 336 S--QLRQGYIPLEFCE----------GGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred c--ccccccCchhhhc----------CcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1 000000 011111 111234447788999999999998877653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.2e-11 Score=114.00 Aligned_cols=131 Identities=18% Similarity=0.242 Sum_probs=95.0
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccc-cceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLP-LLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~-l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
+.|+.|.++.||++... +..|++|....... ....+..|+.++..+.+.++++ ++.+ .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 45889999999999876 56799998754322 2234678898888886655544 4433 333468999999998775
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+.. . ....++.+++++|+.||....+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~-----------~---~~~~~~~~l~~~l~~LH~~~~~--~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED-----------F---SDPENLEKIAKLLKKLHSSPLP--DLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc-----------c---cCHHHHHHHHHHHHHHhCCCCC--CceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 420 0 1123567899999999998610 22369999999999999 6689999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1e-10 Score=123.24 Aligned_cols=231 Identities=17% Similarity=0.223 Sum_probs=150.8
Q ss_pred EcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccc
Q 047954 289 LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFR 368 (582)
Q Consensus 289 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~ 368 (582)
..++.+|.|...+.......+...+-++.|+.++||||++++..+...+..|+|+|-+. -|..++.+ +.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---------l~ 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---------LG 102 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---------hH
Confidence 45677788877765544445567778889999999999999999999999999999773 56666643 22
Q ss_pred hHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCccc----ccccccccCCCC
Q 047954 369 CRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA----AQRMISYKSPEY 444 (582)
Q Consensus 369 ~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~~----~~~~~~y~aPE~ 444 (582)
.......+.||+.||.|||+.+ .++|++|.-..|+++..|..||++|-+......... ......|..|+.
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~------~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC------NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE 176 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC------CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence 3345556789999999999877 399999999999999999999999987644332211 111234677775
Q ss_pred CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHH
Q 047954 445 QSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAI 524 (582)
Q Consensus 445 ~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~ 524 (582)
+.... ...|.|-||++++|++.|..+....... ...+.+.......... .... .... ...+++.
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng~~~~~~~~~~--~~~ipk~~~~~~~k~~----~~~~-------~~r~-n~~~~~~ 240 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNGSLLTKTDLSN--TGKIPKALIELYCKKL----GATE-------LKRP-NKLRFIL 240 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCcccCcchhhhc--cCccchhHHHHHHHHh----cccc-------cccc-chhhHHH
Confidence 54332 4579999999999999994333221111 1111111111110000 0000 0000 1445666
Q ss_pred HcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 525 QCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 525 ~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
.|...-+--|=.+-+++..|+++...+.
T Consensus 241 ~~~~~~gff~n~fvd~~~fLeel~lks~ 268 (690)
T KOG1243|consen 241 ECRLLGGFFRNDFVDTLLFLEELRLKSV 268 (690)
T ss_pred HHHhccccccchHHHHHHHHHhcccCcH
Confidence 7776677777777777777777765443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.4e-12 Score=134.33 Aligned_cols=142 Identities=13% Similarity=0.144 Sum_probs=90.0
Q ss_pred ccccccCceEEEEEEEcC-CceEEEEEecCCCcc----------------------------------hHH------HHH
Q 047954 274 EGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPL----------------------------------ITE------EFR 312 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~------~~~ 312 (582)
+.||+|++|.||+|++++ |+.||||+.+..-.. ..+ +|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999987 999999999743100 011 133
Q ss_pred HHHHHHhcC----CCCCccccceEEEe-CCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHh
Q 047954 313 KQLLVIADQ----KHPNLLPLLAYYFS-NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387 (582)
Q Consensus 313 ~e~~~l~~l----~H~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH 387 (582)
+|...+.++ .+.+.+.+-.++.+ ....+|||||+.|+.+.+.-.-.....+...+.......++.| ++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HH
Confidence 344333333 24444444444433 3457899999999999774221111001111222222233333 34
Q ss_pred ccCCCCCCCcceecCCCCCCeeecCCC----ceEEeeccccccccC
Q 047954 388 HKDKSRTQSAVIHGNLKSTNILLDDNE----MVLVSDYGFSSLVAQ 429 (582)
Q Consensus 388 ~~~~~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DfG~a~~~~~ 429 (582)
..+ ++|+|+||.||+++.++ .+++.|||+...+..
T Consensus 278 ~~G-------ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDG-------FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCC-------eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 466 99999999999999888 899999999877654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.2e-13 Score=119.21 Aligned_cols=131 Identities=25% Similarity=0.349 Sum_probs=108.6
Q ss_pred CCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 19 NSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 19 ~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
+.++++.|.|++|.++ .+||. +..|.+|++|++++|++..-.++++++.+|+.|+++.|.|. .+|..||.++.|++|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppn-ia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPN-IAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCc-HHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4678899999999998 46665 89999999999999999999999999999999999999998 889999999999999
Q ss_pred ecccCcccC-CCCCC--CCCCCCEEEeecCcccccCCCCCcccccccccccCCCCCC
Q 047954 99 QLQNNNLTG-PVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLC 152 (582)
Q Consensus 99 ~l~~N~l~g-~ip~~--~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l~ 152 (582)
||++|+|+- .+|.. .++.|+.|.|+.|.|.=--|+-+.+..+..+++..|..+.
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~ 164 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLS 164 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhh
Confidence 999999974 56752 4677778888888886444444566666666666665543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=6e-10 Score=103.80 Aligned_cols=137 Identities=12% Similarity=0.113 Sum_probs=96.8
Q ss_pred ccccccCceEEEEEEEcC-------CceEEEEEecCCC----------------------cchHHHH----HHHHHHHhc
Q 047954 274 EGLGKGIFGNSYKALLEG-------RAPVVVKRLRDLK----------------------PLITEEF----RKQLLVIAD 320 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~e~~~l~~ 320 (582)
..||.|.-+.||.|...+ +..+|||..+... ....+.+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 4789999874210 0112223 389999988
Q ss_pred CCC--CCccccceEEEeCCeeEEEEEeCCCCChHH-HHhcCCCCCCCCccchHHHHHHHHHHHHHHHHH-hccCCCCCCC
Q 047954 321 QKH--PNLLPLLAYYFSNDEKLLVYKFAGNGNLFN-RIHGGKSSKNRIPFRCRSRLLVARGVARALEYL-HHKDKSRTQS 396 (582)
Q Consensus 321 l~H--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~~~ 396 (582)
+.. -++.+.+++ ...++||||+.+..+.. .+.. ..++..+...+..+++.+|.+| |..+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~H~~g------ 145 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLYKECN------ 145 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHHHhCC------
Confidence 743 455556654 46789999997654422 2221 1234445567788999999999 7776
Q ss_pred cceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 397 AVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 397 ~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
|||+||++.|||++ ++.+.|+|||.+-....
T Consensus 146 -lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 146 -LVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred -eecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999999999997 46799999998866544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.3e-10 Score=108.28 Aligned_cols=146 Identities=19% Similarity=0.244 Sum_probs=110.2
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCc-chHHHHHHHHHHHhcCCC--CCccccceEEEeCC---eeEEEEEeCC
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKP-LITEEFRKQLLVIADQKH--PNLLPLLAYYFSND---EKLLVYKFAG 347 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~---~~~lv~e~~~ 347 (582)
+.|+.|.++.||++...++..+++|....... .....+..|++++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999987767899998764322 134578899999999866 34566777765532 5689999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCC-----------------------------------
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS----------------------------------- 392 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------------------------------- 392 (582)
+.++.+.+.. ..++...+..++.+++++|.+||+...+
T Consensus 84 G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 84 GRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 9888765421 1366677888899999999999974321
Q ss_pred --------------CCCCcceecCCCCCCeeecC--CCceEEeecccccc
Q 047954 393 --------------RTQSAVIHGNLKSTNILLDD--NEMVLVSDYGFSSL 426 (582)
Q Consensus 393 --------------~~~~~ivH~Dlkp~NILl~~--~~~~kl~DfG~a~~ 426 (582)
.....++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 01356899999999999998 56689999997754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.7e-11 Score=122.71 Aligned_cols=240 Identities=18% Similarity=0.197 Sum_probs=165.9
Q ss_pred ccccccCceEEEEEEE--cCCceEEEEEecCCCcchHHH--HHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALL--EGRAPVVVKRLRDLKPLITEE--FRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
..||.|.|+.||+... .++..+++|.+.........+ -..|+.+...+ .|.+++.++..+......++--|||.+
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 4699999999999874 467788998876543332222 23455555544 688889888877777788899999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC-CceEEeeccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN-EMVLVSDYGFSSLV 427 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DfG~a~~~ 427 (582)
+++...+.. ...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||+++.+
T Consensus 351 ~s~~l~~~~------~~~~d~~~~~~~~~q~~~~l~~i~s~~-------~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 351 GSSSLRSVT------SQMLDEDPRLRLTAQILTALNVIHSKL-------FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cchhhhhHH------HHhcCcchhhhhHHHHHhccccccchh-------hhcccccccceeeccchhhhhcccccccccc
Confidence 988766521 124677788889999999999999987 9999999999999876 78899999998654
Q ss_pred cCcccc-ccccccc--CCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 428 AQPIAA-QRMISYK--SPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 428 ~~~~~~-~~~~~y~--aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.-.... ...-++. +++......+..+.|+||||..+.|.+++..--... .. |. .++.+....
T Consensus 418 ~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~------~~---~~--~i~~~~~p~---- 482 (524)
T KOG0601|consen 418 AFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG------VQ---SL--TIRSGDTPN---- 482 (524)
T ss_pred ceecccccccccccccchhhccccccccccccccccccccccccCcccCccc------cc---ce--eeecccccC----
Confidence 322111 1222333 555666677889999999999999999986432210 00 00 000111110
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
..... .++..+...+...++..||.+.+...+.+...
T Consensus 483 ----~~~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 483 ----LPGLK---LQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ----CCchH---HhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 11111 24556666788899999999998877666544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.5e-09 Score=95.34 Aligned_cols=131 Identities=23% Similarity=0.381 Sum_probs=98.1
Q ss_pred cccccCceEEEEEEEcCCceEEEEE-ecCCC--c-----chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 275 GLGKGIFGNSYKALLEGRAPVVVKR-LRDLK--P-----LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~--~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+++|+-+.+|.+.+.+.. +++|. +.+.- + ...+.-.+|..++.+++--.|..-+=+..+.+...++|||.
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999876555 44553 22211 1 12234578899998886555555555667788889999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++..|.+.+... +..++..+-.-+.-||..+ |||+||.++||++..+. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~g-------ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA-------------RPDLLREVGRLVGKLHKAG-------IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc-------------chHHHHHHHHHHHHHHhcC-------eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 998888888532 2446777888889999998 99999999999998765 99999999864
Q ss_pred c
Q 047954 427 V 427 (582)
Q Consensus 427 ~ 427 (582)
-
T Consensus 141 s 141 (204)
T COG3642 141 S 141 (204)
T ss_pred c
Confidence 3
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.7e-09 Score=95.53 Aligned_cols=142 Identities=18% Similarity=0.293 Sum_probs=101.3
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCC-------CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDL-------KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
++|-+|+-+.|+++.+.+...++-+++.+. .......-.+|.+.+.+++--.|.--.=++.+...-.++|||+
T Consensus 13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 468899999999999876654443343221 1123456788999999876555544444566777778999999
Q ss_pred CC-CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc---eEEeecc
Q 047954 347 GN-GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM---VLVSDYG 422 (582)
Q Consensus 347 ~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DfG 422 (582)
++ -++.+++...... .........+++.|-+.+.-||..+ |||+||..+||++..++. +.++|||
T Consensus 93 ~g~~~vk~~i~~~~~~----~~~d~~~~~~~~~iG~~igklH~nd-------iiHGDLTTSNill~~~~~~~~~~lIdfg 161 (229)
T KOG3087|consen 93 DGASTVKDFILSTMED----ESEDEGLAELARRIGELIGKLHDND-------IIHGDLTTSNILLRSDGNQITPILIDFG 161 (229)
T ss_pred cchhHHHHHHHHHccC----cccchhHHHHHHHHHHHHHHhhhCC-------eecccccccceEEecCCCcCceEEEeec
Confidence 76 4777777654322 1222223678889999999999998 999999999999976554 5899999
Q ss_pred cccc
Q 047954 423 FSSL 426 (582)
Q Consensus 423 ~a~~ 426 (582)
++..
T Consensus 162 ls~~ 165 (229)
T KOG3087|consen 162 LSSV 165 (229)
T ss_pred chhc
Confidence 9754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.9e-08 Score=101.84 Aligned_cols=170 Identities=19% Similarity=0.237 Sum_probs=128.2
Q ss_pred ceEEEEEE-EcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEe----CCeeEEEEEeCCC-CChHHH
Q 047954 281 FGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS----NDEKLLVYKFAGN-GNLFNR 354 (582)
Q Consensus 281 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~ 354 (582)
-.+.||+. ..+|..|++|+++..+.........-++..+++.|.|||++.+++.. +...++||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45789998 45788899999954433333334456788999999999999988873 3467899999987 678776
Q ss_pred HhcCCCCC---------CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 355 IHGGKSSK---------NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 355 l~~~~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
-....... .....++...+.++.|+..||.++|+.| +.-+-|.+.+||++.+.+++|+..|+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG-------LAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG-------LACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC-------ceeecccHhHeEeeCcceEEEeccccee
Confidence 55433221 1234677889999999999999999998 8889999999999999999999888776
Q ss_pred cccCcccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCC
Q 047954 426 LVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470 (582)
Q Consensus 426 ~~~~~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~ 470 (582)
.+..+.. |-+.. -.+-|.=.||.+++.|.||.
T Consensus 442 vl~~d~~----------~~le~---~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 442 VLQEDPT----------EPLES---QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred eecCCCC----------cchhH---HhhhhHHHHHHHHHHHhhcc
Confidence 5543320 11211 24678899999999999995
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.4e-10 Score=120.06 Aligned_cols=85 Identities=29% Similarity=0.397 Sum_probs=56.1
Q ss_pred CCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC---CCCCCCEEEeecCcccccCCCCCccccc
Q 047954 64 NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIPKTQTLQLF 140 (582)
Q Consensus 64 ~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~---~~~~l~~l~ls~N~l~g~ip~~~~~~~~ 140 (582)
++..+..|+.||||.|+|. +.|..+-+.+++-+|+||+|++. +||.. +++.|-+||||+|.|.---|....+..+
T Consensus 98 diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~L 175 (1255)
T KOG0444|consen 98 DIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSML 175 (1255)
T ss_pred hhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhh
Confidence 4444555666666666666 66666666666666666666665 56653 5667777888888887555554556667
Q ss_pred ccccccCCCC
Q 047954 141 RSYSYSNNPY 150 (582)
Q Consensus 141 ~~~~~~~n~~ 150 (582)
..+.+++||.
T Consensus 176 qtL~Ls~NPL 185 (1255)
T KOG0444|consen 176 QTLKLSNNPL 185 (1255)
T ss_pred hhhhcCCChh
Confidence 7777888864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.5e-10 Score=125.37 Aligned_cols=235 Identities=18% Similarity=0.221 Sum_probs=150.0
Q ss_pred cccccCceEEEEEEEcC-CceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 275 GLGKGIFGNSYKALLEG-RAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
-+-+|+++.++-+.-.. +...++|..... .....+....+-.++-..+||-++...-.+......+|+++|+.+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 57788898888876332 222333332211 11112222233333333455777765555455667899999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC-
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ- 429 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~- 429 (582)
|...++... ..+..-.......+..+++|||+.. ++|||++|.|+|+..++..+++|||.......
T Consensus 891 ~~Skl~~~~------~~saepaRs~i~~~vqs~e~L~s~~-------r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 891 LPSKLHNSG------CLSAEPARSPILERVQSLESLHSSL-------RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred chhhhhcCC------CcccccccchhHHHHhhhhccccch-------hhcccccccchhhcccCCcccCccccccccccc
Confidence 999998543 1222223334456788999999986 89999999999999999999999984322100
Q ss_pred ----------------------------------cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 047954 430 ----------------------------------PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHS 475 (582)
Q Consensus 430 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~ 475 (582)
.....+++.|.+||...+......+|+|+.|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0112356779999999999999999999999999999999999975
Q ss_pred CCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChH
Q 047954 476 APQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMA 538 (582)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 538 (582)
.... .+.+ .+....+.....+.+...+..+++..-+..+|.+|-.|.
T Consensus 1038 ~tpq----~~f~------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQ----QIFE------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchh----hhhh------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 4321 1111 111111111111222222445566667778888887776
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.4e-08 Score=97.24 Aligned_cols=149 Identities=11% Similarity=0.018 Sum_probs=100.9
Q ss_pred hHhhhcccccccccCceEEEEEEEcCCceEEEEEecCCCcc-----------hHHHHHHHHHHHhcCCCCC--ccccceE
Q 047954 266 NDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPL-----------ITEEFRKQLLVIADQKHPN--LLPLLAY 332 (582)
Q Consensus 266 ~~l~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~H~n--iv~l~~~ 332 (582)
+.+.....+.+-+-....|+++.+ +|+.+.||+....... ....+.+|...+.++...+ +.+.+++
T Consensus 20 ~~~~~~~~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~ 98 (268)
T PRK15123 20 EEVKTLQGEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAF 98 (268)
T ss_pred HHHHhcCCcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEE
Confidence 333333344455444455777766 4567889976432210 1114778888888874333 3444556
Q ss_pred EEe-----CCeeEEEEEeCCCC-ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCC
Q 047954 333 YFS-----NDEKLLVYKFAGNG-NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKST 406 (582)
Q Consensus 333 ~~~-----~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~ 406 (582)
... ....++|+|++++- +|.+++..... .+.+...+..++.+++..+.-||..+ |+|+|++++
T Consensus 99 ~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~~G-------i~HgDL~~~ 167 (268)
T PRK15123 99 GERGSNPATRTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHAAG-------INHRDCYIC 167 (268)
T ss_pred EEecCCCccceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCc-------CccCCCChh
Confidence 543 23478999999876 79888753211 12445567789999999999999998 999999999
Q ss_pred CeeecC-------CCceEEeecccccc
Q 047954 407 NILLDD-------NEMVLVSDYGFSSL 426 (582)
Q Consensus 407 NILl~~-------~~~~kl~DfG~a~~ 426 (582)
|||++. +..+.++||+.+..
T Consensus 168 NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 168 HFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred hEEEeccccCCCCCceEEEEECCcccc
Confidence 999985 46789999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.5e-08 Score=92.57 Aligned_cols=127 Identities=20% Similarity=0.277 Sum_probs=82.8
Q ss_pred EEEEEEEcCCceEEEEEecCCCc--------------------------chHHHHHHHHHHHhcCCCC--CccccceEEE
Q 047954 283 NSYKALLEGRAPVVVKRLRDLKP--------------------------LITEEFRKQLLVIADQKHP--NLLPLLAYYF 334 (582)
Q Consensus 283 ~Vy~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~H~--niv~l~~~~~ 334 (582)
.||.|...++..+|+|..+.... .......+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999999999999998742110 0123467899999999765 455555442
Q ss_pred eCCeeEEEEEeCC--CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHH-hccCCCCCCCcceecCCCCCCeeec
Q 047954 335 SNDEKLLVYKFAG--NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL-HHKDKSRTQSAVIHGNLKSTNILLD 411 (582)
Q Consensus 335 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~~~~ivH~Dlkp~NILl~ 411 (582)
..++||||++ +..+..+.. . .++......++.+++..+..+ |..+ |||+||.+.|||++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-~-------~~~~~~~~~~~~~il~~~~~~~~~~g-------ivHGDLs~~NIlv~ 141 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-V-------DLSPEEPKELLEEILEEIIKMLHKAG-------IVHGDLSEYNILVD 141 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-C-------GGGGSTHHHHHHHHHHHHHHHHHCTT-------EEESS-STTSEEEE
T ss_pred ---CCEEEEEecCCCccchhhHHh-c-------cccchhHHHHHHHHHHHHHHHHHhcC-------ceecCCChhhEEee
Confidence 4579999998 544443332 1 122344566778888866664 6776 99999999999999
Q ss_pred CCCceEEeeccccccccC
Q 047954 412 DNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 412 ~~~~~kl~DfG~a~~~~~ 429 (582)
++ .+.|+|||.+.....
T Consensus 142 ~~-~~~iIDf~qav~~~~ 158 (188)
T PF01163_consen 142 DG-KVYIIDFGQAVDSSH 158 (188)
T ss_dssp TT-CEEE--GTTEEETTS
T ss_pred cc-eEEEEecCcceecCC
Confidence 87 899999998765543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.3e-10 Score=115.35 Aligned_cols=104 Identities=25% Similarity=0.355 Sum_probs=65.9
Q ss_pred EEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCccc--------------------
Q 047954 23 VTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFY-------------------- 82 (582)
Q Consensus 23 ~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~-------------------- 82 (582)
...|+|++|++. +||...+-+|+.|-+||||+|+|.--+|.+..+..|++|+||+|-|.
T Consensus 128 ~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~ 206 (1255)
T KOG0444|consen 128 SIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSN 206 (1255)
T ss_pred cEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhccc
Confidence 445555555554 56666666777777777777777776666666666666666666321
Q ss_pred -----ccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCccc
Q 047954 83 -----GEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLS 128 (582)
Q Consensus 83 -----g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~ 128 (582)
..||.++-.|.+|..+|||.|+|. .+|.. .+.+|+.||||+|.++
T Consensus 207 TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it 258 (1255)
T KOG0444|consen 207 TQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT 258 (1255)
T ss_pred ccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence 146666666777777777777775 45542 5555666666666554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.3e-07 Score=91.90 Aligned_cols=265 Identities=17% Similarity=0.160 Sum_probs=152.4
Q ss_pred cccccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceE----EE--eCC-eeEEE
Q 047954 271 APAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAY----YF--SND-EKLLV 342 (582)
Q Consensus 271 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~----~~--~~~-~~~lv 342 (582)
..+.-||+|+-+.+|-.---.+ -+.|+...-...... +.+..|.+. .||-+-.-+.+ .. +.. ..-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchhhc--hhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3466799999999996432222 234555433222111 222333333 56544331111 11 111 24577
Q ss_pred EEeCCCC-ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 343 YKFAGNG-NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 343 ~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
|..+++. -...++.-...........|...+++++.+|.+.+-||..| .+-+|+.++|+|+.++..+.|.|-
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G-------h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG-------HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC-------CcccccCccceeeecCceEEEEcc
Confidence 7777653 22333332222223456889999999999999999999998 888999999999999999999875
Q ss_pred cccccccCccc---ccccccccCCCCCC-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCccchHH-HHHH
Q 047954 422 GFSSLVAQPIA---AQRMISYKSPEYQS-----SKKISRKSDVWSFGCLLLELLTG-RISTHSAPQGINGADLCS-WVLR 491 (582)
Q Consensus 422 G~a~~~~~~~~---~~~~~~y~aPE~~~-----~~~~~~k~DVwS~Gvvl~elltG-~~P~~~~~~~~~~~~~~~-~~~~ 491 (582)
..-........ ..+...|.+||... +..-+...|-|.+||++++++.| ++||...........-.+ .+..
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 43222222221 12445699999654 33446789999999999999986 999976543222111111 1110
Q ss_pred HHhhcccccccchhh---hhhhch--HHHHHHHHHHHHHcccC--CCCCCCChHHHHHHHhhcccCC
Q 047954 492 AVREEWTAEIFDSEI---SVQRSA--AHGMLKLLQVAIQCCNK--SPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 492 ~~~~~~~~~~~d~~~---~~~~~~--~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~L~~i~~~~ 551 (582)
+......+... ...... .--...+-.+..+|+.. .+.-|||++..+..|..+.+..
T Consensus 242 ----g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 242 ----GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred ----ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 00000000000 000000 01112344566688865 3678999999999887776443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.2e-09 Score=112.70 Aligned_cols=127 Identities=26% Similarity=0.311 Sum_probs=97.0
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..+..|+|+.|+++--- ...+-.|+.|+.|+||.|.+.-.-+ .++...+|+.||||+|+++---|.+|.-|..|+.|+
T Consensus 269 ~kme~l~L~~N~l~~vn-~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~Ln 347 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQAVN-EGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELN 347 (873)
T ss_pred cccceeecccchhhhhh-cccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhc
Confidence 45788899999987432 3446679999999999999887655 577788999999999999976677788888888888
Q ss_pred cccCcccCCCCCC---CCCCCCEEEeecCcccccCCCC----CcccccccccccCCC
Q 047954 100 LQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIPKT----QTLQLFRSYSYSNNP 149 (582)
Q Consensus 100 l~~N~l~g~ip~~---~~~~l~~l~ls~N~l~g~ip~~----~~~~~~~~~~~~~n~ 149 (582)
|++|.++ .|-+. .+++|+.|||++|.+++.|-+. .++..+..+.+.||.
T Consensus 348 Ls~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq 403 (873)
T KOG4194|consen 348 LSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ 403 (873)
T ss_pred ccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence 8888876 33332 5678888888888888887654 235666777777774
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=2e-08 Score=111.69 Aligned_cols=117 Identities=21% Similarity=0.253 Sum_probs=66.7
Q ss_pred CeEEEEEeCCCcceec--cCcc---------ccCC----CCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccc
Q 047954 21 AHVTGIVLEDMRLNGE--IKSD---------AFAD----IPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEI 85 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~--ip~~---------~~~~----l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~i 85 (582)
+.+..|+|++|+|++. +|.. .+.. ..+|+.|+|++|+|++ +|.+ ..+|+.|++++|+|++ |
T Consensus 302 ~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~-LP~l--p~~L~~L~Ls~N~L~~-L 377 (788)
T PRK15387 302 PGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLAS-LPTL--PSELYKLWAYNNRLTS-L 377 (788)
T ss_pred cccceeECCCCccccCCCCcccccccccccCccccccccccccceEecCCCccCC-CCCC--Ccccceehhhcccccc-C
Confidence 5677777777777762 2211 0111 1368888888888886 4432 2356666777777663 5
Q ss_pred cccccCCCcCCeeecccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCC
Q 047954 86 SRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNP 149 (582)
Q Consensus 86 p~~~~~l~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~ 149 (582)
|... .+|+.|+|++|+|++ +|.. .++|+.|++|+|.|++ ||.. ...+..+++++|.
T Consensus 378 P~l~---~~L~~LdLs~N~Lt~-LP~l-~s~L~~LdLS~N~Lss-IP~l--~~~L~~L~Ls~Nq 433 (788)
T PRK15387 378 PALP---SGLKELIVSGNRLTS-LPVL-PSELKELMVSGNRLTS-LPML--PSGLLSLSVYRNQ 433 (788)
T ss_pred cccc---cccceEEecCCcccC-CCCc-ccCCCEEEccCCcCCC-CCcc--hhhhhhhhhccCc
Confidence 6432 356677777777764 5542 3456666666666664 5532 2233444455543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.2e-08 Score=110.55 Aligned_cols=99 Identities=20% Similarity=0.395 Sum_probs=65.4
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCeeec
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l 100 (582)
.++.|+|++|+++ .+|... .++|+.|+|++|+|+. +|. +. .+|+.|+|++|++. .||..+. ++|+.|+|
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~l---~~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 200 QITTLILDNNELK-SLPENL---QGNIKTLYANSNQLTS-IPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred CCcEEEecCCCCC-cCChhh---ccCCCEEECCCCcccc-CChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 4667777777777 455432 2467777777777774 332 22 35777777777776 6676654 46777788
Q ss_pred ccCcccCCCCCCCCCCCCEEEeecCcccccCC
Q 047954 101 QNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIP 132 (582)
Q Consensus 101 ~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip 132 (582)
++|+|+ .||.....+|+.|+|++|+|++ +|
T Consensus 270 s~N~L~-~LP~~l~~sL~~L~Ls~N~Lt~-LP 299 (754)
T PRK15370 270 FHNKIS-CLPENLPEELRYLSVYDNSIRT-LP 299 (754)
T ss_pred cCCccC-ccccccCCCCcEEECCCCcccc-Cc
Confidence 877777 4666544577777777777774 44
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2e-07 Score=89.07 Aligned_cols=139 Identities=14% Similarity=0.212 Sum_probs=97.3
Q ss_pred HhhhcccccccccCceEEEEEEEcCCceEEEEEecCCCc----------------------chHHHHHHHHHHHhcCCCC
Q 047954 267 DLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKP----------------------LITEEFRKQLLVIADQKHP 324 (582)
Q Consensus 267 ~l~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~H~ 324 (582)
+..++.++.||-|.-+.||.|....+.++|||.-+.... ..+...++|.+.|.++.-.
T Consensus 90 ~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~ 169 (304)
T COG0478 90 GIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE 169 (304)
T ss_pred ChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence 344566889999999999999999999999996532110 1123467899999988554
Q ss_pred --CccccceEEEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecC
Q 047954 325 --NLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGN 402 (582)
Q Consensus 325 --niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~D 402 (582)
.|.+.+++ +...+||||..+--|...- ++....-.|+..|++-+.-.-..| |||+|
T Consensus 170 G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~~G-------iVHGD 227 (304)
T COG0478 170 GVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYRRG-------IVHGD 227 (304)
T ss_pred CCCCCCcccc----ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHHcC-------ccccC
Confidence 56665543 4568999999885554321 112223334445555454444555 99999
Q ss_pred CCCCCeeecCCCceEEeeccccccc
Q 047954 403 LKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 403 lkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+.+-||++++++.+.++||--+...
T Consensus 228 lSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 228 LSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred CchheEEEecCCCEEEEeCcccccC
Confidence 9999999999999999999655433
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.1e-09 Score=116.55 Aligned_cols=127 Identities=24% Similarity=0.363 Sum_probs=91.7
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..+..|.|.+|.|+-..-| .+.+...|++|+|+.|+|.--.. .+.++..|+.|+||+|.|+ .||.++.+|..|++|-
T Consensus 359 ~~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLR 436 (1081)
T ss_pred HHHHHHHHhcCcccccchh-hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHh
Confidence 4466778888888766533 47788888888888888753332 3566777888888888887 7888888888888888
Q ss_pred cccCcccCCCCCC-CCCCCCEEEeecCccc-ccCCCCCcccccccccccCCCC
Q 047954 100 LQNNNLTGPVPEF-NQSSLKVFNVSNNNLS-GSIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 100 l~~N~l~g~ip~~-~~~~l~~l~ls~N~l~-g~ip~~~~~~~~~~~~~~~n~~ 150 (582)
..+|++. .+|.. .++.|+++|||.|+|+ +.+|....-+.+..++++||..
T Consensus 437 ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 437 AHSNQLL-SFPELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hcCCcee-echhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 8888876 56654 6778888888888886 3455443346777788888864
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.60 E-value=4.5e-08 Score=73.37 Aligned_cols=60 Identities=32% Similarity=0.401 Sum_probs=37.8
Q ss_pred CCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcc
Q 047954 46 PELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNL 105 (582)
Q Consensus 46 ~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l 105 (582)
|+|++|++++|+++...+ .|.++++|++|+|++|.++..-|..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 355666666666664443 355666666666666666655555666666777777766654
|
... |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.7e-09 Score=93.88 Aligned_cols=137 Identities=22% Similarity=0.352 Sum_probs=112.6
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCccc-ccccccccCCCcCCeee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFY-GEISRSLLSLKFLESLQ 99 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~-g~ip~~~~~l~~l~~l~ 99 (582)
.++..|++.+|++. .+|. .++.|+.|+.|+++-|+|.-..-.|++++.|+.|||++|+|+ -.+|-.|.-++.|+.|.
T Consensus 56 ~nlevln~~nnqie-~lp~-~issl~klr~lnvgmnrl~~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly 133 (264)
T KOG0617|consen 56 KNLEVLNLSNNQIE-ELPT-SISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY 133 (264)
T ss_pred hhhhhhhcccchhh-hcCh-hhhhchhhhheecchhhhhcCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence 34677899999987 4665 489999999999999999877678999999999999999997 56899999999999999
Q ss_pred cccCcccCCCCC-CCCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCCCCCCCCCC
Q 047954 100 LQNNNLTGPVPE-FNQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCGPPSLNNC 160 (582)
Q Consensus 100 l~~N~l~g~ip~-~~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~~~~~~~~~ 160 (582)
|+.|.|.---|+ ..+++|+.|.+..|.|- ++|.. +.+..+..+...||...--||.+.+.
T Consensus 134 l~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~~l 195 (264)
T KOG0617|consen 134 LGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELANL 195 (264)
T ss_pred hcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhhhh
Confidence 999999843333 38899999999999986 56765 55777888889999766556655443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=7.9e-09 Score=106.75 Aligned_cols=104 Identities=19% Similarity=0.240 Sum_probs=48.0
Q ss_pred EEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 23 VTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 23 ~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
+..|+|+.|.+.-.= .+.+.-.+.|.+|+|++|+++---+ .|-.+..|+.|+|+.|.++-.--..|-.+++|+.|||+
T Consensus 295 L~~L~lS~NaI~rih-~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 295 LEQLDLSYNAIQRIH-IDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hhhhccchhhhheee-cchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence 444555555554322 2234455566666666666554433 23334444444444444442222233344444444444
Q ss_pred cCcccCCCCCC-----CCCCCCEEEeecCcc
Q 047954 102 NNNLTGPVPEF-----NQSSLKVFNVSNNNL 127 (582)
Q Consensus 102 ~N~l~g~ip~~-----~~~~l~~l~ls~N~l 127 (582)
+|.+++.|-+. .+++|+.|+|-+|++
T Consensus 374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNql 404 (873)
T KOG4194|consen 374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQL 404 (873)
T ss_pred CCeEEEEEecchhhhccchhhhheeecCcee
Confidence 44444444331 344444444444444
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.8e-08 Score=107.08 Aligned_cols=146 Identities=23% Similarity=0.324 Sum_probs=96.9
Q ss_pred HHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcccc-------------cccccccCCC
Q 047954 377 RGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA-------------QRMISYKSPE 443 (582)
Q Consensus 377 ~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~~~-------------~~~~~y~aPE 443 (582)
.+++.||.|+|... .+||++|.|++|.++..+..||+.|+.+.....+... .....|.|||
T Consensus 106 ~~v~dgl~flh~sA------k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA------KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred hcccchhhhhccCc------ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence 45669999999875 4999999999999999999999999986544332111 1124599999
Q ss_pred CCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHH
Q 047954 444 YQSSKKISRKSDVWSFGCLLLELL-TGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQV 522 (582)
Q Consensus 444 ~~~~~~~~~k~DVwS~Gvvl~ell-tG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l 522 (582)
++.....+.++|+||+||++|.+. .|+.-+... +..+.........+. .. ......-..++.+=
T Consensus 180 ~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~-----~~~~~~~~~~~~~~~-~~---------~~~s~~~p~el~~~ 244 (700)
T KOG2137|consen 180 YLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAAN-----GGLLSYSFSRNLLNA-GA---------FGYSNNLPSELRES 244 (700)
T ss_pred hhccccccccccceeeeeEEEEEecCCcchhhcc-----CCcchhhhhhccccc-cc---------ccccccCcHHHHHH
Confidence 999988899999999999999998 455444321 111111111110000 00 00001122356666
Q ss_pred HHHcccCCCCCCCChHHHHHH
Q 047954 523 AIQCCNKSPEKRPEMAEVVSE 543 (582)
Q Consensus 523 ~~~Cl~~dP~~RPs~~evl~~ 543 (582)
+.+.+..++.-||++.++...
T Consensus 245 l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 245 LKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred HHHHhcCCcccCcchhhhhcc
Confidence 778888999999987776543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.56 E-value=6.1e-09 Score=103.10 Aligned_cols=102 Identities=19% Similarity=0.295 Sum_probs=53.3
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
+++.+++.+|++.- +|++.+. ++.|+.||.-.|.++--+|+++++.+|..|+|..|.+. .+| +|..|+.|..|.++
T Consensus 161 ~l~~l~~~~n~l~~-l~~~~i~-m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g 236 (565)
T KOG0472|consen 161 KLSKLDLEGNKLKA-LPENHIA-MKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVG 236 (565)
T ss_pred HHHHhhccccchhh-CCHHHHH-HHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhc
Confidence 34556777777663 3344333 66666666666666555556666666666666666554 344 44444444444444
Q ss_pred cCcccCCCCCC---CCCCCCEEEeecCccc
Q 047954 102 NNNLTGPVPEF---NQSSLKVFNVSNNNLS 128 (582)
Q Consensus 102 ~N~l~g~ip~~---~~~~l~~l~ls~N~l~ 128 (582)
.|++. .+|.. .+++|.+|||..|++.
T Consensus 237 ~N~i~-~lpae~~~~L~~l~vLDLRdNklk 265 (565)
T KOG0472|consen 237 ENQIE-MLPAEHLKHLNSLLVLDLRDNKLK 265 (565)
T ss_pred ccHHH-hhHHHHhcccccceeeeccccccc
Confidence 44443 33331 3344444444444443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.5e-06 Score=79.76 Aligned_cols=138 Identities=15% Similarity=0.137 Sum_probs=101.4
Q ss_pred ccccCceEEEEEEEcCCceEEEEEecCC-----C-cchHHHHHHHHHHHhcCCCC--CccccceEEE-e----CCeeEEE
Q 047954 276 LGKGIFGNSYKALLEGRAPVVVKRLRDL-----K-PLITEEFRKQLLVIADQKHP--NLLPLLAYYF-S----NDEKLLV 342 (582)
Q Consensus 276 lG~G~~g~Vy~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~-~----~~~~~lv 342 (582)
-|+||.+.|++..+.+. .+-+|+.... . +.....|.+|+..+.++... .+.+.. ++. . ....+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 47799999999887666 5778876411 1 34567899999999887432 244444 332 1 1236799
Q ss_pred EEeCCC-CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc--eEEe
Q 047954 343 YKFAGN-GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM--VLVS 419 (582)
Q Consensus 343 ~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~--~kl~ 419 (582)
+|-+.+ -+|.+++..... .+.+...+..+..+|+..+.-||+.+ +.|+|+-+.||+++.++. ++++
T Consensus 104 Te~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~~G-------v~Hgdly~khIll~~~g~~~v~lI 172 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHSVN-------RQHGCCYVRHIYVKTEGKAEAGFL 172 (216)
T ss_pred EEeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHHCC-------CcCCCCCHhheeecCCCCeeEEEE
Confidence 997764 588888854322 13566777889999999999999998 999999999999986666 8999
Q ss_pred ecccccc
Q 047954 420 DYGFSSL 426 (582)
Q Consensus 420 DfG~a~~ 426 (582)
||--++.
T Consensus 173 DlEk~r~ 179 (216)
T PRK09902 173 DLEKSRR 179 (216)
T ss_pred Ehhccch
Confidence 9976543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=2e-07 Score=104.24 Aligned_cols=122 Identities=20% Similarity=0.299 Sum_probs=95.7
Q ss_pred eeCCCCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCc
Q 047954 15 QCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKF 94 (582)
Q Consensus 15 ~c~~~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~ 94 (582)
.|. ....+.|+|++++|+. +|.. + .+.|+.|+|++|.|+.....+. .+|+.|+|++|+|+ .||..+. .+
T Consensus 174 ~Cl--~~~~~~L~L~~~~Lts-LP~~-I--p~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~ 242 (754)
T PRK15370 174 DCL--KNNKTELRLKILGLTT-IPAC-I--PEQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLT-SIPATLP--DT 242 (754)
T ss_pred hhc--ccCceEEEeCCCCcCc-CCcc-c--ccCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccc-cCChhhh--cc
Confidence 464 3467899999999994 7643 3 3689999999999995433333 58999999999999 6887664 47
Q ss_pred CCeeecccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCCC
Q 047954 95 LESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 95 l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~ 150 (582)
|+.|+|++|+++ .||....++|+.|+|++|+|+ .+|... ...+..+++++|..
T Consensus 243 L~~L~Ls~N~L~-~LP~~l~s~L~~L~Ls~N~L~-~LP~~l-~~sL~~L~Ls~N~L 295 (754)
T PRK15370 243 IQEMELSINRIT-ELPERLPSALQSLDLFHNKIS-CLPENL-PEELRYLSVYDNSI 295 (754)
T ss_pred ccEEECcCCccC-cCChhHhCCCCEEECcCCccC-cccccc-CCCCcEEECCCCcc
Confidence 999999999998 788876678999999999998 477642 24677777888754
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.5e-09 Score=103.46 Aligned_cols=125 Identities=24% Similarity=0.381 Sum_probs=79.4
Q ss_pred EEEEEeCCCcceeccCc-----------------------cccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCC
Q 047954 23 VTGIVLEDMRLNGEIKS-----------------------DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGN 79 (582)
Q Consensus 23 ~~~l~l~~~~l~g~ip~-----------------------~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N 79 (582)
|+.++++.|++. ++|. ..++.+++|..|+|+||.+..-+.+++++..|+.||||.|
T Consensus 390 Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~N 468 (565)
T KOG0472|consen 390 VTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFN 468 (565)
T ss_pred eEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhhhcchhhhhhhhhheeccccc
Confidence 777888888765 3332 2355566666666666666555556666666666666666
Q ss_pred cccccccccccCCCcCCeeecccCcccCCCCCC---CCCCCCEEEeecCcccccCCCCCcccccccccccCCCC
Q 047954 80 KFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 80 ~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~---~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~ 150 (582)
+|- .+|..+-.+..|+.+-.++|++. .+|.. ++.+|..|||.+|.+.-.-|..+.+.++..+.+.||++
T Consensus 469 rFr-~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 469 RFR-MLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred ccc-cchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence 665 56665555555555555555553 34432 56788888888888874333346677888888888876
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.2e-08 Score=110.77 Aligned_cols=104 Identities=24% Similarity=0.310 Sum_probs=92.7
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..++..|+|++|+|+ ++|...+.++..|+.|+||+|.|+--...+..+..|++|...+|++. ..| ++.++++|+.+|
T Consensus 382 ~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lD 458 (1081)
T KOG0618|consen 382 FKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLD 458 (1081)
T ss_pred ccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEe
Confidence 578999999999996 68888899999999999999999876667788899999999999998 788 999999999999
Q ss_pred cccCccc-CCCCCCCC-CCCCEEEeecCc
Q 047954 100 LQNNNLT-GPVPEFNQ-SSLKVFNVSNNN 126 (582)
Q Consensus 100 l~~N~l~-g~ip~~~~-~~l~~l~ls~N~ 126 (582)
||.|+|+ +.+|..-- +.|++|||++|.
T Consensus 459 lS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 459 LSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred cccchhhhhhhhhhCCCcccceeeccCCc
Confidence 9999998 56666433 799999999997
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.52 E-value=8.4e-08 Score=87.70 Aligned_cols=79 Identities=28% Similarity=0.442 Sum_probs=17.6
Q ss_pred EEEEEeCCCcceeccCccccC-CCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccc-cCCCcCCeeec
Q 047954 23 VTGIVLEDMRLNGEIKSDAFA-DIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSL-LSLKFLESLQL 100 (582)
Q Consensus 23 ~~~l~l~~~~l~g~ip~~~~~-~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~-~~l~~l~~l~l 100 (582)
+..|+|.+|.++- |. .++ .++.|+.|||++|.++. +..+..+.+|+.|+|++|.++ .|+..+ ..+++|+.|+|
T Consensus 21 ~~~L~L~~n~I~~-Ie--~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 21 LRELNLRGNQIST-IE--NLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYL 95 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-
T ss_pred ccccccccccccc-cc--chhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEEC
Confidence 4455555555542 21 233 34555555555555553 344555555555555555555 233333 23555555555
Q ss_pred ccCccc
Q 047954 101 QNNNLT 106 (582)
Q Consensus 101 ~~N~l~ 106 (582)
++|++.
T Consensus 96 ~~N~I~ 101 (175)
T PF14580_consen 96 SNNKIS 101 (175)
T ss_dssp TTS---
T ss_pred cCCcCC
Confidence 555554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.52 E-value=8.1e-08 Score=106.86 Aligned_cols=115 Identities=23% Similarity=0.314 Sum_probs=88.5
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
.++.|+|++|+|++ ||+. .++|..|++++|.|++ +|.+. .+|+.|+|++|.|++ +|... ++|+.|+|+
T Consensus 343 ~Lq~LdLS~N~Ls~-LP~l----p~~L~~L~Ls~N~L~~-LP~l~--~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS 410 (788)
T PRK15387 343 GLQELSVSDNQLAS-LPTL----PSELYKLWAYNNRLTS-LPALP--SGLKELIVSGNRLTS-LPVLP---SELKELMVS 410 (788)
T ss_pred ccceEecCCCccCC-CCCC----Ccccceehhhcccccc-Ccccc--cccceEEecCCcccC-CCCcc---cCCCEEEcc
Confidence 68899999999995 6541 3577888999999985 66542 578999999999984 77543 578899999
Q ss_pred cCcccCCCCCCCCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCC
Q 047954 102 NNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 102 ~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l 151 (582)
+|+|++ ||.. ..+|+.|+|++|+|+ .||.. ..+..+..+++++|+..
T Consensus 411 ~N~Lss-IP~l-~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 411 GNRLTS-LPML-PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred CCcCCC-CCcc-hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCC
Confidence 999985 7763 456888999999987 67864 34667778888888754
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.3e-07 Score=108.98 Aligned_cols=125 Identities=17% Similarity=0.184 Sum_probs=101.7
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeec
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l 100 (582)
..++.|+|.+|++. .+|. .+..+++|+.|+|++|..-+.+|+++.+++|+.|+|++|.....+|.++++|++|+.|+|
T Consensus 611 ~~L~~L~L~~s~l~-~L~~-~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWD-GVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-cccc-ccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 46788888888876 4543 467899999999998887788899989999999999998888899999999999999999
Q ss_pred ccCcccCCCCCC-CCCCCCEEEeecCcccccCCCCCcccccccccccCCC
Q 047954 101 QNNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNP 149 (582)
Q Consensus 101 ~~N~l~g~ip~~-~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~ 149 (582)
++|+.-+.+|.. ++++|+.|+|++|...+.+|.. ...+..+.+.+|.
T Consensus 689 ~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~--~~nL~~L~L~~n~ 736 (1153)
T PLN03210 689 SRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDI--STNISWLDLDETA 736 (1153)
T ss_pred CCCCCcCccCCcCCCCCCCEEeCCCCCCccccccc--cCCcCeeecCCCc
Confidence 998777788875 7889999999998877777753 3355666666665
|
syringae 6; Provisional |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.4e-07 Score=70.68 Aligned_cols=59 Identities=42% Similarity=0.547 Sum_probs=50.7
Q ss_pred CCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcc
Q 047954 69 HKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNL 127 (582)
Q Consensus 69 ~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l 127 (582)
++|+.|+|++|+++..-+..+.++++|++|+|++|+++.--|.. .+++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 46899999999999655578899999999999999998554443 789999999999986
|
... |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.9e-06 Score=82.01 Aligned_cols=107 Identities=17% Similarity=0.225 Sum_probs=81.5
Q ss_pred HHHHHHHHHHHhcCCC--CCccccceEEEeCC----eeEEEEEeCCCC-ChHHHHhcCCCCCCCCccchHHHHHHHHHHH
Q 047954 308 TEEFRKQLLVIADQKH--PNLLPLLAYYFSND----EKLLVYKFAGNG-NLFNRIHGGKSSKNRIPFRCRSRLLVARGVA 380 (582)
Q Consensus 308 ~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia 380 (582)
.....+|...+.++.. =.+.+.+++..... ..++|+|++++- +|.+++.... ..+......++.+++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRALA 128 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHHH
Confidence 3457778887777643 33455666665532 358999999874 7998886422 144556778999999
Q ss_pred HHHHHHhccCCCCCCCcceecCCCCCCeeecCCC---ceEEeeccccccc
Q 047954 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE---MVLVSDYGFSSLV 427 (582)
Q Consensus 381 ~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DfG~a~~~ 427 (582)
..+.-||..+ |+|+|+++.|||++.+. .+.++||+.++..
T Consensus 129 ~~i~~lH~~g-------i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 129 RLIAKLHDAG-------IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHCc-------CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999998 99999999999999887 7899999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.44 E-value=6.4e-07 Score=106.57 Aligned_cols=86 Identities=20% Similarity=0.256 Sum_probs=42.4
Q ss_pred cceeeeCCCCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccc
Q 047954 11 WYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSL 89 (582)
Q Consensus 11 w~gv~c~~~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~ 89 (582)
|.|+.+ ..++..|+|++++.-+.+|. ++.+++|+.|+|++|.....+| .+.++.+|+.|+|++|..-+.+|..+
T Consensus 627 ~~~~~~---l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i 701 (1153)
T PLN03210 627 WDGVHS---LTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI 701 (1153)
T ss_pred cccccc---CCCCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC
Confidence 555543 34566666666554455542 4555566666665554444444 23444555555555544444444433
Q ss_pred cCCCcCCeeeccc
Q 047954 90 LSLKFLESLQLQN 102 (582)
Q Consensus 90 ~~l~~l~~l~l~~ 102 (582)
++++|+.|+|++
T Consensus 702 -~l~sL~~L~Lsg 713 (1153)
T PLN03210 702 -NLKSLYRLNLSG 713 (1153)
T ss_pred -CCCCCCEEeCCC
Confidence 333344433333
|
syringae 6; Provisional |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.9e-06 Score=79.70 Aligned_cols=136 Identities=15% Similarity=0.084 Sum_probs=84.3
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCC--ccccceEEEeCCeeEEEEEeCCCCC-
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPN--LLPLLAYYFSNDEKLLVYKFAGNGN- 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gs- 350 (582)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 24457788875422 3455688999998875433 4666777777777889999998863
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCC------------------------------------CCC
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK------------------------------------SRT 394 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~------------------------------------~~~ 394 (582)
+...+. .+......++..+++.+.-||+... ...
T Consensus 82 ~~~~~~----------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 82 FSRIIS----------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred hhhhhc----------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 211111 0001111122222222222221100 001
Q ss_pred CCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 395 QSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 395 ~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
.+.++|+|+.|.||++++++ +.|+||+.+.
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 33578999999999999888 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.7e-07 Score=85.65 Aligned_cols=105 Identities=30% Similarity=0.447 Sum_probs=36.5
Q ss_pred cCCCCCCcEEEccCCccccccCCCC-CCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCC-C--CCCCC
Q 047954 42 FADIPELIVINFKNNIISGNFMNFS-SNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE-F--NQSSL 117 (582)
Q Consensus 42 ~~~l~~L~~l~l~~n~~~g~~~~~~-~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~-~--~~~~l 117 (582)
+.+...++.|+|++|.++- |..++ .+.+|+.||||+|.++. |+ .+..|+.|+.|+|++|.++. |+. . .+++|
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-Ie~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L 90 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-IENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT-
T ss_pred ccccccccccccccccccc-ccchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCcC
Confidence 5566788999999999875 45666 57899999999999984 44 47789999999999999984 543 2 47899
Q ss_pred CEEEeecCcccc--cCCCCCcccccccccccCCCC
Q 047954 118 KVFNVSNNNLSG--SIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 118 ~~l~ls~N~l~g--~ip~~~~~~~~~~~~~~~n~~ 150 (582)
+.|+|++|++.. .+-....++.+..+++.+||.
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence 999999999964 222223466778888888863
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.7e-06 Score=89.85 Aligned_cols=150 Identities=16% Similarity=0.216 Sum_probs=94.5
Q ss_pred hhHhhhccc-ccccccCceEEEEEEEcCCceEEEEEecCCCcch--------------------------H----H----
Q 047954 265 LNDLLKAPA-EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLI--------------------------T----E---- 309 (582)
Q Consensus 265 ~~~l~~~~~-~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~----~---- 309 (582)
.+++...+. +-|+.++-|.||+|++++|+.||||+.+..-... . +
T Consensus 121 iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 121 IEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred HHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 344444443 5688999999999999999999999985321100 0 0
Q ss_pred ------HHHHHHHHHhcC----CCCCccccceEEEe-CCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHH
Q 047954 310 ------EFRKQLLVIADQ----KHPNLLPLLAYYFS-NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARG 378 (582)
Q Consensus 310 ------~~~~e~~~l~~l----~H~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ 378 (582)
++.+|..-+.++ ++..=+++=.+|++ .....|+|||+.|-.+.+...-... .++ +..++..
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~-----g~d---~k~ia~~ 272 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA-----GID---RKELAEL 272 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc-----CCC---HHHHHHH
Confidence 133444444433 22222333333332 4567899999999888776432221 133 2333333
Q ss_pred HHHH-HHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 379 VARA-LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 379 ia~g-L~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
++++ +..+-..+ ++|.|..|.||+++.++.+.+.|||+...+.+
T Consensus 273 ~~~~f~~q~~~dg-------ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 273 LVRAFLRQLLRDG-------FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHhcC-------ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3332 22333344 99999999999999999999999999877654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.24 E-value=7.2e-07 Score=90.95 Aligned_cols=129 Identities=24% Similarity=0.309 Sum_probs=89.7
Q ss_pred CeEEEEEeCCCccee----ccCccccCCC-CCCcEEEccCCccccccC-----CCCCCCCCCEEeCCCCcccc----ccc
Q 047954 21 AHVTGIVLEDMRLNG----EIKSDAFADI-PELIVINFKNNIISGNFM-----NFSSNHKLKDIDLSGNKFYG----EIS 86 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g----~ip~~~~~~l-~~L~~l~l~~n~~~g~~~-----~~~~~~~l~~l~l~~N~l~g----~ip 86 (582)
.+++.|++++|++++ .+. ..+..+ ++|+.|+|++|.+++... .+..+.+|+.|+|++|.|++ .++
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~-~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~ 186 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLA-KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALA 186 (319)
T ss_pred CcccEEEeeCCccchHHHHHHH-HHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHH
Confidence 458899999998883 221 234556 889999999999986431 34566789999999999985 355
Q ss_pred ccccCCCcCCeeecccCcccCCCCC------CCCCCCCEEEeecCcccccCCCC--C----cccccccccccCCCC
Q 047954 87 RSLLSLKFLESLQLQNNNLTGPVPE------FNQSSLKVFNVSNNNLSGSIPKT--Q----TLQLFRSYSYSNNPY 150 (582)
Q Consensus 87 ~~~~~l~~l~~l~l~~N~l~g~ip~------~~~~~l~~l~ls~N~l~g~ip~~--~----~~~~~~~~~~~~n~~ 150 (582)
..+..+++|+.|+|++|.+++.-.. ..+++|+.|++++|.+++..... . ....+..+++.+|..
T Consensus 187 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i 262 (319)
T cd00116 187 EGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262 (319)
T ss_pred HHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCC
Confidence 5566778899999999988754322 15678999999999887521111 0 124667777777743
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.4e-07 Score=94.47 Aligned_cols=128 Identities=19% Similarity=0.235 Sum_probs=73.7
Q ss_pred CeEEEEEeCCCccee------ccCccccCCCCCCcEEEccCCccccccC-CCCCC---CCCCEEeCCCCcccc----ccc
Q 047954 21 AHVTGIVLEDMRLNG------EIKSDAFADIPELIVINFKNNIISGNFM-NFSSN---HKLKDIDLSGNKFYG----EIS 86 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g------~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~---~~l~~l~l~~N~l~g----~ip 86 (582)
+.++.++++++.+.+ .++ ..+..+++|+.|+|++|.+++..+ .+..+ ++|+.|+|++|++++ .+.
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~-~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~ 129 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLL-QGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA 129 (319)
T ss_pred CCceEEeccccccCCcchHHHHHH-HHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH
Confidence 446677777776652 121 235566777777777777765442 12222 347777777777762 344
Q ss_pred ccccCC-CcCCeeecccCcccCCCCC------CCCCCCCEEEeecCccccc----CCC-CCcccccccccccCCC
Q 047954 87 RSLLSL-KFLESLQLQNNNLTGPVPE------FNQSSLKVFNVSNNNLSGS----IPK-TQTLQLFRSYSYSNNP 149 (582)
Q Consensus 87 ~~~~~l-~~l~~l~l~~N~l~g~ip~------~~~~~l~~l~ls~N~l~g~----ip~-~~~~~~~~~~~~~~n~ 149 (582)
..+..+ ++|+.|+|++|.+++..+. ..+..|+.|++++|++++. ++. ...+..+..+++++|.
T Consensus 130 ~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~ 204 (319)
T cd00116 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNG 204 (319)
T ss_pred HHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCc
Confidence 455556 6777777777777753322 1345677777777777642 111 0122356666666664
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.15 E-value=4.1e-05 Score=72.80 Aligned_cols=138 Identities=20% Similarity=0.267 Sum_probs=92.5
Q ss_pred cccccCceEEEEEEEcCCceEEEEEecCCCcchH------------------------HHHHHHHHHHhcCC--CCCccc
Q 047954 275 GLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLIT------------------------EEFRKQLLVIADQK--HPNLLP 328 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~e~~~l~~l~--H~niv~ 328 (582)
.|..|.-+.||+|.-.++..+|||+.+....... ....+|+.-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 5888899999999988899999999863221110 12345666666652 333334
Q ss_pred cceEEEeCCeeEEEEEeCCCCCh-HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCC
Q 047954 329 LLAYYFSNDEKLLVYKFAGNGNL-FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTN 407 (582)
Q Consensus 329 l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~N 407 (582)
-+++. ...|||||+..... .-.|. ..++.......+..++++.+.-|-..+ .+||+||..=|
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk-------Dv~~e~~e~~~~~~~~v~~~~~l~~~a------~LVHgDLSEyN 197 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLK-------DVPLELEEAEGLYEDVVEYMRRLYKEA------GLVHGDLSEYN 197 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcc-------cCCcCchhHHHHHHHHHHHHHHHHHhc------Ccccccchhhh
Confidence 44432 45799999965311 11111 112233356667778888888888743 39999999999
Q ss_pred eeecCCCceEEeeccccccccCc
Q 047954 408 ILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 408 ILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
||+. ++.+.|+|||-|.....+
T Consensus 198 iL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 198 ILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred eEEE-CCeEEEEECccccccCCC
Confidence 9999 889999999988766544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.7e-07 Score=95.36 Aligned_cols=178 Identities=17% Similarity=0.166 Sum_probs=129.4
Q ss_pred cccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCC-ccccceEEEeCCeeEEEEEeCCCC-ChH
Q 047954 275 GLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPN-LLPLLAYYFSNDEKLLVYKFAGNG-NLF 352 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e~~~~g-sL~ 352 (582)
-+++|+++++||.+-...+....+.+.. .....-++++|.+++||| .+..++-+..++..+++++|+..| +-.
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 4789999999998744333333444322 145567889999999999 788888887888899999999887 221
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc--
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP-- 430 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~-- 430 (582)
..+.. ....+...+...+.+.-.++++|||+.- =+||| ||+..+ ...|..||+....+...
T Consensus 324 ~~~~~-----se~~~~~~~~~~~~r~et~~l~~l~~~~-------~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~ 386 (829)
T KOG0576|consen 324 LEMTV-----SEIALEQYQFAYPLRKETRPLAELHSSY-------KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK 386 (829)
T ss_pred ccCCh-----hhHhhhhhhhhhhhhhhccccccccccc-------ccCcc----cccccc-cccccccccCCcccCcccc
Confidence 11110 1122444455556677788999999864 48999 877765 67899999998776554
Q ss_pred -ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 047954 431 -IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTH 474 (582)
Q Consensus 431 -~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~ 474 (582)
....++..|+|||+.....+..+.|+|+.|+-..+|--|-.|-.
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 33446778999999999999999999999987777777766654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.3e-05 Score=74.76 Aligned_cols=74 Identities=9% Similarity=-0.010 Sum_probs=51.1
Q ss_pred ccccCc-eEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEEeCCCCChHH
Q 047954 276 LGKGIF-GNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYKFAGNGNLFN 353 (582)
Q Consensus 276 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 353 (582)
|-.|.. ..||+....+ ..+++|...... .....+|++++..+. +--+.+++++....+..++|||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444544 7899987654 668888875432 335667888887763 3445577777766667899999999877754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.2e-07 Score=100.58 Aligned_cols=126 Identities=28% Similarity=0.299 Sum_probs=91.3
Q ss_pred EEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccc-cccCCCcCCeeeccc
Q 047954 24 TGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISR-SLLSLKFLESLQLQN 102 (582)
Q Consensus 24 ~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~-~~~~l~~l~~l~l~~ 102 (582)
...+.+.|.|.- + .+.+.-++.|+.|||+.|+|+-.- .+..+.+|++|||++|.|. .+|. +...+. |+.|+|+|
T Consensus 167 ~~a~fsyN~L~~-m-D~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrn 241 (1096)
T KOG1859|consen 167 ATASFSYNRLVL-M-DESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRN 241 (1096)
T ss_pred hhhhcchhhHHh-H-HHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhhh-heeeeecc
Confidence 344555555542 2 345677889999999999998765 6777888999999999998 4553 445555 99999999
Q ss_pred CcccCCCCCCCCCCCCEEEeecCccccc--CCCCCcccccccccccCCCCCCCC
Q 047954 103 NNLTGPVPEFNQSSLKVFNVSNNNLSGS--IPKTQTLQLFRSYSYSNNPYLCGP 154 (582)
Q Consensus 103 N~l~g~ip~~~~~~l~~l~ls~N~l~g~--ip~~~~~~~~~~~~~~~n~~l~~~ 154 (582)
|.++--.--.++.+|..||||+|-|+|- +-....+..+..+.+.|||.-|.+
T Consensus 242 N~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 242 NALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred cHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 9988433334788999999999998863 212234556777889999977753
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.08 E-value=6.3e-07 Score=85.88 Aligned_cols=61 Identities=26% Similarity=0.307 Sum_probs=28.4
Q ss_pred CCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCccc
Q 047954 44 DIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLT 106 (582)
Q Consensus 44 ~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~ 106 (582)
....|+.+|||.|.++-.-.+..-.+.++.|+||.|.+. .+- ++.-|++|+.||||+|.|+
T Consensus 282 TWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls 342 (490)
T KOG1259|consen 282 TWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA 342 (490)
T ss_pred hHhhhhhccccccchhhhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH
Confidence 344555555555555443322233344555555555554 111 1444455555555555544
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.06 E-value=5e-07 Score=93.64 Aligned_cols=125 Identities=22% Similarity=0.304 Sum_probs=75.2
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
.++.|+|+.|+++ .+|.. ++.|+ |+.|-++||+++--.++++....|..||.|.|++. .+|+.++.|.+|+.|++.
T Consensus 122 ~lt~l~ls~NqlS-~lp~~-lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr 197 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPDG-LCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR 197 (722)
T ss_pred HHHHhhhccchhh-cCChh-hhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence 3455555555555 23332 33332 45555666666555555555556666666666665 566666666666666666
Q ss_pred cCcccCCCCCCCCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCC
Q 047954 102 NNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 102 ~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l 151 (582)
.|++.--.+....-.|..||+|.|+++ .||.+ ..+..|..+.+.+||..
T Consensus 198 Rn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 198 RNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 666653322223345778899999887 57754 34666777788888753
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.04 E-value=3.6e-06 Score=58.03 Aligned_cols=37 Identities=35% Similarity=0.587 Sum_probs=29.0
Q ss_pred CCCCEEeCCCCcccccccccccCCCcCCeeecccCccc
Q 047954 69 HKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLT 106 (582)
Q Consensus 69 ~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~ 106 (582)
++|++|+|++|+++ .||..+++|++|+.|+|++|+++
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 36888888888888 67878888888888888888887
|
... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=4.9e-05 Score=81.06 Aligned_cols=151 Identities=15% Similarity=0.202 Sum_probs=91.2
Q ss_pred hhHhhhccc-ccccccCceEEEEEEEcCCceEEEEEecCCCcch---------------------------HH-------
Q 047954 265 LNDLLKAPA-EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLI---------------------------TE------- 309 (582)
Q Consensus 265 ~~~l~~~~~-~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------~~------- 309 (582)
++++...+. +-||.-+.|.||+|++++|+.||||+.+..-... .+
T Consensus 157 ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 157 IEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred HHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 344444443 5699999999999999999999999976421110 00
Q ss_pred ---HHHHHHHHHhc----CCCCCc---cccceEEEe-CCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHH
Q 047954 310 ---EFRKQLLVIAD----QKHPNL---LPLLAYYFS-NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARG 378 (582)
Q Consensus 310 ---~~~~e~~~l~~----l~H~ni---v~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ 378 (582)
+|.+|.+-..+ ++|-+. |.+=.++++ .....|+||||+|..+.+.-.-... .++.. .|+..
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-----gi~~~---~i~~~ 308 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-----GISPH---DILNK 308 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-----CCCHH---HHHHH
Confidence 14444433322 345441 112223332 3467899999999876554322111 13333 33333
Q ss_pred HHHHHHH-HhccCCCCCCCcceecCCCCCCeeecC----CCceEEeeccccccccCc
Q 047954 379 VARALEY-LHHKDKSRTQSAVIHGNLKSTNILLDD----NEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 379 ia~gL~y-LH~~~~~~~~~~ivH~Dlkp~NILl~~----~~~~kl~DfG~a~~~~~~ 430 (582)
+.++... +-..| ++|+|-.|-||++.. ++.+.+-|||+...+...
T Consensus 309 l~~~~~~qIf~~G-------ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 309 LVEAYLEQIFKTG-------FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHHHHHHHhcC-------CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 3333222 22233 999999999999984 677999999998776543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.4e-05 Score=72.94 Aligned_cols=105 Identities=15% Similarity=0.165 Sum_probs=81.1
Q ss_pred HHHHHHHhcCCC-CCccccceEEEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccC
Q 047954 312 RKQLLVIADQKH-PNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390 (582)
Q Consensus 312 ~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 390 (582)
..|..++..+.+ +++.+++|+| ..++|.||...+++...... -.....-+|..|.+||.++++.+.+|++.-
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~---l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP---LSQFLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc---cccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 357788888876 6999999999 34789999987766432100 001124689999999999999999999854
Q ss_pred CCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 391 ~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
...+.-.|++++|+-+++++++|++|.......
T Consensus 80 ----~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 ----LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred ----CCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 223888999999999999999999999866443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.98 E-value=6e-05 Score=72.83 Aligned_cols=77 Identities=18% Similarity=0.222 Sum_probs=55.4
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCC--CccccceEEEeC---CeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHP--NLLPLLAYYFSN---DEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~~~---~~~~lv~e~~~~ 348 (582)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.+.... ...+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 458899999999999888 57999997543 3456778888888877433 345666654332 346899999999
Q ss_pred CChHH
Q 047954 349 GNLFN 353 (582)
Q Consensus 349 gsL~~ 353 (582)
..+..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 87766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00022 Score=66.85 Aligned_cols=128 Identities=13% Similarity=0.208 Sum_probs=88.8
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCC----------------cchHHHHHHHHHHHhcCC------CCCccccc
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLK----------------PLITEEFRKQLLVIADQK------HPNLLPLL 330 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------H~niv~l~ 330 (582)
...||+|+.=.||. +++.....||+++... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35799999999996 4455557788886544 122455667766555554 88999999
Q ss_pred eEEEeCCeeEEEEEeCCC------CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCC
Q 047954 331 AYYFSNDEKLLVYKFAGN------GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLK 404 (582)
Q Consensus 331 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlk 404 (582)
|+..++....+|+|.+.+ -+|.+++.... ++. . +...+-+-..||-... |+.+|++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-------~~~-~---~~~~L~~f~~~l~~~~-------Iv~~dl~ 145 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-------LTE-E---LRQALDEFKRYLLDHH-------IVIRDLN 145 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-------ccH-H---HHHHHHHHHHHHHHcC-------CeecCCC
Confidence 999999999999998754 26777775332 333 2 2233334456666666 9999999
Q ss_pred CCCeeecCCC----ceEEee
Q 047954 405 STNILLDDNE----MVLVSD 420 (582)
Q Consensus 405 p~NILl~~~~----~~kl~D 420 (582)
|.||++.... .+.|+|
T Consensus 146 ~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 146 PHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cccEEEEecCCCceEEEEEe
Confidence 9999996432 466777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00013 Score=84.01 Aligned_cols=154 Identities=10% Similarity=0.194 Sum_probs=92.6
Q ss_pred ccccccCceEEEEEEEcCC---ceEEEEEecCCC-cchHHHHHHHHHHHhcCC-CCCc--cccceEEEeC---CeeEEEE
Q 047954 274 EGLGKGIFGNSYKALLEGR---APVVVKRLRDLK-PLITEEFRKQLLVIADQK-HPNL--LPLLAYYFSN---DEKLLVY 343 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lv~ 343 (582)
+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++++|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5688999999999887654 357777764322 123457889999999885 6654 7778887664 4578999
Q ss_pred EeCCCCChHH-----------------------HHhcCCCCC-----CCCccch--HHHHHHH---------------HH
Q 047954 344 KFAGNGNLFN-----------------------RIHGGKSSK-----NRIPFRC--RSRLLVA---------------RG 378 (582)
Q Consensus 344 e~~~~gsL~~-----------------------~l~~~~~~~-----~~~~l~~--~~~~~i~---------------~~ 378 (582)
||+++..+.+ .||.-.... ...+..+ .+...+. -.
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 9998754321 122111000 0000011 0111110 12
Q ss_pred HHHHHHHHhccCCCCC----CCcceecCCCCCCeeecCC-Cc-eEEeeccccccc
Q 047954 379 VARALEYLHHKDKSRT----QSAVIHGNLKSTNILLDDN-EM-VLVSDYGFSSLV 427 (582)
Q Consensus 379 ia~gL~yLH~~~~~~~----~~~ivH~Dlkp~NILl~~~-~~-~kl~DfG~a~~~ 427 (582)
+.+.+.+|..+-+... .+.+||+|+++.|||++.+ .. +-|.||.++..-
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 3344667765543221 2469999999999999853 33 568899987653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=3e-06 Score=84.29 Aligned_cols=129 Identities=23% Similarity=0.340 Sum_probs=100.6
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCC-CCccccccc-ccccCCCcCCee
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLS-GNKFYGEIS-RSLLSLKFLESL 98 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~-~N~l~g~ip-~~~~~l~~l~~l 98 (582)
..+.|+|..|+++ .||+..|+.+..|+.||||+|+++-.-| .|.++.+|..|-|. +|+++ .|| ..|++|.+|+.|
T Consensus 68 ~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrL 145 (498)
T KOG4237|consen 68 ETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRL 145 (498)
T ss_pred cceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHH
Confidence 3578999999998 6889999999999999999999998777 48888887766555 48888 555 568999999999
Q ss_pred ecccCcccCCCCC--CCCCCCCEEEeecCcccccCCCC--CcccccccccccCCCCCCC
Q 047954 99 QLQNNNLTGPVPE--FNQSSLKVFNVSNNNLSGSIPKT--QTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 99 ~l~~N~l~g~ip~--~~~~~l~~l~ls~N~l~g~ip~~--~~~~~~~~~~~~~n~~l~~ 153 (582)
.|.-|+++=.... ..+.+|..|.+-.|.+. .|+.+ ..+..+..+.++-|++.|.
T Consensus 146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icd 203 (498)
T KOG4237|consen 146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICD 203 (498)
T ss_pred hcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccc
Confidence 9999999843333 26788888888888886 45543 2345566677888887764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.0002 Score=67.47 Aligned_cols=123 Identities=12% Similarity=0.103 Sum_probs=75.3
Q ss_pred CceEEEEEEEcCCceEEEEEecCCCcchHHHH---------HHHHHHHhcCCC---CCccccceEEEe-----CCeeEEE
Q 047954 280 IFGNSYKALLEGRAPVVVKRLRDLKPLITEEF---------RKQLLVIADQKH---PNLLPLLAYYFS-----NDEKLLV 342 (582)
Q Consensus 280 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~H---~niv~l~~~~~~-----~~~~~lv 342 (582)
....|.+...+ +..+++|..+.......+.| .+++..+.+++. -..+.++..... ....+++
T Consensus 43 ~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll 121 (229)
T PF06176_consen 43 KRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLL 121 (229)
T ss_pred CccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEE
Confidence 33444444444 45688888765433322222 233333333322 222332322222 2345689
Q ss_pred EEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecc
Q 047954 343 YKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG 422 (582)
Q Consensus 343 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 422 (582)
|||++|..|.+... ++. .++..+++++.-||..| ++|+|..|.|+++++++ +++.||+
T Consensus 122 ~EYIeG~~l~d~~~----------i~e----~~~~ki~~~ikqlH~~G-------~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 122 MEYIEGVELNDIED----------IDE----DLAEKIVEAIKQLHKHG-------FYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred EEEecCeecccchh----------cCH----HHHHHHHHHHHHHHHcC-------CccCCCCcCcEEEECCc-EEEEECc
Confidence 99999987765432 221 24556788899999998 99999999999999654 8999998
Q ss_pred ccc
Q 047954 423 FSS 425 (582)
Q Consensus 423 ~a~ 425 (582)
..+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.81 E-value=4e-06 Score=80.45 Aligned_cols=122 Identities=22% Similarity=0.293 Sum_probs=61.2
Q ss_pred EEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeeccc
Q 047954 23 VTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQN 102 (582)
Q Consensus 23 ~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~ 102 (582)
++.++|++|.++- | .+...-+|.++.|++|.|.+.- +.++..+.+|+.||||+|.|+ .+--+-.+|-+++.|.|+.
T Consensus 286 LtelDLS~N~I~~-i-DESvKL~Pkir~L~lS~N~i~~-v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 286 LTELDLSGNLITQ-I-DESVKLAPKLRRLILSQNRIRT-VQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhccccccchhh-h-hhhhhhccceeEEeccccceee-ehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence 3455666665542 2 2334455666666666666542 222444556666666666665 2222333445566666666
Q ss_pred CcccCCCCC-CCCCCCCEEEeecCcccc--cCCCCCcccccccccccCCC
Q 047954 103 NNLTGPVPE-FNQSSLKVFNVSNNNLSG--SIPKTQTLQLFRSYSYSNNP 149 (582)
Q Consensus 103 N~l~g~ip~-~~~~~l~~l~ls~N~l~g--~ip~~~~~~~~~~~~~~~n~ 149 (582)
|.+.. +.. ..+-+|..||+++|++.- .+-..+.++-+..+.+.+||
T Consensus 362 N~iE~-LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 362 NKIET-LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred hhHhh-hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence 65431 111 134456666666666541 12222333344455555555
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00023 Score=69.23 Aligned_cols=73 Identities=11% Similarity=0.025 Sum_probs=43.9
Q ss_pred ccccccCce-EEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCC---CccccceEEEeC---CeeEEEEEeC
Q 047954 274 EGLGKGIFG-NSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHP---NLLPLLAYYFSN---DEKLLVYKFA 346 (582)
Q Consensus 274 ~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~~~---~~~~lv~e~~ 346 (582)
+.|+.|+.. .||+. +..+++|..+. ......+.+|.+++..+... -+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 346767766 58875 23466776543 22345788899888877532 233333333222 1347899999
Q ss_pred CCCChH
Q 047954 347 GNGNLF 352 (582)
Q Consensus 347 ~~gsL~ 352 (582)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.76 E-value=1.4e-05 Score=84.25 Aligned_cols=120 Identities=28% Similarity=0.410 Sum_probs=81.7
Q ss_pred EEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCC-CCCEEeCCCCcccccccccccCCCcCCeeecccC
Q 047954 25 GIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNH-KLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNN 103 (582)
Q Consensus 25 ~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~-~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N 103 (582)
.+.+..|.+...+. .+..++.+..|++.+|.++-..+...... +|+.|++++|++. .+|..+.+++.|+.|++++|
T Consensus 97 ~l~~~~~~~~~~~~--~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSNIS--ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccCch--hhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 46777777655543 24556777888888888776666656553 7888888888877 66677778888888888888
Q ss_pred cccCCCCCC--CCCCCCEEEeecCcccccCCCCC-cccccccccccCCC
Q 047954 104 NLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQ-TLQLFRSYSYSNNP 149 (582)
Q Consensus 104 ~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~~-~~~~~~~~~~~~n~ 149 (582)
+++ .+|.. ..+.|+.|++++|+++ .||... ....+..+.+++|.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 887 44443 6677777888888776 455442 33346666666663
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00021 Score=80.79 Aligned_cols=198 Identities=17% Similarity=0.214 Sum_probs=133.7
Q ss_pred HHHHHHHHhcCCCCCccccceEEEeCCee----EEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHH
Q 047954 311 FRKQLLVIADQKHPNLLPLLAYYFSNDEK----LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386 (582)
Q Consensus 311 ~~~e~~~l~~l~H~niv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL 386 (582)
...|+..+.++.|+|++.+++|....... .+..||+..-++...+..- ...+....+.+..++.+||.|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v------~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV------GSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc------cccCHHHHHHHHHHHhhhHHHH
Confidence 34566778889999999999987765432 2455788888888777543 2466777888889999999999
Q ss_pred hccCCCCCCCcceecCCCCC---CeeecCCCceEEe--eccccccccCccccc---ccccccCCCCCCCCCCCc--chhH
Q 047954 387 HHKDKSRTQSAVIHGNLKST---NILLDDNEMVLVS--DYGFSSLVAQPIAAQ---RMISYKSPEYQSSKKISR--KSDV 456 (582)
Q Consensus 387 H~~~~~~~~~~ivH~Dlkp~---NILl~~~~~~kl~--DfG~a~~~~~~~~~~---~~~~y~aPE~~~~~~~~~--k~DV 456 (582)
|+.. ..|.-+..+ +--.+..+...++ ||+.++.+....... ....|.|+|......+.. ..|+
T Consensus 303 h~~~-------l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 303 HSLS-------LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred HHhc-------cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHH
Confidence 9986 566555554 4445566667766 898887765543222 234577888776655544 4799
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCC
Q 047954 457 WSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE 536 (582)
Q Consensus 457 wS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 536 (582)
|.+|..+..+..|..+-.... . +..+.+.. ......+...+|+..++++|++
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~-------~------------~~~~l~~~---------~~~~~~d~~~~~~~~~~~~Rl~ 427 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSA-------V------------PVSLLDVL---------STSELLDALPKCLDEDSEERLS 427 (1351)
T ss_pred HHHHHHHhhhhhcCccccccc-------c------------hhhhhccc---------cchhhhhhhhhhcchhhhhccc
Confidence 999999999988765432100 0 00000100 0003556777999999999999
Q ss_pred hHHHHHHHhhccc
Q 047954 537 MAEVVSELEIIKV 549 (582)
Q Consensus 537 ~~evl~~L~~i~~ 549 (582)
+.+++.+...-.+
T Consensus 428 ~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 428 ALELLTHPFLRFP 440 (1351)
T ss_pred hhhhhhchhcccc
Confidence 9999988764433
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00024 Score=63.96 Aligned_cols=129 Identities=18% Similarity=0.206 Sum_probs=85.0
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccc-cceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLP-LLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~-l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
...|++|.+|.||++.+.++ .+|+|+-+.. .....+..|.++|..+.--++.+ +|.| +..++.|||..|..|
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~~L 99 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGG-EVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhcccccEEEEeeccCc-eEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCcch
Confidence 35799999999999998876 5888886543 34677899999999887766644 3333 233456999988788
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCC-CCeeecCCCceEEeecccccccc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKS-TNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp-~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
.++-... +-.. ...++++---|-..+ |-|..|.- ..++|..+..+.|+||..|+.-.
T Consensus 100 ~~~~~~~---------~rk~----l~~vlE~a~~LD~~G-------I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 100 GKLEIGG---------DRKH----LLRVLEKAYKLDRLG-------IEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhhcc---------cHHH----HHHHHHHHHHHHHhc-------cchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 7655321 1111 233444422334444 88888764 44444445589999999887543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 582 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-30 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-30 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-09 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-04 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-04 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-04 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-04 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-04 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-58
Identities = 93/312 (29%), Positives = 152/312 (48%), Gaps = 25/312 (8%)
Query: 259 QPAGFKLNDLLKA-----PAEGLGKGIFGNSYKALLEGRAPVVVKRL-RDLKPLITEEFR 312
Q F L +L A LG+G FG YK L V VKRL + +F+
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 313 KQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSR 372
++ +I+ H NLL L + + E+LLVY + NG++ + + +++ P R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE--RPESQPPLDWPKR 133
Query: 373 LLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA 432
+A G AR L YLH + +IH ++K+ NILLD+ +V D+G + L+
Sbjct: 134 QRIALGSARGLAYLHDHCDPK----IIHRDVKAANILLDEEFEAVVGDFGLAKLMD---Y 186
Query: 433 AQRMIS--------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRIST-HSAPQGINGA 483
++ + +PEY S+ K S K+DV+ +G +LLEL+TG+ + + +
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 484 DLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543
L WV ++E+ + D ++ + +L+QVA+ C SP +RP+M+EVV
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDE-EVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 544 LEIIKVTESTEE 555
LE + E EE
Sbjct: 306 LEGDGLAERWEE 317
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-56
Identities = 90/306 (29%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 263 FKLNDLLKA-----PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLV 317
L DL +A +G G+FG YK +L A V +KR EEF ++
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 318 IADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVAR 377
++ +HP+L+ L+ + +E +L+YK+ NGNL ++G + + RL +
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE--QRLEICI 146
Query: 378 GVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI 437
G AR L YLH + A+IH ++KS NILLD+N + ++D+G S Q +
Sbjct: 147 GAARGLHYLHTR-------AIIHRDVKSINILLDENFVPKITDFGISKKG--TELDQTHL 197
Query: 438 S--------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR--ISTHSAPQGINGADLCS 487
S Y PEY +++ KSDV+SFG +L E+L R I + +N L
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN---LAE 254
Query: 488 WVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-I 546
W + + +I D ++ + + K A++C S E RP M +V+ +LE
Sbjct: 255 WAVESHNNGQLEQIVDPNLADKIR-PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
Query: 547 IKVTES 552
+++ ES
Sbjct: 314 LRLQES 319
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-52
Identities = 80/290 (27%), Positives = 138/290 (47%), Gaps = 36/290 (12%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLIT----EEFRKQLLVIADQKHPNLLPLLA 331
+G+G FG YK + V VK+L + + T ++F +++ V+A +H NL+ LL
Sbjct: 39 MGEGGFGVVYKGYVNNT-TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
+ D+ LVY + NG+L +R+ P R +A+G A + +LH
Sbjct: 98 FSSDGDDLCLVYVYMPNGSLLDRLSC---LDGTPPLSWHMRCKIAQGAANGINFLHEN-- 152
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS--------YKSPE 443
IH ++KS NILLD+ +SD+G + AQ +++ Y +PE
Sbjct: 153 -----HHIHRDIKSANILLDEAFTAKISDFGLARAS--EKFAQTVMTSRIVGTTAYMAPE 205
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTGR--ISTHSAPQGINGADLCSWVLRAVREEWT-AE 500
+I+ KSD++SFG +LLE++TG + H PQ L EE T +
Sbjct: 206 ALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-----LLLDIKEEIEDEEKTIED 259
Query: 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550
D +++ + + + + VA QC ++ KRP++ +V L+ + +
Sbjct: 260 YIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-40
Identities = 67/298 (22%), Positives = 126/298 (42%), Gaps = 33/298 (11%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
+G+G FG KA + V +K++ + F +L ++ HPN++ L
Sbjct: 16 VGRGAFGVVCKAKWRAK-DVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYG--AC 70
Query: 336 NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQ 395
+ LV ++A G+L+N +HG ++ + + ++ + YLH S
Sbjct: 71 LNPVCLVMEYAEGGSLYNVLHG---AEPLPYYTAAHAMSWCLQCSQGVAYLH----SMQP 123
Query: 396 SAVIHGNLKSTNILLDDNEMVL-VSDYGFSSLVAQPIAAQR-MISYKSPEYQSSKKISRK 453
A+IH +LK N+LL VL + D+G + + + + ++ +PE S K
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 454 SDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAVREEWTAEIFDSEISVQRSA 512
DV+S+G +L E++T R P I G ++ AV + ++
Sbjct: 184 CDVFSWGIILWEVITRRK-----PFDEIGGPAFR--IMWAVHNGTRPPL-------IKNL 229
Query: 513 AHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-IIKVTESTEEEEDFWLDQSLTDES 569
+ L+ +C +K P +RP M E+V + +++ +E + SL
Sbjct: 230 PKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGE 284
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-38
Identities = 73/286 (25%), Positives = 132/286 (46%), Gaps = 45/286 (15%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
+G G FG YK G V VK L P + F+ ++ V+ +H N+L + Y
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88
Query: 334 FSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
S +L +V ++ +L++ +H + F + + +AR AR ++YLH K
Sbjct: 89 -STAPQLAIVTQWCEGSSLYHHLH-----ASETKFEMKKLIDIARQTARGMDYLHAKS-- 140
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM------ISYKSPE--- 443
+IH +LKS NI L ++ V + D+G ++ ++ + + I + +PE
Sbjct: 141 -----IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSW-VLRAVREEWTAEI 501
Q S S +SDV++FG +L EL+TG++ P IN D V R +++
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQL-----PYSNINNRDQIIEMVGRGSLSPDLSKV 250
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547
+ + M +L+ +C K ++RP +++E+E +
Sbjct: 251 -------RSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIEEL 286
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 34/279 (12%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
+G G FG ++A G V VK L D EF +++ ++ +HPN++ +
Sbjct: 45 IGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+V ++ G+L+ +H ++ ++ R RL +A VA+ + YLH+++
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDER--RRLSMAYDVAKGMNYLHNRNPP- 159
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM----ISYKSPEYQSSKK 449
++H NLKS N+L+D V V D+G S L A + + + +PE +
Sbjct: 160 ----IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 450 ISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAVREEWTAEIFDSEISV 508
+ KSDV+SFG +L EL T + P +N A + V + EI
Sbjct: 216 SNEKSDVYSFGVILWELATLQQ-----PWGNLNPAQV---VAAVGFKCKRLEI------- 260
Query: 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547
R+ + +++ C P KRP A ++ L +
Sbjct: 261 PRNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPL 296
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 60/287 (20%), Positives = 112/287 (39%), Gaps = 49/287 (17%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
L + G +K +G +VVK L+ D + +F ++ + HPN+LP+L
Sbjct: 18 LNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 334 FSNDEKLL--VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
S + + G+L+N +H + A +AR + +LH +
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLH----EGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYK--SPE---YQS 446
+ L S ++++D++ +S P RM + +PE +
Sbjct: 133 L-----IPRHALNSRSVMIDEDMTARISMADVKFSFQSP---GRMYAPAWVAPEALQKKP 184
Query: 447 SKKISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWV----LRAVREEWTAEI 501
R +D+WSF LL EL+T + P ++ ++ V LR
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREV-----PFADLSNMEIGMKVALEGLR---------- 229
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548
++ + + KL++ C N+ P KRP+ +V LE ++
Sbjct: 230 ----PTIPPGISPHVSKLMK---ICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-37
Identities = 54/301 (17%), Positives = 104/301 (34%), Gaps = 45/301 (14%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRL--RDLKPLITEEFRKQLLVIADQKHPNLLPLLA 331
E +G FG +KA L V VK +D + + + ++ + KH N+L +
Sbjct: 30 EVKARGRFGCVWKAQLLNE-YVAVKIFPIQDKQ---SWQNEYEVYSLPGMKHENILQFIG 85
Query: 332 Y----YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
+ + L+ F G+L + + N + + +A +AR L YLH
Sbjct: 86 AEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWN--ELCHIAETMARGLAYLH 138
Query: 388 HKDKSRTQS---AVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS------ 438
A+ H ++KS N+LL +N ++D+G + +A
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 439 YKSPEY-----QSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAV 493
Y +PE + + D+++ G +L EL + + +
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT-----AADGPVDEYMLPFEEEI 253
Query: 494 REEWTAEIFDSEISVQR---------SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
+ + E + ++ GM L + +C + E R V +
Sbjct: 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313
Query: 545 E 545
Sbjct: 314 T 314
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-36
Identities = 77/287 (26%), Positives = 118/287 (41%), Gaps = 45/287 (15%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLR----DLKPLITEEFRKQLLVIADQKHPNLLPLLA 331
+G G FG Y+A G V VK R + E R++ + A KHPN++ L
Sbjct: 15 IGIGGFGKVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
LV +FA G L + RIP + A +AR + YLH
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPD--ILVNWAVQIARGMNYLH---- 122
Query: 392 SRTQSAVIHGNLKSTNILLD--------DNEMVLVSDYGFSSLVAQPIAAQRMISYK--S 441
+IH +LKS+NIL+ N+++ ++D+G + + +Y +
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMA 182
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAVREEWTAE 500
PE + S+ SDVWS+G LL ELLTG + P +GI+G + V +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEV-----PFRGIDGLAVAYGV---AMNKLALP 234
Query: 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547
I + KL++ C N P RP ++ +L I
Sbjct: 235 I-------PSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 56/307 (18%), Positives = 111/307 (36%), Gaps = 55/307 (17%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
+GKG FG Y G V ++ + + F+++++ +H N++ +
Sbjct: 41 IGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
S ++ L++ + +I +A+ + + + YLH K
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVR-----DAKIVLDVNKTRQIAQEIVKGMGYLHAKG--- 150
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR-----------------M 436
++H +LKS N+ D+ V+++D+G S+ A +R +
Sbjct: 151 ----ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 437 ISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAVR 494
I SP+ + K S+ SDV++ G + EL P + + + ++
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW-----PFKTQPAEAIIWQMGTGMK 260
Query: 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-IIKVTEST 553
+ EIS +L C E+RP +++ LE + K
Sbjct: 261 PNLSQIGMGKEIS----------DILL---FCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307
Query: 554 EEEEDFW 560
FW
Sbjct: 308 SHPGHFW 314
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 57/289 (19%), Positives = 119/289 (41%), Gaps = 45/289 (15%)
Query: 276 LGKGIFGNSYKALLEGR-APVVVKRLRD-------LKPLITEEFRKQLLVIADQKHPNLL 327
+GKG FG +K L + V +K L +EF++++ ++++ HPN++
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
L ++ +V +F G+L++R+ P + +L + +A +EY+
Sbjct: 87 KLYG--LMHNPPRMVMEFVPCGDLYHRLL-----DKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVL-----VSDYGFSSLVAQPIAAQR-MISYKS 441
+++ ++H +L+S NI L + V+D+G S ++ + +
Sbjct: 140 NQNPP-----IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMA 194
Query: 442 PE--YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAVREEWT 498
PE + + K+D +SF +L +LTG P + + ++ E
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEG-----PFDEYSYGKI-KFINMIREEGLR 248
Query: 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547
I + +++ C + P+KRP + +V EL +
Sbjct: 249 PTI-------PEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-34
Identities = 62/313 (19%), Positives = 118/313 (37%), Gaps = 57/313 (18%)
Query: 276 LGKGIFGNSYKALLEGRA-PVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
LGKG FG + K +V+K L F K++ V+ +HPN+L + +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRT 394
+ + ++ G L I + R+ A+ +A + YLH +
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIK-----SMDSQYPWSQRVSFAKDIASGMAYLHSMN---- 128
Query: 395 QSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ-PIAAQRMISYKSPEYQSSKKI--- 450
+IH +L S N L+ +N+ V+V+D+G + L+ + + S K P+ + +
Sbjct: 129 ---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 451 --------------SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496
K DV+SFG +L E++ +
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN---------------------ADPD 224
Query: 497 WTAEIFDSEISVQRSA-----AHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551
+ D ++V+ + + ++CC+ PEKRP ++ LE +++
Sbjct: 225 YLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
Query: 552 STEEEEDFWLDQS 564
+ L+Q
Sbjct: 285 AGHLPLGPQLEQL 297
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 59/319 (18%), Positives = 113/319 (35%), Gaps = 53/319 (16%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRL--RDLKPLITEEFRKQLLVIADQKHPNLLPLLAY- 332
+G+G +G YK L+ R PV VK + + I E K + + +H N+ +
Sbjct: 21 IGRGRYGAVYKGSLDER-PVAVKVFSFANRQNFINE---KNIYRVPLMEHDNIARFIVGD 76
Query: 333 ----YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
E LLV ++ NG+L + + + RL A V R L YLH
Sbjct: 77 ERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRL--AHSVTRGLAYLHT 129
Query: 389 KDKSRTQS--AVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-------- 438
+ A+ H +L S N+L+ ++ ++SD+G S + +
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 439 ----YKSPEY-------QSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCS 487
Y +PE + + ++ D+++ G + E+ T P +
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TDLFPGESVPEYQMA 247
Query: 488 WVLRAVREEWTAEIFDSEISVQR----------SAAHGMLKLLQVAIQCCNKSPEKRPEM 537
+ V T E +S ++ + + L + C ++ E R
Sbjct: 248 FQ-TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA 306
Query: 538 AEVVSELE-IIKVTESTEE 555
+ ++ + E +
Sbjct: 307 QXAEERMAELMMIWERNKS 325
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 59/310 (19%), Positives = 113/310 (36%), Gaps = 59/310 (19%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFR-KQLLVIADQKHPNLLPLLAY 332
E +GKG +G ++ +G V VK FR +L +H N+L +A
Sbjct: 14 ECVGKGRYGEVWRGSWQGE-NVAVKIFSS--RDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 333 ----YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
S+ + L+ + G+L++ + + S L + +A L +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTV--SCLRIVLSIASGLAHLHI 123
Query: 389 K-DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS--------Y 439
+ ++ + A+ H +LKS NIL+ N ++D G + + +Q + + Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 440 KSPE------YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP------QGINGADLCS 487
+PE ++ D+W+FG +L E+ +S + D
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 488 WVLRAV----------REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM 537
+R V W ++ + KL++ +C ++P R
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSD----------PTLTSLAKLMK---ECWYQNPSARLTA 290
Query: 538 AEVVSELEII 547
+ L I
Sbjct: 291 LRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 6e-28
Identities = 56/311 (18%), Positives = 108/311 (34%), Gaps = 59/311 (18%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFR-KQLLVIADQKHPNLLPLLAY 332
+ +GKG +G + G V VK FR ++ +H N+L +A
Sbjct: 43 KQIGKGRYGEVWMGKWRGE-KVAVKVFFT--TEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 333 ----YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH- 387
S + L+ + NG+L++ + + + S L +A L +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAK--SMLKLAYSSVSGLCHLHT 152
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS--------Y 439
++ + A+ H +LKS NIL+ N ++D G + + Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 440 KSPE------YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP------QGINGADLCS 487
PE ++ + +D++SFG +L E+ +S + +D
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 488 WVLRAV----------REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM 537
+R + W+++ ++ KL+ +C +P R
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMG----------KLMT---ECWAHNPASRLTA 319
Query: 538 AEVVSELEIIK 548
V L +
Sbjct: 320 LRVKKTLAKMS 330
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 54/309 (17%), Positives = 110/309 (35%), Gaps = 43/309 (13%)
Query: 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFR-KQLLVIADQKHPNLLPLLAY 332
E +GKG FG ++ G V VK FR ++ +H N+L +A
Sbjct: 48 ESIGKGRFGEVWRGKWRGE-EVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 333 YFSNDEK----LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH- 387
++ LV + +G+LF+ ++ + + + +A A L +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVE--GMIKLALSTASGLAHLHM 157
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS--------Y 439
++ + A+ H +LKS NIL+ N ++D G + + Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 440 KSPE------YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP------QGINGADLCS 487
+PE + +++D+++ G + E+ + +D
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 488 WVLRA--VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+R ++ I + S + A M K+++ +C + R + L
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCE--ALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332
Query: 546 IIKVTESTE 554
+ E +
Sbjct: 333 QLSQQEGIK 341
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 65/291 (22%), Positives = 121/291 (41%), Gaps = 34/291 (11%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLLPLL 330
+G+G F Y+A L PV +K++ + L+ + R + ++ HPN++
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
A + ++E +V + A G+L I K K + R+ + ALE++H +
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFK--KQKRLIPERTVWKYFVQLCSALEHMHSRR 156
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-SLVAQPIAAQRMI---SYKSPEYQS 446
V+H ++K N+ + +V + D G ++ AA ++ Y SPE
Sbjct: 157 -------VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 447 SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506
+ KSD+WS GCLL E+ + + +N LC + + ++ + E+
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267
Query: 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEE 557
Q+ C N PEKRP++ V + + ++ E
Sbjct: 268 R-------------QLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH 305
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-26
Identities = 39/173 (22%), Positives = 60/173 (34%), Gaps = 29/173 (16%)
Query: 32 RLNGEIKSDAFADIPELIVINFKNNIISG------------NFMNFSSNH---------- 69
G + N + + G F++ S N
Sbjct: 595 EFQGIRSEQ-LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIG 653
Query: 70 ---KLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSN 124
L ++L N G I + L+ L L L +N L G +P+ + L ++SN
Sbjct: 654 SMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713
Query: 125 NNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCSSTGNYVTNSDDKGSND 177
NNLSG IP+ + F + NNP LCG P L C + + +
Sbjct: 714 NNLSGPIPEMGQFETFPPAKFLNNPGLCGYP-LPRCDPSNADGYAHHQRSHHH 765
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 40/170 (23%), Positives = 68/170 (40%), Gaps = 26/170 (15%)
Query: 10 QWYGIQCDINSAHVTGIVLEDMRLNGEIK--SDAFADIPELIVINFKNNIISGNFMNFSS 67
+ G+ C VT I L LN S + + L + N+ I+G+ F
Sbjct: 41 TFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKC 98
Query: 68 NHKLKDIDLSGNKFYGEIS--RSLLSLKFLESLQLQNNNLTGPVP---EFNQSSLKVFNV 122
+ L +DLS N G ++ SL S L+ L + +N L P +SL+V ++
Sbjct: 99 SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158
Query: 123 SNNNLSGSIPKT----------QTLQLFRSYSYSNNPYLCGPPSLNNCSS 162
S N++SG+ + L + S N + G ++ C +
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAI------SGN-KISGDVDVSRCVN 201
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 9e-22
Identities = 34/154 (22%), Positives = 64/154 (41%), Gaps = 20/154 (12%)
Query: 19 NSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSG 78
+ + + +++G++ + L ++ +N S L+ +D+SG
Sbjct: 176 GCGELKHLAISGNKISGDV---DVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISG 232
Query: 79 NKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKT---- 134
NK G+ SR++ + L+ L + +N GP+P SL+ +++ N +G IP
Sbjct: 233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 135 ----QTLQLFRSYSYSNNPYLCG--PPSLNNCSS 162
L L S N + G PP +CS
Sbjct: 293 CDTLTGLDL------SGN-HFYGAVPPFFGSCSL 319
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-21
Identities = 47/143 (32%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 32 RLNGEIKSDAFADIPELIVINFKNNIISGNF-MNFSSNHKLKDIDLSGNKFYGEISRSLL 90
G+I ++ EL+ ++ N +SG + S KL+D+ L N GEI + L+
Sbjct: 405 GFTGKI-PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM 463
Query: 91 SLKFLESLQLQNNNLTGPVPE--FNQSSLKVFNVSNNNLSGSIPKT-------QTLQLFR 141
+K LE+L L N+LTG +P N ++L ++SNN L+G IPK L+L
Sbjct: 464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKL-- 521
Query: 142 SYSYSNNPYLCG--PPSLNNCSS 162
SNN G P L +C S
Sbjct: 522 ----SNN-SFSGNIPAELGDCRS 539
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-20
Identities = 38/145 (26%), Positives = 63/145 (43%), Gaps = 21/145 (14%)
Query: 32 RLNGEIKSDAFADIPELIVINFKNNIISGNF---MNFSSNHKLKDIDLSGNKFYGEISRS 88
+GE+ L+ ++ +N SG + + + L+++ L N F G+I +
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 89 LLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-------QTLQL 139
L + L SL L N L+G +P + S L+ + N L G IP+ +TL L
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473
Query: 140 FRSYSYSNNPYLCG--PPSLNNCSS 162
N L G P L+NC++
Sbjct: 474 ------DFN-DLTGEIPSGLSNCTN 491
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-17
Identities = 40/144 (27%), Positives = 58/144 (40%), Gaps = 19/144 (13%)
Query: 32 RLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNH--KLKDIDLSGNKFYGEISRSL 89
+ G I L ++ N +G +F S L +DLSGN FYG +
Sbjct: 258 QFVGPIPPLPL---KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314
Query: 90 LSLKFLESLQLQNNNLTGPVPE---FNQSSLKVFNVSNNNLSGSIPK-----TQTLQLFR 141
S LESL L +NN +G +P LKV ++S N SG +P+ + +L
Sbjct: 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTL- 373
Query: 142 SYSYSNNPYLCG--PPSLNNCSST 163
S+N G P+L
Sbjct: 374 --DLSSN-NFSGPILPNLCQNPKN 394
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-16
Identities = 33/138 (23%), Positives = 47/138 (34%), Gaps = 12/138 (8%)
Query: 32 RLNGEIKSDAFADIPELIVINFKNNIISGNF-MNFSSNHKLKDIDLSGNKFYGEISRSLL 90
L GEI ++ L I+ NN ++G L + LS N F G I L
Sbjct: 477 DLTGEI-PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535
Query: 91 SLKFLESLQLQNNNLTGPVPE--FNQSSLKVFNVSNNNLSGSIPKT--QTLQLFRSYSYS 146
+ L L L N G +P F QS ++ N ++G +
Sbjct: 536 DCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAG 591
Query: 147 NNPYLCG--PPSLNNCSS 162
N G LN S+
Sbjct: 592 NLLEFQGIRSEQLNRLST 609
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-11
Identities = 24/105 (22%), Positives = 32/105 (30%), Gaps = 4/105 (3%)
Query: 32 RLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLS 91
NG I A I NF N + + +F G S L
Sbjct: 549 LFNGTI-PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKEC-HGAGNLLEFQGIRSEQLNR 606
Query: 92 LKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT 134
L + + G N S+ ++S N LSG IPK
Sbjct: 607 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE 651
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 63/276 (22%), Positives = 102/276 (36%), Gaps = 35/276 (12%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLLPLL 330
+G G +G K +V K L +TE ++ L+ ++ + KHPN++
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 331 AYYFSNDEKLL--VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
L V ++ G+L + I K +K R L V + AL+ H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVIT--KGTKERQYLDEEFVLRVMTQLTLALKECH- 128
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-SLVAQPIAAQRMI---SYKSPEY 444
+S V+H +LK N+ LD + V + D+G + L A+ + Y SPE
Sbjct: 129 -RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187
Query: 445 QSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504
+ + KSD+WS GCLL EL + +L + +
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALM----PPFTAFSQKELAGKIREGKFRRI-PYRYSD 242
Query: 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
E+ ML N RP + E+
Sbjct: 243 EL---NEIITRML----------NLKDYHRPSVEEI 265
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 53/296 (17%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
LG+G FG + G V +K L+ E F ++ V+ +H L+ L A S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV-VS 249
Query: 336 NDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLL-VARGVARALEYLHHKDKS 392
+ +V ++ G+L + + GK + +L+ +A +A + Y+ +
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLR-------LPQLVDMAAQIASGMAYVERMN-- 300
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI---AAQRMISYK--SPEYQSS 447
+H +L++ NIL+ +N + V+D+G + L+ K +PE
Sbjct: 301 -----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 448 KKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR----EEWTAEI 501
+ + KSDVWSFG LL EL T GR+ P G+ ++ V R R E +
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESL 410
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEE 557
+ QC K PE+RP + + LE + + +
Sbjct: 411 H------------------DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 73/301 (24%), Positives = 112/301 (37%), Gaps = 60/301 (19%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR-----DLKPLITE-EFRKQLLVIADQKHPNLLP 328
LG+G F L +KR+ D + E + + HPN+L
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF------NHPNILR 90
Query: 329 LLAYYF----SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALE 384
L+AY + E L+ F G L+N I K N + L + G+ R LE
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT--EDQILWLLLGICRGLE 148
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI------- 437
+H K H +LK TNILL D ++ D G + + R
Sbjct: 149 AIHAK-------GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 438 ------SYKSPE---YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCS 487
SY++PE QS I ++DVWS GC+L ++ G P +
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE-----GPYDMVFQKGDS- 255
Query: 488 WVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547
V AV+ + + S SA +L P +RP + ++S+LE +
Sbjct: 256 -VALAVQNQLSIPQSPR-HS---SALWQLLN------SMMTVDPHQRPHIPLLLSQLEAL 304
Query: 548 K 548
+
Sbjct: 305 Q 305
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-24
Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 53/296 (17%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
LG+G FG + G V +K L+ E F ++ V+ +H L+ L A S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV-VS 332
Query: 336 NDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLL-VARGVARALEYLHHKDKS 392
+ +V ++ G+L + + GK + +L+ +A +A + Y+ +
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLR-------LPQLVDMAAQIASGMAYVERMN-- 383
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI---AAQRMISYK--SPEYQSS 447
+H +L++ NIL+ +N + V+D+G + L+ K +PE
Sbjct: 384 -----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 438
Query: 448 KKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR----EEWTAEI 501
+ + KSDVWSFG LL EL T GR+ P G+ ++ V R R E +
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRV-----PYPGMVNREVLDQVERGYRMPCPPECPESL 493
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEE 557
+ QC K PE+RP + + LE + + +
Sbjct: 494 H------------------DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 531
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 78/297 (26%), Positives = 128/297 (43%), Gaps = 51/297 (17%)
Query: 276 LGKGIFGNSYKALLEGRA-PVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
LG G +G Y+ + + + V VK L++ + EEF K+ V+ + KHPNL+ LL
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 335 SNDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
++ +F GNL + R + L +A ++ A+EYL K+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQ------EVSAVVLLYMATQISSAMEYLEKKN-- 338
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI-----AAQRMISYKSPEYQSS 447
IH NL + N L+ +N +V V+D+G S L+ A+ I + +PE +
Sbjct: 339 -----FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 448 KKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR----EEWTAEI 501
K S KSDVW+FG LL E+ T G P GI+ + + + + R E ++
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKV 448
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEED 558
+ ++ C +P RP AE+ E + S +E +
Sbjct: 449 Y------------------ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 487
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 41/180 (22%), Positives = 65/180 (36%), Gaps = 52/180 (28%)
Query: 32 RLNGEIKSDAFADIPELIVINFKNNIISG-------------NFMNFSSNH--------- 69
L+G + + +P L+ I F N ISG M S N
Sbjct: 136 ALSGTLPPS-ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF 194
Query: 70 ---KLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQ-SSLKVFNVSNN 125
L +DLS N G+ S S K + + L N+L + + +L ++ NN
Sbjct: 195 ANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNN 254
Query: 126 NLSGSIPKT-------QTLQL-----------------FRSYSYSNNPYLCGPPSLNNCS 161
+ G++P+ +L + F +Y+NN LCG P L C+
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP-LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 38/195 (19%), Positives = 66/195 (33%), Gaps = 47/195 (24%)
Query: 8 PSQWYGIQCDI--NSAHVTGIVLEDMRLNGEIK-SDAFADIPELIVINF-KNNIISG--- 60
W G+ CD + V + L + L + A++P L + N + G
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 61 ---------NFMNFSSNH-------------KLKDIDLSGNKFYGEISRSLLSLKFLESL 98
+++ + + L +D S N G + S+ SL L +
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 99 QLQNNNLTGPVPE--FNQSSLKVF-NVSNNNLSGSIPKT------QTLQLFRSYSYSNNP 149
N ++G +P+ + S L +S N L+G IP T + L S N
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL------SRN- 207
Query: 150 YLCG--PPSLNNCSS 162
L G + +
Sbjct: 208 MLEGDASVLFGSDKN 222
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 8e-07
Identities = 20/104 (19%), Positives = 33/104 (31%), Gaps = 21/104 (20%)
Query: 73 DIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTG--PVPEF--NQSSLKVFNVSN-NNL 127
D + G + + + +L L NL P+P N L + NNL
Sbjct: 30 TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89
Query: 128 SGSIPKT-------QTLQLFRSYSYSNNPYLCG--PPSLNNCSS 162
G IP L + ++ + G P L+ +
Sbjct: 90 VGPIPPAIAKLTQLHYLYI------THT-NVSGAIPDFLSQIKT 126
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 58/304 (19%), Positives = 109/304 (35%), Gaps = 60/304 (19%)
Query: 274 EGLGKGIFGNSYKA--LLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLA 331
E +G G FG +KA ++G+ V+KR++ E+ +++ +A H N++
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGK-TYVIKRVK----YNNEKAEREVKALAKLDHVNIVHYNG 71
Query: 332 YYFSNDEKLLVYK----------------FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLV 375
+ D F G L I + L +
Sbjct: 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE----KRRGEKLDKVLALEL 127
Query: 376 ARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR 435
+ + ++Y+H K +I+ +LK +NI L D + V + D+G + + R
Sbjct: 128 FEQITKGVDYIHSKK-------LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180
Query: 436 MI---SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492
Y SPE SS+ ++ D+++ G +L ELL + + +
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------CDTAFETSKFFTDLRDG 234
Query: 493 VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552
I +L+ + +K PE RP +E++ L + K +
Sbjct: 235 --------IISDIFD---KKEKTLLQ------KLLSKKPEDRPNTSEILRTLTVWKKSPE 277
Query: 553 TEEE 556
E
Sbjct: 278 KNER 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 60/274 (21%), Positives = 118/274 (43%), Gaps = 40/274 (14%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLLPLL 330
+G+G FG + E V+K + ++ + R++ V+A+ KHPN++
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEIN--ISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
+ N +V + G+LF RI +++ + F+ L + AL+++H +
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRI----NAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS-SLVAQPIAAQRMI---SYKSPEYQS 446
++H ++KS NI L + V + D+G + L + A+ I Y SPE
Sbjct: 146 -------ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198
Query: 447 SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506
+K + KSD+W+ GC+L EL T + A + + +L ++ + + ++
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLK----HAFEAGSMKNLVLKIISGSFPPVS-LHYSYDL 253
Query: 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
RS + ++P RP + +
Sbjct: 254 ---RSLVSQLF----------KRNPRDRPSVNSI 274
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 65/296 (21%), Positives = 124/296 (41%), Gaps = 53/296 (17%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
LG G FG + A V VK ++ + E F + V+ +H L+ L A +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAV-VT 253
Query: 336 NDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLL-VARGVARALEYLHHKDKS 392
+ ++ +F G+L F + G +L+ + +A + ++ ++
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQP-------LPKLIDFSAQIAEGMAFIEQRN-- 304
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI-----AAQRMISYKSPEYQSS 447
IH +L++ NIL+ + + ++D+G + ++ A+ I + +PE +
Sbjct: 305 -----YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 359
Query: 448 KKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR----EEWTAEI 501
+ KSDVWSFG LL+E++T GRI P G++ ++ + R R E E+
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRI-----PYPGMSNPEVIRALERGYRMPRPENCPEEL 414
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEE 557
+ + ++C PE+RP + S L+ ++ EE
Sbjct: 415 Y------------------NIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEE 452
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 49/287 (17%)
Query: 276 LGKGIFGNSYKALLEG-RAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
+G+G FG + L V VK R L P + +F ++ ++ HPN++ L+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+V + G+ + R ++ L + A +EYL K
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR-----TEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI----AAQRMISYK--SPEYQSS 447
IH +L + N L+ + ++ +SD+G S A + R + K +PE +
Sbjct: 234 ----CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 448 KKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR----EEWTAEI 501
+ S +SDVWSFG LL E + G P ++ +V + R E +
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGAS-----PYPNLSNQQTREFVEKGGRLPCPELCPDAV 344
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548
F + M QC P +RP + + EL+ I+
Sbjct: 345 F--RL---------ME-------QCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 66/339 (19%), Positives = 118/339 (34%), Gaps = 83/339 (24%)
Query: 276 LGKGIFGNSYKALLEGR-----APVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLL 330
LGKG FG+ + A V VK+L+ P +F++++ ++ ++
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 331 AYYFSNDEK--LLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386
+ + LV ++ +G L F + H + +R+ LL + + + +EYL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-------LLYSSQICKGMEYL 143
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQS 446
+ +H +L + NIL++ V ++D+G + +++ Y
Sbjct: 144 GSRR-------CVHRDLAARNILVESEAHVKIADFGLA----------KLLPLDKDYYVV 186
Query: 447 S-----------------KKISRKSDVWSFGCLLLELLT-GRIS----------THSAPQ 478
SR+SDVWSFG +L EL T S
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246
Query: 479 GINGADLCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKR 534
+ L + R AE+ E+ M C SP+ R
Sbjct: 247 VPALSRLLELLEEGQRLPAPPACPAEVH--EL---------MK-------LCWAPSPQDR 288
Query: 535 PEMAEVVSELEIIKVTESTEEEEDFWLDQSLTDESLSIS 573
P + + +L+++ E F SLS S
Sbjct: 289 PSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 327
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 78/297 (26%), Positives = 126/297 (42%), Gaps = 51/297 (17%)
Query: 276 LGKGIFGNSYKALLEGRA-PVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
LG G +G Y+ + + + V VK L++ EEF K+ V+ + KHPNL+ LL
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 335 SNDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
++ +F GNL + R + L +A ++ A+EYL K+
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQE------VSAVVLLYMATQISSAMEYLEKKN-- 131
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQSS 447
IH +L + N L+ +N +V V+D+G S L+ I + +PE +
Sbjct: 132 -----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 448 KKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR----EEWTAEI 501
K S KSDVW+FG LL E+ T G P GI+ + + + + R E ++
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMS-----PYPGIDLSQVYELLEKDYRMERPEGCPEKV 241
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEED 558
+ E+ M C +P RP AE+ E + S +E +
Sbjct: 242 Y--EL---------MR-------ACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 280
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 59/294 (20%), Positives = 111/294 (37%), Gaps = 59/294 (20%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
LG G FG G+ V +K +++ +EF ++ V+ + H L+ L
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 336 NDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
++ ++ NG L N R + ++ L + + V A+EYL K
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQL-------LEMCKDVCEAMEYLESKQ--- 140
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR---MISYK--SPEYQSSK 448
+H +L + N L++D +V VSD+G S V + PE
Sbjct: 141 ----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 449 KISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR--------EEWT 498
K S KSD+W+FG L+ E+ + G++ P + ++ + +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKM-----PYERFTNSE----TAEHIAQGLRLYRPHLAS 247
Query: 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552
+++ M C ++ ++RP ++S + + ES
Sbjct: 248 EKVYTI-----------MY-------SCWHEKADERPTFKILLSNILDVMDEES 283
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 67/296 (22%), Positives = 119/296 (40%), Gaps = 52/296 (17%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
LG G FG + G V VK L+ + + F + ++ +H L+ L A +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAV-VT 78
Query: 336 NDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+ ++ ++ NG+L + + G L +A +A + ++ ++
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIK------LTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR---MISYK--SPEYQSSK 448
IH +L++ NIL+ D ++D+G + L+ R K +PE +
Sbjct: 130 ----YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 449 KISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR----EEWTAEIF 502
+ KSDVWSFG LL E++T GRI P G+ ++ + R R + E++
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240
Query: 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-IIKVTESTEEEE 557
++ M C + PE RP + S LE TE + +
Sbjct: 241 --QL---------MR-------LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQ 278
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 59/298 (19%), Positives = 114/298 (38%), Gaps = 74/298 (24%)
Query: 276 LGKGIFGNSYKALL-----EGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPL 329
LG G FG YK L + + PV +K LR P +E + V+A +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
L L+ + G L + + +++ + L +A+ + YL +
Sbjct: 83 LGI-CLTSTVQLITQLMPFGCLLDYVR-----EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSK- 448
++H +L + N+L+ + V ++D+G + +++ + EY +
Sbjct: 137 R-------LVHRDLAARNVLVKTPQHVKITDFGLA----------KLLGAEEKEYHAEGG 179
Query: 449 ---------------KISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLR 491
+ +SDVWS+G + EL+T G P GI +++ S + +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEK 234
Query: 492 AVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
R T +++ I M +C + RP+ E++ E
Sbjct: 235 GERLPQPPICTIDVY--MI---------MR-------KCWMIDADSRPKFRELIIEFS 274
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 9e-22
Identities = 65/287 (22%), Positives = 112/287 (39%), Gaps = 59/287 (20%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
+G G FG + + V +K +R+ + E+F ++ V+ HP L+ L
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 336 NDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
LV +F +G L + R G F + L + V + YL
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGL-------FAAETLLGMCLDVCEGMAYLEEAC--- 124
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI---AAQRMISYK--SPEYQSSK 448
VIH +L + N L+ +N+++ VSD+G + V + K SPE S
Sbjct: 125 ----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 449 KISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR--------EEWT 498
+ S KSDVWSFG L+ E+ + G+I P + + ++ V+ + +
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKI-----PYENRSNSE----VVEDISTGFRLYKPRLAS 231
Query: 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
++ M C + PE RP + ++ +L
Sbjct: 232 THVYQI-----------MN-------HCWRERPEDRPAFSRLLRQLA 260
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 59/294 (20%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
LG G FG +G+ V VK +++ +EF ++ + HP L+
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 336 NDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+V ++ NG L N R HG +++ L + V + +L
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-------LEMCYDVCEGMAFLESHQ--- 124
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR---MISYK--SPEYQSSK 448
IH +L + N L+D + V VSD+G + V K +PE
Sbjct: 125 ----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 449 KISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR--------EEWT 498
K S KSDVW+FG L+ E+ + G++ P ++ V+ V +
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKM-----PYDLYTNSE----VVLKVSQGHRLYRPHLAS 231
Query: 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552
I+ +I M C ++ PEKRP +++S +E ++ +
Sbjct: 232 DTIY--QI---------MY-------SCWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 61/304 (20%), Positives = 116/304 (38%), Gaps = 64/304 (21%)
Query: 276 LGKGIFGNSYKALLEGR-----APVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLL 330
LGKG FG+ + V VK+L+ +F +++ ++ +H N++
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 331 AYYFSNDEK--LLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386
+S + L+ ++ G+L + + H + ++ L + + +EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-------LQYTSQICKGMEYL 130
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-------ISY 439
K IH +L + NIL+++ V + D+G + ++ Q ++ I +
Sbjct: 131 GTKR-------YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 440 KSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQ------------GINGADLCS 487
+PE + K S SDVWSFG +L EL T + S P + L
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243
Query: 488 WVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543
+ R + EI+ M +C N + +RP ++
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMI-----------MT-------ECWNNNVNQRPSFRDLALR 285
Query: 544 LEII 547
++ I
Sbjct: 286 VDQI 289
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 69/296 (23%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
+GKG FG+ G V VK +++ + F + V+ +H NL+ LL
Sbjct: 29 IGKGEFGDVMLGDYRGN-KVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 336 NDEKL-LVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
L +V ++ G+L + R G L + V A+EYL +
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRS------VLGGDCLLKFSLDVCEAMEYLEGNN-- 137
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKS----------- 441
+H +L + N+L+ ++ + VSD+G + + S
Sbjct: 138 -----FVHRDLAARNVLVSEDNVAKVSDFGLT----------KEASSTQDTGKLPVKWTA 182
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR----E 495
PE KK S KSDVWSFG LL E+ + GR+ P I D+ V + + +
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMDAPD 237
Query: 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551
+++ M C + RP ++ +LE IK E
Sbjct: 238 GCPPAVYEV-----------MK-------NCWHLDAAMRPSFLQLREQLEHIKTHE 275
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLLPLL 330
LGKG FGN Y A + + + +K L L QL + + +HPN+L L
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 331 AYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
YF + ++ L+ ++A G ++ + + R+ + +A AL Y H K
Sbjct: 76 -GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ-----RTATYITE-LANALSYCHSK 128
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEY 444
VIH ++K N+LL + ++D+G+S +++R + Y PE
Sbjct: 129 R-------VIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEM 178
Query: 445 QSSKKISRKSDVWSFGCLLLELLTGR 470
+ K D+WS G L E L G+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 61/304 (20%), Positives = 116/304 (38%), Gaps = 64/304 (21%)
Query: 276 LGKGIFGNSYKALLEGR-----APVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLL 330
LGKG FG+ + V VK+L+ +F +++ ++ +H N++
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 331 AYYFSNDEK--LLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386
+S + L+ ++ G+L + + H + ++ L + + +EYL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-------LQYTSQICKGMEYL 161
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-------ISY 439
K IH +L + NIL+++ V + D+G + ++ Q ++ I +
Sbjct: 162 GTKR-------YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214
Query: 440 KSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQ------------GINGADLCS 487
+PE + K S SDVWSFG +L EL T + S P + L
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274
Query: 488 WVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543
+ R + EI+ M +C N + +RP ++
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMI-----------MT-------ECWNNNVNQRPSFRDLALR 316
Query: 544 LEII 547
++ I
Sbjct: 317 VDQI 320
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 59/335 (17%), Positives = 122/335 (36%), Gaps = 76/335 (22%)
Query: 276 LGKGIFGNSYKALL-----EGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPL 329
LG G FG YK L + + PV +K LR P +E + V+A +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
L L+ + G L + + +++ + L +A+ + YL +
Sbjct: 83 LGI-CLTSTVQLITQLMPFGCLLDYVR-----EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSK- 448
++H +L + N+L+ + V ++D+G + +++ + EY +
Sbjct: 137 R-------LVHRDLAARNVLVKTPQHVKITDFGLA----------KLLGAEEKEYHAEGG 179
Query: 449 ---------------KISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLR 491
+ +SDVWS+G + EL+T G P GI +++ S + +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEK 234
Query: 492 AVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547
R T +++ + ++C + RP+ E++ E +
Sbjct: 235 GERLPQPPICTIDVY------------------MIMVKCWMIDADSRPKFRELIIEFSKM 276
Query: 548 KVTEST--EEEEDFWLDQSLTDESLSISTVASASE 580
+ D + +S + +
Sbjct: 277 ARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEED 311
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 8e-21
Identities = 69/287 (24%), Positives = 115/287 (40%), Gaps = 51/287 (17%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLIT-EEFRKQLLVIADQKHPNLLPLLAYYF 334
+GKG FG+ G V VK + K T + F + V+ +H NL+ LL
Sbjct: 201 IGKGEFGDVMLGDYRGN-KVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 335 SNDEKL-LVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
L +V ++ G+L + R G L + V A+EYL +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRS------VLGGDCLLKFSLDVCEAMEYLEGNN- 309
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-ISYKSPEYQSSKKI 450
+H +L + N+L+ ++ + VSD+G + + ++ + + +PE KK
Sbjct: 310 ------FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKF 363
Query: 451 SRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR----EEWTAEIFDS 504
S KSDVWSFG LL E+ + GR+ P I D+ V + + + ++D
Sbjct: 364 STKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV 418
Query: 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551
M C + RP ++ +LE I+ E
Sbjct: 419 -----------MK-------NCWHLDAATRPTFLQLREQLEHIRTHE 447
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 67/308 (21%), Positives = 117/308 (37%), Gaps = 66/308 (21%)
Query: 276 LGKGIFGNSYKALL----EGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLL 330
+G G G L + PV +K L+ +F + ++ HPN++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 331 AYYFSNDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
++V ++ NG+L R H G+ + ++ + + RGV + YL
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-------VGMLRGVGAGMRYLSD 169
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR-----MISYK--S 441
+H +L + N+L+D N + VSD+G S ++ A I + +
Sbjct: 170 L-------GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR----- 494
PE + + S SDVWSFG ++ E+L G P + D V+ +V
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGER-----PYWNMTNRD----VISSVEEGYRL 273
Query: 495 ---EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-IIKVT 550
+ ML C +K +RP +++VS L+ +I+
Sbjct: 274 PAPMGCPHALHQL-----------ML-------DCWHKDRAQRPRFSQIVSVLDALIRSP 315
Query: 551 ESTEEEED 558
ES
Sbjct: 316 ESLRATAT 323
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 56/315 (17%), Positives = 113/315 (35%), Gaps = 85/315 (26%)
Query: 276 LGKGIFGNSYKALL---EGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLA 331
LG G FG+ + + + + V +K L+ + TEE ++ ++ +P ++ L+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 332 YYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
+ +LV + AG G L F + + + + V+ ++YL K
Sbjct: 78 V-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-------AELLHQVSMGMKYLEEK 129
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSS-- 447
+ +H +L + N+LL + +SD+G S + + Y +
Sbjct: 130 N-------FVHRDLAARNVLLVNRHYAKISDFGLS----------KALGADDSYYTARSA 172
Query: 448 ---------------KKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVL 490
+K S +SDVWS+G + E L+ G+ P + + G + V+
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPE----VM 223
Query: 491 RAVR--------EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVS 542
+ E E++ + C E RP+ V
Sbjct: 224 AFIEQGKRMECPPECPPELY------------------ALMSDCWIYKWEDRPDFLTVEQ 265
Query: 543 ELEIIKVTESTEEEE 557
+ + +++ E
Sbjct: 266 RMRACYYSLASKVEG 280
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 29/206 (14%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLLPLL 330
LGKG FGN Y A + + + +K L L E QL + + +HPN+L +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVL-FKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 331 AYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
YF + +++ L+ +FA G L+ + R + RS + +A AL Y H +
Sbjct: 81 -NYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQ-RSATFMEE-LADALHYCHER 133
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEY 444
VIH ++K N+L+ + ++D+G+S +R + Y PE
Sbjct: 134 K-------VIHRDIKPENLLMGYKGELKIADFGWSVHAPS---LRRRTMCGTLDYLPPEM 183
Query: 445 QSSKKISRKSDVWSFGCLLLELLTGR 470
K K D+W G L E L G
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 5e-20
Identities = 57/313 (18%), Positives = 111/313 (35%), Gaps = 78/313 (24%)
Query: 276 LGKGIFGNSYKALLE---GRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLA 331
LG G FG+ + + + V +K L+ + TEE ++ ++ +P ++ L+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 332 YYFSNDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
+ +LV + AG G L + + + + V+ ++YL K
Sbjct: 404 V-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-------AELLHQVSMGMKYLEEK 455
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSS-- 447
+ +H NL + N+LL + +SD+G S + + Y +
Sbjct: 456 N-------FVHRNLAARNVLLVNRHYAKISDFGLS----------KALGADDSYYTARSA 498
Query: 448 ---------------KKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVL 490
+K S +SDVWS+G + E L+ G+ P + + G ++ +++
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPEVMAFIE 553
Query: 491 RAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE- 545
+ R E E++ + C E RP+ V +
Sbjct: 554 QGKRMECPPECPPELY------------------ALMSDCWIYKWEDRPDFLTVEQRMRA 595
Query: 546 IIKVTESTEEEED 558
S E
Sbjct: 596 CYYSLASKVEGGS 608
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 60/309 (19%), Positives = 110/309 (35%), Gaps = 75/309 (24%)
Query: 276 LGKGIFGNSYKALLEGRA---PVVVKRLRD--LKPLITEEFRKQLLVIADQKHPNLLPLL 330
LG G FG K + + V VK L++ P + +E + V+ +P ++ ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
+ +LV + A G L + + + ++ + + V+ ++YL +
Sbjct: 85 GI-CEAESWMLVMEMAELGPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLEESN 137
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSS--- 447
+H +L + N+LL +SD+G S + + Y++
Sbjct: 138 -------FVHRDLAARNVLLVTQHYAKISDFGLS----------KALRADENYYKAQTHG 180
Query: 448 --------------KKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLR 491
K S KSDVWSFG L+ E + G+ P +G+ G+++ + + +
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK-----PYRGMKGSEVTAMLEK 235
Query: 492 AVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547
R E++D M C E RP A V L
Sbjct: 236 GERMGCPAGCPREMYDL-----------MN-------LCWTYDVENRPGFAAVELRLRNY 277
Query: 548 KVTESTEEE 556
E
Sbjct: 278 YYDVVNEGH 286
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 51/304 (16%), Positives = 102/304 (33%), Gaps = 64/304 (21%)
Query: 276 LGKGIFGNSYKALLEGRA-----PVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPL 329
LG+G FG + V VK L+ + + +K++ ++ + H N++
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 330 LA--YYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
+ L+ +F +G+L + + K + + L A + + ++Y
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ-------LKYAVQICKGMDY 141
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-------IS 438
L + +H +L + N+L++ V + D+G + + + +
Sbjct: 142 LGSRQ-------YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194
Query: 439 YKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQ----------GINGADLCS 487
+ +PE K SDVWSFG L ELLT + + L +
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254
Query: 488 WVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543
+ R E++ M +C P R ++
Sbjct: 255 TLKEGKRLPCPPNCPDEVYQL-----------MR-------KCWEFQPSNRTSFQNLIEG 296
Query: 544 LEII 547
E +
Sbjct: 297 FEAL 300
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 63/304 (20%), Positives = 115/304 (37%), Gaps = 63/304 (20%)
Query: 276 LGKGIFGNSYKA--LLEGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
LG+G FG ++A ++ +KR+R + L E+ +++ +A +HP ++
Sbjct: 13 LGRGGFGVVFEAKNKVDDC-NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 333 YFSNDE---------KLLVY---KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVA 380
+ + K+ +Y + NL + + L + +A
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERSVCLHIFLQIA 128
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-- 438
A+E+LH K ++H +LK +NI +++V V D+G + + Q Q +++
Sbjct: 129 EAVEFLHSKG-------LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 439 --------------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD 484
Y SPE S K D++S G +L ELL ST
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-PFSTQMERVR----- 235
Query: 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
L VR +F + + ML + SP +RPE ++ E
Sbjct: 236 ----TLTDVRNLKFPPLFTQKYPCEYVMVQDML----------SPSPMERPEAINII-EN 280
Query: 545 EIIK 548
+ +
Sbjct: 281 AVFE 284
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 58/288 (20%), Positives = 110/288 (38%), Gaps = 54/288 (18%)
Query: 276 LGKGIFGNSYKALL-----EGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPL 329
LG G+FG +K + + PV +K + + +L I H +++ L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
L LV ++ G+L + + ++R + L +A+ + YL
Sbjct: 81 LGL-CPGSSLQLVTQYLPLGSLLDHVR-----QHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ----PIAAQRMISYK--SPE 443
++H NL + N+LL V V+D+G + L+ + ++ K + E
Sbjct: 135 G-------MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 444 YQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR----EEW 497
K + +SDVWS+G + EL+T G P G+ A++ + + R +
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAE-----PYAGLRLAEVPDLLEKGERLAQPQIC 242
Query: 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
T +++ M+ +C RP E+ +E
Sbjct: 243 TIDVYMV-----------MV-------KCWMIDENIRPTFKELANEFT 272
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 45/211 (21%), Positives = 86/211 (40%), Gaps = 28/211 (13%)
Query: 274 EGLGKGIFGNSYKAL--LEGRAPVVVK--RLRDLKPLITEEFRKQLLVIADQKHPNLLPL 329
+G+G F YK L V + R L + F+++ ++ +HPN++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVE-VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 330 LAYYFSNDEK----LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
+ S + +LV + +G L + K + + R + + L++
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQF 144
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNE-MVLVSDYGFSSLVAQPIAAQRMISYKSPEY 444
LH + +IH +LK NI + V + D G ++L A+ +I +PE+
Sbjct: 145 LHTRTP-----PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVI--GTPEF 196
Query: 445 QS----SKKISRKSDVWSFGCLLLELLTGRI 471
+ +K DV++FG +LE+ T
Sbjct: 197 MAPEMYEEKYDESVDVYAFGMCMLEMATSEY 227
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 50/280 (17%), Positives = 84/280 (30%), Gaps = 57/280 (20%)
Query: 276 LGKGIFGNSYKAL--LEGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQ-KHPNLLP 328
LG G +G +K +GR VKR P + R + L +HP +
Sbjct: 65 LGHGSYGEVFKVRSKEDGRL-YAVKRSM--SPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
L + L + G +L R AL +LH
Sbjct: 122 LEQAWEEGGILYLQTELCG-PSLQQHC-----EAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKSPE-- 443
+ ++H ++K NI L + D+G + A + Y +PE
Sbjct: 176 QG-------LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL 228
Query: 444 ---YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAE 500
Y +DV+S G +LE+ H + +R+ +
Sbjct: 229 QGSY------GTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQGYLPP 271
Query: 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
F + +S S +L P+ R +
Sbjct: 272 EFTAGLS---SELRSVLV------MMLEPDPKLRATAEAL 302
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-20
Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 55/302 (18%)
Query: 274 EGLGKGIFGNSYKALLEGRA----PVVVKRLRDLKPLIT-EEFRKQLLVIADQKHPNLLP 328
E +G+G FG Y L VK L + + +F + +++ D HPN+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 329 LLAYYFSNDEKLL-VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
LL ++ L V + +G+L N I + + VA+ ++YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR-----NETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV------AQPIAAQRMISYK- 440
K +H +L + N +LD+ V V+D+G + + + + K
Sbjct: 146 SKK-------FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 441 -SPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR--- 494
+ E ++K + KSDVWSFG LL EL+T G P +N D+ ++L+ R
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQ 253
Query: 495 -EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTEST 553
E ++ E+ ML +C + E RP +E+VS + I T
Sbjct: 254 PEYCPDPLY--EV---------ML-------KCWHPKAEMRPSFSELVSRISAIFSTFIG 295
Query: 554 EE 555
E
Sbjct: 296 EH 297
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 32/314 (10%), Positives = 76/314 (24%), Gaps = 60/314 (19%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR---DLKPLITEEFRKQLLVIADQKHPNLLPLLA 331
L G + +E +K + E + A +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 332 YY--------------------------FSNDEKLLVYKFAGNGNLFNRIHG-GKSSKNR 364
++ LL+ A +L R
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 365 IPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424
+ ++ + R L K ++HG+ N+ + + +++ D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG-------LVHGHFTPDNLFIMPDGRLMLGDVSA- 240
Query: 425 SLVAQPIAAQRMIS-----YKSPEYQSSKKI--SRKSDVWSFGCLLLELLTGRISTHSAP 477
+ + S Y E+ ++ + + W G + + +
Sbjct: 241 ---LWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 478 QGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM 537
GI G+ + + F S + + + L +R
Sbjct: 298 PGIKGSWKRPSLRVPGTDSL---AFGSCTPLPDFVKTLIGRFLN-------FDRRRRLLP 347
Query: 538 AEVVSELEIIKVTE 551
E + E +++
Sbjct: 348 LEAMETPEFLQLQN 361
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 60/312 (19%), Positives = 112/312 (35%), Gaps = 70/312 (22%)
Query: 274 EGLGKGIFGNSYKALL--------EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPN 325
E LG+G F +K + V++K L +E F + +++ H +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 326 LLPLLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARAL 383
L+ DE +LV +F G+L + + + + L VA+ +A A+
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-------LEVAKQLAAAM 126
Query: 384 EYLHHKDKSRTQSAVIHGNLKSTNILLD--------DNEMVLVSDYGFSSLVAQPIAAQR 435
+L +IHGN+ + NILL + + +SD G S V Q
Sbjct: 127 HFLEENT-------LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE 179
Query: 436 MISYKSPE-YQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRA 492
I + PE ++ K ++ +D WSFG L E+ + G P ++ L+
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK-----PLSALDSQR----KLQF 230
Query: 493 VRE-------EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+ + E+ + + C + P+ RP ++ +L
Sbjct: 231 YEDRHQLPAPKAA-ELANL-----------IN-------NCMDYEPDHRPSFRAIIRDLN 271
Query: 546 IIKVTESTEEEE 557
+ +
Sbjct: 272 SLFTPDLVPRGS 283
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 64/314 (20%), Positives = 109/314 (34%), Gaps = 83/314 (26%)
Query: 276 LGKGIFGNSYKALLEGRA----PVVVKRLRD---LKPLITEEFRKQLLVIADQKHPNLLP 328
LG G FG + + + V VK L+ +P ++F +++ + H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 329 LLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
L + +V + A G+L +R+ + F + A VA + YL
Sbjct: 86 LYG--VVLTPPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLSRYAVQVAEGMGYLE 138
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSS 447
K IH +L + N+LL ++V + D+G R + Y
Sbjct: 139 SKR-------FIHRDLAARNLLLATRDLVKIGDFGLM----------RALPQNDDHYVMQ 181
Query: 448 K-----------------KISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSW 488
+ S SD W FG L E+ T G+ P G+NG+
Sbjct: 182 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQ---- 232
Query: 489 VLRAVREEWTAEIFDSEISVQRSAAHGMLK-------LLQVAIQCCNKSPEKRPEMAEVV 541
+L + + +R + + + V +QC PE RP +
Sbjct: 233 ILHKI-----------DKEGER-----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 276
Query: 542 SELEIIKVTESTEE 555
L + T+ E
Sbjct: 277 DFLLEAQPTDMRAE 290
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 68/300 (22%), Positives = 116/300 (38%), Gaps = 56/300 (18%)
Query: 276 LGKGIFGNSYKALLEGRA----PVVVKRLRDLKPLIT-EEFRKQLLVIADQKHPNLLPLL 330
+GKG FG Y +A +K L + + E F ++ L++ HPN+L L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 331 AYYFSNDE-KLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
+ ++ + +G+L I + + + VAR +EYL +
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIR-----SPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV------AQPIAAQRMISYK--S 441
+H +L + N +LD++ V V+D+G + + + + K +
Sbjct: 144 K-------FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR----E 495
E + + + KSDVWSFG LL ELLT G P + I+ DL ++ + R E
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAP-----PYRHIDPFDLTHFLAQGRRLPQPE 251
Query: 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-IIKVTESTE 554
++ M QC P RP +V E+E I+
Sbjct: 252 YCPDSLYQV-----------MQ-------QCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 36/218 (16%), Positives = 75/218 (34%), Gaps = 31/218 (14%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLK----PLITEEF--RKQLLVIADQKHPNLLPL 329
LG+G F Y+A K+ LK E + + + + +
Sbjct: 73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKF 132
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
+ + + +LV + G L N I+ K++ + + A + +E +H
Sbjct: 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEK-VMPQGLVISFAMRMLYMIEQVHDC 191
Query: 390 DKSRTQSAVIHGNLKSTNILL-----------DDNEMVLVSDYGFSSLVAQPIAAQRMIS 438
+ +IHG++K N +L D + + + D G S + +
Sbjct: 192 E-------IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 439 ------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
++ E S+K + + D + + +L G
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 61/309 (19%), Positives = 111/309 (35%), Gaps = 62/309 (20%)
Query: 276 LGKGIFGNSYKALLEG-----RAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPL 329
LG+G FG + V VK L+ D P +++++ ++ H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 330 LAYYFSNDEK--LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
LV ++ G+L + + ++ I LL A+ + + YLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLA--QLLLFAQQICEGMAYLH 151
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-------ISYK 440
+ IH +L + N+LLD++ +V + D+G + V + R+ + +
Sbjct: 152 AQH-------YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204
Query: 441 SPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP----------QGINGADLCSWV 489
+PE K SDVWSFG L ELLT S + L +
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
Query: 490 LRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
R R ++ AE++ + M C RP ++ L+
Sbjct: 265 ERGERLPRPDKCPAEVY--HL---------MK-------NCWETEASFRPTFENLIPILK 306
Query: 546 IIKVTESTE 554
+ +
Sbjct: 307 TVHEKYQGQ 315
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 88.6 bits (219), Expect = 5e-19
Identities = 44/311 (14%), Positives = 83/311 (26%), Gaps = 79/311 (25%)
Query: 276 LGKGIFGNSYKA--LLEGRAPVVVKRLR--------DLKPLITEEFRKQLL--------- 316
LG+ +A G V +K + E R +LL
Sbjct: 86 LGQEDPYAYLEATDQETGE-SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 317 -----------VIADQKHPNLLPLLAY---YFSNDEKLLVYKFAGNGNLFNRIHGGKSSK 362
++ D + ++ + + L + N F + SS
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 363 NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG 422
++ +RL + V R L LHH ++H L+ +I+LD V ++ +
Sbjct: 205 HK-SLVHHARLQLTLQVIRLLASLHHYG-------LVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 423 FSSLVAQPIAAQRMISYKSPEY----------QSSKKISRKSDVWSFGCLLLELLTGRIS 472
+ + PE ++ D W+ G + +
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD-- 314
Query: 473 THSAP-QGINGADLCSWVLRAVREEWTAEIFDSEISVQ-RSAAHGMLKLLQVAIQCCNKS 530
P W+ R+ + I R+ G L
Sbjct: 315 ---LPNTDDAALGGSEWIFRSCK----------NIPQPVRALLEGFL----------RYP 351
Query: 531 PEKRPEMAEVV 541
E R + +
Sbjct: 352 KEDRLLPLQAM 362
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 7e-19
Identities = 73/306 (23%), Positives = 123/306 (40%), Gaps = 55/306 (17%)
Query: 274 EGLGKGIFGNSYKALLEGRA----PVVVKRLRDLKPLIT-EEFRKQLLVIADQKHPNLLP 328
E +G+G FG Y L VK L + + +F + +++ D HPN+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 329 LLAYYFSNDEKLL-VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
LL ++ L V + +G+L N I + + VA+ +++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIR-----NETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV------AQPIAAQRMISYK- 440
K +H +L + N +LD+ V V+D+G + + + + K
Sbjct: 210 SKK-------FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 441 -SPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR--- 494
+ E ++K + KSDVWSFG LL EL+T G P +N D+ ++L+ R
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQ 317
Query: 495 -EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTEST 553
E ++ E+ ML +C + E RP +E+VS + I T
Sbjct: 318 PEYCPDPLY--EV---------ML-------KCWHPKAEMRPSFSELVSRISAIFSTFIG 359
Query: 554 EEEEDF 559
E
Sbjct: 360 EHYVHV 365
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 56/304 (18%), Positives = 111/304 (36%), Gaps = 64/304 (21%)
Query: 276 LGKGIFGNSYKALLEGRA----PVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLL 330
LG+G FG Y+ + V VK + D E+F + +++ + HP+++ L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 331 AYYFSNDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
+ ++ + G L + + + +L + + +A+ YL
Sbjct: 80 GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTL-------VLYSLQICKAMAYLES 131
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI---AAQRMISYK--SPE 443
+ +H ++ NIL+ E V + D+G S + A+ + K SPE
Sbjct: 132 IN-------CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 184
Query: 444 YQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR------- 494
+ ++ + SDVW F + E+L+ G+ P + D V+ +
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQ-----PFFWLENKD----VIGVLEKGDRLPK 235
Query: 495 -EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTEST 553
+ ++ + M +C + P RP E+V L + E
Sbjct: 236 PDLCPPVLY--TL---------MT-------RCWDYDPSDRPRFTELVCSLSDVYQMEKD 277
Query: 554 EEEE 557
E
Sbjct: 278 IAME 281
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 65/308 (21%), Positives = 125/308 (40%), Gaps = 55/308 (17%)
Query: 276 LGKGIFGNSYKALLEGRA----PVVVKRLRD--LKPLITEEFRKQLLVIADQKHPNLLPL 329
LGKG FG+ +A L+ V VK L+ + EEF ++ + + HP++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 330 LA------YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARAL 383
+ +++ F +G+L + + +N ++ + +A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 384 EYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP----IAAQRMISY 439
EYL ++ IH +L + N +L ++ V V+D+G S + +
Sbjct: 151 EYLSSRN-------FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 440 K--SPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR- 494
K + E + + SDVW+FG + E++T G+ P GI A++ ++++ R
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT-----PYAGIENAEIYNYLIGGNRL 258
Query: 495 ---EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-IIKVT 550
E E++ ++ M QC + P++RP + ELE I+
Sbjct: 259 KQPPECMEEVY--DL---------MY-------QCWSADPKQRPSFTCLRMELENILGHL 300
Query: 551 ESTEEEED 558
+D
Sbjct: 301 SVLSTSQD 308
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLV-IADQK---HPNLLPLL 330
LGKG F Y+A + V +K + D K + +++ + HP++L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMI-DKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 331 AYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
Y F + + LV + NG + + ++ + +R + + + YLH
Sbjct: 78 NY-FEDSNYVYLVLEMCHNGEMNRYLK----NRVKPFSENEARHFM-HQIITGMLYLHSH 131
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM------ISYKSPE 443
++H +L +N+LL N + ++D+G ++ + P ++ +Y SPE
Sbjct: 132 G-------ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--HEKHYTLCGTPNYISPE 182
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTGR 470
+ +SDVWS GC+ LL GR
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 49/228 (21%), Positives = 90/228 (39%), Gaps = 46/228 (20%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRL-----RDLKPLITE-EFRKQLLVIADQKHPNLLP 328
L +G F Y+A + +KRL + +I E F K+L HPN++
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKL-----SGHPNIVQ 90
Query: 329 LLAYYFSNDEK-------LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR 381
+ E+ L+ G L + K ++R P C + L + R
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL---KKMESRGPLSCDTVLKIFYQTCR 147
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI---- 437
A++++H + + +IH +LK N+LL + + + D+G ++ ++
Sbjct: 148 AVQHMHRQ-----KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 438 ------------SYKSPE---YQSSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE S+ I K D+W+ GC+L L +
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 71/310 (22%), Positives = 135/310 (43%), Gaps = 67/310 (21%)
Query: 276 LGKGIFGNSYKALL-----EGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPL 329
+G G FG YK +L + PV +K L+ +F + ++ H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 330 LAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
+++ ++ NG L F R G+ S ++ + + RG+A ++YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL-------VGMLRGIAAGMKYLA 164
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-------ISYK 440
+ + +H +L + NIL++ N + VSD+G S ++ A I +
Sbjct: 165 NMN-------YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 441 SPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVREEW- 497
+PE S +K + SDVWSFG ++ E++T G P ++ + V++A+ + +
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGER-----PYWELSNHE----VMKAINDGFR 268
Query: 498 -------TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-IIKV 549
+ I+ M+ QC + +RP+ A++VS L+ +I+
Sbjct: 269 LPTPMDCPSAIYQL-----------MM-------QCWQQERARRPKFADIVSILDKLIRA 310
Query: 550 TESTEEEEDF 559
+S + DF
Sbjct: 311 PDSLKTLADF 320
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 70/297 (23%), Positives = 122/297 (41%), Gaps = 71/297 (23%)
Query: 276 LGKGIFGNSYKALL----EGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLL 327
+G G FG L + V +K L K TE+ R+ L ++ HPN++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTL---KVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
L + ++V ++ NG+L F R H + F + + RG+A ++Y
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-------FTVIQLVGMLRGIASGMKY 162
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-------IS 438
L +H +L + NIL++ N + VSD+G ++ A I
Sbjct: 163 LSDM-------GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 439 YKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVREE 496
+ SPE + +K + SDVWS+G +L E+++ G P ++ D V++AV E
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER-----PYWEMSNQD----VIKAVDEG 266
Query: 497 W--------TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+ A ++ Q+ + C K RP+ ++VS L+
Sbjct: 267 YRLPPPMDCPAALY------------------QLMLDCWQKDRNNRPKFEQIVSILD 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 44/207 (21%), Positives = 81/207 (39%), Gaps = 31/207 (14%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
+G+G FG ++ + VK++ L+ EE L+ A P ++PL
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEE----LVACAGLSSPRIVPLYGAVR 120
Query: 335 SNDEKLLVYKFAGNGNLFNRI-HGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+ + G+L I G ++R + L LEYLH +
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL-------EGLEYLHTRR--- 170
Query: 394 TQSAVIHGNLKSTNILLDDN-EMVLVSDYGFSSLVAQPIAAQRMISYKS---------PE 443
++HG++K+ N+LL + + D+G + + + +++ PE
Sbjct: 171 ----ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTGR 470
K K D+WS C++L +L G
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 33/271 (12%), Positives = 75/271 (27%), Gaps = 53/271 (19%)
Query: 292 RAPVVVKRLRDLKPLITEEFRKQLLVIAD----QKHPNLLPLLAYYFSNDEK---LLVYK 344
+ ++ LR +K + + + D + ++ + L +
Sbjct: 122 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR 181
Query: 345 FAGN-GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNL 403
N + S+ + R +L V R L LHH ++H L
Sbjct: 182 MQSNLQTFGEVLLSHSSTHKSLVHHARLQL--TLQVIRLLASLHHYG-------LVHTYL 232
Query: 404 KSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEY-----------QSSKKISR 452
+ +I+LD V ++ + + + ++ PE ++
Sbjct: 233 RPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTF 292
Query: 453 KSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAVREEWTAEIFDSEISVQRS 511
D W+ G ++ + + P W+ R+ + I
Sbjct: 293 SFDAWALGLVIYWIWCADL-----PITKDAALGGSEWIFRSCK----------NIP---Q 334
Query: 512 AAHGMLKLLQVAIQCCNKSPEKRPEMAEVVS 542
+L+ E R + +
Sbjct: 335 PVRALLE------GFLRYPKEDRLLPLQAME 359
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 57/308 (18%), Positives = 106/308 (34%), Gaps = 62/308 (20%)
Query: 275 GLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEF---RKQLLVIADQKHPNLLPLL 330
G G A V V+R+ +L+ E + +L V HPN++P
Sbjct: 34 GKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 331 AYYFSNDEKLLVYKFAGNG---NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
A + +++E +V F G +L ++ I + + GV +AL+Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ-------GVLKALDYIH 145
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYK------- 440
H +H ++K+++IL+ + V +S + + QR++
Sbjct: 146 HMGY-------VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 441 ----SPE--YQSSKKISRKSDVWSFGCLLLELLTGR--------------ISTHSAPQGI 480
SPE Q+ + KSD++S G EL G + P +
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258
Query: 481 NGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAI-------------QCC 527
+ + + + L A S+ + QC
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318
Query: 528 NKSPEKRP 535
++P+ RP
Sbjct: 319 QRNPDARP 326
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 70/317 (22%), Positives = 121/317 (38%), Gaps = 83/317 (26%)
Query: 276 LGKGIFGNSYKALLEGRA----PVVVKRLRDLKPLITE--EFRKQLLVIADQKHPNLLPL 329
LG+G FG+ + L+ V VK ++ E EF + + D HPN++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 330 LA-----YYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLL-VARGVAR 381
L + +++ F G+L + ++ IP + LL +A
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ---TLLKFMVDIAL 158
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKS 441
+EYL +++ +H +L + N +L D+ V V+D+G S + I Y
Sbjct: 159 GMEYLSNRN-------FLHRDLAARNCMLRDDMTVCVADFGLS----------KKI-YSG 200
Query: 442 PEYQSSKKI-----------------SRKSDVWSFGCLLLELLT-GRISTHSAP-QGING 482
Y+ + + KSDVW+FG + E+ T G P G+
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT-----PYPGVQN 255
Query: 483 ADLCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMA 538
++ ++L R E+ E++ EI M C P RP +
Sbjct: 256 HEMYDYLLHGHRLKQPEDCLDELY--EI---------MY-------SCWRTDPLDRPTFS 297
Query: 539 EVVSELEIIKVTESTEE 555
+ +LE K+ ES +
Sbjct: 298 VLRLQLE--KLLESLPD 312
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 56/300 (18%), Positives = 119/300 (39%), Gaps = 65/300 (21%)
Query: 276 LGKGIFGNSYKALL----EGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLL 330
+G+G FG+ ++ + V +K + + E+F ++ L + HP+++ L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 331 AYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
+ + ++ + G L F ++ + +L A ++ AL YL
Sbjct: 83 GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASL-------ILYAYQLSTALAYLES 134
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI---AAQRMISYK--SPE 443
K +H ++ + N+L+ N+ V + D+G S + A++ + K +PE
Sbjct: 135 KR-------FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 187
Query: 444 YQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR------- 494
+ ++ + SDVW FG + E+L G P QG+ D V+ +
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNND----VIGRIENGERLPM 238
Query: 495 -EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-IIKVTES 552
++ + M +C P +RP E+ ++L I++ ++
Sbjct: 239 PPNCPPTLY--SL---------MT-------KCWAYDPSRRPRFTELKAQLSTILEEEKA 280
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 39/221 (17%), Positives = 79/221 (35%), Gaps = 36/221 (16%)
Query: 276 LGKGIFGNSYKA----------------LLEGRAPVVVKRLRDLKPLITEEFRKQLLVIA 319
L +G F L + R + ++F+ +L +I
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 320 DQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRI--HGGKSSKNRIPFRCRSRLLVA 376
D K+ L +N +++ ++Y++ N ++ + +
Sbjct: 99 DIKNEYCLTCE-GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 377 RGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM 436
+ V + Y+H + + H ++K +NIL+D N V +SD+G S + +
Sbjct: 158 KSVLNSFSYIH------NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD---KKIK 208
Query: 437 IS-----YKSPEYQSSKKI--SRKSDVWSFGCLLLELLTGR 470
S + PE+ S++ K D+WS G L +
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 50/301 (16%), Positives = 106/301 (35%), Gaps = 69/301 (22%)
Query: 276 LGKGIFGNSYKA--LLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG+G FG KA L+ R +K++ +++++A H ++ A +
Sbjct: 14 LGQGAFGQVVKARNALDSRY-YAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 334 FSNDEKLLVYK-------------FAGNGNLFNRI--HGGKSSKNRIPFRCRSRLLVARG 378
+ + NG L++ I ++ + R
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY-------WRLFRQ 124
Query: 379 VARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS 438
+ AL Y+H + +IH +LK NI +D++ V + D+G + V + + ++ S
Sbjct: 125 ILEALSYIHSQG-------IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 439 ------------------YKSPE-YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQG 479
Y + E + + K D++S G + E++ G
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP------FSTG 231
Query: 480 INGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAE 539
+ ++ L+ +R + F + + K+++ + P KRP
Sbjct: 232 MERVNI----LKKLRSV--SIEFPPDFDDNKMKV--EKKIIR---LLIDHDPNKRPGART 280
Query: 540 V 540
+
Sbjct: 281 L 281
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 67/294 (22%), Positives = 113/294 (38%), Gaps = 66/294 (22%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLIT--EEFRKQLLVIADQKHPNLLPLL 330
E +G G A + V +KR+ +L+ T +E K++ ++ HPN++
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIV--- 76
Query: 331 AYY--FSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLL--VARGVARALEY 385
+YY F ++L LV K G++ + I + + + R V LEY
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKS---- 441
LH + IH ++K+ NILL ++ V ++D+G S+ +A R K+
Sbjct: 137 LHKNGQ-------IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 442 -----PE-YQSSKKISRKSDVWSFGCLLLELLTGR--------------ISTHSAPQGIN 481
PE + + K+D+WSFG +EL TG + P
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 482 GADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP 535
G + + +++ M+ L C K PEKRP
Sbjct: 250 GVQ-----DKEMLKKYGKSFRK------------MISL------CLQKDPEKRP 280
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 62/316 (19%), Positives = 119/316 (37%), Gaps = 67/316 (21%)
Query: 274 EGLGKGIFGNSYKALLEGRAP------VVVKRLRDLKPLITEEFRKQLLVIADQKHPNLL 327
LG+G FG + A P V VK L++ ++F+++ ++ +H +++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNL--FNRIHG-------GKSSKNRIPFRCRSRLLVARG 378
L+V+++ +G+L F R HG G P L VA
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 379 VARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP----IAAQ 434
VA + YL +H +L + N L+ +V + D+G S + + +
Sbjct: 167 VAAGMVYLAGLH-------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 219
Query: 435 RMISYK--SPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVL 490
M+ + PE +K + +SDVWSFG +L E+ T G+ P ++ + +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ-----PWYQLSNTE----AI 270
Query: 491 RAVR--------EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVS 542
+ E++ M C + P++R + +V +
Sbjct: 271 DCITQGRELERPRACPPEVYAI-----------MR-------GCWQREPQQRHSIKDVHA 312
Query: 543 ELEIIKVTESTEEEED 558
L+ + ++ D
Sbjct: 313 RLQ--ALAQAPPVYLD 326
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 43/220 (19%), Positives = 83/220 (37%), Gaps = 44/220 (20%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKR--LRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
+G G ++ L E + +K L + + +R ++ + + + ++ Y
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD-KIIRLY 94
Query: 334 --FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR----ALEYLH 387
D+ + + GN +L + + K I + + A+ +H
Sbjct: 95 DYEITDQYIYMVMECGNIDLNSWLK----KKKSID------PWERKSYWKNMLEAVHTIH 144
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS------YKS 441
++H +LK N L+ D M+ + D+G ++ + + S Y
Sbjct: 145 QHG-------IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 442 PE-----------YQSSKKISRKSDVWSFGCLLLELLTGR 470
PE +S KIS KSDVWS GC+L + G+
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 70/340 (20%), Positives = 123/340 (36%), Gaps = 82/340 (24%)
Query: 276 LGKGIFGNSYKALL---EGRAPVVVKRLRDLKPLITEEFRKQLLVIAD-----QKHPNLL 327
+G+G FG KA + R +KR+ K +++ + + HPN++
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNL----------FNRIHGGKSSKNRIPFRCRSRLLVAR 377
LL L ++A +GNL ++ + L A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 378 GVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI 437
VAR ++YL K IH +L + NIL+ +N + ++D+G S R
Sbjct: 150 DVARGMDYLSQKQ-------FIHRDLAARNILVGENYVAKIADFGLS----------RGQ 192
Query: 438 SYK-------------SPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGING 482
+ E + + SDVWS+G LL E+++ G P G+
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTC 247
Query: 483 ADLCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMA 538
A+L + + R E++D M QC + P +RP A
Sbjct: 248 AELYEKLPQGYRLEKPLNCDDEVYDL-----------MR-------QCWREKPYERPSFA 289
Query: 539 EVVSELEIIKVTESTEEEEDFWLDQSLTDESLSISTVASA 578
+++ L ++ E + + L + T + S +A
Sbjct: 290 QILVSLN--RMLEERKTYVNTTLYEKFTYAGIDCSAEEAA 327
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 44/220 (20%), Positives = 80/220 (36%), Gaps = 44/220 (20%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKR--LRDLKPLITEEFRK--QLLVIADQKHPNLLPLLA 331
+G G ++ L E + +K L + + +R L Q ++ L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR----ALEYLH 387
Y ++ +V + +L + + K I + + A+ +H
Sbjct: 77 YEITDQYIYMVMECGN-IDLNSWLK----KKKSID------PWERKSYWKNMLEAVHTIH 125
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS------YKS 441
++H +LK N L+ D M+ + D+G ++ + + S Y
Sbjct: 126 QHG-------IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 442 PE-----------YQSSKKISRKSDVWSFGCLLLELLTGR 470
PE +S KIS KSDVWS GC+L + G+
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 276 LGKGIFGNSYKA-LLEGRAPV---VVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLA 331
LGKG F ++ + + +V + LKP E+ ++ + H +++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFR-CRSRLLVARGVARALEYLHHKD 390
++ ND +V + +L K R +R + R + +YLH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH------KRRKALTEPEARYYL-RQIVLGCQYLHRNR 161
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSPEYQS 446
VIH +LK N+ L+++ V + D+G ++ V ++++ +Y +PE S
Sbjct: 162 -------VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 214
Query: 447 SKKISRKSDVWSFGCLLLELLTGR 470
K S + DVWS GC++ LL G+
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 46/228 (20%), Positives = 88/228 (38%), Gaps = 49/228 (21%)
Query: 332 YYFSNDEKLLVY---KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
+ K+ +Y + NL + ++ S ++R C + +A A+E+LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH---IFIQIAEAVEFLHS 182
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS---------- 438
K ++H +LK +NI +++V V D+G + + Q Q +++
Sbjct: 183 KG-------LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235
Query: 439 ------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492
Y SPE S K D++S G +L ELL + + ++
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR----------IITD 285
Query: 493 VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
VR +F + + ++Q + SP +RPE ++
Sbjct: 286 VRNLKFPLLFTQKYPQEH-------MMVQ---DMLSPSPTERPEATDI 323
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 46/204 (22%), Positives = 90/204 (44%), Gaps = 23/204 (11%)
Query: 276 LGKGIFGNSYKA--LLEGR--APVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLA 331
LGKG F ++ A +V + LKP E+ ++ + H +++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 332 YYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
+ F +++ + +V + +L + + +R + R + +YLH
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELH----KRRKALT-EPEARYYL-RQIVLGCQYLHRN- 134
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSPEYQS 446
VIH +LK N+ L+++ V + D+G ++ V ++++ +Y +PE S
Sbjct: 135 ------RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 188
Query: 447 SKKISRKSDVWSFGCLLLELLTGR 470
K S + DVWS GC++ LL G+
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 75/377 (19%), Positives = 136/377 (36%), Gaps = 68/377 (18%)
Query: 199 FYLTKRTRKPNIMIKKQEEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDE 258
+Y +I E + + G + + E K+ K + ++ + N F
Sbjct: 3 YYHHHHHHDYDI---PTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKT 59
Query: 259 QPAGFKLNDLLKAPAEG------LGKGIFGNSYKALLEGRAP------VVVKRLRDLKPL 306
++DL + P + LG G FG Y+ + G V VK L ++
Sbjct: 60 SS----ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE 115
Query: 307 ITE-EFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKN 363
E +F + L+I+ H N++ + + + ++ + G+L F R + S+
Sbjct: 116 QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 175
Query: 364 RIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD---DNEMVLVSD 420
L VAR +A +YL IH ++ + N LL + + D
Sbjct: 176 S-SLAMLDLLHVARDIACGCQYLEENH-------FIHRDIAARNCLLTCPGPGRVAKIGD 227
Query: 421 YGFSSLVAQ----PIAAQRMISYK--SPEYQSSKKISRKSDVWSFGCLLLELLT-GRIST 473
+G + + + M+ K PE + K+D WSFG LL E+ + G +
Sbjct: 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM-- 285
Query: 474 HSAP-QGINGADLCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCN 528
P + ++ +V R + ++ I M QC
Sbjct: 286 ---PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY--RI---------MT-------QCWQ 324
Query: 529 KSPEKRPEMAEVVSELE 545
PE RP A ++ +E
Sbjct: 325 HQPEDRPNFAIILERIE 341
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 67/337 (19%), Positives = 121/337 (35%), Gaps = 85/337 (25%)
Query: 276 LGKGIFGNSYKALLEGRA--------PVVVKRLRDL-KPLITEEFRKQLLVIAD-QKHPN 325
LG+G FG A G V VK L+ + ++ ++ KH N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 326 LLPLLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSR--------LLV 375
++ LL + ++ ++A GNL + + + +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 376 ARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR 435
A VAR +EYL K IH +L + N+L+ ++ ++ ++D+G + R
Sbjct: 197 AYQVARGMEYLASKK-------CIHRDLAARNVLVTEDNVMKIADFGLA----------R 239
Query: 436 MISYKSPEYQSSKKI-----------------SRKSDVWSFGCLLLELLT-GRISTHSAP 477
I + Y+ + + +SDVWSFG LL E+ T G P
Sbjct: 240 DI-HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----P 293
Query: 478 -QGINGADLCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPE 532
G+ +L + R T E++ + M C + P
Sbjct: 294 YPGVPVEELFKLLKEGHRMDKPSNCTNELY--MM---------MR-------DCWHAVPS 335
Query: 533 KRPEMAEVVSELEIIKVTESTEEEEDFWLDQSLTDES 569
+RP ++V +L+ I V ++ +E ++ D
Sbjct: 336 QRPTFKQLVEDLDRI-VALTSNQEMGYYHHHHHHDYD 371
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 62/315 (19%), Positives = 120/315 (38%), Gaps = 88/315 (27%)
Query: 274 EGLGKGIFGNSYKALLEGRAP------VVVKRLRDLKPLITEEFRKQLLVIADQKHPNLL 327
LG+G FG + A +P V VK L+D ++F+++ ++ + +H +++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNL--FNRIHG--------GKSSKNRIPFRCRSRLLVAR 377
D ++V+++ +G+L F R HG G+ + + L +A
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 378 GVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI 437
+A + YL + +H +L + N L+ N +V + D+G S R +
Sbjct: 141 QIASGMVYLASQH-------FVHRDLATRNCLVGANLLVKIGDFGMS----------RDV 183
Query: 438 SYKSPEY--QSSKKI---------------SRKSDVWSFGCLLLELLT-GRISTHSAP-Q 478
Y + Y + + +SDVWSFG +L E+ T G+ P
Sbjct: 184 -YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ-----PWF 237
Query: 479 GINGADLCSWVLRAVR--------EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKS 530
++ + V+ + E++D + ML C +
Sbjct: 238 QLSNTE----VIECITQGRVLERPRVCPKEVYD--V---------ML-------GCWQRE 275
Query: 531 PEKRPEMAEVVSELE 545
P++R + E+ L
Sbjct: 276 PQQRLNIKEIYKILH 290
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 63/326 (19%), Positives = 105/326 (32%), Gaps = 89/326 (27%)
Query: 276 LGKGIFGNSYKALLEGRA------PVVVKRLRDLKPLITEEFRKQLLVIAD-----QKHP 324
LG G FG +A G V VK L K + ++ L+ +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMSHLGQHE 110
Query: 325 NLLPLLAYYFSNDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRL----LV--A 376
N++ LL L++ ++ G+L N R + S L+ +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 377 RGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM 436
VA+ + +L K+ IH ++ + N+LL + + + D+G + R
Sbjct: 171 SQVAQGMAFLASKN-------CIHRDVAARNVLLTNGHVAKIGDFGLA----------RD 213
Query: 437 ISYKSPEYQSSKKI-----------------SRKSDVWSFGCLLLELLT-GRISTHSAP- 477
I Y + +SDVWS+G LL E+ + G P
Sbjct: 214 I-MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN-----PY 267
Query: 478 QGI-NGADLCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPE 532
GI + V + I+ I M C P
Sbjct: 268 PGILVNSKFYKLVKDGYQMAQPAFAPKNIYS--I---------MQ-------ACWALEPT 309
Query: 533 KRPEMAEVVSELEIIKVTESTEEEED 558
RP ++ S L+ + + E D
Sbjct: 310 HRPTFQQICSFLQ--EQAQEDRRERD 333
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 42/230 (18%), Positives = 83/230 (36%), Gaps = 34/230 (14%)
Query: 257 DEQPAGFKLNDLLKAPAEGLGKGIFGNSYKA-LLEGRAPVVVKR-LRDLKPLITEEFRKQ 314
DE+ + + + P + LG G G + + R V VKR L + E Q
Sbjct: 13 DEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNR-DVAVKRILPECFSFADREV--Q 69
Query: 315 LLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLL 374
LL +D+ HPN++ + + + L + + +
Sbjct: 70 LLRESDE-HPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVE-----QKDFAHLGLEPIT 122
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM-----VLVSDYGFSSLVAQ 429
+ + L +LH + ++H +LK NIL+ ++SD+G +A
Sbjct: 123 LLQQTTSGLAHLHSLN-------IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175
Query: 430 PIAAQRMIS-------YKSPEY---QSSKKISRKSDVWSFGCLLLELLTG 469
+ S + +PE + + D++S GC+ +++
Sbjct: 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 46/220 (20%), Positives = 81/220 (36%), Gaps = 44/220 (20%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKR--LRDLKPLITEEFRK--QLLVIADQKHPNLLPLLA 331
+G G ++ L E + +K L + + +R L Q ++ L
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR----ALEYLH 387
Y D+ + + GN +L + + K I + + A+ +H
Sbjct: 124 Y-EITDQYIYMVMECGNIDLNSWLK----KKKSID------PWERKSYWKNMLEAVHTIH 172
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS------YKS 441
++H +LK N L+ D M+ + D+G ++ + + S Y
Sbjct: 173 QHG-------IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 442 PE-----------YQSSKKISRKSDVWSFGCLLLELLTGR 470
PE +S KIS KSDVWS GC+L + G+
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 69/326 (21%), Positives = 116/326 (35%), Gaps = 90/326 (27%)
Query: 276 LGKGIFGNSYKALLEGRA--------PVVVKRLRDLKPLITEEFRKQLLVIAD-----QK 322
LG+G FG A G V VK L K TE+ L+ + K
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 145
Query: 323 HPNLLPLLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSR-------- 372
H N++ LL + ++ ++A GNL + R +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 373 LLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA 432
+ +AR +EYL + IH +L + N+L+ +N ++ ++D+G +
Sbjct: 206 VSCTYQLARGMEYLASQK-------CIHRDLAARNVLVTENNVMKIADFGLA-------- 250
Query: 433 AQRMISYKSPEY--QSSKKI---------------SRKSDVWSFGCLLLELLT-GRISTH 474
R I Y ++ ++ + +SDVWSFG L+ E+ T G
Sbjct: 251 --RDI-NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS--- 304
Query: 475 SAP-QGINGADLCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNK 529
P GI +L + R T E++ M C +
Sbjct: 305 --PYPGIPVEELFKLLKEGHRMDKPANCTNELYMM-----------MR-------DCWHA 344
Query: 530 SPEKRPEMAEVVSELEIIKVTESTEE 555
P +RP ++V +L+ I + EE
Sbjct: 345 VPSQRPTFKQLVEDLDRILTLTTNEE 370
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 56/293 (19%), Positives = 113/293 (38%), Gaps = 52/293 (17%)
Query: 276 LGKGIFGNSYKALL----EGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLL 330
+G+G FG+ ++ + V +K + + E+F ++ L + HP+++ L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
+ + ++ + G L + + + S +L A ++ AL YL K
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQ 445
+H ++ + N+L+ N+ V + D+G S + + I + +PE
Sbjct: 512 -------FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 564
Query: 446 SSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAVR----EEWTA 499
+ ++ + SDVW FG + E+L G P QG+ D+ + R
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVIGRIENGERLPMPPNCPP 619
Query: 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552
++ M +C P +RP E+ ++L I E
Sbjct: 620 TLYSL-----------MT-------KCWAYDPSRRPRFTELKAQLSTILEEEK 654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 62/319 (19%), Positives = 116/319 (36%), Gaps = 75/319 (23%)
Query: 274 EGLGKGIFGNSYKALLEGRAP------VVVKRLRDLKPLIT-EEFRKQLLVIADQKHPNL 326
LG+G FG Y+ + +G V +K + + + EF + V+ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 327 LPLLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKN--RIPFRCRSRLLVARGVARA 382
+ LL L++ + G+L + R + N P + +A +A
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS---- 438
+ YL+ +H +L + N ++ ++ V + D+G + R I
Sbjct: 151 MAYLNANK-------FVHRDLAARNCMVAEDFTVKIGDFGMT----------RDIYETDY 193
Query: 439 YK------------SPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGAD 484
Y+ SPE + SDVWSFG +L E+ T P QG++
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-----PYQGLSNEQ 248
Query: 485 LCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
+ +V+ + +F E+ M C +P+ RP E+
Sbjct: 249 VLRFVMEGGLLDKPDNCPDMLF--EL---------MR-------MCWQYNPKMRPSFLEI 290
Query: 541 VSELEIIKVTESTEEEEDF 559
+S ++ + E E F
Sbjct: 291 ISSIK--EEMEPGFREVSF 307
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 55/288 (19%), Positives = 108/288 (37%), Gaps = 78/288 (27%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLIT--EEFRKQLLVIADQKHPNLLPLL 330
E +GKG FG +K + + V +K + DL+ E+ ++++ V++ P +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
Y + + ++ ++ G G+ + + G + +I R L + L+YLH +
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL-------KGLDYLHSEK 139
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR---------MISYKS 441
K IH ++K+ N+LL ++ V ++D+G + + +R M +
Sbjct: 140 K-------IHRDIKAANVLLSEHGEVKLADFGVAGQLTD-TQIKRNTFVGTPFWM----A 187
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTGR--------------ISTHSAPQGINGADLCS 487
PE K+D+WS G +EL G I ++ P
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT--------- 238
Query: 488 WVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP 535
+ ++ + ++ C NK P RP
Sbjct: 239 -----LEGNYSKPL------------KEFVE------ACLNKEPSFRP 263
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 68/329 (20%), Positives = 110/329 (33%), Gaps = 96/329 (29%)
Query: 276 LGKGIFGNSYKALLEGRA------PVVVKRLR------DLKPLITE-EFRKQLLVIADQK 322
LG G FG +A G V VK L+ + + L++E + L
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL-----GN 85
Query: 323 HPNLLPLLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSR-------- 372
H N++ LL L++ ++ G+L F R ++
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 373 --LLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430
L + VA+ + +L K+ IH +L + NILL + + D+G +
Sbjct: 146 DLLSFSYQVAKGMAFLASKN-------CIHRDLAARNILLTHGRITKICDFGLA------ 192
Query: 431 IAAQRMISYKSPEYQSSKKI-----------------SRKSDVWSFGCLLLELLT-GRIS 472
R I Y + +SDVWS+G L EL + G
Sbjct: 193 ----RDI-KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS- 246
Query: 473 THSAP-QGI-NGADLCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQC 526
P G+ + + R E AE++D M C
Sbjct: 247 ----PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDI-----------MK-------TC 284
Query: 527 CNKSPEKRPEMAEVVSELEIIKVTESTEE 555
+ P KRP ++V +E ++EST
Sbjct: 285 WDADPLKRPTFKQIVQLIEKQ-ISESTNH 312
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 68/321 (21%), Positives = 117/321 (36%), Gaps = 99/321 (30%)
Query: 274 EGLGKGIFGNSYKALLEGRAP------VVVKRLRDLKPLITEEFRKQLL----VIADQKH 323
E LG+ FG YK L G AP V +K L K R++ + A +H
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL---KDKAEGPLREEFRHEAMLRARLQH 71
Query: 324 PNLLPLLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSR--------L 373
PN++ LL + +++ + +G+L F + S + +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 374 LVARGVARALEYL--HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431
+ +A +EYL HH V+H +L + N+L+ D V +SD G
Sbjct: 132 HLVAQIAAGMEYLSSHH---------VVHKDLATRNVLVYDKLNVKISDLGLF------- 175
Query: 432 AAQRMISYKSPEY--QSSKKI---------------SRKSDVWSFGCLLLELLT-GRIST 473
R + Y + Y + + S SD+WS+G +L E+ + G
Sbjct: 176 ---REV-YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ-- 229
Query: 474 HSAP-QGINGADLCSWVLRAVR--------EEWTAEIFDSEISVQRSAAHGMLKLLQVAI 524
P G + D V+ +R ++ A ++ M+
Sbjct: 230 ---PYCGYSNQD----VVEMIRNRQVLPCPDDCPAWVYAL-----------MI------- 264
Query: 525 QCCNKSPEKRPEMAEVVSELE 545
+C N+ P +RP ++ S L
Sbjct: 265 ECWNEFPSRRPRFKDIHSRLR 285
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 67/327 (20%), Positives = 116/327 (35%), Gaps = 84/327 (25%)
Query: 276 LGKGIFGNSYKALLEGRA--------PVVVKRLRDL-KPLITEEFRKQLLVIAD-QKHPN 325
LG+G FG A G V VK L+D + ++ ++ KH N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 326 LLPLLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSR--------LLV 375
++ LL + ++ ++A GNL + R + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 376 ARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR 435
+AR +EYL + IH +L + N+L+ +N ++ ++D+G + R
Sbjct: 163 TYQLARGMEYLASQK-------CIHRDLAARNVLVTENNVMKIADFGLA----------R 205
Query: 436 MISYKSPEYQSSKKI-----------------SRKSDVWSFGCLLLELLT-GRISTHSAP 477
I Y+ + + +SDVWSFG L+ E+ T G P
Sbjct: 206 DI-NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS-----P 259
Query: 478 -QGINGADLCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPE 532
GI +L + R T E++ + M C + P
Sbjct: 260 YPGIPVEELFKLLKEGHRMDKPANCTNELYM--M---------MR-------DCWHAVPS 301
Query: 533 KRPEMAEVVSELEIIKVTESTEEEEDF 559
+RP ++V +L+ I + EE D
Sbjct: 302 QRPTFKQLVEDLDRILTLTTNEEYLDL 328
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 65/320 (20%), Positives = 115/320 (35%), Gaps = 56/320 (17%)
Query: 274 EGLGKGIFGNSYKALLEGRAP------VVVKRLRDLKPLITE-EFRKQLLVIADQKHPNL 326
GLG G FG Y+ + G V VK L ++ E +F + L+I+ H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 327 LPLLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSRLLVARGVARALE 384
+ + + + ++ + G+L F R + S+ L VAR +A +
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQ 154
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLD---DNEMVLVSDYGFSSLVAQ----PIAAQRMI 437
YL IH ++ + N LL + + D+G + + + M+
Sbjct: 155 YLEENH-------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 438 SYK--SPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAP-QGINGADLCSWVLRAV 493
K PE + K+D WSFG LL E+ + G + P + ++ +V
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM-----PYPSKSNQEVLEFVTSGG 262
Query: 494 R----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-IIK 548
R + ++ I M QC PE RP A ++ +E +
Sbjct: 263 RMDPPKNCPGPVY--RI---------MT-------QCWQHQPEDRPNFAIILERIEYCTQ 304
Query: 549 VTESTEEEEDFWLDQSLTDE 568
+ + +E
Sbjct: 305 DPDVINTALPIEYGPLVEEE 324
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 70/328 (21%), Positives = 117/328 (35%), Gaps = 92/328 (28%)
Query: 276 LGKGIFGNSYKALL------EGRAPVVVKRLRDLKPLITEEFRKQLLVIAD-----QKHP 324
LG+G FG +A V VK L K T + L+ H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 91
Query: 325 NLLPLLAYYFSNDEKLLV-YKFAGNGNL--FNRIHGGKSSKNRIPFRCRSR--------L 373
N++ LL L+V +F GNL + R + ++ + +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 374 LVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA 433
+ VA+ +E+L + IH +L + NILL + +V + D+G +
Sbjct: 152 CYSFQVAKGMEFLASRK-------CIHRDLAARNILLSEKNVVKICDFGLA--------- 195
Query: 434 QRMISYKSPEYQSSKKI-----------------SRKSDVWSFGCLLLELLT-GRISTHS 475
R I YK P+Y + +SDVWSFG LL E+ + G
Sbjct: 196 -RDI-YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---- 249
Query: 476 AP-QGI-NGADLCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNK 529
P G+ + C + R + T E++ ML C +
Sbjct: 250 -PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ--T---------ML-------DCWHG 290
Query: 530 SPEKRPEMAEVVSELEIIKVTESTEEEE 557
P +RP +E+V L + ++ +++
Sbjct: 291 EPSQRPTFSELVEHLG--NLLQANAQQD 316
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-16
Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 45/232 (19%)
Query: 259 QPAGFKLND--LLKAPAEGLGKGIFGNSYKALL----EGRAPVVVKRLRDLKPLITEEFR 312
QP + D K LG+G F +L +K L K I +
Sbjct: 23 QPRKKRPEDFKFGKI----LGEGSFS---TVVLARELATSREYAIKILE--KRHIIK--E 71
Query: 313 KQL-------LVIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNR 364
++ V++ HP + L + F +DEKL +A NG L I K
Sbjct: 72 NKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFD 128
Query: 365 IPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424
+R A + ALEYLH K +IH +LK NILL+++ + ++D+G +
Sbjct: 129 ET---CTRFYTAE-IVSALEYLHGKG-------IIHRDLKPENILLNEDMHIQITDFGTA 177
Query: 425 SLVAQPIAAQRMIS------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+++ R S Y SPE + K + SD+W+ GC++ +L+ G
Sbjct: 178 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 71/335 (21%), Positives = 109/335 (32%), Gaps = 98/335 (29%)
Query: 276 LGKGIFGNSYKALLEGRA------PVVVKRLRDLKPLITEEFRKQLLVIAD-----QKHP 324
LG G FG A G + V VK L K R+ L+ H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMMTQLGSHE 109
Query: 325 NLLPLLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSR---------- 372
N++ LL + L++++ G+L + R K S++ I + + R
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 373 -----LLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427
L A VA+ +E+L K +H +L + N+L+ ++V + D+G +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS-------CVHRDLAARNVLVTHGKVVKICDFGLA--- 219
Query: 428 AQPIAAQRMISYKSPEYQSSKKI-----------------SRKSDVWSFGCLLLELLT-G 469
R I Y + KSDVWS+G LL E+ + G
Sbjct: 220 -------RDI-MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271
Query: 470 RISTHSAP-QGI-NGADLCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVA 523
P GI A+ + + T EI+ I M
Sbjct: 272 VN-----PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYI--I---------MQ------ 309
Query: 524 IQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEED 558
C KRP + S L EE
Sbjct: 310 -SCWAFDSRKRPSFPNLTSFLG--CQLADAEEAMY 341
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 49/308 (15%), Positives = 94/308 (30%), Gaps = 51/308 (16%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVK-----RLRDLKPLITEEFR--KQLLVIADQKHPNLL 327
LG+G N ++ + +K + EF K+L H N++
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL------NHKNIV 70
Query: 328 PLLAYYFSNDEKL--LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
L A + L+ +F G+L+ + + N L+V R V + +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILL----DDNEMVLVSDYGFSSLVAQ----------PI 431
L ++H N+K NI+ D + ++D+G + +
Sbjct: 128 LRENG-------IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 432 -AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVL 490
M KK D+WS G TG + ++ ++
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 491 RAVREEWTAEI---------FDSEISVQRSAAHGMLKLLQVAIQCC-NKSPEKRPEMAEV 540
+ + + ++ V S + G+ LL + EK +
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 541 VSELEIIK 548
+E I
Sbjct: 301 FAETSDIL 308
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 33/208 (15%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
+G+G G A V VK + K E +++++ D +H N++ +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
Y +E ++ +F G L + + + ++ +I C + L +AL YLH +
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL-------QALAYLHAQGV- 162
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ--PIAAQR---------MISYKS 441
IH ++KS +ILL + V +SD+GF AQ +R M +
Sbjct: 163 ------IHRDIKSDSILLTLDGRVKLSDFGFC---AQISKDVPKRKSLVGTPYWM----A 209
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTG 469
PE S + + D+WS G +++E++ G
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
E +G+G G Y A+ + V ++++ + E ++LV+ + K+PN++ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
Y DE +V ++ G+L + + + +I CR L +ALE+LH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLHSNQV- 137
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ--PIAAQR---------MISYKS 441
IH ++KS NILL + V ++D+GF AQ P ++R M +
Sbjct: 138 ------IHRDIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSTMVGTPYWM----A 184
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTG 469
PE + K K D+WS G + +E++ G
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 61/310 (19%), Positives = 117/310 (37%), Gaps = 43/310 (13%)
Query: 255 IEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALL-EGRAPVVVKRLR-DLKPLITEEFR 312
+ ++ K +D K LG G G +K + K + ++KP I +
Sbjct: 22 TQKQKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 79
Query: 313 KQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSR 372
++L V+ + P ++ ++S+ E + + G+L + RIP + +
Sbjct: 80 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGK 135
Query: 373 LLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA 432
V+ V + L YL K K ++H ++K +NIL++ + + D+G S + +A
Sbjct: 136 --VSIAVIKGLTYLREKHK------IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 187
Query: 433 AQRM--ISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR----ISTHSAPQGINGADLC 486
+ SY SPE S +SD+WS G L+E+ GR + + G +
Sbjct: 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 247
Query: 487 SWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAI---------------------Q 525
T ++ + + +LL + +
Sbjct: 248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 307
Query: 526 CCNKSPEKRP 535
C K+P +R
Sbjct: 308 CLIKNPAERA 317
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 47/290 (16%), Positives = 101/290 (34%), Gaps = 66/290 (22%)
Query: 276 LGKGIFGNSYKA--LLEGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQ-KHPNLLP 328
+G G FG+ +K L+G +KR + KPL + L A +H +++
Sbjct: 19 IGSGEFGSVFKCVKRLDGCI-YAIKRSK--KPLAGSVDEQNALREVYAHAVLGQHSHVV- 74
Query: 329 LLAYY--FSNDEKLLVY-KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
Y+ ++ D+ +L+ ++ G+L + I ++ + F+ + V R L Y
Sbjct: 75 --RYFSAWAEDDHMLIQNEYCNGGSLADAIS--ENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS----------------LVAQ 429
+H ++H ++K +NI + + + V +
Sbjct: 131 IHSMS-------LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 430 PIAAQRMI---SYKSPE-YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADL 485
+ Q + + E Q + K+D+++ ++ P+ +
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE----PLPRNGDQ--- 236
Query: 486 CSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP 535
+R+ I +S +LK + PE+RP
Sbjct: 237 ----WHEIRQGRLPRI-PQVLS---QEFTELLK------VMIHPDPERRP 272
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 23/132 (17%), Positives = 46/132 (34%), Gaps = 7/132 (5%)
Query: 32 RLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLL 90
D F ++ L ++ + F+S L+ +++S N F+ +
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 515
Query: 91 SLKFLESLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIPKT---QTLQLFRSYS 144
L L+ L N++ + SSL N++ N+ + + Q ++ R
Sbjct: 516 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLL 575
Query: 145 YSNNPYLCGPPS 156
C PS
Sbjct: 576 VEVERMECATPS 587
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 24/121 (19%), Positives = 45/121 (37%), Gaps = 4/121 (3%)
Query: 18 INSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDL 76
+ + + + L + F + LI ++ + F F+ L+ + +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 77 SGNKFYGEISRSLLS-LKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPK 133
+GN F + + L+ L L L L P + SSL+V N+S+NN
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512
Query: 134 T 134
Sbjct: 513 P 513
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 17/100 (17%), Positives = 35/100 (35%), Gaps = 3/100 (3%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLL-SLKF 94
S + L ++ N + NF +L+ +D + S+ SL+
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 95 LESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIP 132
L L + + + SSL+V ++ N+ +
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 24/103 (23%), Positives = 40/103 (38%), Gaps = 4/103 (3%)
Query: 36 EIKSDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKF 94
+ S +F PEL V++ I + S L + L+GN + L
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
Query: 95 LESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNL-SGSIPKT 134
L+ L NL + +LK NV++N + S +P+
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 18/101 (17%), Positives = 35/101 (34%), Gaps = 5/101 (4%)
Query: 39 SDAFADIPELIVINFKNNIISGNFMN--FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLE 96
S F + +L ++F+++ + F S L +D+S + L LE
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 97 SLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIPKT 134
L++ N+ +L ++S L P
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 36/185 (19%), Positives = 60/185 (32%), Gaps = 20/185 (10%)
Query: 19 NSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINF-KNNIISGNFMN-FSSNHKLKDIDL 76
+ + +V + L + + L +N N I S FS+ L+ +DL
Sbjct: 98 GLSSLQKLVAVETNLASLE-NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156
Query: 77 SGNKFYGEISRSLLSLKFLE----SLQLQNNNLTGPVPE-FNQSSLKVFNVSNNNLSGSI 131
S NK L L + SL L N + P F + L + NN S ++
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNV 216
Query: 132 PKT--------QTLQLFRSYSYSNNPYLCGPPS----LNNCSSTGNYVTNSDDKGSNDLK 179
KT + +L + S L N + + D + +
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276
Query: 180 IFYFL 184
+F L
Sbjct: 277 LFNCL 281
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 18/92 (19%), Positives = 31/92 (33%), Gaps = 3/92 (3%)
Query: 46 PELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNN 104
++ N + +F S +L+ +DLS + + SL L +L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 105 LTGPVPE--FNQSSLKVFNVSNNNLSGSIPKT 134
+ SSL+ NL+
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 14/147 (9%), Positives = 37/147 (25%), Gaps = 13/147 (8%)
Query: 26 IVLEDMRLNGEIKSDAFADIPELIV-------INFKNNIISGNFMNFSSNHKLKDIDLSG 78
+ L + + + + L V + N+ + L +
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 79 NK---FYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQ 135
+ +I L + S L + + + + N
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT--L 322
Query: 136 TLQLFRSYSYSNNPYLCGPPSLNNCSS 162
L+ + ++++N S + S
Sbjct: 323 KLKSLKRLTFTSN-KGGNAFSEVDLPS 348
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 26/138 (18%), Positives = 47/138 (34%), Gaps = 7/138 (5%)
Query: 28 LEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISR 87
L + + D F + + + + I +FS N + ++L KF +
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK-DFSYNFGWQHLELVNCKFGQFPTL 322
Query: 88 SLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLS--GSIPKT-QTLQLFRSYS 144
L SLK L +N E + SL+ ++S N LS G ++ +
Sbjct: 323 KLKSLK---RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 145 YSNNPYLCGPPSLNNCSS 162
S N + +
Sbjct: 380 LSFNGVITMSSNFLGLEQ 397
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 67/318 (21%), Positives = 117/318 (36%), Gaps = 89/318 (27%)
Query: 276 LGKGIFGNSYKALL------EGRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLP 328
LG+G FG KA G V VK L++ P + + V+ HP+++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 329 LLAYYFSNDEKLLVYKFAGNGNL------------------FNRIHGGKSSKNRIPFRCR 370
L + LL+ ++A G+L +R +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 371 SRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430
+ A +++ ++YL ++H +L + NIL+ + + +SD+G S
Sbjct: 151 DLISFAWQISQGMQYLAEMK-------LVHRDLAARNILVAEGRKMKISDFGLS------ 197
Query: 431 IAAQRMISYKSPEYQSSKKI-----------------SRKSDVWSFGCLLLELLT-GRIS 472
R + Y+ Y + + +SDVWSFG LL E++T G
Sbjct: 198 ----RDV-YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN- 251
Query: 473 THSAP-QGINGADLCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCC 527
P GI L + + R + + E++ + ML QC
Sbjct: 252 ----PYPGIPPERLFNLLKTGHRMERPDNCSEEMYR--L---------ML-------QCW 289
Query: 528 NKSPEKRPEMAEVVSELE 545
+ P+KRP A++ +LE
Sbjct: 290 KQEPDKRPVFADISKDLE 307
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 40/220 (18%), Positives = 70/220 (31%), Gaps = 41/220 (18%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVK-----RLRDLKPLITEEFR--KQLLVIADQKHPNLL 327
LG+G N ++ + +K + EF K+L H N++
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL------NHKNIV 70
Query: 328 PLLAYYFSNDEKL--LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
L A + L+ +F G+L+ + + N L+V R V + +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILL----DDNEMVLVSDYGFSSLVAQ----------PI 431
L ++H N+K NI+ D + ++D+G + +
Sbjct: 128 LRENG-------IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 432 -AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
M KK D+WS G TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 8e-15
Identities = 39/208 (18%), Positives = 77/208 (37%), Gaps = 35/208 (16%)
Query: 276 LGKGIFGNSYKAL---LEGRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLA 331
+ G G Y AL + GR PVV+K L + +A+ HP+++ +
Sbjct: 88 IAHGGLGWIYLALDRNVNGR-PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 332 YYFSNDEKL-----LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386
+ D +V ++ G +L ++P + + AL YL
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVA--EAIAYLLEILPALSYL 198
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSP 442
H +++ +LK NI+L + + + + D G I + + +++P
Sbjct: 199 HSIG-------LVYNDLKPENIMLTEEQ-LKLIDLG----AVSRINSFGYLYGTPGFQAP 246
Query: 443 EYQSSKKISRKSDVWSFGCLLLELLTGR 470
E + +D+++ G L L
Sbjct: 247 E-IVRTGPTVATDIYTVGRTLAALTLDL 273
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 60/280 (21%), Positives = 105/280 (37%), Gaps = 55/280 (19%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLL-----VIADQKHPNLLPL 329
LG+G +G K + + VKR+R + + +K+LL + P +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIR---ATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
F + + + +L IP + +A + +ALE+LH K
Sbjct: 72 YGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLHSK 128
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKSPE--- 443
VIH ++K +N+L++ V + D+G S + +A Y +PE
Sbjct: 129 LS------VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERIN 182
Query: 444 -YQSSKKISRKSDVWSFGCLLLELLTGR--ISTHSAPQGINGADLCSWVL-----RAVRE 495
+ K S KSD+WS G ++EL R + P V+ + +
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEEPSPQLPAD 237
Query: 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP 535
+++AE F S QC K+ ++RP
Sbjct: 238 KFSAE-FVDFTS-----------------QCLKKNSKERP 259
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 40/208 (19%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYY- 333
LGKG +G Y L + + +K + + ++ +++ + KH N++ Y
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV---QYLG 86
Query: 334 -FSNDEKLLVY-KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
FS + + ++ + G+L + +S + ++ + + L+YLH
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ- 142
Query: 392 SRTQSAVIHGNLKSTNILLDDNE-MVLVSDYGFSSLVAQPIAAQRMISYK------SPE- 443
++H ++K N+L++ ++ +SD+G S +A ++ +PE
Sbjct: 143 ------IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEI 194
Query: 444 -YQSSKKISRKSDVWSFGCLLLELLTGR 470
+ + + +D+WS GC ++E+ TG+
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 59/236 (25%), Positives = 94/236 (39%), Gaps = 26/236 (11%)
Query: 248 EDRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPL 306
E + I EQ F DL +G+G +G+ K + + VKR+R
Sbjct: 4 ESSGKLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIR---ST 58
Query: 307 ITEEFRKQLL-----VIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSS 361
+ E+ +KQLL V+ P ++ F + + + +
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118
Query: 362 KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421
+ IP + + +AL +L K +IH ++K +NILLD + + + D+
Sbjct: 119 DDVIPEEILGK--ITLATVKALNHLKENLK------IIHRDIKPSNILLDRSGNIKLCDF 170
Query: 422 GFSSLVAQPIAAQRMI---SYKSPE----YQSSKKISRKSDVWSFGCLLLELLTGR 470
G S + IA R Y +PE S + +SDVWS G L EL TGR
Sbjct: 171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 27/208 (12%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLL-----VIADQKHPNLLPLL 330
+G G G +K V+ + +E K++L V+ P ++
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
+ +N + + + G + K + IP R + + + +AL YL K
Sbjct: 91 GTFITNTDVFIAMELMGTCAEKLK----KRMQGPIPERILGK--MTVAIVKALYYLKEKH 144
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKSPE---- 443
VIH ++K +NILLD+ + + D+G S + A R +Y +PE
Sbjct: 145 G------VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDP 198
Query: 444 -YQSSKKISRKSDVWSFGCLLLELLTGR 470
+ ++DVWS G L+EL TG+
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 50/225 (22%), Positives = 93/225 (41%), Gaps = 43/225 (19%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKR-LRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG G G +GR PV VKR L D + E +LL +D HPN++
Sbjct: 23 LGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIALME--IKLLTESDD-HPNVIRYYCSE 78
Query: 334 FSNDEKLLVYKFAGNGNLFNRI-HGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
++ + + NL + + S +N + + + + R +A + +LH
Sbjct: 79 TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-- 135
Query: 393 RTQSAVIHGNLKSTNILLD-------------DNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
+IH +LK NIL+ +N +L+SD+G + ++ R
Sbjct: 136 -----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 439 -------YKSPE-------YQSSKKISRKSDVWSFGCLLLELLTG 469
+++PE Q+ ++++R D++S GC+ +L+
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 58/304 (19%), Positives = 111/304 (36%), Gaps = 48/304 (15%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRL--RDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
LG G +G +K + + + +++ V+ HPN++ L +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
+ LV + G LF+ I +R+ F ++ + V + YLH +
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEI------IHRMKFNEVDAAVIIKQVLSGVTYLHKHN-- 156
Query: 393 RTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKSPEYQS 446
++H +LK N+LL + + ++ + D+G S++ + + Y +PE
Sbjct: 157 -----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE-VL 210
Query: 447 SKKISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAV----REEWTAEI 501
KK K DVWS G +L LL G P G ++ V + EW
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGY-----PPFGGQTDQEILRKVEKGKYTFDSPEW---- 261
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEEDFWL 561
+S A + ++LQ ++R + + I ++ E +
Sbjct: 262 --KNVS--EGAKDLIKQMLQ-------FDSQRRISAQQALEHPWIKEMCSKKESGIELPS 310
Query: 562 DQSL 565
+
Sbjct: 311 LANA 314
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 60/290 (20%), Positives = 98/290 (33%), Gaps = 59/290 (20%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ------------- 321
LG G +G G + +K ++ + +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 322 KHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR 381
HPN++ L + LV +F G LF +I NR F + + +
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI------INRHKFDECDAANIMKQILS 157
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMI- 437
+ YLH + ++H ++K NILL + + + D+G SS ++ + +
Sbjct: 158 GICYLHKHN-------IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG 210
Query: 438 --SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAV- 493
Y +PE KK + K DVWS G ++ LL G P G N D+ V +
Sbjct: 211 TAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG-----YPPFGGQNDQDIIKKVEKGKY 264
Query: 494 ---REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
+W IS A + +L KR E
Sbjct: 265 YFDFNDW------KNIS--DEAKELIKLMLT-------YDYNKRCTAEEA 299
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 66/335 (19%), Positives = 124/335 (37%), Gaps = 95/335 (28%)
Query: 274 EGLGKGIFGNSYKALLEGRAP------VVVKRLR-DLKPLITEEFRKQLLVIADQKHPNL 326
+G+G FG ++A G P V VK L+ + + +F+++ ++A+ +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 327 LPLLAYYFSNDEKLLVYKFAGNGNL--FNRIHGGKSSKNRIPFRCRSR------------ 372
+ LL L++++ G+L F R + + +R
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 373 ----LLVARGVARALEYL--HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426
L +AR VA + YL +H +L + N L+ +N +V ++D+G S
Sbjct: 173 CAEQLCIARQVAAGMAYLSERK---------FVHRDLATRNCLVGENMVVKIADFGLS-- 221
Query: 427 VAQPIAAQRMISYKSPEY--QSSKKI---------------SRKSDVWSFGCLLLELLT- 468
R I Y + Y + I + +SDVW++G +L E+ +
Sbjct: 222 --------RNI-YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 469 GRISTHSAP-QGINGADLCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVA 523
G P G+ ++ +V E E+++ + M
Sbjct: 273 GLQ-----PYYGMAHEEVIYYVRDGNILACPENCPLELYN--L---------MR------ 310
Query: 524 IQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEED 558
C +K P RP + L+ ++ E E
Sbjct: 311 -LCWSKLPADRPSFCSIHRILQ--RMCERAEGTVG 342
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 23/105 (21%), Positives = 46/105 (43%), Gaps = 20/105 (19%)
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ 434
+ R + AL+ H H ++K NIL+ ++ + D+G +A +
Sbjct: 139 IVRQIGSALDAAHAAG-------ATHRDVKPENILVSADDFAYLVDFG----IASATTDE 187
Query: 435 RM---------ISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
++ + Y +PE S + ++D+++ C+L E LTG
Sbjct: 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 74/348 (21%), Positives = 134/348 (38%), Gaps = 53/348 (15%)
Query: 140 FRSYSYSNNPYLCGPPSLNNCSSTGNYVTNSDDKGSNDLKIFYFLLAALCIVTVLMLFIF 199
F Y LNN S + ++ N F++ L TV+
Sbjct: 35 FIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNT-----FIIRCLQWTTVIERTFH 89
Query: 200 YLTKRTRKPNI-MIKKQEEYMDQEKESGDDEEEEEEKIGKGKRKL-VVAGEDRNLVFIED 257
T R+ I+ + + ++ + D G ++ V + ++ V + +
Sbjct: 90 VETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE 149
Query: 258 EQPAGFKLNDLLKAPAEGLGKGIFG----------NSYKALLEGRAPVVVKRLRDLKPLI 307
F + LK LGKG FG Y A+ + V+V + ++ +
Sbjct: 150 -----F---EYLKL----LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-DEVAHTL 196
Query: 308 TEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIP 366
TE + V+ + +HP L L Y F ++L V ++A G LF + + R+
Sbjct: 197 TE--NR---VLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS-----RERVF 245
Query: 367 FRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426
R+R A + AL+YLH + V++ +LK N++LD + + ++D+G
Sbjct: 246 SEDRARFYGAE-IVSALDYLHSEK------NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298
Query: 427 VAQPIAAQR----MISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+ A + Y +PE R D W G ++ E++ GR
Sbjct: 299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 29/135 (21%), Positives = 50/135 (37%), Gaps = 15/135 (11%)
Query: 37 IKSDAFADIPELIVINFKNNIIS---------GNFMNFSSNHKLKDIDLSGNKFYGEISR 87
I D + +L +++ ++N ++ G L ++L N F
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 88 SLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSY 145
L L+ + L NNL NQ SLK N+ N ++ + K FR+ +
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTE 613
Query: 146 ---SNNPYLCGPPSL 157
NP+ C S+
Sbjct: 614 LDMRFNPFDCTCESI 628
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 23/107 (21%), Positives = 41/107 (38%), Gaps = 8/107 (7%)
Query: 36 EIKSDAFADIPELIVINFKNNIISG---NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSL 92
K + L + NN I ++ +N LK ++LS N+ ++
Sbjct: 135 STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAI 194
Query: 93 KFLESLQLQNNNLTGPVPE-----FNQSSLKVFNVSNNNLSGSIPKT 134
L L L N L + E +S++ ++SN+ LS + T
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 26/104 (25%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 36 EIKSDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKF 94
++ FA L ++ +N I F L +DLS N + + L+
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 95 LESLQLQNNNLTGPVPE----FNQSSLKVFNVSNNNLSGSIPKT 134
L+ L L NN + E F SSLK +S+N + P
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGC 190
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 25/118 (21%), Positives = 48/118 (40%), Gaps = 11/118 (9%)
Query: 26 IVLEDMRLNGEIKSDAFADIPELIVINFKNNIIS------GNFMNFSSNHKLKDIDLSGN 79
+ +ED + G IKS+ F + L ++ N+ S F++ + + L ++L+ N
Sbjct: 334 LNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA-HSPLHILNLTKN 391
Query: 80 KFYGEISRSLLSLKFLESLQLQNNNLTGPVP--EF-NQSSLKVFNVSNNNLSGSIPKT 134
K S + L LE L L N + + E+ ++ +S N +
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS 449
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 24/112 (21%), Positives = 46/112 (41%), Gaps = 5/112 (4%)
Query: 36 EIKSDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISR--SLLSL 92
+IK++ F LI ++ +N +S L+++ LS NK S + +
Sbjct: 111 KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFAN 170
Query: 93 KFLESLQLQNNNLTGPVPE--FNQSSLKVFNVSNNNLSGSIPKTQTLQLFRS 142
L+ L+L +N + P L ++N L S+ + L+L +
Sbjct: 171 SSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANT 222
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 24/130 (18%), Positives = 44/130 (33%), Gaps = 10/130 (7%)
Query: 42 FADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100
+ L ++N ++N F +LK IDL N + + L+SL L
Sbjct: 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNL 591
Query: 101 QNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIPKTQTLQLF-----RSYSYSNNPYLC 152
Q N +T + +L ++ N + + + ++ YLC
Sbjct: 592 QKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLC 651
Query: 153 G-PPSLNNCS 161
PP +
Sbjct: 652 NTPPHYHGFP 661
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 26/112 (23%), Positives = 43/112 (38%), Gaps = 13/112 (11%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMN---FSSNHKLKDIDLSGNKFYGEISRSLLSL 92
++ ++FA +P L + + + + F L +DLS N L L
Sbjct: 444 QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGL 503
Query: 93 KFLESLQLQNNNLT---------GPVPEF-NQSSLKVFNVSNNNLSGSIPKT 134
+ LE L LQ+NNL GP+ S L + N+ +N +
Sbjct: 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 19/95 (20%), Positives = 39/95 (41%), Gaps = 4/95 (4%)
Query: 44 DIPE-LIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101
D+P + V+N +N + NF+ +L +D+ N L L+ L LQ
Sbjct: 22 DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQ 81
Query: 102 NNNLTGPVPE--FNQSSLKVFNVSNNNLSGSIPKT 134
+N L+ + ++L ++ +N++
Sbjct: 82 HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 18/115 (15%), Positives = 36/115 (31%), Gaps = 16/115 (13%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMN----------FSSNHKLKDIDLSGNKFYGEI 85
+ S + + + +N K + + F L+ +++ N G
Sbjct: 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK 345
Query: 86 SRSLLSLKFLESLQLQNNNLTGPVPEFN------QSSLKVFNVSNNNLSGSIPKT 134
S L L+ L L N+ + S L + N++ N +S
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA 400
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 23/141 (16%), Positives = 48/141 (34%), Gaps = 10/141 (7%)
Query: 19 NSAHVTGIVLEDMRLNGEIKSDAFADI--PELIVINFKNN----IISGNFMNFSSNHKLK 72
+ G+ L +++L + ++ + ++ N+ + F+ L
Sbjct: 193 AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK-WTNLT 251
Query: 73 DIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE--FNQSSLKVFNVSNNNLSGS 130
+DLS N + S L LE L+ NN+ +++ N+ + S
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311
Query: 131 IPKTQTLQLFRSYSYSNNPYL 151
I L +S+ L
Sbjct: 312 ISLAS-LPKIDDFSFQWLKCL 331
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 49/270 (18%), Positives = 102/270 (37%), Gaps = 51/270 (18%)
Query: 233 EEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLNDLLKAPAEG--------------LGK 278
E +GKGKR+ + + + + + + F DL LG
Sbjct: 89 TELVGKGKRRPL---NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGS 145
Query: 279 GIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ---------KHPNLLP 328
G G A + V ++ + + R+ + + HP ++
Sbjct: 146 GACGEVKLAFERKTCKKVAIRII-SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
+ ++ + D +V + G LF+++ R+ + A++YLH
Sbjct: 205 IKNFFDAED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYF--YQMLLAVQYLHE 257
Query: 389 KDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKSP 442
+IH +LK N+LL +++ ++ ++D+G S ++ + + + +Y +P
Sbjct: 258 NG-------IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 443 E---YQSSKKISRKSDVWSFGCLLLELLTG 469
E + +R D WS G +L L+G
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 65/286 (22%), Positives = 118/286 (41%), Gaps = 73/286 (25%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
E LG+G +G+ YKA+ E V +K++ ++ + +E K++ ++ P+++
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDL-QEIIKEISIMQQCDSPHVVKYYGS 92
Query: 333 YFSNDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
YF N + +V ++ G G++ + R+ +++ I +S L + LEYLH
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL-------KGLEYLHFMR 145
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ--PIAAQR--MIS---YKSPE 443
K IH ++K+ NILL+ ++D+G + Q A+R +I + +PE
Sbjct: 146 K-------IHRDIKAGNILLNTEGHAKLADFGVA---GQLTDTMAKRNTVIGTPFWMAPE 195
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTGR--------------ISTHSAPQGINGADLCSWV 489
+ +D+WS G +E+ G+ I T+ P
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT----------- 244
Query: 490 LRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP 535
R E W+ F + QC KSPE+R
Sbjct: 245 FRK-PELWSDN-FTDFVK-----------------QCLVKSPEQRA 271
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 61/280 (21%), Positives = 102/280 (36%), Gaps = 49/280 (17%)
Query: 276 LGKGIFGNSYKALL----EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLA 331
LGKG FG + A V+ + + + E +++ ++ HPN++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
++ LV + G LF+ I +R F + R V + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIRQVLSGITYMHKNK- 146
Query: 392 SRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKSPEYQ 445
++H +LK N+LL + + + D+G S+ + I Y +PE
Sbjct: 147 ------IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE-V 199
Query: 446 SSKKISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAV----REEWTAE 500
K DVWS G +L LL+G P G N D+ V + +W
Sbjct: 200 LHGTYDEKCDVWSTGVILYILLSGC-----PPFNGANEYDILKKVEKGKYTFELPQW--- 251
Query: 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
++S SA + K+L P R +
Sbjct: 252 ---KKVS--ESAKDLIRKMLT-------YVPSMRISARDA 279
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 5e-13
Identities = 50/215 (23%), Positives = 82/215 (38%), Gaps = 36/215 (16%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR-----DLKPLITEEFR--KQLLVIADQKHPNLL 327
LG G FG + + + V +K+ R + E + K+L HPN++
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL------NHPNVV 75
Query: 328 PLLAYY------FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR 381
ND LL ++ G+L ++ +N + + ++
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN---QFENCCGLKEGPIRTLLSDISS 132
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE---MVLVSDYGFSSLVAQPIAAQRMI- 437
AL YLH +IH +LK NI+L + + D G++ + Q +
Sbjct: 133 ALRYLHENR-------IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185
Query: 438 --SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y +PE KK + D WSFG L E +TG
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 38/211 (18%), Positives = 83/211 (39%), Gaps = 32/211 (15%)
Query: 274 EGLGKGIFGNSYKA--LLEGRAPVVVKRLR-DLK--PLITEEFRKQLLVIADQKHPNLLP 328
+ LG G Y A + V +K + + + F +++ + H N++
Sbjct: 17 DKLGGGGMSTVYLAEDTILNI-KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
++ +D LV ++ L I S + + + + +++ H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVD--TAINFTNQILDGIKHAHD 129
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM---------ISY 439
++H ++K NIL+D N+ + + D+G +A+ ++ + + Y
Sbjct: 130 MR-------IVHRDIKPQNILIDSNKTLKIFDFG----IAKALSETSLTQTNHVLGTVQY 178
Query: 440 KSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
SPE + +D++S G +L E+L G
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 68/307 (22%), Positives = 108/307 (35%), Gaps = 54/307 (17%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRL--RDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
LGKG FG K + VK + K T +++ ++ HPN++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
+ +V + G LF+ I R F + + V + Y+H +
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 393 RTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRM------ISYKSPE 443
++H +LK NILL + + + + D+G S+ Q +M Y +PE
Sbjct: 142 -----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPE 193
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAV----REEWT 498
K DVWS G +L LL+G + P G N D+ V +W
Sbjct: 194 -VLRGTYDEKCDVWSAGVILYILLSG-----TPPFYGKNEYDILKRVETGKYAFDLPQW- 246
Query: 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEED 558
IS A + K+L P R + + I K + T D
Sbjct: 247 -----RTIS--DDAKDLIRKMLT-------FHPSLRITATQCLEHPWIQKYSSETPTISD 292
Query: 559 FWLDQSL 565
+S
Sbjct: 293 LPSLESA 299
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 42/216 (19%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLIT-EEFRKQLLVIADQKHPNLLPLLA 331
LG G FG YKA E A K + + K E++ ++ ++A HP ++ LL
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 332 YYFSNDEKLLVYKFAGNGNLFN--RIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
Y+ + + ++ +F G + ++ +I CR L AL +LH K
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-------EALNFLHSK 136
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ--PIAAQR---------MIS 438
IH +LK+ N+L+ + ++D+G S A+ +R M
Sbjct: 137 RI-------IHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSFIGTPYWM-- 184
Query: 439 YKSPEYQSSKKISR-----KSDVWSFGCLLLELLTG 469
+PE + + K+D+WS G L+E+
Sbjct: 185 --APEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 44/247 (17%), Positives = 85/247 (34%), Gaps = 59/247 (23%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVK-----RLRDLKPLITEEFRKQLLVIADQKHPNLLPL 329
+G+G +G A+ + RA +K ++R + P E + ++ ++ HPN+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLV-------------- 375
Y LV + G+L ++++ + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 376 ----------------ARGVAR----ALEYLHHKDKSRTQSAVIHGNLKSTNILL--DDN 413
+ R AL YLH++ + H ++K N L + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-------ICHRDIKPENFLFSTNKS 206
Query: 414 EMVLVSDYGFSSLVAQPIAAQRMI--------SYKSPE--YQSSKKISRKSDVWSFGCLL 463
+ + D+G S + + + +PE +++ K D WS G LL
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 464 LELLTGR 470
LL G
Sbjct: 267 HLLLMGA 273
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 5e-12
Identities = 61/291 (20%), Positives = 110/291 (37%), Gaps = 57/291 (19%)
Query: 200 YLTKRTRKPNIMIKKQEEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQ 259
+L K+ P++ EE + + E +K R + E
Sbjct: 135 HLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDK------------FTRFCQWKNVEL 182
Query: 260 PAGFKLND--LLKAPAEGLGKGIFGNSY-------------KALLEGRAPVVVKRLRDLK 304
+ND + + +G+G FG Y K L + R +K +
Sbjct: 183 NIHLTMNDFSVHRI----IGRGGFGEVYGCRKADTGKMYAMKCLDKKR----IKMKQGET 234
Query: 305 PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRI-HGGKSSK 362
+ E R L +++ P ++ + +Y F +KL + G+L + G S+
Sbjct: 235 LALNE--RIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE 291
Query: 363 NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG 422
+ F A + LE++H++ V++ +LK NILLD++ V +SD G
Sbjct: 292 ADMRF-------YAAEIILGLEHMHNRF-------VVYRDLKPANILLDEHGHVRISDLG 337
Query: 423 FSSLVAQPIAAQRM--ISYKSPEYQSSKKISRKS-DVWSFGCLLLELLTGR 470
+ ++ + Y +PE S D +S GC+L +LL G
Sbjct: 338 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 63/304 (20%), Positives = 113/304 (37%), Gaps = 88/304 (28%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLA 331
E +G G +G YK ++ +K + D+ EE ++++ ++ H N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 332 YYF-----SNDEKL-LVYKFAGNG---NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARA 382
+ D++L LV +F G G +L G + I + CR L R
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL-------RG 141
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR------- 435
L +LH IH ++K N+LL +N V + D+G S+ + + + +
Sbjct: 142 LSHLHQHKV-------IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194
Query: 436 -MISYKSPEYQSSKKISR-----KSDVWSFGCLLLELLTGR--------------ISTHS 475
M +PE + + KSD+WS G +E+ G I +
Sbjct: 195 WM----APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250
Query: 476 APQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP 535
AP+ L++ ++W+ + F S I C K+ +RP
Sbjct: 251 APR-----------LKS--KKWSKK-FQSFIE-----------------SCLVKNHSQRP 279
Query: 536 EMAE 539
+
Sbjct: 280 ATEQ 283
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 33/166 (19%), Positives = 71/166 (42%), Gaps = 37/166 (22%)
Query: 322 KHPNLLPLL-AYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGV 379
HPN++ L+ N++ L +V++ G + S++ AR
Sbjct: 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED-----------QARFY 142
Query: 380 AR----ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR 435
+ +EYLH++ +IH ++K +N+L+ ++ + ++D+G S + +
Sbjct: 143 FQDLIKGIEYLHYQK-------IIHRDIKPSNLLVGEDGHIKIADFGVS---NEFKGSDA 192
Query: 436 MIS-------YKSPEYQSSKKIS---RKSDVWSFGCLLLELLTGRI 471
++S + +PE S + + DVW+ G L + G+
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 56/296 (18%), Positives = 110/296 (37%), Gaps = 44/296 (14%)
Query: 259 QPAGFKLNDLLKAPAEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLV 317
+P + + D + + LG G+ G + +K L D P +E
Sbjct: 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-SPKARQEVDHHWQA 78
Query: 318 IADQKHPNLLPLLAYYFSNDEK----LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRL 373
P+++ +L Y + L++ + G LF+RI + F R
Sbjct: 79 ---SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTEREAA 131
Query: 374 LVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQP 430
+ R + A+++LH + + H ++K N+L + + ++ ++D+GF+ Q
Sbjct: 132 EIMRDIGTAIQFLHSHN-------IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184
Query: 431 IAAQRMIS--YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCS 487
+ Y +PE +K + D+WS G ++ LL G P G +
Sbjct: 185 ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF-----PPFYSNTGQAISP 239
Query: 488 WVLRAVREEWTAEI-FDSEI--SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
+ R +R + F + V A + LL+ P +R + +
Sbjct: 240 GMKRRIRL---GQYGFPNPEWSEVSEDAKQLIRLLLKT-------DPTERLTITQF 285
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 77/366 (21%), Positives = 115/366 (31%), Gaps = 140/366 (38%)
Query: 276 LGKGIFGNSYKALLEG------RAPVVVKRLRDLKPLITEEFRKQLLV-----IADQKHP 324
LG+G FG +A G V VK L K T + L+ I H
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 86
Query: 325 NLLPLLAYYFSNDEKLLV-YKFAGNGNLFN-----------------RIHGGKSSKNRIP 366
N++ LL L+V +F GNL R GK IP
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 367 FRCRSR-------------------------------------------LLVARGVARAL 383
+ R + + VA+ +
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 384 EYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPE 443
E+L + IH +L + NILL + +V + D+G + R I YK P+
Sbjct: 207 EFLASRK-------CIHRDLAARNILLSEKNVVKICDFGLA----------RDI-YKDPD 248
Query: 444 YQSSKKI-----------------SRKSDVWSFGCLLLELLT-GRISTHSAP-QGI-NGA 483
Y + +SDVWSFG LL E+ + G P G+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 303
Query: 484 DLCSWVLRAVR----EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAE 539
+ C + R + T E++ + ML C + P +RP +E
Sbjct: 304 EFCRRLKEGTRMRAPDYTTPEMYQT-----------ML-------DCWHGEPSQRPTFSE 345
Query: 540 VVSELE 545
+V L
Sbjct: 346 LVEHLG 351
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 28/103 (27%), Positives = 44/103 (42%), Gaps = 14/103 (13%)
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG---FSSLVAQPI 431
V +AL + H +IH ++K NI++ V V D+G + +
Sbjct: 121 VIADACQALNFSHQNG-------IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 432 AAQRMI----SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+ Y SPE + +SDV+S GC+L E+LTG
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 26/189 (13%), Positives = 51/189 (26%), Gaps = 37/189 (19%)
Query: 6 DFPSQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-- 63
D G+ + ++ VTG+ LE +G + DA + EL V+ ++ N
Sbjct: 67 DMWGAQPGVSLN-SNGRVTGLSLEGFGASGRV-PDAIGQLTELEVLALGSHGEKVNERLF 124
Query: 64 --------------NFSSNH---------------KLKDIDLSGNKFYGEISRSLLSLKF 94
H L ++ + I +S
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184
Query: 95 LESLQLQNNNLTGPVPEFNQ-SSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCG 153
+ +NN+T + + L+ F + N+ Y+
Sbjct: 185 DTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT---E 241
Query: 154 PPSLNNCSS 162
+N
Sbjct: 242 DLKWDNLKD 250
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 14/116 (12%), Positives = 33/116 (28%), Gaps = 9/116 (7%)
Query: 65 FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF------NQSSLK 118
+SN ++ + L G G + ++ L LE L L ++ F S +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 119 VFNVSNNNLSGSIPKTQTLQLFRSYSY---SNNPYLCGPPSLNNCSSTGNYVTNSD 171
+ + + F +++P + + +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLS 192
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 22/136 (16%), Positives = 40/136 (29%), Gaps = 10/136 (7%)
Query: 32 RLNGEIKSDAFADIPELIVINFKNNIIS------GNFMNFSSNHKLKDIDLSGNKFYGEI 85
+L +P L+ I+ N S N D GN+ E
Sbjct: 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREW 558
Query: 86 SRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKT---QTLQLFRS 142
+ L LQ+ +N++ V E ++ V ++ +N
Sbjct: 559 PEGITLCPSLTQLQIGSNDIRK-VNEKITPNISVLDIKDNPNISIDLSYVCPYIEAGMYM 617
Query: 143 YSYSNNPYLCGPPSLN 158
Y + G +L+
Sbjct: 618 LFYDKTQDIRGCDALD 633
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 23/109 (21%), Positives = 42/109 (38%), Gaps = 12/109 (11%)
Query: 36 EIKSDAFADIPELIVINFKNNIISG--NFMNFSSNHKLKDIDLSGNKFYG-------EIS 86
EI ++ ++ ++F +N + N + S + ID S N+ +
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 87 RSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPK 133
+ + S+ L NN ++ E S L N+ N L+ IPK
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPK 474
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 20/101 (19%), Positives = 39/101 (38%), Gaps = 5/101 (4%)
Query: 40 DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLS-LKFLESL 98
+ + +L ++ N + G F S KL ++L+ N+ EI + + +E+L
Sbjct: 324 TSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQI-TEIPANFCGFTEQVENL 382
Query: 99 QLQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIPKTQT 136
+N L F + S + + S N + K
Sbjct: 383 SFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 18/109 (16%), Positives = 30/109 (27%), Gaps = 17/109 (15%)
Query: 48 LIVINFKNNIISGNFMN--------FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99
+ I+F N I + I+LS N+ + L S+
Sbjct: 404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSIN 463
Query: 100 LQNNNLTGPVPEFNQS---------SLKVFNVSNNNLSGSIPKTQTLQL 139
L N LT + L ++ N L+ + L
Sbjct: 464 LMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTL 512
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 19/132 (14%), Positives = 36/132 (27%), Gaps = 23/132 (17%)
Query: 45 IPELIVINFKNNIISGNFMNFSSN-------HKLKDIDLSGNKFYGEISRSLLSLKFLES 97
I + I K+ I N + KL+ + + F E E+
Sbjct: 175 IKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN---EN 231
Query: 98 LQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKT-------QTLQLFRSYSYSNNPY 150
+ T + N L V N +P Q + + + N
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINV------ACNRG 285
Query: 151 LCGPPSLNNCSS 162
+ G ++ +
Sbjct: 286 ISGEQLKDDWQA 297
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 14/130 (10%), Positives = 36/130 (27%), Gaps = 29/130 (22%)
Query: 52 NFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTG---- 107
+ + N L D+++ ++ L +L ++ + + N
Sbjct: 235 AQQYKTEDLKWDNLKD---LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291
Query: 108 ------PVPEFNQSSLKVFNVSNNNL-SGSIPKT-------QTLQLFRSYSYSNNPYLCG 153
+++ + NNL + + + L+ N L G
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC-----LYNQ--LEG 344
Query: 154 -PPSLNNCSS 162
P+ +
Sbjct: 345 KLPAFGSEIK 354
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 12/84 (14%), Positives = 26/84 (30%), Gaps = 8/84 (9%)
Query: 88 SLLSLKFLESLQLQNNNLTGPVPE--FNQSSLKVFNVSNNNLSG----SIPK--TQTLQL 139
SL S + L L+ +G VP+ + L+V + ++ PK + +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 140 FRSYSYSNNPYLCGPPSLNNCSST 163
+ + +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFS 159
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 25/134 (18%), Positives = 48/134 (35%), Gaps = 8/134 (5%)
Query: 32 RLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLL 90
S+ FA+ L ++ + F + H+L+ +++S N S
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 91 SLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNN 148
L L +L N + SL FN++NN+++ I Q F +
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CIC---EHQKFLQWVKEQK 574
Query: 149 PYLCGPPSLNNCSS 162
+L + C++
Sbjct: 575 QFLVNVEQM-TCAT 587
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 23/115 (20%), Positives = 44/115 (38%), Gaps = 6/115 (5%)
Query: 37 IKSDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFL 95
I+ A+ + L + N I + +FS L+++ K S + L L
Sbjct: 71 IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 96 ESLQLQNNNLTG-PVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSN 147
+ L + +N + +P + N ++L ++S N + LQ R N
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN--DLQFLRENPQVN 183
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 22/97 (22%), Positives = 37/97 (38%), Gaps = 3/97 (3%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKF 94
+KS +F++ EL ++ I + H L ++ L+GN S L
Sbjct: 46 ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS 105
Query: 95 LESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSG 129
LE+L L +LK NV++N +
Sbjct: 106 LENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 24/115 (20%), Positives = 44/115 (38%), Gaps = 8/115 (6%)
Query: 28 LEDMRLNG---EIKSDAFADIPELIVINFKNNIISG--NFMNFSSNHKLKDIDLSGNKFY 82
L + L+ I S F + EL ++F+++ + F F S KL +D+S
Sbjct: 378 LRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 83 GEISRSLLSLKFLESLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIPKT 134
+ L L L +L++ N+ N ++L ++S L
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 16/102 (15%), Positives = 33/102 (32%), Gaps = 5/102 (4%)
Query: 36 EIKSDAFADI--PELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLL-SL 92
+++D+ L ++ N NF +L+ +D + S SL
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423
Query: 93 KFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIP 132
+ L L + N +SL ++ N+ +
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 25/111 (22%), Positives = 38/111 (34%), Gaps = 7/111 (6%)
Query: 36 EIKSDAFADIPELIVINFKNNIISG--NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLK 93
++S + L +N +N I FS+ L +DLS N L L+
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 94 ----FLESLQLQNNNLTGPVPE-FNQSSLKVFNVSNNNLSGSIPKTQTLQL 139
SL + N + + F L + N S +I KT L
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNL 228
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 20/109 (18%), Positives = 38/109 (34%), Gaps = 8/109 (7%)
Query: 28 LEDMRLNG----EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYG 83
+++ RL F + + ++ I + + K + + + +
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLK- 320
Query: 84 EISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIP 132
L L FL+SL L N + + SL ++S N LS S
Sbjct: 321 --QFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGC 367
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 21/94 (22%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 43 ADIPE-LIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100
DIP I+ N + +FS+ +L+ +DLS + ++ L L +L L
Sbjct: 28 DDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLIL 87
Query: 101 QNNNLTGPVPE-FNQ-SSLKVFNVSNNNLSGSIP 132
N + P F+ +SL+ L+
Sbjct: 88 TGNPIQSFSPGSFSGLTSLENLVAVETKLASLES 121
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 13/151 (8%), Positives = 33/151 (21%), Gaps = 22/151 (14%)
Query: 26 IVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGN----------FMNFSSNHKLKDID 75
+ L + I ++ L V +
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID-EFR 267
Query: 76 LSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSG----SI 131
L+ + + L + ++ L ++ + ++ L +
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDL 327
Query: 132 PKTQTLQLFRSYSYSNNPYLCGPPSLNNCSS 162
P ++L L + N S
Sbjct: 328 PFLKSLTL------TMNK-GSISFKKVALPS 351
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 48/244 (19%), Positives = 98/244 (40%), Gaps = 51/244 (20%)
Query: 256 EDEQPAGFKLNDLLKA--PAEGLGKGIFGNSYKA--------------LLEGRAPVVVKR 299
+ P + + P E LG+G+ + + G +
Sbjct: 3 DAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEE 62
Query: 300 LRDLKPLITEEFR--KQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHG 357
+++L+ +E +++ HPN++ L Y +N LV+ G LF+ +
Sbjct: 63 VQELREATLKEVDILRKV-----SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 115
Query: 358 GKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL 417
+ K + + +++ R + + LH + ++H +LK NILLDD+ +
Sbjct: 116 --TEKVTLSEKETRKIM--RALLEVICALHKLN-------IVHRDLKPENILLDDDMNIK 164
Query: 418 VSDYGFSSLVAQPIAAQRMI------SYKSPE------YQSSKKISRKSDVWSFGCLLLE 465
++D+GFS + +++ SY +PE + ++ D+WS G ++
Sbjct: 165 LTDFGFSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221
Query: 466 LLTG 469
LL G
Sbjct: 222 LLAG 225
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 62/334 (18%), Positives = 121/334 (36%), Gaps = 47/334 (14%)
Query: 221 QEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLNDLLKA--PAEGLGK 278
+ + D +E+ + GKG ++ QP K + +L E LG
Sbjct: 108 KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGT 167
Query: 279 GIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND 337
G FG ++ K + E RK++ ++ +HP L+ L + ++
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227
Query: 338 EKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSA 397
E +++Y+F G LF ++ + + R V + L ++H +
Sbjct: 228 EMVMIYEFMSGGELFEKV-----ADEHNKMSEDEAVEYMRQVCKGLCHMHENN------- 275
Query: 398 VIHGNLKSTNILLDDNE--MVLVSDYGFSSLVAQPIAAQRM-ISYKSPEYQS-----SKK 449
+H +LK NI+ + + D+G ++ + Q + ++ + E+ + K
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVAEGKP 332
Query: 450 ISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAVREEWTAEIFDSEI-- 506
+ +D+WS G L LL+G +P G N + V +W D
Sbjct: 333 VGYYTDMWSVGVLSYILLSGL-----SPFGGENDDETLRNVKSC---DWN---MDDSAFS 381
Query: 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
+ + KLL P R + +
Sbjct: 382 GISEDGKDFIRKLLL-------ADPNTRMTIHQA 408
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 48/223 (21%), Positives = 85/223 (38%), Gaps = 53/223 (23%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRK----------QLLVIADQKHP 324
LG G FG+ Y + + PV +K + K I++ LL
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVE--KDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 325 NLLPLLAYYFSNDEKLLVYKFA-GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR-- 381
++ LL ++ D +L+ + +LF+ I + + + +AR
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI----TERGALQEE------LARSFFWQV 158
Query: 382 --ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL-VSDYGFSSLVAQ--------- 429
A+ + H+ V+H ++K NIL+D N L + D+G +L+
Sbjct: 159 LEAVRHCHNC-------GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGT 211
Query: 430 PIAAQRMISYKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGRI 471
Y PE+ + R + VWS G LL +++ G I
Sbjct: 212 R-------VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 49/219 (22%), Positives = 82/219 (37%), Gaps = 43/219 (19%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR----------DLKPLITEEFRKQLLVIADQKHP 324
LGKG FG + L R V +K + E V A HP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 325 NLLPLLAYYFSNDEKLLVYKFAGNGN-LFNRIHGGKSSKNRIP-FRCRSRLLVARGVARA 382
++ LL ++ + + +LV + LF+ I + K + R V A
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYI----TEKGPLGEGPSRC---FFGQVVAA 151
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL-VSDYGFSSLVAQPIAAQRM----- 436
+++ H + V+H ++K NIL+D + D+G +L+
Sbjct: 152 IQHCHSR-------GVVHRDIKDENILIDLRRGCAKLIDFGSGALL------HDEPYTDF 198
Query: 437 ---ISYKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGRI 471
Y PE+ S + + + VWS G LL +++ G I
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 44/208 (21%), Positives = 75/208 (36%), Gaps = 30/208 (14%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEE----FRKQLLVIADQKHPNLLP 328
+G G FG Y A + V +K++ + E K++ + +HPN +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 329 LLAYYFSNDEKLLVYKFAGNGNL-FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
Y LV ++ +H + I L + L YLH
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL-------QGLAYLH 171
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS---YKSPE- 443
+ IH ++K+ NILL + +V + D+G + + A + + +PE
Sbjct: 172 SHNM-------IHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANSFVGTPYWMAPEV 221
Query: 444 --YQSSKKISRKSDVWSFGCLLLELLTG 469
+ K DVWS G +EL
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 44/207 (21%), Positives = 84/207 (40%), Gaps = 22/207 (10%)
Query: 276 LGKGIFGNSYKALL----EGRA--PVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPL 329
+GKG F + + + A V V + L TE+ +++ + KHP+++ L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
L Y S+ +V++F +L I + S + R + AL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM--RQILEALRYCHDN 149
Query: 390 DKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSP 442
+ +IH ++K +LL +++ V + +G + + + + +P
Sbjct: 150 N-------IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 443 EYQSSKKISRKSDVWSFGCLLLELLTG 469
E + + DVW G +L LL+G
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 33/161 (20%)
Query: 322 KHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR 381
HPN++ L + L+ ++A G +F+ + + R+ + AR R
Sbjct: 72 NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL----VAHGRMKEK------EARSKFR 121
Query: 382 ----ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI 437
A++Y H K ++H +LK+ N+LLD + + ++D+GFS+ +
Sbjct: 122 QIVSAVQYCHQKR-------IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG----GKL 170
Query: 438 S-------YKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGR 470
Y +PE KK + DVWS G +L L++G
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 38/164 (23%), Positives = 70/164 (42%), Gaps = 39/164 (23%)
Query: 322 KHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR 381
+HP+++ L + + +V ++ G LF+ I R+ AR + +
Sbjct: 69 RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI----CKHGRVEEM------EARRLFQ 118
Query: 382 ----ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ-------- 429
A++Y H V+H +LK N+LLD + ++D+G S++++
Sbjct: 119 QILSAVDYCHRH-------MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 171
Query: 430 --PIAAQRMISYKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGR 470
P +Y +PE S + + D+WS G +L LL G
Sbjct: 172 GSP-------NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 49/216 (22%), Positives = 83/216 (38%), Gaps = 43/216 (19%)
Query: 276 LGKGIFGNSY-------------KALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK 322
LG+G FG + K L + KR + + + E K++L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKL---NKKRLKKR-KGYQGAMVE---KKILAKV--H 243
Query: 323 HPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR 381
++ L AY F L LV G++ I+ R+ A+ +
Sbjct: 244 SRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-RAIFYTAQ-IVS 300
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS--- 438
LE+LH ++ +I+ +LK N+LLDD+ V +SD G L + A Q
Sbjct: 301 GLEHLHQRN-------IIYRDLKPENVLLDDDGNVRISDLG---LAVELKAGQTKTKGYA 350
Query: 439 ----YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+ +PE ++ D ++ G L E++ R
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 43/222 (19%)
Query: 267 DLLKAPAEGLGKGIFG----------NSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLL 316
++L+A +GKG FG A+ V+R +++ + E Q++
Sbjct: 18 EILRA----IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-NEVRNVFKE---LQIM 69
Query: 317 VIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFR-CRSRLL 374
+HP L+ L Y F ++E + +V G+L + +N F+ +L
Sbjct: 70 QGL--EHPFLVNL-WYSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVH-FKEETVKLF 120
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ 434
+ + AL+YL ++ +IH ++K NILLD++ V ++D+ ++++ +
Sbjct: 121 ICE-LVMALDYLQNQR-------IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172
Query: 435 RM---ISYKSPEYQSSKKI---SRKSDVWSFGCLLLELLTGR 470
M Y +PE SS+K S D WS G ELL GR
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 43/222 (19%), Positives = 83/222 (37%), Gaps = 51/222 (22%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVK--------RLRDLKPLITEEFR--KQLLVIADQKHP 324
LG+G +G + L E VK R+ + + + +E + ++L +H
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL------RHK 66
Query: 325 NLLPLL-AYYFSNDEKL-LVYKFAGNGN--LFNRIHGGKSSKNRIPFRCRSRLLVARGVA 380
N++ L+ Y +K+ +V ++ G + + + + A G
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVC-----------QAHGYF 115
Query: 381 R----ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM 436
LEYLH + ++H ++K N+LL + +S G + + A
Sbjct: 116 CQLIDGLEYLHSQG-------IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
Query: 437 IS------YKSPEYQSSKKI--SRKSDVWSFGCLLLELLTGR 470
+ ++ PE + K D+WS G L + TG
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 57/278 (20%), Positives = 101/278 (36%), Gaps = 53/278 (19%)
Query: 217 EYMDQEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPA-GFKLND--LLKAPA 273
Y D E +G + E + E + + L D LL+
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRV-- 59
Query: 274 EGLGKGIFG-----------NSY--KALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIAD 320
+G+G + Y + + + +V D+ + TE K + A
Sbjct: 60 --IGRGSYAKVLLVRLKKTDRIYAMRVV---KKELVNDD-EDIDWVQTE---KHVFEQAS 110
Query: 321 QKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGV 379
HP L+ L F + +L V ++ G+L + + R +R A +
Sbjct: 111 -NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAE-I 162
Query: 380 ARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
+ AL YLH + +I+ +LK N+LLD + ++DYG + + + S
Sbjct: 163 SLALNYLHERG-------IIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRPGDTTST 212
Query: 439 ------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y +PE + D W+ G L+ E++ GR
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 49/220 (22%), Positives = 87/220 (39%), Gaps = 54/220 (24%)
Query: 276 LGKGIFGNSYKA--LLEGRAPVVVK-----RLRDLKPLITEEFR--KQLLVIADQKHPNL 326
LG+G +G A + A V VK R D I +E K L H N+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKML------NHENV 67
Query: 327 LPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR----- 381
+ + + + L ++ G LF+RI +P A+
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMP----------EPDAQRFFHQ 113
Query: 382 ---ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS 438
+ YLH + H ++K N+LLD+ + + +SD+G +++ + +R+++
Sbjct: 114 LMAGVVYLHGI-------GITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLN 165
Query: 439 -------YKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGR 470
Y +PE ++ + DVWS G +L +L G
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 40/213 (18%)
Query: 276 LGKGIFGNSY-------------KALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK 322
LGKG FG K L + KR + + E KQ+L +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKR-KGEAMALNE---KQILEKVN-- 242
Query: 323 HPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFR-CRSRLLVARGVA 380
++ L AY + + L LV G+L I+ + F R+ A +
Sbjct: 243 SRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY----HMGQAGFPEARAVFYAAE-IC 296
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM---I 437
LE LH + +++ +LK NILLDD+ + +SD G + V + + +
Sbjct: 297 CGLEDLHRER-------IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV 349
Query: 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y +PE +++ + D W+ GCLL E++ G+
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 59/263 (22%), Positives = 106/263 (40%), Gaps = 41/263 (15%)
Query: 264 KLNDLLKAPAEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIAD-Q 321
+ D+ + + LG+G + L VK + I +++ ++ Q
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 322 KHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR 381
H N+L L+ ++ D LV++ G++ + IH R F +V + VA
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH------KRRHFNELEASVVVQDVAS 122
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLV-----AQPIAA 433
AL++LH+K + H +LK NIL + V + D+ S + PI+
Sbjct: 123 ALDFLHNKG-------IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 434 QRMIS------YKSPE-----YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAP-QGIN 481
+++ Y +PE + + ++ D+WS G +L LL+G P G
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY-----PPFVGRC 230
Query: 482 GADLCSWVLRAVREEWTAEIFDS 504
G+D C W +F+S
Sbjct: 231 GSD-CGWDRGEACPACQNMLFES 252
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 9e-11
Identities = 48/213 (22%), Positives = 80/213 (37%), Gaps = 45/213 (21%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
LG G F + +K ++ ++ V+ KH N++ L Y
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARG-------------VAR 381
S LV + G LF+RI + RG V
Sbjct: 77 STTHYYLVMQLVSGGELFDRI-------------------LERGVYTEKDASLVIQQVLS 117
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMIS 438
A++YLH ++H +LK N+L ++N ++++D+G S + I + +
Sbjct: 118 AVKYLHENG-------IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGT 170
Query: 439 --YKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
Y +PE + K S+ D WS G + LL G
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 20/113 (17%), Positives = 43/113 (38%), Gaps = 6/113 (5%)
Query: 28 LEDMRLNGEIKSDAFADIPELIVINFKNNIISG---NFMNFSSNHKLKDIDLSGNKFYGE 84
++ E+ + ++ L ++ ++ I + + L+ ++LS N+
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391
Query: 85 ISRSLLSLKFLESLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIPKT 134
+ + LE L L L + N LKV N+S++ L S +
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 19/102 (18%), Positives = 39/102 (38%), Gaps = 3/102 (2%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKF 94
I++ F+ + L ++ I + F S H+L + L+ N +L K
Sbjct: 47 TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKA 106
Query: 95 LESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT 134
L+ L ++ NQ +L+ + +N++S
Sbjct: 107 LKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 22/114 (19%), Positives = 41/114 (35%), Gaps = 4/114 (3%)
Query: 28 LEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISR 87
L+ I S+ F L ++ +S LK + LS NKF
Sbjct: 261 LQKHYFFN-ISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQI 319
Query: 88 SLLSLKFLESLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIPKTQTLQ 138
S + L L ++ N + N +L+ ++S++++ S L+
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 24/124 (19%), Positives = 45/124 (36%), Gaps = 10/124 (8%)
Query: 37 IKSDAFADIPELIVINFKNNIISGNFM----NFSSNHKLKDIDLSGNKFYGEISRSLLSL 92
F +P L +N + N + + + +L+ + LS + SL
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499
Query: 93 KFLESLQLQNNNLTGPVPE-FNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSY---SNN 148
K + + L +N LT E + N+++N++S +P L + N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILP--SLLPILSQQRTINLRQN 557
Query: 149 PYLC 152
P C
Sbjct: 558 PLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 19/102 (18%), Positives = 35/102 (34%), Gaps = 4/102 (3%)
Query: 37 IKSDAFADIPELIVINFKNN---IISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLK 93
K + I L + F++ IS ++ I+L + F+ S +
Sbjct: 219 FKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFS 278
Query: 94 FLESLQLQNNNLTGPVPEFNQ-SSLKVFNVSNNNLSGSIPKT 134
L+ L L +L+ S+LK +S N +
Sbjct: 279 GLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQIS 320
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 23/137 (16%), Positives = 46/137 (33%), Gaps = 15/137 (10%)
Query: 36 EIKSDAFADIPELIVINFKNN----IISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLS 91
K+++ + L ++ I F + + +DLS N+ +L
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKM---MNHVDLSHNRLTSSSIEALSH 522
Query: 92 LKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNP 149
LK + L L +N+++ +P S + N+ N L + + F + N
Sbjct: 523 LKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC----SNIYFLEWYKENMQ 577
Query: 150 YLCGPPSLNNCSSTGNY 166
L C +
Sbjct: 578 KLEDTEDT-LCENPPLL 593
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 21/118 (17%), Positives = 41/118 (34%), Gaps = 5/118 (4%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKF 94
+ A + L + F IS + L+ + L N +
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 95 LESLQLQNNNLTGPVPE----FNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNN 148
L+ L QNN + E Q++ N++ N+++G P +F+S ++
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 12/107 (11%), Positives = 37/107 (34%), Gaps = 8/107 (7%)
Query: 36 EIKSDAFADIPEL--IVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSL--LS 91
+ + + + + + +N N I+G + + ++ G + I + L +
Sbjct: 167 YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
Query: 92 LKFLESLQLQNNNLTGPVPE----FNQSSLKVFNVSNNNLSGSIPKT 134
++ L ++ + P + S++ N+ + T
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 10/66 (15%), Positives = 20/66 (30%), Gaps = 2/66 (3%)
Query: 71 LKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLS 128
+ ++ S N + + L L L L + + +Q L ++ N L
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 129 GSIPKT 134
Sbjct: 95 FMAETA 100
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 27/202 (13%), Positives = 59/202 (29%), Gaps = 44/202 (21%)
Query: 274 EGLGKGIFGNSYKALLE--GRAPVVVKRLR---DLKPLITEEFRKQLLVIADQKHPNLLP 328
G ++AL R V + + L + +E + L ++ P +
Sbjct: 37 IFHGGVPPLQFWQALDTALDR-QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
+L + L+V ++ G+L S P + + +A A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPS-----PVG---AIRAMQSLAAAADAAH- 146
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSK 448
++ V + + + + V+++
Sbjct: 147 ------RAGVALSIDHPSRVRVSIDGDVVLAYPA----------------TMPDA----- 179
Query: 449 KISRKSDVWSFGCLLLELLTGR 470
+ + D+ G L LL R
Sbjct: 180 --NPQDDIRGIGASLYALLVNR 199
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 58/271 (21%), Positives = 104/271 (38%), Gaps = 60/271 (22%)
Query: 221 QEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLND--LLKAPAEGLGK 278
+ G ++E +E + K K L E +L+ +K LG
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDF--------LKKWETPSQNTAQLDQFDRIKT----LGT 51
Query: 279 GIFG----------NSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLP 328
G FG ++ A+ VVK + ++ + E ++ L + P L+
Sbjct: 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNE--KRILQAV---NFPFLVK 105
Query: 329 LLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
L + F ++ L +V ++ G +F+ + R +R A+ + EYLH
Sbjct: 106 LE-FSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFS-EPHARFYAAQ-IVLTFEYLH 158
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ--------PIAAQRMISY 439
D +I+ +LK N+L+D + V+D+GF+ V P
Sbjct: 159 SLD-------LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP-------EA 204
Query: 440 KSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+PE SK ++ D W+ G L+ E+ G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 48/215 (22%), Positives = 86/215 (40%), Gaps = 44/215 (20%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVK-----RLRDLKPLITEEFR--KQLLVIADQKHPNLL 327
LG+G +G A+ V VK R D I +E K L H N++
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML------NHENVV 68
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR----AL 383
+ + + L ++ G LF+RI +P A+ +
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEP------DAQRFFHQLMAGV 118
Query: 384 EYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS----- 438
YLH + H ++K N+LLD+ + + +SD+G +++ + +R+++
Sbjct: 119 VYLHGI-------GITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGT 170
Query: 439 --YKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGR 470
Y +PE ++ + DVWS G +L +L G
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 68/228 (29%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKR--------LRDLKPLITEEFRKQLLVIADQKHPNL 326
+G G FG Y+A L + V +K+ R+L+ + ++L H N+
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIM------RKL------DHCNI 109
Query: 327 LPLLAYYFSNDEKL------LVYKFAGNGNLFNRIHGGKSSKNRIP-FRCRSR---LLVA 376
+ L +++S+ EK LV + ++ +K +P + L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF-- 166
Query: 377 RGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL-VSDYGFSSLVAQPIAAQR 435
R+L Y+H + H ++K N+LLD + VL + D+G Q + +
Sbjct: 167 ----RSLAYIHSFG-------ICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEP 212
Query: 436 MIS------YKSPE-------YQSSKKISRKSDVWSFGCLLLELLTGR 470
+S Y++PE Y + I DVWS GC+L ELL G+
Sbjct: 213 NVSYICSRYYRAPELIFGATDY--TSSI----DVWSAGCVLAELLLGQ 254
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 40/164 (24%)
Query: 322 KHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR 381
+HP+++ L + + ++V ++AG G LF+ I K R+ R +
Sbjct: 67 RHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYI----VEKKRMTED------EGRRFFQ 115
Query: 382 ----ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ-------- 429
A+EY H ++H +LK N+LLDDN V ++D+G S+++
Sbjct: 116 QIICAIEYCHRHK-------IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC 168
Query: 430 --PIAAQRMISYKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGR 470
P +Y +PE + K + DVWS G +L +L GR
Sbjct: 169 GSP-------NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 42/203 (20%), Positives = 81/203 (39%), Gaps = 20/203 (9%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLRDLKPLITEE-FRKQLLVIADQKHPNLLPLLAYY 333
LG G FG+ + V+K + + + E ++ V+ HPN++ + +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+V + G L RI ++ + + L+ + + AL Y H +
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELM--KQMMNALAYFHSQH--- 144
Query: 394 TQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQS---- 446
V+H +LK NIL + + + D+G + L + + Y +
Sbjct: 145 ----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG--TALYMAPEVF 198
Query: 447 SKKISRKSDVWSFGCLLLELLTG 469
+ ++ K D+WS G ++ LLTG
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 36/164 (21%), Positives = 70/164 (42%), Gaps = 39/164 (23%)
Query: 322 KHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR 381
+HP+++ L + + +V ++ G LF+ I R+ + +R + +
Sbjct: 74 RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEK------ESRRLFQ 123
Query: 382 ----ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ-------- 429
++Y H V+H +LK N+LLD + ++D+G S++++
Sbjct: 124 QILSGVDYCHRH-------MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 176
Query: 430 --PIAAQRMISYKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGR 470
P +Y +PE S + + D+WS G +L LL G
Sbjct: 177 GSP-------NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 61/271 (22%), Positives = 107/271 (39%), Gaps = 46/271 (16%)
Query: 220 DQEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLND--LLKAPAEGLG 277
E ++ E KIG+G + + F + KL D L LG
Sbjct: 295 GSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMV----LG 350
Query: 278 KGIFG----------NSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLL 327
KG FG + A+ + VV++ D++ + E K++L + K P L
Sbjct: 351 KGSFGKVMLSERKGTDELYAVKILKKDVVIQD-DDVECTMVE---KRVLALPG-KPPFLT 405
Query: 328 PLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386
L F ++L V ++ G+L I + + + P + A +A L +L
Sbjct: 406 QLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGRFKEP---HAVFYAAE-IAIGLFFL 458
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-------Y 439
K +I+ +LK N++LD + ++D+G + + I Y
Sbjct: 459 QSKG-------IIYRDLKLDNVMLDSEGHIKIADFG---MCKENIWDGVTTKTFCGTPDY 508
Query: 440 KSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+PE + + + D W+FG LL E+L G+
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 41/201 (20%), Positives = 83/201 (41%), Gaps = 20/201 (9%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
LG G FG ++ + V K + PL + ++ ++ HP L+ L +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRT 394
E +L+ +F G LF+RI + + R L+++H
Sbjct: 119 DKYEMVLILEFLSGGELFDRI-----AAEDYKMSEAEVINYMRQACEGLKHMHEHS---- 169
Query: 395 QSAVIHGNLKSTNILLDDNE--MVLVSDYGFSSLVAQPIAAQRMI----SYKSPEYQSSK 448
++H ++K NI+ + + V + D+G ++ + P ++ + +PE +
Sbjct: 170 ---IVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIVDRE 225
Query: 449 KISRKSDVWSFGCLLLELLTG 469
+ +D+W+ G L LL+G
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSG 246
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 41/217 (18%), Positives = 86/217 (39%), Gaps = 40/217 (18%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLRDLKPLITEEFRK-QLLVIADQKHPNLLPLLAYY 333
G+G FG V +K++ E + Q L + HPN++ L +Y+
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH--HPNIVQLQSYF 88
Query: 334 FSNDEK-------LLVYKFAGNGNLFNRIHGGKSSKNRIPFR-CRSR---LLVARGVARA 382
++ E+ +V ++ + L + P + L+ R+
Sbjct: 89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI------RS 141
Query: 383 LEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVL-VSDYGFSSLVAQPIAAQRMIS-- 438
+ LH S V H ++K N+L+++ + L + D+G + ++ ++
Sbjct: 142 IGCLH------LPSVNVCHRDIKPHNVLVNEADGTLKLCDFG---SAKKLSPSEPNVAYI 192
Query: 439 ----YKSPEY-QSSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE ++ + D+WS GC+ E++ G
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 6e-10
Identities = 54/228 (23%), Positives = 93/228 (40%), Gaps = 53/228 (23%)
Query: 267 DLLKAPAEGLGKGIFG--------------NSY--KALLEGRAPVVVKRLRDLKPLITEE 310
+LL+ LGKG +G + K L + ++V+ +D E
Sbjct: 20 ELLRV----LGKGGYGKVFQVRKVTGANTGKIFAMKVL---KKAMIVRNAKDTAHTKAE- 71
Query: 311 FRKQLLVIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFR- 368
R ++ + KHP ++ L Y F KL L+ ++ G LF ++ + I F
Sbjct: 72 -RN---ILEEVKHPFIVDL-IYAFQTGGKLYLILEYLSGGELFMQLE-----REGI-FME 120
Query: 369 CRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428
+ +A ++ AL +LH K +I+ +LK NI+L+ V ++D+G
Sbjct: 121 DTACFYLAE-ISMALGHLHQKG-------IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172
Query: 429 QPIAAQRMIS------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+ Y +PE +R D WS G L+ ++LTG
Sbjct: 173 HD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 64/282 (22%), Positives = 109/282 (38%), Gaps = 52/282 (18%)
Query: 215 QEEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLND--LLKAP 272
+ ++E S G G +L+ + + + + LLK
Sbjct: 4 HHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEK-VGIENFELLKV- 61
Query: 273 AEGLGKGIFGNSY----------------KALLEGRAPVVVKRLRDLKPLITEEFRKQLL 316
LG G +G + K L + +V++ + + TE +Q+L
Sbjct: 62 ---LGTGAYGKVFLVRKISGHDTGKLYAMKVL---KKATIVQKAKTTEHTRTE---RQVL 112
Query: 317 VIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLV 375
+ P L+ L Y F + KL L+ + G LF + S+ ++ V
Sbjct: 113 EHIR-QSPFLVTL-HYAFQTETKLHLILDYINGGELFTHL-----SQRERFTEHEVQIYV 165
Query: 376 ARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS--SLVAQPIAA 433
+ ALE+LH +I+ ++K NILLD N V+++D+G S + + A
Sbjct: 166 GE-IVLALEHLHKLG-------IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217
Query: 434 QRM---ISYKSPE-YQSSKKISRKS-DVWSFGCLLLELLTGR 470
I Y +P+ + K+ D WS G L+ ELLTG
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 16/126 (12%), Positives = 39/126 (30%), Gaps = 11/126 (8%)
Query: 55 NNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQ 114
+ ++ +N ++ + L+G G + ++ L L+ L ++ T F
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 115 SSL--KVFNVSNNNLSGSIPKT--------QTLQLFRSYSYSNNPYLCGPPSLNNCSSTG 164
L + + + K L + + + NP + + S
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD-AINRNPEMKPIKKDSRISLKD 427
Query: 165 NYVTNS 170
+ N
Sbjct: 428 TQIGNL 433
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 26/122 (21%), Positives = 44/122 (36%), Gaps = 10/122 (8%)
Query: 36 EIKSDAFADIPELIVINFKNNIISG--NFMNFSSNHKLKDIDLSGNKFYGE-----ISRS 88
EI D A ++ + F +N + N N S + + +D S NK E S
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 89 LLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYS 146
++ L N + E S + +SNN ++ SIP+ +Y +
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNT 727
Query: 147 NN 148
Sbjct: 728 YL 729
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 21/137 (15%), Positives = 43/137 (31%), Gaps = 12/137 (8%)
Query: 32 RLNGEIKSDAFADIPELIVINFKNNIIS------GNFMNFSSNHKLKDIDLSGNKFYGEI 85
+L +P L ++ N S N + D GN+ +
Sbjct: 739 KLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798
Query: 86 SRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLS----GSIPKTQTLQLFR 141
+ + L LQ+ +N++ V E L + ++++N S+ +
Sbjct: 799 PTGITTCPSLIQLQIGSNDIRK-VDEKLTPQLYILDIADNPNISIDVTSVCPYIEAGM-Y 856
Query: 142 SYSYSNNPYLCGPPSLN 158
Y + G +L
Sbjct: 857 VLLYDKTQDIRGCDALG 873
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 21/119 (17%), Positives = 38/119 (31%), Gaps = 15/119 (12%)
Query: 28 LEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM----------NFSSNHKLKDIDLS 77
L + ++ D D+PEL +N N + + K++ +
Sbjct: 498 LYNCPNMTQL-PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG 556
Query: 78 GNKFYG-EISRSLLSLKFLESLQLQNNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIPKT 134
N S SL + L L +N + + F L + N + IP+
Sbjct: 557 YNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYNQIE-EIPED 613
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 18/125 (14%), Positives = 36/125 (28%), Gaps = 19/125 (15%)
Query: 52 NFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE 111
+ ++ N L D++L ++ L L L+SL + N
Sbjct: 477 AKQYENEELSWSNLKD---LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL 533
Query: 112 FNQ-----------SSLKVFNVSNNNLSGSIPKTQTLQLFRSYSY---SNNPYLCGPPSL 157
+++F + NNL P + +LQ +N + +
Sbjct: 534 KADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNK-VRHLEAF 591
Query: 158 NNCSS 162
Sbjct: 592 GTNVK 596
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 6/101 (5%)
Query: 39 SDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98
S A + +L +I F N+ + + +D + K Y S +LK L +
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTY----DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV 496
Query: 99 QLQNNNLTGPVPE--FNQSSLKVFNVSNNNLSGSIPKTQTL 137
+L N +P+ ++ L+ N++ N +
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 18/130 (13%), Positives = 41/130 (31%), Gaps = 11/130 (8%)
Query: 51 INFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVP 110
++ KN +N + + + + + + + L + + L L G VP
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP 340
Query: 111 E--FNQSSLKVFNVSNNNLSGSI---------PKTQTLQLFRSYSYSNNPYLCGPPSLNN 159
+ + LKV + ++ + S P + R + +L LN
Sbjct: 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNL 400
Query: 160 CSSTGNYVTN 169
+ +
Sbjct: 401 SDLLQDAINR 410
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 24/169 (14%), Positives = 44/169 (26%), Gaps = 39/169 (23%)
Query: 32 RLNGEIKSDAFADIPELIVINFKNNIISGN----FMNFSSNHKLKD--IDLSGNKFYGEI 85
R+ K L + + + I+ N + S LKD I N+ I
Sbjct: 382 RIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI-TFI 440
Query: 86 SRSLLSLKFLESLQLQNNNLTGPVPEF---------------------NQSSLKVFNVSN 124
S+++ L L+ + N+ T N L + N
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500
Query: 125 NNLSGSIPKT-------QTLQL----FRSYSYSNNPYLCGPPSLNNCSS 162
+P Q+L + S + + +
Sbjct: 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 16/102 (15%), Positives = 32/102 (31%), Gaps = 16/102 (15%)
Query: 46 PELIVINFKNNIISG------NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99
+ ++F N I M+ + LS N+ + + + ++
Sbjct: 644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703
Query: 100 LQNNNLTG---------PVPEFNQSSLKVFNVSNNNLSGSIP 132
L NN +T N L ++ N L+ S+
Sbjct: 704 LSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLS 744
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 25/136 (18%), Positives = 44/136 (32%), Gaps = 10/136 (7%)
Query: 6 DFPSQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISG----- 60
D G+ D N+ VTG+ L G + DA + EL V++F + +
Sbjct: 309 DMWGDQPGVDLD-NNGRVTGLSLAGFGAKGRV-PDAIGQLTELKVLSFGTHSETVSGRLF 366
Query: 61 ---NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSL 117
S + I + K + + + L L+ +N + + S
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLK 426
Query: 118 KVFNVSNNNLSGSIPK 133
+ N I K
Sbjct: 427 DTQIGNLTNRITFISK 442
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 48/201 (23%), Positives = 86/201 (42%), Gaps = 22/201 (10%)
Query: 276 LGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
LG+G Y+ +G + P +K L K + + R ++ V+ HPN++ L +
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRT 394
+ E LV + G LF+RI K R + + + + A+ YLH
Sbjct: 119 TPTEISLVLELVTGGELFDRI----VEKGYYSERDAADAV--KQILEAVAYLHENG---- 168
Query: 395 QSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKSPEYQSSK 448
++H +LK N+L + + ++D+G S +V + + + Y +PE
Sbjct: 169 ---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 449 KISRKSDVWSFGCLLLELLTG 469
+ D+WS G + LL G
Sbjct: 226 AYGPEVDMWSVGIITYILLCG 246
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 7e-10
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 49/225 (21%)
Query: 267 DLLKAPAEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ---- 321
+LLK LG+G FG K L + + ++L +K L +K L + D+
Sbjct: 27 ELLKV----LGQGSFG---KVFLVKKISGSDARQLYAMKVL-----KKATLKVRDRVRTK 74
Query: 322 ---------KHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRS 371
HP ++ L Y F + KL L+ F G+LF R+ SK +
Sbjct: 75 MERDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDV 128
Query: 372 RLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431
+ +A +A AL++LH +I+ +LK NILLD+ + ++D+G S
Sbjct: 129 KFYLAE-LALALDHLHSLG-------IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH- 179
Query: 432 AAQRMIS------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
++ S Y +PE + + ++ +D WSFG L+ E+LTG
Sbjct: 180 -EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 34/190 (17%), Positives = 67/190 (35%), Gaps = 31/190 (16%)
Query: 42 FADIPELIVINFKNNIISGNFMN------FSSNHKLKDIDLSGNKFYGEISRSLLSLKFL 95
++ P L + N++ + F L+ + L+ N L L
Sbjct: 447 PSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL 506
Query: 96 ESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLC--- 152
L L +N LT ++L++ ++S N L P ++N ++C
Sbjct: 507 RGLSLNSNRLTVLSHNDLPANLEILDISRNQL--LAPNPDVFVSLSVLDITHNKFICECE 564
Query: 153 ----------------GPPSLNNCSS----TGNYVTNSDDKGSNDLKIFYFLLAALCIVT 192
GPP+ C +G + + +G ++ ++ L +L IV
Sbjct: 565 LSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVC 624
Query: 193 VLMLFIFYLT 202
+ L +F +T
Sbjct: 625 TVTLTLFLMT 634
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 18/99 (18%), Positives = 38/99 (38%), Gaps = 6/99 (6%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMN--FSSNHKLKDIDLSGNKFYGEISRSLLSLK 93
+ + +F + +L ++ + F + L+ +DL +K Y + L
Sbjct: 38 TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLF 97
Query: 94 FLESLQLQNNNLTGPVPEF----NQSSLKVFNVSNNNLS 128
L L+L L+ V + N +L ++S N +
Sbjct: 98 HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 4/94 (4%)
Query: 36 EIKSDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKF 94
+I +AF + L V+N N++ NF K+ IDL N ++ L+
Sbjct: 304 KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK 363
Query: 95 LESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLS 128
L++L L++N LT S+ +S N L
Sbjct: 364 LQTLDLRDNALTT---IHFIPSIPDIFLSGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 29/150 (19%), Positives = 50/150 (33%), Gaps = 16/150 (10%)
Query: 34 NGEIKSDAFADIPELIVINFKNNIIS--GNFMNFSSNHKLKDIDLSGNKFYGEISRSLLS 91
+ +K F ++ L ++ N I +F + LK ID S N+ + L
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170
Query: 92 LKF--LESLQLQNNNLTGPVPE--------FNQSSLKVFNVSNNNLSGSIPKTQTLQLFR 141
L+ L L N+L V F L++ +VS N + I
Sbjct: 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGN----FSN 226
Query: 142 SYSYSNNPYLCGPPSLNNCSSTGNYVTNSD 171
+ S S L + + + + D
Sbjct: 227 AISKSQAFSLILAHHIMGAGFGFHNIKDPD 256
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 21/99 (21%), Positives = 40/99 (40%), Gaps = 7/99 (7%)
Query: 36 EIKSDAFADIPELIVINFKNNIIS----GNFMNFSSNHKLKDIDLSGNKFYGEISRSLLS 91
+ ++ + ++ F + I F + + ++ +DLS + SR +
Sbjct: 230 KSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSS-VRHLDLSHGFVFSLNSRVFET 288
Query: 92 LKFLESLQLQNNNLTG-PVPEF-NQSSLKVFNVSNNNLS 128
LK L+ L L N + F +L+V N+S N L
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 23/119 (19%), Positives = 40/119 (33%), Gaps = 15/119 (12%)
Query: 28 LEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISR 87
L+ + I+ F + +L ++ ++N + DI LSGNK
Sbjct: 345 LQKNHIA-IIQDQTFKFLEKLQTLDLRDN----ALTTIHFIPSIPDIFLSGNKL-----V 394
Query: 88 SLLSLKF-LESLQLQNNNLTG---PVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRS 142
+L + + L N L L++ ++ N S S QT S
Sbjct: 395 TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPS 452
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 29/210 (13%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLL--------VIADQKHPNL 326
LG G FG + A+ E VVVK ++ K L L +++ +H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 327 LPLLAYYFSNDEKL-LVYKFAGNGN-LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALE 384
+ +L F N LV + G+G LF I R+ S + R + A+
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGSGLDLFAFI----DRHPRLDEPLASYIF--RQLVSAVG 144
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM---ISYKS 441
YL K +IH ++K NI++ ++ + + D+G ++ + + I Y +
Sbjct: 145 YLRLK-------DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCA 197
Query: 442 PEYQSSKK-ISRKSDVWSFGCLLLELLTGR 470
PE + ++WS G L L+
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 9e-10
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 44/215 (20%)
Query: 276 LGKGIFG----------NSY---KALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK 322
LGKG FG N + KAL + VV+ D++ + E K++L +A +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKAL---KKDVVLMD-DDVECTMVE---KRVLSLAW-E 76
Query: 323 HPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR 381
HP L + F E L V ++ G+L I K + R+ A +
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLS---RATFYAAE-IIL 129
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS--- 438
L++LH K +++ +LK NILLD + + ++D+G + +
Sbjct: 130 GLQFLHSKG-------IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCG 180
Query: 439 ---YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y +PE +K + D WSFG LL E+L G+
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 50/225 (22%)
Query: 267 DLLKAPAEGLGKGIFG-----------NSY--KALLEGRAPVVVKRLRDLKPLITEEFRK 313
DLL+ +G+G + Y K + + +V D+ + TE K
Sbjct: 12 DLLRV----IGRGSYAKVLLVRLKKTDRIYAMKVV---KKELVNDD-EDIDWVQTE---K 60
Query: 314 QLLVIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSR 372
+ A HP L+ L F + +L V ++ G+L + + R +R
Sbjct: 61 HVFEQAS-NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEHAR 113
Query: 373 LLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA 432
A ++ AL YLH + +I+ +LK N+LLD + ++DYG + + +
Sbjct: 114 FYSAE-ISLALNYLHERG-------IIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLR 162
Query: 433 AQRMIS-------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
S Y +PE + D W+ G L+ E++ GR
Sbjct: 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 42/203 (20%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
LG+G FG ++ + + + K ++ +K +K++ ++ +H N+L L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 335 SNDEKLLVYKFAGNGNLFNRI--HGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
S +E +++++F ++F RI + ++ I + V AL++LH +
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREI-------VSYVHQVCEALQFLHSHN-- 122
Query: 393 RTQSAVIHGNLKSTNILLDDNE--MVLVSDYGFSSLVAQPIAAQRMI----SYKSPEYQS 446
+ H +++ NI+ + + ++G + + +P R++ Y +PE
Sbjct: 123 -----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPEVHQ 176
Query: 447 SKKISRKSDVWSFGCLLLELLTG 469
+S +D+WS G L+ LL+G
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSG 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 23/121 (19%), Positives = 45/121 (37%), Gaps = 3/121 (2%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFL 95
+I F + L + NN + + LK +DLS N + R+ L
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 320
Query: 96 ESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPP 155
E+L L +N++ + +LK +S+N+ + + + R + + C
Sbjct: 321 ENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARP-AVDDADQHCKID 378
Query: 156 S 156
Sbjct: 379 Y 379
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 28/105 (26%), Positives = 44/105 (41%), Gaps = 5/105 (4%)
Query: 36 EIKSDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLS-LK 93
+ F ++P L V+ + N +S F + KL + +S N I
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATT 165
Query: 94 FLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQ 138
L++LQL +N LT V SL NVS N LS ++ ++
Sbjct: 166 SLQNLQLSSNRLTH-VDLSLIPSLFHANVSYNLLS-TLAIPIAVE 208
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 25/108 (23%), Positives = 45/108 (41%), Gaps = 11/108 (10%)
Query: 28 LEDMRLNG-EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEIS 86
L++++L+ + + IP L N N++S + ++++D S N +
Sbjct: 167 LQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS----TLAIPIAVEELDASHNSI-NVVR 221
Query: 87 RSLLSLKFLESLQLQNNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIPK 133
+ L L+LQ+NNLT N L ++S N L I
Sbjct: 222 GPVNV--ELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE-KIMY 265
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 23/126 (18%), Positives = 49/126 (38%), Gaps = 14/126 (11%)
Query: 18 INSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN------FSSNHKL 71
I+S V D+ ++ D + ++ + N K + M S ++
Sbjct: 13 IDSNLQYDCVFYDVHID-MQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 72 KDIDLSGNKFYGEISRSLLS-LKFLESLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNL 127
+ ++L+ + EI + ++ L + N + +P N L V + N+L
Sbjct: 72 ELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDL 129
Query: 128 SGSIPK 133
S S+P+
Sbjct: 130 S-SLPR 134
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 23/124 (18%), Positives = 46/124 (37%), Gaps = 2/124 (1%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFL 95
+I F + L + NN + + LK +DLS N + R+ L
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 326
Query: 96 ESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPP 155
E+L L +N++ + +LK +S+N+ + + + R + +
Sbjct: 327 ENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDY 385
Query: 156 SLNN 159
L +
Sbjct: 386 QLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 27/107 (25%), Positives = 43/107 (40%), Gaps = 9/107 (8%)
Query: 36 EIKSDAFADIPELIVINFKNN---IISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLS- 91
+ F ++P L V+ + N + F + KL + +S N I
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLSSLPRGI--FHNTPKLTTLSMSNNNL-ERIEDDTFQA 169
Query: 92 LKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQ 138
L++LQL +N LT V SL NVS N LS ++ ++
Sbjct: 170 TTSLQNLQLSSNRLTH-VDLSLIPSLFHANVSYNLLS-TLAIPIAVE 214
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 20/102 (19%), Positives = 42/102 (41%), Gaps = 6/102 (5%)
Query: 36 EIKSDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLS-LK 93
++ + ++ ++N + I + F+ H ++ + + N + + +
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVP 123
Query: 94 FLESLQLQNNNLTG-PVPEF-NQSSLKVFNVSNNNLSGSIPK 133
L L L+ N+L+ P F N L ++SNNNL I
Sbjct: 124 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIED 164
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 25/108 (23%), Positives = 45/108 (41%), Gaps = 11/108 (10%)
Query: 28 LEDMRLNG-EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEIS 86
L++++L+ + + IP L N N++S + ++++D S N +
Sbjct: 173 LQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS----TLAIPIAVEELDASHNSI-NVVR 227
Query: 87 RSLLSLKFLESLQLQNNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIPK 133
+ L L+LQ+NNLT N L ++S N L I
Sbjct: 228 GPVNV--ELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE-KIMY 271
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 42/208 (20%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 276 LGKGIFGNSYKAL-----LEGRAPVVVKR--LRDLKPLITEEFRKQLLVIADQKHPNLLP 328
LG G F K LE A + KR + + EE +++ ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
L Y + + +L+ + G LF+ + + K + + + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFI--KQILDGVNYLHT 133
Query: 389 KDKSRTQSAVIHGNLKSTNILL----DDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKS 441
K + H +LK NI+L + + D+G + + + + + + +
Sbjct: 134 KK-------IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTG 469
PE + + + ++D+WS G + LL+G
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 23/203 (11%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRL--RDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
LGKG FG K + VK + K T +++ ++ HPN++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
+ +V + G LF+ I + R +R++ + V + Y+H +
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARII--KQVFSGITYMHKHN-- 141
Query: 393 RTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKSPEYQS 446
++H +LK NILL + + + + D+G S+ Q + I Y +PE
Sbjct: 142 -----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VL 195
Query: 447 SKKISRKSDVWSFGCLLLELLTG 469
K DVWS G +L LL+G
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSG 218
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 44/207 (21%), Positives = 74/207 (35%), Gaps = 29/207 (14%)
Query: 276 LGKGIFGNSYKALL----EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLA 331
LGKG F + + + A ++ + L ++ ++ + KHPN++ L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYA-AMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
L++ G LF I R + + + A+ + H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDI------VAREYYSEADASHCIQQILEAVLHCHQMG- 130
Query: 392 SRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMIS------YKSP 442
V+H NLK N+LL V ++D+G + V Q Y SP
Sbjct: 131 ------VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPGYLSP 182
Query: 443 EYQSSKKISRKSDVWSFGCLLLELLTG 469
E + D+W+ G +L LL G
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 50/225 (22%)
Query: 267 DLLKAPAEGLGKGIFG-----------NSY--KALLEGRAPVVVKRLRDLKPLITEEFRK 313
+ ++ LGKG FG + Y K L + V+++ D++ +TE K
Sbjct: 26 EFIRV----LGKGSFGKVMLARVKETGDLYAVKVL---KKDVILQD-DDVECTMTE---K 74
Query: 314 QLLVIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSR 372
++L +A HP L L F ++L V +F G+L I K+R R+R
Sbjct: 75 RILSLAR-NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ-----KSRRFDEARAR 127
Query: 373 LLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA 432
A + AL +LH K +I+ +LK N+LLD ++D+G + + I
Sbjct: 128 FYAAE-IISALMFLHDKG-------IIYRDLKLDNVLLDHEGHCKLADFG---MCKEGIC 176
Query: 433 AQRMIS-------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+ Y +PE D W+ G LL E+L G
Sbjct: 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 55/221 (24%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKR--------LRDLKPLITEEFRKQLLVIADQKHPNLL 327
+G G FG ++A L V +K+ R+L+ + + + KHPN++
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIM------RIV------KHPNVV 95
Query: 328 PLLAYYFSNDEKL------LVYKFAGNGNLFNRIHGGKSSKNRIP-FRCRSR---LLVAR 377
L A+++SN +K LV ++ ++ K +P + LL
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL--- 151
Query: 378 GVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL-VSDYGFSSLVAQPIAAQRM 436
R+L Y+H + H ++K N+LLD VL + D+G S+ + +
Sbjct: 152 ---RSLAYIHSIG-------ICHRDIKPQNLLLDPPSGVLKLIDFG-SAKILIA--GEPN 198
Query: 437 IS------YKSPE-YQSSKKISRKSDVWSFGCLLLELLTGR 470
+S Y++PE + + D+WS GC++ EL+ G+
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 45/222 (20%)
Query: 267 DLLKAPAEGLGKGIFG----------NSY---KALLEGRAPVVVKRLRDLKPLITEEFRK 313
D LK LGKG FG Y K L R V++ + ++ +TE +
Sbjct: 8 DYLKL----LGKGTFGKVILVREKATGRYYAMKIL---RKEVIIAK-DEVAHTVTE--SR 57
Query: 314 QLLVIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSR 372
V+ + +HP L L Y F ++L V ++A G LF + S+ R+ R+R
Sbjct: 58 ---VLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERAR 108
Query: 373 LLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA 432
A + ALEYLH +D V++ ++K N++LD + + ++D+G A
Sbjct: 109 FYGAE-IVSALEYLHSRD-------VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160
Query: 433 AQR----MISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+ Y +PE R D W G ++ E++ GR
Sbjct: 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 33/214 (15%)
Query: 269 LKAPAEGLGKGIFGNSYKAL-LEGRAPVVVKRL--RDLKPLITE-EFRKQLLVIADQKHP 324
L + LG+G F K + + VK + R E K + HP
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLC-----EGHP 66
Query: 325 NLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALE 384
N++ L + LV + G LF RI K + F + R + A+
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERI------KKKKHFSETEASYIMRKLVSAVS 120
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMIS--- 438
++H V+H +LK N+L +DN + + D+GF+ L P Q + +
Sbjct: 121 HMHDVG-------VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK--PPDNQPLKTPCF 171
Query: 439 ---YKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
Y +PE + D+WS G +L +L+G
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 43/208 (20%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 276 LGKGIFGNSYKAL-----LEGRAPVVVKR--LRDLKPLITEEFRKQLLVIADQKHPNLLP 328
LG G F K LE A + KR + + EE +++ ++ HPN++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
L Y + + +L+ + G LF+ + + K + + + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFI--KQILDGVNYLHT 133
Query: 389 KDKSRTQSAVIHGNLKSTNILL----DDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKS 441
K + H +LK NI+L + + D+G + + + + + + +
Sbjct: 134 KK-------IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTG 469
PE + + + ++D+WS G + LL+G
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 44/203 (21%), Positives = 75/203 (36%), Gaps = 22/203 (10%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRL--RDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
LGKG F + + K + + L ++ ++ + +HPN++ L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
LV+ G LF I ++ S + + + ++ Y H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCI--QQILESIAYCHSNG-- 148
Query: 393 RTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKSPEYQS 446
++H NLK N+LL V ++D+G + V A Y SPE
Sbjct: 149 -----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 203
Query: 447 SKKISRKSDVWSFGCLLLELLTG 469
S+ D+W+ G +L LL G
Sbjct: 204 KDPYSKPVDIWACGVILYILLVG 226
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 58/270 (21%), Positives = 102/270 (37%), Gaps = 56/270 (20%)
Query: 221 QEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGI 280
+ + + +++ + D F LK +GKG
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSD-----F---HFLKV----IGKGS 50
Query: 281 FG-----------NSY--KALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLL 327
FG Y K L + ++K+ ++ K +++E + +L+ KHP L+
Sbjct: 51 FGKVLLARHKAEEVFYAVKVL---QKKAILKK-KEEKHIMSE---RNVLLKNV-KHPFLV 102
Query: 328 PLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386
L + F +KL V + G LF + + R R+R A +A AL YL
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEPRARFYAAE-IASALGYL 155
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS------YK 440
H + +++ +LK NILLD ++++D+G + + Y
Sbjct: 156 HSLN-------IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NSTTSTFCGTPEYL 206
Query: 441 SPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
+PE + R D W G +L E+L G
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 53/279 (18%), Positives = 109/279 (39%), Gaps = 30/279 (10%)
Query: 209 NIMIKKQEEYMDQEKESGDDEEEEEEKIGKGKRKLVVAGEDRNLVFIEDEQPAGFKLNDL 268
N+ + + DQ+ SG +E +E ++ V + + + ++ P + +
Sbjct: 18 NLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRI 77
Query: 269 LKA------------PAEGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQL 315
+ A E LG G FG +K + K ++ EE + ++
Sbjct: 78 VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 316 LVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLV 375
V+ H NL+ L + S ++ +LV ++ G LF+RI + +
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFM- 193
Query: 376 ARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL--DDNEMVLVSDYGFSSLVAQPIAA 433
+ + + ++H ++H +LK NIL D + + + D+G +
Sbjct: 194 -KQICEGIRHMHQMY-------ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245
Query: 434 QRMI---SYKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
+ + +PE + +S +D+WS G + LL+G
Sbjct: 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 47/206 (22%), Positives = 84/206 (40%), Gaps = 31/206 (15%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
+G G + + + VK + K TEE +++ +HPN++ L Y
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPNIITLKDVYD 86
Query: 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRT 394
+V + G L ++I + R S +L + + +EYLH +
Sbjct: 87 DGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVL--FTITKTVEYLHAQG---- 136
Query: 395 QSAVIHGNLKSTNILL----DDNEMVLVSDYGFSSLVAQPIAAQRMIS-------YKSPE 443
V+H +LK +NIL + E + + D+GF+ + A ++ + +PE
Sbjct: 137 ---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR---AENGLLMTPCYTANFVAPE 190
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTG 469
+ D+WS G LL +LTG
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 43/206 (20%), Positives = 76/206 (36%), Gaps = 28/206 (13%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRL--RDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
LGKG F + + K + + L ++ ++ + +HPN++ L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
LV+ G LF I ++ S + + + ++ Y H
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCI--QQILESIAYCHSNG-- 125
Query: 393 RTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMI------SYKSPE 443
++H NLK N+LL V ++D+G + V ++ Y SPE
Sbjct: 126 -----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSPE 177
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTG 469
S+ D+W+ G +L LL G
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVG 203
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 44/211 (20%), Positives = 85/211 (40%), Gaps = 34/211 (16%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITE-EFRKQLLVIADQKHPNLLPLLA 331
+ LG GI G + + +K L+D E E + + P+++ ++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA-----SQCPHIVRIVD 122
Query: 332 YY----FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
Y L+V + G LF+RI + F R + + + A++YLH
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 388 HKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMIS------ 438
+ + H ++K N+L N ++ ++D+GF+ + + +
Sbjct: 179 SIN-------IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---SHNSLTTPCYTPY 228
Query: 439 YKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
Y +PE +K + D+WS G ++ LL G
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 55/219 (25%), Positives = 85/219 (38%), Gaps = 45/219 (20%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLV-IADQKHPNLLPLLA 331
+ +GKG FG KA + V +K +R+ K F +Q I +L L
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR-----FHRQAAEEI------RILEHLR 151
Query: 332 YYFSNDEKLLV-----YKFAG---------NGNLFNRIHGGKSSKNRIPFRCRSRLLVAR 377
++ ++ + F + NL+ I K +K + F A
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELI---KKNKFQ-GFSLPLVRKFAH 207
Query: 378 GVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE--MVLVSDYGFSSLVAQPIAAQR 435
+ + L+ LH +IH +LK NILL + V D+G S Q +
Sbjct: 208 SILQCLDALHKNR-------IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--T 258
Query: 436 MIS---YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRI 471
I Y++PE + D+WS GC+L ELLTG
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 45/216 (20%), Positives = 92/216 (42%), Gaps = 38/216 (17%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ---------KHPN 325
+G+G+ + + VK + ++ E +++ + HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 326 LLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
++ L+ Y S+ LV+ G LF+ + + K + + ++ R + A+ +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYL----TEKVALSEKETRSIM--RSLLEAVSF 215
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI------SY 439
LH + ++H +LK NILLDDN + +SD+GFS + +++ Y
Sbjct: 216 LHANN-------IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP---GEKLRELCGTPGY 265
Query: 440 KSPE------YQSSKKISRKSDVWSFGCLLLELLTG 469
+PE ++ ++ D+W+ G +L LL G
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 44/225 (19%), Positives = 85/225 (37%), Gaps = 47/225 (20%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQ---------LLVIADQKHP- 324
LG G F + A + V +K +R + + + + AD
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 325 -----NLLPLLAY-YFSNDEKL---LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLV 375
++L LL + + +V++ G NL I K ++R +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALI---KKYEHR-GIPLIYVKQI 136
Query: 376 ARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE------MVLVSDYGFSSLVAQ 429
++ + L+Y+H + +IH ++K N+L++ + + ++D G + +
Sbjct: 137 SKQLLLGLDYMHRRCG------IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 430 PIAAQRMIS---YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRI 471
I Y+SPE +D+WS CL+ EL+TG
Sbjct: 191 HYT--NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 44/216 (20%), Positives = 82/216 (37%), Gaps = 49/216 (22%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
+G G FG + + V VK + + I E +++++ +HPN++
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIP-------FRCRSRLLVARGVARALEYLH 387
+ ++ ++A G L+ RI + R F+ L++ + Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERI----CNAGRFSEDEARFFFQQ----LLS-----GVSYCH 133
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEM--VLVSDYGFSSLVAQ----------PIAAQR 435
+ H +LK N LLD + + + D+G+S P
Sbjct: 134 SM-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP----- 181
Query: 436 MISYKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGR 470
+Y +PE ++ + +DVWS G L +L G
Sbjct: 182 --AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 7e-09
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 50/216 (23%)
Query: 276 LGKGIFGNSYKALL----EGRAPVVVKRLRDLKPLITEEFRKQL-------LVIADQKHP 324
LG G FG + L +K L+ K ++ KQ+ L+++ HP
Sbjct: 14 LGTGSFG---RVHLIRSRHNGRYYAMKVLK--KEIVVR--LKQVEHTNDERLMLSIVTHP 66
Query: 325 NLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFR-CRSRLLVARGVARA 382
++ + F + +++ ++ + G LF+ + K++ F ++ A V A
Sbjct: 67 FIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL-----RKSQR-FPNPVAKFYAAE-VCLA 118
Query: 383 LEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ--------PIAAQ 434
LEYLH KD +I+ +LK NILLD N + ++D+GF+ V P
Sbjct: 119 LEYLHSKD-------IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP---- 167
Query: 435 RMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y +PE S+K ++ D WSFG L+ E+L G
Sbjct: 168 ---DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 46/216 (21%)
Query: 276 LGKGIFG-----------NSY--KALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK 322
LGKG FG Y K L + VV++ D++ + E K++L + K
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKIL---KKDVVIQD-DDVECTMVE---KRVLALPG-K 79
Query: 323 HPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVAR 381
P L L F ++L V ++ G+L I + + + P + A +A
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGRFKEP---HAVFYAAE-IAI 132
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS--- 438
L +L K +I+ +LK N++LD + ++D+G + + I
Sbjct: 133 GLFFLQSKG-------IIYRDLKLDNVMLDSEGHIKIADFG---MCKENIWDGVTTKTFC 182
Query: 439 ----YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y +PE + + + D W+FG LL E+L G+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 24/98 (24%), Positives = 46/98 (46%), Gaps = 20/98 (20%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
+++LH SA +IH +LK +NI++ + + + D+G A+ M++
Sbjct: 138 CGIKHLH--------SAGIIHRDLKPSNIVVKSDCTLKILDFGL----ARTAGTSFMMTP 185
Query: 439 ------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE D+WS GC++ E++ G
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 26/166 (15%)
Query: 317 VIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFR-CRSRLL 374
V+ + + L Y F +D L LV + G+L + SK +R
Sbjct: 127 VLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL-----SKFEDRLPEEMARFY 180
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ 434
+A + A++ +H +H ++K NIL+D N + ++D+G + + Q
Sbjct: 181 LAE-MVIAIDSVHQLH-------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232
Query: 435 RM-----ISYKSPEYQSSKKISRKS-----DVWSFGCLLLELLTGR 470
Y SPE + + + D WS G + E+L G
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 1e-08
Identities = 43/208 (20%), Positives = 90/208 (43%), Gaps = 27/208 (12%)
Query: 276 LGKGIFGNSYKAL-----LEGRAPVVVKR--LRDLKPLITEEFRKQLLVIADQKHPNLLP 328
LG G F K E A + KR + + EE +++ ++ + +HPN++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
L + + + +L+ + G LF+ + + K + ++ L + + + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFL--KQILDGVHYLHS 126
Query: 389 KDKSRTQSAVIHGNLKSTNILL----DDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKS 441
K + H +LK NI+L N + + D+G + + + + + +
Sbjct: 127 KR-------IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTG 469
PE + + + ++D+WS G + LL+G
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 42/201 (20%), Positives = 80/201 (39%), Gaps = 21/201 (10%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
+G+G +G A+ R K++ + F++++ ++ HPN++ L +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRT 394
N + LV + G LF R+ K +R++ + V A+ Y H +
Sbjct: 77 DNTDIYLVMELCTGGELFERV----VHKRVFRESDAARIM--KDVLSAVAYCHKLN---- 126
Query: 395 QSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKSPEYQSSK 448
V H +LK N L + + + D+G ++ + + Y SP+
Sbjct: 127 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ-VLEG 182
Query: 449 KISRKSDVWSFGCLLLELLTG 469
+ D WS G ++ LL G
Sbjct: 183 LYGPECDEWSAGVMMYVLLCG 203
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 24/99 (24%), Positives = 47/99 (47%), Gaps = 20/99 (20%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
+++LH SA +IH +LK +NI++ + + + D+G A+ M++
Sbjct: 175 CGIKHLH--------SAGIIHRDLKPSNIVVKSDCTLKILDFGL----ARTAGTSFMMTP 222
Query: 439 ------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRI 471
Y++PE D+WS GC++ E++ +I
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 33/158 (20%), Positives = 70/158 (44%), Gaps = 25/158 (15%)
Query: 322 KHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVA 380
HP ++ + ++ + E +V + G LF+++ R+ +
Sbjct: 73 NHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYF--YQML 124
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMI 437
A++YLH +IH +LK N+LL +++ ++ ++D+G S ++ + + +
Sbjct: 125 LAVQYLHENG-------IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 438 ---SYKSPE---YQSSKKISRKSDVWSFGCLLLELLTG 469
+Y +PE + +R D WS G +L L+G
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 40/216 (18%), Positives = 84/216 (38%), Gaps = 21/216 (9%)
Query: 264 KLNDLLKAPAEGLGKGIFGNSYKAL-LEGRAPVVVK--RLRDLKPLITEEFRKQLLVIAD 320
N+ ++ LG+G F + + K + R E ++ V+
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 321 -QKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGV 379
+ P ++ L Y + E +L+ ++A G +F+ + + + + +
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC----LPELAEMVSENDVIRLIKQI 140
Query: 380 ARALEYLHHKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRM 436
+ YLH + ++H +LK NILL + + D+G S + + +
Sbjct: 141 LEGVYYLHQNN-------IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI 193
Query: 437 I---SYKSPEYQSSKKISRKSDVWSFGCLLLELLTG 469
+ Y +PE + I+ +D+W+ G + LLT
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 23/137 (16%), Positives = 54/137 (39%), Gaps = 5/137 (3%)
Query: 28 LEDMRLNG-EIKS-DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEI 85
L ++ LN +++ +++ L + N IS + SS KL+ + NK
Sbjct: 289 LTNLELNENQLEDISPISNLKNLTYLTLYFNNIS-DISPVSSLTKLQRLFFYNNKV--SD 345
Query: 86 SRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSY 145
SL +L + L +N ++ P N + + +++ + + + +
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVK 405
Query: 146 SNNPYLCGPPSLNNCSS 162
+ L P ++++ S
Sbjct: 406 NVTGALIAPATISDGGS 422
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 19/99 (19%), Positives = 39/99 (39%), Gaps = 3/99 (3%)
Query: 34 NGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLK 93
N A++ L ++ +N +S + + L+ + + N+ L L
Sbjct: 165 NQVTDLKPLANLTTLERLDISSNKVS-DISVLAKLTNLESLIATNNQISDITP--LGILT 221
Query: 94 FLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIP 132
L+ L L N L + ++L +++NN +S P
Sbjct: 222 NLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 34/134 (25%), Positives = 55/134 (41%), Gaps = 7/134 (5%)
Query: 40 DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99
A + L ++ NN IS N S KL ++ L N+ L L L +L+
Sbjct: 237 GTLASLTNLTDLDLANNQIS-NLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293
Query: 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNN----PYLCGPP 155
L N L P N +L + NN+S P + +L R + Y+N L
Sbjct: 294 LNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSSLANLT 353
Query: 156 SLNNCSSTGNYVTN 169
++N S+ N +++
Sbjct: 354 NINWLSAGHNQISD 367
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 27/149 (18%), Positives = 52/149 (34%), Gaps = 8/149 (5%)
Query: 14 IQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKD 73
I D A VL + + + D+ ++ + I + + L
Sbjct: 17 IFTDTALAEKMKTVLGKTNVTDTV---SQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQ 72
Query: 74 IDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPK 133
I+ S N+ L +L L + + NN + P N ++L + NN ++ P
Sbjct: 73 INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 130
Query: 134 TQTLQLFRSYSYSNNPYLCGPPSLNNCSS 162
L S+N + +L+ +S
Sbjct: 131 KNLTNL-NRLELSSNT-ISDISALSGLTS 157
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 21/127 (16%), Positives = 47/127 (37%), Gaps = 14/127 (11%)
Query: 40 DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99
++ +L+ I NN I+ + ++ L + L N+ L +L L L+
Sbjct: 84 TPLKNLTKLVDILMNNNQIA-DITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 140
Query: 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLS----GSIPKTQTLQLFRSYSYSNNPYLCGPP 155
L +N ++ +SL+ + N ++ + L + S+N +
Sbjct: 141 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDI------SSN-KVSDIS 193
Query: 156 SLNNCSS 162
L ++
Sbjct: 194 VLAKLTN 200
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 11/111 (9%), Positives = 39/111 (35%), Gaps = 1/111 (0%)
Query: 40 DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99
+ A++ + ++ +N IS + ++ ++ + L+ + ++ +++
Sbjct: 347 SSLANLTNINWLSAGHNQIS-DLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVK 405
Query: 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150
L P + S +++ N S + + T + +
Sbjct: 406 NVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTF 456
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 17/100 (17%), Positives = 35/100 (35%), Gaps = 3/100 (3%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLL-SLKF 94
S + L ++ N + NF +L+ +D + S+ SL+
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 95 LESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIP 132
L L + + + SSL+V ++ N+ +
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 21/101 (20%), Positives = 42/101 (41%), Gaps = 5/101 (4%)
Query: 37 IKSDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFL 95
I+ A+ + L + N I FS L+ + + + LK L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 96 ESLQLQNNNLT-GPVPEF--NQSSLKVFNVSNNNLSGSIPK 133
+ L + +N + +PE+ N ++L+ ++S+N + SI
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC 166
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 23/106 (21%), Positives = 38/106 (35%), Gaps = 4/106 (3%)
Query: 36 EIKSDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKF 94
+ S +F PEL V++ I + S L + L+GN + L
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
Query: 95 LESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQ 138
L+ L NL + +LK NV++N + S +
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFS 146
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 19/100 (19%), Positives = 38/100 (38%), Gaps = 6/100 (6%)
Query: 39 SDAFADIPELIVINFKNNIISG--NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLE 96
S F + +L ++F+++ + F F S L +D+S + L LE
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 97 SLQLQNNNLTGPVPE--FNQ-SSLKVFNVSNNNLSGSIPK 133
L++ N+ F + +L ++S L +
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSP 487
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 23/101 (22%), Positives = 40/101 (39%), Gaps = 4/101 (3%)
Query: 28 LEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISR 87
L + + D F + + + + I +FS N + ++L KF +
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPT- 321
Query: 88 SLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLS 128
L LK L+ L +N E + SL+ ++S N LS
Sbjct: 322 --LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 4/90 (4%)
Query: 43 ADIPE-LIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100
++P ++ N + +F S +L+ +DLS + + SL L +L L
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83
Query: 101 QNNNLTG-PVPEFNQ-SSLKVFNVSNNNLS 128
N + + F+ SSL+ NL+
Sbjct: 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLA 113
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 14/66 (21%), Positives = 23/66 (34%), Gaps = 2/66 (3%)
Query: 71 LKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTG-PVPEF-NQSSLKVFNVSNNNLS 128
K++DLS N S S S L+ L L + + + S L ++ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 129 GSIPKT 134
Sbjct: 90 SLALGA 95
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 20/89 (22%), Positives = 42/89 (47%), Gaps = 1/89 (1%)
Query: 40 DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99
+A D+ +L ++N +N IS + ++ +L + L+ N+ E + L L +L
Sbjct: 259 NAVKDLTKLKMLNVGSNQIS-DISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317
Query: 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLS 128
L N++T P + S + + +N +
Sbjct: 318 LSQNHITDIRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 18/95 (18%), Positives = 42/95 (44%), Gaps = 3/95 (3%)
Query: 40 DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99
A++ L + NN I+ + ++ +L +++ N+ +I+ ++ L L+ L
Sbjct: 215 TPVANMTRLNSLKIGNNKIT-DLSPLANLSQLTWLEIGTNQI-SDIN-AVKDLTKLKMLN 271
Query: 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKT 134
+ +N ++ N S L ++NN L +
Sbjct: 272 VGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEV 306
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 8e-07
Identities = 19/123 (15%), Positives = 42/123 (34%), Gaps = 5/123 (4%)
Query: 40 DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99
+++ L + + + + ++ L + L+ N+ L SL L
Sbjct: 149 SPLSNMTGLNYLTVTESKVK-DVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFT 205
Query: 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNN 159
N +T P N + L + NN ++ P QL +N + ++ +
Sbjct: 206 AYVNQITDITPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQ--ISDINAVKD 263
Query: 160 CSS 162
+
Sbjct: 264 LTK 266
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.5 bits (114), Expect = 6e-06
Identities = 22/138 (15%), Positives = 50/138 (36%), Gaps = 14/138 (10%)
Query: 30 DMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSL 89
++ ++ + + ++ + L+ ++L+GN+ L
Sbjct: 28 VLQKASVTDVVTQEELESITKLVVAGEKVA-SIQGIEYLTNLEYLNLNGNQITDISP--L 84
Query: 90 LSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIP-----KTQTLQLFRSYS 144
+L L +L + N +T N ++L+ ++ +N+S P K +L L
Sbjct: 85 SNLVKLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISPLANLTKMYSLNL----- 139
Query: 145 YSNNPYLCGPPSLNNCSS 162
N L L+N +
Sbjct: 140 -GANHNLSDLSPLSNMTG 156
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 6/95 (6%)
Query: 40 DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISR--SLLSLKFLES 97
A++ ++ +N N + S+ L + ++ +K + + +L L S
Sbjct: 126 SPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESK----VKDVTPIANLTDLYS 181
Query: 98 LQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIP 132
L L N + P + +SL F N ++ P
Sbjct: 182 LSLNYNQIEDISPLASLTSLHYFTAYVNQITDITP 216
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 41/208 (19%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 276 LGKGIFGNSYKAL-----LEGRAPVVVKR--LRDLKPLITEEFRKQLLVIADQKHPNLLP 328
LG G F K L+ A + KR + + E+ +++ ++ + +HPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
L Y + + +L+ + G LF+ + + K + + L + + + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFL--KQILNGVYYLHS 132
Query: 389 KDKSRTQSAVIHGNLKSTNILL----DDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKS 441
+ H +LK NI+L + + D+G + + + + + +
Sbjct: 133 LQ-------IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTG 469
PE + + + ++D+WS G + LL+G
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 28/100 (28%), Positives = 53/100 (53%), Gaps = 18/100 (18%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVL-VSDYGFSSLVAQPIAAQRMIS 438
R L+Y+H SA V+H +LK N+ ++ ++VL + D+G + ++ + + +S
Sbjct: 131 RGLKYIH--------SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 439 -------YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y+SP S ++ D+W+ GC+ E+LTG+
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL--DDNEMVLVSDYGFSSLVAQPIA 432
A+ + AL +L + S +IH +LK NILL + + D+G S + Q I
Sbjct: 162 FAQQMCTALLFLATPELS-----IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 216
Query: 433 AQRMIS---YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRI 471
I Y+SPE D+WS GC+L+E+ TG
Sbjct: 217 Q--YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
R L+Y+H SA V+H +LK +N+LL+ + + D+G + + ++
Sbjct: 139 RGLKYIH--------SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 439 ------YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE +SK ++ D+WS GC+L E+L+ R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 29/154 (18%), Positives = 47/154 (30%), Gaps = 12/154 (7%)
Query: 34 NGEIKS-DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSL 92
N I + L + +N I+ ++ S N L + NK + + L
Sbjct: 51 NSSITDMTGIEKLTGLTKLICTSNNITT--LDLSQNTNLTYLACDSNKLT---NLDVTPL 105
Query: 93 KFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNN---- 148
L L N LT + L N + N L+ I + QL + N
Sbjct: 106 TKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARNTLT-EIDVSHNTQLTELDCHLNKKITK 163
Query: 149 PYLCGPPSLNNCSSTGNYVTNSDDKGSNDLKIFY 182
+ L + N +T D + L
Sbjct: 164 LDVTPQTQLTTLDCSFNKITELDVSQNKLLNRLN 197
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 23/127 (18%), Positives = 42/127 (33%), Gaps = 8/127 (6%)
Query: 55 NNIISGNFMNFSSNHKLKDIDLSGNKFYGEISR-SLLSLKFLESLQLQNNNLTGPVPEFN 113
I ++ + N +L +D I+ L L L L N LT + +
Sbjct: 285 CRKIK--ELDVTHNTQLYLLDCQAAG----ITELDLSQNPKLVYLYLNNTELTE-LDVSH 337
Query: 114 QSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCSSTGNYVTNSDDK 173
+ LK + N ++ + L ++ +L N S T + D+
Sbjct: 338 NTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQ 397
Query: 174 GSNDLKI 180
N + I
Sbjct: 398 FGNPMNI 404
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 15/102 (14%), Positives = 36/102 (35%), Gaps = 6/102 (5%)
Query: 28 LEDMRLNG-EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEIS 86
L + + ++ + + +L +N N ++ ++ S N L ++ + N
Sbjct: 87 LTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLTK--LDVSQNPLLTYLNCARNTLT---E 141
Query: 87 RSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLS 128
+ L L N + Q+ L + S N ++
Sbjct: 142 IDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 15/107 (14%), Positives = 35/107 (32%), Gaps = 6/107 (5%)
Query: 42 FADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101
+L ++ +N ++ ++ + +L D S N + +L L +L
Sbjct: 208 LNQNIQLTFLDCSSNKLTE--IDVTPLTQLTYFDCSVNPL---TELDVSTLSKLTTLHCI 262
Query: 102 NNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNN 148
+L + + + L F + T QL+ +
Sbjct: 263 QTDLLE-IDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAG 308
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 9/87 (10%), Positives = 27/87 (31%), Gaps = 5/87 (5%)
Query: 42 FADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101
+ +L + N ++ ++ S+ KL + + L L Q +
Sbjct: 229 VTPLTQLTYFDCSVNPLTE--LDVSTLSKLTTLHCIQTDL---LEIDLTHNTQLIYFQAE 283
Query: 102 NNNLTGPVPEFNQSSLKVFNVSNNNLS 128
+ + + L + + ++
Sbjct: 284 GCRKIKELDVTHNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 25/158 (15%), Positives = 52/158 (32%), Gaps = 12/158 (7%)
Query: 29 EDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRS 88
+ N D FA + F+ + ++ L +D + +++
Sbjct: 7 QTQSFNDWFPDDNFA---SEVAAAFEMQAT--DTISEEQLATLTSLDCHNSSI-TDMT-G 59
Query: 89 LLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNN 148
+ L L L +NN+T + ++L +N L+ ++ T +L +N
Sbjct: 60 IEKLTGLTKLICTSNNITT-LDLSQNTNLTYLACDSNKLT-NLDVTPLTKLTYLNCDTNK 117
Query: 149 ---PYLCGPPSLNNCSSTGNYVTNSDDKGSNDLKIFYF 183
+ P L + N +T D + L
Sbjct: 118 LTKLDVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDC 155
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 18/102 (17%), Positives = 41/102 (40%), Gaps = 4/102 (3%)
Query: 39 SDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLES 97
+ + + ++ + + S +K++DLSGN + L LE
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 98 LQLQNNNLTGPVPEFNQ-SSLKVFNVSNNNLSGSIPKTQTLQ 138
L L +N L + S+L+ +++NN + + +++
Sbjct: 63 LNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-ELLVGPSIE 102
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 21/99 (21%), Positives = 43/99 (43%), Gaps = 7/99 (7%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFL 95
+I + A +L ++N +N++ ++ S L+ +DL+ N + LL +
Sbjct: 48 QISAADLAPFTKLELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYV-----QELLVGPSI 101
Query: 96 ESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKT 134
E+L NNN++ V K ++NN ++
Sbjct: 102 ETLHAANNNISR-VSCSRGQGKKNIYLANNKITMLRDLD 139
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 19/94 (20%), Positives = 38/94 (40%), Gaps = 4/94 (4%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFL 95
++K +L ++ +N ++ F S + I L NK I ++L + L
Sbjct: 183 DVKGQVV--FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNL 239
Query: 96 ESLQLQNNNL-TGPVPEFNQSSLKVFNVSNNNLS 128
E L+ N G + +F + +V V+ +
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 17/81 (20%), Positives = 33/81 (40%), Gaps = 2/81 (2%)
Query: 55 NNIISGNFMNFSSNHKLKDIDLSGNKFYG-EISRSLLSLKFLESLQLQNNNLTGPVPEFN 113
N I ++ +++ +DL N+ + S LE L LQ N + +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVV 189
Query: 114 QSSLKVFNVSNNNLSGSIPKT 134
+ LK ++S+N L+ +
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPE 209
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 18/102 (17%), Positives = 40/102 (39%), Gaps = 4/102 (3%)
Query: 39 SDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLES 97
+ + + ++ + S +K++DLSGN + L LE
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 98 LQLQNNNLTGPVPEFNQ-SSLKVFNVSNNNLSGSIPKTQTLQ 138
L L +N L + S+L+ +++NN + + +++
Sbjct: 63 LNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-ELLVGPSIE 102
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 21/93 (22%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFL 95
+I + A +L ++N +N++ ++ S L+ +DL+ N + LL +
Sbjct: 48 QISAADLAPFTKLELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYV-----QELLVGPSI 101
Query: 96 ESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLS 128
E+L NNN++ V K ++NN ++
Sbjct: 102 ETLHAANNNISR-VSCSRGQGKKNIYLANNKIT 133
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 21/122 (17%), Positives = 42/122 (34%), Gaps = 5/122 (4%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFL 95
++K +L ++ +N ++ F S + I L NK I ++L + L
Sbjct: 183 DVKGQVV--FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNL 239
Query: 96 ESLQLQNNNLT-GPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGP 154
E L+ N G + +F + +V V+ + + + Y C
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCED 298
Query: 155 PS 156
Sbjct: 299 LP 300
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 17/81 (20%), Positives = 33/81 (40%), Gaps = 2/81 (2%)
Query: 55 NNIISGNFMNFSSNHKLKDIDLSGNKFYG-EISRSLLSLKFLESLQLQNNNLTGPVPEFN 113
N I ++ +++ +DL N+ + S LE L LQ N + +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVV 189
Query: 114 QSSLKVFNVSNNNLSGSIPKT 134
+ LK ++S+N L+ +
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPE 209
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 29/127 (22%), Positives = 51/127 (40%), Gaps = 18/127 (14%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFL 95
I AF + L +N I + N + L+++++SGN F S L L
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSL 244
Query: 96 ESLQLQNNNLTGPVPE---FNQSSLKVFNVSNNNLS-------GSIPKTQTLQLFRSYSY 145
+ L + N+ ++ + +SL N+++NNLS + L L
Sbjct: 245 KKLWVMNSQVSL-IERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHL------ 297
Query: 146 SNNPYLC 152
+NP+ C
Sbjct: 298 HHNPWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 28/115 (24%), Positives = 40/115 (34%), Gaps = 15/115 (13%)
Query: 28 LEDMRLNG----EIKSDAFADIPELIVINFKNNIIS----GNFMNFSSNHKLKDIDLSGN 79
L + L I S AF + +L + +NN I F S L +DL
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPS---LMRLDLGEL 181
Query: 80 KFYGEISRSLLS-LKFLESLQLQNNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIP 132
K IS L L+ L L N+ +P L+ +S N+ I
Sbjct: 182 KKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNHFP-EIR 234
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 26/104 (25%), Positives = 38/104 (36%), Gaps = 11/104 (10%)
Query: 36 EIKSDAFADIPELIVINFKNNIIS----GNFMNFSSNHKLKDIDLSGNKFYGEISRSLLS 91
I++D F + L V+ N I G F +S L ++L N I
Sbjct: 89 MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLAS---LNTLELFDNWL-TVIPSGAFE 144
Query: 92 -LKFLESLQLQNNNLTG-PVPEFNQ-SSLKVFNVSNNNLSGSIP 132
L L L L+NN + P FN+ SL ++ I
Sbjct: 145 YLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYIS 188
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 9e-08
Identities = 56/363 (15%), Positives = 106/363 (29%), Gaps = 84/363 (23%)
Query: 284 SYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKH----PNLLP---LLAYYFSN 336
YK +L V D K ++ K +L + H + + L + +
Sbjct: 17 QYKDILSVFEDAFVDNF-DCKD--VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS 73
Query: 337 DEKLLVYKFAGNG---N---LFNRIHG---GKSSKNRIPFRCRSRL------LVARGVAR 381
++ +V KF N L + I S R+ R RL V+R
Sbjct: 74 KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR 133
Query: 382 ALEYLHHKDK----SRTQSAVIHGNL---KSTNILLDDNEMVLV----SDYGFSSLVAQP 430
YL + ++ +I G L K+ + Y +
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSGKT----------WVALDVCLSYKVQCKMDFK 183
Query: 431 IAAQRMISYKSPE----------YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGI 480
I + + SPE YQ + +SD S L + + + +
Sbjct: 184 IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 481 NGADLCSWVLRAVREEWTAEIFD-----------SEISVQRSAAH-----------GMLK 518
L VL V+ F+ +++ SAA +
Sbjct: 244 ENCLL---VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 519 --LLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEEDFWLDQSLTDESLSISTVA 576
+ + ++ + P+ P + + + ES + W D ++T+
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW-DNWKHVNCDKLTTII 359
Query: 577 SAS 579
+S
Sbjct: 360 ESS 362
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 2e-04
Identities = 64/512 (12%), Positives = 137/512 (26%), Gaps = 158/512 (30%)
Query: 1 IHCFKDFPSQWYGI-QCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIIS 59
+ C DF W + C NS +L+ + + + +D I + + I
Sbjct: 176 VQCKMDFKIFWLNLKNC--NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI--HSIQ 231
Query: 60 GNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSL------KFLESLQLQ--------NNNL 105
+ + LL L K + L +
Sbjct: 232 AELRRLLKSKPYE--------------NCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV 277
Query: 106 TGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSY-----------SYSNNPYLCG- 153
T + S+ ++S ++ S ++ + L Y + NP
Sbjct: 278 TDFL-----SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI 332
Query: 154 -PPSLNNCSST-GNYVTNSDDKGSNDLKIFYFLLAALCIVTVL----------MLFIFYL 201
S+ + +T N+ + DK + ++ + VL L +F
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESS---------LNVLEPAEYRKMFDRLSVF-- 381
Query: 202 TKRTRKP---NIMIKKQEEYMDQEKESGDDEEEEEEKIGKG--KRKLVVAGEDRNLVFIE 256
P +I D + + + K LV + + I
Sbjct: 382 ------PPSAHIPTILLSLIW------FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP 429
Query: 257 DEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLL 316
+ LK E + L + + D +
Sbjct: 430 S-------IYLELKVKLEN----------EYALH-------RSIVD---------HYNIP 456
Query: 317 VIADQKHPNLLPLLAYYFSNDEKLLVY--KFAGNG---NLFNRIH------GGKSSKNRI 365
D L Y++S+ + + K + LF + K +
Sbjct: 457 KTFDSDDLIPPYLDQYFYSH----IGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDST 512
Query: 366 PFRCRSRLLVARGVARALE-YL--HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG 422
+ +L + + Y+ + R +A++ L E ++ S Y
Sbjct: 513 AWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILD-------FLPKIEENLICSKY- 564
Query: 423 FSSLVAQPIAAQRMISYKSPEY--QSSKKISR 452
+ L+ + + + ++ K++ R
Sbjct: 565 -TDLL------RIALMAEDEAIFEEAHKQVQR 589
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 28/113 (24%), Positives = 54/113 (47%), Gaps = 10/113 (8%)
Query: 28 LEDMRLNG----EIKSDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFY 82
LE + L I ++A + + LIV+ ++ I+ +F ++LK +++S +
Sbjct: 154 LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213
Query: 83 GEISRSLLSLKFLESLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIP 132
++ + L L SL + + NLT VP + L+ N+S N +S +I
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPIS-TIE 264
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 24/121 (19%), Positives = 46/121 (38%), Gaps = 13/121 (10%)
Query: 18 INSAHVTGIVLEDMRLNG----EIKSDAFADIPELIVINFKNNIIS--GNFMNFSSNHKL 71
+ + G+ L + + + A + L +N N IS M +L
Sbjct: 216 MTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSM-LHELLRL 274
Query: 72 KDIDLSGNKFYGEISRSLLS-LKFLESLQLQNNNLTGPVPE--FNQ-SSLKVFNVSNNNL 127
++I L G + + L +L L + N LT + E F+ +L+ + +N L
Sbjct: 275 QEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLTT-LEESVFHSVGNLETLILDSNPL 332
Query: 128 S 128
+
Sbjct: 333 A 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 31/144 (21%), Positives = 51/144 (35%), Gaps = 22/144 (15%)
Query: 28 LEDMRLNG----EIKSDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFY 82
L + L I F + L ++ N I F + LK +++ N
Sbjct: 82 LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL- 140
Query: 83 GEISRSLLS-LKFLESLQLQNNNLTG-PVPEF-NQSSLKVFNVSNNNLS-------GSIP 132
IS S L LE L L+ NLT P + L V + + N++ +
Sbjct: 141 VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLY 200
Query: 133 KTQTLQLFRSYSYSNNPYLCGPPS 156
+ + L++ S+ PYL
Sbjct: 201 RLKVLEI------SHWPYLDTMTP 218
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 23/102 (22%), Positives = 42/102 (41%), Gaps = 8/102 (7%)
Query: 36 EIKSDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLS-LK 93
+ D FA P L + NI+S F++ L+ + L N+ I + + L
Sbjct: 46 TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL-KLIPLGVFTGLS 104
Query: 94 FLESLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIP 132
L L + N + + ++ + +LK V +N+L I
Sbjct: 105 NLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDLV-YIS 144
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 23/95 (24%), Positives = 43/95 (45%), Gaps = 7/95 (7%)
Query: 43 ADIP-ELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLS-LKFLESLQ 99
IP E +++ N I N F+S L++++L+ N + + L L +L
Sbjct: 28 EGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLG 86
Query: 100 LQNNNLTG-PVPEF-NQSSLKVFNVSNNNLSGSIP 132
L++N L P+ F S+L ++S N + +
Sbjct: 87 LRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILL 120
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 15/95 (15%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA---AQRM 436
R L+Y+H SA +IH +LK +N+ ++++ + + D+G + A + A R
Sbjct: 143 RGLKYIH--------SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW 194
Query: 437 ISYKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE + ++ D+WS GC++ ELLTGR
Sbjct: 195 --YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 24/106 (22%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
RA++ LH + VIH +LK +N+L++ N + V D+G + ++ + A +
Sbjct: 123 RAVKVLH--------GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 439 -------------YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE +S K SR DVWS GC+L EL R
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 26/95 (27%), Positives = 50/95 (52%), Gaps = 15/95 (15%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA---AQRM 436
+ L+Y+H SA V+H +LK N+ ++++ + + D+G + + R
Sbjct: 137 KGLKYIH--------SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW 188
Query: 437 ISYKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE S ++ D+WS GC++ E+LTG+
Sbjct: 189 --YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 26/99 (26%), Positives = 42/99 (42%), Gaps = 21/99 (21%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
L LH A V+H +L NILL DN + + D+ A+ A +
Sbjct: 145 LGLHVLH--------EAGVVHRDLHPGNILLADNNDITICDFNL----AREDTADANKTH 192
Query: 439 ------YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE K ++ D+WS GC++ E+ +
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 24/102 (23%), Positives = 36/102 (35%), Gaps = 4/102 (3%)
Query: 36 EIKSDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKF 94
I L V+ K++ I+ F S L+ +DLS N S L
Sbjct: 40 YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS 99
Query: 95 LESLQLQNNNLT--GPVPEF-NQSSLKVFNVSNNNLSGSIPK 133
L+ L L N G F N ++L+ + N I +
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 22/142 (15%), Positives = 41/142 (28%), Gaps = 22/142 (15%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLS---- 91
+ + + L ++ N + K++ ++LS + +
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGI-RVVKTCIPQTLEV 435
Query: 92 --------------LKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKT--Q 135
L L+ L + N L L V +S N L S+P
Sbjct: 436 LDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLK-SVPDGIFD 494
Query: 136 TLQLFRSYSYSNNPYLCGPPSL 157
L + NP+ C P +
Sbjct: 495 RLTSLQKIWLHTNPWDCSCPRI 516
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 27/129 (20%), Positives = 52/129 (40%), Gaps = 17/129 (13%)
Query: 22 HVTGIVLEDMRLNG-----EIKSDAFADIPELIVINFKNNIISGNFMN------FSSNHK 70
++ + +D LNG +SD +++ ++ + + I ++ +S K
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
Query: 71 LKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTG-----PVPEFNQSSLKVFNVSNN 125
+K I + +K + LK LE L L N + + SL+ +S N
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
Query: 126 NLSGSIPKT 134
+L S+ KT
Sbjct: 372 HLR-SMQKT 379
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 23/180 (12%), Positives = 58/180 (32%), Gaps = 17/180 (9%)
Query: 26 IVLEDMRLNGEIKSDAFADIPELIVINF-KNNIISG-NFMNFSSNHKLKDIDLSGNKFYG 83
+ L + F ++ L + S ++F+ L ++++
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162
Query: 84 EISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFR 141
S+SL S++ + L L + + F SS++ + + NL+
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA------------- 209
Query: 142 SYSYSNNPYLCGPPSLNNCSSTGNYVTNSDDKGSNDLKIFYFLLAALCIVTVLMLFIFYL 201
+ +S P + + G+ +T+ L + L+ + + +
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDF 269
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 25/164 (15%)
Query: 317 VIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLV 375
++A P ++ L Y F +D L +V ++ G+L N + S +P +R
Sbjct: 122 IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM-----SNYDVP-EKWARFYT 174
Query: 376 ARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR 435
A V AL+ +H IH ++K N+LLD + + ++D+G + + +
Sbjct: 175 AE-VVLALDAIHSMG-------FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226
Query: 436 MIS-----YKSPEYQSSKKIS----RKSDVWSFGCLLLELLTGR 470
+ Y SPE S+ R+ D WS G L E+L G
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 49/247 (19%), Positives = 84/247 (34%), Gaps = 73/247 (29%)
Query: 274 EGLGKGIFGNSYKA--LLEGRAPVVVKRLRDLKPLITEEFRKQLLV-IADQKHPNLLPLL 330
LG+G FG + G++ V +K +R++ +R+ + I N+L +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK-----YREAARLEI------NVLKKI 73
Query: 331 AYYFSNDEKLLV-----YKFAG---------NGNLFNRIHGGKSSKNRIPFRCRSRLLVA 376
++ L V + F G N F + K + + P+ +A
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL---KENNFQ-PYPLPHVRHMA 129
Query: 377 RGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ-R 435
+ AL +LH + H +LK NIL ++E + + S R
Sbjct: 130 YQLCHALRFLHENQ-------LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 436 MI-------------------SYKSPE------YQSSKKISRKSDVWSFGCLLLELLTGR 470
+ Y+ PE + ++ DVWS GC+L E G
Sbjct: 183 VADFGSATFDHEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYRGF 236
Query: 471 I--STHS 475
TH
Sbjct: 237 TLFQTHE 243
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 23/95 (24%), Positives = 50/95 (52%), Gaps = 15/95 (15%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIA---AQRM 436
+ L Y+H +A +IH +LK N+ ++++ + + D+G + + R
Sbjct: 139 KGLRYIH--------AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW 190
Query: 437 ISYKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE + + ++ D+WS GC++ E++TG+
Sbjct: 191 --YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 52/279 (18%), Positives = 98/279 (35%), Gaps = 60/279 (21%)
Query: 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
+ LG GI G + + +K L+D P E + P+++ ++
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRA---SQCPHIVRIVDV 79
Query: 333 Y----FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
Y L+V + G LF+RI + F R + + + A++YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRI----QDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 389 KDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQ 445
+ + H ++K N+L N ++ ++D+GF+ E
Sbjct: 136 IN-------IAHRDVKPENLLYTSKRPNAILKLTDFGFA-----------------KETT 171
Query: 446 SSKKISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAVREEWTAEI-FD 503
+K + D+WS G ++ LL G P +G + + +R + F
Sbjct: 172 G-EKYDKSCDMWSLGVIMYILLCGY-----PPFYSNHGLAISPGMKTRIRM---GQYEFP 222
Query: 504 SEI--SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
+ V + LL+ P +R + E
Sbjct: 223 NPEWSEVSEEVKMLIRNLLKT-------EPTQRMTITEF 254
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 22/98 (22%), Positives = 48/98 (48%), Gaps = 18/98 (18%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL-VSDYGFSSLVAQPIAAQRMIS- 438
RA+ ++H + H ++K N+L++ + L + D+G + I ++ ++
Sbjct: 152 RAVGFIHSLG-------ICHRDIKPQNLLVNSKDNTLKLCDFG---SAKKLIPSEPSVAY 201
Query: 439 -----YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE + + + D+WS GC+ EL+ G+
Sbjct: 202 ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 39/229 (17%), Positives = 70/229 (30%), Gaps = 73/229 (31%)
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM------------------- 415
+ + V + L+YLH T+ +IH ++K NILL NE
Sbjct: 151 IIQQVLQGLDYLH------TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204
Query: 416 ------------------------------VLVSDYGFSSLVAQPIAAQRM-ISYKSPEY 444
V ++D G + V + Y+S E
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEV 264
Query: 445 QSSKKISRKSDVWSFGCLLLELLTGR--ISTHSAPQGINGADL------------CSWVL 490
+ +D+WS C+ EL TG HS + D ++
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 491 RAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAE 539
+++ E F + ++ L +V ++ S E+ +
Sbjct: 325 AG---KYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTD 370
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 26/125 (20%), Positives = 48/125 (38%), Gaps = 20/125 (16%)
Query: 39 SDAFADIPELIVINFKNNIISGNFM--NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLE 96
++ + L ++ N +S + + S L +++S N I R L ++
Sbjct: 367 AEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR--IK 424
Query: 97 SLQLQNNNLTG-PVPEFNQSSLKVFNVSNNNLSGSIPKT--------QTLQLFRSYSYSN 147
L L +N + P +L+ NV++N L S+P Q + L
Sbjct: 425 VLDLHSNKIKSIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWL------HT 477
Query: 148 NPYLC 152
NP+ C
Sbjct: 478 NPWDC 482
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 20/99 (20%), Positives = 43/99 (43%), Gaps = 5/99 (5%)
Query: 55 NNIISGNFMNFSSNHKLKDIDLSGNKF--YGEISRSLLSLKFLESLQLQNNNLTGPVPE- 111
N + F N +L+ + L N+ +I+ +K L+ L + N+++ +
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393
Query: 112 -FNQ-SSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNN 148
+ SL N+S+N L+ +I + ++ +SN
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNK 432
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 24/102 (23%), Positives = 42/102 (41%), Gaps = 5/102 (4%)
Query: 36 EIKSDAFADIPELIVINFKNN---IISGNFMNFSSNHKLKDIDLSGNKF-YGEISRSLLS 91
+ + + EL + + N +S + L+ +D+S N Y E
Sbjct: 338 DTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397
Query: 92 LKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPK 133
K L SL + +N LT + +KV ++ +N + SIPK
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPK 438
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 29/150 (19%), Positives = 53/150 (35%), Gaps = 10/150 (6%)
Query: 36 EIKSDAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKF 94
E+ + + +L ++ +N I + F N +L+ +DLS NK ++LK
Sbjct: 35 ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKH 94
Query: 95 LESLQLQNNNLT--GPVPEF-NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYL 151
L+ L N EF N S LK +S +L S
Sbjct: 95 LD---LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY 151
Query: 152 C---GPPSLNNCSSTGNYVTNSDDKGSNDL 178
P L + ++ ++ +K + +
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFI 181
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 26/119 (21%), Positives = 47/119 (39%), Gaps = 9/119 (7%)
Query: 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN---FSSNHKLKDIDL 76
+ T + LE +L + F + +L ++ +N +S LK +DL
Sbjct: 27 PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85
Query: 77 SGNKFYGEISRSLLSLKFLESLQLQNNNLT--GPVPEFNQ-SSLKVFNVSNNNLSGSIP 132
S N +S + L L+ LE L Q++NL F +L ++S+ +
Sbjct: 86 SFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAF 142
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 22/99 (22%), Positives = 40/99 (40%), Gaps = 7/99 (7%)
Query: 40 DAFADIPELIVINFKNNIISG-NFMNFSSNHKLKDIDLSGNKFYGEISRSLLS-LKFLES 97
F + LI ++ + F+ L+ + ++GN F + + L+ L
Sbjct: 120 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179
Query: 98 LQLQNNNLTGPVPE---FNQSSLKVFNVSNNNLSGSIPK 133
L L L + + SSL+V N+S+NN S+
Sbjct: 180 LDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFF-SLDT 216
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 24/142 (16%), Positives = 45/142 (31%), Gaps = 16/142 (11%)
Query: 28 LEDMRLNGEIKSDAFADIPELIVINFKNNIIS----GNFMNFSSNHKLKDIDLSGNKFYG 83
+ D F ++ L ++ + F + SS L+ +++S N F
Sbjct: 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS---LQVLNMSHNNF-F 212
Query: 84 EISRSLLS-LKFLESLQLQNNNLTG-PVPEFN--QSSLKVFNVSNNNLS---GSIPKTQT 136
+ L L+ L N++ E SSL N++ N+ + Q
Sbjct: 213 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQW 272
Query: 137 LQLFRSYSYSNNPYLC-GPPSL 157
++ R C P
Sbjct: 273 IKDQRQLLVEVERMECATPSDK 294
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 7e-07
Identities = 18/123 (14%), Positives = 42/123 (34%), Gaps = 12/123 (9%)
Query: 18 INSAHVTGIVLEDMRLNGEI-KSDAFADIPELIVINFKNNIISGNFMNFS-----SNHKL 71
+ + + + LE++ + G A P+L ++N +N + + L
Sbjct: 92 LGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGL 151
Query: 72 KDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQ------SSLKVFNVSNN 125
K + ++ + L +L L +N G + +L+V + N
Sbjct: 152 KVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNA 211
Query: 126 NLS 128
+
Sbjct: 212 GME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 15/100 (15%), Positives = 33/100 (33%), Gaps = 6/100 (6%)
Query: 33 LNGEIKSDAFADIPELIVINFKNNIISG--NFMNFSSNHKLKDIDLSGNKFYGEISRSLL 90
+G + A +L ++ +N + + +L ++LS ++ + L
Sbjct: 216 PSGVCSAL-AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273
Query: 91 SLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGS 130
+ L L L N L + ++ N S
Sbjct: 274 AK--LSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLDS 311
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 25/129 (19%), Positives = 44/129 (34%), Gaps = 41/129 (31%)
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA- 433
+A + +++ +LH + H +LK NIL ++ + I
Sbjct: 123 MAYQICKSVNFLHSNK-------LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 434 -------------QRMIS------YKSPE------YQSSKKISRKSDVWSFGCLLLELLT 468
+ + Y++PE + S+ DVWS GC+L+E
Sbjct: 176 IKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYL 229
Query: 469 GRI--STHS 475
G TH
Sbjct: 230 GFTVFPTHD 238
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 9e-07
Identities = 32/150 (21%), Positives = 53/150 (35%), Gaps = 13/150 (8%)
Query: 42 FADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISR--SLLSLKFLESLQ 99
++ L + N I + + KLK + L N IS L+ L LESL
Sbjct: 83 LTNLKNLGWLFLDENKIK-DLSSLKDLKKLKSLSLEHNG----ISDINGLVHLPQLESLY 137
Query: 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNN-----PYLCGP 154
L NN +T + L ++ +N +S I L ++ S N L G
Sbjct: 138 LGNNKITDITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHISDLRALAGL 196
Query: 155 PSLNNCSSTGNYVTNSDDKGSNDLKIFYFL 184
+L+ N ++L + +
Sbjct: 197 KNLDVLELFSQECLNKPINHQSNLVVPNTV 226
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 5e-06
Identities = 31/217 (14%), Positives = 64/217 (29%), Gaps = 9/217 (4%)
Query: 28 LEDMRLNG-EIKS-DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEI 85
L+ + L I + +P+L + NN I+ + S KL + L N+ I
Sbjct: 111 LKSLSLEHNGISDINGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQ----I 165
Query: 86 S--RSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSY 143
S L L L++L L N+++ +L V + + Q+ + +
Sbjct: 166 SDIVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 225
Query: 144 SYSNNPYLCGPPSLNNCSSTGNYVTNSDDKGSNDLKIFYFLLAALCIVTVLMLFIFYLTK 203
+ + L P +++ + F F
Sbjct: 226 VKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQP 285
Query: 204 RTRKPNIMIKKQEEYMDQEKESGDDEEEEEEKIGKGK 240
+ + + E+G + +G
Sbjct: 286 LKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGY 322
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 21/117 (17%), Positives = 43/117 (36%), Gaps = 20/117 (17%)
Query: 28 LEDMRLNG----EIKSDAFADIPELIVINFKNNIIS----GNFMNFSSNHKLKDIDLSGN 79
L ++ L+ I+ + +L + +N I G+ + L+++ L N
Sbjct: 195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPT---LRELHLDNN 251
Query: 80 KFYGEISRSLLSLKFLESLQLQNNNLT--------GPVPEFNQSSLKVFNVSNNNLS 128
K + L LK L+ + L NN+T ++ ++ NN +
Sbjct: 252 KLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 26/99 (26%), Positives = 43/99 (43%), Gaps = 8/99 (8%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKF 94
E++ D F + L + NN IS FS KL+ + +S N EI +L
Sbjct: 68 ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSS 124
Query: 95 LESLQLQNNNLTGPVPE--FNQ-SSLKVFNVSNNNLSGS 130
L L++ +N + VP+ F+ ++ + N L S
Sbjct: 125 LVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENS 162
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 32/168 (19%), Positives = 63/168 (37%), Gaps = 28/168 (16%)
Query: 317 VIADQKHPNLLPLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFR-CRSRLL 374
V+ + + L + F ++ L LV ++ G+L + SK +R
Sbjct: 114 VLVNGDRRWITQL-HFAFQDENYLYLVMEYYVGGDLLTLL-----SKFGERIPAEMARFY 167
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ 434
+A + A++ +H +H ++K NILLD + ++D+G + +
Sbjct: 168 LAE-IVMAIDSVHRLG-------YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219
Query: 435 RM-----ISYKSPE-------YQSSKKISRKSDVWSFGCLLLELLTGR 470
+ Y SPE + + D W+ G E+ G+
Sbjct: 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 20/153 (13%), Positives = 47/153 (30%), Gaps = 31/153 (20%)
Query: 28 LEDMRLNG----EIKSDAFADIPELIVINFKNN---IISGNFMNFSSNHKLKDIDLSGNK 80
LE++ ++ + + I + + ++ F ++ ++L
Sbjct: 176 LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIF--VDVTSSVECLELRDTD 233
Query: 81 FYGEISRSLLSLKF--------LESLQLQNNNLTGPVPEFNQ-SSLKVFNVSNNNLSG-- 129
L + + ++++ + +L + NQ S L S N L
Sbjct: 234 LDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVP 293
Query: 130 -----SIPKTQTLQLFRSYSYSNNPYLCGPPSL 157
+ Q + L NP+ C P +
Sbjct: 294 DGIFDRLTSLQKIWL------HTNPWDCSCPRI 320
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 33/135 (24%), Positives = 44/135 (32%), Gaps = 47/135 (34%)
Query: 375 VARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ 434
+ +AL YL + H +LK NILLDD + I
Sbjct: 142 YCIEILKALNYLRKMS-------LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 435 RMIS--------------------------YKSPE------YQSSKKISRKSDVWSFGCL 462
R S Y++PE + SD+WSFGC+
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCV 248
Query: 463 LLELLTGRI--STHS 475
L EL TG + TH
Sbjct: 249 LAELYTGSLLFRTHE 263
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 21/118 (17%), Positives = 49/118 (41%), Gaps = 18/118 (15%)
Query: 28 LEDMRLNGEIKSDAFADIPELIVINFKNNIIS----GNFMNFSSNHKLKDIDLSGNKFYG 83
L+ ++ ++ + + + L + N IS G+ N L+++ L+ NK
Sbjct: 199 LDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH---LRELHLNNNKLV- 253
Query: 84 EISRSLLSLKFLESLQLQNNNLT--------GPVPEFNQSSLKVFNVSNNNLS-GSIP 132
++ L K+++ + L NNN++ P ++S ++ +N + I
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 311
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 28/113 (24%), Positives = 50/113 (44%), Gaps = 9/113 (7%)
Query: 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSG 78
+ L++ ++ EIK F ++ L + NN IS F+ KL+ + LS
Sbjct: 51 PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109
Query: 79 NKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE--FNQ-SSLKVFNVSNNNLS 128
N+ E+ + K L+ L++ N +T V + FN + + V + N L
Sbjct: 110 NQLK-ELPEKM--PKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLK 158
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 8e-06
Identities = 20/99 (20%), Positives = 46/99 (46%), Gaps = 16/99 (16%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ------ 434
L Y+H ++H ++K+ N+L+ + ++ ++D+G + + +Q
Sbjct: 135 NGLYYIHRNK-------ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 435 RMIS--YKSPEY-QSSKKISRKSDVWSFGCLLLELLTGR 470
R+++ Y+ PE + D+W GC++ E+ T
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 9e-06
Identities = 14/76 (18%), Positives = 27/76 (35%), Gaps = 1/76 (1%)
Query: 54 KNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF- 112
++ S N S L +D+S + I + +L + S+ L N +
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLK 156
Query: 113 NQSSLKVFNVSNNNLS 128
LK N+ + +
Sbjct: 157 TLPELKSLNIQFDGVH 172
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 41/205 (20%), Positives = 83/205 (40%), Gaps = 30/205 (14%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
LG+G + ++A+ + VVVK L+ +K + R+ ++ + PN++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLADIVK 101
Query: 335 SNDEKLLVYKFA-GNGNLFNRIHGGKSSKNRIPFRCRS---RLLVARGVARALEYLHHKD 390
+ F N F +++ + + R +L +AL+Y H
Sbjct: 102 DPVSRTPALVFEHVNNTDFKQLYQTLT-----DYDIRFYMYEIL------KALDYCHSMG 150
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVL-VSDYGFS-SLVAQPIAAQRMIS--YKSPEYQ- 445
++H ++K N+++D L + D+G + R+ S +K PE
Sbjct: 151 -------IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 203
Query: 446 SSKKISRKSDVWSFGCLLLELLTGR 470
+ D+WS GC+L ++ +
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRK 228
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 25/98 (25%), Positives = 45/98 (45%), Gaps = 18/98 (18%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-- 438
+ + H + +IH ++K NIL+ + +V + D+GF+ +A P +
Sbjct: 135 NGIGFCHSHN-------IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---EVYDDE 184
Query: 439 -----YKSPEY-QSSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE K + DVW+ GCL+ E+ G
Sbjct: 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 23/124 (18%), Positives = 54/124 (43%), Gaps = 11/124 (8%)
Query: 32 RLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISR--SL 89
R++ E+++ +D+ EL++ N ++N +L+ + ++ +L
Sbjct: 6 RIHLELRNRTPSDVKELVLDNSRSNEGK-LEGLTDEFEELEFLSTINV----GLTSIANL 60
Query: 90 LSLKFLESLQLQNNNLTGPVPEFNQS--SLKVFNVSNNNLS--GSIPKTQTLQLFRSYSY 145
L L+ L+L +N ++G + + +L N+S N + +I + L+ +S
Sbjct: 61 PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDL 120
Query: 146 SNNP 149
N
Sbjct: 121 FNCE 124
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 29/150 (19%), Positives = 51/150 (34%), Gaps = 23/150 (15%)
Query: 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN--FSSNHKLKDIDLSG 78
AHV + L + E+ +F+ + +L + + N F L + L
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 79 NKFYGEISRSLL-SLKFLESLQLQNNNLTG-PVPEF---NQSSLKVFNVSNNNLSGSIPK 133
N+F ++ L LE L L NL G + +SL++ + +NN+ P
Sbjct: 89 NQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA 147
Query: 134 T--------QTLQLFRSYSYSNNPYLCGPP 155
+ L L + N
Sbjct: 148 SFFLNMRRFHVLDL------TFNKVKSICE 171
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 29/115 (25%), Positives = 42/115 (36%), Gaps = 15/115 (13%)
Query: 28 LEDMRLNG----EIKSDAFADIPELIVINFKNNIIS----GNFMNFSSNHKLKDIDLSGN 79
L + L I + AF + +L + +NN I F L+ +DL
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIP---SLRRLDLGEL 170
Query: 80 KFYGEISRSLLS-LKFLESLQLQNNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIP 132
K IS L L L L NL +P L ++S N+LS +I
Sbjct: 171 KRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLS-AIR 223
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 28/122 (22%), Positives = 41/122 (33%), Gaps = 17/122 (13%)
Query: 45 IPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNN 104
P L + NN + ++ LK ID+ N ++ SL E + NN
Sbjct: 130 PPLLEYLGVSNNQLE-KLPELQNSSFLKIIDVDNNSL-KKLPDLPPSL---EFIAAGNNQ 184
Query: 105 LTGPVPEF-NQSSLKVFNVSNNNLS---GSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNC 160
L +PE N L NN+L +++ NN L P L N
Sbjct: 185 LEE-LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVA------GNNI-LEELPELQNL 236
Query: 161 SS 162
Sbjct: 237 PF 238
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 26/122 (21%), Positives = 36/122 (29%), Gaps = 16/122 (13%)
Query: 45 IPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNN 104
P L I NN + + L I N ++ LSL ES+ NN
Sbjct: 172 PPSLEFIAAGNNQLE-ELPELQNLPFLTAIYADNNSL-KKLPDLPLSL---ESIVAGNNI 226
Query: 105 LTGPVPEFNQ-SSLKVFNVSNNNLS---GSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNC 160
L PE L NN L P + L + +N P +
Sbjct: 227 LEEL-PELQNLPFLTTIYADNNLLKTLPDLPPSLEALNV------RDNYLTDLPELPQSL 279
Query: 161 SS 162
+
Sbjct: 280 TF 281
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 2e-05
Identities = 22/94 (23%), Positives = 35/94 (37%), Gaps = 7/94 (7%)
Query: 64 NFSSNHKLKDIDLSGNKFYGEI-SRSLLSLKFLESLQLQNNNLTGPVPE-FNQ-SSLKVF 120
+ L ++ + + + R L L L +L + + L P+ F+ L
Sbjct: 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85
Query: 121 NVSNNNLSGSIPKT--QTLQLFRSYSYSNNPYLC 152
N+S N L S+ Q L L S NP C
Sbjct: 86 NLSFNALE-SLSWKTVQGLSLQELV-LSGNPLHC 117
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 26/98 (26%), Positives = 45/98 (45%), Gaps = 18/98 (18%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-- 438
+A+ + H + IH ++K NIL+ + ++ + D+GF+ L+ P
Sbjct: 113 QAVNFCHKHN-------CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS---DYYDDE 162
Query: 439 -----YKSPEY-QSSKKISRKSDVWSFGCLLLELLTGR 470
Y+SPE + DVW+ GC+ ELL+G
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 30/117 (25%), Positives = 49/117 (41%), Gaps = 35/117 (29%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
+ ++YLH S ++H ++K +NILL+ V V+D+G S I
Sbjct: 120 KVIKYLH--------SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 439 ------------------------YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE S K ++ D+WS GC+L E+L G+
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 21/104 (20%), Positives = 37/104 (35%), Gaps = 7/104 (6%)
Query: 36 EIKSDAFADIPELIVINFKNNIIS--GNFMNFSSNHKLKDIDLSGNKFYGEISRSLLS-- 91
I DA ++P L + N + + S ++++ N + I +
Sbjct: 95 YIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGL 154
Query: 92 LKFLESLQLQNNNLTGPVPE--FNQSSLKVFNVSNNNLSGSIPK 133
+L+L NN T V FN + L ++ N I K
Sbjct: 155 CNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDK 197
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 21/106 (19%), Positives = 43/106 (40%), Gaps = 12/106 (11%)
Query: 36 EIKSDAFADIPELIVINFKNNI----ISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLS 91
I S AF+++P + I ++ + + +F + K+ I++ + I L
Sbjct: 45 TIPSHAFSNLPNISRIYVSIDVTLQQLESH--SFYNLSKVTHIEIRNTRNLTYIDPDALK 102
Query: 92 -LKFLESLQLQNNNLTGPVPEFNQ----SSLKVFNVSNNNLSGSIP 132
L L+ L + N L P+ + + +++N SIP
Sbjct: 103 ELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIP 147
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 25/131 (19%), Positives = 53/131 (40%), Gaps = 6/131 (4%)
Query: 40 DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99
A + L ++ N +S + ++ KL + NK +IS L SL L +
Sbjct: 145 SPLAGLTNLQYLSIGNAQVS-DLTPLANLSKLTTLKADDNKI-SDIS-PLASLPNLIEVH 201
Query: 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNN 159
L+NN ++ P N S+L + ++N ++ + + + P ++++
Sbjct: 202 LKNNQISDVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISD 261
Query: 160 CSSTGNYVTNS 170
G Y + +
Sbjct: 262 ---NGTYASPN 269
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 24/109 (22%), Positives = 51/109 (46%), Gaps = 4/109 (3%)
Query: 40 DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99
+ + LI + K+N I+ + + K+ +++LSGN +S ++ L+ +++L
Sbjct: 57 EGVQYLNNLIGLELKDNQIT-DLAPLKNLTKITELELSGNPL-KNVS-AIAGLQSIKTLD 113
Query: 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNN 148
L + +T P S+L+V + N ++ +I L + S N
Sbjct: 114 LTSTQITDVTPLAGLSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNA 161
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 25/127 (19%), Positives = 44/127 (34%), Gaps = 36/127 (28%)
Query: 381 RALEYLHHKDKSRTQSA-VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS- 438
++H + +IH +LK N LL+ + V V D+G + + +
Sbjct: 140 LGENFIH--------ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 439 -------------------------YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGRIS 472
Y++PE + ++ D+WS GC+ ELL S
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
Query: 473 THSAPQG 479
+ P
Sbjct: 252 HINDPTN 258
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 4e-05
Identities = 23/95 (24%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA--QRMIS 438
+ L + H ++H +LK N+L++ + + D+G + P+ +++
Sbjct: 119 QGLAFCHEN-------KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 439 --YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y++P+ S+ S D+WS GC+L E++TG+
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 5e-05
Identities = 22/96 (22%), Positives = 43/96 (44%), Gaps = 16/96 (16%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-- 438
R L++LH ++H +LK NIL+ V ++D+G + + + + +
Sbjct: 131 RGLDFLHAN-------CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVV 180
Query: 439 ----YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE + D+WS GC+ E+ +
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 29/134 (21%), Positives = 58/134 (43%), Gaps = 8/134 (5%)
Query: 40 DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEIS--RSLLSLKFLES 97
+ D+ +L ++ ++N IS + +L+ + L NK I+ L L L++
Sbjct: 106 SSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNK----ITDITVLSRLTKLDT 160
Query: 98 LQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSL 157
L L++N ++ VP + L+ +S N++S + L+ + L P +
Sbjct: 161 LSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINH 219
Query: 158 NNCSSTGNYVTNSD 171
+ N V N+D
Sbjct: 220 QSNLVVPNTVKNTD 233
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 12/89 (13%), Positives = 30/89 (33%), Gaps = 1/89 (1%)
Query: 40 DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99
A + +L + N IS + + L ++L + + +L +++
Sbjct: 172 VPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 230
Query: 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLS 128
+ +L P + + NV +
Sbjct: 231 NTDGSLVTPEIISDDGDYEKPNVKWHLPE 259
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 21/89 (23%), Positives = 33/89 (37%), Gaps = 8/89 (8%)
Query: 42 FADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISR--SLLSLKFLESLQ 99
++ + N N+ I + LK++ LS N+ IS L L LE L
Sbjct: 37 QKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHNQ----ISDLSPLKDLTKLEELS 91
Query: 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLS 128
+ N L + + L + NN L
Sbjct: 92 VNRNRLKN-LNGIPSACLSRLFLDNNELR 119
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 23/113 (20%), Positives = 44/113 (38%), Gaps = 9/113 (7%)
Query: 40 DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEIS--RSLLSLKFLES 97
D+ +L ++ N + +N + L + L N+ + SL+ LK LE
Sbjct: 79 SPLKDLTKLEELSVNRNRLKN--LNGIPSACLSRLFLDNNE----LRDTDSLIHLKNLEI 132
Query: 98 LQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150
L ++NN L V S L+V ++ N ++ + L+ +
Sbjct: 133 LSIRNNKLKSIVMLGFLSKLEVLDLHGNEIT-NTGGLTRLKKVNWIDLTGQKC 184
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 29/108 (26%), Positives = 45/108 (41%), Gaps = 31/108 (28%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLD---DNEMVL-VSDYGFSSLVAQPIAAQRM 436
+ YLH V+H +LK NIL+ + ++D GF+ L P+
Sbjct: 139 DGIHYLHANW-------VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 437 IS-------YKSPE-------YQSSKKISRKSDVWSFGCLLLELLTGR 470
+ Y++PE Y +K I D+W+ GC+ ELLT
Sbjct: 192 LDPVVVTFWYRAPELLLGARHY--TKAI----DIWAIGCIFAELLTSE 233
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 6e-05
Identities = 24/95 (25%), Positives = 51/95 (53%), Gaps = 12/95 (12%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA--QRMIS 438
R + + H ++H +LK N+L++ + + ++D+G + P+ + +++
Sbjct: 130 RGVAHCHQH-------RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT 182
Query: 439 --YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y++P+ SKK S D+WS GC+ E++TG+
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 7e-05
Identities = 23/96 (23%), Positives = 45/96 (46%), Gaps = 16/96 (16%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-- 438
R L++LH V+H +LK NIL+ + + ++D+G + + + + + S
Sbjct: 131 RGLDFLHSH-------RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVV 180
Query: 439 ----YKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE + D+WS GC+ E+ +
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 8e-05
Identities = 24/95 (25%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA--QRMIS 438
+ Y H + V+H +LK N+L++ + ++D+G + P+ +++
Sbjct: 111 NGIAYCHDR-------RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT 163
Query: 439 --YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y++P+ SKK S D+WS GC+ E++ G
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 9e-05
Identities = 25/95 (26%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA--QRMIS 438
R L Y H + V+H +LK N+L+++ + ++D+G + + P +++
Sbjct: 111 RGLAYCHRQ-------KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVT 163
Query: 439 --YKSPEY-QSSKKISRKSDVWSFGCLLLELLTGR 470
Y+ P+ S S + D+W GC+ E+ TGR
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 32/151 (21%), Positives = 53/151 (35%), Gaps = 39/151 (25%)
Query: 28 LEDMRLNG----EIKSDAFADIPELIVINFKNNIIS--GNFMNFSSNHKLKDIDLSGNKF 81
L + L+ I S+AF +P L ++ +N + F+ FS L+ + L N
Sbjct: 66 LHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFL-FSDLQALEVLLLYNNH- 123
Query: 82 YGEISR----SLLSLKFLESLQLQNNNLTGPVPE------FNQSSLKVFNVSNNNLSGSI 131
I + + L+ L L N ++ P L + ++S+N L +
Sbjct: 124 ---IVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLK-KL 178
Query: 132 P----------KTQTLQLFRSYSYSNNPYLC 152
P L L NNP C
Sbjct: 179 PLTDLQKLPAWVKNGLYL------HNNPLEC 203
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 28/126 (22%), Positives = 53/126 (42%), Gaps = 15/126 (11%)
Query: 32 RLNGEIKSDAFADIPELIVINFKNNI--ISGNFMNFSSNHKLKDIDLSGNKFYGEISR-- 87
R++ E+++ A + EL++ N K+N I G F L+ + L +
Sbjct: 13 RIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFV---NLEFLSLINVG----LISVS 65
Query: 88 SLLSLKFLESLQLQNNNLTGPVPEFNQS--SLKVFNVSNNNLS--GSIPKTQTLQLFRSY 143
+L L L+ L+L N + G + + +L N+S N L ++ + L+ +S
Sbjct: 66 NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSL 125
Query: 144 SYSNNP 149
N
Sbjct: 126 DLFNCE 131
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 2e-04
Identities = 22/95 (23%), Positives = 45/95 (47%), Gaps = 12/95 (12%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA--QRMIS 438
+ L + H + V+H +LK N+L++ N + ++++G + P+ +++
Sbjct: 112 KGLGFCHSR-------NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT 164
Query: 439 --YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
Y+ P+ +K S D+WS GC+ EL
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 25/100 (25%), Positives = 41/100 (41%), Gaps = 17/100 (17%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLD----DNEMVL-VSDYGFSSLVAQPIAA-- 433
+ + H + +H +LK N+LL VL + D+G + PI
Sbjct: 143 NGVNFCHSR-------RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195
Query: 434 QRMIS--YKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGR 470
+I+ Y+ PE S+ S D+WS C+ E+L
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 23/103 (22%), Positives = 44/103 (42%), Gaps = 22/103 (21%)
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLD--DNEMVLVSDYGFSSLVAQPIAAQRMISY 439
LEY+H + +HG++K++N+LL+ + + V + DYG + + +
Sbjct: 164 ILEYIHEHE-------YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE-GVHKAYAA 215
Query: 440 KS-------PEYQS-----SKKISRKSDVWSFGCLLLELLTGR 470
E+ S SR+ D+ G +++ LTG
Sbjct: 216 DPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 19/103 (18%), Positives = 38/103 (36%), Gaps = 7/103 (6%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMN--FSSNHKLKDIDLSGNKFYGEISRSLLS-L 92
I+ AF+ +L I N + FS+ KL +I + I+ L
Sbjct: 44 VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNL 103
Query: 93 KFLESLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIP 132
L+ L + N + +P+ + + ++ +N +I
Sbjct: 104 PNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIE 145
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 32/124 (25%), Positives = 54/124 (43%), Gaps = 26/124 (20%)
Query: 363 NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL--DDNEMVLVSD 420
+ RS L VA + ALE+LH + +HGN+ + NI + +D V ++
Sbjct: 152 PKHVLSERSVLQVACRLLDALEFLHENE-------YVHGNVTAENIFVDPEDQSQVTLAG 204
Query: 421 YGFSSLVAQPIAAQRMISYKS---------PEYQS-----SKKISRKSDVWSFGCLLLEL 466
YGF+ + + + ++Y E+ S SR+SD+ S G +L+
Sbjct: 205 YGFAF---RYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKW 261
Query: 467 LTGR 470
L G
Sbjct: 262 LYGF 265
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 7/96 (7%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISR--SLLSLK 93
E + A E + ++ I S+ K + LS N I + SL ++
Sbjct: 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNN----IEKISSLSGME 70
Query: 94 FLESLQLQNNNLTGPVP-EFNQSSLKVFNVSNNNLS 128
L L L N + + +L+ +S N ++
Sbjct: 71 NLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA 106
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 24/112 (21%), Positives = 40/112 (35%), Gaps = 17/112 (15%)
Query: 28 LEDMRLNG----EIKSDAFADIPELIVINFKNNIIS----GNFMNFSSNHKLKDIDLSGN 79
L+ + L + D F D+ L + N IS F S L + L N
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS---LDRLLLHQN 187
Query: 80 KFYGEISRSLLS-LKFLESLQLQNNNLTGPVPE--FNQ-SSLKVFNVSNNNL 127
+ + L L +L L NNL+ +P +L+ +++N
Sbjct: 188 RV-AHVHPHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 19/105 (18%), Positives = 42/105 (40%), Gaps = 13/105 (12%)
Query: 36 EIKSDAFADIPELIVINFKNNIIS----GNFMNFSSNHKLKDIDLSGNKFYGEISRSLLS 91
+ + +F L ++ +N+++ F + L+ +DLS N + +
Sbjct: 46 HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL---LEQLDLSDNAQLRSVDPATFH 102
Query: 92 -LKFLESLQLQNNNLTGPVPE--F-NQSSLKVFNVSNNNLSGSIP 132
L L +L L L + F ++L+ + +N L ++P
Sbjct: 103 GLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALP 145
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 26/103 (25%), Positives = 43/103 (41%), Gaps = 22/103 (21%)
Query: 382 ALEYLHHKDKSRTQSAVIHGNLKSTNILLD--DNEMVLVSDYGFSSLVAQPIAAQRMISY 439
LEY+H + +HG++K+ N+LL + + V ++DYG S +
Sbjct: 163 VLEYIHENE-------YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN-GNHKQYQE 214
Query: 440 KS-------PEYQS-----SKKISRKSDVWSFGCLLLELLTGR 470
E+ S +SR+SDV G +L L G+
Sbjct: 215 NPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 28/96 (29%), Positives = 52/96 (54%), Gaps = 14/96 (14%)
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAA--QRMIS 438
+ LEYLH ++H +LK N+LLD+N ++ ++D+G + P A ++++
Sbjct: 123 QGLEYLHQH-------WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT 175
Query: 439 --YKSPE--YQSSKKISRKSDVWSFGCLLLELLTGR 470
Y++PE + + + D+W+ GC+L ELL
Sbjct: 176 RWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRV 210
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 582 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.82 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.74 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.73 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.71 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.7 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.7 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.7 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.68 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.63 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.58 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.56 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.55 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.53 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.53 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.53 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.51 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.5 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.5 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.49 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.49 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.49 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.49 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.48 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.48 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.47 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.47 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.46 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.46 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.46 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.45 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.45 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.45 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.44 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.43 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.43 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.43 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.43 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.42 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.42 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.42 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.41 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.41 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.41 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.41 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.41 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.41 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.4 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.4 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.39 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.39 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.39 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.39 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.39 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.38 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.38 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.37 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.37 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.37 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.37 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.37 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.37 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.37 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.36 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.36 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.36 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.35 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.35 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.35 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.34 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.34 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.34 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.33 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.33 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.33 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.32 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.31 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.31 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.31 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.3 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.3 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.3 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.3 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.29 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.29 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.28 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.27 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.27 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.27 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.27 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.26 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.26 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.26 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.25 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.24 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.24 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.24 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.23 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.22 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.22 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.22 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.21 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.21 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.2 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.2 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.2 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.19 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.19 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.18 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.18 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.17 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.16 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.16 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.14 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.14 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.1 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.09 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.06 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.04 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.03 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.02 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.84 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.78 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.67 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.6 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.53 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.42 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.39 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.33 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.19 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.17 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.09 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.88 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.85 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.84 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.81 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.72 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.71 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.64 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.6 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.6 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.5 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.4 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.12 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.05 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.99 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.97 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.82 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.72 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.45 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.27 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.17 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.87 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.79 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.61 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.5 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 95.39 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.29 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 94.89 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 94.8 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.57 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.64 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 89.6 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 88.63 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.19 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 85.02 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 80.62 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 80.01 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-55 Score=445.39 Aligned_cols=254 Identities=21% Similarity=0.343 Sum_probs=204.6
Q ss_pred ccccccccCceEEEEEEEc------CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 272 PAEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
..+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3578999999999999875 4678999999877666778899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCC---------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCce
Q 047954 346 AGNGNLFNRIHGGKSS---------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMV 416 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~ 416 (582)
|++|+|.++++..... ....+++|.+++.|+.|||+||+|||+++ ||||||||+||||++++.+
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-------iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-------FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEEETTTEE
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC-------eecccccHhhEEECCCCcE
Confidence 9999999999865321 11236999999999999999999999988 9999999999999999999
Q ss_pred EEeeccccccccCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHH
Q 047954 417 LVSDYGFSSLVAQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWV 489 (582)
Q Consensus 417 kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 489 (582)
||+|||+|+.+... ....+|+.|||||++.+..|+.++|||||||+||||+| |+.||... ...++...+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~----~~~~~~~~i 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL----SNTEAIDCI 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS----CHHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC----CHHHHHHHH
Confidence 99999999876432 22347889999999999999999999999999999999 89999643 223333333
Q ss_pred HHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 490 LRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 490 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
.. +...+.. .....++.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 274 ~~----g~~~~~p----------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQ----GRELERP----------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HH----TCCCCCC----------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred Hc----CCCCCCc----------ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 22 2111111 11123678899999999999999999999999988653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=442.39 Aligned_cols=253 Identities=20% Similarity=0.361 Sum_probs=207.0
Q ss_pred ccccccccCceEEEEEEEc------CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 272 PAEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
..+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..++||||
T Consensus 17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence 3578999999999999864 4678999999877666778899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCC-------CCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEE
Q 047954 346 AGNGNLFNRIHGGKS-------SKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLV 418 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl 418 (582)
|++|+|.++++.... ......++|.+++.|+.|||+||+|||+++ ||||||||+|||+++++.+||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-------iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH-------FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECGGGCEEE
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------cccCccCHhhEEECCCCcEEE
Confidence 999999999976431 112346999999999999999999999998 999999999999999999999
Q ss_pred eeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHH
Q 047954 419 SDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLR 491 (582)
Q Consensus 419 ~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 491 (582)
+|||+|+...... ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||... ...++...+..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~----~~~~~~~~i~~ 245 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL----SNNEVIECITQ 245 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS----CHHHHHHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHc
Confidence 9999998764332 2246789999999999999999999999999999999 89999643 22333333322
Q ss_pred HHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 492 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
+...... .....++.+|+.+||+.||++||||+||++.|+.+..
T Consensus 246 ----~~~~~~p----------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 246 ----GRVLQRP----------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp ----TCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCC----------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2111111 1122367889999999999999999999999988764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-55 Score=439.56 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=205.1
Q ss_pred cccccccCceEEEEEEEc------CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||+||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..++||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 467999999999999873 45789999997543 34567899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCC----------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc
Q 047954 346 AGNGNLFNRIHGGKSS----------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM 415 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~ 415 (582)
|++|+|.++|+..... .....++|.+++.|+.|||+||+|||+++ ||||||||+||||++++.
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-------iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-------VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECGGGC
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCCCccccceEECCCCC
Confidence 9999999999754321 11235899999999999999999999998 999999999999999999
Q ss_pred eEEeeccccccccCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHH
Q 047954 416 VLVSDYGFSSLVAQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSW 488 (582)
Q Consensus 416 ~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 488 (582)
+||+|||+|+.+... ....+|+.|||||++.+..|+.++|||||||+||||+| |+.||... ...++...
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~----~~~~~~~~ 259 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY----SNQDVVEM 259 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC----CHHHHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC----CHHHHHHH
Confidence 999999999876432 22347789999999999999999999999999999999 89999643 22333333
Q ss_pred HHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 489 VLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 489 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
+ ..+...... ..+..++.+|+.+||+.||++||||.||+++|+...
T Consensus 260 i----~~~~~~~~p----------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 260 I----RNRQVLPCP----------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp H----HTTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred H----HcCCCCCCc----------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 2 222221111 122336889999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-54 Score=430.83 Aligned_cols=250 Identities=25% Similarity=0.465 Sum_probs=197.6
Q ss_pred ccccccccCceEEEEEEEcCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
..+.||+|+||+||+|++.+ .||||+++... ....+.|.+|+.+|++++|||||+++|+|. .+..+||||||++|
T Consensus 40 l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gG 116 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGS 116 (307)
T ss_dssp EEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSC
T ss_pred EeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCC
Confidence 35789999999999998754 59999986433 344578999999999999999999999885 45689999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.++++... ..++|.+++.|+.|||.||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 117 sL~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~-------IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 117 SLYKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHAKN-------IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp BHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHTT-------CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred CHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999997543 25899999999999999999999988 99999999999999999999999999987643
Q ss_pred c------ccccccccccCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 430 P------IAAQRMISYKSPEYQSS---KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 430 ~------~~~~~~~~y~aPE~~~~---~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
. ....||+.|||||++.+ ..|+.++|||||||+||||+||+.||.... .. ..+...+.......
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~----~~---~~~~~~~~~~~~~p 257 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN----NR---DQIIFMVGRGYASP 257 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC----CH---HHHHHHHHTTCCCC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC----hH---HHHHHHHhcCCCCC
Confidence 2 23358899999999853 468999999999999999999999996432 11 12222222221111
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
... ........++.+|+.+||+.||++||||.||+++|+.++.
T Consensus 258 ~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 258 DLS------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CST------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred Ccc------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 000 0111223367889999999999999999999999998864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-53 Score=430.00 Aligned_cols=247 Identities=26% Similarity=0.438 Sum_probs=198.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+.+|++++|||||++++++.+++..|||||||++|
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg 108 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 467999999999999964 6889999999654 3334578999999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++...+. ..+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 109 ~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~~~-------IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 109 DLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHDRK-------ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp BHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHTT-------CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred cHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999975432 25788899999999999999999998 99999999999999999999999999998765
Q ss_pred cc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 PI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
.. ...||+.|||||++.+..|+.++|||||||++|||+||+.||... + ..+.+......... .. ..
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~----~---~~~~~~~i~~~~~~-~~-~~- 247 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG----S---MKNLVLKIISGSFP-PV-SL- 247 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----S---HHHHHHHHHHTCCC-CC-CT-
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----C---HHHHHHHHHcCCCC-CC-Cc-
Confidence 32 235899999999999999999999999999999999999999642 2 22222222222221 11 11
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
....++.+|+.+||+.||++|||++|+++|.|..+
T Consensus 248 --------~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 248 --------HYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp --------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred --------cCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 11225778999999999999999999999876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=415.49 Aligned_cols=246 Identities=21% Similarity=0.347 Sum_probs=196.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEe----CCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFS----NDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~ 345 (582)
.+.||+|+||+||+|... ++..||+|++... .....+.|.+|+++|++++|||||+++++|.+ ....+|||||
T Consensus 31 ~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 356999999999999965 5778999998643 33445779999999999999999999999875 3457999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec-CCCceEEeecccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD-DNEMVLVSDYGFS 424 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DfG~a 424 (582)
|++|+|.+++.... .+++..+..|+.||+.||+|||++++ +||||||||+||||+ .++.+||+|||+|
T Consensus 111 ~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~~~-----~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 111 MTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTRTP-----PIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp CCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTSSS-----CCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCC-----CEEecccChhheeEECCCCCEEEEeCcCC
Confidence 99999999997532 58899999999999999999999863 499999999999998 4789999999999
Q ss_pred ccccCc--ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 425 SLVAQP--IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 425 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
+..... ....||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ... .+...+.....+..+
T Consensus 180 ~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~---~~~----~~~~~i~~~~~~~~~ 251 (290)
T 3fpq_A 180 TLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ---NAA----QIYRRVTSGVKPASF 251 (290)
T ss_dssp GGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS---SHH----HHHHHHTTTCCCGGG
T ss_pred EeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC---cHH----HHHHHHHcCCCCCCC
Confidence 865443 23458999999998865 69999999999999999999999996421 111 122222222111111
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
+.. ...++.+|+.+||+.||++|||++|+++|.|.
T Consensus 252 ~~~---------~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 252 DKV---------AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp GGC---------CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred Ccc---------CCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 111 11257789999999999999999999998774
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=426.66 Aligned_cols=245 Identities=22% Similarity=0.320 Sum_probs=204.1
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
+.||+|+||+||+|+.. +++.||||++........+.+.+|+.+|++++|||||+++++|.+++..|||||||++|+|.
T Consensus 80 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~ 159 (346)
T 4fih_A 80 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 159 (346)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHH
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHH
Confidence 56999999999999975 68899999997555555667899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc--
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP-- 430 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~-- 430 (582)
+++... .+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 160 ~~l~~~-------~l~e~~~~~~~~qi~~aL~ylH~~~-------IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 160 DIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQG-------VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp HHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred HHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-------cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999743 3889999999999999999999998 999999999999999999999999999877543
Q ss_pred --ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 431 --IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 431 --~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
....||+.|||||++.+..|+.++|||||||++|||++|+.||... ...++...+ ...........
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~~~~~~i----~~~~~~~~~~~---- 293 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----PPLKAMKMI----RDNLPPRLKNL---- 293 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHH----HHSSCCCCSCG----
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHHHHH----HcCCCCCCCcc----
Confidence 2345899999999999999999999999999999999999999642 222222222 22211111110
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.....++.+|+.+||+.||++|||++|+++|.|..+
T Consensus 294 ----~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 294 ----HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp ----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred ----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 011225778999999999999999999999988654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-53 Score=424.97 Aligned_cols=266 Identities=18% Similarity=0.241 Sum_probs=198.1
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCC----eeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND----EKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv~e~~~~ 348 (582)
.+.||+|+||+||+|++ .++.||||++.... .....+..|+..+.+++|||||+++|+|..++ ..+||||||++
T Consensus 8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 46899999999999998 46789999996432 12223345666677899999999999998764 57999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCC-CCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS-RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
|+|.++++.. .++|..+++++.|+|+||+|||+++.. ...++||||||||+||||+.++.+||+|||+|+..
T Consensus 86 gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 86 GSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999753 488999999999999999999987200 00234999999999999999999999999999876
Q ss_pred cCcc--------cccccccccCCCCCCCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-------CccchH
Q 047954 428 AQPI--------AAQRMISYKSPEYQSSK------KISRKSDVWSFGCLLLELLTGRISTHSAPQGI-------NGADLC 486 (582)
Q Consensus 428 ~~~~--------~~~~~~~y~aPE~~~~~------~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~-------~~~~~~ 486 (582)
.... ...||+.|||||++.+. .++.++|||||||+||||+||+.||....... ......
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 4322 23478999999998764 36789999999999999999988775322110 011112
Q ss_pred HHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 487 SWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 487 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
..+......+ ..++.++......+....+.+|+.+||+.||++||||.||++.|+.+.+.+
T Consensus 239 ~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 239 EEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 2222222221 112222212223345567889999999999999999999999999987544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=427.02 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=204.8
Q ss_pred ccccccccCceEEEEEEEcC------CceEEEEEecCCC-cchHHHHHHHHHHHhcCCC-CCccccceEEEeC-CeeEEE
Q 047954 272 PAEGLGKGIFGNSYKALLEG------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKH-PNLLPLLAYYFSN-DEKLLV 342 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~-~~~~lv 342 (582)
..+.||+|+||+||+|.+.+ ++.||||+++... ....+.|.+|+++|.+++| ||||+++|+|... +..++|
T Consensus 68 l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV 147 (353)
T 4ase_A 68 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 147 (353)
T ss_dssp EEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred EeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEE
Confidence 35789999999999998654 2579999997543 3345679999999999966 8999999999765 568999
Q ss_pred EEeCCCCChHHHHhcCCCC----------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC
Q 047954 343 YKFAGNGNLFNRIHGGKSS----------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD 412 (582)
Q Consensus 343 ~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~ 412 (582)
||||++|+|.++|+..... .....+++..++.|+.|||+||+|||+++ ||||||||+|||+++
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~-------iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-------CIHRDLAARNILLSE 220 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECG
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC-------eecCccCccceeeCC
Confidence 9999999999999764321 11235899999999999999999999998 999999999999999
Q ss_pred CCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccch
Q 047954 413 NEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADL 485 (582)
Q Consensus 413 ~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~ 485 (582)
++.+||+|||+|+.+.... ...+|+.|||||++.+..|+.++|||||||+||||+| |+.||..... ...
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~---~~~- 296 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DEE- 296 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---SHH-
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH---HHH-
Confidence 9999999999998764432 2346788999999999999999999999999999998 9999964321 122
Q ss_pred HHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 486 CSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 486 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
+...+..+......+ ....++.+++.+||+.||++||||.||+++|+.+.+..
T Consensus 297 ---~~~~i~~g~~~~~p~----------~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 297 ---FCRRLKEGTRMRAPD----------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp ---HHHHHHHTCCCCCCT----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---HHHHHHcCCCCCCCc----------cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 223333322222111 11236788999999999999999999999999886543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=421.89 Aligned_cols=243 Identities=20% Similarity=0.235 Sum_probs=198.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.++||+|+||+||+|+.. +++.||||+++.... ..+|+.++++++|||||++++++.+++..|||||||++|+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 467999999999999964 578999999975332 24699999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC-ceEEeeccccccccCc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE-MVLVSDYGFSSLVAQP 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfG~a~~~~~~ 430 (582)
.++++... .+++..+..|+.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+...
T Consensus 138 ~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~~-------IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 138 GQLIKQMG------CLPEDRALYYLGQALEGLEYLHTRR-------ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp HHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTTT-------EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred HHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99997532 5899999999999999999999998 99999999999999987 5999999999876532
Q ss_pred c---------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 431 I---------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 431 ~---------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
. ...||+.|||||++.+..|+.++|||||||++|||+||+.||..... ..+...+.. ......-
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~i~~---~~~~~~~ 277 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR----GPLCLKIAS---EPPPIRE 277 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC----SCCHHHHHH---SCCGGGG
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH----HHHHHHHHc---CCCCchh
Confidence 1 23589999999999999999999999999999999999999975432 223332221 1110000
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
+. ......+.+++.+||++||++|||+.|++++|.....
T Consensus 278 ~~---------~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 278 IP---------PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp SC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cC---------ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 01 1112357789999999999999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=427.56 Aligned_cols=246 Identities=22% Similarity=0.318 Sum_probs=204.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||+||+|+.. +++.||||++........+.+.+|+.+|++++|||||+++++|.+.+..|||||||++|+|
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L 235 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence 357999999999999965 6889999999766555667799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++... .+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 236 ~~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~~~-------IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 236 TDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQG-------VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp HHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred HHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHCC-------eecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999743 3889999999999999999999998 999999999999999999999999999877543
Q ss_pred ---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 431 ---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
....||+.|||||++.+..|+.++|||||||++|||++|+.||... ...++...+ ..........
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~~~~~~i----~~~~~~~~~~---- 369 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----PPLKAMKMI----RDNLPPRLKN---- 369 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHH----HHSCCCCCSC----
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHHHHH----HcCCCCCCcc----
Confidence 2345889999999999999999999999999999999999999642 222222222 2221111111
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.. ....++.+|+.+||..||++|||+.|+++|.|..+
T Consensus 370 -~~---~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 370 -LH---KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp -TT---SSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred -cc---cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 00 11125778999999999999999999999987654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=410.31 Aligned_cols=240 Identities=22% Similarity=0.346 Sum_probs=198.1
Q ss_pred ccccccccCceEEEEEEE-cCCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 272 PAEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
..+.||+|+||+||+|+. .+++.||||++... .....+.+.+|+++|++++|||||++++++.+++..|+|||||+
T Consensus 36 i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~ 115 (311)
T 4aw0_A 36 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 115 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 357899999999999996 46789999999642 22345779999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+
T Consensus 116 gG~L~~~i~~~~------~l~e~~~~~~~~qi~~al~ylH~~~-------IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 116 NGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGKG-------IIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp TEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------CccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 999999997532 4889999999999999999999998 999999999999999999999999999877
Q ss_pred cCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 428 AQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 428 ~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
... ....||+.|||||++.+..|+.++||||+||++|||+||+.||... +..++...+ ..... ++
T Consensus 183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~~~~~~i---~~~~~--~~ 253 (311)
T 4aw0_A 183 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NEGLIFAKI---IKLEY--DF 253 (311)
T ss_dssp CTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHH---HHTCC--CC
T ss_pred CCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHH---HcCCC--CC
Confidence 432 2335899999999999999999999999999999999999999642 222222222 22211 11
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHH
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSE 543 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 543 (582)
...+ ..++.+|+.+||+.||++|||++|++.+
T Consensus 254 -p~~~---------s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 254 -PEKF---------FPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp -CTTC---------CHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred -Cccc---------CHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 1111 1257789999999999999999986443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=398.43 Aligned_cols=241 Identities=21% Similarity=0.307 Sum_probs=187.7
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..|+||||+ +
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~ 96 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G 96 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-C
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-C
Confidence 46799999999999995 468899999996432 334567999999999999999999999999999999999999 6
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 97 g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~~-------IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 97 NELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRHK-------IVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------cccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 89999997542 5899999999999999999999998 9999999999999999999999999998765
Q ss_pred Cc---ccccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP---IAAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~---~~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.. ....||+.|||||++.+..| +.++||||+||++|||+||+.||... ....+.+.+. ... . .+ ..
T Consensus 164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~----~~~~~~~~i~---~~~-~-~~-p~ 233 (275)
T 3hyh_A 164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE----SIPVLFKNIS---NGV-Y-TL-PK 233 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHH---HTC-C-CC-CT
T ss_pred CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHH---cCC-C-CC-CC
Confidence 43 23458999999999998876 58999999999999999999999642 1222222221 111 1 00 11
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
. ...++.+|+.+||+.||++|||++|+++|.|.
T Consensus 234 ~---------~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 234 F---------LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp T---------SCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred C---------CCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 1 11257789999999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-51 Score=406.67 Aligned_cols=242 Identities=21% Similarity=0.333 Sum_probs=191.5
Q ss_pred cccccccCceEEEEEEEc----CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE----GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||+||+|+.. .++.||||+++... ......+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~ 108 (304)
T 3ubd_A 29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL 108 (304)
T ss_dssp EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCC
T ss_pred EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcC
Confidence 468999999999999863 46789999986432 223346889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|.+++.... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 109 ~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~~-------IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 109 RGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSLG-------IIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp TTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred CCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 9999999997532 5889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 427 VAQP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 427 ~~~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
.... ....||+.|||||++.+..|+.++||||+||++|||+||+.||... +..++...+. ... . ..
T Consensus 176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~----~~~~~~~~i~---~~~-~-~~- 245 (304)
T 3ubd_A 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK----DRKETMTMIL---KAK-L-GM- 245 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHH---HCC-C-CC-
T ss_pred ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc----CHHHHHHHHH---cCC-C-CC-
Confidence 5432 2345899999999999999999999999999999999999999642 2222222221 111 1 11
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHHhh
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSELEI 546 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~ 546 (582)
.. . ...++.+|+.+||+.||++||| ++|+++|.|.
T Consensus 246 p~------~---~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 246 PQ------F---LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp CT------T---SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred CC------c---CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 00 0 1125778999999999999998 4788888774
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=397.79 Aligned_cols=244 Identities=22% Similarity=0.319 Sum_probs=185.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCC------------e
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSND------------E 338 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------------~ 338 (582)
.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+ .
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~ 89 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence 367999999999999964 67899999986433 334567999999999999999999999987654 3
Q ss_pred eEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEE
Q 047954 339 KLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLV 418 (582)
Q Consensus 339 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl 418 (582)
.|+|||||++|+|.+++..... ....++..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~al~ylH~~~-------IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRCT---IEERERSVCLHIFLQIAEAVEFLHSKG-------LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCCS---GGGSCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTCCEEE
T ss_pred EEEEEecCCCCcHHHHHHhcCC---CChhHHHHHHHHHHHHHHHHHHHHHCc-------CccccCcHHHeEECCCCcEEE
Confidence 6899999999999999975432 123456678899999999999999998 999999999999999999999
Q ss_pred eeccccccccCcc----------------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 047954 419 SDYGFSSLVAQPI----------------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGING 482 (582)
Q Consensus 419 ~DfG~a~~~~~~~----------------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~ 482 (582)
+|||+|+.+.... ...||+.|||||++.+..|+.++|||||||++|||++ ||.. .
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~------~ 230 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST------Q 230 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS------H
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC------c
Confidence 9999998765421 1248899999999999999999999999999999996 7742 1
Q ss_pred cchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 483 ADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.+....+... .....+. ........+.+|+.+||+.||++|||+.|+++|.+.
T Consensus 231 ~~~~~~~~~~-~~~~~p~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~ 283 (299)
T 4g31_A 231 MERVRTLTDV-RNLKFPP----------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283 (299)
T ss_dssp HHHHHHHHHH-HTTCCCH----------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred cHHHHHHHHH-hcCCCCC----------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 1111111111 1111111 111222346679999999999999999999987653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=389.31 Aligned_cols=257 Identities=19% Similarity=0.284 Sum_probs=196.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeC------CeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN------DEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~ 343 (582)
.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+++|++++|||||++++++... +..||||
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivm 138 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 138 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEE
Confidence 468999999999999964 68899999997543 23446788999999999999999999988643 5689999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
|||. |+|.+++... ..+++..+..|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 139 E~~~-g~L~~~i~~~------~~l~~~~~~~~~~qil~al~ylH~~~-------iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 139 DLME-SDLHQIIHSS------QPLTLEHVRYFLYQLLRGLKYMHSAQ-------VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp ECCS-EEHHHHHTSS------SCCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred eCCC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCc-------CcCCCcCccccccCCCCCEEEeecce
Confidence 9995 7899999643 25899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCc--------ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 424 SSLVAQP--------IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 424 a~~~~~~--------~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
|+.+... ....||+.|||||++.+. .++.++||||+||++|||++|+.||... +..+....+.....
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~----~~~~~l~~I~~~~g 280 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK----NYVHQLQLIMMVLG 280 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS----SHHHHHHHHHHHHC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC----CHHHHHHHHHHhcC
Confidence 9876432 234588999999998775 5699999999999999999999999643 22223332222211
Q ss_pred hcccccccch---------------hh--hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 495 EEWTAEIFDS---------------EI--SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 495 ~~~~~~~~d~---------------~~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
... .+.... .. ...........++.+|+.+||..||++|||++|+++|.|.-.
T Consensus 281 ~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 281 TPS-PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp CCC-GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred CCC-hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 100 000000 00 000000011235778999999999999999999999988654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=383.70 Aligned_cols=253 Identities=15% Similarity=0.248 Sum_probs=192.5
Q ss_pred cccccccCceEEEEEEEc----CCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE----GRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|.++ +|||||++++++.+.+..++|||||+
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~ 103 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLE 103 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCC
Confidence 467999999999999853 45789999986543 345688999999988 69999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC-CceEEeecccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN-EMVLVSDYGFSSL 426 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DfG~a~~ 426 (582)
+|+|.+++. .+++.++..++.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||+|+.
T Consensus 104 g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~g-------IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 104 HESFLDILN---------SLSFQEVREYMLNLFKALKRIHQFG-------IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp CCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred cccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999984 3788899999999999999999998 9999999999999876 7999999999975
Q ss_pred ccCcc--------------------------------cccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 047954 427 VAQPI--------------------------------AAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRIST 473 (582)
Q Consensus 427 ~~~~~--------------------------------~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~ 473 (582)
..... ...||+.|+|||++.+. .|+.++||||+||++|||+||+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 43211 12478999999998775 5899999999999999999999999
Q ss_pred CCCCCCCCccchHHHHHHHHhhc--------ccc------ccc--------------c---hhhh--------hhhchHH
Q 047954 474 HSAPQGINGADLCSWVLRAVREE--------WTA------EIF--------------D---SEIS--------VQRSAAH 514 (582)
Q Consensus 474 ~~~~~~~~~~~~~~~~~~~~~~~--------~~~------~~~--------------d---~~~~--------~~~~~~~ 514 (582)
.... +..+....+....... ... +.. + +... .......
T Consensus 248 ~~~~---~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 248 YKAS---DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SCCS---SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCC---CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 6432 2222222221111000 000 000 0 0000 0000001
Q ss_pred HHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 515 GMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 515 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
...++.+|+.+||+.||++|||++|+++|.|.
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 12357789999999999999999999999774
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=402.77 Aligned_cols=248 Identities=19% Similarity=0.313 Sum_probs=203.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... +++.||+|++........+.+.+|+.+|++++|||||+++++|.+....++|||||++|+|
T Consensus 162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L 241 (573)
T 3uto_A 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241 (573)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcH
Confidence 567999999999999964 6889999999776666677899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC--CceEEeeccccccccC
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN--EMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~--~~~kl~DfG~a~~~~~ 429 (582)
.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 242 ~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~-------iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 242 FEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHENN-------YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp HHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred HHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99996432 24899999999999999999999998 9999999999999854 7899999999998765
Q ss_pred cc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 430 PI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 ~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.. ...||+.|||||++.+..|+.++||||+||++|||++|+.||... ...+... ......+. ..+...
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~----~~~~~~~---~i~~~~~~--~~~~~~ 380 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE----NDDETLR---NVKSCDWN--MDDSAF 380 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHHH---HHHTTCCC--CCSGGG
T ss_pred CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHHH---HHHhCCCC--CCcccc
Confidence 43 335889999999999999999999999999999999999999643 2222222 22221111 001100
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.....++.+|+.+||+.||++|||+.|+++|.|.-
T Consensus 381 ------~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~ 415 (573)
T 3uto_A 381 ------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415 (573)
T ss_dssp ------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTS
T ss_pred ------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcC
Confidence 01112577899999999999999999999998744
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=368.98 Aligned_cols=268 Identities=29% Similarity=0.513 Sum_probs=221.9
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 46799999999999998889999999988766667788999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc--
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP-- 430 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~-- 430 (582)
+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 124 ~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~-------ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 124 RHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHTRA-------IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194 (321)
T ss_dssp GGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred HHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcCCC-------eecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99865432 2235899999999999999999999998 999999999999999999999999999765322
Q ss_pred ----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 431 ----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 431 ----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
....++..|+|||++.+..++.++|||||||++|||+||+.||...... .......|.............+++..
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS-SCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH-HHHHHHHHhhhccccccHHHhcChhh
Confidence 1233678899999998889999999999999999999999999764432 33345555544444444444444433
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
. .....+....+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 274 ~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 274 A-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp T-TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred c-cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 2 1223456678999999999999999999999999999886543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=395.78 Aligned_cols=245 Identities=20% Similarity=0.239 Sum_probs=194.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHH---HHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITE---EFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~---~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||+||+|+.. +++.||||++.... ..... ..+.++.+++.++|||||+++++|.+.+..|+||||
T Consensus 194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy 273 (689)
T 3v5w_A 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 273 (689)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence 478999999999999965 58899999985321 11122 233456777888999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
|+||+|.+++.... .+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 274 ~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~~g-------IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 274 MNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNRF-------VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp CCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHTTT-------EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999997532 4889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCc--ccccccccccCCCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 426 LVAQP--IAAQRMISYKSPEYQS-SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 426 ~~~~~--~~~~~~~~y~aPE~~~-~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
.+... ....||+.|||||++. +..|+.++||||+||++|||++|+.||..... .+............ . .+.
T Consensus 341 ~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~----~~~~~i~~~i~~~~-~-~~p 414 (689)
T 3v5w_A 341 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEIDRMTLTMA-V-ELP 414 (689)
T ss_dssp ECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC----CCHHHHHHHHHHCC-C-CCC
T ss_pred ecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhhcCCC-C-CCC
Confidence 77543 3456899999999986 45799999999999999999999999964321 11211111111111 0 110
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHHhh
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSELEI 546 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~ 546 (582)
.. ...++.+|+.+||..||++|++ ++||++|.|.
T Consensus 415 -~~---------~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF 453 (689)
T 3v5w_A 415 -DS---------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453 (689)
T ss_dssp -TT---------SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred -cc---------CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence 00 1125778999999999999998 7999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=368.32 Aligned_cols=285 Identities=33% Similarity=0.503 Sum_probs=225.0
Q ss_pred CCCChhHhhhcc-----cccccccCceEEEEEEEcCCceEEEEEecCCCc-chHHHHHHHHHHHhcCCCCCccccceEEE
Q 047954 261 AGFKLNDLLKAP-----AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKP-LITEEFRKQLLVIADQKHPNLLPLLAYYF 334 (582)
Q Consensus 261 ~~~~~~~l~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 334 (582)
..|++.++..+. .+.||+|+||.||+|...+++.||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 456677776654 367999999999999988899999999975432 22336899999999999999999999999
Q ss_pred eCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC
Q 047954 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE 414 (582)
Q Consensus 335 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~ 414 (582)
.....++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+.. .++|+||||||+|||++.++
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~----~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLHDHC----DPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTT--CCCCCHHHHHHHHHHHHHHHHHHHHSS----SSCEECCCCSGGGEEECTTC
T ss_pred cCCceEEEEEeccCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCC----CCCeEeCCCchhhEEECCCC
Confidence 999999999999999999999865432 345899999999999999999999982 11299999999999999999
Q ss_pred ceEEeeccccccccCcc-----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-CCCccchHHH
Q 047954 415 MVLVSDYGFSSLVAQPI-----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQ-GINGADLCSW 488 (582)
Q Consensus 415 ~~kl~DfG~a~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~-~~~~~~~~~~ 488 (582)
.+||+|||+++...... ...+++.|+|||++.+..++.++|||||||++|||+||+.||..... .........|
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 99999999998764321 23378899999999888899999999999999999999999963211 1123344555
Q ss_pred HHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 489 VLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 489 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
+...........+.+.... ..........+.+++.+||+.||++|||+.||+++|+.....+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~ 314 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAER 314 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSS
T ss_pred HHHHhhchhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhh
Confidence 5444444434444443332 22345566789999999999999999999999999998665543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=358.36 Aligned_cols=250 Identities=24% Similarity=0.412 Sum_probs=205.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 578999999999999975 5788999998776666778899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~-------ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 95 RGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSMN-------IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp HHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred HHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC-------ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999976432 4889999999999999999999998 9999999999999999999999999997764321
Q ss_pred ------------------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHH
Q 047954 432 ------------------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 432 ------------------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
...+|+.|+|||.+.+..++.++|||||||++|||++|..|+............ ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--~~~~~~ 240 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--NVRGFL 240 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--CHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--hhhccc
Confidence 234788899999999999999999999999999999999998654322111110 011111
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
....... ....+.+++.+||+.||++|||+.++++.|+.++..
T Consensus 241 ~~~~~~~--------------~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 241 DRYCPPN--------------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHTCCTT--------------CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCCCC--------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111 112577899999999999999999999999988743
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=354.82 Aligned_cols=246 Identities=23% Similarity=0.353 Sum_probs=201.9
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence 46799999999999985 56889999999765555677899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 105 TDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQ-------VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp HHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred HHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCC-------ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999753 3788999999999999999999998 999999999999999999999999998776543
Q ss_pred ---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 431 ---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
....+++.|+|||.+.+..++.++|||||||++|||+||+.||.... ............ ......+
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~~~~~~-~~~~~~~--- 239 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-------PLRALYLIATNG-TPELQNP--- 239 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHHC-SCCCSCG---
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCC-CCCCCCc---
Confidence 23357889999999999999999999999999999999999996421 111111111111 1111111
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
......+.+++.+||+.||++|||+.|+++|.+.-.
T Consensus 240 -----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 240 -----EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp -----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred -----cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 011225778999999999999999999999877543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=355.28 Aligned_cols=246 Identities=21% Similarity=0.314 Sum_probs=203.6
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
+.||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 130 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHH
Confidence 47999999999999976 68899999998666666788999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc--
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP-- 430 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~-- 430 (582)
+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 131 ~~l~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~-------ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 131 DIVSQV-------RLNEEQIATVCEAVLQALAYLHAQG-------VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp HHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred HHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence 998632 4889999999999999999999998 999999999999999999999999998776443
Q ss_pred --ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 431 --IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 431 --~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ ..........
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~----~~~~~~~~----~~~~~~~~~~----- 263 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS----PVQAMKRL----RDSPPPKLKN----- 263 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHH----HHSSCCCCTT-----
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH----hcCCCCCcCc-----
Confidence 23457889999999999999999999999999999999999996421 11121111 1111111110
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.. .....+.+++.+||+.||++|||+.|++++.+....
T Consensus 264 ~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 264 SH---KVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp GG---GSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred cc---cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 00 111257789999999999999999999999887653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=366.44 Aligned_cols=255 Identities=22% Similarity=0.376 Sum_probs=204.3
Q ss_pred ccccccccCceEEEEEEEc--------CCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEE
Q 047954 272 PAEGLGKGIFGNSYKALLE--------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLL 341 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 341 (582)
..+.||+|+||.||+|... ++..||||+++... ....+.+.+|+.+++++ +||||++++++|...+..++
T Consensus 85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence 3578999999999999863 34569999997543 23456789999999999 89999999999999999999
Q ss_pred EEEeCCCCChHHHHhcCCCC----------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSS----------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD 411 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~ 411 (582)
||||+++|+|.+++...... .....+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-------ivHrDlkp~NIll~ 237 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-------CIHRDLAARNVLVT 237 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCGGGEEEC
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-------eeccccchhhEEEC
Confidence 99999999999999865421 01234788999999999999999999998 99999999999999
Q ss_pred CCCceEEeeccccccccCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccc
Q 047954 412 DNEMVLVSDYGFSSLVAQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGAD 484 (582)
Q Consensus 412 ~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~ 484 (582)
.++.+||+|||+++..... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||... ...+
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~----~~~~ 313 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----PVEE 313 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CGGG
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC----CHHH
Confidence 9999999999999866432 22334578999999999999999999999999999999 99999643 2223
Q ss_pred hHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
+...+ ......... .....++.+++.+||+.||++|||+.|++++|+.+....
T Consensus 314 ~~~~~----~~~~~~~~~----------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 314 LFKLL----KEGHRMDKP----------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHH----HTTCCCCCC----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHH----hcCCCCCCC----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 32222 222111110 111235788999999999999999999999999886543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=355.05 Aligned_cols=254 Identities=27% Similarity=0.390 Sum_probs=196.3
Q ss_pred ccccccccCceEEEEEEEcCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
..+.||+|+||.||+|.. .+..||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 41 i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 3p86_A 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119 (309)
T ss_dssp EEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTC
T ss_pred eeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCC
Confidence 357899999999999987 56779999986543 233467899999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++..... ...+++..++.++.||+.||+|||+.++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~-----~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 120 SLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNRNP-----PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp BHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTSSS-----CCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCC-----CEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 99999975421 1248899999999999999999999863 499999999999999999999999999976543
Q ss_pred c----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 P----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
. ....++..|+|||.+.+..++.++|||||||++|||+||+.||.... .......+ ........+ ..
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~----~~~~~~~~---~~~~~~~~~-~~- 262 (309)
T 3p86_A 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN----PAQVVAAV---GFKCKRLEI-PR- 262 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC----HHHHHHHH---HHSCCCCCC-CT-
T ss_pred cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH---HhcCCCCCC-Cc-
Confidence 3 23457889999999999999999999999999999999999996421 11111111 111111111 00
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
....++.+++.+||+.||++|||+.++++.|+.+....
T Consensus 263 --------~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 263 --------NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp --------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred --------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 11125788999999999999999999999999887544
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=359.43 Aligned_cols=258 Identities=19% Similarity=0.235 Sum_probs=198.9
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCC----eeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND----EKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv~e~~~~ 348 (582)
.+.||+|+||+||+|+.. ++.||||++.... .....+..|+.++++++|||||++++++.... ..++||||+++
T Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 467999999999999876 6789999996432 23445667899999999999999999998754 36999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc----------CCCCCCCcceecCCCCCCeeecCCCceEE
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK----------DKSRTQSAVIHGNLKSTNILLDDNEMVLV 418 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~~~~~ivH~Dlkp~NILl~~~~~~kl 418 (582)
|+|.+++... .+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||
T Consensus 107 g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~-------ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 107 GSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA-------ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp CBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE-------EECSCCSGGGEEECTTCCEEE
T ss_pred CCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC-------EEeCCCChHhEEECCCCeEEE
Confidence 9999999753 388999999999999999999998 6 999999999999999999999
Q ss_pred eeccccccccCcc------cccccccccCCCCCCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccc---
Q 047954 419 SDYGFSSLVAQPI------AAQRMISYKSPEYQSSK-----KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD--- 484 (582)
Q Consensus 419 ~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~-----~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~--- 484 (582)
+|||+++...... ...+++.|+|||++.+. .++.++|||||||++|||+||+.||...........
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 9999997654322 23578899999998763 456789999999999999999999975432211000
Q ss_pred -----hHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 485 -----LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 485 -----~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
....+............+.. .........++.+++.+||+.||++|||+.||++.|+.++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRD----YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCG----GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccc----cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01111111111111111111 111223445688999999999999999999999999988653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=354.90 Aligned_cols=244 Identities=22% Similarity=0.352 Sum_probs=199.9
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~ 99 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence 46799999999999997 57889999998643 3344567889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~~-------ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 100 EVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQKR-------IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp BHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred cHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999996532 4888999999999999999999998 99999999999999999999999999976644
Q ss_pred c---ccccccccccCCCCCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 P---IAAQRMISYKSPEYQSSKKIS-RKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~---~~~~~~~~y~aPE~~~~~~~~-~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
. ....+++.|+|||++.+..++ .++||||+||++|||++|+.||... ....+.. ......... ..
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~---~i~~~~~~~---p~- 235 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ----NLKELRE---RVLRGKYRI---PF- 235 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHH---HHHHCCCCC---CT-
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC----CHHHHHH---HHHhCCCCC---CC-
Confidence 3 234578899999999887765 7999999999999999999999642 1122222 222211110 00
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
....++.+++.+||..||++|||++|+++|.|...
T Consensus 236 --------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 236 --------YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp --------TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred --------CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 01125778999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=346.55 Aligned_cols=246 Identities=25% Similarity=0.450 Sum_probs=203.1
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||+++|+|.
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence 46799999999999999888899999997543 34577999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc--
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP-- 430 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~-- 430 (582)
+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~-------i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 94 DYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEAC-------VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp HHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred HHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHhCC-------eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 99975432 4889999999999999999999998 999999999999999999999999999876443
Q ss_pred ---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 431 ---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..++...+ ....... .+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~----~~~~~~~~----~~~~~~~--~~~- 230 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDI----STGFRLY--KPR- 230 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHH----HTTCCCC--CCT-
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC----HHHHHHHH----hcCccCC--CCC-
Confidence 22334567999999988899999999999999999999 999996421 12222211 1111110 000
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.....+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 231 -------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 231 -------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 011257889999999999999999999999998864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=357.55 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=200.4
Q ss_pred cccccccCceEEEEEEEc----CCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE----GRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|... .+..||||+++.. .....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 133 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence 578999999999999974 3446999999754 33445679999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 134 ~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~-------ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 134 NGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSDLG-------YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp TCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCC-------eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999997543 24889999999999999999999998 999999999999999999999999999876
Q ss_pred cCcc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 428 AQPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 428 ~~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
.... ...+++.|+|||++.+..++.++|||||||++|||++ |+.||... ...++...+ ......
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~----~~~~~~~~~----~~~~~~ 273 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM----TNRDVISSV----EEGYRL 273 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS----CHHHHHHHH----HTTCCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC----CHHHHHHHH----HcCCCC
Confidence 4432 1223567999999988899999999999999999999 99999642 122222222 111111
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
.. . ......+.+++.+||..||++|||+.||++.|+.+...
T Consensus 274 ~~-~---------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 274 PA-P---------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CC-C---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CC-C---------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 10 0 01123678899999999999999999999999988753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=372.86 Aligned_cols=251 Identities=22% Similarity=0.399 Sum_probs=205.1
Q ss_pred ccccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
..+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|++++|||||++++++. .+..++||||+++|+|
T Consensus 192 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L 269 (454)
T 1qcf_A 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSL 269 (454)
T ss_dssp EEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcH
Confidence 357899999999999999888899999997643 45778999999999999999999999986 6678999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.++++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~-------ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 270 LDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQRN-------YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp HHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred HHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999974321 24778899999999999999999998 9999999999999999999999999998765432
Q ss_pred -----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 432 -----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 432 -----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
...++..|+|||++....++.++|||||||++|||+| |+.||... ...++...+. .......
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~----~~~~~~~~i~----~~~~~~~---- 406 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALE----RGYRMPR---- 406 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHHHHHHHH----HTCCCCC----
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC----CHHHHHHHHH----cCCCCCC----
Confidence 2234578999999988899999999999999999999 99999642 2223332222 2211110
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCC
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTEST 553 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 553 (582)
+.....++.+++.+||+.||++|||+++|++.|+.+......
T Consensus 407 ------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 407 ------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred ------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 011123678899999999999999999999999998765443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=348.63 Aligned_cols=272 Identities=27% Similarity=0.462 Sum_probs=212.3
Q ss_pred CCCChhHhhhccc-----------ccccccCceEEEEEEEcCCceEEEEEecCC----CcchHHHHHHHHHHHhcCCCCC
Q 047954 261 AGFKLNDLLKAPA-----------EGLGKGIFGNSYKALLEGRAPVVVKRLRDL----KPLITEEFRKQLLVIADQKHPN 325 (582)
Q Consensus 261 ~~~~~~~l~~~~~-----------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~H~n 325 (582)
..|++.++..++. +.||+|+||.||+|.. ++..||||++... .....+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 4566666666542 5799999999999986 5678999998643 2334678999999999999999
Q ss_pred ccccceEEEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCC
Q 047954 326 LLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKS 405 (582)
Q Consensus 326 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp 405 (582)
|+++++++...+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~-------i~H~dlkp 161 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHENH-------HIHRDIKS 161 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG---CCCCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCG
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCC-------eecCCCCH
Confidence 99999999999999999999999999999974322 235889999999999999999999998 99999999
Q ss_pred CCeeecCCCceEEeeccccccccCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 047954 406 TNILLDDNEMVLVSDYGFSSLVAQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQG 479 (582)
Q Consensus 406 ~NILl~~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~ 479 (582)
+|||++.++.+||+|||+++..... ....++..|+|||.+.+ .++.++||||||+++|||++|+.||......
T Consensus 162 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred HHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 9999999999999999998765432 12346789999998765 5899999999999999999999999754322
Q ss_pred CCccchHHHHHHHHhh-cccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 480 INGADLCSWVLRAVRE-EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 480 ~~~~~~~~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
. .+..+....... ....+.++..+ ..........+.+++.+||+.||++|||+.+|+++|+.+..
T Consensus 241 ~---~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 241 Q---LLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp S---BTTHHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred H---HHHHHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1 122221111111 11112222221 11233455678899999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=367.66 Aligned_cols=248 Identities=24% Similarity=0.408 Sum_probs=201.8
Q ss_pred ccccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 272 PAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
..+.||+|+||.||+|... ++..||||.++... ....+.|.+|+.++++++|||||++++++...+..++||||+++|
T Consensus 118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 3578999999999999986 67889999987542 233457889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 198 ~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~-------ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 198 DFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLESKC-------CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp BHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999997532 24888999999999999999999998 99999999999999999999999999986543
Q ss_pred cc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 430 PI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 430 ~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
.. ...++..|+|||.+.+..++.++|||||||++|||+| |+.||... ........+ .........
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~----~~~~~~~~~----~~~~~~~~~ 337 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL----SNQQTREFV----EKGGRLPCP 337 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS----CHHHHHHHH----HTTCCCCCC
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHH----HcCCCCCCC
Confidence 32 1123567999999988889999999999999999999 99998642 222222222 221111110
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.....++.+++.+||+.||++|||+.+|++.|+.++.
T Consensus 338 ----------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 338 ----------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 0112357889999999999999999999999998864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=349.56 Aligned_cols=256 Identities=22% Similarity=0.379 Sum_probs=200.1
Q ss_pred cccccccCceEEEEEEE-----cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALL-----EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~ 345 (582)
.+.||+|+||.||+|++ .++..||||++........+.+.+|+.++++++||||+++++++... ...++||||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 94 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 94 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEEC
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEe
Confidence 46799999999999985 35788999999876666667899999999999999999999998654 458999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-------ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 95 LPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTKR-------YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcCC-------cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 999999999976432 4889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCcc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------CCCccchHHHHH
Q 047954 426 LVAQPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQ--------GINGADLCSWVL 490 (582)
Q Consensus 426 ~~~~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~--------~~~~~~~~~~~~ 490 (582)
...... ...++..|+|||.+.+..++.++||||||+++|||+||..|+..... ..........+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 764432 22345679999999988999999999999999999999999864211 000111111111
Q ss_pred HHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 491 RAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 491 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
........... ......++.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 243 ~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 243 ELLKNNGRLPR----------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHTTCCCCC----------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhccCcCCC----------CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11111111110 111223688899999999999999999999999988643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=344.30 Aligned_cols=248 Identities=24% Similarity=0.419 Sum_probs=202.4
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..||+|+++... ...+.+.+|+.++.+++||||+++++++......++||||+++++|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 46799999999999999988899999997543 34577999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~-------i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 92 NYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLESHQ-------FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp HHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHTT-------EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred HHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9997542 24889999999999999999999998 9999999999999999999999999998664432
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
...++..|+|||.+.+..++.++||||||+++|||+| |+.||.... .... .... ...... ..+.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~---~~~~-~~~~~~--~~~~- 228 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT----NSEV---VLKV-SQGHRL--YRPH- 228 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC----HHHH---HHHH-HTTCCC--CCCT-
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC----hHHH---HHHH-HcCCCC--CCCC-
Confidence 2234567999999988889999999999999999999 999996422 1111 1111 111110 0000
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
.....+.+++.+||+.||++|||+.|++++|+.++...
T Consensus 229 -------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 229 -------LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp -------TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred -------cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 01125788999999999999999999999999987643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=345.62 Aligned_cols=248 Identities=23% Similarity=0.409 Sum_probs=200.9
Q ss_pred ccccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
..+.||+|+||.||+|...++..||+|+++... ...+.+.+|++++.+++||||+++++++......++||||+++|+|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (283)
T 3gen_A 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106 (283)
T ss_dssp EEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBH
T ss_pred hHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcH
Confidence 357899999999999999988899999997543 3457799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 107 ~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~-------i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 107 LNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESKQ-------FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp HHHHHCGG-----GCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred HHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC-------ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99997532 24889999999999999999999998 999999999999999999999999999876443
Q ss_pred ----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 431 ----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 431 ----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.... .......+ ....... ...
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~----~~~~~~~~----~~~~~~~-~~~- 244 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT----NSETAEHI----AQGLRLY-RPH- 244 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC----HHHHHHHH----HTTCCCC-CCT-
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC----hhHHHHHH----hcccCCC-CCC-
Confidence 22335577999999988899999999999999999999 999996422 11222111 1111100 000
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
.....+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 245 --------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 245 --------LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 0112577899999999999999999999999988643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=346.78 Aligned_cols=250 Identities=20% Similarity=0.305 Sum_probs=192.6
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhc--CCCCCccccceEEEeC----CeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIAD--QKHPNLLPLLAYYFSN----DEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~----~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|+. +++.||||++.. ...+.+..|.+++.. ++||||+++++++... ...++||||+
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred EEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 46799999999999987 578899999854 234556667776665 8999999999997653 4578999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHh--------ccCCCCCCCcceecCCCCCCeeecCCCceEE
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH--------HKDKSRTQSAVIHGNLKSTNILLDDNEMVLV 418 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl 418 (582)
++|+|.++++.. .+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 89 ~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-------ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 89 EMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA-------IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE-------EECSCCCGGGEEECTTSCEEE
T ss_pred cCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC-------eecCCCChHhEEEcCCCCEEE
Confidence 999999999532 4889999999999999999999 665 999999999999999999999
Q ss_pred eeccccccccCcc--------cccccccccCCCCCCCC------CCCcchhHHHHHHHHHHHHhC----------CCCCC
Q 047954 419 SDYGFSSLVAQPI--------AAQRMISYKSPEYQSSK------KISRKSDVWSFGCLLLELLTG----------RISTH 474 (582)
Q Consensus 419 ~DfG~a~~~~~~~--------~~~~~~~y~aPE~~~~~------~~~~k~DVwS~Gvvl~elltG----------~~P~~ 474 (582)
+|||+++...... ...+|+.|+|||.+.+. .++.++|||||||++|||+|| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999997654332 12578899999998876 455799999999999999999 77876
Q ss_pred CCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 475 SAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
...... .....+.......... +.............++.+++.+||+.||++|||+.||++.|+.+
T Consensus 235 ~~~~~~---~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPND---PSFEDMRKVVCVDQQR----PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSS---CCHHHHHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCC---cchhhhhHHHhccCCC----CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 543221 1112222222111111 11111112223455788999999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=359.45 Aligned_cols=259 Identities=23% Similarity=0.384 Sum_probs=207.3
Q ss_pred ccccccccCceEEEEEEEc--------CCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEE
Q 047954 272 PAEGLGKGIFGNSYKALLE--------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLL 341 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 341 (582)
..+.||+|+||.||+|... .+..||||+++... ....+.+.+|+++++++ +|||||++++++...+..++
T Consensus 73 i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 152 (382)
T 3tt0_A 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 152 (382)
T ss_dssp EEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEE
Confidence 4578999999999999863 23569999997543 33456789999999999 99999999999999999999
Q ss_pred EEEeCCCCChHHHHhcCCCC----------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSS----------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD 411 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~ 411 (582)
||||+++|+|.+++...... .....+++..++.|+.||+.||+|||+.+ |+||||||+|||++
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-------CIHRDLAARNVLVT 225 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEEC
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-------EecCCCCcceEEEc
Confidence 99999999999999865421 11235899999999999999999999998 99999999999999
Q ss_pred CCCceEEeeccccccccCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccc
Q 047954 412 DNEMVLVSDYGFSSLVAQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGAD 484 (582)
Q Consensus 412 ~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~ 484 (582)
.++.+||+|||+++..... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||... ...+
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~----~~~~ 301 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV----PVEE 301 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----CHHH
Confidence 9999999999999876432 22335678999999999999999999999999999999 99999642 1122
Q ss_pred hHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCCcc
Q 047954 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEE 555 (582)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 555 (582)
+. ..+.......... ....++.+++.+||+.||++|||+.||+++|+.+......++
T Consensus 302 ~~----~~~~~~~~~~~~~----------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 302 LF----KLLKEGHRMDKPS----------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HH----HHHHTTCCCCCCS----------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HH----HHHHcCCCCCCCc----------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 22 2222221111110 112257889999999999999999999999999986665444
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=374.36 Aligned_cols=251 Identities=29% Similarity=0.457 Sum_probs=206.4
Q ss_pred ccccccccCceEEEEEEEcC-CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 272 PAEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
..+.||+|+||.||+|.+.. +..||||.++... ...+.|.+|+.+|++++|||||+++++|......++||||+++|+
T Consensus 224 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~ 302 (495)
T 1opk_A 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 302 (495)
T ss_dssp EEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred eeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCC
Confidence 45789999999999999875 7789999997543 346789999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 303 L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~-------ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 303 LLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKN-------FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp HHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred HHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999976432 25889999999999999999999998 999999999999999999999999999876443
Q ss_pred c-----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 431 I-----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 431 ~-----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
. ...+++.|+|||++.+..++.++|||||||++|||+| |+.||... ....+...+ .........
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~----~~~~~~~~~----~~~~~~~~~-- 441 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELL----EKDYRMERP-- 441 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC----CGGGHHHHH----HTTCCCCCC--
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC----CHHHHHHHH----HcCCCCCCC--
Confidence 2 2234568999999988889999999999999999999 99998643 222333322 222111110
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
.....++.+|+.+||+.||++|||+.+|++.|+.+.....
T Consensus 442 --------~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~ 481 (495)
T 1opk_A 442 --------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481 (495)
T ss_dssp --------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSC
T ss_pred --------CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccc
Confidence 1112367889999999999999999999999998875544
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=361.09 Aligned_cols=249 Identities=24% Similarity=0.407 Sum_probs=193.0
Q ss_pred ccccccccCceEEEEEEEc----CCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 272 PAEGLGKGIFGNSYKALLE----GRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
..+.||+|+||.||+|+.. ++..||||+++.. .....+.|.+|+.++++++||||+++++++...+..++||||+
T Consensus 49 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 128 (373)
T 2qol_A 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128 (373)
T ss_dssp CCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCC
Confidence 3578999999999999865 5677999999754 3344568999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|.++++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 129 ~~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~-------ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 129 ENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMG-------YVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp TTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999997543 24889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccc-------ccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 427 VAQPIA-------AQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 427 ~~~~~~-------~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
...... ..+++.|+|||++.+..++.++|||||||++|||++ |+.||... ...++.. .+.....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~----~~~~~~~----~i~~~~~ 268 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM----SNQDVIK----AVDEGYR 268 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC----CHHHHHH----HHHTTEE
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC----CHHHHHH----HHHcCCC
Confidence 654321 123467999999998899999999999999999998 99999643 1222222 2222211
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
... ......++.+++.+||+.||++||++.+|++.|+.+...
T Consensus 269 ~~~----------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 LPP----------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp CCC----------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCC----------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 110 011123688899999999999999999999999988643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=347.40 Aligned_cols=247 Identities=25% Similarity=0.340 Sum_probs=200.5
Q ss_pred cccccccCceEEEEEEEcC-C-------ceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLEG-R-------APVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 344 (582)
.+.||+|+||.||+|.... + ..||+|.+........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence 4679999999999998653 2 4699999976666677889999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc--------e
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM--------V 416 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~--------~ 416 (582)
|+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +
T Consensus 93 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~-------ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 93 FVKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEENT-------LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhhCC-------eECCCcCcceEEEecCCccccccccee
Confidence 999999999997643 24888999999999999999999998 999999999999998887 9
Q ss_pred EEeeccccccccCcccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh
Q 047954 417 LVSDYGFSSLVAQPIAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE 495 (582)
Q Consensus 417 kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 495 (582)
||+|||++..........++..|+|||.+.+ ..++.++|||||||++|||++|..|+.... . ...........
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~---~~~~~~~~~~~ 234 (289)
T 4fvq_A 161 KLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL---D---SQRKLQFYEDR 234 (289)
T ss_dssp EECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS---C---HHHHHHHHHTT
T ss_pred eeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc---c---hHHHHHHhhcc
Confidence 9999999988766666667889999999887 678999999999999999999655543211 1 11111111111
Q ss_pred cccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 496 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
....... ..++.+++.+||+.||++|||+.|++++|+.+...
T Consensus 235 ~~~~~~~-------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 235 HQLPAPK-------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp CCCCCCS-------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred CCCCCCC-------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1111111 11477899999999999999999999999988753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=366.91 Aligned_cols=246 Identities=24% Similarity=0.414 Sum_probs=200.8
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCC-eeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND-EKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.+|++++|||||++++++.... ..++||||+++|+|
T Consensus 198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred EeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 468999999999999986 5689999997543 4578999999999999999999999988765 78999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 275 ~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~-------ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 275 VDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGNN-------FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp HHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred HHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 999975432 24788899999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhh
Q 047954 431 IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQ 509 (582)
Q Consensus 431 ~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 509 (582)
....++..|+|||.+.+..++.++|||||||++|||+| |+.||.... ..++...+. .+......
T Consensus 344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~----~~~~~~~i~----~~~~~~~p------- 408 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPRVE----KGYKMDAP------- 408 (450)
T ss_dssp ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC----TTTHHHHHH----TTCCCCCC-------
T ss_pred cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHH----cCCCCCCC-------
Confidence 22345678999999999999999999999999999999 999996432 223333222 22111111
Q ss_pred hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 510 RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 510 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
.....++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 409 ---~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 409 ---DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11123678899999999999999999999999988754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=353.49 Aligned_cols=248 Identities=19% Similarity=0.320 Sum_probs=196.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 91 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence 467999999999999976 67889999986433 2234678899999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 92 L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~g-------ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 92 LFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp GGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred HHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-------ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99998643 24889999999999999999999998 999999999999999999999999999765322
Q ss_pred ------ccccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 431 ------IAAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 431 ------~~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
....+++.|+|||++.+..+ +.++|||||||++|||++|+.||...... ......+. ..... ..
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~----~~~~~---~~ 229 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWK----EKKTY---LN 229 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT--SHHHHHHH----TTCTT---ST
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHh----ccccc---CC
Confidence 23457889999999887665 78999999999999999999999653221 11111111 11100 00
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
+ .......+.+++.+||+.||++|||+.|++++.|....
T Consensus 230 ~-------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 230 P-------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp T-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred c-------cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 0 00112256789999999999999999999999886543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=353.40 Aligned_cols=247 Identities=19% Similarity=0.302 Sum_probs=200.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc------chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP------LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|... ++..||+|.++.... ...+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~ 96 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEc
Confidence 467999999999999975 578899999865322 2357899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC----ceEEeec
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE----MVLVSDY 421 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Df 421 (582)
+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 97 ~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g-------ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 97 VSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHTKK-------IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp CCSCBHHHHHTTC------SCCBHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999643 25899999999999999999999998 99999999999998877 7999999
Q ss_pred cccccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 422 GFSSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 422 G~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
|+++..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ..++...+ ....+
T Consensus 164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~----~~~~~~~i---~~~~~- 235 (361)
T 2yab_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANI---TAVSY- 235 (361)
T ss_dssp SSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHH---HTTCC-
T ss_pred CCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH---HhcCC-
Confidence 999876543 23457889999999999899999999999999999999999996421 12222111 11111
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
-+++... ......+.+++.+||..||++|||+.|+++|.|..
T Consensus 236 --~~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 236 --DFDEEFF-----SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp --CCCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred --CCCchhc-----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 0111100 01123577899999999999999999999988754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=360.45 Aligned_cols=254 Identities=22% Similarity=0.374 Sum_probs=201.7
Q ss_pred cccccccCceEEEEEEEc------CCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE------GRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|.+. ++..||||+++.. .......+.+|+.++++++|||||++++++......++||||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 155 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence 467999999999999854 3567999999654 334456788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCC-CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC---ceEEeec
Q 047954 346 AGNGNLFNRIHGGKSSK-NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE---MVLVSDY 421 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~---~~kl~Df 421 (582)
+++|+|.+++....... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-------ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-------FIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC-------eeCCCCChhhEEEecCCCCceEEECCC
Confidence 99999999997644221 1235889999999999999999999998 99999999999999554 5999999
Q ss_pred cccccccC------cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 422 GFSSLVAQ------PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 422 G~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
|+++.+.. .....+++.|+|||.+.+..++.++|||||||++|||+| |+.||... ...++...+ .
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~----~~~~~~~~i----~ 300 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK----SNQEVLEFV----T 300 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHHHHHHH----H
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHH----H
Confidence 99975422 223345778999999988899999999999999999998 99999642 222222222 1
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
........ ......+.+++.+||+.||++|||+.+|+++|+.+....
T Consensus 301 ~~~~~~~~----------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 301 SGGRMDPP----------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp TTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred cCCCCCCC----------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 11111110 011225788999999999999999999999999887543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=347.21 Aligned_cols=258 Identities=19% Similarity=0.297 Sum_probs=198.8
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||+||+|...+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||++ |+
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 104 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KD 104 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EE
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CC
Confidence 36799999999999999889999999986432 2335678899999999999999999999999999999999997 58
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+.+.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 105 l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~-------ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 105 LKKVLDENK-----TGLQDSQIKIYLYQLLRGVAHCHQHR-------ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp HHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred HHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 888887543 24889999999999999999999998 999999999999999999999999999876432
Q ss_pred ----ccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc---
Q 047954 431 ----IAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF--- 502 (582)
Q Consensus 431 ----~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 502 (582)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+.............
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD----DDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST----TTHHHHHHHHHCCCCTTTSGGGT
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHHCCCChHHhhhhh
Confidence 22346788999998876 5689999999999999999999999975432 22233332222211110000
Q ss_pred chh------------hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 503 DSE------------ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 503 d~~------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+.. ............++.+++.+||+.||++|||++|+++|.+.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 305 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 000 000000011123678899999999999999999999987643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.88 Aligned_cols=266 Identities=17% Similarity=0.243 Sum_probs=204.6
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCC--eeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSND--EKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 4679999999999999764 7889999997433 234577889999999999999999999998765 67999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee----cCCCceEEeecccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL----DDNEMVLVSDYGFS 424 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DfG~a 424 (582)
|+|.+++...... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 94 ~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~-------ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 94 GSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRENG-------IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp CBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred CCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHCC-------EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999754321 23889999999999999999999998 9999999999999 78888999999999
Q ss_pred ccccCcc---cccccccccCCCCCC--------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHH
Q 047954 425 SLVAQPI---AAQRMISYKSPEYQS--------SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 425 ~~~~~~~---~~~~~~~y~aPE~~~--------~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
+...... ...++..|+|||++. +..++.++|||||||++|||+||+.||...........+...+....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 8765432 334788999999875 56789999999999999999999999975432222222222222221
Q ss_pred hhcccccccc---------hhhhh-hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 494 REEWTAEIFD---------SEISV-QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 494 ~~~~~~~~~d---------~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.......+.. ..+.. ..........+.+++.+||+.||++|||++|++++..+..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111111000 00000 0112344556888999999999999999999999998654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.52 Aligned_cols=254 Identities=13% Similarity=0.135 Sum_probs=201.8
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|.. .+++.||||.+..... .+.+.+|+.+++++ +||||+++++++...+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPS 90 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCC
Confidence 46799999999999996 5778899999864332 34588999999999 9999999999999999999999999 999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc-----eEEeeccccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM-----VLVSDYGFSS 425 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~DfG~a~ 425 (582)
|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 91 L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~-------iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 91 LEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYVHSKN-------LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp HHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred HHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 999997542 25899999999999999999999998 999999999999998887 9999999998
Q ss_pred cccCc-----------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 426 LVAQP-----------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 426 ~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
.+... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~----~~~~~~~~~i~~ 234 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA----DTLKERYQKIGD 234 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----SSHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc----ccHHHHHHHHHh
Confidence 75432 234578899999999999999999999999999999999999975421 222222221111
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCC
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTEST 553 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 553 (582)
..... .... ...... ++.+++..||+.||.+||++.+|++.|+.+......
T Consensus 235 ~~~~~---~~~~----~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 235 TKRAT---PIEV----LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HHHHS---CHHH----HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhccC---CHHH----HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 11000 0000 000011 688899999999999999999999999988655443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=357.19 Aligned_cols=248 Identities=21% Similarity=0.278 Sum_probs=197.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... ++..||+|+++.......+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 357999999999999864 6788999999876555677899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee--cCCCceEEeeccccccccC
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL--DDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl--~~~~~~kl~DfG~a~~~~~ 429 (582)
.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 174 ~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~-------ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 174 FDRIIDES-----YNLTELDTILFMKQICEGIRHMHQMY-------ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp HHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------cccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 99887542 24889999999999999999999998 9999999999999 5678899999999987654
Q ss_pred cc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 430 PI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 ~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.. ...+++.|+|||++.+..++.++|||||||++|||++|+.||.... .. ..........+.. .....
T Consensus 242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~---~~~~~i~~~~~~~--~~~~~ 312 (373)
T 2x4f_A 242 REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN----DA---ETLNNILACRWDL--EDEEF 312 (373)
T ss_dssp TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS----HH---HHHHHHHHTCCCS--CSGGG
T ss_pred ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----HH---HHHHHHHhccCCC--Chhhh
Confidence 32 2347889999999998899999999999999999999999996432 11 2222222222110 01000
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.....++.+++.+||+.||++|||+.|+++|.+..
T Consensus 313 ------~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~ 347 (373)
T 2x4f_A 313 ------QDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347 (373)
T ss_dssp ------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ------ccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence 01123578899999999999999999999987743
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=347.14 Aligned_cols=242 Identities=22% Similarity=0.326 Sum_probs=198.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||+||+|+.. +++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g 89 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 467999999999999975 5788999998642 223456788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 90 g~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-------ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 90 GELFFHLSRER------VFTEERARFYGAEIVSALEYLHSRD-------VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp CBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999987532 4888999999999999999999998 9999999999999999999999999998643
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.. ....+|+.|+|||++.+..++.++|||||||++|||++|+.||... +...+...+ ..... .. ..
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~~~~~~~i---~~~~~--~~-p~ 226 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHERLFELI---LMEEI--RF-PR 226 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHH---HHCCC--CC-CT
T ss_pred cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC----CHHHHHHHH---HcCCC--CC-CC
Confidence 22 2345788999999999999999999999999999999999999642 112222211 11110 00 00
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEI 546 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 546 (582)
....++.+++.+||+.||++|| +++||++|.+.
T Consensus 227 ---------~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f 264 (337)
T 1o6l_A 227 ---------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp ---------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred ---------CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence 1112577899999999999999 99999999764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=354.81 Aligned_cols=263 Identities=17% Similarity=0.221 Sum_probs=199.5
Q ss_pred cccccccCceEEEEEEEcC------CceEEEEEecCCCcchH-----------HHHHHHHHHHhcCCCCCccccceEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEG------RAPVVVKRLRDLKPLIT-----------EEFRKQLLVIADQKHPNLLPLLAYYFS 335 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~H~niv~l~~~~~~ 335 (582)
.+.||+|+||.||+|.... +..||||++........ ..+..|+..+.+++||||+++++++..
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 119 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH 119 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence 4679999999999999765 36899999865432111 123455667788899999999999987
Q ss_pred C----CeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec
Q 047954 336 N----DEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD 411 (582)
Q Consensus 336 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~ 411 (582)
. ...++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+.+ |+||||||+|||++
T Consensus 120 ~~~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~-------iiHrDlkp~Nill~ 186 (364)
T 3op5_A 120 DKNGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHEHE-------YVHGDIKASNLLLN 186 (364)
T ss_dssp EETTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEEE
T ss_pred ccCCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eEEecCCHHHEEEe
Confidence 5 4579999999 999999997642 25899999999999999999999998 99999999999999
Q ss_pred --CCCceEEeeccccccccCcc-----------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 047954 412 --DNEMVLVSDYGFSSLVAQPI-----------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQ 478 (582)
Q Consensus 412 --~~~~~kl~DfG~a~~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~ 478 (582)
.++.+||+|||+++.+.... ...+|+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~- 265 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL- 265 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT-
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc-
Confidence 88999999999997764321 2237889999999999999999999999999999999999997422
Q ss_pred CCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCCccc
Q 047954 479 GINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEE 556 (582)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~ 556 (582)
................ ..+++++.+.. .....++.+++..||+.||++||++.+|++.|+.+........+
T Consensus 266 --~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 266 --KDPKYVRDSKIRYREN-IASLMDKCFPA----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp --TCHHHHHHHHHHHHHC-HHHHHHHHSCT----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred --cCHHHHHHHHHHhhhh-HHHHHHHhccc----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 1122222222221111 11222211100 11123688899999999999999999999999988765554443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=350.32 Aligned_cols=253 Identities=23% Similarity=0.395 Sum_probs=191.1
Q ss_pred cccccccCceEEEEEEEcCCc----eEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCee------E
Q 047954 273 AEGLGKGIFGNSYKALLEGRA----PVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEK------L 340 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~------~ 340 (582)
.+.||+|+||.||+|...... .||||+++.. .....+.+.+|+.++++++||||+++++++...... +
T Consensus 28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 107 (323)
T 3qup_A 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM 107 (323)
T ss_dssp EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEE
T ss_pred eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccE
Confidence 468999999999999865432 7999998653 334567899999999999999999999999887655 9
Q ss_pred EEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEee
Q 047954 341 LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSD 420 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 420 (582)
+||||+.+|+|.+++...........+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-------ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-------FIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECTTSCEEECC
T ss_pred EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC-------cccCCCCcceEEEcCCCCEEEee
Confidence 99999999999999975443333345889999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHH
Q 047954 421 YGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 421 fG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
||+++...... ...+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... ...+...+..
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~----~~~~~~~~~~-- 254 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE----NAEIYNYLIG-- 254 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----GGGHHHHHHT--
T ss_pred ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC----hHHHHHHHhc--
Confidence 99998764332 2334567999999998899999999999999999999 999996432 2222222211
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
.. .... . .....++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 255 -~~-~~~~-~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 255 -GN-RLKQ-P---------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp -TC-CCCC-C---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CC-CCCC-C---------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11 1100 0 11123578899999999999999999999999988753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=351.10 Aligned_cols=246 Identities=22% Similarity=0.416 Sum_probs=193.9
Q ss_pred cccccccCceEEEEEEEc-CCc----eEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRA----PVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||+||+|... ++. .||+|.++.. .....+.+.+|+.++++++||||++++++|.... .++|+||+
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~ 98 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM 98 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECC
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEec
Confidence 467999999999999964 333 3688887543 2345678999999999999999999999998754 78999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
.+|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~-------ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 99 PFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRR-------LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp TTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhCC-------eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999976432 4889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 427 VAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 427 ~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
..... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.... ...+...+.. ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~~~~~~~~~----~~~~ 238 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSILEK----GERL 238 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----GGGHHHHHHT----TCCC
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC----HHHHHHHHHc----CCCC
Confidence 64332 2234668999999999999999999999999999999 999996432 2222222211 1110
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.. .......+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 239 ~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 239 PQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CC----------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CC----------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 01112257889999999999999999999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=350.89 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=201.6
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCc---chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKP---LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+.
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~- 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence 46799999999999996 5788899999865432 234578899999999999999999999999999999999997
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 138 g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~-------ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 138 GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN-------MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 68888886432 25889999999999999999999998 9999999999999999999999999998887
Q ss_pred CcccccccccccCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 429 QPIAAQRMISYKSPEYQS---SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 429 ~~~~~~~~~~y~aPE~~~---~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
......+++.|+|||++. ...++.++|||||||++|||+||+.||.... ....+....... ........
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-------~~~~~~~~~~~~-~~~~~~~~ 277 (348)
T 1u5q_A 206 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNE-SPALQSGH 277 (348)
T ss_dssp SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSC-CCCCCCTT
T ss_pred CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcC-CCCCCCCC
Confidence 766677899999999874 5678999999999999999999999996421 112222222211 11111111
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
....+.+++.+||+.||++|||+++++++.+.....
T Consensus 278 ---------~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 278 ---------WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp ---------SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred ---------CCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 112577899999999999999999999998876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=346.80 Aligned_cols=248 Identities=19% Similarity=0.298 Sum_probs=200.3
Q ss_pred ccccccccCceEEEEEEEc-CCceEEEEEecCCCc------chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEE
Q 047954 272 PAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP------LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 344 (582)
..+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++++++||||+++++++......++|||
T Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEE
Confidence 3567999999999999975 578899999864322 246789999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC----ceEEee
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE----MVLVSD 420 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~----~~kl~D 420 (582)
|+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 95 ~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~~-------ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 95 LVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHSLQ-------IAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp CCCSCBHHHHHTTS------SCCBHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred cCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHHCC-------eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 99999999999643 25899999999999999999999998 99999999999999887 799999
Q ss_pred ccccccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 421 YGFSSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 421 fG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
||+++..... ....+++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+ .....
T Consensus 162 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~~---~~~~~ 234 (326)
T 2y0a_A 162 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANV---SAVNY 234 (326)
T ss_dssp CTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHH---HHTCC
T ss_pred CCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC----HHHHHHHH---HhcCC
Confidence 9999876433 23457889999999998999999999999999999999999996421 11111111 11110
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
...+ .. .......+.+++.+||..||++|||+.|+++|.+..
T Consensus 235 --~~~~-~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 276 (326)
T 2y0a_A 235 --EFED-EY-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276 (326)
T ss_dssp --CCCH-HH-----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred --CcCc-cc-----cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence 0000 00 001123577899999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=367.50 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=199.8
Q ss_pred ccccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
..+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|++++||||+++++++.. +..++||||+++|+|
T Consensus 188 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL 265 (452)
T 1fmk_A 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 265 (452)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred eeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCH
Confidence 356899999999999999988889999997543 346789999999999999999999999866 678999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 266 ~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~-------ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 266 LDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERMN-------YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp HHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred HHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999964321 24888999999999999999999998 9999999999999999999999999998764322
Q ss_pred -----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 432 -----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 432 -----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
...++..|+|||.+.+..++.++|||||||++|||+| |+.||... ...++...+ ........
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~----~~~~~~~~i----~~~~~~~~---- 402 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQV----ERGYRMPC---- 402 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHH----HTTCCCCC----
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC----CHHHHHHHH----HcCCCCCC----
Confidence 2234578999999988899999999999999999999 99999642 222222222 22211111
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
+......+.+++.+||+.||++|||++++++.|+.+.....
T Consensus 403 ------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 403 ------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 01112357889999999999999999999999998875443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=346.17 Aligned_cols=249 Identities=20% Similarity=0.322 Sum_probs=201.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... ++..||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 88 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence 467999999999999975 5678999998643 34456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC--CCceEEeeccccccccC
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD--NEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~--~~~~kl~DfG~a~~~~~ 429 (582)
.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 89 ~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~g-------ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 89 FERINTSA-----FELNEREIVSYVHQVCEALQFLHSHN-------IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp HHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99996432 24889999999999999999999998 999999999999987 78999999999987754
Q ss_pred cc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 430 PI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 ~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.. ...+++.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ...... ++...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i---~~~~~~---~~~~~ 226 (321)
T 1tki_A 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----NQQIIENI---MNAEYT---FDEEA 226 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHH---HHTCCC---CCHHH
T ss_pred CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC----HHHHHHHH---HcCCCC---CChhh
Confidence 32 2347789999999998889999999999999999999999996422 12222221 111111 00000
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
......++.+++.+||..||++|||+.|+++|.|....
T Consensus 227 -----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 227 -----FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 00112357889999999999999999999999886543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=340.35 Aligned_cols=254 Identities=18% Similarity=0.287 Sum_probs=200.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 95 (294)
T 4eqm_A 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCC
Confidence 467999999999999964 6788999998543 233456789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 96 PTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDMR-------IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp CBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999997532 4889999999999999999999998 9999999999999999999999999998765
Q ss_pred Ccc-----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 429 QPI-----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 429 ~~~-----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
... ...+++.|+|||.+.+..++.++|||||||++|||+||+.||.... ............. ...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-------~~~~~~~~~~~~~-~~~-- 232 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET-------AVSIAIKHIQDSV-PNV-- 232 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC-------HHHHHHHHHSSCC-CCH--
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhhccC-CCc--
Confidence 432 2347889999999999999999999999999999999999996422 1111122222111 100
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCC-ChHHHHHHHhhcccCCCC
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-EMAEVVSELEIIKVTEST 553 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~~ 553 (582)
... ........+.+++.+||+.||++|| +++++.+.|+.+......
T Consensus 233 -~~~---~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 233 -TTD---VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp -HHH---SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred -chh---cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 000 0011123578899999999999998 899999999988755543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=339.70 Aligned_cols=256 Identities=13% Similarity=0.169 Sum_probs=203.1
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.++.++ +|+|++++++++......++||||+ +++
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 91 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 91 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCC
Confidence 46799999999999995 578899999986432 234578899999999 8999999999999999999999999 999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc-----eEEeeccccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM-----VLVSDYGFSS 425 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~DfG~a~ 425 (582)
|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++
T Consensus 92 L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~-------ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 92 LEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKS-------LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTTT-------EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred HHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhCC-------EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 9999975432 4889999999999999999999998 999999999999987776 9999999998
Q ss_pred cccCc-----------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 426 LVAQP-----------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 426 ~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
..... ....++..|+|||.+.+..++.++|||||||++|||++|+.||...... ........+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-TNKQKYERIGEKKQ 238 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-CHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc-ccHHHHHHHHhhcc
Confidence 76543 2234778899999999999999999999999999999999999754321 11112222211111
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCCc
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTE 554 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 554 (582)
.....+. ......++.+++.+||+.||++||++++|++.|+.+.......
T Consensus 239 ~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 239 STPLREL----------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp HSCHHHH----------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CccHHHH----------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 1100000 0011236888999999999999999999999999987655443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.77 Aligned_cols=252 Identities=20% Similarity=0.342 Sum_probs=183.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|... +++.||||++.. .....+.+|+.++.++. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 467999999999999975 578899999854 34567889999999997 9999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC---ceEEeeccccccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE---MVLVSDYGFSSLV 427 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DfG~a~~~ 427 (582)
|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 93 L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~-------ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 93 LFERIKKKK------HFSETEASYIMRKLVSAVSHMHDVG-------VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp HHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred HHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 999997542 5889999999999999999999998 99999999999997665 7999999999866
Q ss_pred cCcc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
.... ...++..|+|||++.+..++.++|||||||++|||++|+.||.................. +...... ...
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~~-~~~ 237 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDFS-FEG 237 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCCC-CCS
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCCC-CCc
Confidence 4432 234578899999999999999999999999999999999999754332222222222222 2211110 000
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
. .......++.+++.+||+.||++|||+.|+++|.|...
T Consensus 238 ~------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 238 E------AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp H------HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred c------cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 0 00112236788999999999999999999998877543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=342.79 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=193.1
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|... ++.||||++... ...+.+.+|+.++++++||||+++++++. +..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred eeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence 467999999999999876 577999998643 34678999999999999999999999876 4579999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc-eEEeeccccccccCc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM-VLVSDYGFSSLVAQP- 430 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~-~kl~DfG~a~~~~~~- 430 (582)
+++..... ...+++..++.++.|+++||+|||+.+ ..+|+||||||+|||++.++. +||+|||++......
T Consensus 88 ~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~----~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~ 160 (307)
T 2eva_A 88 NVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQ----PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM 160 (307)
T ss_dssp HHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCS----SSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred HHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCC----CCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence 99975432 124778889999999999999999932 012999999999999998886 799999999766443
Q ss_pred ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhh
Q 047954 431 IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQR 510 (582)
Q Consensus 431 ~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 510 (582)
....++..|+|||.+.+..++.++|||||||++|||+||+.||..... ......... ..........
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~-~~~~~~~~~~------- 227 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG-----PAFRIMWAV-HNGTRPPLIK------- 227 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS-----SHHHHHHHH-HTTCCCCCBT-------
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc-----cHHHHHHHH-hcCCCCCccc-------
Confidence 234578899999999999999999999999999999999999964321 111111111 1111111110
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCC
Q 047954 511 SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTEST 553 (582)
Q Consensus 511 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 553 (582)
.....+.+++.+||+.||++|||+.+++++|+.+......
T Consensus 228 ---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 228 ---NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ---ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 1112577899999999999999999999999998765543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=346.04 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=203.4
Q ss_pred ccccccccCceEEEEEEE------cCCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEE
Q 047954 272 PAEGLGKGIFGNSYKALL------EGRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 344 (582)
..+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEe
Confidence 457899999999999986 234789999997543 3345778999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcCCCCC------------------CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCC
Q 047954 345 FAGNGNLFNRIHGGKSSK------------------NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKST 406 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~ 406 (582)
|+++|+|.+++....... ....+++..++.++.||+.||+|||+++ |+||||||+
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-------ivH~dikp~ 179 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-------LVHRDLAAR 179 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGG
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC-------Ccccccchh
Confidence 999999999998654210 1234889999999999999999999998 999999999
Q ss_pred CeeecCCCceEEeeccccccccCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 047954 407 NILLDDNEMVLVSDYGFSSLVAQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQG 479 (582)
Q Consensus 407 NILl~~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~ 479 (582)
|||++.++.+||+|||+++..... ....+++.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-- 257 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP-- 257 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 999999999999999999766432 12235677999999988889999999999999999999 999996432
Q ss_pred CCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 480 INGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
...+...+ ......... .....++.+++.+||+.||++|||+.|++++|+.+...
T Consensus 258 --~~~~~~~~----~~~~~~~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 --PERLFNLL----KTGHRMERP----------DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp --GGGHHHHH----HTTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --HHHHHHHh----hcCCcCCCC----------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 22222222 111111110 01123578899999999999999999999999987643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=351.66 Aligned_cols=254 Identities=23% Similarity=0.411 Sum_probs=202.4
Q ss_pred cccccccCceEEEEEEEcC------CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEG------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|...+ +..||||+++... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 131 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 131 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEec
Confidence 4679999999999999753 4789999997543 33456799999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCC------------------CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCC
Q 047954 346 AGNGNLFNRIHGGKSSK------------------NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTN 407 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~N 407 (582)
+++|+|.+++....... ....+++..++.++.||+.||+|||+++ |+||||||+|
T Consensus 132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-------ivH~Dlkp~N 204 (343)
T 1luf_A 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-------FVHRDLATRN 204 (343)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGG
T ss_pred CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCcce
Confidence 99999999997643210 0146899999999999999999999998 9999999999
Q ss_pred eeecCCCceEEeeccccccccCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 047954 408 ILLDDNEMVLVSDYGFSSLVAQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGI 480 (582)
Q Consensus 408 ILl~~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~ 480 (582)
||++.++.+||+|||+++..... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--- 281 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA--- 281 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC---
Confidence 99999999999999998765332 22345678999999988899999999999999999999 999996421
Q ss_pred CccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 481 NGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
..++.. .+......... .....++.+++.+||+.||++|||+.+++++|+.+....
T Consensus 282 -~~~~~~----~~~~~~~~~~~----------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 282 -HEEVIY----YVRDGNILACP----------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp -HHHHHH----HHHTTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred -hHHHHH----HHhCCCcCCCC----------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 122221 12221111111 011225788999999999999999999999999987543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=337.25 Aligned_cols=246 Identities=25% Similarity=0.426 Sum_probs=202.7
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 467999999999999998888999999976433 4578999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc--
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP-- 430 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~-- 430 (582)
+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 92 ~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 92 DYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEAC-------VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp HHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred HHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 99975432 4788999999999999999999998 999999999999999999999999999876432
Q ss_pred ---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 431 ---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ....... +....... ...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~----i~~~~~~~-~~~-- 228 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVED----ISTGFRLY-KPR-- 228 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHH----HHTTCCCC-CCT--
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC----HHHHHHH----HhcCCcCC-CCc--
Confidence 22335567999999988889999999999999999999 899986421 1122211 11111110 000
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.....+.+++.+||+.||++|||+.+++++|+.+..
T Consensus 229 -------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 229 -------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011257789999999999999999999999998864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=342.25 Aligned_cols=248 Identities=21% Similarity=0.406 Sum_probs=190.7
Q ss_pred ccccccccCceEEEEEEEcC----CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 272 PAEGLGKGIFGNSYKALLEG----RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
..+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++ ..+..++||||+
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~ 97 (281)
T 1mp8_A 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELC 97 (281)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred EEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEecC
Confidence 35789999999999998743 3469999986543 33456789999999999999999999997 456789999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 98 TLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESKR-------FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp TTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEEEETTEEEECC------
T ss_pred CCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eecccccHHHEEECCCCCEEECccccccc
Confidence 9999999997543 24889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCcc-----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 427 VAQPI-----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 427 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
..... ...+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+....+.. .. ...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~----~~~~~~~i~~---~~-~~~ 237 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----NNDVIGRIEN---GE-RLP 237 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC----GGGHHHHHHT---TC-CCC
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC----HHHHHHHHHc---CC-CCC
Confidence 65432 2234568999999988899999999999999999997 999996432 2223222211 11 111
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
. .+ .....+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 238 ~-~~---------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 238 M-PP---------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp C-CT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-CC---------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0 11 1123577899999999999999999999999988643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=353.92 Aligned_cols=248 Identities=19% Similarity=0.329 Sum_probs=201.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... ++..||+|.+..........+.+|+.++++++||||+++++++.+....++||||+++|+|
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L 135 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcH
Confidence 467999999999999975 5788999998765555567889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC--CCceEEeeccccccccC
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD--NEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~--~~~~kl~DfG~a~~~~~ 429 (582)
.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 136 ~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g-------ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 136 FDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEHS-------IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp HHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99986432 24889999999999999999999998 999999999999974 56799999999987654
Q ss_pred cc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 430 PI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 ~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.. ...+|+.|+|||++.+..++.++|||||||++|||+||+.||.... .... ........+.. +...
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~---~~~i~~~~~~~---~~~~ 273 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED----DLET---LQNVKRCDWEF---DEDA 273 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHHH---HHHHHHCCCCC---CSST
T ss_pred CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC----HHHH---HHHHHhCCCCC---Cccc
Confidence 32 3357889999999999999999999999999999999999996421 1122 22221111110 0000
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
......++.+++.+||+.||++|||+.|++++.+..
T Consensus 274 -----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (387)
T 1kob_A 274 -----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309 (387)
T ss_dssp -----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred -----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcccc
Confidence 001122578899999999999999999999997754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=336.01 Aligned_cols=246 Identities=28% Similarity=0.440 Sum_probs=187.6
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCc----chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKP----LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +..||||+++.... ...+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence 467999999999999975 67899999864322 2346789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC--------CCceEEee
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD--------NEMVLVSD 420 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~--------~~~~kl~D 420 (582)
++|.+++... .+++..++.++.|++.||+|||+++ ..+|+||||||+|||++. ++.+||+|
T Consensus 91 ~~L~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~----~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 91 GPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLHDEA----IVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHHHSS----SSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred CCHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCC----CCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999998532 4888999999999999999999986 224889999999999986 67899999
Q ss_pred ccccccccCcc--cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 421 YGFSSLVAQPI--AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 421 fG~a~~~~~~~--~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
||+++...... ...++..|+|||.+.+..++.++||||||+++|||++|+.||.... .. ............
T Consensus 160 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~---~~~~~~~~~~~~ 232 (271)
T 3dtc_A 160 FGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID----GL---AVAYGVAMNKLA 232 (271)
T ss_dssp CCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC----HH---HHHHHHHTSCCC
T ss_pred CCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HH---HHHHhhhcCCCC
Confidence 99998764432 3457889999999988899999999999999999999999996421 11 111111111111
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
... .. .....+.+++.+||+.||++|||+.|++++|+.+
T Consensus 233 ~~~-~~---------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 LPI-PS---------TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCC-CT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCC-Cc---------ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111 10 1123578899999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=354.53 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=199.9
Q ss_pred cccccccCceEEEEEEEc------CCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCe-eEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDE-KLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~-~~lv~ 343 (582)
.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++.++ +|||||++++++...+. .++||
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 467999999999999743 34689999997543 33456799999999999 88999999999987654 89999
Q ss_pred EeCCCCChHHHHhcCCCCC------------------------------------------------------------C
Q 047954 344 KFAGNGNLFNRIHGGKSSK------------------------------------------------------------N 363 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~------------------------------------------------------------~ 363 (582)
||+++|+|.+++....... .
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 9999999999998653210 0
Q ss_pred CCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc------cccccc
Q 047954 364 RIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI------AAQRMI 437 (582)
Q Consensus 364 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~------~~~~~~ 437 (582)
...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...++.
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~-------ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLASRK-------CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence 112889999999999999999999998 9999999999999999999999999998764321 233567
Q ss_pred cccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHH
Q 047954 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGM 516 (582)
Q Consensus 438 ~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 516 (582)
.|+|||++.+..++.++|||||||++|||+| |+.||..... .. .+.............+ ...
T Consensus 260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~----~~~~~~~~~~~~~~~~----------~~~ 322 (359)
T 3vhe_A 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DE----EFCRRLKEGTRMRAPD----------YTT 322 (359)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---SH----HHHHHHHHTCCCCCCT----------TCC
T ss_pred eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch---hH----HHHHHHHcCCCCCCCC----------CCC
Confidence 8999999988999999999999999999999 9999964321 11 1222222221111110 011
Q ss_pred HHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 517 LKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 517 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.++.+++.+||+.||++|||+.|++++|+.+..
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 257889999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=344.46 Aligned_cols=243 Identities=22% Similarity=0.322 Sum_probs=192.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCC-------------
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSND------------- 337 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------------- 337 (582)
.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++|||||++++++.+..
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~ 90 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL 90 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence 467999999999999976 78899999996433 345678999999999999999999999986643
Q ss_pred --------------------------------------------eeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHH
Q 047954 338 --------------------------------------------EKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRL 373 (582)
Q Consensus 338 --------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~ 373 (582)
..++||||+++|+|.+++..... ....++..++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~ 167 (332)
T 3qd2_B 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS---LEDREHGVCL 167 (332)
T ss_dssp -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS---GGGSCHHHHH
T ss_pred ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC---ccchhhHHHH
Confidence 27999999999999999986542 2345666789
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc----------------cccccc
Q 047954 374 LVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI----------------AAQRMI 437 (582)
Q Consensus 374 ~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~----------------~~~~~~ 437 (582)
.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...+++
T Consensus 168 ~i~~qi~~aL~~LH~~~-------ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSKG-------LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHhCC-------eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 99999999999999998 9999999999999999999999999998765431 234788
Q ss_pred cccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHH
Q 047954 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGML 517 (582)
Q Consensus 438 ~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 517 (582)
.|+|||.+.+..++.++|||||||++|||++|..|+.. ... ..........+ ........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---------~~~-~~~~~~~~~~~----------~~~~~~~~ 300 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---------RVR-IITDVRNLKFP----------LLFTQKYP 300 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---------HHH-HHHHHHTTCCC----------HHHHHHCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---------HHH-HHHHhhccCCC----------cccccCCh
Confidence 99999999999999999999999999999998766421 111 11111111111 01112233
Q ss_pred HHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 518 KLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 518 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
++.+++.+||+.||++|||+.|++++.+
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIENAI 328 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHHSTT
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhhchh
Confidence 5678999999999999999999998765
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=353.67 Aligned_cols=262 Identities=20% Similarity=0.263 Sum_probs=198.3
Q ss_pred ccccccc--CceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKG--IFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|||||++++++...+..++||||++
T Consensus 30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 109 (389)
T 3gni_B 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 109 (389)
T ss_dssp EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccC
Confidence 4679999 99999999976 68899999996432 3345678899999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+...
T Consensus 110 ~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~-------ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 110 YGSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHHMG-------YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp TCBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999976532 24889999999999999999999998 999999999999999999999999987543
Q ss_pred cC-----------cccccccccccCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 428 AQ-----------PIAAQRMISYKSPEYQSS--KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 428 ~~-----------~~~~~~~~~y~aPE~~~~--~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
.. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+...+.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~ 255 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT---QMLLEKLNGTVP 255 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST---THHHHC------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHhcCCCC
Confidence 21 112346778999999887 57899999999999999999999999754321 111110000000
Q ss_pred h---------c-------------ccccccc--------hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHH
Q 047954 495 E---------E-------------WTAEIFD--------SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544 (582)
Q Consensus 495 ~---------~-------------~~~~~~d--------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 544 (582)
. . ...+... ..............++.+|+.+||+.||++|||+.|+++|.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 0 0 0000000 00000000111224688899999999999999999999997
Q ss_pred hhcc
Q 047954 545 EIIK 548 (582)
Q Consensus 545 ~~i~ 548 (582)
+.-.
T Consensus 336 ~f~~ 339 (389)
T 3gni_B 336 FFKQ 339 (389)
T ss_dssp GGGG
T ss_pred HHHH
Confidence 6543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=348.58 Aligned_cols=246 Identities=20% Similarity=0.280 Sum_probs=198.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++|||||++++++.+.+..++||||+++|
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg 113 (362)
T 2bdw_A 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 113 (362)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 567999999999999965 57889999996543 234567889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC---ceEEeecccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE---MVLVSDYGFSSL 426 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DfG~a~~ 426 (582)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.
T Consensus 114 ~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~~-------ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 114 ELFEDIVAR------EFYSEADASHCIQQILESIAYCHSNG-------IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp BHHHHHTTC------SCCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC-------eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999998643 24889999999999999999999998 99999999999998654 599999999987
Q ss_pred ccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 427 VAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 427 ~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
..... ...+++.|+|||++.+..++.++|||||||++|||++|+.||... ....+...+. ..... ...
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~----~~~~~~~~i~---~~~~~--~~~ 251 (362)
T 2bdw_A 181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQHRLYAQIK---AGAYD--YPS 251 (362)
T ss_dssp CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHH---HTCCC--CCT
T ss_pred ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHH---hCCCC--CCc
Confidence 75432 345788999999999989999999999999999999999999642 1122222221 11110 000
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
+.. .....++.+++.+||+.||++|||+.|+++|.|.
T Consensus 252 ~~~------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 252 PEW------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp TGG------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred ccc------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 000 0112357789999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=340.06 Aligned_cols=243 Identities=19% Similarity=0.322 Sum_probs=189.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc--------------------------chHHHHHHHHHHHhcCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP--------------------------LITEEFRKQLLVIADQKHPN 325 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~H~n 325 (582)
.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++|||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 97 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence 467999999999999864 578899999864321 11356889999999999999
Q ss_pred ccccceEEEe--CCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCC
Q 047954 326 LLPLLAYYFS--NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNL 403 (582)
Q Consensus 326 iv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dl 403 (582)
|+++++++.+ .+..++||||+++|+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||
T Consensus 98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~-------ivH~Dl 163 (298)
T 2zv2_A 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-------KPLSEDQARFYFQDLIKGIEYLHYQK-------IIHRDI 163 (298)
T ss_dssp BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-------SCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCC
T ss_pred CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeccCC
Confidence 9999999987 5678999999999999876432 25889999999999999999999998 999999
Q ss_pred CCCCeeecCCCceEEeeccccccccCc----ccccccccccCCCCCCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 047954 404 KSTNILLDDNEMVLVSDYGFSSLVAQP----IAAQRMISYKSPEYQSSKK---ISRKSDVWSFGCLLLELLTGRISTHSA 476 (582)
Q Consensus 404 kp~NILl~~~~~~kl~DfG~a~~~~~~----~~~~~~~~y~aPE~~~~~~---~~~k~DVwS~Gvvl~elltG~~P~~~~ 476 (582)
||+|||++.++.+||+|||+++..... ....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||...
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999999876543 2345788999999987665 378899999999999999999999642
Q ss_pred CCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 477 PQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
. ....... ....... ..+ . .....++.+++.+||+.||++|||+.|+++|.+.
T Consensus 244 ~-------~~~~~~~-~~~~~~~-~~~-----~---~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~ 296 (298)
T 2zv2_A 244 R-------IMCLHSK-IKSQALE-FPD-----Q---PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296 (298)
T ss_dssp S-------HHHHHHH-HHHCCCC-CCS-----S---SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred c-------HHHHHHH-HhcccCC-CCC-----c---cccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence 1 1111111 1111110 000 0 0111257889999999999999999999988763
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=357.89 Aligned_cols=247 Identities=20% Similarity=0.265 Sum_probs=198.0
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.++++++|||||++++++.+.+..++||||+.+|
T Consensus 16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (444)
T 3soa_A 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 95 (444)
T ss_dssp EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCC
T ss_pred EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCC
Confidence 46799999999999986 467889999986543 234467899999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec---CCCceEEeecccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD---DNEMVLVSDYGFSSL 426 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DfG~a~~ 426 (582)
+|.+.+.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 96 ~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~g-------ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 96 ELFEDIVARE------YYSEADASHCIQQILEAVLHCHQMG-------VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp BHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred CHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999997542 4889999999999999999999998 99999999999998 467899999999987
Q ss_pred ccCcc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 427 VAQPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 427 ~~~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
..... ...+++.|+|||++.+..++.++||||+||++|+|++|+.||... ....+...+. .... ...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~----~~~~~~~~i~---~~~~--~~~ 233 (444)
T 3soa_A 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE----DQHRLYQQIK---AGAY--DFP 233 (444)
T ss_dssp CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHH---HTCC--CCC
T ss_pred ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc----cHHHHHHHHH---hCCC--CCC
Confidence 65432 345789999999999989999999999999999999999999642 2222222221 1111 011
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.+.. .....++.+++.+||+.||++|||+.|+++|.|.-
T Consensus 234 ~~~~------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 234 SPEW------DTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272 (444)
T ss_dssp TTTT------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred cccc------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 1100 01122577899999999999999999999997743
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=338.36 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=199.8
Q ss_pred ccccccccCceEEEEEEEcCC----ceEEEEEecCCCc-chHHHHHHHHHHHhcCCCCCccccceEEEeCCee-EEEEEe
Q 047954 272 PAEGLGKGIFGNSYKALLEGR----APVVVKRLRDLKP-LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEK-LLVYKF 345 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~-~lv~e~ 345 (582)
..+.||+|+||.||+|...+. ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 457899999999999986432 2699999875433 3457889999999999999999999999876665 999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+.+|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~-------i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 105 MCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAEQK-------FVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp CTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred ccCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 99999999997532 25889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCc--------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 426 LVAQP--------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 426 ~~~~~--------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
..... ....++..|+|||.+.+..++.++||||||+++|||+||..|+.... ...++...+.. ..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~---~~~~~~~~~~~----~~ 245 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI---DPFDLTHFLAQ----GR 245 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CGGGHHHHHHT----TC
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC---CHHHHHHHhhc----CC
Confidence 65432 12335678999999999999999999999999999999666654321 22233322221 11
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
.... .. .....+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 246 ~~~~-~~---------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 246 RLPQ-PE---------YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp CCCC-CT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CCCC-Cc---------cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1000 00 111257889999999999999999999999999875443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=334.39 Aligned_cols=249 Identities=21% Similarity=0.299 Sum_probs=199.2
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|+.. +..||||+++... ....+.+.+|+.++++++||||+++++++.+. ...++||||+++
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence 468999999999999986 6789999997543 33456799999999999999999999999887 678999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++..... ..+++..++.++.||+.||+|||+.++ +|+||||||+|||++.++.++|+|||++....
T Consensus 94 ~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~~-----~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 94 GSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTLEP-----LIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp CBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTTSSS-----CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred CcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcCCC-----ceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999986432 258999999999999999999999763 49999999999999999999999998876543
Q ss_pred CcccccccccccCCCCCCCCCCCc---chhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 429 QPIAAQRMISYKSPEYQSSKKISR---KSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 429 ~~~~~~~~~~y~aPE~~~~~~~~~---k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
. ....+++.|+|||.+.+..++. ++|||||||++|||+||+.||.... .................. .
T Consensus 165 ~-~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~-~- 234 (271)
T 3kmu_A 165 S-PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-------NMEIGMKVALEGLRPTIP-P- 234 (271)
T ss_dssp C-TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-------HHHHHHHHHHSCCCCCCC-T-
T ss_pred c-cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-------hHHHHHHHHhcCCCCCCC-C-
Confidence 3 2345788999999988765544 8999999999999999999996421 111112222222111111 1
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
....++.+++.+||+.||++|||++|+++.|+.+..
T Consensus 235 --------~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 235 --------GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 112257889999999999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=348.99 Aligned_cols=251 Identities=20% Similarity=0.298 Sum_probs=198.9
Q ss_pred ccccccccCceEEEEEEEc-CCceEEEEEecCC-----CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 272 PAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL-----KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
..+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 107 (351)
T 3c0i_A 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEF 107 (351)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence 3578999999999999864 6789999998532 122467899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc---eEEeecc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM---VLVSDYG 422 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DfG 422 (582)
+++|+|.+++...... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||
T Consensus 108 ~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~-------ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 108 MDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHDNN-------IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp CSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCC-------ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999887643211 224788999999999999999999998 999999999999986654 9999999
Q ss_pred ccccccCcc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 423 FSSLVAQPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 423 ~a~~~~~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
+++...... ...+|+.|+|||++.+..++.++|||||||++|||++|+.||... ...+...+ ......
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~i---~~~~~~ 250 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-----KERLFEGI---IKGKYK 250 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-----HHHHHHHH---HHTCCC
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-----HHHHHHHH---HcCCCC
Confidence 998765432 234788999999999999999999999999999999999999642 11111111 111110
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
..+.. ......++.+++.+||+.||++|||+.|+++|.+..
T Consensus 251 ---~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 251 ---MNPRQ-----WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp ---CCHHH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ---CCccc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 01100 001123578899999999999999999999987643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.31 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=192.2
Q ss_pred ccccccccCceEEEEEEEcC--C--ceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEe-CCeeEEEEEe
Q 047954 272 PAEGLGKGIFGNSYKALLEG--R--APVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFS-NDEKLLVYKF 345 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~ 345 (582)
..+.||+|+||.||+|...+ + ..||||.++... ....+.|.+|+.++++++||||+++++++.. .+..++||||
T Consensus 93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence 35689999999999998642 2 358999986533 3456789999999999999999999999765 4578999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 173 ~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~-------ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 173 MKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASKK-------FVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp CTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CCCCCHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCC-------EecCccchheEEECCCCCEEEeeccccc
Confidence 99999999997543 24788999999999999999999998 9999999999999999999999999998
Q ss_pred cccCc--------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 426 LVAQP--------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 426 ~~~~~--------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
.+... ....+++.|+|||.+.+..++.++|||||||++|||+| |..||.... ..++...+.. .
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~----~~~~~~~~~~----~ 312 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDITVYLLQ----G 312 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC----SSCHHHHHHT----T
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC----HHHHHHHHHc----C
Confidence 65432 12234567999999998999999999999999999999 677775432 2223322211 1
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
... ..+ ......+.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 313 ~~~--~~p--------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 313 RRL--LQP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CCC--CCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCC--CCC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 110 000 0111257889999999999999999999999999876554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=341.49 Aligned_cols=243 Identities=23% Similarity=0.323 Sum_probs=199.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g 90 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence 467999999999999975 67889999986421 23456788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 91 g~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-------ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 91 GELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSKD-------IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTTT-------EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999997542 4788999999999999999999998 9999999999999999999999999998765
Q ss_pred Cc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 429 QP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 429 ~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
.. ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... .... ......... .. .+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~---~~~i~~~~~--~~-p~--- 224 (318)
T 1fot_A 158 DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----TMKT---YEKILNAEL--RF-PP--- 224 (318)
T ss_dssp SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHH---HHHHHHCCC--CC-CT---
T ss_pred CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHH---HHHHHhCCC--CC-CC---
Confidence 43 23457899999999999999999999999999999999999996421 1112 222222111 00 00
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhhc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEII 547 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~i 547 (582)
....++.+++.+||..||++|| +++|+++|.+.-
T Consensus 225 ------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~ 263 (318)
T 1fot_A 225 ------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263 (318)
T ss_dssp ------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred ------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcccc
Confidence 0112577899999999999999 999999997753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=333.79 Aligned_cols=248 Identities=24% Similarity=0.409 Sum_probs=194.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcch-------HHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLI-------TEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 344 (582)
.+.||+|+||.||+|... +++.||+|++....... .+.+.+|+.++++++||||+++++++.+.. ++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e 101 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVME 101 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEE
Confidence 467999999999999974 67889999986432211 167899999999999999999999986554 79999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc-----eEEe
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM-----VLVS 419 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~ 419 (582)
|+++|+|.+++.... ..+++..++.++.|++.||+|||++++ +|+||||||+|||++.++. +||+
T Consensus 102 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~-----~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 102 FVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQNQNP-----PIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp CCTTCBHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHTSSS-----CCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred ecCCCCHHHHHhccc-----CCccHHHHHHHHHHHHHHHHHHHhCCC-----CeecCCCCcceEEEeccCCCCceeEEeC
Confidence 999999999887543 258999999999999999999999863 4999999999999988776 9999
Q ss_pred eccccccccCc-ccccccccccCCCCCC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 420 DYGFSSLVAQP-IAAQRMISYKSPEYQS--SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 420 DfG~a~~~~~~-~~~~~~~~y~aPE~~~--~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
|||+++..... ....++..|+|||.+. ...++.++|||||||++|||++|+.||...... -...........
T Consensus 172 Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~ 246 (287)
T 4f0f_A 172 DFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-----KIKFINMIREEG 246 (287)
T ss_dssp CCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-----HHHHHHHHHHSC
T ss_pred CCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-----HHHHHHHHhccC
Confidence 99999865543 2345788999999983 456789999999999999999999999643211 111111111222
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
..... .. ....++.+++.+||+.||++|||+.|+++.|+.+
T Consensus 247 ~~~~~-~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 LRPTI-PE---------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCC-CT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCC-Cc---------ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111 11 1123578899999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=346.93 Aligned_cols=256 Identities=22% Similarity=0.378 Sum_probs=203.4
Q ss_pred ccccccccCceEEEEEEEc--------CCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEE
Q 047954 272 PAEGLGKGIFGNSYKALLE--------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLL 341 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 341 (582)
..+.||+|+||.||+|... ++..||||+++... ....+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 118 (334)
T 2pvf_A 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118 (334)
T ss_dssp EEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEE
T ss_pred EeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEE
Confidence 4578999999999999863 45679999997543 33456789999999999 99999999999999999999
Q ss_pred EEEeCCCCChHHHHhcCCCCC----------CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSSK----------NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD 411 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~ 411 (582)
||||+++|+|.+++....... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-------ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-------CIHRDLAARNVLVT 191 (334)
T ss_dssp EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEEC
T ss_pred EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-------eeCCCCccceEEEc
Confidence 999999999999998654210 1124888999999999999999999998 99999999999999
Q ss_pred CCCceEEeeccccccccCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccc
Q 047954 412 DNEMVLVSDYGFSSLVAQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGAD 484 (582)
Q Consensus 412 ~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~ 484 (582)
.++.+||+|||+++..... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||... ...+
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----~~~~ 267 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----PVEE 267 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC----CHHH
Confidence 9999999999999876442 22335678999999988889999999999999999999 99999642 1222
Q ss_pred hHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
+...+ ......... .....++.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 268 ~~~~~----~~~~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 268 LFKLL----KEGHRMDKP----------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHH----HHTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHH----hcCCCCCCC----------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 22222 211111110 0112257889999999999999999999999999876544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=345.50 Aligned_cols=250 Identities=24% Similarity=0.426 Sum_probs=196.5
Q ss_pred cccccccCceEEEEEEEcCC-----ceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEGR-----APVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|..... ..||||.++... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 46799999999999986532 359999997543 334567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 129 ~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~-------ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 129 ENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANMN-------YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp TTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC-------eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999975432 4889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCcc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 427 VAQPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 427 ~~~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
..... ...++..|+|||.+.+..++.++|||||||++|||++ |+.||... ...++.. .+.....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~----~~~~~~~----~~~~~~~ 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVMK----AINDGFR 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHH----HHHTTCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC----CHHHHHH----HHHCCCc
Confidence 64331 1224567999999988899999999999999999999 99999642 1122222 2222111
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
... . ......+.+++.+||+.||++||++.+++++|+.+.....
T Consensus 269 ~~~-~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 269 LPT-P---------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CCC-C---------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CCC-c---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 110 0 0112257889999999999999999999999998875443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=339.61 Aligned_cols=257 Identities=18% Similarity=0.312 Sum_probs=196.3
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCc--chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|...+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||+++ +
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 367999999999999998889999999965432 2346788999999999999999999999999999999999975 9
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 86 LKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR-------VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp HHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred HHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 999887542 24888999999999999999999998 999999999999999999999999999765432
Q ss_pred ----ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccc---c--
Q 047954 431 ----IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTA---E-- 500 (582)
Q Consensus 431 ----~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 500 (582)
....++..|+|||++.+. .++.++|||||||++|||+||+.||.... ..+....+.+........ .
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS----EADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHHCCCChhhchhhh
Confidence 223467889999998764 58999999999999999999999996432 222222222221110000 0
Q ss_pred ---ccchhhhh------hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 501 ---IFDSEISV------QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 501 ---~~d~~~~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
..++.... .........++.+++.+||+.||++|||++|+++|.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 284 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 00000000 00001112357789999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=352.63 Aligned_cols=250 Identities=18% Similarity=0.297 Sum_probs=196.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||+||+|+.. +++.||+|+++... ....+.+..|..++.++ +|||||++++++.+.+..++||||++
T Consensus 57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 136 (396)
T 4dc2_A 57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence 468999999999999976 46789999986432 22234578899999886 89999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 137 gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g-------ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 137 GGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHERG-------IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp TCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999997532 4889999999999999999999998 999999999999999999999999999863
Q ss_pred cC----cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC-ccchHHHHHHHHhhccccccc
Q 047954 428 AQ----PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGIN-GADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 428 ~~----~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 502 (582)
.. .....+|+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+...+..... .+
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~- 281 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RI- 281 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-CC-
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-CC-
Confidence 22 2234578999999999999999999999999999999999999964321111 11112222222222111 00
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh------HHHHHHHhh
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM------AEVVSELEI 546 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L~~ 546 (582)
.. ....++.+|+.+||+.||++||++ .||++|.+.
T Consensus 282 p~---------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 282 PR---------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp CT---------TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred CC---------cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 00 111257789999999999999985 789888764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=342.35 Aligned_cols=254 Identities=23% Similarity=0.393 Sum_probs=203.4
Q ss_pred ccccccccCceEEEEEEE------cCCceEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEE
Q 047954 272 PAEGLGKGIFGNSYKALL------EGRAPVVVKRLRDLKP-LITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 343 (582)
..+.||+|+||.||+|.. .++..||||+++.... ...+.+.+|+.++.++ +||||+++++++...+..++||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 106 (313)
T 1t46_A 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (313)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEE
Confidence 457899999999999985 3457899999975432 3457799999999999 9999999999999999999999
Q ss_pred EeCCCCChHHHHhcCCCC------------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec
Q 047954 344 KFAGNGNLFNRIHGGKSS------------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD 411 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~ 411 (582)
||+++|+|.+++...... .....+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-------CIHRDLAARNILLT 179 (313)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEEE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCccceEEEc
Confidence 999999999999865421 11225889999999999999999999998 99999999999999
Q ss_pred CCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccc
Q 047954 412 DNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGAD 484 (582)
Q Consensus 412 ~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~ 484 (582)
.++.+||+|||+++...... ...++..|+|||.+.+..++.++||||||+++|||+| |+.||..... ...
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~ 256 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---DSK 256 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---SHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc---hhH
Confidence 99999999999998765432 2234567999999988899999999999999999999 9999965321 111
Q ss_pred hHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
............ ... ....++.+++.+||+.||++|||+.|++++|+.+..
T Consensus 257 ----~~~~~~~~~~~~-~~~---------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 257 ----FYKMIKEGFRML-SPE---------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp ----HHHHHHHTCCCC-CCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHhccCCCCC-Ccc---------cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 112222211111 011 112357889999999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=341.96 Aligned_cols=253 Identities=22% Similarity=0.357 Sum_probs=193.0
Q ss_pred ccccccccCceEEEEEEEcC----CceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCe-----eE
Q 047954 272 PAEGLGKGIFGNSYKALLEG----RAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE-----KL 340 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----~~ 340 (582)
..+.||+|+||.||+|.... +..||+|.++... ....+.+.+|+.++++++||||+++++++..... .+
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEE
T ss_pred eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccE
Confidence 45789999999999998643 3479999986442 3345678999999999999999999999987653 49
Q ss_pred EEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEee
Q 047954 341 LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSD 420 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 420 (582)
+||||+++|+|.+++...........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-------ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-------FLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT-------CCCCCCSGGGEEECTTSCEEECS
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCCcceEEEcCCCcEEEee
Confidence 99999999999999965443333346899999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHH
Q 047954 421 YGFSSLVAQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 421 fG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
||+++..... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ...+...+..
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~~~~~~~~-- 264 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ----NHEMYDYLLH-- 264 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----GGGHHHHHHT--
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC----HHHHHHHHHc--
Confidence 9999876432 22335678999999999999999999999999999999 888986432 2222222211
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
....... .....++.+++.+||+.||++|||+.+++++|+.+..
T Consensus 265 --~~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 265 --GHRLKQP----------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp --TCCCCCB----------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCC----------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111110 0112257889999999999999999999999998864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.66 Aligned_cols=261 Identities=19% Similarity=0.280 Sum_probs=195.3
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhc--CCCCCccccceEEEeC----CeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIAD--QKHPNLLPLLAYYFSN----DEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~----~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|+.. +..||||++... ....+..|.+++.. ++||||+++++++... ...++||||+
T Consensus 42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 117 (337)
T 3mdy_A 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117 (337)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCC
T ss_pred EeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEecc
Confidence 578999999999999876 788999998542 33445556666555 4999999999999987 6789999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCC-CCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS-RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
++|+|.+++... .+++..++.++.|++.||+|||+.... ....+|+||||||+|||++.++.+||+|||+++
T Consensus 118 ~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 118 ENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp TTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 999999999643 488999999999999999999988100 000129999999999999999999999999997
Q ss_pred cccCcc--------cccccccccCCCCCCCCCCCcc------hhHHHHHHHHHHHHhC----------CCCCCCCCCCCC
Q 047954 426 LVAQPI--------AAQRMISYKSPEYQSSKKISRK------SDVWSFGCLLLELLTG----------RISTHSAPQGIN 481 (582)
Q Consensus 426 ~~~~~~--------~~~~~~~y~aPE~~~~~~~~~k------~DVwS~Gvvl~elltG----------~~P~~~~~~~~~ 481 (582)
.+.... ...++..|+|||++.+..++.+ +|||||||++|||+|| +.||......
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~-- 268 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS-- 268 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS--
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC--
Confidence 654322 2357889999999987766665 9999999999999999 5666433221
Q ss_pred ccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 482 GADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
.................. .............++.+++.+||+.||++|||+.||+++|+.+....
T Consensus 269 -~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 269 -DPSYEDMREIVCIKKLRP----SFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp -SCCHHHHHHHHTTSCCCC----CCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred -CCchhhhHHHHhhhccCc----cccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 111122222222111111 11111122345567899999999999999999999999999987654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=371.61 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=204.0
Q ss_pred ccccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
..+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|++++|||||++++++.. +..++||||+.+|+|
T Consensus 271 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL 348 (535)
T 2h8h_A 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 348 (535)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEH
T ss_pred hheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcH
Confidence 357899999999999999988889999997543 346789999999999999999999999866 678999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++..... ..+++..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++......
T Consensus 349 ~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~-------ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 349 LDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERMN-------YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp HHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred HHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999964321 24788999999999999999999998 9999999999999999999999999998765431
Q ss_pred -----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 432 -----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 432 -----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
...++..|+|||.+.+..++.++|||||||++|||+| |+.||... ...++...+ .........
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~----~~~~~~~~i----~~~~~~~~~--- 486 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQV----ERGYRMPCP--- 486 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC----CHHHHHHHH----HTTCCCCCC---
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHH----HcCCCCCCC---
Confidence 2334578999999988899999999999999999999 99999642 222222222 222111110
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
......+.+|+.+||+.||++|||+++|++.|+.+.....
T Consensus 487 -------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 487 -------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred -------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 1112357889999999999999999999999998875444
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=342.89 Aligned_cols=240 Identities=18% Similarity=0.193 Sum_probs=188.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc--chHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP--LITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||+||+|... +++.||||++..... .....+..|+..+.++ +||||++++++|.+.+..++||||+ +
T Consensus 62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~ 140 (311)
T 3p1a_A 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence 467999999999999976 688999999865332 2334455666666554 9999999999999999999999999 7
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 141 ~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~-------ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 141 PSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHSQG-------LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp CBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 79999887543 24899999999999999999999998 9999999999999999999999999987765
Q ss_pred Cc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 429 QP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 429 ~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
.. ....+|+.|+|||++.+ .++.++|||||||++|||++|..|+... .. ...+.... ..+.
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~-----~~~~~~~~----~~~~ 272 (311)
T 3p1a_A 209 TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EG-----WQQLRQGY----LPPE 272 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HH-----HHHHTTTC----CCHH
T ss_pred cCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cH-----HHHHhccC----CCcc
Confidence 43 23347889999998876 7999999999999999999997766421 11 11111111 1111
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
+. .....++.+++.+||+.||++|||++|++++.|.
T Consensus 273 ~~-----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (311)
T 3p1a_A 273 FT-----AGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308 (311)
T ss_dssp HH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred cc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence 11 0112368889999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.82 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=200.8
Q ss_pred cccccccCceEEEEEEE-----cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEe--CCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALL-----EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS--NDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|++ .++..||||++........+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 107 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence 46899999999999984 4578899999987666667789999999999999999999999884 4568899999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~-------ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 108 LPSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLGSRR-------CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp CTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred cCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC-------ccCCCCChhhEEECCCCCEEEcccccce
Confidence 99999999997532 24889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCcc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-------CCccchHHHHHH
Q 047954 426 LVAQPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQG-------INGADLCSWVLR 491 (582)
Q Consensus 426 ~~~~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~-------~~~~~~~~~~~~ 491 (582)
...... ...++..|+|||.+.+..++.++||||||+++|||++|+.||...... .........+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 764322 233566799999998888999999999999999999999998532110 000000111111
Q ss_pred HHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCCc
Q 047954 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTE 554 (582)
Q Consensus 492 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 554 (582)
.......... .......+.+++.+||+.||++|||+.|++++|+.+.......
T Consensus 256 ~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 256 LLEEGQRLPA----------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp HHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred HhhcccCCCC----------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 1111111100 1112236788999999999999999999999999887655433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=373.39 Aligned_cols=245 Identities=23% Similarity=0.381 Sum_probs=198.1
Q ss_pred cccccCceEEEEEEEc---CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 275 GLGKGIFGNSYKALLE---GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.||+|+||.||+|.+. ++..||||+++... ....+.|.+|+++|++++|||||+++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999864 45679999997543 3456889999999999999999999999976 56899999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 422 L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~-------iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 422 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEKN-------FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred HHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 999996432 25899999999999999999999998 999999999999999999999999999876433
Q ss_pred c-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 431 I-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 431 ~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
. ...+++.|+|||++.+..++.++|||||||++|||+| |+.||... ...++...+. .+......
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~----~~~~~~~~i~----~~~~~~~p 561 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAFIE----QGKRMECP 561 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CSHHHHHHHH----TTCCCCCC
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----CHHHHHHHHH----cCCCCCCC
Confidence 2 1223468999999998899999999999999999998 99999643 2233333222 22111111
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
.....++.+|+.+||+.||++||++.+|++.|+.+...
T Consensus 562 ----------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 562 ----------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp ----------TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11123688899999999999999999999999887543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=351.23 Aligned_cols=249 Identities=20% Similarity=0.335 Sum_probs=191.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHh-cCCCCCccccceEEEe----CCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIA-DQKHPNLLPLLAYYFS----NDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~----~~~~~lv~e~~ 346 (582)
.+.||+|+||+||+|... ++..||||++.. ...+.+|+.++. ..+||||+++++++.. ....++||||+
T Consensus 67 ~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred cceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 357999999999999965 578899999863 245678888874 4589999999999876 55689999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC---CCceEEeeccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD---NEMVLVSDYGF 423 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DfG~ 423 (582)
++|+|.+++..... ..+++..+..|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 142 ~gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~-------ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 142 DGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSIN-------IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp CSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CCCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999975432 25899999999999999999999998 999999999999997 78899999999
Q ss_pred cccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 424 SSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 424 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
++..... ....+|..|+|||++.+..++.++|||||||++|||++|+.||...............+.. ..+.
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~---~~~~-- 285 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---GQYE-- 285 (400)
T ss_dssp CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH---TCCC--
T ss_pred ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc---Cccc--
Confidence 9876533 2334688899999999999999999999999999999999999754322111122222211 1110
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
...+. ......++.+|+.+||+.||++|||+.|+++|.|...
T Consensus 286 ~~~~~------~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 286 FPNPE------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp CCTTT------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred CCCcc------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 00000 0011235788999999999999999999999988654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=348.33 Aligned_cols=250 Identities=20% Similarity=0.332 Sum_probs=192.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 467999999999999976 67889999996543 2346788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc--eEEeeccccccccC
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM--VLVSDYGFSSLVAQ 429 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DfG~a~~~~~ 429 (582)
.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 104 ~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~~~-------ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 104 YERICNAG------RFSEDEARFFFQQLLSGVSYCHSMQ-------ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp HHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99986432 4889999999999999999999998 999999999999987765 99999999975432
Q ss_pred c---ccccccccccCCCCCCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 P---IAAQRMISYKSPEYQSSKKISRK-SDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~---~~~~~~~~y~aPE~~~~~~~~~k-~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
. ....+|+.|+|||++.+..++.+ +|||||||++|||++|+.||...... ......+......... ..+ .
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~~~~~~~~~--~~~-~ 244 (361)
T 3uc3_A 171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---RDYRKTIQRILSVKYS--IPD-D 244 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C---CCHHHHHHHHHTTCCC--CCT-T
T ss_pred cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHhcCCCC--CCC-c
Confidence 2 33457889999999988777655 89999999999999999999754321 2222222222222111 000 0
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
. ....++.+|+.+||+.||++|||+.|+++|.|..+.
T Consensus 245 ~-------~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 245 I-------RISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp S-------CCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred C-------CCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 0 011257789999999999999999999999887553
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=350.04 Aligned_cols=242 Identities=23% Similarity=0.295 Sum_probs=195.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|..++.++ +||||+++++++.+.+..++||||++
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 107 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence 467999999999999965 5788999998642 223456688899999988 79999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~g-------ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 108 GGDLMFHIQKSR------RFDEARARFYAAEIISALMFLHDKG-------IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp SCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999997542 4889999999999999999999998 999999999999999999999999999864
Q ss_pred cCc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||... ...++...+ ...... +.
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~----~~~~~~~~i---~~~~~~---~p 244 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE----NEDDLFEAI---LNDEVV---YP 244 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHH---HHCCCC---CC
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC----CHHHHHHHH---HcCCCC---CC
Confidence 322 2345788999999998888999999999999999999999999643 222222222 111110 00
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh------HHHHHHHhh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM------AEVVSELEI 546 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L~~ 546 (582)
.. ....+.+++.+||+.||++||++ +|+++|.+.
T Consensus 245 ~~---------~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f 284 (353)
T 3txo_A 245 TW---------LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284 (353)
T ss_dssp TT---------SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred CC---------CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence 00 11257789999999999999999 889988764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=341.14 Aligned_cols=264 Identities=16% Similarity=0.303 Sum_probs=193.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|... ++..||+|+++... ....+.+.+|+.++++++||||+++++++...+..++||||++ |+
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 88 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-ND 88 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CB
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CC
Confidence 367999999999999864 57889999986432 2344678899999999999999999999999999999999997 69
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++...........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~-------ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-------ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-------eeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 9998875432222335888999999999999999999998 999999999999999999999999999876432
Q ss_pred ----ccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---ccccc-
Q 047954 431 ----IAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE---WTAEI- 501 (582)
Q Consensus 431 ----~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~- 501 (582)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||.... ..+....+....... ....+
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN----DEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCChhHhhhhh
Confidence 23346788999999876 468999999999999999999999996432 222222222221110 00000
Q ss_pred ----cchhhh-----------hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 502 ----FDSEIS-----------VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 502 ----~d~~~~-----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
..+.+. ..........++.+++.+||+.||++|||+.|+++|.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 000000 00000011236889999999999999999999999877544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=345.46 Aligned_cols=246 Identities=25% Similarity=0.330 Sum_probs=189.9
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCe----eEEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE----KLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----~~lv~e 344 (582)
.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++.+++||||+++++++..... .++|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e 96 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence 46799999999999996 567889999997542 2334578899999999999999999999887553 399999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-------ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 97 YVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG-------IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp CCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 999999999997532 4889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCcc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 425 SLVAQPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 425 ~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
+.+.... ...++..|+|||.+.+..++.++|||||||++|||+||+.||.... .............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-------~~~~~~~~~~~~~ 236 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------PVSVAYQHVREDP 236 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhcCCC
Confidence 8764321 2336889999999999999999999999999999999999996422 1111222222111
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.. +... ......++.+++.+||+.||++||++.+++.+.+.
T Consensus 237 ~~----~~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 237 IP----PSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp CC----HHHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CC----cccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 11 0000 00112357889999999999999988887766543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=346.37 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=194.2
Q ss_pred cccccccCceEEEEEEEcC-Cce----EEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAP----VVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|.... +.. ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 96 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL 96 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence 4679999999999999643 443 7788775332 223356788999999999999999999885 56689999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
.+|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-------ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 97 PLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLEEHG-------MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp TTCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHHHTT-------CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred CCCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHHhCC-------CCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999997542 25888999999999999999999998 99999999999999999999999999987
Q ss_pred ccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 427 VAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 427 ~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
+.... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||.... ...+...+. .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~~----~~~~~ 236 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR----LAEVPDLLE----KGERL 236 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----TTHHHHHHH----TTCBC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC----HHHHHHHHH----cCCCC
Confidence 64432 2235568999999998899999999999999999999 999996532 122222221 11111
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.... . ...++.+++.+||+.||++|||+.|++++|+.+..
T Consensus 237 ~~~~-~---------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 237 AQPQ-I---------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CCCT-T---------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCC-c---------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0000 0 11146789999999999999999999999998864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=346.80 Aligned_cols=243 Identities=21% Similarity=0.299 Sum_probs=196.6
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+ +
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~ 92 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence 46799999999999996 567899999985321 122357889999999999999999999999999999999999 7
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 93 g~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~g-------ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 93 GELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRHK-------IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHHT-------CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 89999886532 4889999999999999999999998 9999999999999999999999999998765
Q ss_pred Ccc---cccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QPI---AAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~~---~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
... ...+++.|+|||.+.+..+ +.++|||||||++|||++|+.||.......... .+...
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~i~~~ 223 (336)
T 3h4j_B 160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------KVNSC 223 (336)
T ss_dssp TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------CCCSS
T ss_pred CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------HHHcC
Confidence 432 3457889999999988776 789999999999999999999997533211000 00000
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
...... .....+.+++.+||+.||++|||++|++++.|.-.
T Consensus 224 ~~~~p~---~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 224 VYVMPD---FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp CCCCCT---TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred CCCCcc---cCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 000000 01125778999999999999999999999988643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=346.96 Aligned_cols=257 Identities=22% Similarity=0.345 Sum_probs=199.6
Q ss_pred ccccccccCceEEEEEEEc------CCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEE
Q 047954 272 PAEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 343 (582)
..+.||+|+||.||+|... .+..||||.+.... ....+.+.+|+.++.++ +||||+++++++...+..++||
T Consensus 49 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 128 (344)
T 1rjb_A 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 128 (344)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEE
Confidence 3578999999999999962 34579999997432 23456789999999999 9999999999999999999999
Q ss_pred EeCCCCChHHHHhcCCCCC-----------------CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCC
Q 047954 344 KFAGNGNLFNRIHGGKSSK-----------------NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKST 406 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~ 406 (582)
||+++|+|.+++....... ....+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------ivH~Dikp~ 201 (344)
T 1rjb_A 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-------CVHRDLAAR 201 (344)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-------EEETTCSGG
T ss_pred ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCChh
Confidence 9999999999997653210 0124789999999999999999999998 999999999
Q ss_pred CeeecCCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 047954 407 NILLDDNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQG 479 (582)
Q Consensus 407 NILl~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~ 479 (582)
|||++.++.+||+|||+++...... ...+++.|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 280 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 280 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc-
Confidence 9999999999999999998764332 2234567999999988899999999999999999998 9999965321
Q ss_pred CCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 480 INGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
... +............. . ....++.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 281 --~~~----~~~~~~~~~~~~~~-~---------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 281 --DAN----FYKLIQNGFKMDQP-F---------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp --SHH----HHHHHHTTCCCCCC-T---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred --HHH----HHHHHhcCCCCCCC-C---------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 111 12222222111110 0 112357889999999999999999999999998876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=337.43 Aligned_cols=247 Identities=22% Similarity=0.377 Sum_probs=200.0
Q ss_pred ccccccCceEEEEEEEc---CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLE---GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+.||+|+||.||+|... ++..||||+++... ....+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 47999999999999854 56789999997643 34567799999999999999999999999 556789999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 95 ~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 95 PLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEKN-------FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CHHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHHCC-------EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 9999996432 24889999999999999999999998 99999999999999999999999999987643
Q ss_pred cc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 430 PI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 430 ~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
.. ...+++.|+|||.+.+..++.++||||||+++|||+| |+.||.... ..++...+ ........
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~~~~~~i----~~~~~~~~ 234 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK----GPEVMAFI----EQGKRMEC 234 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----THHHHHHH----HTTCCCCC
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----HHHHHHHH----hcCCcCCC
Confidence 21 2234678999999988889999999999999999999 999996432 22222222 11111111
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
.+ ....++.+++.+||+.||++||++.+++++|+.+....
T Consensus 235 -~~---------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 235 -PP---------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp -CT---------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CC---------CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 11236788999999999999999999999999886443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=345.20 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=196.2
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||||+++|+
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 46799999999999985 46889999999766556678899999999884 79999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc---eEEeeccccccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM---VLVSDYGFSSLV 427 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DfG~a~~~ 427 (582)
|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++..
T Consensus 98 L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~-------ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 98 ILSHIHKRR------HFNELEASVVVQDVASALDFLHNKG-------IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp HHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred HHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhCC-------ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999997532 4888999999999999999999998 999999999999998776 999999998765
Q ss_pred cCc-----------ccccccccccCCCCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccc-------
Q 047954 428 AQP-----------IAAQRMISYKSPEYQSS-----KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD------- 484 (582)
Q Consensus 428 ~~~-----------~~~~~~~~y~aPE~~~~-----~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~------- 484 (582)
... ....++..|+|||++.. ..++.++|||||||++|||++|+.||...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 321 12237789999998864 4578999999999999999999999975432211100
Q ss_pred hHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
....+...+..... ....... .....++.+++.+||+.||++|||+.|+++|.+..
T Consensus 245 ~~~~~~~~i~~~~~-~~~~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 245 CQNMLFESIQEGKY-EFPDKDW------AHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp HHHHHHHHHHHCCC-CCCHHHH------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred HHHHHHHHHhccCc-ccCchhc------ccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 01111111111111 0000000 01123578899999999999999999999987753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=339.86 Aligned_cols=251 Identities=29% Similarity=0.446 Sum_probs=205.0
Q ss_pred ccccccccCceEEEEEEEcC-CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 272 PAEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
..+.||+|+||.||+|.... +..||+|.+... ....+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 17 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 95 (288)
T 3kfa_A 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 95 (288)
T ss_dssp EEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEE
T ss_pred EEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCc
Confidence 35789999999999999764 778999998653 3456789999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 96 L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~-------i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 96 LLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKN-------FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp HHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHHT-------CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred HHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHCC-------ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999976432 25889999999999999999999998 999999999999999999999999999876543
Q ss_pred c-----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 431 I-----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 431 ~-----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
. ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ...+...+. ........
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~----~~~~~~~~~----~~~~~~~~-- 234 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELLE----KDYRMERP-- 234 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----GGGHHHHHH----TTCCCCCC--
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHh----ccCCCCCC--
Confidence 2 2234567999999988899999999999999999999 999986432 222222221 11111110
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
......+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 235 --------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 235 --------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp --------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0111357889999999999999999999999998875443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=343.63 Aligned_cols=246 Identities=22% Similarity=0.394 Sum_probs=192.7
Q ss_pred cccccccCceEEEEEEEc-CCce----EEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAP----VVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|... ++.. |++|.+... .....+.+.+|+.++++++||||+++++++.... .++|+||+
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~ 98 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM 98 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEec
Confidence 467999999999999964 3433 577777543 3445678999999999999999999999998765 78999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
.+|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~-------ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 99 PFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRR-------LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhCC-------CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999976432 4889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 427 VAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 427 ~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
..... ...++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ...+...+. .....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~----~~~~~~~~~----~~~~~ 238 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSILE----KGERL 238 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----GGGHHHHHH----TTCCC
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC----HHHHHHHHH----cCCCC
Confidence 64332 2234567999999999999999999999999999999 999996432 222322221 11111
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.. . .....++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 239 ~~-~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 239 PQ-P---------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CC-C---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CC-C---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 00 0 0112257889999999999999999999999998864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=344.97 Aligned_cols=245 Identities=20% Similarity=0.336 Sum_probs=193.2
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCC--CCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKH--PNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|...++..||||++.... ....+.+.+|+.++.+++| |||+++++++......++||| +.+
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 92 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 92 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCC
Confidence 46799999999999999889999999986432 3345778999999999987 999999999999999999999 568
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 93 ~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~-------iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 93 IDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHG-------IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 89999997542 4888999999999999999999998 99999999999997 5789999999998765
Q ss_pred Ccc------cccccccccCCCCCCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHH
Q 047954 429 QPI------AAQRMISYKSPEYQSS-----------KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLR 491 (582)
Q Consensus 429 ~~~------~~~~~~~y~aPE~~~~-----------~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 491 (582)
... ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ........
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~ 232 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHA 232 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh------hHHHHHHH
Confidence 432 2347889999998754 678999999999999999999999996422 11122222
Q ss_pred HHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 492 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
...........+ . ...++.+++.+||+.||++|||+.|+++|.|.-.
T Consensus 233 ~~~~~~~~~~~~-------~---~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 233 IIDPNHEIEFPD-------I---PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp HHCTTSCCCCCC-------C---SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HhcCCcccCCcc-------c---CCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 222111111110 0 0125778999999999999999999999988654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.11 Aligned_cols=243 Identities=19% Similarity=0.290 Sum_probs=189.9
Q ss_pred cccccccCceEEEEEEE----cCCceEEEEEecCCC----cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALL----EGRAPVVVKRLRDLK----PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 344 (582)
.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 101 (327)
T 3a62_A 22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILE 101 (327)
T ss_dssp EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEe
Confidence 46799999999999997 478899999997532 2234567889999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~~-------ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 102 YLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQKG-------IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred CCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCC-------EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999997532 4788899999999999999999998 999999999999999999999999999
Q ss_pred ccccCc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 425 SLVAQP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 425 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
+..... ....+++.|+|||++.+..++.++|||||||++|||++|+.||.... ...... ....... .
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~---~i~~~~~--~ 239 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN----RKKTID---KILKCKL--N 239 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHH---HHHHTCC--C
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC----HHHHHH---HHHhCCC--C
Confidence 764322 23357889999999998899999999999999999999999996421 112221 2111110 0
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhhc
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEII 547 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~i 547 (582)
. .+ ....++.+++.+||+.||++|| ++.|+++|.+.-
T Consensus 240 ~-p~---------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~ 281 (327)
T 3a62_A 240 L-PP---------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281 (327)
T ss_dssp C-CT---------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred C-CC---------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence 0 00 0112577899999999999999 888999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.03 Aligned_cols=250 Identities=19% Similarity=0.298 Sum_probs=197.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+.+..++||||++
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 467999999999999975 57889999996432 23345688999999987 89999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~-------ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 94 GGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHERG-------IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp SCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999997532 4889999999999999999999998 999999999999999999999999999864
Q ss_pred cC----cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC-ccchHHHHHHHHhhccccccc
Q 047954 428 AQ----PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGIN-GADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 428 ~~----~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 502 (582)
.. .....+|+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+...+..... .+
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~- 238 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RI- 238 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-CC-
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-CC-
Confidence 32 2234578899999999999999999999999999999999999964321100 01111222222221111 00
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh------HHHHHHHhh
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM------AEVVSELEI 546 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L~~ 546 (582)
.. ....++.+++.+||+.||++||++ .|+++|.+.
T Consensus 239 p~---------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f 279 (345)
T 3a8x_A 239 PR---------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279 (345)
T ss_dssp CT---------TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred CC---------CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence 00 112257789999999999999995 789888764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=358.59 Aligned_cols=249 Identities=16% Similarity=0.190 Sum_probs=197.2
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||+||+|+... ++.||+|+++... ....+.+.+|+.++.+++||||++++++|.+.+..++|||||++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 4679999999999999764 6789999986421 11223488999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... ..+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+...
T Consensus 159 g~L~~~l~~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~g-------iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 159 GDLLTLLSKFE-----DRLPEEMARFYLAEMVIAIDSVHQLH-------YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp CBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 99999997532 24889999999999999999999998 9999999999999999999999999997664
Q ss_pred Ccc-----cccccccccCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 429 QPI-----AAQRMISYKSPEYQS-----SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 429 ~~~-----~~~~~~~y~aPE~~~-----~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
... ...||+.|+|||++. ...++.++|||||||++|||++|+.||... +..+....+......-..
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHKERFQF 302 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTHHHHCCC
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC----ChhHHHHhhhhccccccC
Confidence 332 235789999999986 567899999999999999999999999642 222222222211111111
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCC--CCChHHHHHHHhhc
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEK--RPEMAEVVSELEII 547 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~~i 547 (582)
+... .....++.+|+.+||..+|++ ||+++|+++|.+.-
T Consensus 303 p~~~----------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~ 343 (437)
T 4aw2_A 303 PTQV----------TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343 (437)
T ss_dssp CSSC----------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred Cccc----------ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence 1110 001125778889999888888 99999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=345.03 Aligned_cols=243 Identities=21% Similarity=0.274 Sum_probs=200.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 467999999999999975 67899999985421 23456788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 126 g~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-------ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 126 GEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSLD-------LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp CBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------cccccCccceEEECCCCCEEEcccccceecc
Confidence 99999997532 4888999999999999999999998 9999999999999999999999999998765
Q ss_pred Cc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 429 QP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 429 ~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
.. ....+|+.|+|||++.+..++.++|||||||++|||++|+.||... ....+...+ .... . .. ..
T Consensus 193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~~~~~~~i---~~~~-~-~~-p~--- 259 (350)
T 1rdq_E 193 GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----QPIQIYEKI---VSGK-V-RF-PS--- 259 (350)
T ss_dssp SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHH---HHCC-C-CC-CT---
T ss_pred CCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC----CHHHHHHHH---HcCC-C-CC-CC---
Confidence 43 2345789999999999999999999999999999999999999642 112222211 1111 1 00 00
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHHhhc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSELEII 547 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~i 547 (582)
....++.+++.+||+.||++||+ ++||++|.+..
T Consensus 260 ------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~ 298 (350)
T 1rdq_E 260 ------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp ------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred ------CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence 11125778999999999999998 99999988753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=345.73 Aligned_cols=247 Identities=21% Similarity=0.300 Sum_probs=185.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... +++.||||+++... ..+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 135 (349)
T 2w4o_A 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135 (349)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCH
Confidence 467999999999999976 46789999997532 346788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC---CCceEEeecccccccc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD---NEMVLVSDYGFSSLVA 428 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DfG~a~~~~ 428 (582)
.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 136 ~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~-------ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 136 FDRIVEKG------YYSERDAADAVKQILEAVAYLHENG-------IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp HHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99996432 4889999999999999999999998 999999999999975 8899999999998765
Q ss_pred Cc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 429 QP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 429 ~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
.. ....+++.|+|||++.+..++.++|||||||++|||++|+.||..... ...+. ......... ...+.
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~---~~i~~~~~~--~~~~~ 274 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG---DQFMF---RRILNCEYY--FISPW 274 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC---HHHHH---HHHHTTCCC--CCTTT
T ss_pred cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc---cHHHH---HHHHhCCCc--cCCch
Confidence 43 234478899999999999999999999999999999999999964321 11111 111111110 00000
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
......++.+++.+||+.||++|||+.|++++.+...
T Consensus 275 ------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 275 ------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp ------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ------hhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 0111235778999999999999999999999987544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=347.25 Aligned_cols=245 Identities=21% Similarity=0.317 Sum_probs=196.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++|||||++++++.+.+..++||||+.+
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g 99 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG 99 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 467999999999999965 4678999998542 123456788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 100 g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g-------ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 100 GDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQR-------IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999997532 4889999999999999999999998 9999999999999999999999999998764
Q ss_pred Cc---ccccccccccCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 429 QP---IAAQRMISYKSPEYQSS---KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 429 ~~---~~~~~~~~y~aPE~~~~---~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
.. ....+|+.|+|||++.. ..++.++|||||||++|||++|+.||..... ......... ...... ..
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~-~~~~~~-~~- 239 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS----TSSKEIVHT-FETTVV-TY- 239 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT----SCHHHHHHH-HHHCCC-CC-
T ss_pred CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC----ccHHHHHHH-Hhhccc-CC-
Confidence 43 23457889999999864 4589999999999999999999999964322 111111111 111110 00
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCC-hHHHHHHHhh
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE-MAEVVSELEI 546 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~~ 546 (582)
. ......+.+++.+||+.||++||+ ++++++|.+.
T Consensus 240 p---------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f 275 (384)
T 4fr4_A 240 P---------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275 (384)
T ss_dssp C---------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGG
T ss_pred C---------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhh
Confidence 0 011125788999999999999998 7888876654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=354.77 Aligned_cols=247 Identities=19% Similarity=0.234 Sum_probs=197.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||+||+|+.. +++.||+|+++... ....+.+.+|+.+++.++|||||+++++|.+.+..++||||+++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 467999999999999976 57789999985421 12234578999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 154 g~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~g-------ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 154 GDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSMG-------FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 9999999743 3788899999999999999999998 9999999999999999999999999998765
Q ss_pred Ccc-----cccccccccCCCCCCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 429 QPI-----AAQRMISYKSPEYQSSKK----ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 429 ~~~-----~~~~~~~y~aPE~~~~~~----~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
... ...+|+.|+|||++.+.. ++.++|||||||++|||+||+.||... +.......+.........+
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~~i~~~~~~~~~p 295 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKIMNHKNSLTFP 295 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTHHHHCCCC
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC----ChhhHHHHHHhccccccCC
Confidence 432 345889999999987655 789999999999999999999999642 2222222222111110011
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCC--CCChHHHHHHHhhcc
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEK--RPEMAEVVSELEIIK 548 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~~i~ 548 (582)
.. . ....++.+|+.+||..+|++ ||+++||++|.+.-.
T Consensus 296 ~~--~---------~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 296 DD--N---------DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp TT--C---------CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred Cc--c---------cccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 00 0 01125778899999999988 999999999988643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=345.94 Aligned_cols=242 Identities=22% Similarity=0.328 Sum_probs=196.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++.++ +||||+++++++.+.+..++||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 467999999999999975 57889999996421 23456678899999876 99999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 102 gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-------ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 102 GGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSKG-------IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp TCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999997532 4888999999999999999999998 999999999999999999999999999864
Q ss_pred cC----cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQ----PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~----~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
.. .....+|+.|+|||++.+..++.++|||||||++|||++|+.||... +...+...+. ... . . +.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~~~~~~~i~---~~~-~-~-~p 238 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ----DEEELFHSIR---MDN-P-F-YP 238 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHH---HCC-C-C-CC
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHH---hCC-C-C-CC
Confidence 32 22345788999999999999999999999999999999999999642 1222222221 111 0 0 00
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChH-HHHHHHhh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMA-EVVSELEI 546 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~L~~ 546 (582)
.. ...++.+++.+||..||++||++. ||++|.+.
T Consensus 239 ~~---------~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f 273 (345)
T 1xjd_A 239 RW---------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273 (345)
T ss_dssp TT---------SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred cc---------cCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence 00 112577899999999999999998 88887664
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=335.33 Aligned_cols=258 Identities=19% Similarity=0.277 Sum_probs=196.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+.+
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence 367999999999999975 57889999996433 33457788999999999999999999999999999999999975
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
++.+.+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~-------ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 86 DLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRN-------VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 6666665432 24889999999999999999999998 99999999999999999999999999987643
Q ss_pred c----ccccccccccCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc-
Q 047954 430 P----IAAQRMISYKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD- 503 (582)
Q Consensus 430 ~----~~~~~~~~y~aPE~~~~~~-~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d- 503 (582)
. ....++..|+|||++.+.. ++.++|||||||++|||+||..|+.... ...+....+.+............
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~---~~~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS---SHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC---CHHHHHHHHHHHhCCCChhhhhhh
Confidence 3 2334678899999987765 7999999999999999999988864321 22222332322221110000000
Q ss_pred -------------hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 504 -------------SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 504 -------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
..............++.+++.+||+.||++|||++|+++|.|.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence 0000000001122357789999999999999999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.88 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=196.2
Q ss_pred ccccccccCceEEEEEEEcCC----ceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEe-CCeeEEEEEe
Q 047954 272 PAEGLGKGIFGNSYKALLEGR----APVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFS-NDEKLLVYKF 345 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~ 345 (582)
..+.||+|+||.||+|...+. ..||+|.+.... ....+.+.+|+.++++++||||+++++++.. .+..++||||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred hcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeC
Confidence 357899999999999986432 358899987543 3345778999999999999999999998654 4578999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 109 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~~-------i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 109 MKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLASKK-------FVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CTTCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred CCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC-------ccCCCCchheEEECCCCCEEECcccccc
Confidence 99999999997533 24788999999999999999999998 9999999999999999999999999998
Q ss_pred cccCcc--------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 426 LVAQPI--------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTG-RISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 426 ~~~~~~--------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
...... ...+++.|+|||.+.+..++.++||||||+++|||++| ..||... ...+....+.. ..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~~~~~~~~~---~~ 249 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVYLLQ---GR 249 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS----CTTTHHHHHHT---TC
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC----CHHHHHHHHhc---CC
Confidence 764432 22345679999999888999999999999999999994 5555432 12222222211 11
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
. ...... ....+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 250 -~-~~~~~~---------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 250 -R-LLQPEY---------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -C-CCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -C-CCCCcc---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 000000 11257889999999999999999999999999876443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=340.32 Aligned_cols=255 Identities=27% Similarity=0.367 Sum_probs=198.7
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEe----CCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS----NDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....++||||+.
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 113 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCT
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCC
Confidence 46799999999999996 5788999999876666667789999999999999999999999973 346789999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++...... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 114 ~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~-------ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 114 RGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHAKG-------YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp TCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred CCcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999998753211 235889999999999999999999998 999999999999999999999999998765
Q ss_pred cCcc-------------cccccccccCCCCCCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHH
Q 047954 428 AQPI-------------AAQRMISYKSPEYQSSKK---ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLR 491 (582)
Q Consensus 428 ~~~~-------------~~~~~~~y~aPE~~~~~~---~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 491 (582)
.... ...++..|+|||.+.+.. ++.++|||||||++|||++|+.||...... ...+...+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~-- 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK--GDSVALAV-- 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT--TSCHHHHH--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc--cchhhHHh--
Confidence 3221 123478899999987654 689999999999999999999998531110 11111111
Q ss_pred HHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 492 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
....... . .......+.+++.+||+.||++|||+.+++++|+.+.....
T Consensus 261 --~~~~~~~--~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 261 --QNQLSIP--Q--------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp --HCC--CC--C--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred --hccCCCC--c--------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 1110000 0 00112357889999999999999999999999999876544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.07 Aligned_cols=245 Identities=20% Similarity=0.337 Sum_probs=193.3
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCC--cchHHHHHHHHHHHhcCC--CCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQK--HPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|...++..||||++.... ....+.+.+|+.++.+++ ||||+++++++...+..++||| +.+
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~ 139 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139 (390)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence 46799999999999998888999999986432 334578999999999996 5999999999999999999999 568
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+.
T Consensus 140 ~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~-------ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 140 IDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHG-------IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTTT-------CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 89999997543 4788889999999999999999998 99999999999996 5789999999998765
Q ss_pred Ccc------cccccccccCCCCCCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHH
Q 047954 429 QPI------AAQRMISYKSPEYQSS-----------KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLR 491 (582)
Q Consensus 429 ~~~------~~~~~~~y~aPE~~~~-----------~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 491 (582)
... ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+..
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------~~~~~~~~ 279 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHA 279 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------CHHHHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh------HHHHHHHH
Confidence 332 3347899999998764 468999999999999999999999996422 11122222
Q ss_pred HHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 492 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
...........+ .. ..++.+++.+||+.||++|||+.|++++.+...
T Consensus 280 ~~~~~~~~~~~~-------~~---~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 280 IIDPNHEIEFPD-------IP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp HHCTTSCCCCCC-------CS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HhCccccCCCCc-------cc---hHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 222111111100 00 125778999999999999999999999987643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=335.29 Aligned_cols=249 Identities=26% Similarity=0.473 Sum_probs=188.7
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|...+ .||+|+++... ....+.+.+|+.++++++||||+++++++ .....++||||+++++
T Consensus 29 ~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~ 105 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSS 105 (289)
T ss_dssp EEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEE
T ss_pred eeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCc
Confidence 4689999999999998654 49999986543 33456799999999999999999999965 5567899999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 106 L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~-------i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 106 LYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHAKS-------IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp HHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred HHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------cccccCccceEEECCCCCEEEccceeccccccc
Confidence 999996443 25889999999999999999999998 999999999999999999999999999765431
Q ss_pred ------ccccccccccCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 431 ------IAAQRMISYKSPEYQS---SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 431 ------~~~~~~~~y~aPE~~~---~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
....++..|+|||.+. +..++.++||||||+++|||++|+.||.... ....+. ...........
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~----~~~~~~~~~~~ 246 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN---NRDQII----EMVGRGSLSPD 246 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC---CHHHHH----HHHHHTSCCCC
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc---hHHHHH----HHhcccccCcc
Confidence 1234688999999886 5678899999999999999999999996432 111122 22222111110
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
... .......++.+++.+||+.||++|||+.++++.|+.+..
T Consensus 247 ~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 247 LSK------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TTS------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hhh------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 000 001112368889999999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=337.51 Aligned_cols=254 Identities=20% Similarity=0.335 Sum_probs=197.2
Q ss_pred cccccccCceEEEEEEE-----cCCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-----EGRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 344 (582)
.+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|+.++++++||||+++++++... ...++|||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 105 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence 46899999999999984 46788999999743 234457899999999999999999999999877 56899999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 106 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 106 FLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLGSRQ-------YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp CCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred eCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhhcCC-------cccCCCchheEEEcCCCCEEECccccc
Confidence 9999999999964332 4889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCcc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------CCCccchHHHHH
Q 047954 425 SLVAQPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQ-------GINGADLCSWVL 490 (582)
Q Consensus 425 ~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~-------~~~~~~~~~~~~ 490 (582)
+...... ...++..|+|||.+.+..++.++||||||+++|||+||..|+..... ..........+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 8765432 23456679999999888899999999999999999999988642210 000111111111
Q ss_pred HHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 491 RAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 491 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
........... ......++.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 254 ~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLKEGKRLPC----------PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHTTCCCCC----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccCCCCC----------CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11111111100 0111236888999999999999999999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=336.54 Aligned_cols=248 Identities=19% Similarity=0.304 Sum_probs=200.4
Q ss_pred ccccccccCceEEEEEEEc-CCceEEEEEecCCCc------chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEE
Q 047954 272 PAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP------LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 344 (582)
..+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (321)
T 2a2a_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE 95 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEE
Confidence 3578999999999999975 578899999864322 246789999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC----ceEEee
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE----MVLVSD 420 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~----~~kl~D 420 (582)
|+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 96 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~-------ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 96 LVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTKK-------IAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp CCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCChHHEEEecCCCCcCCEEEcc
Confidence 999999999997432 5889999999999999999999998 99999999999999888 799999
Q ss_pred ccccccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 421 YGFSSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 421 fG~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
||+++...... ...+++.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+. .........
T Consensus 163 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~---~~~i~~~~~ 235 (321)
T 2a2a_A 163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQET---LANITSVSY 235 (321)
T ss_dssp CTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHH---HHHHHTTCC
T ss_pred CccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC----HHHH---HHHHHhccc
Confidence 99998765432 3347889999999999999999999999999999999999996421 1111 111111110
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
..++... ......+.+++.+||+.||++|||+.|+++|.+..
T Consensus 236 ---~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~ 277 (321)
T 2a2a_A 236 ---DFDEEFF-----SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (321)
T ss_dssp ---CCCHHHH-----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred ---ccChhhh-----cccCHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 0111110 01123578899999999999999999999987753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.45 Aligned_cols=254 Identities=19% Similarity=0.274 Sum_probs=195.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC-----CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL-----KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 110 (345)
T 3hko_A 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110 (345)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCC
Confidence 578999999999999964 5678999998532 3345678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCC----------------------------------CCCCccchHHHHHHHHHHHHHHHHHhccCCC
Q 047954 347 GNGNLFNRIHGGKSS----------------------------------KNRIPFRCRSRLLVARGVARALEYLHHKDKS 392 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~----------------------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 392 (582)
++|+|.+++...... .....+++..++.++.||+.||+|||+.+
T Consensus 111 ~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-- 188 (345)
T 3hko_A 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-- 188 (345)
T ss_dssp CSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 999999998521110 00123467778889999999999999998
Q ss_pred CCCCcceecCCCCCCeeecCCC--ceEEeeccccccccCc--------ccccccccccCCCCCCC--CCCCcchhHHHHH
Q 047954 393 RTQSAVIHGNLKSTNILLDDNE--MVLVSDYGFSSLVAQP--------IAAQRMISYKSPEYQSS--KKISRKSDVWSFG 460 (582)
Q Consensus 393 ~~~~~ivH~Dlkp~NILl~~~~--~~kl~DfG~a~~~~~~--------~~~~~~~~y~aPE~~~~--~~~~~k~DVwS~G 460 (582)
|+||||||+|||++.++ .+||+|||+++.+... ....+++.|+|||.+.+ ..++.++||||||
T Consensus 189 -----ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 189 -----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp -----EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred -----ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 99999999999998776 8999999999765331 23347788999998865 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHH
Q 047954 461 CLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540 (582)
Q Consensus 461 vvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 540 (582)
|++|||++|+.||.... . ............. ...+.. ......+.+++.+||+.||++|||+.|+
T Consensus 264 ~il~el~~g~~pf~~~~----~---~~~~~~~~~~~~~--~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVN----D---ADTISQVLNKKLC--FENPNY------NVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHSSCSSCCSS----H---HHHHHHHHHCCCC--TTSGGG------GGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHCCCCCCCCC----h---HHHHHHHHhcccc--cCCccc------ccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 99999999999996432 1 1222222221111 011110 0112357789999999999999999999
Q ss_pred HHHHhhcc
Q 047954 541 VSELEIIK 548 (582)
Q Consensus 541 l~~L~~i~ 548 (582)
+++.+.-.
T Consensus 329 l~hp~~~~ 336 (345)
T 3hko_A 329 LQHPWISQ 336 (345)
T ss_dssp HHSHHHHT
T ss_pred hcChhhcc
Confidence 99887543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=330.03 Aligned_cols=257 Identities=15% Similarity=0.187 Sum_probs=201.1
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEE-EeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYY-FSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.++.+++|++++..+.++ ...+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 46799999999999996 6788999999865332 34688999999999998888777766 4566789999999 899
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee---cCCCceEEeeccccccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DfG~a~~~ 427 (582)
|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 91 L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~-------ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 91 LEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKN-------FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred HHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCC-------eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9999974332 4889999999999999999999998 9999999999999 48889999999999876
Q ss_pred cCc-----------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 428 AQP-----------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 428 ~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
... ....++..|+|||.+.+..++.++|||||||++|||++|+.||...... ........+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-TKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-SSSSHHHHHHHHHHHS
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch-hhhhhhhhhcccccCC
Confidence 443 2334778899999999999999999999999999999999999754322 1222222222211111
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCCcc
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEE 555 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 555 (582)
.... .. .....++.+++.+||+.||++|||+.+|++.|+.+........
T Consensus 238 ~~~~-~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~ 286 (296)
T 3uzp_A 238 PIEV-LC---------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp CHHH-HT---------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred chHH-HH---------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcc
Confidence 0000 00 0112358889999999999999999999999999876665443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.05 Aligned_cols=248 Identities=21% Similarity=0.358 Sum_probs=197.1
Q ss_pred ccccccccCceEEEEEEEcCC----ceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 272 PAEGLGKGIFGNSYKALLEGR----APVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
..+.||+|+||.||+|...+. ..||+|.+... .....+.+.+|+.++++++||||+++++++.. +..++||||+
T Consensus 16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 94 (281)
T 3cc6_A 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELY 94 (281)
T ss_dssp EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecC
Confidence 357899999999999986532 35999998754 33456789999999999999999999999764 4578999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 95 PYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLESIN-------CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp TTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999997532 24888999999999999999999998 99999999999999999999999999987
Q ss_pred ccCcc-----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 427 VAQPI-----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 427 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
..... ...++..|+|||.+.+..++.++||||||+++|||+| |+.||.... ..+....+.. .....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~----~~~~~~~~~~----~~~~~ 234 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE----NKDVIGVLEK----GDRLP 234 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----GGGHHHHHHH----TCCCC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC----hHHHHHHHhc----CCCCC
Confidence 65432 2335678999999988899999999999999999998 999996432 2223222211 11110
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
..+ .....+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 235 ~~~----------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 235 KPD----------LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCT----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC----------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 000 0112578899999999999999999999999988654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=330.66 Aligned_cols=247 Identities=20% Similarity=0.318 Sum_probs=199.0
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|.... +..||+|++........+.+.+|++++++++||||+++++++.+....++||||+++++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL 93 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcH
Confidence 4679999999999999764 568999999765555678899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee---cCCCceEEeecccccccc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DfG~a~~~~ 428 (582)
.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 94 ~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~-------i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 94 FERVVHKR------VFRESDAARIMKDVLSAVAYCHKLN-------VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp HHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred HHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99886532 4889999999999999999999998 9999999999999 788999999999997765
Q ss_pred Cc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 429 QP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 429 ~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
.. ....+++.|+|||.+.+. ++.++||||||+++|||++|+.||.... ..+.... ....... .....
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~----~~~~~~~-~~~~~ 230 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT----DSEVMLK----IREGTFT-FPEKD 230 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHH----HHHCCCC-CCHHH
T ss_pred CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC----HHHHHHH----HHhCCCC-CCchh
Confidence 43 234477889999988654 8999999999999999999999996432 1111111 1111110 00000
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.......+.+++.+||+.||++|||+.|+++|.+.-.
T Consensus 231 ------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 231 ------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp ------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred ------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 0011236788999999999999999999999877543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=341.48 Aligned_cols=255 Identities=19% Similarity=0.308 Sum_probs=201.7
Q ss_pred ccccccccCceEEEEEEEc------CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEE
Q 047954 272 PAEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 344 (582)
..+.||+|+||.||+|... .+..||||.+.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 108 (322)
T 1p4o_A 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 108 (322)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEE
Confidence 3578999999999999864 36789999997543 2344578999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcCCC----CCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEee
Q 047954 345 FAGNGNLFNRIHGGKS----SKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSD 420 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 420 (582)
|+++|+|.+++..... ......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-------i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-------FVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-------CBCSCCSGGGEEECTTCCEEECC
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-------CccCCCccceEEEcCCCeEEECc
Confidence 9999999999875321 001124688999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHH
Q 047954 421 YGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 421 fG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
||+++...... ...+++.|+|||.+.+..++.++||||||+++|||+| |+.||... ....+... .
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----~~~~~~~~----~ 253 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL----SNEQVLRF----V 253 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----CHHHHHHH----H
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC----CHHHHHHH----H
Confidence 99998664332 2234677999999988899999999999999999999 88998542 11122211 1
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
......... ......+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 254 ~~~~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 254 MEGGLLDKP----------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp HTTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred HcCCcCCCC----------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 111111110 011225788999999999999999999999999886533
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=335.13 Aligned_cols=248 Identities=25% Similarity=0.422 Sum_probs=200.3
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++. .+..++||||+++++|.
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence 46799999999999999888899999997543 34678999999999999999999999986 45689999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 96 ~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-------i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 96 DFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEERN-------YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp HHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred HHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-------eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9986421 124888999999999999999999998 9999999999999999999999999998765432
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||... ...++...+ ........ ..
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----~~~~~~~~~----~~~~~~~~-~~-- 233 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----TNPEVIQNL----ERGYRMVR-PD-- 233 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHH----HTTCCCCC-CT--
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc----CHHHHHHHH----hcccCCCC-cc--
Confidence 2234567999999988889999999999999999999 99998642 112222221 11111110 00
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
....++.+++.+||+.||++|||+.++++.|+.+....
T Consensus 234 -------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 234 -------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp -------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -------cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 11236788999999999999999999999999886443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=334.67 Aligned_cols=246 Identities=16% Similarity=0.266 Sum_probs=197.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||+|++... .......+.+|+..+.++ +||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 95 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence 467999999999999976 6889999998753 233456788999999998 999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC----------------
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD---------------- 412 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~---------------- 412 (582)
|+|.+++...... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 96 ~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~-------ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 96 GSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIHSMS-------LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp CBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEEC-----------------
T ss_pred CcHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHHhCC-------EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999753211 124889999999999999999999998 999999999999984
Q ss_pred ---CCceEEeeccccccccCcccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHH
Q 047954 413 ---NEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSW 488 (582)
Q Consensus 413 ---~~~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~ 488 (582)
...+||+|||.+..........++..|+|||.+.+. .++.++|||||||++|||++|..|+... ....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~- 238 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-------DQWH- 238 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-------HHHH-
T ss_pred cCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-------hHHH-
Confidence 447999999999888777667789999999998765 5678999999999999999998776321 1111
Q ss_pred HHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 489 VLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 489 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.........+.. .....+.+++.+||+.||++|||+.|+++|.+...
T Consensus 239 ---~~~~~~~~~~~~----------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 239 ---EIRQGRLPRIPQ----------VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp ---HHHTTCCCCCSS----------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred ---HHHcCCCCCCCc----------ccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 111111111110 01125788999999999999999999999877543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=371.35 Aligned_cols=243 Identities=23% Similarity=0.367 Sum_probs=195.9
Q ss_pred ccccccCceEEEEEEEc---CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLE---GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
+.||+|+||.||+|.+. .+..||||+++... ....+++.+|+.+|++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 45689999997532 3346789999999999999999999999964 568899999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++.+.
T Consensus 454 g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~~-------iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 454 GPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEESN-------FVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred CCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHCC-------EeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 99999997542 4889999999999999999999998 9999999999999999999999999998764
Q ss_pred Ccc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 429 QPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 429 ~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
... ...+++.|+|||++.+..++.++|||||||++|||+| |+.||... ...++...+ .......
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~----~~~~~~~~i----~~~~~~~ 592 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KGSEVTAML----EKGERMG 592 (635)
T ss_dssp C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHH----HTTCCCC
T ss_pred cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHH----HcCCCCC
Confidence 332 2234577999999998899999999999999999998 99999643 222222222 2221111
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.. .....++.+++.+||+.||++||++.+|++.|+.+.
T Consensus 593 ~p----------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 593 CP----------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CC----------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CC----------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11 111236888999999999999999999999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=332.35 Aligned_cols=242 Identities=24% Similarity=0.391 Sum_probs=196.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEe----------------
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS---------------- 335 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~---------------- 335 (582)
.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCE
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccC
Confidence 467999999999999976 78899999996543 357789999999999999999999865
Q ss_pred CCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc
Q 047954 336 NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM 415 (582)
Q Consensus 336 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~ 415 (582)
....++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~-------i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHSKK-------LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEEEETTE
T ss_pred cceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eeeccCCHHHEEEcCCCC
Confidence 3457899999999999999975432 25889999999999999999999998 999999999999999999
Q ss_pred eEEeeccccccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHH
Q 047954 416 VLVSDYGFSSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492 (582)
Q Consensus 416 ~kl~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 492 (582)
+||+|||+++..... ....++..|+|||.+.+..++.++||||||+++|||++|..|+.. . .. ....
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~------~---~~-~~~~ 230 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE------T---SK-FFTD 230 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH------H---HH-HHHH
T ss_pred EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh------H---HH-HHHH
Confidence 999999999876543 234477899999999988999999999999999999999988731 0 11 1111
Q ss_pred HhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 493 VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 493 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
.........++ ..+.+++.+||+.||++|||+.|++++|+.++....
T Consensus 231 ~~~~~~~~~~~-------------~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 231 LRDGIISDIFD-------------KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHTTCCCTTSC-------------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred hhcccccccCC-------------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11221111111 246788999999999999999999999999876544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=341.91 Aligned_cols=260 Identities=19% Similarity=0.312 Sum_probs=194.9
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC-----cchHHHHHHHHHHHhcC---CCCCccccceEEEeCC-----e
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK-----PLITEEFRKQLLVIADQ---KHPNLLPLLAYYFSND-----E 338 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~-----~ 338 (582)
.+.||+|+||+||+|+. .+++.||||++.... ......+.+|+.+++++ +||||+++++++.... .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 46799999999999995 567889999986322 12234566777777665 5999999999998765 4
Q ss_pred eEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEE
Q 047954 339 KLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLV 418 (582)
Q Consensus 339 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl 418 (582)
.++||||+. |+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~-------ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHANC-------IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCCT----TCSCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCTTTEEECTTSCEEE
T ss_pred EEEEehhhh-cCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEEcCCCCEEE
Confidence 789999996 699999976432 24899999999999999999999998 999999999999999999999
Q ss_pred eeccccccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh
Q 047954 419 SDYGFSSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE 495 (582)
Q Consensus 419 ~DfG~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 495 (582)
+|||+++...... ...+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+......
T Consensus 162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS----EADQLGKIFDLIGL 237 (308)
T ss_dssp CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS----HHHHHHHHHHHHCC
T ss_pred eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCC
Confidence 9999998765432 3356889999999988999999999999999999999999996432 22222222222211
Q ss_pred ----cccccccchh--hh------hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 496 ----EWTAEIFDSE--IS------VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 496 ----~~~~~~~d~~--~~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.|......+. +. ......+...++.+++.+||+.||++|||+.|+++|.|...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 1110000000 00 00000111236788999999999999999999999887554
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=337.98 Aligned_cols=250 Identities=19% Similarity=0.280 Sum_probs=197.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++.++ .||||+++++++...+..++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (327)
T 3lm5_A 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113 (327)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence 478999999999999965 5789999998643 234467899999999998 569999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC---CCceEEeeccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD---NEMVLVSDYGFSS 425 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DfG~a~ 425 (582)
|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 114 ~~L~~~~~~~~~----~~~~~~~~~~i~~ql~~~L~~LH~~g-------ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 114 GEIFSLCLPELA----EMVSENDVIRLIKQILEGVYYLHQNN-------IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred CcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC-------eecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 999999864322 25889999999999999999999998 999999999999998 7899999999998
Q ss_pred cccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 426 LVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 426 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
...... ...+++.|+|||++.+..++.++|||||||++|||++|+.||.... .......+... ......+.
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~-~~~~~~~~- 256 (327)
T 3lm5_A 183 KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED----NQETYLNISQV-NVDYSEET- 256 (327)
T ss_dssp EC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHT-CCCCCTTT-
T ss_pred ccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHHHhc-ccccCchh-
Confidence 765432 3357889999999999999999999999999999999999996422 11111111110 00101100
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.......+.+++.+||+.||++|||++|++++.+.-.
T Consensus 257 ---------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~ 293 (327)
T 3lm5_A 257 ---------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293 (327)
T ss_dssp ---------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred ---------hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence 0011235778999999999999999999999987543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=341.56 Aligned_cols=255 Identities=20% Similarity=0.310 Sum_probs=197.4
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCC-----CCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-----HPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|.. .++..||||+++.. ....+.+..|+.++.++. ||||+++++++...+..++||||+
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 118 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC
Confidence 46799999999999997 46788999999642 334567788999999886 999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC--------------
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD-------------- 412 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~-------------- 412 (582)
+++|.+++...... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 119 -~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~-------ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 119 -GPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLRKMS-------LTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp -CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred -CCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCC-------eeeCCCCcccEEEccccccccccchhccc
Confidence 89999999865422 4888999999999999999999998 999999999999975
Q ss_pred -----------CCceEEeeccccccccCc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 047954 413 -----------NEMVLVSDYGFSSLVAQP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGI 480 (582)
Q Consensus 413 -----------~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~ 480 (582)
++.+||+|||+++..... ....+++.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--- 263 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE--- 263 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS---
T ss_pred ccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc---
Confidence 788999999999876543 34457889999999999999999999999999999999999996432
Q ss_pred CccchHHHHHHHHhhcccccc------------cchh-----hhhhhch---------------HHHHHHHHHHHHHccc
Q 047954 481 NGADLCSWVLRAVREEWTAEI------------FDSE-----ISVQRSA---------------AHGMLKLLQVAIQCCN 528 (582)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~------------~d~~-----~~~~~~~---------------~~~~~~l~~l~~~Cl~ 528 (582)
..+....+...... ..... .+.. ....... ......+.+++.+||+
T Consensus 264 -~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 264 -HMEHLAMMESIIQP-IPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp -HHHHHHHHHHHTCC-CCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred -HHHHHHHHHHhcCC-CCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 12222222111100 00000 0000 0000000 0001457799999999
Q ss_pred CCCCCCCChHHHHHHHh
Q 047954 529 KSPEKRPEMAEVVSELE 545 (582)
Q Consensus 529 ~dP~~RPs~~evl~~L~ 545 (582)
.||++|||+.|+++|.|
T Consensus 342 ~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 342 IDPTLRPSPAELLKHKF 358 (360)
T ss_dssp SSGGGSCCHHHHTTSGG
T ss_pred CChhhCCCHHHHhcCcc
Confidence 99999999999998765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=343.12 Aligned_cols=255 Identities=18% Similarity=0.231 Sum_probs=191.3
Q ss_pred cccccccCceEEEEEEEc----CCceEEEEEecCCCcch-----------HHHHHHHHHHHhcCCCCCccccceEEEe--
Q 047954 273 AEGLGKGIFGNSYKALLE----GRAPVVVKRLRDLKPLI-----------TEEFRKQLLVIADQKHPNLLPLLAYYFS-- 335 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~H~niv~l~~~~~~-- 335 (582)
.+.||+|+||.||+|... .+..||||+........ .+.+.+|+..+..++||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~ 121 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF 121 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence 467999999999999975 56789999986543211 1246678889999999999999999988
Q ss_pred --CCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC
Q 047954 336 --NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN 413 (582)
Q Consensus 336 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~ 413 (582)
....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 122 ~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~-------ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 122 KGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHENE-------YVHGDIKAANLLLGYK 187 (345)
T ss_dssp SSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEEESS
T ss_pred CCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eeCCCcCHHHEEEccC
Confidence 67889999999 999999986432 5899999999999999999999998 9999999999999988
Q ss_pred C--ceEEeeccccccccCc-----------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 047954 414 E--MVLVSDYGFSSLVAQP-----------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGI 480 (582)
Q Consensus 414 ~--~~kl~DfG~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~ 480 (582)
+ .+||+|||+++.+... ....++..|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-- 265 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK-- 265 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT--
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc--
Confidence 7 9999999999766432 223467899999999998999999999999999999999999953211
Q ss_pred CccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 481 NGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
................... +...........++.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 266 -~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 266 -DPVAVQTAKTNLLDELPQS-----VLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -CHHHHHHHHHHHHHTTTHH-----HHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -ccHHHHHHHHhhcccccHH-----HHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111111111111110 00000000122368889999999999999999999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=341.12 Aligned_cols=242 Identities=22% Similarity=0.287 Sum_probs=196.5
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCC---CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDL---KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|+... ++.||+|+++.. .....+.+..|..++..+ +||||+++++++.+.+..++||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 4679999999999999764 678999998643 123456788999999987 89999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 105 gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~g-------ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 105 GGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSKG-------IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp SCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999997532 4888999999999999999999998 999999999999999999999999999864
Q ss_pred cC----cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQ----PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~----~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
.. .....+|+.|+|||++.+..++.++|||||||++|||++|+.||... +...+...+ ..... .. .
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~----~~~~~~~~i---~~~~~--~~-p 241 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE----DEDELFQSI---MEHNV--AY-P 241 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHH---HHCCC--CC-C
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC----CHHHHHHHH---HhCCC--CC-C
Confidence 32 22345789999999999999999999999999999999999999642 222222222 11111 00 0
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHHhh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSELEI 546 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~ 546 (582)
. ....++.+++.+||..||++||+ ++||++|.+.
T Consensus 242 ~---------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f 280 (353)
T 2i0e_A 242 K---------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280 (353)
T ss_dssp T---------TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred C---------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence 0 11125778999999999999995 5889888764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=338.80 Aligned_cols=254 Identities=18% Similarity=0.291 Sum_probs=198.8
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhc--CCCCCccccceEEEeCC----eeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIAD--QKHPNLLPLLAYYFSND----EKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~~----~~~lv~e~~ 346 (582)
.+.||+|+||.||+|+.. ++.||||++.. ...+.+.+|.+++.. ++||||+++++++.... ..++||||+
T Consensus 47 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~ 122 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122 (342)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCC
T ss_pred EeeecCCCCcEEEEEEEc-CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeec
Confidence 568999999999999984 78899999853 345677888888877 79999999999998876 789999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHh--------ccCCCCCCCcceecCCCCCCeeecCCCceEE
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH--------HKDKSRTQSAVIHGNLKSTNILLDDNEMVLV 418 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl 418 (582)
++|+|.+++... .+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 123 ~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-------ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 123 EHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-------IAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp TTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE-------EECSCCSGGGEEECTTSCEEE
T ss_pred CCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC-------eeeCCCCHHHEEECCCCCEEE
Confidence 999999999743 4889999999999999999999 665 999999999999999999999
Q ss_pred eeccccccccCcc--------cccccccccCCCCCCCCC------CCcchhHHHHHHHHHHHHhC----------CCCCC
Q 047954 419 SDYGFSSLVAQPI--------AAQRMISYKSPEYQSSKK------ISRKSDVWSFGCLLLELLTG----------RISTH 474 (582)
Q Consensus 419 ~DfG~a~~~~~~~--------~~~~~~~y~aPE~~~~~~------~~~k~DVwS~Gvvl~elltG----------~~P~~ 474 (582)
+|||+++...... ...++..|+|||.+.+.. ++.++|||||||++|||+|| +.||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999997664432 234778999999987652 34789999999999999999 77876
Q ss_pred CCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 475 SAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
..... .... ..+.......... +.+.......+....+.+++.+||+.||++|||+.||+++|+.+....
T Consensus 269 ~~~~~--~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 269 DLVPS--DPSV-EEMRKVVCEQKLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTSCS--SCCH-HHHHHHHTTSCCC----CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccCcC--cccH-HHHHHHHHHHHhC----CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 43321 1111 2222222221111 111111112344557889999999999999999999999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.60 Aligned_cols=249 Identities=23% Similarity=0.294 Sum_probs=202.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+|++++|||||++++++.+.+..++||||+++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 467999999999999975 6889999998542 123356688999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++..... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++.+.
T Consensus 269 g~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~~g-------IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 269 GDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHRER-------IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp CBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999975432 24889999999999999999999998 9999999999999999999999999998765
Q ss_pred Cc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 429 QP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 429 ~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
.. ....+|+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ..+... .... ...
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~----~~i~~~-~~~~-p~~ 411 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----RLVKEV-PEEY-SER 411 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH----HHHHHC-CCCC-CTT
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH----HHhhcc-cccC-Ccc
Confidence 43 23457899999999999899999999999999999999999997543221111222 221111 1111 111
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhhc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEII 547 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~i 547 (582)
...++.+|+.+||+.||++|| +++||++|.+.-
T Consensus 412 ---------~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~ 449 (576)
T 2acx_A 412 ---------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449 (576)
T ss_dssp ---------SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred ---------CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence 112577899999999999999 789999997754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=331.63 Aligned_cols=248 Identities=22% Similarity=0.347 Sum_probs=192.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||+++|+
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 106 (285)
T 3is5_A 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCB
T ss_pred cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCc
Confidence 578999999999999964 57889999986432 3456789999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee---cCCCceEEeeccccccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DfG~a~~~ 427 (582)
|.+++...... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 107 L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~-------ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 107 LLERIVSAQAR--GKALSEGYVAELMKQMMNALAYFHSQH-------VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp HHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred HHHHHHhhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC-------EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99988643211 125889999999999999999999998 9999999999999 45678999999999876
Q ss_pred cCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 428 AQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 428 ~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
... ....++..|+|||.+. ..++.++||||||+++|||++|+.||.... ...+.. ..............
T Consensus 178 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~----~~~~~~---~~~~~~~~~~~~~~ 249 (285)
T 3is5_A 178 KSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEVQQ---KATYKEPNYAVECR 249 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH---HHHHCCCCCCC--C
T ss_pred CCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC----HHHHHh---hhccCCcccccccC
Confidence 543 2344778899999875 568999999999999999999999996422 111111 11111100000000
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
....++.+++.+||+.||++|||+.|++++.+.
T Consensus 250 ---------~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f 282 (285)
T 3is5_A 250 ---------PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282 (285)
T ss_dssp ---------CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred ---------cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence 011257789999999999999999999988664
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=353.53 Aligned_cols=243 Identities=20% Similarity=0.327 Sum_probs=198.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 100 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 467999999999999975 68899999986421 22356789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 101 g~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g-------ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 101 GELFDYICKN------GRLDEKESRRLFQQILSGVDYCHRHM-------VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEHHHHTTSS------SSCCHHHHHHHHHHHHHHHHHHHTTT-------EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-------CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999643 24889999999999999999999998 9999999999999999999999999998765
Q ss_pred Ccc---cccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QPI---AAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~~---~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
... ...+++.|+|||++.+..+ +.++|||||||++|||++|+.||.... ...+.. ........ . +
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~---~i~~~~~~--~--p 236 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH----VPTLFK---KICDGIFY--T--P 236 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS----SHHHHH---HHHTTCCC--C--C
T ss_pred ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC----HHHHHH---HHhcCCcC--C--C
Confidence 432 3457889999999988765 789999999999999999999996432 112222 11111110 0 0
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
. ....++.+++.+||+.||++|||+.|+++|.+..
T Consensus 237 -----~---~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~ 271 (476)
T 2y94_A 237 -----Q---YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271 (476)
T ss_dssp -----T---TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred -----c---cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence 0 0112577899999999999999999999987653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=343.40 Aligned_cols=251 Identities=22% Similarity=0.335 Sum_probs=184.8
Q ss_pred ccccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCC-CCCccccceEEEe--------CCeeEE
Q 047954 272 PAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-HPNLLPLLAYYFS--------NDEKLL 341 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--------~~~~~l 341 (582)
..+.||+|+||.||+|... +++.||||++........+.+.+|+.++.++. ||||+++++++.. ....++
T Consensus 32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~l 111 (337)
T 3ll6_A 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111 (337)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEE
T ss_pred EEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEE
Confidence 4578999999999999964 67889999987666566678999999999996 9999999999953 334789
Q ss_pred EEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
||||+. |+|.+++..... ...+++..++.++.||+.||+|||+.++ +|+||||||+|||++.++.+||+||
T Consensus 112 v~e~~~-g~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~-----~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 112 LTELCK-GQLVEFLKKMES---RGPLSCDTVLKIFYQTCRAVQHMHRQKP-----PIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEECCS-EEHHHHHHHHHT---TCSCCHHHHHHHHHHHHHHHHHHHTSSS-----CCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred EEEecC-CCHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCC-----CEEEccCCcccEEECCCCCEEEecC
Confidence 999995 799998865221 1258999999999999999999999862 4999999999999999999999999
Q ss_pred cccccccCcc----------------cccccccccCCCCC---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 047954 422 GFSSLVAQPI----------------AAQRMISYKSPEYQ---SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGING 482 (582)
Q Consensus 422 G~a~~~~~~~----------------~~~~~~~y~aPE~~---~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~ 482 (582)
|+++...... ...+++.|+|||++ .+..++.++|||||||++|||+||+.||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 9998765422 22367889999998 5667899999999999999999999999642211
Q ss_pred cchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 483 ADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
..... .......+ .....+.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 260 ----~~~~~----~~~~~~~~----------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 260 ----RIVNG----KYSIPPHD----------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp --------------CCCCTTC----------CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ----HhhcC----cccCCccc----------ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 00100 00000000 001136788999999999999999999999999876443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.51 Aligned_cols=244 Identities=21% Similarity=0.308 Sum_probs=190.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... ++..||||++... .......+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 232 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 232 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSS
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCC
Confidence 478999999999999964 6788999998642 233445678899999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhc-cCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH-KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
|+|.+++.... .+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++..
T Consensus 233 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~g-------iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 233 GELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEKN-------VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp CBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHTC-------CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcCC-------EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999987532 48899999999999999999998 77 999999999999999999999999999864
Q ss_pred cCc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ..... .+ .
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~i---~~~~~--~~-p 369 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFELI---LMEEI--RF-P 369 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHH---HHCCC--CC-C
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC----HHHHHHHH---HhCCC--CC-C
Confidence 332 23457889999999999999999999999999999999999996421 12222211 11111 00 0
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhhcc
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEIIK 548 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~i~ 548 (582)
. ....++.+++.+||+.||++|| +++|+++|.+.-.
T Consensus 370 ~---------~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 370 R---------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp T---------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred c---------cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 0 0112577899999999999999 9999999987543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=332.11 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=197.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... +++.||+|.++.......+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccH
Confidence 467999999999999975 6788999999765544556789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee---cCCCceEEeecccccccc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DfG~a~~~~ 428 (582)
.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++...
T Consensus 94 ~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 94 FDRILERG------VYTEKDASLVIQQVLSAVKYLHENG-------IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred HHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99986532 4788999999999999999999998 9999999999999 788899999999997654
Q ss_pred Ccc--cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 429 QPI--AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 429 ~~~--~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
... ...++..|+|||.+.+..++.++|||||||++|||++|+.||.... ...+.. .+...... ...+ .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~----~i~~~~~~-~~~~-~ 230 (304)
T 2jam_A 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET----ESKLFE----KIKEGYYE-FESP-F 230 (304)
T ss_dssp CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHH----HHHHCCCC-CCTT-T
T ss_pred CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HHHHHH----HHHcCCCC-CCcc-c
Confidence 432 2346789999999999999999999999999999999999996421 112221 11111110 0000 0
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
......++.+++.+||+.||++|||+.|++++.+.-.
T Consensus 231 -----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 231 -----WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp -----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred -----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 0011235788999999999999999999999887543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=343.16 Aligned_cols=238 Identities=21% Similarity=0.312 Sum_probs=195.8
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCc--------chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKP--------LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 343 (582)
.+.||+|+||.||+|.. .++..||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 108 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence 46799999999999985 4678899999875431 12345778999999999999999999999999999999
Q ss_pred EeCCCC-ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecc
Q 047954 344 KFAGNG-NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG 422 (582)
Q Consensus 344 e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 422 (582)
||+..| +|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 109 e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~-------ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 109 EKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLKD-------IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp ECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECTTSCEEECCCT
T ss_pred EeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eEEeccCHHHEEEcCCCcEEEeecc
Confidence 999877 9999997542 4889999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCcc---cccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 423 FSSLVAQPI---AAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 423 ~a~~~~~~~---~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
+++...... ...+++.|+|||++.+..+ +.++|||||||++|||++|+.||...... .
T Consensus 176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------~ 237 (335)
T 3dls_A 176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------V 237 (335)
T ss_dssp TCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------T
T ss_pred cceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------H
Confidence 998765432 3347889999999988776 88999999999999999999999642110 0
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
...... ... ...++.+++.+||+.||++|||+.|++++.|.-.
T Consensus 238 ~~~~~~----~~~---~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 238 EAAIHP----PYL---VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp TTCCCC----SSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred hhccCC----Ccc---cCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 000000 000 1125788999999999999999999999988654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.53 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=199.9
Q ss_pred cccccccCceEEEEEEEc-----CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeC--CeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-----GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--DEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 344 (582)
.+.||+|+||.||++.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 115 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence 467999999999998753 57889999997543 33456789999999999999999999999884 57899999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++|+|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~~~-------ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 116 YVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHAQH-------YIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp CCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred cccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhCC-------ccCCCCchheEEEcCCCCEEECCcccc
Confidence 99999999999643 3888999999999999999999998 999999999999999999999999999
Q ss_pred ccccCcc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-------CCccchHHHHH
Q 047954 425 SLVAQPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQG-------INGADLCSWVL 490 (582)
Q Consensus 425 ~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~-------~~~~~~~~~~~ 490 (582)
+...... ...++..|+|||.+.+..++.++||||||+++|||+||+.||...... .........+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 8765432 223566799999998888999999999999999999999998642110 00000000111
Q ss_pred HHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 491 RAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 491 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
.......... .......++.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 262 ~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 262 ELLERGERLP----------RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhcccCCC----------CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 1111111100 01112236889999999999999999999999999886543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=327.22 Aligned_cols=249 Identities=19% Similarity=0.271 Sum_probs=199.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 90 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence 467999999999999965 5788999998643 2334567889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc---eEEeecccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM---VLVSDYGFSSL 426 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DfG~a~~ 426 (582)
+|.+.+.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 91 ~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 91 ELFEDIVARE------FYSEADASHCIQQILESIAYCHSNG-------IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp BHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred CHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999886532 4889999999999999999999998 999999999999986655 99999999977
Q ss_pred ccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 427 VAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 427 ~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
..... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+ ...... ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~---~~~~~~--~~~ 228 (284)
T 3kk8_A 158 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQI---KAGAYD--YPS 228 (284)
T ss_dssp CCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHH---HHTCCC--CCT
T ss_pred cccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc----hhHHHHHH---Hhcccc--CCc
Confidence 65433 2457889999999999999999999999999999999999996421 11222111 111110 000
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
+.. .....++.+++.+||+.||++|||+.|++++.+....
T Consensus 229 ~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 229 PEW------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp TTT------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred hhh------cccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 000 0111257789999999999999999999999876443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=329.29 Aligned_cols=245 Identities=22% Similarity=0.378 Sum_probs=179.5
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence 46799999999999996 578889999985321 12346789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 96 GEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHSHG-------ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT-------EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999997542 25889999999999999999999998 9999999999999999999999999998764
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.. ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .. ..... ..+...
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~---~~~~~----~~~~~~- 231 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK----NT---LNKVV----LADYEM- 231 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CC----SSCCCC-
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH----HH---HHHHh----hcccCC-
Confidence 32 2234678899999999888999999999999999999999999653221 10 00000 000000
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.. ....++.+++.+||+.||++|||+.+++++.+...
T Consensus 232 ----~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 232 ----PS---FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp ----CT---TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred ----cc---ccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 00 01125778999999999999999999999877544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=333.97 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=194.5
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (310)
T 2wqm_A 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116 (310)
T ss_dssp EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCS
T ss_pred EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCC
Confidence 46799999999999996 46889999999743 233456789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 117 ~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-------i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 117 GDLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMHSRR-------VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp CBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred CCHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHhhCC-------eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999998642211 225888999999999999999999998 9999999999999999999999999987764
Q ss_pred Ccc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
... ...++..|+|||.+.+..++.++||||||+++|||++|+.||.... ......... ............
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~-~~~~~~~~~~~~ 261 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKK-IEQCDYPPLPSD 261 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCHHHHHHH-HHTTCSCCCCTT
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc-----hhHHHHHHH-hhcccCCCCccc
Confidence 432 2346788999999999999999999999999999999999996422 112222211 111111111111
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
....++.+++.+||+.||++|||+.+|++.|+.+.....
T Consensus 262 ---------~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 262 ---------HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp ---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---------ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 111257889999999999999999999999999976544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=334.13 Aligned_cols=259 Identities=20% Similarity=0.339 Sum_probs=196.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc--chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence 467999999999999975 478899999865432 23567889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~l~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~-------ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 88 VLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHKHN-------CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp HHHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred hHHHHHhhhc------CCCHHHHHHHHHHHHHHHHHHHHCC-------CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9998886432 4889999999999999999999998 99999999999999999999999999987653
Q ss_pred cc----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh---------
Q 047954 430 PI----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE--------- 495 (582)
Q Consensus 430 ~~----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--------- 495 (582)
.. ...++..|+|||.+.+ ..++.++|||||||++|||+||+.||.... ..+....+......
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS----DVDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhccccccccccc
Confidence 32 2346788999998875 578999999999999999999999996432 12222222221111
Q ss_pred ---ccccc--ccchhh--hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 496 ---EWTAE--IFDSEI--SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 496 ---~~~~~--~~d~~~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.+... +.++.. ............+.+++.+||+.||++|||++|+++|.+.-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 00000 000000 000000112235788999999999999999999999977544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.67 Aligned_cols=268 Identities=17% Similarity=0.236 Sum_probs=204.6
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCC--eeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSND--EKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||||+++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 4679999999999999764 7899999997432 234577889999999999999999999998765 67999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee----cCCCceEEeecccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL----DDNEMVLVSDYGFS 424 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DfG~a 424 (582)
|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 94 g~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~-------ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 94 GSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRENG-------IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEHHHHTTSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred CCHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC-------EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999975432 123889999999999999999999998 9999999999999 77888999999999
Q ss_pred ccccCcc---cccccccccCCCCCCC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHH
Q 047954 425 SLVAQPI---AAQRMISYKSPEYQSS--------KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 425 ~~~~~~~---~~~~~~~y~aPE~~~~--------~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
+...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||..........++...+....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 8765443 3347889999998764 4678899999999999999999999975432222222222222211
Q ss_pred hhccccccc---------chhhhh-hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 494 REEWTAEIF---------DSEISV-QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 494 ~~~~~~~~~---------d~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
.......+. ...+.. ..........+.+++.+||+.||++||++.|++++++.+...
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111110000 000000 011234455678999999999999999999999999887643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=328.87 Aligned_cols=256 Identities=15% Similarity=0.196 Sum_probs=199.0
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEE-EeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYY-FSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.++.+++|++++..++++ ...+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCC
Confidence 46799999999999996 567889999875432 223578899999999998888877766 5567789999999 999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee---cCCCceEEeeccccccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DfG~a~~~ 427 (582)
|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 91 L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~-------ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 91 LEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKN-------FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp HHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred HHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999975332 4889999999999999999999998 9999999999999 78899999999999876
Q ss_pred cCcc-----------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 428 AQPI-----------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 428 ~~~~-----------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
.... ...++..|+|||.+.+..++.++|||||||++|||++|+.||......... .....+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-hhhhhhhcccccc
Confidence 4432 334678999999999999999999999999999999999999764332221 2222221111110
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCCc
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTE 554 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 554 (582)
... ... .....++.+++.+||+.||++|||+.+|++.|+.+.......
T Consensus 238 ~~~-~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 238 PIE-VLC---------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp CHH-HHT---------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred hhh-hhh---------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 000 000 011236888999999999999999999999999987655543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.89 Aligned_cols=256 Identities=22% Similarity=0.374 Sum_probs=201.2
Q ss_pred ccccccccCceEEEEEEE-----cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCC--eeEEEEE
Q 047954 272 PAEGLGKGIFGNSYKALL-----EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND--EKLLVYK 344 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~e 344 (582)
..+.||+|+||.||+|.+ .++..||||++........+.+.+|+.++++++||||+++++++...+ ..++|||
T Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEE
Confidence 357899999999999984 367889999998766666778999999999999999999999987654 6799999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 125 ~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~-------ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTKR-------YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCC-------EeccCCCcceEEEcCCCcEEEecCcch
Confidence 9999999999976432 4889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCcc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------CCCccchHHHH
Q 047954 425 SLVAQPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQ--------GINGADLCSWV 489 (582)
Q Consensus 425 ~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~--------~~~~~~~~~~~ 489 (582)
+...... ...++..|+|||.+.+..++.++||||||+++|||+||+.|+..... ..........+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 8765432 22345679999999888899999999999999999999998853210 00001111111
Q ss_pred HHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 490 LRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 490 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
............ ......++.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 273 ~~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 273 IELLKNNGRLPR----------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHTTCCCCC----------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCC----------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111111100 01112368889999999999999999999999998764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=333.38 Aligned_cols=244 Identities=23% Similarity=0.368 Sum_probs=195.4
Q ss_pred cccccCceEEEEEEEc---CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 275 GLGKGIFGNSYKALLE---GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.||+|+||.||+|.+. .+..||||+++... ....+.+.+|+.++++++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 7999999999999653 35789999997542 23357899999999999999999999999 567789999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~-------i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 103 PLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEESN-------FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhCC-------eEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 9999997542 4888999999999999999999998 99999999999999999999999999987644
Q ss_pred cc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 430 PI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 430 ~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
.. ...++..|+|||.+.+..++.++||||||+++|||+| |+.||.... ...+... +........
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~----~~~~~~~~~ 241 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----GSEVTAM----LEKGERMGC 241 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHH----HHTTCCCCC
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHH----HHcCCCCCC
Confidence 32 1224577999999988889999999999999999999 999996421 2222222 221111111
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
. ......+.+++.+||+.||++|||+.++++.|+.+-..
T Consensus 242 -~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 242 -P---------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp -C---------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -C---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0 01123578899999999999999999999999987543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=330.67 Aligned_cols=249 Identities=18% Similarity=0.321 Sum_probs=196.4
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
..||+|+||.||+|.. .++..||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999996 457789999997766666788999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC-CCceEEeeccccccccCc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD-NEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DfG~a~~~~~~- 430 (582)
+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||+++.....
T Consensus 108 ~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 108 ALLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHDNQ-------IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp HHHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred HHHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHhCC-------EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99976432 234678888999999999999999998 999999999999987 899999999999776432
Q ss_pred ---ccccccccccCCCCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 431 ---IAAQRMISYKSPEYQSSK--KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~~~--~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
....++..|+|||++.+. .++.++||||||+++|||++|+.||..... . ...............+ ..
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~--~~~~~~~~~~~~~~~~-~~- 249 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE----P--QAAMFKVGMFKVHPEI-PE- 249 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS----H--HHHHHHHHHHCCCCCC-CT-
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc----h--hHHHHhhccccccccc-cc-
Confidence 234577899999998654 388999999999999999999999953211 1 1111111111111111 00
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
....++.+++.+||+.||++|||+.|++++.+...
T Consensus 250 --------~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 250 --------SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp --------TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred --------cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 11225778999999999999999999998876543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=337.29 Aligned_cols=254 Identities=23% Similarity=0.367 Sum_probs=200.3
Q ss_pred cccccccCceEEEEEEE------cCCceEEEEEecCCCc-chHHHHHHHHHHHhcC-CCCCccccceEEEeCC-eeEEEE
Q 047954 273 AEGLGKGIFGNSYKALL------EGRAPVVVKRLRDLKP-LITEEFRKQLLVIADQ-KHPNLLPLLAYYFSND-EKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~-~~~lv~ 343 (582)
.+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+.++.++ +||||+++++++...+ ..++||
T Consensus 32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~ 111 (316)
T 2xir_A 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111 (316)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence 56899999999999984 3457899999975432 3446789999999999 7999999999988765 489999
Q ss_pred EeCCCCChHHHHhcCCCCC----------CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC
Q 047954 344 KFAGNGNLFNRIHGGKSSK----------NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN 413 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~ 413 (582)
||+++|+|.+++....... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-------i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-------CIHRDLAARNILLSEK 184 (316)
T ss_dssp ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECGG
T ss_pred EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC-------cccccCccceEEECCC
Confidence 9999999999998654210 0123889999999999999999999998 9999999999999999
Q ss_pred CceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchH
Q 047954 414 EMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLC 486 (582)
Q Consensus 414 ~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~ 486 (582)
+.+||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||..... ...+
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~- 260 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DEEF- 260 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC---SHHH-
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch---hHHH-
Confidence 999999999998764322 2235678999999988899999999999999999998 9999964321 1111
Q ss_pred HHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 487 SWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 487 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
.............+ ....++.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 261 ---~~~~~~~~~~~~~~----------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 261 ---CRRLKEGTRMRAPD----------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp ---HHHHHHTCCCCCCT----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHhccCccCCCCC----------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 12222211111110 0112578899999999999999999999999988653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=345.17 Aligned_cols=257 Identities=18% Similarity=0.189 Sum_probs=199.2
Q ss_pred cccccccCceEEEEEEEcC---------CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccc---------------
Q 047954 273 AEGLGKGIFGNSYKALLEG---------RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLP--------------- 328 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~--------------- 328 (582)
.+.||+|+||.||+|.... +..||+|.+... +.+.+|+.++++++||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 4679999999999999764 788999998643 45889999999999999988
Q ss_pred cceEEEe-CCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCC
Q 047954 329 LLAYYFS-NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTN 407 (582)
Q Consensus 329 l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~N 407 (582)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~-------ivH~Dikp~N 189 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHENE-------YVHGNVTAEN 189 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHTT-------CBCSCCCGGG
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHhCC-------ccCCCCCHHH
Confidence 6777776 67889999999 999999998542 125899999999999999999999998 9999999999
Q ss_pred eeecCCC--ceEEeeccccccccCcc-----------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 047954 408 ILLDDNE--MVLVSDYGFSSLVAQPI-----------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTH 474 (582)
Q Consensus 408 ILl~~~~--~~kl~DfG~a~~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~ 474 (582)
||++.++ .+||+|||+++.+.... ...+++.|+|||.+.+..++.++|||||||++|||+||+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 89999999997764321 2256789999999999899999999999999999999999996
Q ss_pred CCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCCc
Q 047954 475 SAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTE 554 (582)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 554 (582)
.... ....+...... .... .....+..... .....++.+++.+||+.||++|||+++|++.|+.+.......
T Consensus 270 ~~~~--~~~~~~~~~~~-~~~~-~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 270 NCLP--NTEDIMKQKQK-FVDK-PGPFVGPCGHW----IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GGTT--CHHHHHHHHHH-HHHS-CCCEECTTSCE----ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCCc--CHHHHHHHHHh-ccCC-hhhhhhhcccc----CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 4321 11122222111 1111 11111110000 001136788999999999999999999999999987665543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=328.76 Aligned_cols=244 Identities=24% Similarity=0.403 Sum_probs=195.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence 467999999999999865 45689999985421 22356788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~l~~~l~~~~------~~~~~~~~~~~~qi~~~l~~LH~~~-------i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 94 GTVYRELQKLS------KFDEQRTATYITELANALSYCHSKR-------VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTTT-------CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999987532 4888999999999999999999998 9999999999999999999999999986654
Q ss_pred Cc--ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 429 QP--IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 429 ~~--~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.. ....++..|+|||.+.+..++.++||||||+++|||++|+.||.... .......+ ..... .. ..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~---~~~~~--~~-~~-- 228 (279)
T 3fdn_A 161 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----YQETYKRI---SRVEF--TF-PD-- 228 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHH---HHTCC--CC-CT--
T ss_pred cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc----HHHHHHHH---HhCCC--CC-CC--
Confidence 33 23457789999999999999999999999999999999999996421 11111111 11110 00 00
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.....+.+++.+||+.||++|||+.|+++|.+...
T Consensus 229 -------~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 229 -------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp -------TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred -------cCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 01125778999999999999999999999988654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=329.11 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=199.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 467999999999999976 4678999988543 233456789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~-------i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 100 RSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRNR-------VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp CBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999886432 4889999999999999999999998 9999999999999999999999999997764
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.. ....++..|+|||.+.+..++.++||||||+++|||+||+.||.... ............. .. ..
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~--~~-~~ 236 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-------LKETYLRIKKNEY--SI-PK 236 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTTCC--CC-CT
T ss_pred cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhhccC--CC-cc
Confidence 32 22346788999999998889999999999999999999999996422 1111111111111 00 00
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.....+.+++.+||+.||++|||++|++++.+....
T Consensus 237 ---------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 237 ---------HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp ---------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ---------ccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 011257789999999999999999999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=344.42 Aligned_cols=256 Identities=20% Similarity=0.338 Sum_probs=186.5
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC--CcchHHHHHHHHHHHhcCC-CCCccccceEEEeCC--eeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQK-HPNLLPLLAYYFSND--EKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~~lv~e~~ 346 (582)
.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..++|||||
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 46799999999999986 46788999998643 2334567889999999997 999999999998654 689999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
. |+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 94 ~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~-------ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 94 E-TDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHSGG-------LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp S-EEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred C-cCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCC-------EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 7 6999998753 4788899999999999999999998 99999999999999999999999999976
Q ss_pred ccCc-------------------------ccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 047954 427 VAQP-------------------------IAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGI 480 (582)
Q Consensus 427 ~~~~-------------------------~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~ 480 (582)
+... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--- 235 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS--- 235 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---
Confidence 5321 12347788999999876 678999999999999999999999996432
Q ss_pred CccchHHHHHHHHhhccccc---ccch----------------------hhhh-------hhchHHHHHHHHHHHHHccc
Q 047954 481 NGADLCSWVLRAVREEWTAE---IFDS----------------------EISV-------QRSAAHGMLKLLQVAIQCCN 528 (582)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~---~~d~----------------------~~~~-------~~~~~~~~~~l~~l~~~Cl~ 528 (582)
..+....+........... +..+ .+.. .........++.+|+.+||.
T Consensus 236 -~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 236 -TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp -HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred -HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 2222222221111000000 0000 0000 00000112367899999999
Q ss_pred CCCCCCCChHHHHHHHhhc
Q 047954 529 KSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 529 ~dP~~RPs~~evl~~L~~i 547 (582)
.||++|||++|+++|.+.-
T Consensus 315 ~dP~~R~t~~e~l~Hp~~~ 333 (388)
T 3oz6_A 315 FNPNKRISANDALKHPFVS 333 (388)
T ss_dssp SSGGGSCCHHHHTTSTTTT
T ss_pred cCcccCCCHHHHhCCHHHH
Confidence 9999999999999997754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=354.13 Aligned_cols=247 Identities=15% Similarity=0.176 Sum_probs=195.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||+||+|+.. +++.||+|+++... ....+.+.+|..++.+++||||+++++++.+.+..++||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 467999999999999975 68899999986421 12234578899999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... ..+++..++.++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+++...
T Consensus 146 g~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g-------iiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 146 GDLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVHRLG-------YVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp CBHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeecccCHHHeeecCCCCEEEeechhheecc
Confidence 99999997532 14888999999999999999999998 9999999999999999999999999998765
Q ss_pred Ccc-----cccccccccCCCCCC-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 429 QPI-----AAQRMISYKSPEYQS-------SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 429 ~~~-----~~~~~~~y~aPE~~~-------~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
... ...+|+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+....+.......
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~----~~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS----TAETYGKIVHYKEHL 289 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHTHHHHC
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC----HHHHHHHHHhcccCc
Confidence 432 235789999999886 3568999999999999999999999996432 222222221111100
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCC---CChHHHHHHHhh
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKR---PEMAEVVSELEI 546 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~L~~ 546 (582)
..+. .+ .....++.+++.+||. +|++| |+++|+++|.+.
T Consensus 290 ~~p~-~~---------~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 290 SLPL-VD---------EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp CCC--------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred CCCc-cc---------cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence 0000 00 0112257789999998 99998 699999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=330.88 Aligned_cols=250 Identities=17% Similarity=0.287 Sum_probs=192.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCC
Confidence 467999999999999975 67889999986532 22346789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~-------i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 119 VDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAAG-------ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCc-------CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999997532 4889999999999999999999998 9999999999999999999999999987764
Q ss_pred Ccc-----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc-cccc
Q 047954 429 QPI-----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT-AEIF 502 (582)
Q Consensus 429 ~~~-----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 502 (582)
... ...++..|+|||.+.+..++.++||||||+++|||+||+.||.... . ..+......... ....
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~-~~~~~~~~~~~~~~~~~ 257 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ-------L-SVMGAHINQAIPRPSTV 257 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH-------H-HHHHHHHHSCCCCGGGT
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch-------H-HHHHHHhccCCCCcccc
Confidence 432 2346788999999999999999999999999999999999996421 1 111122111111 0001
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCC-ChHHHHHHHhhcccCCC
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-EMAEVVSELEIIKVTES 552 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~ 552 (582)
.+ ....++.+++.+||+.||++|| +++++++.|+.+.....
T Consensus 258 ~~---------~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 258 RP---------GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp ST---------TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CC---------CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 11 1112577899999999999999 99999999998765543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=344.21 Aligned_cols=263 Identities=18% Similarity=0.299 Sum_probs=196.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcc-hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPL-ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|... ++..||+|++...... ....+.+|+.++++++||||+++++++...+..++||||+. |+
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 85 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence 367999999999999976 6788999998643321 11245579999999999999999999999999999999997 59
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~-------ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 86 LKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQK-------VLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT-------EEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred HHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCC-------ccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 9998875432 4888999999999999999999998 999999999999999999999999999766433
Q ss_pred c----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc---cccc
Q 047954 431 I----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT---AEIF 502 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 502 (582)
. ...++..|+|||++.+ ..++.++|||||||++|||++|+.||... ...+....+.+....... ....
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS----TVEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCChHhchhhh
Confidence 2 2346788999998876 56899999999999999999999999643 222333333332221100 0000
Q ss_pred ch-hhhh-----------hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 503 DS-EISV-----------QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 503 d~-~~~~-----------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
.. .... .........++.+++.+||+.||++|||++|+++|.|.....+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 00 0000 00000112357789999999999999999999999887655443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=326.75 Aligned_cols=246 Identities=19% Similarity=0.326 Sum_probs=196.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence 467999999999999975 6788999998643 23445788999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 92 L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 92 LFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp GGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred HHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhCC-------eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99988642 25888999999999999999999998 999999999999999999999999999765322
Q ss_pred ------ccccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 431 ------IAAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 431 ------~~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
....++..|+|||.+.+..+ +.++||||||+++|||++|+.||...... ......+. ... . ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~----~~~-~--~~~ 229 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWK----EKK-T--YLN 229 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT--SHHHHHHH----TTC-T--TST
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHhh----hcc-c--ccC
Confidence 23346788999999987665 78999999999999999999999753221 11111111 110 0 000
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
. .......+.+++.+||+.||++|||+.|++++.+.-
T Consensus 230 ~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 266 (276)
T 2yex_A 230 P-------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266 (276)
T ss_dssp T-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred c-------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcccc
Confidence 0 001112577899999999999999999999876643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=327.59 Aligned_cols=246 Identities=20% Similarity=0.345 Sum_probs=194.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEe----CCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFS----NDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 457999999999999865 5678999998643 33455778999999999999999999999876 3457999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec-CCCceEEeecccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD-DNEMVLVSDYGFS 424 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DfG~a 424 (582)
+++|+|.+++.... .+++..++.++.||+.||.|||+.++ +|+||||||+|||++ .++.+||+|||++
T Consensus 111 ~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~~-----~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 111 MTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTRTP-----PIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp CCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTSSS-----CCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred cCCCCHHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHcCCC-----CEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999997532 47889999999999999999999862 499999999999998 7899999999999
Q ss_pred ccccCc--ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 425 SLVAQP--IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 425 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
...... ....++..|+|||.+. ..++.++|||||||++|||++|+.||.... .... ..............
T Consensus 180 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~-~~~~~~~~~~~~~~ 251 (290)
T 1t4h_A 180 TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQ-IYRRVTSGVKPASF 251 (290)
T ss_dssp GGCCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHH-HHHHHTTTCCCGGG
T ss_pred ccccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC------cHHH-HHHHHhccCCcccc
Confidence 765443 2344788999999876 458999999999999999999999996422 1111 11222221111111
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
+. ....++.+++.+||+.||++|||+.|+++|.+.
T Consensus 252 ~~---------~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f 286 (290)
T 1t4h_A 252 DK---------VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp GG---------CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CC---------CCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence 11 011257889999999999999999999998764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=345.86 Aligned_cols=260 Identities=21% Similarity=0.311 Sum_probs=198.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 467999999999999976 6788999998754 33445778999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++....
T Consensus 118 L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~~-------i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 118 LDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKHK-------IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp HHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHHC-------CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred HHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHhCC-------EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999997532 478899999999999999999986 6 99999999999999999999999999875532
Q ss_pred c--ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc----------
Q 047954 430 P--IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW---------- 497 (582)
Q Consensus 430 ~--~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~---------- 497 (582)
. ....++..|+|||++.+..++.++|||||||++|||+||+.||..... .++............
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA----KELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH----HHHHHHHC-----------------
T ss_pred ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhcccccccCCCCCCCcccC
Confidence 2 234578899999999999999999999999999999999999964321 111000000000000
Q ss_pred ----------------cccccchhhhh---hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 498 ----------------TAEIFDSEISV---QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 498 ----------------~~~~~d~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
..+..+..... .........++.+++.+||+.||++|||++|+++|.+.-..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 00000000000 00000112357889999999999999999999999886543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=333.89 Aligned_cols=246 Identities=25% Similarity=0.418 Sum_probs=192.1
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeC-CeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN-DEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... +..||||.++... ..+.+.+|+.++++++||||+++++++... +..++||||+++|+|
T Consensus 26 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102 (278)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence 467999999999999875 6789999986533 467799999999999999999999997655 468999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 103 VDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGNN-------FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp HHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred HHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHhCC-------ccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 999974321 13788889999999999999999998 999999999999999999999999999766443
Q ss_pred ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhh
Q 047954 431 IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQ 509 (582)
Q Consensus 431 ~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 509 (582)
....++..|+|||.+.+..++.++||||||+++|||+| |+.||.... ..++...+ .........
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~----~~~~~~~~----~~~~~~~~~------- 236 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPRV----EKGYKMDAP------- 236 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC----GGGHHHHH----TTTCCCCCC-------
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHH----hcCCCCCCc-------
Confidence 23345678999999988899999999999999999998 999996432 22222221 111111111
Q ss_pred hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 510 RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 510 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
......+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 237 ---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 237 ---DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 01123578899999999999999999999999988754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=353.66 Aligned_cols=242 Identities=14% Similarity=0.134 Sum_probs=186.9
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecC---CCcchHHHHHHHH---HHHhcCCCCCccccc-------eEEEeCC-
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRD---LKPLITEEFRKQL---LVIADQKHPNLLPLL-------AYYFSND- 337 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~---~~l~~l~H~niv~l~-------~~~~~~~- 337 (582)
.+.||+|+||.||+|.. .+++.||||++.. ......+.+.+|+ .++++++|||||+++ +++...+
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 46799999999999995 5688999999963 2334567889999 556666899999998 6666553
Q ss_pred ----------------eeEEEEEeCCCCChHHHHhcCCCC-CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCccee
Q 047954 338 ----------------EKLLVYKFAGNGNLFNRIHGGKSS-KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIH 400 (582)
Q Consensus 338 ----------------~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH 400 (582)
..++||||+ +|+|.+++...... .....+++..++.|+.||+.||+|||+++ |+|
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------ivH 229 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-------LVH 229 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT-------EEC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC-------eec
Confidence 278999999 68999999753211 11234566888999999999999999998 999
Q ss_pred cCCCCCCeeecCCCceEEeeccccccccCcc-cccccccccCCCCCCCC-----------CCCcchhHHHHHHHHHHHHh
Q 047954 401 GNLKSTNILLDDNEMVLVSDYGFSSLVAQPI-AAQRMISYKSPEYQSSK-----------KISRKSDVWSFGCLLLELLT 468 (582)
Q Consensus 401 ~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~-~~~~~~~y~aPE~~~~~-----------~~~~k~DVwS~Gvvl~ellt 468 (582)
|||||+|||++.++.+||+|||+++...... ...+ ..|+|||++.+. .++.++|||||||++|||+|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt 308 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence 9999999999999999999999998755432 2335 889999999877 89999999999999999999
Q ss_pred CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 469 GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 469 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
|+.||.......... .+... .. ....++.+++.+||+.||++|||+.|++++.+.
T Consensus 309 g~~Pf~~~~~~~~~~----------------~~~~~----~~---~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 309 ADLPITKDAALGGSE----------------WIFRS----CK---NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp SSCCC------CCSG----------------GGGSS----CC---CCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred CCCCCcccccccchh----------------hhhhh----cc---CCCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 999996432211100 00000 00 011257789999999999999999999988664
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=354.20 Aligned_cols=255 Identities=18% Similarity=0.264 Sum_probs=190.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCC------eeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND------EKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 343 (582)
.+.||+|+||+||+|... +++.||||++... .....+.+.+|+.++++++|||||++++++.... ..++||
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 146 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence 467999999999999864 5788999999653 3344567889999999999999999999997653 569999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+.+ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 147 E~~~~-~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~~-------iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 147 ELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp ECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eCCCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 99975 57777642 3788899999999999999999998 99999999999999999999999999
Q ss_pred cccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc---
Q 047954 424 SSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW--- 497 (582)
Q Consensus 424 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~--- 497 (582)
|+..... ....+|+.|+|||++.+..|+.++||||+||++|||++|+.||.... ..+....+........
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~----~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD----YIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCSCCHHH
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcCCCCHHH
Confidence 9877543 23457889999999999999999999999999999999999996432 1222222211111000
Q ss_pred c-----------------c-----cccchhh-hh-hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 498 T-----------------A-----EIFDSEI-SV-QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 498 ~-----------------~-----~~~d~~~-~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
. . ..+.... .. .........++.+|+.+||..||++|||++|+++|.+.-
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 0 0 0000000 00 000111245688999999999999999999999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=336.14 Aligned_cols=245 Identities=22% Similarity=0.332 Sum_probs=199.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||+.+
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 125 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence 467999999999999976 4678999998643 234557789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 126 ~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~-------ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 126 RSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRNR-------VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp CBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCC-------CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999886432 4889999999999999999999998 9999999999999999999999999998764
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.. ....++..|+|||++.+..++.++||||||+++|||++|+.||.... .............. + ..
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~--~-~~ 262 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-------LKETYLRIKKNEYS--I-PK 262 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCC--C-CT
T ss_pred cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-------HHHHHHHHhcCCCC--C-Cc
Confidence 32 22346788999999988889999999999999999999999996421 11111111111110 0 00
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.....+.+++.+||+.||++|||+.|++++.+....
T Consensus 263 ---------~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 263 ---------HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp ---------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ---------cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 011257789999999999999999999998776543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=332.07 Aligned_cols=248 Identities=20% Similarity=0.382 Sum_probs=202.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++......++||||+++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 467999999999999864 67889999986443 3456789999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 107 L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 107 ALDLLEPG-------PLDETQIATILREILKGLDYLHSEK-------KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp HHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred HHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-------CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99998632 4889999999999999999999998 999999999999999999999999999776543
Q ss_pred ----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 431 ----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 431 ----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ....... ......... ...
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~----~~~~~~~~~-~~~- 242 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH----PMKVLFL----IPKNNPPTL-EGN- 242 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHH----HHHSCCCCC-CSS-
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC----HHHHHHH----hhcCCCCCC-ccc-
Confidence 23346788999999999999999999999999999999999996421 1111111 111111111 111
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
....+.+++.+||+.||++|||+.|++++.+.......
T Consensus 243 --------~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 280 (303)
T 3a7i_A 243 --------YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 280 (303)
T ss_dssp --------CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred --------cCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCc
Confidence 11257889999999999999999999999887665443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=336.69 Aligned_cols=268 Identities=20% Similarity=0.263 Sum_probs=191.6
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHH--HhcCCCCCccccceEEEe-----CCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLV--IADQKHPNLLPLLAYYFS-----NDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~~-----~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++||||+++++++.. ....++||||
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence 46799999999999976 5688999998643 23444445444 456899999999986653 2256899999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCC--CCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS--RTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~--~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
+++|+|.+++... ..++..++.++.||+.||+|||+..+. ...++|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 94 YPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp CTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred CCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 9999999999754 257888999999999999999998100 0001299999999999999999999999999
Q ss_pred cccccCcc------------cccccccccCCCCCCC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccc
Q 047954 424 SSLVAQPI------------AAQRMISYKSPEYQSS-------KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD 484 (582)
Q Consensus 424 a~~~~~~~------------~~~~~~~y~aPE~~~~-------~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~ 484 (582)
++.+.... ...+|..|+|||++.+ ..++.++|||||||++|||+||..||...........
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 97664321 2347889999999876 3567799999999999999999877754322111111
Q ss_pred hH----------HHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCCc
Q 047954 485 LC----------SWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTE 554 (582)
Q Consensus 485 ~~----------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 554 (582)
.. ...............+... .........++.+++.+||+.||++|||+.|+++.|+.+.......
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEA---WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT---CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred hhhcccCCCchHHHHHhhhcccccCCCCCcc---cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 10 1111111111111111100 0111234456889999999999999999999999999998655443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=338.77 Aligned_cols=254 Identities=22% Similarity=0.383 Sum_probs=198.1
Q ss_pred cccccccCceEEEEEEE------cCCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALL------EGRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|.. .++..||||.+... .......+.+|+.++++++||||+++++++......++||||
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 114 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEec
Confidence 46799999999999984 34668999999643 334456789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCC-CCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC---CCceEEeec
Q 047954 346 AGNGNLFNRIHGGKSSK-NRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD---NEMVLVSDY 421 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Df 421 (582)
+++|+|.+++....... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+||
T Consensus 115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-------i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-------FIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-------eecCcCCHhHEEEecCCCcceEEECcc
Confidence 99999999998654321 1135888999999999999999999998 999999999999984 456999999
Q ss_pred cccccccCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 422 GFSSLVAQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 422 G~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
|+++..... ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||... ....+...+ .
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----~~~~~~~~~----~ 259 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK----SNQEVLEFV----T 259 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHHHHHHH----H
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc----CHHHHHHHH----h
Confidence 998754322 22345678999999988899999999999999999998 99998642 122222222 1
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
....... .. .....+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 260 ~~~~~~~-~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 260 SGGRMDP-PK---------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp TTCCCCC-CT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred cCCCCCC-CC---------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 1111110 00 11125788999999999999999999999999887543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.81 Aligned_cols=247 Identities=20% Similarity=0.311 Sum_probs=187.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--------cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--------PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 343 (582)
.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++. .+..++||
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~ 218 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVL 218 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEE
Confidence 467999999999999865 56889999986421 111235789999999999999999999975 45689999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC---CceEEee
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN---EMVLVSD 420 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~---~~~kl~D 420 (582)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.+ ..+||+|
T Consensus 219 e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~-------ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 219 ELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHENG-------IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp ECCTTCBGGGGTSSS------CCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred EcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCChHhEEEecCCCcceEEEee
Confidence 999999999988643 25889999999999999999999998 9999999999999754 4599999
Q ss_pred ccccccccCcc---cccccccccCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 421 YGFSSLVAQPI---AAQRMISYKSPEYQSS---KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 421 fG~a~~~~~~~---~~~~~~~y~aPE~~~~---~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
||+++...... ...+++.|+|||++.+ ..++.++|||||||++|||+||+.||..... ...+...+.
T Consensus 286 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~i~---- 358 (419)
T 3i6u_A 286 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QVSLKDQIT---- 358 (419)
T ss_dssp SSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS---SCCHHHHHH----
T ss_pred cccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc---hHHHHHHHh----
Confidence 99998875432 3347889999999853 5788999999999999999999999975322 122222221
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
..... . .+.. ......++.+++.+||+.||++|||++|+++|.|.-
T Consensus 359 ~~~~~-~-~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 404 (419)
T 3i6u_A 359 SGKYN-F-IPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404 (419)
T ss_dssp TTCCC-C-CHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred cCCCC-C-Cchh-----hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence 11110 0 0000 001123578899999999999999999999998753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=342.17 Aligned_cols=254 Identities=21% Similarity=0.353 Sum_probs=200.4
Q ss_pred cccccccCceEEEEEEEcCC------ceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLEGR------APVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 344 (582)
.+.||+|+||.||+|..... ..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 57899999999999996532 369999997543 33456789999999999 89999999999999999999999
Q ss_pred eCCCCChHHHHhcCCCC--------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCce
Q 047954 345 FAGNGNLFNRIHGGKSS--------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMV 416 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~ 416 (582)
|+++|+|.+++...... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-------ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-------CIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGCEEEGGGEE
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC-------cccCCcccceEEECCCCeE
Confidence 99999999998753210 00124788999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHH
Q 047954 417 LVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWV 489 (582)
Q Consensus 417 kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 489 (582)
||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||+| |..||..... ...+
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~---- 276 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV---NSKF---- 276 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS---SHHH----
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch---hHHH----
Confidence 999999998664322 2234568999999988899999999999999999999 9999964321 1111
Q ss_pred HHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 490 LRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 490 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
............ .. .....+.+++.+||+.||++|||+.||+++|+.+...
T Consensus 277 ~~~~~~~~~~~~-~~---------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 277 YKLVKDGYQMAQ-PA---------FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHTCCCCC-CT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCC-CC---------CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 122222211110 00 0112578899999999999999999999999987643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=338.00 Aligned_cols=255 Identities=23% Similarity=0.394 Sum_probs=198.3
Q ss_pred cccccccCceEEEEEEEc-CCce--EEEEEecCC-CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAP--VVVKRLRDL-KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|... ++.. ||+|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 578999999999999965 4443 489988643 233456789999999999 99999999999999999999999999
Q ss_pred CCChHHHHhcCCC----------CCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceE
Q 047954 348 NGNLFNRIHGGKS----------SKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVL 417 (582)
Q Consensus 348 ~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~k 417 (582)
+|+|.+++..... ......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-------ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-------FIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECGGGCEE
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-------ccCCCCccceEEEcCCCeEE
Confidence 9999999975430 001235889999999999999999999998 99999999999999999999
Q ss_pred EeeccccccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHH
Q 047954 418 VSDYGFSSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 418 l~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
|+|||+++..... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||.... ... +...+
T Consensus 183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~----~~~----~~~~~ 254 (327)
T 1fvr_A 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAE----LYEKL 254 (327)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHH----HHHHG
T ss_pred EcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc----HHH----HHHHh
Confidence 9999998754322 22335678999999988889999999999999999998 999996432 111 11222
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
........ . .....++.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 255 ~~~~~~~~-~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 255 PQGYRLEK-P---------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp GGTCCCCC-C---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred hcCCCCCC-C---------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 22111110 0 0111257889999999999999999999999998876544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=326.36 Aligned_cols=246 Identities=19% Similarity=0.316 Sum_probs=196.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC------cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK------PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 89 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEee
Confidence 467999999999999976 57899999986432 12467899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC----ceEEeec
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE----MVLVSDY 421 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Df 421 (582)
+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 90 ~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 90 VSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSKR-------IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp CCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999996432 4889999999999999999999998 99999999999998877 7999999
Q ss_pred cccccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 422 GFSSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 422 G~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
|++....... ...++..|+|||.+.+..++.++||||||+++|||++|+.||.... ..... ........
T Consensus 157 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~---~~~~~~~~- 228 (283)
T 3bhy_A 157 GIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET----KQETL---TNISAVNY- 228 (283)
T ss_dssp TTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHH---HHHHTTCC-
T ss_pred ccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc----hHHHH---HHhHhccc-
Confidence 9998764432 2347788999999998899999999999999999999999996422 11111 11111100
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
..+... .......+.+++.+||..||++|||+.|++++.+.
T Consensus 229 --~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 269 (283)
T 3bhy_A 229 --DFDEEY-----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269 (283)
T ss_dssp --CCCHHH-----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred --CCcchh-----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence 001100 00112357889999999999999999999998653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=331.15 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=194.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... ++..||+|++........+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 103 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEH
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcH
Confidence 467999999999999976 4788999999766666678899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC--
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ-- 429 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~-- 429 (582)
.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 104 ~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 104 DAIMLELD-----RGLTEPQIQVVCRQMLEALNFLHSKR-------IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp HHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred HHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhcCC-------cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99886532 24889999999999999999999998 99999999999999999999999998754321
Q ss_pred --cccccccccccCCCCC-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 430 --PIAAQRMISYKSPEYQ-----SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 430 --~~~~~~~~~y~aPE~~-----~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
.....++..|+|||++ ....++.++||||||+++|||++|+.||.... ............ .....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~-~~~~~ 243 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSD-PPTLL 243 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSC-CCCCS
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-------HHHHHHHHhccC-CcccC
Confidence 2234577889999987 46778999999999999999999999996421 111122221111 11111
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.+ ......+.+++.+||+.||++|||+.|+++|.+...
T Consensus 244 ~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 244 TP--------SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp SG--------GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred Cc--------cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence 10 011225788999999999999999999999876443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=354.03 Aligned_cols=250 Identities=18% Similarity=0.232 Sum_probs=200.2
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 57999999999999975 58899999996421 223467889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++...... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 271 ~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g-------IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 271 DIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQRN-------IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp BHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHHcC-------CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999754321 235889999999999999999999998 99999999999999999999999999987654
Q ss_pred cc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 430 PI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 430 ~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
.. ...+|+.|+|||++.+..++.++|||||||++|||+||+.||...........+...+ .... . .. ..
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i---~~~~-~-~~-p~- 414 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV---LEQA-V-TY-PD- 414 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH---HHCC-C-CC-CT-
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH---hhcc-c-CC-Cc-
Confidence 32 2367899999999999999999999999999999999999997543221112222211 1111 0 00 00
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCCh-----HHHHHHHhhc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM-----AEVVSELEII 547 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~L~~i 547 (582)
.....+.+++.+||+.||++||++ ++|++|.+.-
T Consensus 415 --------~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~ 453 (543)
T 3c4z_A 415 --------KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453 (543)
T ss_dssp --------TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGT
T ss_pred --------ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcccc
Confidence 111257789999999999999965 7888876643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.92 Aligned_cols=274 Identities=21% Similarity=0.367 Sum_probs=189.9
Q ss_pred ChhHhhhcccccccccCceEEEEEEEc---CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEe--CCe
Q 047954 264 KLNDLLKAPAEGLGKGIFGNSYKALLE---GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS--NDE 338 (582)
Q Consensus 264 ~~~~l~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~ 338 (582)
.+.+.....+++||+|+||.||+|+.. ++..||||++.... ..+.+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 345555555678999999999999975 46789999996532 33568899999999999999999999965 567
Q ss_pred eEEEEEeCCCCChHHHHhcCCC---CCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee----c
Q 047954 339 KLLVYKFAGNGNLFNRIHGGKS---SKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL----D 411 (582)
Q Consensus 339 ~~lv~e~~~~gsL~~~l~~~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl----~ 411 (582)
.++||||+. |+|.+++..... ......+++..++.|+.||+.||+|||+.+ |+||||||+|||+ +
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------ivH~Dlkp~NIll~~~~~ 166 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-------VLHRDLKPANILVMGEGP 166 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECCSST
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-------EeCCCcCHHHeEEecCCC
Confidence 899999996 588887753211 111234889999999999999999999998 9999999999999 7
Q ss_pred CCCceEEeeccccccccCc-------ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC--
Q 047954 412 DNEMVLVSDYGFSSLVAQP-------IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGIN-- 481 (582)
Q Consensus 412 ~~~~~kl~DfG~a~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~-- 481 (582)
.++.+||+|||+++..... ....+|+.|+|||++.+. .++.++|||||||++|||+||+.||........
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 246 (405)
T 3rgf_A 167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246 (405)
T ss_dssp TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence 7889999999999876532 223467889999998874 589999999999999999999999975432110
Q ss_pred ---ccchHHHHHHHHhhccc---ccc---c----------chhhhhhhchH--------HHHHHHHHHHHHcccCCCCCC
Q 047954 482 ---GADLCSWVLRAVREEWT---AEI---F----------DSEISVQRSAA--------HGMLKLLQVAIQCCNKSPEKR 534 (582)
Q Consensus 482 ---~~~~~~~~~~~~~~~~~---~~~---~----------d~~~~~~~~~~--------~~~~~l~~l~~~Cl~~dP~~R 534 (582)
..+....+...+..... ..+ . ..... ..... .....+.+|+.+||+.||++|
T Consensus 247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R 325 (405)
T 3rgf_A 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYT-NCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR 325 (405)
T ss_dssp CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGT-TCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCC-cchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence 01112222111110000 000 0 00000 00000 002357789999999999999
Q ss_pred CChHHHHHHHhhcc
Q 047954 535 PEMAEVVSELEIIK 548 (582)
Q Consensus 535 Ps~~evl~~L~~i~ 548 (582)
||++|+++|.|...
T Consensus 326 ~ta~e~L~hp~f~~ 339 (405)
T 3rgf_A 326 ITSEQAMQDPYFLE 339 (405)
T ss_dssp CCHHHHHTSGGGTS
T ss_pred CCHHHHhcChhhcc
Confidence 99999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.40 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=200.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++|||||++++++...+..++||||+.+
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 110 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 467999999999999975 67899999985432 34567899999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee---cCCCceEEeeccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSS 425 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DfG~a~ 425 (582)
|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 111 ~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~-------ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 111 GELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKNK-------IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp CBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999997542 4889999999999999999999998 9999999999999 567889999999998
Q ss_pred cccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 426 LVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 426 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
...... ...+++.|+|||++.+ .++.++||||+||++|+|++|+.||... ...++...+. ........
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~---~~~~~~~~- 248 (484)
T 3nyv_A 178 HFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA----NEYDILKKVE---KGKYTFEL- 248 (484)
T ss_dssp HBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHH---HCCCCCCS-
T ss_pred EcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHH---cCCCCCCC-
Confidence 765432 3347889999998876 6899999999999999999999999643 2222222221 11111110
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
+. ......++.+++.+||+.||++|||+.|+++|.|...
T Consensus 249 -~~------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 249 -PQ------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp -GG------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred -cc------cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 00 0011235778999999999999999999999988654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.84 Aligned_cols=254 Identities=15% Similarity=0.199 Sum_probs=197.4
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCC-CCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKH-PNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|.. .++..||||++..... .+.+..|++++..++| ++|..+..++...+..++||||+ +++
T Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~s 88 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (483)
T ss_dssp CCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCC
Confidence 46799999999999996 5688999998764332 2357889999999987 55555566667778889999999 999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee---cCCCceEEeeccccccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DfG~a~~~ 427 (582)
|.+++..... .+++..++.|+.||+.||+|||+++ ||||||||+|||+ +.++.+||+|||+++.+
T Consensus 89 L~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~g-------IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 89 LEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSKS-------FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred HHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-------EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 9999975332 4899999999999999999999998 9999999999999 68899999999999876
Q ss_pred cCcc-----------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 428 AQPI-----------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 428 ~~~~-----------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
.... ...++..|+|||++.+..++.++|||||||++|||++|+.||...... ........+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVAT 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-SHHHHHHHHHHHHHHS
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch-hHHHHHHHHhhccccc
Confidence 5432 345778999999999999999999999999999999999999754322 1111111111111111
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
....+ ......++.+++..||+.||++||++.+|++.|+.+.....
T Consensus 236 ~~~~l----------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 236 SIEAL----------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp CHHHH----------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cHHHH----------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 00000 00112368899999999999999999999999998865443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=347.16 Aligned_cols=251 Identities=13% Similarity=0.081 Sum_probs=178.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc---chHHHHHHHH---HHHhcCCCCCccccc-------eEEEeC--
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP---LITEEFRKQL---LVIADQKHPNLLPLL-------AYYFSN-- 336 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~H~niv~l~-------~~~~~~-- 336 (582)
.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+ .+|+. +||||++++ +++...
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTS
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCC
Confidence 468999999999999965 678999999976432 2345677775 45555 799988755 444433
Q ss_pred ---------------CeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHH------HHHHHHHHHHHHHHhccCCCCCC
Q 047954 337 ---------------DEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSR------LLVARGVARALEYLHHKDKSRTQ 395 (582)
Q Consensus 337 ---------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~~~ 395 (582)
...++||||++ |+|.+++..... .+.+..+ +.++.||+.||+|||+++
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~----- 214 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQSKG----- 214 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-----
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-----
Confidence 23799999998 899999975421 2445555 788899999999999998
Q ss_pred CcceecCCCCCCeeecCCCceEEeeccccccccCcc-cccccccccCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCC
Q 047954 396 SAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI-AAQRMISYKSPEYQSS--KKISRKSDVWSFGCLLLELLTGRIS 472 (582)
Q Consensus 396 ~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~k~DVwS~Gvvl~elltG~~P 472 (582)
|+||||||+|||++.++.+||+|||+++...... ...+++.|+|||++.+ ..++.++|||||||++|||+||+.|
T Consensus 215 --ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 215 --LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp --EEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred --CccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999998876654 4556789999999987 6799999999999999999999999
Q ss_pred CCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 473 THSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 473 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
|.......... ... . ............+. .......+.+++.+||+.||++|||+.|+++|.+.-
T Consensus 293 f~~~~~~~~~~-~~~-~--~~~~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 293 FGLVTPGIKGS-WKR-P--SLRVPGTDSLAFGS------CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp TTBCCTTCTTC-CCB-C--CTTSCCCCSCCCTT------SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred CCCcCcccccc-hhh-h--hhhhccccccchhh------ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 97643221100 000 0 00000000000000 001123678899999999999999999999887643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=348.57 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=198.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||+||+|... +++.||||++... .....+.+.+|+.++++++|||||++++++.+....++||||+.+|
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 106 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence 468999999999999975 6788999998532 2234678899999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec---CCCceEEeecccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD---DNEMVLVSDYGFSSL 426 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DfG~a~~ 426 (582)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 107 ~L~~~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~-------ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 107 ELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKHN-------IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp BHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999886532 4889999999999999999999998 99999999999995 456799999999987
Q ss_pred ccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 427 VAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 427 ~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
..... ...+++.|+|||++.+ .++.++||||+||++|+|++|+.||.... ..++...+ ....+....
T Consensus 174 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i---~~~~~~~~~-- 243 (486)
T 3mwu_A 174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN----EYDILKRV---ETGKYAFDL-- 243 (486)
T ss_dssp BCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHH---HHTCCCSCS--
T ss_pred CCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH---HhCCCCCCC--
Confidence 65432 3457889999999876 59999999999999999999999996432 22222222 111111110
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
+.. .....++.+++.+||+.||++|||+.|+++|.|....
T Consensus 244 ~~~------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 244 PQW------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp GGG------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred ccc------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 000 0112257789999999999999999999999886543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=352.11 Aligned_cols=183 Identities=20% Similarity=0.385 Sum_probs=147.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeC-----CeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN-----DEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e 344 (582)
.+.||+|+||+||+|... +++.||||++... .....+.+.+|+.+|++++|||||++++++... ...|+|||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 137 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE 137 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEe
Confidence 578999999999999865 6788999998653 233456789999999999999999999999543 46899999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+ +|+|.+++... ..+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|
T Consensus 138 ~~-~~~L~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~-------iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 138 IA-DSDFKKLFRTP------VYLTELHIKTLLYNLLVGVKYVHSAG-------ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CC-SEEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cc-ccchhhhcccC------CCCCHHHHHHHHHHHHHHHHHHHhCC-------cCCCCCChhhEEECCCCCEeecccccc
Confidence 98 57999998743 24889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCc-------------------------------ccccccccccCCCCC-CCCCCCcchhHHHHHHHHHHHHhC
Q 047954 425 SLVAQP-------------------------------IAAQRMISYKSPEYQ-SSKKISRKSDVWSFGCLLLELLTG 469 (582)
Q Consensus 425 ~~~~~~-------------------------------~~~~~~~~y~aPE~~-~~~~~~~k~DVwS~Gvvl~elltG 469 (582)
+..... ....+|..|+|||++ ....++.++|||||||++|||+||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 876422 122357889999975 566799999999999999999994
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=335.76 Aligned_cols=257 Identities=17% Similarity=0.307 Sum_probs=190.7
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCC------eeEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND------EKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 343 (582)
.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++.... ..++||
T Consensus 30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 109 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109 (367)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence 46799999999999996 46889999998543 2334567889999999999999999999998753 459999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+ +++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 110 e~~-~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~-------ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 110 PFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAAG-------IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp ECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 999 88999998752 4788899999999999999999998 99999999999999999999999999
Q ss_pred cccccCc-ccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---cc
Q 047954 424 SSLVAQP-IAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE---WT 498 (582)
Q Consensus 424 a~~~~~~-~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~ 498 (582)
++..... ....+|..|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+....+....... ..
T Consensus 175 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 175 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD----HLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCHHHH
T ss_pred ccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcCCCCHHHH
Confidence 9876543 23457889999998876 679999999999999999999999996432 122222221111100 00
Q ss_pred ccccchhh-------------hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 499 AEIFDSEI-------------SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 499 ~~~~d~~~-------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
..+..... ............+.+|+.+||..||++|||++|+++|.+.-.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 00000000 000000111235788999999999999999999999977543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=336.92 Aligned_cols=247 Identities=21% Similarity=0.324 Sum_probs=193.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|... +++.||||++...... ..+|++++.++ +||||+++++++.+.+..++||||+++|+
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 102 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCc
Confidence 467999999999999975 5788999999754332 34678888887 89999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC----CceEEeecccccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN----EMVLVSDYGFSSL 426 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DfG~a~~ 426 (582)
|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 103 L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~g-------ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 103 LLDKILRQK------FFSEREASAVLFTITKTVEYLHAQG-------VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp HHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred HHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999997532 4889999999999999999999998 9999999999998543 3599999999987
Q ss_pred ccCcc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 427 VAQPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 427 ~~~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
..... ...+|+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ..+...+...... ..
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~-~~~~~~i~~~~~~-~~ 243 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD----DTP-EEILARIGSGKFS-LS 243 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT----SCH-HHHHHHHHHCCCC-CC
T ss_pred CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc----CCH-HHHHHHHccCCcc-cC
Confidence 64432 33467889999999887889999999999999999999999974321 111 1122222221111 00
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.. . ......++.+++.+||..||++|||+.|+++|.|...
T Consensus 244 ~~-~-----~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 244 GG-Y-----WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp ST-T-----TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred cc-c-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 00 0 0011225778999999999999999999999988643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=334.38 Aligned_cols=259 Identities=20% Similarity=0.318 Sum_probs=195.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc--chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 109 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence 468999999999999976 478899999864432 33466889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~l~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~~-------ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 110 ILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHSHN-------IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp HHHHHHHSTT------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred hHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC-------EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9988775432 4889999999999999999999998 99999999999999999999999999977644
Q ss_pred c----ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh---------
Q 047954 430 P----IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE--------- 495 (582)
Q Consensus 430 ~----~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~--------- 495 (582)
. ....++..|+|||.+.+. .++.++|||||||++|||++|+.||.... ..+....+......
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS----DIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCHHHHHHH
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHHhCCCChhhhhHh
Confidence 3 233467889999998775 78999999999999999999999996432 11111111111000
Q ss_pred ---cccccccchhhh----hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 496 ---EWTAEIFDSEIS----VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 496 ---~~~~~~~d~~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
........+... ...........+.+++.+||+.||++|||+.|+++|.+.-.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 000000000000 00000112346889999999999999999999999987543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=334.84 Aligned_cols=256 Identities=18% Similarity=0.269 Sum_probs=188.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc--chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP--LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+.++++++||||+++++++...+..++||||++ |
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 117 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-N 117 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-C
Confidence 467999999999999854 678899999964432 234567899999999999999999999999999999999997 5
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee-----cCCCceEEeecccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL-----DDNEMVLVSDYGFS 424 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl-----~~~~~~kl~DfG~a 424 (582)
+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 118 ~L~~~~~~~~------~~~~~~~~~i~~ql~~~l~~LH~~~-------ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 118 DLKKYMDKNP------DVSMRVIKSFLYQLINGVNFCHSRR-------CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred CHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9999997543 4888999999999999999999998 9999999999999 45556999999999
Q ss_pred ccccCc----ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc-
Q 047954 425 SLVAQP----IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT- 498 (582)
Q Consensus 425 ~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~- 498 (582)
+..... ....++..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+....+.........
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS----EIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC----HHHHHHHHHHHhCCCchh
Confidence 766432 223457889999998774 48999999999999999999999996432 11222222111110000
Q ss_pred ------------c---cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 499 ------------A---EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 499 ------------~---~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
. ......+.. ........++.+++.+||+.||++|||++|+++|.+.-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 323 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKR-VLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHH-HHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhh-hcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccC
Confidence 0 000000000 00000123678999999999999999999999987754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=331.65 Aligned_cols=254 Identities=16% Similarity=0.284 Sum_probs=194.6
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCC-CCCccccceEEEe--CCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-HPNLLPLLAYYFS--NDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|+.++++++ ||||+++++++.. ....++||||+.+
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 46799999999999985 56789999998643 3577899999999997 9999999999998 5678999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC-ceEEeeccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE-MVLVSDYGFSSLV 427 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfG~a~~~ 427 (582)
++|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 118 ~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~-------ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 118 TDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSMG-------IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp CCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhCC-------eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999884 3778889999999999999999998 99999999999999776 8999999999876
Q ss_pred cCcc---cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccc---
Q 047954 428 AQPI---AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAE--- 500 (582)
Q Consensus 428 ~~~~---~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 500 (582)
.... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ...+....+..........+
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~---~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH---DNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS---SHHHHHHHHHHHHCHHHHHHHHH
T ss_pred CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC---chHHHHHHHHHhcCCchhhhHHH
Confidence 4432 3346788999999877 678999999999999999999999995422 11111111111111000000
Q ss_pred ----ccchhhh---------------hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 501 ----IFDSEIS---------------VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 501 ----~~d~~~~---------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
..++... ..........++.+++.+||+.||++|||++|+++|.+.-.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 0000000 00000012346889999999999999999999999877543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.88 Aligned_cols=246 Identities=20% Similarity=0.336 Sum_probs=196.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc--------chHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP--------LITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLV 342 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 342 (582)
.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+.++.++ +||||+++++++......++|
T Consensus 99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 178 (365)
T 2y7j_A 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178 (365)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence 368999999999999985 688999999864321 1245678999999998 899999999999999999999
Q ss_pred EEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecc
Q 047954 343 YKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYG 422 (582)
Q Consensus 343 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG 422 (582)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 179 ~e~~~g~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~g-------i~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 179 FDLMRKGELFDYLTEK------VALSEKETRSIMRSLLEAVSFLHANN-------IVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp ECCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEECCCCCEEEEecC
Confidence 9999999999999743 24889999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCc---ccccccccccCCCCCCC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHH
Q 047954 423 FSSLVAQP---IAAQRMISYKSPEYQSS------KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 423 ~a~~~~~~---~~~~~~~~y~aPE~~~~------~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
++..+... ....+++.|+|||++.+ ..++.++|||||||++|||+||+.||.... .......+
T Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~i---- 317 (365)
T 2y7j_A 246 FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR----QILMLRMI---- 317 (365)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHH----
T ss_pred cccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC----HHHHHHHH----
Confidence 99876543 23457889999998753 358899999999999999999999996421 11111111
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
...... ...+.. ......+.+++.+||+.||++|||+.|++++.+.
T Consensus 318 ~~~~~~-~~~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f 363 (365)
T 2y7j_A 318 MEGQYQ-FSSPEW------DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363 (365)
T ss_dssp HHTCCC-CCHHHH------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HhCCCC-CCCccc------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 111110 000000 0112357889999999999999999999998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.79 Aligned_cols=246 Identities=21% Similarity=0.347 Sum_probs=193.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||+||+|+.. ++..||+|++.... ....+.+.+|+.++++++|||||+++++|.+....++||||+++|
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 121 (494)
T 3lij_A 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121 (494)
T ss_dssp EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 468999999999999975 67789999986532 334567899999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC---CCceEEeecccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD---NEMVLVSDYGFSSL 426 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DfG~a~~ 426 (582)
+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 122 ~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~-------ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 122 ELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKHN-------IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp BHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred cHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999886432 4888999999999999999999998 999999999999976 44599999999987
Q ss_pred ccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 427 VAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 427 ~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
..... ...+|+.|+|||++. ..++.++||||+||++|+|++|+.||.... ..++...+. ..... ...
T Consensus 189 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~---~~~~~--~~~ 258 (494)
T 3lij_A 189 FENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT----DQEILRKVE---KGKYT--FDS 258 (494)
T ss_dssp CBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHH---HTCCC--CCS
T ss_pred CCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHH---hCCCC--CCc
Confidence 65432 345788999999876 469999999999999999999999996432 222222221 11111 001
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+.. ......+.+++.+||+.||++|||+.|+++|.|..
T Consensus 259 ~~~------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 296 (494)
T 3lij_A 259 PEW------KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296 (494)
T ss_dssp GGG------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred hhc------ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence 100 01122577899999999999999999999997754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=338.97 Aligned_cols=241 Identities=23% Similarity=0.313 Sum_probs=184.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHH-HhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLV-IADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|+.. ++..||+|+++... ....+.+..|..+ ++.++|||||++++++.+.+..++||||++
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 122 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999976 46789999996432 2233456667766 567899999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~g-------ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 123 GGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSLN-------IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp SCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred CCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999997532 4788889999999999999999998 999999999999999999999999999864
Q ss_pred cCc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||... +..++...+ ..... . +.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~----~~~~~~~~i---~~~~~--~-~~ 259 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR----NTAEMYDNI---LNKPL--Q-LK 259 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS----BHHHHHHHH---HHSCC--C-CC
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC----CHHHHHHHH---Hhccc--C-CC
Confidence 322 2345788999999999999999999999999999999999999642 112222211 11110 0 01
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChH----HHHHHHh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMA----EVVSELE 545 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~----evl~~L~ 545 (582)
+. ....+.+++.+||+.||++||++. ++.+|.+
T Consensus 260 ~~---------~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~ 296 (373)
T 2r5t_A 260 PN---------ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296 (373)
T ss_dssp SS---------SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred CC---------CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcc
Confidence 11 112577899999999999999984 6666544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=340.45 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=196.0
Q ss_pred cccccccCceEEEEEEE----cCCceEEEEEecCCC----cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALL----EGRAPVVVKRLRDLK----PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 343 (582)
.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++......++||
T Consensus 59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 138 (355)
T 1vzo_A 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138 (355)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence 57899999999999997 468899999986432 22345677899999999 6999999999999999999999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 139 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-------ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 139 DYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKLG-------IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp CCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999997532 4888999999999999999999998 99999999999999999999999999
Q ss_pred cccccCc-----ccccccccccCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 424 SSLVAQP-----IAAQRMISYKSPEYQSS--KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 424 a~~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
++..... ....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ............
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~ 282 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRILKSE 282 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHHHHHCC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch---HHHHHHHHhccC
Confidence 9765332 12347889999999875 3578999999999999999999999975432211 111111111111
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhhcc
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEIIK 548 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~i~ 548 (582)
... .. .....+.+++.+||..||++|| +++|++++++...
T Consensus 283 --~~~-~~---------~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 283 --PPY-PQ---------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp --CCC-CT---------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred --CCC-Cc---------ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 000 00 1112577899999999999999 9999999988654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=328.00 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=197.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEe--CCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFS--NDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....++||||++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 90 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence 467999999999999975 67889999986432 3345678999999999999999999998865 567899999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++..... ....+++..++.++.|++.||+|||+.+.. ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~--~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~ 166 (279)
T 2w5a_A 91 GGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDG--GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166 (279)
T ss_dssp TEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHHC--------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred CCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcccCC--CCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence 9999999975332 123488999999999999999999997611 124999999999999999999999999999776
Q ss_pred cCcc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
.... ...++..|+|||.+.+..++.++||||||+++|||+||+.||.... ..++... +.......+.
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~----i~~~~~~~~~- 237 (279)
T 2w5a_A 167 NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----QKELAGK----IREGKFRRIP- 237 (279)
T ss_dssp ---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHH----HHHTCCCCCC-
T ss_pred ccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC----HHHHHHH----HhhcccccCC-
Confidence 5432 2346788999999988899999999999999999999999996431 1222222 2222111111
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
. ....++.+++.+||+.||++|||+.|++++++....
T Consensus 238 ~---------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 238 Y---------RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp T---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred c---------ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 0 111257889999999999999999999998876543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=324.13 Aligned_cols=244 Identities=23% Similarity=0.369 Sum_probs=198.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 98 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence 467999999999999976 56789999985321 22346789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 99 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 99 GELYKELQKHG------RFDEQRSATFMEELADALHYCHERK-------VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTTT-------EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999997532 4788999999999999999999998 9999999999999999999999999987654
Q ss_pred Cc--ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 429 QP--IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 429 ~~--~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.. ....++..|+|||.+.+..++.++||||||+++|||++|+.||.... .... ......... . +.+
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~---~~~~~~~~~--~-~~~-- 233 (284)
T 2vgo_A 166 SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS----HTET---HRRIVNVDL--K-FPP-- 233 (284)
T ss_dssp SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHH---HHHHHTTCC--C-CCT--
T ss_pred ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC----HhHH---HHHHhcccc--C-CCC--
Confidence 32 23457789999999999899999999999999999999999996421 1111 111111110 0 000
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.....+.+++.+||+.||++|||+.|+++|.+...
T Consensus 234 -------~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 234 -------FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp -------TSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred -------cCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 01125778999999999999999999999877543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=321.10 Aligned_cols=243 Identities=20% Similarity=0.314 Sum_probs=191.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence 467999999999999976 68899999985421 23456789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 96 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 96 GELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRHM-------VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp CBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHHC-------SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred CcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCC-------CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999997532 4788999999999999999999998 9999999999999999999999999998765
Q ss_pred Ccc---cccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QPI---AAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~~---~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
... ...++..|+|||.+.+..+ +.++||||||+++|||++|+.||.... ...+.. ....... . ...
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~----~~~~~~~-~-~~~ 232 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH----VPTLFK----KIRGGVF-Y-IPE 232 (276)
T ss_dssp C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH----HHHHCCC-C-CCT
T ss_pred CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc----HHHHHH----HhhcCcc-c-Cch
Confidence 432 2346788999999987765 689999999999999999999996421 111211 1111110 0 000
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.....+.+++.+||+.||++|||+.|++++.+.-
T Consensus 233 ---------~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~ 266 (276)
T 2h6d_A 233 ---------YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266 (276)
T ss_dssp ---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred ---------hcCHHHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence 0112577899999999999999999999987753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=328.83 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=188.7
Q ss_pred cccccccCceEEEEEEEcC--Cc--eEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEG--RA--PVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~--~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|.+.. +. .||||+++.. .....+.+.+|+.++++++||||+++++++.... .++||||
T Consensus 23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~ 101 (291)
T 1u46_A 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTEL 101 (291)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEEC
T ss_pred eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEec
Confidence 4679999999999998642 22 5899988643 2344578899999999999999999999997765 8899999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~-------i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 102 APLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESKR-------FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCchheEEEcCCCCEEEccccccc
Confidence 99999999997532 24888999999999999999999998 9999999999999999999999999998
Q ss_pred cccCcc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 426 LVAQPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 426 ~~~~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
...... ...++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ...+ .........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~---~~~~~~~~~ 242 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN----GSQI---LHKIDKEGE 242 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHH---HHHHHTSCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC----HHHH---HHHHHccCC
Confidence 764432 2234567999999988889999999999999999999 999996431 1122 212111111
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
.... . .....++.+++.+||+.||++|||+.+++++|+.+....
T Consensus 243 ~~~~-~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 243 RLPR-P---------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp CCCC-C---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCCC-C---------cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 1100 0 011235788999999999999999999999999887543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=326.92 Aligned_cols=250 Identities=21% Similarity=0.262 Sum_probs=182.9
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCc-ch-HHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKP-LI-TEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|.. .+++.||+|+++.... .. .+.+.++...++.++||||+++++++...+..++||||++ |
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 90 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-T 90 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-E
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-c
Confidence 46799999999999996 4678899999975422 22 2334455556788999999999999999999999999997 5
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
+|.+++..... ....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~l~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-------i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 91 SLDKFYKQVID--KGQTIPEDILGKIAVSIVKALEHLHSKLS-------VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHHSC-------CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred chHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCC-------eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 88887754211 123589999999999999999999998 7 9999999999999999999999999998765
Q ss_pred Ccc---cccccccccCCCCC----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 429 QPI---AAQRMISYKSPEYQ----SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 429 ~~~---~~~~~~~y~aPE~~----~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
... ...++..|+|||.+ .+..++.++|||||||++|||+||+.||.... .....+........ ...
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~-~~~ 234 (290)
T 3fme_A 162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG------TPFQQLKQVVEEPS-PQL 234 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS------CHHHHHHHHHHSCC-CCC
T ss_pred ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC------chHHHHHHHhccCC-CCc
Confidence 432 23577889999995 56678999999999999999999999996421 11111222222211 111
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
... ....++.+++.+||+.||++|||+.|+++|.+.-.
T Consensus 235 ~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 235 PAD---------KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp CTT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ccc---------cCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 111 11225788999999999999999999999887654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=326.55 Aligned_cols=246 Identities=20% Similarity=0.327 Sum_probs=195.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|... ++..||+|.+.... ..+.+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 111 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence 467999999999999976 47889999987533 346789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~-------i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 112 SDIIRLRN-----KTLTEDEIATILQSTLKGLEYLHFMR-------KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp HHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99986322 24889999999999999999999998 999999999999999999999999999766443
Q ss_pred ---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 431 ---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
....++..|+|||.+.+..++.++||||||+++|||++|+.||.... . ...... ...........+.
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~---~~~~~~-~~~~~~~~~~~~~-- 249 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH----P---MRAIFM-IPTNPPPTFRKPE-- 249 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC----H---HHHHHH-HHHSCCCCCSSGG--
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----h---HHHHHH-HhcCCCcccCCcc--
Confidence 23346788999999998899999999999999999999999996421 1 111111 1111111111110
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.....+.+++.+||+.||++|||+.+++++.+...
T Consensus 250 ------~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 250 ------LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp ------GSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred ------cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence 01225788999999999999999999999877543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.45 Aligned_cols=259 Identities=22% Similarity=0.300 Sum_probs=197.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcC------CCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQ------KHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.++..+ .|+||+++++++......++||||
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 180 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECC
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEec
Confidence 467999999999999865 4788999999653 33456677888888776 677999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc--eEEeeccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM--VLVSDYGF 423 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DfG~ 423 (582)
+. ++|.+++..... ..+++..++.|+.||+.||+|||+.+ ||||||||+|||++.++. +||+|||+
T Consensus 181 ~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~-------ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 181 LS-MNLYELIKKNKF----QGFSLPLVRKFAHSILQCLDALHKNR-------IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp CC-CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHHT-------EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cC-CCHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 96 699999976542 24889999999999999999999998 999999999999999887 99999999
Q ss_pred cccccCc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc-----
Q 047954 424 SSLVAQP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW----- 497 (582)
Q Consensus 424 a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~----- 497 (582)
++..... ....+++.|+|||++.+..++.++|||||||++|||+||+.||.... ..+....+........
T Consensus 249 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~----~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 249 SCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED----EGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp CEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCHHHHH
T ss_pred ceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCCHHHHH
Confidence 9766543 23457889999999999999999999999999999999999996432 2222222222111000
Q ss_pred ----cccccch---------------hh---------------hhhhchH-----HHHHHHHHHHHHcccCCCCCCCChH
Q 047954 498 ----TAEIFDS---------------EI---------------SVQRSAA-----HGMLKLLQVAIQCCNKSPEKRPEMA 538 (582)
Q Consensus 498 ----~~~~~d~---------------~~---------------~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~ 538 (582)
....++. .. ....... .....+.+|+.+||+.||++|||+.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 0000000 00 0000000 0123578999999999999999999
Q ss_pred HHHHHHhhcc
Q 047954 539 EVVSELEIIK 548 (582)
Q Consensus 539 evl~~L~~i~ 548 (582)
|+++|.|...
T Consensus 405 e~L~Hpw~~~ 414 (429)
T 3kvw_A 405 QALRHPWLRR 414 (429)
T ss_dssp HHHTSTTTC-
T ss_pred HHhCChhhcc
Confidence 9999988654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=333.98 Aligned_cols=250 Identities=19% Similarity=0.364 Sum_probs=190.9
Q ss_pred ccccccccCceEEEEEEEcCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
..+.||+|+||.||+|...+ .||+|+++... ....+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114 (319)
T ss_dssp CCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred EeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCC
Confidence 35789999999999998764 49999986432 223456788999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++....
T Consensus 115 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~-------i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 115 TLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHAKG-------ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp EHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999996532 24888999999999999999999998 99999999999998 67999999999876432
Q ss_pred c---------ccccccccccCCCCCCC---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHH
Q 047954 430 P---------IAAQRMISYKSPEYQSS---------KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLR 491 (582)
Q Consensus 430 ~---------~~~~~~~~y~aPE~~~~---------~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 491 (582)
. ....++..|+|||.+.. ..++.++|||||||++|||++|+.||.... ...+. .
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~----~ 253 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP----AEAII----W 253 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC----HHHHH----H
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHH----H
Confidence 1 12346788999998764 457899999999999999999999996422 11111 1
Q ss_pred HHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCC
Q 047954 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTEST 553 (582)
Q Consensus 492 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 553 (582)
..............+ ..++.+++.+||..||++|||+.++++.|+.+......
T Consensus 254 ~~~~~~~~~~~~~~~---------~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 254 QMGTGMKPNLSQIGM---------GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HHHTTCCCCCCCSSC---------CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred HhccCCCCCCCcCCC---------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111111111111111 12477899999999999999999999999999866543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=336.53 Aligned_cols=259 Identities=21% Similarity=0.301 Sum_probs=195.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcc-----hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPL-----ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 94 (346)
T 1ua2_A 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94 (346)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcC
Confidence 467999999999999965 5788999998643211 1246789999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-------ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 95 ET-DLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHW-------ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp SE-EHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred CC-CHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHCC-------EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 75 8988886532 25888899999999999999999998 99999999999999999999999999987
Q ss_pred ccCcc----cccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc----c
Q 047954 427 VAQPI----AAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE----W 497 (582)
Q Consensus 427 ~~~~~----~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~----~ 497 (582)
..... ...++..|+|||.+.+. .++.++|||||||++|||++|..||.... ..+....+....... |
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~----~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS----DLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCTTTS
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHcCCCChhhh
Confidence 64432 23467889999998654 58999999999999999999999986431 222222222221110 1
Q ss_pred cccccchh---------hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 498 TAEIFDSE---------ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 498 ~~~~~d~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
......+. ............++.+++.+||+.||++|||+.|+++|.+.-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 00000000 0000000111246888999999999999999999999988654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.60 Aligned_cols=261 Identities=20% Similarity=0.298 Sum_probs=196.8
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCC--------CCCccccceEEE----eCCee
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK--------HPNLLPLLAYYF----SNDEK 339 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------H~niv~l~~~~~----~~~~~ 339 (582)
.+.||+|+||.||+|+. .+++.||||+++.. ....+.+.+|+.++++++ |+||+++++++. .....
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~ 120 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI 120 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEE
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceE
Confidence 46799999999999985 45788999999643 344577889999999885 788999999998 45678
Q ss_pred EEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeecCCC----
Q 047954 340 LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLDDNE---- 414 (582)
Q Consensus 340 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~~~~---- 414 (582)
++||||+ +++|.+.+..... ..+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 121 ~lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~g-------ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 121 CMVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHTKCR-------IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTC-------EECCCCSGGGEEECCCHHHHH
T ss_pred EEEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHhCC-------EecCCCCHHHeeEeccchhhh
Confidence 9999999 6677777764422 2588999999999999999999998 7 99999999999999775
Q ss_pred ---------------------------------------------ceEEeeccccccccCc-ccccccccccCCCCCCCC
Q 047954 415 ---------------------------------------------MVLVSDYGFSSLVAQP-IAAQRMISYKSPEYQSSK 448 (582)
Q Consensus 415 ---------------------------------------------~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~ 448 (582)
.+||+|||+++..... ....+|..|+|||++.+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTS
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCC
Confidence 7999999999876543 234578899999999998
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCc--cchHHHHHHHHhh---------cccccccchh------------
Q 047954 449 KISRKSDVWSFGCLLLELLTGRISTHSAPQGING--ADLCSWVLRAVRE---------EWTAEIFDSE------------ 505 (582)
Q Consensus 449 ~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~--~~~~~~~~~~~~~---------~~~~~~~d~~------------ 505 (582)
.++.++|||||||++|||+||+.||......... .+....+...... .+..+.+...
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 9999999999999999999999999754322111 1111111111110 0000000000
Q ss_pred ------hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 506 ------ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 506 ------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.............+.+|+.+||+.||++|||++|+++|.+.
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 395 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence 00001123455678899999999999999999999998763
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=333.97 Aligned_cols=257 Identities=17% Similarity=0.261 Sum_probs=190.3
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCc-----------chHHHHHHHHHHHhcCCCCCccccceEEEeC-----
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKP-----------LITEEFRKQLLVIADQKHPNLLPLLAYYFSN----- 336 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~----- 336 (582)
.+.||+|+||.||+|...++..||||++..... ...+.+.+|+.++++++||||+++++++...
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 106 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence 367999999999999988899999999854221 1237789999999999999999999999653
Q ss_pred CeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCce
Q 047954 337 DEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMV 416 (582)
Q Consensus 337 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~ 416 (582)
...++||||+. |+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-------ivH~Dlkp~NIl~~~~~~~ 173 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHEAG-------VVHRDLHPGNILLADNNDI 173 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTCCE
T ss_pred ceEEEEEccCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCc-------CEecCCChHHEEEcCCCCE
Confidence 35799999997 69999887442 25889999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCc---ccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHH
Q 047954 417 LVSDYGFSSLVAQP---IAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492 (582)
Q Consensus 417 kl~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 492 (582)
||+|||+++..... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ..+....+...
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~i~~~ 249 (362)
T 3pg1_A 174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST----FYNQLNKIVEV 249 (362)
T ss_dssp EECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHH
T ss_pred EEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHH
Confidence 99999999765433 22346788999998876 678999999999999999999999996432 11222222111
Q ss_pred Hhhcccc-------------------cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 493 VREEWTA-------------------EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 493 ~~~~~~~-------------------~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
....... ....... ..........+.+++.+||+.||++|||+.|+++|.+.-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 322 (362)
T 3pg1_A 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW--TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322 (362)
T ss_dssp HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH--HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred cCCCChHHhhhccchhhhHHHHhhcccCChhhH--HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence 1110000 0000000 0000111235788999999999999999999999987544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=335.29 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=191.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc--------chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP--------LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 343 (582)
.+.||+|+||.||+|... +++.||||.+..... .....+.+|+.++++++||||+++++++.... .++||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~ 93 (322)
T 2ycf_A 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVL 93 (322)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEE
T ss_pred eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEE
Confidence 467999999999999975 568899999864321 12345889999999999999999999987655 89999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc---eEEee
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM---VLVSD 420 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~---~kl~D 420 (582)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 94 e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~-------ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 94 ELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHENG-------IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp ECCTTEETHHHHSTT------CCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred ecCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 999999999998643 24888999999999999999999998 999999999999987654 99999
Q ss_pred ccccccccCcc---cccccccccCCCCC---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 421 YGFSSLVAQPI---AAQRMISYKSPEYQ---SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 421 fG~a~~~~~~~---~~~~~~~y~aPE~~---~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
||+++...... ...++..|+|||++ ....++.++|||||||++|||++|+.||..... ...+...+..
T Consensus 161 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~--- 234 (322)
T 2ycf_A 161 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QVSLKDQITS--- 234 (322)
T ss_dssp CTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC---SSCHHHHHHH---
T ss_pred CccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---HHHHHHHHHh---
Confidence 99998775432 23467899999986 356789999999999999999999999965322 1222222211
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.... . .+.. ......++.+++.+||+.||++|||+.|+++|.+..
T Consensus 235 -~~~~-~-~~~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~ 279 (322)
T 2ycf_A 235 -GKYN-F-IPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279 (322)
T ss_dssp -TCCC-C-CHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGC
T ss_pred -Cccc-c-Cchh-----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcC
Confidence 1110 0 0000 001123678899999999999999999999987643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=340.93 Aligned_cols=188 Identities=21% Similarity=0.364 Sum_probs=159.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeC-----CeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN-----DEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e 344 (582)
.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++... ...++|||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 110 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE 110 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence 467999999999999965 5678999999753 233456789999999999999999999999876 56899999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+. |+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 111 ~~~-~~L~~~~~~~------~~l~~~~~~~i~~qil~aL~~LH~~g-------ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 111 IAD-SDLKKLFKTP------IFLTEEHIKTILYNLLLGENFIHESG-------IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CCS-EEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cCC-cCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC-------CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 986 6999999743 24889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCc--------------------------ccccccccccCCCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 047954 425 SLVAQP--------------------------IAAQRMISYKSPEYQ-SSKKISRKSDVWSFGCLLLELLTGRISTH 474 (582)
Q Consensus 425 ~~~~~~--------------------------~~~~~~~~y~aPE~~-~~~~~~~k~DVwS~Gvvl~elltG~~P~~ 474 (582)
+..... ....+|..|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876432 223467889999985 56679999999999999999998766654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=349.73 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=196.2
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc-------------chHHHHHHHHHHHhcCCCCCccccceEEEeCCe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP-------------LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE 338 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 338 (582)
.+.||+|+||+||+|... ++..||+|++..... ...+.+.+|+.++++++|||||++++++.+...
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 120 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 467999999999999975 567899999864321 235678999999999999999999999999999
Q ss_pred eEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC---c
Q 047954 339 KLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE---M 415 (582)
Q Consensus 339 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~---~ 415 (582)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 121 ~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~-------ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 121 FYLVTEFYEGGELFEQIINRH------KFDECDAANIMKQILSGICYLHKHN-------IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEESSTTCCSS
T ss_pred EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999986532 4889999999999999999999998 99999999999998775 6
Q ss_pred eEEeeccccccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHH
Q 047954 416 VLVSDYGFSSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492 (582)
Q Consensus 416 ~kl~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 492 (582)
+||+|||+++..... ....+++.|+|||++. ..++.++||||+||++|+|++|+.||.... ..++...+.
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~-- 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN----DQDIIKKVE-- 260 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHH--
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHH--
Confidence 999999999876543 2345788999999887 468999999999999999999999996432 222222221
Q ss_pred HhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 493 VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 493 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
..... ++... ......++.+++.+||..||++|||+.|+++|.|....
T Consensus 261 -~~~~~---~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 261 -KGKYY---FDFND-----WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp -HCCCC---CCHHH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred -cCCCC---CCccc-----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 11110 00000 00112357889999999999999999999999886543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.18 Aligned_cols=262 Identities=19% Similarity=0.286 Sum_probs=176.3
Q ss_pred CCCChhHhhhcccccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEe----
Q 047954 261 AGFKLNDLLKAPAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS---- 335 (582)
Q Consensus 261 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~---- 335 (582)
..+.+.+-.....+.||+|+||.||+|... +++.||||++... ..........+..+.||||+++++++..
T Consensus 22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 344444444444567999999999999976 6889999998642 1222223334566799999999999976
Q ss_pred CCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC---
Q 047954 336 NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD--- 412 (582)
Q Consensus 336 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~--- 412 (582)
....++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~-------ivH~dlkp~NIll~~~~~ 166 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSHN-------IAHRDVKPENLLYTSKEK 166 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEESCSST
T ss_pred CceEEEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------eecCCCCHHHEEEEecCC
Confidence 4457999999999999999986432 25899999999999999999999998 999999999999976
Q ss_pred CCceEEeeccccccccCc--ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHH
Q 047954 413 NEMVLVSDYGFSSLVAQP--IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVL 490 (582)
Q Consensus 413 ~~~~kl~DfG~a~~~~~~--~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 490 (582)
++.+||+|||+++..... ....+++.|+|||++.+..++.++|||||||++|||++|+.||...... .......
T Consensus 167 ~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~ 242 (336)
T 3fhr_A 167 DAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ----AISPGMK 242 (336)
T ss_dssp TCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred CceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch----hhhhhHH
Confidence 455999999999766543 2334678899999998888999999999999999999999999653321 1110011
Q ss_pred HHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 491 RAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 491 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
........ ....+. ......++.+++.+||+.||++|||+.|+++|.+...
T Consensus 243 ~~~~~~~~-~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 243 RRIRLGQY-GFPNPE------WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ---------CCCTTT------STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred Hhhhcccc-ccCchh------hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 11000000 000000 0011235788999999999999999999999988654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.43 Aligned_cols=243 Identities=17% Similarity=0.189 Sum_probs=192.4
Q ss_pred cccccccCceEEEEEE------EcCCceEEEEEecCCCcchHHHHHHHHHHHhcCC---CCCccccceEEEeCCeeEEEE
Q 047954 273 AEGLGKGIFGNSYKAL------LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK---HPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~ 343 (582)
.+.||+|+||.||+|. ...++.||||+++.. ...++..|+.++.+++ |+||+++++++...+..++||
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~ 146 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEE
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEE
Confidence 4679999999999994 556788999999653 3566788888888876 999999999999999999999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC-----------
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD----------- 412 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~----------- 412 (582)
||+++|+|.+++...... ....+++..++.|+.||+.||+|||+.+ ||||||||+|||++.
T Consensus 147 e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~-------ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 147 ELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHDCE-------IIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp CCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHTTT-------EECCCCSGGGEEECGGGTCC------
T ss_pred eccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC-------eecCCCCHHHEEecccccCccccccc
Confidence 999999999999753221 1235899999999999999999999998 999999999999998
Q ss_pred CCceEEeeccccccccC------cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchH
Q 047954 413 NEMVLVSDYGFSSLVAQ------PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLC 486 (582)
Q Consensus 413 ~~~~kl~DfG~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~ 486 (582)
++.+||+|||+|+.+.. .....+|..|+|||++.+..++.++|||||||++|||+||+.||...... ..
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~--- 293 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--EC--- 293 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT--EE---
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC--ce---
Confidence 89999999999975431 12334788999999999999999999999999999999999998532211 00
Q ss_pred HHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCC-CChHHHHHHHhhccc
Q 047954 487 SWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKR-PEMAEVVSELEIIKV 549 (582)
Q Consensus 487 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~i~~ 549 (582)
.....+. .. .. ...+.+++..|++.+|.+| |+++++.+.|+.+..
T Consensus 294 ----------~~~~~~~-~~----~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 294 ----------KPEGLFR-RL----PH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ----------EECSCCT-TC----SS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----------eechhcc-cc----Cc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 0001110 00 01 1245577889999999999 678888888877654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=331.17 Aligned_cols=258 Identities=16% Similarity=0.282 Sum_probs=196.0
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeC--------CeeEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--------DEKLL 341 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~~~~l 341 (582)
.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++||||+++++++... +..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 101 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 101 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence 46799999999999997 568899999985432 23346788999999999999999999999873 46899
Q ss_pred EEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
||||+.+ +|.+.+..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 102 v~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~-------ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 102 VFDFCEH-DLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRNK-------ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp EEECCSE-EHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTSCEEECCC
T ss_pred EEeccCC-CHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC-------eeCCCCCHHHEEEcCCCCEEEccc
Confidence 9999975 88888865432 4889999999999999999999998 999999999999999999999999
Q ss_pred cccccccCc--------ccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHH
Q 047954 422 GFSSLVAQP--------IAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492 (582)
Q Consensus 422 G~a~~~~~~--------~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 492 (582)
|+++.+... ....+++.|+|||++.+ ..++.++|||||||++|||+||+.||.... .......+...
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~ 244 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT----EQHQLALISQL 244 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHH
Confidence 999765421 12345788999998876 458999999999999999999999996432 22222222222
Q ss_pred Hhhcccccccchh----h--------hhhhchHHH------HHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 493 VREEWTAEIFDSE----I--------SVQRSAAHG------MLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 493 ~~~~~~~~~~d~~----~--------~~~~~~~~~------~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
... ...+..... . .......+. ...+.+|+.+||+.||++|||++|+++|.+...
T Consensus 245 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 245 CGS-ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp HCC-CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred hCC-CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 111 011100000 0 000000111 235789999999999999999999999988643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=328.75 Aligned_cols=259 Identities=19% Similarity=0.324 Sum_probs=194.0
Q ss_pred cccccccCceEEEEEEE--cCCceEEEEEecCCC--cchHHHHHHHHHHHhcC---CCCCccccceEEE-----eCCeeE
Q 047954 273 AEGLGKGIFGNSYKALL--EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQ---KHPNLLPLLAYYF-----SNDEKL 340 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~-----~~~~~~ 340 (582)
.+.||+|+||.||+|.. .++..||+|+++... ......+.+|+.+++++ +||||+++++++. .....+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 95 (326)
T 1blx_A 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence 46799999999999997 467889999986322 12223466777766655 8999999999997 456789
Q ss_pred EEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEee
Q 047954 341 LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSD 420 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 420 (582)
+||||+. |+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 96 lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~g-------i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHR-------VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp EEEECCS-CBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTCCEEECS
T ss_pred EEEecCC-CCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHCC-------ceeccCCHHHeEEcCCCCEEEec
Confidence 9999997 699999976432 24889999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh--
Q 047954 421 YGFSSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE-- 495 (582)
Q Consensus 421 fG~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~-- 495 (582)
||+++...... ...++..|+|||++.+..++.++|||||||++|||+||+.||.... ..+....+......
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS----DVDQLGKILDVIGLPG 239 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCC
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHHHcCCCC
Confidence 99998765432 3346788999999998899999999999999999999999996432 22222222222111
Q ss_pred --cccccccchhh--------hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 496 --EWTAEIFDSEI--------SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 496 --~~~~~~~d~~~--------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.|......+.. ............+.+++.+||+.||++|||+.|+++|.+.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 301 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccc
Confidence 11110000000 00000011223577899999999999999999999987753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=328.29 Aligned_cols=257 Identities=20% Similarity=0.321 Sum_probs=198.5
Q ss_pred cccccccCceEEEEEEE--cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCC------CccccceEEEeCCeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALL--EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHP------NLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~------niv~l~~~~~~~~~~~lv~e 344 (582)
.+.||+|+||.||+|.. .++..||||+++.. ....+.+.+|+.++.+++|+ +++++++++...+..++|||
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 97 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEc
Confidence 46799999999999986 36788999999653 33456788999999888665 49999999999999999999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC------------
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD------------ 412 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~------------ 412 (582)
|+ +++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 98 ~~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~-------ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 98 LL-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSNK-------LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp CC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEESCCCEEEEEC----
T ss_pred CC-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHCC-------CcCCCCCHHHEEEeccccccccCCccc
Confidence 99 8899999976532 25888999999999999999999998 999999999999987
Q ss_pred -------CCceEEeeccccccccCc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccc
Q 047954 413 -------NEMVLVSDYGFSSLVAQP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD 484 (582)
Q Consensus 413 -------~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~ 484 (582)
++.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~ 241 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD----SKE 241 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC----HHH
T ss_pred cccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----hHH
Confidence 668999999999876543 23457889999999999999999999999999999999999996432 222
Q ss_pred hHHHHHHHHhhcccccc------------------------------cchhhhhhhchHHHHHHHHHHHHHcccCCCCCC
Q 047954 485 LCSWVLRAVREEWTAEI------------------------------FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKR 534 (582)
Q Consensus 485 ~~~~~~~~~~~~~~~~~------------------------------~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 534 (582)
....+...... ..... ..+.............++.+++.+||+.||++|
T Consensus 242 ~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 242 HLAMMERILGP-LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHCS-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHhCC-CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 22222211110 00000 000000001112334578899999999999999
Q ss_pred CChHHHHHHHhhc
Q 047954 535 PEMAEVVSELEII 547 (582)
Q Consensus 535 Ps~~evl~~L~~i 547 (582)
||+.|+++|.+.-
T Consensus 321 pt~~ell~hp~f~ 333 (339)
T 1z57_A 321 ITLREALKHPFFD 333 (339)
T ss_dssp CCHHHHTTSGGGG
T ss_pred cCHHHHhcCHHHH
Confidence 9999999886643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=334.58 Aligned_cols=257 Identities=21% Similarity=0.321 Sum_probs=180.1
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeC------CeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN------DEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~ 343 (582)
.+.||+|+||.||+|.. .++..||||++... .....+.+.+|+.++++++||||+++++++... ...++|+
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~ 113 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence 46799999999999985 46788999998653 233456788999999999999999999999754 4579999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+ +++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 114 e~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~g-------ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 114 HLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSAD-------IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp ECC-CEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTCCEEECC---
T ss_pred ccc-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 999 78999888642 4889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCc-ccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---cc
Q 047954 424 SSLVAQP-IAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE---WT 498 (582)
Q Consensus 424 a~~~~~~-~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~ 498 (582)
++..... ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+....... ..
T Consensus 179 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 179 ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD----HIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCHHHH
T ss_pred cccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCHHHH
Confidence 9876543 23457888999999876 678999999999999999999999996432 222222222221110 00
Q ss_pred ccccchhh-------------hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 499 AEIFDSEI-------------SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 499 ~~~~d~~~-------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
..+..... ............+.+|+.+||..||++|||+.|+++|.+.-.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 00000000 000000011235788999999999999999999999987554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=333.30 Aligned_cols=255 Identities=17% Similarity=0.264 Sum_probs=188.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCC------eeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND------EKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 343 (582)
.+.||+|+||.||+|... ++..||||++... .....+.+.+|+.++++++||||+++++++.... ..++||
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~ 109 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 109 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence 467999999999999864 5788999998643 2334567889999999999999999999998765 679999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+. |+|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 110 e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~-------ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 110 ELMD-ANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp ECCS-EEHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred EcCC-CCHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHCC-------eecccCCHHHEEEcCCCCEEEEEeec
Confidence 9997 588888852 3788899999999999999999998 99999999999999999999999999
Q ss_pred cccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---c
Q 047954 424 SSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE---W 497 (582)
Q Consensus 424 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---~ 497 (582)
++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+....... .
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD----HIDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHC-CCCCCHHH
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCHHH
Confidence 9876543 23357788999999999999999999999999999999999996432 111111111000000 0
Q ss_pred --------------ccc--------ccchh-hhh-hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 498 --------------TAE--------IFDSE-ISV-QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 498 --------------~~~--------~~d~~-~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
... .+... .+. .........++.+|+.+||..||++|||++|+++|.+.-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 000 00000 000 000112245688999999999999999999999998864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=321.21 Aligned_cols=246 Identities=19% Similarity=0.264 Sum_probs=192.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC----cchHHHHHHHHHHHhcCCCCCccccceEEEe--CCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK----PLITEEFRKQLLVIADQKHPNLLPLLAYYFS--NDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|... ++..||+|+++... ....+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence 467999999999999964 57889999986432 2345779999999999999999999999854 4578999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+.++ |.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~-l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~-------i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 90 CVCG-MQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHSQG-------IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp CSEE-HHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ccCC-HHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHHCC-------eeecCCCcccEEEcCCCcEEeecccccc
Confidence 9876 7777765432 25889999999999999999999998 9999999999999999999999999997
Q ss_pred cccCc------ccccccccccCCCCCCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 426 LVAQP------IAAQRMISYKSPEYQSSKK--ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 426 ~~~~~------~~~~~~~~y~aPE~~~~~~--~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
..... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||.... ....... +....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~-i~~~~ 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-------IYKLFEN-IGKGS 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHH-HHHCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-------HHHHHHH-HhcCC
Confidence 65421 2334778999999987644 3789999999999999999999996421 1111111 11111
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
. .. .. .....+.+++.+||+.||++|||+.|++++.+....
T Consensus 230 ~-~~-~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 230 Y-AI-PG---------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp C-CC-CS---------SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred C-CC-CC---------ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 1 00 00 111257789999999999999999999999876543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=358.59 Aligned_cols=247 Identities=21% Similarity=0.398 Sum_probs=197.5
Q ss_pred ccccccccCceEEEEEEEcC----CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 272 PAEGLGKGIFGNSYKALLEG----RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
..+.||+|+||.||+|.+.. +..||||+++... ....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 394 i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~ 472 (656)
T 2j0j_A 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 472 (656)
T ss_dssp EEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcC
Confidence 35789999999999998743 4568999986543 334578999999999999999999999984 56789999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 473 ~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g-------ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 473 TLGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLESKR-------FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp TTCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred CCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999997543 24889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCcc-----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 427 VAQPI-----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 427 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
..... ...+++.|+|||++.+..++.++|||||||++|||++ |..||... ...++...+.. .....
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~----~~~~~~~~i~~----~~~~~ 612 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRIEN----GERLP 612 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHH----TCCCC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHc----CCCCC
Confidence 75432 2234578999999988899999999999999999997 99999643 22222222211 11111
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
. .+ .....+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 613 ~-~~---------~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 613 M-PP---------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp C-CT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-Cc---------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1 00 112357889999999999999999999999998864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=332.61 Aligned_cols=258 Identities=18% Similarity=0.307 Sum_probs=196.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeC-----CeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN-----DEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~ 345 (582)
.+.||+|+||.||+|... ++..||||++.... ....+.+.+|++++.+++||||+++++++... ...++||||
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~ 111 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL 111 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence 467999999999999865 67789999997533 33447789999999999999999999999765 368999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+. |+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 112 ~~-~~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~-------ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 112 ME-TDLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSAN-------VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp CS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cC-cCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 97 5999998643 3888999999999999999999998 9999999999999999999999999998
Q ss_pred cccCcc-------cccccccccCCCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 426 LVAQPI-------AAQRMISYKSPEYQS-SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 426 ~~~~~~-------~~~~~~~y~aPE~~~-~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
...... ...+++.|+|||++. ...++.++|||||||++|||++|+.||.... ..+....+........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH----YLDQLNHILGILGSPS 252 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS----GGGHHHHHHHHHCSCC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC----hHHHHHHHHHHhCCCC
Confidence 765332 235688899999765 4558999999999999999999999996432 2233333222211100
Q ss_pred cc---cccchh-------------hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 498 TA---EIFDSE-------------ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 498 ~~---~~~d~~-------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.. .+.+.. ............++.+++.+||+.||++|||+.|+++|.+.-..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 00 000000 00000001112357899999999999999999999999886543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=328.57 Aligned_cols=257 Identities=19% Similarity=0.308 Sum_probs=188.5
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEE--------------eCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF--------------SND 337 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--------------~~~ 337 (582)
.+.||+|+||.||+|.... ++.||+|++........+.+.+|+.++++++||||+++++++. ...
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~ 95 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence 4679999999999999764 7889999997666666778999999999999999999999874 345
Q ss_pred eeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec-CCCce
Q 047954 338 EKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD-DNEMV 416 (582)
Q Consensus 338 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~-~~~~~ 416 (582)
..++||||+. |+|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+|||++ +++.+
T Consensus 96 ~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 96 SVYIVQEYME-TDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHSAN-------VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp EEEEEEECCS-EEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCSGGGEEEETTTTEE
T ss_pred ceeEEeeccC-CCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHhCC-------EecCCCCHHHEEEcCCCCeE
Confidence 7899999997 6999998532 4788899999999999999999998 99999999999997 56799
Q ss_pred EEeeccccccccCc-------ccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHH
Q 047954 417 LVSDYGFSSLVAQP-------IAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSW 488 (582)
Q Consensus 417 kl~DfG~a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~ 488 (582)
||+|||+++..... ....++..|+|||.+.+ ..++.++|||||||++|||+||+.||.... ..+....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~~~~~ 236 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH----ELEQMQL 236 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC----HHHHHHH
Confidence 99999999876432 12234678999998765 678999999999999999999999996432 1111111
Q ss_pred HHHHHhhc----------ccccccchhhh-----hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 489 VLRAVREE----------WTAEIFDSEIS-----VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 489 ~~~~~~~~----------~~~~~~d~~~~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
+....... ........... ..........++.+++.+||+.||++|||++|+++|.+.-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 11110000 00000000000 00000112346889999999999999999999999877543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=327.53 Aligned_cols=247 Identities=21% Similarity=0.323 Sum_probs=191.1
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEe------CCeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFS------NDEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~------~~~~~lv~e 344 (582)
.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.++.++ +||||+++++++.. .+..++|||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 107 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence 46799999999999997 467889999986433 3456789999999998 89999999999987 457899999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~-------ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 108 FCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQHK-------VIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cCCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 9999999999976432 25888899999999999999999998 999999999999999999999999999
Q ss_pred ccccCc----ccccccccccCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh
Q 047954 425 SLVAQP----IAAQRMISYKSPEYQS-----SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE 495 (582)
Q Consensus 425 ~~~~~~----~~~~~~~~y~aPE~~~-----~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 495 (582)
...... ....++..|+|||.+. +..++.++|||||||++|||+||+.||.... .. ........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~---~~~~~~~~- 248 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH----PM---RALFLIPR- 248 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC----HH---HHHHHHHH-
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc----HH---HHHHHhhc-
Confidence 876432 2334778899999886 5678999999999999999999999996421 11 11111111
Q ss_pred cccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 496 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.......... ....+.+++.+||..||++|||+.+++++.+...
T Consensus 249 ~~~~~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 249 NPAPRLKSKK---------WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp SCCCCCSCSC---------SCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred CccccCCccc---------cCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 1111111111 1125788999999999999999999999876543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=332.24 Aligned_cols=256 Identities=18% Similarity=0.244 Sum_probs=197.7
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcc-----------------hHHHHHHHHHHHhcCCCCCccccceEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPL-----------------ITEEFRKQLLVIADQKHPNLLPLLAYYFS 335 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 335 (582)
.+.||+|+||.||+|.. ++..||||++...... ..+.+.+|+.++++++||||+++++++.+
T Consensus 36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 114 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN 114 (348)
T ss_dssp EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES
T ss_pred EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee
Confidence 46799999999999999 8899999998632111 12789999999999999999999999999
Q ss_pred CCeeEEEEEeCCCCChHHH------HhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhc-cCCCCCCCcceecCCCCCCe
Q 047954 336 NDEKLLVYKFAGNGNLFNR------IHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH-KDKSRTQSAVIHGNLKSTNI 408 (582)
Q Consensus 336 ~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~ivH~Dlkp~NI 408 (582)
.+..++||||+++|+|.++ +.... ...+++..++.++.||+.||+|||+ .+ |+||||||+||
T Consensus 115 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~~-------i~H~dl~p~Ni 183 (348)
T 2pml_X 115 YDEVYIIYEYMENDSILKFDEYFFVLDKNY----TCFIPIQVIKCIIKSVLNSFSYIHNEKN-------ICHRDVKPSNI 183 (348)
T ss_dssp SSEEEEEEECCTTCBSSEESSSEESSCSSS----CCCCCHHHHHHHHHHHHHHHHHHHHTSC-------EECCCCCGGGE
T ss_pred CCeEEEEEeccCCCcHHHHHHHhhhhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhccCC-------EeecCCChHhE
Confidence 9999999999999999998 43321 2368999999999999999999999 87 99999999999
Q ss_pred eecCCCceEEeeccccccccCc--ccccccccccCCCCCCCC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCCCCCCccc
Q 047954 409 LLDDNEMVLVSDYGFSSLVAQP--IAAQRMISYKSPEYQSSK-KISR-KSDVWSFGCLLLELLTGRISTHSAPQGINGAD 484 (582)
Q Consensus 409 Ll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~-k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~ 484 (582)
|++.++.+||+|||++...... ....++..|+|||.+.+. .++. ++|||||||++|||++|+.||..... ..+
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~ 260 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS---LVE 260 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC---SHH
T ss_pred EEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc---HHH
Confidence 9999999999999999876443 234577889999999877 6666 99999999999999999999974321 112
Q ss_pred hHHHHHHHHhhcccccc------cchhhh--hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 485 LCSWVLRAVREEWTAEI------FDSEIS--VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 485 ~~~~~~~~~~~~~~~~~------~d~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+...+ ........ ..+... ..........++.+++.+||+.||++|||+.|+++|.+..
T Consensus 261 ~~~~i----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~ 327 (348)
T 2pml_X 261 LFNNI----RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327 (348)
T ss_dssp HHHHH----TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHH----hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence 22211 11111000 000000 0000011223678899999999999999999999987754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=320.01 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=196.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---------cchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---------PLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLL 341 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l 341 (582)
.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.++. ||||+++++++......++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 467999999999999975 57889999986432 122456889999999995 9999999999999999999
Q ss_pred EEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 102 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 102 VFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKLN-------IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp EEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECTTCCEEECCC
T ss_pred EEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999997532 4889999999999999999999998 999999999999999999999999
Q ss_pred cccccccCcc---cccccccccCCCCCC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHH
Q 047954 422 GFSSLVAQPI---AAQRMISYKSPEYQS------SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492 (582)
Q Consensus 422 G~a~~~~~~~---~~~~~~~y~aPE~~~------~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 492 (582)
|++....... ...++..|+|||++. ...++.++||||||+++|||++|+.||.... ...... ..
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~---~~ 241 (298)
T 1phk_A 169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK----QMLMLR---MI 241 (298)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH---HH
T ss_pred cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc----HHHHHH---HH
Confidence 9997765432 334678899999874 4568899999999999999999999996421 111111 11
Q ss_pred HhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 493 VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 493 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
...... ...+. .......+.+++.+||+.||++|||+.|++++.+..
T Consensus 242 ~~~~~~--~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (298)
T 1phk_A 242 MSGNYQ--FGSPE------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288 (298)
T ss_dssp HHTCCC--CCTTT------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hcCCcc--cCccc------ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence 111111 00000 011123578899999999999999999999987754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.57 Aligned_cols=246 Identities=20% Similarity=0.332 Sum_probs=192.6
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCC--CcchHHHHHHHHHHHhcCC--CCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQK--HPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..++||| +.+
T Consensus 33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 111 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111 (313)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence 4679999999999999888999999998643 2334578899999999997 5999999999999999999999 568
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||+++ +.+||+|||+++...
T Consensus 112 ~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~-------ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 112 IDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHG-------IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 89999997542 4788899999999999999999998 999999999999974 889999999998764
Q ss_pred Ccc------cccccccccCCCCCCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHH
Q 047954 429 QPI------AAQRMISYKSPEYQSS-----------KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLR 491 (582)
Q Consensus 429 ~~~------~~~~~~~y~aPE~~~~-----------~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 491 (582)
... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .......
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~ 251 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHA 251 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH------HHHHHHH
Confidence 432 2346889999998865 4788999999999999999999999964321 1112222
Q ss_pred HHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 492 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
...........+ . ...++.+++.+||+.||++|||+.|++++.+....
T Consensus 252 ~~~~~~~~~~~~-------~---~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 252 IIDPNHEIEFPD-------I---PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHCTTSCCCCCC-------C---SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHhcccccCCcc-------c---chHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 222111111100 0 01257789999999999999999999999876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=329.94 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=180.8
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+.++.+++||||+++++++...+..++||||+++|+
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 99 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence 46799999999999985 467889999986432 2345678899999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCC--CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 351 LFNRIHGGKSS--KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 351 L~~~l~~~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|.+++...... .....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-------i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG-------QIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 99998642110 11235889999999999999999999998 9999999999999999999999999987654
Q ss_pred Cc---------ccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 429 QP---------IAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 429 ~~---------~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
.. ....++..|+|||.+.+ ..++.++||||||+++|||+||+.||..... .... ....... .
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~---~~~~~~~-~ 244 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP----MKVL---MLTLQND-P 244 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG----GGHH---HHHHTSS-C
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch----hhHH---HHHhccC-C
Confidence 32 12346788999998865 5689999999999999999999999965321 1111 1111111 1
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
..... .............++.+++.+||+.||++|||+.|++++.+..
T Consensus 245 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 292 (303)
T 2vwi_A 245 PSLET-GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292 (303)
T ss_dssp CCTTC------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-
T ss_pred Ccccc-ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhh
Confidence 10000 0000000001123578899999999999999999999987644
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=335.14 Aligned_cols=257 Identities=20% Similarity=0.331 Sum_probs=188.6
Q ss_pred ccccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCe------eEEEEEe
Q 047954 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE------KLLVYKF 345 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~lv~e~ 345 (582)
..+.||+|+||.||+|+...+..||+|++...... ..+|+.++++++||||+++++++..... .++||||
T Consensus 44 ~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 44 NCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred EeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 35689999999999999988777999988643321 2369999999999999999999976543 7899999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec-CCCceEEeecccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD-DNEMVLVSDYGFS 424 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DfG~a 424 (582)
++++ +.+.+..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 120 ~~~~-l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-------ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 120 VPET-VYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSIG-------ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp CSEE-HHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cCcc-HHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-------ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 9874 4433321111 1125888999999999999999999998 99999999999999 7999999999999
Q ss_pred ccccCc---ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh-----
Q 047954 425 SLVAQP---IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE----- 495 (582)
Q Consensus 425 ~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----- 495 (582)
+..... ....++..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+....+......
T Consensus 190 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 190 KILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES----GIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp EECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCHHH
T ss_pred ccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCHHH
Confidence 876433 234567889999988764 58999999999999999999999996432 22222222221110
Q ss_pred ------cccc----cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 496 ------EWTA----EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 496 ------~~~~----~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.+.. .+...... .........++.+|+.+||+.||++|||+.|+++|.+.-
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFS-KVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHH-HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred HHhhChhhhhhccccccCCcHH-HhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence 0000 00000000 000001223688999999999999999999999997754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=342.56 Aligned_cols=249 Identities=19% Similarity=0.279 Sum_probs=185.8
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||+||.+...+++.||||++... ..+.+.+|+.++.++ +|||||++++++.+.+..++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 4679999999998877778899999998542 345678999999876 89999999999999999999999995 699
Q ss_pred HHHHhcCCCCCCC-CccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC-------------CceE
Q 047954 352 FNRIHGGKSSKNR-IPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN-------------EMVL 417 (582)
Q Consensus 352 ~~~l~~~~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~-------------~~~k 417 (582)
.+++......... ...++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+|
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-------ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-------IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC-------ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 9999765432111 11234456789999999999999998 9999999999999754 4799
Q ss_pred EeeccccccccCcc--------cccccccccCCCCCCC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 047954 418 VSDYGFSSLVAQPI--------AAQRMISYKSPEYQSS-------KKISRKSDVWSFGCLLLELLT-GRISTHSAPQGIN 481 (582)
Q Consensus 418 l~DfG~a~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~ 481 (582)
|+|||+++.+.... ...+|+.|+|||++.+ ..++.++|||||||++|||+| |+.||.....
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--- 245 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS--- 245 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT---
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh---
Confidence 99999998765432 2347889999998865 678999999999999999999 9999964321
Q ss_pred ccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 482 GADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.. . ............. .........++.+++.+||+.||++|||+.||++|.+.
T Consensus 246 --~~-~---~i~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f 299 (434)
T 2rio_A 246 --RE-S---NIIRGIFSLDEMK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299 (434)
T ss_dssp --HH-H---HHHHTCCCCCCCT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred --hH-H---HHhcCCCCccccc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence 00 1 1111111100000 00112334568899999999999999999999998764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=359.23 Aligned_cols=242 Identities=21% Similarity=0.276 Sum_probs=196.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|... +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..|+||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 467999999999999965 5678999998642 123346678899999887 79999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..++.|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+..
T Consensus 426 gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~g-------IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 426 GGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSKG-------IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp SCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTS-------EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred CCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999997542 4889999999999999999999998 999999999999999999999999999864
Q ss_pred cCc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
... ....||+.|+|||++.+..|+.++|||||||++|||++|+.||... +..++.. ....... .+ .
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~----~~~~~~~---~i~~~~~--~~-p 562 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE----DEDELFQ---SIMEHNV--AY-P 562 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHH---HHHSSCC--CC-C
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC----CHHHHHH---HHHhCCC--CC-C
Confidence 222 2345789999999999999999999999999999999999999642 2222222 2211110 00 0
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCCh-----HHHHHHHhh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEM-----AEVVSELEI 546 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~L~~ 546 (582)
. ....++.+|+.+||+.||++||++ +||++|.+.
T Consensus 563 ~---------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff 601 (674)
T 3pfq_A 563 K---------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601 (674)
T ss_dssp T---------TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGG
T ss_pred c---------cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccc
Confidence 0 112257889999999999999998 888887654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.05 Aligned_cols=256 Identities=18% Similarity=0.311 Sum_probs=192.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCee------EEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEK------LLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~------~lv~ 343 (582)
.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+.. ++||
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 126 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 126 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence 467999999999999865 57889999997532 23456788999999999999999999999877654 9999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+. ++|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 127 e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~-------ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 127 PFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSAG-------VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp ECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred cccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHCC-------CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 9997 688887732 3889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCcc-cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---cc
Q 047954 424 SSLVAQPI-AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE---WT 498 (582)
Q Consensus 424 a~~~~~~~-~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~ 498 (582)
++...... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+....... +.
T Consensus 191 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 191 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD----YLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp C--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCHHHH
T ss_pred ccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCcHHHH
Confidence 98765432 3456889999998877 688999999999999999999999996432 122222221111100 00
Q ss_pred ccccchhh-------------hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 499 AEIFDSEI-------------SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 499 ~~~~d~~~-------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
..+.+... ............+.+|+.+||+.||++|||+.|+++|.+.-.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 00000000 000000111346889999999999999999999999988643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=335.83 Aligned_cols=256 Identities=16% Similarity=0.244 Sum_probs=188.7
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeC---------------
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN--------------- 336 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------------- 336 (582)
.+.||+|+||.||+|.. .+++.||||++..... ...+|+.++++++|||||++++++...
T Consensus 12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp EEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC---------------
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccc
Confidence 46799999999999986 5688999999864332 234799999999999999999998543
Q ss_pred -----------------------CeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCC
Q 047954 337 -----------------------DEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393 (582)
Q Consensus 337 -----------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 393 (582)
...++||||++ |+|.+.+...... ...+++..+..++.||+.||+|||+.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g--- 161 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS--GRSIPMNLISIYIYQLFRAVGFIHSLG--- 161 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHTTT---
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCc---
Confidence 33789999998 5887777542111 225889999999999999999999998
Q ss_pred CCCcceecCCCCCCeeec-CCCceEEeeccccccccCc---ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHh
Q 047954 394 TQSAVIHGNLKSTNILLD-DNEMVLVSDYGFSSLVAQP---IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLT 468 (582)
Q Consensus 394 ~~~~ivH~Dlkp~NILl~-~~~~~kl~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~ellt 468 (582)
|+||||||+|||++ .++.+||+|||+++.+... ....++..|+|||.+.+. .++.++||||+||++|||++
T Consensus 162 ----i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 162 ----ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp ----EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred ----CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 99999999999998 6889999999999876433 233467889999988765 48999999999999999999
Q ss_pred CCCCCCCCCCCCCccchHHHHHHHHhhccc---------------ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCC
Q 047954 469 GRISTHSAPQGINGADLCSWVLRAVREEWT---------------AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEK 533 (582)
Q Consensus 469 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~ 533 (582)
|+.||.... ..+....+......... ......... .........++.+|+.+||+.||++
T Consensus 238 g~~pf~~~~----~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 238 GKPLFSGET----SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR-KILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp SSCSSCCSS----HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHH-HHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred CCCCCCCCC----hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHH-hhCCCCCCHHHHHHHHHHccCChhh
Confidence 999996432 22222222221111000 000000000 0000111235789999999999999
Q ss_pred CCChHHHHHHHhhc
Q 047954 534 RPEMAEVVSELEII 547 (582)
Q Consensus 534 RPs~~evl~~L~~i 547 (582)
|||+.|+++|.+.-
T Consensus 313 R~t~~e~l~hp~f~ 326 (383)
T 3eb0_A 313 RINPYEAMAHPFFD 326 (383)
T ss_dssp SCCHHHHHTSGGGH
T ss_pred CCCHHHHhcCHHHH
Confidence 99999999987643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.22 Aligned_cols=263 Identities=18% Similarity=0.295 Sum_probs=196.3
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCC-----------CCCccccceEEEeCC---
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-----------HPNLLPLLAYYFSND--- 337 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~~~~--- 337 (582)
.+.||+|+||.||+|.. .+++.||||++.. .....+.+.+|+.++.+++ ||||+++++++...+
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 102 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC
Confidence 46799999999999996 5678899999864 2334567889999998876 899999999998654
Q ss_pred -eeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeec----
Q 047954 338 -EKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLD---- 411 (582)
Q Consensus 338 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~---- 411 (582)
..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++ + |+||||||+|||++
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~~-------ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 103 VHVVMVFEVL-GENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRRCG-------IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEEEECCC-CEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTC-------EECSCCSGGGEEEEEEET
T ss_pred ceEEEEEecC-CCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHhcCC-------EEecCCChHHeEEeccCC
Confidence 689999999 8899999976432 2488899999999999999999998 7 99999999999994
Q ss_pred --CCCceEEeeccccccccCc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC--ccchH
Q 047954 412 --DNEMVLVSDYGFSSLVAQP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGIN--GADLC 486 (582)
Q Consensus 412 --~~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~--~~~~~ 486 (582)
..+.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+||+.||........ ..+..
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred CcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 4457999999999876543 334578899999999999999999999999999999999999975432110 11111
Q ss_pred HHHHHHHhhc---------ccccccc-----------------hhh-hhhhchHHHHHHHHHHHHHcccCCCCCCCChHH
Q 047954 487 SWVLRAVREE---------WTAEIFD-----------------SEI-SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAE 539 (582)
Q Consensus 487 ~~~~~~~~~~---------~~~~~~d-----------------~~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 539 (582)
..+....... +....+. ..+ ...........++.+|+.+||+.||++|||++|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 1111111000 0000000 000 000122345567889999999999999999999
Q ss_pred HHHHHhhcc
Q 047954 540 VVSELEIIK 548 (582)
Q Consensus 540 vl~~L~~i~ 548 (582)
+++|.+...
T Consensus 331 ll~hp~f~~ 339 (373)
T 1q8y_A 331 LVNHPWLKD 339 (373)
T ss_dssp HHTCGGGTT
T ss_pred HhhChhhhc
Confidence 999988654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=339.77 Aligned_cols=258 Identities=20% Similarity=0.286 Sum_probs=188.2
Q ss_pred ccccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCC------eeEEEEE
Q 047954 272 PAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND------EKLLVYK 344 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~e 344 (582)
..+.||+|+||.||+|+.. +++.||||++..... .+.+|++++++++|||||+++++|.... ..++|||
T Consensus 58 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred eeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 3578999999999999975 588999999865322 2347999999999999999999986521 3679999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC-CceEEeeccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN-EMVLVSDYGF 423 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DfG~ 423 (582)
|+++ +|.+.+..... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+
T Consensus 134 ~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~-------ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFG-------ICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp CCCE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTT-------EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred cccc-cHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-------ccccCCChhhEEEeCCCCeEEeccchh
Confidence 9975 67666543211 1235889999999999999999999998 9999999999999965 5689999999
Q ss_pred cccccCc---ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc--
Q 047954 424 SSLVAQP---IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW-- 497 (582)
Q Consensus 424 a~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~-- 497 (582)
++.+... ....++..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+....+........
T Consensus 204 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~----~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 204 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS----GVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp CEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCSCCHH
T ss_pred hhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCHH
Confidence 9876433 234567889999998764 78999999999999999999999996432 1222222211111000
Q ss_pred --------cccccchhhhhh----hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 498 --------TAEIFDSEISVQ----RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 498 --------~~~~~d~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
..+...+.+... ........++.+|+.+||..||++|||+.|+++|.+.-
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 000000000000 00001123678999999999999999999999997753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.15 Aligned_cols=257 Identities=20% Similarity=0.290 Sum_probs=193.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeC-----CeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN-----DEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~ 345 (582)
.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++... ...++||||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 95 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence 467999999999999975 57889999996433 33456788999999999999999999988764 578999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+. |+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~-------ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 96 MQ-TDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHGSN-------VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp CS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cC-ccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC-------eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 97 6999998753 4888999999999999999999998 9999999999999999999999999998
Q ss_pred cccCcc--------------cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHH
Q 047954 426 LVAQPI--------------AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVL 490 (582)
Q Consensus 426 ~~~~~~--------------~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 490 (582)
...... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~ 236 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD----YRHQLLLIF 236 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHH
Confidence 764321 1245788999998654 678999999999999999999999996432 111111111
Q ss_pred HHHhhcccc----cccchhh-------------hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 491 RAVREEWTA----EIFDSEI-------------SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 491 ~~~~~~~~~----~~~d~~~-------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
......... .+..... ...........++.+++.+||+.||++|||+.|+++|.+.-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 111100000 0000000 000000112236788999999999999999999999987644
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=315.50 Aligned_cols=246 Identities=22% Similarity=0.303 Sum_probs=195.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCC
Confidence 467999999999999975 6788999998643 2345678999999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC---CceEEeecccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN---EMVLVSDYGFSSL 426 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DfG~a~~ 426 (582)
+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..
T Consensus 107 ~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~-------i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 107 ELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKHN-------IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp BHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred CHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999886432 4889999999999999999999998 9999999999999754 4699999999987
Q ss_pred ccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 427 VAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 427 ~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
..... ...++..|+|||.+.+ .++.++||||||+++|+|++|+.||.... ..++...+ .........
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~---~~~~~~~~~-- 243 (287)
T 2wei_A 174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN----EYDILKRV---ETGKYAFDL-- 243 (287)
T ss_dssp BCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHH---HHCCCCCCS--
T ss_pred ecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC----HHHHHHHH---HcCCCCCCc--
Confidence 65432 2236778999998875 48999999999999999999999996431 12222211 111111000
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
+. ......++.+++.+||+.||++|||+.|++++.+..
T Consensus 244 ~~------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~ 281 (287)
T 2wei_A 244 PQ------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281 (287)
T ss_dssp GG------GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred hh------hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHh
Confidence 00 001123578899999999999999999999987654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=320.01 Aligned_cols=246 Identities=20% Similarity=0.356 Sum_probs=187.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEe-------------CCe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS-------------NDE 338 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-------------~~~ 338 (582)
.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 467999999999999964 6889999998542 2345678999999999999999999999865 346
Q ss_pred eEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEE
Q 047954 339 KLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLV 418 (582)
Q Consensus 339 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl 418 (582)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~-------i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHSQG-------IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECTTSCEEE
T ss_pred eEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHhCC-------eecccCCHHhEEEcCCCCEEE
Confidence 789999999999999997532 24778889999999999999999998 999999999999999999999
Q ss_pred eeccccccccCc------------------ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 047954 419 SDYGFSSLVAQP------------------IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQG 479 (582)
Q Consensus 419 ~DfG~a~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~ 479 (582)
+|||+++..... ....++..|+|||.+.+. .++.++|||||||++|||++ ||..
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~---- 230 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST---- 230 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS----
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC----
Confidence 999999876422 122366789999998764 68999999999999999998 5531
Q ss_pred CCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 480 INGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
..+....... ..... .. +.+.. .......+.+++.+||+.||++|||+.|++++.|...
T Consensus 231 --~~~~~~~~~~-~~~~~-~~-~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 231 --GMERVNILKK-LRSVS-IE-FPPDF-----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp --HHHHHHHHHH-HHSTT-CC-CCTTC-----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred --chhHHHHHHh-ccccc-cc-cCccc-----cccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 1111111111 11110 00 00000 1112235778999999999999999999999887543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=328.76 Aligned_cols=260 Identities=20% Similarity=0.276 Sum_probs=196.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCC-CC-----CccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-HP-----NLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||+||+|... +++.||||+++.. ....+.+..|+.++..++ |+ +|+++++++...+..++||||
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 137 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEec
Confidence 467999999999999865 5778999999743 334567788888888874 44 499999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec--CCCceEEeeccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD--DNEMVLVSDYGF 423 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DfG~ 423 (582)
+. |+|.+++..... ..+++..+..++.|++.||.|||++. .+||||||||+|||++ .++.+||+|||+
T Consensus 138 ~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~-----~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 138 LS-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATPE-----LSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp CC-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTSTT-----TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CC-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccCC-----CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 96 599999976532 24889999999999999999999632 1399999999999994 577899999999
Q ss_pred cccccCc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc------
Q 047954 424 SSLVAQP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE------ 496 (582)
Q Consensus 424 a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~------ 496 (582)
++..... ....+++.|+|||++.+..++.++|||||||++|||+||+.||.... ..+....+.......
T Consensus 208 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 208 SCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN----EVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp CEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCSCCHHHHT
T ss_pred ceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCHHHHH
Confidence 9877543 33457889999999999999999999999999999999999996432 222222222211100
Q ss_pred -------ccccccchh------------------------h------------hhhhchHHHHHHHHHHHHHcccCCCCC
Q 047954 497 -------WTAEIFDSE------------------------I------------SVQRSAAHGMLKLLQVAIQCCNKSPEK 533 (582)
Q Consensus 497 -------~~~~~~d~~------------------------~------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~ 533 (582)
....+.+.. + ........+..++.+|+.+||+.||++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 363 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence 000000000 0 000011223357889999999999999
Q ss_pred CCChHHHHHHHhhc
Q 047954 534 RPEMAEVVSELEII 547 (582)
Q Consensus 534 RPs~~evl~~L~~i 547 (582)
|||++|+++|.+.-
T Consensus 364 Rpta~e~L~hp~f~ 377 (382)
T 2vx3_A 364 RIQPYYALQHSFFK 377 (382)
T ss_dssp SCCHHHHTTSGGGC
T ss_pred CCCHHHHhcCcccc
Confidence 99999999988754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=324.77 Aligned_cols=258 Identities=19% Similarity=0.320 Sum_probs=197.0
Q ss_pred cccccccCceEEEEEEEcC--CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCC------ccccceEEEeCCeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLEG--RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPN------LLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~~~~lv~e 344 (582)
.+.||+|+||.||+|.... +..||+|+++.. ....+.+.+|+.++++++|++ ++.+++++...+..++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE 102 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence 4679999999999999653 368999998643 344567889999999987766 8999999999999999999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeee--------------
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILL-------------- 410 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl-------------- 410 (582)
|+ +++|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 103 ~~-~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~-------ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 103 LL-GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHENQ-------LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp CC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHTTT-------EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred cc-CCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEEEeccccccccccccc
Confidence 99 6788887765432 25889999999999999999999998 9999999999999
Q ss_pred -----cCCCceEEeeccccccccCc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccc
Q 047954 411 -----DDNEMVLVSDYGFSSLVAQP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD 484 (582)
Q Consensus 411 -----~~~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~ 484 (582)
+.++.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE----NRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHH
T ss_pred ccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHH
Confidence 56789999999999875443 33457889999999999999999999999999999999999996432 122
Q ss_pred hHHHHHHHHhhcccccc----------------cch-----h---------hhhhhchHHHHHHHHHHHHHcccCCCCCC
Q 047954 485 LCSWVLRAVREEWTAEI----------------FDS-----E---------ISVQRSAAHGMLKLLQVAIQCCNKSPEKR 534 (582)
Q Consensus 485 ~~~~~~~~~~~~~~~~~----------------~d~-----~---------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 534 (582)
....+...... ..... .+. . ............++.+|+.+||+.||++|
T Consensus 247 ~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 247 HLVMMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 22222221110 00000 000 0 00000111234478899999999999999
Q ss_pred CChHHHHHHHhhcc
Q 047954 535 PEMAEVVSELEIIK 548 (582)
Q Consensus 535 Ps~~evl~~L~~i~ 548 (582)
||+.|+++|.+.-.
T Consensus 326 pt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 326 ITLAEALLHPFFAG 339 (355)
T ss_dssp CCHHHHTTSGGGGG
T ss_pred cCHHHHhcChhhcC
Confidence 99999999877543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=324.43 Aligned_cols=256 Identities=19% Similarity=0.314 Sum_probs=191.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCe------eEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE------KLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~lv~ 343 (582)
.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++..... .++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 467999999999999964 67899999996532 2335678899999999999999999999987654 49999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+. |+|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 109 e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~~-------ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 109 PFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSAG-------VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp ECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred cccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC-------cccCCCCHHHEeECCCCcEEEeeccc
Confidence 9997 688877632 3888999999999999999999998 99999999999999999999999999
Q ss_pred cccccCcc-cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh---ccc
Q 047954 424 SSLVAQPI-AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE---EWT 498 (582)
Q Consensus 424 a~~~~~~~-~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~ 498 (582)
++...... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ..+....+...... .+.
T Consensus 173 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 173 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD----YLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp TTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC----HHHHHHHHHHHHCBCCHHHH
T ss_pred ccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCHHHH
Confidence 98765432 3356889999998876 678999999999999999999999996432 12222222111100 000
Q ss_pred ccccchhh-------------hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 499 AEIFDSEI-------------SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 499 ~~~~d~~~-------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
..+.+... ...........++.+++.+||+.||++|||+.|+++|.+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00000000 000000112346788999999999999999999999987543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=325.91 Aligned_cols=261 Identities=16% Similarity=0.236 Sum_probs=182.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCe-------eEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE-------KLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-------~~lv~e 344 (582)
.+.||+|+||.||+|... ++..||||++.... .....+.+++..+.+++||||+++++++..... .++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEee
Confidence 467999999999999975 57889999986432 233456778888899999999999999976443 789999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHh--ccCCCCCCCcceecCCCCCCeeecC-CCceEEeec
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH--HKDKSRTQSAVIHGNLKSTNILLDD-NEMVLVSDY 421 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Df 421 (582)
|+++ +|.+.+..... ....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+||+||
T Consensus 107 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~~-------ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPSVN-------VCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CCSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC-------CBCSCCCGGGEEEETTTTEEEECCC
T ss_pred cccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCCCC-------eecCcCCHHHEEEeCCCCcEEEeeC
Confidence 9976 55554432111 1235788899999999999999999 776 999999999999996 899999999
Q ss_pred cccccccCcc---cccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 422 GFSSLVAQPI---AAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 422 G~a~~~~~~~---~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
|+++...... ...++..|+|||++.+. .++.++|||||||++|||+||+.||.... .......+.+......
T Consensus 177 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 177 GSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN----SAGQLHEIVRVLGCPS 252 (360)
T ss_dssp TTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCC
T ss_pred CCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC----hHHHHHHHHHHcCCCC
Confidence 9998765432 33467889999988665 48999999999999999999999996532 2222222222111000
Q ss_pred -------cccccchhhh----------hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 498 -------TAEIFDSEIS----------VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 498 -------~~~~~d~~~~----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.....+.... ..........++.+|+.+||+.||++|||+.|+++|.+.-.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 0000000000 00000112346889999999999999999999999987654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=322.23 Aligned_cols=248 Identities=20% Similarity=0.310 Sum_probs=175.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcc-h-HHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPL-I-TEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... +++.||||++...... . .+.+..+..+++.++||||+++++++...+..++||||+ ++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 108 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT 108 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence 467999999999999975 6789999999754322 2 233445556788889999999999999999999999999 44
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
.+..+..... ..+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 109 ~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~-------i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 109 CAEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLKEKHG-------VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHHHC-------CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhhCC-------EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 5555443221 2488899999999999999999995 7 9999999999999999999999999997664
Q ss_pred Ccc---cccccccccCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 429 QPI---AAQRMISYKSPEYQS-----SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 429 ~~~---~~~~~~~y~aPE~~~-----~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
... ...++..|+|||.+. ...++.++|||||||++|||++|+.||.... .. ........... ...
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~---~~~~~~~~~~~-~~~ 249 (318)
T 2dyl_A 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK---TD---FEVLTKVLQEE-PPL 249 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC---SH---HHHHHHHHHSC-CCC
T ss_pred CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC---cc---HHHHHHHhccC-CCC
Confidence 432 234678899999984 4578999999999999999999999996421 11 11122222211 111
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
... .. ....++.+++.+||+.||++|||+.|++++.+...
T Consensus 250 ~~~-----~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 250 LPG-----HM---GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CCS-----SS---CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCc-----cC---CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 100 00 01125778999999999999999999999877543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=327.27 Aligned_cols=256 Identities=21% Similarity=0.280 Sum_probs=176.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHH-HHhcCCCCCccccceEEEeCCeeEEEEEeCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLL-VIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNG 349 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 349 (582)
.+.||+|+||.||+|... +++.||||+++... ......+..|+. +++.++||||+++++++...+..++||||+.+
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 467999999999999975 67889999997543 233445566665 67778999999999999999999999999975
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
+|.+++...... ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-------ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 106 SFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENLK-------IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp EHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHHHS-------CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhccCC-------EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 887777531110 122588899999999999999999998 7 9999999999999999999999999998765
Q ss_pred Ccc---cccccccccCCCCC----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 429 QPI---AAQRMISYKSPEYQ----SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 429 ~~~---~~~~~~~y~aPE~~----~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
... ...++..|+|||.+ .+..++.++|||||||++|||++|+.||...... ...+.... ......+
T Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~-~~~~~~~ 250 (327)
T 3aln_A 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV------FDQLTQVV-KGDPPQL 250 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCC-CSCCCCC
T ss_pred cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH------HHHHHHHh-cCCCCCC
Confidence 432 22477889999998 4567899999999999999999999999643211 00000000 0000000
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
... ........+.+++.+||+.||++|||+.|++++.+.....
T Consensus 251 ~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 251 SNS------EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CCC------SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCc------ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 000 0001123578899999999999999999999998766543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=330.62 Aligned_cols=242 Identities=17% Similarity=0.232 Sum_probs=183.0
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||+||.....+++.||||++..... ..+.+|+.+++++ +|||||++++++.+....++||||+. |+|
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L 104 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL 104 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence 467999999997766667788999999965332 2356899999998 89999999999999999999999996 699
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC-----CCceEEeecccccc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD-----NEMVLVSDYGFSSL 426 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~DfG~a~~ 426 (582)
.+++..... .+....++.++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++.
T Consensus 105 ~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~-------ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 105 QEYVEQKDF-----AHLGLEPITLLQQTTSGLAHLHSLN-------IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp HHHHHSSSC-----CCCSSCHHHHHHHHHHHHHHHHHTT-------CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred HHHHHhcCC-----CccchhHHHHHHHHHHHHHHHHHCc-------CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 999975532 2445567789999999999999998 999999999999953 34588999999987
Q ss_pred ccCc-------ccccccccccCCCCCC---CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhh
Q 047954 427 VAQP-------IAAQRMISYKSPEYQS---SKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVRE 495 (582)
Q Consensus 427 ~~~~-------~~~~~~~~y~aPE~~~---~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 495 (582)
.... ....+|+.|+|||++. ...++.++|||||||++|||+| |+.||..... ..... ...
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--------~~~~~-~~~ 243 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--------RQANI-LLG 243 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--------HHHHH-HTT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--------HHHHH-Hhc
Confidence 6532 2344789999999987 4567889999999999999999 9999853211 11111 111
Q ss_pred cccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 496 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
........+ .......+.+|+.+||+.||++|||+.||++|.+.
T Consensus 244 ~~~~~~~~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f 287 (432)
T 3p23_A 244 ACSLDCLHP-------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287 (432)
T ss_dssp CCCCTTSCT-------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred cCCccccCc-------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence 111111111 11122346789999999999999999999988654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=318.85 Aligned_cols=238 Identities=22% Similarity=0.378 Sum_probs=186.6
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcc------hHHHHHHHHHHHhcC----CCCCccccceEEEeCCeeEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPL------ITEEFRKQLLVIADQ----KHPNLLPLLAYYFSNDEKLL 341 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~H~niv~l~~~~~~~~~~~l 341 (582)
.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.++.++ +||||+++++++...+..++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~ 115 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence 46799999999999986 46788999999654321 223456788888888 89999999999999999999
Q ss_pred EEEe-CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec-CCCceEEe
Q 047954 342 VYKF-AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD-DNEMVLVS 419 (582)
Q Consensus 342 v~e~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~-~~~~~kl~ 419 (582)
|||| +.+++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+||+++ .++.+||+
T Consensus 116 v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-------i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 116 VLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSRG-------VVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp EEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHHT-------EECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeecCCChhhEEEeCCCCeEEEE
Confidence 9999 78999999997532 4889999999999999999999998 99999999999999 88999999
Q ss_pred eccccccccCc--ccccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 420 DYGFSSLVAQP--IAAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 420 DfG~a~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
|||+++..... ....++..|+|||++.+..+ +.++||||||+++|||++|+.||... .. + ....
T Consensus 183 dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~----~---~~~~ 249 (312)
T 2iwi_A 183 DFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QE----I---LEAE 249 (312)
T ss_dssp CCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HH----H---HHTC
T ss_pred EcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HH----H---hhhc
Confidence 99999876543 23346788999998876665 45899999999999999999999531 10 0 0110
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
. . +.. ....++.+++.+||+.||++|||+.|++++.+...
T Consensus 250 ~--~-~~~---------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 250 L--H-FPA---------HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp C--C-CCT---------TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred c--C-Ccc---------cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 0 0 000 01125778999999999999999999999877544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.28 Aligned_cols=238 Identities=20% Similarity=0.349 Sum_probs=191.6
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcc------hHHHHHHHHHHHhcCC--CCCccccceEEEeCCeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPL------ITEEFRKQLLVIADQK--HPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~ 343 (582)
.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.++++++ |+||+++++++...+..++||
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~ 127 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence 46799999999999985 46788999998643211 2245678999999986 599999999999999999999
Q ss_pred EeCCC-CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec-CCCceEEeec
Q 047954 344 KFAGN-GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD-DNEMVLVSDY 421 (582)
Q Consensus 344 e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Df 421 (582)
||+.+ ++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++ +++.+||+||
T Consensus 128 e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~-------ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 128 ERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNCG-------VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp ECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEEETTTTEEEECCC
T ss_pred EcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCC-------cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 99976 89999987532 4788999999999999999999998 99999999999999 7889999999
Q ss_pred cccccccCcc--cccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 422 GFSSLVAQPI--AAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 422 G~a~~~~~~~--~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
|+++...... ...++..|+|||++.+..+ +.++|||||||++|||+||+.||.... .......
T Consensus 195 g~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------~~~~~~~- 260 (320)
T 3a99_A 195 GSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQV- 260 (320)
T ss_dssp TTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCCC-
T ss_pred ccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------------hhhcccc-
Confidence 9998765432 3357889999998876665 688999999999999999999995310 0011110
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
..... ...++.+++.+||+.||++|||++|++++.+...
T Consensus 261 --~~~~~---------~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 261 --FFRQR---------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp --CCSSC---------CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred --ccccc---------CCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 00111 1125778999999999999999999999877543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.42 Aligned_cols=228 Identities=12% Similarity=0.053 Sum_probs=177.0
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCCCc---chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKP---LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|.... ++.||||++..... ...+.+.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 115 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence 4679999999999999764 78999999975432 2347789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
++|.+++... ....+...|+.|++.||+|||+++ |+||||||+|||++.++.+||+++|
T Consensus 116 ~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~g-------ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 116 GSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRAG-------VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred CCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHCC-------CccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999532 234467889999999999999998 9999999999999999999998554
Q ss_pred CcccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhh
Q 047954 429 QPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508 (582)
Q Consensus 429 ~~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 508 (582)
|++ .++.++|||||||++|||+||+.||...............+ . .....+.
T Consensus 175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~----~----~~~~~~~--- 226 (286)
T 3uqc_A 175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT----A----GQPIEPA--- 226 (286)
T ss_dssp ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT----T----SCBCCHH---
T ss_pred ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh----c----cCCCChh---
Confidence 343 36899999999999999999999997543221000000000 0 0000000
Q ss_pred hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 509 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
........++.+++.+||+.||++| |+.|+++.|+.+....
T Consensus 227 -~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 227 -DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp -HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred -hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0001112357889999999999999 9999999999987654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.53 Aligned_cols=232 Identities=20% Similarity=0.342 Sum_probs=178.3
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHH-hcCCCCCccccceEEEe----CCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVI-ADQKHPNLLPLLAYYFS----NDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~~~lv~e~~ 346 (582)
.+.||+|+||.||+|.. .+++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ....++||||+
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred CcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 36799999999999996 4678999999854 24577888887 55699999999999987 66789999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC---CCceEEeeccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD---NEMVLVSDYGF 423 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DfG~ 423 (582)
++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 98 ~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~-------i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 98 DGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSIN-------IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp CSCBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC-------cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999986432 25899999999999999999999998 999999999999998 78899999999
Q ss_pred cccccCcccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 424 SSLVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 424 a~~~~~~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
++... +..++.++|||||||++|||+||+.||.......... .....+..
T Consensus 167 a~~~~------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------------~~~~~~~~ 216 (299)
T 3m2w_A 167 AKETT------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------GMKTRIRM 216 (299)
T ss_dssp CEECT------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------------CSCCSSCT
T ss_pred ccccc------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------------HHHHHHhh
Confidence 86542 2457889999999999999999999996432110000 00000000
Q ss_pred hhhhhh-hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccC
Q 047954 504 SEISVQ-RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVT 550 (582)
Q Consensus 504 ~~~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~ 550 (582)
...... ........++.+++.+||+.||++|||+.|+++|.+.....
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 000000 00011123678899999999999999999999998865543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.69 Aligned_cols=241 Identities=15% Similarity=0.109 Sum_probs=176.5
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCc---chHHHHHHHHHHHhcCCC-CCccccceE---------------
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKP---LITEEFRKQLLVIADQKH-PNLLPLLAY--------------- 332 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H-~niv~l~~~--------------- 332 (582)
.+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+.++..++| +|...+..+
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 46799999999999995 4688999999873322 225679999999999987 332211111
Q ss_pred ------EEe-----CCeeEEEEEeCCCCChHHHHhcCCC-CCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCccee
Q 047954 333 ------YFS-----NDEKLLVYKFAGNGNLFNRIHGGKS-SKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIH 400 (582)
Q Consensus 333 ------~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH 400 (582)
+.. ....+++|+++ +++|.+++..... ......+++..++.++.||+.||+|||+++ |||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------iiH 234 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-------LVH 234 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-------EEC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-------ccc
Confidence 111 12356777765 6899988842100 011235888999999999999999999998 999
Q ss_pred cCCCCCCeeecCCCceEEeeccccccccCcc-cccccccccCCCCC----------CCCCCCcchhHHHHHHHHHHHHhC
Q 047954 401 GNLKSTNILLDDNEMVLVSDYGFSSLVAQPI-AAQRMISYKSPEYQ----------SSKKISRKSDVWSFGCLLLELLTG 469 (582)
Q Consensus 401 ~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~-~~~~~~~y~aPE~~----------~~~~~~~k~DVwS~Gvvl~elltG 469 (582)
|||||+|||++.++.+||+|||+++...... ...+ +.|+|||++ ....++.++|||||||++|||+||
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999999999999999998765442 2335 889999998 556688999999999999999999
Q ss_pred CCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 470 RISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 470 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
+.||...... .. ...++.. ... ...++.+++.+||+.||++||++.|++++.+
T Consensus 314 ~~Pf~~~~~~----~~------------~~~~~~~----~~~---~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~ 366 (413)
T 3dzo_A 314 DLPNTDDAAL----GG------------SEWIFRS----CKN---IPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366 (413)
T ss_dssp SCCCCTTGGG----SC------------SGGGGSS----CCC---CCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred CCCCCCcchh----hh------------HHHHHhh----ccc---CCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 9999653211 10 0001110 000 1135788999999999999999999877643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=340.65 Aligned_cols=233 Identities=18% Similarity=0.223 Sum_probs=186.4
Q ss_pred cccccccCceEEEEEEEc--CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCe-----eEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE--GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE-----KLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----~~lv~e 344 (582)
.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++|||||++++++...+. .++|||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E 164 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence 467999999999999975 57889999986433 3445678999999999999999999999988765 699999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++++|.+++.. .+++..++.|+.||+.||.|||+++ ||||||||+|||++.+ .+||+|||++
T Consensus 165 ~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~g-------iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 165 YVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSIG-------LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp CCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHCC-------CeecccChHHeEEeCC-cEEEEecccc
Confidence 9999999887642 4889999999999999999999998 9999999999999986 8999999999
Q ss_pred ccccCcccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 425 SLVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 425 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
+.........+|+.|+|||++.+. ++.++|||||||++|||++|..||...... .+...
T Consensus 229 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------------------~~~~~ 287 (681)
T 2pzi_A 229 SRINSFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD--------------------GLPED 287 (681)
T ss_dssp EETTCCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS--------------------SCCTT
T ss_pred hhcccCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc--------------------ccccc
Confidence 888776666789999999988764 489999999999999999999887532110 00000
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHH-HHHHHhhc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAE-VVSELEII 547 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e-vl~~L~~i 547 (582)
.........+.+++.+||+.||++||+..+ +...|..+
T Consensus 288 -----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 288 -----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 000111235778999999999999996544 44555544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.03 Aligned_cols=253 Identities=22% Similarity=0.268 Sum_probs=189.9
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEe------CCeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFS------NDEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~~~lv~e 344 (582)
.+.||+|+||.||+|.. .++..||||+++.. .....+.+.+|++++++++||||+++++++.. .+..++|||
T Consensus 19 ~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmE 98 (676)
T 3qa8_A 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98 (676)
T ss_dssp CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEE
Confidence 46899999999999986 46788999998653 33445778999999999999999999998765 567899999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCc---eEEeec
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEM---VLVSDY 421 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~---~kl~Df 421 (582)
|+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 99 y~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs~g-------IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 99 YCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHENR-------IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHHTT-------BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-------CccCCCCHHHeEeecCCCceeEEEccc
Confidence 9999999999986432 225888899999999999999999998 999999999999997665 999999
Q ss_pred cccccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHH---HHhh
Q 047954 422 GFSSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLR---AVRE 495 (582)
Q Consensus 422 G~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~---~~~~ 495 (582)
|+++...... ...++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...|... ....
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~------~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ------PVQWHGKVREKSNE 242 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH------HHHSSTTCC-----
T ss_pred ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc------hhhhhhhhhcccch
Confidence 9998765432 33577899999999999999999999999999999999999964210 0000000 0000
Q ss_pred -cccccccc------hhhhh-hhchHHHHHHHHHHHHHcccCCCCCCCChHHHH
Q 047954 496 -EWTAEIFD------SEISV-QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVV 541 (582)
Q Consensus 496 -~~~~~~~d------~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 541 (582)
....+... ..... ..........+.+++.+||..||++|||+.|++
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 00000000 00000 001112334688899999999999999998854
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.73 Aligned_cols=239 Identities=13% Similarity=0.119 Sum_probs=179.3
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCC--------cchHHHHHHHHHHHhcCC---------CCCccccceEE--
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLK--------PLITEEFRKQLLVIADQK---------HPNLLPLLAYY-- 333 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------H~niv~l~~~~-- 333 (582)
.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ |||||++.+.+
T Consensus 25 ~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~ 103 (336)
T 2vuw_A 25 CEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCV 103 (336)
T ss_dssp CEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEE
T ss_pred eeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEe
Confidence 57899999999999998 67899999996432 233477889999988885 66666665543
Q ss_pred ---------------Ee-------------CCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHH
Q 047954 334 ---------------FS-------------NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385 (582)
Q Consensus 334 ---------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~y 385 (582)
.+ .+..++||||+++|++.+.+.. ..+++..++.|+.||+.||+|
T Consensus 104 ~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 104 QGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp ESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHHHHHHHH
T ss_pred cCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHHHHHHHH
Confidence 32 6789999999999987777643 147889999999999999999
Q ss_pred Hh-ccCCCCCCCcceecCCCCCCeeecCCC--------------------ceEEeeccccccccCcccccccccccCCCC
Q 047954 386 LH-HKDKSRTQSAVIHGNLKSTNILLDDNE--------------------MVLVSDYGFSSLVAQPIAAQRMISYKSPEY 444 (582)
Q Consensus 386 LH-~~~~~~~~~~ivH~Dlkp~NILl~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~ 444 (582)
|| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...+|+.|+|||+
T Consensus 177 lH~~~~-------ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 177 AEASLR-------FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHC-------CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGG
T ss_pred HHHhCC-------EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhh
Confidence 99 888 99999999999999887 8999999999877654 3468899999999
Q ss_pred CCCCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCCCCCccchHHHHHHHHh-hcccccccchhhhhhhchHHHHHHHHHH
Q 047954 445 QSSKKISRKSDVWSFGCL-LLELLTGRISTHSAPQGINGADLCSWVLRAVR-EEWTAEIFDSEISVQRSAAHGMLKLLQV 522 (582)
Q Consensus 445 ~~~~~~~~k~DVwS~Gvv-l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~~l~~l 522 (582)
+.+.. +.++||||+|++ .+++++|..||.. ............ ......... .........++.+|
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-------~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-------VLWLHYLTDKMLKQMTFKTKCN-----TPAMKQIKRKIQEF 315 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-------HHHHHHHHHHHHHTCCCSSCCC-----SHHHHHHHHHHHHH
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcc-------hhhhhHHHHhhhhhhccCcccc-----hhhhhhcCHHHHHH
Confidence 98766 899999998777 7788889988831 111011111111 100110000 11122344578899
Q ss_pred HHHcccCCCCCCCChHHHH-HHHh
Q 047954 523 AIQCCNKSPEKRPEMAEVV-SELE 545 (582)
Q Consensus 523 ~~~Cl~~dP~~RPs~~evl-~~L~ 545 (582)
+.+||+.| |++|++ +|.+
T Consensus 316 i~~~L~~d-----sa~e~l~~Hp~ 334 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLLCQHSL 334 (336)
T ss_dssp HHHGGGSS-----SHHHHHHHCGG
T ss_pred HHHHhccC-----CHHHHHhcCCC
Confidence 99999976 999999 8765
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=280.90 Aligned_cols=182 Identities=13% Similarity=0.008 Sum_probs=128.1
Q ss_pred ccccccCceEEEEEE-EcCCceEEEEEecCCC----------cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEE
Q 047954 274 EGLGKGIFGNSYKAL-LEGRAPVVVKRLRDLK----------PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLL 341 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 341 (582)
...+.|++|.+..++ ...|+.+++|.+.... ....++|.+|+++|+++ .|+||+++++++.+++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 357778888777765 4567889999986431 12345799999999999 79999999999999999999
Q ss_pred EEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
||||++||+|.+++.... +++.. +|+.||+.||+|+|+++ ||||||||+|||+++++.+||+||
T Consensus 320 VMEyv~G~~L~d~i~~~~------~l~~~---~I~~QIl~AL~ylH~~G-------IIHRDIKPeNILL~~dg~vKL~DF 383 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE------EIDRE---KILGSLLRSLAALEKQG-------FWHDDVRPWNVMVDARQHARLIDF 383 (569)
T ss_dssp EEECCCSEEHHHHHHTTC------CCCHH---HHHHHHHHHHHHHHHTT-------CEESCCCGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHHhCC------CCCHH---HHHHHHHHHHHHHHHCC-------ceeccCchHhEEECCCCCEEEeec
Confidence 999999999999997543 34433 58899999999999998 999999999999999999999999
Q ss_pred cccccccCcc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 047954 422 GFSSLVAQPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRIS 472 (582)
Q Consensus 422 G~a~~~~~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P 472 (582)
|+|+...... ...||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 384 GlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 384 GSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp TTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 9998775432 2347889999999875 467789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-27 Score=254.23 Aligned_cols=178 Identities=17% Similarity=0.165 Sum_probs=144.1
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcc--------hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPL--------ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 344 (582)
.+.||+|+||.||+|.. .+..+++|+....... ..+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999954 4566888876432211 13458999999999999999988888888888999999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++|+|.+++.. ++.++.|+++||+|||+++ |+||||||+|||++. .+||+|||++
T Consensus 420 ~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~g-------IiHrDiKp~NILl~~--~~kL~DFGla 476 (540)
T 3en9_A 420 YINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKND-------VIHNDLTTSNFIFDK--DLYIIDFGLG 476 (540)
T ss_dssp CCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHTT-------EECTTCCTTSEEESS--SEEECCCTTC
T ss_pred CCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHCc-------CccCCCCHHHEEECC--eEEEEECccC
Confidence 9999999999863 4578999999999999998 999999999999998 9999999999
Q ss_pred ccccCcc-----------cccccccccCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 047954 425 SLVAQPI-----------AAQRMISYKSPEYQSS--KKISRKSDVWSFGCLLLELLTGRISTH 474 (582)
Q Consensus 425 ~~~~~~~-----------~~~~~~~y~aPE~~~~--~~~~~k~DVwS~Gvvl~elltG~~P~~ 474 (582)
+...... ...+|+.|||||++.. ..|+.++|+||..+-.++.+.++.+|.
T Consensus 477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9876532 3347889999999876 568888999999999999988877663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-23 Score=206.44 Aligned_cols=140 Identities=16% Similarity=0.205 Sum_probs=114.2
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCc------------------chHHHHHHHHHHHhcCCCCCccccceEEE
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKP------------------LITEEFRKQLLVIADQKHPNLLPLLAYYF 334 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 334 (582)
.+.||+|+||.||+|...+++.||+|.++.... .....+.+|+.++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 478999999999999997789999999964321 13457899999999999 5 77777654
Q ss_pred eCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC
Q 047954 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE 414 (582)
Q Consensus 335 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~ 414 (582)
. +..++||||+++|+|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++ ++
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~~g-------iiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYHRG-------IVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHHTT-------EECSCCSTTSEEEE-TT
T ss_pred c-cceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHHCC-------CEeCCCCHHHEEEE-CC
Confidence 4 55699999999999988 421 124469999999999999998 99999999999999 99
Q ss_pred ceEEeeccccccccCcccccccccccCCCCCC
Q 047954 415 MVLVSDYGFSSLVAQPIAAQRMISYKSPEYQS 446 (582)
Q Consensus 415 ~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~ 446 (582)
.+||+|||+|+.. ..|+|||++.
T Consensus 230 ~vkl~DFG~a~~~---------~~~~a~e~l~ 252 (282)
T 1zar_A 230 GIWIIDFPQSVEV---------GEEGWREILE 252 (282)
T ss_dssp EEEECCCTTCEET---------TSTTHHHHHH
T ss_pred cEEEEECCCCeEC---------CCCCHHHHHH
Confidence 9999999998644 2367888764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-20 Score=214.53 Aligned_cols=121 Identities=31% Similarity=0.515 Sum_probs=111.8
Q ss_pred cCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCC
Q 047954 42 FADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLK 118 (582)
Q Consensus 42 ~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~ 118 (582)
++.+++|+.|||++|+|+|.+| .++++++|+.|+|++|+|+|.||.++++|++|+.|||++|+|+|.||.. .+++|+
T Consensus 628 ~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~ 707 (768)
T 3rgz_A 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707 (768)
T ss_dssp CSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCS
T ss_pred hhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCC
Confidence 3446789999999999999998 5899999999999999999999999999999999999999999999985 789999
Q ss_pred EEEeecCcccccCCCCCcccccccccccCCCCCCCCCCCCCCCCC
Q 047954 119 VFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCSST 163 (582)
Q Consensus 119 ~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l~~~~~~~~~~~~ 163 (582)
+||||+|+|+|.||..+.+..+...+|.||+++||+|.. .|...
T Consensus 708 ~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~ 751 (768)
T 3rgz_A 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS 751 (768)
T ss_dssp EEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred EEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence 999999999999999999999999999999999998754 77643
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.80 E-value=7.5e-20 Score=185.04 Aligned_cols=143 Identities=25% Similarity=0.422 Sum_probs=127.4
Q ss_pred CCCC--cceeeeCCCC--CeEEEEEeCCCccee--ccCccccCCCCCCcEEEccC-CccccccC-CCCCCCCCCEEeCCC
Q 047954 7 FPSQ--WYGIQCDINS--AHVTGIVLEDMRLNG--EIKSDAFADIPELIVINFKN-NIISGNFM-NFSSNHKLKDIDLSG 78 (582)
Q Consensus 7 ~~~~--w~gv~c~~~~--~~~~~l~l~~~~l~g--~ip~~~~~~l~~L~~l~l~~-n~~~g~~~-~~~~~~~l~~l~l~~ 78 (582)
.||. |.||+|+... ++|+.|+|++|+++| .+|+ .++.+++|++|+|++ |.++|.+| .+.++++|++|+|++
T Consensus 32 ~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~ 110 (313)
T 1ogq_A 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110 (313)
T ss_dssp CTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEE
T ss_pred CCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcC
Confidence 5687 9999997533 799999999999999 8976 589999999999994 99999998 588999999999999
Q ss_pred CcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-Cccc-ccccccccCCCC
Q 047954 79 NKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQ-LFRSYSYSNNPY 150 (582)
Q Consensus 79 N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~-~~~~~~~~~n~~ 150 (582)
|+++|.+|..+.++++|++|+|++|.++|.+|.. .+++|+.|+|++|.++|.+|.. ..+. .+..+++++|..
T Consensus 111 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l 186 (313)
T 1ogq_A 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp ECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred CeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCee
Confidence 9999999999999999999999999999999974 7899999999999999999965 3344 677788888754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.9e-19 Score=176.78 Aligned_cols=134 Identities=18% Similarity=0.171 Sum_probs=103.7
Q ss_pred cccccccCceEEEEEEE-cCCce--EEEEEecCCCcc------------------------hHHHHHHHHHHHhcCCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAP--VVVKRLRDLKPL------------------------ITEEFRKQLLVIADQKHPN 325 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~H~n 325 (582)
.+.||+|+||.||+|.. .++.. ||||+++..... ....+.+|+.++.++.|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 46799999999999997 68888 999987543111 1136789999999998886
Q ss_pred c--cccceEEEeCCeeEEEEEeCCC-C----ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHh-ccCCCCCCCc
Q 047954 326 L--LPLLAYYFSNDEKLLVYKFAGN-G----NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH-HKDKSRTQSA 397 (582)
Q Consensus 326 i--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~~~~ 397 (582)
+ ..++++ ...++||||+.+ | +|.++... .++.....++.|++.||.||| +.+
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~g------- 191 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEAE------- 191 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTSC-------
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHCC-------
Confidence 5 333332 356899999942 4 66665421 234567789999999999999 887
Q ss_pred ceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 398 VIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 398 ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
||||||||+|||++. .++|+|||+|....
T Consensus 192 ivHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 192 LVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp EECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred EEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999999999999998 99999999997653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.74 E-value=1e-18 Score=198.27 Aligned_cols=138 Identities=22% Similarity=0.314 Sum_probs=116.9
Q ss_pred ceeeeCCCCCeEEEEEeCCCcceeccCccccCCCCCCcEEEc-cCCccccc-----------------------------
Q 047954 12 YGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINF-KNNIISGN----------------------------- 61 (582)
Q Consensus 12 ~gv~c~~~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l-~~n~~~g~----------------------------- 61 (582)
.||+|+. .++|+.|+|++|+|+|.||+ .+++|++|+.|+| ++|.++|.
T Consensus 315 ~GV~C~~-~~~V~~L~Ls~~~L~G~ip~-~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l 392 (876)
T 4ecn_A 315 PGVDLDN-NGRVTGLSLAGFGAKGRVPD-AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFL 392 (876)
T ss_dssp TTEEECT-TSCEEEEECTTTCCEEEECG-GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHT
T ss_pred CceEecC-CCCEEEEECccCCCCCcCch-HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhh
Confidence 9999984 68999999999999999986 4999999999999 88887776
Q ss_pred -----------------------------------------------cC-CCCCCCCCCEEeCCCCcccc----------
Q 047954 62 -----------------------------------------------FM-NFSSNHKLKDIDLSGNKFYG---------- 83 (582)
Q Consensus 62 -----------------------------------------------~~-~~~~~~~l~~l~l~~N~l~g---------- 83 (582)
|| .++++++|+.|+|++|+|+|
T Consensus 393 ~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~ 472 (876)
T 4ecn_A 393 DYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDA 472 (876)
T ss_dssp CCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT
T ss_pred ccCcchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCccccccccc
Confidence 54 46778899999999999998
Q ss_pred -------ccccccc--CCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCc-ccc-cCCCC-Ccc-------ccccc
Q 047954 84 -------EISRSLL--SLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNN-LSG-SIPKT-QTL-------QLFRS 142 (582)
Q Consensus 84 -------~ip~~~~--~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~-l~g-~ip~~-~~~-------~~~~~ 142 (582)
.||.+++ +|++|++|+|++|+++|.+|.. .+++|+.|+|++|+ |+| .+|.. ..+ +.+..
T Consensus 473 s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~ 552 (876)
T 4ecn_A 473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552 (876)
T ss_dssp TSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCE
T ss_pred ccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccE
Confidence 4999988 9999999999999999999974 78899999999998 888 88853 222 36777
Q ss_pred ccccCCCCC
Q 047954 143 YSYSNNPYL 151 (582)
Q Consensus 143 ~~~~~n~~l 151 (582)
+++++|...
T Consensus 553 L~Ls~N~L~ 561 (876)
T 4ecn_A 553 FYMGYNNLE 561 (876)
T ss_dssp EECCSSCCC
T ss_pred EEeeCCcCC
Confidence 888888654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.9e-18 Score=191.72 Aligned_cols=142 Identities=22% Similarity=0.321 Sum_probs=125.0
Q ss_pred CCCCc---ceeeeCCCCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCc--------------------------
Q 047954 7 FPSQW---YGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNI-------------------------- 57 (582)
Q Consensus 7 ~~~~w---~gv~c~~~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~-------------------------- 57 (582)
.+|.| .||+|+. .++|+.|+|++++++|.+|+ .+++|++|++|+|++|.
T Consensus 65 ~~c~w~~~~GV~C~~-~~~V~~L~L~~~~l~g~lp~-~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~ 142 (636)
T 4eco_A 65 ELDMWGAQPGVSLNS-NGRVTGLSLEGFGASGRVPD-AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR 142 (636)
T ss_dssp CGGGTTCCTTEEECT-TCCEEEEECTTSCCEEEECG-GGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHH
T ss_pred CcccccCCCCeEEcC-CCCEEEEEecCcccCCcCCh-HHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHH
Confidence 35789 9999974 48999999999999999986 59999999999999984
Q ss_pred ----------------------------------------------------cccccC-CCCCCCCCCEEeCCCCccccc
Q 047954 58 ----------------------------------------------------ISGNFM-NFSSNHKLKDIDLSGNKFYGE 84 (582)
Q Consensus 58 ----------------------------------------------------~~g~~~-~~~~~~~l~~l~l~~N~l~g~ 84 (582)
|+| || .++++++|++|+|++|.|+|.
T Consensus 143 l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~ 221 (636)
T 4eco_A 143 MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAE 221 (636)
T ss_dssp THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGG
T ss_pred hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccc
Confidence 446 55 488899999999999999997
Q ss_pred -----------------cccccc--CCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCc-ccc-cCCCCC-cc---
Q 047954 85 -----------------ISRSLL--SLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNN-LSG-SIPKTQ-TL--- 137 (582)
Q Consensus 85 -----------------ip~~~~--~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~-l~g-~ip~~~-~~--- 137 (582)
||.+++ ++++|++|+|++|+++|.+|.. .+++|+.|+|++|+ |+| .+|... .+
T Consensus 222 ~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~ 301 (636)
T 4eco_A 222 NICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADA 301 (636)
T ss_dssp GBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHS
T ss_pred cccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhcc
Confidence 999999 9999999999999999999984 78999999999998 999 898652 23
Q ss_pred ---cccccccccCCCCC
Q 047954 138 ---QLFRSYSYSNNPYL 151 (582)
Q Consensus 138 ---~~~~~~~~~~n~~l 151 (582)
..+..+++++|...
T Consensus 302 ~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 302 PVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp GGGGTCCEEECCSSCCS
T ss_pred ccCCCCCEEECCCCcCC
Confidence 78888899988655
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=4e-17 Score=156.18 Aligned_cols=151 Identities=21% Similarity=0.337 Sum_probs=130.5
Q ss_pred CCCCCCCCcceeeeCCCC---------CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCC
Q 047954 3 CFKDFPSQWYGIQCDINS---------AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLK 72 (582)
Q Consensus 3 ~~~~~~~~w~gv~c~~~~---------~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~ 72 (582)
|-.+=.|.|..+.|+.+. ..++.|+|++|++++..|...+..+++|+.|+|++|.+++..+ .+.++++|+
T Consensus 5 CP~~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~ 84 (220)
T 2v70_A 5 CPEKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVN 84 (220)
T ss_dssp CCTTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred CCCCCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCC
Confidence 433333689999996421 2467899999999998777778999999999999999999887 689999999
Q ss_pred EEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCC
Q 047954 73 DIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNP 149 (582)
Q Consensus 73 ~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~ 149 (582)
.|+|++|++++..|..+.++++|++|+|++|++++..|.. .+++|+.|+|++|++++..|.. ..+..+..+++++|+
T Consensus 85 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 164 (220)
T 2v70_A 85 EILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANP 164 (220)
T ss_dssp EEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcC
Confidence 9999999999988989999999999999999999988874 6899999999999999987855 457788899999998
Q ss_pred CCCC
Q 047954 150 YLCG 153 (582)
Q Consensus 150 ~l~~ 153 (582)
..|.
T Consensus 165 l~c~ 168 (220)
T 2v70_A 165 FNCN 168 (220)
T ss_dssp EECS
T ss_pred CcCC
Confidence 8764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=167.26 Aligned_cols=137 Identities=30% Similarity=0.521 Sum_probs=98.2
Q ss_pred CeEEEEEeCCCcceeccCccccCCCC-CCcEEEccCCccccccC------------------------CCCCCCCCCEEe
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIP-ELIVINFKNNIISGNFM------------------------NFSSNHKLKDID 75 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~-~L~~l~l~~n~~~g~~~------------------------~~~~~~~l~~l~ 75 (582)
.+++.|+|++|+++|.+|.. ++.++ .|+.|+|++|.++|.+| .+..+++|+.|+
T Consensus 149 ~~L~~L~L~~N~l~~~~p~~-l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 227 (313)
T 1ogq_A 149 PNLVGITFDGNRISGAIPDS-YGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227 (313)
T ss_dssp TTCCEEECCSSCCEEECCGG-GGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred CCCCeEECcCCcccCcCCHH-HhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEE
Confidence 44556666666666666543 45554 55566665555555443 244556666666
Q ss_pred CCCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCCCcccccccccccCCCCCCC
Q 047954 76 LSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 76 l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l~~ 153 (582)
|++|.++|.+|. +..+++|++|+|++|+++|.+|.. .+++|+.|+|++|+++|.+|....+..+..+++.+|+.+||
T Consensus 228 L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 228 LAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp CCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES
T ss_pred CCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccC
Confidence 666666666665 666777888888888888888874 67899999999999999999888888999999999999999
Q ss_pred CCCCCCC
Q 047954 154 PPSLNNC 160 (582)
Q Consensus 154 ~~~~~~~ 160 (582)
.|.. .|
T Consensus 307 ~p~~-~C 312 (313)
T 1ogq_A 307 SPLP-AC 312 (313)
T ss_dssp TTSS-CC
T ss_pred CCCC-CC
Confidence 7643 35
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.2e-17 Score=187.32 Aligned_cols=141 Identities=26% Similarity=0.318 Sum_probs=87.0
Q ss_pred CCCCcceeeeCCCCCeEEEEEeCCCcceec---cCc----------------------cccCCCCCCcEEEccCCccccc
Q 047954 7 FPSQWYGIQCDINSAHVTGIVLEDMRLNGE---IKS----------------------DAFADIPELIVINFKNNIISGN 61 (582)
Q Consensus 7 ~~~~w~gv~c~~~~~~~~~l~l~~~~l~g~---ip~----------------------~~~~~l~~L~~l~l~~n~~~g~ 61 (582)
.+|.|.||+|+ .++|+.|+|++++++|. +|+ +.++.+++|++|+|++|.++|.
T Consensus 38 ~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~ 115 (768)
T 3rgz_A 38 NPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGP 115 (768)
T ss_dssp CGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEE
T ss_pred CCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCc
Confidence 46899999998 68999999999999998 764 2355566666666666666666
Q ss_pred cC---CCCCCCCCCEEeCCCCcccccccccc-cCCCcCCeeecccCcccCCCCC-----CCCCCCCEEEeecCcccccCC
Q 047954 62 FM---NFSSNHKLKDIDLSGNKFYGEISRSL-LSLKFLESLQLQNNNLTGPVPE-----FNQSSLKVFNVSNNNLSGSIP 132 (582)
Q Consensus 62 ~~---~~~~~~~l~~l~l~~N~l~g~ip~~~-~~l~~l~~l~l~~N~l~g~ip~-----~~~~~l~~l~ls~N~l~g~ip 132 (582)
+| .++++++|++|||++|.++|.+|..+ +++++|++|||++|+++|.+|. ..+++|+.|++++|.++|.+|
T Consensus 116 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 195 (768)
T 3rgz_A 116 VTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD 195 (768)
T ss_dssp GGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB
T ss_pred CCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC
Confidence 54 35556666666666666666666554 5555555555555555554442 134444444444444444444
Q ss_pred CCCcccccccccccCCCC
Q 047954 133 KTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 133 ~~~~~~~~~~~~~~~n~~ 150 (582)
. ..+..+..+++++|..
T Consensus 196 ~-~~l~~L~~L~Ls~n~l 212 (768)
T 3rgz_A 196 V-SRCVNLEFLDVSSNNF 212 (768)
T ss_dssp C-TTCTTCCEEECCSSCC
T ss_pred c-ccCCcCCEEECcCCcC
Confidence 3 2344445555555543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.70 E-value=8.5e-17 Score=154.89 Aligned_cols=145 Identities=19% Similarity=0.212 Sum_probs=123.6
Q ss_pred CCCCcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeC
Q 047954 7 FPSQWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDL 76 (582)
Q Consensus 7 ~~~~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l 76 (582)
..|+|.+|.|+.. .+.++.|+|++|++++..| ..+..+++|+.|+|++|.|++..+. +..+++|+.|+|
T Consensus 17 ~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 95 (229)
T 3e6j_A 17 CSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEP-GVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDL 95 (229)
T ss_dssp CEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCH-HHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEEC
Confidence 4589999999642 2468899999999998765 4689999999999999999766654 688999999999
Q ss_pred CCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCCC
Q 047954 77 SGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 77 ~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~~ 153 (582)
++|+|++..|..+..+++|++|+|++|+|+ .||.. .+++|+.|+|++|+|++..+.. ..+..+..+.+.+|+..|.
T Consensus 96 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 96 GTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 999999877777899999999999999999 78874 7899999999999999655432 4577888899999988764
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.2e-16 Score=149.43 Aligned_cols=146 Identities=20% Similarity=0.250 Sum_probs=123.6
Q ss_pred CCcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCC
Q 047954 9 SQWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSG 78 (582)
Q Consensus 9 ~~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~ 78 (582)
|.|.+|.|+.. ..+++.|+|++|++++ +|+..++.+++|++|+|++|.+++..+. +..+++|++|+|++
T Consensus 7 C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 7 CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKS-LPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCc-CChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 78999999642 2358899999999995 5566689999999999999999977665 67899999999999
Q ss_pred CcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCCCCC
Q 047954 79 NKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCGPP 155 (582)
Q Consensus 79 N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~~~~ 155 (582)
|++++..+..+.++++|++|+|++|++++..|.. .+++|+.|+|++|.+++..+.. ..+..+..+++++|+..|..+
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 9999777777899999999999999999766652 6899999999999999755542 457788999999998876543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=6.3e-17 Score=151.34 Aligned_cols=148 Identities=22% Similarity=0.362 Sum_probs=113.3
Q ss_pred CCCcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCC
Q 047954 8 PSQWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLS 77 (582)
Q Consensus 8 ~~~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~ 77 (582)
.|.|..|.|+.+ ...++.|+|++|++++..+...++.+++|++|+|++|.+++.+| .+.++++|+.|+|+
T Consensus 7 ~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred EECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 368999999642 13678899999999876654457889999999999999998876 57888899999999
Q ss_pred CCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCCCcccccccccccCCCCCCCCC
Q 047954 78 GNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPP 155 (582)
Q Consensus 78 ~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l~~~~ 155 (582)
+|+|++..|..+.++++|++|+|++|+|++.+|.. .+++|+.|+|++|.|+|..+.......+....+.++...|+.|
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 99999888888889999999999999999888864 6788999999999998876632111122333444555556544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.9e-16 Score=150.09 Aligned_cols=151 Identities=23% Similarity=0.290 Sum_probs=126.7
Q ss_pred CCCCCCCCCcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCC
Q 047954 2 HCFKDFPSQWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKL 71 (582)
Q Consensus 2 ~~~~~~~~~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l 71 (582)
.|-.+-.|.|..|.|... ...++.|+|++|++++. |+..+..+++|+.|+|++|.+++..| .+.++++|
T Consensus 4 ~CP~~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i-~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L 82 (220)
T 2v9t_B 4 HCPAACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVI-PPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82 (220)
T ss_dssp CSCTTSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEE-CTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSC
T ss_pred CCCCCCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCc-CHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCC
Confidence 455444468999999642 13689999999999975 45568999999999999999999876 58899999
Q ss_pred CEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCC
Q 047954 72 KDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNN 148 (582)
Q Consensus 72 ~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n 148 (582)
++|+|++|+|++..+..+..+++|++|+|++|++++..|.. .+++|+.|+|++|.|++..|.. ..+..+..+++++|
T Consensus 83 ~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 162 (220)
T 2v9t_B 83 NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162 (220)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCC
Confidence 99999999999555556789999999999999999987764 6899999999999999876643 45778888999999
Q ss_pred CCCCC
Q 047954 149 PYLCG 153 (582)
Q Consensus 149 ~~l~~ 153 (582)
++.|.
T Consensus 163 ~~~c~ 167 (220)
T 2v9t_B 163 PFICD 167 (220)
T ss_dssp CEECS
T ss_pred CcCCC
Confidence 98763
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=6.5e-17 Score=165.28 Aligned_cols=137 Identities=12% Similarity=0.055 Sum_probs=96.5
Q ss_pred ccccccccCceEEEEEEEcCCceEEEEEecCCCc--------------chHHH--------HHHHHHHHhcCCCCCcccc
Q 047954 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKP--------------LITEE--------FRKQLLVIADQKHPNLLPL 329 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~e~~~l~~l~H~niv~l 329 (582)
....||+|+||.||+|...+|+.||||+++.... ..... ..+|...|.++.+..+.-.
T Consensus 99 I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp 178 (397)
T 4gyi_A 99 VGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP 178 (397)
T ss_dssp EEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred ecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 4578999999999999999999999998753210 01111 2345666666644433222
Q ss_pred ceEEEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCee
Q 047954 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNIL 409 (582)
Q Consensus 330 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NIL 409 (582)
.-+.. ...+|||||+.+++|..+.. . .....++.||+.+|.|||..+ ||||||||.|||
T Consensus 179 ~p~~~--~~~~LVME~i~G~~L~~l~~----------~--~~~~~l~~qll~~l~~lH~~g-------IVHrDLKp~NIL 237 (397)
T 4gyi_A 179 EPIAQ--SRHTIVMSLVDALPMRQVSS----------V--PDPASLYADLIALILRLAKHG-------LIHGDFNEFNIL 237 (397)
T ss_dssp CEEEE--ETTEEEEECCSCEEGGGCCC----------C--SCHHHHHHHHHHHHHHHHHTT-------EECSCCSTTSEE
T ss_pred eeeec--cCceEEEEecCCccHhhhcc----------c--HHHHHHHHHHHHHHHHHHHCC-------CcCCCCCHHHEE
Confidence 11211 22379999999988865431 1 223567899999999999998 999999999999
Q ss_pred ecCCC----------ceEEeeccccccccC
Q 047954 410 LDDNE----------MVLVSDYGFSSLVAQ 429 (582)
Q Consensus 410 l~~~~----------~~kl~DfG~a~~~~~ 429 (582)
+++++ .+.|+||+-+-....
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred EeCCCCcccccccccceEEEEeCCcccCCC
Confidence 98776 388999997755433
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.63 E-value=2e-16 Score=160.86 Aligned_cols=141 Identities=16% Similarity=0.189 Sum_probs=122.5
Q ss_pred CCCCCcceeeeCC--------CCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeC
Q 047954 6 DFPSQWYGIQCDI--------NSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDL 76 (582)
Q Consensus 6 ~~~~~w~gv~c~~--------~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l 76 (582)
+..|.|.|+.|+. ..++|+.|+|++|+++ .||+. ++.+++|++|+|++|.++ .+| .+..+++|++|+|
T Consensus 58 ~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~-l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~L 134 (328)
T 4fcg_A 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ-AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTL 134 (328)
T ss_dssp TTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC-GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEE
T ss_pred ccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh-hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEEC
Confidence 4568999999942 3478999999999998 88765 778999999999999999 776 5889999999999
Q ss_pred CCCcccccccccccCCCcCCeeecccCcccCCCCCCC-----------CCCCCEEEeecCcccccCCCC-Cccccccccc
Q 047954 77 SGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFN-----------QSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYS 144 (582)
Q Consensus 77 ~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~~-----------~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~ 144 (582)
++|.++ .||..++++++|++|+|++|++.|.+|... +++|+.|+|++|.++ .+|.. ..+..+..++
T Consensus 135 s~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~ 212 (328)
T 4fcg_A 135 ARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK 212 (328)
T ss_dssp ESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEE
T ss_pred CCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEE
Confidence 999999 999999999999999999999999999852 889999999999998 78864 4567788888
Q ss_pred ccCCCCC
Q 047954 145 YSNNPYL 151 (582)
Q Consensus 145 ~~~n~~l 151 (582)
+++|...
T Consensus 213 L~~N~l~ 219 (328)
T 4fcg_A 213 IRNSPLS 219 (328)
T ss_dssp EESSCCC
T ss_pred ccCCCCC
Confidence 8888654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.60 E-value=3.8e-15 Score=139.12 Aligned_cols=126 Identities=21% Similarity=0.319 Sum_probs=111.4
Q ss_pred EEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC--CCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 24 TGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN--FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 24 ~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~--~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
+.+++++|+| +.||.. +. .+|++|+|++|.+++..+. +..+++|++|+|++|++++.+|..+.++++|++|+|+
T Consensus 11 ~~l~~s~~~l-~~ip~~-~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGL-KEIPRD-IP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCC-SSCCSC-CC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCc-CcCccC-CC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 5789999999 578764 32 4899999999999998875 8899999999999999999999999999999999999
Q ss_pred cCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCCC
Q 047954 102 NNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 102 ~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~~ 153 (582)
+|+|++..|.. .+++|+.|+|++|++++.+|.. ..+..+..+++++|++.|.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 99999988863 7899999999999999998865 4577888999999987654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=3.1e-15 Score=137.71 Aligned_cols=123 Identities=22% Similarity=0.259 Sum_probs=90.7
Q ss_pred CCcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCC
Q 047954 9 SQWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSG 78 (582)
Q Consensus 9 ~~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~ 78 (582)
|+|.+|.|+.+ ...++.|+|++|++++ +|+..++.+++|++|+|++|.+++..+. +..+++|+.|+|++
T Consensus 7 C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccE-eCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 68999999642 1457778888888875 4455577788888888888888766654 56778888888888
Q ss_pred CcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCC
Q 047954 79 NKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIP 132 (582)
Q Consensus 79 N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip 132 (582)
|++++..|..+.++++|++|+|++|+|++..+.. .+++|+.|+|++|.++|..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 8888766666777888888888888887544432 46778888888888877665
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-14 Score=143.74 Aligned_cols=127 Identities=19% Similarity=0.221 Sum_probs=74.5
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
+.++.|+|++|++++ ++ .++.+++|++|+|++|.+++..+. +..+++|+.|+|++|++++..|..++++++|++|+
T Consensus 63 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-IS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp TTCCEEECTTSCCCC-CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCC-ch--hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 456666666666665 22 356666666666666666655543 45566666666666666655555566666666666
Q ss_pred cccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCC
Q 047954 100 LQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 100 l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~ 150 (582)
|++|++++..|.. .+++|+.|+|++|++++..|.. ..+..+..+++++|..
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 193 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL 193 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcC
Confidence 6666666544432 4566666666666666544432 3345555556665543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.5e-14 Score=141.18 Aligned_cols=130 Identities=19% Similarity=0.202 Sum_probs=108.7
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..++.|+|++|++++..| ..++.+++|++|+|++|.+++..+. +..+++|+.|+|++|++++..|..+..+++|++|+
T Consensus 35 ~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 113 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSD-ATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLY 113 (251)
T ss_dssp TTCCEEECTTSCCCCCCT-TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEEccCCCcCccCH-hHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEE
Confidence 457789999999998654 4588999999999999999998775 78899999999999999987778889999999999
Q ss_pred cccCcccCCCCCC--CCCCCCEEEeecCcccccCCC-CCcccccccccccCCCCC
Q 047954 100 LQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPK-TQTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 100 l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~-~~~~~~~~~~~~~~n~~l 151 (582)
|++|++++..|.. .+++|+.|+|++|++++..|. ...+..+..+++++|...
T Consensus 114 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 168 (251)
T 3m19_A 114 LGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ 168 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred cCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCC
Confidence 9999999665543 578999999999999876553 345778888899888654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.55 E-value=2.2e-14 Score=139.97 Aligned_cols=133 Identities=21% Similarity=0.278 Sum_probs=115.1
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
..+++.|+|++|++++.. +..+..+++|++|+|++|.+++..+. +..+++|+.|+|++|++++..|..+.++++|++|
T Consensus 58 l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 136 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLS-AGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL 136 (251)
T ss_dssp CTTCCEEECTTSCCCCCC-TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cccCCEEECCCCcCCccC-HhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEE
Confidence 467899999999999865 45689999999999999999987764 6889999999999999997777778999999999
Q ss_pred ecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCCC
Q 047954 99 QLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 99 ~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~~ 153 (582)
+|++|+|++..|.. .+++|+.|+|++|.|++..|.. ..+..+..+++++|+..|.
T Consensus 137 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 137 RLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred ECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999999766642 6899999999999999766643 4577888999999988764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.53 E-value=5.3e-15 Score=132.03 Aligned_cols=110 Identities=23% Similarity=0.283 Sum_probs=99.3
Q ss_pred CeEEEEEeCCCcce-eccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 21 AHVTGIVLEDMRLN-GEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 21 ~~~~~l~l~~~~l~-g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
++++.|++++|+++ |.+|. .++.+++|+.|+|++|.+++. +.+..+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56899999999999 89976 589999999999999999988 8889999999999999999999999999999999999
Q ss_pred cccCcccCC-CCC--CCCCCCCEEEeecCcccccCC
Q 047954 100 LQNNNLTGP-VPE--FNQSSLKVFNVSNNNLSGSIP 132 (582)
Q Consensus 100 l~~N~l~g~-ip~--~~~~~l~~l~ls~N~l~g~ip 132 (582)
|++|.+++. .|. ..+++|+.|++++|.+++..+
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 999999983 333 278999999999999997654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.53 E-value=7.9e-15 Score=149.07 Aligned_cols=133 Identities=12% Similarity=0.154 Sum_probs=105.4
Q ss_pred CCeEEEEEeCCCcceeccCccc--------cCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCccccccccccc
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDA--------FADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLL 90 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~--------~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~ 90 (582)
..++..|+|++|++.|.+|... ++.+++|++|+|++|.++ .+| .+..+++|+.|+|++|.+++ +|..++
T Consensus 149 l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~ 226 (328)
T 4fcg_A 149 LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIH 226 (328)
T ss_dssp CTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGG
T ss_pred CcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchhhc
Confidence 4568888898888888887642 224888888888888888 555 57788888888888888885 777788
Q ss_pred CCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCCCC
Q 047954 91 SLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCGP 154 (582)
Q Consensus 91 ~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~~~ 154 (582)
++++|++|+|++|++.|.+|.. .+++|+.|+|++|++.|.+|.. ..+..+..+++++|+.+...
T Consensus 227 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~i 293 (328)
T 4fcg_A 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293 (328)
T ss_dssp GCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCC
T ss_pred cCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhc
Confidence 8888888888888888888874 6788888888888888888865 45677788888888765543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.53 E-value=7.9e-15 Score=133.72 Aligned_cols=129 Identities=22% Similarity=0.254 Sum_probs=111.2
Q ss_pred CCeEEEEEeCCCcce-eccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLN-GEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~-g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
...++.|+|++|+++ |.+|. .+..+++|++|+|++|.+++. +.+..+++|+.|+|++|.+++.+|..+.++++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 367999999999999 89975 478999999999999999987 889999999999999999999999999999999999
Q ss_pred ecccCcccCCC--CCC-CCCCCCEEEeecCcccccCC----CCCcccccccccccCCCC
Q 047954 99 QLQNNNLTGPV--PEF-NQSSLKVFNVSNNNLSGSIP----KTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 99 ~l~~N~l~g~i--p~~-~~~~l~~l~ls~N~l~g~ip----~~~~~~~~~~~~~~~n~~ 150 (582)
+|++|++++.- +.. .+++|+.|++++|.+++..+ ....++.+..+++.+|..
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 99999999732 232 78999999999999997655 234567778888887754
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.9e-14 Score=155.23 Aligned_cols=141 Identities=20% Similarity=0.186 Sum_probs=121.5
Q ss_pred CCCcceeeeCCC-----------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEe
Q 047954 8 PSQWYGIQCDIN-----------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDID 75 (582)
Q Consensus 8 ~~~w~gv~c~~~-----------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~ 75 (582)
+|.|.|+ |+.. ...++.|+|++|++++..| ..++.+++|++|+|++|.+++..| .+.++++|++||
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 80 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGH-GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD 80 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECS-STTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccCh-hhhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence 5889999 8632 2468999999999998765 458999999999999999999886 589999999999
Q ss_pred CCCCcccccccccccCCCcCCeeecccCcccC-CCCCC--CCCCCCEEEeecCcccccCCCC--CcccccccccccCCCC
Q 047954 76 LSGNKFYGEISRSLLSLKFLESLQLQNNNLTG-PVPEF--NQSSLKVFNVSNNNLSGSIPKT--QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 76 l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g-~ip~~--~~~~l~~l~ls~N~l~g~ip~~--~~~~~~~~~~~~~n~~ 150 (582)
|++|.+++..|..++++++|++|+|++|.+++ .+|.. .+++|+.|++++|.+.+.+|.. ..+..+..+++++|..
T Consensus 81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 99999999888889999999999999999997 46653 7899999999999988888743 4577788888888864
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.9e-14 Score=137.39 Aligned_cols=112 Identities=19% Similarity=0.203 Sum_probs=102.4
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
..+++.|+|++|++++.. +..++.+++|++|+|++|.+++..+. +.++++|+.|+|++|++++..|..+.++++|++|
T Consensus 56 l~~L~~L~L~~N~i~~i~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 134 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIE-EGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL 134 (220)
T ss_dssp CTTCCEEECCSSCCCEEC-TTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEE
T ss_pred CCCCCEEECCCCcCCEEC-HHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEE
Confidence 467999999999999765 45689999999999999999998875 8889999999999999999999999999999999
Q ss_pred ecccCcccCCCCCC--CCCCCCEEEeecCcccccCC
Q 047954 99 QLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIP 132 (582)
Q Consensus 99 ~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip 132 (582)
+|++|++++..|.. .+++|+.|+|++|.+++..+
T Consensus 135 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 135 SLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp ECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99999999988874 68999999999999998765
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=7.6e-14 Score=130.36 Aligned_cols=124 Identities=19% Similarity=0.235 Sum_probs=83.4
Q ss_pred EEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcc
Q 047954 26 IVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNL 105 (582)
Q Consensus 26 l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l 105 (582)
+++++|+++ .||.. + .++|+.|+|++|.++.....+.++++|+.|+|++|.+++..|..|.++++|++|+|++|++
T Consensus 15 l~~~~~~l~-~ip~~-~--~~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKG-I--PRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSC-C--CTTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCC-C--CCCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 344455555 45543 2 2577778888887773333567777788888888888777777777778888888888887
Q ss_pred cCCCCCC--CCCCCCEEEeecCcccccCCC-CCcccccccccccCCCCCCC
Q 047954 106 TGPVPEF--NQSSLKVFNVSNNNLSGSIPK-TQTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 106 ~g~ip~~--~~~~l~~l~ls~N~l~g~ip~-~~~~~~~~~~~~~~n~~l~~ 153 (582)
++..|.. .+++|+.|+|++|.+++..+. ...+..+..+++++|+..|.
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 7766542 567778888888877754332 23466677777777777653
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=4.8e-14 Score=149.77 Aligned_cols=143 Identities=20% Similarity=0.218 Sum_probs=123.4
Q ss_pred CCCcce--eeeCCCC--------CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC--CCCCCCCCCEEe
Q 047954 8 PSQWYG--IQCDINS--------AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM--NFSSNHKLKDID 75 (582)
Q Consensus 8 ~~~w~g--v~c~~~~--------~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~--~~~~~~~l~~l~ 75 (582)
.|.|.+ |.|+... .+++.|+|++|++++..| ..++.+++|++|+|++|.+++.++ .+.++++|++|+
T Consensus 7 ~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 7 ECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNE-TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECT-TTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred eeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCCh-hHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 466655 8896432 568999999999998765 468999999999999999998885 488999999999
Q ss_pred CCCCcccccccccccCCCcCCeeecccCcccCCCCCC----CCCCCCEEEeecCcccccCCCC--CcccccccccccCCC
Q 047954 76 LSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF----NQSSLKVFNVSNNNLSGSIPKT--QTLQLFRSYSYSNNP 149 (582)
Q Consensus 76 l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~----~~~~l~~l~ls~N~l~g~ip~~--~~~~~~~~~~~~~n~ 149 (582)
|++|.+++.+|..++++++|++|+|++|+++|.+|.. .+++|+.|+|++|.+++..|.. ..+..+..+++++|.
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999999999999999999999999999976642 6789999999999999988863 467888899999986
Q ss_pred CC
Q 047954 150 YL 151 (582)
Q Consensus 150 ~l 151 (582)
..
T Consensus 166 l~ 167 (455)
T 3v47_A 166 VK 167 (455)
T ss_dssp BS
T ss_pred cc
Confidence 53
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.6e-14 Score=163.70 Aligned_cols=133 Identities=18% Similarity=0.251 Sum_probs=111.2
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCcccccc-----C-CCCCCCCCCEEeCCCCcccccccccccCCC
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNF-----M-NFSSNHKLKDIDLSGNKFYGEISRSLLSLK 93 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~-----~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~ 93 (582)
.++++.|+|++|++++..+...+..+++|+.|+|++|.+++.. + .+.++++|+.|+|++|+|++.+|..+.+++
T Consensus 425 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 504 (844)
T 3j0a_A 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT 504 (844)
T ss_dssp CTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCC
T ss_pred CCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchh
Confidence 4567888888888887655445566888888888888887433 2 367889999999999999999999999999
Q ss_pred cCCeeecccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCCCCCCC
Q 047954 94 FLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGP 154 (582)
Q Consensus 94 ~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l~~~ 154 (582)
+|+.|+|++|+|++..|....++|+.|+|++|+|+|.+|.. +..+..+++++|++.|..
T Consensus 505 ~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 505 ALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICEC 563 (844)
T ss_dssp SCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSS
T ss_pred hhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhH--hCCcCEEEecCCCccccc
Confidence 99999999999998666655589999999999999999864 567888999999999853
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=9.2e-14 Score=147.59 Aligned_cols=134 Identities=22% Similarity=0.234 Sum_probs=117.8
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..++.|+|++|++++.+|. .++.+++|+.|+|++|.+++..| .+.++++|+.|+|++|.+++..|..+.++++|++|+
T Consensus 275 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 353 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKS-VFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353 (455)
T ss_dssp SCCCEEECCSSCCCEECTT-TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred cCceEEEecCccccccchh-hcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEE
Confidence 4689999999999988754 58999999999999999999887 688899999999999999999899999999999999
Q ss_pred cccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCCCCC
Q 047954 100 LQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCGPP 155 (582)
Q Consensus 100 l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~~~~ 155 (582)
|++|++++..|.. .+++|+.|+|++|++++..+.. ..+..+..+++++|+..|..+
T Consensus 354 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 9999999988874 7899999999999999744433 467888999999999877654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.8e-14 Score=159.86 Aligned_cols=130 Identities=15% Similarity=0.210 Sum_probs=116.6
Q ss_pred CCeEEEEEeCCCcceec-----------------cCccccC--CCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCC
Q 047954 20 SAHVTGIVLEDMRLNGE-----------------IKSDAFA--DIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGN 79 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~-----------------ip~~~~~--~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N 79 (582)
.++++.|+|++|.|+|. ||.. ++ ++++|++|+|++|.++|.+| .+.++++|+.|+|++|
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~-l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n 283 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED-LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTC
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchh-hhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCC
Confidence 56799999999999996 8764 88 99999999999999999998 5889999999999999
Q ss_pred c-ccc-cccccccCC------CcCCeeecccCcccCCCCC--C--CCCCCCEEEeecCcccccCCCCCcccccccccccC
Q 047954 80 K-FYG-EISRSLLSL------KFLESLQLQNNNLTGPVPE--F--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSN 147 (582)
Q Consensus 80 ~-l~g-~ip~~~~~l------~~l~~l~l~~N~l~g~ip~--~--~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~ 147 (582)
+ |+| .+|..++++ ++|++|+|++|+++ .||. . .+++|+.|+|++|.++|.+|....+..+..+++++
T Consensus 284 ~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAY 362 (636)
T ss_dssp TTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCS
T ss_pred CCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCC
Confidence 8 999 999999887 99999999999999 8998 3 78999999999999999999555677888888888
Q ss_pred CCCC
Q 047954 148 NPYL 151 (582)
Q Consensus 148 n~~l 151 (582)
|...
T Consensus 363 N~l~ 366 (636)
T 4eco_A 363 NQIT 366 (636)
T ss_dssp SEEE
T ss_pred Cccc
Confidence 8543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.48 E-value=3.6e-14 Score=152.16 Aligned_cols=126 Identities=20% Similarity=0.085 Sum_probs=90.2
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCccccccccccc-CCCcCCee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLL-SLKFLESL 98 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~-~l~~l~~l 98 (582)
+.+..|+|++|++++..+ ..+++|+.|+|++|.++|.+| .++++++|+.|+|++|.|+|.+|..+. ++++|+.|
T Consensus 99 ~~L~~L~L~~N~l~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L 174 (487)
T 3oja_A 99 PSIETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (487)
T ss_dssp TTCCEEECCSSCCCCEEE----CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCcCEEECcCCcCCCCCc----cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEE
Confidence 456667777777776543 245777788888888877765 466777788888888888877777775 67788888
Q ss_pred ecccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCCC
Q 047954 99 QLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 99 ~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~ 150 (582)
+|++|.|++..+...+++|+.|+|++|.|+|..|....+..+..+++++|..
T Consensus 175 ~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l 226 (487)
T 3oja_A 175 NLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226 (487)
T ss_dssp ECTTSCCCEEECCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCC
T ss_pred ecCCCccccccccccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcC
Confidence 8888887776444567778888888888877655555566677777777754
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.48 E-value=4.4e-14 Score=153.26 Aligned_cols=127 Identities=22% Similarity=0.357 Sum_probs=101.9
Q ss_pred CCCC-----Cccee-eeCCCCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCC
Q 047954 6 DFPS-----QWYGI-QCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGN 79 (582)
Q Consensus 6 ~~~~-----~w~gv-~c~~~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N 79 (582)
..|| .|.|+ .|. .++++.|+|++|+|+| ||... +++|+.|+|++|.|+ .+| ..+++|+.|+|++|
T Consensus 40 ~~~~~~~~~~~~~l~~C~--~~~L~~L~Ls~n~L~~-lp~~l---~~~L~~L~Ls~N~l~-~ip--~~l~~L~~L~Ls~N 110 (571)
T 3cvr_A 40 ALPGENRNEAVSLLKECL--INQFSELQLNRLNLSS-LPDNL---PPQITVLEITQNALI-SLP--ELPASLEYLDACDN 110 (571)
T ss_dssp CCTTCCHHHHHHHHHHHH--HTTCSEEECCSSCCSC-CCSCC---CTTCSEEECCSSCCS-CCC--CCCTTCCEEECCSS
T ss_pred CCccccccchhhhccccc--cCCccEEEeCCCCCCc-cCHhH---cCCCCEEECcCCCCc-ccc--cccCCCCEEEccCC
Confidence 4567 69999 786 4579999999999998 87653 378999999999998 567 55788999999999
Q ss_pred cccccccccccCCCcCCeeecccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCCC
Q 047954 80 KFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 80 ~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~ 150 (582)
+|++ ||. +.+ +|++|+|++|+|++ ||. .+++|+.|+|++|.|++ ||. .+..+..+++++|..
T Consensus 111 ~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 111 RLST-LPE-LPA--SLKHLDVDNNQLTM-LPE-LPALLEYINADNNQLTM-LPE--LPTSLEVLSVRNNQL 172 (571)
T ss_dssp CCSC-CCC-CCT--TCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCC
T ss_pred CCCC-cch-hhc--CCCEEECCCCcCCC-CCC-cCccccEEeCCCCccCc-CCC--cCCCcCEEECCCCCC
Confidence 9987 887 665 88888888888887 777 77888888888888886 775 456677777777753
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.47 E-value=2.9e-13 Score=133.41 Aligned_cols=126 Identities=19% Similarity=0.244 Sum_probs=72.3
Q ss_pred EEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 23 VTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 23 ~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
++.|+|++|++++ +|+..+..+++|++|+|++|.+++..+. +..+++|++|+|++|.+++..+..+.++++|++|+|+
T Consensus 39 l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 39 TKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp CSEEECCSSCCSC-CCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCEEECcCCCCCe-eCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 4556666666653 3333466666666666666666644443 3556666666666666665545555666666666666
Q ss_pred cCcccCCCCCC--CCCCCCEEEeecCcccccCCC-CCcccccccccccCCC
Q 047954 102 NNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPK-TQTLQLFRSYSYSNNP 149 (582)
Q Consensus 102 ~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~-~~~~~~~~~~~~~~n~ 149 (582)
+|++++..|.. .+++|+.|+|++|.+++..+. ...+..+..+++++|.
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 168 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQ 168 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCc
Confidence 66666544432 456666666666666543332 1334555555555554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.47 E-value=3.6e-13 Score=134.24 Aligned_cols=127 Identities=20% Similarity=0.230 Sum_probs=82.5
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..+++.|+|++|++++.- + .+.+++|++|+|++|.++.....+..+++|+.|+|++|++++..|..+.++++|++|+
T Consensus 54 l~~L~~L~L~~n~l~~~~-~--~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~ 130 (290)
T 1p9a_G 54 YTRLTQLNLDRAELTKLQ-V--DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (290)
T ss_dssp CTTCCEEECTTSCCCEEE-C--CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccc-C--CCCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEE
Confidence 456777777777777642 2 2567777777777777764333456667777777777777766666677777777777
Q ss_pred cccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC--CcccccccccccCCCC
Q 047954 100 LQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT--QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 100 l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~--~~~~~~~~~~~~~n~~ 150 (582)
|++|++++..|.. .+++|+.|+|++|+|++ +|.. ..+..+..+++++|..
T Consensus 131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~L~~N~l 184 (290)
T 1p9a_G 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSL 184 (290)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC-CCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCCCCccChhhcccccCCCEEECCCCcCCc-cCHHHhcCcCCCCEEECCCCcC
Confidence 7777777544432 45677777777777764 3332 2355666666666654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.3e-13 Score=127.11 Aligned_cols=128 Identities=23% Similarity=0.276 Sum_probs=109.0
Q ss_pred CCCCCCCCCcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCC
Q 047954 2 HCFKDFPSQWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKL 71 (582)
Q Consensus 2 ~~~~~~~~~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l 71 (582)
.|-..-.|.|..|.|+.+ ...++.|+|++|+++ .|| ..+..+++|+.|+|++|.+++..+ .|.++++|
T Consensus 3 ~CP~~C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip-~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L 80 (193)
T 2wfh_A 3 RCPTECTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVP-KELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80 (193)
T ss_dssp -CCTTCEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCC-GGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCCCCCEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhH-HHhhcccCCCEEECCCCcCCEeCHhHccCCCCC
Confidence 355444568999999642 246889999999998 787 468999999999999999999886 48999999
Q ss_pred CEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCC-C-CCCCCCEEEeecCcccccC
Q 047954 72 KDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE-F-NQSSLKVFNVSNNNLSGSI 131 (582)
Q Consensus 72 ~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~-~-~~~~l~~l~ls~N~l~g~i 131 (582)
+.|+|++|++++..|..|.++++|++|+|++|++++..+. + .+++|+.|+|++|.+.+.-
T Consensus 81 ~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 81 LTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 9999999999999899999999999999999999965443 2 6889999999999998643
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.1e-13 Score=137.57 Aligned_cols=132 Identities=16% Similarity=0.142 Sum_probs=104.5
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
..+++.|+|++|.+-+.+++..+..+++|++|+|++|.+++..|. +.++++|+.|+|++|.+++..+..++++++|++|
T Consensus 79 l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 158 (285)
T 1ozn_A 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158 (285)
T ss_dssp CTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEE
Confidence 467889999999844556556688899999999999999887764 6778889999999999987777778889999999
Q ss_pred ecccCcccCCCCC-C-CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCC
Q 047954 99 QLQNNNLTGPVPE-F-NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 99 ~l~~N~l~g~ip~-~-~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l 151 (582)
+|++|++++..+. + .+++|+.|+|++|.+++..|.. ..+..+..+++++|...
T Consensus 159 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 214 (285)
T 1ozn_A 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214 (285)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCC
Confidence 9999998865543 2 5788899999999988877754 34667788888888543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.9e-13 Score=151.18 Aligned_cols=129 Identities=22% Similarity=0.213 Sum_probs=111.6
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..++.|+|++|++++ ||+..|..+++|++|+|++|.+++..+. |.++++|++|+|++|+|++..|..|.+|++|++|+
T Consensus 52 ~~~~~LdLs~N~i~~-l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred cCCCEEEeeCCCCCC-CCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 468899999999996 5566799999999999999999998774 88999999999999999987778899999999999
Q ss_pred cccCcccCCCCC--CCCCCCCEEEeecCcccc-cCCCC-CcccccccccccCCCC
Q 047954 100 LQNNNLTGPVPE--FNQSSLKVFNVSNNNLSG-SIPKT-QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 100 l~~N~l~g~ip~--~~~~~l~~l~ls~N~l~g-~ip~~-~~~~~~~~~~~~~n~~ 150 (582)
|++|++++..|. ..+++|+.|+|++|.+++ .+|.. ..+..+..+++++|..
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 185 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 185 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccc
Confidence 999999975554 278999999999999976 56654 3467788888888864
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.45 E-value=4.4e-13 Score=132.16 Aligned_cols=131 Identities=21% Similarity=0.246 Sum_probs=105.1
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
..+++.|+|++|+++ .+|+..+..+++|++|+|++|.+++..+. +.++++|+.|+|++|++++..|..+.++++|++|
T Consensus 60 l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 138 (270)
T 2o6q_A 60 LTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYL 138 (270)
T ss_dssp CTTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEE
Confidence 467889999999998 56666678899999999999999887664 5788899999999999998888888899999999
Q ss_pred ecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCC
Q 047954 99 QLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 99 ~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l 151 (582)
+|++|.+++..+.. .+++|+.|+|++|.+++..|.. ..+..+..+++++|...
T Consensus 139 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (270)
T 2o6q_A 139 SLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194 (270)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCC
Confidence 99999988654432 6788899999999888755432 34677788888888543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.7e-13 Score=136.16 Aligned_cols=132 Identities=21% Similarity=0.279 Sum_probs=90.5
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccc-cccccccCCCcCCe
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYG-EISRSLLSLKFLES 97 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g-~ip~~~~~l~~l~~ 97 (582)
...++.|+|++|++++..+...+..+++|++|+|++|.+++.++. +..+++|+.|+|++|.+++ .+|..+..+++|++
T Consensus 100 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 179 (306)
T 2z66_A 100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179 (306)
T ss_dssp CTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred CCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCE
Confidence 456777777777777654434567777777777777777777664 5667777777777777776 56777777777777
Q ss_pred eecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCC
Q 047954 98 LQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 98 l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l 151 (582)
|+|++|++++..|.. .+++|+.|+|++|.+++..+.. ..+..+..+++++|...
T Consensus 180 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 236 (306)
T 2z66_A 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236 (306)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred EECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCc
Confidence 777777777766653 5677777777777777644422 34556666777777543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.9e-13 Score=144.63 Aligned_cols=131 Identities=22% Similarity=0.290 Sum_probs=96.9
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
.+..|+|++|+..+.+++..+..+++|+.|+|++|.++ .+|.+..+++|+.|+|++|.+++..|..+.++++|+.|+|+
T Consensus 161 ~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 239 (440)
T 3zyj_A 161 SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239 (440)
T ss_dssp TCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred ccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccccCCCcccCEEECCCCccCccChhhhccCccCCEEECC
Confidence 44455555544445555555667777777777777776 45677777888888888888888888888888888888888
Q ss_pred cCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCCC
Q 047954 102 NNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 102 ~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~~ 153 (582)
+|++++..|.. .+++|+.|+|++|+|++..+.. ..+..+..+++++|++.|.
T Consensus 240 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 240 QSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp TCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred CCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 88888776653 6788888888888888654433 3467778888888888775
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.44 E-value=2.8e-13 Score=143.88 Aligned_cols=132 Identities=22% Similarity=0.270 Sum_probs=97.6
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
.+..|+|++|+.-+.+|+..+..+++|+.|+|++|.+++ +|.+..+.+|+.|+|++|.+++..|..+.++++|+.|+|+
T Consensus 172 ~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 250 (452)
T 3zyi_A 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250 (452)
T ss_dssp TCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECT
T ss_pred cccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cccccccccccEEECcCCcCcccCcccccCccCCCEEEeC
Confidence 344444444444444555456677777777777777775 4677778888888888888888888888888899999999
Q ss_pred cCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCCCC
Q 047954 102 NNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCGP 154 (582)
Q Consensus 102 ~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~~~ 154 (582)
+|++++..|.. .+++|+.|+|++|+|++..+.. ..+..+..+++++|++.|..
T Consensus 251 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 251 NSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred CCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence 99888877763 6788899999999888654443 34677788888888887753
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.7e-13 Score=137.57 Aligned_cols=140 Identities=21% Similarity=0.285 Sum_probs=115.4
Q ss_pred CCcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccc--c-CCCCCCCCCCEEeC
Q 047954 9 SQWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGN--F-MNFSSNHKLKDIDL 76 (582)
Q Consensus 9 ~~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~--~-~~~~~~~~l~~l~l 76 (582)
|.|.+|.|+.. ...++.|+|++|+++ .+|+..+..+++|+.|+|++|.++.. + ..+..+++|++|+|
T Consensus 7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 78999999742 146899999999998 67777789999999999999999854 2 35667889999999
Q ss_pred CCCcccccccccccCCCcCCeeecccCcccCCCC-C--CCCCCCCEEEeecCcccccCCCC-CcccccccccccCCCC
Q 047954 77 SGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVP-E--FNQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 77 ~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip-~--~~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~ 150 (582)
++|.++ .+|..+..+++|++|+|++|++++..+ . ..+++|+.|++++|.+.+..|.. ..+..+..+++++|..
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 162 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEE
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcc
Confidence 999998 588889999999999999999987655 2 26789999999999998887764 3467778888888754
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.43 E-value=6.6e-13 Score=131.03 Aligned_cols=135 Identities=18% Similarity=0.201 Sum_probs=110.3
Q ss_pred CCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCe
Q 047954 19 NSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLES 97 (582)
Q Consensus 19 ~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~ 97 (582)
...+++.|+|++|++++.. +..++.+++|++|+|++|.+++..+. +..+++|++|+|++|++++..|..++++++|+.
T Consensus 83 ~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 161 (272)
T 3rfs_A 83 ELTNLTYLILTGNQLQSLP-NGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTE 161 (272)
T ss_dssp TCTTCCEEECTTSCCCCCC-TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCCCEEECCCCccCccC-hhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCE
Confidence 3567889999999998654 45678899999999999999987775 678889999999999999777777888999999
Q ss_pred eecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCCCC
Q 047954 98 LQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCGP 154 (582)
Q Consensus 98 l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~~~ 154 (582)
|+|++|++++..|.. .+++|+.|+|++|.+++..|.. ..+..+..+++.+|+..|..
T Consensus 162 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 221 (272)
T 3rfs_A 162 LDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 221 (272)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred EECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccC
Confidence 999999999766653 6788999999999999876653 45778888889999877654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.43 E-value=4.3e-13 Score=138.07 Aligned_cols=140 Identities=19% Similarity=0.153 Sum_probs=114.8
Q ss_pred CCcceeeeCCC---------CCeEEEEEeCCCcceeccCccccC-CCCCCcEEEccCCccccccC-CCCCCCCCCEEeCC
Q 047954 9 SQWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFA-DIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLS 77 (582)
Q Consensus 9 ~~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~-~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~ 77 (582)
|.|..|.|..+ ...++.|+|++|++++.. +..+. .+++|+.|+|++|+|++..+ .|.++++|+.|+|+
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~-~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLR-AEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEEC-TTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccC-hhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 57888999642 133678999999999755 45566 89999999999999998887 48899999999999
Q ss_pred CCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-----CcccccccccccCCCC
Q 047954 78 GNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-----QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 78 ~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-----~~~~~~~~~~~~~n~~ 150 (582)
+|+|++..|..|.++++|++|+|++|++++..|.. .+++|+.|+|++|.|++ +|.. ..+..+..+++++|..
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGTC----CTTCCEEECCSSCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHhcCcccCCcCCEEECCCCCC
Confidence 99999887888999999999999999999876763 68899999999999986 5543 2366777888888854
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.9e-13 Score=126.83 Aligned_cols=124 Identities=14% Similarity=0.182 Sum_probs=68.3
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
+++.|+|++|+++ .+| .+..+++|+.|++++|.++. ++.+..+++|++|+|++|.+++..|..++.+++|++|+|+
T Consensus 45 ~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCSC-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCCc-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 4556666666665 444 25555666666666664322 2345555566666666666665555556666666666666
Q ss_pred cCcccCCCCC--CCCCCCCEEEeecCcccccCCCCCcccccccccccCCC
Q 047954 102 NNNLTGPVPE--FNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNP 149 (582)
Q Consensus 102 ~N~l~g~ip~--~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~ 149 (582)
+|++++.+|. ..+++|+.|+|++|.+.+.+|....+..+..+++++|.
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDG 170 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBC
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCC
Confidence 6666554444 24555666666666544445543444555555555553
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.1e-12 Score=120.47 Aligned_cols=127 Identities=18% Similarity=0.190 Sum_probs=105.8
Q ss_pred EEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 23 VTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 23 ~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
.+.+++++++++. +|.. ..++|+.|+|++|.+++..+. +..+++|++|+|++|++++..|..+.++++|++|+|+
T Consensus 9 ~~~l~~~~~~l~~-~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTG---IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp TTEEECCSSCCSS-CCTT---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCcc-CCCC---CCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 4578999999874 6543 347999999999999987765 6889999999999999997777778999999999999
Q ss_pred cCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCCC
Q 047954 102 NNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 102 ~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~~ 153 (582)
+|++++..|.. .+++|+.|+|++|.+++..+.. ..+..+..+++++|+..|.
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 99999876653 6899999999999999644433 4577888999999987664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.1e-13 Score=157.22 Aligned_cols=129 Identities=11% Similarity=0.138 Sum_probs=114.8
Q ss_pred CCeEEEEEeCCCccee-----------------ccCccccC--CCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCC
Q 047954 20 SAHVTGIVLEDMRLNG-----------------EIKSDAFA--DIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGN 79 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g-----------------~ip~~~~~--~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N 79 (582)
.++++.|+|++|+|+| .||.. ++ ++++|++|+|++|.+.|.+| .+.++++|+.|+|++|
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~-l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N 525 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE-LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTC
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCChh-hhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCC
Confidence 4678999999999999 48765 66 99999999999999999998 4889999999999999
Q ss_pred c-ccc-cccccccCCC-------cCCeeecccCcccCCCCC--C--CCCCCCEEEeecCcccccCCCCCccccccccccc
Q 047954 80 K-FYG-EISRSLLSLK-------FLESLQLQNNNLTGPVPE--F--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYS 146 (582)
Q Consensus 80 ~-l~g-~ip~~~~~l~-------~l~~l~l~~N~l~g~ip~--~--~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~ 146 (582)
+ |+| .||..+++++ +|+.|+|++|+|+ .||. . .+++|+.|+|++|.++ .||....+..+..++++
T Consensus 526 ~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLD 603 (876)
T ss_dssp TTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECC
T ss_pred CCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECc
Confidence 8 999 9999888776 9999999999999 8998 3 7899999999999999 89966677888889999
Q ss_pred CCCCC
Q 047954 147 NNPYL 151 (582)
Q Consensus 147 ~n~~l 151 (582)
+|...
T Consensus 604 ~N~l~ 608 (876)
T 4ecn_A 604 YNQIE 608 (876)
T ss_dssp SSCCS
T ss_pred CCccc
Confidence 88754
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=4.5e-13 Score=146.45 Aligned_cols=130 Identities=21% Similarity=0.315 Sum_probs=62.1
Q ss_pred EEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCccc-ccccccccCCCcCCeeec
Q 047954 23 VTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFY-GEISRSLLSLKFLESLQL 100 (582)
Q Consensus 23 ~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~-g~ip~~~~~l~~l~~l~l 100 (582)
++.|+|++|.+++..|...+..+++|+.|+|++|.+++.+|. +.++++|+.|+|++|.++ |.+|..+..+++|++|+|
T Consensus 398 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l 477 (570)
T 2z63_A 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477 (570)
T ss_dssp CCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred CCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEEC
Confidence 344444444444443333344445555555555555444442 344455555555555554 445555555555555555
Q ss_pred ccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCC
Q 047954 101 QNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLC 152 (582)
Q Consensus 101 ~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~ 152 (582)
++|++++.+|.. .+++|+.|+|++|++++..|.. ..+..+..+++++|+..|
T Consensus 478 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 532 (570)
T 2z63_A 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 532 (570)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccC
Confidence 555555544432 3445555555555555444332 234444455555555444
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.41 E-value=7e-13 Score=125.20 Aligned_cols=113 Identities=19% Similarity=0.263 Sum_probs=99.6
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
..+++.|+|++|++++ +|+..+..+++|++|+|++|.+++..+. +..+++|+.|+|++|++++..|..+.++++|++|
T Consensus 51 l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 129 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDL 129 (208)
T ss_dssp CTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cccCcEEECCCCccCc-cChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEE
Confidence 4679999999999995 5566688999999999999999987765 6889999999999999998777778999999999
Q ss_pred ecccCcccCCCCCC--CCCCCCEEEeecCcccccCCC
Q 047954 99 QLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPK 133 (582)
Q Consensus 99 ~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~ 133 (582)
+|++|++++..+.. .+++|+.|+|++|.+.|..|.
T Consensus 130 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 166 (208)
T 2o6s_A 130 RLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 166 (208)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTT
T ss_pred ECCCCccceeCHHHhccCCCccEEEecCCCeecCCCC
Confidence 99999999766642 688999999999999988774
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=1.4e-13 Score=138.55 Aligned_cols=129 Identities=16% Similarity=0.172 Sum_probs=102.1
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccc--c-CC--CCCCCCCCEEeCCCCccc--cccccc-ccC
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGN--F-MN--FSSNHKLKDIDLSGNKFY--GEISRS-LLS 91 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~--~-~~--~~~~~~l~~l~l~~N~l~--g~ip~~-~~~ 91 (582)
..+++.|+|++|++++.. +..++.+++|++|+|++|.+.|. + +. +..+++|++|+|++|+++ +.++.. +.+
T Consensus 144 ~~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFS-CEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCC-TTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhh-HHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhc
Confidence 467999999999997765 45689999999999999999874 2 22 367888999999999997 333333 478
Q ss_pred CCcCCeeecccCcccCCCCCC--CC---CCCCEEEeecCcccccCCCCCcccccccccccCCCCC
Q 047954 92 LKFLESLQLQNNNLTGPVPEF--NQ---SSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 92 l~~l~~l~l~~N~l~g~ip~~--~~---~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l 151 (582)
+++|++|||++|++++.+|.. .+ ++|+.|+|++|.|+ .+|... ...+..+++++|...
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~-~~~L~~L~Ls~N~l~ 285 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGL-PAKLRVLDLSSNRLN 285 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCC-CSCCSCEECCSCCCC
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhh-cCCCCEEECCCCcCC
Confidence 899999999999999987753 33 68999999999998 777654 367888888888643
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=6.4e-13 Score=127.62 Aligned_cols=112 Identities=21% Similarity=0.234 Sum_probs=99.6
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
...++.|+|++|+++ .+|+..+..+++|++|+|++|.|++..+. +..+.+|+.|+|++|+|+ .||..+.++++|++|
T Consensus 63 l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 140 (229)
T 3e6j_A 63 LINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHL 140 (229)
T ss_dssp CTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEE
T ss_pred ccCCcEEECCCCCCC-CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEE
Confidence 467999999999995 56677789999999999999999988775 688999999999999999 899999999999999
Q ss_pred ecccCcccCCCCCC--CCCCCCEEEeecCcccccCCC
Q 047954 99 QLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPK 133 (582)
Q Consensus 99 ~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~ 133 (582)
+|++|+|++..+.. .+++|+.|+|++|.+.+..+.
T Consensus 141 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 177 (229)
T 3e6j_A 141 ALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRD 177 (229)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBGG
T ss_pred ECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcch
Confidence 99999999655542 678999999999999987653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=4.9e-13 Score=153.15 Aligned_cols=139 Identities=17% Similarity=0.172 Sum_probs=114.1
Q ss_pred CCcceeeeCCCCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCcccccc-C-CCCCCCCCCEEeCCCCccccccc
Q 047954 9 SQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNF-M-NFSSNHKLKDIDLSGNKFYGEIS 86 (582)
Q Consensus 9 ~~w~gv~c~~~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~-~-~~~~~~~l~~l~l~~N~l~g~ip 86 (582)
++|+.|.+ ..++++.|+|++|.+++..| ..+..+++|++|+|++|.+.+.+ | .+.++++|++|+|++|.+++.+|
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~-~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p 90 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTA-SSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP 90 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECS-SSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccCh-hHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH
Confidence 45777777 34689999999999998765 45899999999999999888887 3 48889999999999999999999
Q ss_pred ccccCCCcCCeeecccCcccCCCCCC----CCCCCCEEEeecCcccccCCC--CCcccccccccccCCCC
Q 047954 87 RSLLSLKFLESLQLQNNNLTGPVPEF----NQSSLKVFNVSNNNLSGSIPK--TQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 87 ~~~~~l~~l~~l~l~~N~l~g~ip~~----~~~~l~~l~ls~N~l~g~ip~--~~~~~~~~~~~~~~n~~ 150 (582)
..+++|++|++|+|++|.+++.+|.. .+++|+.|+|++|.+++..|. ...+..+..+++++|..
T Consensus 91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i 160 (844)
T 3j0a_A 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160 (844)
T ss_dssp TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCC
T ss_pred hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcC
Confidence 99999999999999999999877752 678899999999999876553 24566677777777753
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=7.7e-13 Score=145.82 Aligned_cols=143 Identities=21% Similarity=0.149 Sum_probs=120.0
Q ss_pred CCCCc----ceeeeCC---------CCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCC
Q 047954 7 FPSQW----YGIQCDI---------NSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLK 72 (582)
Q Consensus 7 ~~~~w----~gv~c~~---------~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~ 72 (582)
.||.| ..|.|.. -..+++.|+|++|++++..| ..++.+++|++|+|++|.+++..| .|.++++|+
T Consensus 5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 83 (606)
T 3vq2_A 5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKS-YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83 (606)
T ss_dssp -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeCh-hhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence 35655 3577853 12568999999999998664 468999999999999999999887 478999999
Q ss_pred EEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccc-cCCCC-CcccccccccccCC
Q 047954 73 DIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSG-SIPKT-QTLQLFRSYSYSNN 148 (582)
Q Consensus 73 ~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g-~ip~~-~~~~~~~~~~~~~n 148 (582)
+|+|++|.+++..|..|++|++|++|+|++|.+++..|.. .+++|+.|+|++|.+++ .+|.. ..+..+..+++++|
T Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred EeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 9999999999999999999999999999999999766543 78999999999999986 77864 45778888888888
Q ss_pred CC
Q 047954 149 PY 150 (582)
Q Consensus 149 ~~ 150 (582)
..
T Consensus 164 ~l 165 (606)
T 3vq2_A 164 YI 165 (606)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=5.1e-13 Score=147.26 Aligned_cols=129 Identities=19% Similarity=0.215 Sum_probs=74.8
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCccccc-ccccccCCCcCCee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGE-ISRSLLSLKFLESL 98 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~-ip~~~~~l~~l~~l 98 (582)
..++.|+|++|.+++..|...+..+++|++|++++|.+++.+|. +.++++|+.|+|++|.+++. +|..++++++|+.|
T Consensus 399 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 478 (606)
T 3vq2_A 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFL 478 (606)
T ss_dssp TTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEE
Confidence 45666666666666665534456666666666666666665543 45556666666666666653 55556666666666
Q ss_pred ecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCC
Q 047954 99 QLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNP 149 (582)
Q Consensus 99 ~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~ 149 (582)
+|++|++++.+|.. .+++|+.|+|++|++++.+|.. ..+..+..+++++|.
T Consensus 479 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 532 (606)
T 3vq2_A 479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532 (606)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSC
T ss_pred ECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCc
Confidence 66666666555542 4556666666666666555533 234445555555554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=6.3e-13 Score=136.38 Aligned_cols=143 Identities=22% Similarity=0.256 Sum_probs=115.4
Q ss_pred CCCCCCcceeeeCCC-----------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCC
Q 047954 5 KDFPSQWYGIQCDIN-----------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLK 72 (582)
Q Consensus 5 ~~~~~~w~gv~c~~~-----------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~ 72 (582)
...+|.|.|+ |+.. ..+++.|+|++|++++ +|+..+..+++|+.|+|++|.+++..|. +.++++|+
T Consensus 26 ~~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (353)
T 2z80_A 26 ASLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE 103 (353)
T ss_dssp -CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred cCCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCC
Confidence 3456889998 6421 2368899999999997 5555689999999999999999998774 88999999
Q ss_pred EEeCCCCcccccccccccCCCcCCeeecccCcccCCCCC---C-CCCCCCEEEeecCcccccC-CCC-Cccccccccccc
Q 047954 73 DIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE---F-NQSSLKVFNVSNNNLSGSI-PKT-QTLQLFRSYSYS 146 (582)
Q Consensus 73 ~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~---~-~~~~l~~l~ls~N~l~g~i-p~~-~~~~~~~~~~~~ 146 (582)
+|+|++|++++..+..+.++++|++|+|++|++++ +|. + .+++|+.|++++|+..+.+ |.. ..+..+..++++
T Consensus 104 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 182 (353)
T 2z80_A 104 HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182 (353)
T ss_dssp EEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred EEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECC
Confidence 99999999996555558999999999999999995 655 2 6899999999999644444 432 457778888888
Q ss_pred CCCC
Q 047954 147 NNPY 150 (582)
Q Consensus 147 ~n~~ 150 (582)
+|..
T Consensus 183 ~n~l 186 (353)
T 2z80_A 183 ASDL 186 (353)
T ss_dssp ETTC
T ss_pred CCCc
Confidence 8864
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.40 E-value=9.5e-13 Score=125.59 Aligned_cols=110 Identities=18% Similarity=0.172 Sum_probs=98.8
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
..++..|+|++|++++..| ..+..+++|++|+|++|.|++..+. +.++.+|+.|+|++|++++..|..+.++++|++|
T Consensus 55 l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 133 (220)
T 2v9t_B 55 YKKLRRIDLSNNQISELAP-DAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLL 133 (220)
T ss_dssp CTTCCEEECCSSCCCEECT-TTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCCcCH-HHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEE
Confidence 4679999999999998765 4699999999999999999976665 6889999999999999999999999999999999
Q ss_pred ecccCcccCCCCCC--CCCCCCEEEeecCccccc
Q 047954 99 QLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGS 130 (582)
Q Consensus 99 ~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ 130 (582)
+|++|+|++..|.. .+++|+.|+|++|.+...
T Consensus 134 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 134 SLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 99999999877753 678999999999999864
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=1.2e-12 Score=129.38 Aligned_cols=110 Identities=17% Similarity=0.246 Sum_probs=74.1
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
..+++.|+|++|++++.. +..+..+++|++|+|++|.+++..+ .+.++++|+.|+|++|++++..+..++++++|++|
T Consensus 51 l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 129 (276)
T 2z62_A 51 FPELQVLDLSRCEIQTIE-DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129 (276)
T ss_dssp CTTCSEEECTTCCCCEEC-TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEE
T ss_pred ccCCcEEECCCCcCCccC-HHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEE
Confidence 356777888888777543 4457777788888888887777664 36666777777777777776655566677777777
Q ss_pred ecccCcccC-CCCCC--CCCCCCEEEeecCccccc
Q 047954 99 QLQNNNLTG-PVPEF--NQSSLKVFNVSNNNLSGS 130 (582)
Q Consensus 99 ~l~~N~l~g-~ip~~--~~~~l~~l~ls~N~l~g~ 130 (582)
+|++|++++ .+|.. .+++|+.|+|++|.+++.
T Consensus 130 ~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~ 164 (276)
T 2z62_A 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (276)
T ss_dssp ECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred ECcCCccceecCchhhccCCCCCEEECCCCCCCcC
Confidence 777777665 35543 456666666666666554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=1.4e-12 Score=129.62 Aligned_cols=130 Identities=17% Similarity=0.139 Sum_probs=111.8
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCc-cccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCe
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNI-ISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLES 97 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~-~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~ 97 (582)
..+++.|+|++|.+++..| ..+..+++|++|+|++|. +++..| .+..+++|+.|+|++|.+++..|..+.++++|++
T Consensus 55 ~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 133 (285)
T 1ozn_A 55 CRNLTILWLHSNVLARIDA-AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133 (285)
T ss_dssp CTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCCEEECCCCccceeCH-hhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCE
Confidence 4679999999999998765 468999999999999998 666645 5788999999999999999988999999999999
Q ss_pred eecccCcccCCCCCC--CCCCCCEEEeecCcccccCCC-CCcccccccccccCCCC
Q 047954 98 LQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPK-TQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 98 l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~-~~~~~~~~~~~~~~n~~ 150 (582)
|+|++|.+++..+.. .+++|+.|+|++|.+++..+. ...+..+..+++++|..
T Consensus 134 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 189 (285)
T 1ozn_A 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189 (285)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcc
Confidence 999999999766653 689999999999999975554 34577888899999864
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=8.9e-13 Score=145.70 Aligned_cols=133 Identities=18% Similarity=0.199 Sum_probs=112.6
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccc-cC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCe
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGN-FM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLES 97 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~-~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~ 97 (582)
...+..++++.|.+++..| ..+..++.|+.|+|++|.+.+. +| .+..+++|+.|||++|+|++.+|..|.+|++|++
T Consensus 444 l~~l~~l~ls~n~l~~~~~-~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~ 522 (635)
T 4g8a_A 444 LRNLIYLDISHTHTRVAFN-GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 522 (635)
T ss_dssp CTTCCEEECTTSCCEECCT-TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred ccccccccccccccccccc-cccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCE
Confidence 3457788888888888775 4578889999999999986554 45 4788899999999999999999999999999999
Q ss_pred eecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCCC-cc-cccccccccCCCCCCC
Q 047954 98 LQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQ-TL-QLFRSYSYSNNPYLCG 153 (582)
Q Consensus 98 l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~~-~~-~~~~~~~~~~n~~l~~ 153 (582)
|+|++|+|++..|.. .+++|++|+|++|+|++..|... .+ ..+..+++++|++.|.
T Consensus 523 L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 523 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp EECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred EECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 999999999877763 68999999999999999888653 33 5788899999999874
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.39 E-value=4.6e-13 Score=143.49 Aligned_cols=139 Identities=20% Similarity=0.269 Sum_probs=101.3
Q ss_pred CcceeeeCCCCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CC-CCCCCCEEeCCCCcccccccc
Q 047954 10 QWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FS-SNHKLKDIDLSGNKFYGEISR 87 (582)
Q Consensus 10 ~w~gv~c~~~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~-~~~~l~~l~l~~N~l~g~ip~ 87 (582)
.+.++.|. ..+.+..|+|++|+++|..|. .++.+++|+.|+|++|.++|.+|. +. .+++|+.|+|++|.|++..+
T Consensus 110 ~l~~~~~~-~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~- 186 (487)
T 3oja_A 110 NISRVSCS-RGQGKKNIYLANNKITMLRDL-DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG- 186 (487)
T ss_dssp CCCCEEEC-CCSSCEEEECCSSCCCSGGGB-CGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC-
T ss_pred cCCCCCcc-ccCCCCEEECCCCCCCCCCch-hhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc-
Confidence 45666665 346688888888888877654 477788888888888888887653 43 67888888888888887632
Q ss_pred cccCCCcCCeeecccCcccCCCCCC-CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCCC
Q 047954 88 SLLSLKFLESLQLQNNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 88 ~~~~l~~l~~l~l~~N~l~g~ip~~-~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~~ 153 (582)
+..+++|+.|+|++|.|+|..|.+ .+++|+.|+|++|.|++ +|.. ..+..+..+++++|+..|+
T Consensus 187 -~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 187 -QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp -CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred -cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence 345788888888888888765554 56788888888888886 5543 3456677778888877654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=5.1e-13 Score=145.42 Aligned_cols=107 Identities=17% Similarity=0.189 Sum_probs=91.8
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeeec
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l 100 (582)
.+..|+|++|+|++ ||. ++.+++|+.|+|++|.|+ .+| .++++++|+.|+|++|+|++ || .+++|++|+.|+|
T Consensus 442 ~L~~L~Ls~n~l~~-lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~L 515 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLL 515 (567)
T ss_dssp TCSEEECTTSCCSS-CCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEEC
T ss_pred CceEEEecCCCCCC-CcC--ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEEC
Confidence 36789999999987 663 888999999999999999 565 68888999999999999997 78 8999999999999
Q ss_pred ccCcccCCC-CCC--CCCCCCEEEeecCcccccCCCC
Q 047954 101 QNNNLTGPV-PEF--NQSSLKVFNVSNNNLSGSIPKT 134 (582)
Q Consensus 101 ~~N~l~g~i-p~~--~~~~l~~l~ls~N~l~g~ip~~ 134 (582)
++|+|++.+ |.. .+++|+.|+|++|.|+|..|..
T Consensus 516 s~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp CSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred CCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 999999886 763 7889999999999999877643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.38 E-value=8.5e-14 Score=140.37 Aligned_cols=131 Identities=15% Similarity=0.210 Sum_probs=94.2
Q ss_pred CCeEEEEEeCCCcceeccCcccc-CCCCCCcEEEccCCccccccCCCCCC-----CCCCEEeCCCCcccccccccccCCC
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAF-ADIPELIVINFKNNIISGNFMNFSSN-----HKLKDIDLSGNKFYGEISRSLLSLK 93 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~-~~l~~L~~l~l~~n~~~g~~~~~~~~-----~~l~~l~l~~N~l~g~ip~~~~~l~ 93 (582)
..+++.|+|++|+++|.+|...+ +.+++|++|+|++|.+++....+..+ ++|++|+|++|++++..|..+++++
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 45678888888888888876532 77888888888888888873334444 7788888888888877778888888
Q ss_pred cCCeeecccCcccCCCC--C----CCCCCCCEEEeecCcccc--cCCCC--CcccccccccccCCCC
Q 047954 94 FLESLQLQNNNLTGPVP--E----FNQSSLKVFNVSNNNLSG--SIPKT--QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 94 ~l~~l~l~~N~l~g~ip--~----~~~~~l~~l~ls~N~l~g--~ip~~--~~~~~~~~~~~~~n~~ 150 (582)
+|++|+|++|+++|.++ . ..+++|+.|+|++|.+++ .+|.. ..+..+..+++++|..
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l 240 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSL 240 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCC
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcC
Confidence 88888888888877632 1 356778888888888873 33322 1345677777777754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.38 E-value=6.4e-13 Score=136.78 Aligned_cols=131 Identities=24% Similarity=0.301 Sum_probs=110.0
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
..+++.|+|++|++++.. +..+..+++|++|+|++|.|++..+ .+.++.+|+.|+|++|++++..|..|.++++|+.|
T Consensus 63 l~~L~~L~L~~N~i~~i~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFIS-SEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CTTCCEEECCSSCCCEEC-TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred ccccCEEECCCCcCCccC-hhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 567999999999999755 5569999999999999999998877 47899999999999999999999999999999999
Q ss_pred ecccCcccCCCCCC------CCCCCCEEEeecCcccccCCCC--Ccccc--cccccccCCCCCCC
Q 047954 99 QLQNNNLTGPVPEF------NQSSLKVFNVSNNNLSGSIPKT--QTLQL--FRSYSYSNNPYLCG 153 (582)
Q Consensus 99 ~l~~N~l~g~ip~~------~~~~l~~l~ls~N~l~g~ip~~--~~~~~--~~~~~~~~n~~l~~ 153 (582)
+|++|+|++ +|.. .+++|+.|+|++|+|++ +|.. ..+.. +..+.+.+|++.|.
T Consensus 142 ~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 142 YLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKK-LPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp ECCSSCCCS-CCGGGTC----CTTCCEEECCSSCCCC-CCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred ECCCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCCc-cCHHHhhhccHhhcceEEecCCCccCC
Confidence 999999997 5542 47899999999999985 4421 12222 35678999998774
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.37 E-value=2.7e-12 Score=127.92 Aligned_cols=128 Identities=18% Similarity=0.110 Sum_probs=109.5
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeec
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l 100 (582)
..++.|+|++|++++..| ..+..+++|+.|+|++|.+++..+ ...+++|+.|+|++|+++ .+|..+..+++|++|+|
T Consensus 31 ~~l~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSL-ATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TTCCEEECTTSCCSEEEG-GGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCcCCccCH-HHhhcCCCCCEEECCCCccCcccC-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 468899999999987764 568999999999999999998655 478899999999999998 89999999999999999
Q ss_pred ccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCC
Q 047954 101 QNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 101 ~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l 151 (582)
++|++++..|.. .+++|+.|+|++|++++..|.. ..+..+..+++++|...
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence 999999766653 7899999999999999654433 35678888999998654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.8e-12 Score=128.05 Aligned_cols=129 Identities=22% Similarity=0.188 Sum_probs=111.5
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..++.|+|++|++++.. +..+..+++|++|+|++|.+++..+ .+.++++|++|+|++|.+++..|..+.++++|++|+
T Consensus 28 ~~l~~L~ls~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLG-SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (276)
T ss_dssp TTCCEEECTTCCCCEEC-TTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCccEEECCCCcccccC-HhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence 35899999999999765 4468999999999999999998876 588899999999999999999999999999999999
Q ss_pred cccCcccCCCCC--CCCCCCCEEEeecCcccc-cCCCC-CcccccccccccCCCC
Q 047954 100 LQNNNLTGPVPE--FNQSSLKVFNVSNNNLSG-SIPKT-QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 100 l~~N~l~g~ip~--~~~~~l~~l~ls~N~l~g-~ip~~-~~~~~~~~~~~~~n~~ 150 (582)
|++|++++..+. ..+++|+.|+|++|.+++ .+|.. ..+..+..+++++|..
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l 161 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCC
Confidence 999999986663 378999999999999987 46754 4567788888888853
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=2e-12 Score=138.24 Aligned_cols=140 Identities=19% Similarity=0.229 Sum_probs=117.7
Q ss_pred CcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCC
Q 047954 10 QWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGN 79 (582)
Q Consensus 10 ~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N 79 (582)
.|..|.|... ...++.|+|++|++++..| ..+..+++|++|+|++|.+++..| .+.++++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQ-DEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECH-hHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 4889999642 2457899999999998664 568999999999999999999876 5889999999999999
Q ss_pred cccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCC
Q 047954 80 KFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 80 ~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~ 150 (582)
++++..+..+.++++|++|+|++|++++.+|.. .+++|+.|+|++|.+++..|.. ..+..+..+++++|..
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 164 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL 164 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCC
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcC
Confidence 999666667899999999999999999887764 6889999999999998877643 4567778888888754
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.37 E-value=1.9e-12 Score=118.15 Aligned_cols=105 Identities=20% Similarity=0.178 Sum_probs=89.2
Q ss_pred EEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccC
Q 047954 25 GIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNN 103 (582)
Q Consensus 25 ~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N 103 (582)
.|++++|+|+. ||.. + .++|++|+|++|.|++..|. +.++++|+.|+|++|+|++..|..+.++++|++|+|++|
T Consensus 13 ~l~~s~n~l~~-ip~~-~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTG-I--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EEECTTSCCSS-CCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCcc-C--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 55666778875 7654 3 48999999999999999874 889999999999999999777777899999999999999
Q ss_pred cccCCCCC-C-CCCCCCEEEeecCcccccCCC
Q 047954 104 NLTGPVPE-F-NQSSLKVFNVSNNNLSGSIPK 133 (582)
Q Consensus 104 ~l~g~ip~-~-~~~~l~~l~ls~N~l~g~ip~ 133 (582)
+|++..|. + .+++|+.|+|++|.|++..+.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 99986665 2 689999999999999877653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.37 E-value=6.6e-13 Score=149.02 Aligned_cols=108 Identities=24% Similarity=0.259 Sum_probs=57.2
Q ss_pred ccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCC
Q 047954 39 SDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSS 116 (582)
Q Consensus 39 ~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~ 116 (582)
+..+..++.|+.|+|++|.++...+.+.++++|+.|+|++|.|+ .||..|++|++|++|+|++|.|+ .||.. .+++
T Consensus 217 ~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~ 294 (727)
T 4b8c_D 217 KDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQ 294 (727)
T ss_dssp -----CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTT
T ss_pred hhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCC
Confidence 33445555666666666665522224445555666666666665 55655666666666666666665 55543 4555
Q ss_pred CCEEEeecCcccccCCCC-CcccccccccccCCC
Q 047954 117 LKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNP 149 (582)
Q Consensus 117 l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~ 149 (582)
|+.|+|++|.|+ .||.. ..+..|..+++++|.
T Consensus 295 L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~ 327 (727)
T 4b8c_D 295 LKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNP 327 (727)
T ss_dssp CSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSC
T ss_pred CCEEECCCCCCC-ccChhhhcCCCccEEeCCCCc
Confidence 666666666554 45543 334455555555554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.4e-12 Score=140.92 Aligned_cols=131 Identities=18% Similarity=0.226 Sum_probs=105.0
Q ss_pred CCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCcccc--ccC-CCCCCCCCCEEeCCCCccccccccc-ccCCCc
Q 047954 19 NSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISG--NFM-NFSSNHKLKDIDLSGNKFYGEISRS-LLSLKF 94 (582)
Q Consensus 19 ~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g--~~~-~~~~~~~l~~l~l~~N~l~g~ip~~-~~~l~~ 94 (582)
....++.|+|++|++++.+|. .++.+++|++|+|++|.+++ .+| .+..+++|+.|+|++|.+++.+|.. +..+++
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFE-NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTT-TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hCCcccEEEeECCccChhhhh-hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 356788889999999887765 47888899999999999887 454 4677888999999999998878875 778888
Q ss_pred CCeeecccCcccCCCCCCCCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCC
Q 047954 95 LESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 95 l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l 151 (582)
|+.|+|++|+++|.+|....++|+.|+|++|+++ .+|.. ..+..+..+++++|...
T Consensus 401 L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~ 457 (520)
T 2z7x_B 401 LLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457 (520)
T ss_dssp CCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCEEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC
Confidence 9999999998888888765578888888888888 67754 45677788888888654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.37 E-value=7.5e-13 Score=133.39 Aligned_cols=127 Identities=20% Similarity=0.214 Sum_probs=61.9
Q ss_pred CeEEEEEeCCCcceeccCccccCCC-----CCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCccccc--ccccc--c
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADI-----PELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGE--ISRSL--L 90 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l-----~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~--ip~~~--~ 90 (582)
.+++.|+|++|++++. |. .++.+ ++|++|+|++|.+++..| .+..+++|+.|+|++|+++|. +|..+ +
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~-~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DA-WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp CCCSEEEEESCBCSSS-SS-HHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCccEEEccCCCCcch-hH-HHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 4455666666666554 32 23333 555555555555555543 345555555555555555554 23333 4
Q ss_pred CCCcCCeeecccCcccC--CCCCC---CCCCCCEEEeecCcccccCCC--CCcccccccccccCCC
Q 047954 91 SLKFLESLQLQNNNLTG--PVPEF---NQSSLKVFNVSNNNLSGSIPK--TQTLQLFRSYSYSNNP 149 (582)
Q Consensus 91 ~l~~l~~l~l~~N~l~g--~ip~~---~~~~l~~l~ls~N~l~g~ip~--~~~~~~~~~~~~~~n~ 149 (582)
++++|++|+|++|++++ .+|.. .+++|+.|+|++|.+++.+|. ...+..+..+++++|.
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~ 264 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSC
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCc
Confidence 55555555555555552 22221 334555555555555554421 1223444445555543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.2e-12 Score=142.23 Aligned_cols=139 Identities=18% Similarity=0.241 Sum_probs=119.0
Q ss_pred cceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCc
Q 047954 11 WYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNK 80 (582)
Q Consensus 11 w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~ 80 (582)
+..|.|... ...++.|+|++|++++..| ..++.+++|++|+|++|.+++..| .|.++++|++|+|++|.
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQN-TTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECT-TTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCCh-hHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 445778531 2468999999999997664 569999999999999999999877 48999999999999999
Q ss_pred ccccccccccCCCcCCeeecccCcccCC--CCCCCCCCCCEEEeecCcccc-cCCCCCcccccccccccCCCC
Q 047954 81 FYGEISRSLLSLKFLESLQLQNNNLTGP--VPEFNQSSLKVFNVSNNNLSG-SIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 81 l~g~ip~~~~~l~~l~~l~l~~N~l~g~--ip~~~~~~l~~l~ls~N~l~g-~ip~~~~~~~~~~~~~~~n~~ 150 (582)
+++..|..++++++|++|+|++|.+++. .+-..+++|+.|+|++|.+++ .+|....+..+..+++++|..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 165 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCC
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcc
Confidence 9999999999999999999999999984 333478999999999999998 667766678888888888854
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.36 E-value=6.4e-13 Score=124.45 Aligned_cols=127 Identities=11% Similarity=0.164 Sum_probs=108.4
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCcccccc-CCCCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNF-MNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~-~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
..+++.|+|++|.++ .++ .+..+++|++|+|++|.+++.. ..+..+++|+.|+|++|.+++.+|..++.+++|++|
T Consensus 65 l~~L~~L~l~~n~~~--~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L 141 (197)
T 4ezg_A 65 AHNIKDLTINNIHAT--NYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141 (197)
T ss_dssp CTTCSEEEEESCCCS--CCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEE
T ss_pred CCCCCEEEccCCCCC--cch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEE
Confidence 457899999999664 333 5889999999999999999965 578899999999999999999999999999999999
Q ss_pred ecccCcccCCCCCC-CCCCCCEEEeecCcccccCCCCCcccccccccccCCCC
Q 047954 99 QLQNNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 99 ~l~~N~l~g~ip~~-~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~ 150 (582)
+|++|.+.+.+|.. .+++|+.|++++|.+++ +|....+..+..+++.+|+.
T Consensus 142 ~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~-~~~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 142 DLSYNGAITDIMPLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp ECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC-CTTGGGCSSCCEEEECBC--
T ss_pred EccCCCCccccHhhcCCCCCCEEECCCCCCcC-hHHhccCCCCCEEEeeCccc
Confidence 99999966677764 78999999999999987 55555677888889998863
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.9e-12 Score=117.41 Aligned_cols=105 Identities=21% Similarity=0.199 Sum_probs=88.2
Q ss_pred EEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeeeccc
Q 047954 24 TGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQN 102 (582)
Q Consensus 24 ~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~ 102 (582)
+.+++++|+| +.||.. + .++|++|+|++|.|++.+| .+.++++|+.|+|++|+|++..+..+.++++|++|+|++
T Consensus 15 ~~l~~~~n~l-~~iP~~-~--~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRL-ASVPAG-I--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCC-SSCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCC-CccCCC-c--CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 5688999998 478764 3 3899999999999999987 578899999999999999986555678999999999999
Q ss_pred CcccCCCCC-C-CCCCCCEEEeecCcccccCC
Q 047954 103 NNLTGPVPE-F-NQSSLKVFNVSNNNLSGSIP 132 (582)
Q Consensus 103 N~l~g~ip~-~-~~~~l~~l~ls~N~l~g~ip 132 (582)
|+|++..|. + .+++|+.|+|++|.|....+
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 999975554 2 68899999999999986543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.35 E-value=3.1e-12 Score=135.83 Aligned_cols=140 Identities=17% Similarity=0.138 Sum_probs=116.2
Q ss_pred CcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCC
Q 047954 10 QWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGN 79 (582)
Q Consensus 10 ~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N 79 (582)
.|..|.|... ...++.|+|++|++++..| ..+..+++|+.|+|++|.+++..+ .+.++++|+.|+|++|
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQA-DTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECH-HHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 3678999642 2468899999999998664 568999999999999999999886 5888999999999999
Q ss_pred cccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC--CcccccccccccCCCC
Q 047954 80 KFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT--QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 80 ~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~--~~~~~~~~~~~~~n~~ 150 (582)
++++..+..+.++++|++|+|++|++++..+.. .+++|+.|+|++|+..+.+|.. ..+..+..+++++|..
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l 208 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcc
Confidence 999777778999999999999999998543332 6789999999997777777753 4567788888888854
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.8e-12 Score=119.08 Aligned_cols=123 Identities=17% Similarity=0.204 Sum_probs=98.6
Q ss_pred CCeEEEEEeCCCcceeccCccccCCC-CCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADI-PELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l-~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
...++.|+|++|+++ .+| . +..+ ++|++|+|++|.+++. +.+..+++|+.|+|++|.+++..|..+..+++|++|
T Consensus 18 ~~~L~~L~l~~n~l~-~i~-~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 18 AVRDRELDLRGYKIP-VIE-N-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TTSCEEEECTTSCCC-SCC-C-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCCceEEEeeCCCCc-hhH-H-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 357999999999999 454 3 4444 4999999999999986 889999999999999999996544555999999999
Q ss_pred ecccCcccCCCCC---C-CCCCCCEEEeecCcccccCCCC-----CcccccccccccCC
Q 047954 99 QLQNNNLTGPVPE---F-NQSSLKVFNVSNNNLSGSIPKT-----QTLQLFRSYSYSNN 148 (582)
Q Consensus 99 ~l~~N~l~g~ip~---~-~~~~l~~l~ls~N~l~g~ip~~-----~~~~~~~~~~~~~n 148 (582)
+|++|.++ .+|. . .+++|+.|++++|.++ .+|.. ..++.+..+++++|
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n 150 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKV 150 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEEC
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcC
Confidence 99999995 5665 2 6789999999999997 45642 33555666666555
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.7e-12 Score=139.10 Aligned_cols=131 Identities=19% Similarity=0.222 Sum_probs=108.8
Q ss_pred CCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCcccc--ccC-CCCCCCCCCEEeCCCCccccccccc-ccCCCc
Q 047954 19 NSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISG--NFM-NFSSNHKLKDIDLSGNKFYGEISRS-LLSLKF 94 (582)
Q Consensus 19 ~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g--~~~-~~~~~~~l~~l~l~~N~l~g~ip~~-~~~l~~ 94 (582)
...+++.|+|++|++++.+|. .++.+++|+.|+|++|.+++ .+| .+.++++|+.|+|++|.+++.+|.. +..+++
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 351 SPSSFTFLNFTQNVFTDSVFQ-GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SCCCCCEEECCSSCCCTTTTT-TCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred CCCCceEEECCCCccccchhh-hhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 456789999999999998865 48899999999999999997 334 4788899999999999999988865 778899
Q ss_pred CCeeecccCcccCCCCCCCCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCC
Q 047954 95 LESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 95 l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l 151 (582)
|++|+|++|+++|.+|....++|+.|+|++|+++ .||.. ..+..+..+++++|...
T Consensus 430 L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~ 486 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC
T ss_pred CCEEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC
Confidence 9999999999999888754478999999999988 67754 45677888888888654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.1e-12 Score=144.49 Aligned_cols=130 Identities=21% Similarity=0.235 Sum_probs=84.0
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCccccc---ccccccCCCcC
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGE---ISRSLLSLKFL 95 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~---ip~~~~~l~~l 95 (582)
.+.++.|+|++|.+++.+|+..+..+++|+.|+|++|.+++.+|. +..+++|+.|+|++|.+++. .+..+..+++|
T Consensus 399 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L 478 (606)
T 3t6q_A 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478 (606)
T ss_dssp CTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTC
T ss_pred CccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCc
Confidence 355777777777777776655567777777777777777776653 56666777777777777662 22456667777
Q ss_pred CeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCC
Q 047954 96 ESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 96 ~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~ 150 (582)
++|+|++|++++.+|.. .+++|+.|+|++|++++.+|.. ..+..+ .+++++|..
T Consensus 479 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l 535 (606)
T 3t6q_A 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535 (606)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCC
T ss_pred cEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcc
Confidence 77777777777666653 5566777777777776666543 234444 555566543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.9e-12 Score=140.00 Aligned_cols=129 Identities=22% Similarity=0.364 Sum_probs=113.1
Q ss_pred CCeEEEEEeCCCccee--ccCccccCCCCCCcEEEccCCccccccC--CCCCCCCCCEEeCCCCcccccccccccCCCcC
Q 047954 20 SAHVTGIVLEDMRLNG--EIKSDAFADIPELIVINFKNNIISGNFM--NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFL 95 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g--~ip~~~~~~l~~L~~l~l~~n~~~g~~~--~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l 95 (582)
...++.|+|++|++++ .+| ..++.+++|++|+|++|.+++.+| .+..+++|+.|+|++|.++|.+|..+. ++|
T Consensus 347 l~~L~~L~L~~N~l~~l~~~~-~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L 423 (520)
T 2z7x_B 347 LTELETLILQMNQLKELSKIA-EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRI 423 (520)
T ss_dssp CSSCCEEECCSSCCCBHHHHH-HHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTC
T ss_pred CCCCCEEEccCCccCccccch-HHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccC
Confidence 4679999999999997 664 358999999999999999999776 378889999999999999999998876 799
Q ss_pred CeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC--CcccccccccccCCCCCCC
Q 047954 96 ESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT--QTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 96 ~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~--~~~~~~~~~~~~~n~~l~~ 153 (582)
+.|+|++|+++ .||.. .+++|+.|+|++|+|+ .+|.. ..+..+..+++++|+..|.
T Consensus 424 ~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 424 KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp CEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCccc
Confidence 99999999999 88874 7899999999999999 57764 4577888999999988764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.6e-12 Score=140.38 Aligned_cols=129 Identities=20% Similarity=0.348 Sum_probs=112.2
Q ss_pred CCeEEEEEeCCCccee--ccCccccCCCCCCcEEEccCCccccccCC--CCCCCCCCEEeCCCCcccccccccccCCCcC
Q 047954 20 SAHVTGIVLEDMRLNG--EIKSDAFADIPELIVINFKNNIISGNFMN--FSSNHKLKDIDLSGNKFYGEISRSLLSLKFL 95 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g--~ip~~~~~~l~~L~~l~l~~n~~~g~~~~--~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l 95 (582)
.+.++.|+|++|++++ .+| ..++.+++|+.|+|++|.+++.+|. +..+++|+.|+|++|+++|.+|..+. ++|
T Consensus 376 l~~L~~L~L~~N~l~~~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L 452 (562)
T 3a79_B 376 LKRLQTLILQRNGLKNFFKVA-LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKV 452 (562)
T ss_dssp CSSCCEEECCSSCCCBTTHHH-HTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTC
T ss_pred cCCCCEEECCCCCcCCcccch-hhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcC
Confidence 4679999999999997 443 3588999999999999999997763 78889999999999999999998776 789
Q ss_pred CeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC--CcccccccccccCCCCCCC
Q 047954 96 ESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT--QTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 96 ~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~--~~~~~~~~~~~~~n~~l~~ 153 (582)
+.|+|++|+++ .||.. .+++|+.|+|++|+|+ .+|.. ..+..+..+++++|++.|.
T Consensus 453 ~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp SEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred CEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCC
Confidence 99999999999 78874 7899999999999999 57764 4577888899999988764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=3.4e-12 Score=130.49 Aligned_cols=108 Identities=17% Similarity=0.182 Sum_probs=91.9
Q ss_pred CCCcceeeeCCCCCeEEEEEeCCC-cceeccCccccCCCCCCcEEEccC-CccccccC-CCCCCCCCCEEeCCCCccccc
Q 047954 8 PSQWYGIQCDINSAHVTGIVLEDM-RLNGEIKSDAFADIPELIVINFKN-NIISGNFM-NFSSNHKLKDIDLSGNKFYGE 84 (582)
Q Consensus 8 ~~~w~gv~c~~~~~~~~~l~l~~~-~l~g~ip~~~~~~l~~L~~l~l~~-n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ 84 (582)
.|.|.+|.|+ ++ +|++ ||. +..+++|+.|+|++ |.|++.++ .|.++.+|+.|+|++|+|+|.
T Consensus 7 ~C~~~~v~~~------------~~n~l~~-ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 71 (347)
T 2ifg_A 7 PHGSSGLRCT------------RDGALDS-LHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71 (347)
T ss_dssp CSSSSCEECC------------SSCCCTT-TTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEE
T ss_pred cccCCEEEcC------------CCCCCCc-cCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCcccee
Confidence 3778888885 34 6764 775 89999999999996 99999886 589999999999999999999
Q ss_pred ccccccCCCcCCeeecccCcccCCCCCC-CCCCCCEEEeecCccccc
Q 047954 85 ISRSLLSLKFLESLQLQNNNLTGPVPEF-NQSSLKVFNVSNNNLSGS 130 (582)
Q Consensus 85 ip~~~~~l~~l~~l~l~~N~l~g~ip~~-~~~~l~~l~ls~N~l~g~ 130 (582)
.|..|.+|++|+.|+|++|+|++..|.. ....|+.|+|++|.|...
T Consensus 72 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp CTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CHHHhcCCcCCCEEeCCCCccceeCHHHcccCCceEEEeeCCCccCC
Confidence 9999999999999999999999654442 333499999999999864
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.33 E-value=2.9e-12 Score=140.97 Aligned_cols=129 Identities=16% Similarity=0.218 Sum_probs=108.2
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..+..+++++|.++ .+|+..++.+++|++|+|++|.+++..| .+..+++|+.|+|++|.+++..|..++++++|++|+
T Consensus 51 ~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp CCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 34567888888875 4677778889999999999999999887 688999999999999999998888899999999999
Q ss_pred cccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCC
Q 047954 100 LQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 100 l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~ 150 (582)
|++|.|++..|.. .+++|+.|+|++|.+++..|.. ..+..+..+++++|..
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 183 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 183 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCC
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCC
Confidence 9999999544432 6889999999999999887753 4577888888888854
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.6e-12 Score=130.85 Aligned_cols=131 Identities=15% Similarity=0.113 Sum_probs=104.2
Q ss_pred CCeEEEEEeCCCcceeccCc---cccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCccccc--ccc--cccC
Q 047954 20 SAHVTGIVLEDMRLNGEIKS---DAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGE--ISR--SLLS 91 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~---~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~--ip~--~~~~ 91 (582)
..+++.|+|++|.+++.+|. ..+..+++|++|+|++|.+++.++ .+..+++|++|||++|++.|. +|. .+++
T Consensus 116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 195 (310)
T 4glp_A 116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK 195 (310)
T ss_dssp CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence 56788999999999987652 234578999999999999988886 578899999999999999874 433 3478
Q ss_pred CCcCCeeecccCcccCCCCC------CCCCCCCEEEeecCcccccCCCC-Ccc---cccccccccCCCCC
Q 047954 92 LKFLESLQLQNNNLTGPVPE------FNQSSLKVFNVSNNNLSGSIPKT-QTL---QLFRSYSYSNNPYL 151 (582)
Q Consensus 92 l~~l~~l~l~~N~l~g~ip~------~~~~~l~~l~ls~N~l~g~ip~~-~~~---~~~~~~~~~~n~~l 151 (582)
+++|++|+|++|+++. +|. ..+++|+.|+||+|.+++.+|.. ..+ ..+..+++++|...
T Consensus 196 l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~ 264 (310)
T 4glp_A 196 FPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE 264 (310)
T ss_dssp SCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC
T ss_pred CCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC
Confidence 9999999999999973 332 15689999999999999987754 233 57888899988754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.33 E-value=3e-12 Score=123.69 Aligned_cols=128 Identities=18% Similarity=0.231 Sum_probs=107.5
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCc-cccccC-CCCCCCCCCEEeCCC-CcccccccccccCCCcCCe
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNI-ISGNFM-NFSSNHKLKDIDLSG-NKFYGEISRSLLSLKFLES 97 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~-~~g~~~-~~~~~~~l~~l~l~~-N~l~g~ip~~~~~l~~l~~ 97 (582)
..++.|+|++|++++. |+..++.+++|+.|+|++|. +++..+ .+.++++|+.|+|++ |++++..|..+.++++|++
T Consensus 31 ~~l~~L~l~~n~l~~i-~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTI-PSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp TTCCEEEEESCCCSEE-CTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CcccEEEEeCCcceEE-CHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 4689999999999975 45568999999999999997 777665 578999999999999 9999777788999999999
Q ss_pred eecccCcccCCCCCC-CCCCCC---EEEeecC-cccccCCC-CCcccccc-cccccCCCC
Q 047954 98 LQLQNNNLTGPVPEF-NQSSLK---VFNVSNN-NLSGSIPK-TQTLQLFR-SYSYSNNPY 150 (582)
Q Consensus 98 l~l~~N~l~g~ip~~-~~~~l~---~l~ls~N-~l~g~ip~-~~~~~~~~-~~~~~~n~~ 150 (582)
|+|++|.+++ +|.+ .+++|+ .|++++| .+++..+. ...+..+. .+++++|..
T Consensus 110 L~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l 168 (239)
T 2xwt_C 110 LGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168 (239)
T ss_dssp EEEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCC
T ss_pred EeCCCCCCcc-ccccccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCC
Confidence 9999999998 8874 667777 9999999 88765443 24567778 888888854
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.7e-12 Score=125.98 Aligned_cols=119 Identities=19% Similarity=0.249 Sum_probs=51.8
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
+++.|+|++|++++.. + +..+++|+.|+|++|.+++ +|.+.. .+|+.|+|++|++++ +| .+.++++|+.|+|+
T Consensus 64 ~L~~L~L~~N~i~~~~-~--l~~l~~L~~L~L~~N~l~~-l~~~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls 136 (263)
T 1xeu_A 64 NLKELHLSHNQISDLS-P--LKDLTKLEELSVNRNRLKN-LNGIPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIR 136 (263)
T ss_dssp TCCEEECCSSCCCCCG-G--GTTCSSCCEEECCSSCCSC-CTTCCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECT
T ss_pred CCCEEECCCCccCCCh-h--hccCCCCCEEECCCCccCC-cCcccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECC
Confidence 3444444444444322 1 4444444444444444444 222222 444444444444443 22 34445555555555
Q ss_pred cCcccCCCCC-CCCCCCCEEEeecCcccccCCCCCcccccccccccCCC
Q 047954 102 NNNLTGPVPE-FNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNP 149 (582)
Q Consensus 102 ~N~l~g~ip~-~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~ 149 (582)
+|++++. |. ..+++|+.|+|++|.+++. +....+..+..+++++|+
T Consensus 137 ~N~i~~~-~~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~ 183 (263)
T 1xeu_A 137 NNKLKSI-VMLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQK 183 (263)
T ss_dssp TSCCCBC-GGGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEE
T ss_pred CCcCCCC-hHHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCc
Confidence 5555442 22 1344455555555555443 222333444444444443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=4.1e-12 Score=142.03 Aligned_cols=141 Identities=20% Similarity=0.172 Sum_probs=110.4
Q ss_pred CCcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCC
Q 047954 9 SQWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSG 78 (582)
Q Consensus 9 ~~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~ 78 (582)
|.+.-|.|+.. ..+++.|+|++|++++. |+..++.+++|++|+|++|.+++..|. +.++++|++|+|++
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 82 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRL-PAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCC-CGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCc-CHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence 55666778531 25688999999999975 455688999999999999999988775 67788899999999
Q ss_pred CcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCC
Q 047954 79 NKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 79 N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~ 150 (582)
|++++..+..++++++|++|+|++|++++..|.. .+++|++|+|++|.+++..|.. ..+..+..+++++|..
T Consensus 83 n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 157 (680)
T 1ziw_A 83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157 (680)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCC
T ss_pred CccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcc
Confidence 9888654557888999999999999888765543 6788889999999888877654 3566777777777753
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.31 E-value=2.6e-12 Score=128.05 Aligned_cols=123 Identities=24% Similarity=0.316 Sum_probs=100.9
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..+++.|+|++|++++.. + +..+++|+.|+|++|.+++ ++.+..+++|+.|+|++|++++. +.+.++++|+.|+
T Consensus 67 l~~L~~L~L~~n~l~~~~-~--l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIK-P--LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLY 140 (291)
T ss_dssp CTTCCEEECCSSCCCCCG-G--GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEE
T ss_pred CCCCCEEEccCCccCCCc-c--cccCCCCCEEECCCCcCCC-ChhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEE
Confidence 467899999999998754 3 7899999999999999987 56688889999999999999873 4688899999999
Q ss_pred cccCcccCCCCCC-CCCCCCEEEeecCcccccCCCCCcccccccccccCCCC
Q 047954 100 LQNNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 100 l~~N~l~g~ip~~-~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~ 150 (582)
|++|++++. +.. .+++|+.|+|++|.+++..| ...+..+..+++++|..
T Consensus 141 l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 141 LGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp CCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred ccCCcCCcc-hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcC
Confidence 999999875 443 67889999999999887655 55677788888888854
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.3e-12 Score=146.60 Aligned_cols=127 Identities=18% Similarity=0.179 Sum_probs=107.0
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
...+..|+|++|.+. .||.. +..+++|+.|+|++|.|+ .+| .++++++|++|||++|.|+ .||.+|++|++|++|
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 298 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISAN-IFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYF 298 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGG-GGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred CCCCcEEECCCCCCC-CCChh-hcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence 466889999999998 78765 568999999999999999 666 5889999999999999999 899999999999999
Q ss_pred ecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCCCcccc--cccccccCCCCC
Q 047954 99 QLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQL--FRSYSYSNNPYL 151 (582)
Q Consensus 99 ~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~~~~~~--~~~~~~~~n~~l 151 (582)
+|++|.|+ .||.. .+++|+.|+|++|.|+|.+|....... ...+.+.+|...
T Consensus 299 ~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~ 354 (727)
T 4b8c_D 299 YFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPE 354 (727)
T ss_dssp ECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred ECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCccc
Confidence 99999997 88874 789999999999999999986532211 122456666543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.30 E-value=3.7e-12 Score=139.60 Aligned_cols=123 Identities=24% Similarity=0.329 Sum_probs=91.2
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..++..|+|++|++++..| +..|++|+.|+|++|.|++ +|.+..+++|+.|+|++|.|++ + +.+..|++|+.|+
T Consensus 64 l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~ 137 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDIKP---LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 137 (605)
T ss_dssp CTTCCEEECTTSCCCCCGG---GGGCTTCCEEECCSSCCCC-CTTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEE
T ss_pred CCCCCEEEeeCCCCCCChh---hccCCCCCEEECcCCCCCC-ChhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEE
Confidence 4568888888888887543 7788888888888888876 5677778888888888888876 3 3577788888888
Q ss_pred cccCcccCCCCCC-CCCCCCEEEeecCcccccCCCCCcccccccccccCCCC
Q 047954 100 LQNNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 100 l~~N~l~g~ip~~-~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~ 150 (582)
|++|.|++. +.. .+++|+.|+|++|.|++..| ...+..|..+++++|..
T Consensus 138 Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 138 LGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp CCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred CCCCccCCc-hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCC
Confidence 888888765 433 67778888888888877666 45566677777777743
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.30 E-value=5e-12 Score=126.02 Aligned_cols=122 Identities=19% Similarity=0.279 Sum_probs=101.9
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeec
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l 100 (582)
.+++.|++++|+++.. + .++.+++|+.|+|++|.+++..+ +..+++|+.|+|++|.+++ +| .+.++++|++|+|
T Consensus 46 ~~L~~L~l~~~~i~~~-~--~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L 119 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV-Q--GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (291)
T ss_dssp HTCCEEECTTSCCCCC-T--TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred CcccEEEccCCCcccC-h--hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEEC
Confidence 4578999999998753 3 37889999999999999998766 8899999999999999987 44 4899999999999
Q ss_pred ccCcccCCCCCC-CCCCCCEEEeecCcccccCCCCCcccccccccccCCCC
Q 047954 101 QNNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 101 ~~N~l~g~ip~~-~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~ 150 (582)
++|++++ +|.. .+++|+.|++++|.+++. +....+..+..+++++|..
T Consensus 120 ~~n~i~~-~~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l 168 (291)
T 1h6t_A 120 EHNGISD-INGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQI 168 (291)
T ss_dssp TTSCCCC-CGGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCC
T ss_pred CCCcCCC-ChhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCcc
Confidence 9999987 4543 788999999999999875 5555677888888888854
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.30 E-value=7.6e-12 Score=135.69 Aligned_cols=114 Identities=24% Similarity=0.312 Sum_probs=88.9
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeec
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l 100 (582)
.+++.|+|++|+|+ .|| ..+++|+.|+|++|.|++ +|.+.+ +|+.|+|++|+|++ ||. .+++|+.|+|
T Consensus 80 ~~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~-ip~l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPELPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TTCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCCCCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCC-cchhhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 46888999999988 676 347888899999999888 666544 88888888888887 777 6788888888
Q ss_pred ccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCCCC
Q 047954 101 QNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 101 ~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l 151 (582)
++|+|++ ||. .+++|+.|+|++|.|++ +|. .. ..+..+++++|...
T Consensus 148 s~N~l~~-lp~-~l~~L~~L~Ls~N~L~~-lp~-l~-~~L~~L~Ls~N~L~ 193 (571)
T 3cvr_A 148 DNNQLTM-LPE-LPTSLEVLSVRNNQLTF-LPE-LP-ESLEALDVSTNLLE 193 (571)
T ss_dssp CSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC-CC-TTCCEEECCSSCCS
T ss_pred CCCccCc-CCC-cCCCcCEEECCCCCCCC-cch-hh-CCCCEEECcCCCCC
Confidence 8888887 777 67788888888888887 776 22 66777777777543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.1e-11 Score=125.88 Aligned_cols=137 Identities=21% Similarity=0.227 Sum_probs=87.9
Q ss_pred CCcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCC
Q 047954 9 SQWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSG 78 (582)
Q Consensus 9 ~~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~ 78 (582)
|.|..+.|+.. ...++.|+|++|++++.. +..++.+++|++|+|++|.+++..| .+.++++|++|+|++
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELR-KDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEEC-TTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccC-HhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 46777777531 135677777777777544 3457777777777777777777655 466777777777777
Q ss_pred CcccccccccccCCCcCCeeecccCcccCCCCC--CCCCCCCEEEeecCccc--ccCCCCCcccccccccccCCC
Q 047954 79 NKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE--FNQSSLKVFNVSNNNLS--GSIPKTQTLQLFRSYSYSNNP 149 (582)
Q Consensus 79 N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~--~~~~~l~~l~ls~N~l~--g~ip~~~~~~~~~~~~~~~n~ 149 (582)
|.++ .+|..+. ++|++|+|++|++++..+. ..+++|+.|++++|.++ |..|.......+..+++++|.
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~ 183 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSB
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCC
Confidence 7777 6666655 6777777777777754333 25677777777777775 234433211155556666664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=5.5e-12 Score=141.01 Aligned_cols=134 Identities=22% Similarity=0.284 Sum_probs=101.8
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCcccccc---------CCCCCCCCCCEEeCCCCcccccccc-cc
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNF---------MNFSSNHKLKDIDLSGNKFYGEISR-SL 89 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~---------~~~~~~~~l~~l~l~~N~l~g~ip~-~~ 89 (582)
...++.|+|++|++++ +|+..+..+++|++|+|++|.+++.. ..+.++++|+.|+|++|+++ .||. .+
T Consensus 479 l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~ 556 (680)
T 1ziw_A 479 LRNLTILDLSNNNIAN-INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVF 556 (680)
T ss_dssp CTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTT
T ss_pred CCCCCEEECCCCCCCc-CChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHc
Confidence 3567788888888885 44556788888888888888887642 12677788888888888888 5665 57
Q ss_pred cCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCCC--cccccccccccCCCCCCCCC
Q 047954 90 LSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQ--TLQLFRSYSYSNNPYLCGPP 155 (582)
Q Consensus 90 ~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~~--~~~~~~~~~~~~n~~l~~~~ 155 (582)
.++++|+.|+|++|++++-.|.. .+++|+.|+|++|.|++..|... .+..+..+++++|++.|...
T Consensus 557 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 557 KDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred ccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 88889999999999998543332 56889999999999988666432 46778888999999988653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=2.4e-12 Score=140.02 Aligned_cols=129 Identities=18% Similarity=0.272 Sum_probs=109.6
Q ss_pred CCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccc-cccccccCCCcCC
Q 047954 19 NSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYG-EISRSLLSLKFLE 96 (582)
Q Consensus 19 ~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g-~ip~~~~~l~~l~ 96 (582)
...+++.|+|++|++++..| ..++.+++|++|+|++|.+++.+|. +.++++|++|+|++|.+++ .+|..++++++|+
T Consensus 48 ~l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~ 126 (549)
T 2z81_A 48 ACANLQVLILKSSRINTIEG-DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126 (549)
T ss_dssp SCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCC
T ss_pred cCCcccEEECCCCCcCccCh-hhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCcc
Confidence 35679999999999998664 5689999999999999999998886 8999999999999999998 6788999999999
Q ss_pred eeecccCcccCCCCCC---CCCCCCEEEeecCcccccCCCC-CcccccccccccCC
Q 047954 97 SLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNN 148 (582)
Q Consensus 97 ~l~l~~N~l~g~ip~~---~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n 148 (582)
+|+|++|++.+.+|.. .+++|+.|++++|.+++.+|.. ..+..+..+.+.+|
T Consensus 127 ~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n 182 (549)
T 2z81_A 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182 (549)
T ss_dssp EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECS
T ss_pred EEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccC
Confidence 9999999988888852 6789999999999999988865 23444444444444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.28 E-value=1e-11 Score=113.26 Aligned_cols=105 Identities=17% Similarity=0.161 Sum_probs=89.6
Q ss_pred CcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecC
Q 047954 48 LIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNN 125 (582)
Q Consensus 48 L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N 125 (582)
.+.+++++|.|+.....+. .+|+.|+|++|++++..|..+.++++|++|+|++|+|++..|.. .+++|+.|+|++|
T Consensus 11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 4789999999988544443 78999999999999999999999999999999999999766553 6899999999999
Q ss_pred cccccCCC-CCcccccccccccCCCCCCCC
Q 047954 126 NLSGSIPK-TQTLQLFRSYSYSNNPYLCGP 154 (582)
Q Consensus 126 ~l~g~ip~-~~~~~~~~~~~~~~n~~l~~~ 154 (582)
+|++..|. ...+..+..+++++|+..|..
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 99986664 356788999999999987653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.4e-11 Score=125.09 Aligned_cols=144 Identities=18% Similarity=0.211 Sum_probs=102.3
Q ss_pred CCCCCCCCcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCC
Q 047954 3 CFKDFPSQWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLK 72 (582)
Q Consensus 3 ~~~~~~~~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~ 72 (582)
|..+-.|.|..+.|+.. ...++.|+|++|++++.. +..++.+++|++|+|++|.+++..| .+.++++|+
T Consensus 25 cp~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (330)
T 1xku_A 25 CPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIK-DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103 (330)
T ss_dssp CCTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBC-TTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCC
T ss_pred CCCCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeC-hhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCC
Confidence 44443457888888631 235678888888888644 4457888888888888888888765 577888888
Q ss_pred EEeCCCCcccccccccccCCCcCCeeecccCcccCCCCC--CCCCCCCEEEeecCcccc--cCCCC-CcccccccccccC
Q 047954 73 DIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE--FNQSSLKVFNVSNNNLSG--SIPKT-QTLQLFRSYSYSN 147 (582)
Q Consensus 73 ~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~--~~~~~l~~l~ls~N~l~g--~ip~~-~~~~~~~~~~~~~ 147 (582)
+|+|++|.++ .+|..+. ++|++|+|++|.+++..|. ..+++|+.|++++|.+.. ..|.. ..+..+..+.+++
T Consensus 104 ~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~ 180 (330)
T 1xku_A 104 RLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 180 (330)
T ss_dssp EEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCS
T ss_pred EEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCC
Confidence 8888888887 6777665 6788888888888865554 267788888888888753 44432 3355666677776
Q ss_pred CCC
Q 047954 148 NPY 150 (582)
Q Consensus 148 n~~ 150 (582)
|..
T Consensus 181 n~l 183 (330)
T 1xku_A 181 TNI 183 (330)
T ss_dssp SCC
T ss_pred Ccc
Confidence 643
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.2e-11 Score=135.93 Aligned_cols=126 Identities=20% Similarity=0.125 Sum_probs=106.4
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..+..|+|++|++++..| ..++.+++|+.|+|++|.+++.+|. ++++++|++|+|++|.|++..|..++++++|++|+
T Consensus 75 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDT-YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCCCCh-HHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 568899999999998664 4689999999999999999998875 68999999999999999965555579999999999
Q ss_pred cccCcccCCCCCC--CCCCCCEEEeecCcccccCCCCCcccccccccccCCC
Q 047954 100 LQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNP 149 (582)
Q Consensus 100 l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~ 149 (582)
|++|.+++..|.. .+++|+.|+|++|.+++. | ...+..+..+++++|.
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~l~~L~~L~l~~n~ 203 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D-LSLIPSLFHANVSYNL 203 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-C-GGGCTTCSEEECCSSC
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-C-hhhhhhhhhhhcccCc
Confidence 9999999988863 789999999999999874 2 2345566666777664
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.27 E-value=6.6e-12 Score=126.74 Aligned_cols=127 Identities=20% Similarity=0.089 Sum_probs=100.7
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCccccccccccc-CCCcCCee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLL-SLKFLESL 98 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~-~l~~l~~l 98 (582)
+.++.|+|++|++++..+ ..+++|+.|+|++|.+++..+ .+..+++|+.|+|++|.+++..|..+. ++++|++|
T Consensus 99 ~~L~~L~l~~n~l~~~~~----~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L 174 (317)
T 3o53_A 99 PSIETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (317)
T ss_dssp TTCCEEECCSSCCSEEEE----CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCcCEEECCCCccCCcCc----cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEE
Confidence 567778888888877543 246889999999999998776 577888999999999999988887774 78899999
Q ss_pred ecccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCCCC
Q 047954 99 QLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 99 ~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l 151 (582)
+|++|.+++.-+...+++|+.|+|++|.+++..|....+..+..+++++|...
T Consensus 175 ~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 175 NLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp ECTTSCCCEEECCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred ECCCCcCcccccccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc
Confidence 99999988763334688899999999999876555556677888888888654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.7e-11 Score=129.60 Aligned_cols=140 Identities=16% Similarity=0.193 Sum_probs=113.2
Q ss_pred CcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCC
Q 047954 10 QWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGN 79 (582)
Q Consensus 10 ~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N 79 (582)
.|..|.|... ...++.|+|++|++++..+ ..+..+++|+.|+|++|.+++..+ .+.++++|+.|+|++|
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKV-NSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECT-TTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCH-HHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 3678999631 2457889999999997664 568999999999999999998775 5788999999999999
Q ss_pred cccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC--CcccccccccccCCCC
Q 047954 80 KFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT--QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 80 ~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~--~~~~~~~~~~~~~n~~ 150 (582)
+|++..+..+..+++|++|+|++|.+++..+.. .+++|+.|+|++|+..+.+|.. ..+..+..+++++|..
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l 197 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCC
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcC
Confidence 999766778999999999999999998544432 6788999999997777777753 4567778888888854
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.7e-11 Score=112.34 Aligned_cols=104 Identities=17% Similarity=0.191 Sum_probs=87.2
Q ss_pred cEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCc
Q 047954 49 IVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNN 126 (582)
Q Consensus 49 ~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~ 126 (582)
+.+++++|.|+.....+. .+|+.|+|++|+|++.+|..+.++++|++|+|++|+|++..+.. .+++|+.|+|++|+
T Consensus 15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 689999999954333343 78999999999999999999999999999999999999854442 68999999999999
Q ss_pred ccccCCC-CCcccccccccccCCCCCCCC
Q 047954 127 LSGSIPK-TQTLQLFRSYSYSNNPYLCGP 154 (582)
Q Consensus 127 l~g~ip~-~~~~~~~~~~~~~~n~~l~~~ 154 (582)
|++..|. ...+..+..+++++|+..|.+
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred cceeCHHHhccccCCCEEEeCCCCccccc
Confidence 9975554 356788899999999887643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.26 E-value=1.1e-11 Score=135.86 Aligned_cols=122 Identities=19% Similarity=0.295 Sum_probs=65.1
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeec
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l 100 (582)
.++..|+|++|++++ +| .+..|++|+.|+|++|.|++ ++.+..+++|+.|+|++|.|++. ..+..|++|+.|+|
T Consensus 87 ~~L~~L~Ls~N~l~~-l~--~l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L 160 (605)
T 1m9s_A 87 KNLGWLFLDENKIKD-LS--SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 160 (605)
T ss_dssp TTCCEEECCSSCCCC-CT--TSTTCTTCCEEECTTSCCCC-CGGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEEC
T ss_pred CCCCEEECcCCCCCC-Ch--hhccCCCCCEEEecCCCCCC-CccccCCCccCEEECCCCccCCc--hhhcccCCCCEEEC
Confidence 345555555555554 22 25555555555555555554 34455555555555555555543 34555555555555
Q ss_pred ccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCC
Q 047954 101 QNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNP 149 (582)
Q Consensus 101 ~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~ 149 (582)
++|.|++..|-..+++|+.|+|++|.|++ +|....+..|..+++++|+
T Consensus 161 s~N~l~~~~~l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 161 EDNQISDIVPLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQE 208 (605)
T ss_dssp CSSCCCCCGGGTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEECCSEE
T ss_pred cCCcCCCchhhccCCCCCEEECcCCCCCC-ChHHccCCCCCEEEccCCc
Confidence 55555555553345555555555555554 2433444455555555554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.26 E-value=6.9e-12 Score=126.06 Aligned_cols=126 Identities=20% Similarity=0.251 Sum_probs=102.0
Q ss_pred CCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 19 NSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 19 ~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
...+++.|+|++|.+++ +| .+..+++|+.|+|++|.+++. +.+..+++|+.|+|++|.+++..| +.++++|+.|
T Consensus 83 ~l~~L~~L~L~~n~l~~-~~--~~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L 156 (308)
T 1h6u_A 83 NLTKITELELSGNPLKN-VS--AIAGLQSIKTLDLTSTQITDV-TPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYL 156 (308)
T ss_dssp TCCSCCEEECCSCCCSC-CG--GGTTCTTCCEEECTTSCCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred cCCCCCEEEccCCcCCC-ch--hhcCCCCCCEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCcCcc--ccCCCCccEE
Confidence 35678999999999987 33 488899999999999999884 558888999999999999987554 8889999999
Q ss_pred ecccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCCCC
Q 047954 99 QLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 99 ~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l 151 (582)
+|++|++++..|-..+++|+.|+|++|.+++..| ...+..+..+++++|...
T Consensus 157 ~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~ 208 (308)
T 1h6u_A 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQIS 208 (308)
T ss_dssp ECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCC
T ss_pred EccCCcCCCChhhcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccC
Confidence 9999999875553477889999999999986443 455677788888888643
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.25 E-value=9.9e-12 Score=129.19 Aligned_cols=128 Identities=17% Similarity=0.244 Sum_probs=109.9
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..+..|++++|.++ .+|+..+..+++|++|+|++|.+++..+ .+..+++|++|+|++|.+++..|..++++++|++|+
T Consensus 45 ~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 55778899988876 4777778899999999999999998876 688999999999999999998888999999999999
Q ss_pred cccCcccCCCCCC---CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCC
Q 047954 100 LQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 100 l~~N~l~g~ip~~---~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~ 150 (582)
|++|+++ .+|.. .+++|+.|+|++|.+++..|.. ..+..+..+++++|..
T Consensus 124 L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 177 (390)
T 3o6n_A 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 177 (390)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCC
T ss_pred CCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcC
Confidence 9999999 56652 6889999999999999876653 4577888888888864
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.25 E-value=3.4e-14 Score=133.31 Aligned_cols=129 Identities=20% Similarity=0.270 Sum_probs=107.8
Q ss_pred CCeEEEEEeCCCcceeccCc-----cccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCc
Q 047954 20 SAHVTGIVLEDMRLNGEIKS-----DAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKF 94 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~-----~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~ 94 (582)
...++.++|+.+.|+|.+|+ ..++.+++|++|+|++|.+++ +|.+..+++|+.|+|++|.++ .+|..+..+++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 35688889999999999875 247889999999999999998 778888999999999999999 78998888999
Q ss_pred CCeeecccCcccCCCCCC-CCCCCCEEEeecCccccc--CCCCCcccccccccccCCCCC
Q 047954 95 LESLQLQNNNLTGPVPEF-NQSSLKVFNVSNNNLSGS--IPKTQTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 95 l~~l~l~~N~l~g~ip~~-~~~~l~~l~ls~N~l~g~--ip~~~~~~~~~~~~~~~n~~l 151 (582)
|++|+|++|++++ +|.. .+++|+.|+|++|.+++. ++....+..+..+++++|+..
T Consensus 95 L~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~ 153 (198)
T 1ds9_A 95 LEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp CSEEEEEEEECCC-HHHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHH
T ss_pred CCEEECcCCcCCc-CCccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccc
Confidence 9999999999997 6653 678899999999999852 223345667788888888643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2e-11 Score=119.58 Aligned_cols=140 Identities=16% Similarity=0.078 Sum_probs=105.1
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
..++.|+++.||++... +..+++|............+.+|+.+++.+. |..+.++++++...+..++||||++|.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 34677888999999755 5779999986421122345888999998884 677889999999888999999999999987
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCC----------------------------------------
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS---------------------------------------- 392 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~---------------------------------------- 392 (582)
+.+. +......++.+++++|..||+....
T Consensus 99 ~~~~-----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 99 EEYE-----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp HHCC-----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred hccC-----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 7531 1122346788999999999982110
Q ss_pred ------------CCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 393 ------------RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 393 ------------~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
.....++|+|+++.|||++++..+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 011458999999999999876566799998763
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.5e-11 Score=120.53 Aligned_cols=122 Identities=16% Similarity=0.220 Sum_probs=101.9
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeec
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l 100 (582)
.+++.|+|++|+++ .+| .++.+++|+.|+|++|.+++..+ +..+++|+.|+|++|++++ +|.... ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEEC
T ss_pred CcCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEc
Confidence 56889999999998 465 48889999999999999998777 8899999999999999987 554333 89999999
Q ss_pred ccCcccCCCCCC-CCCCCCEEEeecCcccccCCCCCcccccccccccCCCCC
Q 047954 101 QNNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 101 ~~N~l~g~ip~~-~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l 151 (582)
++|++++ +|.. .+++|+.|+|++|++++. |....+..+..+++++|...
T Consensus 114 ~~N~l~~-~~~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 114 DNNELRD-TDSLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp CSSCCSB-SGGGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCC
T ss_pred cCCccCC-ChhhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCc
Confidence 9999997 4543 789999999999999874 55556778888899988643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-11 Score=123.37 Aligned_cols=122 Identities=17% Similarity=0.321 Sum_probs=69.5
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeec
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l 100 (582)
.+++.|+|++|++++.. + +..+++|++|+|++|.+++ ++.+..+++|+.|+|++|.+++ +|. +..+++|++|+|
T Consensus 63 ~~L~~L~L~~n~i~~~~-~--~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 136 (308)
T 1h6u_A 63 NNLIGLELKDNQITDLA-P--LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYL 136 (308)
T ss_dssp TTCCEEECCSSCCCCCG-G--GTTCCSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCCCh-h--HccCCCCCEEEccCCcCCC-chhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEEC
Confidence 44566666666665432 2 5566666666666666655 3455556666666666666654 332 566666666666
Q ss_pred ccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCC
Q 047954 101 QNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNP 149 (582)
Q Consensus 101 ~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~ 149 (582)
++|.+++..|-..+++|+.|+|++|.+++..| ...+..+..+++++|.
T Consensus 137 ~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 137 DLNQITNISPLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNK 184 (308)
T ss_dssp CSSCCCCCGGGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred CCCccCcCccccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCc
Confidence 66666654433355666666666666654322 3344555556666554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.4e-11 Score=131.53 Aligned_cols=130 Identities=18% Similarity=0.187 Sum_probs=107.8
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
..+++.|+|++|.+++..| ..++.+++|++|+|++|.+++..+. +.++++|+.|+|++|.+++.+|..+.++++|+.|
T Consensus 55 l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 133 (477)
T 2id5_A 55 FPHLEELELNENIVSAVEP-GAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133 (477)
T ss_dssp CTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccCEeCh-hhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEE
Confidence 4678999999999998765 4589999999999999999977664 6889999999999999999999999999999999
Q ss_pred ecccCcccCCCCCC--CCCCCCEEEeecCcccccCCC-CCcccccccccccCCCC
Q 047954 99 QLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPK-TQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 99 ~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~-~~~~~~~~~~~~~~n~~ 150 (582)
+|++|.+++..|.. .+++|+.|+|++|++++..+. ...+..+..+++.+|..
T Consensus 134 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i 188 (477)
T 2id5_A 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188 (477)
T ss_dssp EECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCC
T ss_pred ECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcC
Confidence 99999999877753 678999999999998864332 23456667777777653
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.6e-11 Score=123.92 Aligned_cols=100 Identities=18% Similarity=0.110 Sum_probs=44.2
Q ss_pred CCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC---CCCCCCEEEe
Q 047954 46 PELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF---NQSSLKVFNV 122 (582)
Q Consensus 46 ~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~---~~~~l~~l~l 122 (582)
++|+.|++++|.+++..+.. +++|+.|+|++|++++..|..++.+++|++|+|++|.+++..|.. .+++|+.|+|
T Consensus 99 ~~L~~L~l~~n~l~~~~~~~--~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 176 (317)
T 3o53_A 99 PSIETLHAANNNISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (317)
T ss_dssp TTCCEEECCSSCCSEEEECC--CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred CCcCEEECCCCccCCcCccc--cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEEC
Confidence 44444444444444443321 234444444444444444444444444444444444444433331 2344444444
Q ss_pred ecCcccccCCCCCcccccccccccCC
Q 047954 123 SNNNLSGSIPKTQTLQLFRSYSYSNN 148 (582)
Q Consensus 123 s~N~l~g~ip~~~~~~~~~~~~~~~n 148 (582)
++|.+++. |....+..+..+++++|
T Consensus 177 ~~N~l~~~-~~~~~l~~L~~L~Ls~N 201 (317)
T 3o53_A 177 QYNFIYDV-KGQVVFAKLKTLDLSSN 201 (317)
T ss_dssp TTSCCCEE-ECCCCCTTCCEEECCSS
T ss_pred CCCcCccc-ccccccccCCEEECCCC
Confidence 44444432 22222344444444444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.22 E-value=1.3e-11 Score=119.22 Aligned_cols=126 Identities=13% Similarity=0.140 Sum_probs=99.8
Q ss_pred CCeEEEEEeCCCc-ceeccCccccCCCCCCcEEEccC-CccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCC
Q 047954 20 SAHVTGIVLEDMR-LNGEIKSDAFADIPELIVINFKN-NIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLE 96 (582)
Q Consensus 20 ~~~~~~l~l~~~~-l~g~ip~~~~~~l~~L~~l~l~~-n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~ 96 (582)
.++++.|+|++|+ ++ .||+..+..+++|++|+|++ |.+++..+ .+.++++|+.|+|++|.+++ +|. +..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~ 130 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTD 130 (239)
T ss_dssp CTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCC
T ss_pred CCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccc
Confidence 4678999999997 55 56666688999999999998 99987765 46788899999999999987 787 88888888
Q ss_pred ---eeecccC-cccCCCCC-C-CCCCCC-EEEeecCcccccCCCC-CcccccccccccCCC
Q 047954 97 ---SLQLQNN-NLTGPVPE-F-NQSSLK-VFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNP 149 (582)
Q Consensus 97 ---~l~l~~N-~l~g~ip~-~-~~~~l~-~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~ 149 (582)
+|+|++| ++++..+. + .+++|+ .|++++|.++ .+|.. .....+..+++++|.
T Consensus 131 ~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp SEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred cccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 9999999 88764443 2 578888 9999999988 67654 222567778888885
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=1.4e-11 Score=134.04 Aligned_cols=100 Identities=22% Similarity=0.196 Sum_probs=91.4
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccc-cccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEI-SRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~i-p~~~~~l~~l~~l 98 (582)
..+++.|+|++|+|+ .||. .++.|++|+.|+|++|.|++ +|.++.+++|+.|+|++|+|++.+ |..+++|++|+.|
T Consensus 462 l~~L~~L~Ls~N~l~-~lp~-~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 462 LLLVTHLDLSHNRLR-ALPP-ALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp GTTCCEEECCSSCCC-CCCG-GGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred cccCcEeecCccccc-ccch-hhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 457999999999999 8876 59999999999999999998 779999999999999999999998 9999999999999
Q ss_pred ecccCcccCCCCCC-----CCCCCCEEEe
Q 047954 99 QLQNNNLTGPVPEF-----NQSSLKVFNV 122 (582)
Q Consensus 99 ~l~~N~l~g~ip~~-----~~~~l~~l~l 122 (582)
+|++|.|+|.+|.. .+++|+.||+
T Consensus 539 ~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 539 NLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp ECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred EecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999999987753 3788998874
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=2.2e-11 Score=133.00 Aligned_cols=129 Identities=17% Similarity=0.207 Sum_probs=98.0
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC--CCCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM--NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~--~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
.+++.|+|++|.+++.. +. +..+++|+.|++++|.+++.++ .+.++++|+.|+|++|.+++.+|..+.++++|++|
T Consensus 373 ~~L~~L~l~~n~l~~~~-~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 450 (570)
T 2z63_A 373 TSLKYLDLSFNGVITMS-SN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450 (570)
T ss_dssp SCCCEEECCSCSEEEEE-EE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred CccCEEECCCCcccccc-cc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEE
Confidence 45666666666666543 33 6777888888888888887765 46778888888888888888888888888888888
Q ss_pred ecccCccc-CCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCC
Q 047954 99 QLQNNNLT-GPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 99 ~l~~N~l~-g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l 151 (582)
+|++|.++ |.+|.. .+++|+.|+|++|.+++..|.. ..+..+..+++++|...
T Consensus 451 ~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 507 (570)
T 2z63_A 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507 (570)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred ECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCC
Confidence 88888887 677764 6788888888888888877754 45677788888888543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.21 E-value=4.2e-11 Score=127.00 Aligned_cols=78 Identities=27% Similarity=0.330 Sum_probs=40.9
Q ss_pred CCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC-CCCCCCEEEeec
Q 047954 46 PELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF-NQSSLKVFNVSN 124 (582)
Q Consensus 46 ~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~-~~~~l~~l~ls~ 124 (582)
++|++|+|++|.+++ +|++.++++|++|+|++|++++ +|..+ .+|++|+|++|++++ +|.. .+++|+.|++++
T Consensus 131 ~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~~~~~l~~L~~L~l~~ 204 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LPELQNLPFLTAIYADN 204 (454)
T ss_dssp TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCS
T ss_pred CCCCEEECcCCCCCC-CcccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-CccccCCCCCCEEECCC
Confidence 355555555555554 4455555555555555555554 44332 245555555555554 4432 445555555555
Q ss_pred Ccccc
Q 047954 125 NNLSG 129 (582)
Q Consensus 125 N~l~g 129 (582)
|.+++
T Consensus 205 N~l~~ 209 (454)
T 1jl5_A 205 NSLKK 209 (454)
T ss_dssp SCCSS
T ss_pred CcCCc
Confidence 55554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.5e-11 Score=126.00 Aligned_cols=128 Identities=17% Similarity=0.242 Sum_probs=106.5
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccc--cccCCCcCC
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISR--SLLSLKFLE 96 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~--~~~~l~~l~ 96 (582)
..+++.|+|++|++++..| ..++.+++|++|+|++|.+++..+. +.++++|++|+|++|.+++ +|. .+.++++|+
T Consensus 75 l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~ 152 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEE-DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQ 152 (353)
T ss_dssp CTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCC
T ss_pred CCCCCEEECCCCccCccCH-hhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCc
Confidence 5679999999999998654 5689999999999999999986665 7889999999999999994 665 789999999
Q ss_pred eeecccCcccCCCC-CC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCC
Q 047954 97 SLQLQNNNLTGPVP-EF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNP 149 (582)
Q Consensus 97 ~l~l~~N~l~g~ip-~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~ 149 (582)
+|+|++|+..+.+| .. .+++|+.|++++|.+++..|.. ..+..+..+++++|.
T Consensus 153 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 209 (353)
T 2z80_A 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209 (353)
T ss_dssp EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSC
T ss_pred EEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCc
Confidence 99999996444454 32 6789999999999999987765 446677777777764
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.20 E-value=1.8e-11 Score=111.22 Aligned_cols=105 Identities=18% Similarity=0.186 Sum_probs=90.8
Q ss_pred CCCCCcEEEccCCccc-cccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCE
Q 047954 44 DIPELIVINFKNNIIS-GNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKV 119 (582)
Q Consensus 44 ~l~~L~~l~l~~n~~~-g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~ 119 (582)
..++|+.|+|++|.++ |.+|. +..+++|+.|+|++|.+++. ..+..+++|++|+|++|.+++.+|.. .+++|+.
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 4588999999999999 88886 48899999999999999976 78999999999999999999988875 5899999
Q ss_pred EEeecCcccccC--CCCCcccccccccccCCCC
Q 047954 120 FNVSNNNLSGSI--PKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 120 l~ls~N~l~g~i--p~~~~~~~~~~~~~~~n~~ 150 (582)
|+|++|.+++.- +....+..+..+++++|..
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l 132 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGG
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcC
Confidence 999999998732 3445677888888888864
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=7.2e-11 Score=119.72 Aligned_cols=127 Identities=20% Similarity=0.272 Sum_probs=76.3
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCcccc--ccC-CCCCC---------------------CCCCEEeCC
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISG--NFM-NFSSN---------------------HKLKDIDLS 77 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g--~~~-~~~~~---------------------~~l~~l~l~ 77 (582)
.++.|+|++|.+++.. +..+..+++|+.|+|++|.++. ..+ .+.++ ++|+.|+|+
T Consensus 122 ~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~ 200 (330)
T 1xku_A 122 TLQELRVHENEITKVR-KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLD 200 (330)
T ss_dssp TCCEEECCSSCCCBBC-HHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECT
T ss_pred cccEEECCCCcccccC-HhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECC
Confidence 4666666666666432 3345556666666666665542 222 12223 456666666
Q ss_pred CCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCC
Q 047954 78 GNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 78 ~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~ 150 (582)
+|.+++..|..+.++++|+.|+|++|.+++..|.. .+++|+.|+|++|.++ .+|.. ..+..+..+++++|..
T Consensus 201 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i 275 (330)
T 1xku_A 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275 (330)
T ss_dssp TSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcC
Confidence 77777666667777777777777777777655532 5567777777777776 55543 3455666666666653
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.20 E-value=5.7e-11 Score=123.43 Aligned_cols=125 Identities=21% Similarity=0.173 Sum_probs=105.1
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCccccccccc-ccCCCcCCee
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRS-LLSLKFLESL 98 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~-~~~l~~l~~l 98 (582)
.+++.|+|++|++++.. +..++.+++|++|+|++|.+++..|. +.++++|++|+|++|.++ .+|.. +.++++|++|
T Consensus 69 ~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L 146 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEID-TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTL 146 (390)
T ss_dssp CCCSEEECTTSCCCEEC-TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred ccCcEEECCCCcccccC-hhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEE
Confidence 56889999999998754 45689999999999999999998875 789999999999999999 56655 6899999999
Q ss_pred ecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCCCcccccccccccCCC
Q 047954 99 QLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNP 149 (582)
Q Consensus 99 ~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~ 149 (582)
+|++|.+++..|.. .+++|+.|++++|.+++. + ...+..+..+.+++|.
T Consensus 147 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~-~~~l~~L~~L~l~~n~ 197 (390)
T 3o6n_A 147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D-LSLIPSLFHANVSYNL 197 (390)
T ss_dssp ECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-C-GGGCTTCSEEECCSSC
T ss_pred ECCCCccCccChhhccCCCCCCEEECCCCcCCcc-c-cccccccceeeccccc
Confidence 99999999877763 689999999999999864 2 2345666677777764
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.19 E-value=2.7e-11 Score=123.67 Aligned_cols=123 Identities=16% Similarity=0.159 Sum_probs=71.2
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeec
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l 100 (582)
..+..|++++|.+++..+ +..+++|+.|+|++|.+++..+ +..+++|+.|+|++|.+++. +.+..+++|++|+|
T Consensus 199 ~~L~~L~l~~n~l~~~~~---~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP---VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNV 272 (347)
T ss_dssp TTCCEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEEC
T ss_pred CccceeecccCCCCCCch---hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEc
Confidence 445666666666665432 5566666666666666665444 55666666666666666642 34566666666666
Q ss_pred ccCcccCCCCCC-CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCC
Q 047954 101 QNNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 101 ~~N~l~g~ip~~-~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~ 150 (582)
++|++++. |.. .+++|+.|++++|.+++..|.. ..+..+..+++++|+.
T Consensus 273 ~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 323 (347)
T 4fmz_A 273 GSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323 (347)
T ss_dssp CSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSC
T ss_pred cCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcc
Confidence 66666653 332 4556666666666666554432 2344555566666653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.19 E-value=2.8e-11 Score=128.93 Aligned_cols=124 Identities=19% Similarity=0.210 Sum_probs=87.4
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..+++.|+|++|.+++..| +..+++|+.|+|++|.+++..+ +..+++|+.|+|++|++++..| +..+++|+.|+
T Consensus 242 l~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 315 (466)
T 1o6v_A 242 LTNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLT 315 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG---GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEE
T ss_pred CCCCCEEECCCCccccchh---hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEE
Confidence 3567788888888877543 6777888888888888877555 6677777777777777776544 67777777777
Q ss_pred cccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCCC
Q 047954 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 100 l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~ 150 (582)
|++|++++..|-..+++|+.|++++|.+++. |....+..+..+++++|..
T Consensus 316 L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l 365 (466)
T 1o6v_A 316 LYFNNISDISPVSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQI 365 (466)
T ss_dssp CCSSCCSCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCC
T ss_pred CcCCcCCCchhhccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCcc
Confidence 7777777766655667777777777777664 4444555666666666654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.18 E-value=1.9e-11 Score=108.69 Aligned_cols=105 Identities=16% Similarity=0.199 Sum_probs=90.6
Q ss_pred CCCCCcEEEccCCccc-cccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCE
Q 047954 44 DIPELIVINFKNNIIS-GNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKV 119 (582)
Q Consensus 44 ~l~~L~~l~l~~n~~~-g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~ 119 (582)
..++|+.|++++|.++ |.+|. +..+++|+.|+|++|.+++. ..++++++|++|+|++|.+++.+|.. .+++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 4578999999999999 88875 58899999999999999987 78999999999999999999988875 5899999
Q ss_pred EEeecCccccc-C-CCCCcccccccccccCCCC
Q 047954 120 FNVSNNNLSGS-I-PKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 120 l~ls~N~l~g~-i-p~~~~~~~~~~~~~~~n~~ 150 (582)
|++++|.+++. . +....++.+..+++++|..
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l 125 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGG
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcc
Confidence 99999999983 3 3335577788888988853
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.7e-11 Score=128.65 Aligned_cols=121 Identities=18% Similarity=0.152 Sum_probs=89.6
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
.+.++.|+|++|++++ +| ++.+++|+.|++++|.+++. .+..+++|+.|+|++|+|+| || ++.+++|++|+
T Consensus 169 l~~L~~L~ls~n~l~~-l~---l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~ 239 (457)
T 3bz5_A 169 QTQLTTLDCSFNKITE-LD---VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFD 239 (457)
T ss_dssp CTTCCEEECCSSCCCC-CC---CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEE
T ss_pred CCcCCEEECCCCccce-ec---cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEE
Confidence 4568888999998887 54 67788888888888888875 47778888888888888887 66 77888888888
Q ss_pred cccCcccCCCCCCCCC----------CCCEEEeecCcccccCCCCCcccccccccccCCCCC
Q 047954 100 LQNNNLTGPVPEFNQS----------SLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 100 l~~N~l~g~ip~~~~~----------~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l 151 (582)
|++|+|+|..+ ..++ +|+.|++++|.+.|.+|. ..+..+..+++++|..+
T Consensus 240 l~~N~l~~~~~-~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~-~~l~~L~~L~Ls~n~~l 299 (457)
T 3bz5_A 240 CSVNPLTELDV-STLSKLTTLHCIQTDLLEIDLTHNTQLIYFQA-EGCRKIKELDVTHNTQL 299 (457)
T ss_dssp CCSSCCSCCCC-TTCTTCCEEECTTCCCSCCCCTTCTTCCEEEC-TTCTTCCCCCCTTCTTC
T ss_pred eeCCcCCCcCH-HHCCCCCEEeccCCCCCEEECCCCccCCcccc-cccccCCEEECCCCccc
Confidence 88888887433 2222 455667777777777773 34566777777777643
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.18 E-value=3.7e-11 Score=128.03 Aligned_cols=125 Identities=24% Similarity=0.296 Sum_probs=108.4
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..+++.|+|++|++++. + .+..+++|+.|++++|.+++..+ +..+++|+.|+|++|.+++..| +..+++|+.|+
T Consensus 220 l~~L~~L~l~~n~l~~~-~--~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 293 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDI-G--TLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293 (466)
T ss_dssp CTTCCEEECCSSCCCCC-G--GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred cCCCCEEECCCCCcccc-h--hhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc--ccCCCccCeEE
Confidence 46789999999999873 3 47889999999999999998877 8889999999999999998655 88999999999
Q ss_pred cccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCCCC
Q 047954 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYL 151 (582)
Q Consensus 100 l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l 151 (582)
|++|++++..|-..+++|+.|+|++|++++..| ...+..+..+++++|...
T Consensus 294 L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~ 344 (466)
T 1o6v_A 294 LNENQLEDISPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVS 344 (466)
T ss_dssp CCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCC
T ss_pred cCCCcccCchhhcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccC
Confidence 999999987665688999999999999998776 456778888999988643
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.2e-10 Score=123.74 Aligned_cols=101 Identities=20% Similarity=0.253 Sum_probs=61.1
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
...++.|+|++|++++ +| ++.+++|+.|++++|.+++. +++.+++|+.|+|++|.+.|.+ .++.+++|+.|+
T Consensus 105 l~~L~~L~L~~N~l~~-l~---~~~l~~L~~L~l~~N~l~~l--~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ 176 (457)
T 3bz5_A 105 LTKLTYLNCDTNKLTK-LD---VSQNPLLTYLNCARNTLTEI--DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD 176 (457)
T ss_dssp CTTCCEEECCSSCCSC-CC---CTTCTTCCEEECTTSCCSCC--CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred CCcCCEEECCCCcCCe-ec---CCCCCcCCEEECCCCcccee--ccccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence 4567778888888776 43 67777777777777777773 2555566666666666555555 255555555555
Q ss_pred cccCcccCCCCCCCCCCCCEEEeecCcccc
Q 047954 100 LQNNNLTGPVPEFNQSSLKVFNVSNNNLSG 129 (582)
Q Consensus 100 l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g 129 (582)
|++|++++ +|-..+++|+.|++++|++++
T Consensus 177 ls~n~l~~-l~l~~l~~L~~L~l~~N~l~~ 205 (457)
T 3bz5_A 177 CSFNKITE-LDVSQNKLLNRLNCDTNNITK 205 (457)
T ss_dssp CCSSCCCC-CCCTTCTTCCEEECCSSCCSC
T ss_pred CCCCccce-eccccCCCCCEEECcCCcCCe
Confidence 55555555 443344444444444444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.16 E-value=2.7e-11 Score=111.10 Aligned_cols=104 Identities=21% Similarity=0.262 Sum_probs=91.6
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCC-CCCCCCCEEeCCCCcccccccc--cccCCCcCCe
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNF-SSNHKLKDIDLSGNKFYGEISR--SLLSLKFLES 97 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~-~~~~~l~~l~l~~N~l~g~ip~--~~~~l~~l~~ 97 (582)
++++.|+|++|++++. ..++.+++|++|+|++|.+++..+.+ ..+++|+.|+|++|.++ .+|. .+..+++|+.
T Consensus 42 ~~L~~L~Ls~N~l~~~---~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~ 117 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL---DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTY 117 (176)
T ss_dssp TCCSEEECCSSCCCEE---CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred CCCCEEECCCCCCCcc---cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCE
Confidence 3799999999999985 35899999999999999999876665 88999999999999994 6887 8999999999
Q ss_pred eecccCcccCCCCCC------CCCCCCEEEeecCcccc
Q 047954 98 LQLQNNNLTGPVPEF------NQSSLKVFNVSNNNLSG 129 (582)
Q Consensus 98 l~l~~N~l~g~ip~~------~~~~l~~l~ls~N~l~g 129 (582)
|+|++|.++ .+|.. .+++|+.||+++|....
T Consensus 118 L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 118 LCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp EECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred EEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 999999998 56652 67999999999998764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.1e-10 Score=118.59 Aligned_cols=124 Identities=21% Similarity=0.301 Sum_probs=107.2
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeeec
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l 100 (582)
++..+++++++++ .+|.. + .++|+.|+|++|.+++..| .+.++++|++|+|++|++++..|..++++++|++|+|
T Consensus 34 ~l~~l~~~~~~l~-~ip~~-~--~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKE-I--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp ETTEEECCSSCCS-SCCSC-C--CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred cCCEEECCCCCcc-ccCCC-C--CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 4678999999997 77764 3 3789999999999998877 6899999999999999999999999999999999999
Q ss_pred ccCcccCCCCCCCCCCCCEEEeecCcccccCCC-CCcccccccccccCCCC
Q 047954 101 QNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPK-TQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 101 ~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~-~~~~~~~~~~~~~~n~~ 150 (582)
++|+++ .+|....++|+.|++++|.+++..+. ...+..+..+++++|..
T Consensus 110 ~~n~l~-~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l 159 (332)
T 2ft3_A 110 SKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPL 159 (332)
T ss_dssp CSSCCC-SCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCC
T ss_pred CCCcCC-ccCccccccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcc
Confidence 999998 78876668999999999999865443 24577888889988865
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.14 E-value=7.9e-11 Score=120.29 Aligned_cols=104 Identities=18% Similarity=0.204 Sum_probs=88.3
Q ss_pred cEEEccCC-ccccccCCCCCCCCCCEEeCCC-CcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeec
Q 047954 49 IVINFKNN-IISGNFMNFSSNHKLKDIDLSG-NKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSN 124 (582)
Q Consensus 49 ~~l~l~~n-~~~g~~~~~~~~~~l~~l~l~~-N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~ 124 (582)
..+++++| .|++ ||.+..+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|.. .+++|+.|+|++
T Consensus 11 ~~v~~~~~n~l~~-ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 11 SGLRCTRDGALDS-LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp SCEECCSSCCCTT-TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CEEEcCCCCCCCc-cCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 35689998 8987 55588899999999996 9999998899999999999999999999988863 789999999999
Q ss_pred CcccccCCCCCcccccccccccCCCCCCC
Q 047954 125 NNLSGSIPKTQTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 125 N~l~g~ip~~~~~~~~~~~~~~~n~~l~~ 153 (582)
|+|++..|.......+..+.+.+|+..|.
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CccceeCHHHcccCCceEEEeeCCCccCC
Confidence 99997555443333388889999988775
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1.3e-10 Score=123.24 Aligned_cols=117 Identities=22% Similarity=0.360 Sum_probs=89.2
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeec
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l 100 (582)
++++.|+|++|+++| +|. .+++|+.|++++|.+++ +|.+. ++|++|+|++|++++ || +++++++|++|+|
T Consensus 91 ~~L~~L~l~~n~l~~-lp~----~~~~L~~L~l~~n~l~~-l~~~~--~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPE----LPQSLKSLLVDNNNLKA-LSDLP--PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp TTCSEEECCSSCCSS-CCC----CCTTCCEEECCSSCCSC-CCSCC--TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCc-ccc----ccCCCcEEECCCCccCc-ccCCC--CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 356677777777776 653 23677777887777776 22221 579999999999987 88 5899999999999
Q ss_pred ccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCCC
Q 047954 101 QNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 101 ~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~ 150 (582)
++|++++ +|.. ..+|+.|++++|.+++ +|....+..+..+++++|..
T Consensus 161 ~~N~l~~-lp~~-~~~L~~L~L~~n~l~~-l~~~~~l~~L~~L~l~~N~l 207 (454)
T 1jl5_A 161 DNNSLKK-LPDL-PPSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSL 207 (454)
T ss_dssp CSSCCSC-CCCC-CTTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCC
T ss_pred CCCcCcc-cCCC-cccccEEECcCCcCCc-CccccCCCCCCEEECCCCcC
Confidence 9999987 7754 4689999999999987 77666777888888888854
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.3e-10 Score=118.94 Aligned_cols=140 Identities=15% Similarity=0.101 Sum_probs=103.2
Q ss_pred CCcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC--CCCCCCCCE-EeC
Q 047954 9 SQWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN--FSSNHKLKD-IDL 76 (582)
Q Consensus 9 ~~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~--~~~~~~l~~-l~l 76 (582)
|+|..|.|+.+ ...++.|+|++|+++ .||+..|..|++|++|+|++|.+.+.+|. |.++++|.. +++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 68999999642 135788999999998 57777789999999999999999888863 677877764 677
Q ss_pred CCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC--Ccc-cccccccccCCC
Q 047954 77 SGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT--QTL-QLFRSYSYSNNP 149 (582)
Q Consensus 77 ~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~--~~~-~~~~~~~~~~n~ 149 (582)
++|++++..|..+.++++|++|++++|++++..+.. ....+..|++++|+--..+|.. ..+ ..+..+.+++|.
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~ 165 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccc
Confidence 789999888888999999999999999998655443 3455667787765544455543 111 234455666664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=2.3e-10 Score=111.55 Aligned_cols=132 Identities=15% Similarity=0.107 Sum_probs=97.3
Q ss_pred cccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCC--ccccceEEEeCCeeEEEEEeCCCCChHHH
Q 047954 277 GKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPN--LLPLLAYYFSNDEKLLVYKFAGNGNLFNR 354 (582)
Q Consensus 277 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 354 (582)
+.|..+.||++...++..+++|..... ....+..|+.+++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355669999998777788999997543 2245778999888885544 456888888878889999999998873
Q ss_pred HhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCC------------------------------------------
Q 047954 355 IHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS------------------------------------------ 392 (582)
Q Consensus 355 l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~------------------------------------------ 392 (582)
... . ....++.++++.|..||+...+
T Consensus 104 ~~~---------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 104 SSH---------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp TSC---------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cCc---------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 210 1 1235678888888988875310
Q ss_pred ---------CCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 393 ---------RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 393 ---------~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
.....++|+|++|.|||++++..+.|+|||.+.
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 011239999999999999877667799999864
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.2e-11 Score=128.28 Aligned_cols=129 Identities=20% Similarity=0.289 Sum_probs=84.0
Q ss_pred CeEEEEEeCCCcce-eccCc--cccCCCCCCcEEEccCCccc--c---ccC-CCCCCCCCCEEeCCCCccc----ccccc
Q 047954 21 AHVTGIVLEDMRLN-GEIKS--DAFADIPELIVINFKNNIIS--G---NFM-NFSSNHKLKDIDLSGNKFY----GEISR 87 (582)
Q Consensus 21 ~~~~~l~l~~~~l~-g~ip~--~~~~~l~~L~~l~l~~n~~~--g---~~~-~~~~~~~l~~l~l~~N~l~----g~ip~ 87 (582)
+++..|+|++|+++ +.+|. ..+..+++|+.|+|++|.++ | .++ .+..+++|+.|+|++|.++ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 45666677777665 44431 23456677777777777776 3 234 5666777777777777776 66777
Q ss_pred cccCCCcCCeeecccCcccCC----CCC----CCCCCCCEEEeecCcccc----cCCCCC--cccccccccccCCC
Q 047954 88 SLLSLKFLESLQLQNNNLTGP----VPE----FNQSSLKVFNVSNNNLSG----SIPKTQ--TLQLFRSYSYSNNP 149 (582)
Q Consensus 88 ~~~~l~~l~~l~l~~N~l~g~----ip~----~~~~~l~~l~ls~N~l~g----~ip~~~--~~~~~~~~~~~~n~ 149 (582)
.+..+++|+.|+|++|.+++. +|. ..+++|+.|+|++|.+++ .+|... .++.+..+++++|.
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence 777777777777777777765 443 236777777777777776 466432 24566666666664
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.7e-10 Score=117.74 Aligned_cols=124 Identities=21% Similarity=0.280 Sum_probs=107.8
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
...+..|+|++|++++.. + +..+++|+.|++++|.+++ ++.+..+++|+.|+|++|.+++. +.+..+++|+.|+
T Consensus 220 ~~~L~~L~l~~n~l~~~~-~--~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~ 293 (347)
T 4fmz_A 220 MTRLNSLKIGNNKITDLS-P--LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLF 293 (347)
T ss_dssp CTTCCEEECCSSCCCCCG-G--GTTCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred CCcCCEEEccCCccCCCc-c--hhcCCCCCEEECCCCccCC-ChhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEE
Confidence 467999999999998754 2 8899999999999999987 47788999999999999999975 4589999999999
Q ss_pred cccCcccCCCCCC--CCCCCCEEEeecCcccccCCCCCcccccccccccCCCC
Q 047954 100 LQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 100 l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~ 150 (582)
|++|.+++..|.. .+++|+.|+|++|.+++..| ...+..+..+++++|+.
T Consensus 294 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQVI 345 (347)
T ss_dssp CCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC--
T ss_pred CcCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhhcc
Confidence 9999999888773 78999999999999998777 55678888999998863
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.04 E-value=3.1e-11 Score=122.57 Aligned_cols=133 Identities=17% Similarity=0.250 Sum_probs=77.1
Q ss_pred CcceeeeCCCCCeEEEEEeCCCcceeccCccccCCC--CCCcEEEccCCccccccCCCCCCCCCCEEeCCCCccccc-cc
Q 047954 10 QWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADI--PELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGE-IS 86 (582)
Q Consensus 10 ~w~gv~c~~~~~~~~~l~l~~~~l~g~ip~~~~~~l--~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~-ip 86 (582)
.|.++.|+ ...+..|+|+++++.. ..+..+ +.|+.|++++|.+++.++.+..+++|+.|+|++|.+++. +|
T Consensus 38 ~W~~~~~~--~~~~~~l~l~~~~~~~----~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~ 111 (336)
T 2ast_B 38 RWYRLASD--ESLWQTLDLTGKNLHP----DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 111 (336)
T ss_dssp HHHHHHTC--STTSSEEECTTCBCCH----HHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHH
T ss_pred HHHHHhcC--chhheeeccccccCCH----HHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHH
Confidence 47777664 2345566666666552 223444 566666666666666666666666666666666666655 66
Q ss_pred ccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecC-ccccc-CCCC-CcccccccccccCC
Q 047954 87 RSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNN-NLSGS-IPKT-QTLQLFRSYSYSNN 148 (582)
Q Consensus 87 ~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N-~l~g~-ip~~-~~~~~~~~~~~~~n 148 (582)
..+..+++|++|+|++|.+++.+|.. .+++|+.|+|++| .+++. +|.. ..+..+..+++++|
T Consensus 112 ~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 178 (336)
T 2ast_B 112 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 178 (336)
T ss_dssp HHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred HHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCC
Confidence 66666666666666666666555542 4566666666666 45542 3331 23445555555555
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.04 E-value=3e-10 Score=124.66 Aligned_cols=126 Identities=17% Similarity=0.215 Sum_probs=92.9
Q ss_pred CCCCccee--------eeCCCCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCC
Q 047954 7 FPSQWYGI--------QCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSG 78 (582)
Q Consensus 7 ~~~~w~gv--------~c~~~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~ 78 (582)
.+|.|.|. .|. ...++.|++++|+|+ .||.. +. ++|+.|+|++|.|++ +|. .+++|++|+|++
T Consensus 20 ~~~~~~~r~~~~~~~~~c~--~~~l~~L~ls~n~L~-~lp~~-l~--~~L~~L~L~~N~l~~-lp~--~l~~L~~L~Ls~ 90 (622)
T 3g06_A 20 PAEESRGRAAVVQKMRACL--NNGNAVLNVGESGLT-TLPDC-LP--AHITTLVIPDNNLTS-LPA--LPPELRTLEVSG 90 (622)
T ss_dssp CGGGHHHHHHHHHHHHHHH--HHCCCEEECCSSCCS-CCCSC-CC--TTCSEEEECSCCCSC-CCC--CCTTCCEEEECS
T ss_pred CcchhccccccCccccccc--CCCCcEEEecCCCcC-ccChh-hC--CCCcEEEecCCCCCC-CCC--cCCCCCEEEcCC
Confidence 45677664 232 235888999999998 78764 33 789999999999884 555 567899999999
Q ss_pred CcccccccccccCCCcCCeeecccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCCC
Q 047954 79 NKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 79 N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~ 150 (582)
|+|+ .||. .+++|++|+|++|++++ +|. .+++|+.|+|++|++++ +|.. +..+..+++++|..
T Consensus 91 N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~-~l~~L~~L~L~~N~l~~-lp~~--l~~L~~L~Ls~N~l 153 (622)
T 3g06_A 91 NQLT-SLPV---LPPGLLELSIFSNPLTH-LPA-LPSGLCKLWIFGNQLTS-LPVL--PPGLQELSVSDNQL 153 (622)
T ss_dssp CCCS-CCCC---CCTTCCEEEECSCCCCC-CCC-CCTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCC
T ss_pred CcCC-cCCC---CCCCCCEEECcCCcCCC-CCC-CCCCcCEEECCCCCCCc-CCCC--CCCCCEEECcCCcC
Confidence 9988 4776 67888888888888886 555 56778888888888775 5543 35666777777743
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.03 E-value=1.8e-12 Score=121.39 Aligned_cols=108 Identities=18% Similarity=0.224 Sum_probs=93.0
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
...++.|+|++|++++ +| .+..+++|+.|+|++|.++ .+|. +..+++|+.|+|++|++++ +| .+.++++|++|
T Consensus 47 l~~L~~L~ls~n~l~~-l~--~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L 120 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVL 120 (198)
T ss_dssp TTTCSEEECSEEEESC-CC--CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEE
T ss_pred CCCCCEEECCCCCCcc-cc--ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEE
Confidence 3578999999999998 76 5889999999999999999 5664 4556899999999999997 66 69999999999
Q ss_pred ecccCcccCCCC--C-CCCCCCCEEEeecCcccccCCC
Q 047954 99 QLQNNNLTGPVP--E-FNQSSLKVFNVSNNNLSGSIPK 133 (582)
Q Consensus 99 ~l~~N~l~g~ip--~-~~~~~l~~l~ls~N~l~g~ip~ 133 (582)
+|++|++++.-+ . ..+++|+.|++++|.+++.+|.
T Consensus 121 ~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp EESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred ECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 999999986322 2 3789999999999999998876
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.02 E-value=6.3e-10 Score=122.09 Aligned_cols=52 Identities=35% Similarity=0.346 Sum_probs=29.4
Q ss_pred CcCCeeecccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCC
Q 047954 93 KFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNP 149 (582)
Q Consensus 93 ~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~ 149 (582)
++|+.|+|++|+|++ || ..+++|+.|+|++|+|+ .||. .+..+..+++++|.
T Consensus 221 ~~L~~L~Ls~N~L~~-lp-~~l~~L~~L~Ls~N~L~-~lp~--~~~~L~~L~Ls~N~ 272 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP-VLPSELKELMVSGNRLT-SLPM--LPSGLLSLSVYRNQ 272 (622)
T ss_dssp TTCCEEECCSSCCSC-CC-CCCTTCCEEECCSSCCS-CCCC--CCTTCCEEECCSSC
T ss_pred CCCCEEEccCCccCc-CC-CCCCcCcEEECCCCCCC-cCCc--ccccCcEEeCCCCC
Confidence 456666666666665 45 33456666666666665 3454 34455555555554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.01 E-value=2.4e-11 Score=123.37 Aligned_cols=140 Identities=14% Similarity=0.175 Sum_probs=114.8
Q ss_pred CCCcceeeeCCCC-----------CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccc-cC-CCCCCCCCCEE
Q 047954 8 PSQWYGIQCDINS-----------AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGN-FM-NFSSNHKLKDI 74 (582)
Q Consensus 8 ~~~w~gv~c~~~~-----------~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~-~~-~~~~~~~l~~l 74 (582)
|..|..+..+.+. ..+..|++++|.+++.++. +..+++|+.|+|++|.+++. ++ .+..+++|+.|
T Consensus 46 ~~~~~~l~l~~~~~~~~~~~~~~~~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 46 ESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp STTSSEEECTTCBCCHHHHHHHHHTTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred chhheeeccccccCCHHHHHhhhhccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4568877664321 6789999999999998764 56899999999999999986 65 46788999999
Q ss_pred eCCCCcccccccccccCCCcCCeeecccC-cccCC-CCCC--CCCCCCEEEeecC-ccccc-CCCC-Cccc-cccccccc
Q 047954 75 DLSGNKFYGEISRSLLSLKFLESLQLQNN-NLTGP-VPEF--NQSSLKVFNVSNN-NLSGS-IPKT-QTLQ-LFRSYSYS 146 (582)
Q Consensus 75 ~l~~N~l~g~ip~~~~~l~~l~~l~l~~N-~l~g~-ip~~--~~~~l~~l~ls~N-~l~g~-ip~~-~~~~-~~~~~~~~ 146 (582)
+|++|.+++.+|..++.+++|++|+|++| .+++. +|.. .+++|+.|+|++| .+++. +|.. ..++ .+..++++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999999999999999999999999999 78873 6653 6899999999999 99864 4432 3455 67777777
Q ss_pred CCC
Q 047954 147 NNP 149 (582)
Q Consensus 147 ~n~ 149 (582)
+|.
T Consensus 204 ~~~ 206 (336)
T 2ast_B 204 GYR 206 (336)
T ss_dssp SCG
T ss_pred CCc
Confidence 763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=8.9e-10 Score=113.05 Aligned_cols=145 Identities=15% Similarity=0.246 Sum_probs=104.8
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEec--CCCc-chHHHHHHHHHHHhcCC--CCCccccceEEEeC---CeeEEEEEe
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLR--DLKP-LITEEFRKQLLVIADQK--HPNLLPLLAYYFSN---DEKLLVYKF 345 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~-~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~e~ 345 (582)
+.|+.|.++.||+....+ ..+++|+.. .... .....+.+|+.+++.+. +..+.++++++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 468999999999998765 568888765 3221 12356788999998886 45678888888766 347999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCC--------------------------------
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR-------------------------------- 393 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-------------------------------- 393 (582)
+++..+.+.. ...++...+..++.++++.|..||+...+.
T Consensus 123 v~G~~l~~~~--------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 123 VSGRVLWDQS--------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CCCBCCCCTT--------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred cCCeecCCCc--------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9987774321 113667778889999999999999843211
Q ss_pred -------------------CCCcceecCCCCCCeeecCCCc--eEEeeccccccc
Q 047954 394 -------------------TQSAVIHGNLKSTNILLDDNEM--VLVSDYGFSSLV 427 (582)
Q Consensus 394 -------------------~~~~ivH~Dlkp~NILl~~~~~--~kl~DfG~a~~~ 427 (582)
....++|+|+++.|||++.++. +.|.||+.+..-
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 0256999999999999997753 689999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=6e-10 Score=111.55 Aligned_cols=184 Identities=17% Similarity=0.200 Sum_probs=120.0
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCC-CCC--ccccceEEEeCC---eeEEEEEeCC
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-HPN--LLPLLAYYFSND---EKLLVYKFAG 347 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~e~~~ 347 (582)
+.++.|.+..||+.. ..+++|..... .....+.+|.++++.+. +.. +.+++.+..... ..|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458999999999863 45888886432 34567889999998873 332 233443332222 3478999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCC-----------------------------------
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS----------------------------------- 392 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------------------------------- 392 (582)
|.+|.+.... .++..++..++.++++.|..||+...+
T Consensus 100 G~~l~~~~~~--------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 100 GVPLTPLLLN--------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CEECCHHHHH--------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred CeECCccccc--------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9888654321 256677788888999999998873210
Q ss_pred ----------------CCCCcceecCCCCCCeeecC--CCceEEeeccccccccCcccccccc----------------c
Q 047954 393 ----------------RTQSAVIHGNLKSTNILLDD--NEMVLVSDYGFSSLVAQPIAAQRMI----------------S 438 (582)
Q Consensus 393 ----------------~~~~~ivH~Dlkp~NILl~~--~~~~kl~DfG~a~~~~~~~~~~~~~----------------~ 438 (582)
...+.++|+|+++.||++++ ...+.|+||+.+..-.......... .
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 11246899999999999998 4567899999876533211100000 1
Q ss_pred c--cC-CCCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 047954 439 Y--KS-PEYQSSKKISRKSDVWSFGCLLLELLTGRIST 473 (582)
Q Consensus 439 y--~a-PE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~ 473 (582)
| .. |+... ......+.|++|.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 2 11 11110 1122368999999999999998765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.90 E-value=5.9e-11 Score=115.49 Aligned_cols=125 Identities=18% Similarity=0.246 Sum_probs=88.0
Q ss_pred CCCcceeeeCCCCCeEEEEEeCC---CcceeccCcccc-----------------------CCCCCCcE--EEccCCc--
Q 047954 8 PSQWYGIQCDINSAHVTGIVLED---MRLNGEIKSDAF-----------------------ADIPELIV--INFKNNI-- 57 (582)
Q Consensus 8 ~~~w~gv~c~~~~~~~~~l~l~~---~~l~g~ip~~~~-----------------------~~l~~L~~--l~l~~n~-- 57 (582)
.|.|.|+.|+.++-+|+.+...+ ..+.|.++++.+ ...+.|.. ++++.|.
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 46799999986666787777766 455566654432 12223333 4555552
Q ss_pred -cccccCCC-CCCCCCCEEeCCCCcccc--cccccccCCCcCCeeecccCcccCC--CCCC-CCCCCCEEEeecCccccc
Q 047954 58 -ISGNFMNF-SSNHKLKDIDLSGNKFYG--EISRSLLSLKFLESLQLQNNNLTGP--VPEF-NQSSLKVFNVSNNNLSGS 130 (582)
Q Consensus 58 -~~g~~~~~-~~~~~l~~l~l~~N~l~g--~ip~~~~~l~~l~~l~l~~N~l~g~--ip~~-~~~~l~~l~ls~N~l~g~ 130 (582)
+.+.+... .++++|+.|+||+|+|++ .||..+..+++|+.|+|++|+|++. +... .+ +|+.|+|++|.+++.
T Consensus 157 ~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~~ 235 (267)
T 3rw6_A 157 CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDT 235 (267)
T ss_dssp HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGGG
T ss_pred HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCccc
Confidence 22222211 356789999999999999 7888889999999999999999974 2222 23 899999999999998
Q ss_pred CCC
Q 047954 131 IPK 133 (582)
Q Consensus 131 ip~ 133 (582)
+|.
T Consensus 236 ~~~ 238 (267)
T 3rw6_A 236 FRD 238 (267)
T ss_dssp CSS
T ss_pred cCc
Confidence 884
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.89 E-value=1.9e-10 Score=119.35 Aligned_cols=130 Identities=23% Similarity=0.260 Sum_probs=99.3
Q ss_pred CCeEEEEEeCCCcceeccCc---cccCCCCCCcEEEccCC---ccccccCC--------CCCCCCCCEEeCCCCcccc--
Q 047954 20 SAHVTGIVLEDMRLNGEIKS---DAFADIPELIVINFKNN---IISGNFMN--------FSSNHKLKDIDLSGNKFYG-- 83 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~---~~~~~l~~L~~l~l~~n---~~~g~~~~--------~~~~~~l~~l~l~~N~l~g-- 83 (582)
.++++.|+|++|++++..+. ..+..+++|+.|+|++| +++|.+|. +..+++|++|+|++|.+++
T Consensus 31 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 110 (386)
T 2ca6_A 31 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 110 (386)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHH
Confidence 35689999999999876322 23678999999999984 66677653 3678899999999999998
Q ss_pred --cccccccCCCcCCeeecccCcccCCCCCC------CC---------CCCCEEEeecCccc-ccCCCC----Ccccccc
Q 047954 84 --EISRSLLSLKFLESLQLQNNNLTGPVPEF------NQ---------SSLKVFNVSNNNLS-GSIPKT----QTLQLFR 141 (582)
Q Consensus 84 --~ip~~~~~l~~l~~l~l~~N~l~g~ip~~------~~---------~~l~~l~ls~N~l~-g~ip~~----~~~~~~~ 141 (582)
.+|..+.++++|++|+|++|.+++..+.. .+ ++|+.|+|++|.++ +.+|.. ..+..+.
T Consensus 111 ~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~ 190 (386)
T 2ca6_A 111 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 190 (386)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCC
T ss_pred HHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcC
Confidence 68889999999999999999997544431 22 78999999999997 556531 2345677
Q ss_pred cccccCCC
Q 047954 142 SYSYSNNP 149 (582)
Q Consensus 142 ~~~~~~n~ 149 (582)
.+++++|.
T Consensus 191 ~L~L~~n~ 198 (386)
T 2ca6_A 191 TVKMVQNG 198 (386)
T ss_dssp EEECCSSC
T ss_pred EEECcCCC
Confidence 77888774
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.84 E-value=8.7e-10 Score=113.28 Aligned_cols=107 Identities=22% Similarity=0.251 Sum_probs=53.9
Q ss_pred EEEEEeCCCcceeccCc---cccCCCC-CCcEEEccCCccccccC-CCCCC-----CCCCEEeCCCCcccccccccccCC
Q 047954 23 VTGIVLEDMRLNGEIKS---DAFADIP-ELIVINFKNNIISGNFM-NFSSN-----HKLKDIDLSGNKFYGEISRSLLSL 92 (582)
Q Consensus 23 ~~~l~l~~~~l~g~ip~---~~~~~l~-~L~~l~l~~n~~~g~~~-~~~~~-----~~l~~l~l~~N~l~g~ip~~~~~l 92 (582)
++.|+|++|++++.-+. ..+..++ +|+.|+|++|.+++..+ .+..+ ++|+.|+|++|.+++..+..+..+
T Consensus 24 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 103 (362)
T 3goz_A 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103 (362)
T ss_dssp CCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred ceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHH
Confidence 55566666655543210 2344455 56666666665555432 12221 556666666666655555533332
Q ss_pred -----CcCCeeecccCcccCCCCCC------C-CCCCCEEEeecCcccc
Q 047954 93 -----KFLESLQLQNNNLTGPVPEF------N-QSSLKVFNVSNNNLSG 129 (582)
Q Consensus 93 -----~~l~~l~l~~N~l~g~ip~~------~-~~~l~~l~ls~N~l~g 129 (582)
++|++|+|++|.+++..+.. . .++|+.|+|++|.+++
T Consensus 104 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 152 (362)
T 3goz_A 104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGI 152 (362)
T ss_dssp HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGG
T ss_pred HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCH
Confidence 55666666666655443321 1 2356666666665553
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.78 E-value=9.4e-10 Score=113.04 Aligned_cols=125 Identities=15% Similarity=0.128 Sum_probs=97.4
Q ss_pred EEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-----CCCCCC-CCCEEeCCCCcccccccccccCC-----C
Q 047954 25 GIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-----NFSSNH-KLKDIDLSGNKFYGEISRSLLSL-----K 93 (582)
Q Consensus 25 ~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-----~~~~~~-~l~~l~l~~N~l~g~ip~~~~~l-----~ 93 (582)
.+.|+.|+++|.+| +.+...++|+.|+|++|.+++..+ .+..++ +|+.|+|++|.+++..+..+..+ +
T Consensus 2 ~~~ls~n~~~~~~~-~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPVE-EFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHHH-HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccccchHHHH-HHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 35788999999885 456667779999999999988764 355666 89999999999999888888775 8
Q ss_pred cCCeeecccCcccCCCCCC------CC-CCCCEEEeecCcccccCCCCC-----c-ccccccccccCCCC
Q 047954 94 FLESLQLQNNNLTGPVPEF------NQ-SSLKVFNVSNNNLSGSIPKTQ-----T-LQLFRSYSYSNNPY 150 (582)
Q Consensus 94 ~l~~l~l~~N~l~g~ip~~------~~-~~l~~l~ls~N~l~g~ip~~~-----~-~~~~~~~~~~~n~~ 150 (582)
+|++|+|++|.+++..+.. .+ ++|+.|+|++|.+++..+... . ...+..+++++|..
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l 150 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDL 150 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCG
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcC
Confidence 9999999999999877651 33 789999999999976554321 1 14677788888854
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.67 E-value=4.3e-08 Score=100.09 Aligned_cols=109 Identities=14% Similarity=0.056 Sum_probs=75.5
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcE-EEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCe
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIV-INFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLES 97 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~-l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~ 97 (582)
.++++.|+|++|++.+.||+..+.++++|.. +.++.|++++..|. +..+++|++|+|++|++++..+..+....++..
T Consensus 53 l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~ 132 (350)
T 4ay9_X 53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 132 (350)
T ss_dssp CTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEE
T ss_pred CCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhh
Confidence 4679999999999999999888889988775 66778999888774 688899999999999988766655555555555
Q ss_pred eecccCcccCCCCCC---CC-CCCCEEEeecCccc
Q 047954 98 LQLQNNNLTGPVPEF---NQ-SSLKVFNVSNNNLS 128 (582)
Q Consensus 98 l~l~~N~l~g~ip~~---~~-~~l~~l~ls~N~l~ 128 (582)
|++++|+--..+|.. .+ ..|+.|+|++|+++
T Consensus 133 l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp EEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred hhhccccccccccccchhhcchhhhhhcccccccc
Confidence 555443332333331 11 23444555555554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.60 E-value=3.5e-09 Score=112.21 Aligned_cols=129 Identities=19% Similarity=0.201 Sum_probs=72.8
Q ss_pred CeEEEEEeCCCcceec----cCccccCCCCCCcEEEccCCccccc----cC-CCCCCCCCCEEeCCCCcccccccccccC
Q 047954 21 AHVTGIVLEDMRLNGE----IKSDAFADIPELIVINFKNNIISGN----FM-NFSSNHKLKDIDLSGNKFYGEISRSLLS 91 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~----ip~~~~~~l~~L~~l~l~~n~~~g~----~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~ 91 (582)
.+++.|+|++|.+++. +.+.....+++|+.|+|++|.+++. ++ .+..+++|+.|+|++|.+++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 4577777777777653 2222233567777777777777764 33 2445666777777777666554444432
Q ss_pred C-----CcCCeeecccCcccCC----CCCC--CCCCCCEEEeecCcccccCCCCC------cccccccccccCCC
Q 047954 92 L-----KFLESLQLQNNNLTGP----VPEF--NQSSLKVFNVSNNNLSGSIPKTQ------TLQLFRSYSYSNNP 149 (582)
Q Consensus 92 l-----~~l~~l~l~~N~l~g~----ip~~--~~~~l~~l~ls~N~l~g~ip~~~------~~~~~~~~~~~~n~ 149 (582)
. ++|+.|+|++|.+++. +|.. .+++|+.|+|++|.+++..+... ....+..+++++|.
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence 2 4666677776666654 2322 34666666666666655432210 02345555565553
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.53 E-value=4.4e-09 Score=111.44 Aligned_cols=129 Identities=14% Similarity=0.182 Sum_probs=102.2
Q ss_pred CCeEEEEEeCCCcceec----cCccccCCCCCCcEEEccCCcccccc-----CC-CCCCCCCCEEeCCCCccccc----c
Q 047954 20 SAHVTGIVLEDMRLNGE----IKSDAFADIPELIVINFKNNIISGNF-----MN-FSSNHKLKDIDLSGNKFYGE----I 85 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~----ip~~~~~~l~~L~~l~l~~n~~~g~~-----~~-~~~~~~l~~l~l~~N~l~g~----i 85 (582)
..+++.|+|++|++++. ++ ..+..+++|+.|+|++|.+++.- +. +..+++|+.|+|++|.+++. +
T Consensus 198 ~~~L~~L~L~~n~l~~~~~~~l~-~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l 276 (461)
T 1z7x_W 198 PCQLEALKLESCGVTSDNCRDLC-GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL 276 (461)
T ss_dssp CCCCCEEECTTSCCBTTHHHHHH-HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHH
T ss_pred CCCceEEEccCCCCcHHHHHHHH-HHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHH
Confidence 35799999999999873 54 34778999999999999998752 22 33578999999999999986 8
Q ss_pred cccccCCCcCCeeecccCcccCCCCCC-------CCCCCCEEEeecCccccc----CCCC-CcccccccccccCCC
Q 047954 86 SRSLLSLKFLESLQLQNNNLTGPVPEF-------NQSSLKVFNVSNNNLSGS----IPKT-QTLQLFRSYSYSNNP 149 (582)
Q Consensus 86 p~~~~~l~~l~~l~l~~N~l~g~ip~~-------~~~~l~~l~ls~N~l~g~----ip~~-~~~~~~~~~~~~~n~ 149 (582)
|..+.++++|++|+|++|.+++.-+.. ..++|+.|+|++|.+++. +|.. ..+..+..+++++|.
T Consensus 277 ~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 352 (461)
T 1z7x_W 277 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNR 352 (461)
T ss_dssp HHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSB
T ss_pred HHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCc
Confidence 888999999999999999997654431 336999999999999875 3322 234677888888884
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.51 E-value=5.6e-09 Score=107.45 Aligned_cols=130 Identities=12% Similarity=0.127 Sum_probs=89.9
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-----C-CCCCCCCEEeCCCCcccc----ccccccc
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-----F-SSNHKLKDIDLSGNKFYG----EISRSLL 90 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-----~-~~~~~l~~l~l~~N~l~g----~ip~~~~ 90 (582)
..++.|+|++|+++..-.......+++|+.|+|++|.++..-.. + ..+.+|+.|+|++|.++. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 57889999999886543222233467888999999988765321 1 345789999999999875 4566667
Q ss_pred CCCcCCeeecccCcccCC----CCC--CCCCCCCEEEeecCccccc----CCCC-CcccccccccccCCCC
Q 047954 91 SLKFLESLQLQNNNLTGP----VPE--FNQSSLKVFNVSNNNLSGS----IPKT-QTLQLFRSYSYSNNPY 150 (582)
Q Consensus 91 ~l~~l~~l~l~~N~l~g~----ip~--~~~~~l~~l~ls~N~l~g~----ip~~-~~~~~~~~~~~~~n~~ 150 (582)
.+++|++|||++|.++.. ++. ...++|+.|+|++|.++.. ++.. .....+..+++++|..
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i 251 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCC
Confidence 888999999999998752 122 1456899999999998752 1111 1235677788888853
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.6e-06 Score=84.67 Aligned_cols=138 Identities=15% Similarity=0.188 Sum_probs=97.9
Q ss_pred cccccCce-EEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 275 GLGKGIFG-NSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 275 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+..|..+ .||+.... ++..+++|+-.. .....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455555 68987754 456788888643 24566888999888773 33367788999999999999999999888
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCC---------------------------------------
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS--------------------------------------- 392 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~--------------------------------------- 392 (582)
.+..... ......++.+++..|.-||....+
T Consensus 108 ~~~~~~~----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 108 FQVLEEY----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp HHHHHHC----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred cccccCC----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 7765321 223445667777777777764211
Q ss_pred ------------CCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 393 ------------RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 393 ------------~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
.....++|+|+.+.|||+++++.+-|.||+.+.
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 112347999999999999987767799998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.2e-06 Score=87.63 Aligned_cols=139 Identities=16% Similarity=0.138 Sum_probs=97.2
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCC---CccccceEEE-eCCeeEEEEEeCCCC
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHP---NLLPLLAYYF-SNDEKLLVYKFAGNG 349 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~~~g 349 (582)
+.++.|....||+. +..+++|.-. .......+..|.++|..+.+. .+.+.+.++. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888899988 4668888853 223456788999999998653 2456666664 345578999999998
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCC-------------------------------------
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS------------------------------------- 392 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~------------------------------------- 392 (582)
.+.+.... .++...+..++.++++.|..||+...+
T Consensus 99 ~l~~~~~~--------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 99 ILGEDGMA--------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp ECHHHHHT--------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred ECchhhhh--------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 88764321 234555666677777777777764310
Q ss_pred ----------------CCCCcceecCCCCCCeeecC---CCc-eEEeecccccc
Q 047954 393 ----------------RTQSAVIHGNLKSTNILLDD---NEM-VLVSDYGFSSL 426 (582)
Q Consensus 393 ----------------~~~~~ivH~Dlkp~NILl~~---~~~-~kl~DfG~a~~ 426 (582)
...+.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 02345799999999999997 455 47999997754
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.39 E-value=2e-07 Score=90.48 Aligned_cols=77 Identities=31% Similarity=0.438 Sum_probs=64.2
Q ss_pred CCCCCCcEEEccCCcccc--ccCC-CCCCCCCCEEeCCCCcccccccccccCCC--cCCeeecccCcccCCCCC------
Q 047954 43 ADIPELIVINFKNNIISG--NFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLK--FLESLQLQNNNLTGPVPE------ 111 (582)
Q Consensus 43 ~~l~~L~~l~l~~n~~~g--~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~--~l~~l~l~~N~l~g~ip~------ 111 (582)
.++++|+.|+|++|.|++ .+|. +..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 468999999999999999 5664 46789999999999999986 4455555 999999999999999984
Q ss_pred ---CCCCCCCEEE
Q 047954 112 ---FNQSSLKVFN 121 (582)
Q Consensus 112 ---~~~~~l~~l~ 121 (582)
..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 1567888776
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.33 E-value=9.4e-08 Score=98.29 Aligned_cols=110 Identities=17% Similarity=0.227 Sum_probs=84.3
Q ss_pred CeEEEEEeCCCcceeccCcc---cc-CCCCCCcEEEccCCccccc----cC-CCCCCCCCCEEeCCCCcccc----cccc
Q 047954 21 AHVTGIVLEDMRLNGEIKSD---AF-ADIPELIVINFKNNIISGN----FM-NFSSNHKLKDIDLSGNKFYG----EISR 87 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~---~~-~~l~~L~~l~l~~n~~~g~----~~-~~~~~~~l~~l~l~~N~l~g----~ip~ 87 (582)
.+++.|+|++|+++..-... .+ ...+.|+.|+|++|.++.. ++ .+..+++|++|||++|.++. .++.
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence 35899999999997542111 12 3568999999999999863 22 24567889999999999985 3567
Q ss_pred cccCCCcCCeeecccCcccCC----CCCC--CCCCCCEEEeecCccccc
Q 047954 88 SLLSLKFLESLQLQNNNLTGP----VPEF--NQSSLKVFNVSNNNLSGS 130 (582)
Q Consensus 88 ~~~~l~~l~~l~l~~N~l~g~----ip~~--~~~~l~~l~ls~N~l~g~ 130 (582)
.+..+++|+.|+|++|+++.. ++.. ..++|+.|||++|.++..
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 788889999999999999753 2221 457899999999998753
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.19 E-value=6.7e-08 Score=105.75 Aligned_cols=129 Identities=9% Similarity=-0.017 Sum_probs=80.6
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEcc----CCccccc-----cCC-CCCCCCCCEEeCCC--Cccccccccc
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFK----NNIISGN-----FMN-FSSNHKLKDIDLSG--NKFYGEISRS 88 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~----~n~~~g~-----~~~-~~~~~~l~~l~l~~--N~l~g~ip~~ 88 (582)
++++.|+|..|++++..+......+++|+.|+|+ .|.+++. ++. +.++++|+.|+|++ |.+++..+..
T Consensus 378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 4566666666666665543322236777777775 6666663 221 34567777777763 3467666666
Q ss_pred ccC-CCcCCeeecccCcccC-CCCC--CCCCCCCEEEeecCccccc-CCCC-CcccccccccccCCC
Q 047954 89 LLS-LKFLESLQLQNNNLTG-PVPE--FNQSSLKVFNVSNNNLSGS-IPKT-QTLQLFRSYSYSNNP 149 (582)
Q Consensus 89 ~~~-l~~l~~l~l~~N~l~g-~ip~--~~~~~l~~l~ls~N~l~g~-ip~~-~~~~~~~~~~~~~n~ 149 (582)
++. +++|+.|+|++|++++ .+|. ..+++|+.|+|++|.|++. ++.. ..++.+..+++++|.
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 654 7778888888888776 3343 2567788888888887654 2221 235566777777775
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.09 E-value=5.7e-07 Score=82.73 Aligned_cols=107 Identities=15% Similarity=0.206 Sum_probs=57.3
Q ss_pred CeEEEEEeCCC-cceec----cCccccCCCCCCcEEEccCCccccc----cC-CCCCCCCCCEEeCCCCccccc----cc
Q 047954 21 AHVTGIVLEDM-RLNGE----IKSDAFADIPELIVINFKNNIISGN----FM-NFSSNHKLKDIDLSGNKFYGE----IS 86 (582)
Q Consensus 21 ~~~~~l~l~~~-~l~g~----ip~~~~~~l~~L~~l~l~~n~~~g~----~~-~~~~~~~l~~l~l~~N~l~g~----ip 86 (582)
..++.|+|++| ++... + ...+...+.|++|+|++|.++.. +. .+..+++|+.|+|++|.++.. |.
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l-~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKAC-AEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHH-HHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHH-HHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 45666666666 55421 2 12244456666666666666542 11 133445566666666666543 44
Q ss_pred ccccCCCcCCeeec--ccCcccCCCC----CC--CCCCCCEEEeecCccc
Q 047954 87 RSLLSLKFLESLQL--QNNNLTGPVP----EF--NQSSLKVFNVSNNNLS 128 (582)
Q Consensus 87 ~~~~~l~~l~~l~l--~~N~l~g~ip----~~--~~~~l~~l~ls~N~l~ 128 (582)
..+...+.|++|+| ++|.++..-- .. ..++|+.|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 55555566666666 5566653211 10 2355666666666653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=4e-06 Score=85.51 Aligned_cols=79 Identities=9% Similarity=0.008 Sum_probs=53.1
Q ss_pred ccc-cccCceEEEEEEEc-------CCceEEEEEecCCC---cchHHHHHHHHHHHhcCCC---CCccccceEEEeC---
Q 047954 274 EGL-GKGIFGNSYKALLE-------GRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKH---PNLLPLLAYYFSN--- 336 (582)
Q Consensus 274 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H---~niv~l~~~~~~~--- 336 (582)
+.| +.|....+|+.... ++..+++|...... ......+..|+.+++.+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78889999998765 25678888764322 0012456778888777632 3566778777654
Q ss_pred CeeEEEEEeCCCCChH
Q 047954 337 DEKLLVYKFAGNGNLF 352 (582)
Q Consensus 337 ~~~~lv~e~~~~gsL~ 352 (582)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999987654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.92 E-value=4.2e-06 Score=91.42 Aligned_cols=101 Identities=10% Similarity=0.171 Sum_probs=68.9
Q ss_pred eEEEEEeCCCc-cee-ccCccccCCCCCCcEEEccCCccccc----cCC-CCCCCCCCEEeCCCCccc----cccccccc
Q 047954 22 HVTGIVLEDMR-LNG-EIKSDAFADIPELIVINFKNNIISGN----FMN-FSSNHKLKDIDLSGNKFY----GEISRSLL 90 (582)
Q Consensus 22 ~~~~l~l~~~~-l~g-~ip~~~~~~l~~L~~l~l~~n~~~g~----~~~-~~~~~~l~~l~l~~N~l~----g~ip~~~~ 90 (582)
+++.|+|+++. ++. .+ ......+++|++|+|++|.+++. ++. ..++++|+.|+|++|.++ +.++..+.
T Consensus 139 ~L~~L~L~~~~~~~~~~l-~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~ 217 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGL-LSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR 217 (592)
T ss_dssp GCCEEEEESCEEEEHHHH-HHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHH-HHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHh
Confidence 38888888776 221 12 12234678888888888887765 322 245677888888888887 56666677
Q ss_pred CCCcCCeeecccCcccCCCCCC--CCCCCCEEEeec
Q 047954 91 SLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSN 124 (582)
Q Consensus 91 ~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~ 124 (582)
++++|+.|+|++|.+++ +|.. .+++|+.|+++.
T Consensus 218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 78888888888888776 4442 556777777765
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.88 E-value=5.2e-07 Score=98.68 Aligned_cols=126 Identities=11% Similarity=0.098 Sum_probs=64.9
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEcc--C----Ccccccc-----CC-CCCCCCCCEEeCCCCcccccccccc
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFK--N----NIISGNF-----MN-FSSNHKLKDIDLSGNKFYGEISRSL 89 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~--~----n~~~g~~-----~~-~~~~~~l~~l~l~~N~l~g~ip~~~ 89 (582)
+++.|.+..|++++..+......+++|+.|+|+ + |.+++.. +. +.++++|+.|+|++ ++++..+..+
T Consensus 373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l 451 (594)
T 2p1m_B 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYI 451 (594)
T ss_dssp TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHH
T ss_pred hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHH
Confidence 455555555555544322222245666666666 2 4444211 11 33455666666655 5555555555
Q ss_pred cC-CCcCCeeecccCcccCCCCCC---CCCCCCEEEeecCcccccCCC-C-CcccccccccccCC
Q 047954 90 LS-LKFLESLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIPK-T-QTLQLFRSYSYSNN 148 (582)
Q Consensus 90 ~~-l~~l~~l~l~~N~l~g~ip~~---~~~~l~~l~ls~N~l~g~ip~-~-~~~~~~~~~~~~~n 148 (582)
+. +++|+.|+|++|.+++..+.. .+++|+.|+|++|.+++..+. . ..++.+..+++++|
T Consensus 452 ~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~ 516 (594)
T 2p1m_B 452 GTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSC 516 (594)
T ss_dssp HHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESS
T ss_pred HHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCC
Confidence 54 666777777766665543321 356667777777766443221 1 12445555555544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.85 E-value=8.2e-05 Score=73.26 Aligned_cols=74 Identities=19% Similarity=0.256 Sum_probs=54.2
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCC---CCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKH---PNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H---~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
+.+|.|..+.||+....+|+.|++|+-..........|..|...|+.+.- --+.+++++ +..++||||+.++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 56899999999999999999999998765444444568889988887732 223444443 23478999998765
Q ss_pred h
Q 047954 351 L 351 (582)
Q Consensus 351 L 351 (582)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=2.2e-05 Score=81.27 Aligned_cols=74 Identities=12% Similarity=0.171 Sum_probs=48.1
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCCc-------chHHHHHHHHHHHhcCCC--CCc-cccceEEEeCCeeEEE
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP-------LITEEFRKQLLVIADQKH--PNL-LPLLAYYFSNDEKLLV 342 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~H--~ni-v~l~~~~~~~~~~~lv 342 (582)
+.||.|.++.||++... ++..++||....... ...+.+..|.+++..+.. +.. .+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 56899999999999754 467899998643211 123456778888877632 333 345443 45567899
Q ss_pred EEeCCCC
Q 047954 343 YKFAGNG 349 (582)
Q Consensus 343 ~e~~~~g 349 (582)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00025 Score=71.29 Aligned_cols=143 Identities=17% Similarity=0.166 Sum_probs=78.2
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcC-----CCCCccccc-e--EEEeCCeeEEEEEe
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-----KHPNLLPLL-A--YYFSNDEKLLVYKF 345 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~-~--~~~~~~~~~lv~e~ 345 (582)
+.|+.|..+.||+....++. +++|+.... .+....|..++..+ ..|.++... | +....+..++||+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGA-VCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTEE-EEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCCC-EEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 34666778999999876654 889988642 23333444444433 234444311 1 22346678999999
Q ss_pred CCCCChH--------------HHHhcCCCC---C-C----CCccchHHH-------------------------------
Q 047954 346 AGNGNLF--------------NRIHGGKSS---K-N----RIPFRCRSR------------------------------- 372 (582)
Q Consensus 346 ~~~gsL~--------------~~l~~~~~~---~-~----~~~l~~~~~------------------------------- 372 (582)
++|..+. ..+|..... . . ...-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 122211100 0 0 000122110
Q ss_pred HHHHHHHHHHHHHHhc--------c--CCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 373 LLVARGVARALEYLHH--------K--DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 373 ~~i~~~ia~gL~yLH~--------~--~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
..+...+..++++|+. . . ...++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~----~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKK----SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHH----SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccc----cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111224456677763 0 1 2349999999999999888889999998653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0002 Score=71.29 Aligned_cols=74 Identities=16% Similarity=0.027 Sum_probs=58.3
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCC---CCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK---HPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
+.|+.|.+..+|+... ++..+++|..... ....+..|.+.|+.+. ...+.++++++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 4588999999999876 4567888886532 3567888988888773 3668888988888888999999999876
Q ss_pred h
Q 047954 351 L 351 (582)
Q Consensus 351 L 351 (582)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.71 E-value=3.9e-06 Score=91.66 Aligned_cols=83 Identities=18% Similarity=0.245 Sum_probs=46.4
Q ss_pred CCCCCcEEEccCCccccccCC-CC-CCCCCCEEeCCCC-ccccc-ccccccCCCcCCeeecccCcccCCCCCC------C
Q 047954 44 DIPELIVINFKNNIISGNFMN-FS-SNHKLKDIDLSGN-KFYGE-ISRSLLSLKFLESLQLQNNNLTGPVPEF------N 113 (582)
Q Consensus 44 ~l~~L~~l~l~~n~~~g~~~~-~~-~~~~l~~l~l~~N-~l~g~-ip~~~~~l~~l~~l~l~~N~l~g~ip~~------~ 113 (582)
.+++|+.|+|++|.+++..+. +. .+++|+.|+|++| .++.. ++..+.++++|++|+|++|.+++..+.. .
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 182 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence 456666666666666655432 22 3556666666666 34332 4444445666666666666665543321 3
Q ss_pred CCCCCEEEeecCc
Q 047954 114 QSSLKVFNVSNNN 126 (582)
Q Consensus 114 ~~~l~~l~ls~N~ 126 (582)
+++|+.|+|++|.
T Consensus 183 ~~~L~~L~l~~~~ 195 (594)
T 2p1m_B 183 YTSLVSLNISCLA 195 (594)
T ss_dssp CCCCCEEECTTCC
T ss_pred CCcCcEEEecccC
Confidence 4566666666665
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.64 E-value=1.2e-05 Score=82.10 Aligned_cols=124 Identities=12% Similarity=0.141 Sum_probs=85.0
Q ss_pred CCeEEEEEeCCCc-ceeccCccccCCCCCCcEEEccCCccccccC-CC--CCCCCCCEEeCCC--Cccccc--c---ccc
Q 047954 20 SAHVTGIVLEDMR-LNGEIKSDAFADIPELIVINFKNNIISGNFM-NF--SSNHKLKDIDLSG--NKFYGE--I---SRS 88 (582)
Q Consensus 20 ~~~~~~l~l~~~~-l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~--~~~~~l~~l~l~~--N~l~g~--i---p~~ 88 (582)
.+++..|.|++|. + .+++ +. +++|+.|+|..|.++.... .+ ..+++|+.|+|+. |...|. + -..
T Consensus 171 ~P~L~~L~L~g~~~l--~l~~--~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~ 245 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNL--SIGK--KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL 245 (362)
T ss_dssp CTTCCEEEEECCBTC--BCCS--CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGG
T ss_pred CCCCcEEEEeCCCCc--eecc--cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHH
Confidence 4679999998873 2 3443 33 8899999999888776542 22 3678899999863 333332 1 112
Q ss_pred c--cCCCcCCeeecccCcccCCCCC-----CCCCCCCEEEeecCccccc----CCCC-CcccccccccccCC
Q 047954 89 L--LSLKFLESLQLQNNNLTGPVPE-----FNQSSLKVFNVSNNNLSGS----IPKT-QTLQLFRSYSYSNN 148 (582)
Q Consensus 89 ~--~~l~~l~~l~l~~N~l~g~ip~-----~~~~~l~~l~ls~N~l~g~----ip~~-~~~~~~~~~~~~~n 148 (582)
+ ..+++|++|+|++|.+++..+. ..++.|+.|+||+|.+.+. ++.. ..+..+..+++++|
T Consensus 246 l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n 317 (362)
T 2ra8_A 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317 (362)
T ss_dssp SCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSB
T ss_pred HhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCC
Confidence 2 3578999999999998864432 2478899999999999863 4433 34566777777766
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.60 E-value=1.8e-05 Score=72.59 Aligned_cols=89 Identities=20% Similarity=0.279 Sum_probs=69.3
Q ss_pred ccCCCCCCcEEEccCC-ccccc----c-CCCCCCCCCCEEeCCCCccccc----ccccccCCCcCCeeecccCcccCC--
Q 047954 41 AFADIPELIVINFKNN-IISGN----F-MNFSSNHKLKDIDLSGNKFYGE----ISRSLLSLKFLESLQLQNNNLTGP-- 108 (582)
Q Consensus 41 ~~~~l~~L~~l~l~~n-~~~g~----~-~~~~~~~~l~~l~l~~N~l~g~----ip~~~~~l~~l~~l~l~~N~l~g~-- 108 (582)
.+...+.|+.|+|++| .++.. + ..+..+++|+.|+|++|.++.. |...+...+.|++|+|++|.++..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 4677899999999999 88754 2 2355678999999999999753 455666778999999999999753
Q ss_pred --CCCC--CCCCCCEEEe--ecCcccc
Q 047954 109 --VPEF--NQSSLKVFNV--SNNNLSG 129 (582)
Q Consensus 109 --ip~~--~~~~l~~l~l--s~N~l~g 129 (582)
|... ..++|+.|+| ++|.++.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCH
Confidence 2221 4578999999 8899864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.0002 Score=74.69 Aligned_cols=73 Identities=16% Similarity=0.223 Sum_probs=47.8
Q ss_pred cceecCCCCCCeeecCCCceEEeeccccccccCccccc-----ccccccCCCCCCCC---CCCcchhHHHHHHHHHHHHh
Q 047954 397 AVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ-----RMISYKSPEYQSSK---KISRKSDVWSFGCLLLELLT 468 (582)
Q Consensus 397 ~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~~~~-----~~~~y~aPE~~~~~---~~~~k~DVwS~Gvvl~ellt 468 (582)
.++|+|+++.|||++.++ ++|.||+.+..-....... -...|.+|+..... .-....++.+....+|+.++
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 311 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLFN 311 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHHH
Confidence 499999999999999776 9999999886543221111 11346666654321 11223556688888888877
Q ss_pred CC
Q 047954 469 GR 470 (582)
Q Consensus 469 G~ 470 (582)
++
T Consensus 312 ~~ 313 (420)
T 2pyw_A 312 KR 313 (420)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00017 Score=72.49 Aligned_cols=81 Identities=16% Similarity=0.204 Sum_probs=47.3
Q ss_pred CCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCC-eeecccCcccCCCCCC---CCCCCCE
Q 047954 45 IPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLE-SLQLQNNNLTGPVPEF---NQSSLKV 119 (582)
Q Consensus 45 l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~-~l~l~~N~l~g~ip~~---~~~~l~~ 119 (582)
+++|+.|+|++|+++...+ .|.++.+|+.|+|++| +.-.=+..|.+|++|+ .|+|.+ +++ .|+.. .+++|+.
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCE
Confidence 5666667776666653332 3566666777777666 4422233466666676 666666 443 34432 4566666
Q ss_pred EEeecCccc
Q 047954 120 FNVSNNNLS 128 (582)
Q Consensus 120 l~ls~N~l~ 128 (582)
+++++|+++
T Consensus 302 l~l~~n~i~ 310 (329)
T 3sb4_A 302 VLATGDKIT 310 (329)
T ss_dssp EEECSSCCC
T ss_pred EEeCCCccC
Confidence 666666664
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00033 Score=70.25 Aligned_cols=37 Identities=14% Similarity=0.388 Sum_probs=27.5
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccc
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIIS 59 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~ 59 (582)
..++.|+|++ +++ .|+...|..+++|+.|+|++|.++
T Consensus 101 ~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~ 137 (329)
T 3sb4_A 101 QTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAP 137 (329)
T ss_dssp TTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCC
T ss_pred CCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCcc
Confidence 4677888887 665 467777888888888888888753
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00028 Score=71.80 Aligned_cols=126 Identities=16% Similarity=0.226 Sum_probs=83.1
Q ss_pred CeEEEEEeCCCcc---------eeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCccccccccccc-
Q 047954 21 AHVTGIVLEDMRL---------NGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLL- 90 (582)
Q Consensus 21 ~~~~~l~l~~~~l---------~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~- 90 (582)
+++..|.+.++.+ .+.++ ..+..+++|+.|+|++|.- -.++.+ .+.+|+.|+|..|.++...-..+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~-~ll~~~P~L~~L~L~g~~~-l~l~~~-~~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLS-PVLDAMPLLNNLKIKGTNN-LSIGKK-PRPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCH-HHHHTCTTCCEEEEECCBT-CBCCSC-BCTTCSEEEEECSBCCHHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHH-HHHhcCCCCcEEEEeCCCC-ceeccc-cCCCCcEEEEecCCCChHHHHHHHH
Confidence 4677888866543 12342 3456789999999988731 134443 378999999998888766555555
Q ss_pred -CCCcCCeeeccc--CcccCC--C----C---CCCCCCCCEEEeecCcccccCCC----CCcccccccccccCCC
Q 047954 91 -SLKFLESLQLQN--NNLTGP--V----P---EFNQSSLKVFNVSNNNLSGSIPK----TQTLQLFRSYSYSNNP 149 (582)
Q Consensus 91 -~l~~l~~l~l~~--N~l~g~--i----p---~~~~~~l~~l~ls~N~l~g~ip~----~~~~~~~~~~~~~~n~ 149 (582)
++++|+.|+|+. |+..|. + + ...+++|+.|+|++|.+.+..+. ...++.+..++++.|.
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~ 290 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGV 290 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSC
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCC
Confidence 789999999864 332222 1 1 12468999999999998754321 1235667777776653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0017 Score=64.14 Aligned_cols=70 Identities=7% Similarity=0.085 Sum_probs=41.5
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCc-cccceEEEeCCeeEEEEEeC-CCCCh
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNL-LPLLAYYFSNDEKLLVYKFA-GNGNL 351 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~-~~gsL 351 (582)
+.|+.|....+|+. ..+++|+........ ....+|+.+++.+....+ .+++++ +.+.-++|+||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 45888999999998 558888875432111 112457766665532223 344443 444467899999 55444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0053 Score=61.19 Aligned_cols=148 Identities=14% Similarity=0.103 Sum_probs=80.3
Q ss_pred cccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCC--CCccccceE-----EEeCCeeEEEEEeCC
Q 047954 275 GLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKH--PNLLPLLAY-----YFSNDEKLLVYKFAG 347 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~-----~~~~~~~~lv~e~~~ 347 (582)
.++ |....||+....++..+++|...... ...+.+..|..++..+.. -.+.+++.. ....+..++||+|++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 77789999887777779999986322 234566677777766632 123444442 223456688999998
Q ss_pred CCChH-----H---------HHhcC---CCCCCCCccchHHH----HH---------------HHHHHHHHHHHHhccCC
Q 047954 348 NGNLF-----N---------RIHGG---KSSKNRIPFRCRSR----LL---------------VARGVARALEYLHHKDK 391 (582)
Q Consensus 348 ~gsL~-----~---------~l~~~---~~~~~~~~l~~~~~----~~---------------i~~~ia~gL~yLH~~~~ 391 (582)
|..+. . .+|.. ........+++... .. +...+...++.+...-.
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75431 1 12211 00000111221110 00 11111122333332110
Q ss_pred CCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 392 ~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
......++|+|+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 00124589999999999999 4 899999987643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0017 Score=67.73 Aligned_cols=72 Identities=8% Similarity=0.068 Sum_probs=47.5
Q ss_pred ccccccCceEEEEEEEcC--------CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCc-cccceEEEeCCeeEEEEE
Q 047954 274 EGLGKGIFGNSYKALLEG--------RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNL-LPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e 344 (582)
+.|+.|....||++...+ +..+++|+.... ...+.+..|..++..+...++ .++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 457788889999998753 467888887432 122456678888887743333 56666542 2 38999
Q ss_pred eCCCCCh
Q 047954 345 FAGNGNL 351 (582)
Q Consensus 345 ~~~~gsL 351 (582)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.005 Score=61.60 Aligned_cols=31 Identities=23% Similarity=0.295 Sum_probs=26.5
Q ss_pred CcceecCCCCCCeeecCC----CceEEeecccccc
Q 047954 396 SAVIHGNLKSTNILLDDN----EMVLVSDYGFSSL 426 (582)
Q Consensus 396 ~~ivH~Dlkp~NILl~~~----~~~kl~DfG~a~~ 426 (582)
..++|+|+.+.|||++.+ ..+.|.||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999875 6789999997754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.015 Score=57.61 Aligned_cols=149 Identities=13% Similarity=0.128 Sum_probs=79.3
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCC--ccccce------EEEeCCeeEEEEEe
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPN--LLPLLA------YYFSNDEKLLVYKF 345 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~------~~~~~~~~~lv~e~ 345 (582)
+.|+.|....+|+....++ .+++|...... ..+.+..|+.++..+.... +.+++. +....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3477788899999987766 58888876521 1234455666665552111 233332 12234567899999
Q ss_pred CCCCChHH--------------HHhcCCCC--CCC----CccchHHHHH------------HHHHHHHHHHHHhccCCCC
Q 047954 346 AGNGNLFN--------------RIHGGKSS--KNR----IPFRCRSRLL------------VARGVARALEYLHHKDKSR 393 (582)
Q Consensus 346 ~~~gsL~~--------------~l~~~~~~--~~~----~~l~~~~~~~------------i~~~ia~gL~yLH~~~~~~ 393 (582)
++|..+.. .+|..... ... ....|..... +...+...+++++...+..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98865311 12221100 000 0012222110 1112445566665432111
Q ss_pred CCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 394 ~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23468999999999999987656899998653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0046 Score=64.86 Aligned_cols=73 Identities=11% Similarity=0.077 Sum_probs=45.4
Q ss_pred ccccccCceEEEEEEEcC-CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCc-cccceEEEeCCeeEEEEEeCCCCCh
Q 047954 274 EGLGKGIFGNSYKALLEG-RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNL-LPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
+.|+.|-...+|++...+ +..+++|+......... .-..|..++..+...++ .++++++ .+ .+||||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 457888889999998765 46788887643221111 12478888887754444 4666665 22 359999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0061 Score=62.20 Aligned_cols=144 Identities=13% Similarity=0.152 Sum_probs=79.5
Q ss_pred ccccccCceEEEEEEEcC--------CceEEEEEecCCCcchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEE
Q 047954 274 EGLGKGIFGNSYKALLEG--------RAPVVVKRLRDLKPLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 344 (582)
+.|..|-...+|++...+ +..+++|+.... ........+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 456677788899988642 467888886332 123456678988887763 2223556665532 39999
Q ss_pred eCCCCChHH-----------------HHhcCCCCCCCCcc-chHHHHHHHHHHH-------------------HHHHHHh
Q 047954 345 FAGNGNLFN-----------------RIHGGKSSKNRIPF-RCRSRLLVARGVA-------------------RALEYLH 387 (582)
Q Consensus 345 ~~~~gsL~~-----------------~l~~~~~~~~~~~l-~~~~~~~i~~~ia-------------------~gL~yLH 387 (582)
|++|..|.. .+|.........+. -|.+..++..++. ..+.+|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999855431 12221111011111 2344444443331 1233332
Q ss_pred ----ccCCCCCCCcceecCCCCCCeeecCC----CceEEeeccccc
Q 047954 388 ----HKDKSRTQSAVIHGNLKSTNILLDDN----EMVLVSDYGFSS 425 (582)
Q Consensus 388 ----~~~~~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DfG~a~ 425 (582)
... ....++|+|+.+.|||++.+ +.+.++||..+.
T Consensus 211 ~~L~~~~---~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTP---SPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSC---CCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcC---CCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 222 23468999999999999876 689999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0035 Score=63.84 Aligned_cols=73 Identities=12% Similarity=0.064 Sum_probs=41.5
Q ss_pred ccccccCceEEEEEEEcC---------CceEEEEEecCCCcchHHHHHHHHHHHhcCCCCC-ccccceEEEeCCeeEEEE
Q 047954 274 EGLGKGIFGNSYKALLEG---------RAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPN-LLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~ 343 (582)
..|+.|....+|+....+ +..+++|+....... ......|..++..+.... +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 357788888999988654 256888876542211 112356777777663333 34566543 2 36899
Q ss_pred EeCCCCCh
Q 047954 344 KFAGNGNL 351 (582)
Q Consensus 344 e~~~~gsL 351 (582)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0044 Score=52.88 Aligned_cols=35 Identities=23% Similarity=0.227 Sum_probs=17.9
Q ss_pred CCEEeCCCCcccccccccccCCCcCCeeecccCcc
Q 047954 71 LKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNL 105 (582)
Q Consensus 71 l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l 105 (582)
|+.|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 55555555555533333345555555555555544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.018 Score=57.83 Aligned_cols=31 Identities=19% Similarity=0.446 Sum_probs=27.1
Q ss_pred CcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 396 SAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 396 ~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
..++|+|+.+.||++++++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.17 E-value=0.044 Score=50.55 Aligned_cols=102 Identities=10% Similarity=0.020 Sum_probs=65.9
Q ss_pred ChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 350 NLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 350 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
+|.+.|.... .++++.+++.++.|.+.+|.-+-.... -..+=+.|..|++..+|.+...+ ..+.
T Consensus 34 SL~eIL~~~~-----~PlsEEqaWALc~Qc~~~L~~~~~~~~------~~~~i~~~~~i~l~~dG~V~f~~-~~s~---- 97 (229)
T 2yle_A 34 SLEEILRLYN-----QPINEEQAWAVCYQCCGSLRAAARRRQ------PRHRVRSAAQIRVWRDGAVTLAP-AADD---- 97 (229)
T ss_dssp EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTTC------CCCCCCSGGGEEEETTSCEEECC-C-------
T ss_pred cHHHHHHHcC-----CCcCHHHHHHHHHHHHHHHHhhhhccc------CCceecCCcceEEecCCceeccc-cccc----
Confidence 7888887554 379999999999999999877622110 01223346889999999988764 2111
Q ss_pred cccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 047954 430 PIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRIS 472 (582)
Q Consensus 430 ~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P 472 (582)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1223467898764 3557888999999999999874433
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.87 E-value=0.0024 Score=58.54 Aligned_cols=84 Identities=17% Similarity=0.207 Sum_probs=56.9
Q ss_pred cCCCCCCcEEEccCC-ccccc----c-CCCCCCCCCCEEeCCCCccccc----ccccccCCCcCCeeecccCcccCCCCC
Q 047954 42 FADIPELIVINFKNN-IISGN----F-MNFSSNHKLKDIDLSGNKFYGE----ISRSLLSLKFLESLQLQNNNLTGPVPE 111 (582)
Q Consensus 42 ~~~l~~L~~l~l~~n-~~~g~----~-~~~~~~~~l~~l~l~~N~l~g~----ip~~~~~l~~l~~l~l~~N~l~g~ip~ 111 (582)
+.+-+.|+.|+|++| .+... + ..+..++.|+.|+|++|++... |-..+..-+.|+.|+|++|.++..==.
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 456678899999885 66532 1 2345678899999999998743 333444557899999999998742110
Q ss_pred ------CCCCCCCEEEeecC
Q 047954 112 ------FNQSSLKVFNVSNN 125 (582)
Q Consensus 112 ------~~~~~l~~l~ls~N 125 (582)
..-+.|+.|+|++|
T Consensus 117 ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHhhCCceeEEECCCC
Confidence 12356899999865
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.79 E-value=0.0031 Score=56.63 Aligned_cols=81 Identities=15% Similarity=0.137 Sum_probs=48.8
Q ss_pred CCCcEEEccCCccccc-cCCCCCCCCCCEEeCCCCc-ccccccccccCC----CcCCeeecccCc-ccC--CCCCCCCCC
Q 047954 46 PELIVINFKNNIISGN-FMNFSSNHKLKDIDLSGNK-FYGEISRSLLSL----KFLESLQLQNNN-LTG--PVPEFNQSS 116 (582)
Q Consensus 46 ~~L~~l~l~~n~~~g~-~~~~~~~~~l~~l~l~~N~-l~g~ip~~~~~l----~~l~~l~l~~N~-l~g--~ip~~~~~~ 116 (582)
-.|+.|||+++.++.. +..+.++++|+.|+|+++. ++..-=..++.+ ++|++|+|+++. +|. -..-..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 3577777777776543 3445677777777777774 554433445543 367777777764 542 111124677
Q ss_pred CCEEEeecCc
Q 047954 117 LKVFNVSNNN 126 (582)
Q Consensus 117 l~~l~ls~N~ 126 (582)
|+.|+|++..
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 7777777653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.61 E-value=0.0049 Score=55.34 Aligned_cols=85 Identities=12% Similarity=0.064 Sum_probs=62.8
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCc-cccc-cCCCCCC----CCCCEEeCCCCc-ccccccccccCCC
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNI-ISGN-FMNFSSN----HKLKDIDLSGNK-FYGEISRSLLSLK 93 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~-~~g~-~~~~~~~----~~l~~l~l~~N~-l~g~ip~~~~~l~ 93 (582)
-.++.|+|+++.++-.= -..+..+++|+.|+|+++. ++.. +..+..+ ++|+.|+|+++. +|..==..+.+++
T Consensus 61 ~~L~~LDLs~~~Itd~G-L~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIG-FDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCEEEEEEESCCCCGGG-GGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred ceEeEEeCcCCCccHHH-HHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 46999999999876321 1246789999999999985 6653 2234432 479999999974 7754334678899
Q ss_pred cCCeeecccCc-cc
Q 047954 94 FLESLQLQNNN-LT 106 (582)
Q Consensus 94 ~l~~l~l~~N~-l~ 106 (582)
+|+.|+|+++. +|
T Consensus 140 ~L~~L~L~~c~~It 153 (176)
T 3e4g_A 140 NLKYLFLSDLPGVK 153 (176)
T ss_dssp TCCEEEEESCTTCC
T ss_pred CCCEEECCCCCCCC
Confidence 99999999885 44
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.50 E-value=0.017 Score=49.09 Aligned_cols=52 Identities=19% Similarity=0.211 Sum_probs=28.4
Q ss_pred EEeCCCCccc-ccccccccCCCcCCeeecccCcccCCCCCC---CCCCCCEEEeecCcc
Q 047954 73 DIDLSGNKFY-GEISRSLLSLKFLESLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNL 127 (582)
Q Consensus 73 ~l~l~~N~l~-g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~---~~~~l~~l~ls~N~l 127 (582)
.++.++++|+ -.||..+. ++|+.|+|++|+|+. ||.. .+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTA-LPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSS-CCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCc-cChhhhhhccccCEEEecCCCe
Confidence 5666666665 45554432 246666666666663 4432 344555555555544
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=95.39 E-value=0.034 Score=57.16 Aligned_cols=120 Identities=12% Similarity=0.208 Sum_probs=75.7
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCcccccc-CCCCCCCCCCEEeCCCCccc----cccc-ccccCCC
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNF-MNFSSNHKLKDIDLSGNKFY----GEIS-RSLLSLK 93 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~-~~~~~~~~l~~l~l~~N~l~----g~ip-~~~~~l~ 93 (582)
...++.|.|.++ ++ .|+...+.+ .+|+.+.|.+ +++-.- -.|.++.+|+.|+|.+|.+. ..|+ ..|.+|+
T Consensus 225 ~~~L~~l~l~~~-l~-~I~~~aF~~-~~L~~i~lp~-~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~ 300 (401)
T 4fdw_A 225 TSQLKTIEIPEN-VS-TIGQEAFRE-SGITTVKLPN-GVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCP 300 (401)
T ss_dssp CTTCCCEECCTT-CC-EECTTTTTT-CCCSEEEEET-TCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCT
T ss_pred CCCCCEEecCCC-cc-Ccccccccc-CCccEEEeCC-CccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCc
Confidence 346777777764 32 455556666 7888888843 343222 24778888888888888775 1243 4577888
Q ss_pred cCCeeecccCcccCCCCCC---CCCCCCEEEeecCcccccCCCC--CcccccccccccCC
Q 047954 94 FLESLQLQNNNLTGPVPEF---NQSSLKVFNVSNNNLSGSIPKT--QTLQLFRSYSYSNN 148 (582)
Q Consensus 94 ~l~~l~l~~N~l~g~ip~~---~~~~l~~l~ls~N~l~g~ip~~--~~~~~~~~~~~~~n 148 (582)
+|+.++|.+ +++ .|+.. .+++|+.++|.+| ++ .|+.. ..+ .+..+.+.+|
T Consensus 301 ~L~~l~l~~-~i~-~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~aF~~~-~L~~l~l~~n 355 (401)
T 4fdw_A 301 KLARFEIPE-SIR-ILGQGLLGGNRKVTQLTIPAN-VT-QINFSAFNNT-GIKEVKVEGT 355 (401)
T ss_dssp TCCEECCCT-TCC-EECTTTTTTCCSCCEEEECTT-CC-EECTTSSSSS-CCCEEEECCS
T ss_pred cCCeEEeCC-ceE-EEhhhhhcCCCCccEEEECcc-cc-EEcHHhCCCC-CCCEEEEcCC
Confidence 888888884 454 55553 5678888888655 32 23322 223 5666666666
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=94.89 E-value=0.2 Score=51.42 Aligned_cols=66 Identities=15% Similarity=0.129 Sum_probs=30.1
Q ss_pred cCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccC
Q 047954 37 IKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNN 103 (582)
Q Consensus 37 ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N 103 (582)
|+...+..+++|+.++|++|.++-.......+.+|+.+.|..| +.-.=...|.+|++|+.|+|.+|
T Consensus 171 I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~ 236 (401)
T 4fdw_A 171 LKEDIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN 236 (401)
T ss_dssp ECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT
T ss_pred ehHHHhhCcccCCeeecCCCcceEechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC
Confidence 3333455555555555555554433322222345555555432 33112233455555555555543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=94.80 E-value=0.0098 Score=54.39 Aligned_cols=38 Identities=13% Similarity=0.183 Sum_probs=16.7
Q ss_pred CCCCcEEEccCCcccccc----C-CCCCCCCCCEEeCCCCccc
Q 047954 45 IPELIVINFKNNIISGNF----M-NFSSNHKLKDIDLSGNKFY 82 (582)
Q Consensus 45 l~~L~~l~l~~n~~~g~~----~-~~~~~~~l~~l~l~~N~l~ 82 (582)
-+.|+.|+|++|.++..- . .+..++.|+.|+|+.|+++
T Consensus 69 N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 69 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 344555555555544221 0 1223344555555555554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.71 E-value=0.039 Score=57.03 Aligned_cols=73 Identities=8% Similarity=0.043 Sum_probs=44.5
Q ss_pred ccccccCceEEEEEEEcC--------CceEEEEEecCCCcchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEE
Q 047954 274 EGLGKGIFGNSYKALLEG--------RAPVVVKRLRDLKPLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 344 (582)
+.+..|-...+|+....+ +..+++++........ -.-.+|..+++.+. +.-..++++.+ . -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 456677788899988763 4678888864432111 12346777776663 22234555533 2 378999
Q ss_pred eCCCCCh
Q 047954 345 FAGNGNL 351 (582)
Q Consensus 345 ~~~~gsL 351 (582)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.57 E-value=0.65 Score=47.45 Aligned_cols=29 Identities=28% Similarity=0.575 Sum_probs=24.0
Q ss_pred cceecCCCCCCeee------cCCCceEEeeccccc
Q 047954 397 AVIHGNLKSTNILL------DDNEMVLVSDYGFSS 425 (582)
Q Consensus 397 ~ivH~Dlkp~NILl------~~~~~~kl~DfG~a~ 425 (582)
.++|+|+.+.|||+ +++..+.++||-.|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 35799999999999 456679999998764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.64 E-value=0.9 Score=41.74 Aligned_cols=117 Identities=15% Similarity=0.197 Sum_probs=79.6
Q ss_pred CCCCCccccceEEEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCccee
Q 047954 321 QKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIH 400 (582)
Q Consensus 321 l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH 400 (582)
..||+.+.. .+-.+.+...+.|+.-+.+-=+..++ .++...+++++..|+....++++ -+|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---------~~~~~eKlr~l~ni~~l~~~~~~---------r~t 102 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---------SFTKNEKLRYLLNIKNLEEVNRT---------RYT 102 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---------GSCHHHHHHHHHHGGGGGGGGGS---------SEE
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---------hcCHHHHHHHHHHHHHHHHHhcC---------ceE
Confidence 378888876 56666666666666544322222232 36778899999999888866654 368
Q ss_pred cCCCCCCeeecCCCceEEeeccccccccCcccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 047954 401 GNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTH 474 (582)
Q Consensus 401 ~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~ 474 (582)
--|.|+||+++.++.+++.-.|+-..+ +|. ..+...=.-.+=+++..+++++..|+
T Consensus 103 f~L~P~NL~f~~~~~p~i~~RGik~~l-------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 103 FVLAPDELFFTRDGLPIAKTRGLQNVV-------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CCCSGGGEEECTTSCEEESCCEETTTB-------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEecceEEEcCCCCEEEEEccCccCC-------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 889999999999999999877764322 222 22222224467888999999998885
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=89.60 E-value=1.3 Score=44.96 Aligned_cols=79 Identities=18% Similarity=0.284 Sum_probs=36.5
Q ss_pred ccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCccccccc-ccccCCCcCCeeecccCcccCCCCCC---CCCC
Q 047954 41 AFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEIS-RSLLSLKFLESLQLQNNNLTGPVPEF---NQSS 116 (582)
Q Consensus 41 ~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip-~~~~~l~~l~~l~l~~N~l~g~ip~~---~~~~ 116 (582)
.+..++.|+.+.+.++..+=.--.|.++.+|+.+.+. +.++ .|+ ..|.+|++|+.++|..| ++ .|... .+++
T Consensus 260 aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~ 335 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQ 335 (394)
T ss_dssp TTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTT
T ss_pred eeeecccccEEecccccceecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCC
Confidence 3455566666666544332111234455556655554 2232 233 23455555666555533 22 23331 3455
Q ss_pred CCEEEee
Q 047954 117 LKVFNVS 123 (582)
Q Consensus 117 l~~l~ls 123 (582)
|+.+.|.
T Consensus 336 L~~i~ip 342 (394)
T 4gt6_A 336 LERIAIP 342 (394)
T ss_dssp CCEEEEC
T ss_pred CCEEEEC
Confidence 5555554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=88.63 E-value=0.93 Score=45.63 Aligned_cols=96 Identities=11% Similarity=0.187 Sum_probs=50.8
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCcccccc--CCCCCCCCCCEEeCCCCccccccc-ccccCCCcCCee
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNF--MNFSSNHKLKDIDLSGNKFYGEIS-RSLLSLKFLESL 98 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~--~~~~~~~~l~~l~l~~N~l~g~ip-~~~~~l~~l~~l 98 (582)
.+..+.+..+ +. .|+...+..++.|+.+.+..+ ++ .| -.+.++.+|+.+.+..+ +. .|+ ..+.+|++|+.+
T Consensus 218 ~l~~i~~~~~-~~-~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i 291 (379)
T 4h09_A 218 NLKKITITSG-VT-TLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKV 291 (379)
T ss_dssp SCSEEECCTT-CC-EECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEE
T ss_pred ccceeeeccc-ee-EEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ce-eccccccccccccccc
Confidence 3444554433 11 233344556677777776554 22 12 13455666777666543 32 233 345666777777
Q ss_pred ecccCcccCCCCCC---CCCCCCEEEeec
Q 047954 99 QLQNNNLTGPVPEF---NQSSLKVFNVSN 124 (582)
Q Consensus 99 ~l~~N~l~g~ip~~---~~~~l~~l~ls~ 124 (582)
.|.+|.++ .|+.. ++.+|+.++|..
T Consensus 292 ~l~~~~i~-~I~~~aF~~c~~L~~i~lp~ 319 (379)
T 4h09_A 292 VMDNSAIE-TLEPRVFMDCVKLSSVTLPT 319 (379)
T ss_dssp EECCTTCC-EECTTTTTTCTTCCEEECCT
T ss_pred cccccccc-eehhhhhcCCCCCCEEEcCc
Confidence 77666655 34442 456677666643
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.19 E-value=1.9 Score=39.68 Aligned_cols=114 Identities=15% Similarity=0.100 Sum_probs=78.1
Q ss_pred CCCCccccceEEEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHH-HHhccCCCCCCCccee
Q 047954 322 KHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALE-YLHHKDKSRTQSAVIH 400 (582)
Q Consensus 322 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~~~~~ivH 400 (582)
.||+. -..+-.+++...+.|+.-+++.=+..++ .++...+++++..|+.... ++++ -+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---------~~~~~eKlrll~nl~~L~~~~~~~---------r~t 107 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---------KTTLLSRIRAAIHLVSKVKHHSAR---------RLI 107 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---------TSCHHHHHHHHHHHHHHHSSCCSS---------SEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---------hcCHHHHHHHHHHHHHHHHHhhhC---------cee
Confidence 67777 3444466777777777664544444443 3677889999988887776 5554 467
Q ss_pred cCCCCCCeeecCCCceEEeeccccccccCcccccccccccCCCCCCCCCCCcchh-HHHHHHHHHHHHhCCCCCC
Q 047954 401 GNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQSSKKISRKSD-VWSFGCLLLELLTGRISTH 474 (582)
Q Consensus 401 ~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~k~D-VwS~Gvvl~elltG~~P~~ 474 (582)
--|.|+||++|.++.+++.-.|+-.. ++|.- .+ ..| .-.+=+++..++.++..|+
T Consensus 108 f~l~P~NL~f~~~~~p~i~hRGi~~~-------------lpP~e-----~~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 108 FIVCPENLMFNRALEPFFLHVGVKES-------------LPPDE-----WD-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CCCCGGGEEECTTCCEEESCCEETTT-------------BSSCS-----CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCceEEEeCCCcEEEEEcCCccc-------------CCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 78899999999999999987776432 33332 12 223 3367788888888887774
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=85.02 E-value=2.1 Score=43.39 Aligned_cols=74 Identities=19% Similarity=0.272 Sum_probs=31.1
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCccccccc-ccccCCCcCCeeec
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEIS-RSLLSLKFLESLQL 100 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip-~~~~~l~~l~~l~l 100 (582)
.+..+.+..+..+ |....+..++.|..+.+..+.+.. ..+..+.+|+.+.+..| +. .|+ ..+.+|++|+.++|
T Consensus 254 ~l~~~~~~~~~~~--i~~~~F~~~~~l~~~~~~~~~i~~--~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~l 327 (394)
T 4fs7_A 254 DLESISIQNNKLR--IGGSLFYNCSGLKKVIYGSVIVPE--KTFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDL 327 (394)
T ss_dssp SCCEEEECCTTCE--ECSCTTTTCTTCCEEEECSSEECT--TTTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECC
T ss_pred cceeEEcCCCcce--eeccccccccccceeccCceeecc--ccccccccccccccccc-cc-eechhhhcCCCCCCEEEe
Confidence 3444444443322 333334555555555554432110 12344445555555433 22 222 23444555555555
Q ss_pred c
Q 047954 101 Q 101 (582)
Q Consensus 101 ~ 101 (582)
.
T Consensus 328 p 328 (394)
T 4fs7_A 328 P 328 (394)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=80.62 E-value=6.3 Score=39.67 Aligned_cols=79 Identities=27% Similarity=0.422 Sum_probs=36.4
Q ss_pred ccCCCCCCcEEEccCCccccccC--CCCCCCCCCEEeCCCCccccccc-ccccCCCcCCeeecccCcccCCCCCC---CC
Q 047954 41 AFADIPELIVINFKNNIISGNFM--NFSSNHKLKDIDLSGNKFYGEIS-RSLLSLKFLESLQLQNNNLTGPVPEF---NQ 114 (582)
Q Consensus 41 ~~~~l~~L~~l~l~~n~~~g~~~--~~~~~~~l~~l~l~~N~l~g~ip-~~~~~l~~l~~l~l~~N~l~g~ip~~---~~ 114 (582)
.+.+++.|+.+.+.++ ++ .|+ .|.++.+|+.++|..| ++ .|. ..|.+|++|+.+.|..| ++ .|+.. ++
T Consensus 283 aF~~c~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C 356 (394)
T 4gt6_A 283 AFMNCPALQDIEFSSR-IT-ELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNC 356 (394)
T ss_dssp TTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTC
T ss_pred ccccccccccccCCCc-cc-ccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCC
Confidence 3445555555555322 21 122 2455555555555533 22 222 23455555555555433 32 34331 44
Q ss_pred CCCCEEEeecC
Q 047954 115 SSLKVFNVSNN 125 (582)
Q Consensus 115 ~~l~~l~ls~N 125 (582)
++|+.+++++|
T Consensus 357 ~~L~~i~~~~~ 367 (394)
T 4gt6_A 357 TALNNIEYSGS 367 (394)
T ss_dssp TTCCEEEESSC
T ss_pred CCCCEEEECCc
Confidence 55555555544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=80.01 E-value=2.6 Score=42.58 Aligned_cols=83 Identities=19% Similarity=0.224 Sum_probs=62.6
Q ss_pred cCccccCCCCCCcEEEccCCccccccC--CCCCCCCCCEEeCCCCccccccc-ccccCCCcCCeeecccCcccCCCCCC-
Q 047954 37 IKSDAFADIPELIVINFKNNIISGNFM--NFSSNHKLKDIDLSGNKFYGEIS-RSLLSLKFLESLQLQNNNLTGPVPEF- 112 (582)
Q Consensus 37 ip~~~~~~l~~L~~l~l~~n~~~g~~~--~~~~~~~l~~l~l~~N~l~g~ip-~~~~~l~~l~~l~l~~N~l~g~ip~~- 112 (582)
|+...+..+++|+.+.+.+| ++ .|+ .|.++.+|+.++|..+ ++ .|+ ..|.+|++|+.++|..| ++ .|+..
T Consensus 288 i~~~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~a 361 (394)
T 4fs7_A 288 VPEKTFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LR-KIGANA 361 (394)
T ss_dssp ECTTTTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTT
T ss_pred eccccccccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-cc-EehHHH
Confidence 55556778999999999765 32 333 4788899999999755 54 454 56889999999999877 54 56653
Q ss_pred --CCCCCCEEEeecC
Q 047954 113 --NQSSLKVFNVSNN 125 (582)
Q Consensus 113 --~~~~l~~l~ls~N 125 (582)
.+++|+.+++..|
T Consensus 362 F~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 362 FQGCINLKKVELPKR 376 (394)
T ss_dssp BTTCTTCCEEEEEGG
T ss_pred hhCCCCCCEEEECCC
Confidence 6789999998755
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 582 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-38 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-35 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-35 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-35 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-35 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-34 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-33 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-31 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-30 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-28 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-26 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-25 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-24 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-24 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-23 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-23 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-21 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-20 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-19 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-04 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-15 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.001 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 9e-47
Identities = 59/282 (20%), Positives = 126/282 (44%), Gaps = 35/282 (12%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
+G G FG YK G V + + P + F+ ++ V+ +H N+L + Y +
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 74
Query: 336 NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQ 395
+ +V ++ +L++ +H F + +AR A+ ++YLH K
Sbjct: 75 APQLAIVTQWCEGSSLYHHLH-----IIETKFEMIKLIDIARQTAQGMDYLHAKS----- 124
Query: 396 SAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM------ISYKSPEY---QS 446
+IH +LKS NI L ++ V + D+G +++ ++ + + I + +PE Q
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 447 SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506
S +SDV++FG +L EL+TG++ + + ++ V + +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548
S + + ++ +C K ++RP ++++ +E++
Sbjct: 236 S------NCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-45
Identities = 64/278 (23%), Positives = 111/278 (39%), Gaps = 33/278 (11%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
+GKG FG+ G V VK ++ + F + V+ +H NL+ LL
Sbjct: 15 IGKGEFGDVMLGDYRGN-KVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 336 NDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRT 394
L +V ++ G+L + + S+ R L + V A+EYL +
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---- 123
Query: 395 QSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI-AAQRMISYKSPEYQSSKKISRK 453
+H +L + N+L+ ++ + VSD+G + + + + + +PE KK S K
Sbjct: 124 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTK 180
Query: 454 SDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAA 513
SDVWSFG LL E+ + I D+ V + + + +
Sbjct: 181 SDVWSFGILLWEIYSFG---RVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA--------- 228
Query: 514 HGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551
+ +V C + RP ++ +LE IK E
Sbjct: 229 -----VYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-44
Identities = 63/282 (22%), Positives = 114/282 (40%), Gaps = 36/282 (12%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
LG G FG + G V VK L+ + + F + ++ +H L+ L A +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAV-VT 78
Query: 336 NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQ 395
+ ++ ++ NG+L + + + + I L +A +A + ++ ++
Sbjct: 79 QEPIYIITEYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMAFIEERN----- 129
Query: 396 SAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQSSKKI 450
IH +L++ NIL+ D ++D+G + L+ R I + +PE +
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 451 SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQR 510
+ KSDVWSFG LL E++T G+ ++ + R R +
Sbjct: 188 TIKSDVWSFGILLTEIVTHG---RIPYPGMTNPEVIQNLERGYRMVRPDNCPE------- 237
Query: 511 SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-IIKVTE 551
+L Q+ C + PE RP + S LE TE
Sbjct: 238 -------ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 6e-43
Identities = 62/282 (21%), Positives = 112/282 (39%), Gaps = 37/282 (13%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
+G G FG + + V +K +R+ + E+F ++ V+ HP L+ L
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 336 NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQ 395
LV++F +G L + + R F + L + V + YL
Sbjct: 72 QAPICLVFEFMEHGCLSDYLR-----TQRGLFAAETLLGMCLDVCEGMAYLEEAC----- 121
Query: 396 SAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQSSKKI 450
VIH +L + N L+ +N+++ VSD+G + V + + SPE S +
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 451 SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQR 510
S KSDVWSFG L+ E+ + + + +++ + R
Sbjct: 180 SSKSDVWSFGVLMWEVFSEG---KIPYENRSNSEVVEDISTGFRLYKPRLAST------- 229
Query: 511 SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552
+ Q+ C + PE RP + ++ +L ++ ES
Sbjct: 230 -------HVYQIMNHCWKERPEDRPAFSRLLRQLA--EIAES 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-42
Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 35/275 (12%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
LG+G FG + G V +K L+ + E F ++ V+ +H L+ L A S
Sbjct: 25 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VS 82
Query: 336 NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQ 395
+ +V ++ G+L + + G R+P +A +A + Y+ +
Sbjct: 83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD----MAAQIASGMAYVERMN----- 133
Query: 396 SAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQSSKKI 450
+H +L++ NIL+ +N + V+D+G + L+ R I + +PE +
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 451 SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQR 510
+ KSDVWSFG LL EL T G+ ++ V R R E +S
Sbjct: 192 TIKSDVWSFGILLTELTTKG---RVPYPGMVNREVLDQVERGYRMPCPPECPES------ 242
Query: 511 SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
L + QC K PE+RP + + LE
Sbjct: 243 --------LHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 4e-42
Identities = 46/299 (15%), Positives = 103/299 (34%), Gaps = 31/299 (10%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
+GKG FG ++ G V VK + + ++ +H N+L +A
Sbjct: 11 IGKGRFGEVWRGKWRGE-EVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 336 NDEKL----LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-D 390
++ LV + +G+LF+ ++ + + +A A L +LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG-------MIKLALSTASGLAHLHMEIV 121
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM--------ISYKSP 442
++ + A+ H +LKS NIL+ N ++D G + + Y +P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 443 EYQSSK------KISRKSDVWSFGCLLLELLTGRISTHSAPQG---INGADLCSWVLRAV 493
E + +++D+++ G + E+ + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552
R+ + I + + + + ++ +C + R + L + E
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-41
Identities = 63/305 (20%), Positives = 123/305 (40%), Gaps = 42/305 (13%)
Query: 263 FKLNDLLKAPAEGLGKGIFGNSYKALLEGR---APVVVKRLR-DLKPLITEEFRKQLLVI 318
K ++LL A E LG G FG+ + + R V +K L+ + TEE ++ ++
Sbjct: 5 LKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 63
Query: 319 ADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARG 378
+P ++ L+ + +LV + AG G L + G R + +
Sbjct: 64 HQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVG-----KREEIPVSNVAELLHQ 117
Query: 379 VARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-- 436
V+ ++YL K+ +H +L + N+LL + +SD+G S + +
Sbjct: 118 VSMGMKYLEEKN-------FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170
Query: 437 -----ISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLR 491
+ + +PE + +K S +SDVWS+G + E L+ + + G ++ +++ +
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG---QKPYKKMKGPEVMAFIEQ 227
Query: 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551
R E E +L + C E RP+ V + +
Sbjct: 228 GKRMECPPECPP--------------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
Query: 552 STEEE 556
+++ E
Sbjct: 274 ASKVE 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-41
Identities = 57/275 (20%), Positives = 111/275 (40%), Gaps = 35/275 (12%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS 335
LG G FG G+ V +K +++ + +EF ++ V+ + H L+ L
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 336 NDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQ 395
++ ++ NG L N + + R F+ + L + + V A+EYL K
Sbjct: 71 QRPIFIITEYMANGCLLNYLR-----EMRHRFQTQQLLEMCKDVCEAMEYLESKQ----- 120
Query: 396 SAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQSSKKI 450
+H +L + N L++D +V VSD+G S V + + + PE K
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 451 SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQR 510
S KSD+W+FG L+ E+ + + ++ + + +R +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLG---KMPYERFTNSETAEHIAQGLRLYRPHLASE------- 228
Query: 511 SAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
K+ + C ++ ++RP ++S +
Sbjct: 229 -------KVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (365), Expect = 8e-40
Identities = 78/289 (26%), Positives = 129/289 (44%), Gaps = 36/289 (12%)
Query: 276 LGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
LG G +G Y+ + + V VK L++ + EEF K+ V+ + KHPNL+ LL
Sbjct: 25 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRT 394
++ +F GNL + + NR L +A ++ A+EYL K+
Sbjct: 84 REPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAMEYLEKKN---- 135
Query: 395 QSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP-----IAAQRMISYKSPEYQSSKK 449
IH +L + N L+ +N +V V+D+G S L+ A+ I + +PE + K
Sbjct: 136 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 450 ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQ 509
S KSDVW+FG LL E+ T S GI+ + + + + R E +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYG---MSPYPGIDLSQVYELLEKDYRMERPEGCPE------ 243
Query: 510 RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-IIKVTESTEEEE 557
K+ ++ C +P RP AE+ E + + + ++E E
Sbjct: 244 --------KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 284
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-39
Identities = 64/298 (21%), Positives = 125/298 (41%), Gaps = 43/298 (14%)
Query: 276 LGKGIFGNSYKALLEG-----RAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPL 329
+G G FG YK +L+ PV +K L+ +F + ++ H N++ L
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
+++ ++ NG L + + F + + RG+A ++YL +
Sbjct: 75 EGVISKYKPMMIITEYMENGALDKFLR-----EKDGEFSVLQLVGMLRGIAAGMKYLANM 129
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-------YKSP 442
+ +H +L + NIL++ N + VSD+G S ++ A S + +P
Sbjct: 130 N-------YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 443 EYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502
E S +K + SDVWSFG ++ E++T ++ ++ + R +
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYG---ERPYWELSNHEVMKAINDGFRLPTPMDC- 238
Query: 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-IIKVTESTEEEEDF 559
+ Q+ +QC + +RP+ A++VS L+ +I+ +S + DF
Sbjct: 239 -------------PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 283
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 2e-39
Identities = 60/301 (19%), Positives = 118/301 (39%), Gaps = 55/301 (18%)
Query: 276 LGKGIFGNSYKALLEGRAP------VVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLP 328
+G+G FG ++A G P V VK L+ + + +F+++ ++A+ +PN++
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGK------------------SSKNRIPFRCR 370
LL L++++ G+L + SS P C
Sbjct: 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 140
Query: 371 SRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430
+L +AR VA + YL + +H +L + N L+ +N +V ++D+G S +
Sbjct: 141 EQLCIARQVAAGMAYLSERK-------FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 431 IAAQRM------ISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD 484
+ I + PE + + +SDVW++G +L E+ + + + G+ +
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY---YGMAHEE 250
Query: 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
+ +V L+L + C +K P RP + L
Sbjct: 251 VIYYVRDGNILACPENC--------------PLELYNLMRLCWSKLPADRPSFCSIHRIL 296
Query: 545 E 545
+
Sbjct: 297 Q 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-39
Identities = 61/309 (19%), Positives = 117/309 (37%), Gaps = 59/309 (19%)
Query: 249 DRNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALLEGR---APVVVKRLRD--L 303
DR L+ +ED++ LG G FG K + + V VK L++
Sbjct: 4 DRKLLTLEDKE----------------LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN 47
Query: 304 KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKN 363
P + +E + V+ +P ++ ++ + +LV + A G L + +
Sbjct: 48 DPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNR---- 102
Query: 364 RIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423
+ ++ + + V+ ++YL + +H +L + N+LL +SD+G
Sbjct: 103 --HVKDKNIIELVHQVSMGMKYLEESN-------FVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 424 SSLVAQPIAAQRM-------ISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSA 476
S + + + + +PE + K S KSDVWSFG L+ E +
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG---QKP 210
Query: 477 PQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE 536
+G+ G+++ + + + R A ++ + C E RP
Sbjct: 211 YRGMKGSEVTAMLEKGERMGCPAGCPR--------------EMYDLMNLCWTYDVENRPG 256
Query: 537 MAEVVSELE 545
A V L
Sbjct: 257 FAAVELRLR 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-39
Identities = 69/294 (23%), Positives = 117/294 (39%), Gaps = 43/294 (14%)
Query: 276 LGKGIFGNSYKALLEG----RAPVVVKRL-RDLKPLITEEFRKQLLVIADQKHPNLLPLL 330
+G+G FG Y L + VK L R +F + +++ D HPN+L LL
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 331 AYYFSNDEK-LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
++ L+V + +G+L N I + + VA+ +++L K
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFIR-----NETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS--------YKS 441
+H +L + N +LD+ V V+D+G + + + +
Sbjct: 150 K-------FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501
E ++K + KSDVWSFG LL EL+T +N D+ ++L+ R
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRG---APPYPDVNTFDITVYLLQGRRLLQPEYC 259
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEE 555
D L +V ++C + E RP +E+VS + I T E
Sbjct: 260 PD--------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 8e-39
Identities = 58/306 (18%), Positives = 120/306 (39%), Gaps = 50/306 (16%)
Query: 254 FIEDEQPAGFKLNDLLKAPAEGLGKGIFGNSYKALL----EGRAPVVVKRLR-DLKPLIT 308
F ++ + K+ ++ G G FG L + V +K L+
Sbjct: 19 FAKEIDISCVKIEQVI-------GAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR 71
Query: 309 EEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFR 368
+F + ++ HPN++ L + +++ +F NG+L + + +N F
Sbjct: 72 RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-----QNDGQFT 126
Query: 369 CRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428
+ + RG+A ++YL + +H +L + NIL++ N + VSD+G S +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN-------YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 429 QPIAAQRMIS---------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQG 479
+ S + +PE +K + SDVWS+G ++ E+++
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG---ERPYWD 236
Query: 480 INGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAE 539
+ D+ + + + R + L Q+ + C K RP+ +
Sbjct: 237 MTNQDVINAIEQDYRLPPPMDCPS--------------ALHQLMLDCWQKDRNHRPKFGQ 282
Query: 540 VVSELE 545
+V+ L+
Sbjct: 283 IVNTLD 288
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-38
Identities = 58/275 (21%), Positives = 99/275 (36%), Gaps = 31/275 (11%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
+G G +G K +V K L + + ++ ++ + KHPN++
Sbjct: 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71
Query: 333 YFSNDEKLL--VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
L V ++ G+L + I K +K R L V + AL+ H +
Sbjct: 72 IIDRTNTTLYIVMEYCEGGDLASVIT--KGTKERQYLDEEFVLRVMTQLTLALKECHRR- 128
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI----AAQRMISYKSPEYQS 446
S V+H +LK N+ LD + V + D+G + ++ A Y SPE +
Sbjct: 129 -SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN 187
Query: 447 SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506
+ KSD+WS GCLL EL + +L + D
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALM----PPFTAFSQKELAGKIREGKFRRIPYRYSDE-- 241
Query: 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVV 541
L ++ + N RP + E++
Sbjct: 242 ------------LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 69/323 (21%), Positives = 133/323 (41%), Gaps = 49/323 (15%)
Query: 276 LGKGIFGNSYKALLEG---RAPVVVKRLRDLK-PLITEEFRKQLLVIAD-QKHPNLLPLL 330
+G+G FG KA ++ R +KR+++ +F +L V+ HPN++ LL
Sbjct: 18 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 77
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRS----------RLLVARGVA 380
L ++A +GNL + + + + F + L A VA
Sbjct: 78 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 137
Query: 381 RALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM---I 437
R ++YL K IH +L + NIL+ +N + ++D+G S + +
Sbjct: 138 RGMDYLSQKQ-------FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 190
Query: 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497
+ + E + + SDVWS+G LL E+++ + G+ A+L + + R E
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG---GTPYCGMTCAELYEKLPQGYRLEK 247
Query: 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEE 557
D ++ + QC + P +RP A+++ L + EE
Sbjct: 248 PLNCDD--------------EVYDLMRQCWREKPYERPSFAQILVSLNRML------EER 287
Query: 558 DFWLDQSLTDESLSISTVASASE 580
+++ +L E + + + ++E
Sbjct: 288 KTYVNTTL-YEKFTYAGIDCSAE 309
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 56/294 (19%), Positives = 109/294 (37%), Gaps = 41/294 (13%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG G G +K + K + ++KP I + ++L V+ + P ++ +
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+S+ E + + G+L + + V+ V + L YL K K
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKHK-- 125
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM--ISYKSPEYQSSKKIS 451
++H ++K +NIL++ + + D+G S + +A + SY SPE S
Sbjct: 126 ----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 452 RKSDVWSFGCLLLELLTGRI----STHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507
+SD+WS G L+E+ GR + + G + T S
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 508 VQRSAAHGMLKLLQVAI---------------------QCCNKSPEKRPEMAEV 540
+ + +LL + +C K+P +R ++ ++
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 63/304 (20%), Positives = 115/304 (37%), Gaps = 50/304 (16%)
Query: 276 LGKGIFGNSYKALLEGRA------PVVVKRLR-DLKPLITEEFRKQLLVIAD-QKHPNLL 327
LG G FG +A G V VK L+ E +L V++ H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSS------------KNRIPFRCRSRLLV 375
LL L++ ++ G+L N + + S + + L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 376 ARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR 435
+ VA+ + +L K+ IH +L + NILL + + D+G + +
Sbjct: 151 SYQVAKGMAFLASKN-------CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 436 M------ISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWV 489
+ + +PE + + +SDVWS+G L EL + S + G + S
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP------GMPVDSKF 257
Query: 490 LRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549
+ ++E + + H ++ + C + P KRP ++V +E +
Sbjct: 258 YKMIKEGFRMLSPE----------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ-I 306
Query: 550 TEST 553
+EST
Sbjct: 307 SEST 310
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-35
Identities = 52/277 (18%), Positives = 110/277 (39%), Gaps = 38/277 (13%)
Query: 276 LGKGIFGNSYKALL-EGRAPVVVKRLRD--LKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
+G+G F YK L E V L+D L + F+++ ++ +HPN++
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 333 YFSNDEK----LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
+ S + +LV + +G L + K + + R + + L++LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHT 130
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVL-VSDYGFSSLVAQPIAAQRM--ISYKSPEYQ 445
+ +IH +LK NI + + + D G ++L A + + +PE
Sbjct: 131 RTP-----PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEM- 184
Query: 446 SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505
+K DV++FG +LE+ T + + N A + V V+ ++ E
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSE---YPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVS 542
+ ++ C ++ ++R + ++++
Sbjct: 242 -------------VKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 1e-35
Identities = 55/275 (20%), Positives = 102/275 (37%), Gaps = 38/275 (13%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
LG G FG YKA E K + E++ ++ ++A HPN++ LL ++
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRT 394
+ ++ +F G + + + P +V + AL YLH
Sbjct: 80 YENNLWILIEFCAGGAVDAVML-----ELERPLTESQIQVVCKQTLDALNYLHDNK---- 130
Query: 395 QSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR----MISYKSPEY-----Q 445
+IH +LK+ NIL + + ++D+G S+ + I + + +PE
Sbjct: 131 ---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 446 SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505
+ K+DVWS G L+E+ H + +L+ + E S
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHH-------ELNPMRVLLKIAKSEPPTLAQPSR 240
Query: 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
S +C K+ + R +++
Sbjct: 241 WSSN---------FKDFLKKCLEKNVDARWTTSQL 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 6e-35
Identities = 60/273 (21%), Positives = 105/273 (38%), Gaps = 38/273 (13%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLRD---LKPLITEEFRKQLLVIADQKHPNLLPLLA 331
LGKG FGN Y A + + + +K L K + + R+++ + + +HPN+L L
Sbjct: 14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
Y+ L+ ++A G ++ + F + +A AL Y H K
Sbjct: 74 YFHDATRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSKR- 126
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM--ISYKSPEYQSSKK 449
VIH ++K N+LL + ++D+G+S + Y PE +
Sbjct: 127 ------VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 450 ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQ 509
K D+WS G L E L G+ + + + R F ++
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRVEFT------FPDFVT-- 228
Query: 510 RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVS 542
G L+ + +P +RP + EV+
Sbjct: 229 ----EGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 7e-35
Identities = 54/301 (17%), Positives = 106/301 (35%), Gaps = 54/301 (17%)
Query: 276 LGKGIFGNSYKALLEG------RAPVVVKRLR-DLKPLITEEFRKQLLVIAD-QKHPNLL 327
LG G FG A G V VK L+ E +L ++ H N++
Sbjct: 45 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 104
Query: 328 PLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGK-----------------SSKNRIPFRCR 370
LL + L++++ G+L N + + ++
Sbjct: 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164
Query: 371 SRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430
L A VA+ +E+L K +H +L + N+L+ ++V + D+G + +
Sbjct: 165 DLLCFAYQVAKGMEFLEFKS-------CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 431 IAAQRMIS------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD 484
+ + +PE + KSDVWS+G LL E+ + ++ + G
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP------GIP 271
Query: 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSEL 544
+ + + ++ + + + + + + C KRP + S L
Sbjct: 272 VDANFYKLIQNGFKMDQ-PFYATEE---------IYIIMQSCWAFDSRKRPSFPNLTSFL 321
Query: 545 E 545
Sbjct: 322 G 322
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 7e-35
Identities = 55/285 (19%), Positives = 111/285 (38%), Gaps = 42/285 (14%)
Query: 276 LGKGIFGNSYKALL-----EGRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPL 329
LG G FG YK L + + PV +K LR+ P +E + V+A +P++ L
Sbjct: 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
L L+ + G L + + +++ + L +A+ + YL +
Sbjct: 77 L-GICLTSTVQLITQLMPFGCLLDYVR-----EHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM------ISYKSPE 443
++H +L + N+L+ + V ++D+G + L+ I + + E
Sbjct: 131 R-------LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503
+ + +SDVWS+G + EL+T GI +++ S + + R
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFG---SKPYDGIPASEISSILEKGERLPQPPICTI 240
Query: 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548
+ + ++C + RP+ E++ E +
Sbjct: 241 --------------DVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 7e-35
Identities = 62/272 (22%), Positives = 115/272 (42%), Gaps = 39/272 (14%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
+G+G G Y A+ + V ++++ + E ++LV+ + K+PN++ L Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRT 394
DE +V ++ G+L + + + +I V R +ALE+LH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQI-------AAVCRECLQALEFLHSNQ---- 136
Query: 395 QSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSPEYQSSKKI 450
VIH ++KS NILL + V ++D+GF + + + + + + +PE + K
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 451 SRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAVREEWTAEI-FDSEISV 508
K D+WS G + +E++ G P N L + T E+ ++S
Sbjct: 194 GPKVDIWSLGIMAIEMIEGE-----PPYLNENPLR----ALYLIATNGTPELQNPEKLS- 243
Query: 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
+ L +C + EKR E+
Sbjct: 244 --AIFRDFLN------RCLDMDVEKRGSAKEL 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (330), Expect = 1e-34
Identities = 53/274 (19%), Positives = 95/274 (34%), Gaps = 37/274 (13%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR---DLKPLITEEFRKQLLVIADQKHPNLLPLLA 331
+G G FG Y A + V +K++ ++ K++ + +HPN +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
Y LV ++ K P + V G + L YLH +
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHSHN- 135
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEY---QSSK 448
+IH ++K+ NILL + +V + D+G +S++A + + +PE
Sbjct: 136 ------MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEG 189
Query: 449 KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508
+ K DVWS G +EL + +N L + + + + S
Sbjct: 190 QYDGKVDVWSLGITCIELAERK----PPLFNMNAMS----ALYHIAQNESPALQSGHWSE 241
Query: 509 QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVS 542
C K P+ RP ++
Sbjct: 242 Y---------FRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 3e-34
Identities = 50/276 (18%), Positives = 98/276 (35%), Gaps = 38/276 (13%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG+G +G A V VK + E +K++ + H N++ +
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+ + L ++ G LF+RI I + + YLH
Sbjct: 73 REGNIQYLFLEYCSGGELFDRIE------PDIGMPEPDAQRFFHQLMAGVVYLHGIG--- 123
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM------ISYKSPEY-QS 446
+ H ++K N+LLD+ + + +SD+G +++ + + + Y +PE +
Sbjct: 124 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 447 SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506
+ + DVWS G +L +L G + +E+ T +I
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QEYSDWKEKKTYLNPWKKI 232
Query: 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVS 542
L LL + ++P R + ++
Sbjct: 233 D------SAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 7e-34
Identities = 55/305 (18%), Positives = 115/305 (37%), Gaps = 43/305 (14%)
Query: 276 LGKGIFGNSYKALLEGRA------PVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLP 328
LG+G FG Y+ + +G V +K + EF + V+ + +++
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIH----GGKSSKNRIPFRCRSRLLVARGVARALE 384
LL L++ + G+L + + ++ P + +A +A +
Sbjct: 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS------ 438
YL+ +H +L + N ++ ++ V + D+G + + + ++
Sbjct: 148 YLNANK-------FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 439 YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498
+ SPE + SDVWSFG +L E+ T QG++ + +V+ +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLA---EQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEED 558
D L ++ C +P+ RP E++S ++ + E E
Sbjct: 258 DNCPD--------------MLFELMRMCWQYNPKMRPSFLEIISSIK--EEMEPGFREVS 301
Query: 559 FWLDQ 563
F+ +
Sbjct: 302 FYYSE 306
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-33
Identities = 53/282 (18%), Positives = 111/282 (39%), Gaps = 40/282 (14%)
Query: 276 LGKGIFGNSYKALL----EGRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLL 330
+G+G FG+ ++ + V +K ++ + E+F ++ L + HP+++ L+
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
+ + ++ + G L + + + S +L A ++ AL YL K
Sbjct: 75 GV-ITENPVWIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESKR 128
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-----ISYKSPEYQ 445
+H ++ + N+L+ N+ V + D+G S + + I + +PE
Sbjct: 129 -------FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 446 SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505
+ ++ + SDVW FG + E+L QG+ D+ + R +
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHG---VKPFQGVKNNDVIGRIENGERLPMPPNCPPT- 237
Query: 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547
L + +C P +RP E+ ++L I
Sbjct: 238 -------------LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 3e-33
Identities = 62/284 (21%), Positives = 105/284 (36%), Gaps = 43/284 (15%)
Query: 276 LGKGIFGNSYKALLEGR----APVVVKRLRD---LKPLITEEFRKQLLVIADQKHPNLLP 328
LG G FG + + V VK L+ +P ++F +++ + H NL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
L +V + A G+L +R+ K++ F + A VA + YL
Sbjct: 76 LYGV-VLTPPMKMVTELAPLGSLLDRLR-----KHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-------ISYKS 441
K IH +L + N+LL ++V + D+G + Q M ++ +
Sbjct: 130 KR-------FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501
PE ++ S SD W FG L E+ T G+NG+ + + + E
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
+ + V +QC PE RP + L
Sbjct: 240 CPQD-------------IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 125 bits (315), Expect = 2e-32
Identities = 49/271 (18%), Positives = 94/271 (34%), Gaps = 33/271 (12%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
LG G FG ++ K + E RK++ ++ +HP L+ L +
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRT 394
++E +++Y+F G LF ++ + R V + L ++H +
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVA-----DEHNKMSEDEAVEYMRQVCKGLCHMHENN---- 144
Query: 395 QSAVIHGNLKSTNILL--DDNEMVLVSDYGFSSLVAQPIAAQ---RMISYKSPEYQSSKK 449
+H +LK NI+ + + + D+G ++ + + + + +PE K
Sbjct: 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 201
Query: 450 ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQ 509
+ +D+WS G L LL+G S G N + V D
Sbjct: 202 VGYYTDMWSVGVLSYILLSGL----SPFGGENDDETLRNVKSCDWN------MDDSAFSG 251
Query: 510 RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
S + P R + +
Sbjct: 252 ISED-----GKDFIRKLLLADPNTRMTIHQA 277
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-32
Identities = 63/302 (20%), Positives = 119/302 (39%), Gaps = 51/302 (16%)
Query: 276 LGKGIFGNSYKALLEGR--------APVVVKRLR-DLKPLITEEFRKQLLVIAD-QKHPN 325
LG+G FG A G V VK L+ D + ++ ++ KH N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 326 LLPLLAYYFSNDEKLLVYKFAGNGNLFNRIH----------GGKSSKNRIPFRCRSRLLV 375
++ LL + ++ ++A GNL + S + +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140
Query: 376 ARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR 435
A VAR +EYL K IH +L + N+L+ ++ ++ ++D+G + + ++
Sbjct: 141 AYQVARGMEYLASKK-------CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 436 MIS------YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWV 489
+ + +PE + + +SDVWSFG LL E+ T S G+ +L +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG---GSPYPGVPVEELFKLL 250
Query: 490 LRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE-IIK 548
R + + + +L + C + P +RP ++V +L+ I+
Sbjct: 251 KEGHRMDKPSNCTN--------------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
Query: 549 VT 550
+T
Sbjct: 297 LT 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 4e-31
Identities = 58/295 (19%), Positives = 108/295 (36%), Gaps = 48/295 (16%)
Query: 276 LGKGIFGNSYKALLEGRA------PVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLP 328
LG+G FG +A G V VK L+ +L ++ H +
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80
Query: 329 LLAYYFSNDEK--LLVYKFAGNGNLFNRIHGGKS----------SKNRIPFRCRSRLLVA 376
L + +++ +F GNL + ++ + + +
Sbjct: 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140
Query: 377 RGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM 436
VA+ +E+L + IH +L + NILL + +V + D+G + + + R
Sbjct: 141 FQVAKGMEFLASRK-------CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 437 ------ISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVL 490
+ + +PE + + +SDVWSFG LL E+ + S + G +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKIDEEFC 247
Query: 491 RAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545
R ++E D ++ Q + C + P +RP +E+V L
Sbjct: 248 RRLKEGTRMRAPDYTTP----------EMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 121 bits (305), Expect = 6e-31
Identities = 52/271 (19%), Positives = 99/271 (36%), Gaps = 33/271 (12%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
LG G FG ++ + V K + PL + ++ ++ HP L+ L +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRT 394
E +L+ +F G LF+RI + R L+++H
Sbjct: 97 DKYEMVLILEFLSGGELFDRIA-----AEDYKMSEAEVINYMRQACEGLKHMHEHS---- 147
Query: 395 QSAVIHGNLKSTNILLDDNE--MVLVSDYGFSSLVAQPIAAQRMI---SYKSPEYQSSKK 449
++H ++K NI+ + + V + D+G ++ + + + +PE +
Sbjct: 148 ---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 204
Query: 450 ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQ 509
+ +D+W+ G L LL+G S G + + V R E FD +
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGL----SPFAGEDDLETLQNVKRCDWE------FDEDAFSS 254
Query: 510 RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
S ++ K P KR + +
Sbjct: 255 VSPE--AKDFIK---NLLQKEPRKRLTVHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 3e-30
Identities = 48/271 (17%), Positives = 110/271 (40%), Gaps = 34/271 (12%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
LG+G FG ++ + + + K ++ +K +K++ ++ +H N+L L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 335 SNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRT 394
S +E +++++F ++F RI+ + R + V AL++LH +
Sbjct: 72 SMEELVMIFEFISGLDIFERIN-----TSAFELNEREIVSYVHQVCEALQFLHSHN---- 122
Query: 395 QSAVIHGNLKSTNILLD--DNEMVLVSDYGFSSLVAQPIAAQRMIS---YKSPEYQSSKK 449
+ H +++ NI+ + + + ++G + + + + + Y +PE
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 450 ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQ 509
+S +D+WS G L+ LL+G + + ++ A FD E +
Sbjct: 180 VSTATDMWSLGTLVYVLLSGI----NPFLAETNQQIIENIMNAEYT------FDEEAFKE 229
Query: 510 RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
S + + + K + R +E
Sbjct: 230 ISIE--AMDFVD---RLLVKERKSRMTASEA 255
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 3e-30
Identities = 56/283 (19%), Positives = 104/283 (36%), Gaps = 42/283 (14%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR---DLKPLITEEFRKQLLVIADQKHPNLLPLLA 331
LG+G F A L +K L +K ++ V++ HP + L
Sbjct: 16 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
+ +++ +A NG L I F + ALEYLH K
Sbjct: 76 TFQDDEKLYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGKG- 128
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS------YKSPEYQ 445
+IH +LK NILL+++ + ++D+G + +++ R S Y SPE
Sbjct: 129 ------IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 446 SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505
+ K + SD+W+ GC++ +L+ G + N + +++ + F +
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL----PPFRAGNEYLIFQKIIKLEYD------FPEK 232
Query: 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548
A +++ + KR E+ +
Sbjct: 233 FF---PKARDLVE------KLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 114 bits (286), Expect = 6e-29
Identities = 46/304 (15%), Positives = 99/304 (32%), Gaps = 45/304 (14%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
+G+G FG ++ L V +K + + R + +P + Y+
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 335 SNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
LV G G+ F ++ + A+ + ++ +H K
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLDLCGR------KFSVKTVAMAAKQMLARVQSIHEKS--- 121
Query: 394 TQSAVIHGNLKSTNILLDD-----NEMVLVSDYGFSSLVAQPIAAQRMIS---------- 438
+++ ++K N L+ M+ V D+G P+ Q +
Sbjct: 122 ----LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 439 -YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497
Y S ++ SR+ D+ + G + + L G + QG+ A R ++
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP----WQGLKAATNKQKYERIGEKKQ 233
Query: 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEE 557
+ + + + N + + P+ + + +T E+E
Sbjct: 234 STPLRELCAGFPEE-------FYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 286
Query: 558 DF-W 560
+F W
Sbjct: 287 NFDW 290
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 112 bits (281), Expect = 2e-28
Identities = 64/286 (22%), Positives = 104/286 (36%), Gaps = 44/286 (15%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR---DLKPLITEEFRKQLLVIADQKHPNLLPLLA 331
LG G + A L V VK LR P FR++ A HP ++ +
Sbjct: 15 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 74
Query: 332 YYFSNDEKL----LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
+ +V ++ L + +H P + + V +AL + H
Sbjct: 75 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSH 128
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM-------ISYK 440
+IH ++K NI++ V V D+G + +A + Y
Sbjct: 129 QNG-------IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 441 SPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAE 500
SPE + +SDV+S GC+L E+LTG G + + +R
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGE----PPFTGDSPVSVAYQHVREDP------ 231
Query: 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE-MAEVVSELE 545
I S SA L V ++ K+PE R + AE+ ++L
Sbjct: 232 IPPSARHEGLSAD-----LDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (281), Expect = 3e-28
Identities = 46/302 (15%), Positives = 96/302 (31%), Gaps = 43/302 (14%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
+G G FG+ Y + V +K + + + + +P + +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 335 SNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+ + +V + G + F ++ LL+A + +EY+H K+
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSR------KFSLKTVLLLADQMISRIEYIHSKN--- 123
Query: 394 TQSAVIHGNLKSTNILLDDNEM---VLVSDYGFSSLVAQPIAAQRM-----------ISY 439
IH ++K N L+ + V + D+G + Q + Y
Sbjct: 124 ----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 440 KSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTA 499
S + SR+ D+ S G +L+ G QG+ A R ++ +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGS----LPWQGLKAATKRQKYERISEKKMST 235
Query: 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTEEEEDF 559
I A + C + + +P+ + + + + + F
Sbjct: 236 PIEVLCKGYPSEFATYLNF-------CRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288
Query: 560 -W 560
W
Sbjct: 289 DW 290
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (280), Expect = 5e-28
Identities = 64/273 (23%), Positives = 100/273 (36%), Gaps = 36/273 (13%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR-DLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
LG G F A + V +K + ++ V+ KHPN++ L Y
Sbjct: 17 LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 76
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
S L+ + G LF+RI + + R + V A++YLH
Sbjct: 77 ESGGHLYLIMQLVSGGELFDRI------VEKGFYTERDASRLIFQVLDAVKYLHDLG--- 127
Query: 394 TQSAVIHGNLKSTNILL---DDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKSPEYQSS 447
++H +LK N+L D++ +++SD+G S + Y +PE +
Sbjct: 128 ----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 183
Query: 448 KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507
K S+ D WS G + LL G + N A L +L+A E FDS
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFY----DENDAKLFEQILKAEYE------FDSPYW 233
Query: 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
S + K PEKR +
Sbjct: 234 DDISDS-----AKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 109 bits (273), Expect = 2e-27
Identities = 50/285 (17%), Positives = 96/285 (33%), Gaps = 48/285 (16%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR-----DLKPLITEEFRKQLLVIAD-----QKHP 324
LG+G+ + + VK + +E R+ L D HP
Sbjct: 11 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70
Query: 325 NLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALE 384
N++ L Y +N LV+ G LF+ + ++ + + R + +
Sbjct: 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLT------EKVTLSEKETRKIMRALLEVIC 124
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS------ 438
LH + ++H +LK NILLDD+ + ++D+GFS + + +
Sbjct: 125 ALHKLN-------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 177
Query: 439 ---YKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE 495
+ + ++ D+WS G ++ LL G + ++ +
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS----PPFWHRKQMLMLRMIMSGNYQ 233
Query: 496 EWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
F S S + + + P+KR E
Sbjct: 234 ------FGSPEWDDYSDT-----VKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-26
Identities = 50/283 (17%), Positives = 104/283 (36%), Gaps = 25/283 (8%)
Query: 276 LGKGIFGNSYKA--LLEGRAPVVVKRLR-----DLKPLITEEFRKQLLVIADQKHPNLLP 328
+G+G +G +KA L G V +KR+R + PL T L + +HPN++
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
L + ++ + + + + R L++LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKSPEYQ 445
V+H +LK NIL+ + + ++D+G + + + +A ++ Y++PE
Sbjct: 135 HR-------VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 187
Query: 446 SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505
+ D+WS GC+ E+ + + + + E+W ++
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 506 ISVQRSAAHGMLKL--------LQVAIQCCNKSPEKRPEMAEV 540
+ +A + K + ++C +P KR
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-26
Identities = 57/273 (20%), Positives = 103/273 (37%), Gaps = 41/273 (15%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLRDLKPLITEEFRKQL----LVIADQKHPNLLPLL 330
LGKG FG + A + +K L+ L+ ++ + ++ +HP L +
Sbjct: 10 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
+ + + V ++ G+L I + F A + L++LH K
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHIQ------SCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSPEYQS 446
+++ +LK NILLD + + ++D+G A Y +PE
Sbjct: 124 -------IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 176
Query: 447 SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506
+K + D WSFG LL E+L G+ S G + +L + + +
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQ----SPFHGQDEEELFHSIRMDNPF------YPRWL 226
Query: 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAE 539
+ A ++KL + PEKR +
Sbjct: 227 E--KEAKDLLVKLFV-------REPEKRLGVRG 250
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 9e-26
Identities = 52/277 (18%), Positives = 100/277 (36%), Gaps = 39/277 (14%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITE-EFRKQLLVIADQKHPNLLPLLAYY 333
LG GI G + + +K L+D E E + + P+++ ++ Y
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRAS-----QCPHIVRIVDVY 74
Query: 334 ---FSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
++ + L +V + G LF+RI + F R + + + A++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 390 DKSRTQSAVIHGNLKSTNILLD---DNEMVLVSDYGFSSLVA---QPIAAQRMISYKSPE 443
+ + H ++K N+L N ++ ++D+GF+ Y +PE
Sbjct: 131 N-------IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 183
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503
+K + D+WS G ++ LL G +G + + +R
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGY----PPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
V + LL+ P +R + E
Sbjct: 240 EWSEVSEEVKMLIRNLLK-------TEPTQRMTITEF 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (263), Expect = 1e-25
Identities = 58/269 (21%), Positives = 100/269 (37%), Gaps = 37/269 (13%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLRD---LKPLITEEFRKQLLVIADQKHPNLLPLLA 331
LG G FG + +K L+ ++ E + L+++ HP ++ +
Sbjct: 12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71
Query: 332 YYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
+ + ++ + G LF+ + F A V ALEYLH KD
Sbjct: 72 TFQDAQQIFMIMDYIEGGELFSLLR------KSQRFPNPVAKFYAAEVCLALEYLHSKD- 124
Query: 392 SRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI-AAQRMISYKSPEYQSSKKI 450
+I+ +LK NILLD N + ++D+GF+ V Y +PE S+K
Sbjct: 125 ------IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPY 178
Query: 451 SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQR 510
++ D WSFG L+ E+L G + N +L A F +
Sbjct: 179 NKSIDWWSFGILIYEMLAGY----TPFYDSNTMKTYEKILNAELR------FPPFFN--E 226
Query: 511 SAAHGMLKLLQVAIQCCNKSPEKRPEMAE 539
+ +L+ + +R +
Sbjct: 227 DVKDLLSRLIT-------RDLSQRLGNLQ 248
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 5e-25
Identities = 55/285 (19%), Positives = 99/285 (34%), Gaps = 33/285 (11%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLR-----DLKPLITEEFRKQLLVIADQKHPNLLPL 329
LG+G F YKA V +K+++ + K I +++ ++ + HPN++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 330 LAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
L + LV+ F N + + LEYLH
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKD------NSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSPE-Y 444
++H +LK N+LLD+N ++ ++D+G + P A Y++PE
Sbjct: 120 W-------ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 172
Query: 445 QSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504
++ D+W+ GC+L ELL + + E+W
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 505 EISVQRSAAHGMLKLLQVAI---------QCCNKSPEKRPEMAEV 540
+ +S L + A +P R +
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 104 bits (260), Expect = 5e-25
Identities = 49/270 (18%), Positives = 94/270 (34%), Gaps = 39/270 (14%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLRDLKPLITE------EFRKQLLVIADQKHPNLLP 328
+G+G FG Y + +K L + + + R L +++ P ++
Sbjct: 12 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 71
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
+ + + D+ + G+L + F A + LE++H+
Sbjct: 72 MSYAFHTPDKLSFILDLMNGGDLHYHLS------QHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA--QPIAAQRMISYKSPEY-Q 445
+ V++ +LK NILLD++ V +SD G + + +P A+ Y +PE Q
Sbjct: 126 RF-------VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ 178
Query: 446 SSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505
+D +S GC+L +LL G + + +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK---------TKDKHEIDRMTLTMAVELP 229
Query: 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRP 535
S + LLQ + +R
Sbjct: 230 DSFSPELRSLLEGLLQ-------RDVNRRL 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 100 bits (249), Expect = 4e-24
Identities = 45/286 (15%), Positives = 100/286 (34%), Gaps = 38/286 (13%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLLAYY 333
+G+G +G YKA +K++R I +++ ++ + KH N++ L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 334 FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR 393
+ +LV++ + + + Y H +
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLD------VCEGGLESVTAKSFLLQLLNGIAYCHDRR--- 120
Query: 394 TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR----MISYKSPE-YQSSK 448
V+H +LK N+L++ + ++D+G + P+ + Y++P+ SK
Sbjct: 121 ----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 449 KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISV 508
K S D+WS GC+ E++ G G++ AD + R + + +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT----PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 509 QRSAAHGMLK--------------LLQVAIQCCNKSPEKRPEMAEV 540
+ + + + + + P +R +
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.6 bits (247), Expect = 8e-24
Identities = 48/289 (16%), Positives = 99/289 (34%), Gaps = 42/289 (14%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
+G+G +G YKA V +K++R + +++ ++ + HPN++ LL
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
+ ++ LV++F + + L + H
Sbjct: 70 IHTENKLYLVFEFLHQDLKKFMDA-----SALTGIPLPLIKSYLFQLLQGLAFCHSHR-- 122
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR----MISYKSPE-YQSS 447
V+H +LK N+L++ + ++D+G + P+ + Y++PE
Sbjct: 123 -----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 448 KKISRKSDVWSFGCLLLELLTGRI----------------STHSAPQGINGADLCSWVLR 491
K S D+WS GC+ E++T R + + + + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 492 AVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
+W + F + +L Q + P KR
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLS------QMLHYDPNKRISAKAA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.4 bits (247), Expect = 1e-23
Identities = 48/279 (17%), Positives = 103/279 (36%), Gaps = 42/279 (15%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR------DLKPLITEEFRKQLLVIADQKHPNLLP 328
LG G F K K ++ + + E+ +++ ++ + +HPN++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 329 LLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
L Y + + +L+ + G LF+ + + + + + YLH
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLA------EKESLTEEEATEFLKQILNGVYYLHS 131
Query: 389 KDKSRTQSAVIHGNLKSTNILLDDNEM----VLVSDYGFSSLVAQPIAAQRMI---SYKS 441
+ H +LK NI+L D + + + D+G + + + + + +
Sbjct: 132 LQ-------IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501
PE + + + ++D+WS G + LL+G G + + V E
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGAS----PFLGDTKQETLANVSAVNYE------ 234
Query: 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
F+ E SA ++ + K P+KR + +
Sbjct: 235 FEDEYFSNTSAL--AKDFIR---RLLVKDPKKRMTIQDS 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 5e-23
Identities = 56/292 (19%), Positives = 103/292 (35%), Gaps = 46/292 (15%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
+G G FG Y+A L + V +K++ K ++L ++ H N++ L +++
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 335 SNDEK------LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH 388
S+ EK LV + H S+ + L + R+L Y+H
Sbjct: 84 SSGEKKDEVYLNLVLDYVPETVYRVARHY---SRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 389 KDKSRTQSAVIHGNLKSTNILLD-DNEMVLVSDYGFSSLVAQPIAAQRMIS---YKSP-E 443
+ H ++K N+LLD D ++ + D+G + + + I Y++P
Sbjct: 141 FG-------ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 444 YQSSKKISRKSDVWSFGCLLLELLTGR---------------ISTHSAPQGINGADLCSW 488
+ + DVWS GC+L ELL G+ I P ++
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 489 VLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
+ A + + + L + +P R E
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPE--AIALCS---RLLEYTPTARLTPLEA 300
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.3 bits (239), Expect = 9e-23
Identities = 52/278 (18%), Positives = 92/278 (33%), Gaps = 50/278 (17%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRK--------QLLVIADQKHPNL 326
LG G FG+ Y + + PV +K + + E LL +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 327 LPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386
+ LL ++ D +L+ + R + V A+ +
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLEAVRHC 126
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEM-VLVSDYGFSSLVAQPIAAQRMIS--YKSPE 443
H+ V+H ++K NIL+D N + + D+G +L+ + + Y PE
Sbjct: 127 HNCG-------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 179
Query: 444 Y-QSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502
+ + + R + VWS G LL +++ G I + I G F
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV----------------FF 223
Query: 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
+S + + C P RP E+
Sbjct: 224 RQRVSSE---------CQHLIRWCLALRPSDRPTFEEI 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 5e-22
Identities = 48/291 (16%), Positives = 111/291 (38%), Gaps = 40/291 (13%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYY 333
+G+G +G A + V +K++ + + +++ ++ +H N++ +
Sbjct: 16 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 75
Query: 334 ----FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK 389
+ + + +L+ + S + I + + R L+Y+H
Sbjct: 76 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHSA 128
Query: 390 DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-------YKSP 442
+ V+H +LK +N+LL+ + + D+G + + ++ Y++P
Sbjct: 129 N-------VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 443 EY-QSSKKISRKSDVWSFGCLLLELLTGRI------------STHSAPQGINGADLCSWV 489
E +SK ++ D+WS GC+L E+L+ R + DL +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 490 LRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEV 540
R + +++ R + K L + + +P KR E+ +
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.9 bits (232), Expect = 7e-22
Identities = 48/284 (16%), Positives = 93/284 (32%), Gaps = 32/284 (11%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
+G+G +G +KA E V +KR+R D + +++ ++ + KH N++ L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKS 392
S+ + LV++F I + + L + H ++
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI------VKSFLFQLLKGLGFCHSRN-- 121
Query: 393 RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS-----YKSPEYQSS 447
V+H +LK N+L++ N + ++++G + P+ +
Sbjct: 122 -----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 448 KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507
K S D+WS GC+ EL + +L EE +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 508 VQRSAAHGMLKLLQVAI-----------QCCNKSPEKRPEMAEV 540
L+ V +P +R E
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.1 bits (233), Expect = 2e-21
Identities = 60/319 (18%), Positives = 103/319 (32%), Gaps = 51/319 (15%)
Query: 224 ESGDDEEEEEEKIGKGKRKLVVAGED--RNLVFIEDEQPAGFKLNDLLKAPAEGLGKGIF 281
+ G ++E +E + K K + E +N ++ F L G G F
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQ-----FDRIKTL-------GTGSF 54
Query: 282 GNSYKAL-LEGRAPVVVKRLR---DLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND 337
G E +K L +K E + ++ P L+ L + N
Sbjct: 55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 338 EKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSA 397
+V ++ G +F+ + F A + EYLH D
Sbjct: 115 NLYMVMEYVAGGEMFSHLR------RIGRFSEPHARFYAAQIVLTFEYLHSLD------- 161
Query: 398 VIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQR-MISYKSPEYQSSKKISRKSDV 456
+I+ +LK N+L+D + V+D+GF+ V +PE SK ++ D
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDW 221
Query: 457 WSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGM 516
W+ G L+ E+ G + ++ F S S S +
Sbjct: 222 WALGVLIYEMAAGY----PPFFADQPIQIYEKIVSGKVR------FPSHFS---SDLKDL 268
Query: 517 LKLLQVAIQCCNKSPEKRP 535
L+ KR
Sbjct: 269 LR------NLLQVDLTKRF 281
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (225), Expect = 1e-20
Identities = 56/273 (20%), Positives = 96/273 (35%), Gaps = 42/273 (15%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLLPLL 330
LGKG FG +K LR + +I ++ + V+ + +HP L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
+ ++D V ++A G LF + F + ALEYLH +D
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLS------RERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI----SYKSPEYQS 446
V++ ++K N++LD + + ++D+G A + Y +PE
Sbjct: 126 -------VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 447 SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506
R D W G ++ E++ GR + L +L F +
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR----LPFYNQDHERLFELILMEEIR------FPRTL 228
Query: 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAE 539
S A +L K P++R
Sbjct: 229 S---PEAKSLLA------GLLKKDPKQRLGGGP 252
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 1e-20
Identities = 63/281 (22%), Positives = 100/281 (35%), Gaps = 46/281 (16%)
Query: 276 LGKGIFGNSYKALL----EGRAPVVVKRLR----DLKPLITEEFRKQLLVIADQKHPNLL 327
LG G +G + + +K L+ K TE R + V+ + L
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 328 PLLAYYFSNDEKL-LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYL 386
L Y F + KL L+ + G LF + R F + + ALE+L
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHLS------QRERFTEHEVQIYVGEIVLALEHL 145
Query: 387 HHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYKSPEYQS 446
H +I+ ++K NILLD N V+++D+G S + + EY +
Sbjct: 146 HKLG-------IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 447 -------SKKISRKSDVWSFGCLLLELLTGRISTHSAP-QGINGADLCSWVLRAVREEWT 498
+ D WS G L+ ELLTG +P + + + R
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGA-----SPFTVDGEKNSQAEISRR------ 247
Query: 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAE 539
I SE + + L+Q + K P+KR
Sbjct: 248 --ILKSEPPYPQEMSALAKDLIQ---RLLMKDPKKRLGCGP 283
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 1e-19
Identities = 42/298 (14%), Positives = 101/298 (33%), Gaps = 46/298 (15%)
Query: 276 LGKGIFGNSYKA-LLEGRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
+G+G FG +KA + V +K++ + K +++ ++ KH N++ L+
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 333 YFSNDEK--------LLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALE 384
+ LV+ F + + + F V + + L
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------VLVKFTLSEIKRVMQMLLNGLY 131
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMISYK---S 441
Y+H ++H ++K+ N+L+ + ++ ++D+G + + +Q +
Sbjct: 132 YIHRNK-------ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 442 PEY------QSSKKISRKSDVWSFGCLLLELLTGRI---STHSAPQGINGADLCSWVLRA 492
Y + D+W GC++ E+ T Q + LC +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 493 VREEWTAEIFDSEISVQRSAAHGMLKLLQVAI----------QCCNKSPEKRPEMAEV 540
V ++ + + + L+ + + P +R + +
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (214), Expect = 4e-19
Identities = 46/284 (16%), Positives = 101/284 (35%), Gaps = 30/284 (10%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLLPLL 330
+G G +G A+ A V +K+L +P +E F K+ ++ +H N++ LL
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLY--RPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 331 AYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKD 390
+ ++ F G ++ L + + L Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL--VYQMLKGLRYIHAAG 141
Query: 391 KSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMIS--YKSPEYQSSK 448
IH +LK N+ ++++ + + D+G + + + +
Sbjct: 142 I-------IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWM 194
Query: 449 KISRKSDVWSFGCLLLELLTGR--------ISTHSAPQGINGADLCSWVLRAVREEWTAE 500
+ ++ D+WS GC++ E++TG+ + + G +V R +E
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254
Query: 501 IFDSEISVQRSAAHGMLKLLQVAI----QCCNKSPEKRPEMAEV 540
+ ++ A + +A+ + E+R E
Sbjct: 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 79.1 bits (194), Expect = 1e-16
Identities = 36/204 (17%), Positives = 83/204 (40%), Gaps = 28/204 (13%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIAD-QKHPNLLPLLAYY 333
LG+G + ++A+ + VVVK L KP+ ++ ++++ ++ + + PN++ L
Sbjct: 43 LGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADIV 99
Query: 334 FSNDEKL--LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDK 391
+ LV++ N + + +AL+Y H
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSMG- 149
Query: 392 SRTQSAVIHGNLKSTNILLD-DNEMVLVSDYGFSSLVAQPIAAQRMI---SYKSPE-YQS 446
++H ++K N+++D ++ + + D+G + + +K PE
Sbjct: 150 ------IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 447 SKKISRKSDVWSFGCLLLELLTGR 470
+ D+WS GC+L ++ +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.9 bits (188), Expect = 7e-16
Identities = 50/287 (17%), Positives = 104/287 (36%), Gaps = 36/287 (12%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLR--DLKPLITEEFRKQLLVIADQKHPNLLPLLAY 332
+G G +G+ A + V VK+L + + ++L ++ KH N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 333 Y-----FSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLH 387
+ + + +L N + K + + + F + R L+Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY-------QILRGLKYIH 138
Query: 388 HKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRM--ISYKSPEYQ 445
D IH +LK +N+ ++++ + + D+G + +
Sbjct: 139 SADI-------IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML 191
Query: 446 SSKKISRKSDVWSFGCLLLELLTGR--------ISTHSAPQGINGADLCSWVLRAVREEW 497
+ ++ D+WS GC++ ELLTGR I + G + + E
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 498 TAEIFDSEISVQRSAAHGMLKLLQVAI----QCCNKSPEKRPEMAEV 540
I + + A+ + +A+ + +KR A+
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 74.0 bits (180), Expect = 4e-15
Identities = 30/71 (42%), Positives = 38/71 (53%), Gaps = 3/71 (4%)
Query: 93 KFLESLQLQNNNLTGPVPE--FNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPY 150
K L L L+NN + G +P+ L NVS NNL G IP+ LQ F +Y+NN
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 151 LCGPPSLNNCS 161
LCG P L C+
Sbjct: 304 LCGSP-LPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.8 bits (99), Expect = 8e-05
Identities = 15/61 (24%), Positives = 25/61 (40%), Gaps = 3/61 (4%)
Query: 50 VINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNN-LTG 107
++ +NN I G + L +++S N GEI +L+ + NN L G
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG 306
Query: 108 P 108
Sbjct: 307 S 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 28/135 (20%), Positives = 53/135 (39%), Gaps = 7/135 (5%)
Query: 8 PSQWYGIQCDINS--AHVTGIVLEDMRLNGEIK-SDAFADIPELIVINFKN--NIISGNF 62
W G+ CD ++ V + L + L + A++P L + N++
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 63 MNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE--FNQSSLKVF 120
+ +L + ++ G I L +K L +L N L+G +P + +L
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 121 NVSNNNLSGSIPKTQ 135
N +SG+IP +
Sbjct: 155 TFDGNRISGAIPDSY 169
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 73.9 bits (180), Expect = 8e-15
Identities = 35/213 (16%), Positives = 72/213 (33%), Gaps = 25/213 (11%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYF 334
LG G F + A + V +K +R + TE ++ ++ + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 335 SNDEKLLVYKFAGNGNLF----------NRIHGGKSSKNRIPFRCRSRLLVARGVARALE 384
++ KLL + N + +++ + L+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMV-------LVSDYGFSSLVAQPIAAQRMI 437
Y+H + +IH ++K N+L++ + + + +
Sbjct: 140 YMHRRCG------IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 438 SYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR 470
Y+SPE +D+WS CL+ EL+TG
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.4 bits (171), Expect = 1e-13
Identities = 35/209 (16%), Positives = 76/209 (36%), Gaps = 32/209 (15%)
Query: 276 LGKGIFGNSYKAL-LEGRAPVVVKRLRDLKPLITEEFRKQLL----VIADQKHPNLLPLL 330
+G G G A V +K+L +P + K+ ++ H N++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 331 AYYFSND------EKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALE 384
+ + LV + ++ + R+ + + + ++
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLC--QVIQMELDHERMSY-------LLYQMLCGIK 133
Query: 385 YLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQRMI---SYKS 441
+LH IH +LK +NI++ + + + D+G + + Y++
Sbjct: 134 HLHSAGI-------IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 442 PEYQSSKKISRKSDVWSFGCLLLELLTGR 470
PE D+WS GC++ E++ +
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 57.9 bits (139), Expect = 2e-10
Identities = 30/203 (14%), Positives = 65/203 (32%), Gaps = 32/203 (15%)
Query: 276 LGKGIFGNSYKALLEGRAPVVVKRLR----------DLKPLITEEFRKQLLVIADQKHPN 325
+G+G + E VVK + + + F + A +
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 326 LLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEY 385
L L Y + GN L I + + R+ V + +
Sbjct: 68 LQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE----VLDMILEEVAK 118
Query: 386 LHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPIAAQ---RMISYKSP 442
+H+ ++HG+L N+L+ + + ++ D+ S V + + R +
Sbjct: 119 FYHRG-------IVHGDLSQYNVLVSEEGIWII-DFPQSVEVGEEGWREILERDVRNIIT 170
Query: 443 EYQSSKKISRKSDVWSFGCLLLE 465
+ + + D+ S +L+
Sbjct: 171 YFS--RTYRTEKDINSAIDRILQ 191
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 5e-09
Identities = 21/115 (18%), Positives = 42/115 (36%), Gaps = 3/115 (2%)
Query: 11 WYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHK 70
I A +T + ++ N +++ L + N IS SS K
Sbjct: 272 ANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD-ISPVSSLTK 330
Query: 71 LKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNN 125
L+ + + NK SL +L + L +N ++ P N + + +++
Sbjct: 331 LQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.4 bits (132), Expect = 9e-09
Identities = 14/72 (19%), Positives = 27/72 (37%), Gaps = 2/72 (2%)
Query: 61 NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVF 120
+ S+ L + L N + SL L+ L NN ++ N +++
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLANLTNINWL 356
Query: 121 NVSNNNLSGSIP 132
+ +N +S P
Sbjct: 357 SAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 4e-06
Identities = 32/133 (24%), Positives = 52/133 (39%), Gaps = 5/133 (3%)
Query: 30 DMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSL 89
+ N A + L ++ NN IS S KL ++ L N+ L
Sbjct: 225 SLNGNQLKDIGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISNISP--L 281
Query: 90 LSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNP 149
L L +L+L N L P N +L + NN+S P + +L + ++NN
Sbjct: 282 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKL-QRLFFANN- 339
Query: 150 YLCGPPSLNNCSS 162
+ SL N ++
Sbjct: 340 KVSDVSSLANLTN 352
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 15/102 (14%), Positives = 36/102 (35%), Gaps = 6/102 (5%)
Query: 2 HCFKDFPSQWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGN 61
+ +Q I N ++T + L ++ + + +L + F NN +S
Sbjct: 288 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS---PVSSLTKLQRLFFANNKVSD- 343
Query: 62 FMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNN 103
+ ++ + + N+ L +L + L L +
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLT--PLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 8e-04
Identities = 16/106 (15%), Positives = 38/106 (35%), Gaps = 4/106 (3%)
Query: 61 NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVF 120
+ + L+ + + N+ +L+ L+ L L N L + ++L
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKDIGTLASLTNLTDL 246
Query: 121 NVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCSSTGNY 166
+++NN +S P + +L + + L ++ N
Sbjct: 247 DLANNQISNLAPLSGLTKL--TELKLGANQISNISPLAGLTALTNL 290
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 6e-06
Identities = 12/87 (13%), Positives = 23/87 (26%), Gaps = 11/87 (12%)
Query: 58 ISGNFMNFSSNHKLKDIDLSGNKFYGE----ISRSLLSLKFLESLQLQNNNLTGPVPEF- 112
L+ + L+ ++ +LL+ L L L NN L
Sbjct: 358 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417
Query: 113 ------NQSSLKVFNVSNNNLSGSIPK 133
L+ + + S +
Sbjct: 418 VESVRQPGCLLEQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 1e-05
Identities = 11/70 (15%), Positives = 25/70 (35%), Gaps = 7/70 (10%)
Query: 71 LKDIDLSGNKFYGEISRSLLS-LKFLESLQLQNNNLTGPVPEF------NQSSLKVFNVS 123
++ +D+ + LL L+ + ++L + LT + +L N+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 124 NNNLSGSIPK 133
+N L
Sbjct: 64 SNELGDVGVH 73
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 2e-04
Identities = 18/91 (19%), Positives = 34/91 (37%), Gaps = 14/91 (15%)
Query: 48 LIVINFKNNIISGNFMN-----FSSNHKLKDIDLSGNKFYGEISRSLLS-----LKFLES 97
L V+ + +S + + +NH L+++DLS N L+ LE
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 98 LQLQNNNLTGPVPEFNQSSLKVFNVSNNNLS 128
L L + + + + Q+ K +L
Sbjct: 431 LVLYDIYWSEEMEDRLQALEK----DKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 4e-04
Identities = 10/85 (11%), Positives = 29/85 (34%), Gaps = 5/85 (5%)
Query: 28 LEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-----FSSNHKLKDIDLSGNKFY 82
++ L+ ++ + + V+ + ++ N L +++L N+
Sbjct: 9 IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68
Query: 83 GEISRSLLSLKFLESLQLQNNNLTG 107
+L S ++Q +L
Sbjct: 69 DVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 4e-04
Identities = 13/88 (14%), Positives = 27/88 (30%), Gaps = 6/88 (6%)
Query: 47 ELIVINFKNNIISGNFMN--FSSNHKLKDIDLSGNKFYGE----ISRSLLSLKFLESLQL 100
++ ++ + +S + + + L IS +L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 101 QNNNLTGPVPEFNQSSLKVFNVSNNNLS 128
++N L L+ + LS
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLS 90
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 4e-05
Identities = 16/64 (25%), Positives = 28/64 (43%), Gaps = 2/64 (3%)
Query: 61 NFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVF 120
+ ++ KL + NK L SL L + L+NN ++ P N S+L +
Sbjct: 165 DLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIV 222
Query: 121 NVSN 124
++N
Sbjct: 223 TLTN 226
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 42.3 bits (98), Expect = 9e-05
Identities = 19/139 (13%), Positives = 50/139 (35%), Gaps = 2/139 (1%)
Query: 36 EIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFL 95
E+ + EL V + + + N + + ++ + K G + + +K L
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 152
Query: 96 ESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCGP 154
+++ + N+T +P+ SL ++ N ++ + + L S N
Sbjct: 153 SYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 211
Query: 155 PSLNNCSSTGNYVTNSDDK 173
+ + +++K
Sbjct: 212 NGSLANTPHLRELHLNNNK 230
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 38.9 bits (89), Expect = 0.001
Identities = 20/94 (21%), Positives = 31/94 (32%), Gaps = 3/94 (3%)
Query: 71 LKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE--FNQSSLKVFNVSNNNLS 128
+DL NK +LK L +L L NN ++ P L+ +S N L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 129 GSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCSS 162
+P+ L + N N +
Sbjct: 93 -ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQ 125
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 9e-05
Identities = 23/91 (25%), Positives = 39/91 (42%), Gaps = 9/91 (9%)
Query: 52 NFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE 111
+ N + L+++++S NK E+ L E L N+L VPE
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRL---ERLIASFNHLAE-VPE 321
Query: 112 FNQSSLKVFNVSNNNLSG--SIPKT-QTLQL 139
Q+ LK +V N L IP++ + L++
Sbjct: 322 LPQN-LKQLHVEYNPLREFPDIPESVEDLRM 351
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 15/93 (16%), Positives = 38/93 (40%), Gaps = 5/93 (5%)
Query: 74 IDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE-FNQSSLKVFNVSNNNLSGSIP 132
+DL+G + +++ LLS + + + + + P+ E F+ ++ ++SN+ + S
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 133 KT--QTLQLFRSYSYSNNPYLC-GPPSLNNCSS 162
++ S +L S+
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSN 96
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 6e-04
Identities = 15/97 (15%), Positives = 33/97 (34%), Gaps = 1/97 (1%)
Query: 65 FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSN 124
+++ + +++DL G K I +L +++ +N + LK V+N
Sbjct: 14 YTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNN 72
Query: 125 NNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNCS 161
N + + N L L+ +
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLA 109
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 0.001
Identities = 25/127 (19%), Positives = 42/127 (33%), Gaps = 4/127 (3%)
Query: 37 IKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFL 95
+ D F D+ L + N IS F H L + L N+ + L L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 96 ESLQLQNNNLTG--PVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLC- 152
+L L NNL+ +L+ +++N + + S++ C
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263
Query: 153 GPPSLNN 159
P L
Sbjct: 264 LPQRLAG 270
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.004
Identities = 24/144 (16%), Positives = 54/144 (37%), Gaps = 6/144 (4%)
Query: 10 QWYGIQCDINSAHVTGIVLEDMRLNG----EIKSDAFADIPELIVINFKNNIISGNFMN- 64
Q +Q + L + L+G + AF + L + N ++ +
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 65 FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSS-LKVFNVS 123
F +L + L N + +L L+ L+ L+L +N + L+ F S
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGS 256
Query: 124 NNNLSGSIPKTQTLQLFRSYSYSN 147
++ + S+P+ + + + ++
Sbjct: 257 SSEVPCSLPQRLAGRDLKRLAAND 280
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.004
Identities = 10/61 (16%), Positives = 24/61 (39%), Gaps = 5/61 (8%)
Query: 51 INFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLS-----LKFLESLQLQNNNL 105
++ + + + N L+ + L N+ + R+L + + L L+L N
Sbjct: 255 LSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314
Query: 106 T 106
+
Sbjct: 315 S 315
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 582 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.62 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.53 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.48 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.35 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.29 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.29 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.26 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.2 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.18 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.16 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.08 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.04 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.03 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.01 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.0 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.0 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.97 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.97 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.94 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.93 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.9 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.87 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.71 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.6 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.55 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.36 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.31 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.3 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.26 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.88 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.73 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.72 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.64 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.61 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.54 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.53 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.3 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.27 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.9 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.79 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.68 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.21 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.86 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.86 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 93.02 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=411.87 Aligned_cols=247 Identities=24% Similarity=0.408 Sum_probs=196.1
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||+||+|.+.++..||||+++.. ....++|.+|++++++++|||||+++|+|..++..++||||+++|+|.
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~ 88 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHH
Confidence 4679999999999999998889999999754 345678999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++.... ..+++..++.|+.|||.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 89 ~~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH~~~-------iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 89 DYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEAC-------VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp HHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred HHhhccc-----cCCCHHHHHHHHHHHHHHHHhhhccc-------eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9987543 25889999999999999999999998 9999999999999999999999999998765432
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
...+|+.|+|||++.+..++.++|||||||++|||+|+..|+... ....++...+.. ..... .+.
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~---~~~~~~~~~i~~----~~~~~--~p~-- 225 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN---RSNSEVVEDIST----GFRLY--KPR-- 225 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS---CCHHHHHHHHHH----TCCCC--CCT--
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC---CCHHHHHHHHHh----cCCCC--Ccc--
Confidence 234678899999999999999999999999999999964444321 122233333222 21111 111
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
....++.+++.+||+.||++||||+||+++|+.+++
T Consensus 226 ------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 ------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 112367889999999999999999999999998864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=410.02 Aligned_cols=249 Identities=24% Similarity=0.447 Sum_probs=196.4
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||+||+|++++ .||||+++.. .....+.|.+|+.+|++++|||||+++|++. .+..++|||||++|+
T Consensus 13 ~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSS 89 (276)
T ss_dssp CSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEE
T ss_pred EEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCC
Confidence 5789999999999998654 5999998643 3445678999999999999999999999875 456899999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.++++.... .+++..++.|+.|||+||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 90 L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~~-------ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 90 LYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAKS-------IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp HHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred HHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhcCC-------EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999975432 4899999999999999999999998 999999999999999999999999999876432
Q ss_pred ------ccccccccccCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 431 ------IAAQRMISYKSPEYQSS---KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 431 ------~~~~~~~~y~aPE~~~~---~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
....+|+.|||||++.+ ..|+.++|||||||++|||+||+.||.... .. ..+............
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~----~~---~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NR---DQIIFMVGRGYLSPD 230 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC----CH---HHHHHHHHHTSCCCC
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC----hH---HHHHHHHhcCCCCCc
Confidence 23357889999999864 358999999999999999999999996432 11 112222222211110
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.. ........++.+|+.+||+.||++||||+||+++|+.++.
T Consensus 231 ~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 231 LS------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GG------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ch------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 00 0011122367889999999999999999999999998875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.8e-52 Score=411.15 Aligned_cols=251 Identities=28% Similarity=0.445 Sum_probs=205.6
Q ss_pred ccccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 272 PAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
..+.||+|+||+||+|.+. +++.||||+++... ...++|.+|+.+|++++|||||+++|+|.+.+..++|||||++|+
T Consensus 21 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 99 (287)
T d1opja_ 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99 (287)
T ss_dssp EEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcc
Confidence 3578999999999999976 47789999987543 456789999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++..... ..+++..++.|+.|||.||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 100 l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~~-------iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 100 LLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKN-------FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp HHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred hHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHCC-------cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999976432 36899999999999999999999998 999999999999999999999999999887543
Q ss_pred c-----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 431 I-----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 431 ~-----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
. ...+++.|+|||++.+..|+.++|||||||++|||++|..|+.... ....+. ..+......+..+
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~---~~~~~~----~~i~~~~~~~~~~-- 239 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVY----ELLEKDYRMERPE-- 239 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHH----HHHHTTCCCCCCT--
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc---hHHHHH----HHHhcCCCCCCCc--
Confidence 2 2235678999999999999999999999999999999877764321 222222 2222222221111
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
....++.+|+.+||+.||++||||+||++.|+.+.+..
T Consensus 240 --------~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 240 --------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp --------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred --------cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 11235788999999999999999999999998876543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-51 Score=411.92 Aligned_cols=247 Identities=22% Similarity=0.403 Sum_probs=193.7
Q ss_pred cccccccCceEEEEEEEcC-C---ceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLEG-R---APVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.++||+|+||+||+|.+.. + ..||||++... .....+.|.+|+++|++++|||||+++|+|...+..++|||||+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 4689999999999999753 2 25888988653 33455789999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... ..+++.+++.|+.|||+||+|||+++ ||||||||+|||++.++.+||+|||+|+.+
T Consensus 111 ~g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH~~~-------iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 111 NGSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLADMN-------YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp TEEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCcceeeecccc-----CCCCHHHHHHHHHHHHHHHHHHhhCC-------CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999887543 24899999999999999999999998 999999999999999999999999999876
Q ss_pred cCcc---------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 428 AQPI---------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 428 ~~~~---------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
.... ...+++.|+|||.+.+..++.++|||||||++|||+| |+.||... ...++...+ ..+.
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~----~~~~~~~~i----~~~~ 250 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----TNQDVINAI----EQDY 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHH----HTTC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC----CHHHHHHHH----HcCC
Confidence 5432 1235678999999999999999999999999999998 89999643 222333322 2221
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.... +.+...++.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 251 ~~~~----------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 RLPP----------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCCC----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCC----------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1111 01122367889999999999999999999999988754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=399.62 Aligned_cols=250 Identities=25% Similarity=0.426 Sum_probs=204.4
Q ss_pred CChhHhhhcccccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCe
Q 047954 263 FKLNDLLKAPAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE 338 (582)
Q Consensus 263 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 338 (582)
|++++. ...+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|+.++++++|||||++++++.+++.
T Consensus 3 ~~l~dy--~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 80 (263)
T d2j4za1 3 WALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 80 (263)
T ss_dssp CCGGGE--EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhHe--EEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCE
Confidence 444442 23578999999999999975 5788999998532 23346778999999999999999999999999999
Q ss_pred eEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEE
Q 047954 339 KLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLV 418 (582)
Q Consensus 339 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl 418 (582)
.++|||||++|+|.+++.... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~~lH~~~-------ivHrDiKp~Nill~~~~~~kl 147 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSKR-------VIHRDIKPENLLLGSAGELKI 147 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEeecCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC-------eeeeeeccccceecCCCCEee
Confidence 999999999999999997532 4889999999999999999999998 999999999999999999999
Q ss_pred eeccccccccCc--ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 419 SDYGFSSLVAQP--IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 419 ~DfG~a~~~~~~--~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
+|||+|+..... ....||+.|+|||++.+..++.++|||||||++|||+||+.||... ...++.. ......
T Consensus 148 ~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~---~i~~~~ 220 (263)
T d2j4za1 148 ADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN----TYQETYK---RISRVE 220 (263)
T ss_dssp CCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHH---HHHTTC
T ss_pred cccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC----CHHHHHH---HHHcCC
Confidence 999999877543 3345889999999999999999999999999999999999999642 1222222 111111
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
. . +.. ....++.+++.+||+.||++|||++|+++|.|.
T Consensus 221 ~--~-~p~---------~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 221 F--T-FPD---------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp C--C-CCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred C--C-CCc---------cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCc
Confidence 1 0 000 011257789999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-51 Score=404.95 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=201.9
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||+||+|.. .+++.||||+++.......+.+.+|+.++++++|||||++++++.+.+..++|||||++|+|
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 104 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence 36799999999999985 56889999999765555678899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++... .+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+...
T Consensus 105 ~~~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~~-------iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 105 TDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQ-------VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp HHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred HHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHCC-------CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9988643 4889999999999999999999998 999999999999999999999999999876433
Q ss_pred ---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 431 ---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
....||+.|+|||++.+..|+.++|||||||++|||+||+.||.... .. ..+........ .....+
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~~---~~~~~~~~~~~-~~~~~~--- 239 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN----PL---RALYLIATNGT-PELQNP--- 239 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HH---HHHHHHHHHCS-CCCSSG---
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC----HH---HHHHHHHhCCC-CCCCCc---
Confidence 23348899999999999999999999999999999999999996421 11 11222222211 111110
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.....++.+++.+||+.||++|||+.|+++|.|.
T Consensus 240 -----~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~ 273 (293)
T d1yhwa1 240 -----EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (293)
T ss_dssp -----GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred -----ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 0112257789999999999999999999988764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=407.75 Aligned_cols=246 Identities=24% Similarity=0.395 Sum_probs=199.3
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||+||+|.++++..||||+++... ...+.|.+|++++++++|||||+++|++. .+..++||||+++|+|.
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~ 95 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHH
Confidence 46799999999999999988899999997543 45678999999999999999999999875 45679999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++.... ...+++..++.|+.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 96 ~~~~~~~----~~~l~~~~~~~i~~qi~~gl~~lH~~~-------ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 96 DFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEERN-------YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp HHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred HHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-------cccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9875432 124899999999999999999999998 9999999999999999999999999998875432
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
...+++.|+|||++.+..++.++|||||||++|||+||..|+.... ...++...+ .........+
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~---~~~~~~~~i----~~~~~~~~p~---- 233 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNL----ERGYRMVRPD---- 233 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHH----HTTCCCCCCT----
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC---CHHHHHHHH----HhcCCCCCcc----
Confidence 3346788999999998899999999999999999999766654221 222222222 2221111111
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
....++.+|+.+||+.||++||||+||++.|+.+-
T Consensus 234 ------~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 11225788999999999999999999999988653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-51 Score=398.41 Aligned_cols=244 Identities=23% Similarity=0.429 Sum_probs=203.7
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
.+.||+|+||+||+|+++++..||||+++... ...++|.+|+.++++++|||||+++|+|.+++..++||||+++|+|.
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 56799999999999999988899999997643 35678999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc-
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI- 431 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~- 431 (582)
+++..... .+++..+++++.|||+||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 88 ~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~~~-------iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 88 NYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESKQ-------FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp HHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHHTT-------BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred Hhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhhcC-------cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99865432 4888999999999999999999998 9999999999999999999999999998765432
Q ss_pred ----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 432 ----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 432 ----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
...+++.|+|||.+.+..++.|+|||||||++|||+| |+.||... ...++.. .+....... .+.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~----~~~~~~~----~i~~~~~~~--~p~- 224 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF----TNSETAE----HIAQGLRLY--RPH- 224 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS----CHHHHHH----HHHTTCCCC--CCT-
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC----CHHHHHH----HHHhCCCCC--Ccc-
Confidence 2346788999999999999999999999999999998 89999643 2222322 222221111 111
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
....++.+++.+||+.||++|||++||+++|.+|
T Consensus 225 -------~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 -------LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -------cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1123678999999999999999999999999764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=402.81 Aligned_cols=248 Identities=23% Similarity=0.394 Sum_probs=196.3
Q ss_pred cccccccCceEEEEEEEcCC-----ceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEGR-----APVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.++||+|+||.||+|.+++. ..||||+++... ....+.|.+|+.++++++|||||+++|++.+.+..++||||+
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 46799999999999997643 369999996543 334567999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
.+|++.+++..... .+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 92 ~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH~~~-------iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 92 ENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANMN-------YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp TTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred ccCcchhhhhcccc-----cccHHHHHHHHHHHHHhhhhccccc-------cccCccccceEEECCCCeEEEcccchhhc
Confidence 99999998875432 5899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCcc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 427 VAQPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 427 ~~~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
+.... ...+|+.|+|||++.+..++.++|||||||++|||+||..|+.... ...++... +..+...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~---~~~~~~~~----i~~~~~~ 232 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEVMKA----INDGFRL 232 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHH----HHTTCCC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC---CHHHHHHH----HhccCCC
Confidence 64321 2346788999999999999999999999999999999766654321 22223322 2222221
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
... .....++.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 233 ~~~----------~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 233 PTP----------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCC----------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCc----------hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 111 1112367889999999999999999999999988764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=399.69 Aligned_cols=246 Identities=18% Similarity=0.273 Sum_probs=195.7
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++|||||++|+
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 89 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence 467999999999999974 68899999986543 2334678999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 90 L~~~l~~~------~~l~e~~~~~i~~qi~~al~ylH~~~-------IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 90 LFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp GGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred HHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcC-------CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99998643 25899999999999999999999998 999999999999999999999999999876432
Q ss_pred ------ccccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 431 ------IAAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 431 ------~~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
....||+.|||||++.+..+ +.++||||+||++|||+||+.||...... . .............. ..
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~---~---~~~~~~~~~~~~~~-~~ 229 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---C---QEYSDWKEKKTYLN-PW 229 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT---S---HHHHHHHTTCTTST-TG
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH---H---HHHHHHhcCCCCCC-cc
Confidence 23458899999999987776 67899999999999999999999653221 1 11111111110000 00
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
. ....++.+|+.+||+.||++|||++|+++|.|.-
T Consensus 230 ~---------~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 264 (271)
T d1nvra_ 230 K---------KIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264 (271)
T ss_dssp G---------GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred c---------cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence 0 1112567889999999999999999999887753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=402.93 Aligned_cols=243 Identities=23% Similarity=0.384 Sum_probs=198.1
Q ss_pred cccccCceEEEEEEEc---CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 275 GLGKGIFGNSYKALLE---GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 275 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.||+|+||+||+|.+. ++..||||+++... ....+.|.+|+++|++++|||||+++|+|.+ +..++|||||++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999864 34579999997543 3456789999999999999999999999865 46899999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|.+++.... ..+++..++.++.|||.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+...
T Consensus 95 L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~~~-------iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 95 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEKN-------FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred HHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC-------eecCcCchhheeeccCCceeeccchhhhccccc
Confidence 999986433 25899999999999999999999998 999999999999999999999999999876432
Q ss_pred c-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 431 I-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 431 ~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
. ...+|+.|+|||++.+..++.++|||||||++|||+| |+.||... ...++...+ ..+...+..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~----~~~~~~~~i----~~~~~~~~p 234 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAFI----EQGKRMECP 234 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC----CTHHHHHHH----HTTCCCCCC
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC----CHHHHHHHH----HcCCCCCCC
Confidence 1 2346788999999998899999999999999999998 89999643 222333322 222222111
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
. ....++.+|+.+||+.||++||||.+|++.|+.+.
T Consensus 235 ~----------~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 235 P----------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp T----------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----------cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 11236788999999999999999999999987654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=403.07 Aligned_cols=246 Identities=20% Similarity=0.319 Sum_probs=201.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||+||+|+.. ++..||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||++|+|
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L 96 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcH
Confidence 357999999999999965 6788999999766666667899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++.... ..+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 97 ~~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~~~-------ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 97 DAVMLELE-----RPLTESQIQVVCKQTLDALNYLHDNK-------IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp HHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------EEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99876432 25899999999999999999999998 999999999999999999999999999766432
Q ss_pred ---ccccccccccCCCCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 431 ---IAAQRMISYKSPEYQS-----SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~-----~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
....||+.|+|||++. ...|+.++|||||||++|||+||+.||.... ..++...+. ... .....
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~----~~~~~~~i~---~~~-~~~~~ 236 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN----PMRVLLKIA---KSE-PPTLA 236 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC----GGGHHHHHH---HSC-CCCCS
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC----HHHHHHHHH---cCC-CCCCC
Confidence 2456889999999874 4568999999999999999999999996432 222222221 111 11111
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.+ .....++.+|+.+||+.||++|||++|+++|.|.
T Consensus 237 ~~--------~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 237 QP--------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp SG--------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred cc--------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 11 1112357789999999999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=395.27 Aligned_cols=244 Identities=21% Similarity=0.353 Sum_probs=194.6
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEe----CCeeEEEEEeC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFS----NDEKLLVYKFA 346 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~ 346 (582)
+.||+|+||+||+|+.. ++..||+|++... .....+.|.+|+++|++++|||||++++++.+ ....++||||+
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 46999999999999975 5778999998643 33445679999999999999999999999875 34578999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec-CCCceEEeeccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD-DNEMVLVSDYGFSS 425 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DfG~a~ 425 (582)
++|+|.+++.... .+++..++.++.||+.||+|||++++ +||||||||+|||++ +++.+||+|||+|+
T Consensus 95 ~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~gl~yLH~~~~-----~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 95 TSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTRTP-----PIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp CSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTSSS-----CCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CCCcHHHHHhccc------cccHHHHHHHHHHHHHHHHHHHHCCC-----CEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 9999999997532 58899999999999999999999863 499999999999996 57899999999998
Q ss_pred cccCc--ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 426 LVAQP--IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 426 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
..... ....||+.|+|||++.+ .++.++|||||||++|||+||+.||.... ....+ .+.+.....+..++
T Consensus 164 ~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~---~~~~~----~~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 164 LKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ---NAAQI----YRRVTSGVKPASFD 235 (270)
T ss_dssp GCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS---SHHHH----HHHHTTTCCCGGGG
T ss_pred eccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc---cHHHH----HHHHHcCCCCcccC
Confidence 76543 34468999999998865 69999999999999999999999996422 11112 22222221111111
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
. ....++.+++.+||+.||++|||++|+++|.|
T Consensus 236 ~---------~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 236 K---------VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp G---------CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred c---------cCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 1 11125778999999999999999999998865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=400.63 Aligned_cols=242 Identities=23% Similarity=0.372 Sum_probs=195.3
Q ss_pred ccccccCceEEEEEEEcC---CceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 274 EGLGKGIFGNSYKALLEG---RAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
++||+|+||+||+|.+.+ ++.||||+++.. .....+.|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998654 357999999643 23345789999999999999999999999865 457899999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.++++... .+++..++.|+.|||.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+.
T Consensus 92 g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~~-------iiHrDlKp~Nill~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 92 GPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEESN-------FVHRDLAARNVLLVTQHYAKISDFGLSKALR 158 (277)
T ss_dssp EEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhCC-------cccCCCcchhhcccccCcccccchhhhhhcc
Confidence 99999997543 4899999999999999999999998 9999999999999999999999999998764
Q ss_pred Ccc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 429 QPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 429 ~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
... ...+|+.|+|||.+.+..++.++|||||||++|||+| |+.||... ...++...+ ..+...+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~----~~~~~~~~i----~~~~~~~ 230 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KGSEVTAML----EKGERMG 230 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHH----HTTCCCC
T ss_pred ccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC----CHHHHHHHH----HcCCCCC
Confidence 331 2346788999999999999999999999999999998 89999642 222232222 2222111
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
.. .....++.+|+.+||+.||++||||++|++.|+..
T Consensus 231 ~p----------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 CP----------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CC----------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC----------cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11 01123678899999999999999999999888754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-51 Score=401.33 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=189.9
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEe--CCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFS--NDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~ 347 (582)
.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..++|||||+
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~ 88 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 88 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence 367999999999999864 67889999986543 3345678999999999999999999999975 456799999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++..... ....+++..++.++.||+.||+|||+++. ...+||||||||+|||++.++.+||+|||+|+.+
T Consensus 89 ~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~--~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 89 GGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSD--GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp TEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC-----------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred CCcHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHhcC--CCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 9999999864321 12358999999999999999999998651 1234999999999999999999999999999877
Q ss_pred cCcc----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQPI----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
.... ...+|+.|+|||++.+..|+.++|||||||++|||+||+.||... ...++...+ .......+.
T Consensus 165 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~----~~~~~~~~i----~~~~~~~~~- 235 (269)
T d2java1 165 NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF----SQKELAGKI----REGKFRRIP- 235 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHH----HHTCCCCCC-
T ss_pred ccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC----CHHHHHHHH----HcCCCCCCC-
Confidence 5432 345788999999999999999999999999999999999999642 222222222 222221111
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
.. ...++.+|+.+||+.||++|||++|+++|.|
T Consensus 236 ~~---------~s~~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 236 YR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp TT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cc---------cCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 11 1125788999999999999999999998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-50 Score=401.44 Aligned_cols=246 Identities=21% Similarity=0.317 Sum_probs=201.9
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCc---chHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKP---LITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+.+|++++|||||++++++.+++..++|||||.+
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 99 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence 35799999999999986 4678899999865432 2345688999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|..++.... .+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 100 g~l~~~~~~~~------~l~e~~~~~i~~qi~~aL~yLH~~~-------iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 100 SASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHSHN-------MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp EHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred CchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCC-------EeccCCCcceEEECCCCCEEEeecccccccC
Confidence 99977665432 5899999999999999999999998 9999999999999999999999999999888
Q ss_pred CcccccccccccCCCCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 429 QPIAAQRMISYKSPEYQSS---KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 429 ~~~~~~~~~~y~aPE~~~~---~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
......||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.... . .+.+....... ........
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~----~---~~~~~~i~~~~-~~~~~~~~ 238 (309)
T d1u5ra_ 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----A---MSALYHIAQNE-SPALQSGH 238 (309)
T ss_dssp SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----H---HHHHHHHHHSC-CCCCSCTT
T ss_pred CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC----H---HHHHHHHHhCC-CCCCCCCC
Confidence 7777889999999998864 468999999999999999999999996421 1 12222222221 11111111
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
+ ..++.+|+.+||+.||++|||++|+++|.+-.+
T Consensus 239 ~---------s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 239 W---------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp S---------CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred C---------CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 1 125778999999999999999999999876544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-50 Score=405.80 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=197.7
Q ss_pred ccccccccCceEEEEEEEcCC------ceEEEEEecCC-CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEE
Q 047954 272 PAEGLGKGIFGNSYKALLEGR------APVVVKRLRDL-KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~------~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 343 (582)
..+.||+|+||+||+|+..+. ..||||++... .......+.+|+.++.++ +|||||+++++|.+.+..++||
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence 357899999999999996542 25899998643 333456789999999998 8999999999999999999999
Q ss_pred EeCCCCChHHHHhcCCCC-----------------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCC
Q 047954 344 KFAGNGNLFNRIHGGKSS-----------------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKST 406 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~ 406 (582)
|||++|+|.++++..... .....+++..++.|+.||+.||+|||+++ ||||||||+
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-------IiHRDlKp~ 193 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-------CVHRDLAAR 193 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-------EEETTCSGG
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-------eeeccCchh
Confidence 999999999999765421 01235889999999999999999999998 999999999
Q ss_pred CeeecCCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 047954 407 NILLDDNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQG 479 (582)
Q Consensus 407 NILl~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~ 479 (582)
|||++.++.+||+|||+|+...... ...+|+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~- 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH-
Confidence 9999999999999999998765432 2335788999999999999999999999999999998 8999964321
Q ss_pred CCccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 480 INGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 480 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
...+ ...+......+.. .....++.+|+.+||+.||++||||+||+++|.
T Consensus 273 --~~~~----~~~~~~~~~~~~p----------~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 --DANF----YKLIQNGFKMDQP----------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp --SHHH----HHHHHTTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --HHHH----HHHHhcCCCCCCC----------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1122 2222222221111 011236788999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=403.96 Aligned_cols=262 Identities=20% Similarity=0.285 Sum_probs=198.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||+||+|+.. ++..||+|+++.. .....+.+.+|+.+|++++|||||+++++|.+.+..++|||||++|+
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence 367999999999999964 6788999998653 34456789999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhcc-CCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccC
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHK-DKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~ 429 (582)
|.+++.... .+++..+..++.|++.||.|||++ + |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 91 L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~~~-------IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 91 LDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKHK-------IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp HHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHHC-------CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred HHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHhCC-------EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999997532 488999999999999999999974 6 99999999999999999999999999987643
Q ss_pred c--ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHH--------------H
Q 047954 430 P--IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA--------------V 493 (582)
Q Consensus 430 ~--~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~--------------~ 493 (582)
. ....||+.|+|||++.+..|+.++||||+||++|||+||+.||...............+... .
T Consensus 158 ~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 3 34468899999999999999999999999999999999999996532110000000000000 0
Q ss_pred hhccccc--------ccchhhhh---hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 494 REEWTAE--------IFDSEISV---QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 494 ~~~~~~~--------~~d~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
....... ..+..... .........++.+++.+||..||++|||++|+++|.+.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~ 302 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence 0000000 00000000 000000123678899999999999999999999997653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=397.94 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=201.7
Q ss_pred ccccccccCceEEEEEEEcCC----ceEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeC-CeeEEEEEe
Q 047954 272 PAEGLGKGIFGNSYKALLEGR----APVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN-DEKLLVYKF 345 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e~ 345 (582)
+.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++|||||+++|++... ...++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 357899999999999997543 35899999743 444567899999999999999999999998764 578999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
|++|+|.+++..... .+++..++.++.|+|+||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 111 ~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~~-------iiHrDLK~~NILl~~~~~~kL~DFG~~~ 178 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASKK-------FVHRDLAARNCMLDEKFTVKVADFGLAR 178 (311)
T ss_dssp CTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECTTCCEEECSSGGGC
T ss_pred eecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhcccC-------cccCCccHHhEeECCCCCEEEecccchh
Confidence 999999999875432 4778889999999999999999998 9999999999999999999999999998
Q ss_pred cccCcc--------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 426 LVAQPI--------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 426 ~~~~~~--------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
.+.... ...+++.|+|||.+....++.++||||||+++|||+||+.||.... ...++..++... .
T Consensus 179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~---~~~~~~~~i~~g----~ 251 (311)
T d1r0pa_ 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFDITVYLLQG----R 251 (311)
T ss_dssp CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHHHTT----C
T ss_pred hccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC---CHHHHHHHHHcC----C
Confidence 764321 2346788999999999999999999999999999999888875422 223333333221 1
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCC
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTES 552 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~ 552 (582)
... .+. ....++.+|+.+||+.||++||||.||+++|+.+.....
T Consensus 252 ~~~--~p~--------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 252 RLL--QPE--------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp CCC--CCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCC--Ccc--------cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 111 110 112257889999999999999999999999999976433
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-50 Score=395.87 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=198.0
Q ss_pred ccccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 272 PAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
..+.||+|+||.||+|++.++..||||+++... ...+.|.+|+.++++++|||||+++|+|. .+..++||||+++|+|
T Consensus 21 i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l 98 (285)
T d1fmka3 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 98 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCch
Confidence 357899999999999999998899999996543 45678999999999999999999999985 5568999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCcc
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQPI 431 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~~ 431 (582)
.+++..... ..++|.+++.|+.|||.||+|||+.+ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 99 ~~~~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~~~-------ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 99 LDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERMN-------YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp HHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhhhhhccc----ccchHHHHHHHHHHHHHHHHHHhhhh-------eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 998865322 24899999999999999999999998 9999999999999999999999999998764332
Q ss_pred -----cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 432 -----AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 432 -----~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
...+++.|+|||++....++.++|||||||++|||+||..|+.... ...++...+. .....++ .+
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~---~~~~~~~~i~----~~~~~~~-~~-- 237 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVE----RGYRMPC-PP-- 237 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHH----TTCCCCC-CT--
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC---CHHHHHHHHH----hcCCCCC-Cc--
Confidence 2346788999999999999999999999999999999766664321 2222333322 2211111 11
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
....++.+++.+||+.||++||||++|++.|+....
T Consensus 238 -------~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 238 -------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -------ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 112357889999999999999999999999887653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=394.63 Aligned_cols=242 Identities=22% Similarity=0.319 Sum_probs=197.7
Q ss_pred ccccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 272 PAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
..+.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++|||||++++++.+.+..|+|||||+
T Consensus 12 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccC
Confidence 3578999999999999974 6889999998632 22345679999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..++.++.|++.||+|||+.+ ||||||||+|||+++++.+||+|||+|+.+
T Consensus 92 gg~L~~~~~~~~------~l~e~~~~~~~~qi~~al~ylH~~~-------iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 92 NGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGKG-------IIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp TEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCHHHhhhccC------CCCHHHHHHHHHHHHHHHHhhcccc-------EEcCcCCccccccCCCceEEecccccceec
Confidence 999999887542 5889999999999999999999998 999999999999999999999999999877
Q ss_pred cCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 428 AQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 428 ~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
... ....||+.|+|||++.+..|+.++|||||||++|||+||+.||... +...+...+ ..... .+
T Consensus 159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~~~~~~~i---~~~~~--~~ 229 (288)
T d1uu3a_ 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NEYLIFQKI---IKLEY--DF 229 (288)
T ss_dssp C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHH---HTTCC--CC
T ss_pred ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc----CHHHHHHHH---HcCCC--CC
Confidence 532 1235889999999999999999999999999999999999999642 222222221 11111 11
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
... ...++.+|+.+||+.||++|||++|++.+.+
T Consensus 230 -p~~---------~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 230 -PEK---------FFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp -CTT---------CCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred -Ccc---------CCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 111 1125778999999999999999999766544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=390.26 Aligned_cols=245 Identities=25% Similarity=0.411 Sum_probs=194.3
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEe-CCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFS-NDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||.||+|.+. +..||||+++.. ...+.|.+|++++++++|||||+++|+|.+ .+..++||||+++|+|
T Consensus 12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred eEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 577999999999999985 567999999653 345789999999999999999999999865 4568999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
.+++..... ..+++..++.|+.|||.||+|||+.+ ||||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~~~-------ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 89 VDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGNN-------FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp HHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred HHHHHhcCC----CCCCHHHHHHHHHHHHhhccccccCc-------eeccccchHhheecCCCCEeecccccceecCCCC
Confidence 999975321 25899999999999999999999988 999999999999999999999999999876543
Q ss_pred ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhhhh
Q 047954 431 IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEISVQ 509 (582)
Q Consensus 431 ~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 509 (582)
....++..|+|||++.+..++.++|||||||++|||+| |+.||... ...++..++.. +...++.+
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~----~~~~~~~~i~~----~~~~~~~~------ 223 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVEK----GYKMDAPD------ 223 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS----CGGGHHHHHTT----TCCCCCCT------
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC----CHHHHHHHHHc----CCCCCCCc------
Confidence 23446788999999998999999999999999999998 68777532 33344444422 22222211
Q ss_pred hchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 510 RSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 510 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
....++.+|+.+||+.||++||||.|++++|+.++.
T Consensus 224 ----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 224 ----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 111267889999999999999999999999998864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.1e-49 Score=400.17 Aligned_cols=249 Identities=19% Similarity=0.313 Sum_probs=203.7
Q ss_pred ccccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 272 PAEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
..+.||+|+||.||+|+.. +++.||||++........+.+.+|+.+|++++|||||++++++.+.+..++|||||++|+
T Consensus 30 i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 109 (350)
T d1koaa2 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence 3578999999999999964 688999999977666667789999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec--CCCceEEeecccccccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD--DNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DfG~a~~~~ 428 (582)
|.+++.... ..+++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.+.
T Consensus 110 L~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~~-------iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 110 LFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHENN-------YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp HHHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred HHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcC-------CeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999996432 24899999999999999999999998 99999999999996 46789999999998775
Q ss_pred Ccc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 429 QPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 429 ~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
... ...+|+.|||||++.+..++.++|||||||++|||+||+.||... ...++.. ......+... ...
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~---~i~~~~~~~~--~~~ 248 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE----NDDETLR---NVKSCDWNMD--DSA 248 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHH---HHHHTCCCSC--CGG
T ss_pred cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC----CHHHHHH---HHHhCCCCCC--ccc
Confidence 443 345789999999999999999999999999999999999999642 2222222 2222211110 000
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
. .....++.+|+.+||..||++|||++|+++|.|.-
T Consensus 249 ~------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~ 284 (350)
T d1koaa2 249 F------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284 (350)
T ss_dssp G------GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred c------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 0 01112577899999999999999999999997643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-49 Score=394.46 Aligned_cols=247 Identities=24% Similarity=0.325 Sum_probs=186.3
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..|+|||||++|+
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~ 93 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE 93 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 468999999999999975 57889999986433 2334568899999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec---CCCceEEeeccccccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD---DNEMVLVSDYGFSSLV 427 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DfG~a~~~ 427 (582)
|.+++.... .+++..+..++.||+.||+|||+++ ||||||||+|||+. +++.+||+|||+|+..
T Consensus 94 L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~~-------iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 94 LFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDLG-------IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp HHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred HHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhce-------eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999997532 5899999999999999999999998 99999999999994 5789999999999876
Q ss_pred cCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 428 AQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 428 ~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.... ...||+.|+|||++.+..|+.++|||||||++|||+||+.||... ...++... ......... .+
T Consensus 161 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~~~~~~~---i~~~~~~~~--~~ 231 (307)
T d1a06a_ 161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE----NDAKLFEQ---ILKAEYEFD--SP 231 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHH---HHTTCCCCC--TT
T ss_pred cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC----CHHHHHHH---HhccCCCCC--Cc
Confidence 5432 345889999999999999999999999999999999999999642 11222222 222111110 00
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
. ......++.+|+.+||+.||++|||++|+++|.+.-
T Consensus 232 ~------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 268 (307)
T d1a06a_ 232 Y------WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268 (307)
T ss_dssp T------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred c------ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 0 001122578899999999999999999999997653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=389.53 Aligned_cols=246 Identities=21% Similarity=0.398 Sum_probs=191.8
Q ss_pred cccccccCceEEEEEEEcC----CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLEG----RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||.||+|++.. +..||||+++... ....+.|.+|+.++++++|||||+++|++. .+..++||||++
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~ 90 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 90 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEecc
Confidence 5689999999999998653 3468899886543 334567999999999999999999999985 567899999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... ..+++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.+
T Consensus 91 ~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~~-------iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 91 LGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESKR-------FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp TEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred CCcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhcccC-------eeccccchhheeecCCCcEEEccchhheec
Confidence 999999876543 25899999999999999999999998 999999999999999999999999999876
Q ss_pred cCc-----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccccc
Q 047954 428 AQP-----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTAEI 501 (582)
Q Consensus 428 ~~~-----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (582)
... ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||... ...++...+.. .....+
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~----~~~~~~~~i~~----~~~~~~ 230 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRIEN----GERLPM 230 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC----CGGGHHHHHHT----TCCCCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC----CHHHHHHHHHc----CCCCCC
Confidence 533 22346788999999999999999999999999999998 88898643 22334333322 211111
Q ss_pred cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 502 FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 502 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
.+ ....++.+|+.+||+.||++|||+.||+++|+.+.+
T Consensus 231 -~~---------~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 231 -PP---------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp -CT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CC---------CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11 112367889999999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-48 Score=397.86 Aligned_cols=246 Identities=20% Similarity=0.324 Sum_probs=202.4
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||+||+|+. .+++.||||+++.......+.+.+|+.+|++++|||||++++++.+++..++|||||++|+|
T Consensus 34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L 113 (352)
T d1koba_ 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 113 (352)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChH
Confidence 46899999999999996 46889999999766555667889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec--CCCceEEeeccccccccC
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD--DNEMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DfG~a~~~~~ 429 (582)
.+++.... ..+++.+++.|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.+..
T Consensus 114 ~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~~-------iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 114 FDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEHS-------IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp HHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC-------eeecccccccccccccCCCeEEEeecccceecCC
Confidence 99876432 25899999999999999999999998 99999999999998 678999999999988765
Q ss_pred cc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc-ccccchh
Q 047954 430 PI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT-AEIFDSE 505 (582)
Q Consensus 430 ~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~d~~ 505 (582)
.. ...+++.|+|||++.+..++.++||||+||++|||+||+.||... ...++...+ ...... .....+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~~~~~~i---~~~~~~~~~~~~~- 253 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE----DDLETLQNV---KRCDWEFDEDAFS- 253 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHHHHH---HHCCCCCCSSTTT-
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC----CHHHHHHHH---HhCCCCCCccccc-
Confidence 43 345788999999999999999999999999999999999999642 122222222 221111 000000
Q ss_pred hhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 506 ISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 506 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
....++.+|+.+||+.||++|||+.|+++|.|.
T Consensus 254 --------~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~ 286 (352)
T d1koba_ 254 --------SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286 (352)
T ss_dssp --------TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred --------CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 111257789999999999999999999998653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=386.79 Aligned_cols=246 Identities=18% Similarity=0.305 Sum_probs=199.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC------cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK------PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (293)
T d1jksa_ 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94 (293)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999974 68899999985321 22467899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC----ceEEeec
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE----MVLVSDY 421 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Df 421 (582)
|++|+|.+++.... .+++..++.++.||+.||+|||+++ ||||||||+|||++.++ .+||+||
T Consensus 95 ~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~~-------ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 95 VAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSLQ-------IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp CCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred CCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhcc-------eeecccccceEEEecCCCcccceEecch
Confidence 99999999997532 5899999999999999999999998 99999999999998776 4999999
Q ss_pred cccccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 422 GFSSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 422 G~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
|+|+..... ....+++.|+|||++.+..++.++|||||||++|||+||+.||... ...+....+ ......
T Consensus 162 G~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~~~~~~~i---~~~~~~ 234 (293)
T d1jksa_ 162 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD----TKQETLANV---SAVNYE 234 (293)
T ss_dssp TTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHH---HTTCCC
T ss_pred hhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC----CHHHHHHHH---HhcCCC
Confidence 999877543 2345778999999999999999999999999999999999999643 222222211 111110
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
. .... ......++.+|+.+||+.||++|||++|+++|.+.
T Consensus 235 --~-~~~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 235 --F-EDEY-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp --C-CHHH-----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred --C-Cchh-----cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 0 0000 00112357789999999999999999999998664
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-48 Score=391.95 Aligned_cols=251 Identities=23% Similarity=0.417 Sum_probs=201.6
Q ss_pred cccccccCceEEEEEEEcC------CceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEG------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||+||+|++.+ ++.||||+++... ....++|.+|++++++++||||++++++|...+..++||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~ 97 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 97 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEe
Confidence 4679999999999999653 4689999997543 33456799999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCC------------------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCC
Q 047954 346 AGNGNLFNRIHGGKSS------------------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTN 407 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~N 407 (582)
+++|+|.++++..... .....+++..++.|+.|||.||+|||+++ ||||||||+|
T Consensus 98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~-------ivHrDlKp~N 170 (301)
T d1lufa_ 98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-------FVHRDLATRN 170 (301)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGG
T ss_pred cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC-------eEeeEEcccc
Confidence 9999999999753321 11234889999999999999999999998 9999999999
Q ss_pred eeecCCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCC
Q 047954 408 ILLDDNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR-ISTHSAPQGI 480 (582)
Q Consensus 408 ILl~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~-~P~~~~~~~~ 480 (582)
||++.++.+||+|||+|+.+.... ...+++.|+|||.+.+..|+.++|||||||++|||++|. .||...
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~---- 246 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM---- 246 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS----
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC----
Confidence 999999999999999997654321 234667899999999999999999999999999999986 456432
Q ss_pred CccchHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 481 NGADLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
...++...+ ..+...++.+ ....++.+|+.+||+.||++||||.||++.|+.+.
T Consensus 247 ~~~e~~~~v----~~~~~~~~p~----------~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 AHEEVIYYV----RDGNILACPE----------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CHHHHHHHH----HTTCCCCCCT----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CHHHHHHHH----HcCCCCCCCc----------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 222333222 2222222111 11236788999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=391.10 Aligned_cols=245 Identities=22% Similarity=0.404 Sum_probs=196.4
Q ss_pred cccccccCceEEEEEEEcC-Cc----eEEEEEecCC-CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEG-RA----PVVVKRLRDL-KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 346 (582)
.++||+|+||+||+|.+.. ++ .||+|+++.. .....+.|.+|+.++++++|||||+++|+|.++ ..++++||+
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~ 92 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 92 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEec
Confidence 3689999999999998653 32 5899988643 344567899999999999999999999999865 567889999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
.+|+|.+++..... .+++..++.|+.|||.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 93 ~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~~-------iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 93 PFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRR-------LVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp TTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred cCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHcC-------cccCcchhhcceeCCCCCeEeecccccee
Confidence 99999998876432 5899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcccc
Q 047954 427 VAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEWTA 499 (582)
Q Consensus 427 ~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (582)
+.... ...+|+.|+|||++.+..++.++|||||||++|||+| |+.||... ...++...+... ...
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~----~~~~~~~~i~~~----~~~ 232 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILEKG----ERL 232 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS----CGGGHHHHHHHT----CCC
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC----CHHHHHHHHHcC----CCC
Confidence 64432 2246789999999999999999999999999999999 78888643 223333333221 111
Q ss_pred cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 500 EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 500 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
... .....++.+|+.+||+.||++|||+.||+++|+.+.
T Consensus 233 ~~p----------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 233 PQP----------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CCC----------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 110 111235788999999999999999999999998775
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=389.39 Aligned_cols=262 Identities=23% Similarity=0.370 Sum_probs=202.7
Q ss_pred CChhHhhhcccccccccCceEEEEEEEcCC-c--eEEEEEecCC-CcchHHHHHHHHHHHhcC-CCCCccccceEEEeCC
Q 047954 263 FKLNDLLKAPAEGLGKGIFGNSYKALLEGR-A--PVVVKRLRDL-KPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSND 337 (582)
Q Consensus 263 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~~-~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 337 (582)
++++++.. .++||+|+||+||+|++.++ . .||||+++.. .....+.|.+|+++|+++ +|||||+++|+|.+.+
T Consensus 7 i~~~~~~~--~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKF--QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEE--EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEE--EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 34444432 57899999999999997643 3 4788887543 333556799999999998 7999999999999999
Q ss_pred eeEEEEEeCCCCChHHHHhcCCC----------CCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCC
Q 047954 338 EKLLVYKFAGNGNLFNRIHGGKS----------SKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTN 407 (582)
Q Consensus 338 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~N 407 (582)
..++||||+++|+|.++++.... ......+++..++.++.|||.||.|||+.+ ||||||||+|
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~-------iiHrDlkp~N 157 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-------FIHRDLAARN 157 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-------ccccccccce
Confidence 99999999999999999975421 011235899999999999999999999998 9999999999
Q ss_pred eeecCCCceEEeeccccccccCcc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCCCCcc
Q 047954 408 ILLDDNEMVLVSDYGFSSLVAQPI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRI-STHSAPQGINGA 483 (582)
Q Consensus 408 ILl~~~~~~kl~DfG~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~-P~~~~~~~~~~~ 483 (582)
||++.++.+||+|||+|+...... ...+|..|+|||.+.+..++.++|||||||++|||++|.. ||... ...
T Consensus 158 IL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~----~~~ 233 (309)
T d1fvra_ 158 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TCA 233 (309)
T ss_dssp EEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC----CHH
T ss_pred EEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC----CHH
Confidence 999999999999999998764432 3346788999999999999999999999999999999765 56432 222
Q ss_pred chHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 484 DLCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
++... +..+...+... ....++.+|+.+||+.||++||||+||+++|+.+.+..
T Consensus 234 ~~~~~----i~~~~~~~~~~----------~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 234 ELYEK----LPQGYRLEKPL----------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHHH----GGGTCCCCCCT----------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHH----HHhcCCCCCCc----------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 22222 22222211110 11226788999999999999999999999999987533
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=387.57 Aligned_cols=264 Identities=18% Similarity=0.244 Sum_probs=196.8
Q ss_pred cccccccCceEEEEEEEcCCceEEEEEecCCCcchHHHHH--HHHHHHhcCCCCCccccceEEEeCC----eeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKPLITEEFR--KQLLVIADQKHPNLLPLLAYYFSND----EKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv~e~~ 346 (582)
.+.||+|+||.||+|++ +++.||||+++.. ..+.+. .|+..+.+++|||||+++++|...+ ..++|||||
T Consensus 8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 46799999999999997 4678999998643 233343 4555556789999999999998754 578999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCC-CCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSR-TQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
++|+|.++++.. .++|..++.++.|+|.||+|||+..... ...+||||||||+||||++++.+||+|||+++
T Consensus 84 ~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 84 EHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp TTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999753 4889999999999999999999742100 01359999999999999999999999999998
Q ss_pred cccCc--------ccccccccccCCCCCCCCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC-------ccc
Q 047954 426 LVAQP--------IAAQRMISYKSPEYQSSKK------ISRKSDVWSFGCLLLELLTGRISTHSAPQGIN-------GAD 484 (582)
Q Consensus 426 ~~~~~--------~~~~~~~~y~aPE~~~~~~------~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~-------~~~ 484 (582)
..... ....+|+.|+|||++.+.. ++.|+|||||||+||||+||..|+........ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76432 1234789999999987643 57799999999999999999988754321110 111
Q ss_pred hHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
...........+. .++.+.......+....+.+|+.+||+.||++||||.||+++|+++...+
T Consensus 237 ~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 1222223222221 12222112223345567889999999999999999999999999887543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=381.72 Aligned_cols=245 Identities=25% Similarity=0.377 Sum_probs=189.1
Q ss_pred cccccccCceEEEEEEEcCC----ceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLEGR----APVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|++... ..||||+++.. .....+.|.+|+.+|++++|||||+++|+|.+ ...++||||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~ 91 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL 91 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence 35799999999999986432 36899988643 23345789999999999999999999999965 467899999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
+++|++.+++.... ..+++..++.++.|||.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~~-------iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 92 APLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESKR-------FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp CTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ecCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhhCC-------EeeeeecHHHhccccccceeeccchhhh
Confidence 99999999886533 25899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCcc-------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 426 LVAQPI-------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 426 ~~~~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
.+.... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||... ...++..++ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~----~~~~~~~~i---~~~~~ 232 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKI---DKEGE 232 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHH---HTSCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc----CHHHHHHHH---HhCCC
Confidence 764432 2235678999999999999999999999999999998 89999532 222332222 22222
Q ss_pred cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 498 TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 498 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
..+..+ ....++.+|+.+||+.||++||||.||++.|++.
T Consensus 233 ~~~~~~----------~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 RLPRPE----------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCCT----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcc----------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 211111 1112578899999999999999999999988764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-47 Score=383.31 Aligned_cols=242 Identities=24% Similarity=0.356 Sum_probs=200.1
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||+||+|+. .+++.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..++|||||++
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 88 (316)
T d1fota_ 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 88 (316)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCC
Confidence 46899999999999996 46889999998632 223457799999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|..++.... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 89 g~l~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~~-------iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 89 GELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSKD-------IIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTTT-------EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred ccccccccccc------cccccHHHHHHHHHHHhhhhhccCc-------EEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999987543 4677888899999999999999998 9999999999999999999999999998875
Q ss_pred Cc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 429 QP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 429 ~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
.. ....||+.|+|||++.+..|+.++||||+||++|||+||+.||... +..++.. ........ +.+.+
T Consensus 156 ~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~---~i~~~~~~---~p~~~- 224 (316)
T d1fota_ 156 DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS----NTMKTYE---KILNAELR---FPPFF- 224 (316)
T ss_dssp SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHH---HHHHCCCC---CCTTS-
T ss_pred cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc----CHHHHHH---HHHcCCCC---CCCCC-
Confidence 54 3456899999999999999999999999999999999999999642 2222222 22221110 11111
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhh
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEI 546 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 546 (582)
..++.+++.+||..||++|+ |++|+++|.+.
T Consensus 225 --------s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 225 --------NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp --------CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred --------CHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence 12577899999999999996 99999998663
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=385.34 Aligned_cols=242 Identities=22% Similarity=0.317 Sum_probs=199.5
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||+||+|+. .+++.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..++|||||++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g 89 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCC
Confidence 46799999999999996 56889999998642 223457788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 90 g~L~~~~~~~~------~~~e~~~~~~~~qil~al~ylH~~~-------iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 90 GELFFHLSRER------VFTEERARFYGAEIVSALEYLHSRD-------VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp CBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred Cchhhhhhccc------CCcHHHHHHHHHHHhhhhhhhhhcC-------ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999997543 4788899999999999999999998 9999999999999999999999999998764
Q ss_pred Cc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccch
Q 047954 429 QP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDS 504 (582)
Q Consensus 429 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 504 (582)
.. ....||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ...+...+ .... . .+ ..
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~----~~~~~~~i---~~~~-~-~~-p~ 226 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERLFELI---LMEE-I-RF-PR 226 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHH---HHCC-C-CC-CT
T ss_pred cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC----HHHHHHHH---hcCC-C-CC-Cc
Confidence 32 23457899999999999999999999999999999999999996432 22222211 1111 1 11 00
Q ss_pred hhhhhhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHHhh
Q 047954 505 EISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSELEI 546 (582)
Q Consensus 505 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~ 546 (582)
....++.+|+.+||++||++||+ ++|+++|.+.
T Consensus 227 ---------~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f 264 (337)
T d1o6la_ 227 ---------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp ---------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred ---------cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccc
Confidence 11125678999999999999995 8999998764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=383.00 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=190.4
Q ss_pred cccccccCceEEEEEEEcC------CceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCC-eeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLEG------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSND-EKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~-~~~lv~ 343 (582)
.+.||+|+||.||+|.... ++.||||+++... ....+.+.+|...+.++ +|+|||.+++++...+ ..++||
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 4689999999999998643 3579999987433 33456788888888776 7899999999987654 689999
Q ss_pred EeCCCCChHHHHhcCCCC----------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC
Q 047954 344 KFAGNGNLFNRIHGGKSS----------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN 413 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~ 413 (582)
|||++|+|.++++..... .....+++.+++.++.||++||+|||+++ ||||||||+|||++++
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~-------ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-------CIHRDLAARNILLSEK 170 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECGG
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC-------CcCCcCCccceeECCC
Confidence 999999999999764321 01235889999999999999999999998 9999999999999999
Q ss_pred CceEEeeccccccccCc------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCCccchH
Q 047954 414 EMVLVSDYGFSSLVAQP------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR-ISTHSAPQGINGADLC 486 (582)
Q Consensus 414 ~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~-~P~~~~~~~~~~~~~~ 486 (582)
+.+||+|||+|+..... ....+|+.|+|||++.+..++.++|||||||++|||+||. .||.... . .
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~---~----~ 243 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK---I----D 243 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---C----S
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC---H----H
Confidence 99999999999876432 1235788999999999999999999999999999999975 5664321 1 1
Q ss_pred HHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 487 SWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 487 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
..+...+..+......+ ....++.+++.+||+.||++||||+||+++|+.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~----------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 244 EEFCRRLKEGTRMRAPD----------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHHTCCCCCCT----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCc----------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22222333332222211 112257889999999999999999999999998753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=381.58 Aligned_cols=253 Identities=23% Similarity=0.390 Sum_probs=198.1
Q ss_pred ccccccccCceEEEEEEEcC--------CceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEE
Q 047954 272 PAEGLGKGIFGNSYKALLEG--------RAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLL 341 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 341 (582)
..+.||+|+||.||+|+..+ +..||||+++... .....++.+|...+.++ +|||||+++++|.+++..++
T Consensus 17 l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~ 96 (299)
T d1fgka_ 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 96 (299)
T ss_dssp EEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEE
Confidence 35789999999999998543 2469999997543 33457788999999888 89999999999999999999
Q ss_pred EEEeCCCCChHHHHhcCCCC----------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSS----------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD 411 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~ 411 (582)
||||+++|+|.+++...... .....+++.+++.++.|||.||+|||+.+ ||||||||+|||++
T Consensus 97 v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~-------ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 97 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-------CIHRDLAARNVLVT 169 (299)
T ss_dssp EECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEEC
T ss_pred EEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-------EEeeeecccceeec
Confidence 99999999999999765421 11235899999999999999999999998 99999999999999
Q ss_pred CCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCccc
Q 047954 412 DNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLT-GRISTHSAPQGINGAD 484 (582)
Q Consensus 412 ~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~ellt-G~~P~~~~~~~~~~~~ 484 (582)
.++.+||+|||+++...... ...+++.|+|||.+.+..|+.++|||||||++|||+| |+.||... ....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~----~~~~ 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV----PVEE 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC----CHHH
Confidence 99999999999998765432 2346788999999999999999999999999999998 68887532 2222
Q ss_pred hHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
+. ..+..+....... ....++.+|+.+||+.||++||||.||++.|+.+..
T Consensus 246 ~~----~~i~~~~~~~~p~----------~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 LF----KLLKEGHRMDKPS----------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HH----HHHHTTCCCCCCS----------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH----HHHHcCCCCCCCc----------cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 22 2222222221111 112257899999999999999999999999988753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-46 Score=370.08 Aligned_cols=246 Identities=21% Similarity=0.297 Sum_probs=197.5
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCc---------chHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKP---------LITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLL 341 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l 341 (582)
.+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+.++++++ |||||++++++.+++..|+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 46799999999999996 4688999999864321 12346889999999997 9999999999999999999
Q ss_pred EEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
|||||++|+|.+++.... .+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 88 vmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~~-------ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKLN-------IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp EEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcC-------CcccccccceEEEcCCCCeEEccc
Confidence 999999999999997532 5899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCc---ccccccccccCCCCCC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHH
Q 047954 422 GFSSLVAQP---IAAQRMISYKSPEYQS------SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492 (582)
Q Consensus 422 G~a~~~~~~---~~~~~~~~y~aPE~~~------~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 492 (582)
|+++.+... ....+|..|+|||.+. ...++.++||||+||++|||+||+.||.... .......+
T Consensus 155 G~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~----~~~~~~~i--- 227 (277)
T d1phka_ 155 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK----QMLMLRMI--- 227 (277)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHH---
T ss_pred hheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC----HHHHHHHH---
Confidence 999887543 3345788999999874 3457899999999999999999999996432 12222211
Q ss_pred HhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 493 VREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 493 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
...... ...+.. .....++.+++.+||+.||++|||++||++|.|.
T Consensus 228 ~~~~~~--~~~~~~------~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~ 273 (277)
T d1phka_ 228 MSGNYQ--FGSPEW------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273 (277)
T ss_dssp HHTCCC--CCTTTG------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred HhCCCC--CCCccc------ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence 111111 111100 0112367889999999999999999999988664
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=380.81 Aligned_cols=255 Identities=19% Similarity=0.298 Sum_probs=202.6
Q ss_pred ccccccccCceEEEEEEEc------CCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEE
Q 047954 272 PAEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 344 (582)
..+.||+|+||+||+|.+. +++.||||+++... ......|.+|+.++++++|||||+++|+|...+..++|||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 4578999999999999864 25689999997543 3344568999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcCCC----CCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEee
Q 047954 345 FAGNGNLFNRIHGGKS----SKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSD 420 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 420 (582)
|+++|+|.+++..... ......+++..+..++.|+|+||.|||+++ |+||||||+|||+++++.+||+|
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-------ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-------FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-------CBCSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC-------eeeceEcCCceeecCCceEEEee
Confidence 9999999998864321 111234788999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCCccchHHHHHHHH
Q 047954 421 YGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGR-ISTHSAPQGINGADLCSWVLRAV 493 (582)
Q Consensus 421 fG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~-~P~~~~~~~~~~~~~~~~~~~~~ 493 (582)
||+|+.+.... ...+++.|+|||.+.+..++.++|||||||++|||+||. .||... ...++.. ...
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~----~~~~~~~---~i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL----SNEQVLR---FVM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----CHHHHHH---HHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC----CHHHHHH---HHH
Confidence 99998764432 224678899999999999999999999999999999985 666422 2222222 222
Q ss_pred hhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCC
Q 047954 494 REEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTE 551 (582)
Q Consensus 494 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 551 (582)
.+...+..+ .....+.+++.+||+.||++||||.||+++|+...+..
T Consensus 250 -~~~~~~~p~----------~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 250 -EGGLLDKPD----------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp -TTCCCCCCT----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred -hCCCCCCcc----------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 222221111 11236889999999999999999999999998775533
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=379.87 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=201.2
Q ss_pred ccccccccCceEEEEEEEc------CCceEEEEEecCCC-cchHHHHHHHHHHHhcC-CCCCccccceEEEeCCeeEEEE
Q 047954 272 PAEGLGKGIFGNSYKALLE------GRAPVVVKRLRDLK-PLITEEFRKQLLVIADQ-KHPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 272 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 343 (582)
..+.||+|+||.||+|++. .++.||||+++... ......|.+|+.+++++ +|||||+++|+|.+.+..++||
T Consensus 27 l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvm 106 (311)
T d1t46a_ 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (311)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEE
Confidence 3578999999999999863 34689999997543 34456789999999998 7999999999999999999999
Q ss_pred EeCCCCChHHHHhcCCCC------------CCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec
Q 047954 344 KFAGNGNLFNRIHGGKSS------------KNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD 411 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~ 411 (582)
|||++|+|.++++..... .....+++..++.++.|||+||+|||+++ ||||||||+|||++
T Consensus 107 E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~-------ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-------CIHRDLAARNILLT 179 (311)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCSGGGEEEE
T ss_pred EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-------eeeccccccccccc
Confidence 999999999999865421 12235889999999999999999999998 99999999999999
Q ss_pred CCCceEEeeccccccccCcc------cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCccc
Q 047954 412 DNEMVLVSDYGFSSLVAQPI------AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTG-RISTHSAPQGINGAD 484 (582)
Q Consensus 412 ~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG-~~P~~~~~~~~~~~~ 484 (582)
.++.+|++|||+++...... ...+++.|+|||++.+..++.++|||||||++|||+|+ .+||.... ...
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~----~~~ 255 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP----VDS 255 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----SSH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC----HHH
Confidence 99999999999998765432 23467889999999999999999999999999999995 54453321 111
Q ss_pred hHHHHHHHHhhcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 485 LCSWVLRAVREEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
.+...+..+....... ....++.+|+.+||+.||++||||.||++.|+++.
T Consensus 256 ---~~~~~i~~~~~~~~~~----------~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 256 ---KFYKMIKEGFRMLSPE----------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ---HHHHHHHHTCCCCCCT----------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHhcCCCCCCcc----------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1222222222111110 11235789999999999999999999999998764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=380.60 Aligned_cols=249 Identities=20% Similarity=0.329 Sum_probs=193.8
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcC-CCCCccccceEEEe----CCeeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQ-KHPNLLPLLAYYFS----NDEKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~~~~lv~e~~ 346 (582)
.+.||+|+||+||+|+. .+++.||||+++. .+.+.+|+.++.++ +|||||+++++|.+ ....|+|||||
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 45799999999999996 5688999999864 24577899887654 89999999999876 35689999999
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC---CCceEEeeccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD---NEMVLVSDYGF 423 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DfG~ 423 (582)
++|+|.+++..... ..+++.++..|+.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+
T Consensus 92 ~gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~~~-------iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 92 DGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSIN-------IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp CSEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCCcHHHHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHHcC-------Cccccccccccccccccccccccccccce
Confidence 99999999975432 25999999999999999999999998 999999999999985 55799999999
Q ss_pred cccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccc
Q 047954 424 SSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAE 500 (582)
Q Consensus 424 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (582)
|+..... ....||+.|+|||++.+..|+.++|||||||++|||+||+.||...... .....+......... .
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~----~~~~~~~~~i~~~~~-~ 235 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKTRIRMGQY-E 235 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSS-S
T ss_pred eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH----HHHHHHHHHHhcCCC-C
Confidence 9876543 3345889999999999999999999999999999999999999643221 111111111110000 0
Q ss_pred ccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 501 IFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 501 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
...+ .......++.+|+.+||+.||++|||+.|+++|.|...
T Consensus 236 ~~~~------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 236 FPNP------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp CCTT------HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred CCCc------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 0000 01122346888999999999999999999999876543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=378.86 Aligned_cols=247 Identities=20% Similarity=0.325 Sum_probs=199.6
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
.+.||+|+||+||+|... +++.||||.++... .....+.+|+++|++++|||||++++++.+.+..|+|||||++|+|
T Consensus 10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L 88 (321)
T d1tkia_ 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcH
Confidence 467999999999999975 67889999997543 3455688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC--CceEEeeccccccccC
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN--EMVLVSDYGFSSLVAQ 429 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~--~~~kl~DfG~a~~~~~ 429 (582)
.+++.... ..+++.++..|+.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++....
T Consensus 89 ~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~~~-------iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 89 FERINTSA-----FELNEREIVSYVHQVCEALQFLHSHN-------IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp HHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcC-------CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99997532 24899999999999999999999998 9999999999999854 5799999999987654
Q ss_pred cc---cccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhh
Q 047954 430 PI---AAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEI 506 (582)
Q Consensus 430 ~~---~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 506 (582)
.. ...+++.|+|||...+..|+.++||||+||++|||++|+.||... ...++...+ ...... ++...
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~----~~~~~~~~i---~~~~~~---~~~~~ 226 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE----TNQQIIENI---MNAEYT---FDEEA 226 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHH---HHTCCC---CCHHH
T ss_pred CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC----CHHHHHHHH---HhCCCC---CChhh
Confidence 32 334678899999999999999999999999999999999999643 222222222 221111 01100
Q ss_pred hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhc
Q 047954 507 SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEII 547 (582)
Q Consensus 507 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i 547 (582)
......++.+|+.+||..||++|||+.|+++|.|..
T Consensus 227 -----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 227 -----FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp -----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred -----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 001122577899999999999999999999987653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-46 Score=381.71 Aligned_cols=242 Identities=21% Similarity=0.279 Sum_probs=200.1
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 348 (582)
.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+|++++|||||++++++......++||||+.+
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~ 125 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccc
Confidence 467999999999999974 6889999998532 223456789999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVA 428 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~ 428 (582)
|+|.+++.... .+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+.
T Consensus 126 g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~~~-------iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 126 GEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSLD-------LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp CBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-------EecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 99999987542 4889999999999999999999998 9999999999999999999999999998876
Q ss_pred Cc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchhhh
Q 047954 429 QP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSEIS 507 (582)
Q Consensus 429 ~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 507 (582)
.. ....||+.|||||++.+..++.++|||||||++|||+||+.||... +...+.. ...... . .. ..
T Consensus 193 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~---~i~~~~-~-~~-p~--- 259 (350)
T d1rdqe_ 193 GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----QPIQIYE---KIVSGK-V-RF-PS--- 259 (350)
T ss_dssp SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHH---HHHHCC-C-CC-CT---
T ss_pred cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc----CHHHHHH---HHhcCC-C-CC-Cc---
Confidence 43 3455889999999999999999999999999999999999999642 1122222 221111 1 00 00
Q ss_pred hhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhh
Q 047954 508 VQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEI 546 (582)
Q Consensus 508 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 546 (582)
....++.+++.+||+.||++|+ |++|+++|.+.
T Consensus 260 ------~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f 297 (350)
T d1rdqe_ 260 ------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp ------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred ------cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccc
Confidence 1112577899999999999994 99999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-46 Score=371.07 Aligned_cols=247 Identities=26% Similarity=0.342 Sum_probs=195.1
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC---cchHHHHHHHHHHHhcCCCCCccccceEEEeCCe----eEEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK---PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDE----KLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----~~lv~e 344 (582)
.+.||+|+||+||+|+. .+++.||||+++... ....+.|.+|++++++++|||||++++++...+. .|+|||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE 91 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence 46799999999999996 468899999996532 2345678999999999999999999999987543 789999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+++|+|.+++.... .+++.+++.++.||+.||+|||+++ ||||||||+|||++.++..+|+|||.+
T Consensus 92 ~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH~~~-------iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 92 YVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG-------IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp CCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred CCCCCEehhhhcccC------CCCHHHHHHHHHHHHHHHHHHHhCC-------ccCccccCcccccCccccceeehhhhh
Confidence 999999999886542 5889999999999999999999998 999999999999999999999999998
Q ss_pred ccccCc-------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcc
Q 047954 425 SLVAQP-------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEW 497 (582)
Q Consensus 425 ~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 497 (582)
+..... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+..........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~~~~~~~ 231 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------PVSVAYQHVREDP 231 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-------HHHHHHHHHhcCC
Confidence 765332 23347889999999999999999999999999999999999996421 1222222222221
Q ss_pred cc-cccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCC-ChHHHHHHHhhcc
Q 047954 498 TA-EIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-EMAEVVSELEIIK 548 (582)
Q Consensus 498 ~~-~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~ 548 (582)
.. ....+ ....++.+++.+||+.||++|| |+++++..|..+.
T Consensus 232 ~~~~~~~~---------~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 IPPSARHE---------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCGGGTSS---------SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCchhcc---------CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 11 11111 1113577899999999999999 8999999888764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=379.10 Aligned_cols=256 Identities=20% Similarity=0.280 Sum_probs=193.2
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCCcc-----hHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPL-----ITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
++||+|+||+||+|+.. +++.||||+++..... ..+.+.+|+.++++++|||||++++++..++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 57999999999999964 6889999998643221 12468899999999999999999999999999999999998
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
++++..+.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ~~~~~~~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~-------iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 84 TDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQHW-------ILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp EEHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred chHHhhhhhcc------cCCCHHHHHHHHHHHHHHHHHhhccc-------eecccCCcceEEecCCCccccccCcccccc
Confidence 87776665422 25888899999999999999999998 999999999999999999999999999876
Q ss_pred cCcc----cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 428 AQPI----AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 428 ~~~~----~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
.... ...+|+.|+|||++.. ..|+.++|||||||++|||+||+.||... ...+....+.+...........
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~----~~~~~l~~i~~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 151 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD----SDLDQLTRIFETLGTPTEEQWP 226 (299)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCTTTSS
T ss_pred CCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC----CHHHHHHHHHHhcCCCChhhcc
Confidence 5432 2347889999998865 46799999999999999999999999643 2223333333322110000000
Q ss_pred c-------------hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 503 D-------------SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 503 d-------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
+ +.............++.+|+.+||+.||++|||++|+++|.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 283 (299)
T d1ua2a_ 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283 (299)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence 0 0000000000112357889999999999999999999988663
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.1e-46 Score=383.32 Aligned_cols=245 Identities=20% Similarity=0.241 Sum_probs=193.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCC---cchHHHHH---HHHHHHhcCCCCCccccceEEEeCCeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK---PLITEEFR---KQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 345 (582)
.+.||+|+||.||+|+.. +++.||||++.... ......+. .|+.+++.++|||||++++++.+.+..|+||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 467999999999999965 68899999985321 11222333 447778888999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
|++|+|.+++.... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 89 ~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH~~~-------iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 89 MNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNRF-------VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp CCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred cCCCcHHHHHHhcc------cccHHHHHHHHHHHHHHHHHHHHCC-------ccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999997542 4788899999999999999999998 9999999999999999999999999998
Q ss_pred cccCc--ccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 426 LVAQP--IAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 426 ~~~~~--~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
.+... ....||+.|+|||++.. ..|+.++|||||||++|||+||+.||..... .+... +.+..... ....
T Consensus 156 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~-~~~~~~~~-~~~~- 228 (364)
T d1omwa3 156 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHE-IDRMTLTM-AVEL- 228 (364)
T ss_dssp ECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS----SCHHH-HHHHSSSC-CCCC-
T ss_pred ecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH----HHHHH-HHHhcccC-CCCC-
Confidence 77543 34568999999999864 5689999999999999999999999975322 11111 11111111 0000
Q ss_pred chhhhhhhchHHHHHHHHHHHHHcccCCCCCCCC-----hHHHHHHHhh
Q 047954 503 DSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPE-----MAEVVSELEI 546 (582)
Q Consensus 503 d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~ 546 (582)
... ...++.+|+.+||+.||++||| ++|+++|.|.
T Consensus 229 ~~~---------~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f 268 (364)
T d1omwa3 229 PDS---------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268 (364)
T ss_dssp CSS---------SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred CCC---------CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence 000 1125788999999999999999 6999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=376.67 Aligned_cols=241 Identities=22% Similarity=0.322 Sum_probs=195.0
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC---CcchHHHHHHHHHHHh-cCCCCCccccceEEEeCCeeEEEEEeCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL---KPLITEEFRKQLLVIA-DQKHPNLLPLLAYYFSNDEKLLVYKFAG 347 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lv~e~~~ 347 (582)
.+.||+|+||+||+|+.. +++.||||+++.. .....+.+..|..++. .++|||||++++++.+++..|+|||||+
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 468999999999999975 6788999999632 1233456677777665 6899999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccc
Q 047954 348 NGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLV 427 (582)
Q Consensus 348 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~ 427 (582)
+|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 87 ~g~L~~~i~~~~------~~~e~~~~~~~~qi~~al~ylH~~~-------iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 87 GGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSKG-------IVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp TCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTT-------CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CCcHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHhCC-------eeeccCcccceeecCCCceeccccchhhhc
Confidence 999999997543 4788899999999999999999998 999999999999999999999999999865
Q ss_pred cCc----ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccc
Q 047954 428 AQP----IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFD 503 (582)
Q Consensus 428 ~~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 503 (582)
... ....||+.|+|||++.+..++.++|||||||++|||+||+.||... ....+...+ ..... .. .
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~----~~~~~~~~i----~~~~~-~~-p 223 (320)
T d1xjda_ 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ----DEEELFHSI----RMDNP-FY-P 223 (320)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHH----HHCCC-CC-C
T ss_pred ccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC----CHHHHHHHH----HcCCC-CC-C
Confidence 432 2345789999999999999999999999999999999999999642 222222222 21111 11 1
Q ss_pred hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChH-HHHHHHh
Q 047954 504 SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMA-EVVSELE 545 (582)
Q Consensus 504 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~L~ 545 (582)
+. ...++.+|+.+||+.||++|||+. |+++|.+
T Consensus 224 ~~---------~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpf 257 (320)
T d1xjda_ 224 RW---------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 257 (320)
T ss_dssp TT---------SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred cc---------CCHHHHHHHHHhcccCCCCCcCHHHHHHhCch
Confidence 10 112577899999999999999996 7887754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=366.72 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=192.2
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++|++++|||||++++++.+++..++||||+.+ +
T Consensus 8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~ 86 (298)
T d1gz8a_ 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-D 86 (298)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-c
Confidence 6799999999999996 568899999996432 22356789999999999999999999999999999999999975 5
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
+.+++..... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 87 ~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH~~~-------IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 87 LKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp HHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred hhhhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcCC-------EEccccCchheeecccCcceeccCCcceeccCC
Confidence 5555543322 25899999999999999999999998 999999999999999999999999999776443
Q ss_pred ----ccccccccccCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhcccccccchh
Q 047954 431 ----IAAQRMISYKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIFDSE 505 (582)
Q Consensus 431 ----~~~~~~~~y~aPE~~~~~~-~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 505 (582)
....+++.|+|||.+.... ++.++||||+||++|||++|+.||.... ..+....+...... ..+...+.
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~----~~~~~~~i~~~~~~--~~~~~~~~ 229 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS----EIDQLFRIFRTLGT--PDEVVWPG 229 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCC--CCTTTSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC----HHHHHHHHHHhcCC--Cchhhccc
Confidence 2335788999999876655 5899999999999999999999996432 12222222111111 00000000
Q ss_pred hh-----------h-----hhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 506 IS-----------V-----QRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 506 ~~-----------~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.. . .........++.+|+.+||+.||++|||++|+++|.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff 286 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence 00 0 00000112467889999999999999999999998553
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.6e-45 Score=364.31 Aligned_cols=255 Identities=18% Similarity=0.265 Sum_probs=195.2
Q ss_pred ccccccCceEEEEEEEcCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCCh
Q 047954 274 EGLGKGIFGNSYKALLEGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGNL 351 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 351 (582)
+.||+|+||+||+|+..+++.||||+++... ....+.+.+|+.+|++++|||||++++++...+..+++|||+.++.+
T Consensus 8 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~ 87 (286)
T d1ob3a_ 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK 87 (286)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHH
T ss_pred cEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhH
Confidence 5799999999999999999999999996543 23357899999999999999999999999999999999999987766
Q ss_pred HHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc-
Q 047954 352 FNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP- 430 (582)
Q Consensus 352 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~- 430 (582)
..+.... ..+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||.|......
T Consensus 88 ~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~-------IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 88 KLLDVCE------GGLESVTAKSFLLQLLNGIAYCHDRR-------VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp HHHHTST------TCCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred HHHHhhc------CCcchhhhHHHHHHHHHHHHHhccCc-------EEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 6665432 25899999999999999999999998 999999999999999999999999999776543
Q ss_pred ---ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc----
Q 047954 431 ---IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF---- 502 (582)
Q Consensus 431 ---~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 502 (582)
....+++.|+|||.+.+. .++.++||||+||++|||++|+.||.... ..+....+.............
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS----EADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC----HHHHHHHHHHhhCCCChhhccchhh
Confidence 233467789999988754 56999999999999999999999996432 222222222221111000000
Q ss_pred ----chhh------hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 503 ----DSEI------SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 503 ----d~~~------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
+... ............+.+++.+||+.||++|||++|+++|.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~ 283 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0000 000001111235778999999999999999999998865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=364.61 Aligned_cols=236 Identities=21% Similarity=0.350 Sum_probs=189.5
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCc------chHHHHHHHHHHHhcCC--CCCccccceEEEeCCeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKP------LITEEFRKQLLVIADQK--HPNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~ 343 (582)
.+.||+|+||+||+|+.. +++.||||+++.... .....+.+|+.++++++ |||||++++++.+.+..++||
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence 467999999999999964 688999999864211 11234678999999986 899999999999999999999
Q ss_pred EeCCC-CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCC-CceEEeec
Q 047954 344 KFAGN-GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDN-EMVLVSDY 421 (582)
Q Consensus 344 e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Df 421 (582)
||+.+ +++.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 89 e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~~~-------iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNCG-------VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp ECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCC-------CccccCcccceEEecCCCeEEECcc
Confidence 99976 67888876432 4889999999999999999999998 9999999999999854 78999999
Q ss_pred cccccccCc--ccccccccccCCCCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 422 GFSSLVAQP--IAAQRMISYKSPEYQSSKKI-SRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 422 G~a~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
|+|+..... ....||+.|+|||++.+..+ +.++||||+||++|||+||+.||... . .+ .....
T Consensus 156 G~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~----~i---~~~~~- 221 (273)
T d1xwsa_ 156 GSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------E----EI---IRGQV- 221 (273)
T ss_dssp TTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------H----HH---HHCCC-
T ss_pred ccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------h----HH---hhccc-
Confidence 999876543 23458899999999887665 67799999999999999999999531 1 11 11110
Q ss_pred ccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 499 AEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 499 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.+.+.+ ..++.+++.+||+.||++|||++|+++|.|.
T Consensus 222 --~~~~~~---------s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 258 (273)
T d1xwsa_ 222 --FFRQRV---------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258 (273)
T ss_dssp --CCSSCC---------CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred --CCCCCC---------CHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 011111 1257789999999999999999999998764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=362.26 Aligned_cols=258 Identities=18% Similarity=0.291 Sum_probs=189.5
Q ss_pred cccccccCceEEEEEEEc-C-CceEEEEEecCC--CcchHHHHHHHHHHHhcC---CCCCccccceEEEe-----CCeeE
Q 047954 273 AEGLGKGIFGNSYKALLE-G-RAPVVVKRLRDL--KPLITEEFRKQLLVIADQ---KHPNLLPLLAYYFS-----NDEKL 340 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~~~~~ 340 (582)
.+.||+|+||+||+|+.. + ++.||||+++.. .......+.+|+.+++.+ +|||||+++++|.. ....+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence 357999999999999963 3 567899998532 222233456677766654 89999999999864 23678
Q ss_pred EEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEee
Q 047954 341 LVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSD 420 (582)
Q Consensus 341 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 420 (582)
++|||+.++++........ ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 92 ~~~e~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~-------ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSHR-------VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp EEEECCSCBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTCCEEECS
T ss_pred EEEEeccCCchhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-------EEecCCCccEEEEcCCCCeeecc
Confidence 9999998877765554332 24888999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh--
Q 047954 421 YGFSSLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE-- 495 (582)
Q Consensus 421 fG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~-- 495 (582)
||+++..... ....||+.|+|||++.+..|+.++||||+||++|||+||+.||.... ..+....+......
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS----DVDQLGKILDVIGLPG 235 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCC
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC----HHHHHHHHHHhhCCCc
Confidence 9999876443 34457899999999999999999999999999999999999996432 22222222222111
Q ss_pred --cccccccchhh--------hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 496 --EWTAEIFDSEI--------SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 496 --~~~~~~~d~~~--------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.+......+.. ............+.+|+.+||+.||++|||++|+++|.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff 296 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 01000000000 0000001112356788999999999999999999999763
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-43 Score=356.15 Aligned_cols=253 Identities=17% Similarity=0.319 Sum_probs=187.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEeCC------eeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFSND------EKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 343 (582)
.+.||+|+||+||+|... +++.||||+++.. .....+.+.+|+.+|++++|||||+++++|...+ +.++||
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 102 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence 357999999999999964 5888999999743 2334567889999999999999999999998654 469999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+ +.+|..+++.. .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+|++|||+
T Consensus 103 e~~-~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~~-------IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 103 PFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAAG-------IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp ECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ecc-cccHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHHhCC-------CcccccCcchhhcccccccccccccc
Confidence 999 56787777532 4889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCcc-cccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc---c-
Q 047954 424 SSLVAQPI-AAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE---W- 497 (582)
Q Consensus 424 a~~~~~~~-~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~---~- 497 (582)
|+...... ...+++.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+............ .
T Consensus 168 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD----HLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCHHHH
T ss_pred eeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC----hHHHHHHHHhccCCCcHHHH
Confidence 98876543 3457889999998876 456899999999999999999999996432 111111111110000 0
Q ss_pred --------------cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 498 --------------TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 498 --------------~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
..+...... ..........+.+|+.+||..||++|||++|+++|.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f 304 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDF--ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG--GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred hhhcchhhhhhhccCCcccccch--HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 000000000 00000112356789999999999999999999999664
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=354.94 Aligned_cols=255 Identities=18% Similarity=0.296 Sum_probs=188.4
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC-cchHHHHHHHHHHHhcCCCCCccccceEEEeCC----eeEEEEEeC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK-PLITEEFRKQLLVIADQKHPNLLPLLAYYFSND----EKLLVYKFA 346 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv~e~~ 346 (582)
.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++|++++|||||++++++.... ..+++++|+
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~ 92 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence 36799999999999985 578899999997543 344567899999999999999999999997653 235556677
Q ss_pred CCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccccc
Q 047954 347 GNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSL 426 (582)
Q Consensus 347 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~ 426 (582)
.+|+|.+++... .+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 93 ~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~~-------iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 93 MGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSAN-------VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp CCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-------CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 799999999643 4889999999999999999999998 99999999999999999999999999976
Q ss_pred ccCc-------ccccccccccCCCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccc
Q 047954 427 VAQP-------IAAQRMISYKSPEYQS-SKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWT 498 (582)
Q Consensus 427 ~~~~-------~~~~~~~~y~aPE~~~-~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (582)
.... ....+++.|+|||++. ...++.++||||+||++|||++|+.||.... ..+..............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~----~~~~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH----YLDQLNHILGILGSPSQ 234 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC----HHHHHHHHhhhccCCCh
Confidence 5432 2233678899999875 4567899999999999999999999996432 11111111111110000
Q ss_pred c---cccchhh-------------hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHh
Q 047954 499 A---EIFDSEI-------------SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELE 545 (582)
Q Consensus 499 ~---~~~d~~~-------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 545 (582)
. ....... ...........++.+|+.+||+.||++|||++|+++|.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 0 0000000 000000011135788999999999999999999999865
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-43 Score=352.67 Aligned_cols=257 Identities=16% Similarity=0.240 Sum_probs=189.6
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCC--CcchHHHHHHHHHHHhcCCCCCccccceEEEe--------CCeeEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDL--KPLITEEFRKQLLVIADQKHPNLLPLLAYYFS--------NDEKLL 341 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~~~~~l 341 (582)
.+.||+|+||+||+|+. .+++.||||++... .....+.+.+|+.+|++++||||+++++++.. .+..++
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i 94 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 94 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEE
Confidence 36799999999999996 47889999998543 23345678999999999999999999999865 345799
Q ss_pred EEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeec
Q 047954 342 VYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDY 421 (582)
Q Consensus 342 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df 421 (582)
||||+.++.+...... ...++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 95 v~e~~~~~~~~~~~~~------~~~~~~~~~~~i~~qil~~l~~lH~~~-------ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 95 VFDFCEHDLAGLLSNV------LVKFTLSEIKRVMQMLLNGLYYIHRNK-------ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp EEECCCEEHHHHHTCT------TCCCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCCGGGEEECTTSCEEECCC
T ss_pred EEeccCCCccchhhhc------ccccccHHHHHHHHHHHHHHHHhccCC-------EEecCcCchheeecCCCcEEeeec
Confidence 9999987766544332 224778889999999999999999998 999999999999999999999999
Q ss_pred cccccccCc--------ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHH
Q 047954 422 GFSSLVAQP--------IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRA 492 (582)
Q Consensus 422 G~a~~~~~~--------~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 492 (582)
|+++..... ....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.... .......+.+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~----~~~~~~~i~~~ 237 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT----EQHQLALISQL 237 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC----HHHHHHHHHHh
Confidence 999765432 223478899999998765 68999999999999999999999996422 22222222222
Q ss_pred Hhhc---ccccccch----hh----hhhhchH------HHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 493 VREE---WTAEIFDS----EI----SVQRSAA------HGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 493 ~~~~---~~~~~~d~----~~----~~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.... ........ .. ....... .....+.+|+.+||+.||++|||++|+++|.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence 1110 00000000 00 0000000 112356789999999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-43 Score=349.92 Aligned_cols=251 Identities=15% Similarity=0.185 Sum_probs=188.1
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccc-eEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLL-AYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~-~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||+||+|+. .+++.||||++.... ..+++..|++++++++|+|+|..+ +++...+..++||||+ +|+
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~ 88 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 88 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCc
Confidence 46799999999999986 467899999886533 234578899999999887766655 4556677889999999 567
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeec---CCCceEEeeccccccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLD---DNEMVLVSDYGFSSLV 427 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DfG~a~~~ 427 (582)
|.+.+..... .+++..++.++.|++.||+|||+++ ||||||||+|||++ .+..+||+|||+|+.+
T Consensus 89 l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-------iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 89 LEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKN-------FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT-------EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred hhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHHCC-------eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 7776654332 4889999999999999999999998 99999999999875 4557999999999876
Q ss_pred cCc-----------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 428 AQP-----------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 428 ~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
... ....||+.|+|||.+.+..++.++|||||||++|||+||+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 432 123478899999999999999999999999999999999999975433211111111111111100
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhccc
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKV 549 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~ 549 (582)
... .......++.+++..||+.+|++||++.++.+.|+.+..
T Consensus 237 -~~~----------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 237 -IEV----------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -HHH----------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -hhH----------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 000 000112367889999999999999999999888876643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=359.63 Aligned_cols=255 Identities=20% Similarity=0.292 Sum_probs=186.4
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCccccceEEEeC------CeeEEEEEe
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNLLPLLAYYFSN------DEKLLVYKF 345 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e~ 345 (582)
.++||+|+||+||+|+.. +++.||||++..... .+.+|+++|++++|||||+++++|... .+.++||||
T Consensus 25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred eeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 467999999999999975 688999999965432 234799999999999999999998653 247899999
Q ss_pred CCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC-ceEEeecccc
Q 047954 346 AGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE-MVLVSDYGFS 424 (582)
Q Consensus 346 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfG~a 424 (582)
|+++.+..+.+... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 101 ~~~~~~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~yLH~~~-------IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 101 VPETVYRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIHSFG-------ICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp CSEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHTTT-------EECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred cCCccHHHHHhhhh---ccCCCCHHHHHHHHHHHHHHHHHHHhcC-------CcccCCCcceEEEecCCCceeEecccch
Confidence 98764443332111 1235899999999999999999999998 99999999999999775 8999999999
Q ss_pred ccccCc---ccccccccccCCCCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh-----
Q 047954 425 SLVAQP---IAAQRMISYKSPEYQSS-KKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE----- 495 (582)
Q Consensus 425 ~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~----- 495 (582)
+..... ....++..|+|||.+.+ ..++.++||||+||++|||++|+.||.... ..+....+.+....
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~----~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS----GVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS----HHHHHHHHHHHHCCCCHHH
T ss_pred hhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC----HHHHHHHHHHHhCCChHHh
Confidence 876543 23446788999998765 578999999999999999999999996432 22222222111110
Q ss_pred ------cc----cccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 496 ------EW----TAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 496 ------~~----~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
.. .......... .........++.+|+.+||..||++|||+.|+++|.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 306 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWT-KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGG-GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhccchhhccccccccCchh-hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 00 0000000000 00001112357789999999999999999999998653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-42 Score=345.41 Aligned_cols=256 Identities=14% Similarity=0.178 Sum_probs=197.8
Q ss_pred cccccccCceEEEEEEEc-CCceEEEEEecCCCcchHHHHHHHHHHHhcCCC-CCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 273 AEGLGKGIFGNSYKALLE-GRAPVVVKRLRDLKPLITEEFRKQLLVIADQKH-PNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
.+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|++.+..+.| +|++.+++++......++||||+ +|+
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~ 86 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 86 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCC
Confidence 467999999999999965 67889999885432 23457788899998866 89999999999999999999999 689
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC-----CCceEEeeccccc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD-----NEMVLVSDYGFSS 425 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~DfG~a~ 425 (582)
|.+++..... .+++..+..++.|++.||+|||+.+ ||||||||+|||++. ++.+||+|||+|+
T Consensus 87 l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH~~g-------iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 87 LEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKS-------LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTTT-------EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred HHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHHHCC-------ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 9998875432 4889999999999999999999998 999999999999974 5679999999998
Q ss_pred cccCc-----------ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHh
Q 047954 426 LVAQP-----------IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVR 494 (582)
Q Consensus 426 ~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 494 (582)
.+... ....||+.|||||.+.+..++.++|||||||++|||+||+.||...... ........+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~-~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-TNKQKYERIGEKKQ 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-CHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch-hHHHHHHHHHhccC
Confidence 76432 1234789999999999999999999999999999999999999753322 11111111111111
Q ss_pred hcccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcccCCCCc
Q 047954 495 EEWTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIKVTESTE 554 (582)
Q Consensus 495 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 554 (582)
.....++ ......++.+++..|+..+|++||+++.+.+.|+++.......
T Consensus 234 ~~~~~~l----------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 234 STPLREL----------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp HSCHHHH----------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CCChHHh----------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 1000000 0011235788889999999999999999998888775544433
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-43 Score=348.07 Aligned_cols=257 Identities=19% Similarity=0.283 Sum_probs=197.4
Q ss_pred ccccccCceEEEEEEE-cCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeCCeeEEEEEeCCCCC
Q 047954 274 EGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSNDEKLLVYKFAGNGN 350 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 350 (582)
+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+.+|++++|||||++++++.+....++|+||+.+++
T Consensus 8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~ 87 (292)
T d1unla_ 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence 5799999999999996 467889999986432 3456789999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccccccccCc
Q 047954 351 LFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSSLVAQP 430 (582)
Q Consensus 351 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~~~~~~ 430 (582)
|..++.... .+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||.|+.....
T Consensus 88 l~~~~~~~~------~~~~~~~~~~~~q~~~aL~~lH~~~-------IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 88 KKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHSRN-------VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp HHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ccccccccc------ccchhHHHHHHHHHHHHHHHhhcCC-------EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 988876432 4788899999999999999999998 999999999999999999999999999876543
Q ss_pred c----cccccccccCCCCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccc-----
Q 047954 431 I----AAQRMISYKSPEYQSSKK-ISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAE----- 500 (582)
Q Consensus 431 ~----~~~~~~~y~aPE~~~~~~-~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 500 (582)
. ...++..|+|||.+.... ++.++||||+||++|||++|+.||.... +..+....+...........
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS---SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC---CHHHHHHHHHhhcCCCChhhhhhhh
Confidence 2 233557799999887655 6999999999999999999999985321 22222222222211100000
Q ss_pred -c--------cchhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 501 -I--------FDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 501 -~--------~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
. .................+.+|+.+||+.||++|||++|+++|.|.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence 0 000000000001112357788999999999999999999998764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.4e-42 Score=349.54 Aligned_cols=252 Identities=16% Similarity=0.288 Sum_probs=190.7
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCC-CCCccccceEEEeC--CeeEEEEEeCCC
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-HPNLLPLLAYYFSN--DEKLLVYKFAGN 348 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~e~~~~ 348 (582)
.+.||+|+||+||+|+. .+++.||||+++.. ..+.+.+|+.+|++++ ||||+++++++... ...++|||||.+
T Consensus 40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~ 116 (328)
T d3bqca1 40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCS
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCC
Confidence 46799999999999996 56888999998643 3567899999999995 99999999999854 468999999999
Q ss_pred CChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCC-ceEEeeccccccc
Q 047954 349 GNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNE-MVLVSDYGFSSLV 427 (582)
Q Consensus 349 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DfG~a~~~ 427 (582)
++|..+.+ .+++..+..++.||+.||+|||+++ ||||||||+|||++.++ .+||+|||+|+..
T Consensus 117 ~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH~~g-------IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 117 TDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSMG-------IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp CBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHHHTT-------EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred CcHHHHhc---------CCCHHHHHHHHHHHHHHHHHHhhcc-------cccccccccceEEcCCCCeeeecccccceec
Confidence 99976542 4888999999999999999999998 99999999999998655 6999999999876
Q ss_pred cCc---ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc-------
Q 047954 428 AQP---IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE------- 496 (582)
Q Consensus 428 ~~~---~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~------- 496 (582)
... ....+|..|+|||.+.+. .++.++||||+||++|||++|+.||..... ..+....+.......
T Consensus 181 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~---~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---NYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS---HHHHHHHHHHHHCHHHHHHHHH
T ss_pred cCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch---hHHHHHHHHHHHCCchhhhhhh
Confidence 543 233467889999997765 579999999999999999999999964321 111111111111000
Q ss_pred -----ccc---cccc-------hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhh
Q 047954 497 -----WTA---EIFD-------SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEI 546 (582)
Q Consensus 497 -----~~~---~~~d-------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 546 (582)
... .... ..............++.+|+.+||..||++|||++|+++|.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F 322 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 000 0000 0000000001112357889999999999999999999998775
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-43 Score=351.49 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=194.4
Q ss_pred cccccccCceEEEEEEEc----CCceEEEEEecCCC----cchHHHHHHHHHHHhcCCC-CCccccceEEEeCCeeEEEE
Q 047954 273 AEGLGKGIFGNSYKALLE----GRAPVVVKRLRDLK----PLITEEFRKQLLVIADQKH-PNLLPLLAYYFSNDEKLLVY 343 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 343 (582)
.+.||+|+||+||+|+.. +++.||||.++... ....+.+.+|++++++++| |||+++++++.+....++||
T Consensus 29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~ 108 (322)
T d1vzoa_ 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 108 (322)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence 578999999999999852 46889999986421 2234668899999999977 89999999999999999999
Q ss_pred EeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeeccc
Q 047954 344 KFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGF 423 (582)
Q Consensus 344 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~ 423 (582)
||+.+|+|.+++.... .+.......++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+
T Consensus 109 e~~~~~~L~~~i~~~~------~~~e~~~~~~~~Qi~~al~~lH~~~-------ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 109 DYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKLG-------IIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp CCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ecccccHHHHHHHhcc------cccHHHHHHHHHHHHHHHHHhhcCC-------EEeccCCccceeecCCCCEEEeeccc
Confidence 9999999999997543 3567888899999999999999998 99999999999999999999999999
Q ss_pred cccccCc-----ccccccccccCCCCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhc
Q 047954 424 SSLVAQP-----IAAQRMISYKSPEYQSSK--KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREE 496 (582)
Q Consensus 424 a~~~~~~-----~~~~~~~~y~aPE~~~~~--~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 496 (582)
|+.+... ....+++.|+|||.+.+. .++.++|||||||+||||+||+.||...... +....+.+.....
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~----~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRILKS 251 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHHHHC
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcccC
Confidence 9876432 234467889999988754 4688999999999999999999999754322 2222232222111
Q ss_pred ccccccchhhhhhhchHHHHHHHHHHHHHcccCCCCCCC-----ChHHHHHHHhh
Q 047954 497 WTAEIFDSEISVQRSAAHGMLKLLQVAIQCCNKSPEKRP-----EMAEVVSELEI 546 (582)
Q Consensus 497 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 546 (582)
.. .+ +.....++.+++.+||+.||++|| |++|+++|.+.
T Consensus 252 ~~-~~----------~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff 295 (322)
T d1vzoa_ 252 EP-PY----------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295 (322)
T ss_dssp CC-CC----------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred CC-CC----------cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence 11 00 011123678899999999999999 48999988774
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=348.34 Aligned_cols=257 Identities=20% Similarity=0.312 Sum_probs=190.7
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeC-----CeeEEEEE
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN-----DEKLLVYK 344 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e 344 (582)
.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+.+|++++|||||++++++... ...+++++
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~ 102 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence 36799999999999995 568899999997543 23446788999999999999999999998743 33467778
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
|+.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 103 ~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~~g-------iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 103 HLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSAD-------IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp ECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHhCC-------CcccccCCccccccccccccccccchh
Confidence 88899999998532 4889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCc-ccccccccccCCCCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhhccccccc
Q 047954 425 SLVAQP-IAAQRMISYKSPEYQSSK-KISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVREEWTAEIF 502 (582)
Q Consensus 425 ~~~~~~-~~~~~~~~y~aPE~~~~~-~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (582)
...... ....++..|+|||...+. .++.++||||+||++|||++|+.||... +.......+....... ..+..
T Consensus 169 ~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~----~~~~~~~~i~~~~~~~-~~~~~ 243 (348)
T d2gfsa1 169 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT----DHIDQLKLILRLVGTP-GAELL 243 (348)
T ss_dssp -CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCC-CHHHH
T ss_pred cccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcCCC-ChHHh
Confidence 776543 334577889999986665 4689999999999999999999999643 2222222222211100 00000
Q ss_pred ----c-------------hhhhhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 503 ----D-------------SEISVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 503 ----d-------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
. +.............++.+|+.+||..||++|||++|+++|.|.-.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 0 000000000011235778999999999999999999999977543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=347.45 Aligned_cols=255 Identities=18% Similarity=0.257 Sum_probs=186.2
Q ss_pred ccccccCceEEEEEEEc-CCceEEEEEecCCC--cchHHHHHHHHHHHhcCCCCCccccceEEEeC------CeeEEEEE
Q 047954 274 EGLGKGIFGNSYKALLE-GRAPVVVKRLRDLK--PLITEEFRKQLLVIADQKHPNLLPLLAYYFSN------DEKLLVYK 344 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~e 344 (582)
+.||+|+||+||+|... +++.||||++.... ......+.+|+.++++++|||||+++++|... ...|+|||
T Consensus 23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~E 102 (355)
T d2b1pa1 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102 (355)
T ss_dssp EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEe
Confidence 57999999999999965 68999999997532 33445788999999999999999999999743 57899999
Q ss_pred eCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecCCCceEEeecccc
Q 047954 345 FAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFS 424 (582)
Q Consensus 345 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a 424 (582)
||.+ ++.+.+.. .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 103 y~~~-~l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~g-------iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 103 LMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp CCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT-------CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred ccch-HHHHhhhc--------CCCHHHHHHHHHHHHHHHHHhhhcc-------cccccCCccccccccccceeeechhhh
Confidence 9965 55555532 3788999999999999999999998 999999999999999999999999998
Q ss_pred ccccCc---ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccchHHHHHHHHhh------
Q 047954 425 SLVAQP---IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGADLCSWVLRAVRE------ 495 (582)
Q Consensus 425 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~------ 495 (582)
+..... ....+|..|+|||++.+..++.++||||+||++|||++|+.||.... .......+......
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~----~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD----YIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCHHHH
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC----HHHHHHHHHHhccCCCHHHH
Confidence 776543 23347789999999999999999999999999999999999996432 11111111111100
Q ss_pred ------------ccc--c-----cccchhh-h-hhhchHHHHHHHHHHHHHcccCCCCCCCChHHHHHHHhhcc
Q 047954 496 ------------EWT--A-----EIFDSEI-S-VQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVVSELEIIK 548 (582)
Q Consensus 496 ------------~~~--~-----~~~d~~~-~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~ 548 (582)
... . ..+.... . ...........+.+|+.+||..||++|||++|+++|.|.-.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 000 0 0000000 0 00111233456889999999999999999999999987643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.1e-37 Score=314.16 Aligned_cols=264 Identities=18% Similarity=0.263 Sum_probs=186.2
Q ss_pred cccccccCceEEEEEEE-cCCceEEEEEecCCCcchHHHHHHHHHHHhcCC-----------CCCccccceEEEeC--Ce
Q 047954 273 AEGLGKGIFGNSYKALL-EGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-----------HPNLLPLLAYYFSN--DE 338 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~~~--~~ 338 (582)
.+.||+|+||+||+|+. .+++.||||+++.. ....+.+.+|+.++++++ |+|||++++++... ..
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~ 96 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccc
Confidence 46899999999999996 57889999999753 234567788998888775 57899999988653 45
Q ss_pred eEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhc-cCCCCCCCcceecCCCCCCeeecCCCc--
Q 047954 339 KLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH-KDKSRTQSAVIHGNLKSTNILLDDNEM-- 415 (582)
Q Consensus 339 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~~~~ivH~Dlkp~NILl~~~~~-- 415 (582)
.+++++++..+.......... ....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~i~~qil~al~~lh~~~~-------IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 97 VHVVMVFEVLGENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCG-------IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEECCCCEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC-------EECSCCSGGGEEEEEEETTT
T ss_pred eeeeeeecccccccccccccc---cccCCcHHHHHHHHHHHHHHHHHHhhhcC-------cccccCChhHeeeeccCccc
Confidence 677777776655433332221 12357888999999999999999998 65 999999999999986553
Q ss_pred ----eEEeeccccccccCc-ccccccccccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCccc--hHHH
Q 047954 416 ----VLVSDYGFSSLVAQP-IAAQRMISYKSPEYQSSKKISRKSDVWSFGCLLLELLTGRISTHSAPQGINGAD--LCSW 488 (582)
Q Consensus 416 ----~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwS~Gvvl~elltG~~P~~~~~~~~~~~~--~~~~ 488 (582)
+|++|||.|...... ....+++.|+|||.+....++.++||||+||+++||++|+.||........... ....
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp TEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred ccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 899999999765443 344578899999999999999999999999999999999999975432111111 0110
Q ss_pred HHHHHhh---------cccccccc--------------h---hh-hhhhchHHHHHHHHHHHHHcccCCCCCCCChHHHH
Q 047954 489 VLRAVRE---------EWTAEIFD--------------S---EI-SVQRSAAHGMLKLLQVAIQCCNKSPEKRPEMAEVV 541 (582)
Q Consensus 489 ~~~~~~~---------~~~~~~~d--------------~---~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 541 (582)
....+.. .......+ + .. ...........++.+|+.+||+.||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 1111000 00000000 0 00 00112234556789999999999999999999999
Q ss_pred HHHhhc
Q 047954 542 SELEII 547 (582)
Q Consensus 542 ~~L~~i 547 (582)
+|.+.-
T Consensus 327 ~Hp~f~ 332 (362)
T d1q8ya_ 327 NHPWLK 332 (362)
T ss_dssp TCGGGT
T ss_pred cCcccC
Confidence 997654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=5.6e-24 Score=197.10 Aligned_cols=163 Identities=16% Similarity=0.184 Sum_probs=120.1
Q ss_pred cccccccccCceEEEEEEEcCCceEEEEEecCCCc------------------chHHHHHHHHHHHhcCCCCCccccceE
Q 047954 271 APAEGLGKGIFGNSYKALLEGRAPVVVKRLRDLKP------------------LITEEFRKQLLVIADQKHPNLLPLLAY 332 (582)
Q Consensus 271 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~H~niv~l~~~ 332 (582)
+.++.||+|+||.||+|...+++.||||+++.... ........|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45688999999999999998999999998753110 011234568889999999999988765
Q ss_pred EEeCCeeEEEEEeCCCCChHHHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhccCCCCCCCcceecCCCCCCeeecC
Q 047954 333 YFSNDEKLLVYKFAGNGNLFNRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHHKDKSRTQSAVIHGNLKSTNILLDD 412 (582)
Q Consensus 333 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~~~~ivH~Dlkp~NILl~~ 412 (582)
. ..+++|||++++.+.+ ++......++.|+++||+|||+++ |+||||||+|||+++
T Consensus 83 ~----~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~g-------iiHrDiKP~NILv~~ 138 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHRG-------IVHGDLSQYNVLVSE 138 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHTT-------EECSCCSTTSEEEET
T ss_pred c----CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhCC-------EEEccCChhheeeeC
Confidence 3 2379999998755432 334456678999999999999998 999999999999996
Q ss_pred CCceEEeeccccccccCcccccccccccC------CCCCCCCCCCcchhHHHHHHHH
Q 047954 413 NEMVLVSDYGFSSLVAQPIAAQRMISYKS------PEYQSSKKISRKSDVWSFGCLL 463 (582)
Q Consensus 413 ~~~~kl~DfG~a~~~~~~~~~~~~~~y~a------PE~~~~~~~~~k~DVwS~Gvvl 463 (582)
+ .++|+|||+|.....+.... |.. .+.+ ...|+.++|+||..--+
T Consensus 139 ~-~~~liDFG~a~~~~~~~~~~----~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 139 E-GIWIIDFPQSVEVGEEGWRE----ILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp T-EEEECCCTTCEETTSTTHHH----HHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred C-CEEEEECCCcccCCCCCcHH----HHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 5 58999999997765432211 110 0111 25678889999976443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.88 E-value=4e-23 Score=206.71 Aligned_cols=153 Identities=32% Similarity=0.519 Sum_probs=115.0
Q ss_pred CCCC--CcceeeeCCCC--CeEEEEEeCCCccee--ccCccccCCCCCCcEEEccC-CccccccC-CCCCCCCCCEEe--
Q 047954 6 DFPS--QWYGIQCDINS--AHVTGIVLEDMRLNG--EIKSDAFADIPELIVINFKN-NIISGNFM-NFSSNHKLKDID-- 75 (582)
Q Consensus 6 ~~~~--~w~gv~c~~~~--~~~~~l~l~~~~l~g--~ip~~~~~~l~~L~~l~l~~-n~~~g~~~-~~~~~~~l~~l~-- 75 (582)
..+| .|.||+|+... .||+.|+|++|+++| +||+ .+++|++|++|+|++ |+|+|.+| .++++++|++|+
T Consensus 31 ~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls 109 (313)
T d1ogqa_ 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYIT 109 (313)
T ss_dssp SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEE
T ss_pred CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh-HHhcCccccccccccccccccccccccccccccchhhhc
Confidence 4567 59999998533 379999999999998 5765 488999999999986 88998876 355554443333
Q ss_pred ----------------------------------------------CCCCccccccccc---------------------
Q 047954 76 ----------------------------------------------LSGNKFYGEISRS--------------------- 88 (582)
Q Consensus 76 ----------------------------------------------l~~N~l~g~ip~~--------------------- 88 (582)
|++|.++|.+|..
T Consensus 110 ~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~ 189 (313)
T d1ogqa_ 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189 (313)
T ss_dssp EECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEE
T ss_pred cccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccc
Confidence 3333333333331
Q ss_pred --------------------------------------------------ccCCCcCCeeecccCcccCCCCCC--CCCC
Q 047954 89 --------------------------------------------------LLSLKFLESLQLQNNNLTGPVPEF--NQSS 116 (582)
Q Consensus 89 --------------------------------------------------~~~l~~l~~l~l~~N~l~g~ip~~--~~~~ 116 (582)
++.+++|++|+|++|+|+|.||.. .+++
T Consensus 190 ~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~ 269 (313)
T d1ogqa_ 190 IPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269 (313)
T ss_dssp CCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCC
Confidence 122456778888888888888874 6789
Q ss_pred CCEEEeecCcccccCCCCCcccccccccccCCCCCCCCCCCCCC
Q 047954 117 LKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGPPSLNNC 160 (582)
Q Consensus 117 l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l~~~~~~~~~ 160 (582)
|+.|+|++|+|+|.||....+..+..+++.+|+.+||.|. ..|
T Consensus 270 L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl-p~c 312 (313)
T d1ogqa_ 270 LHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL-PAC 312 (313)
T ss_dssp CCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS-SCC
T ss_pred CCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC-CCC
Confidence 9999999999999999887888999999999999999763 355
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.62 E-value=3.1e-16 Score=144.36 Aligned_cols=146 Identities=21% Similarity=0.352 Sum_probs=110.3
Q ss_pred CCcceeeeCCCC---------CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCC
Q 047954 9 SQWYGIQCDINS---------AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSG 78 (582)
Q Consensus 9 ~~w~gv~c~~~~---------~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~ 78 (582)
|+|..|.|+... ..++.|+|++|++++.++...++.+++|+.|+|++|.+.+.++ .+..+.+|+.|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 679999996421 3578899999999888877778889999999999999988876 467788899999999
Q ss_pred CcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCCCcccccccccccCCCCCCCC
Q 047954 79 NKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNPYLCGP 154 (582)
Q Consensus 79 N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l~~~ 154 (582)
|++++..|..|.++++|++|+|++|+|++..|.. .+++|++|+|++|.+.+..+.......+....+..|...|..
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCC
Confidence 9999777778888999999999999998765553 678899999999988765432211222333344455555543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.53 E-value=2.1e-15 Score=149.77 Aligned_cols=109 Identities=29% Similarity=0.452 Sum_probs=97.3
Q ss_pred EEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCc
Q 047954 25 GIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNN 104 (582)
Q Consensus 25 ~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~ 104 (582)
.+++.++.+.|.+|. .++.+++|+.+++++|.++|.+|.+..+++|+.|+|++|+|+|.||.+|++|++|++|||++|+
T Consensus 201 ~l~l~~~~~~~~~~~-~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~ 279 (313)
T d1ogqa_ 201 FVDLSRNMLEGDASV-LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279 (313)
T ss_dssp EEECCSSEEEECCGG-GCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCc
Confidence 466777777777754 4788999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCC-CCCCCCEEEeecCc-cccc-CCCC
Q 047954 105 LTGPVPEF-NQSSLKVFNVSNNN-LSGS-IPKT 134 (582)
Q Consensus 105 l~g~ip~~-~~~~l~~l~ls~N~-l~g~-ip~~ 134 (582)
|+|.||.. .+++|+.+++++|+ ++|. +|.+
T Consensus 280 l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 280 LCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp EEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred ccccCCCcccCCCCCHHHhCCCccccCCCCCCC
Confidence 99999986 68899999999997 6774 6753
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.48 E-value=8.1e-14 Score=127.81 Aligned_cols=126 Identities=21% Similarity=0.303 Sum_probs=108.2
Q ss_pred EEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC--CCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 24 TGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM--NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 24 ~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~--~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
+.++.++++|+ +||.. + -+++++|+|++|.|++.++ .|.++++|+.|+|++|++.+.++..+..+++|++|+|+
T Consensus 11 ~~v~Cs~~~L~-~iP~~-l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRD-I--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSC-C--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEEeCCCcC-ccCCC-C--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 36899999999 78865 3 2689999999999998774 46889999999999999999999999999999999999
Q ss_pred cCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCCC
Q 047954 102 NNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 102 ~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~~ 153 (582)
+|++++-.|.. .+++|+.|+|++|+|++..|.. ..+..+..+.+++|+..|.
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 99999765653 6899999999999999866654 4577888899999987654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=3.1e-12 Score=123.40 Aligned_cols=130 Identities=24% Similarity=0.274 Sum_probs=87.1
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCc-------------------
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNK------------------- 80 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~------------------- 80 (582)
.++++.|+|++|+++ .||. ++.+++|+.|+|++|++++..+.+.++++|+.|+|++|.
T Consensus 54 l~~L~~L~L~~N~l~-~l~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~ 130 (266)
T d1p9ag_ 54 YTRLTQLNLDRAELT-KLQV--DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (266)
T ss_dssp CTTCCEEECTTSCCC-EEEC--CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred ccccccccccccccc-cccc--ccccccccccccccccccccccccccccccccccccccccceeecccccccccccccc
Confidence 567888888888887 4543 567888888888888888766555555555555555554
Q ss_pred -----ccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCC
Q 047954 81 -----FYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLC 152 (582)
Q Consensus 81 -----l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~ 152 (582)
+++..|..+..++.|+.|++++|+|++..|.. .+++|+.|+|++|+|+ .||.. ..+..+..+.++||++.|
T Consensus 131 l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 44333444555667777777777777655542 4677777777777777 67654 345566777777777766
Q ss_pred C
Q 047954 153 G 153 (582)
Q Consensus 153 ~ 153 (582)
.
T Consensus 210 d 210 (266)
T d1p9ag_ 210 N 210 (266)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.29 E-value=3.9e-12 Score=107.37 Aligned_cols=100 Identities=17% Similarity=0.202 Sum_probs=81.5
Q ss_pred EEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCc
Q 047954 25 GIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNN 104 (582)
Q Consensus 25 ~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~ 104 (582)
.|+|++|+++ .++ .++.++.|++|+|++|.++.-.+.++.+++|+.|+|++|.+++ +| .+.++++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~--~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC--HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC--CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc--ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 5889999998 554 3788999999999999998644568889999999999999985 55 48999999999999999
Q ss_pred ccCCCC--C-CCCCCCCEEEeecCcccc
Q 047954 105 LTGPVP--E-FNQSSLKVFNVSNNNLSG 129 (582)
Q Consensus 105 l~g~ip--~-~~~~~l~~l~ls~N~l~g 129 (582)
++..-. . ..+++|+.|++++|.+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 984321 1 267889999999999875
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=3.1e-12 Score=124.63 Aligned_cols=132 Identities=20% Similarity=0.297 Sum_probs=93.8
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
.+++..|+|++|.+.+.. ...+..+++|+.+++++|+|++..+. +..+.+|+.|+|++|+|++..|..+.++++|+.|
T Consensus 104 l~~L~~L~l~~n~~~~~~-~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l 182 (284)
T d1ozna_ 104 LGRLHTLHLDRCGLQELG-PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182 (284)
T ss_dssp CTTCCEEECTTSCCCCCC-TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cccCCEEecCCccccccc-ccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchh
Confidence 356777777777776443 34566777777778887777765553 5566778888888888877777777778888888
Q ss_pred ecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC-CcccccccccccCCCCCC
Q 047954 99 QLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLC 152 (582)
Q Consensus 99 ~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~ 152 (582)
++++|++++..|.. .+++|+.|++++|.+.+..|.. ..+..+..+++++|+.-|
T Consensus 183 ~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred hhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 88888888766654 5677888888888887655533 345667777777887665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.26 E-value=5.5e-12 Score=106.41 Aligned_cols=99 Identities=21% Similarity=0.272 Sum_probs=84.2
Q ss_pred cEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC-CCCCCCEEEeecCcc
Q 047954 49 IVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF-NQSSLKVFNVSNNNL 127 (582)
Q Consensus 49 ~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~-~~~~l~~l~ls~N~l 127 (582)
++|+|++|+++ .++.+..+.+|++|||++|.++ .+|+.++.+++|+.|+|++|.+++ +|.. .+++|+.|++++|.+
T Consensus 1 R~L~Ls~n~l~-~l~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRL 77 (124)
T ss_dssp SEEECTTSCCS-SCCCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCC
T ss_pred CEEEcCCCCCC-CCcccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cCccccccccCeEECCCCcc
Confidence 57999999998 6678999999999999999998 689999999999999999999995 5654 789999999999999
Q ss_pred cccC--CCCCcccccccccccCCCC
Q 047954 128 SGSI--PKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 128 ~g~i--p~~~~~~~~~~~~~~~n~~ 150 (582)
+..- .....+..+..+++++|+.
T Consensus 78 ~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 78 QQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp CSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred CCCCCchhhcCCCCCCEEECCCCcC
Confidence 8532 2234566788889999974
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.20 E-value=5.4e-12 Score=122.88 Aligned_cols=112 Identities=23% Similarity=0.238 Sum_probs=100.4
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
...+..+++++|++++ ||+..+..++.|+.|+|++|+|++..+ .+.++++|+.|+|++|++++..|..|.++++|++|
T Consensus 128 ~~~L~~l~l~~N~l~~-i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L 206 (284)
T d1ozna_ 128 LAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206 (284)
T ss_dssp CTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred hcccchhhhccccccc-cChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccc
Confidence 4568899999999985 566778999999999999999998876 47889999999999999999999999999999999
Q ss_pred ecccCcccCCCCCC--CCCCCCEEEeecCcccccCC
Q 047954 99 QLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIP 132 (582)
Q Consensus 99 ~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip 132 (582)
|+++|.+++..|.. .+.+|+.|+|++|.+.+.-+
T Consensus 207 ~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp ECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred cccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 99999999877653 78999999999999997654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=7.7e-11 Score=113.37 Aligned_cols=105 Identities=18% Similarity=0.148 Sum_probs=81.5
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeec
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l 100 (582)
..++.|+|++|++++ ||+..+..+++|++|+|++|+|+ .++.++.+++|+.|+|++|++++ +|..+.++++|+.|+|
T Consensus 31 ~~l~~L~Ls~N~i~~-l~~~~f~~l~~L~~L~L~~N~l~-~l~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCC-EEECCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCC-cCHHHhhcccccccccccccccc-ccccccccccccccccccccccc-cccccccccccccccc
Confidence 458899999999986 55667999999999999999998 56777889999999999999985 4677888999999999
Q ss_pred ccCcccCCCCCC--CCCCCCEEEeecCccc
Q 047954 101 QNNNLTGPVPEF--NQSSLKVFNVSNNNLS 128 (582)
Q Consensus 101 ~~N~l~g~ip~~--~~~~l~~l~ls~N~l~ 128 (582)
++|.+.+..+.. .+.+|..|++++|.++
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~ 137 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELK 137 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred cccccceeeccccccccccccccccccccc
Confidence 988877543321 2334444444444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.16 E-value=3.6e-11 Score=106.38 Aligned_cols=104 Identities=20% Similarity=0.220 Sum_probs=74.9
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeec
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQL 100 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l 100 (582)
..+..|+|++|+++. || ..+..+++|+.|+|++|.++ .++.+..+++|+.|+|++|+++...+..+..+++|+.|+|
T Consensus 18 ~~lr~L~L~~n~I~~-i~-~~~~~l~~L~~L~Ls~N~i~-~l~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIPV-IE-NLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCCS-CC-CGGGGTTCCSEEECCSSCCC-EECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCCc-cC-ccccccccCCEEECCCCCCC-ccCCcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 356778888888764 44 34566788888888888887 4566777888888888888887544444567888888888
Q ss_pred ccCcccCCCCC----CCCCCCCEEEeecCccc
Q 047954 101 QNNNLTGPVPE----FNQSSLKVFNVSNNNLS 128 (582)
Q Consensus 101 ~~N~l~g~ip~----~~~~~l~~l~ls~N~l~ 128 (582)
++|+++. ++. ..+++|+.|++++|.++
T Consensus 95 ~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 95 TNNSLVE-LGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccccccc-cccccccccccccchhhcCCCccc
Confidence 8888763 232 25677888888888775
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.08 E-value=1.5e-10 Score=107.08 Aligned_cols=121 Identities=26% Similarity=0.339 Sum_probs=59.6
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
+++.|+|++|.+++ +++ ++.+++|++|++++|++++ +|.+..+++|+.|++++|.+.. + ..+..++.|+.++++
T Consensus 69 ~L~~L~L~~n~i~~-l~~--~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~ 142 (210)
T d1h6ta2 69 NVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLG 142 (210)
T ss_dssp TCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECC
T ss_pred CCCEEeCCCccccC-ccc--cccCccccccccccccccc-cccccccccccccccccccccc-c-ccccccccccccccc
Confidence 34455555555544 221 3445555555555555443 3334444455555555554431 1 234444555555555
Q ss_pred cCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCC
Q 047954 102 NNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNP 149 (582)
Q Consensus 102 ~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~ 149 (582)
+|.+++..+...+++|+.+++++|++++ ++....+..+..+++++|.
T Consensus 143 ~n~l~~~~~~~~l~~L~~l~l~~n~l~~-i~~l~~l~~L~~L~Ls~N~ 189 (210)
T d1h6ta2 143 NNKITDITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNH 189 (210)
T ss_dssp SSCCCCCGGGGGCTTCSEEECCSSCCCC-CGGGTTCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccccccc-cccccCCCCCCEEECCCCC
Confidence 5555443333345666666666666664 3333445556666666663
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.04 E-value=3.4e-10 Score=103.73 Aligned_cols=120 Identities=28% Similarity=0.368 Sum_probs=68.0
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
.++.|++++|+++- ++ .+..+++|++|+|++|.+++..| +.++++|+.|++++|.+.. +| .+.+++.|+.|+++
T Consensus 41 ~l~~L~l~~~~i~~-l~--~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 41 QVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLF 114 (199)
T ss_dssp TCCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCCC-cc--ccccCCCcCcCccccccccCccc-ccCCccccccccccccccc-cc-cccccccccccccc
Confidence 45666666666652 32 25566667777777776665433 6666666666666666553 33 25566666666666
Q ss_pred cCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCC
Q 047954 102 NNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNN 148 (582)
Q Consensus 102 ~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n 148 (582)
+|.++...+-..++.|+.|++++|.+.. +|....+..+..+.+.+|
T Consensus 115 ~~~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n 160 (199)
T d2omxa2 115 NNQITDIDPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSN 160 (199)
T ss_dssp SSCCCCCGGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSS
T ss_pred ccccccccccchhhhhHHhhhhhhhhcc-cccccccccccccccccc
Confidence 6666554333355666666666666542 333333444444555544
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.03 E-value=1.7e-10 Score=116.51 Aligned_cols=121 Identities=17% Similarity=0.237 Sum_probs=74.5
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCC----------------------CCCCEEeCC
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSN----------------------HKLKDIDLS 77 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~----------------------~~l~~l~l~ 77 (582)
...+..|++++|.+++..+ ++.+++|+.|++++|.+++..+ +.++ .+|+.|+|+
T Consensus 240 l~~L~~L~l~~n~l~~~~~---~~~~~~L~~L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls 315 (384)
T d2omza2 240 LTNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISPISNLKNLTYLTLY 315 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG---GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECC
T ss_pred ccccchhccccCccCCCCc---ccccccCCEeeccCcccCCCCc-cccccccccccccccccccccccchhcccCeEECC
Confidence 3567888999999887543 6788889999999888886532 3333 455666666
Q ss_pred CCcccccccccccCCCcCCeeecccCcccCCCCCC-CCCCCCEEEeecCcccccCCCCCcccccccccccCC
Q 047954 78 GNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNN 148 (582)
Q Consensus 78 ~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~-~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n 148 (582)
+|++++..| +..+++|+.|+|++|++++ +|.. .+++|+.|++++|++++-.| ...+..+..+.+++|
T Consensus 316 ~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 316 FNNISDISP--VSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp SSCCSCCGG--GGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCCCCCCcc--cccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 666665322 5556666666666666654 3332 45566666666666665433 334445555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.01 E-value=3.7e-10 Score=104.40 Aligned_cols=121 Identities=20% Similarity=0.304 Sum_probs=99.4
Q ss_pred CCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 19 NSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 19 ~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
...++..|++++|++++ +| .+..+++|+.|++++|.++ .++.+..++.|+.+++++|.+++ +..+..+++|+.|
T Consensus 88 ~l~~L~~L~l~~n~i~~-l~--~l~~l~~L~~L~l~~~~~~-~~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l 161 (210)
T d1h6ta2 88 NLKNLGWLFLDENKVKD-LS--SLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTL 161 (210)
T ss_dssp TCTTCCEEECCSSCCCC-GG--GGTTCTTCCEEECTTSCCC-CCGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEE
T ss_pred cCccccccccccccccc-cc--ccccccccccccccccccc-ccccccccccccccccccccccc--ccccccccccccc
Confidence 35679999999999986 54 3889999999999999986 46678889999999999999986 3457889999999
Q ss_pred ecccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCccccccccccc
Q 047954 99 QLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYS 146 (582)
Q Consensus 99 ~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~ 146 (582)
++++|++++..|-..+++|+.|+|++|.++. ||....+..+..++++
T Consensus 162 ~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 162 SLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELF 208 (210)
T ss_dssp ECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEE
T ss_pred ccccccccccccccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEcc
Confidence 9999999975444588999999999999974 6655556666666554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.00 E-value=1.1e-09 Score=107.09 Aligned_cols=73 Identities=23% Similarity=0.278 Sum_probs=55.4
Q ss_pred CCcceeeeCCC---------CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCC-CCCCCCCCEEeCCC
Q 047954 9 SQWYGIQCDIN---------SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMN-FSSNHKLKDIDLSG 78 (582)
Q Consensus 9 ~~w~gv~c~~~---------~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~-~~~~~~l~~l~l~~ 78 (582)
|.|.+|.|+.. .+.++.|+|++|+++. ||+..+.++++|++|++++|.++...|. |.++++|+.|+|++
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~-l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCC-cChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 47999999641 1457889999999874 5555688888898898888888876653 66777777777777
Q ss_pred Cccc
Q 047954 79 NKFY 82 (582)
Q Consensus 79 N~l~ 82 (582)
|+++
T Consensus 89 n~l~ 92 (305)
T d1xkua_ 89 NQLK 92 (305)
T ss_dssp SCCS
T ss_pred CccC
Confidence 7654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.00 E-value=2.3e-10 Score=101.10 Aligned_cols=107 Identities=16% Similarity=0.183 Sum_probs=85.2
Q ss_pred cCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCE
Q 047954 42 FADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKV 119 (582)
Q Consensus 42 ~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~ 119 (582)
+.++..|++|+|++|.++....-+..+.+|+.||||+|.++ .|+ .+..+++|++|+|++|+++.--+.. .+++|+.
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred ccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccc
Confidence 56788999999999999876333467889999999999998 564 5899999999999999998644432 6899999
Q ss_pred EEeecCcccc--cCCCCCcccccccccccCCCC
Q 047954 120 FNVSNNNLSG--SIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 120 l~ls~N~l~g--~ip~~~~~~~~~~~~~~~n~~ 150 (582)
|+|++|+++. .+.....++.+..+++.+|+.
T Consensus 92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred ceeccccccccccccccccccccchhhcCCCcc
Confidence 9999999974 222234566778888888863
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.97 E-value=6.6e-10 Score=97.38 Aligned_cols=104 Identities=14% Similarity=0.125 Sum_probs=83.0
Q ss_pred CcceeeeCCCCCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCc-cccccC-CCCCCCCCCEEeCCCCcccccccc
Q 047954 10 QWYGIQCDINSAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNI-ISGNFM-NFSSNHKLKDIDLSGNKFYGEISR 87 (582)
Q Consensus 10 ~w~gv~c~~~~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~-~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~ 87 (582)
.+.+|+|. ++++. .+|. .+..+++|+.|++++|+ ++...+ .|.++++|+.|+|++|+|+..-|.
T Consensus 9 ~~~~l~c~------------~~~~~-~~p~-~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~ 74 (156)
T d2ifga3 9 GSSGLRCT------------RDGAL-DSLH-HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (156)
T ss_dssp SSSCEECC------------SSCCC-TTTT-TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred CCCeEEec------------CCCCc-cCcc-cccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccc
Confidence 46666664 34443 3443 36778999999998765 776544 588999999999999999987788
Q ss_pred cccCCCcCCeeecccCcccCCCCCC--CCCCCCEEEeecCccc
Q 047954 88 SLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKVFNVSNNNLS 128 (582)
Q Consensus 88 ~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~ 128 (582)
.|..+++|++|+|++|+|+ .||.. ...+|+.|+|++|.|.
T Consensus 75 ~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp GGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 8999999999999999999 66663 4457999999999985
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.97 E-value=8.1e-10 Score=101.12 Aligned_cols=122 Identities=20% Similarity=0.295 Sum_probs=95.3
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQ 99 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~ 99 (582)
..+++.|+|++|++++.. + ++.+++|+.|++++|.+.. ++.+.++.+|+.|++++|.+.... .+..+++|+.|+
T Consensus 61 l~nL~~L~Ls~N~l~~~~-~--l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L~ 134 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDIT-P--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLE 134 (199)
T ss_dssp CTTCCEEECCSSCCCCCG-G--GTTCTTCCEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred CCCcCcCccccccccCcc-c--ccCCccccccccccccccc-cccccccccccccccccccccccc--ccchhhhhHHhh
Confidence 457888999999988743 2 7888999999999988765 445788888999999988887643 377888999999
Q ss_pred cccCcccCCCCC-CCCCCCCEEEeecCcccccCCCCCcccccccccccCCC
Q 047954 100 LQNNNLTGPVPE-FNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNP 149 (582)
Q Consensus 100 l~~N~l~g~ip~-~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~ 149 (582)
+++|+++. +|. ..+++|+.|++++|++++ +|....+..+..+++++|.
T Consensus 135 l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~~-l~~l~~l~~L~~L~ls~N~ 183 (199)
T d2omxa2 135 LSSNTISD-ISALSGLTSLQQLNFSSNQVTD-LKPLANLTTLERLDISSNK 183 (199)
T ss_dssp CCSSCCCC-CGGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCCEEECCSSC
T ss_pred hhhhhhcc-cccccccccccccccccccccC-CccccCCCCCCEEECCCCC
Confidence 99998874 454 367889999999998886 4445567778888888885
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.94 E-value=1.1e-09 Score=107.19 Aligned_cols=128 Identities=23% Similarity=0.264 Sum_probs=104.5
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
...++.+++++|+++ .+|. ..+++|+.|++++|..++.++ .+.+++.++.|++++|.+++..|..+.++++|++|
T Consensus 149 l~~L~~l~l~~n~l~-~l~~---~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L 224 (305)
T d1xkua_ 149 MKKLSYIRIADTNIT-TIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 224 (305)
T ss_dssp CTTCCEEECCSSCCC-SCCS---SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEE
T ss_pred ccccCccccccCCcc-ccCc---ccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceee
Confidence 356888999999887 4653 346899999999999999886 57888999999999999999889999999999999
Q ss_pred ecccCcccCCCCCC--CCCCCCEEEeecCcccccCCCC--------CcccccccccccCCCCCCC
Q 047954 99 QLQNNNLTGPVPEF--NQSSLKVFNVSNNNLSGSIPKT--------QTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 99 ~l~~N~l~g~ip~~--~~~~l~~l~ls~N~l~g~ip~~--------~~~~~~~~~~~~~n~~l~~ 153 (582)
+|++|+|+ .||.. .+++|++|+|++|+++ .|+.. .....+..+++.+|+.-+.
T Consensus 225 ~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 225 HLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp ECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred eccccccc-ccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 99999998 67764 6899999999999988 45432 1234567788999986543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.93 E-value=2.1e-09 Score=94.06 Aligned_cols=110 Identities=16% Similarity=0.154 Sum_probs=88.5
Q ss_pred CCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCc-ccccccccccCCCcCCeeecccCcccCCCCCC--CCCCCCE
Q 047954 43 ADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNK-FYGEISRSLLSLKFLESLQLQNNNLTGPVPEF--NQSSLKV 119 (582)
Q Consensus 43 ~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~-l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~--~~~~l~~ 119 (582)
..+.....++++++.+...+..+..+++|+.|+|++|+ ++..-+..|.++++|+.|+|++|+|+.--|.. .+++|+.
T Consensus 5 C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp SCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CCcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence 44556677999999998877778889999999998765 77555567999999999999999999755552 7899999
Q ss_pred EEeecCcccccCCCC-CcccccccccccCCCCCCC
Q 047954 120 FNVSNNNLSGSIPKT-QTLQLFRSYSYSNNPYLCG 153 (582)
Q Consensus 120 l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~l~~ 153 (582)
|+|++|+|+ .+|.. .....+..+.+++|++-|.
T Consensus 85 L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~ 118 (156)
T d2ifga3 85 LNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCS 118 (156)
T ss_dssp EECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred eeccCCCCc-ccChhhhccccccccccCCCcccCC
Confidence 999999998 56644 3334677889999988663
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.90 E-value=9.9e-12 Score=114.04 Aligned_cols=107 Identities=20% Similarity=0.273 Sum_probs=86.8
Q ss_pred ccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCC-CCCCCCE
Q 047954 41 AFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEF-NQSSLKV 119 (582)
Q Consensus 41 ~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~-~~~~l~~ 119 (582)
.++.|++|+.|+|++|.++ .++.+.++++|+.|+|++|.++ .||.....++.|+.|+|++|+++. ++.. .+++|+.
T Consensus 43 sl~~L~~L~~L~Ls~n~I~-~i~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~~~~~l~~L~~ 119 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGIEKLVNLRV 119 (198)
T ss_dssp HHHHTTTCCEEECSEEEES-CCCCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HHHHHHHHHSSE
T ss_pred HHhcccccceeECcccCCC-CcccccCCccccChhhcccccc-cccccccccccccccccccccccc-cccccccccccc
Confidence 4778999999999999998 5677888999999999999997 677766677889999999999985 4443 6788999
Q ss_pred EEeecCccccc--CCCCCcccccccccccCCCC
Q 047954 120 FNVSNNNLSGS--IPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 120 l~ls~N~l~g~--ip~~~~~~~~~~~~~~~n~~ 150 (582)
|+|++|+++.. +.....++.+..+++++|+.
T Consensus 120 L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l 152 (198)
T d1m9la_ 120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp EEESEEECCCHHHHHHHTTTTTCSEEEECSSHH
T ss_pred cccccchhccccccccccCCCccceeecCCCcc
Confidence 99999998742 22234567788888888863
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.87 E-value=3.3e-09 Score=99.03 Aligned_cols=123 Identities=19% Similarity=0.307 Sum_probs=57.4
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccc-------------
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISR------------- 87 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~------------- 87 (582)
++++.|+|++|++++..| +..++.|+.+++++|.++ .++.+..+++|+.|++++|...+..+-
T Consensus 63 ~~L~~L~ls~n~i~~~~~---l~~l~~l~~l~~~~n~~~-~i~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~ 138 (227)
T d1h6ua2 63 NNLIGLELKDNQITDLAP---LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138 (227)
T ss_dssp TTCCEEECCSSCCCCCGG---GTTCCSCCEEECCSCCCS-CCGGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCS
T ss_pred CCCcEeecCCceeecccc---cccccccccccccccccc-ccccccccccccccccccccccccchhccccchhhhhchh
Confidence 345555555555544321 444555555555555443 233344444455555544444332211
Q ss_pred -------cccCCCcCCeeecccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCC
Q 047954 88 -------SLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNN 148 (582)
Q Consensus 88 -------~~~~l~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n 148 (582)
.+.++++|+.|++++|.+++..+-..+++|+.|+|++|++++ +|....++.+..+.+++|
T Consensus 139 ~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N 205 (227)
T d1h6ua2 139 NQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNN 205 (227)
T ss_dssp SCCCCCGGGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTS
T ss_pred hhhchhhhhccccccccccccccccccchhhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCC
Confidence 123344455555555555443332345555555665555553 333334445555555555
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.79 E-value=5.1e-09 Score=105.41 Aligned_cols=125 Identities=23% Similarity=0.272 Sum_probs=83.8
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccc------------
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISR------------ 87 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~------------ 87 (582)
..+++.|++++|.++. +| .+..+++|+.|++++|.+++.. .+..+++|+.|++++|.+++..|-
T Consensus 218 ~~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~ 293 (384)
T d2omza2 218 LTNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQISNISPLAGLTALTNLELN 293 (384)
T ss_dssp CTTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred cCCCCEEECCCCCCCC-cc--hhhcccccchhccccCccCCCC-cccccccCCEeeccCcccCCCCcccccccccccccc
Confidence 4568899999999986 33 4788999999999999999855 488889999999999999875431
Q ss_pred --------cccCCCcCCeeecccCcccCCCCCCCCCCCCEEEeecCcccccCCCCCcccccccccccCCC
Q 047954 88 --------SLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYSNNP 149 (582)
Q Consensus 88 --------~~~~l~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~ 149 (582)
.+..+++++.|+|++|++++..|-..+++|+.|++++|.+++ +|....++.+..+++++|.
T Consensus 294 ~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~ 362 (384)
T d2omza2 294 ENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQ 362 (384)
T ss_dssp SSCCSCCGGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSC
T ss_pred ccccccccccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCc
Confidence 133344555555555555553332345556666666665553 3333344455555555553
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.71 E-value=1.4e-08 Score=94.56 Aligned_cols=120 Identities=13% Similarity=0.218 Sum_probs=87.9
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCcccccc---------------------CCCCCCCCCCEEeCCC
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNF---------------------MNFSSNHKLKDIDLSG 78 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~---------------------~~~~~~~~l~~l~l~~ 78 (582)
...+..+++++|.++ .++ .+..+++|+.+++++|...+.. ..+.++.+|+.|++++
T Consensus 84 l~~l~~l~~~~n~~~-~i~--~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~ 160 (227)
T d1h6ua2 84 LTKITELELSGNPLK-NVS--AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGN 160 (227)
T ss_dssp CCSCCEEECCSCCCS-CCG--GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCS
T ss_pred ccccccccccccccc-ccc--cccccccccccccccccccccchhccccchhhhhchhhhhchhhhhccccccccccccc
Confidence 345677777777766 343 3667777777777777766542 1234557899999999
Q ss_pred CcccccccccccCCCcCCeeecccCcccCCCCC-CCCCCCCEEEeecCcccccCCCCCccccccccccc
Q 047954 79 NKFYGEISRSLLSLKFLESLQLQNNNLTGPVPE-FNQSSLKVFNVSNNNLSGSIPKTQTLQLFRSYSYS 146 (582)
Q Consensus 79 N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~-~~~~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~ 146 (582)
|.+++..+ ++++++|+.|+|++|++++ +|. ..+++|+.|+|++|++++ +|....+..+..++++
T Consensus 161 n~~~~~~~--l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~-i~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 161 AQVSDLTP--LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLT 225 (227)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCCB-CGGGTTCTTCCEEEEE
T ss_pred cccccchh--hcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCCC-CcccccCCCCCEEEee
Confidence 99986544 8899999999999999996 554 478999999999999985 5544455666655553
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.60 E-value=3.2e-10 Score=103.71 Aligned_cols=109 Identities=17% Similarity=0.267 Sum_probs=88.0
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCC-CCCCCCEEeCCCCcccccccccccCCCcCCee
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFS-SNHKLKDIDLSGNKFYGEISRSLLSLKFLESL 98 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~-~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l 98 (582)
..+++.|+|++|+++ .|+ .+..|++|+.|+|++|.++ .+|.+. .+.+|+.|+|++|+++. ++ .+.++++|+.|
T Consensus 47 L~~L~~L~Ls~n~I~-~i~--~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L 120 (198)
T d1m9la_ 47 LKACKHLALSTNNIE-KIS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVL 120 (198)
T ss_dssp TTTCCEEECSEEEES-CCC--CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEE
T ss_pred ccccceeECcccCCC-Ccc--cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-ccccccccccc
Confidence 356889999999998 564 3889999999999999987 455443 34679999999999985 44 48899999999
Q ss_pred ecccCcccCC--CCC-CCCCCCCEEEeecCcccccCCCC
Q 047954 99 QLQNNNLTGP--VPE-FNQSSLKVFNVSNNNLSGSIPKT 134 (582)
Q Consensus 99 ~l~~N~l~g~--ip~-~~~~~l~~l~ls~N~l~g~ip~~ 134 (582)
+|++|+++.. +.. ..+++|+.|+|++|.+....+..
T Consensus 121 ~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 159 (198)
T d1m9la_ 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159 (198)
T ss_dssp EESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTT
T ss_pred ccccchhccccccccccCCCccceeecCCCccccCcccc
Confidence 9999999852 222 37899999999999998765543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=6.6e-08 Score=90.66 Aligned_cols=97 Identities=19% Similarity=0.218 Sum_probs=49.9
Q ss_pred CCcceeeeCCCC---------CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC--CCCCCCCCCEEeCC
Q 047954 9 SQWYGIQCDINS---------AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM--NFSSNHKLKDIDLS 77 (582)
Q Consensus 9 ~~w~gv~c~~~~---------~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~--~~~~~~~l~~l~l~ 77 (582)
|++..|.|.... ..++.|+|++|+++ .||+..|..+++|++|+|++|.+...++ .|.++..++.|++.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 456677774210 13455555555554 3444445555555555555555555443 23445555555543
Q ss_pred -CCcccccccccccCCCcCCeeecccCccc
Q 047954 78 -GNKFYGEISRSLLSLKFLESLQLQNNNLT 106 (582)
Q Consensus 78 -~N~l~g~ip~~~~~l~~l~~l~l~~N~l~ 106 (582)
.|++....|..+.++++|+.|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred ccccccccccccccccccccccccchhhhc
Confidence 34455444555555555555555555554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.36 E-value=8.5e-07 Score=87.24 Aligned_cols=98 Identities=27% Similarity=0.381 Sum_probs=78.6
Q ss_pred eEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecc
Q 047954 22 HVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQ 101 (582)
Q Consensus 22 ~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~ 101 (582)
+++.|+|++++|+ .||. .+++|++|+|++|+|+ .+|.. ..+|+.|++++|+++ .|+. + .+.|++|+|+
T Consensus 39 ~l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~-~lp~~--~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPE----LPPHLESLVASCNSLT-ELPEL--PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCS-SCCCC--CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCC----CCCCCCEEECCCCCCc-ccccc--hhhhhhhhhhhcccc-hhhh-h--cccccccccc
Confidence 4779999999997 5874 3578999999999998 67754 357999999999987 4442 1 1469999999
Q ss_pred cCcccCCCCCC-CCCCCCEEEeecCcccccCC
Q 047954 102 NNNLTGPVPEF-NQSSLKVFNVSNNNLSGSIP 132 (582)
Q Consensus 102 ~N~l~g~ip~~-~~~~l~~l~ls~N~l~g~ip 132 (582)
+|.++ .+|.. .++.|+.|++++|.+.+..+
T Consensus 107 ~n~l~-~lp~~~~l~~L~~L~l~~~~~~~~~~ 137 (353)
T d1jl5a_ 107 NNQLE-KLPELQNSSFLKIIDVDNNSLKKLPD 137 (353)
T ss_dssp SSCCS-SCCCCTTCTTCCEEECCSSCCSCCCC
T ss_pred ccccc-cccchhhhccceeecccccccccccc
Confidence 99998 56764 78999999999999876544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.31 E-value=1.2e-06 Score=82.84 Aligned_cols=133 Identities=17% Similarity=0.101 Sum_probs=90.7
Q ss_pred ceEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEEeCCCCChHHHHhcCC
Q 047954 281 FGNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYKFAGNGNLFNRIHGGK 359 (582)
Q Consensus 281 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 359 (582)
.+.||+.... +..+++|+...........+.+|...+..+. +--+.+++.+...++..++||+++++.++.+....
T Consensus 27 ~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~-- 103 (263)
T d1j7la_ 27 PAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED-- 103 (263)
T ss_dssp SSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT--
T ss_pred CCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc--
Confidence 4689988654 4457788875433333345677877776653 33356778888888889999999999887654421
Q ss_pred CCCCCCccchHHHHHHHHHHHHHHHHHhccCCC-----------------------------------------------
Q 047954 360 SSKNRIPFRCRSRLLVARGVARALEYLHHKDKS----------------------------------------------- 392 (582)
Q Consensus 360 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------------------------------------------- 392 (582)
......++.++++.+..||+...+
T Consensus 104 ---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 104 ---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp ---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred ---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 112334566777777778764321
Q ss_pred -----CCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 393 -----RTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 393 -----~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
.....++|+|+.|.|||++++..+-|.||+.+.
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 012347899999999999987667799998764
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.30 E-value=1.1e-06 Score=81.96 Aligned_cols=101 Identities=24% Similarity=0.276 Sum_probs=83.4
Q ss_pred EEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCCCcccccccc-cccCCCcCCeeeccc
Q 047954 25 GIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSGNKFYGEISR-SLLSLKFLESLQLQN 102 (582)
Q Consensus 25 ~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~N~l~g~ip~-~~~~l~~l~~l~l~~ 102 (582)
.++.++.+|+ .||+.. .+++++|+|++|.++...+ .|.++++|++|+|++|.+...+|. .+.+++.++.|++..
T Consensus 12 ~i~c~~~~l~-~iP~~l---~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp EEEEESCSCS-SCCSCS---CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred EEEEeCCCCC-CcCCCC---CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 5777888888 887653 2578999999999987655 478999999999999999988865 578899999999875
Q ss_pred -CcccCCCCCC--CCCCCCEEEeecCcccc
Q 047954 103 -NNLTGPVPEF--NQSSLKVFNVSNNNLSG 129 (582)
Q Consensus 103 -N~l~g~ip~~--~~~~l~~l~ls~N~l~g 129 (582)
|+++...|.. .+++|+.|++++|.+..
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~ 117 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKH 117 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred cccccccccccccccccccccccchhhhcc
Confidence 6777666553 78999999999999974
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.26 E-value=1.8e-06 Score=84.88 Aligned_cols=95 Identities=24% Similarity=0.340 Sum_probs=76.8
Q ss_pred CCCcEEEccCCccccccCCCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCCCCCCCCCCEEEeecC
Q 047954 46 PELIVINFKNNIISGNFMNFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVPEFNQSSLKVFNVSNN 125 (582)
Q Consensus 46 ~~L~~l~l~~n~~~g~~~~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip~~~~~~l~~l~ls~N 125 (582)
.+|+.|||++|.++. +|++ .++|++|+|++|+|+ .||..+ .+|+.|++++|+++ .|+.. .+.|++|++++|
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~--~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l-p~~L~~L~L~~n 108 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL--PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL-PPLLEYLGVSNN 108 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC--CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC-CTTCCEEECCSS
T ss_pred cCCCEEEeCCCCCCC-CCCC--CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh-cccccccccccc
Confidence 468899999999984 7754 468999999999999 889765 46899999999987 45542 356999999999
Q ss_pred cccccCCCCCcccccccccccCCCC
Q 047954 126 NLSGSIPKTQTLQLFRSYSYSNNPY 150 (582)
Q Consensus 126 ~l~g~ip~~~~~~~~~~~~~~~n~~ 150 (582)
.++ .+|....+..+..+.+.+|..
T Consensus 109 ~l~-~lp~~~~l~~L~~L~l~~~~~ 132 (353)
T d1jl5a_ 109 QLE-KLPELQNSSFLKIIDVDNNSL 132 (353)
T ss_dssp CCS-SCCCCTTCTTCCEEECCSSCC
T ss_pred ccc-cccchhhhccceeeccccccc
Confidence 997 578776777888888877754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=1.9e-05 Score=73.81 Aligned_cols=133 Identities=15% Similarity=0.115 Sum_probs=84.8
Q ss_pred ccccCc-eEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCC--CCCccccceEEEeCCeeEEEEEeCCCCChH
Q 047954 276 LGKGIF-GNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQK--HPNLLPLLAYYFSNDEKLLVYKFAGNGNLF 352 (582)
Q Consensus 276 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 352 (582)
+..|.. +.||+....++..+++|....... ..+..|...++.+. .-.+.+++++..+.+..++||+|+++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444543 679999988888888898754432 34566777666553 333567788888888899999999876543
Q ss_pred HHHhcCCCCCCCCccchHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 047954 353 NRIHGGKSSKNRIPFRCRSRLLVARGVARALEYLHH-------------------------------------------- 388 (582)
Q Consensus 353 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-------------------------------------------- 388 (582)
+.. .. ...++.++++.|.-||+
T Consensus 95 ~~~-----------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 95 SSH-----------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp TSC-----------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred ccc-----------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 210 00 11122233333444443
Q ss_pred -------cCCCCCCCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 389 -------KDKSRTQSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 389 -------~~~~~~~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
..+......++|+|+.|.|||++++..+-|+||+.+.
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 2211123347999999999999987667899998754
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.88 E-value=7e-07 Score=91.13 Aligned_cols=109 Identities=17% Similarity=0.244 Sum_probs=81.5
Q ss_pred CeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCcccc----ccC-CCCCCCCCCEEeCCCCccccc----ccccccC
Q 047954 21 AHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISG----NFM-NFSSNHKLKDIDLSGNKFYGE----ISRSLLS 91 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g----~~~-~~~~~~~l~~l~l~~N~l~g~----ip~~~~~ 91 (582)
..|+.|+++.|++++.--.+.+..+++|+.|+|++|.++- .|+ .+..+++|+.|||++|.++.. +...+..
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 3689999999999875222345668999999999998873 223 256788999999999998632 2333332
Q ss_pred -CCcCCeeecccCcccCC----CCC--CCCCCCCEEEeecCcccc
Q 047954 92 -LKFLESLQLQNNNLTGP----VPE--FNQSSLKVFNVSNNNLSG 129 (582)
Q Consensus 92 -l~~l~~l~l~~N~l~g~----ip~--~~~~~l~~l~ls~N~l~g 129 (582)
..+|+.|+|++|+++.. ++. ..+++|+.|+|++|.++.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 35799999999999754 333 257899999999999864
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.73 E-value=5.4e-06 Score=72.17 Aligned_cols=65 Identities=25% Similarity=0.316 Sum_probs=45.0
Q ss_pred CCCCCCEEeCCCCccccc--ccccccCCCcCCeeecccCcccCCCCC---CCCCCCCEEEeecCcccccCC
Q 047954 67 SNHKLKDIDLSGNKFYGE--ISRSLLSLKFLESLQLQNNNLTGPVPE---FNQSSLKVFNVSNNNLSGSIP 132 (582)
Q Consensus 67 ~~~~l~~l~l~~N~l~g~--ip~~~~~l~~l~~l~l~~N~l~g~ip~---~~~~~l~~l~ls~N~l~g~ip 132 (582)
.+++|+.|+|++|+++.. ++..+..|++|+.|||++|.++. ++. .....|+.|++++|.+++...
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCcc
Confidence 466788888888888753 44556777888888888888773 443 134567778888888776544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.72 E-value=5.1e-06 Score=79.53 Aligned_cols=130 Identities=18% Similarity=0.182 Sum_probs=83.6
Q ss_pred CCeEEEEEeCCCcceeccCccccCCCCCCcEEEccCCccccccC-CCCCCCCCCEEeCCC-Cccccc-ccccccCCCcCC
Q 047954 20 SAHVTGIVLEDMRLNGEIKSDAFADIPELIVINFKNNIISGNFM-NFSSNHKLKDIDLSG-NKFYGE-ISRSLLSLKFLE 96 (582)
Q Consensus 20 ~~~~~~l~l~~~~l~g~ip~~~~~~l~~L~~l~l~~n~~~g~~~-~~~~~~~l~~l~l~~-N~l~g~-ip~~~~~l~~l~ 96 (582)
..++..|+|+++.+++......+..+++|++|+|+++.+++..+ .+..+++|+.|+|++ +.++.. +..-+.++++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence 34678888888887765434457778888888888888876653 456677788888887 355532 233345677777
Q ss_pred eeecccC-cccCC-C--------CC----------------------CCCCCCCEEEeecC-cccccCCC-CCccccccc
Q 047954 97 SLQLQNN-NLTGP-V--------PE----------------------FNQSSLKVFNVSNN-NLSGSIPK-TQTLQLFRS 142 (582)
Q Consensus 97 ~l~l~~N-~l~g~-i--------p~----------------------~~~~~l~~l~ls~N-~l~g~ip~-~~~~~~~~~ 142 (582)
+|+|+++ +++.. + |. ..+++|+.|++++| .+++..+. ...++.+..
T Consensus 125 ~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~ 204 (284)
T d2astb2 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 204 (284)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred ccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCE
Confidence 7777764 33311 0 11 03478999999986 46654433 244566777
Q ss_pred ccccCCC
Q 047954 143 YSYSNNP 149 (582)
Q Consensus 143 ~~~~~n~ 149 (582)
+++++..
T Consensus 205 L~L~~C~ 211 (284)
T d2astb2 205 LSLSRCY 211 (284)
T ss_dssp EECTTCT
T ss_pred EECCCCC
Confidence 7777643
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.64 E-value=1.1e-05 Score=79.46 Aligned_cols=62 Identities=24% Similarity=0.235 Sum_probs=29.0
Q ss_pred CCCCcEEEccCCccccc-----c-CCCCCCCCCCEEeCCCCccccc----ccccccCCCcCCeeecccCccc
Q 047954 45 IPELIVINFKNNIISGN-----F-MNFSSNHKLKDIDLSGNKFYGE----ISRSLLSLKFLESLQLQNNNLT 106 (582)
Q Consensus 45 l~~L~~l~l~~n~~~g~-----~-~~~~~~~~l~~l~l~~N~l~g~----ip~~~~~l~~l~~l~l~~N~l~ 106 (582)
.+.|+.|+|++|.++.. + ..+..+++|+.|+|++|.|+.. +...+..+++|++|+|++|.++
T Consensus 185 ~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred hhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence 44455555555554431 1 1233444555555555554322 3334445555555555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.61 E-value=6.1e-06 Score=81.25 Aligned_cols=109 Identities=16% Similarity=0.202 Sum_probs=81.3
Q ss_pred CeEEEEEeCCCcceec----cCccccCCCCCCcEEEccCCccccc----c-CCCCCCCCCCEEeCCCCccccccccc---
Q 047954 21 AHVTGIVLEDMRLNGE----IKSDAFADIPELIVINFKNNIISGN----F-MNFSSNHKLKDIDLSGNKFYGEISRS--- 88 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~----ip~~~~~~l~~L~~l~l~~n~~~g~----~-~~~~~~~~l~~l~l~~N~l~g~ip~~--- 88 (582)
..+..|+|++|+++.. +-...+..++.|+.|+|++|.++.. + ..+..+++|+.|+|++|.+++.-...
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 4688999999998632 1123467789999999999998754 2 24667889999999999998753333
Q ss_pred -ccC--CCcCCeeecccCcccCC----CCC---CCCCCCCEEEeecCcccc
Q 047954 89 -LLS--LKFLESLQLQNNNLTGP----VPE---FNQSSLKVFNVSNNNLSG 129 (582)
Q Consensus 89 -~~~--l~~l~~l~l~~N~l~g~----ip~---~~~~~l~~l~ls~N~l~g 129 (582)
+.. .+.|+.|||++|+++.. +.. ..+++|+.|+|++|.|..
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 333 36799999999998753 121 146789999999999964
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.54 E-value=9.6e-06 Score=82.36 Aligned_cols=109 Identities=17% Similarity=0.214 Sum_probs=64.6
Q ss_pred CeEEEEEeCCCcceeccCc----cccCCCCCCcEEEccCCccccccC----C-CCCCCCCCEEeCCCCccccc----ccc
Q 047954 21 AHVTGIVLEDMRLNGEIKS----DAFADIPELIVINFKNNIISGNFM----N-FSSNHKLKDIDLSGNKFYGE----ISR 87 (582)
Q Consensus 21 ~~~~~l~l~~~~l~g~ip~----~~~~~l~~L~~l~l~~n~~~g~~~----~-~~~~~~l~~l~l~~N~l~g~----ip~ 87 (582)
..+..+++++|.++..-.. ......+.|+.+++++|.++..-. . +..+.+|+.|+|++|++++. ++.
T Consensus 283 ~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~ 362 (460)
T d1z7xw1 283 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhh
Confidence 4566777777777532111 011234567777777777765431 1 23445677778877777643 444
Q ss_pred ccc-CCCcCCeeecccCcccCC----CCCC--CCCCCCEEEeecCcccc
Q 047954 88 SLL-SLKFLESLQLQNNNLTGP----VPEF--NQSSLKVFNVSNNNLSG 129 (582)
Q Consensus 88 ~~~-~l~~l~~l~l~~N~l~g~----ip~~--~~~~l~~l~ls~N~l~g 129 (582)
.+. ..+.|++|+|++|+|+.. |+.. .+++|++|||++|+++.
T Consensus 363 ~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred hhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 443 355677778887777642 2221 34677777887777754
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.53 E-value=2.4e-06 Score=74.49 Aligned_cols=67 Identities=30% Similarity=0.350 Sum_probs=30.1
Q ss_pred CCCCCcEEEccCCcccccc--CC-CCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccCcccCCCC
Q 047954 44 DIPELIVINFKNNIISGNF--MN-FSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNNNLTGPVP 110 (582)
Q Consensus 44 ~l~~L~~l~l~~n~~~g~~--~~-~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N~l~g~ip 110 (582)
.+++|++|+|++|+++..- +. +..+++|+.|||++|.++..-+-.......|+.|+|++|.++....
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcc
Confidence 3455555555555554321 11 2334555555555555553222122223345555555555554433
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.30 E-value=3.4e-05 Score=73.61 Aligned_cols=82 Identities=20% Similarity=0.188 Sum_probs=50.6
Q ss_pred CCCCCcEEEccCCcccccc-C-CCCCCCCCCEEeCCCCcccccccccccCCCcCCeeecccC-cccCC-CCC--CCCCCC
Q 047954 44 DIPELIVINFKNNIISGNF-M-NFSSNHKLKDIDLSGNKFYGEISRSLLSLKFLESLQLQNN-NLTGP-VPE--FNQSSL 117 (582)
Q Consensus 44 ~l~~L~~l~l~~n~~~g~~-~-~~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~l~~l~l~~N-~l~g~-ip~--~~~~~l 117 (582)
....|++|||+++.+++.. . -+..+++|++|+|+++.+++..+..++.+++|++|+|+++ +++.. +.. ..+++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 4456777777777666543 2 2455667777777777777777777777777777777764 44421 111 145667
Q ss_pred CEEEeecC
Q 047954 118 KVFNVSNN 125 (582)
Q Consensus 118 ~~l~ls~N 125 (582)
+.|+++++
T Consensus 124 ~~L~ls~c 131 (284)
T d2astb2 124 DELNLSWC 131 (284)
T ss_dssp CEEECCCC
T ss_pred cccccccc
Confidence 77777663
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.27 E-value=0.00067 Score=67.40 Aligned_cols=77 Identities=12% Similarity=0.172 Sum_probs=47.5
Q ss_pred cccccccCceEEEEEEEcC-CceEEEEEecCC-------CcchHHHHHHHHHHHhcC-CC--CCccccceEEEeCCeeEE
Q 047954 273 AEGLGKGIFGNSYKALLEG-RAPVVVKRLRDL-------KPLITEEFRKQLLVIADQ-KH--PNLLPLLAYYFSNDEKLL 341 (582)
Q Consensus 273 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l-~H--~niv~l~~~~~~~~~~~l 341 (582)
.+.||.|....||++...+ ++.++||.-... -+...+....|.+.|..+ .+ ..+.+++. .+.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence 3568999999999998654 567888865321 111223455677777654 22 33445554 35666789
Q ss_pred EEEeCCCCCh
Q 047954 342 VYKFAGNGNL 351 (582)
Q Consensus 342 v~e~~~~gsL 351 (582)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.90 E-value=0.0032 Score=60.58 Aligned_cols=141 Identities=13% Similarity=0.143 Sum_probs=79.1
Q ss_pred eEEEEEEEcCCceEEEEEecCCCcchHHHHHHHHHHHhcCCCCCc-----ccc--ceEEEeCCeeEEEEEeCCCCChH--
Q 047954 282 GNSYKALLEGRAPVVVKRLRDLKPLITEEFRKQLLVIADQKHPNL-----LPL--LAYYFSNDEKLLVYKFAGNGNLF-- 352 (582)
Q Consensus 282 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-----v~l--~~~~~~~~~~~lv~e~~~~gsL~-- 352 (582)
-.||++..++|..+++|..+... ...+++..|...+..|....+ +.. -..+...+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999999999999999986542 245667788887776632211 111 12234456678999999763321
Q ss_pred ---H---------HHhc---CCCCCCCCccchH-------------------HHHHHHHHHHHHHHHHhccCCCCCCCcc
Q 047954 353 ---N---------RIHG---GKSSKNRIPFRCR-------------------SRLLVARGVARALEYLHHKDKSRTQSAV 398 (582)
Q Consensus 353 ---~---------~l~~---~~~~~~~~~l~~~-------------------~~~~i~~~ia~gL~yLH~~~~~~~~~~i 398 (582)
. .+|. ......+..+++. .+..+...+.+.++.+...........+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 1111 0111111111111 1112222233344444433222223468
Q ss_pred eecCCCCCCeeecCCCceEEeeccccc
Q 047954 399 IHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 399 vH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
||+|+.+.|||++++ ..+.||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999754 4588999764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.79 E-value=0.00021 Score=62.06 Aligned_cols=106 Identities=16% Similarity=0.212 Sum_probs=59.0
Q ss_pred CCeEEEEEeCCC-cceec----cCccccCCCCCCcEEEccCCcccccc-C----CCCCCCCCCEEeCCCCccccc----c
Q 047954 20 SAHVTGIVLEDM-RLNGE----IKSDAFADIPELIVINFKNNIISGNF-M----NFSSNHKLKDIDLSGNKFYGE----I 85 (582)
Q Consensus 20 ~~~~~~l~l~~~-~l~g~----ip~~~~~~l~~L~~l~l~~n~~~g~~-~----~~~~~~~l~~l~l~~N~l~g~----i 85 (582)
.+.++.|+|+++ .++.. + ...+...+.|+.|+|++|.++..- . .+..++.|+.|+|++|.++.. +
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l-~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSL-IEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHH-HHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHH-HHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 456777777764 34321 1 112455667777777777776432 1 133456677777777777643 2
Q ss_pred cccccCCCcCCeeecccCcccCCCC--------CC--CCCCCCEEEeecCcc
Q 047954 86 SRSLLSLKFLESLQLQNNNLTGPVP--------EF--NQSSLKVFNVSNNNL 127 (582)
Q Consensus 86 p~~~~~l~~l~~l~l~~N~l~g~ip--------~~--~~~~l~~l~ls~N~l 127 (582)
-..+...++|+.|+|++|.+.. +- .. ..++|+.|+++++..
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~-~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSV-LGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCC-CCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCcCCEEECCCCcCCC-ccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 2234555667777777775442 11 00 235666777665543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.68 E-value=0.0003 Score=60.97 Aligned_cols=87 Identities=17% Similarity=0.184 Sum_probs=62.6
Q ss_pred cCCCCCCcEEEccCC-cccccc-----CCCCCCCCCCEEeCCCCccccc----ccccccCCCcCCeeecccCcccCCCCC
Q 047954 42 FADIPELIVINFKNN-IISGNF-----MNFSSNHKLKDIDLSGNKFYGE----ISRSLLSLKFLESLQLQNNNLTGPVPE 111 (582)
Q Consensus 42 ~~~l~~L~~l~l~~n-~~~g~~-----~~~~~~~~l~~l~l~~N~l~g~----ip~~~~~l~~l~~l~l~~N~l~g~ip~ 111 (582)
..+.+.|+.|+|+++ .++..- ..+..++.|+.|+|++|.++.. +-..+...+.|+.|+|++|.++..=-.
T Consensus 11 ~~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~ 90 (167)
T d1pgva_ 11 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 90 (167)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH
Confidence 346789999999974 565432 2356678899999999999743 223455678899999999998753111
Q ss_pred ------CCCCCCCEEEeecCccc
Q 047954 112 ------FNQSSLKVFNVSNNNLS 128 (582)
Q Consensus 112 ------~~~~~l~~l~ls~N~l~ 128 (582)
...++|+.|+|++|.+.
T Consensus 91 ~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 91 RLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHHhCCcCCEEECCCCcCC
Confidence 14578999999988654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.21 E-value=0.0072 Score=59.68 Aligned_cols=72 Identities=7% Similarity=0.018 Sum_probs=45.6
Q ss_pred ccccccCceEEEEEEEcCC--------ceEEEEEecCCCcchHHHHHHHHHHHhcCC-CCCccccceEEEeCCeeEEEEE
Q 047954 274 EGLGKGIFGNSYKALLEGR--------APVVVKRLRDLKPLITEEFRKQLLVIADQK-HPNLLPLLAYYFSNDEKLLVYK 344 (582)
Q Consensus 274 ~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 344 (582)
+.|+-|-.-.+|++...++ ..|++++... .. ......+|..+++.+. +.-..++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 4577788889999986543 3455655542 22 2334567888887763 333446777663 268999
Q ss_pred eCCCCCh
Q 047954 345 FAGNGNL 351 (582)
Q Consensus 345 ~~~~gsL 351 (582)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.86 E-value=0.0031 Score=54.12 Aligned_cols=107 Identities=15% Similarity=0.171 Sum_probs=57.2
Q ss_pred CCeEEEEEeCC-Ccceec----cCccccCCCCCCcEEEccCCccccccC-----CCCCCCCCCEEeCCCCccccc----c
Q 047954 20 SAHVTGIVLED-MRLNGE----IKSDAFADIPELIVINFKNNIISGNFM-----NFSSNHKLKDIDLSGNKFYGE----I 85 (582)
Q Consensus 20 ~~~~~~l~l~~-~~l~g~----ip~~~~~~l~~L~~l~l~~n~~~g~~~-----~~~~~~~l~~l~l~~N~l~g~----i 85 (582)
.+.++.|+|++ ++++-. + ...+...+.|+.|+|++|.++..-. .+..+.+|+.|++++|.++.. +
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l-~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKAC-AEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHH-HHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHH-HHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 45677777776 344321 1 1124456777777777777655421 133456677777777776543 2
Q ss_pred cccccCCCcCCee--ecccCcccCC----CCC--CCCCCCCEEEeecCcc
Q 047954 86 SRSLLSLKFLESL--QLQNNNLTGP----VPE--FNQSSLKVFNVSNNNL 127 (582)
Q Consensus 86 p~~~~~l~~l~~l--~l~~N~l~g~----ip~--~~~~~l~~l~ls~N~l 127 (582)
-..+...++|+.+ ++++|.+... |-. ...+.|+.|+++.|..
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 2345556666653 3345555321 111 1345666777666554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.86 E-value=0.2 Score=46.93 Aligned_cols=31 Identities=26% Similarity=0.459 Sum_probs=26.9
Q ss_pred CCcceecCCCCCCeeecCCCceEEeeccccc
Q 047954 395 QSAVIHGNLKSTNILLDDNEMVLVSDYGFSS 425 (582)
Q Consensus 395 ~~~ivH~Dlkp~NILl~~~~~~kl~DfG~a~ 425 (582)
..++||+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4579999999999999988777899999763
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=93.02 E-value=0.015 Score=49.57 Aligned_cols=86 Identities=20% Similarity=0.238 Sum_probs=56.9
Q ss_pred cCCCCCCcEEEccC-Ccccccc-----CCCCCCCCCCEEeCCCCccccccc----ccccCCCcCCeeecccCcccCCCCC
Q 047954 42 FADIPELIVINFKN-NIISGNF-----MNFSSNHKLKDIDLSGNKFYGEIS----RSLLSLKFLESLQLQNNNLTGPVPE 111 (582)
Q Consensus 42 ~~~l~~L~~l~l~~-n~~~g~~-----~~~~~~~~l~~l~l~~N~l~g~ip----~~~~~l~~l~~l~l~~N~l~g~ip~ 111 (582)
..+.+.|+.|+|++ |.++... -.+..+++|+.|+|++|.++..-- ..+...+.|+.|++++|.++..--.
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 34678999999987 5565432 124567889999999998875432 3445678899999999888643211
Q ss_pred ------CCCCCCCEEEe--ecCcc
Q 047954 112 ------FNQSSLKVFNV--SNNNL 127 (582)
Q Consensus 112 ------~~~~~l~~l~l--s~N~l 127 (582)
...++|+.++| ++|.+
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i 116 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPL 116 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCC
T ss_pred HHHHHHHhCccccEEeeccCCCcC
Confidence 14466776554 45555
|